PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Black, R; Bennett, SRG; Thomas, SM; Beddington, JR				Black, Richard; Bennett, Stephen R. G.; Thomas, Sandy M.; Beddington, John R.			Migration as adaptation	NATURE			English	Editorial Material									[Black, Richard] Univ Sussex, Sch Global Studies, Brighton BN1 9SJ, E Sussex, England; [Bennett, Stephen R. G.] Govt Off Sci, Foresight Programme, London SW1H 0ET, England	University of Sussex	Black, R (corresponding author), Univ Sussex, Sch Global Studies, Brighton BN1 9SJ, E Sussex, England.	foresightweb@bis.gsi.gov.uk		Black, Richard/0000-0003-4276-2057				Cutter S., 2011, KATRINA EXODUS INTER; FINDLEY SE, 1994, INT MIGR REV, V28, P539, DOI 10.2307/2546820; Foresight, 2011, MIGR GLOB ENV CHANG; Gray CL, 2011, GLOBAL ENVIRON CHANG, V21, P421, DOI 10.1016/j.gloenvcha.2011.02.004; Kolmannskog V., 2009, 180 UNHCR; McGregor J., 2011, CONFLICT MIGRATION E; Penning-Rowsell E., 2011, POPULATION MOVEMENT; Ratha D, 2011, LEVERAGING MIGRATION FOR AFRICA: REMITTANCES, SKILLS, AND INVESTMENTS, P1, DOI 10.1596/978-0-8213-8257-8; UNDP, 2009, OV BARR HUM MOB DEV; World Bank, 2010, WORLD DEV REP 2010 P	10	461	469	4	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					447	449		10.1038/478477a	http://dx.doi.org/10.1038/478477a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	837JI	22012304	Bronze			2022-12-24	WOS:000296194200014
J	Senthinathan, A; Kelly, V; Dzingina, M; Jones, D; Baker, M; Longson, D				Senthinathan, A.; Kelly, V.; Dzingina, M.; Jones, D.; Baker, M.; Longson, D.		Guideline Dev Grp	GUIDELINES Hyperglycaemia in acute coronary syndromes: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Longson, D.] Natl Inst Hlth & Clin Excellence, Guideline Dev Grp, Manchester M1 4BD, Lancs, England	National Institute for Health & Care Excellence	Longson, D (corresponding author), Manchester Mental Hlth & Social Care Trust, Dept Psychiat, Manchester M8 5RB, Lancs, England.	damien.longson@manchester.ac.uk	Dzingina, Mendwas/C-4957-2014					Bartnik M, 2004, EUR HEART J, V25, P1880, DOI 10.1016/j.ehj.2004.07.027; *NAT I HLTH CLIN E, 2007, MI SEC PREV CLIN GUI; *NAT I HLTH CLIN E, 2006, OB CLIN GUID 43; *NAT I HLTH CLIN E, 2010, UNST ANG NSTEMI CLIN; *NAT I HLTH CLIN E, 2008, SMOK CESS SERV PUBL; National Institute for Health and Clinical Excellence, 2011, HYP AC COR SYNDR MAN; National Institute for Health and Clinical Excellence, 2006, BRIEF INT REF SMOK C; National Institute for Health & Clinical Excellence, 2006, 4 COMM US METH INCR; Ryden L, 2007, EUR HEART J SUPPL, V9, pC3, DOI 10.1093/eurheartj/ehl261; Stranders I, 2004, ARCH INTERN MED, V164, P982, DOI 10.1001/archinte.164.9.982; Weston C, 2007, HEART, V93, P1542, DOI 10.1136/hrt.2006.108696	11	21	23	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6646	10.1136/bmj.d6646	http://dx.doi.org/10.1136/bmj.d6646			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840CY	22031910				2022-12-24	WOS:000296417100001
J	Rochefort, C; Arabo, A; Andre, M; Poucet, B; Save, E; Rondi-Reig, L				Rochefort, Christelle; Arabo, Arnaud; Andre, Marion; Poucet, Bruno; Save, Etienne; Rondi-Reig, Laure			Cerebellum Shapes Hippocampal Spatial Code	SCIENCE			English	Article							BILATERAL VESTIBULAR DEAFFERENTATION; ENTORHINAL CORTEX; PURKINJE-CELLS; PLACE CELLS; INTEGRATION; ADAPTATION; BEHAVIOR; INPUT; TASK; MICE	Spatial representation is an active process that requires complex multimodal integration from a large interacting network of cortical and subcortical structures. We sought to determine the role of cerebellar protein kinase C (PKC)-dependent plasticity in spatial navigation by recording the activity of hippocampal place cells in transgenic L7PKCI mice with selective disruption of PKC-dependent plasticity at parallel fiber-Purkinje cell synapses. Place cell properties were exclusively impaired when L7PKCI mice had to rely on self-motion cues. The behavioral consequence of such a deficit is evidenced here by selectively impaired navigation capabilities during a path integration task. Together, these results suggest that cerebellar PKC-dependent mechanisms are involved in processing self-motion signals essential to the shaping of hippocampal spatial representation.	[Rochefort, Christelle; Arabo, Arnaud; Rondi-Reig, Laure] Univ Paris 06, CNRS, Navigat Memory & Aging ENMVI Team, Neurobiol Proc Adaptatifs UMR 7102, F-75005 Paris, France; [Andre, Marion; Poucet, Bruno; Save, Etienne] Aix Marseille Univ, CNRS, Lab Neurobiol & Cognit, UMR 6155, F-13331 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Rondi-Reig, L (corresponding author), Univ Paris 06, CNRS, Navigat Memory & Aging ENMVI Team, Neurobiol Proc Adaptatifs UMR 7102, F-75005 Paris, France.	laure.rondi@snv.jussieu.fr	Rondi-Reig, Laure/M-6141-2016; Poucet, Bruno/B-4019-2010; Rondi-Reig, Laure/G-2816-2011	Poucet, Bruno/0000-0003-2704-804X; rochefort, christelle/0000-0001-8466-5218; Rondi-Reig, Laure/0000-0003-1006-0501	Agence Nationale de la Recherche (ANR) [07-JCJC-0108-01, ANR-09-EMER-005-02]; Action Concertee Incitative (ACI) [NIC0027]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Action Concertee Incitative (ACI)	We thank C. De Zeeuw for providing L7PKCI mice; S. Quet and F. Jarlier for technical supports; C. Lamouroux for animal care; G. Dallerac and K. Benchenane for helpful comments on the manuscript and programming; and C. Lena for scientific insights. Supported by grants from Agence Nationale de la Recherche (ANR Young Researcher 07-JCJC-0108-01 and ANR-09-EMER-005-02) (L.R.R.) and by Action Concertee Incitative (ACI) grant NIC0027 (B.P. and E.S.).	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Angelaki DE, 2010, CEREBELLUM, V9, P174, DOI 10.1007/s12311-009-0147-z; Bell CC, 2008, ANNU REV NEUROSCI, V31, P1, DOI 10.1146/annurev.neuro.30.051606.094225; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Brooks JX, 2009, J NEUROSCI, V29, P10499, DOI 10.1523/JNEUROSCI.1937-09.2009; Burguiere E, 2005, NAT NEUROSCI, V8, P1292, DOI 10.1038/nn1532; Burguiere E, 2010, J NEUROSCI, V30, P13265, DOI 10.1523/JNEUROSCI.2190-10.2010; Clower DM, 2001, J NEUROSCI, V21, P6283, DOI 10.1523/JNEUROSCI.21-16-06283.2001; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Eichenbaum H, 2000, CURR BIOL, V10, pR785, DOI 10.1016/S0960-9822(00)00763-6; Giannetti S, 2002, BRAIN RES BULL, V58, P481, DOI 10.1016/S0361-9230(02)00815-8; Goddard M, 2008, BEHAV NEUROSCI, V122, P448, DOI 10.1037/0735-7044.122.2.448; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Jeffery KJ, 2007, HIPPOCAMPUS, V17, P775, DOI 10.1002/hipo.20322; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Pasalar S, 2006, NAT NEUROSCI, V9, P1404, DOI 10.1038/nn1783; Rondi-Reig L, 2001, NEUROSCIENCE, V104, P207, DOI 10.1016/S0306-4522(01)00050-1; Rotenberg A, 1997, PHILOS T R SOC B, V352, P1505, DOI 10.1098/rstb.1997.0137; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Stackman RW, 2002, HIPPOCAMPUS, V12, P291, DOI 10.1002/hipo.1112; Wikgren J, 2010, NEUROSCIENCE, V165, P1538, DOI 10.1016/j.neuroscience.2009.11.044; Yakusheva TA, 2007, NEURON, V54, P973, DOI 10.1016/j.neuron.2007.06.003; Zheng YW, 2009, HIPPOCAMPUS, V19, P480, DOI 10.1002/hipo.20533	28	121	124	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					385	389		10.1126/science.1207403	http://dx.doi.org/10.1126/science.1207403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021859				2022-12-24	WOS:000296052500055
J	Frei, P; Poulsen, AH; Johansen, C; Olsen, JH; Steding-Jessen, M; Schuz, J				Frei, Patrizia; Poulsen, Aslak H.; Johansen, Christoffer; Olsen, Jorgen H.; Steding-Jessen, Marianne; Schuez, Joachim			Use of mobile phones and risk of brain tumours: update of Danish cohort study	BRITISH MEDICAL JOURNAL			English	Article							CELLULAR-TELEPHONE USE; NATIONWIDE COHORT; INCIDENCE TRENDS; TIME TRENDS; CANCER-RISK; DENMARK	Objective To investigate the risk of tumours in the central nervous system among Danish mobile phone subscribers. Design Nationwide cohort study. Setting Denmark. Participants All Danes aged >= 30 and born in Denmark after 1925, subdivided into subscribers and non-subscribers of mobile phones before 1995. Main outcome measures Risk of tumours of the central nervous system, identified from the complete Danish Cancer Register. Sex specific incidence rate ratios estimated with log linear Poisson regression models adjusted for age, calendar period, education, and disposable income. Results 358 403 subscription holders accrued 3.8 million person years. In the follow-up period 1990-2007, there were 10 729 cases of tumours of the central nervous system. The risk of such tumours was close to unity for both men and women. When restricted to individuals with the longest mobile phone use-that is, >= 13 years of subscription-the incidence rate ratio was 1.03 (95% confidence interval 0.83 to 1.27) in men and 0.91 (0.41 to 2.04) in women. Among those with subscriptions of >= 10 years, ratios were 1.04 (0.85 to 1.26) in men and 1.04 (0.56 to 1.95) in women for glioma and 0.90 (0.57 to 1.42) in men and 0.93 (0.46 to 1.87) in women for meningioma. There was no indication of dose-response relation either by years since first subscription for a mobile phone or by anatomical location of the tumour-that is, in regions of the brain closest to where the handset is usually held to the head. Conclusions In this update of a large nationwide cohort study of mobile phone use, there were no increased risks of tumours of the central nervous system, providing little evidence for a causal association.	[Frei, Patrizia; Poulsen, Aslak H.; Johansen, Christoffer; Olsen, Jorgen H.; Steding-Jessen, Marianne] Danish Canc Soc, Inst Canc Epidemiol, DK-2100 Copenhagen, Denmark; [Schuez, Joachim] Int Agcy Res Canc, Sect Environm & Radiat, F-69372 Lyon 08, France	Danish Cancer Society; World Health Organization; International Agency for Research on Cancer (IARC)	Frei, P (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57, CH-4002 Basel, Switzerland.	frei@cancer.dk	Johansen, Christoffer/AAG-7916-2020	Johansen, Christoffer/0000-0002-4384-206X; Olsen, Jorgen Helge/0000-0001-9633-5662	Danish Strategic Research Council [09-059984, 09-059045]; Swiss National Science Foundation; Danish Graduate School in Public Health Science	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Danish Graduate School in Public Health Science	This study was funded by the Danish Strategic Research Council (grant No 09-059984, 09-059045) to cover costs for data linkage. PF received a fellowship for prospective researchers by the Swiss National Science Foundation for this project. AHP was supported by a stipend for PhD students from the Danish Graduate School in Public Health Science. All other authors contributed to this work based on their respective core budget positions.	Ahlbom A, 2009, EPIDEMIOLOGY, V20, P639, DOI 10.1097/EDE.0b013e3181b0927d; Cardis E, 2008, PHYS MED BIOL, V53, P2771, DOI 10.1088/0031-9155/53/11/001; Cardis E, 2010, INT J EPIDEMIOL, V39, P675, DOI 10.1093/ije/dyq079; Dalton SO, 2008, EUR J CANCER, V44, P1938, DOI [10.1016/j.ejca.2008.06.010, 10.1016/j.ejca.2008.06.034]; Deltour I, 2009, J NATL CANCER I, V101, P1721, DOI 10.1093/jnci/djp415; Hardell L, 2010, NEUROEPIDEMIOLOGY, V35, P109, DOI 10.1159/000311044; Inskip PD, 2001, NEW ENGL J MED, V344, P79, DOI 10.1056/NEJM200101113440201; Inskip PD, 2010, NEURO-ONCOLOGY, V12, P1147, DOI 10.1093/neuonc/noq077; *ITU, 2010, KEY GLOB TEL IND WOR; Johansen C, 2001, JNCI-J NATL CANCER I, V93, P203, DOI 10.1093/jnci/93.3.203; Kuhn S, 2009, PHYS MED BIOL, V54, P5493, DOI 10.1088/0031-9155/54/18/010; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; *NAT BOARD HLTH, 2006, CANC INC DENM 2001 H; *NAT IT TEL AG, 2001, TEL YB; Neubauer G, 2010, BIOELECTROMAGNETICS, V31, P535, DOI 10.1002/bem.20587; Olsen JH, 2005, BRIT J CANCER, V92, P201, DOI 10.1038/sj.bjc.6602279; Roosli M, 2007, EUR J CANCER PREV, V16, P77, DOI 10.1097/01.cej.0000203618.61936.cd; Schuz J, 2011, AM J EPIDEMIOL, V174, P416, DOI 10.1093/aje/kwr112; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2006, JNCI-J NATL CANCER I, V98, P1707, DOI 10.1093/jnci/djj464; Schuz J, 2007, BIOELECTROMAGNETICS, V28, P130, DOI 10.1002/bem.20297; *SCI COMM EM NEWL, 2009, HLTH EFF EXP EMF; Storm HH, 1997, DAN MED BULL, V44, P535; Vrijheid M, 2006, J EXPO SCI ENV EPID, V16, P371, DOI 10.1038/sj.jes.7500509; Vrijheid M, 2009, J EXPO SCI ENV EPID, V19, P369, DOI 10.1038/jes.2008.27; World Health Organization, 1976, INT CLASS DIS ONC IC	26	95	99	2	40	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 20	2011	343								d6387	10.1136/bmj.d6387	http://dx.doi.org/10.1136/bmj.d6387			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HQ	22016439	hybrid, Green Published			2022-12-24	WOS:000296184000001
J	Kuehn, BM				Kuehn, Bridget M.			New Model System Offers Clues to ALS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1534	1534		10.1001/jama.2011.1439	http://dx.doi.org/10.1001/jama.2011.1439			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990293				2022-12-24	WOS:000295714700004
J	Sun, B; Johnson, DS; Patel, G; Smith, BY; Pandey, M; Patel, SS; Wang, MD				Sun, Bo; Johnson, Daniel S.; Patel, Gayatri; Smith, Benjamin Y.; Pandey, Manjula; Patel, Smita S.; Wang, Michelle D.			ATP-induced helicase slippage reveals highly coordinated subunits	NATURE			English	Article							T7 DNA HELICASE; HEXAMERIC HELICASES; BACTERIOPHAGE T7; FORCE GENERATION; SINGLE-MOLECULE; PACKAGING MOTOR; GENE-4 PROTEIN; MECHANISM; TRANSLOCATION; RECOGNITION	Helicases are vital enzymes that carry out strand separation of duplex nucleic acids during replication, repair and recombination(1,2). Bacteriophage T7 gene product 4 is a model hexameric helicase that has been observed to use dTTP, but not ATP, to unwind double-stranded (ds)DNA as it translocates from 5' to 3' along single-stranded (ss)DNA(2-6). Whether and how different subunits of the helicase coordinate their chemo-mechanical activities and DNA binding during translocation is still under debate(1,7). Here we address this question using a single-molecule approach to monitor helicase unwinding. We found that T7 helicase does in fact unwind dsDNA in the presence of ATP and that the unwinding rate is even faster than that with dTTP. However, unwinding traces showed a remarkable sawtooth pattern where processive unwinding was repeatedly interrupted by sudden slippage events, ultimately preventing unwinding over a substantial distance. This behaviour was not observed with dTTP alone and was greatly reduced when ATP solution was supplemented with a small amount of dTTP. These findings presented an opportunity to use nucleotide mixtures to investigate helicase subunit coordination. We found that T7 helicase binds and hydrolyses ATP and dTTP by competitive kinetics such that the unwinding rate is dictated simply by their respective maximum rates V(max), Michaelis constants K(M) and concentrations. In contrast, processivity does not follow a simple competitive behaviour and shows a cooperative dependence on nucleotide concentrations. This does not agree with an uncoordinated mechanism where each subunit functions independently, but supports a model where nearly all subunits coordinate their chemo-mechanical activities and DNA binding. Our data indicate that only one subunit at a time can accept a nucleotide while other subunits are nucleotide-ligated and thus they interact with the DNA to ensure processivity. Such subunit coordination may be general to many ring-shaped helicases and reveals a potential mechanism for regulation of DNA unwinding during replication.	[Sun, Bo; Johnson, Daniel S.; Smith, Benjamin Y.; Wang, Michelle D.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Sun, Bo; Johnson, Daniel S.; Smith, Benjamin Y.; Wang, Michelle D.] Cornell Univ, Howard Hughes Med Inst, Ithaca, NY 14853 USA; [Patel, Gayatri; Pandey, Manjula; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Cornell University; Cornell University; Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wang, MD (corresponding author), Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.	patelss@umdnj.edu; mwang@physics.cornell.edu		Sun, Bo/0000-0002-4590-7795; Johnson, Daniel/0000-0001-8906-0509	National Institutes of Health [GM059849, GM55310]; National Science Foundation [MCB-0820293]; Cornell's Molecular Biophysics Training Grant [T32GM008267]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R01GM059849, T32GM008267] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Cornell's Molecular Biophysics Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Wang laboratory for critical reading of the manuscript. We also thank M. A. Hall for assistance with single-molecule assays, data acquisition and data analysis. We wish to acknowledge support from National Institutes of Health grants (GM059849 to M. D. W.; GM55310 to S. S. P.), National Science Foundation grant (MCB-0820293 to M. D. W.) and Cornell's Molecular Biophysics Training Grant (T32GM008267) Traineeship (to D.S.J. and B.Y.S.).	Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Donmez I, 2006, NUCLEIC ACIDS RES, V34, P4216, DOI 10.1093/nar/gkl508; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; HINGORANI MM, 1993, BIOCHEMISTRY-US, V32, P12478, DOI 10.1021/bi00097a028; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Koch SJ, 2002, BIOPHYS J, V83, P1098, DOI 10.1016/S0006-3495(02)75233-8; Lee SJ, 2010, J BIOL CHEM, V285, P31462, DOI 10.1074/jbc.M110.156067; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; PATEL SS, 1992, J BIOL CHEM, V267, P15013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Peterman EJG, 2003, BIOPHYS J, V84, P1308, DOI 10.1016/S0006-3495(03)74946-7; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Sun B, 2008, EMBO J, V27, P3279, DOI 10.1038/emboj.2008.240; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Tsay JM, 2009, P NATL ACAD SCI USA, V106, P14355, DOI 10.1073/pnas.0904364106; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740	28	77	78	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					132	U148		10.1038/nature10409	http://dx.doi.org/10.1038/nature10409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21927003	Green Accepted			2022-12-24	WOS:000295575400049
J	Welp, LR; Keeling, RF; Meijer, HAJ; Bollenbacher, AF; Piper, SC; Yoshimura, K; Francey, RJ; Allison, CE; Wahlen, M				Welp, Lisa R.; Keeling, Ralph F.; Meijer, Harro A. J.; Bollenbacher, Alane F.; Piper, Stephen C.; Yoshimura, Kei; Francey, Roger J.; Allison, Colin E.; Wahlen, Martin			Interannual variability in the oxygen isotopes of atmospheric CO2 driven by El Nino	NATURE			English	Article							TERRESTRIAL GROSS; CARBON-DIOXIDE; DELTA-O-18; MODEL; O-18; VEGETATION; PATTERNS	The stable isotope ratios of atmospheric CO2 (O-18/O-16 and C-13/C-12) have been monitored since 1977 to improve our understanding of the global carbon cycle, because biosphere-atmosphere exchange fluxes affect the different atomic masses in a measurable way(1). Interpreting the O-18/O-16 variability has proved difficult, however, because oxygen isotopes in CO2 are influenced by both the carbon cycle and the water cycle(2). Previous attention focused on the decreasing O-18/O-16 ratio in the 1990s, observed by the global Cooperative Air Sampling Network of the US National Oceanic and Atmospheric Administration Earth System Research Laboratory. This decrease was attributed variously to a number of processes including an increase in Northern Hemisphere soil respiration(3); a global increase in C-4 crops at the expense of C-3 forests(4); and environmental conditions, such as atmospheric turbulence(5) and solar radiation(6), that affect CO2 exchange between leaves and the atmosphere. Here we present 30 years' worth of data on O-18/O-16 in CO2 from the Scripps Institution of Oceanography global flask network and show that the interannual variability is strongly related to the El Nino/Southern Oscillation. We suggest that the redistribution of moisture and rainfall in the tropics during an El Nino increases the O-18/O-16 ratio of precipitation and plant water, and that this signal is then passed on to atmospheric CO2 by biosphere-atmosphere gas exchange. We show how the decay time of the El Nino anomaly in this data set can be useful in constraining global gross primary production. Our analysis shows a rapid recovery from El Nino events, implying a shorter cycling time of CO2 with respect to the terrestrial biosphere and oceans than previously estimated. Our analysis suggests that current estimates of global gross primary production, of 120 petagrams of carbon per year(7), may be too low, and that a best guess of 150-175 petagrams of carbon per year better reflects the observed rapid cycling of CO2. Although still tentative, such a revision would present a new benchmark by which to evaluate global biospheric carbon cycling models.	[Welp, Lisa R.; Keeling, Ralph F.; Bollenbacher, Alane F.; Piper, Stephen C.; Yoshimura, Kei; Wahlen, Martin] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Meijer, Harro A. J.] Univ Groningen, Ctr Isotope Res, NL-9747 AG Groningen, Netherlands; [Francey, Roger J.; Allison, Colin E.] CSIRO Marine & Atmospher Res, Aspendale, Vic 3195, Australia	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Groningen; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Welp, LR (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lwelp@ucsd.edu; rkeeling@ucsd.edu	Meijer, Harro A J/A-5787-2012; Yoshimura, Kei/F-2041-2010; Francey, Roger J/A-2345-2012	Yoshimura, Kei/0000-0002-5761-1561; Meijer, Harro A.J./0000-0001-8744-5632; Welp, Lisa/0000-0001-7125-0478; Allison, Colin/0000-0002-7796-6917	US National Science Foundation (NSF) [ATM06-32770]; US Department of Energy (DOE) [DE-SC0005099]; US National Aeronautics and Space Administration (NASA) [NNX11AF36G]	US National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Energy (DOE)(United States Department of Energy (DOE)); US National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA))	The authors thank S. Walker for programming assistance and all those involved with flask collection and analysis. This work was supported by the US National Science Foundation (NSF) under grant ATM06-32770, by the US Department of Energy (DOE) under grant DE-SC0005099 and by the US National Aeronautics and Space Administration (NASA) under grant NNX11AF36G. Any opinions, findings and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of NSF, DOE or NASA.	Allison CE, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007345; Appenzeller C, 1996, J GEOPHYS RES-ATMOS, V101, P15071, DOI 10.1029/96JD00821; Assonov SS, 2010, ATMOS CHEM PHYS, V10, P8575, DOI 10.5194/acp-10-8575-2010; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Bollenbacher A. F, 2000, CALIBRATION METHODOL; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; Cobb KM, 2007, EARTH PLANET SC LETT, V263, P207, DOI 10.1016/j.epsl.2007.08.024; Cuntz M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003153; Curtis S, 2000, J CLIMATE, V13, P2786, DOI 10.1175/1520-0442(2000)013<2786:EIBOPO>2.0.CO;2; Dai A, 2000, GEOPHYS RES LETT, V27, P1283, DOI 10.1029/1999GL011140; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Evans MN, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001406; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Gat J. R., 2001, ENV ISOTOPES HYDROLO, VII, p[55, 56]; Gillon J, 2001, SCIENCE, V291, P2584, DOI 10.1126/science.1056374; Hoag KJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021011; Ishizawa M, 2002, TELLUS B, V54, P307, DOI 10.1034/j.1600-0889.2002.201312.x; Keeling C. D., 2001, 0106 SCRIPPS I OC; Keeling CD., 2005, HIST ATMOSPHERIC CO2, P83, DOI DOI 10.1007/0-387-27048-5_5; Lee XH, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003331; Montzka SA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007665; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Still CJ, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2007JG000675; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Thompson LG, 2000, QUATERNARY SCI REV, V19, P19, DOI 10.1016/S0277-3791(99)00052-9; Vuille M, 2005, CLIM DYNAM, V25, P401, DOI 10.1007/s00382-005-0049-9; Willett KM, 2008, J CLIMATE, V21, P5364, DOI 10.1175/2008JCLI2274.1; Wingate L, 2009, P NATL ACAD SCI USA, V106, P22411, DOI 10.1073/pnas.0905210106; Yoshimura K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010074; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	30	162	167	3	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					579	582		10.1038/nature10421	http://dx.doi.org/10.1038/nature10421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956330	Green Published, Green Submitted			2022-12-24	WOS:000295320900037
J	Bush, LM; Perez, MT				Bush, Larry M.; Perez, Maria T.			The Anthrax Attacks 10 Years Later	ANNALS OF INTERNAL MEDICINE			English	Article							OUTBREAK	Ten years ago, just weeks after the September 11 attacks, the United States experienced a deliberate act of bioterrorism. Through use of the postal service, anthrax spores were widely disseminated, including to homes, the Senate, and major newsrooms, resulting in morbidity and mortality and effectively disrupting our way of life and revealing our vulnerability. Even though such attacks had been the subject of much writing and had been planned for, detection of and the appropriate response to an attack with an agent from the so-called "Category 'A' List" had only been considered in theoretical terms. What transpired during the following difficult weeks, including how public health and federal government agencies performed, has been both praised and criticized. An intertwined epi-demiologic and criminal investigation of such magnitude was unprecedented in U.S. history. To address the question of whether we as a nation are now better prepared for future threats involving biologic agents, it is important to learn from the lessons of the 2001 anthrax attacks, including the critical role of clinicians in surveillance. As physicians involved in diagnosing anthrax in the index case and alerting authorities, we offer our perspective on these events a decade after their occurrence.	JFK Med Ctr, Atlantis, FL 33462 USA; Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA	State University System of Florida; Florida Atlantic University	Bush, LM (corresponding author), 5503 S Congress Ave,Suite 104, Atlantis, FL 33462 USA.							[Anonymous], 2002, ANTHR AM CHRON AN FA; Brachman P S, 1980, Ann N Y Acad Sci, V353, P83, DOI 10.1111/j.1749-6632.1980.tb18910.x; Broad WA, 2002, NY TIMES        0916; Bush LM, 2001, NEW ENGL J MED, V345, P1607, DOI 10.1056/NEJMoa012948; Cole L.A., 2009, ANTHRAX LETT BIOTERR; Henning Kelly J, 2004, MMWR Suppl, V53, P5; HEYMAN D, 2002, LESSONS ANTHRAX ATTA; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kolata G, 2001, NY TIMES        1005; McGlown K.J., 2011, ANTICIPATE RESPOND R; MESELSON M, 1994, SCIENCE, V266, P1202, DOI 10.1126/science.7973702; Musgrave J., 2011, PALM BEACH POST 0430; Torok TJ, 1997, JAMA-J AM MED ASSOC, V278, P389, DOI 10.1001/jama.278.5.389; Wiser M, 2011, PALM BEACH POST 0719	14	21	21	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2012	156	1	1				41	U87		10.7326/0003-4819-155-12-201112200-00373	http://dx.doi.org/10.7326/0003-4819-155-12-201112200-00373			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	872VK	21969275				2022-12-24	WOS:000298837600006
J	Loo, VG; Bourgault, AM; Poirier, L; Lamothe, F; Michaud, S; Turgeon, N; Toye, B; Beaudoin, A; Frost, EH; Gilca, R; Brassard, P; Dendukuri, N; Beliveau, C; Oughton, M; Brukner, I; Dascal, A				Loo, Vivian G.; Bourgault, Anne-Marie; Poirier, Louise; Lamothe, Francois; Michaud, Sophie; Turgeon, Nathalie; Toye, Baldwin; Beaudoin, Axelle; Frost, Eric H.; Gilca, Rodica; Brassard, Paul; Dendukuri, Nandini; Beliveau, Claire; Oughton, Matthew; Brukner, Ivan; Dascal, Andre			Host and Pathogen Factors for Clostridium difficile Infection and Colonization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TOXIN-A; ANTIBODY; RISK; STRAIN; CARRIAGE; LOCUS	Background Clostridium difficile infection is the leading cause of health care-associated diarrhea, and the bacterium can also be carried asymptomatically. The objective of this study was to identify host and bacterial factors associated with health care-associated acquisition of C. difficile infection and colonization. Methods We conducted a 15-month prospective study in six Canadian hospitals in Quebec and Ontario. Demographic information, known risk factors, potential confounding factors, and weekly stool samples or rectal swabs were collected. Pulsed-field gel electrophoresis (PFGE) was performed on C. difficile isolates to determine the genotype. Levels of serum antibodies against C. difficile toxins A and B were measured. Results A total of 4143 patients were included in the study; 117 (2.8%) and 123 (3.0%) had health care-associated C. difficile infection and colonization, respectively. Older age and use of antibiotics and proton-pump inhibitors were significantly associated with health care-associated C. difficile infection. Hospitalization in the previous 2 months; use of chemotherapy, proton-pump inhibitors, and H-2 blockers; and antibodies against toxin B were associated with health care-associated C. difficile colonization. Among patients with health care-associated C. difficile infection and those with colonization, 62.7% and 36.1%, respectively, had the North American PFGE type 1 (NAP1) strain. Conclusions In this study, health care-associated C. difficile infection and colonization were differentially associated with defined host and pathogen variables. The NAP1 strain was predominant among patients with C. difficile infection, whereas asymptomatic patients were more likely to be colonized with other strains. (Funded by the Consortium de Recherche sur le Clostridium difficile.)	[Loo, Vivian G.] McGill Univ, Ctr Hlth, Dept Microbiol, Montreal, PQ H3A 1A1, Canada; [Bourgault, Anne-Marie; Lamothe, Francois] Univ Montreal, Ctr Hosp, Montreal, PQ H3C 3J7, Canada; [Poirier, Louise; Beliveau, Claire] Univ Montreal, Hop Maison Neuve Rosemont, Montreal, PQ H3C 3J7, Canada; [Bourgault, Anne-Marie] Inst Natl Sante Publ Quebec, Montreal, PQ, Canada; [Michaud, Sophie; Beaudoin, Axelle; Frost, Eric H.] Univ Sherbrooke, Ctr Hosp Univ CHU Sherbrooke, Sherbrooke, PQ J1K 2R1, Canada; [Gilca, Rodica] Univ Laval, CHU Quebec Hotel Dieu Quebec, Quebec City, PQ, Canada; [Gilca, Rodica] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Toye, Baldwin] Univ Ottawa, Ottawa Hosp, Ottawa, ON, Canada	McGill University; Universite de Montreal; Universite de Montreal; Institut national de sante publique du Quebec (INSPQ); University of Sherbrooke; Laval University; Institut national de sante publique du Quebec (INSPQ); University of Ottawa; Ottawa Hospital Research Institute	Loo, VG (corresponding author), McGill Univ, Ctr Hlth, Dept Microbiol, 687 Pine Ave W,Rm L5-06, Montreal, PQ H3A 1A1, Canada.		Brassard, Paul/F-4079-2018; Brukner, Ivan/AAU-7504-2021; Brukner, Ivan/N-5833-2019	Brukner, Ivan/0000-0003-0225-9238; Frost, Eric/0000-0001-8958-4388	Consortium de Recherche sur le Clostridium difficile; Fonds de la Recherche en Sante du Quebec; Canadian Institutes of Health Research; Ministere de la Sante et des Services Sociaux du Quebec; Institut National de Sante Publique du Quebec; Health Canada; Centre Hospitalier de l'Universite de Montreal; McGill University Health Centre; CHU de Quebec; CHU de Sherbrooke; Merck; Pfizer Canada; Cubist Pharmaceuticals; Genome Canada	Consortium de Recherche sur le Clostridium difficile; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministere de la Sante et des Services Sociaux du Quebec; Institut National de Sante Publique du Quebec; Health Canada; Centre Hospitalier de l'Universite de Montreal; McGill University Health Centre; CHU de Quebec; CHU de Sherbrooke; Merck(Merck & Company); Pfizer Canada(Pfizer); Cubist Pharmaceuticals; Genome Canada(Genome Canada)	Supported by the Consortium de Recherche sur le Clostridium difficile; the consortium consists of the following partners: Fonds de la Recherche en Sante du Quebec, Canadian Institutes of Health Research, Ministere de la Sante et des Services Sociaux du Quebec, Institut National de Sante Publique du Quebec, Health Canada, Centre Hospitalier de l'Universite de Montreal, McGill University Health Centre, CHU de Quebec, and CHU de Sherbrooke.; Dr. Loo reports receiving consulting fees from Merck; Dr. Turgeon, receiving lecture fees from Merck; Dr. Toye, receiving lecture fees from Pfizer Canada and owning stock in Spartan Biosciences; Dr. Oughton, receiving consulting fees from Cubist Pharmaceuticals; and Dr. Dascal, receiving grant support from and owning stock in Cepheid and receiving grant support from Genome Canada. No other potential conflict of interest relevant to this article was reported.	Alfa MJ, 2000, J CLIN MICROBIOL, V38, P2706, DOI 10.1128/JCM.38.7.2706-2714.2000; Barbut F, 1996, ARCH INTERN MED, V156, P1449, DOI 10.1001/archinte.156.13.1449; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bignardi GE, 1998, J HOSP INFECT, V40, P1, DOI 10.1016/S0195-6701(98)90019-6; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CLABOTS CR, 1989, J CLIN MICROBIOL, V27, P2386, DOI 10.1128/JCM.27.10.2386-2387.1989; Cohen SH, 2000, J INFECT DIS, V181, P659, DOI 10.1086/315248; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Drudy D, 2007, INT J INFECT DIS, V11, P5, DOI 10.1016/j.ijid.2006.04.003; HAMMOND GA, 1995, MICROB PATHOGENESIS, V19, P203, DOI 10.1016/S0882-4010(95)90263-5; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; JOHNSON S, 1992, J INFECT DIS, V166, P1287, DOI 10.1093/infdis/166.6.1287; Johnson S, 1998, CLIN INFECT DIS, V26, P1027, DOI 10.1086/520276; Kim HT, 2007, CLIN CANCER RES, V13, P559, DOI 10.1158/1078-0432.CCR-06-1210; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Leav BA, 2010, VACCINE, V28, P965, DOI 10.1016/j.vaccine.2009.10.144; Letourneur O, 2003, PROTEIN EXPRES PURIF, V31, P276, DOI 10.1016/S1046-5928(03)00165-7; Loo VG, 2006, NEW ENGL J MED, V354, P2200; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Martin H, 2008, J CLIN MICROBIOL, V46, P2999, DOI 10.1128/JCM.02437-07; McDonald LC, 2005, INFECT CONT HOSP EP, V26, P672; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Merrigan MM, 2009, INT J ANTIMICROB AG, V33, pS46, DOI 10.1016/S0924-8579(09)70017-2; Miller M, 2010, CLIN INFECT DIS, V50, P194, DOI 10.1086/649213; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Tan KS, 2001, J MED MICROBIOL, V50, P613, DOI 10.1099/0022-1317-50-7-613; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994	31	584	624	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2011	365	18					1693	1703		10.1056/NEJMoa1012413	http://dx.doi.org/10.1056/NEJMoa1012413			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840FL	22047560				2022-12-24	WOS:000296424200008
J	Riquelme, CA; Magida, JA; Harrison, BC; Wall, CE; Marr, TG; Secor, SM; Leinwand, LA				Riquelme, Cecilia A.; Magida, Jason A.; Harrison, Brooke C.; Wall, Christopher E.; Marr, Thomas G.; Secor, Stephen M.; Leinwand, Leslie A.			Fatty Acids Identified in the Burmese Python Promote Beneficial Cardiac Growth	SCIENCE			English	Article							GENE-EXPRESSION; MYOCYTES; HYPERTROPHY; MOLURUS; PERFORMANCE; METABOLISM; APOPTOSIS; TISSUE; HEART; MODEL	Burmese pythons display a marked increase in heart mass after a large meal. We investigated the molecular mechanisms of this physiological heart growth with the goal of applying this knowledge to the mammalian heart. We found that heart growth in pythons is characterized by myocyte hypertrophy in the absence of cell proliferation and by activation of physiological signal transduction pathways. Despite high levels of circulating lipids, the postprandial python heart does not accumulate triglycerides or fatty acids. Instead, there is robust activation of pathways of fatty acid transport and oxidation combined with increased expression and activity of superoxide dismutase, a cardioprotective enzyme. We also identified a combination of fatty acids in python plasma that promotes physiological heart growth when injected into either pythons or mice.	[Riquelme, Cecilia A.; Magida, Jason A.; Harrison, Brooke C.; Wall, Christopher E.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Marr, Thomas G.] Hiberna Corp, Boulder, CO 80302 USA; [Secor, Stephen M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA	University of Colorado System; University of Colorado Boulder; University of Alabama System; University of Alabama Tuscaloosa	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@colorado.edu		LEINWAND, LESLIE/0000-0003-1470-4810	NIH [HL050560, 5K01AR055676]; NSF [IOS-0466139]; University of Colorado Technology Transfer Office/State of Colorado [OCG4999B]; Hiberna Corporation; American Heart Association [0725732Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050560, R37HL050560] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR055676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Colorado Technology Transfer Office/State of Colorado; Hiberna Corporation; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by NIH grant HL050560 (L. A. L.), NSF grant IOS-0466139 (S. M. S.), University of Colorado Technology Transfer Office/State of Colorado grant OCG4999B (L. A. L. and T. G. M.), Hiberna Corporation (T. G. M. and S. M. S.), American Heart Association fellowship 0725732Z (C. A. R.), and NIH grant 5K01AR055676 (B. C. H.). L. A. L., T. G. M., and B. C. H. are on the scientific advisory board of, and are shareholders in, Hiberna Corporation, a company that is developing drugs based on natural models of extreme metabolic regulation. C. A. R. is a shareholder in Hiberna Corporation. The authors (L. A. L., C. A. R., J.A.M., B. C. H.) and the University of Colorado have filed a patent relating to methods and compositions for inducing physiological cardiac hypertrophy. We thank S. Cozza and T. Gleason for their technical assistance.	Andersen JB, 2005, NATURE, V434, P37, DOI 10.1038/434037a; Astarita G, 2006, AM J PHYSIOL-REG I, V290, pR1407, DOI 10.1152/ajpregu.00664.2005; CALDERONE A, 1995, CIRCULATION, V92, P2385, DOI 10.1161/01.CIR.92.9.2385; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Coort SLM, 2002, MOL CELL BIOCHEM, V239, P213, DOI 10.1023/A:1020539932353; deVries JE, 1997, J LIPID RES, V38, P1384; Diwan A, 2008, CIRCULATION, V117, P396, DOI 10.1161/CIRCULATIONAHA.107.727073; Fagard RH, 2001, CIRCULATION, V103, pE28; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Harrison BC, 2004, MOL CELL BIOL, V24, P10636, DOI 10.1128/MCB.24.24.10636-10649.2004; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Khan RS, 2010, CURR OPIN CLIN NUTR, V13, P145, DOI 10.1097/MCO.0b013e3283357272; Konhilas JP, 2006, CIRC RES, V98, P540, DOI 10.1161/01.RES.0000205766.97556.00; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Rossi AC, 2010, J PHYSIOL-LONDON, V588, P353, DOI 10.1113/jphysiol.2009.181008; Secor SM, 1997, PHYSIOL ZOOL, V70, P202, DOI 10.1086/639578; SECOR SM, 1995, J EXP BIOL, V198, P1313; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Secor SM, 2010, J EXP BIOL, V213, P78, DOI 10.1242/jeb.034058; Secor SM, 2008, J EXP BIOL, V211, P3767, DOI 10.1242/jeb.023754; Shimizu T, 2010, GERIATR GERONTOL INT, V10, pS70, DOI 10.1111/j.1447-0594.2010.00604.x; Sparagna GC, 2001, ANTIOXID REDOX SIGN, V3, P71, DOI 10.1089/152308601750100524; van der Lee KAJM, 2000, J LIPID RES, V41, P41; Wall CE, 2011, PHYSIOL GENOMICS, V43, P69, DOI 10.1152/physiolgenomics.00162.2010	25	87	89	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					528	531		10.1126/science.1210558	http://dx.doi.org/10.1126/science.1210558			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034436	Green Accepted			2022-12-24	WOS:000296230500051
J	Rambold, AS; Lippincott-Schwartz, J				Rambold, Angelika S.; Lippincott-Schwartz, Jennifer			SevERing Mitochondria	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; FISSION		[Rambold, Angelika S.; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Rambold, AS (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA.	lippincj@mail.nih.gov			Intramural NIH HHS [ZIA HD001609-16, Z01 HD001609-14] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Braschi E, 2010, BIOESSAYS, V32, P958, DOI 10.1002/bies.201000073; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; de Brito OM, 2010, EMBO J, V29, P2715, DOI 10.1038/emboj.2010.177; English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004; Friedman J. R., 2011, SCIENCE         0901, DOI [10.1126/science.1207385, DOI 10.1126/SCIENCE.1207385]; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199; Kornmann B, 2010, J CELL SCI, V123, P1389, DOI 10.1242/jcs.058636; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lackner LL, 2009, BBA-MOL BASIS DIS, V1792, P1138, DOI 10.1016/j.bbadis.2008.11.011; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Soubannier V, 2009, BBA-MOL CELL RES, V1793, P154, DOI 10.1016/j.bbamcr.2008.07.008; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	17	6	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					186	187		10.1126/science.1214059	http://dx.doi.org/10.1126/science.1214059			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998377	Green Published, Green Accepted			2022-12-24	WOS:000295833600033
J	Turner, PJ; Kemp, AS; Campbell, DE				Turner, Paul J.; Kemp, Andrew S.; Campbell, Dianne E.			Advisory food labels: consumers with allergies need more than "traces" of information	BRITISH MEDICAL JOURNAL			English	Editorial Material							NUT ALLERGY; MANAGEMENT; ATTITUDES; INDUSTRY; CHILDREN; COOKIES; PEANUT		[Turner, Paul J.] Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England; [Turner, Paul J.; Kemp, Andrew S.; Campbell, Dianne E.] Univ Sydney, Sydney, NSW 2006, Australia; [Kemp, Andrew S.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Campbell, Dianne E.] Childrens Hosp Westmead, Sydney, NSW, Australia	University of London; University College London; University of Sydney; Murdoch Children's Research Institute; University of Sydney	Turner, PJ (corresponding author), Inst Child Hlth, Mol Immunol Unit, 30 Guilford St, London WC1N 1EH, England.	paulyt@doctors.org.uk		Turner, Paul/0000-0001-9862-5161; Campbell, Dianne/0000-0002-0907-6963	National Institute for Health Research [CL-2009-18-009] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		*ALL BUR, WHAT IS VITAL; Awazuhara H, 1998, CLIN EXP ALLERGY, V28, P1559, DOI 10.1046/j.1365-2222.1998.00431.x; Barnett J, 2011, ALLERGY, V66, P969, DOI 10.1111/j.1398-9995.2011.02563.x; Boden M, 2005, P NUTR SOC, V64, P475, DOI 10.1079/PNS2005453; Crevel RWR, 2008, ALLERGY, V63, P597, DOI 10.1111/j.1398-9995.2008.01636.x; Crotty MP, 2010, J ALLERGY CLIN IMMUN, V125, P935, DOI 10.1016/j.jaci.2009.12.003; Cummings AJ, 2010, PEDIAT ALLERG IMM-UK, V21, P586, DOI 10.1111/j.1399-3038.2009.00975.x; *FOOD STAND AG, 2007, GUID ALL MAN CONS IN; Food Standards Agency, 2002, MAY CONT LAB CONS PE; Ford LS, 2010, J ALLERGY CLIN IMMUN, V126, P384, DOI 10.1016/j.jaci.2010.05.034; *GREEN BLACKS, FREQ ASK QUEST; Hefle SL, 2007, J ALLERGY CLIN IMMUN, V120, P171, DOI 10.1016/j.jaci.2007.04.013; Imamura T, 2008, PEDIAT ALLERG IMM-UK, V19, P270, DOI 10.1111/j.1399-3038.2007.00621.x; NG IE, 2011, PEDIAT ALLERGY  0713; Noimark L, 2009, PEDIATR ALLERGY IMMU, V20, P500, DOI 10.1111/j.1399-3038.2008.00796.x; Nowak-Wegrzyn A, 2009, CURR OPIN ALLERGY CL, V9, P234, DOI 10.1097/ACI.0b013e32832b88e7; Pele M, 2007, FOOD ADDIT CONTAM A, V24, P1334, DOI 10.1080/02652030701458113; Roder M, 2010, J FOOD PROTECT, V73, P1671; Sheth SS, 2010, ANN ALLERG ASTHMA IM, V104, P60, DOI 10.1016/j.anai.2009.11.008; Ward R, 2010, TRENDS FOOD SCI TECH, V21, P619, DOI 10.1016/j.tifs.2010.09.004	20	34	34	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2011	343								d6180	10.1136/bmj.d6180	http://dx.doi.org/10.1136/bmj.d6180			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EQ	21998345				2022-12-24	WOS:000296018300002
J	Baker, M				Baker, Monya			BRIGHT LIGHT, BETTER LABELS	NATURE			English	Editorial Material							LOCALIZATION MICROSCOPY; FLUORESCENT PROTEIN; SUPERRESOLUTION; CELLS											Annibale P, 2011, NAT METHODS, V8, P527, DOI 10.1038/nmeth.1627; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Grotjohann T., 2011, NATURE; Gunewardene MS, 2011, BIOPHYS J, V101, P1522, DOI 10.1016/j.bpj.2011.07.049; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Holden SJ, 2011, NAT METHODS, V8, P279, DOI 10.1038/nmeth0411-279; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; McKinney SA, 2009, NAT METHODS, V6, P131, DOI [10.1038/NMETH.1296, 10.1038/nmeth.1296]; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sengupta P., 2011, NATURE METH; Subach FV, 2010, J AM CHEM SOC, V132, P6481, DOI 10.1021/ja100906g; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664	14	11	12	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					137	142		10.1038/478137a	http://dx.doi.org/10.1038/478137a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979054				2022-12-24	WOS:000295575400051
J	D'Esposito, M; Gazzaley, A				D'Esposito, Mark; Gazzaley, Adam			Can Age-Associated Memory Decline Be Treated?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WORKING-MEMORY		[D'Esposito, Mark] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [D'Esposito, Mark] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Gazzaley, Adam] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco	D'Esposito, M (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.							Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; KOIVISTO K, 1995, NEUROLOGY, V45, P741, DOI 10.1212/WNL.45.4.741; Wang M, 2011, NATURE, V476, P210, DOI 10.1038/nature10243	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1346	1347		10.1056/NEJMcibr1108968	http://dx.doi.org/10.1056/NEJMcibr1108968			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991958				2022-12-24	WOS:000295578700016
J	Berghmans, R; Schouten, HC				Berghmans, Ron; Schouten, Harry C.			A PATIENT'S JOURNEY Sir Karl Popper, swans, and the general practitioner	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Berghmans, Ron] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Eth & Soc, NL-6200 MD Maastricht, Netherlands; [Schouten, Harry C.] Univ Hosp Maastricht, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC)	Berghmans, R (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Eth & Soc, POB 616, NL-6200 MD Maastricht, Netherlands.	r.berghmans@maastrichtuniversity.nl						[Anonymous], 1993, N ENGL J MED, V329, P987; Groopman J., 2008, DOCTORS THINK	2	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 3	2011	343								d5469	10.1136/bmj.d5469	http://dx.doi.org/10.1136/bmj.d5469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CQ	21968125	Bronze			2022-12-24	WOS:000295779200001
J	Hawkes, N				Hawkes, Nigel			DRUG MISUSE Highs and lows of drug decriminalisation	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						CAMPBELL D, 2011, GUARDIAN        0127; COELHO MFP, 2010, BMJ; NHS Information Centre, 2010, SMOK DRINK DRUG US Y; Pacula RL, 2011, INT J DRUG POLICY, V22, P326, DOI 10.1016/j.drugpo.2011.07.008	4	5	5	1	9	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 26	2011	343								d6881	10.1136/bmj.d6881	http://dx.doi.org/10.1136/bmj.d6881			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031913				2022-12-24	WOS:000296417100015
J	Guo, CY; Gerasimova, T; Hao, HP; Ivanova, I; Chakraborty, T; Selimyan, R; Oltz, EM; Sen, RJ				Guo, Changying; Gerasimova, Tatiana; Hao, Haiping; Ivanova, Irina; Chakraborty, Tirtha; Selimyan, Roza; Oltz, Eugene M.; Sen, Ranjan			Two Forms of Loops Generate the Chromatin Conformation of the Immunoglobulin Heavy-Chain Gene Locus	CELL			English	Article							B-CELL DEVELOPMENT; INTRONIC ENHANCER; IGH LOCUS; LYMPHOCYTE DEVELOPMENT; SWITCH RECOMBINATION; REGULATORY ELEMENTS; V(D)J RECOMBINATION; VARIABLE REGION; CTCF SITES; INSULATORS	The immunoglobulin heavy-chain (IgH) gene locus undergoes radial repositioning within the nucleus and locus contraction in preparation for gene recombination. We demonstrate that IgH locus conformation involves two levels of chromosomal compaction. At the first level, the locus folds into several multi-looped domains. One such domain at the 30 end of the locus requires an enhancer, Em; two other domains at the 50 end are Em independent. At the second level, these domains are brought into spatial proximity by Em-dependent interactions with specific sites within the V-H region. Em is also required for radial repositioning of IgH alleles, indicating its essential role in large-scale chromosomal movements in developing lymphocytes. Our observations provide a comprehensive view of the conformation of IgH alleles in pro-B cells and the mechanisms by which it is established.	[Guo, Changying; Gerasimova, Tatiana; Ivanova, Irina; Chakraborty, Tirtha; Selimyan, Roza; Sen, Ranjan] NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, Baltimore, MD 21224 USA; [Hao, Haiping] Johns Hopkins Univ, Sch Med, JHMI Deep Sequencing & Microarray Core, Baltimore, MD 21231 USA; [Oltz, Eugene M.] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University; Washington University (WUSTL)	Sen, RJ (corresponding author), NIA, Gene Regulat Sect, Lab Mol Biol & Immunol, 251 Bayview Blvd, Baltimore, MD 21224 USA.	rs465z@nih.gov	chang-ying, guo/F-2770-2018	Hao, Haiping/0000-0002-8826-1568	National Institute on Aging (Baltimore, MD); NIH [P01 HL68744, CA100905]; NATIONAL CANCER INSTITUTE [R01CA100905, R01CA156690] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000373] Funding Source: NIH RePORTER	National Institute on Aging (Baltimore, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to Cornelis Murre and Suchit Jhunjhunwala for sharing and troubleshooting the procedures for small probe FISH. We thank Drs. Dinah Singer, Amy Kenter, Cornelis Murre, Fred Alt, and Sebastian Fugmann for discussions throughout the work and critical appraisal of the manuscript. This work was supported by the Intramural Research Program of the National Institute on Aging (Baltimore, MD) and by NIH grant (P01 HL68744 and CA100905) to E.M.O.	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chakraborty T, 2009, J EXP MED, V206, P1019, DOI 10.1084/jem.20081621; COOK PR, 1976, J CELL SCI, V22, P303; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; GASSER SM, 1987, TRENDS GENET, V3, P16, DOI 10.1016/0168-9525(87)90156-9; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Kadauke S, 2009, BBA-GENE REGUL MECH, V1789, P17, DOI 10.1016/j.bbagrm.2008.07.002; KLEIN S, 1984, EMBO J, V3, P2473, DOI 10.1002/j.1460-2075.1984.tb02158.x; Knoch T. A., 2000, 3 DIMENSIONAL CHROMO; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Maes J, 2001, J IMMUNOL, V167, P866, DOI 10.4049/jimmunol.167.2.866; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; PARK K, 1991, P NATL ACAD SCI USA, V88, P9804, DOI 10.1073/pnas.88.21.9804; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Retter I, 2007, J IMMUNOL, V179, P2419, DOI 10.4049/jimmunol.179.4.2419; SACHS RK, 1995, P NATL ACAD SCI USA, V92, P2710, DOI 10.1073/pnas.92.7.2710; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Subrahmanyam R, 2010, SEMIN IMMUNOL, V22, P337, DOI 10.1016/j.smim.2010.08.003; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007	44	111	115	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					332	343		10.1016/j.cell.2011.08.049	http://dx.doi.org/10.1016/j.cell.2011.08.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	21982154	Bronze, Green Accepted			2022-12-24	WOS:000296199300012
J	Hvid-Jensen, F; Pedersen, L; Drewes, AM; Sorensen, HT; Funch-Jensen, P				Hvid-Jensen, Frederik; Pedersen, Lars; Drewes, Asbjorn Mohr; Sorensen, Henrik Toft; Funch-Jensen, Peter			Incidence of Adenocarcinoma among Patients with Barrett's Esophagus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; INTESTINAL METAPLASIA; CANCER-RISK; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL-REFLUX; MALIGNANT PROGRESSION; FOLLOW-UP; SURVEILLANCE; COHORT; DIAGNOSIS	BACKGROUND Accurate population-based data are needed on the incidence of esophageal adenocarcinoma and high-grade dysplasia among patients with Barrett's esophagus. METHODS We conducted a nationwide, population-based, cohort study involving all patients with Barrett's esophagus in Denmark during the period from 1992 through 2009, using data from the Danish Pathology Registry and the Danish Cancer Registry. We determined the incidence rates (numbers of cases per 1000 person-years) of adenocarcinoma and high-grade dysplasia. As a measure of relative risk, standardized incidence ratios were calculated with the use of national cancer rates in Denmark during the study period. RESULTS We identified 11,028 patients with Barrett's esophagus and analyzed their data for a median of 5.2 years. Within the first year after the index endoscopy, 131 new cases of adenocarcinoma were diagnosed. During subsequent years, 66 new adenocarcinomas were detected, yielding an incidence rate for adenocarcinoma of 1.2 cases per 1000 person-years (95% confidence interval [CI], 0.9 to 1.5). As compared with the risk in the general population, the relative risk of adenocarcinoma among patients with Barrett's esophagus was 11.3 (95% CI, 8.8 to 14.4). The annual risk of esophageal adenocarcinoma was 0.12% (95% CI, 0.09 to 0.15). Detection of low-grade dysplasia on the index endoscopy was associated with an incidence rate for adenocarcinoma of 5.1 cases per 1000 person-years. In contrast, the incidence rate among patients without dysplasia was 1.0 case per 1000 person-years. Risk estimates for patients with high-grade dysplasia were slightly higher. CONCLUSIONS Barrett's esophagus is a strong risk factor for esophageal adenocarcinoma, but the absolute annual risk, 0.12%, is much lower than the assumed risk of 0.5%, which is the basis for current surveillance guidelines. Data from the current study call into question the rationale for ongoing surveillance in patients who have Barrett's esophagus without dysplasia. (Funded by the Clinical Institute, University of Aarhus, Aarhus, Denmark.)	[Funch-Jensen, Peter] Univ Aarhus, Hamlet Hosp, DK-8200 Aarhus N, Denmark; [Funch-Jensen, Peter] Univ Aarhus, Inst Clin, DK-8200 Aarhus N, Denmark; [Hvid-Jensen, Frederik] Aarhus Univ Hosp, Dept Surg Gastroenterol L, DK-8000 Aarhus, Denmark; [Pedersen, Lars; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Drewes, Asbjorn Mohr] Aarhus Univ Hosp, Mech Sense Dept Gastroenterol, Aalborg, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University; Aarhus University	Funch-Jensen, P (corresponding author), Univ Aarhus, Hamlet Hosp, Brendstrupgardsvej 21, DK-8200 Aarhus N, Denmark.	funchjensen@gmail.com	Sorensen, Henrik Toft/Z-6181-2019; Drewes, Asbjørn/AAR-7479-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Drewes, Asbjørn/0000-0001-7465-964X	Clinical Institute, University of Aarhus, Aarhus, Denmark	Clinical Institute, University of Aarhus, Aarhus, Denmark	Supported by the Clinical Institute, University of Aarhus, Aarhus, Denmark.	Bhat S, 2011, J NATL CANCER I, V103, P1049, DOI 10.1093/jnci/djr203; Bytzer P, 1999, AM J GASTROENTEROL, V94, P86; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; Cameron AJ, 2002, AM J GASTROENTEROL, V97, P1375, DOI 10.1016/S0002-9270(02)04025-X; CAMERON AJ, 1990, GASTROENTEROLOGY, V99, P918, DOI 10.1016/0016-5085(90)90607-3; Chang EY, 2007, ANN SURG, V246, P11, DOI 10.1097/01.sla.0000261459.10565.e9; Conio M, 2003, AM J GASTROENTEROL, V98, P1931, DOI 10.1016/S0002-9270(03)00629-4; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; de Jonge PJF, 2010, GUT, V59, P1030, DOI 10.1136/gut.2009.176701; DeMeester SR, 2000, ANN SURG, V231, P303, DOI 10.1097/00000658-200003000-00003; Dulai GS, 2005, AM J GASTROENTEROL, V100, P775, DOI 10.1111/j.1572-0241.2005.41300.x; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; Erichsen Rune, 2010, Clin Epidemiol, V2, P51; Garside R, 2006, HEALTH TECHNOL ASSES, V10, P1; Gatenby PAC, 2008, SCAND J GASTROENTERO, V43, P524, DOI 10.1080/00365520701879831; Hage M, 2004, SCAND J GASTROENTERO, V39, P1175, DOI 10.1080/00365520410003524; Inadomi JM, 2003, ANN INTERN MED, V138, P176, DOI 10.7326/0003-4819-138-3-200302040-00009; Montgomery E, 2001, HUM PATHOL, V32, P379, DOI 10.1053/hupa.2001.23511; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Murray L, 2003, BRIT MED J, V327, P534, DOI 10.1136/bmj.327.7414.534; O'Connor JB, 1999, AM J GASTROENTEROL, V94, P2037; Pedersen CB, 2006, DAN MED BULL, V53, P441; Playford RJ, 2006, GUT, V55, P442, DOI 10.1136/gut.2005.083600; Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043; Rubenstein JH, 2011, AM J GASTROENTEROL, V106, P254, DOI 10.1038/ajg.2010.470; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Sharma P, 2006, CLIN GASTROENTEROL H, V4, P566, DOI 10.1016/j.cgh.2006.03.001; Sikkema M, 2010, CLIN GASTROENTEROL H, V8, P235, DOI 10.1016/j.cgh.2009.10.010; Solaymani-Dodaran M, 2004, GUT, V53, P1070, DOI 10.1136/gut.2003.028076; Spechler SJ, 2004, AM J GASTROENTEROL, V99, P2295, DOI 10.1111/j.1572-0241.2004.41295_3.x; Spechler SJ, 2003, BRIT MED J, V326, P892, DOI 10.1136/bmj.326.7395.892; Spechler Stuart Jon, 2002, Rev Gastroenterol Disord, V2 Suppl 2, pS25; Stein Hubert J., 1993, Dysphagia, V8, P276, DOI 10.1007/BF01354551; Thomas T, 2007, ALIMENT PHARM THER, V26, P1465, DOI 10.1111/j.1365-2036.2007.03528.x; Vakil N, 2009, CLIN GASTROENTEROL H, V7, P756, DOI 10.1016/j.cgh.2009.03.031; van Blankenstein M, 2005, AM J GASTROENTEROL, V100, P766, DOI 10.1111/j.1572-0241.2005.40790.x; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Weston AP, 1999, AM J GASTROENTEROL, V94, P3413, DOI 10.1111/j.1572-0241.1999.01602.x; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121	41	912	932	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1375	1383		10.1056/NEJMoa1103042	http://dx.doi.org/10.1056/NEJMoa1103042			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995385				2022-12-24	WOS:000295782500005
J	Roos, N; Kieler, H; Sahlin, L; Ekman-Ordeberg, G; Falconer, H; Stephansson, O				Roos, Nathalie; Kieler, Helle; Sahlin, Lena; Ekman-Ordeberg, Gunvor; Falconer, Henrik; Stephansson, Olof			Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							IN-VITRO FERTILIZATION; GLUCOSE-TOLERANCE; COMMUNITY SAMPLE; BIRTH-WEIGHT; PREVALENCE; PCOS; COMPLICATIONS; METAANALYSIS; AGE	Objective To study the risk of adverse pregnancy outcomes in women with polycystic ovary syndrome, taking into account maternal characteristics and assisted reproductive technology. Design Population based cohort study. Setting Singleton births registered in the Swedish medical birth register between 1995 and 2007. Participants By linkage with the Swedish patient register, 3787 births among women with a diagnosis of polycystic ovary syndrome and 1 191 336 births among women without such a diagnosis. Main outcome measures Risk of adverse pregnancy outcomes (gestational diabetes, pre-eclampsia, preterm birth, stillbirth, neonatal death, low Apgar score (<7 at five minutes), meconium aspiration, large for gestational age, macrosomia, small for gestational age), adjusted for maternal characteristics (body mass index, age), socioeconomic factors (educational level, and cohabitating with infant's father), and assisted reproductive technology. Results Women with polycystic ovary syndrome were more often obese and more commonly used assisted reproductive technology than women without such a diagnosis (60.6% v 34.8% and 13.7% v 1.5%). Polycystic ovary syndrome was strongly associated with pre-eclampsia (adjusted odds ratio 1.45, 95% confidence interval 1.24 to 1.69) and very preterm birth (2.21, 1.69 to 2.90) and the risk of gestational diabetes was more than doubled (2.32, 1.88 to 2.88). Infants born to mothers with polycystic ovary syndrome were more prone to be large for gestational age (1.39, 1.19 to 1.62) and were at increased risk of meconium aspiration (2.02, 1.13 to 3.61) and having a low Apgar score (<7) at five minutes (1.41, 1.09 to 1.83). Conclusions Women with polycystic ovary syndrome are at increased risk of adverse pregnancy and birth outcomes that cannot be explained by assisted reproductive technology. These women may need increased surveillance during pregnancy and parturition.	[Roos, Nathalie; Ekman-Ordeberg, Gunvor; Falconer, Henrik] Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynaecol, Dept Womens & Childrens Hlth, SE-17176 Stockholm, Sweden; [Roos, Nathalie; Kieler, Helle; Stephansson, Olof] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Sahlin, Lena] Karolinska Inst, Div Reprod Endocrinol, Dept Womens & Childrens Hlth, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Roos, N (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Div Obstet & Gynaecol, Dept Womens & Childrens Hlth, H2 01, SE-17176 Stockholm, Sweden.	nathalie.roos@karolinska.se		Kieler, Helle/0000-0001-9338-7133; Falconer, Henrik/0000-0003-4427-9421; Sahlin, Lena/0000-0001-5609-4382; Roos, Nathalie/0000-0001-9752-2355; Stephansson, Olof/0000-0003-1528-4563	Swedish Research Council [73X-20137, 73X-14612]; board of postgraduate education at Karolinska Institutet, Stockholm, Sweden (Karolinska Institutet); Stockholm County Council; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); board of postgraduate education at Karolinska Institutet, Stockholm, Sweden (Karolinska Institutet)(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: that this study received financial support from the Swedish Research Council (projects 73X-20137 (LS) 73X-14612 (GEO)) and the board of postgraduate education at Karolinska Institutet, Stockholm, Sweden (Karolinska Institutet Doctoral Student Financing Funds (KID)) (NR) for the submitted work, and that financial support was also provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (LS); no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. Ethical approval: This study was approved by the Karolinska Institute's local ethics committee.	Archer JS, 2004, BEST PRACT RES CL OB, V18, P737, DOI 10.1016/j.bpobgyn.2004.05.007; Asuncion M, 2000, J CLIN ENDOCR METAB, V85, P2434, DOI 10.1210/jc.85.7.2434; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; Cnattingius S, 1998, NEW ENGL J MED, V338, P147, DOI 10.1056/NEJM199801153380302; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cok T, 2011, J MATERN-FETAL NEO M, V24, P1039, DOI 10.3109/14767058.2010.545910; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fridstrom M, 1999, HYPERTENS PREGNANCY, V18, P73, DOI 10.3109/10641959909009612; Haakova L, 2003, HUM REPROD, V18, P1438, DOI 10.1093/humrep/deg289; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Hudecova M, 2009, HUM REPROD, V24, P1176, DOI 10.1093/humrep/den482; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kallen B, 2005, BJOG-INT J OBSTET GY, V112, P1529, DOI 10.1111/j.1471-0528.2005.00745.x; Knochenhauer ES, 1998, J CLIN ENDOCR METAB, V83, P3078, DOI 10.1210/jc.83.9.3078; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Mikola M, 2001, HUM REPROD, V16, P226, DOI 10.1093/humrep/16.2.226; Moran LJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007506.pub3; Radon PA, 1999, OBSTET GYNECOL, V94, P194, DOI 10.1016/S0029-7844(99)00252-5; Rajashekar Lavanya, 2008, J Hum Reprod Sci, V1, P65; Romundstad LB, 2008, LANCET, V372, P737, DOI 10.1016/S0140-6736(08)61041-7; Salvesen KA, 2007, ULTRASOUND OBST GYN, V29, P433, DOI 10.1002/uog.3965; Schieve LA, 2002, NEW ENGL J MED, V346, P731, DOI 10.1056/NEJMoa010806; Sheiner E, 2004, PAEDIATR PERINAT EP, V18, P196, DOI 10.1111/j.1365-3016.2004.00557.x; Sir-Petermann T, 2005, HUM REPROD, V20, P2122, DOI 10.1093/humrep/dei009; Surkan PJ, 2004, OBSTET GYNECOL, V104, P720, DOI 10.1097/01.AOG.0000141442.59573.cd; Tehrani FR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-39; Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P1268; Usta IM, 2008, AM J PERINAT, V25, P521, DOI 10.1055/s-0028-1085620; Vanky E, 2004, HUM REPROD, V19, P1734, DOI 10.1093/humrep/deh347; Vollenhoven B, 2000, AUST NZ J OBSTET GYN, V40, P54, DOI 10.1111/j.1479-828X.2000.tb03167.x	33	178	187	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2011	343								d6309	10.1136/bmj.d6309	http://dx.doi.org/10.1136/bmj.d6309			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EQ	21998337	hybrid, Green Published			2022-12-24	WOS:000296018300004
J	Chung, KY; Rasmussen, SGF; Liu, T; Li, S; DeVree, BT; Chae, PS; Calinski, D; Kobilka, BK; Woods, VL; Sunahara, RK				Chung, Ka Young; Rasmussen, Soren G. F.; Liu, Tong; Li, Sheng; DeVree, Brian T.; Chae, Pil Seok; Calinski, Diane; Kobilka, Brian K.; Woods, Virgil L., Jr.; Sunahara, Roger K.			Conformational changes in the G protein Gs induced by the beta(2) adrenergic receptor	NATURE			English	Article							HETEROTRIMERIC G-PROTEINS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; COUPLED RECEPTOR; MECHANISM; INTERFACE; DYNAMICS; EXCHANGE; HYDROGEN/DEUTERIUM; ACTIVATION	G protein-coupled receptors represent the largest family of membrane receptors(1) that instigate signalling through nucleotide exchange on heterotrimeric G proteins. Nucleotide exchange, or more precisely, GDP dissociation from the G protein alpha-subunit, is the key step towards G protein activation and initiation of downstream signalling cascades. Despite a wealth of biochemical and biophysical studies on inactive and active conformations of several heterotrimeric G proteins, the molecular underpinnings of G protein activation remain elusive. To characterize this mechanism, we applied peptide amide hydrogen-deuterium exchange mass spectrometry to probe changes in the structure of the heterotrimeric bovine G protein, Gs (the stimulatory G protein for adenylyl cyclase) on formation of a complex with agonist-bound human beta(2) adrenergic receptor (beta(2)AR). Here we report structural links between the receptor-binding surface and the nucleotide-binding pocket of Gs that undergo higher levels of hydrogen-deuterium exchange than would be predicted from the crystal structure of the beta(2)AR-Gs complex. Together with X-ray crystallographic and electron microscopic data of the beta(2)AR-Gs complex (from refs 2, 3), we provide a rationale for a mechanism of nucleotide exchange, whereby the receptor perturbs the structure of the amino-terminal region of the alpha-subunit of Gs and consequently alters the 'P-loop' that binds the beta-phosphate in GDP. As with the Ras family of small-molecular-weight G proteins, P-loop stabilization and beta-phosphate coordination are key determinants of GDP (and GTP) binding affinity.	[DeVree, Brian T.; Calinski, Diane; Sunahara, Roger K.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Chung, Ka Young; Rasmussen, Soren G. F.; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Rasmussen, Soren G. F.] Univ Copenhagen, Panum Inst, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, Dept Med, Biomed Sci Grad Program, La Jolla, CA 92023 USA; [Liu, Tong; Li, Sheng; Woods, Virgil L., Jr.] Univ Calif San Diego, UCSD DXMS Prote Resource, La Jolla, CA 92023 USA; [Chae, Pil Seok] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Chae, Pil Seok] Hanyang Univ, Dept Bionano Engn, Ansan 426791, South Korea	University of Michigan System; University of Michigan; Stanford University; University of Copenhagen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; Hanyang University	Sunahara, RK (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	kobilka@stanford.edu; vwoods@ucsd.edu; sunahara@umich.edu	DeVree, Brian T/F-6205-2011; Sunahara, Roger/AAJ-8667-2020; Chung, Ka Young/AAO-7984-2020	Kobilka, Brian/0000-0001-5958-3990; Rasmussen, Soren/0000-0002-1853-1841; DeVree, Brian/0000-0003-0582-8125; Chung, Ka Young/0000-0001-9038-9571	American Lung Association [RT-166882-N]; Lundbeck Foundation; National Institute of General Medical Sciences (NIGMS) [GM008270, GM083118, GM068603]; National Institute of Neural Disorders and Stroke [NS28471]; NHLBI [HL071078]; Mather Charitable Foundation; Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases [P60DK-20572]; University of Michigan; NIH [AI076961, AI081982, AI2008031, CA118595, GM20501, GM066170, GM093325, RR029388]; Lundbeck Foundation [R37-2009-3457] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R21CA118595] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029388] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076961, R01AI081982, R01AI072106, P01AI068730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020501, R01GM068603, F32GM020501, R01GM066170, T32GM008270, R01GM093325, R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471, R01NS070899] Funding Source: NIH RePORTER	American Lung Association; Lundbeck Foundation(Lundbeckfonden); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neural Disorders and Stroke; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Mather Charitable Foundation; Michigan Diabetes Research and Training Center; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan(University of Michigan System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lundbeck Foundation(Lundbeckfonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J.J.G. Tesmer and G. Skiniotis for discussions. This work was supported by an American Lung Association senior research training fellowship (RT-166882-N, to K.Y.C.), the Lundbeck Foundation (a junior group leader fellowship, to S. G. F. R.), a National Institute of General Medical Sciences (NIGMS) molecular biophysics training grant (GM008270, to B. T. D), a National Institute of Neural Disorders and Stroke grant (NS28471, to B. K. K.), a NHLBI grant (HL071078, to B. K. K.), the Mather Charitable Foundation (B. K. K.), NIGMS grants GM083118 (to B. K. K. and R. K. S.) and GM068603 (to R. K. S.), a Michigan Diabetes Research and Training Center grant, the National Institute of Diabetes and Digestive and Kidney Diseases (P60DK-20572, to R. K. S.), the University of Michigan Biological Sciences Scholars Program (R. K. S.), and by the NIH (grants AI076961, AI081982, AI2008031, CA118595, GM20501, GM066170, GM093325 and RR029388 (to V.L.W.)).	Abzalimov RR, 2009, J AM SOC MASS SPECTR, V20, P1514, DOI 10.1016/j.jasms.2009.04.006; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li S, 2011, J BIOL CHEM, V286, P17889, DOI 10.1074/jbc.M111.224535; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tsutsui Y, 2007, CURR MED CHEM, V14, P2344, DOI 10.2174/092986707781745596; Van Eps N, 2011, P NATL ACAD SCI USA, V108, P9420, DOI 10.1073/pnas.1105810108; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Zhang X, 2010, ANAL CHEM, V82, P1100, DOI 10.1021/ac902484p	25	278	283	1	179	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					611	U143		10.1038/nature10488	http://dx.doi.org/10.1038/nature10488			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21956331	Green Accepted			2022-12-24	WOS:000295320900044
J	Cernilogar, FM; Onorati, MC; Kothe, GO; Burroughs, AM; Parsi, KM; Breiling, A; Lo Sardo, F; Saxena, A; Miyoshi, K; Siomi, H; Siomi, MC; Carninci, P; Gilmour, DS; Corona, DFV; Orlando, V				Cernilogar, Filippo M.; Onorati, Maria Cristina; Kothe, Greg O.; Burroughs, A. Maxwell; Parsi, Krishna Mohan; Breiling, Achim; Lo Sardo, Federica; Saxena, Alka; Miyoshi, Keita; Siomi, Haruhiko; Siomi, Mikiko C.; Carninci, Piero; Gilmour, David S.; Corona, Davide F. V.; Orlando, Valerio			Chromatin-associated RNA interference components contribute to transcriptional regulation in Drosophila	NATURE			English	Article							POLYMERASE-II; IN-VIVO; DISTINCT ROLES; SOMATIC-CELLS; HEAT-SHOCK; PATHWAY; POLYCOMB; PROTEINS; PROMOTER; RISC	RNA interference (RNAi) pathways have evolved as important modulators of gene expression that operate in the cytoplasm by degrading RNA target molecules through the activity of short (21-30 nucleotide) RNAs1-6. RNAi components have been reported to have a role in the nucleus, as they are involved in epigenetic regulation and heterochromatin formation(7-10). However, although RNAi-mediated post-transcriptional gene silencing is well documented, the mechanisms of RNAi-mediated transcriptional gene silencing and, in particular, the role of RNAi components in chromatin dynamics, especially in animal multicellular organisms, are elusive. Here we show that the key RNAi components Dicer 2 (DCR2) and Argonaute 2 (AGO2) associate with chromatin (with a strong preference for euchromatic, transcriptionally active, loci) and interact with the core transcription machinery. Notably, loss of function of DCR2 or AGO2 showed that transcriptional defects are accompanied by the perturbation of RNA polymerase II positioning on promoters. Furthermore, after heat shock, both Dcr2 and Ago2 null mutations, as well as missense mutations that compromise the RNAi activity, impaired the global dynamics of RNA polymerase II. Finally, the deep sequencing of the AGO2-associated small RNAs (AGO2 RIP-seq) revealed that AGO2 is strongly enriched in small RNAs that encompass the promoter regions and other regions of heat-shock and other genetic loci on both the sense and antisense DNA strands, but with a strong bias for the antisense strand, particularly after heat shock. Taken together, our results show that DCR2 and AGO2 are globally associated with transcriptionally active loci and may have a pivotal role in shaping the transcriptome by controlling the processivity of RNA polymerase II.	[Cernilogar, Filippo M.; Parsi, Krishna Mohan; Lo Sardo, Federica; Orlando, Valerio] IRCCS Fdn Santa Lucia, Dulbecco Telethon Inst, Epigenet & Genome Reprogramming, I-00143 Rome, Italy; [Cernilogar, Filippo M.; Parsi, Krishna Mohan] IGB ABT CNR, Dulbecco Telethon Inst, I-80131 Naples, Italy; [Onorati, Maria Cristina; Corona, Davide F. V.] Univ Palermo, Dulbecco Telethon Inst, Dipartimento STEMBIO, Sez Biol Cellulare, I-90128 Palermo, Italy; [Kothe, Greg O.; Gilmour, David S.] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Burroughs, A. Maxwell; Saxena, Alka; Carninci, Piero] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Breiling, Achim] German Canc Res Ctr, DKFZ ZMBH Alliance, Div Epigenet, D-69120 Heidelberg, Germany; [Miyoshi, Keita; Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Siomi, Mikiko C.] CREST, JST, Kawaguchi, Saitama 3320012, Japan	Fondazione Telethon; Dulbecco Telethon Institute (DTI); IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Fondazione Telethon; Dulbecco Telethon Institute (DTI); University of Palermo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; RIKEN; Helmholtz Association; German Cancer Research Center (DKFZ); Keio University; Japan Science & Technology Agency (JST)	Orlando, V (corresponding author), IRCCS Fdn Santa Lucia, Dulbecco Telethon Inst, Epigenet & Genome Reprogramming, Via Fosso di Fiorano 64, I-00143 Rome, Italy.	vorlando@dti.telethon.it	Sardo, Federica Lo/AAC-1757-2019; Carninci, Piero/K-1568-2014; Cernilogar, Filippo/AAC-3243-2021; Parsi, Krishna Mohan/AAA-4992-2019; Siomi, Haruhiko/A-7020-2015; Corona, Davide F.V./H-8467-2012	Sardo, Federica Lo/0000-0002-2912-079X; Carninci, Piero/0000-0001-7202-7243; Cernilogar, Filippo/0000-0003-2814-3436; Parsi, Krishna Mohan/0000-0002-6002-3816; Siomi, Haruhiko/0000-0001-8690-3822; Burroughs, A. Max/0000-0002-2229-8771; Breiling, Achim/0000-0002-7928-299X	National Institutes of Health [GM47477]; Deutsche Forschungsgemeinschaft [SPP 1356]; Japan Society for the Promotion of Science (JSPS) [20241047, P09745]; Council for Science and Technology Policy; NEXT Program; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency; Fondazione Telethon; Giovanni Armenise Harvard Foundation; FIRB-MIUR; Associazione Italiana Ricerca Cancro (AIRC); Human Frontier Science Program CDA; EMBO; AIRC; EU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Council for Science and Technology Policy(Council for Science and Technology Policy (CSTP)); NEXT Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Fondazione Telethon(Fondazione TelethonEuropean Commission); Giovanni Armenise Harvard Foundation; FIRB-MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Human Frontier Science Program CDA(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); AIRC(Fondazione AIRC per la ricerca sul cancro); EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are deeply grateful to P. Macino for discussions. We also thank R. Carthew, E. Lai, Q. Liu, R. Paro, Y. Sik Lee, and J. T. Kadonaga for reagents. This work was supported by grants from the following: the National Institutes of Health (GM47477) to D. S. G.; the Deutsche Forschungsgemeinschaft (SPP 1356) to A. B.; the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers' (NEXT Program) (a Grant-in-Aid for Scientific Research (A) No. 20241047) and the Council for Science and Technology Policy to P. C.; the NEXT Program (a Research Grant-in-Aid to the RIKEN OSC) to K. M., M. C. S. and H. S.; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency to M. C. S.; Fondazione Telethon, the Giovanni Armenise Harvard Foundation, FIRB-MIUR, Associazione Italiana Ricerca Cancro (AIRC), the Human Frontier Science Program CDA and the EMBO Young investigator program to D. F. V. C.; Fondazione Telethon, AIRC and the EU FP6 Epigenome Network of Excellence to V.O. This work was also made possible with the contribution of the Italian Ministry of Foreign Affairs, 'Direzione Generale per la Promozione e la Cooperazione Culturale' to V.O. A. S. is supported by a JSPS fellowship (ID P09745). Sequencing was provided by the Genas service (RIKEN Omics Science Center).	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; Breiling A, 2001, NATURE, V412, P651, DOI 10.1038/35088090; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Cartwright IL, 1999, METHOD ENZYMOL, V304, P462; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Corona DFV, 2004, METHOD ENZYMOL, V377, P70; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Hsu JY, 2008, GENE DEV, V22, P2353, DOI 10.1101/gad.1681808; Kavi HH, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-15; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kawano M, 2010, BIOTECHNIQUES, V49, P751, DOI 10.2144/000113516; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lim DH, 2008, BIOCHEM BIOPH RES CO, V371, P525, DOI 10.1016/j.bbrc.2008.04.118; Lis JT, 2007, NATURE, V450, P198, DOI 10.1038/nature06324; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; MESSMER S, 1992, GENE DEV, V6, P1241, DOI 10.1101/gad.6.7.1241; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Miyoshi K, 2009, RNA, V15, P1282, DOI 10.1261/rna.1541209; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Pimpinelli S., 2000, DROSOPHILA LAB MANUA, P1; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; WEEKS JR, 1993, GENE DEV, V7, P2329, DOI 10.1101/gad.7.12a.2329; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403	44	163	171	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					391	U151		10.1038/nature10492	http://dx.doi.org/10.1038/nature10492			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22056986	Green Accepted			2022-12-24	WOS:000298033000057
J	Jacobson, M; Earle, CC; Newhouse, JP				Jacobson, Mireille; Earle, Craig C.; Newhouse, Joseph P.			Geographic Variation in Physicians' Responses to a Reimbursement Change	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER		[Jacobson, Mireille] RAND Corp, Santa Monica, CA 90406 USA; [Earle, Craig C.] Canc Care Ontario, Toronto, ON, Canada; [Newhouse, Joseph P.] Harvard Univ, Sch Med, Boston, MA USA	RAND Corporation; Cancer Care Ontario; Harvard University; Harvard Medical School	Jacobson, M (corresponding author), RAND Corp, Santa Monica, CA 90406 USA.		Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022; Jacobson, Mireille/AAD-1190-2022	Jacobson, Mireille/0000-0002-4977-8783	NCI NIH HHS [R01 CA152043] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA152043] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1999, DARTMOUTH ATLAS HLTH; *BOARDS TRUST FED, 2011, BOARDS TRUST FED 201; Earle CC, 2002, MED CARE, V40, P75; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563	5	26	26	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 1	2011	365	22					2049	2052		10.1056/NEJMp1110117	http://dx.doi.org/10.1056/NEJMp1110117			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	854MO	22047517	Green Accepted			2022-12-24	WOS:000297499000004
J	Kim, JJ				Kim, Jane J.			The Role of Cost-Effectiveness in US Vaccination Policy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA.							Centers for Disease Control and prevention, CDC VACC PRIC LIST; Chesson HW, 2011, VACCINE, V29, P8443, DOI 10.1016/j.vaccine.2011.07.096; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Shepard CW, 2005, PEDIATRICS, V115, P1220, DOI 10.1542/peds.2004-2514; Smith PJ, 2011, PUBLIC HEALTH REP, V126, P109, DOI 10.1177/00333549111260S213	5	30	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1760	1761		10.1056/NEJMp1110539	http://dx.doi.org/10.1056/NEJMp1110539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844QQ	22010866				2022-12-24	WOS:000296762800004
J	Geboes, K				Geboes, Karel			MORE SECRETS OF THE MMR SCARE Commentary: I see no convincing evidence of "enterocolitis," "colitis," or a "unique disease process"	BRITISH MEDICAL JOURNAL			English	Editorial Material									KULeuven, Dept Pathol, Louvain, Belgium	KU Leuven	Geboes, K (corresponding author), KULeuven, Dept Pathol, Louvain, Belgium.	karel.geboes@skynet.be						CORNES JS, 1965, GUT, V6, P225, DOI 10.1136/gut.6.3.225; Deer B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1127; Godlee F, 2011, BRIT MED J, V343, P7284; IACOBUZIODONOHU.CA, 2005, GASTROINTESTINAL LIV; JENKINS D, 1988, J CLIN PATHOL, V41, P72, DOI 10.1136/jcp.41.1.72; PALLONE F, 2003, INFLAMM BOWEL DIS, P85; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	7	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	NOV 9	2011	343								d6985	10.1136/bmj.d6985	http://dx.doi.org/10.1136/bmj.d6985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848NP	22077092	Bronze			2022-12-24	WOS:000297058600013
J	Brown, KN; Chen, S; Han, Z; Lu, CH; Tan, X; Zhang, XJ; Ding, LY; Lopez-Cruz, A; Saur, D; Anderson, SA; Huang, K; Shi, SH				Brown, Keith N.; Chen, She; Han, Zhi; Lu, Chun-Hui; Tan, Xin; Zhang, Xin-Jun; Ding, Liya; Lopez-Cruz, Alejandro; Saur, Dieter; Anderson, Stewart A.; Huang, Kun; Shi, Song-Hai			Clonal Production and Organization of Inhibitory Interneurons in the Neocortex	SCIENCE			English	Article							CORTICAL INTERNEURONS; GABAERGIC INTERNEURONS; EXCITATORY NEURONS; CEREBRAL-CORTEX; MIGRATION; CELLS; GENE; SPECIFICATION; EXPRESSION; DIVERSITY	The neocortex contains excitatory neurons and inhibitory interneurons. Clones of neocortical excitatory neurons originating from the same progenitor cell are spatially organized and contribute to the formation of functional microcircuits. In contrast, relatively little is known about the production and organization of neocortical inhibitory interneurons. We found that neocortical inhibitory interneurons were produced as spatially organized clonal units in the developing ventral telencephalon. Furthermore, clonally related interneurons did not randomly disperse but formed spatially isolated clusters in the neocortex. Individual clonal clusters consisting of interneurons expressing the same or distinct neurochemical markers exhibited clear vertical or horizontal organization. These results suggest that the lineage relationship plays a pivotal role in the organization of inhibitory interneurons in the neocortex.	[Brown, Keith N.; Chen, She; Tan, Xin; Zhang, Xin-Jun; Lopez-Cruz, Alejandro; Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Brown, Keith N.; Anderson, Stewart A.; Shi, Song-Hai] Weill Cornell Med Coll, Grad Program Neurosci, New York, NY 10065 USA; [Han, Zhi; Ding, Liya; Huang, Kun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Han, Zhi; Lu, Chun-Hui] Nankai Univ, Coll Software, Tianjin 300071, Peoples R China; [Tan, Xin; Shi, Song-Hai] Weill Cornell Med Coll, Mol Biol Grad Program, New York, NY 10065 USA; [Saur, Dieter] Tech Univ Munich, Dept Internal Med 2, D-81675 Munich, Germany; [Anderson, Stewart A.] Weill Cornell Med Coll, Dept Psychiat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; University System of Ohio; Ohio State University; Nankai University; Cornell University; Technical University of Munich; Cornell University	Shi, SH (corresponding author), Mem Sloan Kettering Canc Ctr, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.	shis@mskcc.org	Saur, Dieter/G-4629-2011; Huang, Kun/E-3272-2011; Saur, Dieter/O-8355-2015; Ding, Liya/B-8869-2014; Ding, Liya/HHZ-3407-2022; Zhang, Xin-Jun/O-2994-2013	Saur, Dieter/0000-0001-5874-0210; Ding, Liya/0000-0002-1209-875X; Ding, Liya/0000-0002-1209-875X; Zhang, Xin-Jun/0000-0002-0846-0584; Han, Zhi/0000-0002-5603-8433	NIH [R01DA024681, R21NS072483, R21MH083624, R01MH066912, K02MH070031]; McKnight Foundation; March of Dimes Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH070031, R01MH066912, R21MH083624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024681] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank A. L. Joyner and M. E. Ross for comments on the manuscript; the members of the Shi laboratory for valuable discussion and input; E. C. Holland for RCAS-EGFP plasmid and advice on the production of RCAS retroviruses; F. H. Gage for providing 293 gp NIT-EGFP retrovirus packaging cell line; J. A. Kaltschmidt for R26<SUP>LSL-TVAilacZ</SUP> mice; and S. Li for technical assistance. This work was supported by grants from the NIH (R01DA024681 and R21NS072483 to S.-H.S., R21MH083624 to S.-H.S. and K.H., R01MH066912 and K02MH070031 to S.A.A.), the McKnight Foundation, and the March of Dimes Foundation (to S.-H.S.).	Ang ESBC, 2003, J NEUROSCI, V23, P5805; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; Bortone D, 2009, NEURON, V62, P53, DOI 10.1016/j.neuron.2009.01.034; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749; Diggle P., 2003, STAT ANAL SPATIAL PO; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Flames N, 2007, J NEUROSCI, V27, P9682, DOI 10.1523/JNEUROSCI.2750-07.2007; Fogarty M, 2007, J NEUROSCI, V27, P10935, DOI 10.1523/JNEUROSCI.1629-07.2007; Gelman DM, 2010, EUR J NEUROSCI, V31, P2136, DOI 10.1111/j.1460-9568.2010.07267.x; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Katzel D, 2011, NAT NEUROSCI, V14, P100, DOI 10.1038/nn.2687; KORNACK DR, 1995, NEURON, V15, P311, DOI 10.1016/0896-6273(95)90036-5; Lavdas AA, 1996, CEREB CORTEX, V6, P490, DOI 10.1093/cercor/6.3.490; Li HD, 2008, DEV NEUROBIOL, V68, P1549, DOI 10.1002/dneu.20679; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Miyoshi G, 2007, J NEUROSCI, V27, P7786, DOI 10.1523/JNEUROSCI.1807-07.2007; Miyoshi G, 2011, CEREB CORTEX, V21, P845, DOI 10.1093/cercor/bhq155; Miyoshi G, 2010, J NEUROSCI, V30, P1582, DOI 10.1523/JNEUROSCI.4515-09.2010; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nobrega-Pereira S, 2008, NEURON, V59, P733, DOI 10.1016/j.neuron.2008.07.024; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OROURKE NA, 1995, DEVELOPMENT, V121, P2165; PRICE J, 1988, DEVELOPMENT, V104, P473; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Seidler B, 2008, P NATL ACAD SCI USA, V105, P10137, DOI 10.1073/pnas.0800487105; Sheth AN, 1997, J COMP NEUROL, V383, P220; Sussel L, 1999, DEVELOPMENT, V126, P3359; Tanaka DH, 2009, J NEUROSCI, V29, P1300, DOI 10.1523/JNEUROSCI.5446-08.2009; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; WALSH C, 1993, NATURE, V362, P632, DOI 10.1038/362632a0; Wonders CP, 2008, DEV BIOL, V314, P127, DOI 10.1016/j.ydbio.2007.11.018; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	46	110	111	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					480	486		10.1126/science.1208884	http://dx.doi.org/10.1126/science.1208884			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034427	Green Accepted			2022-12-24	WOS:000296230500038
J	Grebien, F; Hantschel, O; Wojcik, J; Kaupe, I; Kovacic, B; Wyrzucki, AM; Gish, GD; Cerny-Reiterer, S; Koide, A; Beug, H; Pawson, T; Valent, P; Koide, S; Superti-Furga, G				Grebien, Florian; Hantschel, Oliver; Wojcik, John; Kaupe, Ines; Kovacic, Boris; Wyrzucki, Arkadiusz M.; Gish, Gerald D.; Cerny-Reiterer, Sabine; Koide, Akiko; Beug, Hartmut; Pawson, Tony; Valent, Peter; Koide, Shohei; Superti-Furga, Giulio			Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; PROTEIN-TYROSINE KINASES; C-ABL; SH2 DOMAINS; BINDING-SITE; ACTIVATION; BCR/ABL; TRANSFORMATION; INDUCTION	Chronic myelogenous leukemia (CML) is caused by the constitutively active tyrosine kinase Bcr-Abl and treated with the tyrosine kinase inhibitor (TKI) imatinib. However, emerging TKI resistance prevents complete cure. Therefore, alternative strategies targeting regulatory modules of Bcr-Abl in addition to the kinase active site are strongly desirable. Here, we show that an intramolecular interaction between the SH2 and kinase domains in Bcr-Abl is both necessary and sufficient for high catalytic activity of the enzyme. Disruption of this interface led to inhibition of downstream events critical for CML signaling and, importantly, completely abolished leukemia formation in mice. Furthermore, disruption of the SH2-kinase interface increased sensitivity of imatinib-resistant Bcr-Abl mutants to TKI inhibition. An engineered Abl SH2-binding fibronectin type III monobody inhibited Bcr-Abl kinase activity both in vitro and in primary CML cells, where it induced apoptosis. This work validates the SH2-kinase interface as an allosteric target for therapeutic intervention.	[Wojcik, John; Wyrzucki, Arkadiusz M.; Koide, Akiko; Koide, Shohei] Univ Chicago, Chicago, IL 60637 USA; [Kovacic, Boris; Beug, Hartmut] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Wyrzucki, Arkadiusz M.] Med Univ Gdansk, Intercoll Fac Biotechnol, Univ Gdansk, PL-80210 Gdansk, Poland; [Gish, Gerald D.; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cerny-Reiterer, Sabine; Valent, Peter] Med Univ Vienna, Dept Internal Med 1, Div Hematol & Hemostaseol & Ludwig Boltzmann Clus, A-1090 Vienna, Austria; [Grebien, Florian; Hantschel, Oliver; Kaupe, Ines; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria	University of Chicago; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Fahrenheit Universities; Medical University Gdansk; University of Gdansk; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Ludwig Boltzmann Institute; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Hantschel, O (corresponding author), Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland.	oliver.hantschel@epfl.ch; gsuperti@cemm.oeaw.ac.at	Test, Test/Y-7921-2019; Hantschel, Oliver D/H-4705-2013; Gamperl, Susi/V-2715-2019; Valent, Peter/B-8533-2016; Test, PV/U-9451-2019; Superti-Furga, Giulio/F-4755-2015; Grebien, Florian/H-9234-2019; Kovacic, Boris/J-1871-2016; Hantschel, Oliver/M-7016-2019; Pawson, Tony J/E-4578-2013; Superti-Furga, Giulio/AAE-5681-2019; Gish, Gerald D/C-7228-2017	Hantschel, Oliver D/0000-0001-8569-8169; Gamperl, Susi/0000-0003-0456-5095; Valent, Peter/0000-0003-0456-5095; Superti-Furga, Giulio/0000-0002-0570-1768; Grebien, Florian/0000-0003-4289-2281; Kovacic, Boris/0000-0002-1148-4149; Hantschel, Oliver/0000-0001-8569-8169; Koide, Shohei/0000-0001-5473-4358	Austrian Academy of Sciences; Austrian Science Fund (FWF) [P18737, P22282]; Canadian Cancer Society; CIHR [MOP-6849]; EMBO [ASTF 293.00-2009]; National Institutes of Health [R01-GM72688, R21-CA132700, T32GM07281]; University of Chicago Cancer Research Center; National Center for Research Resources at NIH [RR-15301]; U.S. Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Novartis; BMS; Austrian Science Fund (FWF) [P 22282] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R21CA132700] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072688, T32GM007281] Funding Source: NIH RePORTER	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Canadian Cancer Society(Canadian Cancer Society (CCS)); CIHR(Canadian Institutes of Health Research (CIHR)); EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Cancer Research Center; National Center for Research Resources at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Novartis(Novartis); BMS(Bristol-Myers Squibb); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Austrian Academy of Sciences, in part by grants from the Austrian Science Fund (FWF) (#P18737 to O.H., I.K., and G.S.-F. and #P22282 to F.G.), a Terry Fox Programme Project grant from the Canadian Cancer Society and CIHR (#MOP-6849 to T.P.), an EMBO short-term fellowship (#ASTF 293.00-2009 to J.W.), the National Institutes of Health (R01-GM72688 and R21-CA132700 to S.K. and T32GM07281 to J.W.), and the University of Chicago Cancer Research Center (to S.K.). Part of the work was conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources at NIH. Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. We wish to thank all members of the participating laboratories for continuous support and discussions, D. Printz (CCRI Vienna) for expert FACS sorting, V. Komnenovic (IMBA Vienna) for help with histology, H. Pickersgill for help with manuscript preparation, and K. De Keersmaecker and T. Buerckstuemmer for critical reading of the manuscript. P.V. received a research grant and honorarium from Novartis and a research grant and honorarium from BMS. This work is dedicated to the memories of Maggie Pawson and Hartmut Beug.	Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; De Keersmaecker K, 2008, LEUKEMIA, V22, P2208, DOI 10.1038/leu.2008.242; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hantschel O, 2008, MOL ONCOL, V2, P272, DOI 10.1016/j.molonc.2008.07.003; Hochhaus A, 2009, LEUKEMIA, V23, P1054, DOI 10.1038/leu.2009.38; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; ILARIA RL, 1995, BLOOD, V86, P3897, DOI 10.1182/blood.V86.10.3897.bloodjournal86103897; Jabbour E, 2010, LEUKEMIA, V24, P6, DOI 10.1038/leu.2009.193; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5595, DOI 10.1021/bi700127c; Koide A, 2007, METH MOL B, V352, P95; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Mikkola ET, 2010, J MOL BIOL, V399, P618, DOI 10.1016/j.jmb.2010.04.045; Million RP, 2000, BLOOD, V96, P664; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nieborowska-Skorska M, 1999, J EXP MED, V189, P1229, DOI 10.1084/jem.189.8.1229; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Shah NP, 2008, CANCER CELL, V14, P485, DOI 10.1016/j.ccr.2008.11.001; Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	36	99	108	0	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					306	319		10.1016/j.cell.2011.08.046	http://dx.doi.org/10.1016/j.cell.2011.08.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000011	hybrid, Green Published, Green Accepted			2022-12-24	WOS:000296199300010
J	Wang, T; Sha, RJ; Dreyfus, R; Leunissen, ME; Maass, C; Pine, DJ; Chaikin, PM; Seeman, NC				Wang, Tong; Sha, Ruojie; Dreyfus, Remi; Leunissen, Mirjam E.; Maass, Corinna; Pine, David J.; Chaikin, Paul M.; Seeman, Nadrian C.			Self-replication of information-bearing nanoscale patterns	NATURE			English	Article							DNA; CRYSTALLIZATION; COLLOIDS; ENZYME; DESIGN; ACID	DNA molecules provide what is probably the most iconic example of self-replication-the ability of a system to replicate, or make copies of, itself. In living cells the process is mediated by enzymes and occurs autonomously, with the number of replicas increasing exponentially over time without the need for external manipulation. Self-replication has also been implemented with synthetic systems, including RNA enzymes designed to undergo self-sustained exponential amplification(1-5). An exciting next step would be to use self-replication in materials fabrication, which requires robust and general systems capable of copying and amplifying functional materials or structures. Here we report a first development in this direction, using DNA tile motifs that can recognize and bind complementary tiles in a pre-programmed fashion. We first design tile motifs so they form a seven-tile seed sequence; then use the seeds to instruct the formation of a first generation of complementary seven-tile daughter sequences; and finally use the daughters to instruct the formation of seven-tile granddaughter sequences that are identical to the initial seed sequences. Considering that DNA is a functional material that can organize itself and other molecules into useful structures(6-13), our findings raise the tantalizing prospect that we may one day be able to realize self-replicating materials with various patterns or useful functions.	[Dreyfus, Remi; Leunissen, Mirjam E.; Maass, Corinna; Pine, David J.; Chaikin, Paul M.] NYU, Ctr Soft Matter Res, New York, NY 10003 USA; [Wang, Tong; Sha, Ruojie; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA	New York University; New York University	Chaikin, PM (corresponding author), NYU, Ctr Soft Matter Res, 550 1St Ave, New York, NY 10003 USA.	chaikin@nyu.edu; ned.seeman@nyu.edu	Maass, Corinna/AAM-2328-2020; Pine, David J/B-7740-2016; Dreyfus, Remi/H-7028-2013	Maass, Corinna/0000-0001-6287-4107; Pine, David J/0000-0002-3304-6684; Dreyfus, Remi/0000-0002-4498-2582	W.M. Keck Foundation; National Science Foundation [DMR-0820341, CTS-0608889, CCF-0726378]; NASA [NNX08AK04G]; National Institute of General Medical Sciences [GM-29554]; Army Research Office [48681-EL, W911NF-07-1-0439]; Office of Naval Research [N000140910181, N000140911118]; Netherlands Organization for Scientific Research; DAAD; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029554, R37GM029554] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Army Research Office; Office of Naval Research(Office of Naval Research); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the W.M. Keck Foundation (P. M. C., D.J.P., N.C.S.), the National Science Foundation (MRSEC Program award DMR-0820341, P. M. C., D.J.P. and grants CTS-0608889 and CCF-0726378, to N.C.S.), NASA (NNX08AK04G, to P. M. C.), the National Institute of General Medical Sciences (grant GM-29554, to N.C.S.), the Army Research Office (grants 48681-EL and W911NF-07-1-0439, to N.C.S.), the Office of Naval Research (grants N000140910181 and N000140911118, to N.C.S.), the Netherlands Organization for Scientific Research (Rubicon grant, to M. E. L.) and DAAD (post-doctoral grant, to C.M.).	Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Kim AJ, 2006, LANGMUIR, V22, P1991, DOI 10.1021/la0528955; Kuzuya A, 2007, NANO LETT, V7, P1757, DOI 10.1021/nl070828k; Lee DH, 1997, NATURE, V390, P591, DOI 10.1038/37569; LEHMAN IR, 1958, J BIOL CHEM, V233, P163; Leunissen ME, 2009, SOFT MATTER, V5, P2422, DOI 10.1039/b817679e; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; Lincoln TA, 2009, SCIENCE, V323, P1229, DOI 10.1126/science.1167856; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Sacanna S, 2010, NATURE, V464, P575, DOI 10.1038/nature08906; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Valignat MP, 2005, P NATL ACAD SCI USA, V102, P4225, DOI 10.1073/pnas.0500507102; Wang RS, 2010, CHEM COMMUN, V46, P4905, DOI 10.1039/c0cc01167c; WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WINTNER EA, 1994, ACCOUNTS CHEM RES, V27, P198, DOI 10.1021/ar00043a003; Zhang ZL, 2004, NANO LETT, V4, P1407, DOI 10.1021/nl0493500; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c; Zhong H, 2006, NANO LETT, V6, P2899, DOI 10.1021/nl062183e; Zhu L, 2003, J AM CHEM SOC, V125, P10178, DOI 10.1021/ja035186r	24	83	83	1	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					225	U107		10.1038/nature10500	http://dx.doi.org/10.1038/nature10500			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993758	Green Accepted			2022-12-24	WOS:000295782800046
J	Gold, KJ				Gold, Katherine J.			In the Still of the Night	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gold, Katherine J.] Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; [Gold, Katherine J.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Gold, KJ (corresponding author), Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA.	ktgold@umich.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1303	1304		10.1001/jama.2011.1361	http://dx.doi.org/10.1001/jama.2011.1361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954469				2022-12-24	WOS:000295257000001
J	Gale, EAM; Yudkin, JS				Gale, Edwin A. M.; Yudkin, John S.			Commentary: Politics of affordable insulin	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gale, Edwin A. M.] Univ Bristol, Bristol, Avon, England; [Yudkin, John S.] UCL, London, England	University of Bristol; University of London; University College London	Gale, EAM (corresponding author), Univ Bristol, Bristol, Avon, England.	Edwin.Gale@bristol.ac.uk	Yudkin, John S/C-1988-2008					18th Expert Committee on the Selection and Use of Essential Medicines, 2011, REV EV COMP INS HUM; [Anonymous], 2011, BBC NEWS        0824; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Currie CJ, 2010, DIABETIC MED, V27, P744, DOI 10.1111/j.1464-5491.2009.02849.x; Gale EAM, 2000, DIABETIC MED, V17, P209; *HAI GLOB, LIF SAV INS LARG UN; Hauber A, 2006, DIABETOLOGIA, V49, P247, DOI 10.1007/s00125-005-0108-0; *HOP WORLDW, EL LILL PROV LIF CHI; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; *NOVONORDISK, NOVO NORD LEAD IN LE; World Health Organization, 2009, PREQ PROGR UN PROGR; World Health Organization, 2011, UN REP 18 EXP COMM S; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9	13	4	4	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5675	10.1136/bmj.d5675	http://dx.doi.org/10.1136/bmj.d5675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917829				2022-12-24	WOS:000295078100004
J	Kiss, EA; Vonarbourg, C; Kopfmann, S; Hobeika, E; Finke, D; Esser, C; Diefenbach, A				Kiss, Elina A.; Vonarbourg, Cedric; Kopfmann, Stefanie; Hobeika, Elias; Finke, Daniela; Esser, Charlotte; Diefenbach, Andreas			Natural Aryl Hydrocarbon Receptor Ligands Control Organogenesis of Intestinal Lymphoid Follicles	SCIENCE			English	Article							ROR-GAMMA-T; INFLAMMATORY-BOWEL-DISEASE; NODE DEVELOPMENT; NKP46(+) CELLS; HOMEOSTASIS; GUT; TISSUES; DIFFERENTIATION; LYMPHOCYTES; GENERATION	Innate lymphoid cells (ILC) expressing the transcription factor ROR gamma t induce the postnatal formation of intestinal lymphoid follicles and regulate intestinal homeostasis. ROR gamma t(+) ILC express the aryl hydrocarbon receptor (AhR), a highly conserved, ligand-inducible transcription factor believed to control adaptation of multicellular organisms to environmental challenges. We show that AhR is required for the postnatal expansion of intestinal ROR gamma t(+) ILC and the formation of intestinal lymphoid follicles. AhR activity within ROR gamma t(+) ILC could be induced by dietary ligands such as those contained in vegetables of the family Brassicaceae. AhR-deficient mice were highly susceptible to infection with Citrobacter rodentium, a mouse model for attaching and effacing infections. Our results establish a molecular link between nutrients and the formation of immune system components required to maintain intestinal homeostasis and resistance to infections.	[Kiss, Elina A.; Vonarbourg, Cedric; Kopfmann, Stefanie; Diefenbach, Andreas] Univ Freiburg, Med Ctr, IMMH, D-79104 Freiburg, Germany; [Kiss, Elina A.; Diefenbach, Andreas] Spemann Grad Sch Biol & Med, D-79104 Freiburg, Germany; [Kiss, Elina A.; Diefenbach, Andreas] Res Training Grp Organogenesis GRK1104, D-79104 Freiburg, Germany; [Hobeika, Elias] Univ Freiburg, Max Planck Inst Immunobiol & Epigenet, Fac Biol 3, D-79108 Freiburg, Germany; [Hobeika, Elias] Univ Freiburg, Fac Biol 3, Dept Mol Immunol, D-79108 Freiburg, Germany; [Finke, Daniela] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Esser, Charlotte] Univ Dusseldorf, Leibniz Res Inst Environm Med, D-40225 Dusseldorf, Germany	University of Freiburg; Max Planck Society; University of Freiburg; University of Freiburg; University of Basel; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF)	Diefenbach, A (corresponding author), Univ Freiburg, Med Ctr, IMMH, Hermann Herder Str 11, D-79104 Freiburg, Germany.	andreas.diefenbach@uniklinik-freiburg.de	hobeika, elias/AAV-6663-2021; Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530	Deutsche Forschungsgemeinschaft [GRK1104, SGBM, SFB620/A14]; Bundesministerium fur Bildung und Forschung; Centrum fur Chronische Immundefizienz; Swiss National Science Foundation [SNF 310030_130674/1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Centrum fur Chronische Immundefizienz; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank G. Hacker for support and for critically reading the manuscript; the members of the Diefenbach laboratory for valuable discussions; H. Pircher, Y. Tanriver, W. Schachterle, and S. Ganal for comments on the manuscript; J. Brandel for help with the figures; and N. Goppert and K. Oberle for technical assistance. We are grateful to T. Haarmann-Stemmann, C. Johner, D. Littman, R. Nechanitzky, G. Niedermann, M. Rosenbaum, F. Santori, and A. Schuhmacher for experimental support and to J. Wersing for cell sorting. The data reported in this paper are tabulated in the main paper and in the supporting online material. The work was supported by the Deutsche Forschungsgemeinschaft (GRK1104, SGBM, and SFB620/A14 to A. D. and E. A. K.), the Bundesministerium fur Bildung und Forschung, Centrum fur Chronische Immundefizienz (to A. D.), and the Swiss National Science Foundation (grant SNF 310030_130674/1 to D.F.).	Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Burow M, 2010, CURR OPIN PLANT BIOL, V13, P348, DOI 10.1016/j.pbi.2010.02.002; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chappaz S, 2010, J IMMUNOL, V185, P3514, DOI 10.4049/jimmunol.1000665; Dixon RA, 2004, ANNU REV PLANT BIOL, V55, P225, DOI 10.1146/annurev.arplant.55.031903.141729; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eckmann L, 2006, ANN NY ACAD SCI, V1072, P28, DOI 10.1196/annals.1326.008; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Lochner M, 2011, J EXP MED, V208, P125, DOI 10.1084/jem.20100052; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; PUDDINGTON L, 1994, IMMUNITY, V1, P733, DOI 10.1016/S1074-7613(94)80015-4; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	32	562	586	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1561	1565		10.1126/science.1214914	http://dx.doi.org/10.1126/science.1214914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22033518				2022-12-24	WOS:000298091400055
J	Fushinobu, S; Nishimasu, H; Hattori, D; Song, HJ; Wakagi, T				Fushinobu, Shinya; Nishimasu, Hiroshi; Hattori, Daiki; Song, Hyun-Jin; Wakagi, Takayoshi			Structural basis for the bifunctionality of fructose-1,6-bisphosphate aldolase/phosphatase	NATURE			English	Article							ALDOLASE; CATALYSIS; ARCHAEA	Enzymes catalyse specific reactions and are essential for maintaining life. Although some are referred to as being bifunctional, they consist of either two distinct catalytic domains or a single domain that displays promiscuous substrate specificity(1). Thus, one enzyme active site is generally responsible for one biochemical reaction. In contrast to this conventional concept, archaeal fructose-1,6-bisphosphate (FBP) aldolase/phosphatase (FBPA/P) consists of a single catalytic domain, but catalyses two chemically distinct reactions of gluconeogenesis: (1) the reversible aldol condensation of dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GA3P) to FBP; (2) the dephosphorylation of FBP to fructose-6-phosphate (F6P)(2). Thus, FBPA/P is fundamentally different from ordinary enzymes whose active sites are responsible for a specific reaction. However, the molecular mechanism by which FBPA/P achieves its unusual bifunctionality remains unknown. Here we report the crystal structure of FBPA/P at 1.5-angstrom resolution in the aldolase form, where a critical lysine residue forms a Schiff base with DHAP. A structural comparison of the aldolase form with a previously determined phosphatase form(3) revealed a dramatic conformational change in the active site, demonstrating that FBPA/P metamorphoses its active-site architecture to exhibit dual activities. Thus, our findings expand the conventional concept that one enzyme catalyses one biochemical reaction.	[Fushinobu, Shinya; Hattori, Daiki; Song, Hyun-Jin; Wakagi, Takayoshi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Nishimasu, Hiroshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo; University of Tokyo	Wakagi, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atwakag@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Wakagi, Takayoshi/AAJ-4145-2021	Fushinobu, Shinya/0000-0003-1346-6435; 				Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Choi KH, 2001, BIOCHEMISTRY-US, V40, P13868, DOI 10.1021/bi0114877; Due AV, 2011, P NATL ACAD SCI USA, V108, P3554, DOI 10.1073/pnas.1015996108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HUBER R, 1983, BIOPOLYMERS, V22, P261, DOI 10.1002/bip.360220136; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rashid N, 2002, J BIOL CHEM, V277, P30649, DOI 10.1074/jbc.M202868200; Sato T, 2004, J BACTERIOL, V186, P5799, DOI 10.1128/JB.186.17.5799-5807.2004; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2007, J BIOL CHEM, V282, P31028, DOI 10.1074/jbc.M704968200; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007	15	44	52	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					538	U139		10.1038/nature10457	http://dx.doi.org/10.1038/nature10457			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21983966				2022-12-24	WOS:000296194200048
J	Kocher, RP; Adashi, EY				Kocher, Robert P.; Adashi, Eli Y.			Hospital Readmissions and the Affordable Care Act Paying for Coordinated Quality Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02905 USA; [Kocher, Robert P.] Brookings Inst, Washington, DC 20036 USA	Brown University; Brookings Institution	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	Eli_Adashi@brown.edu						Centers for Medicare and Medicaid Services, 2011, MED DEM DET COMM BAS; Centers for Medicare & Medicaid Services, FY 2012 IPPS PROP RU; Centers for Medicare & Medicaid Services, 2011, MED DEM IND HOM DEM; Centers for Medicare & Medicaid Services, 2011, CMS LAUNCH TOOLS IN; HealthCare, 2011, REP C NAT STRAT QUAL; Jencks SF, 2010, ANN INTERN MED, V153, P757, DOI 10.7326/0003-4819-153-11-201012070-00010; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Medicare Payment Advisory Commission, 2011, REP C ENH MED TECHN; US Department of Health and Human Services, STRAT PLA 2010 2015; USAID, 2011, WOM WAT WAT ALL CAMP	10	361	362	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1794	1795		10.1001/jama.2011.1561	http://dx.doi.org/10.1001/jama.2011.1561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028355				2022-12-24	WOS:000296181600024
J	Mets, OM; Buckens, CFM; Zanen, P; Isgum, I; van Ginneken, B; Prokop, M; Gietema, HA; Lammers, JWJ; Vliegenthart, R; Oudkerk, M; van Klaveren, RJ; de Koning, HJ; Mali, WPTM; de Jong, PA				Mets, Onno M.; Buckens, Constantinus F. M.; Zanen, Pieter; Isgum, Ivana; van Ginneken, Bram; Prokop, Mathias; Gietema, Hester A.; Lammers, Jan-Willem J.; Vliegenthart, Rozemarijn; Oudkerk, Matthijs; van Klaveren, Rob J.; de Koning, Harry J.; Mali, Willem P. Th M.; de Jong, Pim A.			Identification of Chronic Obstructive Pulmonary Disease in Lung Cancer Screening Computed Tomographic Scans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COPD; DIAGNOSIS; MORTALITY	Context Smoking is a major risk factor for both cancer and chronic obstructive pulmonary disease (COPD). Computed tomography (CT)-based lung cancer screening may provide an opportunity to detect additional individuals with COPD at an early stage. Objective To determine whether low-dose lung cancer screening CT scans can be used to identify participants with COPD. Design, Setting, and Patients Single-center prospective cross-sectional study within an ongoing lung cancer screening trial. Prebronchodilator pulmonary function testing with inspiratory and expiratory CT on the same day was obtained from 1140 male participants between July 2007 and September 2008. Computed tomographic emphysema was defined as percentage of voxels less than -950 Hounsfield units (HU), and CT air trapping was defined as the expiratory: inspiratory ratio of mean lung density. Chronic obstructive pulmonary disease was defined as the ratio of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) of less than 70%. Logistic regression was used to develop a diagnostic prediction model for airflow limitation. Main Outcome Measures Diagnostic accuracy of COPD diagnosis using pulmonary function tests as the reference standard. Results Four hundred thirty-seven participants (38%) had COPD according to lung function testing. A diagnostic model with CT emphysema, CT air trapping, body mass index, pack-years, and smoking status corrected for overoptimism (internal validation) yielded an area under the receiver operating characteristic curve of 0.83 (95% CI, 0.81-0.86). Using the point of optimal accuracy, the model identified 274 participants with COPD with 85 false-positives, a sensitivity of 63% (95% CI, 58%-67%), specificity of 88% (95% CI, 85%-90%), positive predictive value of 76% (95% CI, 72%-81%); and negative predictive value of 79% (95% CI, 76%-82%). The diagnostic model showed an area under the receiver operating characteristic curve of 0.87 (95% CI, 0.86-0.88) for participants with symptoms and 0.78 (95% CI, 0.76-0.80) for those without symptoms. Conclusion Among men who are current and former heavy smokers, low-dose inspiratory and expiratory CT scans obtained for lung cancer screening can identify participants with COPD, with a sensitivity of 63% and a specificity of 88%. JAMA. 2011;306(16):1775-1781	[Mets, Onno M.; Prokop, Mathias; Gietema, Hester A.; Mali, Willem P. Th M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, NL-3508 GA Utrecht, Netherlands; [Buckens, Constantinus F. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Zanen, Pieter; Lammers, Jan-Willem J.] Univ Med Ctr Utrecht, Dept Pulmonol, NL-3508 GA Utrecht, Netherlands; [Isgum, Ivana; van Ginneken, Bram] Univ Med Ctr Utrecht, Image Sci Inst, NL-3508 GA Utrecht, Netherlands; [van Ginneken, Bram] Radboud Univ Nijmegen, Med Ctr, Diagnost Image Anal Grp, NL-6525 ED Nijmegen, Netherlands; [Prokop, Mathias] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Vliegenthart, Rozemarijn; Oudkerk, Matthijs] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands; [van Klaveren, Rob J.] Lievensberg Ziekenhuis, Dept Pulmonol, Bergen Op Zoom, Netherlands; [de Koning, Harry J.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Mets, OM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Heidelberglaan 100,Postbus 85500, NL-3508 GA Utrecht, Netherlands.	o.m.mets@umcutrecht.nl	de+Koning, Harry/AAF-9062-2019; van Ginneken, Bram/A-3728-2012; Prokop, W.M./H-8081-2014; Mali, Willem PThM/I-1123-2014; Isgum, Ivana/H-8659-2014; de Jong, Pim A/G-7220-2014	de+Koning, Harry/0000-0003-4682-3646; van Ginneken, Bram/0000-0003-2028-8972; Mali, Willem PThM/0000-0003-4391-0904; Isgum, Ivana/0000-0003-1869-5034; de Jong, Pim A/0000-0003-4840-6854; Prokop, Mathias/0000-0001-8157-8055; zanen, pieter/0000-0002-5318-8276; Oudkerk, Matthijs/0000-0003-2800-4110	Netherlands Organisation for Health Research and Development; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany; Rotterdam Oncologic Thoracic Steering Committee; G.Ph. Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Cancer Society Koningin Wilhelmina Fonds(KWF Kankerbestrijding); Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany(Siemens AG); Rotterdam Oncologic Thoracic Steering Committee; G.Ph. Verhagen Trust; Flemish League Against Cancer; Foundation Against Cancer; Erasmus Trust	The NELSON-trial was supported by the Netherlands Organisation for Health Research and Development; Dutch Cancer Society Koningin Wilhelmina Fonds; Stichting Centraal Fonds Reserves van Voormalig Vrijwillige Ziekenfondsverzekeringen; Siemens Germany; Rotterdam Oncologic Thoracic Steering Committee; and the G.Ph. Verhagen Trust, Flemish League Against Cancer, Foundation Against Cancer, and Erasmus Trust Fund.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cohen J., 2003, APPL MULTIPLE REGRES; Decramer M, 2011, EUR RESPIR J, V37, P738, DOI 10.1183/09031936.00020211; Decramer M, 2010, THORAX, V65, P837, DOI 10.1136/thx.2009.133355; Efron B., 1994, INTRO BOOTSTRAP; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Harrell FE, 2001, REGRESSION MODELING; Henschke CI, 2011, J THORAC IMAG, V26, P5, DOI 10.1097/RTI.0b013e31820bada2; Kubo K, 1999, EUR RESPIR J, V13, P252, DOI 10.1034/j.1399-3003.1999.13b06.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Matsuoka S, 2008, AM J ROENTGENOL, V190, P762, DOI 10.2214/AJR.07.2820; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Newell J D Jr, 2004, Eur Respir J, V23, P769, DOI 10.1183/09031936.04.00026504; O'Donnell RA, 2004, THORAX, V59, P837, DOI 10.1136/thx.2003.019349; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Schilham AMR, 2006, IEEE T MED IMAGING, V25, P451, DOI 10.1109/TMI.2006.871545; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Steyerberg E., 2009, CLIN PREDICTION MODE; van Iersel CA, 2007, INT J CANCER, V120, P868, DOI 10.1002/ijc.22134; van Klaveren RJ, 2011, J THORAC IMAG, V26, P4, DOI 10.1097/RTI.0b013e31820badb3; van Rikxoort EM, 2009, MED PHYS, V36, P2934, DOI 10.1118/1.3147146	30	109	114	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1775	1781		10.1001/jama.2011.1531	http://dx.doi.org/10.1001/jama.2011.1531			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028353	Green Published, Bronze			2022-12-24	WOS:000296181600022
J	Richards, M				Richards, Mike			BREAST CANCER SCREENING An independent review is under way	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dept Hlth, London SE1 6TE, England		Richards, M (corresponding author), Dept Hlth, London SE1 6TE, England.	Mike.Richards@ncat.nhs.uk						Advisory Committee on Breast Cancer Screening, 2006, J MED SCREEN, V13, P59; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; *INT AG RES CANC, 2002, EFF SCREEN BREAST CA, P119	3	38	39	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2011	343								d6843	10.1136/bmj.d6843	http://dx.doi.org/10.1136/bmj.d6843			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CW	22028483				2022-12-24	WOS:000296416900009
J	Chen, HH; Sun, H; You, FP; Sun, WX; Zhou, X; Chen, L; Yang, J; Wang, YT; Tang, H; Guan, YK; Xia, WW; Gu, J; Ishikawa, H; Gutman, D; Barber, G; Qin, ZH; Jiang, ZF				Chen, Huihui; Sun, Hui; You, Fuping; Sun, Wenxiang; Zhou, Xiang; Chen, Lu; Yang, Jing; Wang, Yutao; Tang, Hong; Guan, Yukun; Xia, Weiwei; Gu, Jun; Ishikawa, Hiroki; Gutman, Delia; Barber, Glen; Qin, Zhihai; Jiang, Zhengfan			Activation of STAT6 by STING Is Critical for Antiviral Innate Immunity	CELL			English	Article							NF-KAPPA-B; RIG-I; ADAPTER PROTEIN; CYTOSOLIC DNA; EXPRESSION; ALPHA; CELLS; INTERLEUKIN-4; RECOGNITION; RESPONSES	STAT6 plays a prominent role in adaptive immunity by transducing signals from extracellular cytokines. We now show that STAT6 is required for innate immune signaling in response to virus infection. Viruses or cytoplasmic nucleic acids trigger STING (also named MITA/ERIS) to recruit STAT6 to the endoplasmic reticulum, leading to STAT6 phosphorylation on Ser(407) by TBK1 and Tyr(641), independent of JAKs. Phosphorylated STAT6 then dimerizes and translocates to the nucleus to induce specific target genes responsible for immune cell homing. Virus-induced STAT6 activation is detected in all cell-types tested, in contrast to the cell-type specific role of STAT6 in cytokine signaling, and Stat6(-/-) mice are susceptible to virus infection. Thus, STAT6 mediates immune signaling in response to both cytokines at the plasma membrane, and virus infection at the endoplasmic reticulum.	[Chen, Huihui; Sun, Hui; You, Fuping; Sun, Wenxiang; Zhou, Xiang; Chen, Lu; Yang, Jing; Wang, Yutao; Tang, Hong; Guan, Yukun; Xia, Weiwei; Gu, Jun; Jiang, Zhengfan] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China; [Chen, Huihui; Sun, Hui; You, Fuping; Sun, Wenxiang; Zhou, Xiang; Chen, Lu; Yang, Jing; Wang, Yutao; Tang, Hong; Guan, Yukun; Jiang, Zhengfan] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Jiang, Zhengfan] Tsinghua Univ, Peking Univ, Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Ishikawa, Hiroki; Gutman, Delia; Barber, Glen] Univ Miami, Sch Med, Dept Med, Miami, FL 33136 USA; [Ishikawa, Hiroki; Gutman, Delia; Barber, Glen] Univ Miami, Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Qin, Zhihai] Inst Biophys, State Key Lab Biomacromol, Beijing, Peoples R China	Peking University; Peking University; Peking University; Tsinghua University; University of Miami; University of Miami; Chinese Academy of Sciences; Institute of Biophysics, CAS	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn	Yang, Jing/GLU-3905-2022; SUN, Wenxiang/Q-3481-2017	Guan, Yukun/0000-0001-9312-0164; Yang, Jing/0000-0001-5414-2141; Qin, Zhihai/0000-0001-9793-7964; Sun, Hui/0000-0002-1152-5932	China Natural Science Foundation [30772024, 31025010]; Chinese Ministry of Science and Technology [2007CB914502]; Chinese Ministry of Education [108002]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Ministry of Education(Ministry of Education, China)	We thank Drs. Junlin Teng for histological processing; Zhijian J. Chen for Mavs<SUP>-/-</SUP> mice; George Stark for 2fTGH, U1A-U6A, and gamma 2A cells; Wen-Chen Yeh for Tbk1<SUP>-/-</SUP> MEFs and Tadatsugu Taniguchi for Irf3<SUP>-/-</SUP> MEFs; and Drs. M. Tian and Y. Rao for critical reading of the manuscript. This work was supported by grants from the China Natural Science Foundation (30772024 and 31025010), the Chinese Ministry of Science and Technology (2007CB914502) and the Chinese Ministry of Education (108002). Z.J. designed research; H.C., H.S., F.Y., W.S., X.Z., L.C., J.Y., Y.W., H.T., and Y.G. performed research; W.X., J.G., H.I., D.G., G.B., and Z.Q. contributed new reagents/ analytical tools; H.C., H.S., F.Y., W.S., X.Z., L.C., J.Y., Y.W., H.T., Y.G., and Z.J. analyzed data; and X.Z. and Z.J. wrote the paper.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Ahn HJ, 2009, KOREAN J PARASITOL, V47, P117, DOI 10.3347/kjp.2009.47.2.117; Akimoto T, 1998, J EXP MED, V187, P1537, DOI 10.1084/jem.187.9.1537; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; Bulanova E, 2003, J IMMUNOL, V170, P5045, DOI 10.4049/jimmunol.170.10.5045; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gupta S, 1999, J IMMUNOL, V163, P3834; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Hokeness KL, 2005, J IMMUNOL, V174, P1549, DOI 10.4049/jimmunol.174.3.1549; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li ZG, 2008, CANCER RES, V68, P8687, DOI 10.1158/0008-5472.CAN-08-0449; Masuda A, 2000, J BIOL CHEM, V275, P29331, DOI 10.1074/jbc.M910290199; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mikita T, 1998, J BIOL CHEM, V273, P17634, DOI 10.1074/jbc.273.28.17634; Mikita T, 1996, MOL CELL BIOL, V16, P5811; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; QUELLE FW, 1995, MOL CELL BIOL, V15, P3336; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shimoda K, 1996, NATURE, V380, P630, DOI 10.1038/380630a0; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Weckmann M, 2007, NAT MED, V13, P1308, DOI 10.1038/nm1660; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yuan Q, 2006, EUR J IMMUNOL, V36, P2700, DOI 10.1002/eji.200636112; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	48	233	252	2	110	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					436	446		10.1016/j.cell.2011.09.022	http://dx.doi.org/10.1016/j.cell.2011.09.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000020	Bronze			2022-12-24	WOS:000296199300020
J	Eisenstein, M				Eisenstein, Michael			TELOMERES All's well that ends well	NATURE			English	Editorial Material							MICE											Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Parry EM, 2011, BLOOD, V117, P5607, DOI 10.1182/blood-2010-11-322149; Sacco A, 2010, CELL, V143, P1059, DOI 10.1016/j.cell.2010.11.039; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837	5	9	9	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					S13	S15		10.1038/478S13a	http://dx.doi.org/10.1038/478S13a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993820	Bronze			2022-12-24	WOS:000295782800010
J	Martin, C; zur Hausen, H				Martin, Chris; zur Hausen, Harald			Science addict	NATURE			English	Editorial Material									[zur Hausen, Harald] German Canc Res Ctr, Heidelberg, Germany; [Martin, Chris] Univ Oxford, Dept Oncol, Oxford OX1 2JD, England	Helmholtz Association; German Cancer Research Center (DKFZ); University of Oxford	Martin, C (corresponding author), Univ Oxford, Dept Oncol, Oxford OX1 2JD, England.								0	1	1	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					S12	S12		10.1038/478S12a	http://dx.doi.org/10.1038/478S12a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21993819	Bronze			2022-12-24	WOS:000295782800009
J	Beaglehole, R; Bonita, R; Alleyne, G; Horton, R				Beaglehole, Robert; Bonita, Ruth; Alleyne, George; Horton, Richard			NCDs: celebrating success, moving forward	LANCET			English	Editorial Material							COSTS		[Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Alleyne, George] Pan Amer Hlth Org, Washington, DC USA; [Horton, Richard] The Lancet, London NW1 7BY, England	University of Auckland; Pan American Health Organization	Beaglehole, R (corresponding author), Univ Auckland, Auckland 1, New Zealand.	r.beaglehole@auckland.ac.nz						Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; *STOP TB, STOP TB PARTN; United Nations Conference on Sustainable Development, RIO 20; WHO, ACC COMM HLTH WOM CH; WHO, 2011, GLOB STAT REP NONC D; World Health Organization, 2007, PREV CARD DIS GUID A; World Health Organization, TARG MON PROGR RED B; PARTNERSHIP MATERNAL	10	21	23	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 8	2011	378	9799					1283	1284		10.1016/S0140-6736(11)61559-6	http://dx.doi.org/10.1016/S0140-6736(11)61559-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	831IU	21982085				2022-12-24	WOS:000295724300008
J	Basu, S; Stuckler, D; Bitton, A; Glantz, SA				Basu, Sanjay; Stuckler, David; Bitton, Asaf; Glantz, Stanton A.			Projected effects of tobacco smoking on worldwide tuberculosis control: mathematical modelling analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FRAMEWORK CONVENTION; CIGARETTE-SMOKING; IMPACT; PROSPECTS; EPIDEMICS; MORTALITY	Objectives Almost 20% of people smoke tobacco worldwide-a percentage projected to rise in many poor countries. Smoking has been linked to increased individual risk of tuberculosis infection and mortality, but it remains unclear how these risks affect population-wide tuberculosis rates. Design We constructed a state transition, compartmental, mathematical model of tuberculosis epidemics to estimate the impact of alternative future smoking trends on tuberculosis control. We projected tuberculosis incidence, prevalence, and mortality in each World Health Organization region from 2010 to 2050, and incorporated changing trends in smoking, case detection, treatment success, and HIV prevalence. Results The model predicted that smoking would produce an excess of 18 million tuberculosis cases (standard error 16-20) and 40 million deaths from tuberculosis (39-41) between 2010 and 2050, if smoking trends continued along current trajectories. The effect of smoking was anticipated to increase the number of tuberculosis cases by 7% (274 million v 256 million) and deaths by 66% (101 million v 61 million), compared with model predictions that did not account for smoking. Smoking was also expected to delay the millennium development goal target to reduce tuberculosis mortality by half from 1990 to 2015. The model estimated that aggressive tobacco control (achieving a 1% decrease in smoking prevalence per year down to eradication) would avert 27 million smoking attributable deaths from tuberculosis by 2050. However, if the prevalence of smoking increased to 50% of adults (as observed in countries with high tobacco use), the model estimated that 34 million additional deaths from tuberculosis would occur by 2050. Conclusions Tobacco smoking could substantially increase tuberculosis cases and deaths worldwide in coming years, undermining progress towards tuberculosis mortality targets. Aggressive tobacco control could avert millions of deaths from tuberculosis.	[Basu, Sanjay; Glantz, Stanton A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; [Basu, Sanjay; Stuckler, David] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1, England; [Stuckler, David] Univ Cambridge, Dept Sociol, Cambridge, England; [Bitton, Asaf] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Bitton, Asaf] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Basu, S (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	sanjay.basu@ucsf.edu	Stuckler, David/H-2261-2012	Stuckler, David/0000-0002-1288-8401	US Centers for Disease Control and Prevention [R36-CI000607-01]; National Institutes of Health [T32-GM07205-32]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R36CI000607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SB is supported partly by the US Centers for Disease Control and Prevention (R36-CI000607-01) and the National Institutes of Health (T32-GM07205-32). The sponsors had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study, and all authors had final responsibility for the decision to submit for publication.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; American Cancer Society, 2009, TOB ATL; ANDERSON R M, 1991; Basu S, 2009, INT J TUBERC LUNG D, V13, P652; Basu S, 2007, LANCET, V370, P1500, DOI 10.1016/S0140-6736(07)61636-5; Basu S, 2009, P NATL ACAD SCI USA, V106, P7672, DOI 10.1073/pnas.0812472106; Bitton A, 2010, ADDICTION, V105, P2184, DOI 10.1111/j.1360-0443.2010.03060.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Broek JBM, 1992, INT C AIDS, V8, pC314; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Crothers K, 2009, AIDS EDUC PREV, V21, P40, DOI 10.1521/aeap.2009.21.3_supp.40; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; Dye C, 2005, JAMA-J AM MED ASSOC, V293, P2767, DOI 10.1001/jama.293.22.2767; Dye C, 2000, P NATL ACAD SCI USA, V97, P8180, DOI 10.1073/pnas.140102797; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; El Sony A, 2007, INT J TUBERC LUNG D, V11, P150; Esson K. M, 2004, MILLENNIUM DEV GOALS; Food and Agriculture Organization of the United Nations, 2010, PROJ TOB PROD CONS T; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; John RM, 2009, TOB CONTROL, V18, P138, DOI 10.1136/tc.2008.027466; Leon-Garcia A., 2008, PROBABILITY STAT RAN; Lightwood JM, 2008, PLOS MED, V5, P1214, DOI 10.1371/journal.pmed.0050178; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Muggli ME, 2003, TOB CONTROL, V12, P104, DOI 10.1136/tc.12.1.104; NIEMAN RB, 1993, AIDS, V7, P705, DOI 10.1097/00002030-199305000-00015; One News, 2011, ONE NEWS; Otanez MG, 2009, AM J PUBLIC HEALTH, V99, P1759, DOI 10.2105/AJPH.2008.146217; Pakhale SS, 1998, FOOD CHEM TOXICOL, V36, P1131, DOI 10.1016/S0278-6915(98)00071-4; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Taylor AL, 2000, B WORLD HEALTH ORGAN, V78, P920; U.N. Population Division Department of Economic and Social Affairs, 2008, WORLD POP PROSP; UNAIDS, 2010, AIDS EP UPD 2009; Wen CP, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-156; WHO, 2010, GLOB TUB CONTR 2010; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102; Williams BG, 2003, SCIENCE, V301, P1535, DOI 10.1126/science.1086845; Wilson D., 2010, NY TIMES; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2005, WHO UN MON TB TOB CO; World Health Organization, 2010, GLOB TB DAT; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2010, WHO GLOB HLTH OBS GH; Zeltner T., 2000, TOBACCO CO STRATEGIE	49	61	61	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2011	343								d5506	10.1136/bmj.d5506	http://dx.doi.org/10.1136/bmj.d5506			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CR	21972295	hybrid, Green Published			2022-12-24	WOS:000295779300001
J	Halpern, DF; Eliot, L; Bigler, RS; Fabes, RA; Hanish, LD; Hyde, J; Liben, LS; Martin, CL				Halpern, Diane F.; Eliot, Lise; Bigler, Rebecca S.; Fabes, Richard A.; Hanish, Laura D.; Hyde, Janet; Liben, Lynn S.; Martin, Carol Lynn			The Pseudoscience of Single-Sex Schooling	SCIENCE			English	Editorial Material							GENDER; BRAIN		[Halpern, Diane F.] Claremont Mckenna Coll, Claremont, CA 91711 USA; [Eliot, Lise] Rosalind Franklin Univ, N Chicago, IL 60064 USA; [Bigler, Rebecca S.] Univ Texas Austin, Austin, TX 78712 USA; [Fabes, Richard A.; Hanish, Laura D.; Martin, Carol Lynn] Arizona State Univ, Tempe, AZ 85287 USA; [Hyde, Janet] Univ Wisconsin, Madison, WI 53706 USA; [Liben, Lynn S.] Penn State Univ, University Pk, PA 16802 USA	Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Rosalind Franklin University Medical & Science; University of Texas System; University of Texas Austin; Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Halpern, DF (corresponding author), Claremont Mckenna Coll, Claremont, CA 91711 USA.	diane.halpern@cmc.edu	/ABF-7278-2020; Fabes, Richard/AAN-1363-2021; Martin, Carol/AAS-8916-2020; /AGH-3726-2022; Hanish, Laura/AAN-1297-2021	Fabes, Richard/0000-0002-9539-8992; Martin, Carol/0000-0003-0666-023X; Hanish, Laura/0000-0003-4540-2655				Adair J. G, 2000, ENCY PSYCHOL, V4, P66; Beaman R, 2006, EDUC REV, V58, P339, DOI 10.1080/00131910600748406; Bigler RS, 2006, ADV CHILD DEV BEHAV, V34, P39, DOI 10.1016/S0065-2407(06)80004-2; Eliot L, 2013, SEX ROLES, V69, P363, DOI 10.1007/s11199-011-0037-y; Fabes RA, 1997, DEV PSYCHOL, V33, P693, DOI 10.1037/0012-1649.33.4.693; Gaertner S.L., 2010, INTERGROUP ATTITUDES, P204; Halpern D.F., 2012, SEX DIFFERENCES COGN, V4th; Harker R, 2000, BRIT J SOCIOL EDUC, V21, P203, DOI 10.1080/713655349; Hayes AR, 2011, SEX ROLES, V65, P693, DOI 10.1007/s11199-010-9903-2; Hilliard LJ, 2010, CHILD DEV, V81, P1787, DOI 10.1111/j.1467-8624.2010.01510.x; LEHMANN C, 2010, URBAN PREP WHOLE STO; Lenroot RK, 2007, NEUROIMAGE, V36, P1065, DOI 10.1016/j.neuroimage.2007.03.053; Leonard D, 2007, RES000221085 ESRC; Levit N, 2005, U ILLINOIS LAW REV, P455; LIBERMAN M, 2008, SEXUAL PSEUDOSCIENCE; Liu HS, 2009, P NATL ACAD SCI USA, V106, P20499, DOI 10.1073/pnas.0908073106; Marsh HW, 1996, AUST J EDUC, V40, P147, DOI 10.1177/000494419604000203; MARTIN CL, 1981, CHILD DEV, V52, P1119, DOI 10.2307/1129498; Martin CL, 2001, DEV PSYCHOL, V37, P431, DOI 10.1037//0012-1649.37.3.431; MEMRICK A, 2011, GASTON GAZETTE  0115, pA1; Orfield G., 2008, URBAN REV, V40, DOI [DOI 10.1007/S11256-007-0073-7, 10.1007/s11256-007-0073-7]; Organization for Economic Cooperation and Development, 2009, EQ PREP LIF; Patterson MM, 2011, SEX ROLES, V65, P737, DOI 10.1007/s11199-010-9904-1; Policy and Program Studies Service of the US Department of Education's Office of Planning Evaluation and Policy Development, 2005, SINGL SEX VERS COED; Sax L, 2005, WHY GENDER MATTERS; Sax L., 2006, EDUC HORIZONS, V84, P190; Shear M. D., 2009, WASHINGTON POST 0723; Smithers A., 1996, PARADOX SINGLE SEX C; SWEET L, 2010, CHICAGO SUN TIM 0727; Thomson T., 2004, SINGLE SEX SCH FINAL; TIBBLES K, 2009, TODAY SHOW      0303	31	141	140	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1706	1707		10.1126/science.1205031	http://dx.doi.org/10.1126/science.1205031			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	823KQ	21940879				2022-12-24	WOS:000295121500025
J	Sothern, M				Sothern, Matthew			PERSONAL VIEW The blood service should ask donors about practice, not just partners	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews KY16 9AL, Fife, Scotland	University of St Andrews	Sothern, M (corresponding author), Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews KY16 9AL, Fife, Scotland.	mbs10@st-andrews.ac.uk		Kesby, Mike/0000-0001-7789-870X				2007, INT J STD AIDS, V18, P810, DOI DOI 10.1258/095646207782717027; 2010, J SEX RES, V47, P123, DOI DOI 10.1080/00224490903402538; 2010, SEX TRANSM DIS, V37, P369, DOI DOI 10.1097/OLQ.0B013E3181CBF77D; 2011, BRIT MED J, V342, pD2078, DOI DOI 10.1136/BMJ.D2078; 2010, SEX TRANSM DIS, V37, P425, DOI DOI 10.1097/OLQ.0B013E3181D13ED8; 2010, SEX TRANSM INFECT, V86, pS45, DOI DOI 10.1136/STI.2010.042283	6	2	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5793	10.1136/bmj.d5793	http://dx.doi.org/10.1136/bmj.d5793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917842	Green Submitted			2022-12-24	WOS:000295078100010
J	Branco, T				Branco, Tiago			The Language of Dendrites	SCIENCE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Branco, T (corresponding author), UCL, Mortimer St, London WC1E 6BT, England.	t.branco@ucl.ac.uk	Branco, Tiago/C-1503-2008					BLOOMFIELD S, 1974, BRAIN RES, V69, P115; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2011, NEURON, V69, P885, DOI 10.1016/j.neuron.2011.02.006; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; McCulloch Warren S., 1943, BULL MATH BIOPHYS, V5, P115, DOI 10.1007/BF02459570; Rall W, 1964, NEURAL THEORY MODELI, P73	7	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					615	616		10.1126/science.1215079	http://dx.doi.org/10.1126/science.1215079			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053040				2022-12-24	WOS:000296494700041
J	Fitzharris, P; Jordan, A				Fitzharris, Penny; Jordan, Anthony			RATIONAL TESTING Investigating recurrent angio-oedema	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Fitzharris, Penny; Jordan, Anthony] Auckland City Hosp, Dept Immunol, Auckland 1023, New Zealand	Auckland City Hospital	Fitzharris, P (corresponding author), Auckland City Hosp, Dept Immunol, Auckland 1023, New Zealand.	pennyf@adhb.govt.nz						[Anonymous], 2010, J ALLERGY CLIN IMMUN, V126, pS5, DOI 10.1016/j.jaci.2010.10.007; Cicardi M, 2004, ARCH INTERN MED, V164, P910, DOI 10.1001/archinte.164.8.910; Grigoriadou S, 2009, CLIN EXP IMMUNOL, V155, P367, DOI 10.1111/j.1365-2249.2008.03845.x; Haymore BR, 2009, ANN ALLERG ASTHMA IM, V103, P83, DOI 10.1016/S1081-1206(10)60151-2; Kaplan AP, 2010, ANN ALLERG ASTHMA IM, V104, P193, DOI 10.1016/j.anai.2010.01.007; Sabroe RA, 1997, BRIT J DERMATOL, V136, P153; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Wagenaar-Bos IGA, 2008, J IMMUNOL METHODS, V338, P14, DOI 10.1016/j.jim.2008.06.004; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zuberbier T, 2009, ALLERGY, V64, P1417, DOI 10.1111/j.1398-9995.2009.02179.x	10	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 24	2011	343								d6607	10.1136/bmj.d6607	http://dx.doi.org/10.1136/bmj.d6607			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840CU	22025533				2022-12-24	WOS:000296416700001
J	Yang, D; Khan, S; Sun, Y; Hess, K; Shmulevich, I; Sood, AK; Zhang, W				Yang, Da; Khan, Sofia; Sun, Yan; Hess, Kenneth; Shmulevich, Ilya; Sood, Anil K.; Zhang, Wei			Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GERM-LINE MUTATIONS; CLINICAL-FEATURES; BINDING; BREAST; WOMEN; RECOMBINATION; CCDC98; REPAIR; RISKS	Context Attempts to determine the clinical significance of BRCA1/2 mutations in ovarian cancer have produced conflicting results. Objective To determine the relationships between BRCA1/2 deficiency (ie, mutation and promoter hypermethylation) and overall survival (OS), progression-free survival (PFS), chemotherapy response, and whole-exome mutation rate in ovarian cancer. Design, Setting, and Patients Observational study of multidimensional genomics and clinical data on 316 high-grade serous ovarian cancer cases that were made public between 2009 and 2010 via The Cancer Genome Atlas project. Main Outcome Measures OS and PFS rates (primary outcomes) and chemotherapy response (secondary outcome). Results BRCA2 mutations (29 cases) were associated with significantly better OS (adjusted hazard ratio [HR], 0.33; 95% CI, 0.16-0.69; P=.003 and 5-year OS, 61% for BRCA2-mutated vs 25% for BRCA wild-type cases) and PFS (adjusted HR, 0.40; 95% CI, 0.22-0.74; P=.004 and 3-year PFS, 44% for BRCA2-mutated vs 16% for BRCA wild-type cases), whereas neither BRCA1 mutations (37 cases) nor BRCA1 methylation (33 cases) was associated with prognosis. Moreover, BRCA2 mutations were associated with a significantly higher primary chemotherapy sensitivity rate (100% for BRCA2-mutated vs 82% [P=.02] and 80% [P=.05] for BRCA wild-type and BRCA1-mutated cases, respectively) and longer platinum-free duration (median platinum-free duration, 18.0 months for BRCA2-mutated vs 11.7 [P=.02] and 12.5 [P=.04] months for BRCA wild-type and BRCA1-mutated cases, respectively). BRCA2-mutated, but not BRCA1-mutated cases, exhibited a "mutator phenotype" by containing significantly more mutations than BRCA wild-type cases across the whole exome (median mutation number per sample, 84 for BRCA2-mutated vs 52 for BRCA wildtype cases, false discovery rate <0.1). Conclusion Among women with high-grade serous ovarian cancer, BRCA2 mutation, but not BRCA1 deficiency, was associated with improved survival, improved chemotherapy response, and genome instability compared with BRCA wild-type. JAMA. 2011;306(14):1557-1565	[Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Unit 85, Dept Pathol, Houston, TX 77030 USA; [Hess, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol & Reprod Med, Dept Canc Biol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Ctr RNAi & Non Coding RNA, Houston, TX 77030 USA; [Sun, Yan] Tianjin Med Univ Canc Inst & Hosp, Dept Pathol, Tianjin, Peoples R China; [Shmulevich, Ilya] Inst Syst Biol, Seattle, WA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tianjin Medical University; Institute for Systems Biology (ISB)	Zhang, W (corresponding author), Univ Texas MD Anderson Canc Ctr, Unit 85, Dept Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	wzhang@mdanderson.org	wang, edwin/G-5372-2010; Hess, Kenneth/K-6546-2019; Yang, Da/I-9054-2012	Hess, Kenneth/0000-0003-1377-6070; Khan, Sofia/0000-0003-4185-8882; Yang, Da/0000-0002-8336-9457	National Institutes of Health (NIH) [U24CA143835]; Blanton-Davis Ovarian Cancer Research Program; Ovarian Cancer SPORE grant [P50 CA083639]; ASLA-Fulbright Research Grant; NATIONAL CANCER INSTITUTE [P50CA083639, P30CA016672, U24CA143835] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Blanton-Davis Ovarian Cancer Research Program; Ovarian Cancer SPORE grant; ASLA-Fulbright Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Hess, Shmulevich, Sood, and Zhang are funded by the National Institutes of Health (NIH) and various foundations and institutional funds. Dr Sun reports no disclosures.; This study was supported by grants from the NIH (U24CA143835) to Drs Shmulevich and Zhang, from the Blanton-Davis Ovarian Cancer Research Program to Dr Zhang, and the Ovarian Cancer SPORE grant (P50 CA083639) to Dr Sood. Dr Yang reports being an Odyssey Fellow at MD Anderson Cancer Center. Dr Khan reports being partially supported by an ASLA-Fulbright Research Grant for a junior scholar.	Aida H, 1998, CLIN CANCER RES, V4, P235; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berchuck A, 1998, CLIN CANCER RES, V4, P2433; Boyd J, 2000, JAMA-J AM MED ASSOC, V283, P2260, DOI 10.1001/jama.283.17.2260; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Chi DS, 2006, GYNECOL ONCOL, V103, P559, DOI 10.1016/j.ygyno.2006.03.051; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Foster KA, 1996, CANCER RES, V56, P3622; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lou ZK, 2005, NAT STRUCT MOL BIOL, V12, P589, DOI 10.1038/nsmb953; Majdak EJ, 2005, CANCER, V104, P1004, DOI 10.1002/cncr.21276; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; National Cancer Institute, CANC GEN ATL DAT POR; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Pharoah PDP, 1999, CANCER RES, V59, P868; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Xia F, 2001, P NATL ACAD SCI USA, V98, P8644, DOI 10.1073/pnas.151253498; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837	37	405	416	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1557	1565		10.1001/jama.2011.1456	http://dx.doi.org/10.1001/jama.2011.1456			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990299	Bronze, Green Accepted			2022-12-24	WOS:000295714700021
J	Elemans, CPH; Mead, AF; Jakobsen, L; Ratcliffe, JM				Elemans, Coen P. H.; Mead, Andrew F.; Jakobsen, Lasse; Ratcliffe, John M.			Superfast Muscles Set Maximum Call Rate in Echolocating Bats	SCIENCE			English	Article							KINETICS; DESIGN; MYOSIN; SPEED	As an echolocating bat closes in on a flying insect, it increases call emission to rates beyond 160 calls per second. This high call rate phase, dubbed the terminal buzz, has proven enigmatic because it is unknown how bats are able to produce calls so quickly. We found that previously unknown and highly specialized superfast muscles power rapid call rates in the terminal buzz. Additionally, we show that laryngeal motor performance, not overlap between call production and the arrival of echoes at the bat's ears, limits maximum call rate. Superfast muscles are rare in vertebrates and always associated with extraordinary motor demands on acoustic communication. We propose that the advantages of rapid auditory updates on prey movement selected for superfast laryngeal muscle in echolocating bats.	[Elemans, Coen P. H.; Jakobsen, Lasse; Ratcliffe, John M.] Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark; [Mead, Andrew F.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Southern Denmark; University of Pennsylvania	Elemans, CPH (corresponding author), Univ So Denmark, Inst Biol, DK-5230 Odense M, Denmark.	coen@biology.sdu.dk; jmr@biology.sdu.dk		Elemans, Coen/0000-0001-6306-5715; Jakobsen, Lasse/0000-0002-8496-5576	Danish Research Council (FNU); Carlsberg Foundation; Grass Foundation; Company of Biologists; Oticon Foundation; FNU	Danish Research Council (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Carlsberg Foundation(Carlsberg Foundation); Grass Foundation; Company of Biologists; Oticon Foundation; FNU(Danish Natural Science Research Council)	We thank R. Suthers for permission to reprint Fig. 3 from (7); R. Langill, P. Martensen, and F. Mortensen for technical assistance; G. Lutz for providing carbon microspheres; T. Gardner for sparse time-frequency Matlab scripts; and F. Jensen, D. Canfield, A. Surlykke, and A. West for use of equipment. F. Andrade, S. Brinklov, P. Faure, B. Fenton, B. Galef, J. van Leeuwen, P. Madsen, M. Nydam, A. Surlykke, H. ter Hofstede, and S. Zawadzki commented on the manuscript. This study was funded by grants from the Danish Research Council (FNU), Carlsberg Foundation, and Grass Foundation to C. P. H. E.; Company of Biologists to A. F. M.; Oticon Foundation to L. J.; and FNU to J. M. R. Animal capture and experimentation was approved by Skov- og Naturstyrelsen (Denmark). C. P. H. E. and J. M. R. conceived of the study. C. P. H. E. and A. F. M. conducted physiological experiments; C. P. H. E., L. J., and J. M. R. conducted behavioral experiments. All authors contributed to data analysis. C. P. H. E. and J. M. R. wrote the manuscript. The data reported in this paper are available from C.P.H.E and J.M.R.	Briggs MM, 2000, J EXP BIOL, V203, P2485; DURANT GE, 1988, THESIS INDIANA U; Elemans CPH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002581; Elemans CPH, 2004, NATURE, V431, P146, DOI 10.1038/431146a; Gardner TJ, 2006, P NATL ACAD SCI USA, V103, P6094, DOI 10.1073/pnas.0601707103; Ghose K, 2006, PLOS BIOL, V4, P865, DOI 10.1371/journal.pbio.0040108; Griffin DR, 1958, LISTENING DARK; Hiryu S, 2010, P NATL ACAD SCI USA, V107, P7048, DOI 10.1073/pnas.1000429107; Hoh JFY, 2005, ACTA PHYSIOL SCAND, V183, P133, DOI 10.1111/j.1365-201X.2004.01402.x; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; KALKO EKV, 1989, BEHAV ECOL SOCIOBIOL, V24, P225, DOI 10.1007/BF00295202; Li ZB, 2000, INVEST OPHTH VIS SCI, V41, P3770; Metzner W, 2010, HBK BEHAV NEUROSCI, V19, P403, DOI 10.1016/B978-0-12-374593-4.00037-1; Nasipak BT, 2008, DEV GENES EVOL, V218, P389, DOI 10.1007/s00427-008-0225-0; Ratcliffe John M., 2009, P201; REGER JF, 1978, J ULTRA MOL STRUCT R, V63, P275, DOI 10.1016/S0022-5320(78)80052-5; REVEL JP, 1962, J CELL BIOL, V12, P571, DOI 10.1083/jcb.12.3.571; Rome LC, 1998, NEWS PHYSIOL SCI, V13, P261, DOI 10.1152/physiologyonline.1998.13.6.261; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Rome LC, 2006, ANNU REV PHYSIOL, V68, P193, DOI 10.1146/annurev.physiol.68.040104.105418; Rome LC, 1996, P NATL ACAD SCI USA, V93, P8095, DOI 10.1073/pnas.93.15.8095; Saillant PA, 2007, J ACOUST SOC AM, V121, P3001, DOI 10.1121/1.2714920; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SUTHERS RA, 1982, J COMP PHYSIOL, V145, P529, DOI 10.1007/BF00612818; SUTHERS RA, 1973, AM ZOOL, V13, P1215; Thomas JA, 2004, ECHOLOCATION BATS DO	27	70	71	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1885	1888		10.1126/science.1207309	http://dx.doi.org/10.1126/science.1207309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960635				2022-12-24	WOS:000295365800055
J	Lo Re, V; Teal, V; Localio, AR; Amorosa, VK; Kaplan, DE; Gross, R				Lo Re, Vincent, III; Teal, Valerie; Localio, A. Russell; Amorosa, Valerianna K.; Kaplan, David E.; Gross, Robert			Relationship Between Adherence to Hepatitis C Virus Therapy and Virologic Outcomes	ANNALS OF INTERNAL MEDICINE			English	Article							INTERFERON-ALPHA-2B PLUS RIBAVIRIN; INITIATED ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PEGINTERFERON ALPHA-2A; COMBINATION THERAPY; SUSTAINED RESPONSE; PHARMACY RECORDS; VIRAL LOAD; INFECTION; COMPLICATIONS	Background: Adherence to therapy with pegylated interferon and ribavirin for hepatitis C virus (HCV) infection has been incompletely examined. Objective: To evaluate the relationship between adherence to HCV therapy and early and sustained virologic response, assess changes in adherence over time, and examine risk factors for nonadherence. Design: Retrospective cohort study. Setting: National Veterans Affairs Hepatitis C Clinical Case Registry. Patients: 5706 HCV-infected patients (genotypes 1, 2, 3, or 4) with at least 1 prescription for both pegylated interferon and ribavirin between 2003 and 2006 and HCV RNA results before and after treatment initiation. Measurements: Adherence was calculated over 12-week intervals by using pharmacy refill data. End points included early virologic response (decrease of >= 2 log(10) HCV RNA at 12 weeks) and sustained virologic response (undetectable HCV RNA 24 weeks after the end of treatment). Results: Early virologic response increased with higher levels of adherence to ribavirin therapy over the initial 12 weeks (patients with HCV genotype 1 or 4, 25 of 68 [37%] with <= 40% adherence vs. 1367 of 2187 [63%] with 91% to 100% adherence [P < 0.001]; patients with HCV genotype 2 or 3, 12 of 18 [67%] with <= 40% adherence vs. 651 of 713 [91%] with 91% to 100% adherence [P < 0.001]). Among patients with HCV genotype 1 or 4, sustained response increased with higher adherence to ribavirin therapy over the second, third, and fourth 12-week intervals. Results were similar for adherence to interferon therapy. Mean adherence to therapy with interferon and ribavirin decreased by 3.4 and 6.6 percentage points per 12-week interval, respectively (P for trend < 0.001 for each drug). Patients who received growth factors or thyroid medications during treatment had higher mean adherence to antiviral therapy. Limitation: This was an observational study without standardized timing for outcome measurements. Conclusion: Early and sustained virologic responses increased with higher levels of adherence to interferon and ribavirin therapy. Adherence to therapy with both antivirals decreased over time, but more so for ribavirin.	[Lo Re, Vincent, III] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Lo Re, V (corresponding author), Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, 836 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	vincentl@mail.med.upenn.edu	Re, Vincent Lo/N-7817-2015	Kaplan, David/0000-0002-3839-336X; Teal, Valerie/0000-0001-7116-5353	Department of Veterans Affairs; National Institutes of Health [K01 AI070001]; Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics [HS10399]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI070001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060455] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This material is based on work supported in part by the Department of Veterans Affairs. The contents do not represent the views of the Department of Veterans Affairs or the U.S. Government.; By grant K01 AI070001 from the National Institutes of Health (Dr. Lo Re), grant HS10399 from the Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics cooperative agreement (Drs. Lo Re, Localio, and Gross), and a Department of Veterans Affairs Competitive Pilot Project Fund grant (Drs. Lo Re and Amorosa).	Backus LI, 2009, J AM MED INFORM ASSN, V16, P775, DOI 10.1197/jamia.M3203; Balding DJ, 2004, APPL LONGITUDINAL AN; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Berenguer J, 2009, HEPATOLOGY, V50, P407, DOI 10.1002/hep.23020; Berlin JA, 1999, BIOMETRICS, V55, P470, DOI 10.1111/j.0006-341X.1999.00470.x; Braithwaite RS, 2007, AIDS, V21, P1579, DOI 10.1097/QAD.0b013e3281532b31; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; ELIXHAUSER A, 1990, MED CARE, V28, P882, DOI 10.1097/00005650-199010000-00003; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gross R, 2002, AIDS, V16, P1835, DOI 10.1097/00002030-200209060-00021; Gross R, 2001, AIDS, V15, P2109, DOI 10.1097/00002030-200111090-00006; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Heisler M, 2008, CIRCULATION, V117, P2884, DOI 10.1161/CIRCULATIONAHA.107.724104; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lima VD, 2009, JAIDS-J ACQ IMM DEF, V50, P529, DOI 10.1097/QAI.0b013e31819675e9; Lo Re V, 2009, CLIN INFECT DIS, V48, P186, DOI 10.1086/595685; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 2002, GASTROENTEROLOGY, V123, P1061, DOI 10.1053/gast.2002.35950; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Raptopoulou M, 2005, J VIRAL HEPATITIS, V12, P91, DOI 10.1111/j.1365-2893.2005.00549.x; Reddy KR, 2007, CLIN GASTROENTEROL H, V5, P124, DOI 10.1016/j.cgh.2006.10.008; Rothman K., 1998, MODERN EPIDEMIOLOGY; Sarrazin C, 2010, GASTROENTEROLOGY, V138, P447, DOI 10.1053/j.gastro.2009.11.055; Shiffman ML, 2007, GASTROENTEROLOGY, V132, P103, DOI 10.1053/j.gastro.2006.11.011; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thompson AJV, 2009, J VIRAL HEPATITIS, V16, P377, DOI 10.1111/j.1365-2893.2009.01124.x; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003; Weiss JJ, 2008, ALIMENT PHARM THER, V28, P289, DOI 10.1111/j.1365-2036.2008.03718.x; Weiss JJ, 2009, ALIMENT PHARM THER, V30, P14, DOI 10.1111/j.1365-2036.2009.04004.x; Yee HS, 2006, AM J GASTROENTEROL, V101, P2360, DOI 10.1111/j.1572-0241.2006.00754.x	37	56	57	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					353	U46		10.7326/0003-4819-155-6-201109200-00003	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930852	Green Accepted			2022-12-24	WOS:000295033400014
J	Yang, T; Wu, MC				Yang, Tian; Wu, Meng-chao			Discrimination against hepatitis B carriers in China	LANCET			English	Editorial Material									[Yang, Tian; Wu, Meng-chao] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China	Naval Medical University	Wu, MC (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai 200438, Peoples R China.	Mengchao_wu@sina.com	Yang, Tian/W-6668-2019; Yang, Tian/M-5484-2018	Yang, Tian/0000-0003-1544-0976				[Anonymous], 2009, CHINA DAILY     0305; *BEJ YIR CTR, 2009, PLEA HALT BIAS HEP S; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; NI CC, 2004, HEPATITIS B CAUSE DI; 2009, CHINA RADIO INT 0106; 2007, XINHUA NEWS AGE 0714; 2010, PEOPLES DAILY   0327; 2009, CHINA CENTRAL T 1230; 2005, CHINA DAILY     0121	10	33	42	1	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2011	378	9796					1059	1059		10.1016/S0140-6736(11)61460-8	http://dx.doi.org/10.1016/S0140-6736(11)61460-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829BE	21924982				2022-12-24	WOS:000295548900008
J	Parsons, HM; Tuttle, TM; Kuntz, KM; Begun, JW; McGovern, PM; Virnig, BA				Parsons, Helen M.; Tuttle, Todd M.; Kuntz, Karen M.; Begun, James W.; McGovern, Patricia M.; Virnig, Beth A.			Association Between Lymph Node Evaluation for Colon Cancer and Node Positivity Over the Past 20 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; RECTAL-CANCER; SURVIVAL; POPULATION; MICROMETASTASES; RESECTION; SURGERY; NUMBER; STAGE; ADENOCARCINOMA	Context Among patients surgically treated for colon cancer, better survival has been demonstrated in those with more lymph nodes evaluated. The presumed mechanism behind this association suggests that a more extensive lymph node evaluation reduces the risk of understaging, leading to improved survival. Objective To further evaluate the mechanism behind lymph node evaluation and survival by examining the association between more extensive lymph node evaluation, identification of lymph node-positive cancers, and hazard of death. Design Observational cohort study. Setting Surveillance, Epidemiology, and End Results (SEER) program data from 1988 through 2008. Patients 86 394 patients surgically treated for colon cancer. Main Outcome Measure We examined the relationship between lymph node evaluation and node positivity using Cochran-Armitage tests and multivariate logistic regression. The association between lymph node evaluation and hazard of death was evaluated using Cox proportional hazards modeling. Results The number of lymph nodes evaluated increased from 1988 to 2008 but did not result in a significant overall increase in lymph node positivity. During 1988-1990, 34.6% of patients (3875/11 200) had 12 or more lymph nodes evaluated, increasing to 73.6% (9798/13 310) during 2006-2008 (P<.001); however, the proportion of node-positive cancers did not change with time (40% in 1988-1990, 42% in 2006-2008, P=.53). Although patients with high levels of lymph node evaluation were only slightly more likely to be node positive (adjusted odds ratio for 30-39 nodes vs 1-8 nodes, 1.11; 95% CI, 1.02-1.20), these patients experienced significantly lower hazard of death compared with those with fewer nodes evaluated (adjusted hazard ratio for 30-39 nodes vs 1-8 nodes, 0.66; 95% CI, 0.62-0.71; unadjusted 5-year mortality, 35.3%). Conclusion The number of lymph nodes evaluated for colon cancer has markedly increased in the past 2 decades but was not associated with an overall shift toward higher-staged cancers, questioning the upstaging mechanism as the primary basis for improved survival in patients with more lymph nodes evaluated. JAMA. 2011;306(10):1089-1097 www.jama.com	[Parsons, Helen M.] NCI, Appl Res Program, Bethesda, MD 20892 USA; [Tuttle, Todd M.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Kuntz, Karen M.; Begun, James W.; Virnig, Beth A.] Univ Minnesota, Div Hlth Policy & Management, Minneapolis, MN 55455 USA; [McGovern, Patricia M.] Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Tuttle, Todd M.; Virnig, Beth A.] Masonic Canc Ctr, Minneapolis, MN USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Parsons, HM (corresponding author), NCI, Appl Res Program, Execut Plaza N,6130 Execut Blvd,MSC 7344, Bethesda, MD 20892 USA.	helen.parsons@nih.gov		Begun, James/0000-0003-1924-6126; Tuttle, Todd/0000-0001-6603-2062				[Anonymous], IS COL CANC STAG; [Anonymous], 1997, AJCC CANC STAGING MA; [Anonymous], ASCO NCCN QUAL MEAS; [Anonymous], UND CHANG 6 7 ED AJC; [Anonymous], 1997, J CLIN PATHOL; Baxter NN, 2010, DIS COLON RECTUM, V53, P65, DOI 10.1007/DCR.0b013e3181c70425; Baxter NN, 2009, J SURG ONCOL, V99, P265, DOI 10.1002/jso.21197; Baxter NN, 2005, INT J RADIAT ONCOL, V61, P426, DOI 10.1016/j.ijrobp.2004.06.259; Bernini A, 2000, CANCER DETECT PREV, V24, P72; Bilimoria KY, 2008, J NATL CANCER I, V100, P1310, DOI 10.1093/jnci/djn293; Bui L, 2006, J SURG ONCOL, V93, P439, DOI 10.1002/jso.20499; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Chen SL, 2006, ANN SURG, V244, P602, DOI 10.1097/01.sla.0000237655.11717.50; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; FIELDING LP, 1991, J GASTROEN HEPATOL, V6, P325, DOI 10.1111/j.1440-1746.1991.tb00867.x; Goldstein NS, 2002, AM J SURG PATHOL, V26, P179, DOI 10.1097/00000478-200202000-00004; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Ho SB, 2004, CLIN CANCER RES, V10, P5777, DOI 10.1158/1078-0432.CCR-03-0507; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Liefers GJ, 1998, NEW ENGL J MED, V339, P223, DOI 10.1056/NEJM199807233390403; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; National Cancer Institute's, SURV EP END RES SEER; Nattinger AB, 1997, J CLIN EPIDEMIOL, V50, P939, DOI 10.1016/S0895-4356(97)00099-1; Nelson H, 2001, JNCI-J NATL CANCER I, V93, P583, DOI 10.1093/jnci/93.8.583; NIVATVONGS S, 1991, DIS COLON RECTUM, V34, P323, DOI 10.1007/BF02050592; Okabe S, 2004, J GASTROINTEST SURG, V8, P1032, DOI 10.1016/j.gassur.2004.09.038; Otchy D, 2004, DIS COLON RECTUM, V47, P1269, DOI 10.1007/s10350-004-0598-8; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Simunovic M, 2007, JAMA-J AM MED ASSOC, V298, P2194, DOI 10.1001/jama.298.18.2194; Wong SL, 2007, JAMA-J AM MED ASSOC, V298, P2149, DOI 10.1001/jama.298.18.2149; Yoshimatsu K, 2005, HEPATO-GASTROENTEROL, V52, P1703	32	138	144	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1089	1097		10.1001/jama.2011.1285	http://dx.doi.org/10.1001/jama.2011.1285			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917579				2022-12-24	WOS:000294806200022
J	Antoniou, T; Gomes, T; Mamdani, MM; Yao, Z; Hellings, C; Garg, AX; Weir, MA; Juurlink, DN				Antoniou, Tony; Gomes, Tara; Mamdani, Muhammad M.; Yao, Zhan; Hellings, Chelsea; Garg, Amit X.; Weir, Matthew A.; Juurlink, David N.			Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study	BRITISH MEDICAL JOURNAL			English	Article							CONGESTIVE-HEART-FAILURE; MECHANISM; THERAPY; DYSFUNCTION; INHIBITORS; MORBIDITY; COHORT	Objectives To characterise the risk of admission to hospital for hyperkalaemia in elderly patients treated with trimethoprim-sulfamethoxazole in combination with spironolactone. Design Population based nested case-control study. Setting Ontario, Canada, from 1 April 1992 to 1 March 2010. Participants Cases were residents of Ontario aged 66 years or above receiving chronic treatment with spironolactone and admitted to hospital with hyperkalaemia within 14 days of receiving a prescription for either trimethoprim-sulfamethoxazole, amoxicillin, norfloxacin, or nitrofurantoin. Up to four controls for each case were identified from the same cohort, matched on age, sex, and presence or absence of chronic kidney disease and diabetes, and required to have received one of the study antibiotics within 14 days before the case's index date. Main outcome measures Odds ratio for association between admission to hospital with hyperkalaemia and receipt of a study antibiotic in the preceding 14 days, adjusted for conditions and drugs that may influence risk of hyperkalaemia. Results During the 18 year study period, 6903 admissions for hyperkalaemia were identified, 306 of which occurred within 14 days of antibiotic use. Of these, 248 (81%) cases were matched to 783 controls. 10.8% (17 859/165 754) of spironolactone users received at least one prescription for trimethoprim-sulfamethoxazole. Compared with amoxicillin, prescription of trimethoprim-sulfamethoxazole was associated with a marked increase in the risk of admission to hospital for hyperkalaemia (adjusted odds ratio 12.4, 95% confidence interval 7.1 to 21.6). The population attributable fraction was 59.7%, suggesting that approximately 60% of all cases of hyperkalaemia in older patients taking spironolactone and treated with an antibiotic for a urinary tract infection could be avoided if trimethoprim-sulfamethoxazole was not prescribed. Treatment with nitrofurantoin was also associated with an increase in the risk of hyperkalaemia (adjusted odds ratio 2.4, 1.3 to 4.6), but no such risk was found with norfloxacin (adjusted odds ratio 1.6, 0.8 to 3.4) Conclusions Among older patients receiving spironolactone, treatment with trimethoprim-sulfamethoxazole was associated with a major increase in the risk of admission to hospital for hyperkalaemia. This drug combination should be avoided when possible.	[Antoniou, Tony; Gomes, Tara; Mamdani, Muhammad M.; Juurlink, David N.] Univ Toronto, Toronto, ON, Canada; [Antoniou, Tony] St Michaels Hosp, Dept Family & Community Med, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Mamdani, Muhammad M.; Yao, Zhan; Hellings, Chelsea; Garg, Amit X.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Mamdani, Muhammad M.] King Saud Univ, Riyadh, Saudi Arabia; [Garg, Amit X.; Weir, Matthew A.] Univ Western Ontario, Div Nephrol, London, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; King Saud University; Western University (University of Western Ontario); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Antoniou, T (corresponding author), 410 Sherbourne St,4th Floor, Toronto, ON M4X 1K2, Canada.	tantoniou@smh.toronto.on.ca	Hug, Balthasar L./G-1568-2010; Garg, Amit X/G-3295-2011; Weir, Matthew/G-3354-2011	Gomes, Tara/0000-0002-1468-1965	Ontario HIV Treatment Network; Canadian Institutes of Health Research; Ontario Drug Policy Research Network; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care (MOHLTC); GlaxoSmithKline; Merck; Pfizer	Ontario HIV Treatment Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Drug Policy Research Network; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Pfizer(Pfizer)	TA is supported by a post-doctoral fellowship award from the Ontario HIV Treatment Network. AG is supported by a clinician scientist award from the Canadian Institutes of Health Research. This project was supported by research funds from the Ontario Drug Policy Research Network and by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The sponsors had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.; All authors have completed the Unified Competing Interest form at www.icmje.org_disclosure.pdf (available on request from the corresponding author). During the past three years, TA has received unrestricted research grants from GlaxoSmithKline, Merck, and Pfizer for different studies. All other authors declare no support from any company for the submitted work; no relationships with any companies that might have an interest in the submitted work in the previous 3 years; and no non-financial interests that may be relevant to the submitted work.	APPEL GB, 1981, NEPHRON, V27, P313, DOI 10.1159/000182077; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cruz CS, 2003, NEPHROL DIAL TRANSPL, V18, P1814, DOI 10.1093/ndt/gfg295; Desai AS, 2007, J AM COLL CARDIOL, V50, P1959, DOI 10.1016/j.jacc.2007.07.067; EiamOng S, 1996, KIDNEY INT, V49, P1372, DOI 10.1038/ki.1996.193; Hanley JA, 2001, J EPIDEMIOL COMMUN H, V55, P508, DOI 10.1136/jech.55.7.508; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jager LP, 1997, EUR J PHARMACOL, V331, P325, DOI 10.1016/S0014-2999(97)01052-2; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Lim PO, 2001, J HYPERTENS, V19, P353, DOI 10.1097/00004872-200103000-00001; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; MARINELLA MA, 1997, INFECT DIS CLIN PRAC, V6, P257; Martin Jennifer, 2003, N Z Med J, V116, pU542; Masoudi FA, 2005, CIRCULATION, V112, P39, DOI 10.1161/CIRCULATIONAHA.104.527549; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Perazella MA, 2000, DRUG SAFETY, V22, P227, DOI 10.2165/00002018-200022030-00006; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; PONCE SP, 1985, MEDICINE, V64, P357, DOI 10.1097/00005792-198511000-00001; Rocha R, 2002, DRUGS, V62, P723, DOI 10.2165/00003495-200262050-00001; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schrier RW, 2010, CLIN J AM SOC NEPHRO, V5, P1132, DOI 10.2215/CJN.01410210; Svensson M, 2004, J CARD FAIL, V10, P297, DOI 10.1016/j.cardfail.2003.10.012; VELAZQUEZ H, 1993, ANN INTERN MED, V119, P296, DOI 10.7326/0003-4819-119-4-199308150-00008	28	45	46	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 12	2011	343								d5228	10.1136/bmj.d5228	http://dx.doi.org/10.1136/bmj.d5228			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822UZ	21911446	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000295076500001
J	Sacco, RL; Smith, SC; Holmes, D; Shurin, S; Brawley, O; Cazap, E; Glass, R; Komajda, M; Koroshetz, W; Mayer-Davis, E; Mbanya, JC; Sledge, G; Varmus, H				Sacco, R. L.; Smith, S. C.; Holmes, D.; Shurin, S.; Brawley, O.; Cazap, E.; Glass, R.; Komajda, M.; Koroshetz, W.; Mayer-Davis, E.; Mbanya, J. C.; Sledge, G.; Varmus, H.			Accelerating progress on non-communicable diseases	LANCET			English	Editorial Material									[Sacco, R. L.] Amer Heart Assoc, Dallas, TX 75231 USA; [Smith, S. C.] World Heart Federat, Geneva, Switzerland; [Holmes, D.] Amer Coll Cardiol, Washington, DC USA; [Shurin, S.] NHLBI, NIH, Bethesda, MD 20892 USA; [Glass, R.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Koroshetz, W.] NINDS, NIH, Bethesda, MD 20892 USA; [Varmus, H.] NCI, NIH, Bethesda, MD 20892 USA; [Brawley, O.] Amer Canc Soc, Atlanta, GA 30329 USA; [Cazap, E.] Union Int Canc Control, Geneva, Switzerland; [Komajda, M.] European Soc Cardiol, Sophia Antipolis, France; [Mayer-Davis, E.] Amer Diabet Assoc, Alexandria, VA USA; [Mbanya, J. C.] Int Diabet Federat, Brussels, Belgium; [Sledge, G.] Amer Soc Clin Oncol, Alexandria, VA USA	American College of Cardiology; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Cancer Society; American Diabetes Association; American Society of Clinical Oncology	Sacco, RL (corresponding author), Amer Heart Assoc, Dallas, TX 75231 USA.	rsacco@med.miami.edu	Sacco, Ralph/Y-9278-2019; Mbanya, Jean Claude N/T-5147-2018	Mbanya, Jean Claude N/0000-0001-9651-8653				[Anonymous], PREV HLTH AM INV DIS; [Anonymous], 2011, BURD BEST BUYS RED E; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Behan D., 2005, EC EFFECTS ENV TOBAC; Dall TM, 2009, AM J HEALTH PROMOT, V23, P412, DOI 10.4278/ajhp.080930-QUAN-226; Organization W. H, 2009, 2008 2013 ACT PLAN G; Sacco RL, 2011, CIRCULATION, V123, P2653, DOI 10.1161/CIR.0b013e318220dec1; WHO, 2011, GLOB STAT REP NONC D; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2010, GLOB STRAT RED HARMF	12	16	18	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 7	2013	382	9895					E4	E5		10.1016/S0140-6736(11)61477-3	http://dx.doi.org/10.1016/S0140-6736(11)61477-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	215WE	21933747				2022-12-24	WOS:000324240700001
J	Goehring, NW; Trong, PK; Bois, JS; Chowdhury, D; Nicola, EM; Hyman, AA; Grill, SW				Goehring, Nathan W.; Trong, Philipp Khuc; Bois, Justin S.; Chowdhury, Debanjan; Nicola, Ernesto M.; Hyman, Anthony A.; Grill, Stephan W.			Polarization of PAR Proteins by Advective Triggering of a Pattern-Forming System	SCIENCE			English	Article							C-ELEGANS EMBRYOS; ANTERIOR-POSTERIOR POLARITY; CELL POLARITY; CAENORHABDITIS-ELEGANS; CORTICAL FLOWS; ESTABLISHMENT; MAINTENANCE; ASYMMETRY; ZYGOTE	In the Caenorhabditis elegans zygote, a conserved network of partitioning-defective (PAR) polarity proteins segregates into an anterior and a posterior domain, facilitated by flows of the cortical actomyosin meshwork. The physical mechanisms by which stable asymmetric PAR distributions arise from transient cortical flows remain unclear. We present evidence that PAR polarity arises from coupling of advective transport by the flowing cell cortex to a multistable PAR reaction-diffusion system. By inducing transient PAR segregation, advection serves as a mechanical trigger for the formation of a PAR pattern within an otherwise stably unpolarized system. We suggest that passive advective transport in an active and flowing material may be a general mechanism for mechanochemical pattern formation in developmental systems.	[Trong, Philipp Khuc; Bois, Justin S.; Chowdhury, Debanjan; Nicola, Ernesto M.; Grill, Stephan W.] Max Planck Inst Phys Complex Syst MPI PKS, D-01187 Dresden, Germany; [Goehring, Nathan W.; Trong, Philipp Khuc; Bois, Justin S.; Hyman, Anthony A.; Grill, Stephan W.] Max Planck Inst Mol Cell Biol & Genet MPI CBG, D-01307 Dresden, Germany	Max Planck Society; Max Planck Society	Grill, SW (corresponding author), Max Planck Inst Phys Complex Syst MPI PKS, D-01187 Dresden, Germany.	grill@mpi-cbg.de	Grill, Stephan/D-9427-2012; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Chowdhury, Debanjan/G-3830-2012; Nicola, Ernesto/G-2290-2010; Goehring, Nathan/AAC-7310-2020	Hyman, Anthony A/0000-0003-3664-154X; Goehring, Nathan/0000-0001-8710-4467; Chowdhury, Debanjan/0000-0003-0758-0282; Bois, Justin/0000-0001-7137-8746	ARCHES Minerva Foundation; European Molecular Biology Organization; Alexander von Humboldt Foundation; European Commission [219286]; Human Frontier Science Program; MPI-PKS	ARCHES Minerva Foundation; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program(Human Frontier Science Program); MPI-PKS	We thank C. Hoege, A. Pozniakovsky, and S. Ernst for help in generating CAI-optimized transgenes and S. Jaensch for embryo size measurements. This work was supported by the ARCHES Minerva Foundation and the European Molecular Biology Organization Young Investigator Programme (S. W. G.), the Alexander von Humboldt Foundation and a Marie Curie Grant (219286) from the European Commission (N.W.G.), the Human Frontier Science Program (J.S.B.), and the MPI-PKS Visitors Program (D.C. and E.M.N.).	Arai Y, 2010, P NATL ACAD SCI USA, V107, P12399, DOI 10.1073/pnas.0908278107; Benton R, 2003, CELL, V115, P691, DOI 10.1016/S0092-8674(03)00938-3; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Boyd L, 1996, DEVELOPMENT, V122, P3075; Chalmers AD, 2005, DEVELOPMENT, V132, P977, DOI 10.1242/dev.01645; Cowan CR, 2004, NATURE, V431, P92, DOI 10.1038/nature02825; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gamba A, 2005, P NATL ACAD SCI USA, V102, P16927, DOI 10.1073/pnas.0503974102; Goehring NW, 2011, J CELL BIOL, V193, P583, DOI 10.1083/jcb.201011094; Hao YS, 2006, DEV CELL, V10, P199, DOI 10.1016/j.devcel.2005.12.015; HILL DP, 1988, DEV BIOL, V125, P75, DOI 10.1016/0012-1606(88)90060-7; HIRD SN, 1993, J CELL BIOL, V121, P1343, DOI 10.1083/jcb.121.6.1343; Hoege C, 2010, CURR BIOL, V20, P1296, DOI 10.1016/j.cub.2010.05.061; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Jilkine A, 2007, B MATH BIOL, V69, P1943, DOI 10.1007/s11538-007-9200-6; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Mori Y, 2008, BIOPHYS J, V94, P3684, DOI [10.1529/biophysj.107.120824, 10.1529/biophysj.107.120827]; Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001; Redemann S, 2011, NAT METHODS, V8, P250, DOI [10.1038/nmeth.1565, 10.1038/NMETH.1565]; Shelton CA, 1999, J CELL BIOL, V146, P439, DOI 10.1083/jcb.146.2.439; Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896; Tostevin F, 2008, BIOPHYS J, V95, P4512, DOI 10.1529/biophysj.108.136416; Tsai MC, 2007, J CELL BIOL, V179, P397, DOI 10.1083/jcb.200708101; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Watts JL, 1996, DEVELOPMENT, V122, P3133; Zonies S, 2010, DEVELOPMENT, V137, P1669, DOI 10.1242/dev.045823	29	200	201	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1137	1141		10.1126/science.1208619	http://dx.doi.org/10.1126/science.1208619			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22021673				2022-12-24	WOS:000297313900052
J	Schroder, FH				Schroeder, Fritz H.			Stratifying Risk - The US Preventive Services Task Force and Prostate-Cancer Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Erasmus Univ, Med Ctr, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Schroder, FH (corresponding author), Erasmus Univ, Med Ctr, Rotterdam, Netherlands.							CHOU R, 2011, ANN INTERN MED  1007; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Roobol MJ, 2010, EUR UROL, V57, P79, DOI 10.1016/j.eururo.2009.08.025; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084	5	39	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1953	1955		10.1056/NEJMp1112140	http://dx.doi.org/10.1056/NEJMp1112140			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22029756				2022-12-24	WOS:000297282600004
J	Yang, XJ; Ren, Z; Kuk, J; Moffat, K				Yang, Xiaojing; Ren, Zhong; Kuk, Jane; Moffat, Keith			Temperature-scan cryocrystallography reveals reaction intermediates in bacteriophytochrome	NATURE			English	Article							PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; CHROMOPHORE-BINDING DOMAIN; GROUND-STATE; MIDINFRARED SPECTROSCOPY; CRYSTAL-STRUCTURE; GAF DOMAIN; PHYTOCHROME; LIGHT; PHOTOCONVERSION; PFR	Light is a fundamental signal that regulates important physiological processes such as development and circadian rhythm in living organisms. Phytochromes form a major family of photoreceptors responsible for red light perception in plants, fungi and bacteria(1). They undergo reversible photoconversion between red-absorbing (Pr) and far-red-absorbing (Pfr) states, thereby ultimately converting a light signal into a distinct biological signal that mediates subsequent cellular responses(2). Several structures of microbial phytochromes have been determined in their dark-adapted Pr or Pfr states(3-7). However, the structural nature of initial photochemical events has not been characterized by crystallography. Here we report the crystal structures of three intermediates in the photoreaction of Pseudomonas aeruginosa bacteriophytochrome (PaBphP). We used cryotrapping crystallography to capture intermediates, and followed structural changes by scanning the temperature at which the photoreaction proceeded. Light-induced conformational changes in PaBphP originate in ring D of the biliverdin (BV) chromophore, and E-to-Z isomerization about the C-15 = C-16 double bond between rings C and D is the initial photochemical event. As the chromophore relaxes, the twist of the C-15 methine bridge about its two dihedral angles is reversed. Structural changes extend further to rings B and A, and to the surrounding protein regions. These data indicate that absorption of a photon by the Pfr state of PaBphP converts a light signal into a structural signal via twisting and untwisting of the methine bridges in the linear tetrapyrrole within the confined protein cavity.	[Yang, Xiaojing; Kuk, Jane; Moffat, Keith] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Ren, Zhong; Moffat, Keith] Univ Chicago, Ctr Adv Radiat Sources, Chicago, IL 60637 USA; [Moffat, Keith] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Yang, XJ (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	xiaojingyang@uchicago.edu; moffat@cars.uchicago.edu		Kuk, Jane/0000-0002-8886-4078	National Institutes of Health [GM036452, RR07707]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR007707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036452, R37GM036452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Moglich for comments and reading of the manuscript, and V. Srajer of BioCARS for assistance in microspectrometer experiments on crystals. We also thank the staff of LSCAT and BioCARS at the Advanced Photon Source, Argonne National Laboratory for beamline access. Supported by National Institutes of Health grant GM036452 to K.M. BioCARS is supported by National Institutes of Health grant RR07707 to K.M.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson S, 2004, PHOTOCHEM PHOTOBIOL, V80, P7, DOI 10.1562/2004-03-15-RA-115.1; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Dasgupta J, 2009, P NATL ACAD SCI USA, V106, P1784, DOI 10.1073/pnas.0812056106; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Foerstendorf H, 1996, BIOCHEMISTRY-US, V35, P10793, DOI 10.1021/bi960960r; Giraud E, 2005, J BIOL CHEM, V280, P32389, DOI 10.1074/jbc.M506890200; Giraud E, 2010, METHOD ENZYMOL, V471, P135, DOI 10.1016/S0076-6879(10)71009-0; Li H, 2010, P NATL ACAD SCI USA, V107, P10872, DOI 10.1073/pnas.1001908107; MOFFAT K, 1995, CURR OPIN STRUC BIOL, V5, P656, DOI 10.1016/0959-440X(95)80059-X; Montgomery BL, 2002, TRENDS PLANT SCI, V7, P357, DOI 10.1016/S1360-1385(02)02304-X; Muller MG, 2008, BIOPHYS J, V94, P4370, DOI 10.1529/biophysj.106.091652; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajagopala S, 2004, ACTA CRYSTALLOGR D, V60, P860, DOI 10.1107/S0907444904004160; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rockwell NC, 2009, P NATL ACAD SCI USA, V106, P6123, DOI 10.1073/pnas.0902370106; Rohmer T, 2010, J AM CHEM SOC, V132, P4431, DOI 10.1021/ja9108616; Schmidt M, 2004, P NATL ACAD SCI USA, V101, P4799, DOI 10.1073/pnas.0305983101; Schumann C, 2008, BIOPHYS J, V94, P3189, DOI 10.1529/biophysj.107.119297; Schwinte P, 2009, PHOTOCHEM PHOTOBIOL, V85, P239, DOI 10.1111/j.1751-1097.2008.00426.x; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; Song C, 2011, P NATL ACAD SCI USA, V108, P3842, DOI 10.1073/pnas.1013377108; Tasler R, 2005, FEBS J, V272, P1927, DOI 10.1111/j.1742-4658.2005.04623.x; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; van Thor JJ, 2007, J AM CHEM SOC, V129, P126, DOI 10.1021/ja0660709; van Wilderen LJGW, 2009, J PHYS CHEM B, V113, P16354, DOI 10.1021/jp9038539; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	35	125	128	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					428	U190		10.1038/nature10506	http://dx.doi.org/10.1038/nature10506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22002602	Green Accepted			2022-12-24	WOS:000297059700052
J	Xue, T; Do, MTH; Riccio, A; Jiang, Z; Hsieh, J; Wang, HC; Merbs, SL; Welsbie, DS; Yoshioka, T; Weissgerber, P; Stolz, S; Flockerzi, V; Freichel, M; Simon, MI; Clapham, DE; Yau, KW				Xue, T.; Do, M. T. H.; Riccio, A.; Jiang, Z.; Hsieh, J.; Wang, H. C.; Merbs, S. L.; Welsbie, D. S.; Yoshioka, T.; Weissgerber, P.; Stolz, S.; Flockerzi, V.; Freichel, M.; Simon, M. I.; Clapham, D. E.; Yau, K. -W.			Melanopsin signalling in mammalian iris and retina	NATURE			English	Article							GANGLION-CELLS; DIFFERENTIAL REGULATION; PUPILLARY CONSTRICTION; LIGHT REFLEX; PHOTOTRANSDUCTION; EXPRESSION; MICE; PHOTOSENSITIVITY; LOCALIZATION; PHOTOPIGMENT	Non-mammalian vertebrates have an intrinsically photosensitive iris and thus a local pupillary light reflex (PLR). In contrast, it is thought that the PLR in mammals generally requires neuronal circuitry connecting the eye and the brain. Here we report that an intrinsic component of the PLR is in fact widespread in nocturnal and crepuscular mammals. In mouse, this intrinsic PLR requires the visual pigment melanopsin; it also requires PLC beta 4, a vertebrate homologue of the Drosophila NorpA phospholipase C which mediates rhabdomeric phototransduction. The Plcb4(-/-) genotype, in addition to removing the intrinsic PLR, also essentially eliminates the intrinsic light response of the M1 subtype of melanopsin-expressing, intrinsically photosensitive retinal ganglion cells (M1-ipRGCs), which are by far the most photosensitive ipRGC subtype and also have the largest response to light. Ablating in mouse the expression of both TRPC6 and TRPC7, members of the TRP channel superfamily, also essentially eliminated the M1-ipRGC light response but the intrinsic PLR was not affected. Thus, melanopsin signalling exists in both iris and retina, involving a PLC beta 4-mediated pathway that nonetheless diverges in the two locations.	[Xue, T.; Do, M. T. H.; Jiang, Z.; Hsieh, J.; Wang, H. C.; Yoshioka, T.; Yau, K. -W.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Xue, T.; Do, M. T. H.; Jiang, Z.; Yau, K. -W.] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Baltimore, MD 21205 USA; [Riccio, A.; Clapham, D. E.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA; [Riccio, A.; Clapham, D. E.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Hsieh, J.] Johns Hopkins Univ, BA MS Concurrent Program Neurosci, Baltimore, MD 21238 USA; [Wang, H. C.] Johns Hopkins Univ, Sch Med, Grad Program Neurosci, Baltimore, MD 21205 USA; [Merbs, S. L.; Welsbie, D. S.; Yau, K. -W.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Yoshioka, T.] Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21238 USA; [Weissgerber, P.; Stolz, S.; Flockerzi, V.; Freichel, M.] Univ Saarland, Inst Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Simon, M. I.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Saarland University; California Institute of Technology	Xue, T (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	txue77@gmail.com; kwyau@mail.jhmi.edu	Jiang, Zheng/A-7674-2015; Clapham, David/R-5974-2019; H, Michael Tri/A-5917-2009; Xue, Tian/G-9009-2018; Clapham, David/S-1123-2019	H, Michael Tri/0000-0001-6418-0977; Clapham, David/0000-0002-4459-9428; Hsieh, Justin/0000-0002-9701-0998; Wang, Han Chin/0000-0001-8270-6645	US NIH [EY14596]; Antonio Champalimaud Vision Award (Portugal); NATIONAL EYE INSTITUTE [R01EY014596, R37EY006837, R01EY006837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006904] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award (Portugal); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the following individuals for providing knockout mouse lines: M. Caterina (Trpv4<SUP>-/-</SUP>), J. Lem (Rho<SUP>-/-</SUP> and Gnat1<SUP>-/-</SUP>), J. C. Chen (Rho<SUP>-/-</SUP>), J. Nathans (cl, also known as cone-DTA), A. Sancar (Cry1<SUP>-/-</SUP>Cry2<SUP>-/-</SUP>) and L. Birnbaumer (Trpc1<SUP>-/-</SUP>, Trpc3<SUP>-/-</SUP> and Trpc6<SUP>-/-</SUP>). We thank D. Marshak, R. von der Heydt, X. Wang and V. Casagrande for eyes from baboon, rhesus monkey, marmoset and bush baby, respectively, and W. Li, R. Mi, B. O'Rourke, L. Pipitone, D. Ruben, D. Ryugo, L. Smale and G. Tomaselli for eyes of other animals. Experiments on bush baby were carried out in the Casagrande laboratory with help and hospitality. We also thank W. Gao for suggestions on the force transducer, F. Rieke and A. Sampath for suggestions on the design of the LED light system, P. Ala-Laurila for the method of equivalent 480-nm-photon conversion, H. Cahill for the mouse-head-anchoring method, X. Ren for help on western blots, O. Garalde and A. Chen for help in the monkey experiments, and W. W. S. Yue for help on RT-PCR. We also thank T. Shelley for fabricating all custom equipment, S. Kulason for help in data analysis, and L. Ding for mouse-genotyping support. Members of the Yau laboratory provided comments on the manuscript. This work was supported by US NIH Grant EY14596 and the Antonio Champalimaud Vision Award (Portugal) to K.-W.Y.	Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Bailes HJ, 2010, CELL MOL LIFE SCI, V67, P99, DOI 10.1007/s00018-009-0155-7; BARR L, 1963, J GEN PHYSIOL, V46, P1249, DOI 10.1085/jgp.46.6.1249; BARR L, 1989, CRIT REV NEUROBIOL, V4, P325; Bellingham J, 2002, MOL BRAIN RES, V107, P128, DOI 10.1016/S0169-328X(02)00454-0; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; BITO LZ, 1975, COMP BIOCHEM PHYSIOL, V50, P407, DOI 10.1016/0300-9629(75)90034-1; Blanchong JA, 1999, J BIOL RHYTHM, V14, P364, DOI 10.1177/074873099129000777; Cahill H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002055; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Gomez MD, 2009, P NATL ACAD SCI USA, V106, P9081, DOI 10.1073/pnas.0900708106; Do MTH, 2009, NATURE, V457, P281, DOI 10.1038/nature07682; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Ghosh S, 2004, NEUROSCI LETT, V370, P7, DOI 10.1016/j.neulet.2004.07.026; Gonzalez-Cobos JC, 2010, FRONT BIOSCI-LANDMRK, V15, P1023, DOI 10.2741/3660; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Grozdanic S, 2003, CURR EYE RES, V26, P371, DOI 10.1076/ceyr.26.5.371.15439; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P14598, DOI 10.1073/pnas.93.25.14598; KARGACIN GJ, 1985, J NEUROSCI, V5, P3081; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; LAU KC, 1992, J NEUROL SCI, V113, P70, DOI 10.1016/0022-510X(92)90267-O; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Nayak SK, 2007, CELL MOL LIFE SCI, V64, P144, DOI 10.1007/s00018-006-5581-1; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Oyster CW., 1999, HUMAN EYE STRUCTURE; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; Perez-Leighton CE, 2011, EUR J NEUROSCI, V33, P856, DOI 10.1111/j.1460-9568.2010.07583.x; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Sekaran S, 2007, J NEUROSCI, V27, P3981, DOI 10.1523/JNEUROSCI.4716-06.2007; SELIGER HH, 1962, J GEN PHYSIOL, V46, P333, DOI 10.1085/jgp.46.2.333; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Zhu YL, 2007, INVEST OPHTH VIS SCI, V48, P1268, DOI 10.1167/iovs.06-0925; ZUCKER R, 1978, NATURE, V274, P78, DOI 10.1038/274078a0	50	186	193	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					67	73		10.1038/nature10567	http://dx.doi.org/10.1038/nature10567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22051675	Green Accepted			2022-12-24	WOS:000296422600033
J	Bayer, R; Oppenheimer, GM				Bayer, Ronald; Oppenheimer, Gerald M.			Routine HIV Screening - What Counts in Evidence-Based Policy?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bayer, Ronald; Oppenheimer, Gerald M.] Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA	Columbia University	Bayer, R (corresponding author), Columbia Univ, Ctr Hist & Eth Publ Hlth, Dept Sociomed Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.							AHRQ, 2007, AHRQ PUB; Beckwith CG, 2005, ANN INTERN MED, V143, P916, DOI 10.7326/0003-4819-143-12-200512200-00012; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Qaseem A, 2009, ANN INTERN MED, V150, P125, DOI 10.7326/0003-4819-150-2-200901200-00300; US Preventive Serv Task Force, 2005, ANN INTERN MED, V143, P32, DOI 10.7326/0003-4819-143-1-200507050-00008	5	14	14	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1265	1268		10.1056/NEJMp1108657	http://dx.doi.org/10.1056/NEJMp1108657			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829KL	21991946				2022-12-24	WOS:000295578700001
J	Schott, GD				Schott, G. D.			The art of medicine Doodling and the default network of the brain	LANCET			English	Editorial Material									Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Schott, GD (corresponding author), Natl Hosp Neurol & Neurosurg, Queen Sq, London WC1N 3BG, England.	g.schott@ucl.ac.uk						Andrade J, 2010, APPL COGNITIVE PSYCH, V24, P100, DOI 10.1002/acp.1561; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Gombrich Ernst H., 1999, USES IMAGES STUDIES, P212; Maclay W S, 1938, Proc R Soc Med, V31, P1337; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295	5	13	13	1	28	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 24	2011	378	9797					1133	1134		10.1016/S0140-6736(11)61496-7	http://dx.doi.org/10.1016/S0140-6736(11)61496-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	829RH	21969958				2022-12-24	WOS:000295601500014
J	Foley, RN; Gilbertson, DT; Murray, T; Collins, AJ				Foley, Robert N.; Gilbertson, David T.; Murray, Thomas; Collins, Allan J.			Long Interdialytic Interval and Mortality among Patients Receiving Hemodialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN-DEATH; SURVIVAL; TIME	Background Patients with end-stage renal disease requiring dialysis have limited tolerance of metabolic and volume-related deviations from normal ranges; in addition, the prevalence of cardiovascular disease is high among such patients. Given these problems, we hypothesized that a long interdialytic interval is associated with adverse events in patients receiving hemodialysis. Methods We studied 32,065 participants in the End-Stage Renal Disease Clinical Performance Measures Project, a nationally representative sample of U.S. patients receiving hemodialysis three times weekly, at the end of calendar years 2004 through 2007. We compared rates of death and cardiovascular-related hospital admissions on the day after the long (2-day) interdialytic interval with rates on other days. Results The mean age of the cohort was 62.2 years; 24.2% of the patients had been receiving dialysis treatment for 1 year or less. Over a mean follow-up interval of 2.2 years, the following event rates were higher on the day after the long interval than on other days: all-cause mortality (22.1 vs. 18.0 deaths per 100 person-years, P<0.001), mortality from cardiac causes (10.2 vs. 7.5, P<0.001), infection-related mortality (2.5 vs. 2.1, P=0.007), mortality from cardiac arrest (1.3 vs. 1.0, P=0.004), mortality from myocardial infarction (6.3 vs. 4.4, P<0.001), and admissions for myocardial infarction (6.3 vs. 3.9, P<0.001), congestive heart failure (29.9 vs. 16.9, P<0.001), stroke (4.7 vs. 3.1, P<0.001), dysrhythmia (20.9 vs. 11.0, P<0.001), and any cardiovascular event (44.2 vs. 19.7, P<0.001). Conclusions The long (2-day) interdialytic interval is a time of heightened risk among patients receiving hemodialysis. (Funded by the National Institutes of Health.)	[Foley, Robert N.; Gilbertson, David T.; Murray, Thomas; Collins, Allan J.] US Renal Data Syst, Minneapolis, MN 55404 USA; [Foley, Robert N.; Murray, Thomas; Collins, Allan J.] Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Foley, RN (corresponding author), US Renal Data Syst, 914 S 8th St,Suite S-406, Minneapolis, MN 55404 USA.	rfoley@usrds.org			National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases [HHSN267200715002C]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by the National Institutes of Health.; Supported by a contract (HHSN267200715002C) from the National Institute of Diabetes and Digestive and Kidney Diseases.	Abbott KC, 2003, AM J KIDNEY DIS, V41, P796, DOI 10.1016/S0272-6386(03)00027-1; Bleyer AJ, 2006, KIDNEY INT, V69, P2268, DOI 10.1038/sj.ki.5000446; Bleyer AJ, 1999, JAMA-J AM MED ASSOC, V281, P1211, DOI 10.1001/jama.281.13.1211; Bleyer AJ, 1999, KIDNEY INT, V55, P1553, DOI 10.1046/j.1523-1755.1999.00391.x; Bliwise DL, 2001, JAMA-J AM MED ASSOC, V286, P2690, DOI 10.1001/jama.286.21.2690; BLIWISE DL, 2002, JAMA-J AM MED ASSOC, V287, P192; Centers for Medicare and Medicaid Services, 2008, REL REP 2000 ESRD CP; Chertow GM, 2011, NEW ENGL J MED, V364, P93; Chertow GM, 2010, NEW ENGL J MED, V363, P2287, DOI 10.1056/NEJMoa1001593; *CTR MED MED SERV, ESRD DEATH NOT END S; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Genovesi S, 2009, NEPHROL DIAL TRANSPL, V24, P2529, DOI 10.1093/ndt/gfp104; Karnik JA, 2001, KIDNEY INT, V60, P350, DOI 10.1046/j.1523-1755.2001.00806.x; Kjellstrand C M, 1975, Kidney Int Suppl, P30; Kjellstrand CM, 1978, KIDNEY INT S, V8, pS120; Lafrance JP, 2006, NEPHROL DIAL TRANSPL, V21, P1006, DOI 10.1093/ndt/gfk007; Office of Clinical Standards and Quality, 2000, 2000 ANN REP ESRD CL; Owen WF, 1999, AM J KIDNEY DIS, V34, pS5, DOI 10.1053/ajkd.1999.v34.aajkd0344b0005; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; United States Renal Data System, 2010, 2010 USRDS ANN DAT R	20	301	320	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1099	1107		10.1056/NEJMoa1103313	http://dx.doi.org/10.1056/NEJMoa1103313			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992122				2022-12-24	WOS:000295081600009
J	Christoffersen, M; Frikke-Schmidt, R; Schnohr, P; Jensen, GB; Nordestgaard, BG; Tybjaerg-Hansen, A				Christoffersen, Mette; Frikke-Schmidt, Ruth; Schnohr, Peter; Jensen, Gorm B.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne			Xanthelasmata, arcus corneae, and ischaemic vascular disease and death in general population: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR RISK-FACTORS; CORONARY HEART-DISEASE; ANKLE-BRACHIAL INDEX; MORTALITY; ATHEROSCLEROSIS; PALPEBRARUM; ASSOCIATION; MEN	Objective To test the hypothesis that xanthelasmata and arcus corneae, individually and combined, predict risk of ischaemic vascular disease and death in the general population. Design Prospective population based cohort study. Setting The Copenhagen City Heart Study. Participants 12 745 people aged 20-93 years free of ischaemic vascular disease at baseline and followed from 1976-8 until May 2009 with 100% complete follow-up. Main outcome measures Hazard ratios for myocardial infarction, ischaemic heart disease, ischaemic stroke, ischaemic cerebrovascular disease, and death; odds ratios for severe atherosclerosis. Results 563 (4.4%) of participants had xanthelasmata and 3159 (24.8%) had arcus corneae at baseline. During 33 years' follow-up (mean 22 years), 1872 developed myocardial infarction, 3699 developed ischaemic heart disease, 1498 developed ischaemic stroke, 1815 developed ischaemic cerebrovascular disease, and 8507 died. Multifactorially adjusted hazard/odds ratios for people with versus those without xanthelasmata were 1.48 (95% confidence interval 1.23 to 1.79) for myocardial infarction, 1.39 (1.20 to 1.60) for ischaemic heart disease, 0.94 (0.73 to 1.21) for ischaemic stroke, 0.91 (0.72 to 1.15) for ischaemic cerebrovascular disease, 1.69 (1.03 to 2.79) for severe atherosclerosis, and 1.14 (1.04 to 1.26) for death. The corresponding hazard/odds ratios for people with versus those without arcus corneae were non-significant. In people with versus those without both xanthelasmata and arcus corneae, hazard/odds ratios were 1.47 (1.09 to 1.99) for myocardial infarction, 1.56 (1.25 to 1.94) for ischaemic heart disease, 0.87 (0.57 to 1.31) for ischaemic stroke, 0.86 (0.58 to 1.26) for ischaemic cerebrovascular disease, 2.75 (0.75 to 10.1) for severe atherosclerosis, and 1.09 (0.93 to 1.28) for death. In all age groups in both women and men, absolute 10 year risk of myocardial infarction, ischaemic heart disease, and death increased in the presence of xanthelasmata. The highest absolute 10 year risks of ischaemic heart disease of 53% and 41% were found in men aged 70-79 years with and without xanthelasmata. Corresponding values in women were 35% and 27%. Conclusion Xanthelasmata predict risk of myocardial infarction, ischaemic heart disease, severe atherosclerosis, and death in the general population, independently of well known cardiovascular risk factors, including plasma cholesterol and triglyceride concentrations. In contrast, arcus corneae is not an important independent predictor of risk.	[Christoffersen, Mette; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Schnohr, Peter; Jensen, Gorm B.; Nordestgaard, Borge G.; Tybjaerg-Hansen, Anne] Bispebjerg Hosp, Copenhagen City Heart Study, DK-2400 Copenhagen, Denmark; [Jensen, Gorm B.] Univ Copenhagen, Hvidovre Hosp, Dept Cardiol, DK-2650 Hvidovre, Denmark; [Nordestgaard, Borge G.] Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Tybjaerg-Hansen, A (corresponding author), Copenhagen Univ Hosp, Rigshosp, Sect Mol Genet KB 4111, Dept Clin Biochem KB 3011, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	at-h@rh.regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020; Christoffersen, Mette/AFE-8953-2022; Hug, Balthasar L./G-1568-2010	Christoffersen, Mette/0000-0001-6614-0899; Nordestgaard, Borge/0000-0002-1954-7220; Frikke-Schmidt, Ruth/0000-0003-4084-5027	Rigshospitalet; Lundbeck Foundation; Danish Medical Research Council; Danish Heart Foundation	Rigshospitalet; Lundbeck Foundation(Lundbeckfonden); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Heart Foundation	This study was funded by the Research Fund at Rigshospitalet, the Lundbeck Foundation, the Danish Medical Research Council, and the Danish Heart Foundation. The sponsors had no role in the design of the study; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. The views expressed in this paper are those of the authors and not those of any funding body or others whose support is acknowledged.	Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; BATES MC, 1989, SOUTHERN MED J, V82, P570, DOI 10.1097/00007611-198905000-00008; BERGMAN R, 1994, J AM ACAD DERMATOL, V30, P236, DOI 10.1016/S0190-9622(94)70023-0; Chan CC, 2008, INT J CLIN PRACT, V62, P221, DOI 10.1111/j.1742-1241.2007.01540.x; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DOUSTEBLAZY P, 1982, ANN INTERN MED, V96, P164, DOI 10.7326/0003-4819-96-2-164; Eldrup N, 2006, EUR HEART J, V27, P316, DOI 10.1093/eurheartj/ehi644; Fernandez A, 2007, ATHEROSCLEROSIS, V193, P235, DOI 10.1016/j.atherosclerosis.2006.08.060; Fernandez AB, 2009, AM J CARDIOL, V103, P64, DOI 10.1016/j.amjcard.2008.08.030; Fox K, 2006, EUR HEART J, V27, P1341, DOI 10.1093/eurheartj/ehl001; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; JONSSON A, 1976, LANCET, V1, P372; KAHAN A, 1967, AM J OPHTHALMOL, V63, P320, DOI 10.1016/0002-9394(67)91557-7; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; KLEIN B, 1975, ARCH INTERN MED, V135, P509, DOI 10.1001/archinte.135.4.509; Langsted A, 2011, J INTERN MED, V270, P65, DOI 10.1111/j.1365-2796.2010.02333.x; MENOTTI A, 1987, J EPIDEMIOL COMMUN H, V41, P243, DOI 10.1136/jech.41.3.243; Menotti A, 1998, ARCH GERONTOL GERIAT, V26, P99, DOI 10.1016/S0167-4943(97)00035-6; Murabito JM, 2003, ARCH INTERN MED, V163, P1939, DOI 10.1001/archinte.163.16.1939; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Noel B, 2007, J EUR ACAD DERMATOL, V21, P1244, DOI 10.1111/j.1468-3083.2007.02252.x; Ozdol S, 2008, INT J DERMATOL, V47, P785, DOI 10.1111/j.1365-4632.2008.03690.x; PARKER F, 1968, AM J PATHOL, V53, P537; PEDACE FJ, 1965, J AMER MED ASSOC, V193, P893, DOI 10.1001/jama.1965.03090110031008; PEDERSEN TR, 1994, LANCET, V344, P1383; PEER J, 1983, BRIT J OPHTHALMOL, V67, P795, DOI 10.1136/bjo.67.12.795; RIBERA M, 1995, AM J MED, V99, P485, DOI 10.1016/S0002-9343(99)80224-1; RIFKIND BM, 1965, LANCET, V1, P312; ROSENMAN RH, 1974, NEW ENGL J MED, V291, P1322, DOI 10.1056/NEJM197412192912503; Schnohr P, 2002, EUR HEART J, V23, P620, DOI 10.1053/euhj.2001.2842; SEGAL P, 1986, CIRCULATION, V73, P108; Thygesen K, 2007, EUR HEART J, V28, P2525; Tursen U, 2006, J EUR ACAD DERMATOL, V20, P260, DOI 10.1111/j.1468-3083.2006.01418.x; WATANABE A, 1981, ATHEROSCLEROSIS, V38, P283, DOI 10.1016/0021-9150(81)90044-7	35	50	52	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2011	343								d5497	10.1136/bmj.d5497	http://dx.doi.org/10.1136/bmj.d5497			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822VP	21920887	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000295078400002
J	De Fazio, S; Bartonicek, N; Di Giacomo, M; Abreu-Goodger, C; Sankar, A; Funaya, C; Antony, C; Moreira, PN; Enright, AJ; O'Carroll, D				De Fazio, Serena; Bartonicek, Nenad; Di Giacomo, Monica; Abreu-Goodger, Cei; Sankar, Aditya; Funaya, Charlotta; Antony, Claude; Moreira, Pedro N.; Enright, Anton J.; O'Carroll, Donal			The endonuclease activity of Mili fuels piRNA amplification that silences LINE1 elements	NATURE			English	Article							DNA METHYLATION; PIWI PROTEINS; GENE; PATHWAY; RISC; RETROTRANSPOSON; TRANSPOSONS; ARGONAUTE2; EXPRESSION; RNAS	Piwi proteins and Piwi-interacting RNAs (piRNAs) have conserved functions in transposon silencing(1). The murine Piwi proteins Mili and Miwi2 (also called Piwil2 and Piwil4, respectively) direct epigenetic LINE1 and intracisternal A particle transposon silencing during genome reprogramming in the embryonic male germ line(2-4). Piwi proteins are proposed to be piRNA-guided endonucleases that initiate secondary piRNA biogenesis(5-7); however, the actual contribution of their endonuclease activities to piRNA biogenesis and transposon silencing remain unknown. To investigate the role of Piwi-catalysed endonucleolytic activity, we engineered point mutations in mice that substitute the second aspartic acid to an alanine in the DDH catalytic triad of Mili and Miwi2, generating the Mili(DAH) and Miwi2(DAH) alleles, respectively. Analysis of Mili-bound piRNAs from homozygous Mili(DAH) fetal gonadocytes revealed a failure of transposon piRNA amplification, resulting in the marked reduction of piRNA bound within Miwi2 ribonuclear particles. We find that Mili-mediated piRNA amplification is selectively required for LINE1, but not intracisternal A particle, silencing. The defective piRNA pathway in Mili(DAH) mice results in spermatogenic failure and sterility. Surprisingly, homozygous Miwi2(DAH) mice are fertile, transposon silencing is established normally and no defects in secondary piRNA biogenesis are observed. In addition, the hallmarks of piRNA amplification are observed in Miwi2-deficient gonadocytes. We conclude that cycles of intra-Mili secondary piRNA biogenesis fuel piRNA amplification that is absolutely required for LINE1 silencing.	[De Fazio, Serena; Di Giacomo, Monica; Sankar, Aditya; Moreira, Pedro N.; O'Carroll, Donal] European Mol Biol Lab, Mouse Biol Unit, I-00015 Monterotondo, Italy; [Bartonicek, Nenad; Abreu-Goodger, Cei; Enright, Anton J.] European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; [Funaya, Charlotta; Antony, Claude] European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	O'Carroll, D (corresponding author), European Mol Biol Lab, Mouse Biol Unit, Via Ramarini 32, I-00015 Monterotondo, Italy.	ocarroll@embl.it	antony, claude/K-5342-2013; Abreu-Goodger, Cei/A-1268-2010; Bartonicek, Nenad/B-6675-2016; Enright, Anton/F-3094-2011	Abreu-Goodger, Cei/0000-0001-8302-9893; Bartonicek, Nenad/0000-0003-2144-1887; Enright, Anton/0000-0002-6090-3100; Fredriksson Funaya, Charlotta/0000-0003-1375-1287; Di Giacomo, Monica/0000-0002-4075-0725; O'Carroll, Donal/0000-0002-8626-2217; Sankar, Aditya/0000-0002-1840-3356				Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Kojima K, 2009, GENES CELLS, V14, P1155, DOI 10.1111/j.1365-2443.2009.01342.x; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Robanus-Maandag E, 1998, GENE DEV, V12, P1599, DOI 10.1101/gad.12.11.1599; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Wen J, 2008, BIOCHEM SOC T, V36, P514, DOI 10.1042/BST0360514; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	40	227	232	3	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					259	U148		10.1038/nature10547	http://dx.doi.org/10.1038/nature10547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22020280				2022-12-24	WOS:000297744200055
J	Anastasiou, D; Poulogiannis, G; Asara, JM; Boxer, MB; Jiang, JK; Shen, M; Bellinger, G; Sasaki, AT; Locasale, JW; Auld, DS; Thomas, CJ; Vander Heiden, MG; Cantley, LC				Anastasiou, Dimitrios; Poulogiannis, George; Asara, John M.; Boxer, Matthew B.; Jiang, Jian-kang; Shen, Min; Bellinger, Gary; Sasaki, Atsuo T.; Locasale, Jason W.; Auld, Douglas S.; Thomas, Craig J.; Vander Heiden, Matthew G.; Cantley, Lewis C.			Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses	SCIENCE			English	Article							OXIDATIVE STRESS; TUMOR-SUPPRESSOR; CELLS; ROS; METABOLISM; CANCER; ISOFORM; PROTEIN	Control of intracellular reactive oxygen species (ROS) concentrations is critical for cancer cell survival. We show that, in human lung cancer cells, acute increases in intracellular concentrations of ROS caused inhibition of the glycolytic enzyme pyruvate kinase M2 (PKM2) through oxidation of Cys(358). This inhibition of PKM2 is required to divert glucose flux into the pentose phosphate pathway and thereby generate sufficient reducing potential for detoxification of ROS. Lung cancer cells in which endogenous PKM2 was replaced with the Cys(358) to Ser(358) oxidation-resistant mutant exhibited increased sensitivity to oxidative stress and impaired tumor formation in a xenograft model. Besides promoting metabolic changes required for proliferation, the regulatory properties of PKM2 may confer an additional advantage to cancer cells by allowing them to withstand oxidative stress.	[Anastasiou, Dimitrios; Poulogiannis, George; Asara, John M.; Bellinger, Gary; Sasaki, Atsuo T.; Locasale, Jason W.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02115 USA; [Anastasiou, Dimitrios; Poulogiannis, George; Sasaki, Atsuo T.; Locasale, Jason W.; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Boxer, Matthew B.; Jiang, Jian-kang; Shen, Min; Auld, Douglas S.; Thomas, Craig J.] NHGRI, NIH Chem Genom Ctr, NIH, Rockville, MD 20850 USA; [Bellinger, Gary; Vander Heiden, Matthew G.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Vander Heiden, Matthew G.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Cantley, LC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02115 USA.	lewis_cantley@hms.harvard.edu	Poulogiannis, George/AAY-2210-2021; Locasale, Jason W/ABE-6505-2020; Cantley, Lewis C/D-1800-2014; Poulogiannis, George/AAE-1966-2019	Locasale, Jason W/0000-0002-7766-3502; Cantley, Lewis C/0000-0002-1298-7653; Poulogiannis, George/0000-0002-0529-8614; Sasaki, Atsuo/0000-0003-2963-4501; Anastasiou, Dimitrios/0000-0002-1269-843X; Thomas, Craig/0000-0001-9386-9001	Japanese Society for the Promotion of Science; Kanae Foundation for Research Abroad; NIH [R03MH085679, 1P30CA147882, R01-GM056203-13, P01-CA089021, P01-CA117969-04]; Burroughs Wellcome Fund; Damon Runyon Cancer Research Foundation; Smith family; Starr Cancer Consortium; Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research; National Human Genome Research Institute, NIH; NATIONAL CANCER INSTITUTE [P30CA147882, P01CA117969, P01CA089021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH085679] Funding Source: NIH RePORTER	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation for Research Abroad; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Damon Runyon Cancer Research Foundation; Smith family; Starr Cancer Consortium; Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank V. Toxavidis and J. Tigges (Beth Israel Deaconess Medical Center flow cytometry facility) for support with flow cytometry applications; X. Yang and S. Breitkopf for technical assistance with mass spectrometry; Ross Dickins and Scott Lowe (Cold Spring Harbor Laboratory) for the gift of tamoxifen-inducible Cre-expressing retroviral plasmid; and C. Benes, N. Wu, A. Shaywitz, B. Emerling, A. Saci, G. DeNicola, K. Courtney, A. Couvillon, S. Soltoff, A. Carracedo, A. Grassian, J. Brugge, and members of the Cantley lab for helpful discussions. L. C. C. is a cofounder of Agios Pharmaceuticals, a company that seeks to develop novel therapeutics that target cancer metabolism. G. P. is a Pfizer Fellow of the Life Sciences Research Foundation. A. T. S. is a Genentech Fellow and supported by the Japanese Society for the Promotion of Science and the Kanae Foundation for Research Abroad. M. G. V. H. is supported by the NIH (R03MH085679 and 1P30CA147882), the Burroughs Wellcome Fund, the Damon Runyon Cancer Research Foundation, and the Smith family. This work was supported by grants from the NIH (R01-GM056203-13, P01-CA089021, and P01-CA117969-04 to L. C. C), the Starr Cancer Consortium (L. C. C. and M. G. V. H.), the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research, and the Intramural Research Program of the National Human Genome Research Institute, NIH (M. B. B., J. J., M. S., D. S. A., and C. J. T.). We apologize to colleagues whose work we could not cite because of space limitations.	Bensaad K, 2009, EMBO J, V28, P3015, DOI 10.1038/emboj.2009.242; Boxer MB, 2010, J MED CHEM, V53, P1048, DOI 10.1021/jm901577g; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Butterfield DA, 2007, J ALZHEIMERS DIS, V12, P61; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Cumming RC, 2004, J BIOL CHEM, V279, P21749, DOI 10.1074/jbc.M312267200; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Le Goffe C, 2002, BIOCHEM J, V364, P349, DOI 10.1042/BJ20011856; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; MAEBA P, 1968, J BIOL CHEM, V243, P448; McDonagh B, 2009, J PROTEOMICS, V72, P677, DOI 10.1016/j.jprot.2009.01.023; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; PANDOLFI PP, 1995, EMBO J, V14, P5209, DOI 10.1002/j.1460-2075.1995.tb00205.x; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004	28	780	808	2	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1278	1283		10.1126/science.1211485	http://dx.doi.org/10.1126/science.1211485			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22052977	Green Accepted, Green Submitted			2022-12-24	WOS:000297553600051
J	Jex, AR; Liu, SP; Li, B; Young, ND; Hall, RS; Li, YR; Yang, LF; Zeng, N; Xu, X; Xiong, ZJ; Chen, FY; Wu, X; Zhang, GJ; Fang, XD; Kang, Y; Anderson, GA; Harris, TW; Campbell, BE; Vlaminck, J; Wang, T; Cantacessi, C; Schwarz, EM; Ranganathan, S; Geldhof, P; Nejsum, P; Sternberg, PW; Yang, HM; Wang, J; Wang, J; Gasser, RB				Jex, Aaron R.; Liu, Shiping; Li, Bo; Young, Neil D.; Hall, Ross S.; Li, Yingrui; Yang, Linfeng; Zeng, Na; Xu, Xun; Xiong, Zijun; Chen, Fangyuan; Wu, Xuan; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Anderson, Garry A.; Harris, Todd W.; Campbell, Bronwyn E.; Vlaminck, Johnny; Wang, Tao; Cantacessi, Cinzia; Schwarz, Erich M.; Ranganathan, Shoba; Geldhof, Peter; Nejsum, Peter; Sternberg, Paul W.; Yang, Huanming; Wang, Jun; Wang, Jian; Gasser, Robin B.			Ascaris suum draft genome	NATURE			English	Article							BRUGIA-MALAYI; RNA-SEQ; SCHISTOSOMA-MANSONI; PARASITIC DISEASES; SWISS-PROT; GENE; DATABASE; TOOL; PREDICTION; NEMATODES	Parasitic diseases have a devastating, long-term impact on human health, welfare and food production worldwide. More than two billion people are infected with geohelminths, including the roundworms Ascaris (common roundworm), Necator and Ancylostoma (hookworms), and Trichuris (whipworm), mainly in developing or impoverished nations of Asia, Africa and Latin America(1). In humans, the diseases caused by these parasites result in about 135,000 deaths annually, with a global burden comparable with that of malaria or tuberculosis in disability-adjusted life years(1). Ascaris alone infects around 1.2 billion people and, in children, causes nutritional deficiency, impaired physical and cognitive development and, in severe cases, death(2). Ascaris also causes major production losses in pigs owing to reduced growth, failure to thrive and mortality(2). The Ascaris-swine model makes it possible to study the parasite, its relationship with the host, and ascariasis at the molecular level. To enable such molecular studies, we report the 273 mega-base draft genome of Ascaris suum and compare it with other nematode genomes. This genome has low repeat content (4.4%) and encodes about 18,500 protein-coding genes. Notably, the A. suum secretome (about 750 molecules) is rich in peptidases linked to the penetration and degradation of host tissues, and an assemblage of molecules likely to modulate or evade host immune responses. This genome provides a comprehensive resource to the scientific community and underpins the development of new and urgently needed interventions (drugs, vaccines and diagnostic tests) against ascariasis and other nematodiases.	[Jex, Aaron R.; Young, Neil D.; Hall, Ross S.; Anderson, Garry A.; Campbell, Bronwyn E.; Cantacessi, Cinzia; Gasser, Robin B.] Univ Melbourne, Fac Vet Sci, Parkville, Vic 3010, Australia; [Liu, Shiping; Li, Bo; Li, Yingrui; Yang, Linfeng; Zeng, Na; Xu, Xun; Xiong, Zijun; Chen, Fangyuan; Wu, Xuan; Zhang, Guojie; Fang, Xiaodong; Kang, Yi; Yang, Huanming; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Harris, Todd W.] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Vlaminck, Johnny; Wang, Tao; Geldhof, Peter] Univ Ghent, Lab Parasitol & Parasit Dis, B-9820 Merelbeke, Belgium; [Schwarz, Erich M.; Sternberg, Paul W.] CALTECH, Pasadena, CA 91125 USA; [Ranganathan, Shoba] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia; [Nejsum, Peter] Univ Copenhagen, Fac Life Sci, DK-2200 Copenhagen, Denmark	University of Melbourne; Beijing Genomics Institute (BGI); Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Ghent University; California Institute of Technology; Macquarie University; University of Copenhagen	Jex, AR (corresponding author), Univ Melbourne, Fac Vet Sci, Parkville, Vic 3010, Australia.	ajex@unimelb.edu.au; wangjun@genomics.org.cn; wangjian@genomics.org.cn; robinbg@unimelb.edu.au	Yang, Linfeng/AAZ-8792-2020; Cantacessi, Cinzia/B-7356-2014; Young, Neil David/AAU-4572-2020; Li, Yingrui/K-1064-2015; Fang, Xiaodong/K-6743-2018; Wang, Jun/A-7261-2013; Xu, Xun/AAI-6763-2020; Zhang, Guojie/B-6188-2014; Rivet, Catherine A/M-7978-2014; Zhang, Guojie/J-7273-2019; Jex, Aaron/AGZ-7897-2022; Gasser, Robin/ABH-6185-2020; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Cantacessi, Cinzia/0000-0001-6863-2950; Young, Neil David/0000-0001-8756-229X; Fang, Xiaodong/0000-0001-7061-3337; Xu, Xun/0000-0002-5338-5173; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Jex, Aaron/0000-0002-1285-7947; Gasser, Robin/0000-0002-4423-1690; Sternberg, Paul/0000-0002-7699-0173; Vlaminck, Johnny/0000-0002-3601-9825; Wang, Jun/0000-0002-2113-5874; Harris, Todd/0000-0003-3406-163X; Ranganathan, Shoba/0000-0002-8290-813X; LIU, Shiping/0000-0003-0019-619X; Wang, Tao/0000-0003-1359-8913; Campbell, Bronwyn/0000-0001-9090-764X; Wang, Jun/0000-0002-8540-8931; Schwarz, Erich/0000-0003-3151-4381; Nejsum, Peter/0000-0002-6673-8505; Xiong, Zijun/0000-0003-3923-0703	Australian Research Council; Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne [VR0007]	Australian Research Council(Australian Research Council); Victorian Life Sciences Computation Initiative on its Peak Computing Facility at the University of Melbourne	This project was funded by the Australian Research Council. This research was supported by a Victorian Life Sciences Computation Initiative (grant number VR0007) on its Peak Computing Facility at the University of Melbourne, an initiative of the Victorian Government. Other support from the Australian Academy of Science, the Australian-American Fulbright Commission, Melbourne Water Corporation, and the IBM Research Collaboratory for Life Sciences-Melbourne is gratefully acknowledged. P. W. S. is an investigator with the Howard Hughes Medical Institute. A.R.J. held a CDA1 (Industry) from the National Health and Medical Research Council of Australia. We are indebted to the faculty and staff of the BGI-Shenzhen, who contributed to this study. We also acknowledge the contributions of staff at WormBase (www.wormbase.org).	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BARGMANN CI, 2006, C ELEGANS WORMBOOK; Bellafiore S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000192; Bennuru S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000410; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Campbell BE, 2011, BIOORG MED CHEM LETT, V21, P3277, DOI 10.1016/j.bmcl.2011.04.031; Campbell BE, 2011, BIOTECHNOL ADV, V29, P28, DOI 10.1016/j.biotechadv.2010.08.008; CAMPBELL WC, 1983, SCIENCE, V221, P823, DOI 10.1126/science.6308762; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cass CL, 2007, MOL BIOCHEM PARASIT, V155, P84, DOI 10.1016/j.molbiopara.2007.06.002; Chen LQ, 2008, BIOORGAN MED CHEM, V16, P9340, DOI 10.1016/j.bmc.2008.08.062; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Crompton DWT, 2001, ADV PARASIT, V48, P285, DOI 10.1016/S0065-308X(01)48008-0; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Doyle MA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-222; Eddy Sean R, 2009, Genome Inform, V23, P205; Edgar RC, 2005, BIOINFORMATICS, V21, pI152, DOI 10.1093/bioinformatics/bti1003; Ewen-Campen B, 2010, MOL REPROD DEV, V77, P3, DOI 10.1002/mrd.21091; Gasser RB, 2006, NAT PROTOC, V1, P3121, DOI 10.1038/nprot.2006.485; Geenen PL, 1999, J PARASITOL, V85, P616, DOI 10.2307/3285733; Geldhof P, 2007, PARASITOLOGY, V134, P609, DOI 10.1017/S0031182006002071; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Goldovsky Leon, 2005, Appl Bioinformatics, V4, P71, DOI 10.2165/00822942-200504010-00009; Harder A, 2003, INT J ANTIMICROB AG, V22, P318, DOI 10.1016/S0924-8579(03)00219-X; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Hewitson JR, 2008, MOL BIOCHEM PARASIT, V160, P8, DOI 10.1016/j.molbiopara.2008.02.007; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaminsky R, 2008, NATURE, V452, P176, DOI 10.1038/nature06722; Keiser J, 2010, ADV PARASIT, V73, P197, DOI 10.1016/S0065-308X(10)73008-6; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kuzniar A, 2008, TRENDS GENET, V24, P539, DOI 10.1016/j.tig.2008.08.009; LANDER E S, 1988, Genomics, V2, P231; Lee I, 2008, NAT GENET, V40, P181, DOI 10.1038/ng.2007.70; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muller F, 2000, INT J PARASITOL, V30, P391, DOI 10.1016/S0020-7519(99)00199-X; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Renslo AR, 2006, NAT CHEM BIOL, V2, P701, DOI 10.1038/nchembio837; Saeed I, 2001, ACTA VET SCAND, V42, P279, DOI 10.1186/1751-0147-42-279; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sambrook J., 2001, MOL CLONING LAB MANU, V3, pE3; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; She R, 2009, GENOME RES, V19, P143, DOI 10.1101/gr.082081.108; Tarailo-Graovac M., 2009, CURR PROTOCOLS BIOIN; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Xu Z, 2007, NUCLEIC ACIDS RES, V35, pW265, DOI 10.1093/nar/gkm286; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh W, 2004, GENOME RES, V14, P917, DOI 10.1101/gr.2050304; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	73	202	206	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					529	U257		10.1038/nature10553	http://dx.doi.org/10.1038/nature10553			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22031327	hybrid, Green Accepted			2022-12-24	WOS:000297285600051
J	Hampton, T				Hampton, Tracy			Knockout Science: Massive Mouse Project to Provide Window Into Human Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 9	2011	306	18					1968	1968		10.1001/jama.2011.1625	http://dx.doi.org/10.1001/jama.2011.1625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843VT	22068986				2022-12-24	WOS:000296704300008
J	Ng, M; Gakidou, E; Levin-Rector, A; Khera, A; Murray, CJL; Dandona, L				Ng, Marie; Gakidou, Emmanuela; Levin-Rector, Alison; Khera, Ajay; Murray, Christopher J. L.; Dandona, Lalit			Assessment of population-level effect of Avahan, an HIV-prevention initiative in India	LANCET			English	Article							FEMALE SEX WORKERS; KARNATAKA STATE; SOUTH-INDIA; PREVALENCE; SURVEILLANCE; HIV/AIDS; DECLINES; PROGRAMS; IMPACT; INTERVENTION	Background The aim of Avahan, the India AIDS Initiative, was to reduce HIV transmission in the general population through large-scale prevention interventions focused on high-risk groups. It was launched in 2003 in six states with a total population of 300 million and a high HIV burden. We assessed the population-level effect of the first phase of Avahan (2003-08). Methods Population prevalence was estimated by use of adjustment factors from the national HIV sentinel surveillance data obtained annually from antenatal clinics. A mixed-effects multilevel regression model was developed to estimate the association between intervention intensity and population HIV prevalence trends, taking into account differences in the underlying epidemic trends in states and other potential confounders, and to estimate the number of HIV infections averted with Avahan. Findings 80 (61%) of 131 districts in the six Avahan states received funding from Avahan for HIV prevention, as the only or shared source. Greater intensity of Avahan, measured as amount of grant per HIV population (medians US$24-432 in the six states), was significantly associated with lower HIV prevalence in Andhra Pradesh (p=0.004), Karnataka (p=0.004), and Maharashtra (p=0.008) states; this association was not significant in TamilNadu (p=0.06), Manipur (p=0.62), and Nagaland (p=0.67). Overall, we estimated that 100 178 HIV infections (95% CI 25 897-207 713) were averted at the population level from 2003 up to 2008 as a result of Avahan. Interpretation The results of our analysis suggest that Avahan had a beneficial effect in reducing HIV prevalence at the population level over 5 years of programme implementation in some of the states. With stagnating funding for HIV prevention globally, our findings support investment in well planned and managed HIV prevention programmes in low-income and middle-income countries.	[Ng, Marie; Gakidou, Emmanuela; Levin-Rector, Alison; Murray, Christopher J. L.; Dandona, Lalit] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Ng, Marie] Univ Hong Kong, Fac Educ, Hong Kong, Hong Kong, Peoples R China; [Khera, Ajay] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Dandona, Lalit] Publ Hlth Fdn India, New Delhi, India	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Hong Kong; Public Health Foundation of India	Gakidou, E (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA.	gakidou@uw.edu	Levin-Rector, Alison/AAA-6756-2020		Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	Alnwick D., 2007, BRINGING HIV PREVENT; [Anonymous], 2011, LANCET, V377, P1719, DOI 10.1016/S0140-6736(11)60713-7; [Anonymous], 2011, AV IND AIDS IN; [Anonymous], 2007, HLTH INSURANCE POOR; Bertozzi SM, 2008, LANCET, V372, P831, DOI 10.1016/S0140-6736(08)60889-2; Bertozzi SM, 2010, SEX TRANSM INFECT, V86, pI4, DOI 10.1136/sti.2009.039263; Bill & Melinda Gates Foundation, 2008, AV IND AIDS IN BUS H, P40; Boily MC, 2008, AIDS, V22, pS149, DOI 10.1097/01.aids.0000343773.59776.5b; Chandrasekaran P, 2008, AIDS, V22, pS1, DOI 10.1097/01.aids.0000343760.70078.89; Chandrasekaran P, 2006, LANCET INFECT DIS, V6, P508, DOI 10.1016/S1473-3099(06)70551-5; Claeson M, 2008, HEALTH AFFAIR, V27, P1091, DOI 10.1377/hlthaff.27.4.1091; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; Dandona Lalit, 2010, BMC Health Serv Res, V10, P117, DOI 10.1186/1472-6963-10-117; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Galiani S, 2005, J POLIT ECON, V113, P83, DOI 10.1086/426041; Garnett GP, 2011, LANCET, V378, P515, DOI 10.1016/S0140-6736(10)61505-X; Global HIV Prevention working Group, BEH CHANG HIV PREV R; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Halperin DT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000414; IIPS, 2007, NAT HLTH FAM SURV NF; Jalan J, 2003, J ECONOMETRICS, V112, P153, DOI 10.1016/S0304-4076(02)00158-6; John TJ, 2011, LANCET, V377, P252, DOI 10.1016/S0140-6736(10)61265-2; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Lipovsek V, 2010, SEX TRANSM INFECT, V86, pI25, DOI 10.1136/sti.2009.038497; Marsh KA, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-27; Merson MH, 2008, LANCET, V372, P475, DOI 10.1016/S0140-6736(08)60884-3; Mogasale V, 2010, SEX TRANSM INFECT, V86, pI83, DOI 10.1136/sti.2009.038364; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Moses S, 2008, AIDS, V22, pS101, DOI 10.1097/01.aids.0000343768.85325.92; Murray CJL, 2011, LANCET, V378, P8, DOI 10.1016/S0140-6736(10)62356-2; NACO, 2008, HIV SENT SURV HIV ES; NACO, 2010, ANN REP 2009 10 GOV; NACO, 2008, OP GUID HIV SENT SUR; *NAT AIDS CONTR OR, FUNDS EXP; National AIDS Control Organisation, 2007, HIV SENT SURV HIV ES; National AIDS Control Organization, 2006, NAT AIDS CONTR PROGR; National Commission on Population, 2006, POP PROJ IND STAT 20; National Intelligence Council, 2002, NEXT WAV HIV AIDS NI; Pandey A, 2009, INDIAN J MED RES, V129, P50; Phoolcharoen W, 1998, SCIENCE, V280, P1873, DOI 10.1126/science.280.5371.1873; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Piot P, 2010, SEX TRANSM INFECT, V86, pI1, DOI 10.1136/sti.2009.040428; Potts M, 2003, BMJ-BRIT MED J, V326, P1389, DOI 10.1136/bmj.326.7403.1389; Ramakrishnan L, 2010, SEX TRANSM INFECT, V86, pI62, DOI 10.1136/sti.2009.038760; Ramesh BM, 2010, SEX TRANSM INFECT, V86, pI17, DOI 10.1136/sti.2009.038513; Reza-Paul S, 2008, AIDS, V22, pS91, DOI 10.1097/01.aids.0000343767.08197.18; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; Stover J, 2002, LANCET, V360, P73, DOI 10.1016/S0140-6736(02)09339-X; *UNAIDS, 2002, REP GLOB HIV AIDS EP; UNAIDS, 2010, UNAIDS REP GLOB AIDS; UNAIDS, 2006, REP GLOB AIDS EP; *UNAIDS, 2007, 2007 AIDS EP UPD	52	65	65	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2011	378	9803					1643	1652		10.1016/S0140-6736(11)61390-1	http://dx.doi.org/10.1016/S0140-6736(11)61390-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844ST	21993161				2022-12-24	WOS:000296768300029
J	Zaratiegui, M; Castel, SE; Irvine, DV; Kloc, A; Ren, J; Li, F; de Castro, E; Marin, L; Chang, AY; Goto, D; Cande, WZ; Antequera, F; Arcangioli, B; Martienssen, RA				Zaratiegui, Mikel; Castel, Stephane E.; Irvine, Danielle V.; Kloc, Anna; Ren, Jie; Li, Fei; de Castro, Elisa; Marin, Laura; Chang, An-Yun; Goto, Derek; Cande, W. Zacheus; Antequera, Francisco; Arcangioli, Benoit; Martienssen, Robert A.			RNAi promotes heterochromatic silencing through replication-coupled release of RNA Pol II	NATURE			English	Article							DNA-REPLICATION; FISSION YEAST; TRANSCRIPTION TERMINATION; HISTONE MODIFICATION; GENOME INTEGRITY; S-PHASE; RECOMBINATION; FORKS; MECHANISMS; REARRANGEMENTS	Heterochromatin comprises tightly compacted repetitive regions of eukaryotic chromosomes. The inheritance of heterochromatin through mitosis requires RNA interference (RNAi), which guides histone modification(1) during the DNA replication phase of the cell cycle(2). Here we show that the alternating arrangement of origins of replication and non-coding RNA in pericentromeric heterochromatin results in competition between transcription and replication in Schizosaccharomyces pombe. Co-transcriptional RNAi releases RNA polymerase II (Pol II), allowing completion of DNA replication by the leading strand DNA polymerase, and associated histone modifying enzymes(3) that spread heterochromatin with the replication fork. In the absence of RNAi, stalled forks are repaired by homologous recombination without histone modification.	[Castel, Stephane E.; Martienssen, Robert A.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Li, Fei; Cande, W. Zacheus] Univ Calif Berkeley, Berkeley, CA 94720 USA; [de Castro, Elisa; Marin, Laura; Antequera, Francisco] Univ Salamanca, CSIC, Inst Biol Func & Genom, Salamanca 37007, Spain; [Chang, An-Yun] SUNY Stony Brook, Mol & Cell Biol Program, Stony Brook, NY 11794 USA; [Arcangioli, Benoit] Inst Pasteur, Paris, France	Cold Spring Harbor Laboratory; University of California System; University of California Berkeley; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Martienssen, RA (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	martiens@cshl.edu	Antequera, Francisco/B-1115-2017; Ren, Jie/L-6197-2013; Kloc, Anna/AAB-8853-2019; Marin Vinader, Laura/F-7878-2016	Antequera, Francisco/0000-0003-2623-4131; Li, Fei/0000-0002-1206-9684; Zaratiegui, Mikel/0000-0002-0342-0268; Marin Vinader, Laura/0000-0002-7707-0811; Kloc, Anna/0000-0003-2074-7884	NHMRC; Spanish Ministry of Science; Spanish Ministry of Science and Innovation [BFU2008-01919, CSD2007-00015]; NIH [R01 GM076396]; Division Of Integrative Organismal Systems [1025830] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076396] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Roh and T. Volpe for isolating cDNA clones. D. V. I. was supported by a NHMRC CJ Martin Postdoctoral Research Fellowship. M.Z. was supported by a fellowship from the Spanish Ministry of Science. This work was supported by grants BFU2008-01919 and Consolider-Ingenio CSD2007-00015 from the Spanish Ministry of Science and Innovation to F. A., and NIH R01 GM076396 to W.Z.C. and R.A.M.	Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Djupedal I, 2005, GENE DEV, V19, P2301, DOI 10.1101/gad.344205; Djupedal I, 2009, EMBO J, V28, P3832, DOI 10.1038/emboj.2009.351; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Irvine DV, 2006, SCIENCE, V313, P1134, DOI 10.1126/science.1128813; Kloc A, 2008, CURR BIOL, V18, P490, DOI 10.1016/j.cub.2008.03.016; Lambert S, 2005, CELL, V121, P689, DOI 10.1016/j.cell.2005.03.022; Lambert S, 2010, MOL CELL, V39, P346, DOI 10.1016/j.molcel.2010.07.015; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Murakami H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000317; Pauler FM, 2007, TRENDS GENET, V23, P284, DOI 10.1016/j.tig.2007.03.018; Pirngruber J, 2009, CELL CYCLE, V8, P3636, DOI 10.4161/cc.8.22.9890; Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606; Salles FJ, 1999, METHODS, V17, P38, DOI 10.1006/meth.1998.0705; Scott KC, 2006, CURR BIOL, V16, P119, DOI 10.1016/j.cub.2005.11.065; Segurado M, 2002, MOL CELL, V10, P907, DOI 10.1016/S1097-2765(02)00684-6; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; SMITH JG, 1995, MOL CELL BIOL, V15, P5165; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Washburn RS, 2011, P NATL ACAD SCI USA, V108, P792, DOI 10.1073/pnas.1009564108; Zaratiegui M, 2011, NATURE, V469, P112, DOI 10.1038/nature09608; Zhang K, 2011, SCIENCE, V331, P1624, DOI 10.1126/science.1198712; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	34	120	121	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					135	U175		10.1038/nature10501	http://dx.doi.org/10.1038/nature10501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22002604	Green Accepted, Green Submitted			2022-12-24	WOS:000296422600047
J	Keshavjee, S; Harrington, M; Gonsalves, G; Chesire, L; Farmer, PE				Keshavjee, Salmaan; Harrington, Mark; Gonsalves, Gregg; Chesire, Lucy; Farmer, Paul E.			Time for zero deaths from tuberculosis	LANCET			English	Editorial Material									[Keshavjee, Salmaan; Gonsalves, Gregg; Farmer, Paul E.] Harvard Univ, Sch Med, Program Infect Dis & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Harrington, Mark] Treatment Action Grp, New York, NY USA; [Chesire, Lucy] TB ACTION Grp, Nairobi, Kenya	Harvard University; Harvard Medical School	Keshavjee, S (corresponding author), Harvard Univ, Sch Med, Program Infect Dis & Social Change, Dept Global Hlth & Social Med, Boston, MA 02115 USA.	salmaan_keshavjee@hms.harvard.edu		Keshavjee, Salmaan/0000-0002-6967-3305; Gonsalves, Gregg/0000-0002-5789-9841				[Anonymous], 2011, LANCET, V378, P2, DOI 10.1016/S0140-6736(11)61000-3; [Anonymous], 2011, STOP TB PARTN SECR F, P6; Castro KG, 2011, EMERG INFECT DIS, V17, P337, DOI 10.3201/eid1703.110031; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Keshavjee S, 2010, NEW ENGL J MED, V363, P1781, DOI 10.1056/NEJMp1010023; KOCH ROBERT, 1932, AMER REV TUBERC, V25, P285; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Stop TB Partnership/World Health Organization, 2011, TIM ACT SAV MILL LIV; Treatment Action Group (TAG), 2011, STEPS BEING TAK COOR; UNAIDS, 2010, UNAIDS 2011 2015 STR; UNICEF, BEL ZER ACH ZER	12	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2011	378	9801					1449	1450		10.1016/S0140-6736(11)61521-3	http://dx.doi.org/10.1016/S0140-6736(11)61521-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	838VC	22018005				2022-12-24	WOS:000296319600009
J	Baker, S				Baker, Stephen			Genomic medicine has failed the poor	NATURE			English	Editorial Material									Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Oxford OX1 2JD, England	University of Oxford	Baker, S (corresponding author), Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Oxford OX1 2JD, England.	sbaker@oucru.org		Baker, Stephen/0000-0003-1308-5755				Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					287	287		10.1038/478287a	http://dx.doi.org/10.1038/478287a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012349	Bronze			2022-12-24	WOS:000296021100006
J	Cassidy, J				Cassidy, Jane			LOBBY WATCH Save Our Pubs & Clubs	BRITISH MEDICAL JOURNAL			English	Editorial Material												janecassi2@googlemail.com						*SCOTT PARL HLTH S, 2009, TOB PRIM MED SERV SC	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6707	10.1136/bmj.d6707	http://dx.doi.org/10.1136/bmj.d6707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012647				2022-12-24	WOS:000296183700007
J	Gostin, LO				Gostin, Lawrence O.			Mandatory HPV Vaccination and Political Debate	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Centers for Disease Control and Prevention (CDC), 2011, REP HLTH FOLL HPV VA; Dorell Christina, 2011, Morbidity and Mortality Weekly Report, V60, P1117; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Insinga RP, 2005, PHARMACOECONOMICS, V23, P1107, DOI 10.2165/00019053-200523110-00004; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; McGreal C, 2011, M BACHMANN HPV ROW P; National Cancer Institute, CERV CANC; National Conference of State Legislatures, 2011, HPV VACC STAT LEG ST	10	34	34	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1699	1700		10.1001/jama.2011.1525	http://dx.doi.org/10.1001/jama.2011.1525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	21979129	Green Published			2022-12-24	WOS:000295963200029
J	Elser, J; Bennett, E				Elser, James; Bennett, Elena			A broken biogeochemical cycle	NATURE			English	Editorial Material							PHOSPHORUS		[Elser, James] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Bennett, Elena] McGill Univ, Dept Nat Resource Sci, Montreal, PQ, Canada; [Bennett, Elena] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada	Arizona State University; Arizona State University-Tempe; McGill University; McGill University	Elser, J (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	j.elser@asu.edu	Elser, James/A-7082-2008; Elser, James J/AAL-6199-2020; Bennett, Elena/A-9553-2008	Elser, James/0000-0002-1460-2155; Elser, James J/0000-0002-1460-2155; Bennett, Elena/0000-0003-3944-2925				Childers DL, 2011, BIOSCIENCE, V61, P117, DOI 10.1525/bio.2011.61.2.6; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Gaxiola RA, 2011, CHEMOSPHERE, V84, P840, DOI 10.1016/j.chemosphere.2011.01.062; Golovan SP, 2001, NAT BIOTECHNOL, V19, P741, DOI 10.1038/90788; Sutton MA, 2011, NATURE, V472, P159, DOI 10.1038/472159a; Van Kauwenbergh S. J., 2010, TECHNICAL B IFDC	7	582	614	29	555	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					29	31		10.1038/478029a	http://dx.doi.org/10.1038/478029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979027	Bronze			2022-12-24	WOS:000295575400014
J	Sellers, WR				Sellers, William R.			A Blueprint for Advancing Genetics-Based Cancer Therapy	CELL			English	Article							RESISTANT PROSTATE-CANCER; FACTOR-H POLYMORPHISM; CHRONIC-PHASE; INHIBITOR; IMATINIB; MUTATION; PATHWAY	In the era of next-generation sequencing, there are significant challenges to harnessing cancer genome information to develop novel therapies. Key research thrusts in both academia and industry will speed this transition, and lessons learned for cancer will more broadly shape the process for genetic contributions to the therapy of disease more broadly.	Novartis Inst Biomed Res, Cambridge, MA 02139 USA	Novartis	Sellers, WR (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	william.sellers@novartis.com						Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Buonamici S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001599; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Haber DA, 2011, CELL, V145, P19, DOI 10.1016/j.cell.2011.03.026; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HUANG ME, 1988, BLOOD, V72, P567, DOI 10.1182/blood.V72.2.567.567; Infante JR, 2011, J CLIN ONCOL, V29; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun HY, 2004, J MED CHEM, V47, P4147, DOI 10.1021/jm0499108; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	33	54	55	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					26	31		10.1016/j.cell.2011.09.016	http://dx.doi.org/10.1016/j.cell.2011.09.016			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962504	Bronze			2022-12-24	WOS:000295396700012
J	Kangovi, S; Grande, D				Kangovi, Shreya; Grande, David			Hospital Readmissions-Not Just a Measure of Quality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INSURANCE STATUS; FOLLOW-UP; CARE; ACCESS; IMPACT		[Kangovi, Shreya] Univ Penn, Robert Wood Johnson Clin Scholars Program, Philadelphia, PA 19104 USA; [Grande, David] Univ Penn, Perelman Sch Med, Div Gen Internal Med, Philadelphia, PA 19104 USA; [Kangovi, Shreya; Grande, David] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Kangovi, Shreya] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center	Kangovi, S (corresponding author), Univ Penn, Robert Wood Johnson Clin Scholars Program, 423 Guardian Dr,13th Floor,Blockley Hall, Philadelphia, PA 19104 USA.	kangovi@mail.med.upenn.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735				ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; Ashton CM, 1996, SOC SCI MED, V43, P1533, DOI 10.1016/S0277-9536(96)00049-4; Asplin BR, 2005, JAMA-J AM MED ASSOC, V294, P1248, DOI 10.1001/jama.294.10.1248; KELLERMANN AL, 1994, NEW ENGL J MED, V330, P1426; McWilliams JM, 2003, JAMA-J AM MED ASSOC, V290, P757, DOI 10.1001/jama.290.6.757; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; Sox CM, 1998, AM J MED, V105, P506, DOI 10.1016/S0002-9343(98)00324-6; Strunin L, 2007, J HOSP MED, V2, P297, DOI 10.1002/jhm.206; Weinberger M, 1996, NEW ENGL J MED, V334, P1441, DOI 10.1056/NEJM199605303342206; WEISSMAN JS, 1994, INQUIRY-J HEALTH CAR, V31, P163	10	115	115	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1796	1797		10.1001/jama.2011.1562	http://dx.doi.org/10.1001/jama.2011.1562			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028356				2022-12-24	WOS:000296181600025
J	Richards, M; Hatch, SL				Richards, Marcus; Hatch, Stephani L.			ESSAY Good news about the ageing brain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							OLDER; HEALTH		[Richards, Marcus] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Hatch, Stephani L.] Kings Coll London, Inst Psychiat, London, England	University of London; King's College London	Richards, M (corresponding author), MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England.	m.richards@nshd.mrc.ac.uk	Hatch, Stephani L/B-4235-2010	Richards, Marcus/0000-0001-9191-2192; Hatch, Stephani/0000-0001-9103-2427	MRC [MC_U123092722] Funding Source: UKRI; Medical Research Council [MC_U123092722] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Abrams L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P49; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Baltes P. B., 1993, CURRENT DIRECTIONS P, V2, P75, DOI [10.1111/1467-8721.ep10770914, DOI 10.1111/1467-8721.EP10770914]; Coleman PG, 2004, AGEING DEV, P64; Greengross S, 1997, BRIT MED J, V315, P1029, DOI 10.1136/bmj.315.7115.1029; Harper S, LIVING LONGER PROSPE; Larrivierre D, 2009, NEUROLOGY, V73, P1; Lupton MK, 2010, INT J GERIATR PSYCH, V25, P30, DOI 10.1002/gps.2294; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; National Audit Office, 2007, IMPR SERV SUPP PEOPL; Nielsen L, 2011, SOC COGN AFFECT NEUR, V6, P149, DOI 10.1093/scan/nsr019; Park D.C., 2000, COGNITIVE AGING PRIM, P217; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Pearlin LI, 2007, J HEALTH SOC BEHAV, V48, P164, DOI 10.1177/002214650704800205; Potter GG, 2007, NEUROLOGIST, V13, P105, DOI 10.1097/01.nrl.0000252947.15389.a9; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; Richards M, 2011, J GERONTOL B-PSYCHOL, V66, P26, DOI 10.1093/geronb/gbr013; Rowe JW, 1998, SUCCESSFUL AGING; Schunk D. H., 2000, HDB SELF REGULATION, P631, DOI [10.1016/B978-012109890-2/50048-2, DOI 10.1016/B978-012109890-2/50048-2]; Weierich MR, 2011, SOC COGN AFFECT NEUR, V6, P195, DOI 10.1093/scan/nsq056; Westerman SJ, 2000, OCCUP MED-OXFORD, V50, P478, DOI 10.1093/occmed/50.7.478	21	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 17	2011	343								d6288	10.1136/bmj.d6288	http://dx.doi.org/10.1136/bmj.d6288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851CH	22006943				2022-12-24	WOS:000297245400003
J	Weismann, D; Hartvigsen, K; Lauer, N; Bennett, KL; Scholl, HPN; Issa, PC; Cano, M; Brandstatter, H; Tsimikas, S; Skerka, C; Superti-Furga, G; Handa, JT; Zipfel, PF; Witztum, JL; Binder, CJ				Weismann, David; Hartvigsen, Karsten; Lauer, Nadine; Bennett, Keiryn L.; Scholl, Hendrik P. N.; Issa, Peter Charbel; Cano, Marisol; Brandstaetter, Hubert; Tsimikas, Sotirios; Skerka, Christine; Superti-Furga, Giulio; Handa, James T.; Zipfel, Peter F.; Witztum, Joseph L.; Binder, Christoph J.			Complement factor H binds malondialdehyde epitopes and protects from oxidative stress	NATURE			English	Article							RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; APOPTOTIC CELLS; INNATE IMMUNITY; END-PRODUCTS; AGE; PHAGOCYTOSIS; PROTEINS; RISK; PHOSPHOLIPIDS	Oxidative stress and enhanced lipid peroxidation are linked to many chronic inflammatory diseases, including age-related macular degeneration (AMD). AMD is the leading cause of blindness in Western societies, but its aetiology remains largely unknown. Malondialdehyde (MDA) is a common lipid peroxidation product that accumulates in many pathophysiological processes, including AMD. Here we identify complement factor H (CFH) as a major MDA-binding protein that can block both the uptake of MDA-modified proteins by macrophages and MDA-induced proinflammatory effects in vivo in mice. The CFH polymorphism H402, which is strongly associated with AMD, markedly reduces the ability of CFH to bind MDA, indicating a causal link to disease aetiology. Our findings provide important mechanistic insights into innate immune responses to oxidative stress, which may be exploited in the prevention of and therapy for AMD and other chronic inflammatory diseases.	[Weismann, David; Hartvigsen, Karsten; Bennett, Keiryn L.; Superti-Furga, Giulio; Binder, Christoph J.] Austrian Acad Sci, CeMM, A-1090 Vienna, Austria; [Weismann, David; Hartvigsen, Karsten; Brandstaetter, Hubert; Binder, Christoph J.] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Hartvigsen, Karsten; Tsimikas, Sotirios; Witztum, Joseph L.; Binder, Christoph J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Lauer, Nadine; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Lauer, Nadine; Skerka, Christine; Zipfel, Peter F.] Univ Jena, D-07745 Jena, Germany; [Scholl, Hendrik P. N.; Cano, Marisol; Handa, James T.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Issa, Peter Charbel] Univ Oxford, Nuffield Lab Ophthalmol, Oxford OX3 9DU, England; [Brandstaetter, Hubert] Octapharma PPGmbH, Res & Dev, A-1100 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; University of California System; University of California San Diego; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; Johns Hopkins University; Johns Hopkins Medicine; University of Oxford; Octapharma	Binder, CJ (corresponding author), Austrian Acad Sci, CeMM, A-1090 Vienna, Austria.	christoph.binder@meduniwien.ac.at	Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Issa, Peter Charbel/E-8935-2018; Issa, Peter Charbel/O-2580-2019	Superti-Furga, Giulio/0000-0002-0570-1768; Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673; Bennett, Keiryn L./0000-0001-9356-7708; Binder, Christoph J./0000-0001-8313-7050	Austrian Academy of Sciences; Austrian Research Promotion Agency; SFB Lipotox F30 of the Austrian Science Fund; NIH [HL088093, RO1 HL086599, EY14005, EY019044]; Edward N. & Della L. Thome Memorial Foundation; Research to Prevent Blindness (Wilmer Eye institute); Deutsche Forschungsgemeinschaft; ProRetina Foundation; Fondation Leducq; Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award; National Neurovision Research Institute - Foundation Fighting Blindness; Macular Degeneration Research Award; American Health Assistance Foundation; European Commission; European Community; American Heart Association [0630228N]; NATIONAL EYE INSTITUTE [R01EY014005, R01EY019904] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088093] Funding Source: NIH RePORTER	Austrian Academy of Sciences; Austrian Research Promotion Agency; SFB Lipotox F30 of the Austrian Science Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward N. & Della L. Thome Memorial Foundation; Research to Prevent Blindness (Wilmer Eye institute)(Research to Prevent Blindness (RPB)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ProRetina Foundation; Fondation Leducq(Leducq Foundation); Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award; National Neurovision Research Institute - Foundation Fighting Blindness; Macular Degeneration Research Award(BrightFocus Foundation); American Health Assistance Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); European Community(European Commission); American Heart Association(American Heart Association); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are indebted to M. Ozsvar-Kozma for technical assistance, S. Halbich for performing the surface plasmon resonance analysis, A. Hartmann for purification of CFH variants from patient plasma, C. Mannhalter for help with genotyping, and E. N. Montano. This work was supported by the Austrian Academy of Sciences, a BRIDGE grant from the Austrian Research Promotion Agency, the SFB Lipotox F30 of the Austrian Science Fund (C.J.B.); NIH grants HL088093 (C.J.B., S. T., J.L.W.), RO1 HL086599 (K. H., J.L.W.), EY14005, EY019044 (J.T.H.); the Edward N. & Della L. Thome Memorial Foundation Awards Program in AMD Research, Research to Prevent Blindness (Wilmer Eye institute) (J.T.H.); the Deutsche Forschungsgemeinschaft (P.F.Z., C. S.); the ProRetina Foundation (N. L., P.F.Z., C. S.); the Fondation Leducq (C.J.B., S. T., J.L.W.); the Wynn-Gund Translational Research Acceleration Program Enhanced Research and Clinical Training Award, National Neurovision Research Institute - Foundation Fighting Blindness, Macular Degeneration Research Award, American Health Assistance Foundation (H. P. N. S.); European Commission and the Seventh European Community Framework Program, Marie Curie Intra-European Fellowship (P. C. I.). K. H. was supported by the Scientist Development Grant 0630228N of the American Heart Association. J. T. H. is the Robert Bond Welch Professor. We thank all patients for participation.	Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Chang MK, 1999, P NATL ACAD SCI USA, V96, P6353, DOI 10.1073/pnas.96.11.6353; Chou MY, 2008, J INTERN MED, V263, P479, DOI 10.1111/j.1365-2796.2008.01968.x; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Clark SJ, 2006, J BIOL CHEM, V281, P24713, DOI 10.1074/jbc.M605083200; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Donoso LA, 2010, SURV OPHTHALMOL, V55, P227, DOI 10.1016/j.survophthal.2009.11.001; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Flierman R, 2007, IMMUNOBIOLOGY, V212, P363, DOI 10.1016/j.imbio.2006.11.005; Goverdhan SV, 2008, BRIT J OPHTHALMOL, V92, P537, DOI 10.1136/bjo.2007.123190; GREEN WR, 1993, OPHTHALMOLOGY, V100, P1519; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Higgins GT, 2003, INVEST OPHTH VIS SCI, V44, P1775, DOI 10.1167/iovs.02-0742; Hollyfield JG, 2008, NAT MED, V14, P194, DOI 10.1038/nm1709; Hughes AE, 2006, NAT GENET, V38, P1173, DOI 10.1038/ng1890; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kaemmerer E, 2007, INVEST OPHTH VIS SCI, V48, P1342, DOI 10.1167/iovs.06-0549; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Leffler J, 2010, J BIOL CHEM, V285, P3766, DOI 10.1074/jbc.M109.045427; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Schutt F, 2003, INVEST OPHTH VIS SCI, V44, P3663, DOI 10.1167/iovs.03-0172; Shanmugam N, 2008, DIABETES, V57, P879, DOI 10.2337/db07-1204; SHECHTER I, 1981, J LIPID RES, V22, P63; Sofat R, 2010, ATHEROSCLEROSIS, V213, P184, DOI 10.1016/j.atherosclerosis.2010.07.021; Sun MJ, 2006, J BIOL CHEM, V281, P4222, DOI 10.1074/jbc.M509769200; Suzuki M, 2007, MOL VIS, V13, P772; Takizawa F, 1996, FEBS LETT, V397, P269, DOI 10.1016/S0014-5793(96)01197-0; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; Thiele Geoffrey M, 2004, Comp Hepatol, V3 Suppl 1, pS25, DOI 10.1186/1476-5926-2-S1-S25; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Xu DS, 1997, CHEM RES TOXICOL, V10, P978, DOI 10.1021/tx970069t; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	42	395	413	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					76	81		10.1038/nature10449	http://dx.doi.org/10.1038/nature10449			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979047	Green Accepted			2022-12-24	WOS:000295575400037
J	Pollock, A; Macfarlane, A; Kirkwood, G; Majeed, FA; Greener, I; Morelli, C; Boyle, S; Mellett, H; Godden, S; Price, D; Brhlikova, P				Pollock, Allyson; Macfarlane, Alison; Kirkwood, Graham; Majeed, F. Azeem; Greener, Ian; Morelli, Carlo; Boyle, Sean; Mellett, Howard; Godden, Sylvia; Price, David; Brhlikova, Petra			No evidence that patient choice in the NHS saves lives	LANCET			English	Editorial Material							MORTALITY; ENGLAND; DISEASE		[Pollock, Allyson; Godden, Sylvia; Price, David] Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England; [Macfarlane, Alison] City Univ London, Sch Hlth Sci, London EC1V 0HB, England; [Kirkwood, Graham; Brhlikova, Petra] Univ Edinburgh, Sch Social & Polit Sci, Edinburgh, Midlothian, Scotland; [Majeed, F. Azeem] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London, England; [Greener, Ian] Univ Durham, NE Doctoral Training Ctr, Durham, England; [Morelli, Carlo] Univ Dundee, Dundee, Scotland; [Boyle, Sean] London Sch Econ & Polit Sci, LSE Hlth & Social Care, London, England; [Mellett, Howard] Cardiff Univ, Cardiff Business Sch, Cardiff, S Glam, Wales	University of London; City University London; University of Edinburgh; Imperial College London; Durham University; University of Dundee; University of London; London School Economics & Political Science; Cardiff University	Pollock, A (corresponding author), Univ London, Ctr Primary Care & Publ Hlth, London E1 4NS, England.	a.pollock@qmul.ac.uk		Greener, Ian/0000-0003-4918-8019; Majeed, Azeem/0000-0002-2357-9858; pollock, allyson/0000-0002-7388-3110; Brhlikova, Petra/0000-0003-2085-0304				Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Bloom N, 2010, IMPACT COMPETITION M; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Cooper Z, 2010, 162010 LSE HLTH LOND; Cooper Z, 2011, ECON J, V121, pF228, DOI 10.1111/j.1468-0297.2011.02449.x; Dixon A., 2010, PATIENT CHOICE PATIE; Dixon S, 2009, REPORT NATL PATIENT; Dixon S, 2006, REPORT NATL PATIENT; Gaynor M, 2010, 10242 U BRIST CTR MA; Goldacre MJ, 2004, EUR J PUBLIC HEALTH, V14, P338, DOI 10.1093/eurpub/14.4.338; Healthcare Commission, 2008, IND SECT TREATM CTR; Healthcare Commission, 2007, IND SECT TREATM CTR; Healthcare Commission and Audit Commission, 2008, IS TREATM WORK PROGR; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; King's Fund, 2008, IND SECT DAT QUAL WO; McClellan M., 1999, 7327 NAT BUR EC RES; National Centre for Health Outcomes Development, 2001, MYOC INF IN IN PRESS; The London School of Economics and Political Science, 2011, LSE RES HOSP COMP IS; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Volpp KGM, 2003, HEALTH SERV RES, V38, P515, DOI 10.1111/1475-6773.00131; West RM, 2011, EUR HEART J, V32, P706, DOI 10.1093/eurheartj/ehq476	21	39	39	1	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2011	378	9809					2057	2060		10.1016/S0140-6736(11)61553-5	http://dx.doi.org/10.1016/S0140-6736(11)61553-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	865EL	21988764				2022-12-24	WOS:000298293600015
J	Moreau, C; Bherer, C; Vezina, H; Jomphe, M; Labuda, D; Excoffier, L				Moreau, Claudia; Bherer, Claude; Vezina, Helene; Jomphe, Michele; Labuda, Damian; Excoffier, Laurent			Deep Human Genealogies Reveal a Selective Advantage to Be on an Expanding Wave Front	SCIENCE			English	Article							POPULATION; MUTATIONS; EXPANSION; EVOLUTION; DYNAMICS; HISTORY; LIFE	Since their origin, human populations have colonized the whole planet, but the demographic processes governing range expansions are mostly unknown. We analyzed the genealogy of more than one million individuals resulting from a range expansion in Quebec between 1686 and 1960 and reconstructed the spatial dynamics of the expansion. We find that a majority of the present Saguenay Lac-Saint-Jean population can be traced back to ancestors having lived directly on or close to the wave front. Ancestors located on the front contributed significantly more to the current gene pool than those from the range core, likely due to a 20% larger effective fertility of women on the wave front. This fitness component is heritable on the wave front and not in the core, implying that this life-history trait evolves during range expansions.	[Moreau, Claudia; Bherer, Claude; Labuda, Damian; Excoffier, Laurent] Univ Montreal, Hop St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Vezina, Helene; Jomphe, Michele] Univ Quebec Chicoutimi, Projet BALSAC, Chicoutimi, PQ G7H 2B1, Canada; [Labuda, Damian] Univ Montreal, Dept Pediat, Montreal, PQ H3T 1J4, Canada; [Excoffier, Laurent] Univ Bern, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Excoffier, Laurent] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	Universite de Montreal; University of Quebec; University of Quebec Chicoutimi; Universite de Montreal; University of Bern; Swiss Institute of Bioinformatics	Labuda, D (corresponding author), Univ Montreal, Hop St Justine, Ctr Rech, 3175 Cote St Catherine, Montreal, PQ H3T 1C5, Canada.	damian.labuda@umontreal.ca; laurent.excoffier@iee.unibe.ch	Excoffier, Laurent/D-3498-2013	Excoffier, Laurent/0000-0002-7507-6494	Swiss NSF [3100A0-126074]; Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec (FRSQ); FRSQ	Swiss NSF(Swiss National Science Foundation (SNSF)); Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); FRSQ(Fonds de la Recherche en Sante du Quebec)	We thank L. Barreiro, D. Bherer, H. Harpending, Y. Idaghdour, D. Reich, R. Shine, and M. Slatkin for their helpful comments on the manuscript. L. E. was supported by Swiss NSF grant 3100A0-126074, D. L. and H. V. by the Reseau de Medecine Genetique Appliquee of the Fonds de Recherche en Sante du Quebec (FRSQ), and C. B. was a recipient of an FRSQ studentship. The raw genealogical data used in this study are available upon request from balsac@uqac.ca.	Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; Bherer C, 2011, AM J PHYS ANTHROPOL, V144, P432, DOI 10.1002/ajpa.21424; Biek R, 2007, P NATL ACAD SCI USA, V104, P7993, DOI 10.1073/pnas.0700741104; Bouchard G., 1983, SAGUENAYENS INTRO HI, P125; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Charbonneau H., 2000, POPULATION HIST N AM, P99; Edmonds CA, 2004, P NATL ACAD SCI USA, V101, P975, DOI 10.1073/pnas.0308064100; Estoup A, 2010, MOL ECOL RESOUR, V10, P886, DOI 10.1111/j.1755-0998.2010.02882.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falconer D. S, 1996, INTRO QUANTITATIVE G; Gauvreau D, 1991, HIST DUN GENOME, P145; Gibson MA, 2011, P NATL ACAD SCI USA, V108, P2200, DOI 10.1073/pnas.1010241108; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hallatschek O, 2008, THEOR POPUL BIOL, V73, P158, DOI 10.1016/j.tpb.2007.08.008; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Hallatschek O, 2010, EVOLUTION, V64, P193, DOI 10.1111/j.1558-5646.2009.00809.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Lavoie TM, 2005, COMMUNITY GENET, V8, P152, DOI 10.1159/000086758; Lewontin R. C., 1965, P77; Milot E, 2011, P NATL ACAD SCI USA, V108, P17040, DOI 10.1073/pnas.1104210108; Phillips BL, 2010, ECOLOGY, V91, P1617, DOI 10.1890/09-0910.1; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Sibert A, 2002, THEOR POPUL BIOL, V62, P181, DOI 10.1006/tpbi.2002.1609; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185	29	61	61	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1148	1150		10.1126/science.1212880	http://dx.doi.org/10.1126/science.1212880			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22052972				2022-12-24	WOS:000297313900055
J	McNaughton-Collins, MF; Barry, MJ				McNaughton-Collins, Mary F.; Barry, Michael J.			One Man at a Time - Resolving the PSA Controversy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McNaughton-Collins, Mary F.] Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	McNaughton-Collins, MF (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							Hoffman RM, 2009, ARCH INTERN MED, V169, P1611, DOI 10.1001/archinternmed.2009.262; Hugosson J, 2010, LANCET ONCOL, V11, P725, DOI 10.1016/S1470-2045(10)70146-7; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; U.S. Preventive Services Task Force, 2011, DRAFT REC STAT; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	5	55	58	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1951	1953		10.1056/NEJMp1111894	http://dx.doi.org/10.1056/NEJMp1111894			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22029758				2022-12-24	WOS:000297282600003
J	Shultz, S; Opie, C; Atkinson, QD				Shultz, Susanne; Opie, Christopher; Atkinson, Quentin D.			Stepwise evolution of stable sociality in primates	NATURE			English	Article							CORRELATED EVOLUTION; ORGANIZATION; DISPERSAL; SELECTION; BRAIN; BIRDS	Although much attention has been focused on explaining and describing the diversity of social grouping patterns among primates(1-3), less effort has been devoted to understanding the evolutionary history of social living(4). This is partly because social behaviours do not fossilize, making it difficult to infer changes over evolutionary time. However, primate social behaviour shows strong evidence for phylogenetic inertia, permitting the use of Bayesian comparative methods to infer changes in social behaviour through time, thereby allowing us to evaluate alternative models of social evolution. Here we present a model of primate social evolution, whereby sociality progresses from solitary foraging individuals directly to large multi-male/multi-female aggregations (approximately 52 million years (Myr) ago), with pair-living (approximately 16 Myr ago) or single-male harem systems (approximately 16 Myr ago) derivative from this second stage. This model fits the data significantly better than the two widely accepted alternatives (an unstructured model implied by the socioecological hypothesis or a model that allows linear stepwise changes in social complexity through time). We also find strong support for the co-evolution of social living with a change from nocturnal to diurnal activity patterns, but not with sex-biased dispersal. This supports suggestions that social living may arise because of increased predation risk associated with diurnal activity. Sociality based on loose aggregation is followed by a second shift to stable or bonded groups. This structuring facilitates the evolution of cooperative behaviours(5) and may provide the scaffold for other distinctive anthropoid traits including coalition formation, cooperative resource defence and large brains.	[Shultz, Susanne; Opie, Christopher; Atkinson, Quentin D.] Univ Oxford, Inst Cognit & Evolutionary Anthropol, Oxford OX2 6PN, England; [Atkinson, Quentin D.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Oxford; University of Auckland	Shultz, S (corresponding author), Univ Oxford, Inst Cognit & Evolutionary Anthropol, 64 Banbury Rd, Oxford OX2 6PN, England.	susanne.shultz@anthro.ox.ac.uk	Shultz, Susanne/C-3162-2012	Atkinson, Quentin/0000-0002-8499-7535; Opie, Christopher/0000-0002-3379-4703; Shultz, Susanne/0000-0002-7135-4880	Royal Society	Royal Society(Royal Society of London)	S.S. is supported by a Royal Society Dorothy Hodgkin Fellowship. We thank R. I. M. Dunbar for comments on the manuscript.	Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Broad KD, 2006, PHILOS T R SOC B, V361, P2199, DOI 10.1098/rstb.2006.1940; Campbell CJ, 2007, PRIMATES PERSPECTIVE; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dunbar R.I.M., 1988, PRIMATE SOCIAL SYSTE; Dunbar RIM, 2000, PRIMATE MALES, P259; Elton S, 2006, J ROY ANTHROPOL INST, V12, P19, DOI 10.1111/j.1467-9655.2006.00279.x; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gompper ME, 1997, ANIM BEHAV, V53, P781, DOI 10.1006/anbe.1996.0344; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Isbell LA, 1996, BEHAVIOUR, V133, P1, DOI 10.1163/156853996X00017; Jack KM, 2009, BEHAVIOUR, V146, P429, DOI 10.1163/156853909X410612; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kappeler PM, 2002, INT J PRIMATOL, V23, P707, DOI 10.1023/A:1015520830318; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Muller AE, 2000, BIOL REV, V75, P405, DOI 10.1017/S0006323100005533; Nowak MA, 2010, NATURE, V466, P1057, DOI 10.1038/nature09205; Nunn CL, 2001, ADV PRIMATO, P159; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Rambaut A, 2014, TRACER V1 6; Schulke O, 2005, EVOL ANTHROPOL, V14, P170, DOI 10.1002/evan.20081; Shultz S, 2007, P ROY SOC B-BIOL SCI, V274, P2429, DOI 10.1098/rspb.2007.0693; Shultz S, 2010, P NATL ACAD SCI USA, V107, P21582, DOI 10.1073/pnas.1005246107; Shultz S, 2010, BIOL J LINN SOC, V100, P111, DOI 10.1111/j.1095-8312.2010.01427.x; Smuts B. B., 1987, PRIMATE SOC; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Stirling DG, 2002, J EVOLUTION BIOL, V15, P277, DOI 10.1046/j.1420-9101.2002.00389.x; TERBORGH J, 1986, ANNU REV ECOL SYST, V17, P111; VANSCHAIK CP, 1983, BEHAVIOUR, V87, P120, DOI 10.1163/156853983X00147	41	210	214	2	223	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					219	U96		10.1038/nature10601	http://dx.doi.org/10.1038/nature10601			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22071768				2022-12-24	WOS:000298030800040
J	Hietz, P; Turner, BL; Wanek, W; Richter, A; Nock, CA; Wright, SJ				Hietz, Peter; Turner, Benjamin L.; Wanek, Wolfgang; Richter, Andreas; Nock, Charles A.; Wright, S. Joseph			Long-Term Change in the Nitrogen Cycle of Tropical Forests	SCIENCE			English	Article							N DEPOSITION; ABUNDANCE; FOLIAR; LOSSES; TRENDS; IMPACT	Deposition of reactive nitrogen (N) from human activities has large effects on temperate forests where low natural N availability limits productivity but is not known to affect tropical forests where natural N availability is often much greater. Leaf N and the ratio of N isotopes (delta N-15) increased substantially in a moist forest in Panama between similar to 1968 and 2007, as did tree-ring delta N-15 in a dry forest in Thailand over the past century. A decade of fertilization of a nearby Panamanian forest with N caused similar increases in leaf N and delta N-15. Therefore, our results indicate regional increases in N availability due to anthropogenic N deposition. Atmospheric nitrogen dioxide measurements and increased emissions of anthropogenic reactive N over tropical land areas suggest that these changes are widespread in tropical forests.	[Hietz, Peter] Univ Nat Resources & Life Sci, Inst Bot, A-1180 Vienna, Austria; [Turner, Benjamin L.; Wright, S. Joseph] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Wanek, Wolfgang] Univ Vienna, Dept Chem Ecol & Ecosyst Res, A-1090 Vienna, Austria; [Richter, Andreas] Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany; [Nock, Charles A.] Univ Quebec, Dept Sci Biol, Ctr Etud Foret, Montreal, PQ H3C 3P8, Canada	University of Natural Resources & Life Sciences, Vienna; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Vienna; University of Bremen; University of Quebec; University of Quebec Montreal	Hietz, P (corresponding author), Univ Nat Resources & Life Sci, Inst Bot, Gregor Mendel Str 33, A-1180 Vienna, Austria.	peter.hietz@boku.ac.at	Wanek, Wolfgang/E-7001-2012; Richter, Andreas/C-4971-2008; Turner, Benjamin L/E-5940-2011; Turner, Benjamin/AAZ-1465-2021; Wright, Stuart Joseph/M-3311-2013	Wanek, Wolfgang/0000-0003-2178-8258; Richter, Andreas/0000-0003-3339-212X; Turner, Benjamin L/0000-0002-6585-0722; Turner, Benjamin/0000-0002-6585-0722; Wright, Stuart Joseph/0000-0003-4260-5676; Hietz, Peter/0000-0002-0458-6593	F. H. Levinson Fund; Austrian Science Fund [P19507-B17]	F. H. Levinson Fund; Austrian Science Fund(Austrian Science Fund (FWF))	We thank D. Agudo, T. Romero, U. Hietz-Seifert, and M. Watzka for laboratory support and the F. H. Levinson Fund and the Austrian Science Fund (grant P19507-B17) for funding. P. H. took herbarium and wood samples and analyzed the leaf, wood, and N emission data; S.J.W. provided 2007 leaves; B. L. T. analyzed 2007 leaves; W. W. analyzed herbarium leaves and wood; C. A. N. synchronized wood cores; A. R. analyzed satellite data; and P. H., B. L. T., and S.J.W. wrote the manuscript. All authors contributed to the discussion of the data. Leaf and wood data are available from P. H.; NO<INF>2</INF> satellite data are available from A.R.	Asner GP, 2001, BIOGEOCHEMISTRY, V54, P1, DOI 10.1023/A:1010653913530; Baker PJ, 2005, ECOL MONOGR, V75, P317, DOI 10.1890/04-0488; Bukata AR, 2005, ENVIRON SCI TECHNOL, V39, P7777, DOI 10.1021/es050733p; Chave J, 2008, PLOS BIOL, V6, P455, DOI 10.1371/journal.pbio.0060045; Chen Y, 2010, GLOBAL CHANGE BIOL, V16, P2024, DOI 10.1111/j.1365-2486.2009.02156.x; Corre MD, 2010, ECOLOGY, V91, P1715, DOI 10.1890/09-0274.1; Elhani S, 2005, TREE PHYSIOL, V25, P1437, DOI 10.1093/treephys/25.11.1437; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Hedin LO, 2009, ANNU REV ECOL EVOL S, V40, P613, DOI 10.1146/annurev.ecolsys.37.091305.110246; Hietz P, 2010, ENVIRON SCI TECHNOL, V44, P1191, DOI 10.1021/es901383g; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; HOGBERG P, 1993, PLANT SOIL, V157, P147, DOI 10.1007/BF02390237; Houlton BZ, 2007, P NATL ACAD SCI USA, V104, P8902, DOI 10.1073/pnas.0609935104; Kaspari M, 2008, ECOL LETT, V11, P35, DOI 10.1111/j.1461-0248.2007.01124.x; Lewis SL, 2009, ANNU REV ECOL EVOL S, V40, P529, DOI 10.1146/annurev.ecolsys.39.110707.173345; Matson PA, 1999, BIOGEOCHEMISTRY, V46, P67, DOI 10.1007/BF01007574; McLauchlan KK, 2007, P NATL ACAD SCI USA, V104, P7466, DOI 10.1073/pnas.0701779104; McLauchlan KK, 2010, NEW PHYTOL, V187, P1135, DOI 10.1111/j.1469-8137.2010.03322.x; Pardo LH, 2006, BIOGEOCHEMISTRY, V80, P143, DOI 10.1007/s10533-006-9015-9; Phoenix GK, 2006, GLOBAL CHANGE BIOL, V12, P470, DOI 10.1111/j.1365-2486.2006.01104.x; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI [10.1111/j.1749-6632.2009.05400.x, 10.1111/j.1749-6632.2010.05455.x]	25	211	221	5	267	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					664	666		10.1126/science.1211979	http://dx.doi.org/10.1126/science.1211979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053047				2022-12-24	WOS:000296494700053
J	Hay, AD; Whiting, P; Butler, CC				Hay, Alastair D.; Whiting, Penny; Butler, Christopher C.			UNCERTAINTIES PAGE How best to diagnose urinary tract infection in preschool children in primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FEBRILE YOUNG GIRLS; SCREENING-TEST; DECISION RULE; INFANTS; RISK; BACTERIURIA; PREVALENCE; CHILDHOOD; AGE		[Hay, Alastair D.] Univ Bristol, Sch Social & Community Med, NIHR Natl Sch Primary Care Res, Acad Unit Primary Hlth Care, Bristol BS8 2PS, Avon, England; [Butler, Christopher C.] Cardiff Univ, Sch Med, Dept Primary Care & Publ Hlth, Cardiff, S Glam, Wales	University of Bristol; Cardiff University	Hay, AD (corresponding author), Univ Bristol, Sch Social & Community Med, NIHR Natl Sch Primary Care Res, Acad Unit Primary Hlth Care, Bristol BS8 2PS, Avon, England.	alastair.hay@bristol.ac.uk	Hay, Alastair/L-1818-2019	Butler, Christopher/0000-0002-0102-3453; Whiting, Penny/0000-0003-1138-5682; Hay, Alastair/0000-0003-3012-375X	MRC [G0801405] Funding Source: UKRI; National Institute for Health Research [CDF-2009-02-10, 08/66/01] Funding Source: researchfish; Medical Research Council [G0801405] Funding Source: Medline; Department of Health [08/66/01, CDF-2009-02-10] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Armengol CE, 2001, PEDIATR INFECT DIS J, V20, P1176, DOI 10.1097/00006454-200112000-00018; Coulthard MG, 2003, BMJ-BRIT MED J, V327, P656, DOI 10.1136/bmj.327.7416.656; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; Dayan PS, 2002, PEDIATR EMERG CARE, V18, P12, DOI 10.1097/00006565-200202000-00004; Etoubleau C, 2009, J PEDIATR-US, V154, P803, DOI 10.1016/j.jpeds.2009.01.008; Gorelick MH, 2003, PEDIATR EMERG CARE, V19, P162, DOI 10.1097/01.pec.0000081238.98249.40; Gorelick MH, 2000, ARCH PEDIAT ADOL MED, V154, P386, DOI 10.1001/archpedi.154.4.386; LEJEUNE B, 1991, J CLIN PATHOL, V44, P1029, DOI 10.1136/jcp.44.12.1029; National Institute for Health and Clinical Excellence (NICE), 2007, UR TRACT INF CHILDR; O'Brien K, 2011, SCAND J PRIM HEALTH, V29, P19, DOI 10.3109/02813432.2011.554268; SACKS SH, 1987, LANCET, V2, P991; Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122; Shaikh N, 2007, JAMA-J AM MED ASSOC, V298, P2895, DOI 10.1001/jama.298.24.2895; Shaikh N, 2010, PEDIATRICS, V126, P1084, DOI 10.1542/peds.2010-0685; SHAW KN, 1991, J PEDIATR-US, V118, P733, DOI 10.1016/S0022-3476(05)80035-6; Shaw KN, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.6.e1; Vernon SJ, 1997, BMJ-BRIT MED J, V315, P905; WETTERGREN B, 1985, ACTA PAEDIATR SCAND, V74, P925, DOI 10.1111/j.1651-2227.1985.tb10059.x; Whiting P, 2006, HEALTH TECHNOL ASSES, V10, P1	19	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2011	343								d6316	10.1136/bmj.d6316	http://dx.doi.org/10.1136/bmj.d6316			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CW	22028485	Green Submitted, Green Accepted			2022-12-24	WOS:000296416900003
J	Liu, PF; Erez, A; Nagamani, SCS; Dhar, SU; Kolodziejska, KE; Dharmadhikari, AV; Cooper, ML; Wiszniewska, J; Zhang, F; Withers, MA; Bacino, CA; Campos-Acevedo, LD; Delgado, MR; Freedenberg, D; Garnica, A; Grebe, TA; Hernandez-Almaguer, D; Immken, L; Lalani, SR; McLean, SD; Northrup, H; Scaglia, F; Strathearn, L; Trapane, P; Kang, SHL; Patel, A; Cheung, SW; Hastings, PJ; Stankiewicz, P; Lupski, JR; Bi, WM				Liu, Pengfei; Erez, Ayelet; Nagamani, Sandesh C. Sreenath; Dhar, Shweta U.; Kolodziejska, Katarzyna E.; Dharmadhikari, Avinash V.; Cooper, M. Lance; Wiszniewska, Joanna; Zhang, Feng; Withers, Marjorie A.; Bacino, Carlos A.; Daniel Campos-Acevedo, Luis; Delgado, Mauricio R.; Freedenberg, Debra; Garnica, Adolfo; Grebe, Theresa A.; Hernandez-Almaguer, Dolores; Immken, LaDonna; Lalani, Seema R.; McLean, Scott D.; Northrup, Hope; Scaglia, Fernando; Strathearn, Lane; Trapane, Pamela; Kang, Sung-Hae L.; Patel, Ankita; Cheung, Sau Wai; Hastings, P. J.; Stankiewicz, Pawel; Lupski, James R.; Bi, Weimin			Chromosome Catastrophes Involve Replication Mechanisms Generating Complex Genomic Rearrangements	CELL			English	Article							COPY-NUMBER; SACCHAROMYCES-CEREVISIAE; GENE AMPLIFICATION; MOLECULAR ANALYSIS; CHROMOTHRIPSIS; DUPLICATIONS; ARCHITECTURE; BREAKPOINTS; MICROARRAY; DISORDERS	Complex genomic rearrangements (CGRs) consisting of two or more breakpoint junctions have been observed in genomic disorders. Recently, a chromosome catastrophe phenomenon termed chromothripsis, in which numerous genomic rearrangements are apparently acquired in one single catastrophic event, was described in multiple cancers. Here, we show that constitutionally acquired CGRs share similarities with cancer chromothripsis. In the 17 CGR cases investigated, we observed localization and multiple copy number changes including deletions, duplications, and/or triplications, as well as extensive translocations and inversions. Genomic rearrangements involved varied in size and complexities; in one case, array comparative genomic hybridization revealed 18 copy number changes. Breakpoint sequencing identified characteristic features, including small templated insertions at breakpoints and microhomology at breakpoint junctions, which have been attributed to replicative processes. The resemblance between CGR and chromothripsis suggests similar mechanistic underpinnings. Such chromosome catastrophic events appear to reflect basic DNA metabolism operative throughout an organism's life cycle.	[Liu, Pengfei; Erez, Ayelet; Nagamani, Sandesh C. Sreenath; Dhar, Shweta U.; Kolodziejska, Katarzyna E.; Dharmadhikari, Avinash V.; Cooper, M. Lance; Wiszniewska, Joanna; Zhang, Feng; Withers, Marjorie A.; Bacino, Carlos A.; Lalani, Seema R.; Scaglia, Fernando; Kang, Sung-Hae L.; Patel, Ankita; Cheung, Sau Wai; Hastings, P. J.; Stankiewicz, Pawel; Lupski, James R.; Bi, Weimin] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lalani, Seema R.; Strathearn, Lane; Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Strathearn, Lane] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Erez, Ayelet; Nagamani, Sandesh C. Sreenath; Dhar, Shweta U.; Bacino, Carlos A.; Lalani, Seema R.; Scaglia, Fernando; Strathearn, Lane; Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Daniel Campos-Acevedo, Luis; Hernandez-Almaguer, Dolores] Univ Autonoma Nuevo Leon, Dept Genet, Univ Hosp, Monterrey 64460, NL, Mexico; [Delgado, Mauricio R.] Texas Scottish Rite Hosp Crippled Children, Dallas, TX 75219 USA; [Freedenberg, Debra] Vanderbilt Univ, Div Med Genet, Med Ctr, Nashville, TN 37232 USA; [Garnica, Adolfo] St Francis Hosp, Tulsa, OK 74136 USA; [Grebe, Theresa A.] Phoenix Childrens Hosp, Div Genet & Metab, Phoenix, AZ 85016 USA; [Immken, LaDonna] Specially Children, Austin, TX 78723 USA; [McLean, Scott D.] San Antonio Mil Med Ctr, Dept Pediat, San Antonio, TX 78234 USA; [Northrup, Hope] Univ Texas Med Sch Houston, Div Med Genet, Dept Pediat, Houston, TX 77030 USA; [Trapane, Pamela] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Texas Scottish Rite Hospital for Children; Vanderbilt University; St. Francis Hospital - Oklahoma; Phoenix Children's Hospital; San Antonio Military Medical Center; University of Texas System; University of Texas Health Science Center Houston; Children's Hospital of Wisconsin	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu	Strathearn, Lane/B-1740-2013; Lalani, Seema/AAI-5090-2020; Stankiewicz, Paweł/AAP-7906-2021; Liu, Pengfei/U-9743-2019; Dharmadhikari, Avinash Vijay/AAA-1514-2021; Zhang, Feng/C-7735-2009; Patel, Ankita/D-3247-2013	Strathearn, Lane/0000-0001-5870-8843; Stankiewicz, Paweł/0000-0002-6456-7490; Liu, Pengfei/0000-0002-4177-709X; Dharmadhikari, Avinash Vijay/0000-0003-4182-4543; Zhang, Feng/0000-0003-4556-8276; Nagamani, Sandesh/0000-0001-6818-7367; Trapane, Pamela/0000-0001-9201-882X	National Institute of Neurological Disorders and Stroke, National Institutes of Health [R01 NS058529]; National Institutes of General Medical Science [R01 GM064022]; BCM IDDRC [P30HD024064]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; LCRC from the Osteogenesis Imperfecta Foundation; National Urea Cycle Disorders Foundation;  [DK081735-02]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK081735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of General Medical Science; BCM IDDRC; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); LCRC from the Osteogenesis Imperfecta Foundation; National Urea Cycle Disorders Foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the patients and their families for participation in this research, the Molecular Cytogenetics Laboratories in the MGL at BCM (https://www.bcm.edu/geneticlabs/) for providing technical support, Dr. Katarzyna Derwinska for helpful discussion, and Roche NimbleGen for supplying NimbleGen aCGH materials. This work was supported in part by National Institute of Neurological Disorders and Stroke, National Institutes of Health grant R01 NS058529 to J.R.L., National Institutes of General Medical Science grant R01 GM064022 to P.J.H., and the BCM IDDRC P30HD024064 funded from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. A.E. is supported by DK081735-02 and S.C.S.N. is supported by a fellowship grants by the LCRC from the Osteogenesis Imperfecta Foundation and the National Urea Cycle Disorders Foundation. J.R.L. is a consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems and is a coinventor on multiple United States and European patents for DNA diagnostics. The Department of Molecular and Human Genetics derives revenue from clinical testing by high-resolution human genome analysis.	Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BATISTA DAS, 1994, AM J MED GENET, V53, P255, DOI 10.1002/ajmg.1320530311; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Boone PM, 2010, HUM MUTAT, V31, P1326, DOI 10.1002/humu.21360; Borg K, 2005, HUM GENET, V118, P267, DOI 10.1007/s00439-005-0021-0; Branzei D, 2010, GENE DEV, V24, P5, DOI 10.1101/gad.1884810; Carvalho C.M., 2011, NAT GENET IN PRESS; Carvalho CMB, 2012, CLIN GENET, V81, P532, DOI 10.1111/j.1399-0004.2011.01716.x; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chen JM, 2010, SEMIN CANCER BIOL, V20, P222, DOI 10.1016/j.semcancer.2010.05.007; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Doksani Y, 2009, CELL, V137, P247, DOI 10.1016/j.cell.2009.02.016; FUTCHER AB, 1986, J THEOR BIOL, V119, P197, DOI 10.1016/S0022-5193(86)80074-1; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Green BM, 2010, SCIENCE, V329, P943, DOI 10.1126/science.1190966; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Kloosterman WP, 2011, HUM MOL GENET, V20, P1916, DOI 10.1093/hmg/ddr073; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Liu PF, 2011, HUM MOL GENET, V20, P1975, DOI 10.1093/hmg/ddr078; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036; Magrangeas F, 2011, BLOOD, V118, P675, DOI 10.1182/blood-2011-03-344069; Morrow DM, 1997, GENETICS, V147, P371; Ou Z, 2008, GENET MED, V10, P278, DOI 10.1097/GIM.0b013e31816b4420; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Smith CE, 2007, NATURE, V447, P102, DOI 10.1038/nature05723; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Yatsenko SA, 2009, HUM MOL GENET, V18, P1924, DOI 10.1093/hmg/ddp114; Zhang F, 2010, AM J HUM GENET, V86, P892, DOI 10.1016/j.ajhg.2010.05.001; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	37	301	307	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					888	902		10.1016/j.cell.2011.07.042	http://dx.doi.org/10.1016/j.cell.2011.07.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925314	Green Accepted, Bronze			2022-12-24	WOS:000295258100012
J	Abubakar, I; Dara, M; Manissero, D; Zumla, A				Abubakar, Ibrahim; Dara, Masoud; Manissero, Davide; Zumla, Alimuddin			Tackling the spread of drug-resistant tuberculosis in Europe	LANCET			English	Editorial Material									[Abubakar, Ibrahim] Hlth Protect Agcy, TB Sect, London NW9 5EQ, England; [Abubakar, Ibrahim] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Dara, Masoud] WHO Reg Off Europe, Copenhagen, Denmark; [Manissero, Davide] European Ctr Dis Control & Prevent, Stockholm, Sweden; [Zumla, Alimuddin] UCL, Sch Med, Div Infect & Immun, London W1N 8AA, England	Health Protection Agency; University of East Anglia; World Health Organization; University of London; University College London; UCL Medical School	Abubakar, I (corresponding author), Hlth Protect Agcy, TB Sect, London NW9 5EQ, England.	ibrahim.abubakar@hpa.org.uk	ZUMLA, Alimuddin/ABA-8208-2020; Manissero, Davide/HGU-6178-2022	ZUMLA, Alimuddin/0000-0002-5111-5735; Manissero, Davide/0000-0002-8887-8795; Abubakar, Ibrahim/0000-0002-0370-1430				[Anonymous], 2009, 62 WORLD HLTH ASS PR; Cohen T, 2004, NAT MED, V10, P1117, DOI 10.1038/nm1110; *DEP HLTH, 2004, STOPP TUB ENGL CHIEF; European Centre for Disease Prevention and Control/WHO, TUB SURV EUR 2009; Fears R, 2010, TUBERCULOSIS, V90, P182, DOI 10.1016/j.tube.2010.03.008; FRIEDEN TR, 1995, NEW ENGL J MED, V333, P229, DOI 10.1056/NEJM199507273330406; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Kruijshaar ME, 2008, BRIT MED J, V336, P1231, DOI 10.1136/bmj.39546.573067.25; Veen J, 2010, REV NATL TUBERCULOSI; WHO, GLOB TUB CONTR 2010; WHO European Region, 2011, EURRC61INFDOC3 WHO E; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	12	16	17	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 28	2012	379	9813					E21	E23		10.1016/S0140-6736(11)61428-1	http://dx.doi.org/10.1016/S0140-6736(11)61428-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	889BA	21924489				2022-12-24	WOS:000300047300002
J	Szijgyarto, Z; Garedew, A; Azevedo, C; Saiardi, A				Szijgyarto, Zsolt; Garedew, Assegid; Azevedo, Cristina; Saiardi, Adolfo			Influence of Inositol Pyrophosphates on Cellular Energy Dynamics	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; SACCHAROMYCES-CEREVISIAE; GENE DELETION; CELLS; PYROPHOSPHORYLATION; PHOSPHORYLATION; REQUIREMENT; METABOLISM; GALACTOSE	With its high-energy phosphate bonds, adenosine triphosphate (ATP) is the main intracellular energy carrier. It also functions in most signaling pathways, as a phosphate donor or a precursor for cyclic adenosine monophosphate. We show here that inositol pyrophosphates participate in the control of intracellular ATP concentration. Yeasts devoid of inositol pyrophosphates have dysfunctional mitochondria but, paradoxically, contain four times as much ATP because of increased glycolysis. We demonstrate that inositol pyrophosphates control the activity of the major glycolytic transcription factor GCR1. Thus, inositol pyrophosphates regulate ATP concentration by altering the glycolytic/mitochondrial metabolic ratio. Metabolic reprogramming through inositol pyrophosphates is an evolutionary conserved mechanism that is also preserved in mammalian systems.	[Szijgyarto, Zsolt; Azevedo, Cristina; Saiardi, Adolfo] UCL, Med Res Council Lab Mol Cell Biol, Cell Biol Unit, London WC1E 6BT, England; [Szijgyarto, Zsolt; Azevedo, Cristina; Saiardi, Adolfo] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Garedew, Assegid] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Saiardi, A (corresponding author), UCL, Med Res Council Lab Mol Cell Biol, Cell Biol Unit, Gower St, London WC1E 6BT, England.	dmcbado@ucl.ac.uk	Azevedo, Cristina/Y-4296-2019	Azevedo, Cristina/0000-0002-6997-1265	Medical Research Council (MRC) [G1001704]; Human Frontier Science Program [RGP0048/2009-C]; British Heart Foundation [PG/10/72/28449]; Medical Research Council [G1001704, MC_U122680443] Funding Source: researchfish; MRC [G1001704, MC_U122680443] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Program(Human Frontier Science Program); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Bhandari, A. Resnick, A. Riccio, and M. Raff for reading the manuscript and M. Bennett for his contribution in the initial phase of the project. This work was supported by the Medical Research Council (MRC) funding to the Cell Biology Unit and by a Human Frontier Science Program Grant (RGP0048/2009-C). A.G. was supported by the British Heart Foundation grant PG/10/72/28449 and MRC grant G1001704.	Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; BALLWJ, 1975, J BACTERIOL, V121, P975; Barker CJ, 2009, CELL MOL LIFE SCI, V66, P3851, DOI 10.1007/s00018-009-0115-2; Bennett M, 2006, CELL MOL LIFE SCI, V63, P552, DOI 10.1007/s00018-005-5446-z; Bhandari R, 2008, P NATL ACAD SCI USA, V105, P2349, DOI 10.1073/pnas.0712227105; Bhandari R, 2007, P NATL ACAD SCI USA, V104, P15305, DOI 10.1073/pnas.0707338104; Burton A, 2009, J CELL PHYSIOL, V220, P8, DOI 10.1002/jcp.21763; Chakraborty A, 2010, CELL, V143, P897, DOI 10.1016/j.cell.2010.11.032; Garedew A, 2008, J CELL SCI, V121, P3468, DOI 10.1242/jcs.034660; Illies C, 2007, SCIENCE, V318, P1299, DOI 10.1126/science.1146824; MENNITI FS, 1993, J BIOL CHEM, V268, P3850; Mizuno T, 2004, YEAST, V21, P851, DOI 10.1002/yea.1123; Morrison BH, 2009, ONCOGENE, V28, P2383, DOI 10.1038/onc.2009.113; Onnebo SMN, 2009, BIOCHEM J, V423, P109, DOI 10.1042/BJ20090241; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Saiardi A, 2004, SCIENCE, V306, P2101, DOI 10.1126/science.1103344; Saiardi A, 2002, P NATL ACAD SCI USA, V99, P14206, DOI 10.1073/pnas.212527899; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shears SB, 2009, MOL PHARMACOL, V76, P236, DOI 10.1124/mol.109.055897; SIMS AP, 1978, J GEN MICROBIOL, V106, P277, DOI 10.1099/00221287-106-2-277; STEPHENS L, 1993, J BIOL CHEM, V268, P4009; Zeng X, 1997, GENETICS, V147, P493	23	144	155	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					802	805		10.1126/science.1211908	http://dx.doi.org/10.1126/science.1211908			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076377				2022-12-24	WOS:000296849600046
J	Yu, M; Wang, CB; Kyle, AF; Jakubec, P; Dixon, DJ; Schrock, RR; Hoveyda, AH				Yu, Miao; Wang, Chenbo; Kyle, Andrew F.; Jakubec, Pavol; Dixon, Darren J.; Schrock, Richard R.; Hoveyda, Amir H.			Synthesis of macrocyclic natural products by catalyst-controlled stereoselective ring-closing metathesis	NATURE			English	Article							MICROTUBULE-STABILIZING AGENTS; ALKYNE METATHESIS; EPOTHILONE-A; MOLYBDENUM; EFFICIENT; NAKADOMARIN; COMPLEXES; ANALOGS	Many natural products contain a C=C double bond through which various other derivatives can be prepared; the stereochemical identity of the alkene can be critical to the biological activities of such molecules. Catalytic ring-closing metathesis (RCM) is a widely used method for the synthesis of large unsaturated rings(1,2); however, cyclizations often proceed without control of alkene stereochemistry(2). This shortcoming is particularly costly when the cyclization reaction is performed after a long sequence of other chemical transformations(2). Here we outline a reliable, practical and general approach for the efficient and highly stereoselective synthesis of macrocyclic alkenes by catalytic RCM; transformations deliver up to 97% of the Z isomer owing to control induced by a tungsten-based alkylidene. Utility is demonstrated through the stereoselective preparation of epothilone C (refs 3-5) and nakadomarin A (ref. 6), the previously reported syntheses of which have been marred by late-stage, non-selective RCM(7-12). The tungsten alkylidene can be manipulated in air, delivering the products in useful yields with high stereoselectivity. As a result of efficient RCM and re-incorporation of side products into the catalytic cycle with minimal alkene isomerization, desired cyclizations proceed in preference to alternative pathways, even under relatively high substrate concentration.	[Yu, Miao; Wang, Chenbo; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Kyle, Andrew F.; Jakubec, Pavol; Dixon, Darren J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Schrock, Richard R.] MIT, Dept Chem, Cambridge, MA 02139 USA	Boston College; University of Oxford; Massachusetts Institute of Technology (MIT)	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu		Jakubec, Pavol/0000-0001-8872-3817	United States National Institutes of Health, Institute of General Medical Sciences [GM-59426]; EPSRC-GlaxoSmithKline; EPSRC; Engineering and Physical Sciences Research Council [EP/G007802/1] Funding Source: researchfish; EPSRC [EP/G007802/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059426] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSRC-GlaxoSmithKline(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health, Institute of General Medical Sciences (grant GM-59426 to A. H. H. and R. R. S.). M. Y. is a John LaMattina graduate fellow, A. F. K. the recipient of an EPSRC-GlaxoSmithKline synthesis studentship, and P.J. an EPSRC postdoctoral fellow. D.J.D. is grateful for an EPSRC leadership fellowship. We thank S. J. Meek, S. J. Malcolmson, R. V. O'Brien, T. J. Mann and E. T. Kiesewetter for discussions; A. R. Zhugralin, S. Torker and D. L. Silverio for DFT calculations; K. Wu for experimental assistance; and Boston College for providing access to computational facilities. The X-ray facilities at Boston College are supported by the United States National Science Foundation (CHE-0923264).	Altmann KH, 2002, HELV CHIM ACTA, V85, P4086, DOI 10.1002/1522-2675(200211)85:11<4086::AID-HLCA4086>3.0.CO;2-7; BOLLAG DM, 1995, CANCER RES, V55, P2325; Coutelier O, 2006, ADV SYNTH CATAL, V348, P2038, DOI 10.1002/adsc.200606116; Furstner A, 2002, CHEM-EUR J, V8, P1856, DOI 10.1002/1521-3765(20020415)8:8<1856::AID-CHEM1856>3.0.CO;2-R; Furstner A, 2001, CHEM-EUR J, V7, P5299, DOI 10.1002/1521-3765(20011217)7:24<5299::AID-CHEM5299>3.0.CO;2-X; Furstner A, 1997, SYNTHESIS-STUTTGART, P792, DOI 10.1055/s-1997-4472; Garber SB, 2000, J AM CHEM SOC, V122, P8168, DOI 10.1021/ja001179g; Gradillas A, 2006, ANGEW CHEM INT EDIT, V45, P6086, DOI 10.1002/anie.200600641; Hofle GH, 1996, ANGEW CHEM INT EDIT, V35, P1567, DOI 10.1002/anie.199615671; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Ibrahem I, 2009, J AM CHEM SOC, V131, P3844, DOI 10.1021/ja900097n; Jakubec P, 2009, J AM CHEM SOC, V131, P16632, DOI 10.1021/ja908399s; Jiang AJ, 2009, J AM CHEM SOC, V131, P16630, DOI 10.1021/ja908098t; Kobayashi J, 1997, J ORG CHEM, V62, P9236, DOI 10.1021/jo9715377; Kowalski RJ, 1997, J BIOL CHEM, V272, P2534; Malcolmson SJ, 2008, NATURE, V456, P933, DOI 10.1038/nature07594; Meek SJ, 2011, NATURE, V471, P461, DOI 10.1038/nature09957; Meng DF, 1997, J AM CHEM SOC, V119, P10073, DOI 10.1021/ja971946k; Nagata T, 2003, J AM CHEM SOC, V125, P7484, DOI 10.1021/ja034464j; Nicolaou KC, 1997, J AM CHEM SOC, V119, P7960, DOI 10.1021/ja971109i; Nilson MG, 2010, ORG LETT, V12, P4912, DOI 10.1021/ol102079z; Ono K, 2004, ANGEW CHEM INT EDIT, V43, P2020, DOI 10.1002/anie.200453673; Schinzer D, 1999, CHEM-EUR J, V5, P2483, DOI 10.1002/(SICI)1521-3765(19990903)5:9<2483::AID-CHEM2483>3.0.CO;2-N; Scholl M, 1999, ORG LETT, V1, P953, DOI 10.1021/ol990909q; Schrock RR, 2003, ANGEW CHEM INT EDIT, V42, P4592, DOI 10.1002/anie.200300576; Smith BJ, 2010, ANGEW CHEM INT EDIT, V49, P1599, DOI 10.1002/anie.200905732; Starks CM, 2003, J NAT PROD, V66, P1313, DOI 10.1021/np030218+; Wang YK, 2011, J AM CHEM SOC, V133, P9196, DOI 10.1021/ja202012s; Young IS, 2007, J AM CHEM SOC, V129, P1465, DOI 10.1021/ja068047t; Zhang W, 2007, ADV SYNTH CATAL, V349, P93, DOI 10.1002/adsc.200600476	30	154	178	1	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2011	479	7371					88	93		10.1038/nature10563	http://dx.doi.org/10.1038/nature10563			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22051677	Green Accepted			2022-12-24	WOS:000296422600037
J	Salvesen, GS; Ashkenazi, A				Salvesen, Guy S.; Ashkenazi, Avi			SnapShot: Caspases	CELL			English	Editorial Material							ACTIVATION; APOPTOSIS; PLATFORM; DEATH		[Salvesen, Guy S.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Ashkenazi, Avi] Genentech Inc, San Francisco, CA 94080 USA	Sanford Burnham Prebys Medical Discovery Institute; Roche Holding; Genentech	Salvesen, GS (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA.		Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kuranaga E, 2007, TRENDS CELL BIOL, V17, P135, DOI 10.1016/j.tcb.2007.01.001; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714	10	41	43	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2							476.e1	10.1016/j.cell.2011.09.030	http://dx.doi.org/10.1016/j.cell.2011.09.030			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000022	Bronze			2022-12-24	WOS:000296199300023
J	Roth, C; Magnus, P; Schjolberg, S; Stoltenberg, C; Suren, P; McKeague, IW; Smith, GD; Reichborn-Kjennerud, T; Susser, E				Roth, Christine; Magnus, Per; Schjolberg, Synnve; Stoltenberg, Camilla; Suren, Pal; McKeague, Ian W.; Smith, George Davey; Reichborn-Kjennerud, Ted; Susser, Ezra			Folic Acid Supplements in Pregnancy and Severe Language Delay in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEURAL-TUBE DEFECTS; PERICONCEPTIONAL VITAMIN SUPPLEMENTATION; NORWEGIAN MOTHER; DIETARY-SUPPLEMENTS; BIRTH COHORT; GENE; PREVENTION; FOLATE; OUTCOMES; WOMEN	Context Prenatal folic acid supplements reduce the risk of neural tube defects and may have beneficial effects on other aspects of neurodevelopment. Objective To examine associations between mothers' use of prenatal folic acid supplements and risk of severe language delay in their children at age 3 years. Design, Setting, and Patients The prospective observational Norwegian Mother and Child Cohort Study recruited pregnant women between 1999 and December 2008. Data on children born before 2008 whose mothers returned the 3-year follow-up questionnaire by June 16, 2010, were used. Maternal use of folic acid supplements within the interval from 4 weeks before to 8 weeks after conception was the exposure. Relative risks were approximated by estimating odds ratios (ORs) with 95% CIs in a logistic regression analysis. Main Outcome Measure Children's language competency at age 3 years measured by maternal report on a 6-point ordinal language grammar scale. Children with minimal expressive language (only 1-word or unintelligible utterances) were rated as having severe language delay. Results Among 38 954 children, 204 (0.5%) had severe language delay. Children whose mothers took no dietary supplements in the specified exposure interval were the reference group (n=9052 [24.0%], with severe language delay in 81 children [0.9%]). Adjusted ORs for 3 patterns of exposure to maternal dietary supplements were (1) other supplements, but no folic acid (n=2480 [6.6%], with severe language delay in 22 children [0.9%]; OR, 1.04; 95% CI, 0.62-1.74); (2) folic acid only (n=7127 [18.9%], with severe language delay in 28 children [0.4%]; OR, 0.55; 95% CI, 0.35-0.86); and (3) folic acid in combination with other supplements (n=19 005 [50.5%], with severe language delay in 73 children [0.4%]; OR, 0.55; 95% CI, 0.39-0.78). Conclusion Among this Norwegian cohort of mothers and children, maternal use of folic acid supplements in early pregnancy was associated with a reduced risk of severe language delay in children at age 3 years. JAMA. 2011;306(14):1566-1573	[Roth, Christine; Schjolberg, Synnve; Reichborn-Kjennerud, Ted] Norwegian Inst Publ Hlth, Div Mental Hlth, N-0403 Oslo, Norway; [Magnus, Per; Stoltenberg, Camilla; Suren, Pal] Norwegian Inst Publ Hlth, Div Epidemiol, N-0403 Oslo, Norway; [McKeague, Ian W.] Columbia Univ, Dept Biostat, New York, NY USA; [Susser, Ezra] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Roth, Christine; Susser, Ezra] Columbia Univ, Imprints Ctr Genet & Environm Life Course Studies, New York, NY USA; [Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Reichborn-Kjennerud, Ted] Univ Oslo, Inst Psychiat, Oslo, Norway; [Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA	Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); Columbia University; Columbia University; Columbia University; University of Bristol; University of Oslo; New York State Psychiatry Institute	Roth, C (corresponding author), Norwegian Inst Publ Hlth, Div Mental Hlth, POB 4404, N-0403 Oslo, Norway.	christine.roth@fhi.no	Stoltenberg, Camilla/G-5090-2017; Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Norwegian Ministry of Health; Ministry of Education and Research; National Institutes of Health/National Institute of Environmental Health Sciences [N01-ES-85433]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE (Funksjonell genomforskning) [151918/S10]; National Alliance for Research on Schizophrenia and Depression; Norwegian Research Council [181847/V50]; American Women's Club of Oslo; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [N01ES085433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Norwegian Ministry of Health; Ministry of Education and Research; National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE (Funksjonell genomforskning)(Research Council of Norway); National Alliance for Research on Schizophrenia and Depression(NARSAD); Norwegian Research Council(Research Council of NorwayEuropean Commission); American Women's Club of Oslo; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Norwegian Ministry of Health and the Ministry of Education and Research, and grants N01-ES-85433 from the National Institutes of Health/National Institute of Environmental Health Sciences, 1 UO1 NS 047537-01 from the National Institutes of Health/National Institute of Neurological Disorders and Stroke, and 151918/S10 from the Norwegian Research Council/FUGE (Funksjonell genomforskning). Dr Susser was supported in part by a National Alliance for Research on Schizophrenia and Depression distinguished investigator award. Dr Roth was supported by grant 181847/V50 from the Norwegian Research Council and by a travel grant from the American Women's Club of Oslo.	Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Brantsaeter AL, 2007, ANN NUTR METAB, V51, P146, DOI 10.1159/000103275; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Dale PS, 2003, J SPEECH LANG HEAR R, V46, P544, DOI 10.1044/1092-4388(2003/044); Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Feldman HM, 2005, CHILD DEV, V76, P856, DOI 10.1111/j.1467-8624.2005.00882.x; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Haberg SE, 2009, ARCH DIS CHILD, V94, P180, DOI 10.1136/adc.2008.142448; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Haugen M, 2008, ANN NUTR METAB, V52, P272, DOI 10.1159/000146274; Iskandar BJ, 2010, J CLIN INVEST, V120, P1603, DOI 10.1172/JCI40000; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Johansson M, 2010, JAMA-J AM MED ASSOC, V303, P2377, DOI 10.1001/jama.2010.808; Julvez J, 2009, PAEDIATR PERINAT EP, V23, P199, DOI 10.1111/j.1365-3016.2009.01032.x; Lawlor DA, 2004, LANCET, V363, P1724, DOI 10.1016/S0140-6736(04)16260-0; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; McClellan JM, 2006, JAMA-J AM MED ASSOC, V296, P582, DOI 10.1001/jama.296.5.582; MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847, DOI 10.1001/jama.262.20.2847; Miniscalco C, 2006, DEV MED CHILD NEUROL, V48, P361, DOI 10.1017/S0012162206000788; Nilsen RM, 2006, AM J CLIN NUTR, V84, P1134, DOI 10.1093/ajcn/84.5.1134; Nilsen RM, 2010, J NUTR, V140, P572, DOI 10.3945/jn.109.118158; Nilsen RM, 2009, PAEDIATR PERINAT EP, V23, P597, DOI 10.1111/j.1365-3016.2009.01062.x; Relton CL, 2004, J MED GENET, V41, P256, DOI 10.1136/jmg.2003.010694; Rice ML, 2008, J SPEECH LANG HEAR R, V51, P394, DOI 10.1044/1092-4388(2008/029); Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Roza SJ, 2010, BRIT J NUTR, V103, P445, DOI 10.1017/S0007114509991954; Schlotz W, 2010, J CHILD PSYCHOL PSYC, V51, P594, DOI 10.1111/j.1469-7610.2009.02182.x; Schmidt RJ, 2011, EPIDEMIOLOGY, V22, P476, DOI 10.1097/EDE.0b013e31821d0e30; SMITHELLS RW, 1980, LANCET, V1, P339; Sparrow S. S., 2005, VINELAND ADAPTIVE BE, V2nd, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Stoltenberg C, 2010, MOL PSYCHIATR, V15, P676, DOI 10.1038/mp.2009.143; WALD N, 1991, LANCET, V338, P131; Wehby GL, 2008, MATERN CHILD HLTH J, V12, P180, DOI 10.1007/s10995-007-0230-3; Zeisel SH, 2009, AM J CLIN NUTR, V89, p673S, DOI 10.3945/ajcn.2008.26811D	37	170	177	1	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1566	1573		10.1001/jama.2011.1433	http://dx.doi.org/10.1001/jama.2011.1433			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990300	Green Accepted, Bronze			2022-12-24	WOS:000295714700022
J	Parodi, G; Marcucci, R; Valenti, R; Gori, AM; Migliorini, A; Giusti, B; Buonamici, P; Gensini, GF; Abbate, R; Abbate, R; Antoniucci, D				Parodi, Guido; Marcucci, Rossella; Valenti, Renato; Gori, Anna Maria; Migliorini, Angela; Giusti, Betti; Buonamici, Piergiovanni; Gensini, Gian Franco; Abbate, Rosanna; Abbate, Rosanna; Antoniucci, David			High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-CARE ASSAY; MYOCARDIAL-INFARCTION; STENT THROMBOSIS; RESISTANCE; INTERVENTION; IMPACT; INDEX; NONRESPONDERS; AGGREGATION; INHIBITION	Context High residual platelet reactivity (HRPR) in patients receiving clopidogrel has been associated with high risk of ischemic events after percutaneous coronary intervention (PCI). Objective To test the hypothesis that HRPR after clopidogrel loading is an independent prognostic marker of risk of long-term thrombotic events in patients with acute coronary syndromes (ACS) undergoing an invasive procedure and antithrombotic treatment adjusted according to the results of platelet function tests. Design, Setting, and Patients Prospective, observational, referral center cohort study of 1789 consecutive patients with ACS undergoing PCI from April 2005 to April 2009 at the Division of Cardiology of Careggi Hospital, Florence, Italy, in whom platelet reactivity was prospectively assessed by light transmittance aggregometry. Interventions All patients received 325 mg of aspirin and a loading dose of 600 mg of clopidogrel followed by a maintenance dosage of 325 mg/d of aspirin and 75 mg/d of clopidogrel for at least 6 months. Patients with HRPR as assessed by adenosine diphosphate test (>= 70% platelet aggregation) received an increased dose of clopidogrel (150-300 mg/d) or switched to ticlopidine (500-1000 mg/d) under adenosine diphosphate test guidance. Main Outcome Measures The primary end point was a composite of cardiac death, myocardial infarction, any urgent coronary revascularization, and stroke at 2-year follow-up. Secondary end points were stent thrombosis and each component of the primary end point. Results The primary end point event rate was 14.6% (36/247) in patients with HRPR and 8.7% (132/1525) in patients with low residual platelet reactivity (absolute risk increase, 5.9%; 95% CI, 1.6%-11.1%; P=.003). Stent thrombosis was higher in the HRPR group compared with the low residual platelet reactivity group (6.1% [15/247] vs 2.9% [44/1525]; absolute risk increase, 3.2%; 95% CI, 0.4%-6.7%; P=.01). By multivariable analysis, HRPR was independently associated with the primary end point (hazard ratio, 1.49; 95% CI, 1.08-2.05; P=.02) and with cardiac mortality (hazard ratio, 1.81; 95% CI, 1.18-2.76; P=.006). Conclusion Among patients receiving platelet reactivity-guided antithrombotic medication after PCI, HRPR status was significantly associated with increased risk of ischemic events at short-and long-term follow-up.	[Antoniucci, David] Careggi Hosp, Div Cardiol, Dept Cardiol, I-50134 Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi	Antoniucci, D (corresponding author), Careggi Hosp, Div Cardiol, Dept Cardiol, Viale Pieraccini 17, I-50134 Florence, Italy.	david.antoniucci@virgilio.it	Marcucci, Rossella/K-8471-2016; Giusti, Betti/K-6978-2016; 刘, 李陆/H-8469-2015; Parodi, Guido/R-9346-2016; Gori, annamaria.gori@unifi.it/K-6077-2016	Giusti, Betti/0000-0002-8708-9444; Parodi, Guido/0000-0002-9718-9107; Gori, annamaria.gori@unifi.it/0000-0001-6857-5861; Marcucci, Rossella/0000-0001-9549-7176	Bayer; Boehringer Ingelheim; Eli Lilly; AstraZeneca; GlaxoSmithKline; Instrumentation Laboratory; Menarini; Sigma Tau; Novo Nordisk; Merck Sharp Dohme; Pfizer; Pierrel; sanofi-aventis; Servier; Daiichi Sankyo/Eli Lilly; Medicines Company; Italian Health Ministry	Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Instrumentation Laboratory; Menarini(Menarini Group); Sigma Tau; Novo Nordisk(Novo Nordisk); Merck Sharp Dohme(Merck & Company); Pfizer(Pfizer); Pierrel; sanofi-aventis(Sanofi-Aventis); Servier(Servier); Daiichi Sankyo/Eli Lilly(Daiichi Sankyo Company LimitedEli Lilly); Medicines Company; Italian Health Ministry(Ministry of Health, Italy)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Parodi reported receiving consulting fees from Daiichi Sankyo/Eli Lilly. Dr Marcucci reported receiving honoraria for lectures from Daiichi Sankyo/Eli Lilly and Merck Sharp & Dohme. Dr Gensini reported receiving consulting fees from Bayer, Boehringer Ingelheim, and Eli Lilly; lecture fees from AstraZeneca, GlaxoSmithKline, Instrumentation Laboratory, Menarini, and Sigma Tau; and research grant funding from Novo Nordisk, Merck Sharp & Dohme, Pfizer, Pierrel, sanofi-aventis, and Servier. Dr Abbate reported receiving consulting fees from Eli Lilly; lecture fees from Instrumentation Laboratory and Sigma Tau; and research grant funding from Bayer, Boehringer Ingelheim, and Pfizer. Dr Antoniucci reported receiving consulting fees from Daiichi Sankyo/Eli Lilly and The Medicines Company and serving on the advisory boards of Cordis and CID. No other disclosures were reported.; This study was supported by an unrestricted grant from the Italian Health Ministry to the Tuscany Region for the Finalized Medical Research Program 2007.	Angiolillo DJ, 2007, J AM COLL CARDIOL, V50, P1541, DOI 10.1016/j.jacc.2007.05.049; Barragan P, 2003, CATHETER CARDIO INTE, V59, P295, DOI 10.1002/ccd.10497; Bonello L, 2007, J THROMB HAEMOST, V5, P1630, DOI 10.1111/j.1538-7836.2007.02609.x; Bonello L, 2008, J AM COLL CARDIOL, V51, P1404, DOI 10.1016/j.jacc.2007.12.044; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bonello L, 2009, AM J CARDIOL, V103, P5, DOI 10.1016/j.amjcard.2008.08.048; Breet NJ, 2010, JAMA-J AM MED ASSOC, V303, P754, DOI 10.1001/jama.2010.181; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Chin CT, 2010, AM HEART J, V160, P16, DOI 10.1016/j.ahj.2010.04.022; Cuisset T, 2009, AM J CARDIOL, V104, P1078, DOI 10.1016/j.amjcard.2009.06.007; Cuisset T, 2008, JACC-CARDIOVASC INTE, V1, P649, DOI 10.1016/j.jcin.2008.08.018; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Frere C, 2007, THROMB HAEMOSTASIS, V98, P838, DOI 10.1160/TH07-04-0296; Gori AM, 2008, J AM COLL CARDIOL, V52, P734, DOI 10.1016/j.jacc.2008.05.032; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2007, J AM COLL CARDIOL, V50, P1822, DOI 10.1016/j.jacc.2007.07.051; Gurbel PA, 2010, CIRCULATION, V121, P1188, DOI 10.1161/CIRCULATIONAHA.109.919456; Marcucci R, 2009, CIRCULATION, V119, P237, DOI 10.1161/CIRCULATIONAHA.108.812636; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; Migliorini A, 2009, CIRCULATION, V120, P2214, DOI 10.1161/CIRCULATIONAHA.109.883454; Price MJ, 2008, EUR HEART J, V29, P992, DOI 10.1093/eurheartj/ehn046; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; Sibbing D, 2007, BLOOD COAGUL FIBRIN, V18, P335, DOI 10.1097/MBC.0b013e3280d21aed; Valgimigli M, 2009, CIRCULATION, V119, P3215, DOI 10.1161/CIRCULATIONAHA.108.833236	25	331	342	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1215	1223		10.1001/jama.2011.1332	http://dx.doi.org/10.1001/jama.2011.1332			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934054	Green Published, Bronze			2022-12-24	WOS:000295033500022
J	Brett, AS; Ablin, RJ				Brett, Allan S.; Ablin, Richard J.			Prostate-Cancer Screening - What the US Preventive Services Task Force Left Out	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Brett, Allan S.] Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA; [Ablin, Richard J.] Univ Arizona, Coll Med, Arizona Canc Ctr, Dept Pathol, Tucson, AZ 85724 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Arizona Center Cancer Care; University of Arizona	Brett, AS (corresponding author), Univ S Carolina, Sch Med, Dept Med, Columbia, SC 29208 USA.							American Urological Association, 2009, PROST SPEC ANT BEST; [Anonymous], 2011, SCREEN PROST CANC DR; Department of Health and Human Services, 2011, ASPE ISS BRIEF OV UN; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2004, NEW ENGL J MED, V351, P1470; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	6	53	53	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 24	2011	365	21					1949	1951		10.1056/NEJMp1112191	http://dx.doi.org/10.1056/NEJMp1112191			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	851PF	22029759				2022-12-24	WOS:000297282600002
J	Wilusz, JE; Whipple, JM; Phizicky, EM; Sharp, PA				Wilusz, Jeremy E.; Whipple, Joseph M.; Phizicky, Eric M.; Sharp, Phillip A.			tRNAs Marked with CCACCA Are Targeted for Degradation	SCIENCE			English	Article							MATURE TRANSFER-RNA; RAPID TRANSFER-RNA; ADDING ENZYME; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; POLYMERIZATION; SUBSTRATE; TEMPLATE; END; NUCLEOTIDYLTRANSFERASE	The CCA-adding enzyme [ATP(CTP): tRNA nucleotidyltransferase] adds CCA to the 3' ends of transfer RNAs (tRNAs), a critical step in tRNA biogenesis that generates the amino acid attachment site. We found that the CCA-adding enzyme plays a key role in tRNA quality control by selectively marking structurally unstable tRNAs and tRNA-like small RNAs for degradation. Instead of adding CCA to the 3' ends of these transcripts, CCA-adding enzymes from all three kingdoms of life add CCACCA. In addition, hypomodified mature tRNAs are subjected to CCACCA addition as part of a rapid tRNA decay pathway in vivo. We conjecture that CCACCA addition is a universal mechanism for controlling tRNA levels and preventing errors in translation.	[Wilusz, Jeremy E.; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Wilusz, Jeremy E.; Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Whipple, Joseph M.; Phizicky, Eric M.] Univ Rochester, Sch Med, Dept Biochem & Biophys, Ctr RNA Biol, Rochester, NY 14642 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Rochester	Wilusz, JE (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wilusz@mit.edu	Wilusz, Jeremy/AAG-4628-2020	Wilusz, Jeremy/0000-0001-6929-8755	NIH [5T32-GM068411, R01-GM34277, R01-CA133404, R01-GM52347]; Cancer Center from the National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA133404, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, R01GM052347, T32GM068411] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Weiner for providing CCA-adding enzyme expression plasmids; A. Leshinsky and D. Cook for performing the deep sequencing; E. Conti for providing the Rrp44 protein; O. Tam, A. Gordon, and G. Hannon for help with the deep sequencing analysis; and C. Koehrer, T. RajBhandary, P. Schimmel, D. Spector, C. Wilusz, J. Wilusz, and members of the Sharp and Phizicky laboratories for discussions and advice. J.E.W. is a fellow of the Leukemia and Lymphoma Society. Supported by NIH Training Grant in Cellular, Biochemical and Molecular Sciences 5T32-GM068411 (J.M.W.); NIH grants R01-GM34277 (P.A.S.), R01-CA133404 (P.A.S.), and R01-GM52347 (E.M.P.); and Cancer Center Support (core) Grant P30-CA14051 from the National Cancer Institute (P.A.S.).	Alexandrov A, 2006, MOL CELL, V21, P87, DOI 10.1016/j.molcel.2005.10.036; Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; Betat H, 2010, CELL MOL LIFE SCI, V67, P1447, DOI 10.1007/s00018-010-0271-4; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Kotelawala L, 2008, RNA, V14, P158, DOI 10.1261/rna.811008; Leigh J, 2004, RNA, V10, P615, DOI 10.1261/rna.5195504; LONERGAN KM, 1993, SCIENCE, V259, P812, DOI 10.1126/science.8430334; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Pan BC, 2010, SCIENCE, V330, P937, DOI 10.1126/science.1194985; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Whipple JM, 2011, GENE DEV, V25, P1173, DOI [10.1101/gad.2050711, 10.1101/gad.2050711.]; Wilusz JE, 2010, RNA, V16, P259, DOI 10.1261/rna.1907510; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Yue DX, 1996, RNA, V2, P895	28	109	116	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					817	821		10.1126/science.1213671	http://dx.doi.org/10.1126/science.1213671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076379	Green Accepted, Green Submitted			2022-12-24	WOS:000296849600050
J	Boyce, N; Evans, G				Boyce, Niall; Evans, Gareth			The art of medicine Nothing but flowers	LANCET			English	Editorial Material									[Boyce, Niall; Evans, Gareth] The Lancet, London NW1 7BY, England		Evans, G (corresponding author), The Lancet, London NW1 7BY, England.	garethhevans@hotmail.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 29	2011	378	9802					1541	1542		10.1016/S0140-6736(11)61543-2	http://dx.doi.org/10.1016/S0140-6736(11)61543-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	844SL	22043491				2022-12-24	WOS:000296767500014
J	Willett, WC; Ludwig, DS				Willett, Walter C.; Ludwig, David S.			The 2010 Dietary Guidelines - The Best Recipe for Health?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; RISK		[Willett, Walter C.; Ludwig, David S.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Willett, WC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544				Barclay AW, 2008, AM J CLIN NUTR, V87, P627, DOI 10.1093/ajcn/87.3.627; Bischoff-Ferrari HA, 2011, J BONE MINER RES, V26, P833, DOI 10.1002/jbmr.279; Institute of Medicine, 2011, DIETARY REFERENCE IN; Mozaffarian D, 2010, JAMA-J AM MED ASSOC, V304, P681, DOI 10.1001/jama.2010.1116; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	5	19	22	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1563	1565		10.1056/NEJMp1107075	http://dx.doi.org/10.1056/NEJMp1107075			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029977				2022-12-24	WOS:000296181800014
J	Dueber, EC; Schoeffler, AJ; Lingel, A; Elliott, JM; Fedorova, AV; Giannetti, AM; Zobel, K; Maurer, B; Varfolomeev, E; Wu, P; Wallweber, HJA; Hymowitz, SG; Deshayes, K; Vucic, D; Fairbrother, WJ				Dueber, Erin C.; Schoeffler, Allyn J.; Lingel, Andreas; Elliott, J. Michael; Fedorova, Anna V.; Giannetti, Anthony M.; Zobel, Kerry; Maurer, Brigitte; Varfolomeev, Eugene; Wu, Ping; Wallweber, Heidi J. A.; Hymowitz, Sarah G.; Deshayes, Kurt; Vucic, Domagoj; Fairbrother, Wayne J.			Antagonists Induce a Conformational Change in cIAP1 That Promotes Autoubiquitination	SCIENCE			English	Article							ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; IAP ANTAGONISTS; CASPASE ACTIVATION; STRUCTURAL BASIS; BIR3 DOMAIN; PROTEINS; CANCER; BINDING; SMAC	Inhibitor of apoptosis (IAP) proteins are negative regulators of cell death. IAP family members contain RING domains that impart E3 ubiquitin ligase activity. Binding of endogenous or small-molecule antagonists to select baculovirus IAP repeat (BIR) domains within cellular IAP (cIAP) proteins promotes autoubiquitination and proteasomal degradation and so releases inhibition of apoptosis mediated by cIAP. Although the molecular details of antagonist-BIR domain interactions are well understood, it is not clear how this binding event influences the activity of the RING domain. Here biochemical and structural studies reveal that the unliganded, multidomain cIAP1 sequesters the RING domain within a compact, monomeric structure that prevents RING dimerization. Antagonist binding induces conformational rearrangements that enable RING dimerization and formation of the active E3 ligase.	[Dueber, Erin C.; Schoeffler, Allyn J.; Lingel, Andreas; Fedorova, Anna V.; Zobel, Kerry; Varfolomeev, Eugene; Deshayes, Kurt; Vucic, Domagoj; Fairbrother, Wayne J.] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Elliott, J. Michael] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Giannetti, Anthony M.] Genentech Inc, Dept Biochem Pharmacol, San Francisco, CA 94080 USA; [Maurer, Brigitte; Wu, Ping; Wallweber, Heidi J. A.; Hymowitz, Sarah G.] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Vucic, D (corresponding author), Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA.	domagoj@gene.com; fairbro@gene.com	Schoeffler, Allyn/GOE-3900-2022; Lingel, Andreas/AAP-5078-2021	Schoeffler, Allyn/0000-0002-7112-409X; 	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; DOE Office of Biological and Environmental Research; National Center for Research Resources, NIH [P41RR001209]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank C. Yu, P. Lupardus, Shamrock Structures LLC, and staff at the Advanced Light Source, the Stanford Synchrotron Radiation Lightsource (SSRL) and the Advanced Photon Source at Argonne National Laboratory for their assistance with sample handling and data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. SSRL is a Directorate of SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the DOE Office of Science by Stanford University. The Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the Biomedical Technology Program, National Center for Research Resources, NIH (P41RR001209). Use of the Advanced Photon Source, a facility operated for DOE Office of Science by Argonne National Laboratory, was supported under contract no. DE-AC02-06CH11357. We also thank the Microchemistry and Proteomics Laboratory and the Oligo Synthesis and DNA Sequencing facilities at Genentech for their technical support. Atomic coordinates and structure factors have been deposited in the Protein DataBank with accession code 3T6P. Reagents are available from Genentech subject to a material transfer agreement.	Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dynek J.N., 2010, CANC LETT; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Flygare JA, 2010, EXPERT OPIN THER PAT, V20, P251, DOI 10.1517/13543770903567077; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Kulathila R, 2009, ACTA CRYSTALLOGR D, V65, P58, DOI 10.1107/S0907444908039243; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Mace PD, 2010, CELL DEATH DIFFER, V17, P46, DOI 10.1038/cdd.2009.45; Mace PD, 2008, J BIOL CHEM, V283, P31633, DOI 10.1074/jbc.M804753200; Ndubaku C, 2009, ACS CHEM BIOL, V4, P557, DOI 10.1021/cb900083m; Oost TK, 2004, J MED CHEM, V47, P4417, DOI 10.1021/jm040037k; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Varfolomeev E, 2006, J BIOL CHEM, V281, P29022, DOI 10.1074/jbc.M605116200; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	25	156	161	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					376	380		10.1126/science.1207862	http://dx.doi.org/10.1126/science.1207862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021857				2022-12-24	WOS:000296052500053
J	Rayner, KJ; Esau, CC; Hussain, FN; McDaniel, AL; Marshall, SM; van Gils, JM; Ray, TD; Sheedy, FJ; Goedeke, L; Liu, XQ; Khatsenko, OG; Kaimal, V; Lees, CJ; Fernandez-Hernando, C; Fisher, EA; Temel, RE; Moore, KJ				Rayner, Katey J.; Esau, Christine C.; Hussain, Farah N.; McDaniel, Allison L.; Marshall, Stephanie M.; van Gils, Janine M.; Ray, Tathagat D.; Sheedy, Frederick J.; Goedeke, Leigh; Liu, Xueqing; Khatsenko, Oleg G.; Kaimal, Vivek; Lees, Cynthia J.; Fernandez-Hernando, Carlos; Fisher, Edward A.; Temel, Ryan E.; Moore, Kathryn J.			Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides	NATURE			English	Article							CHOLESTEROL; MICRORNA-33; INTRON	Cardiovascular disease remains the leading cause of mortality in westernized countries, despite optimum medical therapy to reduce the levels of low-density lipoprotein (LDL)-associated cholesterol. The pursuit of novel therapies to target the residual risk has focused on raising the levels of high-density lipoprotein (HDL)-associated cholesterol in order to exploit its atheroprotective effects(1). MicroRNAs (miRNAs) have emerged as important posttranscriptional regulators of lipid metabolism and are thus a new class of target for therapeutic intervention(2). MicroRNA-33a and microRNA-33b (miR-33a/b) are intronic miRNAs whose encoding regions are embedded in the sterol-response-element-binding protein genes SREBF2 and SREBF1 (refs 3-5), respectively. These miRNAs repress expression of the cholesterol transporter ABCA1, which is a key regulator of HDL biogenesis. Recent studies in mice suggest that antagonizing miR-33a may be an effective strategy for raising plasma HDL levels(3-5) and providing protection against atherosclerosis(6); however, extrapolating these findings to humans is complicated by the fact that mice lack miR-33b, which is present only in the SREBF1 gene of medium and large mammals. Here we show in African green monkeys that systemic delivery of an anti-miRNA oligonucleotide that targets both miR-33a and miR-33b increased hepatic expression of ABCA1 and induced a sustained increase in plasma HDL levels over 12 weeks. Notably, miR-33 antagonism in this non-human primate model also increased the expression of miR-33 target genes involved in fatty acid oxidation (CROT, CPT1A, HADHB and PRKAA1) and reduced the expression of genes involved in fatty acid synthesis (SREBF1, FASN, ACLY and ACACA), resulting in a marked suppression of the plasma levels of very-low-density lipoprotein (VLDL)-associated triglycerides, a finding that has not previously been observed in mice. These data establish, in a model that is highly relevant to humans, that pharmacological inhibition of miR-33a and miR33b is a promising therapeutic strategy to raise plasma HDL and lower VLDL triglyceride levels for the treatment of dyslipidaemias that increase cardiovascular disease risk.	[Rayner, Katey J.; Hussain, Farah N.; van Gils, Janine M.; Ray, Tathagat D.; Sheedy, Frederick J.; Goedeke, Leigh; Fernandez-Hernando, Carlos; Fisher, Edward A.; Moore, Kathryn J.] NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10016 USA; [Esau, Christine C.; Liu, Xueqing; Khatsenko, Oleg G.; Kaimal, Vivek] Regulus Therapeut, San Diego, CA 92121 USA; [McDaniel, Allison L.; Marshall, Stephanie M.; Temel, Ryan E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Sect Lipid Sci, Winston Salem, NC 27157 USA; [Lees, Cynthia J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Comparat Med Sect, Winston Salem, NC 27157 USA	New York University; Isis Pharmaceuticals Inc; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Moore, KJ (corresponding author), NYU, Sch Med, Marc & Ruti Bell Vasc Biol & Dis Program, Leon H Charney Div Cardiol,Dept Med, New York, NY 10016 USA.	rtemel@wfubmc.edu; kathryn.moore@nyumc.org	Rayner, Katey/K-8914-2012; Fisher, Edward/ABE-7469-2020; 应, 宁宁/G-9472-2011; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Rayner, Katey/0000-0001-6230-426X; Goedeke, Leigh/0000-0002-7690-1572; Sheedy, Frederick/0000-0002-4722-3135; Kaimal, Vivek/0000-0003-4807-4394; Sheedy, Frederick/0000-0003-2645-8493; van Gils, Janine/0000-0003-2429-7462; Fisher, Edward/0000-0001-9802-143X	National Institutes of Health [R01AG02055, R01HL108182, P01HL098055, R01HL084312, R01HL58541, 1P30HL101270, R01HL107953, R00HL088528]; Canadian Institutes of Health Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108182, P01HL098055, R00HL088528, R01HL107953, P30HL101270, R01HL058541, R01HL084312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health to K.J.M. (R01AG02055 and R01HL108182), E.A.F. (P01HL098055, R01HL084312 and R01HL58541), C.F.-H. (1P30HL101270 and R01HL107953), R.E.T. (R00HL088528), as well as by the Canadian Institutes of Health Research (K.J.R.)	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Chyu KY, 2011, CURR ATHEROSCLER REP, V13, P405, DOI 10.1007/s11883-011-0189-9; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Garber DW, 2000, J LIPID RES, V41, P1020; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680, 10.1517/17425250902877680 ]; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Horie T, 2010, P NATL ACAD SCI USA, V107, P17321, DOI 10.1073/pnas.1008499107; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Jeyarajah EJ, 2006, CLIN LAB MED, V26, P847, DOI 10.1016/j.cll.2006.07.006; KIEFT KA, 1991, J LIPID RES, V32, P859; KORITNIK DL, 1983, J LIPID RES, V24, P1639; Marquart TJ, 2010, P NATL ACAD SCI USA, V107, P12228, DOI 10.1073/pnas.1005191107; Moore KJ, 2010, TRENDS ENDOCRIN MET, V21, P699, DOI 10.1016/j.tem.2010.08.008; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Wagner JD, 2006, ILAR J, V47, P259, DOI 10.1093/ilar.47.3.259; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	20	556	594	4	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					404	+		10.1038/nature10486	http://dx.doi.org/10.1038/nature10486			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012398	Green Accepted			2022-12-24	WOS:000296021100050
J	Nicholas, LH; Langa, KM; Iwashyna, TJ; Weir, DR				Nicholas, Lauren Hersch; Langa, Kenneth M.; Iwashyna, Theodore J.; Weir, David R.			Regional Variation in the Association Between Advance Directives and End-of-Life Medicare Expenditures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT PREFERENCES; HEALTH-CARE; OUTCOMES; QUALITY; VALIDATION; DEATH	Context It is unclear if advance directives (living wills) are associated with end-of-life expenditures and treatments. Objective To examine regional variation in the associations between treatment-limiting advance directive use, end-of-life Medicare expenditures, and use of palliative and intensive treatments. Design, Setting, and Patients Prospectively collected survey data from the Health and Retirement Study for 3302 Medicare beneficiaries who died between 1998 and 2007 linked to Medicare claims and the National Death Index. Multivariable regression models examined associations between advance directives, end-of-life Medicare expenditures, and treatments by level of Medicare spending in the decedent's hospital referral region. Main Outcome Measures Medicare expenditures, life-sustaining treatments, hospice care, and in-hospital death over the last 6 months of life. Results Advance directives specifying limits in care were associated with lower spending in hospital referral regions with high average levels of end-of-life expenditures (-$5585 per decedent; 95% CI, -$10 903 to -$267), but there was no difference in spending in hospital referral regions with low or medium levels of end-of-life expenditures. Directives were associated with lower adjusted probabilities of in-hospital death in high-and medium-spending regions (-9.8%; 95% CI, -16% to -3% in high-spending regions; -5.3%; 95% CI, -10% to -0.4% in medium-spending regions). Advance directives were associated with higher adjusted probabilities of hospice use in high-and medium-spending regions (17%; 95% CI, 11% to 23% in high-spending regions, 11%; 95% CI, 6% to 16% in medium-spending regions), but not in low-spending regions. Conclusion Advance directives specifying limitations in end-of-life care were associated with significantly lower levels of Medicare spending, lower likelihood of in-hospital death, and higher use of hospice care in regions characterized by higher levels of end-of-life spending. JAMA. 2011;306(13):1447-1453	[Nicholas, Lauren Hersch; Langa, Kenneth M.; Iwashyna, Theodore J.; Weir, David R.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; [Langa, Kenneth M.; Iwashyna, Theodore J.] Vet Affairs Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nicholas, LH (corresponding author), 3005 Inst Social Res, 426 Thompson St, Ann Arbor, MI 48104 USA.	lnichola@umich.edu		Iwashyna, Theodore/0000-0002-4226-9310; Langa, Kenneth/0000-0002-2798-1836	National Institutes of Health [U01 AG09740, R01 AG030155, K08 HL091249]; Michigan Institute for Clinical and Health Research [UL1RR024986]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD041028] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000221, U01AG009740, P30AG012846, R01AG030155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Institute for Clinical and Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants U01 AG09740, R01 AG030155, K08 HL091249 from the National Institutes of Health and Clinical and Translational Science Award grant UL1RR024986 from the Michigan Institute for Clinical and Health Research.	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Barnato AE, 2009, J GEN INTERN MED, V24, P695, DOI 10.1007/s11606-009-0952-6; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Curtis JR, 2002, J PAIN SYMPTOM MANAG, V24, P17, DOI 10.1016/S0885-3924(02)00419-0; *DARTM, DARTM ATL HLTH CAR D; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fried TR, 2011, J AM GERIATR SOC, V59, P1105, DOI 10.1111/j.1532-5415.2011.03412.x; Greene W., 2012, ECONOMETRIC ANAL, V7th; Juster FT, 1995, J HUM RESOUR, V30, pS7, DOI 10.2307/146277; Kelley AS, 2011, ANN INTERN MED, V154, P235, DOI 10.7326/0003-4819-154-4-201102150-00004; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; McPherson CJ, 2003, SOC SCI MED, V56, P95, DOI 10.1016/S0277-9536(02)00011-4; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Riley GF, 2010, HEALTH SERV RES, V45, P565, DOI 10.1111/j.1475-6773.2010.01082.x; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; Taylor JS, 1999, CAN FAM PHYSICIAN, V45, P2408; Teno J, 1997, J AM GERIATR SOC, V45, P513, DOI 10.1111/j.1532-5415.1997.tb05180.x; Teno J, 1997, J AM GERIATR SOC, V45, P500, DOI 10.1111/j.1532-5415.1997.tb05178.x; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Zhang BH, 2009, ARCH INTERN MED, V169, P480, DOI 10.1001/archinternmed.2008.587	28	212	213	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1447	1453		10.1001/jama.2011.1410	http://dx.doi.org/10.1001/jama.2011.1410			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	828MZ	21972306	Green Accepted			2022-12-24	WOS:000295506900023
J	Quill, TE; Holloway, R				Quill, Timothy E.; Holloway, Robert			Time-Limited Trials Near the End of Life	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMUNICATION; PREFERENCES; CARE		[Quill, Timothy E.] Univ Rochester, Med Ctr, Palliat Care Program, Ctr Eth Humanities & Palliat Care, Rochester, NY 14642 USA; [Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Holloway, Robert] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Palliat Care Program, Ctr Eth Humanities & Palliat Care, 601 Elmwood Ave,Box 687, Rochester, NY 14642 USA.	timothy_quill@urmc.rochester.edu						Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Chung GS, 2012, J MED ETHICS, V38, P77, DOI 10.1136/jme.2010.040618; Hagerty RG, 2004, J CLIN ONCOL, V22, P1721, DOI 10.1200/JCO.2004.04.095; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Quill TE, 2009, ANN INTERN MED, V151, P345, DOI 10.7326/0003-4819-151-5-200909010-00010; Tulsky JA, 2005, JAMA-J AM MED ASSOC, V294, P359, DOI 10.1001/jama.294.3.359; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008	10	132	134	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1483	1484		10.1001/jama.2011.1413	http://dx.doi.org/10.1001/jama.2011.1413			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972312				2022-12-24	WOS:000295506900029
J	Lencer, WI; von Andrian, UH				Lencer, Wayne I.; von Andrian, Ulrich H.			Eliciting Mucosal Immunity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DENDRITIC CELLS		[Lencer, Wayne I.] Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA; [von Andrian, Ulrich H.] Harvard Univ, Sch Med, Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Lencer, WI (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Dept Med, Boston, MA 02115 USA.		von Andrian, Ulrich H/A-5775-2008	Lencer, Wayne/0000-0001-7346-2730	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, P30DK034854, R37DK048106] Funding Source: NIH RePORTER; NIDDK NIH HHS [R37 DK048106, R01 DK048106, P30 DK034854] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fairfield KM, 2002, JAMA-J AM MED ASSOC, V287, P3116, DOI 10.1001/jama.287.23.3116; Fairfield KM, 2002, JAMA-J AM MED ASSOC, V288, P1720; HAMMERSCHMIDT SI, 2011, J CLIN INVEST   0701; Moore SR, 2011, NAT REV GASTRO HEPAT, V8, P363, DOI 10.1038/nrgastro.2011.103; Mora JR, 2006, SCIENCE, V314, P1157, DOI 10.1126/science.1132742; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Tan XF, 2011, J VIROL, V85, P8316, DOI 10.1128/JVI.00781-11	7	6	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1151	1153		10.1056/NEJMcibr1107816	http://dx.doi.org/10.1056/NEJMcibr1107816			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992128	Green Accepted			2022-12-24	WOS:000295081600017
J	Li, PP; Fan, WQ; Xu, JF; Lu, M; Yamamoto, H; Auwerx, J; Sears, DD; Talukdar, S; Oh, D; Chen, A; Bandyopadhyay, G; Scadeng, M; Ofrecio, JM; Nalbandian, S; Olefsky, JM				Li, Pingping; Fan, WuQiang; Xu, Jianfeng; Lu, Min; Yamamoto, Hiroyasu; Auwerx, Johan; Sears, Dorothy D.; Talukdar, Saswata; Oh, DaYoung; Chen, Ai; Bandyopadhyay, Gautam; Scadeng, Miriam; Ofrecio, Jachelle M.; Nalbandian, Sarah; Olefsky, Jerrold M.			Adipocyte NCoR Knockout Decreases PPAR gamma Phosphorylation and Enhances PPAR gamma Activity and Insulin Sensitivity	CELL			English	Article							ACTIVATED RECEPTOR-GAMMA; ADIPOSE-TISSUE; NUCLEAR RECEPTORS; OBESITY; INFLAMMATION; RESISTANCE; MACROPHAGES; FAT; ROSIGLITAZONE; COREGULATORS	Insulin resistance, tissue inflammation, and adipose tissue dysfunction are features of obesity and Type 2 diabetes. We generated adipocyte-specific Nuclear Receptor Corepressor (NCoR) knockout (AKO) mice to investigate the function of NCoR in adipocyte biology, glucose and insulin homeostasis. Despite increased obesity, glucose tolerance was improved in AKO mice, and clamp studies demonstrated enhanced insulin sensitivity in liver, muscle, and fat. Adipose tissue macrophage infiltration and inflammation were also decreased. PPAR gamma response genes were upregulated in adipose tissue from AKO mice and CDK5-mediated PPAR gamma ser-273 phosphorylation was reduced, creating a constitutively active PPAR gamma state. This identifies NCoR as an adaptor protein that enhances the ability of CDK5 to associate with and phosphorylate PPAR gamma. The dominant function of adipocyte NCoR is to transrepress PPAR gamma and promote PPAR gamma ser-273 phosphorylation, such that NCoR deletion leads to adipogenesis, reduced inflammation, and enhanced systemic insulin sensitivity, phenocopying the TZD-treated state.	[Li, Pingping; Fan, WuQiang; Xu, Jianfeng; Lu, Min; Sears, Dorothy D.; Talukdar, Saswata; Oh, DaYoung; Chen, Ai; Bandyopadhyay, Gautam; Ofrecio, Jachelle M.; Nalbandian, Sarah; Olefsky, Jerrold M.] Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, San Diego, CA 92093 USA; [Yamamoto, Hiroyasu; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Scadeng, Miriam] Univ Calif San Diego, Dept Radiol, San Diego, CA 92098 USA	University of California System; University of California San Diego; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, 9500 Gilman Dr, San Diego, CA 92093 USA.	jolefsky@ucsd.edu	Li, Pingping/F-1109-2019; OH, DA YOUNG/B-2369-2008; Sears, Dorothy D/AHE-5524-2022; Auwerx, Johan/ABE-9307-2021	Li, Pingping/0000-0003-0679-270X; Sears, Dorothy D/0000-0002-9260-3540; Talukdar, Saswata/0000-0003-3042-0025; Auwerx, Johan/0000-0002-5065-5393; Scadeng, Miriam/0000-0002-9593-2956	National Institutes of Health [NIDDK DK033651, DK063491, DK 074868, DK059820]; EU [ERC-2008-AdG-23118]; Swiss National Science Foundation; Eunice Kennedy Shriver NICHD/NIH [U54 HD 012303-25]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK033651, P01DK074868, T32DK007494, R37DK033651, P01DK059820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Eunice Kennedy Shriver NICHD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Elizabeth J. Hansen for editorial assistance; the Flow Cytometry Resource (Dennis Young) for FACS analysis at the Rebecca and John Moores Cancer Center; and we thank the UCSD Histology Core lab for technical help with processing tissue specimens and microscope analysis. This study was funded in part by the National Institutes of Health grants NIDDK DK033651 (J.M.O.), DK063491 (J.M.O.), DK 074868 (J.M.O.), DK059820 (J. A.), and EU Ideas program (ERC-2008-AdG-23118), the Swiss National Science Foundation, and the Eunice Kennedy Shriver NICHD/NIH through a cooperative agreement U54 HD 012303-25 as part of the specialized Cooperative Centers Program in Reproduction and Infertility Research.	CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Collingwood TN, 1999, J MOL ENDOCRINOL, V23, P255, DOI 10.1677/jme.0.0230255; Cusi K, 2010, CURR DIABETES REP, V10, P306, DOI 10.1007/s11892-010-0122-6; Djaouti L, 2010, DIABETES-METAB RES, V26, P297, DOI 10.1002/dmrr.1081; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fowler Amy M, 2004, Sci STKE, V2004, ppe51, DOI 10.1126/stke.2562004pe51; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Glass CK, 2000, GENE DEV, V14, P121; Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Imai T, 2004, P NATL ACAD SCI USA, V101, P4543, DOI 10.1073/pnas.0400356101; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Lessard SJ, 2007, DIABETES, V56, P1856, DOI 10.2337/db06-1065; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Lu M, 2010, MOL ENDOCRINOL, V24, P1413, DOI 10.1210/me.2009-0462; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Revilla Y, 2009, CRIT REV IMMUNOL, V29, P131, DOI 10.1615/CritRevImmunol.v29.i2.30; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200	46	214	222	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					815	826		10.1016/j.cell.2011.09.050	http://dx.doi.org/10.1016/j.cell.2011.09.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078880	Green Accepted, Bronze			2022-12-24	WOS:000296902300015
J	Rodriguez, MM; Bill, E; Brennessel, WW; Holland, PL				Rodriguez, Meghan M.; Bill, Eckhard; Brennessel, William W.; Holland, Patrick L.			N-2 Reduction and Hydrogenation to Ammonia by a Molecular Iron-Potassium Complex	SCIENCE			English	Article							ELECTRON-PARAMAGNETIC-RESONANCE; HIGH-SPIN; DINITROGEN; MOSSBAUER; HYDRAZINE; MECHANISM; H-2	The most common catalyst in the Haber-Bosch process for the hydrogenation of dinitrogen (N-2) to ammonia (NH3) is an iron surface promoted with potassium cations (K+), but soluble iron complexes have neither reduced the N-N bond of N-2 to nitride (N3-) nor produced large amounts of NH3 from N-2. We report a molecular iron complex that reacts with N-2 and a potassium reductant to give a complex with two nitrides, which are bound to iron and potassium cations. The product has a Fe3N2 core, implying that three iron atoms cooperate to break the N-N triple bond through a six-electron reduction. The nitride complex reacts with acid and with H-2 to give substantial yields of N-2-derived ammonia. These reactions, although not yet catalytic, give structural and spectroscopic insight into N-2 cleavage and N-H bond-forming reactions of iron.	[Rodriguez, Meghan M.; Brennessel, William W.; Holland, Patrick L.] Univ Rochester, Dept Chem, Rochester, NY 14627 USA; [Bill, Eckhard] Max Planck Inst Bioanorgan, D-45470 Mulheim, Germany	University of Rochester; Max Planck Society	Holland, PL (corresponding author), Univ Rochester, Dept Chem, Rochester, NY 14627 USA.	holland@chem.rochester.edu		Brennessel, William/0000-0001-5461-1825	NIH [GM-065313]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065313] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from NIH (GM-065313). We thank C. Scarborough and R. Cowley for valuable discussions. Materials and methods are available as supporting material on Science Online. Crystallographic data for 2 (two independent structures with different solvents of crystallization), L<SUP>3</SUP>FeCl<INF>2</INF>, L<SUP>3</SUP>FeCl<INF>2</INF>K(18-crown-6), and [L<SUP>3</SUP>FeH]<INF>2</INF> have been deposited with the Cambridge Crystallographic Data Centre with deposition numbers CCDC 836870 to 836874.	Andres H, 2002, J AM CHEM SOC, V124, P3012, DOI 10.1021/ja012327l; Arashiba K, 2011, NAT CHEM, V3, P120, DOI 10.1038/NCHEM.906; Bennett MV, 2006, ANGEW CHEM INT EDIT, V45, P5613, DOI 10.1002/anie.200601570; Bennett MV, 2005, J AM CHEM SOC, V127, P12378, DOI 10.1021/ja052150l; Betley TA, 2004, J AM CHEM SOC, V126, P6252, DOI 10.1021/ja048713v; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Chomitz WA, 2007, CHEM COMMUN, P4797, DOI 10.1039/b709763h; Crossland JL, 2010, COORDIN CHEM REV, V254, P1883, DOI 10.1016/j.ccr.2010.01.005; Eckert NA, 2004, INORG CHEM, V43, P3306, DOI 10.1021/ic035483x; GEORGE TA, 1995, INORG CHEM, V34, P1295, DOI 10.1021/ic00109a046; Gilbertson JD, 2005, J AM CHEM SOC, V127, P10184, DOI 10.1021/ja053030g; Hall DA, 1996, J CHEM SOC DALTON, P3539, DOI 10.1039/dt9960003539; Hazari N, 2010, CHEM SOC REV, V39, P4044, DOI 10.1039/b919680n; Hellman A, 2006, J PHYS CHEM B, V110, P17719, DOI 10.1021/jp056982h; HILLS A, 1993, J CHEM SOC DALTON, P3041, DOI 10.1039/dt9930003041; Hoffman BM, 2009, ACCOUNTS CHEM RES, V42, P609, DOI 10.1021/ar8002128; Mittasch A., 1951, GESCH AMMONIAKSYNTHE; Mortensen JJ, 1999, J CATAL, V182, P479, DOI 10.1006/jcat.1998.2364; Pool JA, 2004, NATURE, V427, P527, DOI 10.1038/nature02274; Schlogl R., 2008, HDB HETEROGENEOUS CA, V5, P2501; SCHRAUZER GN, 1976, J AM CHEM SOC, V98, P3508, DOI 10.1021/ja00428a019; Smil V, 1997, SCI AM, V277, P76, DOI 10.1038/scientificamerican0797-76; Smith JM, 2006, J AM CHEM SOC, V128, P756, DOI 10.1021/ja052707x; Smith JM, 2001, J AM CHEM SOC, V123, P9222, DOI 10.1021/ja016094+; Stoian SA, 2008, INORG CHEM, V47, P8687, DOI 10.1021/ic8004568; STRONGIN DR, 1987, J CATAL, V103, P213, DOI 10.1016/0021-9517(87)90109-6; Yandulov DV, 2003, SCIENCE, V301, P76, DOI 10.1126/science.1085326	27	377	381	6	408	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					780	783		10.1126/science.1211906	http://dx.doi.org/10.1126/science.1211906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076372	Green Accepted			2022-12-24	WOS:000296849600039
J	Evan, AT; Kossin, JP; Chung, C; Ramanathan, V				Evan, Amato T.; Kossin, James P.; Chung, Chul 'Eddy'; Ramanathan, V.			Arabian Sea tropical cyclones intensified by emissions of black carbon and other aerosols	NATURE			English	Article							VERTICAL WIND SHEAR; INDIAN-OCEAN; CLIMATE; IMPACTS	Throughout the year, average sea surface temperatures in the Arabian Sea are warm enough to support the development of tropical cyclones(1), but the atmospheric monsoon circulation and associated strong vertical wind shear limits cyclone development and intensification, only permitting a pre-monsoon and post-monsoon period for cyclogenesis(1-4). Thus a recent increase in the intensity of tropical cyclones over the northern Indian Ocean(5) is thought to be related to the weakening of the climatological vertical wind shear(3,4). At the same time, anthropogenic emissions of aerosols have increased sixfold since the 1930s, leading to a weakening of the southwesterly lower-level and easterly upper-level winds that define the monsoonal circulation over the Arabian Sea(6-9). In principle, this aerosol-driven circulation modification could affect tropical cyclone intensity over the Arabian Sea, but so far no such linkage has been shown. Here we report an increase in the intensity of pre-monsoon Arabian Sea tropical cyclones during the period 1979-2010, and show that this change in storm strength is a consequence of a simultaneous upward trend in anthropogenic black carbon and sulphate emissions. We use a combination of observational, reanalysis and model data to demonstrate that the anomalous circulation, which is radiatively forced by these anthropogenic aerosols, reduces the basin-wide vertical wind shear, creating an environment more favourable for tropical cyclone intensification. Because most Arabian Sea tropical cyclones make landfall(1), our results suggest an additional impact on human health from regional air pollution.	[Evan, Amato T.] Univ Virginia, Charlottesville, VA 22904 USA; [Kossin, James P.] NOAA, Natl Climat Data Ctr, Asheville, NC 28801 USA; [Kossin, James P.] NOAA, Cooperat Inst Meteorol Satellite Studies, Madison, WI 53706 USA; [Chung, Chul 'Eddy'] Gwangju Inst Sci & Technol, Kwangju 500712, South Korea; [Ramanathan, V.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Virginia; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Gwangju Institute of Science & Technology (GIST); University of California System; University of California San Diego; Scripps Institution of Oceanography	Evan, AT (corresponding author), Univ Virginia, Charlottesville, VA 22904 USA.	ate9c@virginia.edu	Evan, Amato/GZL-2684-2022; Kossin, James/C-2022-2016	Evan, Amato/0000-0003-2812-3750; Kossin, James/0000-0003-0461-9794	National Oceanic & Atmospheric Administration (NOAA)/Climate Program Office [NA10OAR4310136]; Korea's Research Agency for Climate Science [RACS 2010-2603]; National Science Foundation [ATM-0721142]	National Oceanic & Atmospheric Administration (NOAA)/Climate Program Office(National Oceanic Atmospheric Admin (NOAA) - USA); Korea's Research Agency for Climate Science; National Science Foundation(National Science Foundation (NSF))	Partial funding for this work was provided by National Oceanic & Atmospheric Administration (NOAA)/Climate Program Office (NA10OAR4310136), Korea's Research Agency for Climate Science (RACS 2010-2603) and the National Science Foundation (ATM-0721142). Data from National Centers for Environmental Prediction reanalyses 1 and 2 were provided by the NOAA/Office of Oceanic and Atmospheric Research/Earth System Research Laboratory Physical Sciences Division, Boulder, Colorado, USA, from their website (http://www.esrl.noaa.gov/psd/).	Chung CE, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006356; Chung CE, 2003, J CLIMATE, V16, P1791, DOI 10.1175/1520-0442(2003)016<1791:SAHFRI>2.0.CO;2; Chung CE, 2006, J CLIMATE, V19, P2036, DOI 10.1175/JCLI3820.1; Dash SK, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010572; DeMaria M, 1999, WEATHER FORECAST, V14, P326, DOI 10.1175/1520-0434(1999)014<0326:AUSHIP>2.0.CO;2; Dvorak V. F., 1984, 11 NOAA; Elsberry RL, 1996, MON WEATHER REV, V124, P1374, DOI 10.1175/1520-0493(1996)124<1374:VWSIOT>2.0.CO;2; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Emanuel K, 2003, ANNU REV EARTH PL SC, V31, P75, DOI 10.1146/annurev.earth.31.100901.141259; EMANUEL KA, 1988, J ATMOS SCI, V45, P1143, DOI 10.1175/1520-0469(1988)045<1143:TMIOH>2.0.CO;2; Evan AT, 2011, J CLIMATE, V24, P140, DOI 10.1175/2010JCLI3611.1; Frank WM, 2001, MON WEATHER REV, V129, P2249, DOI 10.1175/1520-0493(2001)129<2249:EOVWSO>2.0.CO;2; GRAY WM, 1968, MON WEATHER REV, V96, P669, DOI 10.1175/1520-0493(1968)096<0669:GVOTOO>2.0.CO;2; Integrated assessment of black carbon and tropospheric ozone, 2011, UNEPGC26INF20 WORLD; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kiehl JT, 1998, J CLIMATE, V11, P1131, DOI 10.1175/1520-0442(1998)011<1131:TNCFAR>2.0.CO;2; Knapp KR, 2010, B AM METEOROL SOC, V91, P363, DOI 10.1175/2009BAMS2755.1; Kossin JP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028836; Kossin JP, 2009, CLIMATIC CHANGE, V97, P329, DOI 10.1007/s10584-009-9748-2; Krishna KM, 2009, GLOBAL PLANET CHANGE, V65, P12, DOI 10.1016/j.gloplacha.2008.10.007; Kumari BP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031133; Meehl GA, 2008, J CLIMATE, V21, P2869, DOI 10.1175/2007JCLI1777.1; Ramanathan V, 2001, J GEOPHYS RES-ATMOS, V106, P28371, DOI 10.1029/2001JD900133; Ramanathan V, 2005, P NATL ACAD SCI USA, V102, P5326, DOI 10.1073/pnas.0500656102; Rao VB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034729; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Singh OP, 2001, CURR SCI INDIA, V80, P575; Wang C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040114	28	109	111	2	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					94	U119		10.1038/nature10552	http://dx.doi.org/10.1038/nature10552			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22051678				2022-12-24	WOS:000296422600038
J	Rougier, GW; Apesteguia, S; Gaetano, LC				Rougier, Guillermo W.; Apesteguia, Sebastian; Gaetano, Leandro C.			Highly specialized mammalian skulls from the Late Cretaceous of South America	NATURE			English	Article							ARGENTINA; PATAGONIA; SYMMETRODONTA; PHYLOGENY	Dryolestoids are an extinct mammalian group belonging to the lineage leading to modern marsupials and placentals(1,2). Dryolestoids are known by teeth and jaws from the Jurassic period of North America and Europe(2,3), but they thrived in South America up to the end of the Mesozoic era and survived to the beginnings of the Cenozoic(2,4-7). Isolated teeth and jaws from the latest Cretaceous of South America provide mounting evidence that, at least in western Gondwana, dryolestoids developed into strongly endemic groups by the Late Cretaceous(4-9). However, the lack of pre-Late Cretaceous dryolestoid remains made study of their origin and early diversification intractable. Here we describe the first mammalian remains from the early Late Cretaceous of South America, including two partial skulls and jaws of a derived dryolestoid showing dental and cranial features unknown among any other group of Mesozoic mammals, such as single-rooted molars preceded by double-rooted premolars, combined with a very long muzzle, exceedingly long canines and evidence of highly specialized masticatory musculature. On one hand, the new mammal shares derived features of dryolestoids(1-3) with forms from the Jurassic of Laurasia, whereas on the other hand, it is very specialized and highlights the endemic, diverse dryolestoid fauna from the Cretaceous of South America. Our specimens include only the second mammalian skull known for the Cretaceous of Gondwana, bridging a previous 60-million-year gap in the fossil record, and document the whole cranial morphology of a dryolestoid, revealing an unsuspected morphological and ecological diversity for non-tribosphenic mammals.	[Rougier, Guillermo W.] Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA; [Apesteguia, Sebastian] Univ Maimonides, CEBBAD Fdn Hist Nat Felix de Azara, RA-1405 Buenos Aires, DF, Argentina; [Apesteguia, Sebastian; Gaetano, Leandro C.] Consejo Nacl Invest Cient & Tecn, CONICET, Buenos Aires, DF, Argentina; [Gaetano, Leandro C.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Cs Geol, Buenos Aires, DF, Argentina	University of Louisville; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Rougier, GW (corresponding author), Univ Louisville, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA.	grougier@louisville.edu	Apesteguía, Sebastian/F-4034-2018	Apesteguía, Sebastian/0000-0002-0414-0524	Antorchas Foundation; American Museum of Natural History; NSF [DEB 0946430, DEB 1068089, ATOL 0629959]; Jurassic Foundation; NASA; Field Museum Womens' Board	Antorchas Foundation; American Museum of Natural History; NSF(National Science Foundation (NSF)); Jurassic Foundation; NASA(National Aeronautics & Space Administration (NASA)); Field Museum Womens' Board	We thank M. Salinas, P. A. Gallina and P. J. Makovicky for finding the best specimens; the Avelas and Pincheira families for logistical support; C. Munoz and R. Barbieri from the MPCA for access to collections under their care; J. A. Gonzalez and A. Davidson for illustration and technical assistance. Field work permits and loans were facilitated by M. Solorza. C. Corbitt and J. R. Wible read an earlier version of the manuscript. Field work and research was supported by the Antorchas Foundation, American Museum of Natural History and NSF grants DEB 0946430, DEB 1068089 and ATOL 0629959 (to G. W. R.), The Jurassic Foundation (to S. A.) and NASA and Field Museum Womens' Board (to P. J. Makovicky). This is L.C.G.'s R-46 contribution to the IDEAN.	Apesteguia S, 2006, NATURE, V440, P1037, DOI 10.1038/nature04413; Apesteguia S, 2003, NATURE, V425, P609, DOI 10.1038/nature01995; Bonaparte J. F, 1986, ACT 4 C ARG PAL BIOE, V2, P63; BONAPARTE JF, 1990, NATL GEOGR RES, V6, P63; Bonaparte JF., 1994, BERLINER GEOWISS, V13, P30; Bonaparte Jose F., 1992, Ameghiniana, V29, P99; Chornogubsky L., 2011, PALAONT, V85, P1; FOX RC, 1985, J PALEONTOL, V59, P21; Gallina Pablo A., 2005, Revista del Museo Argentino de Ciencias Naturales, V7, P153; Gelfo J. N., 2001, GEODIVERSITAS, V23, P69; Gurovich Y, 2009, J MAMM EVOL, V16, P25, DOI 10.1007/s10914-008-9097-3; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Krebs Bernard, 1998, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V28, P91; Leanza HA, 2004, CRETACEOUS RES, V25, P61, DOI 10.1016/j.cretres.2003.10.005; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Martin Thomas, 1999, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, V550, P1; Meng J, 2011, NATURE, V472, P181, DOI 10.1038/nature09921; Migale, 2010, PROTOMAMIFEROS MAMIF; Paez Arango N., 2008, THESIS U LOUISVILLE; Prothero D.R., 1981, Bulletin of the American Museum of Natural History, V167, P281; Rougier G. W., 2011, DINOSAURIOS PALEONTO, P195; Rougier Guillermo W., 2006, P269; Rougier GW, 2009, ACTA PALAEONTOL POL, V54, P195, DOI 10.4202/app.2006.0026; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Sigogneau-Russell D, 1998, CRETACEOUS RES, V19, P445, DOI 10.1006/cres.1998.0115; Sigogneau-Russell D, 1995, B MUSEUM NATL HIST N, V16, P291; TURNBULL W D, 1970, Fieldiana Geology, V18, P153; Wible JR, 2009, B AM MUS NAT HIST, P1, DOI 10.1206/623.1; Wilson GP, 2007, J VERTEBR PALEONTOL, V27, P521, DOI 10.1671/0272-4634(2007)27[521:LCSGFI]2.0.CO;2	30	77	84	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					98	102		10.1038/nature10591	http://dx.doi.org/10.1038/nature10591			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22051679				2022-12-24	WOS:000296422600039
J	Chen, HN; Gu, XY; Liu, YH; Wang, J; Wirt, SE; Bottino, R; Schorle, H; Sage, J; Kim, SK				Chen, Hainan; Gu, Xueying; Liu, Yinghua; Wang, Jing; Wirt, Stacey E.; Bottino, Rita; Schorle, Hubert; Sage, Julien; Kim, Seung K.			PDGF signalling controls age-dependent proliferation in pancreatic beta-cells	NATURE			English	Article							GROWTH-FACTOR; TRANSGENIC MICE; DNA-SYNTHESIS; RAT ISLETS; MASS; RECEPTOR; EXPRESSION; REPLICATION; EXPANSION; EZH2	Determining the signalling pathways that direct tissue expansion is a principal goal of regenerative biology. Vigorous pancreatic beta-cell replication in juvenile mice and humans declines with age, and elucidating the basis for this decay may reveal strategies for inducing beta-cell expansion, a long-sought goal for diabetes therapy. Here we show that platelet-derived growth factor receptor (Pdgfr) signalling controls age-dependent beta-cell proliferation in mouse and human pancreatic islets. With age, declining beta-cell Pdgfr levels were accompanied by reductions in beta-cell enhancer of zeste homologue 2 (Ezh2) levels and beta-cell replication. Conditional inactivation of the Pdgfra gene in beta-cells accelerated these changes, preventing mouse neonatal beta-cell expansion and adult beta-cell regeneration. Targeted human PDGFR-a activation in mouse beta-cells stimulated Erk1/2 phosphorylation, leading to Ezh2-dependent expansion of adult beta-cells. Adult human islets lack PDGF signalling competence, but exposure of juvenile human islets to PDGF-AA stimulated beta-cell proliferation. The discovery of a conserved pathway controlling age-dependent beta-cell proliferation indicates new strategies for beta-cell expansion.	[Chen, Hainan; Gu, Xueying; Liu, Yinghua; Wang, Jing; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wirt, Stacey E.; Sage, Julien] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Wirt, Stacey E.; Sage, Julien] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Bottino, Rita] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Div Immunogenet,Dept Pediat, Pittsburgh, PA 15213 USA; [Schorle, Hubert] Univ Bonn, Sch Med, Inst Pathol, Dept Dev Biol, D-53127 Bonn, Germany; [Kim, Seung K.] Stanford Univ, Sch Med, Dept Med Oncol, Stanford, CA 94305 USA; [Kim, Seung K.] Howard Hughes Med Inst, Dept Dev Biol, Beckman Ctr B300, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bonn; Stanford University; Howard Hughes Medical Institute	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	seungkim@stanford.edu	LIU, YING/GZL-7252-2022; Schorle, Hubert/M-5001-2016; liu, ying/GXF-4294-2022; Schorle, Hubert/S-1713-2019	Schorle, Hubert/0000-0001-8272-0076; Kim, Seung/0000-0001-6135-7810	NIH; NIH-NCI [RO1 CA114102]; Stem Cell Network NRW; Deutsche Krebshilfe; Dewey family fund; Juvenile Diabetes Research Foundation; Snyder Foundation; Stinehart Foundation; NIH Beta Cell Biology Consortium [UO1 DK89532, UO1 DK89572]; Howard Hughes Medical Institute (HHMI); NATIONAL CANCER INSTITUTE [T32CA009302, R01CA114102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075919, U01DK089532, U01DK089572, R01DK056709, R01DK072184] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stem Cell Network NRW; Deutsche Krebshilfe(Deutsche Krebshilfe); Dewey family fund; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Snyder Foundation; Stinehart Foundation; NIH Beta Cell Biology Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Bhushan, A. Stewart, A. Powers, P. Beachy, M. White, X. Chen and X. Li for helpful discussions and advice, A. Tarakhovsky, P. Herrera and M. Hara for mice, A. Powers, A. Thompson and S. Bryant for human islet sample procurement, and members of the S.K.K. laboratory for comments on the manuscript. H.C. was supported by the NIH Ruth L. Kirschstein NRSA/Stanford Regenerative Medicine Training Program. J.S. was supported by NIH-NCI RO1 CA114102. H.S. was supported by the Stem Cell Network NRW and Deutsche Krebshilfe. Work in the S.K.K. laboratory was supported by a gift from the Dewey family fund, and grants from the Juvenile Diabetes Research Foundation, Snyder Foundation, Stinehart Foundation, the NIH Beta Cell Biology Consortium (UO1 DK89532 to S.K.K. and UO1 DK89572 to A. Powers) and by the Howard Hughes Medical Institute (HHMI). S.K.K. is an Investigator of the HHMI.	Beattie GM, 2002, DIABETES, V51, P3435, DOI 10.2337/diabetes.51.12.3435; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRELJE TC, 1994, DIABETES, V43, P263, DOI 10.2337/diabetes.43.2.263; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; EBERT M, 1995, INT J CANCER, V62, P529, DOI 10.1002/ijc.2910620507; FUJII S, 2011, ONCOGENE        0418, DOI DOI 10.1038/ONC.2011.118; Furstoss O, 2002, FEBS LETT, V526, P82, DOI 10.1016/S0014-5793(02)03120-4; Garcia-Ocana A, 2000, J BIOL CHEM, V275, P1226, DOI 10.1074/jbc.275.2.1226; Gupta RK, 2007, GENE DEV, V21, P756, DOI 10.1101/gad.1535507; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Kushner JA, 2005, MOL CELL BIOL, V25, P3752, DOI 10.1128/MCB.25.9.3752-3762.2005; LeBras S, 1998, DIABETOLOGIA, V41, P1474, DOI 10.1007/s001250051094; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; Moberg K, 1996, MOL CELL BIOL, V16, P1436; Moenning A, 2009, MOL CELL BIOL, V29, P881, DOI 10.1128/MCB.00885-08; Nyblom HK, 2009, J PROTEOME RES, V8, P5650, DOI 10.1021/pr9006816; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; SWENNE I, 1988, ENDOCRINOLOGY, V122, P214, DOI 10.1210/endo-122-1-214; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Uhrbom L, 2004, NAT MED, V10, P1257, DOI 10.1038/nm1120; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vasavada RC, 2000, J BIOL CHEM, V275, P15399, DOI 10.1074/jbc.275.20.15399; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; WELSH M, 1990, P NATL ACAD SCI USA, V87, P5807, DOI 10.1073/pnas.87.15.5807; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178	43	206	214	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					349	+		10.1038/nature10502	http://dx.doi.org/10.1038/nature10502			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21993628	Green Accepted			2022-12-24	WOS:000296021100038
J	Yusa, K; Rashid, ST; Strick-Marchand, H; Varela, I; Liu, PQ; Paschon, DE; Miranda, E; Ordonez, A; Hannan, NRF; Rouhani, FJ; Darche, S; Alexander, G; Marciniak, SJ; Fusaki, N; Hasegawa, M; Holmes, MC; Di Santo, JP; Lomas, DA; Bradley, A; Vallier, L				Yusa, Kosuke; Rashid, S. Tamir; Strick-Marchand, Helene; Varela, Ignacio; Liu, Pei-Qi; Paschon, David E.; Miranda, Elena; Ordonez, Adriana; Hannan, Nicholas R. F.; Rouhani, Foad J.; Darche, Sylvie; Alexander, Graeme; Marciniak, Stefan J.; Fusaki, Noemi; Hasegawa, Mamoru; Holmes, Michael C.; Di Santo, James P.; Lomas, David A.; Bradley, Allan; Vallier, Ludovic			Targeted gene correction of alpha(1)-antitrypsin deficiency in induced pluripotent stem cells	NATURE			English	Article							EFFICIENT; GENERATION; PIGGYBAC; GENOME; INDUCTION; COMPLEX	Human induced pluripotent stem cells (iPSCs) represent a unique opportunity for regenerative medicine because they offer the prospect of generating unlimited quantities of cells for autologous transplantation, with potential application in treatments for a broad range of disorders(1-4). However, the use of human iPSCs in the context of genetically inherited human disease will require the correction of disease-causing mutations in a manner that is fully compatible with clinical applications(3,5). The methods currently available, such as homologous recombination, lack the necessary efficiency and also leave residual sequences in the targeted genome(6). Therefore, the development of new approaches to edit the mammalian genome is a prerequisite to delivering the clinical promise of human iPSCs. Here we show that a combination of zinc finger nucleases (ZFNs)(7) and piggyBac(8,9) technology in human iPSCs can achieve biallelic correction of a point mutation (Glu342Lys) in the alpha(1)-antitrypsin (A1AT, also known as SERPINA1) gene that is responsible for alpha(1)-antitrypsin deficiency. Genetic correction of human iPSCs restored the structure and function of A1AT in subsequently derived liver cells in vitro and in vivo. This approach is significantly more efficient than any other gene-targeting technology that is currently available and crucially prevents contamination of the host genome with residual non-human sequences. Our results provide the first proof of principle, to our knowledge, for the potential of combining human iPSCs with genetic correction to generate clinically relevant cells for autologous cell-based therapies.	[Yusa, Kosuke; Rouhani, Foad J.; Bradley, Allan] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Rashid, S. Tamir; Hannan, Nicholas R. F.; Rouhani, Foad J.; Vallier, Ludovic] Univ Cambridge, Anne McLaren Lab Regenerat Med, Dept Surg, Cambridge CB2 0SZ, England; [Rashid, S. Tamir; Miranda, Elena; Ordonez, Adriana; Marciniak, Stefan J.; Lomas, David A.] Univ Cambridge, Dept Med, Cambridge Inst Med Res, Cambridge CB0 2XY, England; [Strick-Marchand, Helene; Darche, Sylvie; Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Strick-Marchand, Helene; Darche, Sylvie; Di Santo, James P.] INSERM, U668, F-75724 Paris, France; [Varela, Ignacio] CSIC UC SODERCAN, Inst Biomed & Biotecnol Cantabria, Santander 39011, Spain; [Liu, Pei-Qi; Paschon, David E.; Holmes, Michael C.] Sangamo BioSci Inc, Richmond, CA 94804 USA; [Miranda, Elena] Univ Roma La Sapienza, Dept Biol Biotecnol Charles Darwin, I-00185 Rome, Italy; [Alexander, Graeme] Cambridge Univ Hosp NHS Trust, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 2QQ, England; [Fusaki, Noemi; Hasegawa, Mamoru] DNAVEC Corp, Tsukuba, Ibaraki 3002611, Japan; [Fusaki, Noemi] JST, PRESTO, Saitama 3320012, Japan	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Sangamo Therapeutics, Inc.; Sapienza University Rome; DNAVEC Corporation; Japan Science & Technology Agency (JST)	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	abradley@sanger.ac.uk; lv225@cam.ac.uk	Varela, Ignacio/AAA-7680-2021; Fusaki, Noemi/U-1628-2019; Marciniak, Stefan J/F-1855-2010; Varela, Ignacio/G-1699-2016; Strick-Marchand, Helene/M-6525-2014; Hannan, Nicholas/A-8731-2013; Miranda, Elena/J-4999-2012; Di Santo, James P/M-4298-2014; vallier, ludovic/C-6368-2011; Hannan, Nicholas/ABG-6497-2020; Wilson, Matthew H/K-3193-2013	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Miranda, Elena/0000-0002-0586-8795; Di Santo, James P/0000-0002-7146-1862; Marciniak, Stefan/0000-0001-8472-7183; Vallier, Ludovic/0000-0002-3848-2602; Hannan, Nicholas/0000-0002-9843-1559; Strick-Marchand, Helene/0000-0002-0519-214X; Bradley, Allan/0000-0002-2349-8839; Rashid, Sheikh Tamir/0000-0001-6779-2506	Wellcome Trust [WT077187]; MRC; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Papworth NHS Trust; Bill and Melinda Gates Foundation; Inserm; Institut Pasteur; Japan Science and Technology Agency; Japan Society for the Promotion of Science; International Human Frontiers Science Program Organization; MRC [G0800784, G0901786, G0601840, G1000847, G0701448] Funding Source: UKRI; Medical Research Council [G0800784, G0601840, G1000847, G0901786, G0800784B, G0701448] Funding Source: researchfish; National Institute for Health Research [CL-2011-14-005] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; Papworth NHS Trust; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur(European Commission); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); International Human Frontiers Science Program Organization(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank A. Klug and M. Minczuk for their advice, M. A. Li for comments on the manuscript, P. Ellis, N. Hammond and C. McGee for CGH analysis, the Sanger Institute sequencing facility for exome sequencing, N. Conte and S. Rice for assistance with bioinformatic analysis, M. Alexander for her help with cell culture reagents. We also thank L. Zhang, S. Hinkley and the production group for ZFN assembly and validation, K. Tong and X. Meng for technical assistance, J. C. Miller and E. Leung for ZFN off-target site analysis and S. Abrahamson and P. D. Gregory for careful reading of the manuscript. This work was supported by the Wellcome Trust (WT077187; A.B.), the MRC Senior non-clinical fellowship and the Cambridge Hospitals National Institute for Health Research Biomedical Research Center (L.V.), the Medical Research Council and Papworth NHS Trust (D.A.L.), the Bill and Melinda Gates Foundation, Inserm and Institut Pasteur (H. S.-M.) and Japan Science and Technology Agency (N.F.). K.Y. is supported by a postdoctoral fellowship of Japan Society for the Promotion of Science. S.T.R. and F.J.R. are Wellcome Trust Clinical Training Fellows. I.V. is supported by a fellowship from the International Human Frontiers Science Program Organization.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; Fairchild PJ, 2010, NAT REV IMMUNOL, V10, P868, DOI 10.1038/nri2878; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Guschin DY, 2010, METHODS MOL BIOL, V649, P247, DOI 10.1007/978-1-60761-753-2_15; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Meier ID, 2010, FASEB J, V24, P1714, DOI 10.1096/fj.09-140749; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Perlmutter DH, 2009, CELL DEATH DIFFER, V16, P39, DOI 10.1038/cdd.2008.103; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tenzen T, 2010, J CELL PHYSIOL, V222, P278, DOI 10.1002/jcp.21948; Touboul T, 2010, HEPATOLOGY, V51, P1754, DOI 10.1002/hep.23506; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	36	484	539	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					391	+		10.1038/nature10424	http://dx.doi.org/10.1038/nature10424			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21993621	Green Accepted, Green Submitted			2022-12-24	WOS:000296021100047
J	Dowswell, G; Ismail, T; Greenfield, S; Clifford, S; Hancock, B; Wilson, S				Dowswell, George; Ismail, Tariq; Greenfield, Sheila; Clifford, Sue; Hancock, Beverley; Wilson, Sue			Men's experience of erectile dysfunction after treatment for colorectal cancer: qualitative interview study	BRITISH MEDICAL JOURNAL			English	Article							GENERAL-PRACTICE CONSULTATIONS; CROSS-SECTIONAL SURVEY; PROSTATE-CANCER; INFORMATION NEEDS; OF-LIFE; SEEKING BEHAVIOR; HEALTH; SILDENAFIL; CONSTRUCTIONS; PREVALENCE	Objectives To examine the experiences of men after treatment for colorectal cancer, identify barriers to accessing services, and suggest improvements to providing information in primary and secondary care. Design Semistructured, qualitative interview study with purposive sampling and thematic analysis. Participants 28 patients treated for colorectal cancer. Setting West Midlands. Results Most men treated for colorectal cancer experience erectile dysfunction as a consequence. Not all, however, want the same response from health professionals. Although, erectile dysfunction is profoundly stressful for most men, affecting self image, behaviour, and relationships, some do not regard it as a health priority. Many of the men were uninformed about erectile dysfunction and were unprepared for it, and the majority neither helped themselves nor asked for help. Almost none were receiving adequate, effective, and affordable care. Evidence of ageism was strong. Conclusions Unlike patients with prostate cancer, men with colorectal cancer are not routinely offered information and treatment for erectile dysfunction. Greater coordination of care and consistent strategies are needed to tackle the unmet needs of this widely diverse patient group. Currently, clinicians are inadvertently neglecting, misleading, and offending such patients; better training could improve this situation, as might the reorganisation of services. Further research is needed to determine whether trained clinical nurse specialists in colorectal cancer units could coordinate ongoing care.	[Dowswell, George; Greenfield, Sheila; Clifford, Sue; Hancock, Beverley; Wilson, Sue] Univ Birmingham, Canc & Chron Dis Team, Birmingham B15 2TT, W Midlands, England; [Ismail, Tariq] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Greenfield, S (corresponding author), Univ Birmingham, Canc & Chron Dis Team, Birmingham B15 2TT, W Midlands, England.	s.m.greenfield@bham.ac.uk		Ismail, Tariq/0000-0002-8554-7974	National Institute for Health Research [PB-PG-0407-13245]	National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the National Institute for Health Research under the research for patient benefit programme (PB-PG-0407-13245). The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health.	Barry CA, 2000, BRIT MED J, V320, P1246, DOI 10.1136/bmj.320.7244.1246; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; CAMPION PD, 1992, FAM PRACT, V9, P181, DOI 10.1093/fampra/9.2.181; *CANC RES UK, 2010, BOW CANC STAT KEY FA; Cancer Research UK, 2010, BOW COL CANC UK INC; Chapple A, 2004, BRIT J GEN PRACT, V54, P25; Charmaz K., 1995, MENS HLTH ILLNESS GE, P266; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Dahn JR, 2004, UROLOGY, V63, P273, DOI 10.1016/j.urology.2003.09.048; Davison BJ, 2007, BJU INT, V100, P780, DOI 10.1111/j.1464-410X.2007.07043.x; Denzin N.K., 2013, LANDSCAPE QUALITATIV; Ellis R, 2010, J SEX MED, V7, P1488, DOI 10.1111/j.1743-6109.2009.01461.x; Galbraith Michael E, 2008, Semin Oncol Nurs, V24, P102, DOI 10.1016/j.soncn.2008.02.010; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Graham J, 2008, BRIT MED J, V336, P610, DOI 10.1136/bmj.39498.525706.AD; Hall JA, 2002, PATIENT EDUC COUNS, V48, P217, DOI 10.1016/S0738-3991(02)00174-X; Hendren SK, 2005, ANN SURG, V242, P212, DOI 10.1097/01.sla.0000171299.43954.ce; Hordern A, 2008, CANCER NURS, V31, pE9, DOI 10.1097/01.NCC.0000305695.12873.d5; Hordern AJ, 2007, SOC SCI MED, V64, P1704, DOI 10.1016/j.socscimed.2006.12.012; Incrocci L, 2003, UROLOGY, V62, P116, DOI 10.1016/S0090-4295(03)00133-X; Johnson JD, 1997, CANC RELATED INFORM; Lee R.M., 1993, DOING RES SENSITIVE; Leydon GM, 2000, BMJ-BRIT MED J, V320, P909, DOI 10.1136/bmj.320.7239.909; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindsey I, 2002, DIS COLON RECTUM, V45, P727, DOI 10.1007/s10350-004-6287-9; Mayer DK, 2007, PATIENT EDUC COUNS, V65, P342, DOI 10.1016/j.pec.2006.08.015; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; Miles BJ, 1999, UROLOGY, V53, P169, DOI 10.1016/S0090-4295(98)00456-7; Milne JL, 2008, INT J NURS STUD, V45, P765, DOI 10.1016/j.ijnurstu.2007.01.006; National Health Service, 2010, NHS CHOIC; National Institute for Health and Clinical Excellence, 2008, NICE CLIN GUID; Oliffe J, 2009, MEN MASC, V11, P346, DOI 10.1177/1097184X06298777; Patton M. Q., 2002, QUALITATIVE RES EVAL, V3rd; Payne S, 2007, J MENS HLTH GENDER, V4, P131, DOI DOI 10.1016/J.JMHG.2007.03.005; Phillips C, 2000, CANCER PRACT, V8, P165, DOI 10.1046/j.1523-5394.2000.84009.x; Pinder R., 1990, MANAGEMENT CHRONIC I; Potosky AL, 2004, J NATL CANCER I, V96, P1358, DOI 10.1093/jnci/djh259; Ralph D, 2000, BRIT MED J, V321, P499, DOI 10.1136/bmj.321.7259.499; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Schover LR, 2002, CANCER, V95, P1773, DOI 10.1002/cncr.10848; Seale C., 1999, QUALITY QUALITATIVE; Selman L, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1326; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; SPRANGERS MAG, 1995, DIS COLON RECTUM, V38, P361, DOI 10.1007/BF02054222; Tomlinson JM, 2004, BMJ-BRIT MED J, V328, P1037, DOI 10.1136/bmj.38044.662176.EE; Wall David, 2005, Nurs Inq, V12, P87, DOI 10.1111/j.1440-1800.2005.00258.x	49	22	23	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d5824	10.1136/bmj.d5824	http://dx.doi.org/10.1136/bmj.d5824			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22010127	Green Published, hybrid			2022-12-24	WOS:000296183400008
J	Li, DK; Yang, CM; Andrade, S; Tavares, V; Ferber, JR				Li, De-Kun; Yang, Chunmei; Andrade, Susan; Tavares, Venessa; Ferber, Jeannette R.			Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							ACE-INHIBITORS; PREGNANCY	Objective To examine a reported association between use of angiotensin converting enzyme (ACE) inhibitors during the first trimester and risk of malformations in offspring. Design A population based, retrospective cohort study linking automated clinical and pharmacy databases including comprehensive electronic medical records. Participants Pregnant women and their live born offspring (465 754 mother-infant pairs) in the Kaiser Permanente Northern California region from 1995 to 2008. Main outcome measure Congenital malformation in live births. Results The prevalence of ACE inhibitor use in the first trimester only was 0.9/1000, and the use of other antihypertensive medications was 2.4/1000. After adjustment for maternal age, ethnicity, parity, and obesity, use of ACE inhibitors during the first trimester only seemed to be associated with increased risk of congenital heart defects in offspring compared with normal controls (those with neither hypertension nor use of any antihypertensives during pregnancy) (15/381 (3.9%) v 6232/400 021 (1.6%) cases, odds ratio 1.54 (95% confidence interval 0.90 to 2.62)). A similar association was observed for use of other antihypertensives (28/1090 (2.6%) cases of congenital heart defects, odds ratio 1.52 (1.04 to 2.21)). However, compared with hypertension controls (those with a diagnosis of hypertension but without use of antihypertensives) (708/29 735 (2.4%) cases of congenital heart defects), neither use of ACE inhibitors or of other antihypertensives in the first trimester was associated with increased congenital heart defects risk (odds ratios 1.14 (0.65 to 1.98) and1.12 (0.76 to 1.64) respectively). Conclusions Maternal use of ACE inhibitors in the first trimester has a risk profile similar to the use of other antihypertensives regarding malformations in live born offspring. The apparent increased risk of malformations associated with use of ACE inhibitors (and other antihypertensives) in the first trimester is likely due to the underlying hypertension rather than the medications.	[Li, De-Kun; Yang, Chunmei; Tavares, Venessa; Ferber, Jeannette R.] Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA; [Andrade, Susan] Meyers Primary Care Inst, Worcester, MA 01605 USA	Kaiser Permanente	Li, DK (corresponding author), Kaiser Permanente, Kaiser Fdn Res Inst, Div Res, Oakland, CA 94612 USA.	de-kun.li@kp.org			Agency for Healthcare Research and Quality, US Department of Health and Human Services [290050033I]; Food and Drug Administration, Office of Women's Health	Agency for Healthcare Research and Quality, US Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Food and Drug Administration, Office of Women's Health	This project was funded under Contract No 290050033I from the Agency for Healthcare Research and Quality, US Department of Health and Human Services as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) programme. The Food and Drug Administration, Office of Women's Health also contributed funds. The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Healthcare Research and Quality, the Food and Drug Administration, or the US Department of Health and Human Services.	Banhidy F, 2011, HYPERTENS RES, V34, P257, DOI 10.1038/hr.2010.227; BARR M, 1994, TERATOLOGY, V50, P399, DOI 10.1002/tera.1420500606; Caton AR, 2009, HYPERTENSION, V54, P63, DOI 10.1161/HYPERTENSIONAHA.109.129098; Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202; Ferrara A, 2003, CIRCULATION, V107, P43, DOI 10.1161/01.CIR.0000042701.17528.95; Friedman JM, 2006, NEW ENGL J MED, V354, P2498, DOI 10.1056/NEJMe068089; Kroner BA, 2008, J MANAGE CARE PHARM, V14, P155, DOI 10.18553/jmcp.2008.14.2.155; Lennestal R, 2009, EUR J CLIN PHARMACOL, V65, P615, DOI 10.1007/s00228-009-0620-0; Ratnapalan S, 2002, CAN FAM PHYSICIAN, V48, P1047; Selby JV, 2001, DIABETES CARE, V24, P1547, DOI 10.2337/diacare.24.9.1547; 1997, MMWR MORB MORTAL WKL, V46, P240	11	98	106	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d5931	10.1136/bmj.d5931	http://dx.doi.org/10.1136/bmj.d5931			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22010128	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000296183400009
J	Wong, CHY; Jenne, CN; Lee, WY; Leger, C; Kubes, P				Wong, Connie H. Y.; Jenne, Craig N.; Lee, Woo-Yong; Leger, Caroline; Kubes, Paul			Functional Innervation of Hepatic iNKT Cells Is Immunosuppressive Following Stroke	SCIENCE			English	Article							KILLER T-CELLS; ISCHEMIC-STROKE; NKT CELLS; ACTIVATION; IMMUNE; INFECTION; ANTIGENS; BRAIN	Systemic immunosuppression has been associated with stroke for many years, but the underlying mechanisms are poorly understood. In this study, we demonstrated that stroke induced profound behavioral changes in hepatic invariant NKT (iNKT) cells in mice. Unexpectedly, these effects were mediated by a noradrenergic neurotransmitter rather than a CD1d ligand or other well-characterized danger signals. Blockade of this innervation was protective in wild-type mice after stroke but had no effect in mice deficient in iNKT cells. Selective immunomodulation of iNKT cells with a specific activator (a-galactosylceramide) promoted proinflammatory cytokine production and prevented infections after stroke. Our results therefore identify a molecular mechanism that leads to immunosuppression after stroke and suggest an attractive potential therapeutic alternative to antibiotics, namely, immunomodulation of iNKT cells to prevent stroke-associated infections.	[Wong, Connie H. Y.; Jenne, Craig N.; Lee, Woo-Yong; Kubes, Paul] Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada; [Jenne, Craig N.; Leger, Caroline; Kubes, Paul] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kubes, Paul] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary	Kubes, P (corresponding author), Univ Calgary, Calvin Phoebe & Joan Snyder Inst Infect Immun & I, Calgary, AB, Canada.	pkubes@ucalgary.ca	Jenne, Craig/HCH-3413-2022	Wong, Connie/0000-0002-9020-1847	Canada Foundation for Innovation; Canadian Association of Gastroenterology; Canadian Institutes of Health Research; Canada Research Chairs Program; Alberta Innovates Health Solutions; Calvin, Phoebe, and Joan Snyder Chair for Translational Research in Critical Care Medicine	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Association of Gastroenterology; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Alberta Innovates Health Solutions; Calvin, Phoebe, and Joan Snyder Chair for Translational Research in Critical Care Medicine	We thank D. R. Littman (New York University School of Medicine) for the Cxcr6<SUP>gfp/+</SUP> knock-in mice, and the Live Cell Imaging Facility funded by the Canada Foundation for Innovation and P. Colarusso for training and assistance related to microscopy. We thank C. Badick for excellent technical support. The NIH Tetramer Core Facility provided mouse PBS57-loaded CD1d-tetramer for identification of iNKT cells by flow cytometry. We also thank the University of Calgary Flow Cytometry Facility and L. Kennedy for their assistance with the flow cytometric analysis. The work is supported by the Canadian Association of Gastroenterology (C.H.Y.W), the Canadian Institutes of Health Research (C.H.Y.W., W-Y.L., and P. K.), the Canada Research Chairs Program (P. K.), the Alberta Innovates Health Solutions (C.N.J and P. K.), and the Calvin, Phoebe, and Joan Snyder Chair for Translational Research in Critical Care Medicine (C. L.). The data reported in this paper are tabulated in the supporting online material. The authors declare no competing financial interests. C.H.Y.W designed and did most of the experiments, analyzed the results, and prepared the manuscript; C.N.J. did some flow cytometry experiments; W-Y.L. isolated iNKT cells for the in vitro experiments; C. L. performed the multiplex mouse cytokine/chemokine assay; and P. K. provided overall supervision, helped design all of the experiments, and prepared the manuscript.	Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brossay L, 1998, J EXP MED, V188, P1521, DOI 10.1084/jem.188.8.1521; Chamorro A, 2006, J NEUROL NEUROSUR PS, V77, P1279, DOI 10.1136/jnnp.2006.100800; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; HOWARD RJ, 1974, SURG GYNECOL OBSTET, V139, P771; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Lee WY, 2010, NAT IMMUNOL, V11, P295, DOI 10.1038/ni.1855; Lichtman JH, 2011, NEUROLOGY, V76, P1976, DOI 10.1212/WNL.0b013e31821e54f3; Liesz A, 2011, BRAIN, V134, P704, DOI 10.1093/brain/awr008; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; Offner H, 2009, NEUROSCIENCE, V158, P1098, DOI 10.1016/j.neuroscience.2008.05.033; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Offner H, 2006, J IMMUNOL, V176, P6523, DOI 10.4049/jimmunol.176.11.6523; Oya H, 2000, CLIN EXP IMMUNOL, V121, P384, DOI 10.1046/j.1365-2249.2000.01310.x; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Velazquez P, 2008, J IMMUNOL, V180, P2024, DOI 10.4049/jimmunol.180.4.2024	26	287	296	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					101	105		10.1126/science.1210301	http://dx.doi.org/10.1126/science.1210301			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21921158				2022-12-24	WOS:000295580300049
J	Ginsburg, D				Ginsburg, David			Genetics and Genomics to the Clinic: A Long Road ahead	CELL			English	Editorial Material								Advances in genomic technology have produced an explosion of new information about the genetic basis for human disease, fueling extraordinarily high expectations for improved treatments. This perspective will take brief stock of what genetics/genomics have brought to clinical practice to date and what we might expect for the future.	[Ginsburg, David] Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu			Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [P01HL057346, R01 HL039693, P01 HL057346, R01HL039693] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL039693] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; KORF BR, 2007, EMERY RIMOINS PRINCI, P49; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Middeldorp S, 2011, J THROMB THROMBOLYS, V31, P275, DOI 10.1007/s11239-011-0572-y; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; PERUTZ MF, 1960, NATURE, V185, P416, DOI 10.1038/185416a0; Rosove MH, 2009, ANN INTERN MED, V151, P270, DOI 10.7326/0003-4819-151-4-200908180-00009; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Zlotogora J, 2009, HUM GENET, V126, P247, DOI 10.1007/s00439-009-0669-y	10	10	10	1	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					17	19		10.1016/j.cell.2011.09.013	http://dx.doi.org/10.1016/j.cell.2011.09.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962500	Bronze			2022-12-24	WOS:000295396700008
J	Whorton, MR; MacKinnon, R				Whorton, Matthew R.; MacKinnon, Roderick			Crystal Structure of the Mammalian GIRK2 K+ Channel and Gating Regulation by G Proteins, PIP2, and Sodium	CELL			English	Article							BETA-GAMMA-SUBUNITS; MUSCARINIC POTASSIUM CHANNEL; DEPENDENT ACTIVATION; ANGSTROM RESOLUTION; ANDERSEN-SYNDROME; RECTIFICATION; MECHANISM; BINDING; KIR2.1; MUTATIONS	G protein-gated K+ channels (Kir3.1-Kir3.4) control electrical excitability in many different cells. Among their functions relevant to human physiology and disease, they regulate the heart rate and govern a wide range of neuronal activities. Here, we present the first crystal structures of a G protein-gated K+ channel. By comparing the wild-type structure to that of a constitutively active mutant, we identify a global conformational change through which G proteins could open a G loop gate in the cytoplasmic domain. The structures of both channels in the absence and presence of PIP2 suggest that G proteins open only the G loop gate in the absence of PIP2, but in the presence of PIP2 the G loop gate and a second inner helix gate become coupled, so that both gates open. We also identify a strategically located Na+ ion-binding site, which would allow intracellular Na+ to modulate GIRK channel activity. These data provide a structural basis for understanding multiligand regulation of GIRK channel gating.	[Whorton, Matthew R.; MacKinnon, Roderick] Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA; [Whorton, Matthew R.; MacKinnon, Roderick] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; Howard Hughes Medical Institute	MacKinnon, R (corresponding author), Rockefeller Univ, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			Howard Hughes Medical Institute Funding Source: Medline; NIBIB NIH HHS [P30 EB009998] Funding Source: Medline; NIGMS NIH HHS [R01 GM043949-21, R01 GM043949] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Clarke OB, 2010, CELL, V141, P1018, DOI 10.1016/j.cell.2010.05.003; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; He C, 2002, J BIOL CHEM, V277, P6088, DOI 10.1074/jbc.M104851200; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Ho IHM, 1999, J PHYSIOL-LONDON, V520, P645, DOI 10.1111/j.1469-7793.1999.00645.x; Ho IHM, 1999, J BIOL CHEM, V274, P8639, DOI 10.1074/jbc.274.13.8639; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Inanobe A, 2007, CHANNELS, V1, P40, DOI 10.4161/chan.3842; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; Lin YW, 2006, J BIOL CHEM, V281, P3006, DOI 10.1074/jbc.M511875200; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Luscher C, 2010, NAT REV NEUROSCI, V11, P301, DOI 10.1038/nrn2834; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yokogawa M, 2011, J BIOL CHEM, V286, P2215, DOI 10.1074/jbc.M110.160754; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103	47	311	314	0	55	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					199	208		10.1016/j.cell.2011.07.046	http://dx.doi.org/10.1016/j.cell.2011.07.046			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962516	Green Accepted, Bronze			2022-12-24	WOS:000295396700026
J	Bhaskaran, K; Hajat, S; Armstrong, B; Haines, A; Herrett, E; Wilkinson, P; Smeeth, L				Bhaskaran, Krishnan; Hajat, Shakoor; Armstrong, Ben; Haines, Andy; Herrett, Emily; Wilkinson, Paul; Smeeth, Liam			The effects of hourly differences in air pollution on the risk of myocardial infarction: case crossover analysis of the MINAP database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINE-PARTICULATE MATTER; HEART-RATE-VARIABILITY; TIME-SERIES; HOSPITAL ADMISSIONS; EXPOSURE; MORTALITY; INFLAMMATION; TEMPERATURE; PARTICLES; COEFFICIENTS	Objectives To investigate associations between air pollution levels and myocardial infarction (MI) on short timescales, with data at an hourly temporal resolution. Design Time stratified case crossover study linking clinical data from the Myocardial Ischaemia National Audit Project (MINAP) with PM10, ozone, CO, NO2, and SO2 data from the UK National Air Quality Archive. Pollution effects were investigated with delays (lags) of 1-6, 7-12, 13-18, 19-24, and 25-72 hours in both single and multi-pollutant models, adjusted for ambient temperature, relative humidity, circulating levels of influenza and respiratory syncytial virus, day of week, holidays, and residual seasonality within calendar month strata. Setting Population based study in 15 conurbations in England and Wales. Subjects 79 288 diagnoses of myocardial infarction recorded over the period 2003-6. Main outcome measures Excess risk of myocardial infarction per 10 mu g/m(3) increase in pollutant level. Results In single pollutant models, PM10 and NO2 levels were associated with a very short term increase in risk of myocardial infarction 1-6 hours later (excess risks 1.2% (95% confidence interval 0.3 to 2.1) and 1.1% (0.3 to 1.8) respectively per 10 mu g/m(3) increase); the effects persisted in multi-pollutant models, though with only weak evidence of an independent PM10 effect (P=0.05). The immediate risk increases were followed by reductions in risk at longer lags: we found no evidence of any net excess risk associated with the five pollutants studied over a 72 hour period after exposure. Conclusions Higher levels of PM10 and NO2, which are typically markers of traffic related pollution, seem to be associated with transiently increased risk of myocardial infarction 1-6 hours after exposure, but later reductions in risk suggest that air pollution may be associated with bringing events forward in time ("short-term displacement") rather than increasing overall risk. The well established effect of air pollution on cardiorespiratory mortality may not be mediated through increasing the acute risk of myocardial infarction, but through another mechanism.	London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; armstrong, benedict/0000-0003-4407-0409; Haines, Andy/0000-0002-8053-4605; Smeeth, Liam/0000-0002-9168-6022; Wilkinson, Paul/0000-0001-7456-259X	British Heart Foundation [FS/04/045]; Garfield Weston Foundation; Wellcome Trust [082178, 076583/Z/05/Z]; Garfield Weston Trust; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Garfield Weston Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Garfield Weston Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Heart Foundation (grant number FS/04/045) and the Garfield Weston Foundation. LS is supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (grant number 082178). SH is funded by a Wellcome Trust Research Career Development Fellowship (grant number 076583/Z/05/Z). The funding bodies had no role in the design or conduct of this study or in the preparation, review, approval, or decision to submit the manuscript. All authors carried out this research independently of the funding bodies.; All authors have completed the unified competing interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: KB, EH, and LS had support for the submitted work from the British Heart Foundation, the Garfield Weston Trust, and the Wellcome Trust respectively; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work	Armstrong B, 2006, EPIDEMIOLOGY, V17, P624, DOI 10.1097/01.ede.0000239732.50999.8f; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2011, HEART, V97, P519, DOI 10.1136/hrt.2010.212183; Bhaskaran K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3823; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Burgan O, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-26; Committee on the Medical Effects of Air Pollutants, 2006, CARD DIS AIR POLL; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Doherty RM, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-S1-S8; Dominici F, 2010, EPIDEMIOLOGY, V21, P187, DOI 10.1097/EDE.0b013e3181cc86e8; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Janssen NAH, 2000, J AIR WASTE MANAGE, V50, P1133, DOI 10.1080/10473289.2000.10464159; Joseph PM, 2007, ENVIRON INT, V33, P1090, DOI 10.1016/j.envint.2007.07.001; Katsouyanni K, 1997, BMJ-BRIT MED J, V314, P1658, DOI 10.1136/bmj.314.7095.1658; Koken PJM, 2003, ENVIRON HEALTH PERSP, V111, P1312, DOI 10.1289/ehp.5957; Lumley T, 2000, ENVIRONMETRICS, V11, P689, DOI 10.1002/1099-095X(200011/12)11:6<689::AID-ENV439>3.0.CO;2-N; Maheswaran R, 2005, EUR HEART J, V26, P2543, DOI 10.1093/eurheartj/ehi457; Mann JK, 2002, ENVIRON HEALTH PERSP, V110, P1247, DOI 10.1289/ehp.021101247; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mills NL, 2007, NEW ENGL J MED, V357, P1075, DOI 10.1056/NEJMoa066314; Murakami Y, 2006, J EPIDEMIOL COMMUN H, V60, P262, DOI 10.1136/jech.2005.038315; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2001, CIRCULATION, V103, P2810; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Peters A, 2005, RES REP HLTH EFF I, P141; Peters A, 2005, RES REP HLTH EFF I, P67; Peters Annette, 2005, Res Rep Health Eff Inst, P1; Pope CA, 1999, AM HEART J, V138, P890, DOI 10.1016/S0002-8703(99)70014-1; Pope CA, 2004, ENVIRON HEALTH PERSP, V112, P339, DOI 10.1289/ehp.6588; POPE CA, 1992, ARCH ENVIRON HEALTH, V47, P211, DOI 10.1080/00039896.1992.9938351; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Schwartz J, 2001, EPIDEMIOLOGY, V12, P55, DOI 10.1097/00001648-200101000-00010; Smith KR, 2009, LANCET, V374, P2091, DOI 10.1016/S0140-6736(09)61716-5; Sullivan J, 2005, EPIDEMIOLOGY, V16, P41, DOI 10.1097/01.ede.0000147116.34813.56; WOOLHISER DA, 1979, J APPL METEOROL, V18, P34, DOI 10.1175/1520-0450(1979)018<0034:MLEOFC>2.0.CO;2; Zanobetti A, 2004, CIRCULATION, V110, P2184, DOI 10.1161/01.CIR.0000143831.33243.D8; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeger SL, 1999, EPIDEMIOLOGY, V10, P171, DOI 10.1097/00001648-199903000-00015	41	107	107	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2011	343								d5531	10.1136/bmj.d5531	http://dx.doi.org/10.1136/bmj.d5531			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	826AF	21933824	hybrid, Green Accepted, Green Published			2022-12-24	WOS:000295323000001
J	Rein, DB; Smith, BD; Wittenborn, JS; Lesesne, SB; Wagner, LD; Roblin, DW; Patel, N; Ward, JW; Weinbaum, CM				Rein, David B.; Smith, Bryce D.; Wittenborn, John S.; Lesesne, Sarah B.; Wagner, Laura D.; Roblin, Douglas W.; Patel, Nita; Ward, John W.; Weinbaum, Cindy M.			The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in US Primary Care Settings	ANNALS OF INTERNAL MEDICINE			English	Article							INJECTION-DRUG USERS; QUALITY-OF-LIFE; UNITED-STATES; VIRUS-INFECTION; ECONOMIC-EVALUATION; PEGINTERFERON ALPHA-2A; LIVER-TRANSPLANTATION; RESOURCE UTILIZATION; COMBINATION THERAPY; ANTIVIRAL TREATMENT	Background: In the United States, hepatitis C virus (HCV) infection is most prevalent among adults born from 1945 through 1965, and approximately 50% to 75% of infected adults are unaware of their infection. Objective: To estimate the cost-effectiveness of birth-cohort screening. Design: Cost-effectiveness simulation. Data Sources: National Health and Nutrition Examination Survey, U.S. Census, Medicare reimbursement schedule, and published sources. Target Population: Adults born from 1945 through 1965 with 1 or more visits to a primary care provider annually. Time Horizon: Lifetime. Perspective: Societal, health care. Intervention: One-time antibody test of 1945-1965 birth cohort. Outcome Measures: Numbers of cases that were identified and treated and that achieved a sustained viral response; liver disease and death from HCV; medical and productivity costs; quality-adjusted life-years (QALYs); incremental cost-effectiveness ratio (ICER). Results of Base-Case Analysis: Compared with the status quo, birth-cohort screening identified 808 580 additional cases of chronic HCV infection at a screening cost of $2874 per case identified. Assuming that birth-cohort screening was followed by pegylated interferon and ribavirin (PEG-IFN+R) for treated patients, screening increased QALYs by 348 800 and costs by $5.5 billion, for an ICER of $15 700 per QALY gained. Assuming that birth-cohort screening was followed by direct-acting antiviral plus PEG-IFN+R treatment for treated patients, screening increased QALYs by 532 200 and costs by $19.0 billion, for an ICER of $35 700 per QALY saved. Results of Sensitivity Analysis: The ICER of birth-cohort screening was most sensitive to sustained viral response of antiviral therapy, the cost of therapy, the discount rate, and the QALY losses assigned to disease states. Limitation: Empirical data on screening and direct-acting antiviral treatment in real-world clinical settings are scarce. Conclusion: Birth-cohort screening for HCV in primary care settings was cost-effective.	[Rein, David B.] Univ Chicago, NORC, Atlanta, GA 30305 USA; Ctr Dis Control & Prevent, RTI Int, Atlanta, GA USA; Kaiser Permanente Georgia, Atlanta, GA USA; Univ N Carolina, Chapel Hill, NC USA	University of Chicago; Centers for Disease Control & Prevention - USA; Research Triangle Institute; Kaiser Permanente; University of North Carolina; University of North Carolina Chapel Hill	Rein, DB (corresponding author), Univ Chicago, NORC, 3520 Piedmont Rd NE, Atlanta, GA 30305 USA.	rein-david@norc.org		Rein, David/0000-0002-1271-5789	Centers for Disease Control and Prevention Division of Viral Hepatitis [200-2003-02489-0007]	Centers for Disease Control and Prevention Division of Viral Hepatitis	By the Centers for Disease Control and Prevention Division of Viral Hepatitis through contract 200-2003-02489-0007.	Allen SA, 2003, ANN INTERN MED, V138, P187, DOI 10.7326/0003-4819-138-3-200302040-00010; American Medical Association, 2007, CPT 2006 CURR PROC T; [Anonymous], 1998, MMWR Recomm Rep, V47, P1; Antonucci G, 2007, AM J GASTROENTEROL, V102, P1383, DOI 10.1111/j.1572-0241.2007.01201.x; Arias Elizabeth, 2006, Natl Vital Stat Rep, V54, P1; Armstrong GL, 2000, HEPATOLOGY, V31, P777, DOI 10.1002/hep.510310332; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Backus LI, 2007, HEPATOLOGY, V46, P37, DOI 10.1002/hep.21662; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Beech Bettina M, 2003, Semin Pediatr Infect Dis, V14, P12, DOI 10.1053/spid.2003.127212; Bennett WG, 1997, ANN INTERN MED, V127, P855, DOI 10.7326/0003-4819-127-10-199711150-00001; Bureau of Labor Statistics, 2010, HOUS DAT ANN AV 37 M; Carey WD, 2007, CLEVELAND CLIN MONOG; Cassidy C, 2010, HLTH AFFAIRS    0520; Centers for Disease Control and Prevention, 2011, EV EL ALT ANTIHCV SC; Centers for Disease Control and Prevention. National Centre for Health Statistics, 2007, NAT CTR HLTH STAT NA; Chong CAKY, 2003, AM J GASTROENTEROL, V98, P630, DOI 10.1111/j.1572-0241.2003.07332.x; Culver DH, 2000, TRANSFUSION, V40, P1176, DOI 10.1046/j.1537-2995.2000.40101176.x; Davis GL, 2003, LIVER TRANSPLANT, V9, P331, DOI 10.1053/jlts.2003.50073; Davis KL, 2011, J CLIN GASTROENTEROL, V45, pE17, DOI 10.1097/MCG.0b013e3181e12c09; Desmond CP, 2006, J VIRAL HEPATITIS, V13, P311, DOI 10.1111/j.1365-2893.2005.00685.x; Deuffic-Burban S, 2007, J VIRAL HEPATITIS, V14, P107, DOI 10.1111/j.1365-2893.2006.00785.x; Dudley T, 2006, GUT, V55, P1362, DOI 10.1136/gut.2006.094292; Englesbe MJ, 2006, AM J TRANSPLANT, V6, P2978, DOI 10.1111/j.1600-6143.2006.01575.x; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Fried MW, 2002, HEPATOLOGY, V36, pS237, DOI 10.1053/jhep.2002.36810; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gray L, 2003, ESSENTIAL RBRVS; Grieve R, 2006, GUT, V55, P1332, DOI 10.1136/gut.2005.064774; Hagan H, 2006, PUBLIC HEALTH REP, V121, P710, DOI 10.1177/003335490612100611; Haubolt RH, 2007, 2007 US ORGAN TISSUE; Heathcote EJ, 2000, NEW ENGL J MED, V343, P1673, DOI 10.1056/NEJM200012073432302; Honeycutt AA, 2007, PUBLIC HEALTH REP, V122, P55, DOI 10.1177/00333549071220S211; Innes HA, 2011, HEPATOLOGY, V54, P2281, DOI [10.1002/hep.24776, 10.1002/hep.24561]; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Jain A, 2000, ANN SURG, V232, P490, DOI 10.1097/00000658-200010000-00004; Kwiatkowski CF, 2002, ADDICTION, V97, P1289, DOI 10.1046/j.1360-0443.2002.00208.x; Maciosek MV, 2006, AM J PREV MED, V31, P52, DOI 10.1016/j.amepre.2006.03.012; Mauss S, 2005, J ANTIMICROB CHEMOTH, V56, P615, DOI 10.1093/jac/dki277; Mauss S, 2004, HEPATOLOGY, V40, P120, DOI 10.1002/hep.20279; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; ORTNER N, 2005, 2005 US ORGAN TISSUE; Perrillo R, 2004, J VIRAL HEPATITIS, V11, P157, DOI 10.1046/j.1365-2893.2003.00482.x; Planas R, 2004, J HEPATOL, V40, P823, DOI 10.1016/j.jhep.2004.01.005; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rein DB, 2011, PUBLIC HEALTH REP, V126, P560, DOI 10.1177/003335491112600412; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Roblin D, 2010, KAISER PERMANENTE GE; Salomon JA, 2003, JAMA-J AM MED ASSOC, V290, P228, DOI 10.1001/jama.290.2.228; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Shepherd J, 2004, Health Technol Assess, V8, piii; Shepherd J, 2004, HEALTH TECHNOL ASSES, V8, P1; Shepherd J, 2005, INT J TECHNOL ASSESS, V21, P47, DOI 10.1017/S0266462305050063; Sherman KE, 2004, ARCH INTERN MED, V164, P2377, DOI 10.1001/archinte.164.21.2377; Showstack J, 1999, JAMA-J AM MED ASSOC, V281, P1381, DOI 10.1001/jama.281.15.1381; Siebert U, 2005, GUT, V54, P172; Solomon L, 2004, J URBAN HEALTH, V81, P25, DOI 10.1093/jurban/jth085; Strader DB, 2004, HEPATOLOGY, V39, P1147, DOI 10.1002/hep.20119; Thein HH, 2005, AM J GASTROENTEROL, V100, P643, DOI 10.1111/j.1572-0241.2005.40976.x; Thomas David L, 2005, Clin Liver Dis, V9, P383, DOI 10.1016/j.cld.2005.05.003; Thomas DL, 2005, CLIN LIVER DIS, V9, pvi; Thomson BJ, 2008, J VIRAL HEPATITIS, V15, P271, DOI 10.1111/j.1365-2893.2007.00941.x; Vlahov D, 2004, ADDICTION, V99, P946, DOI 10.1111/j.1360-0443.2004.00780.x; Vlahov D, 2008, SUBST USE MISUSE, V43, P413, DOI 10.1080/10826080701203013; Wasley A, 2006, J CLIN VIROL, V36, pS198, DOI 10.1016/S1386-6532(06)80618-9; Wise M, 2008, HEPATOLOGY, V47, P1128, DOI 10.1002/hep.22165; Wong JB, 2000, AM J PUBLIC HEALTH, V90, P1562, DOI 10.2105/AJPH.90.10.1562; Wong JB, 2000, AM J MED, V108, P366, DOI 10.1016/S0002-9343(00)00303-X; Wright M, 2006, HEALTH TECHNOL ASSES, V10, P1; Wright M, 2006, HEALTH TECHNOL ASSES, V10, piii; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	71	254	257	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 21	2012	156	4					263	U24		10.7326/0003-4819-156-4-201202210-00378	http://dx.doi.org/10.7326/0003-4819-156-4-201202210-00378			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	896YO	22056542	Green Accepted, Green Submitted			2022-12-24	WOS:000300607600002
J	Phua, J				Phua, Jason			Do You Still Feel It?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Natl Univ Singapore Hosp, Dept Med, Div Resp & Crit Care Med, Singapore 117548, Singapore	National University of Singapore	Phua, J (corresponding author), Natl Univ Singapore Hosp, Dept Med, Div Resp & Crit Care Med, Singapore 117548, Singapore.	jason_phua@nuhs.edu.sg							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1632	1633		10.1001/jama.2011.1472	http://dx.doi.org/10.1001/jama.2011.1472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009086				2022-12-24	WOS:000295963200001
J	Rodrigues, LC; Mangtani, P; Abubakar, I				Rodrigues, Laura Cunha; Mangtani, Punam; Abubakar, Ibrahim			UNCERTAINTIES PAGE How does the level of BCG vaccine protection against tuberculosis fall over time?	BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS; MENINGITIS; EFFICACY	This is one of a series of occasional articles that highlight areas of practice where management lacks convincing supporting evidence. The series adviser is David Tovey, editor in chief, the Cochrane Library. This paper is based on a research priority identified and commissioned by the National Institute for Health Research's Health Technology Assessment programme on an important clinical uncertainty. To suggest a topic for this series, please email us at uncertainties@bmj.com	[Rodrigues, Laura Cunha] London Sch Hyg & Trop Med, Dept Infect Dis, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Abubakar, Ibrahim] Hlth Protect Agcy, TB Sect, London, England; [Abubakar, Ibrahim] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England	University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; University of East Anglia	Rodrigues, LC (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England.	laura.rodrigues@lshtm.ac.uk	RODRIGUES, LAURA CUNHA/AAO-4130-2021	Rodrigues, Laura Cunha/0000-0001-9008-660X; Abubakar, Ibrahim/0000-0002-0370-1430; Mangtani, Punam/0000-0001-7074-2999	National Institute for Health Research [08/17/01, 08/16/01] Funding Source: researchfish; Department of Health [08/17/01, 08/16/01, HTA/08/17/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abubakar I, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4281; Aronson NE, 2004, JAMA-J AM MED ASSOC, V291, P2086, DOI 10.1001/jama.291.17.2086; Barreto ML, 2005, INT J TUBERC LUNG D, V9, P1171; Department of Health, 2011, IMM INF DIS; Fine PE, 1995, LANCET, V46, P1339; FRIMODT-MOLLER J, 1960, Bull World Health Organ, V22, P61; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; *INT UN TUB LUNG D, 1994, TUBERCLE LUNG DIS, V75, P179; Joint Committee for Vaccination and Immunisation, 2005, WORK GROUP BCG VACC; Kaufmann SHE, 2011, NAT MED, V17, P159, DOI 10.1038/nm0211-159; *MRC, 1956, BRIT MED J, V1, P413; RODRIGUES LC, 1993, INT J EPIDEMIOL, V22, P1154, DOI 10.1093/ije/22.6.1154; Rodrigues LC, 1996, LANCET, V348, P611, DOI 10.1016/S0140-6736(05)64823-4; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; *WHO, 2010, GLOB TUB REP	17	29	31	2	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 29	2011	343								d5974	10.1136/bmj.d5974	http://dx.doi.org/10.1136/bmj.d5974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KC	21964347	Green Accepted			2022-12-24	WOS:000295577500002
J	Armstrong, PW; Boden, WE				Armstrong, Paul W.; Boden, William E.			Reperfusion Paradox in ST-Segment Elevation Myocardial Infarction	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION; IN-HOSPITAL MORTALITY; PRIMARY ANGIOPLASTY; NATIONAL-REGISTRY; SYMPTOM ONSET; THERAPY; TIME; OUTCOMES; RISK; TIMELINESS	A transformation in ST-segment elevation myocardial infarction (STEMI) care in the United States has unfolded. It asserts superior reperfusion with primary percutaneous coronary intervention (PPCI) over fibrinolysis on the basis of studies showing the former method to be superior for reperfusion of patients with STEMI. Although clear benefit has resulted from national programs directed toward achieving shorter times to PPCI in facilities with around-the-clock access, most patients present to non-PPCI hospitals. Because delay to PPCI for most patients with STEMI presenting to non-PPCI centers remains outside current guidelines, many are denied benefit from pharmacologic therapy. This article describes why this approach creates a treatment paradox in which more effort to improve treatment for patients with PPCI for acute STEMI often leads to unnecessary avoidance and delay in the use of fibrinolysis. Recent evidence confirms the unfavorable consequences of delay to PPCI and that early prehospital fibrinolysis combined with strategic mechanical co-interventions affords excellent outcomes. The authors believe it is time to embrace an integrated dual reperfusion strategy to best serve all patients with STEMI.	[Armstrong, Paul W.] Univ Alberta, Edmonton, AB T6G 2H7, Canada; Buffalo Gen Hosp, Buffalo, NY 14203 USA	University of Alberta; Buffalo General Medical Center	Armstrong, PW (corresponding author), Univ Alberta, 2-51 MSB, Edmonton, AB T6G 2H7, Canada.	paul.armstrong@ualberta.ca		Armstrong, Paul/0000-0002-0460-3445				Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; ANTMAN EM, 2004, ACC AHA GUIDELINES M; Armstrong PW, 2009, J AM COLL CARDIOL, V53, P1503, DOI 10.1016/j.jacc.2009.01.046; Armstrong PW, 2009, CIRCULATION, V119, P1293, DOI 10.1161/CIRCULATIONAHA.108.796383; Bates ER, 2008, CIRCULATION, V118, P567, DOI 10.1161/CIRCULATIONAHA.108.788620; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Henry TD, 2007, CIRCULATION, V116, P721, DOI 10.1161/CIRCULATIONAHA.107.694141; Kadakia MB, 2010, JACC-CARDIOVASC INTE, V3, P1166, DOI 10.1016/j.jcin.2010.08.015; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Nallamothu BK, 2005, CIRCULATION, V111, P761, DOI 10.1161/01.CIR.0000155258.44268.F8; Peterson ED, 2007, CIRCULATION, V116, pE64, DOI 10.1161/CIRCULATIONAHA.107.184051; Roe MT, 2010, J AM COLL CARDIOL, V56, P254, DOI 10.1016/j.jacc.2010.05.008; Stone GW, 2008, CIRCULATION, V118, P538, DOI 10.1161/CIRCULATIONAHA.107.756494; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Thune JJ, 2005, CIRCULATION, V112, P2017, DOI 10.1161/CIRCULATIONAHA.105.558676; Verheugt FWA, 2006, EUR HEART J, V27, P901, DOI 10.1093/eurheartj/ehi829; Westerhout CM, 2011, AM HEART J, V161, P283, DOI 10.1016/j.ahj.2010.10.033; Williams DO, 2004, CIRCULATION, V109, P1806, DOI 10.1161/01.CIR.0000126892.17646.83	22	36	40	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					389	391		10.7326/0003-4819-155-6-201109200-00008	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930857				2022-12-24	WOS:000295033400019
J	Ning, G; Bi, YF; Wang, TG; Xu, M; Xu, Y; Huang, Y; Li, MA; Li, XY; Wang, WQ; Chen, YH; Wu, YH; Hou, JN; Song, AY; Liu, Y; Lai, SH				Ning, Guang; Bi, Yufang; Wang, Tiange; Xu, Min; Xu, Yu; Huang, Yun; Li, Mian; Li, Xiaoying; Wang, Weiqing; Chen, Yuhong; Wu, Yaohua; Hou, Jianing; Song, Aiyun; Liu, Yu; Lai, Shenghan			Relationship of Urinary Bisphenol A Concentration to Risk for Prevalent Type 2 Diabetes in Chinese Adults A Cross-sectional Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							ESTROGEN-RECEPTOR; POPULATION; EXPOSURE; ALPHA	Background: Greater bisphenol A exposure has been shown to be associated with a higher risk for self-reported adverse health outcomes, including diabetes. Objective: To examine the association between bisphenol A exposure and type 2 diabetes in adults. Design: Cross-sectional study. Setting: Songnan, Baoshan District, Shanghai, China. Participants: 3423 local residents aged 40 years or older who were enrolled from 27 June 2008 to 10 August 2009. Measurements: Urinary concentrations of bisphenol A from morning spot urine samples (exposure) and fasting plasma glucose concentration, plasma glucose concentration 2 hours after an oral glucose tolerance test, and serum insulin concentration (outcomes). Results: Median age of the participants was 59.0 years (interquartile range, 53.0 to 68.7 years), 40% were men, and 1087 had type 2 diabetes. The median urinary bisphenol A level was 0.81 ng/mL (interquartile range, 0.47 to 1.43 ng/mL). Clinical characteristics differed between participants with normal glucose regulation and those with impaired glucose regulation and by bisphenol A quartile, but in multivariable analyses, there was no clear association between bisphenol A levels and type 2 diabetes. The adjusted odds ratio (OR) of type 2 diabetes was slightly increased for participants in the second bisphenol A quartile (0.48 to 0.81 ng/mL) (adjusted OR, 1.30 [95% CI, 1.03 to 1.64]) and the fourth quartile (>1.43 ng/mL) (adjusted OR, 1.37 [CI, 1.08 to 1.74]) but not the third quartile (0.82 to 1.43 ng/mL) (adjusted OR, 1.09 [CI, 0.86 to 1.39]), and a test of the trend of the association was not statistically significant. Limitations: The cross-sectional study design and nonrandom sample of participants limit the conclusions that can be drawn. Many patients in the study already had diabetes, successful treatment of which could have obscured apparent associations. Dietary variables were not measured; however, this is necessary in observational studies of bisphenol A and diabetes because the presence of the chemical in the body may reflect consumption of sugared drinks in plastic bottles. Conclusion: These findings do not confirm a previously reported association between urinary bisphenol A levels and self-reported type 2 diabetes.	[Ning, Guang] Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, Shanghai 200025, Peoples R China; Shanghai Jiao Tong Univ, Key Lab Endocrine & Metab Dis, Minist Hlth, Rui Jin Hosp,Sch Med,E Inst Shanghai Univ, Shanghai 200025, Peoples R China; Johns Hopkins Univ, Sch Med, Baltimore, MD USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Johns Hopkins University	Ning, G (corresponding author), Shanghai Jiao Tong Univ, Shanghai Clin Ctr Endocrine & Metab Dis, Shanghai Inst Endocrine & Metab Dis, Dept Endocrinol & Metab,Rui Jin Hosp,Sch Med, 197 Rui Jin 2nd Rd, Shanghai 200025, Peoples R China.	gning@sibs.ac.cn	Li, Mian/HGE-6038-2022	Li, Xiaoying/0000-0002-9383-5757	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Ministry of Science and Technology [2008ZX09312-019, 2008BAI52B03]; Ministry of Health [201002002]; Creative Research Group of Ministry of Education [IRT0932]; Shanghai Committee of Science and Technology [09DZ1950200]; National Natural Science Foundation of China [30725037]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health; Creative Research Group of Ministry of Education; Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology, Sector Funds of Ministry of Health, Creative Research Group of Ministry of Education, Major Project of Shanghai Committee of Science and Technology, National Key Technologies Research and Development Program of Ministry of Science and Technology, and the National Natural Science Foundation of China.; By Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), National Key New Drug Creation and Manufacturing Program of Ministry of Science and Technology (2008ZX09312-019), Sector Funds of Ministry of Health (201002002), Creative Research Group of Ministry of Education (IRT0932), Major Project of Shanghai Committee of Science and Technology (09DZ1950200), National Key Technologies Research and Development Program of Ministry of Science and Technology (2008BAI52B03), and the National Natural Science Foundation of China (30725037).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Alonso-Magdalena P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002069; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Hastie T.J., 2017, STAT SCI; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hugo ER, 2008, ENVIRON HEALTH PERSP, V116, P1642, DOI 10.1289/ehp.11537; Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Rosenberg PS, 2003, STAT MED, V22, P3369, DOI 10.1002/sim.1638; US FDA, 2010, UPD BISPH BPA US FOO; Vogel Sarah A, 2009, Am J Public Health, V99 Suppl 3, pS559, DOI 10.2105/AJPH.2008.159228; Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010	18	102	114	2	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					368	U62		10.7326/0003-4819-155-6-201109200-00005	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930854				2022-12-24	WOS:000295033400016
J	Harker, JA; Lewis, GM; Mack, L; Zuniga, EI				Harker, James A.; Lewis, Gavin M.; Mack, Lauren; Zuniga, Elina I.			Late Interleukin-6 Escalates T Follicular Helper Cell Responses and Controls a Chronic Viral Infection	SCIENCE			English	Article							DENDRITIC CELLS; SERUM LEVELS; IN-VIVO; VIRUS; MICE; IL-6; INDUCTION; IMMUNE; BCL6; DIFFERENTIATION	Multiple inhibitory molecules create a profoundly immunuosuppressive environment during chronic viral infections in humans and mice. Therefore, eliciting effective immunity in this context represents a challenge. Here, we report that during a murine chronic viral infection, interleukin-6 (IL-6) was produced by irradiation-resistant cells in a biphasic manner, with late IL-6 being absolutely essential for viral control. The underlying mechanism involved IL-6 signaling on virus-specific CD4 T cells that caused up-regulation of the transcription factor Bcl6 and enhanced T follicular helper cell responses at late, but not early, stages of chronic viral infection. This resulted in escalation of germinal center reactions and improved antibody responses. Our results uncover an antiviral strategy that helps to safely resolve a persistent infection in vivo.	[Harker, James A.; Lewis, Gavin M.; Mack, Lauren; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	eizuniga@ucsd.edu		Harker, James/0000-0002-0301-6898	NIH [AI072752, AI081923, AI09484]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI009484, R21AI072752, R01AI081923, R01AI009484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The data reported in this paper are tabulated in the supporting online material. The authors thank A. Drew (University of Cincinnati), P. Schwartzberg (NIH), M. David (University of California, San Diego), and S. Crotty (La Jolla Institute of Allergy and Immunology) for providing IL-6R ko, SAP ko, stat3 ko, and CD45.1<SUP>+</SUP> Smarta mice, respectively; S. Crotty for insightful discussion; L.-Y. Liou for technical help with initial experiment; and A. Dolgoter for technical assistance throughout. This work was supported by grants from the NIH (AI072752 and AI081923 to E.I.Z. and AI09484). J.A.H. and E.I.Z. have a provisional patent (no. 61/475,511) relating in part to methods of treating chronic viral infections by administering compounds that boost IL-6 signaling and/or T<INF>FH</INF> responses.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bergthaler A, 2009, PLOS BIOL, V7, P789, DOI 10.1371/journal.pbio.1000080; BIRX DL, 1990, BLOOD, V76, P2303; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chevalier MF, 2011, J VIROL, V85, P733, DOI 10.1128/JVI.02030-10; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Conry SJ, 2009, J VIROL, V83, P11175, DOI 10.1128/JVI.00753-09; Crotty S, 2006, BLOOD, V108, P3085, DOI 10.1182/blood-2006-04-018929; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Dienz O, 2009, J EXP MED, V206, P69, DOI 10.1084/jem.20081571; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Huber C, 2005, J IMMUNOL, V174, P5526, DOI 10.4049/jimmunol.174.9.5526; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Letvin NL, 2003, NAT MED, V9, P861, DOI 10.1038/nm0703-861; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Netski DM, 2005, CLIN INFECT DIS, V41, P667, DOI 10.1086/432478; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Spanakis NE, 2002, J CLIN LAB ANAL, V16, P40, DOI 10.1002/jcla.2060; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; TORRE D, 1994, CLIN INFECT DIS, V18, P194, DOI 10.1093/clinids/18.2.194; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wu YZ, 2009, INT IMMUNOL, V21, P745, DOI 10.1093/intimm/dxp041; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yue FY, 2010, J IMMUNOL, V185, P498, DOI 10.4049/jimmunol.0903915; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	45	250	255	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					825	829		10.1126/science.1208421	http://dx.doi.org/10.1126/science.1208421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	21960530	Green Accepted			2022-12-24	WOS:000296849600052
J	Shelton, J				Shelton, James			Scientists and the media must give a balanced view	NATURE			English	Editorial Material									US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Shelton, J (corresponding author), US Agcy Int Dev, Bur Global Hlth, Washington, DC 20523 USA.	jshelton@usaid.gov							0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2011	479	7371					7	7		10.1038/479007a	http://dx.doi.org/10.1038/479007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	840FA	22051636	Bronze			2022-12-24	WOS:000296422600004
J	Kumar, PA; Hu, YY; Yamamoto, Y; Hoe, NB; Wei, TS; Mu, DK; Sun, Y; Joo, LS; Dagher, R; Zielonka, EM; Wang, DY; Lim, B; Chow, VT; Crum, CP; Xian, W; McKeon, F				Kumar, Pooja A.; Hu, Yuanyu; Yamamoto, Yusuke; Hoe, Neo Boon; Wei, Tay Seok; Mu, Dakai; Sun, Yan; Joo, Lim Siew; Dagher, Rania; Zielonka, Elisabeth M.; Wang, De Yun; Lim, Bing; Chow, Vincent T.; Crum, Christopher P.; Xian, Wa; McKeon, Frank			Distal Airway Stem Cells Yield Alveoli In Vitro and during Lung Regeneration following H1N1 Influenza Infection	CELL			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MOUSE MODEL; EPITHELIUM; VIRUS; MICE; REPAIR; P63; MAINTENANCE; HOMEOSTASIS; ANTIBODY	The extent of lung regeneration following catastrophic damage and the potential role of adult stem cells in such a process remains obscure. Sublethal infection of mice with an H1N1 influenza virus related to that of the 1918 pandemic triggers massive airway damage followed by apparent regeneration. We show here that p63-expressing stem cells in the bronchiolar epithelium undergo rapid proliferation after infection and radiate to interbronchiolar regions of alveolar ablation. Once there, these cells assemble into discrete, Krt5+ pods and initiate expression of markers typical of alveoli. Gene expression profiles of these pods suggest that they are intermediates in the reconstitution of the alveolar-capillary network eradicated by viral infection. The dynamics of this p63-expressing stem cell in lung regeneration mirrors our parallel finding that defined pedigrees of human distal airway stem cells assemble alveoli-like structures in vitro and suggests new therapeutic avenues to acute and chronic airway disease.	[Kumar, Pooja A.; Hu, Yuanyu; Yamamoto, Yusuke; Hoe, Neo Boon; Wei, Tay Seok; Joo, Lim Siew; Lim, Bing; McKeon, Frank] ASTAR, Genome Inst Singapore, Singapore, Singapore; [Kumar, Pooja A.] Natl Univ Singapore, Singapore Massachusetts Inst Technol Alliance, Singapore 117548, Singapore; [Wei, Tay Seok; Xian, Wa] ASTAR, Inst Med Biol, Singapore, Singapore; [Mu, Dakai; Sun, Yan; McKeon, Frank] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA; [Dagher, Rania; Zielonka, Elisabeth M.] Univ Strasbourg, Inst Sci & Ingn Supramol, Strasbourg, France; [Wang, De Yun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Otolaryngol, Singapore 117595, Singapore; [Chow, Vincent T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Infect Dis Program, Dept Microbiol, Singapore 117595, Singapore; [Crum, Christopher P.; Xian, Wa] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); Harvard University; Harvard Medical School; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; National University of Singapore; National University of Singapore; Harvard University; Brigham & Women's Hospital	Xian, W (corresponding author), ASTAR, Genome Inst Singapore, Singapore, Singapore.	wa.xian@imb.a-star.edu.sg; mckeonf@gis.a-star.edu.sg	Kumar, Pooja Ashok/K-6762-2019	Kumar, Pooja/0000-0002-6589-2447; Chow, Vincent/0000-0003-2634-6213; Hu, Yuanyu/0000-0001-5457-4331	Defense Advanced Research Projects Agency (DARPA) [N66001-09-1-2121]; NIH [RC1 HL100767, RO1-GM083348, R21CA124688]; Singapore-MIT Alliance for Research and Technology; European Research Council; Agence de Nationale; Institute of Medical Biology; Genome Institute of Singapore of the Agency for Science, Technology and Research; NATIONAL CANCER INSTITUTE [R01CA083944, R21CA124688] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083348] Funding Source: NIH RePORTER	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); European Research Council(European Research Council (ERC)European Commission); Agence de Nationale; Institute of Medical Biology(Agency for Science Technology & Research (A*STAR)); Genome Institute of Singapore of the Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is dedicated to Howard Green. We thank Thomas Lufkin and Petra Kraus for their help with mouse models, Jianzhu Chen and his laboratory as well as the staff of the ABSL2 laboratory at NUS for their assistance with the viral model, and Susan and Keith Rogers for help with histology. We thank the staff of the Nikon Imaging Facility at HMS, and Graham Daniel Wright of the IMB imaging facility. We thank all the members in the Xian-McKeon laboratory for helpful discussions, and Edison Liu and Barbara Knowles for their critical review of the manuscript. We are grateful for the timely support of this work by the Defense Advanced Research Projects Agency (DARPA; Project N66001-09-1-2121), as well as the NIH (RC1 HL100767, RO1-GM083348, and R21CA124688), the Singapore-MIT Alliance for Research and Technology, the European Research Council, Agence de Nationale, the Institute of Medical Biology and the Genome Institute of Singapore of the Agency for Science, Technology and Research.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Berthiaume Y, 1999, THORAX, V54, P150, DOI 10.1136/thx.54.2.150; Cole BB, 2010, AM J PATHOL, V177, P362, DOI 10.2353/ajpath.2010.090870; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Gao P, 1999, J VIROL, V73, P3184, DOI 10.1128/JVI.73.4.3184-3189.1999; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Giangreco A, 2009, P NATL ACAD SCI USA, V106, P9286, DOI 10.1073/pnas.0900668106; GILLIS CN, 1982, ANNU REV PHYSIOL, V44, P269, DOI 10.1146/annurev.ph.44.030182.001413; Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Khimji AK, 2010, CELL SIGNAL, V22, P1615, DOI 10.1016/j.cellsig.2010.05.002; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lowy RJ, 2003, INT REV IMMUNOL, V22, P425, DOI 10.1080/08830180305216; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Matuschak George M, 2010, Mo Med, V107, P252; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; MORI I, 1995, MICROB PATHOGENESIS, V19, P237, DOI 10.1016/S0882-4010(95)90290-2; Nakajima N, 2012, MODERN PATHOL, V25, P1, DOI 10.1038/modpathol.2011.125; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; Ramsey C, 2011, CURR OPIN CRIT CARE, V17, P64, DOI 10.1097/MCC.0b013e3283427259; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rock JR, 2010, DIS MODEL MECH, V3, P545, DOI 10.1242/dmm.006031; Sakuma T, 2006, CRIT CARE MED, V34, P676, DOI 10.1097/01.CCM.0000201403.70636.0F; Schmidt D, 1996, TOXICOL LETT, V88, P75, DOI 10.1016/0378-4274(96)03720-4; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wojcik SM, 2000, MOL CELL BIOL, V20, P5248, DOI 10.1128/MCB.20.14.5248-5255.2000; Wu SH, 2011, CURR OPIN INFECT DIS, V24, P235, DOI 10.1097/QCO.0b013e328344c0e3; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	39	374	382	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					525	538		10.1016/j.cell.2011.10.001	http://dx.doi.org/10.1016/j.cell.2011.10.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036562	Green Accepted, Bronze			2022-12-24	WOS:000296573700009
J	Chen, J; Normand, SLT; Wang, Y; Krumholz, HM				Chen, Jersey; Normand, Sharon-Lise T.; Wang, Yun; Krumholz, Harlan M.			National and Regional Trends in Heart Failure Hospitalization and Mortality Rates for Medicare Beneficiaries, 1998-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; LONG-TERM TRENDS; RISK-FACTORS; 1ST HOSPITALIZATION; ELDERLY-PATIENTS; OLDER-ADULTS; OUTCOMES; POPULATION; SURVIVAL; EPIDEMIOLOGY	Context It is not known whether recent declines in ischemic heart disease and its risk factors have been accompanied by declines in heart failure (HF) hospitalization and mortality. Objective To examine changes in HF hospitalization rate and 1-year mortality rate in the United States, nationally and by state or territory. Design, Setting, and Participants From acute care hospitals in the United States and Puerto Rico, 55 097 390 fee-for-service Medicare beneficiaries hospitalized between 1998 and 2008 with a principal discharge diagnosis code for HF. Main Outcome Measures Changes in patient demographics and comorbidities, HF hospitalization rates, and 1-year mortality rates. Results The HF hospitalization rate adjusted for age, sex, and race declined from 2845 per 100 000 person-years in 1998 to 2007 per 100 000 person-years in 2008 (P < .001), a relative decline of 29.5%. Age-adjusted HF hospitalization rates declined over the study period for all race-sex categories. Black men had the lowest rate of decline (4142 to 3201 per 100 000 person-years) among all race-sex categories, which persisted after adjusting for age (incidence rate ratio, 0.81; 95% CI, 0.79-0.84). Heart failure hospitalization rates declined significantly faster than the national mean in 16 states and significantly slower in 3 states. Risk-adjusted 1-year mortality decreased from 31.7% in 1999 to 29.6% in 2008 (P < .001), a relative decline of 6.6%. One-year mortality rates declined significantly in 4 states but increased in 5 states. Conclusions The overall HF hospitalization rate declined substantially from 1998 to 2008 but at a lower rate for black men. The overall 1-year mortality rate declined slightly over the past decade but remains high. Changes in HF hospitalization and 1-year mortality rates were uneven across states. JAMA. 2011;306(15):1669-1678	[Chen, Jersey; Wang, Yun; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Normand, Sharon-Lise T.; Wang, Yun] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Wang, Yun; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA	Yale University; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Yale University	Chen, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Cardiovasc Med, 333 Cedar St, New Haven, CT 06520 USA.	jersey.chen@yale.edu	, Harlan/AAI-2875-2020	Normand, Sharon-Lise/0000-0001-7027-4769	Centers for Medicare & Medicaid Services; Yale University; Medtronic Inc through Yale University; Agency for Healthcare Research and Quality (AHRQ) [1K08HS018781-01]; National Heart, Lung, Blood Institute (NHLBI) [U01HL105270-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018781] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Centers for Medicare & Medicaid Services; Yale University; Medtronic Inc through Yale University(Medtronic); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Chen, Normand, Wang, and Krumholz reported that they develop and maintain performance measures under contract with the Centers for Medicare & Medicaid Services. Dr Normand reported receiving consulting fees from Yale University. Dr Krumholz reported that he chairs a cardiac scientific advisory board for United Healthcare and is the recipient of a research grant from Medtronic Inc through Yale University.; This work was supported by an Agency for Healthcare Research and Quality (AHRQ) Career Development Award (1K08HS018781-01) for Dr Chen and a National Heart, Lung, Blood Institute (NHLBI) Cardiovascular Outcomes Center Award (U01HL105270-01) for Drs Chen, Normand, Wang, and Krumholz.	Bernheim SM, 2010, 2010 MEASURES MAINTE; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Chen J, 2010, CIRCULATION, V121, P1322, DOI 10.1161/CIRCULATIONAHA.109.862094; Curtis LH, 2008, ARCH INTERN MED, V168, P418, DOI 10.1001/archinternmed.2007.80; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dunlay SM, 2009, AM J MED, V122, P1023, DOI 10.1016/j.amjmed.2009.04.022; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Ezekowitz JA, 2011, EUR J HEART FAIL, V13, P142, DOI 10.1093/eurjhf/hfq185; Ezekowitz JA, 2010, HEART FAIL REV, V15, P407, DOI 10.1007/s10741-010-9162-x; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Fonarow GC, 2007, AM HEART J, V153, P1021, DOI [10.1016/j.ahj.2007.03.012, 10.1016/j.ahj.2007.07.043]; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Grosso LM, 2009 MEASURES MAINTE; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Hellermann JP, 2003, AM J EPIDEMIOL, V157, P1101, DOI 10.1093/aje/kwg078; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Lee DS, 2004, AM J MED, V116, P581, DOI 10.1016/j.amjmed.2003.11.025; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Medicare Payment Advisory Commission, 2008, REP C MED PAYM POL M; Mehta PA, 2009, HEART, V95, P1851, DOI 10.1136/hrt.2008.156034; Morgan RO, 1997, NEW ENGL J MED, V337, P169, DOI 10.1056/NEJM199707173370306; Roger VL, 2004, JAMA-J AM MED ASSOC, V292, P344, DOI 10.1001/jama.292.3.344; Schaufelberger M, 2004, EUR HEART J, V25, P300, DOI 10.1016/j.ehj.2003.12.012; Shafazand M, 2011, EUR J HEART FAIL, V13, P135, DOI 10.1093/eurjhf/hfq205; Shah RU, 2011, CIRC-HEART FAIL, V4, P301, DOI 10.1161/CIRCHEARTFAILURE.110.959114; Smith NL, 2004, AM HEART J, V148, P710, DOI 10.1016/j.ahj.2004.04.002; Teng THK, 2010, CIRC-HEART FAIL, V3, P236, DOI 10.1161/CIRCHEARTFAILURE.109.879239; Titler MG, 2008, HEALTH SERV RES, V43, P635, DOI 10.1111/j.1475-6773.2007.00789.x; Wang TJ, 2005, CIRCULATION, V112, P1651, DOI 10.1161/CIRCULATIONAHA.104.490599; Wasywich CA, 2010, EUR J HEART FAIL, V12, P462, DOI 10.1093/eurjhf/hfq027; Wier LM, HCUP FACTS FIGURES S; Wong CY, 2011, AM J MED, V124, P136, DOI 10.1016/j.amjmed.2010.08.017; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	43	514	570	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1669	1678		10.1001/jama.2011.1474	http://dx.doi.org/10.1001/jama.2011.1474			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009099	Bronze, Green Accepted			2022-12-24	WOS:000295963200026
J	Kiaii, M; Djurdjev, O; Farah, M; Levin, A; Jung, B; MacRae, J				Kiaii, Mercedeh; Djurdjev, Ognjenka; Farah, Myriam; Levin, Adeera; Jung, Beverly; MacRae, Jennifer			Use of Electron-Beam Sterilized Hemodialysis Membranes and Risk of Thrombocytopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIALYSIS MEMBRANES; THROMBUS FORMATION; PLATELET; ACTIVATION	Context Thrombocytopenia is not widely recognized as a potential dialyzer-related complication. Following the observation of significant thrombocytopenia among 20 patients undergoing hemodialysis in a single dialysis unit after the introduction of dialyzers sterilized by electron beam (e-beam), a larger investigation was undertaken. Objective To determine the prevalence and etiology of thrombocytopenia in hemodialysis populations of 2 Canadian provinces (British Columbia and Alberta). Design, Setting, and Participants A cohort study of patients undergoing hemodialysis in British Columbia (n = 1706) and southern Alberta (n = 425) between April 1, 2009, and November 30, 2010. Retrospective analyses of historical patient, laboratory, and dialyzer data predating conversion to e-beam dialyzers were undertaken, with prospective collection of predialysis and postdialysis platelet counts before and after the change from e-beam to non-e-beam sterilized dialyzers in September 2009. Main Outcome Measure Significant thrombocytopenia, defined a priori as postdialysis treatment platelet count of less than 100 x 10(3)/mu L and a postdialysis decrease in platelet count of more than 15%. Results Among 1706 patients undergoing hemodialysis in British Columbia, 1411 (83%) were undergoing hemodialysis with e-beam sterilized dialyzers. Of 1706 patients, 194 (11.4%; 95% CI, 9.9%-12.9%) had postdialysis platelet counts of less than 100 x 10(3)/mu L; 400 (23.4%; 95% CI, 21.5%-25.5%) had postdialysis decreases in platelet counts of more than 15%; and 123 (7.2%; 95% CI, 6.0%-8.6%) met both criteria. Among 425 patients in Alberta undergoing dialysis with polysulfone, e-beam sterilized dialyzers made by a different manufacturer, 46 (10.8%; 95% CI, 8.1%-14.3%) had platelet counts of less than 100 x 10(3)/mu L; 156 (32.0%; 95% CI, 27.6%-36.7%) had decreases in platelet counts of more than 15%; and 31 (7.3%; 95% CI, 5.1%-10.3%) met both criteria. In multivariable analysis adjusting for patient and dialysis history characteristics, a significant association was observed between using an e-beam sterilized dialyzer and risk of significant thrombocytopenia (odds ratio [OR], 2.52; 95% CI, 1.20-5.29; P =. 02). Compared with use of e-beam sterilized dialyzers, following the change to use of non-e-beam sterilized dialyzers, among 1784 patients, significant reductions were observed in postdialysis thrombocytopenia (120 patients [6.7%; 95% CI, 5.6%-8.0%; P < .001] had platelet counts of <100 x 10(3)/mu L; 167 patients [9.4%; 95% CI, 8.1%-10.8%; P < .001] had decreases in platelet counts of >15%; and 38 patients [2.1%; 95% CI, 1.5%-2.9%; P < .001] met both criteria). Using generalized estimating equation modeling for repeated data with binary outcome, after adjusting for patient characteristics, the odds of significant thrombocytopenia were higher during the use of e-beam sterilized dialyzers than with use of non-e-beam sterilized dialyzers (OR, 3.57; 95% CI, 2.54-5.04; P < .001). Conclusion In this cohort of patients undergoing hemodialysis in 2 Canadian provinces in 2009-2010, the use of e-beam sterilized dialyzers was associated with significant thrombocytopenia following dialysis. JAMA. 2011;306(15):1679-1687	[Kiaii, Mercedeh; Farah, Myriam; Levin, Adeera; Jung, Beverly] Univ British Columbia, Div Nephrol, Vancouver, BC V6Z 2E8, Canada; [Djurdjev, Ognjenka; Levin, Adeera] British Columbia Prov Renal Agcy, Vancouver, BC, Canada; [MacRae, Jennifer] Univ Calgary, Div Nephrol, Calgary, AB, Canada	University of British Columbia; University of Calgary	Kiaii, M (corresponding author), Univ British Columbia, Div Nephrol, 602-1160 Burrard St, Vancouver, BC V6Z 2E8, Canada.	mkiaii@providencehealth.bc.ca	MacRae, Jennifer/AAV-9827-2020	MacRae, Jennifer/0000-0002-4711-1440				Clark WR, 2002, SEMIN DIALYSIS, V15, P191, DOI 10.1046/j.1525-139X.2002.00019.x; Daugirdas J T, 1988, Kidney Int Suppl, V24, pS37; Gavioli G, 2002, HEMODIALYSIS TECHNOL, P80; GAWAZ MP, 1994, KIDNEY INT, V46, P489, DOI 10.1038/ki.1994.299; Gritters-van den Oever Mareille, 2009, Blood Purif, V28, P253, DOI 10.1159/000232933; HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187; HAKIM RM, 1985, AM J MED, V78, P575, DOI 10.1016/0002-9343(85)90398-5; LINDSAY RM, 1973, BRIT J HAEMATOL, V24, P377, DOI 10.1111/j.1365-2141.1973.tb01661.x; LINDSAY RM, 1972, BRIT MED J, V4, P454, DOI 10.1136/bmj.4.5838.454; LINDSAY RM, 1973, T AM SOC ART INT ORG, V19, P487; LOTNER GZ, 1980, J IMMUNOL, V124, P676; Milburn JA, 2011, INT J ARTIF ORGANS, V34, P280, DOI 10.5301/IJAO.2011.6469; Olafiranye F, 2011, CASE REP MED, V2011, DOI 10.1155/2011/134295; Posadas MA, 2011, HEMODIAL INT, V15, P416, DOI 10.1111/j.1542-4758.2011.00561.x; Post JB, 2010, AM J KIDNEY DIS, V55, pE25, DOI 10.1053/j.ajkd.2009.10.059; SHINTANI H, 1991, J BIOMED MATER RES, V25, P1275, DOI 10.1002/jbm.820251008; Uhlenbusch-Korwer I., 2004, UNDERSTANDING MEMBRA, P265	17	39	40	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1679	1687		10.1001/jama.2011.1499	http://dx.doi.org/10.1001/jama.2011.1499			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009100	Bronze			2022-12-24	WOS:000295963200027
J	Duderstadt, KE; Chuang, K; Berger, JM				Duderstadt, Karl E.; Chuang, Kevin; Berger, James M.			DNA stretching by bacterial initiators promotes replication origin opening	NATURE			English	Article							ESCHERICHIA-COLI CHROMOSOME; AAA PLUS ATPASES; RECA PROTEIN; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; COMPLEX; RECOGNITION; MECHANISM; HELICASE; BINDING	Many replication initiators form higher-order oligomers that process host replication origins to promote replisome formation. In addition to dedicated duplex-DNA-binding domains, cellular initiators possess AAA+ (ATPases associated with various cellular activities) elements that drive functions ranging from protein assembly to origin recognition. In bacteria, the AAA+ domain of the initiator DnaA has been proposed to assist in single-stranded DNA formation during origin melting. Here we show crystallographically and in solution that the ATP-dependent assembly of Aquifex aeolicus DnaA into a spiral oligomer creates a continuous surface that allows successive AAA+ domains to bind and extend single-stranded DNA segments. The mechanism of binding is unexpectedly similar to that of RecA, a homologous recombination factor, but it differs in that DnaA promotes a nucleic acid conformation that prevents pairing of a complementary strand. These findings, combined with strand-displacement assays, indicate that DnaA opens replication origins by a direct ATP-dependent stretching mechanism. Comparative studies reveal notable commonalities between the approach used by DnaA to engage DNA substrates and other, nucleic-acid-dependent, AAA+ systems.	[Duderstadt, Karl E.; Berger, James M.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Chuang, Kevin; Berger, James M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	jmberger@berkeley.edu		Duderstadt, Karl/0000-0002-1279-7841	NIGMS [GM071747]; National Institute of Health [T32 GM008295]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008295, R01GM071747] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank K. Drlica, J. Keck, T. Murray and the Berger laboratory for helpful comments, and M. M. Cox for his contribution of RecA protein. This work was supported by the NIGMS (GM071747) and the National Institute of Health Molecular Biophysics Training Grant T32 GM008295.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BIANCHI M, 1985, EMBO J, V4, P3025, DOI 10.1002/j.1460-2075.1985.tb04039.x; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CANTOR CR, 1980, BIOPHYSICAL CHEM 2, P846; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Clarey MG, 2006, NAT STRUCT MOL BIOL, V13, P684, DOI 10.1038/nsmb1121; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Crisona NJ, 2006, J BIOL CHEM, V281, P18927, DOI 10.1074/jbc.M603068200; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duderstadt KE, 2008, CRIT REV BIOCHEM MOL, V43, P163, DOI [10.1080/10409230802058296, 10.1080/10409230802058296 ]; Duderstadt KE, 2010, J BIOL CHEM, V285, P28229, DOI 10.1074/jbc.M110.147975; Dueber ELC, 2007, SCIENCE, V317, P1210, DOI 10.1126/science.1143690; Egelman E, 2000, Trends Biochem Sci, V25, P179, DOI 10.1016/S0968-0004(00)01555-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Ennifar E, 2002, ACTA CRYSTALLOGR D, V58, P1262, DOI 10.1107/S0907444902009526; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Felczak MM, 2004, J BIOL CHEM, V279, P51156, DOI 10.1074/jbc.M409695200; FULLER RS, 1984, CELL, V38, P889, DOI 10.1016/0092-8674(84)90284-8; FUNNELL BE, 1987, J BIOL CHEM, V262, P10327; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gaudier M, 2007, SCIENCE, V317, P1213, DOI 10.1126/science.1143664; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 2010, NAT REV MICROBIOL, V8, P163, DOI 10.1038/nrmicro2314; Kornberg A., 1992, DNA REPLICATION; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; KOWALSKI D, 1989, EMBO J, V8, P4335, DOI 10.1002/j.1460-2075.1989.tb08620.x; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040; Leonard AC, 2010, CURR OPIN MICROBIOL, V13, P766, DOI 10.1016/j.mib.2010.10.001; Liu XF, 2007, MOL CELL, V25, P825, DOI 10.1016/j.molcel.2007.02.009; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Neuwald AF, 1999, GENOME RES, V9, P27; Nishinaka T, 1997, P NATL ACAD SCI USA, V94, P6623, DOI 10.1073/pnas.94.13.6623; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Simonetta KR, 2009, CELL, V137, P659, DOI 10.1016/j.cell.2009.03.044; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; STASIAK A, 1982, NATURE, V299, P185, DOI 10.1038/299185a0; Stillman B, 2005, FEBS LETT, V579, P877, DOI 10.1016/j.febslet.2004.12.011; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Sutton MD, 1998, J BIOL CHEM, V273, P34255, DOI 10.1074/jbc.273.51.34255; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; WEBER K, 1969, J BIOL CHEM, V244, P4406	60	139	140	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					209	U91		10.1038/nature10455	http://dx.doi.org/10.1038/nature10455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964332	Green Accepted			2022-12-24	WOS:000295782800042
J	Haque, A; Andersen, JN; Salmeen, A; Barford, D; Tonks, NK				Haque, Aftabul; Andersen, Jannik N.; Salmeen, Annette; Barford, David; Tonks, Nicholas K.			Conformation-Sensing Antibodies Stabilize the Oxidized Form of PTP1B and Inhibit Its Phosphatase Activity	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SIGNAL-TRANSDUCTION; INSULIN-RECEPTOR; IN-VIVO; REVERSIBLE OXIDATION; HYDROGEN-PEROXIDE; REDOX REGULATION; 1B; DEPHOSPHORYLATION; MICE	Protein tyrosine phosphatase 1B (PTP1B) plays important roles in downregulation of insulin and leptin signaling and is an established therapeutic target for diabetes and obesity. PTP1B is regulated by reactive oxygen species (ROS) produced in response to various stimuli, including insulin. The reversibly oxidized form of the enzyme (PTP1B-OX) is inactive and undergoes profound conformational changes at the active site. We generated conformation-sensor antibodies, in the form of single-chain variable fragments (scFvs), that stabilize PTP1B-OX and thereby inhibit its phosphatase function. Expression of conformation-sensor scFvs as intracellular antibodies (intrabodies) enhanced insulin-induced tyrosyl phosphorylation of the beta subunit of the insulin receptor and its substrate IRS-1 and increased insulin-induced phosphorylation of PKB/AKT. Our data suggest that stabilization of the oxidized, inactive form of PTP1B with appropriate therapeutic molecules may offer a paradigm for phosphatase drug development.	[Haque, Aftabul; Andersen, Jannik N.; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Haque, Aftabul] SUNY Stony Brook, Mol & Cellular Biol Grad Program, Stony Brook, NY 11790 USA; [Salmeen, Annette; Barford, David] Inst Canc Res, Chester Beatty Labs, Div Struct Biol, London SW3 6JB, England	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Tonks, NK (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	tonks@cshl.edu		Andersen, Jannik/0000-0003-4528-2120	NIH [CA53840, GM55989]; Cancer Research UK; NATIONAL CANCER INSTITUTE [R01CA053840, R37CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants CA53840 and GM55989 to N.K.T. The work in D.B.'s lab was supported by a grant from Cancer Research UK.	Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bandyopadhyay D, 1997, J BIOL CHEM, V272, P1639, DOI 10.1074/jbc.272.3.1639; BARFORD D, 1994, J MOL BIOL, V239, P726, DOI 10.1006/jmbi.1994.1409; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; BRANDT TA, 2010, AM DIAB ASS CARLSB C; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Cardinale A, 2008, TRENDS MOL MED, V14, P373, DOI 10.1016/j.molmed.2008.07.004; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Eden ER, 2010, NAT CELL BIOL, V12, P267, DOI 10.1038/ncb2026; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Goldstein BJ, 2000, J BIOL CHEM, V275, P4283, DOI 10.1074/jbc.275.6.4283; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Iversen LF, 2002, J BIOL CHEM, V277, P19982, DOI 10.1074/jbc.M200567200; Johnson TO, 2002, NAT REV DRUG DISCOV, V1, P696, DOI 10.1038/nrd895; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Lohse DL, 1997, BIOCHEMISTRY-US, V36, P4568, DOI 10.1021/bi963094r; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Marasco WA, 1997, GENE THER, V4, P11, DOI 10.1038/sj.gt.3300346; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Romsicki Y, 2004, J BIOL CHEM, V279, P12868, DOI 10.1074/jbc.M309600200; Rondinone CM, 2002, DIABETES, V51, P2405, DOI 10.2337/diabetes.51.8.2405; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Salmeen A, 2000, MOL CELL, V6, P1401, DOI 10.1016/S1097-2765(00)00137-4; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tjernberg A, 2004, BIOORG MED CHEM LETT, V14, P891, DOI 10.1016/j.bmcl.2003.12.014; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; TONKS NK, 1988, J BIOL CHEM, V263, P6722; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; WHO, 2009, DIAB FACT SHEET; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683; Yudushkin IA, 2007, SCIENCE, V315, P115, DOI 10.1126/science.1134966; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011; Zinker BA, 2002, P NATL ACAD SCI USA, V99, P11357, DOI 10.1073/pnas.142298199	55	108	112	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					185	198		10.1016/j.cell.2011.08.036	http://dx.doi.org/10.1016/j.cell.2011.08.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962515	Green Accepted, Bronze			2022-12-24	WOS:000295396700025
J	Vesper, O; Amitai, S; Belitsky, M; Byrgazov, K; Kaberdina, AC; Engelberg-Kulka, H; Moll, I				Vesper, Oliver; Amitai, Shahar; Belitsky, Maria; Byrgazov, Konstantin; Kaberdina, Anna Chao; Engelberg-Kulka, Hanna; Moll, Isabella			Selective Translation of Leaderless mRNAs by Specialized Ribosomes Generated by MazF in Escherichia coli	CELL			English	Article							PROGRAMMED CELL-DEATH; TOXIN-ANTITOXIN LOCI; ADDICTION MODULE; INITIATION; SEQUENCE; MAINTENANCE; ANTIBIOTICS; EXPRESSION; MECHANISM; SUBUNIT	Escherichia coli (E. coli) mazEF is a stress-induced toxin-antitoxin (TA) module. The toxin MazF is an endoribonuclease that cleaves single-stranded mRNAs at ACA sequences. Here, we show that MazF cleaves at ACA sites at or closely upstream of the AUG start codon of some specific mRNAs and thereby generates leaderless mRNAs. Moreover, we provide evidence that MazF also targets 16S rRNA within 30S ribosomal subunits at the decoding center, thereby removing 43 nucleotides from the 30 terminus. As this region comprises the anti-Shine-Dalgarno (aSD) sequence that is required for translation initiation on canonical mRNAs, a subpopulation of ribosomes is formed that selectively translates the described leaderless mRNAs both in vivo and in vitro. Thus, we have discovered a modified translation machinery that is generated in response to MazF induction and that probably serves for stress adaptation in Escherichia coli.	[Amitai, Shahar; Belitsky, Maria; Engelberg-Kulka, Hanna] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel; [Vesper, Oliver; Byrgazov, Konstantin; Kaberdina, Anna Chao; Moll, Isabella] Univ Vienna, Max F Perutz Labs, Ctr Mol Biol, Dept Microbiol Immunobiol & Genet, A-1030 Vienna, Austria	Hebrew University of Jerusalem; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IMRIC, IL-91120 Jerusalem, Israel.	hanita@cc.huji.ac.il; isabella.moll@univie.ac.at	Moll, Isabella/E-8665-2012; Byrgazov, Konstantin/G-9358-2016	Moll, Isabella/0000-0002-3210-4336; Byrgazov, Konstantin/0000-0002-8924-9536	Austrian Science Fund [P20112-B03, P22249-B20]; Israel Science Foundation (ISF) [66/10]; USA Army [W911NF0910212]; NIH [GM069509]; Austrian Science Fund (FWF) [P 22249] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069509] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Israel Science Foundation (ISF)(Israel Science Foundation); USA Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants P20112-B03 and P22249-B20 from the Austrian Science Fund to I. M., by grant number 66/10 from the Israel Science Foundation (ISF) administrated by the Israel Academy of Science and Humanities, by the USA Army grant W911NF0910212, and by NIH grant GM069509 to H.E.-K.	Agarwal S, 2007, FEBS LETT, V581, P1727, DOI 10.1016/j.febslet.2007.03.051; Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Baik S, 2009, J BACTERIOL, V191, P6157, DOI 10.1128/JB.00699-09; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BROSIUS J, 1981, PLASMID, V6, P112, DOI 10.1016/0147-619X(81)90058-5; CALOGERO RA, 1988, P NATL ACAD SCI USA, V85, P6427, DOI 10.1073/pnas.85.17.6427; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Cochella L, 2004, P NATL ACAD SCI USA, V101, P3786, DOI 10.1073/pnas.0307596101; DELANO WL, 2002, PYMOL MOL SYSTEM; Engelberg-Kulka H, 1998, P NATL ACAD SCI USA, V95, P15481, DOI 10.1073/pnas.95.26.15481; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Engelberg-Kulka H, 2006, PLOS GENET, V2, P1518, DOI 10.1371/journal.pgen.0020135; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; GIBSON T, 1984, THESIS U CAMBRIDGE U; Green J, 1998, MOL MICROBIOL, V29, P1113, DOI 10.1046/j.1365-2958.1998.01002.x; Grill S, 2000, EMBO J, V19, P4101, DOI 10.1093/emboj/19.15.4101; HAMMERJE, 1971, EUR J BIOCHEM, V19, P533; Hayes F, 2003, SCIENCE, V301, P1496, DOI 10.1126/science.1088157; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; HUI A, 1987, P NATL ACAD SCI USA, V84, P4762, DOI 10.1073/pnas.84.14.4762; Kaberdina AC, 2009, MOL CELL, V33, P227, DOI 10.1016/j.molcel.2008.12.014; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Kolodkin-Gal I, 2006, J BACTERIOL, V188, P3420, DOI 10.1128/JB.188.9.3420-3423.2006; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; Kolodkin-Gal I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006785; LUPSKI JR, 1984, MOL GEN GENET, V195, P391, DOI 10.1007/BF00341439; Marianovsky I, 2001, J BIOL CHEM, V276, P5975, DOI 10.1074/jbc.M008832200; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Mawn MV, 2002, J BACTERIOL, V184, P494, DOI 10.1128/JB.184.2.494-502.2002; METZGER S, 1988, J BIOL CHEM, V263, P15699; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Moll I, 2002, MOL MICROBIOL, V44, P1387, DOI 10.1046/j.1365-2958.2002.02971.x; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; Ramage HR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000767; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; SENIOR BW, 1971, P NATL ACAD SCI USA, V68, P959, DOI 10.1073/pnas.68.5.959; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Vila-Sanjurjo A, 2001, J MOL BIOL, V308, P457, DOI 10.1006/jmbi.2001.4576; Wagner AFV, 2001, BIOCHEM BIOPH RES CO, V285, P456, DOI 10.1006/bbrc.2001.5186; Wendrich TM, 2002, MOL CELL, V10, P779, DOI 10.1016/S1097-2765(02)00656-1; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; WRZESINSKI J, 1995, BIOCHEMISTRY-US, V34, P8904, DOI 10.1021/bi00027a043; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200; Zhang JJ, 2003, J BIOL CHEM, V278, P32300, DOI 10.1074/jbc.M304767200; Zhu L, 2008, MOL MICROBIOL, V69, P559, DOI 10.1111/j.1365-2958.2008.06284.x	58	214	219	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					147	157		10.1016/j.cell.2011.07.047	http://dx.doi.org/10.1016/j.cell.2011.07.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21944167	Green Accepted, Bronze			2022-12-24	WOS:000295396700022
J	Watanabe, M; Cheng, K; Murayama, Y; Ueno, K; Asamizuya, T; Tanaka, K; Logothetis, N				Watanabe, Masataka; Cheng, Kang; Murayama, Yusuke; Ueno, Kenichi; Asamizuya, Takeshi; Tanaka, Keiji; Logothetis, Nikos			Attention But Not Awareness Modulates the BOLD Signal in the Human V1 During Binocular Suppression	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; PERCEPTUAL SUPPRESSION; SPATIAL ATTENTION; AWAKE MONKEY; RIVALRY; ABSENCE; DISCRIMINATION	Although recent psychophysical studies indicate that visual awareness and top-down attention are two distinct processes, it is not clear how they are neurally dissociated in the visual system. Using a two-by-two factorial functional magnetic resonance imaging design with binocular suppression, we found that the visibility or invisibility of a visual target led to only nonsignificant blood oxygenation level-dependent (BOLD) effects in the human primary visual cortex (V1). Directing attention toward and away from the target had much larger and robust effects across all study participants. The difference in the lower-level limit of BOLD activation between attention and awareness illustrates dissociated neural correlates of the two processes. Our results agree with previously reported V1 BOLD effects on attention, while they invite a reconsideration of the functional role of V1 in visual awareness.	[Watanabe, Masataka] Univ Tokyo, Sch Engn, Tokyo, Japan; [Watanabe, Masataka; Murayama, Yusuke; Logothetis, Nikos] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Watanabe, Masataka; Cheng, Kang; Ueno, Kenichi; Asamizuya, Takeshi; Tanaka, Keiji] RIKEN, Brain Sci Inst, Wako, Saitama, Japan; [Logothetis, Nikos] Univ Manchester, Manchester, Lancs, England	University of Tokyo; Max Planck Society; RIKEN; University of Manchester	Watanabe, M (corresponding author), Univ Tokyo, Sch Engn, Tokyo, Japan.	watanabe@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015; Cheng, Kang/A-6448-2016	Tanaka, Keiji/0000-0002-1910-3427; Asamizuya, Takeshi/0000-0003-1004-6435; Watanabe, Masataka/0000-0003-0128-3690	Japanese Ministry of Education, Culture, Sports, Science and Technology [1702215]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science and Technology grant no. 1702215 (M.W.). We thank D. Voinescu for help with data collection and S. Tajima for early discussion and model simulation related to the project.	Braun J, 1998, PERCEPT PSYCHOPHYS, V60, P1, DOI 10.3758/BF03211915; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; COWEY A, 1991, TRENDS NEUROSCI, V14, P140, DOI 10.1016/0166-2236(91)90085-9; Gail A, 2004, CEREB CORTEX, V14, P300, DOI 10.1093/cercor/bhg129; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Leopold DA, 1996, NATURE, V379, P549, DOI 10.1038/379549a0; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Maier A, 2005, J VISION, V5, P668, DOI 10.1167/5.9.2; Maier A, 2008, NAT NEUROSCI, V11, P1193, DOI 10.1038/nn.2173; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Maruya K, 2008, J VISION, V8, DOI 10.1167/8.11.7; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Montaser-Kouhsari L, 2004, J VISION, V4, P434, DOI 10.1167/4.6.3; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; Reddy L, 2004, J VISION, V4, P106, DOI 10.1167/4.2.4; Reddy L, 2006, VISION RES, V46, P2336, DOI 10.1016/j.visres.2006.01.020; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Silvanto J, 2005, CEREB CORTEX, V15, P1736, DOI 10.1093/cercor/bhi050; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tsuchiya N, 2005, NAT NEUROSCI, V8, P1096, DOI 10.1038/nn1500; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Weiskrantz I., 1986, BLINDSIGHT; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103	28	131	134	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					829	831		10.1126/science.1203161	http://dx.doi.org/10.1126/science.1203161			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076381				2022-12-24	WOS:000296849600053
J	Fortune, ES; Rodriguez, C; Li, D; Ball, GF; Coleman, MJ				Fortune, Eric S.; Rodriguez, Carlos; Li, David; Ball, Gregory F.; Coleman, Melissa J.			Neural Mechanisms for the Coordination of Duet Singing in Wrens	SCIENCE			English	Article							WHITE-CROWNED SPARROW; BLACK-BELLIED WREN; THRYOTHORUS WRENS; ZEBRA FINCHES; SONG SYSTEM; NEURONS; SELECTIVITY; HVC; REPRESENTATION; COMMUNICATION	Plain-tailed wrens (Pheugopedius euophrys) cooperate to produce a duet song in which males and females rapidly alternate singing syllables. We examined how sensory information from each wren is used to coordinate singing between individuals for the production of this cooperative behavior. Previous findings in nonduetting songbird species suggest that premotor circuits should encode each bird's own contribution to the duet. In contrast, we find that both male and female wrens encode the combined cooperative output of the pair of birds. Further, behavior and neurophysiology show that both sexes coordinate the timing of their singing based on feedback from the partner and suggest that females may lead the duet.	[Fortune, Eric S.; Li, David; Ball, Gregory F.] Johns Hopkins Univ, Dept Neurosci, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Fortune, Eric S.; Rodriguez, Carlos] Pontificia Univ Catolica Ecuador, Museo Zool, Quito, Ecuador; [Coleman, Melissa J.] Pitzer Coll, Claremont Mckenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; [Coleman, Melissa J.] Scripps Coll, Claremont, CA 91711 USA	Johns Hopkins University; Pontificia Universidad Catolica del Ecuador; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College; Claremont Colleges; Scripps College	Fortune, ES (corresponding author), Johns Hopkins Univ, Dept Neurosci, Dept Psychol & Brain Sci, 3400 N Charles St, Baltimore, MD 21218 USA.	eric.fortune@gmail.com	Rodríguez, Carlos A/H-4881-2011	Rodríguez, Carlos A/0000-0001-8077-7263; Rodriguez-Saltos, Carlos/0000-0002-3162-7645; Fortune, Eric/0000-0001-6447-5425; Ball, Gregory/0000-0002-4784-0520	Museum of Zoology (QCAZ), Pontificia Universidad Catolica del Ecuador in Quito; NSF [IOS-0817918]; Johns Hopkins University; Claremont McKenna College; Pitzer College; Scripps College	Museum of Zoology (QCAZ), Pontificia Universidad Catolica del Ecuador in Quito; NSF(National Science Foundation (NSF)); Johns Hopkins University(Johns Hopkins University); Claremont McKenna College; Pitzer College; Scripps College	This research would not have been possible without the help and support of S. Burneo, curator, Museum of Zoology (QCAZ), Pontificia Universidad Catolica del Ecuador in Quito. This project used equipment previously purchased with funds from NSF award IOS-0817918 to E. S. F. Support was also provided by the Johns Hopkins University and Claremont McKenna, Pitzer, Scripps Colleges. We thank H. Greeney, J. Simbana, R. Jarrin, A. Saa, and K. Cisneros for logistical support; N. Cowan, J. Knierim, R. Krahe, and H. Zakon for helpful discussions and feedback; and D. Margoliash for his advice and insights. Behavioral and neurophysiological data are available upon request. Animal tissues are archived in the QCAZ in Quito, Ecuador, and are available in accordance with the relevant laws and regulations of the Republic of Ecuador.	Clayton NS, 2007, PHILOS T R SOC B, V362, P507, DOI 10.1098/rstb.2006.1992; Coleman MJ, 2004, J NEUROSCI, V24, P7251, DOI 10.1523/JNEUROSCI.0947-04.2004; Crawford M.P., 1937, COMP PSYCHOL MONOGR, V14, P1; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Edwards CJ, 2002, NAT NEUROSCI, V5, P934, DOI 10.1038/nn916; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; Hoare DJ, 2004, ANIM BEHAV, V67, P155, DOI 10.1016/j.anbehav.2003.04.004; Levin RN, 1996, ANIM BEHAV, V52, P1107, DOI 10.1006/anbe.1996.0258; Logue DM, 2008, ANIM BEHAV, V75, P1803, DOI 10.1016/j.anbehav.2007.10.036; Logue DM, 2007, ANIM BEHAV, V73, P105, DOI 10.1016/j.anbehav.2006.05.011; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; Long MA, 2010, NATURE, V468, P394, DOI 10.1038/nature09514; Mann NI, 2006, MOL PHYLOGENET EVOL, V40, P750, DOI 10.1016/j.ympev.2006.04.014; Mann NI, 2006, BIOL LETTERS, V2, P1, DOI 10.1098/rsbl.2005.0373; Mann NI, 2009, BEHAVIOUR, V146, P1, DOI 10.1163/156853908X390913; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; Mooney R, 2001, P NATL ACAD SCI USA, V98, P12778, DOI 10.1073/pnas.221453298; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; Nick TA, 2005, J NEUROBIOL, V62, P469, DOI 10.1002/neu.20115; Noe R, 2006, ANIM BEHAV, V71, P1, DOI 10.1016/j.anbehav.2005.03.037; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Peron F, 2011, ANIM COGN, V14, P545, DOI 10.1007/s10071-011-0389-2; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Solis MM, 1997, J NEUROSCI, V17, P6447; Tinbergen, 1951, STUDY INSTINCT; VU ET, 1994, J NEUROSCI, V14, P6924; Wheatcroft DJ, 2008, TRENDS ECOL EVOL, V23, P416, DOI 10.1016/j.tree.2008.04.011	30	63	64	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					666	670		10.1126/science.1209867	http://dx.doi.org/10.1126/science.1209867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053048				2022-12-24	WOS:000296494700054
J	Xu, YM; Masuko, S; Takieddin, M; Xu, HM; Liu, RP; Jing, J; Mousa, SA; Linhardt, RJ; Liu, J				Xu, Yongmei; Masuko, Sayaka; Takieddin, Majde; Xu, Haoming; Liu, Renpeng; Jing, Juliana; Mousa, Shaker A.; Linhardt, Robert J.; Liu, Jian			Chemoenzymatic Synthesis of Homogeneous Ultralow Molecular Weight Heparins	SCIENCE			English	Article							ENZYMATIC-SYNTHESIS; SULFATE; ANTICOAGULANTS; WARFARIN; SULFOTRANSFERASES; OLIGOSACCHARIDES; ANTITHROMBOTICS; PENTASACCHARIDE; THROMBOLYTICS; GENERATION	Ultralow molecular weight (ULMW) heparins are sulfated glycans that are clinically used to treat thrombotic disorders. ULMW heparins range from 1500 to 3000 daltons, corresponding from 5 to 10 saccharide units. The commercial drug Arixtra (fondaparinux sodium) is a structurally homogeneous ULMW heparin pentasaccharide that is synthesized through a lengthy chemical process. Here, we report 10- and 12-step chemoenzymatic syntheses of two structurally homogeneous ULMW heparins (MW = 1778.5 and 1816.5) in 45 and 37% overall yield, respectively, starting from a simple disaccharide. These ULMW heparins display excellent in vitro anticoagulant activity and comparable pharmacokinetic properties to Arixtra, as demonstrated in a rabbit model. The chemoenzymatic approach is scalable and shows promise for a more efficient route to synthesize this important class of medicinal agent.	[Masuko, Sayaka; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA; [Xu, Yongmei; Xu, Haoming; Liu, Renpeng; Jing, Juliana; Liu, Jian] Univ N Carolina, Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA; [Takieddin, Majde; Mousa, Shaker A.] Albany Coll Pharm & Hlth Sci, Pharmaceut Res Inst, Albany, NY 12208 USA; [Mousa, Shaker A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	Rensselaer Polytechnic Institute; University of North Carolina; University of North Carolina Chapel Hill; Albany College of Pharmacy & Health Sciences; King Saud University	Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Chem & Chem Biol, Troy, NY 12180 USA.	linhar@rpi.edu; jian_liu@unc.edu	Liu, Renpeng/G-1625-2011; Mousa, Shaker A/A-7151-2017	Mousa, Shaker A/0000-0002-9294-015X; Xu, Haoming/0000-0002-5151-0727	National Institutes of Health [AI50050, HL094463, AI074775, HL62244, HL096972, GM38060]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463, R01HL096972, R01HL062244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050, R21AI074775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by National Institutes of Health grants AI50050, HL094463, AI074775, HL62244, HL096972, and GM38060. The authors thank Q. Shi (University of North Carolina) for insightful discussion. A provisional patent application describing the chemoenzymatic synthesis of ULMW heparins has been filed with the U.S. Patent and Trademark Office (61/426,921).	Burkart MD, 2000, J ORG CHEM, V65, P5565, DOI 10.1021/jo000266o; Chen JH, 2005, J BIOL CHEM, V280, P42817, DOI 10.1074/jbc.M504338200; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Chen M, 2006, BIOCHEMISTRY-US, V45, P12358, DOI 10.1021/bi060844g; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Hirsh J, 2007, CIRCULATION, V116, P552, DOI 10.1161/CIRCULATIONAHA.106.685974; Hughes B, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3322; Kuberan B, 2003, NAT BIOTECHNOL, V21, P1343, DOI 10.1038/nbt885; Lindahl U, 2005, J MED CHEM, V48, P349, DOI 10.1021/jm049812m; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LINHARDT RJ, 1992, BIOCHEMISTRY-US, V31, P12441, DOI 10.1021/bi00164a020; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Liu RP, 2010, J BIOL CHEM, V285, P34240, DOI 10.1074/jbc.M110.159152; LOGANATHAN D, 1990, BIOCHEMISTRY-US, V29, P4362, DOI 10.1021/bi00470a015; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Martinez-Gonzalez J, 2010, EXPERT REV CARDIOVAS, V8, P625, DOI [10.1586/erc.10.35, 10.1586/ERC.10.35]; Mousa SA, 2010, METHODS MOL BIOL, V663, P1, DOI 10.1007/978-1-60761-803-4_1; Mousa SA, 2010, METHODS MOL BIOL, V663, P29, DOI 10.1007/978-1-60761-803-4_2; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Petitou M, 2004, ANGEW CHEM INT EDIT, V43, P3118, DOI 10.1002/anie.200300640; Petitou M., 1989, U.S. Patent, Patent No. [4,818,816, 4818816]; Seifert J., 2009, U. S. Patent, Patent No. [7,541,445B2, 7541445]; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Tobu M, 2004, CLIN APPL THROMB-HEM, V10, P301, DOI 10.1177/107602960401000402; Wang ZY, 2010, BIOTECHNOL BIOENG, V107, P964, DOI 10.1002/bit.22898; Weitz JI, 2007, EXPERT OPIN INV DRUG, V16, P271, DOI 10.1517/13543784.16.3.271; Weitz JI, 2010, THROMB RES, V125, pS30, DOI 10.1016/S0049-3848(10)70009-8; WEITZ JI, 2005, HEMATOLOGY BASIC PRI, P2249; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66; Zhang ZQ, 2008, J AM CHEM SOC, V130, P12998, DOI 10.1021/ja8026345; Zhou XX, 2011, GLYCOBIOLOGY, V21, P771, DOI 10.1093/glycob/cwr001	32	299	317	8	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					498	501		10.1126/science.1207478	http://dx.doi.org/10.1126/science.1207478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034431	Green Accepted, Green Submitted			2022-12-24	WOS:000296230500043
J	Stewart, DE				Stewart, Donna E.			Depression during Pregnancy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEROTONIN-REUPTAKE INHIBITORS; MATERNAL DEPRESSION; PRENATAL EXPOSURE; CONGENITAL-MALFORMATIONS; NEONATAL OUTCOMES; MAJOR DEPRESSION; RISK; BIRTH; ANTIDEPRESSANTS; METAANALYSIS	A 24-year-old married woman presents with a 1-month history of diminished concentration and interest, insomnia, fatigue, tearfulness, and depressed mood. She is 10 weeks pregnant, stopped working 3 weeks ago, and mostly stays in bed. Two years ago, she was successfully treated briefly with sertraline at a daily dose of 50 mg for depression after a suicide attempt. She reports that she wants to continue the pregnancy and says that she does not feel suicidal. What would you advise?	[Stewart, Donna E.] Univ Toronto, Womens Hlth Program, Univ Hlth Network, Toronto, ON, Canada; [Stewart, Donna E.] Univ Toronto, Toronto Gen Res Inst, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Stewart, DE (corresponding author), Toronto Gen Hosp, 200 Elizabeth St,EN-7-229, Toronto, ON M5G 2C4, Canada.	donna.stewart@uhn.ca	Stewart, Donna Eileen/J-2844-2016	Stewart, Donna Eileen/0000-0002-8157-7746	Eli Lilly; INC Research	Eli Lilly(Eli Lilly); INC Research	Dr. Stewart reports receiving fees for board membership from Eli Lilly and consulting fees from INC Research (a contract research organization) for Eli Lilly. No other potential conflict of interest relevant to this article was reported.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Anderson EL, 2009, PSYCHOSOM MED, V71, P235, DOI 10.1097/PSY.0b013e318190d7ca; [Anonymous], 2010, Obstet Gynecol, V115, P394, DOI 10.1097/AOG.0b013e3181d035aa; [Anonymous], 2010, PRACT GUID TREATM PA, P66; Bar-Oz B, 2007, CLIN THER, V29, P918, DOI 10.1016/j.clinthera.2007.05.003; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bennett HA, 2004, OBSTET GYNECOL, V103, P1344; Chambers CD, 2006, NEW ENGL J MED, V354, P579, DOI 10.1056/NEJMoa052744; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Cooper WO, 2007, AM J OBSTET GYNECOL, V196, P544, DOI 10.1016/j.ajog.2007.01.033; Costei AM, 2002, ARCH PEDIAT ADOL MED, V156, P1129, DOI 10.1001/archpedi.156.11.1129; Cox J. L., 1994, PERINATAL PSYCHIAT U; Croen LA, 2011, ARCH GEN PSYCHI 0704; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; Deave T, 2008, BJOG-INT J OBSTET GY, V115, P1043, DOI 10.1111/j.1471-0528.2008.01752.x; Dennis CL, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006309; Dennis CL, 2008, COCHRANE DB SYST REV, V4; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Dietz PM, 2007, AM J PSYCHIAT, V164, P1515, DOI 10.1176/appi.ajp.2007.06111893; Dimidjian S, 2009, CLIN OBSTET GYNECOL, V52, P498, DOI 10.1097/GRF.0b013e3181b52da6; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Headley J, 2004, EUR J CLIN PHARMACOL, V60, P355, DOI 10.1007/s00228-004-0775-7; Hemels MEH, 2005, ANN PHARMACOTHER, V39, P803, DOI 10.1345/aph.1E547; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Lattimore Keri A, 2005, J Perinatol, V25, P595; Leech SL, 2006, J AM ACAD CHILD PSY, V45, P223, DOI 10.1097/01.chi.0000184930.18552.4d; Linde K, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000448.pub3; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2011, OBSTET GYNECOL, V118, P111, DOI 10.1097/AOG.0b013e318220edcc; National Institute for Health and Clinical Excellence, 2007, ANT POSTN MENT HLTH; Oberlander TF, 2008, MOL PSYCHIATR, V13, P65, DOI 10.1038/sj.mp.4002007; Oberlander TF, 2008, BRIT J PSYCHIAT, V192, P338, DOI 10.1192/bjp.bp.107.037101; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Oberlander TF, 2006, ARCH GEN PSYCHIAT, V63, P898, DOI 10.1001/archpsyc.63.8.898; Patten Scott B, 2006, Clin Pract Epidemiol Ment Health, V2, P13, DOI 10.1186/1745-0179-2-13; Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569; Rahimi R, 2006, REPROD TOXICOL, V22, P571, DOI 10.1016/j.reprotox.2006.03.019; Reis M, 2010, PSYCHOL MED, V40, P1723, DOI 10.1017/S0033291709992194; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Suri R, 2007, AM J PSYCHIAT, V164, P1206, DOI 10.1176/appi.ajp.2007.06071172; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627; Yonkers KA, 2009, GEN HOSP PSYCHIAT, V31, P403, DOI [10.1097/AOG.0b013e3181ba0632, 10.1016/j.genhosppsych.2009.04.003]	51	114	118	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1605	1611		10.1056/NEJMcp1102730	http://dx.doi.org/10.1056/NEJMcp1102730			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029982				2022-12-24	WOS:000296181800005
J	Russell, CJ				Russell, Charles J.			Stalking Influenza Diversity with a Universal Antibody	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Russell, CJ (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.		Russell, Charles/AAU-6006-2020; Russell, Charles/K-4824-2013	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990				Bommakanti G, 2010, P NATL ACAD SCI USA, V107, P13701, DOI 10.1073/pnas.1007465107; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566	5	9	10	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1541	1542		10.1056/NEJMcibr1109447	http://dx.doi.org/10.1056/NEJMcibr1109447			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010922				2022-12-24	WOS:000296009500011
J	Smeulders, MJ; Barends, TRM; Pol, A; Scherer, A; Zandvoort, MH; Udvarhelyi, A; Khadem, AF; Menzel, A; Hermans, J; Shoeman, RL; Wessels, HJCT; van den Heuvel, LP; Russ, L; Schlichting, I; Jetten, MSM; den Camp, HJMO				Smeulders, Marjan J.; Barends, Thomas R. M.; Pol, Arjan; Scherer, Anna; Zandvoort, Marcel H.; Udvarhelyi, Aniko; Khadem, Ahmad F.; Menzel, Andreas; Hermans, John; Shoeman, Robert L.; Wessels, Hans J. C. T.; van den Heuvel, Lambert P.; Russ, Lina; Schlichting, Ilme; Jetten, Mike S. M.; den Camp, Huub J. M. Op			Evolution of a new enzyme for carbon disulphide conversion by an acidothermophilic archaeon	NATURE			English	Article							SULFUR-COMPOUNDS; SULFIDE COS; ANHYDRASE; SUBSTRATE; MODEL; CS2; MACROMOLECULES; CONSUMPTION; METABOLISM; SCATTERING	Extremophilic organisms require specialized enzymes for their exotic metabolisms. Acid-loving thermophilic Archaea that live in the mudpots of volcanic solfataras obtain their energy from reduced sulphur compounds such as hydrogen sulphide (H2S) and carbon disulphide (CS2)(1,2). The oxidation of these compounds into sulphuric acid creates the extremely acidic environment that characterizes solfataras. The hyperthermophilic Acidianus strain A1-3, which was isolated from the fumarolic, ancient sauna building at the Solfatara volcano (Naples, Italy), was shown to rapidly convert CS2 into H2S and carbon dioxide (CO2), but nothing has been known about the modes of action and the evolution of the enzyme(s) involved. Here we describe the structure, the proposed mechanism and evolution of a CS2 hydrolase from Acidianus A1-3. The enzyme monomer displays a typical beta-carbonic anhydrase fold and active site, yet CO2 is not one of its substrates. Owing to large carboxy-and amino-terminal arms, an unusual hexadecameric catenane oligomer has evolved. This structure results in the blocking of the entrance to the active site that is found in canonical beta-carbonic anhydrases and the formation of a single 15-angstrom-long, highly hydrophobic tunnel that functions as a specificity filter. The tunnel determines the enzyme's substrate specificity for CS2, which is hydrophobic. The transposon sequences that surround the gene encoding this CS2 hydrolase point to horizontal gene transfer as a mechanism for its acquisition during evolution. Our results show how the ancient beta-carbonic anhydrase, which is central to global carbon metabolism, was transformed by divergent evolution into a crucial enzyme in CS2 metabolism.	[Smeulders, Marjan J.; Pol, Arjan; Zandvoort, Marcel H.; Khadem, Ahmad F.; Hermans, John; Russ, Lina; Jetten, Mike S. M.; den Camp, Huub J. M. Op] Radboud Univ Nijmegen, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Barends, Thomas R. M.; Scherer, Anna; Udvarhelyi, Aniko; Shoeman, Robert L.; Schlichting, Ilme] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Menzel, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Wessels, Hans J. C. T.; van den Heuvel, Lambert P.] Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Nijmegen Prote Facil, Dept Lab Med,Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Max Planck Society; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Radboud University Nijmegen	Jetten, MSM (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	m.jetten@science.ru.nl	Menzel, Andreas/C-4388-2012; Jetten, Mike/B-8834-2011; Schlichting, Ilme/I-1339-2013; Camp, Huub J.M. Op den/F-5114-2011; van den Heuvel, L.P.W.J./H-8044-2014; van den Heuvel, Lambertus/AAM-1772-2021; Wessels, Hans J/P-6248-2015	Menzel, Andreas/0000-0002-0489-609X; Jetten, Mike/0000-0002-4691-7039; Camp, Huub J.M. Op den/0000-0003-1990-9030; van den Heuvel, L.P.W.J./0000-0003-3917-6727; van den Heuvel, Lambertus/0000-0003-3917-6727; Wessels, Hans J/0000-0001-5957-3127; Udvarhelyi, Aniko/0000-0002-6962-4722	STW [STW_6353]; Max-Planck Society	STW(Technologiestichting STW); Max-Planck Society(Max Planck SocietyFoundation CELLEX)	J. Eygensteyn is acknowledged for ICP-MS analysis. We thank H. Harhangi for advice on cloning, S. Zimmermann for assistance with cloning, A. Meinhart for discussions and support for cloning and crystallography, and D. Ringe and J. Reinstein for discussions. We thank the Dortmund-Heidelberg data collection team, especially W. Blankenfeldt, and the staff of beam lines X10SA and X12SA at the Swiss Light Source of the PSI in Villigen for their help and facilities. We also thank A. Rufer for help with the analytical ultracentrifuge and I. Vetter for support with the crystallographic software. The work was funded by an STW grant (STW_6353) to M.J.S. and M.H.Z. and by the Max-Planck Society.	Alber BE, 1999, BIOCHEMISTRY-US, V38, P13119, DOI 10.1021/bi9828876; ALLARD P, 1991, J VOLCANOL GEOTH RES, V48, P139, DOI 10.1016/0377-0273(91)90039-3; ALLEN MB, 1959, ARCH MIKROBIOL, V32, P270, DOI 10.1007/BF00409348; Blezinger S, 2000, BIOGEOCHEMISTRY, V48, P185, DOI 10.1023/A:1006134213995; Bornberg-Bauer E, 2010, CURR OPIN STRUC BIOL, V20, P390, DOI 10.1016/j.sbi.2010.02.005; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao ZB, 2005, STRUCTURE, V13, P1661, DOI 10.1016/j.str.2005.07.021; CHIN M, 1993, GLOBAL BIOGEOCHEM CY, V7, P321, DOI 10.1029/93GB00568; Covarrubias AS, 2005, J BIOL CHEM, V280, P18782, DOI 10.1074/jbc.M414348200; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DERIKX PJL, 1990, APPL ENVIRON MICROB, V56, P176, DOI 10.1128/AEM.56.1.176-180.1990; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fuchs T, 1996, SYST APPL MICROBIOL, V19, P56, DOI 10.1016/S0723-2020(96)80009-9; Haritos VS, 2005, COMP BIOCHEM PHYS C, V140, P139, DOI 10.1016/j.cca.2005.01.012; He ZG, 2000, FEMS MICROBIOL LETT, V193, P217, DOI 10.1111/j.1574-6968.2000.tb09427.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Jordan SL, 1997, ARCH MICROBIOL, V168, P225, DOI 10.1007/s002030050492; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Kimber MS, 2000, EMBO J, V19, P1407, DOI 10.1093/emboj/19.7.1407; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalchuk G. A., 2004, MOL MICROBIAL ECOLOG, V1; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lane TW, 2005, NATURE, V435, P42, DOI 10.1038/435042a; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notni J, 2007, CHEMBIOCHEM, V8, P530, DOI 10.1002/cbic.200600436; Pol A, 2007, APPL MICROBIOL BIOT, V74, P439, DOI 10.1007/s00253-006-0663-4; ProtoschillKrebs G, 1996, ATMOS ENVIRON, V30, P3151, DOI 10.1016/1352-2310(96)00026-X; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Rowlett RS, 2010, BBA-PROTEINS PROTEOM, V1804, P362, DOI 10.1016/j.bbapap.2009.08.002; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schenk S, 2004, CHEM-EUR J, V10, P3091, DOI 10.1002/chem.200305754; Schlicker C, 2009, J MOL BIOL, V385, P1207, DOI 10.1016/j.jmb.2008.11.037; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sinnecker S, 2001, INORG CHEM, V40, P1006, DOI 10.1021/ic001149e; Smith KS, 1999, J BACTERIOL, V181, P6247, DOI 10.1128/JB.181.20.6247-6253.1999; Smith KS, 1999, P NATL ACAD SCI USA, V96, P15184, DOI 10.1073/pnas.96.26.15184; Strop P, 2001, J BIOL CHEM, V276, P10299, DOI 10.1074/jbc.M009182200; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng YB, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-67; Vasilakos C, 2005, J ATMOS CHEM, V52, P101, DOI 10.1007/s10874-005-8853-5; VISHNIAC W, 1957, BACTERIOL REV, V21, P195, DOI 10.1128/MMBR.21.3.195-213.1957; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wessels HJCT, 2011, METHOD ENZYMOL, V486, P465, DOI [10.1016/S0076-6879(11)86021-0, 10.1016/B978-0-12-381294-0.00021-3]; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	51	69	73	1	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					412	+		10.1038/nature10464	http://dx.doi.org/10.1038/nature10464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012399				2022-12-24	WOS:000296021100052
J	Noggle, S; Fung, HL; Gore, A; Martinez, H; Satriani, KC; Prosser, R; Oum, K; Paull, D; Druckenmiller, S; Freeby, M; Greenberg, E; Zhang, K; Goland, R; Sauer, MV; Leibel, RL; Egli, D				Noggle, Scott; Fung, Ho-Lim; Gore, Athurva; Martinez, Hector; Satriani, Kathleen Crumm; Prosser, Robert; Oum, Kiboong; Paull, Daniel; Druckenmiller, Sarah; Freeby, Matthew; Greenberg, Ellen; Zhang, Kun; Goland, Robin; Sauer, Mark V.; Leibel, Rudolph L.; Egli, Dieter			Human oocytes reprogram somatic cells to a pluripotent state	NATURE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; GENE-EXPRESSION; DEVELOPMENTAL COMPETENCE; DERIVATION; LINES	The exchange of the oocyte's genome with the genome of a somatic cell, followed by the derivation of pluripotent stem cells, could enable the generation of specific cells affected in degenerative human diseases. Such cells, carrying the patient's genome, might be useful for cell replacement. Here we report that the development of human oocytes after genome exchange arrests at late cleavage stages in association with transcriptional abnormalities. In contrast, if the oocyte genome is not removed and the somatic cell genome is merely added, the resultant triploid cells develop to the blastocyst stage. Stem cell lines derived from these blastocysts differentiate into cell types of all three germ layers, and a pluripotent gene expression program is established on the genome derived from the somatic cell. This result demonstrates the feasibility of reprogramming human cells using oocytes and identifies removal of the oocyte genome as the primary cause of developmental failure after genome exchange.	[Noggle, Scott; Martinez, Hector; Paull, Daniel; Druckenmiller, Sarah; Egli, Dieter] New York Stem Cell Fdn Lab, New York, NY USA; [Fung, Ho-Lim; Gore, Athurva; Zhang, Kun] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Satriani, Kathleen Crumm; Prosser, Robert; Oum, Kiboong; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Ctr Womens Reprod Care, New York, NY USA; [Satriani, Kathleen Crumm; Prosser, Robert; Oum, Kiboong; Sauer, Mark V.] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY USA; [Freeby, Matthew; Greenberg, Ellen; Goland, Robin; Leibel, Rudolph L.] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY USA; [Freeby, Matthew; Greenberg, Ellen; Goland, Robin; Leibel, Rudolph L.] Columbia Univ, Dept Pediat, Coll Phys & Surg, New York, NY 10027 USA	The New York Stem Cell Foundation; University of California System; University of California San Diego; Columbia University; Columbia University; Columbia University; Columbia University	Egli, D (corresponding author), New York Stem Cell Fdn Lab, New York, NY USA.	d.egli@nyscf.org	Egli, Dieter/C-3566-2013; Zhang, Kun/ABE-6349-2020	Zhang, Kun/0000-0002-7596-5224; Noggle, Scott/0000-0002-0374-2240	UCSD; New York Stem Cell Foundation; Russell Berrie Foundation	UCSD; New York Stem Cell Foundation; Russell Berrie Foundation	We thank our research subjects for participating. We thank S. Solomon and K. Eggan for discussions and support, L. Bauer for help with blastocyst thawing, D. Kahler for cell sorting, M. Verbitsky and S. Kisselev for microarray hybridization, V. Miljkovic for Affymetrix SNP chip hybridization, C. LeDuc and Y. Ravussin for help with data analysis and mouse work, R. Maehr for DiPS H.1.5, C. Marshall and J. Safran for administrative support, S. Paull for cover art, Z. Hall and S. Chang for critical reading of the manuscript. This research was supported by a UCSD startup fund to K. Z., the New York Stem Cell Foundation primarily, and the Russell Berrie Foundation.	BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Egli D, 2011, CELL STEM CELL, V9, P293, DOI 10.1016/j.stem.2011.08.002; Egli D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1503; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hall VJ, 2007, HUM REPROD, V22, P52, DOI 10.1093/humrep/del345; Heindryckx B, 2007, HUM REPROD, V22, P1982, DOI 10.1093/humrep/dem106; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Imamura M, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-34; Kennedy Donald, 2006, Science, V311, P335; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Kornafel KL, 2007, FERTIL STERIL, V87, P1253, DOI 10.1016/j.fertnstert.2006.11.056; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; McElroy SL, 2008, REPROD BIOMED ONLINE, V16, P684, DOI 10.1016/S1472-6483(10)60483-X; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Pick M, 2009, STEM CELLS, V27, P2686, DOI 10.1002/stem.205; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Stojkovic M, 2005, REPROD BIOMED ONLINE, V11, P226; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	38	149	165	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					70	U81		10.1038/nature10397	http://dx.doi.org/10.1038/nature10397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979046				2022-12-24	WOS:000295575400036
J	Tobian, AAR; Gray, RH				Tobian, Aaron A. R.; Gray, Ronald H.			The Medical Benefits of Male Circumcision	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SEXUAL SATISFACTION; RANDOMIZED-TRIAL; MEN; TRANSMISSION; UGANDA; WOMEN; RAKAI; RISK		[Tobian, Aaron A. R.] Johns Hopkins Univ, Dept Pathol, Sch Med, Baltimore, MD 21287 USA; [Tobian, Aaron A. R.; Gray, Ronald H.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Tobian, AAR (corresponding author), Johns Hopkins Univ, Dept Pathol, Sch Med, Carnegie 667,600 N Wolfe St, Baltimore, MD 21287 USA.	atobian1@jhmi.edu	Hug, Balthasar L./G-1568-2010		NIAID NIH HHS [1K23AI093152-01A1, K23 AI093152-01A1, K23 AI093152, K23 AI093152-02] Funding Source: Medline; NICHD NIH HHS [R24 HD042854] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI093152] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*DC DEP HLTH, HIV AIDS; Kigozi G, 2009, BJU INT, V104, P1698, DOI 10.1111/j.1464-410X.2009.08683.x; Krieger JN, 2008, J SEX MED, V5, P2610, DOI 10.1111/j.1743-6109.2008.00979.x; Lannon CM, 1999, PEDIATRICS, V103, P686; Leibowitz AA, 2009, AM J PUBLIC HEALTH, V99, P138, DOI 10.2105/AJPH.2008.134403; Sansom SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008723; Tobian AAR, 2010, ARCH PEDIAT ADOL MED, V164, P78, DOI 10.1001/archpediatrics.2009.232; *UNAIDS, SAF VOL INF MAL CIRC; Warner L, 2009, J INFECT DIS, V199, P59, DOI 10.1086/595569; Wawer MJ, 2011, LANCET, V377, P209, DOI 10.1016/S0140-6736(10)61967-8	10	71	71	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1479	1480		10.1001/jama.2011.1431	http://dx.doi.org/10.1001/jama.2011.1431			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972310	Green Accepted			2022-12-24	WOS:000295506900027
J	Dagna, L; Salvo, F; Tiraboschi, M; Bozzolo, EP; Franchini, S; Doglioni, C; Manfredi, AA; Baldissera, E; Sabbadini, MG				Dagna, Lorenzo; Salvo, Fulvio; Tiraboschi, Mirta; Bozzolo, Enrica P.; Franchini, Stefano; Doglioni, Claudio; Manfredi, Angelo A.; Baldissera, Elena; Sabbadini, Maria Grazia			Pentraxin-3 as a Marker of Disease Activity in Takayasu Arteritis	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; RECOGNITION RECEPTOR PTX3; REGULATES TISSUE FACTOR; AMYLOID-P COMPONENT; LONG PENTRAXIN; CLOTTING ACTIVATION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; INNATE IMMUNITY; IN-VIVO	Background: Because pentraxin-3 (PTX3) is produced by immune and vascular cells in response to proinflammatory signals, it may be a useful biomarker for defining disease activity in patients with Takayasu arteritis. Objective: To compare PTX3 levels in patients who have Takayasu arteritis with those in healthy and infected controls, and to compare accuracy of PTX3 levels with that of C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) for distinguishing active and inactive disease. Design: Cross-sectional, noninterventional study conducted between September 2005 and October 2008. Setting: Immunology and rheumatology clinic at a university hospital in Italy. Patients: 57 consecutive patients with Takayasu arteritis and known disease activity, 57 healthy blood donor controls, and 15 patients with acute infection. Measurements: Disease activity by clinical criteria; plasma PTX3 and CRP levels and ESR. Results: 27 patients had active Takayasu arteritis; 30 had inactive disease. Levels of PTX3 were higher in patients with active disease(median, >2.14 ng/mL [range, 0.57 to 48.18 ng/mL]) than in those with inactive disease (median, 0.63 ng/mL [range, 0.00 to 1.64 ng/mL]) and were higher than in healthy patients (median, 0.11 ng/mL [range, 0 to 1.20 ng/mL]) or those with acute infection (median, 0.26 ng/mL [range, 0 to 0.75 ng/mL]). A plasma PTX3 level greater than 1 ng/mL was more accurate than normal thresholds of CRP or ESR for distinguishing active from inactive disease. Limitation: The study excluded patients with unknown or equivocal disease status. Conclusion: Plasma levels of PTX3 could help distinguish active from inactive Takayasu arteritis but should not be adopted for clinical use until the findings are confirmed in a broader spectrum of patients whose disease activity is unknown or equivocal before testing.	[Dagna, Lorenzo] Ist Sci San Raffaele, Unit Med & Clin Immunol, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, Sch Med, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Dagna, L (corresponding author), Ist Sci San Raffaele, Unit Med & Clin Immunol, Via Olgettina 60, I-20132 Milan, Italy.	lorenzo.dagna@unisr.it	Manfredi, Angelo A./C-7018-2014; Dagna, Lorenzo/AAB-2790-2019; Franchini, Stefano/AAV-8416-2021	Manfredi, Angelo A./0000-0001-8370-6970; DOGLIONI, Claudio/0000-0002-4969-5216; Dagna, Lorenzo/0000-0002-7428-315X				Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; ALLES VV, 1994, BLOOD, V84, P3483; AREND WP, 1990, ARTHRITIS RHEUM, V33, P1129; Aubert S, 2005, J THORAC CARDIOV SUR, V130, P573, DOI 10.1016/j.jtcvs.2005.02.006; BREVIARIO F, 1992, J BIOL CHEM, V267, P22190; Camozzi M, 2005, ARTERIOSCL THROM VAS, V25, P1837, DOI 10.1161/01.ATV.0000177807.54959.7d; Canas CA, 1998, INT J CARDIOL, V66, pS73, DOI 10.1016/S0167-5273(98)00153-3; Deng JS, 2009, CIRC RES, V104, P488, DOI 10.1161/CIRCRESAHA.108.185777; Dhingra R, 2007, AM J MED, V120, P1054, DOI 10.1016/j.amjmed.2007.08.037; Doni A, 2003, EUR J IMMUNOL, V33, P2886, DOI 10.1002/eji.200324390; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Gotway MB, 2005, AM J ROENTGENOL, V184, P1945, DOI 10.2214/ajr.184.6.01841945; Gravanis MB, 2000, INT J CARDIOL, V75, pS21, DOI 10.1016/S0167-5273(00)00184-4; Hoffman GS, 2004, ARTHRITIS RHEUM, V50, P2296, DOI 10.1002/art.20300; Hoffman GS, 1998, INT J CARDIOL, V66, pS191, DOI 10.1016/S0167-5273(98)00181-8; Hoffman GS, 1996, INT J CARDIOL S, V54, pS99; Holley L, 1999, BIORHEOLOGY, V36, P287; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; KAMENEVA MV, 1994, BIORHEOLOGY, V31, P297; KERR GS, 1995, RHEUM DIS CLIN N AM, V21, P1041; KERR GS, 1994, ANN INTERN MED, V120, P919, DOI 10.7326/0003-4819-120-11-199406010-00004; Koga T, 2010, RHEUMATOL INT, V30, P561, DOI 10.1007/s00296-009-1296-6; Koide K, 1992, Heart Vessels Suppl, V7, P48, DOI 10.1007/BF01744544; Legouffe E, 1998, LEUKEMIA LYMPHOMA, V31, P351, DOI 10.3109/10428199809059228; Luchetti MM, 2004, CLIN EXP RHEUMATOL, V22, pS66; Luchetti MM, 2000, CLIN EXP IMMUNOL, V119, P196, DOI 10.1046/j.1365-2249.2000.01110.x; LUPIHERRERA E, 1977, AM HEART J, V93, P94, DOI 10.1016/S0002-8703(77)80178-6; Maksimowicz-McKinnon K, 2007, ARTHRITIS RHEUM, V56, P1000, DOI 10.1002/art.22404; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Matsuyama A, 2003, CIRCULATION, V108, P1469, DOI 10.1161/01.CIR.0000090689.69973.B1; MORLEY JJ, 1982, ANN NY ACAD SCI, V389, P406, DOI 10.1111/j.1749-6632.1982.tb22153.x; Mwipatayi BP, 2005, ANZ J SURG, V75, P110, DOI 10.1111/j.1445-2197.2005.03312.x; Napoleone E, 2004, J LEUKOCYTE BIOL, V76, P203, DOI 10.1189/jlb.1003528; Napoleone E, 2002, ARTERIOSCL THROM VAS, V22, P782, DOI 10.1161/01.ATV.0000012282.39306.64; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; Noris M, 1999, CIRCULATION, V100, P55, DOI 10.1161/01.CIR.100.1.55; Nozoe T, 1998, AM J SURG, V176, P335, DOI 10.1016/S0002-9610(98)00204-9; Numano F, 1996, Vasc Med, V1, P227; Numano F, 1999, INTERNAL MED, V38, P226, DOI 10.2169/internalmedicine.38.226; Park MC, 2006, RHEUMATOLOGY, V45, P545, DOI 10.1093/rheumatology/kei266; Park Y B, 1992, Heart Vessels Suppl, V7, P55, DOI 10.1007/BF01744545; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Pipitone N, 2008, RHEUMATOLOGY, V47, P403, DOI 10.1093/rheumatology/kem379; Presta M, 2007, J CELL MOL MED, V11, P723, DOI 10.1111/j.1582-4934.2007.00061.x; Pryshchep O, 2008, CIRCULATION, V118, P1276, DOI 10.1161/CIRCULATIONAHA.108.789172; ROBLES M, 1994, CLIN EXP RHEUMATOL, V12, P381; Rosenthal T, 1992, Heart Vessels Suppl, V7, P44, DOI 10.1007/BF01744543; Rovere P, 2000, BLOOD, V96, P4300; Rusnati M, 2004, BLOOD, V104, P92, DOI 10.1182/blood-2003-10-3433; Salustri A, 2004, DEVELOPMENT, V131, P1577, DOI 10.1242/dev.01056; Sato EI, 1998, INT J CARDIOL, V66, pS67, DOI 10.1016/S0167-5273(98)00152-1; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Sharma BK, 1998, INT J CARDIOL, V66, pS85, DOI 10.1016/S0167-5273(98)00155-7; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Tripathy NK, 2003, J RHEUMATOL, V30, P2023; Tripathy NK, 2004, CLIN EXP RHEUMATOL, V22, pS27; Tripathy NK, 2003, CLIN EXP IMMUNOL, V134, P360, DOI 10.1046/j.1365-2249.2003.02282.x; Tso E, 2002, ARTHRITIS RHEUM-US, V46, P1634, DOI 10.1002/art.10251; Turkoglu C, 1996, INT J CARDIOL, V54, pS135; Vanoli M, 2005, ARTHRIT RHEUM-ARTHR, V53, P100, DOI 10.1002/art.20922; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; VouretCraviari V, 1997, INFECT IMMUN, V65, P1345, DOI 10.1128/IAI.65.4.1345-1350.1997	64	109	117	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2011	155	7					425	U51		10.7326/0003-4819-155-7-201110040-00005	http://dx.doi.org/10.7326/0003-4819-155-7-201110040-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	833OC	21969341				2022-12-24	WOS:000295893800003
J	Dymond, JS; Richardson, SM; Coombes, CE; Babatz, T; Muller, H; Annaluru, N; Blake, WJ; Schwerzmann, JW; Dai, JB; Lindstrom, DL; Boeke, AC; Gottschling, DE; Chandrasegaran, S; Bader, JS; Boeke, JD				Dymond, Jessica S.; Richardson, Sarah M.; Coombes, Candice E.; Babatz, Timothy; Muller, Heloise; Annaluru, Narayana; Blake, William J.; Schwerzmann, Joy W.; Dai, Junbiao; Lindstrom, Derek L.; Boeke, Annabel C.; Gottschling, Daniel E.; Chandrasegaran, Srinivasan; Bader, Joel S.; Boeke, Jef D.			Synthetic chromosome arms function in yeast and generate phenotypic diversity by design	NATURE			English	Article							DNA; SELECTION; SEQUENCE; GENES; SITE	Recent advances in DNA synthesis technology have enabled the construction of novel genetic pathways and genomic elements, furthering our understanding of system-level phenomena(1-7). The ability to synthesize large segments of DNA allows the engineering of pathways and genomes according to arbitrary sets of design principles. Here we describe a synthetic yeast genome project, Sc2.0, and the first partially synthetic eukaryotic chromosomes, Saccharomyces cerevisiae chromosome synIXR, and semi-synVIL. We defined three design principles for a synthetic genome as follows: first, it should result in a (near) wild-type phenotype and fitness; second, it should lack destabilizing elements such as tRNA genes or transposons(8,9); and third, it should have genetic flexibility to facilitate future studies. The synthetic genome features several systemic modifications complying with the design principles, including an inducible evolution system, SCRaMbLE (synthetic chromosome rearrangement and modification by loxP-mediated evolution). We show the utility of SCRaMbLE as a novel method of combinatorial mutagenesis, capable of generating complex genotypes and a broad variety of phenotypes. When complete, the fully synthetic genome will allow massive restructuring of the yeast genome, and may open the door to a new type of combinatorial genetics based entirely on variations in gene content and copy number.	[Dymond, Jessica S.; Richardson, Sarah M.; Coombes, Candice E.; Babatz, Timothy; Dai, Junbiao; Boeke, Annabel C.; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Dymond, Jessica S.; Coombes, Candice E.; Dai, Junbiao; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Richardson, Sarah M.; Babatz, Timothy] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Muller, Heloise; Annaluru, Narayana; Schwerzmann, Joy W.; Chandrasegaran, Srinivasan] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Blake, William J.] Codon Devices, Cambridge, MA 02139 USA; [Lindstrom, Derek L.; Gottschling, Daniel E.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Whiting Sch Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Fred Hutchinson Cancer Center; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, 733 North Broadway, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Dai, Junbiao/AAB-8328-2021; Bader, Joel/A-1818-2009	Dai, Junbiao/0000-0002-5299-4700; Bader, Joel/0000-0002-6020-4625; Richardson, Sarah/0000-0002-9820-9421; Boeke, Jef/0000-0001-5322-4946	National Science Foundation [MCB0718846]; Microsoft; Department of Energy [DE-FG02097ER25308]; National Institutes of Health [AG023779]; Fondation pour la Recherche Medicale; Direct For Biological Sciences [1443299] Funding Source: National Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG023779, R37AG023779] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Microsoft(Microsoft); Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank G. Church for suggesting the global substitution of TAG codons with TAA codons, C. Connelly for sharing technical expertise and V. Huang for generating a sequence visualizer. We are grateful to B. Cormack, G. Seydoux and J. Nathans for offering helpful advice, to Y. Cai and J. Peccoud for suggesting methods to validate the sequence data, and to E. Louis for providing expert advice on telomeres. The work was supported by National Science Foundation grant MCB0718846 to J. D. B., J. S. B. and S. C.; by a grant from Microsoft to J. S. B. and J. D. B.; by Department of Energy Fellowship DE-FG02097ER25308 to S. M. R.; by National Institutes of Health grant AG023779 to D. E. G.; and by a fellowship from Fondation pour la Recherche Medicale to H.M.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Admire A, 2006, GENE DEV, V20, P159, DOI 10.1101/gad.1392506; Blake WJ, 2010, NUCLEIC ACIDS RES, V38, P2594, DOI 10.1093/nar/gkq123; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Chan LY, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100025; Churcher C, 1997, NATURE, V387, P84, DOI 10.1038/387s084; Dymond JS, 2009, GENETICS, V181, P13, DOI 10.1534/genetics.108.096784; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Gibson DG, 2008, P NATL ACAD SCI USA, V105, P20404, DOI 10.1073/pnas.0811011106; Hampsey M, 1997, YEAST, V13, P1099, DOI 10.1002/(SICI)1097-0061(19970930)13:12<1099::AID-YEA177>3.3.CO;2-Z; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Hoffman C. S., 2001, CURR PROTOC MOL BIOL; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Kuras L, 1996, EMBO J, V15, P2519, DOI 10.1002/j.1460-2075.1996.tb00609.x; Lartigue C, 2009, SCIENCE, V325, P1693, DOI 10.1126/science.1173759; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lindstrom DL, 2009, GENETICS, V183, P413, DOI 10.1534/genetics.109.106229; Louis EJ, 1995, YEAST, V11, P1553, DOI 10.1002/yea.320111604; OGAWA H, 1978, J BIOL CHEM, V253, P3666; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Park HS, 2011, SCIENCE, V333, P1151, DOI 10.1126/science.1207203; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Richardson SM, 2006, GENOME RES, V16, P550, DOI 10.1101/gr.4431306; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4006; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027	29	278	323	11	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					471	U124		10.1038/nature10403	http://dx.doi.org/10.1038/nature10403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21918511	Green Accepted			2022-12-24	WOS:000295080500042
J	Demireva, EY; Shapiro, LS; Jessell, TM; Zampieri, N				Demireva, Elena Y.; Shapiro, Lawrence S.; Jessell, Thomas M.; Zampieri, Niccolo			Motor Neuron Position and Topographic Order Imposed by beta- and gamma-Catenin Activities	CELL			English	Article							N-CADHERIN; SPINAL-CORD; PROTEIN INTERACTIONS; MOUSE DEVELOPMENT; CELL-ADHESION; ORGANIZATION; PLAKOGLOBIN; EXPRESSION; GENE; MICE	Neurons typically settle at positions that match the location of their synaptic targets, creating topographic maps. In the spinal cord, the organization of motor neurons into discrete clusters is linked to the location of their muscle targets, establishing a topographic map of punctate design. To define the significance of motor pool organization for neuromuscular map formation, we assessed the role of cadherin-catenin signaling in motor neuron positioning and limb muscle innervation. We find that joint inactivation of beta- and gamma-catenin scrambles motor neuron settling position in the spinal cord but fails to erode the predictive link between motor neuron transcriptional identity and muscle target. Inactivation of N-cadherin perturbs pool positioning in similar ways, albeit with reduced penetrance. These findings reveal that cadherin-catenin signaling directs motor pool patterning and imposes topographic order on an underlying identity-based neural map.	[Demireva, Elena Y.; Jessell, Thomas M.; Zampieri, Niccolo] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [Shapiro, Lawrence S.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu	Shapiro, Lawrence/AAE-7172-2019	Zampieri, Niccolo/0000-0002-2228-9453	NINDS [RO1 NS033245]; HHMI; NIH [R01GM062270]; Wellcome Trust; G. Harold and Leila Y. Mathers Foundation; Investigator of the Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R37NS033245] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); G. Harold and Leila Y. Mathers Foundation; Investigator of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors are indebted to Stephen Price for early contributions to this project. The authors thank Qiaolian Liu, Barbara Han and Ira Schieren for technical help, Susan Brenner-Morton for antibody generation, Monica Mendelsohn, Jennifer Kirkland, Barbara Han, and Susan Kales for help in the generation of conditional gamma-catenin mutant mice, Laskaro Zagoraiou and Apostolos Klinakis for DNA constructs, Corey Washington for statistical analysis, Kendall Doerr for valuable perspective, and Ira Schieren and Kathy MacArthur for help in preparing the manuscript. We are grateful to Rolf Kemler, Patricia Ruiz, Masatoshi Takeichi, Barbara Ranscht, Glenn Radice, and Makoto Taketo for mouse lines. Natalia de Marco Garcia, Sebastian Poliak, Joriene de Nooij, Jeremy Dasen, Carol Mason, Christopher Henderson, and Barbara Ranscht provided advice and helpful comments on the manuscript. E.Y.D. was supported by NINDS RO1 NS033245; N.Z. was supported by HHMI; L.S.P. was supported by NIH R01GM062270; T.M.J. was supported by grants from the NINDS RO1 NS033245, the Wellcome Trust, the G. Harold and Leila Y. Mathers Foundation, and Project A.L.S. and is an Investigator of the Howard Hughes Medical Institute.	Brault V, 2001, DEVELOPMENT, V128, P1253; BUTZ S, 1992, SCIENCE, V257, P1142, DOI 10.1126/science.257.5073.1142-a; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Imai T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001776; Jossin Y, 2011, NAT NEUROSCI, V14, P697, DOI 10.1038/nn.2816; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; Luria V, 2008, NEURON, V60, P1039, DOI 10.1016/j.neuron.2008.11.011; Machon O, 2003, NEUROSCIENCE, V122, P129, DOI 10.1016/S0306-4522(03)00519-0; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Megason SG, 2002, DEVELOPMENT, V129, P2087; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Palmesino E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000446; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Personius KE, 2007, P NATL ACAD SCI USA, V104, P11808, DOI 10.1073/pnas.0703357104; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Price SR, 2004, MECH DEVELOP, V121, P1103, DOI 10.1016/j.mod.2004.04.019; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Surmeli G, 2011, CELL, V147, P653, DOI 10.1016/j.cell.2011.10.012; Takai Y, 2003, J CELL SCI, V116, P17, DOI 10.1242/jcs.00167; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yip YP, 2009, J COMP NEUROL, V515, P260, DOI 10.1002/cne.22044; Zelano J, 2006, EXP NEUROL, V201, P461, DOI 10.1016/j.expneurol.2006.04.026; Zhurinsky J, 2000, J CELL SCI, V113, P3127	42	62	63	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					641	652		10.1016/j.cell.2011.09.037	http://dx.doi.org/10.1016/j.cell.2011.09.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036570	Bronze, Green Accepted			2022-12-24	WOS:000296573700018
J	Hussain, K; Challis, B; Rocha, N; Payne, F; Minic, M; Thompson, A; Daly, A; Scott, C; Harris, J; Smillie, BJL; Savage, DB; Ramaswami, U; De Lonlay, P; O'Rahilly, S; Barroso, I; Semple, RK				Hussain, K.; Challis, B.; Rocha, N.; Payne, F.; Minic, M.; Thompson, A.; Daly, A.; Scott, C.; Harris, J.; Smillie, B. J. L.; Savage, D. B.; Ramaswami, U.; De Lonlay, P.; O'Rahilly, S.; Barroso, I.; Semple, R. K.			An Activating Mutation of AKT2 and Human Hypoglycemia	SCIENCE			English	Article							INSULIN-RESISTANCE		[Challis, B.; Rocha, N.; Minic, M.; Harris, J.; Smillie, B. J. L.; Savage, D. B.; O'Rahilly, S.; Barroso, I.; Semple, R. K.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Challis, B.; Rocha, N.; Minic, M.; Harris, J.; Smillie, B. J. L.; Savage, D. B.; O'Rahilly, S.; Barroso, I.; Semple, R. K.] Addenbrookes Hosp, Inst Metab Sci, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge CB2 0QQ, England; [Hussain, K.] UCL, Inst Child Hlth, Clin & Mol Genet Unit, Dev Endocrinol Res Grp, London WC1N 1EH, England; [Payne, F.; Thompson, A.; Daly, A.; Scott, C.; Barroso, I.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Ramaswami, U.] Addenbrookes Hosp, Dept Paediat Endocrinol Diabet & Metab, Cambridge CB2 2QQ, England; [De Lonlay, P.] Univ Paris 05, Hop Necker Enfants Malad, Dept Pediat, F-75743 Paris 15, France	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	O'Rahilly, S (corresponding author), Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England.	so104@medschl.cam.ac.uk; ib1@sanger.ac.uk; rks16@cam.ac.uk	O'Rahilly, Stephen/ABF-6509-2020; Semple, Robert/AAB-2948-2019; Payne, Felicity/GKF-2573-2022	O'Rahilly, Stephen/0000-0003-2199-4449; Payne, Felicity/0000-0003-4228-581X; Barroso, Ines/0000-0001-5800-4520; Semple, Robert Kenneth/0000-0001-6539-3069	Wellcome Trust [080952/Z/06/Z, 078986/Z/06/Z, 077016/Z/05/Z, 091551/Z/10/Z]; Medical Research Council Centre for Obesity and Related Disorders; UK NIHR Cambridge Biomedical Research Centre; NIHR; MRC [G0502115] Funding Source: UKRI; Medical Research Council [G0502115, G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council Centre for Obesity and Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	R.K.S., S.O'R., I.B., and D.B.S. are supported by the Wellcome Trust (grants 080952/Z/06/Z, 078986/Z/06/Z, 077016/Z/05/Z, and 091551/Z/10/Z), the Medical Research Council Centre for Obesity and Related Disorders, and the UK NIHR Cambridge Biomedical Research Centre. B.C. is supported by NIHR and Wellcome Trust, and M.M. by the Gates Cambridge Trust. We thank L. Boyle for confocal microscopy assistance.	Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Gonzalez E, 2009, P NATL ACAD SCI USA, V106, P7004, DOI 10.1073/pnas.0901933106; Hussain K, 2004, Horm Res, V61, P222, DOI 10.1159/000076553; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822	8	113	116	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					474	474		10.1126/science.1210878	http://dx.doi.org/10.1126/science.1210878			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21979934	Green Accepted			2022-12-24	WOS:000296230500036
J	Kim, TW; Lee, K; Najjar, RG; Jeong, HD; Jeong, HJ				Kim, Tae-Wook; Lee, Kitack; Najjar, Raymond G.; Jeong, Hee-Dong; Jeong, Hae Jin			Increasing N Abundance in the Northwestern Pacific Ocean Due to Atmospheric Nitrogen Deposition	SCIENCE			English	Article							EAST CHINA SEA; NUTRIENT LIMITATION; DINITROGEN FIXATION; YELLOW SEA; CYCLES; JAPAN; STOICHIOMETRY; COASTAL; RATIOS; SYSTEM	The relative abundance of nitrate (N) over phosphorus (P) has increased over the period since 1980 in the marginal seas bordering the northwestern Pacific Ocean, located downstream of the populated and industrialized Asian continent. The increase in N availability within the study area was mainly driven by increasing N concentrations and was most likely due to deposition of pollutant nitrogen from atmospheric sources. Atmospheric nitrogen deposition had a high temporal correlation with N availability in the study area (r = 0.74 to 0.88), except in selected areas wherein riverine nitrogen load may be of equal importance. The increase in N availability caused by atmospheric deposition and riverine input has switched extensive parts of the study area from being N-limited to P-limited.	[Kim, Tae-Wook; Lee, Kitack] Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang 790784, South Korea; [Najjar, Raymond G.] Penn State Univ, Dept Meteorol, University Pk, PA 16802 USA; [Jeong, Hee-Dong] Natl Fisheries Res & Dev Inst, E Sea Fisheries Res Inst, Kangnung 210861, South Korea; [Jeong, Hae Jin] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul 151747, South Korea	Pohang University of Science & Technology (POSTECH); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Seoul National University (SNU)	Lee, K (corresponding author), Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Pohang 790784, South Korea.	ktl@postech.ac.kr	Lee, Kitack/G-7184-2015; Kim, Tae-Wook/E-9611-2011; Jeong, hae jin/B-8908-2009	Kim, Tae-Wook/0000-0002-4236-0720; Lee, Kitack/0000-0002-4226-2303; Jeong, Hae Jin/0000-0003-3310-4335	Korea National Research Foundation [2009-0084756]; Korea Meteorological Administration [RACS_2010-1006]; Ministry of Land, Transport, and Maritime Affairs; NASA [NNX08AO25G]	Korea National Research Foundation(National Research Foundation of Korea); Korea Meteorological Administration(Korea Meteorological Administration (KMA)); Ministry of Land, Transport, and Maritime Affairs(Ministry of Land, Transport and Maritime Affairs (MLTM), Republic of Korea); NASA(National Aeronautics & Space Administration (NASA))	This work would not have been possible without the efforts of many scientists who contributed data to National Fisheries Research and Development Institute and Japan Meteorological Agency for the seawater nutrient data and to Acid Deposition Monitoring Network in East Asia and Korea Meteorological Administration (Climate Change Information Center) for the atmospheric deposition data. The preparation of the manuscript was supported by the Mid-career Researcher Program (2009-0084756) of the Korea National Research Foundation (K.L.). Partial support was provided by the Korea Meteorological Administration Research and Development Program under grant RACS_2010-1006 (K.L.). Support for H.J.J. was provided by the Ministry of Land, Transport, and Maritime Affairs' Ecological Disturbance Program. Support for R.G.N. was provided by NASA's Ocean Biology and Biogeochemistry Program (contract NNX08AO25G).	AKIMOTO H, 1994, ATMOS ENVIRON, V28, P213, DOI 10.1016/1352-2310(94)90096-5; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Chen CTA, 2004, J OCEANOGR, V60, P17, DOI 10.1023/B:JOCE.0000038316.56018.d4; Dai ZJ, 2011, ENVIRON SCI TECHNOL, V45, P223, DOI 10.1021/es103026a; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FANNING KA, 1989, NATURE, V339, P460, DOI 10.1038/339460a0; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Ichikawa H, 2002, J OCEANOGR, V58, P77, DOI 10.1023/A:1015876701363; Kang J, 2010, SCI TOTAL ENVIRON, V408, P2369, DOI 10.1016/j.scitotenv.2010.02.022; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kim K, 2008, J OCEANOGR, V64, P721, DOI 10.1007/s10872-008-0061-x; Klausmeier CA, 2004, NATURE, V429, P171, DOI 10.1038/nature02454; Lie HJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001194; Moisander PH, 2010, SCIENCE, V327, P1512, DOI 10.1126/science.1185468; Nakamura T, 2005, ATMOS ENVIRON, V39, P1749, DOI 10.1016/j.atmosenv.2004.11.037; Ohara T, 2007, ATMOS CHEM PHYS, V7, P4419, DOI 10.5194/acp-7-4419-2007; Onitsuka G, 2009, J OCEANOGR, V65, P433, DOI 10.1007/s10872-009-0038-4; OWENS NJP, 1992, NATURE, V357, P397, DOI 10.1038/357397a0; Paerl HW, 2002, ENVIRON SCI TECHNOL, V36, p323A, DOI 10.1021/es022392a; Pahlow M, 2000, SCIENCE, V287, P831, DOI 10.1126/science.287.5454.831; Park GH, 2008, LIMNOL OCEANOGR, V53, P1697, DOI 10.4319/lo.2008.53.5.1697; Wang BD, 2003, ESTUAR COAST SHELF S, V58, P127, DOI 10.1016/S0272-7714(03)00067-2; Watanabe YW, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032188; Weber TS, 2010, NATURE, V467, P550, DOI 10.1038/nature09403; Zhang GS, 2007, J ATMOS CHEM, V57, P41, DOI 10.1007/s10874-007-9060-3	32	178	195	8	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					505	509		10.1126/science.1206583	http://dx.doi.org/10.1126/science.1206583			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21940860				2022-12-24	WOS:000296230500045
J	McDonough, JE; Yuan, R; Suzuki, M; Seyednejad, N; Elliott, WM; Sanchez, PG; Wright, AC; Gefter, WB; Litzky, L; Coxson, HO; Pare, PD; Sin, DD; Pierce, RA; Woods, JC; McWilliams, AM; Mayo, JR; Lam, SC; Cooper, JD; Hogg, JC				McDonough, John E.; Yuan, Ren; Suzuki, Masaru; Seyednejad, Nazgol; Elliott, W. Mark; Sanchez, Pablo G.; Wright, Alexander C.; Gefter, Warren B.; Litzky, Leslie; Coxson, Harvey O.; Pare, Peter D.; Sin, Don D.; Pierce, Richard A.; Woods, Jason C.; McWilliams, Annette M.; Mayo, John R.; Lam, Stephen C.; Cooper, Joel D.; Hogg, James C.			Small-Airway Obstruction and Emphysema in Chronic Obstructive Pulmonary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE IIB TRIAL; LUNGS; DYSPLASIA; PRESSURE; SMOKERS; NUMBER; SITE	BACKGROUND The major sites of obstruction in chronic obstructive pulmonary disease (COPD) are small airways (<2 mm in diameter). We wanted to determine whether there was a relationship between small-airway obstruction and emphysematous destruction in COPD. METHODS We used multidetector computed tomography (CT) to compare the number of airways measuring 2.0 to 2.5 mm in 78 patients who had various stages of COPD, as judged by scoring on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) scale, in isolated lungs removed from patients with COPD who underwent lung transplantation, and in donor (control) lungs. MicroCT was used to measure the extent of emphysema (mean linear intercept), the number of terminal bronchioles per milliliter of lung volume, and the minimum diameters and cross-sectional areas of terminal bronchioles. RESULTS On multidetector CT, in samples from patients with COPD, as compared with control samples, the number of airways measuring 2.0 to 2.5 mm in diameter was reduced in patients with GOLD stage 1 disease (P = 0.001), GOLD stage 2 disease (P = 0.02), and GOLD stage 3 or 4 disease (P<0.001). MicroCT of isolated samples of lungs removed from patients with GOLD stage 4 disease showed a reduction of 81 to 99.7% in the total cross-sectional area of terminal bronchioles and a reduction of 72 to 89% in the number of terminal bronchioles (P<0.001). A comparison of the number of terminal bronchioles and dimensions at different levels of emphysematous destruction (i.e., an increasing value for the mean linear intercept) showed that the narrowing and loss of terminal bronchioles preceded emphysematous destruction in COPD (P<0.001). CONCLUSIONS These results show that narrowing and disappearance of small conducting airways before the onset of emphysematous destruction can explain the increased peripheral airway resistance reported in COPD. (Funded by the National Heart, Lung, and Blood Institute and others.)	[McDonough, John E.; Yuan, Ren; Suzuki, Masaru; Seyednejad, Nazgol; Elliott, W. Mark; Coxson, Harvey O.; Pare, Peter D.; Sin, Don D.; Hogg, James C.] Univ British Columbia, James Hogg Res Ctr, St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Pare, Peter D.; Sin, Don D.] Univ British Columbia, Div Resp, Dept Med, Vancouver, BC V6Z 1Y6, Canada; [McWilliams, Annette M.; Lam, Stephen C.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Coxson, Harvey O.; Mayo, John R.] Vancouver Gen Hosp, Dept Radiol, Vancouver, BC V5Z 1M9, Canada; [Sanchez, Pablo G.; Cooper, Joel D.] Univ Penn, Div Thorac Surg, Philadelphia, PA 19104 USA; [Wright, Alexander C.; Gefter, Warren B.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Litzky, Leslie] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Pierce, Richard A.] Washington Univ, Dept Internal Med, St Louis, MO 63130 USA; [Woods, Jason C.] Washington Univ, Dept Radiol, St Louis, MO 63130 USA	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Washington University (WUSTL); Washington University (WUSTL)	Hogg, JC (corresponding author), Univ British Columbia, James Hogg Res Ctr, St Pauls Hosp, 166-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	jim.hogg@hli.ubc.ca	Sin, Don/AAC-2219-2021; Pare, Peter D/C-7425-2011; Coxson, Harvey O/A-9861-2017; Suzuki, Masaru/H-2087-2012	Coxson, Harvey O/0000-0001-5750-9711; Suzuki, Masaru/0000-0002-2124-6793; McDonough, John/0000-0003-2497-0258	National Heart, Lung, and Blood Institute [HL084922, HL084948, HL062194, HL090806]; Canadian Institute of Health Research-Thoracic Imaging Network of Canada; Canadian Collaborative Innovative Research Fund; GlaxoSmithKline; Lavin Family Supporting Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090806, P50HL084922, P50HL084948, R01HL062194] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institute of Health Research-Thoracic Imaging Network of Canada(Canadian Institutes of Health Research (CIHR)); Canadian Collaborative Innovative Research Fund; GlaxoSmithKline(GlaxoSmithKline); Lavin Family Supporting Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the National Heart, Lung, and Blood Institute and others.; Supported by grants (HL084922, HL084948, HL062194, and HL090806) from the National Heart, Lung, and Blood Institute, by the Canadian Institute of Health Research-Thoracic Imaging Network of Canada, by the Canadian Collaborative Innovative Research Fund, by GlaxoSmithKline, and by the Lavin Family Supporting Foundation.	BIGNON J, 1969, AM REV RESPIR DIS, V99, P669; Choong CK, 2005, J THORAC CARDIOV SUR, V130, P922, DOI 10.1016/j.jtcvs.2005.03.046; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Howard C, 1998, UNBIASED STEREOLOGY; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Lam S, 2004, CLIN CANCER RES, V10, P6502, DOI 10.1158/1078-0432.CCR-04-0686; Lam S, 2002, JNCI-J NATL CANCER I, V94, P1001; LEOPOLD J. G., 1957, THORAX, V12, P219, DOI 10.1136/thx.12.3.219; MATSUBA K, 1972, AM J PATHOL, V67, P265; McWilliams AM, 2006, J THORAC ONCOL, V1, P61, DOI 10.1097/01243894-200601000-00012; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; Robbesom AA, 2003, MODERN PATHOL, V16, P1, DOI 10.1097/01.MP.0000043519.29370.C2; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; VANBRABANDT H, 1983, J APPL PHYSIOL, V55, P1733, DOI 10.1152/jappl.1983.55.6.1733; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; YANAI M, 1992, J APPL PHYSIOL, V72, P1016, DOI 10.1152/jappl.1992.72.3.1016	19	730	752	1	69	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1567	1575		10.1056/NEJMoa1106955	http://dx.doi.org/10.1056/NEJMoa1106955			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	22029978	Green Accepted			2022-12-24	WOS:000296181800001
J	Vladeck, BC				Vladeck, Bruce C.			The Continuing Paradoxes of Nursing Home Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Nexera Inc, New York, NY 10019 USA		Vladeck, BC (corresponding author), Nexera Inc, 555 W 57th St,15th Floor, New York, NY 10019 USA.	bvladeck@nexeraconsulting.com						*ADAPT, ADAPTS DEF OUR FREED; *HJ KAIS FAM FDN K, 2011, POL BRIEF PROP MOD I; *HJ KAIS FAM FDN K, 2011, ISS PAP MED HOM COMM; *MED PAY ADV COMM, REP C MED PAYM POL, pCH7; Mor V, 2007, HEALTH AFFAIR, V26, P1762, DOI 10.1377/hlthaff.26.6.1762; Vladeck BC, 2003, HEALTH AFFAIR, V22, P90, DOI 10.1377/hlthaff.22.1.90; Zweig SC, 2011, JAMA-J AM MED ASSOC, V306, P1468, DOI 10.1001/jama.2011.1420; LONG TERM CARE	8	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1802	1803		10.1001/jama.2011.1527	http://dx.doi.org/10.1001/jama.2011.1527			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	21972271				2022-12-24	WOS:000296181600028
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: rheumatoid arthritis	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						[Anonymous], PRESCRIPTION COST AN; GRANT LH, 2010, ANN RHEUM DIS, V69, P868; Houssien DA, 1998, SCAND J RHEUMATOL, V27, P300; Jordan KP, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-144; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; National Institute for Health and Clinical Excellence (NICE), 2009, RHEUMATOID ARTHRITIS; Pollard LC, 2010, RHEUMATOLOGY, V49, P924, DOI 10.1093/rheumatology/kep458; Weiss RJ, 2008, RHEUMATOLOGY, V47, P491, DOI 10.1093/rheumatology/ken009	8	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 5	2011	343								d6357	10.1136/bmj.d6357	http://dx.doi.org/10.1136/bmj.d6357			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832CS	21976694				2022-12-24	WOS:000295779400006
J	DiTacchio, L; Le, HD; Vollmers, C; Hatori, M; Witcher, M; Secombe, J; Panda, S				DiTacchio, Luciano; Le, Hiep D.; Vollmers, Christopher; Hatori, Megumi; Witcher, Michael; Secombe, Julie; Panda, Satchidananda			Histone Lysine Demethylase JARID1a Activates CLOCK-BMAL1 and Influences the Circadian Clock	SCIENCE			English	Article							DISTINCT	In animals, circadian oscillators are based on a transcription-translation circuit that revolves around the transcription factors CLOCK and BMAL1. We found that the JumonjiC (JmjC) and ARID domain-containing histone lysine demethylase 1a (JARID1a) formed a complex with CLOCK-BMAL1, which was recruited to the Per2 promoter. JARID1a increased histone acetylation by inhibiting histone deacetylase 1 function and enhanced transcription by CLOCK-BMAL1 in a demethylase-independent manner. Depletion of JARID1a in mammalian cells reduced Per promoter histone acetylation, dampened expression of canonical circadian genes, and shortened the period of circadian rhythms. Drosophila lines with reduced expression of the Jarid1a homolog, lid, had lowered Per expression and similarly altered circadian rhythms. JARID1a thus has a nonredundant role in circadian oscillator function.	[DiTacchio, Luciano; Le, Hiep D.; Vollmers, Christopher; Hatori, Megumi; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Witcher, Michael] McGill Univ, Dept Oncol, Montreal, PQ H2W 1S6, Canada; [Secombe, Julie] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA	Salk Institute; McGill University; Yeshiva University; Albert Einstein College of Medicine	Panda, S (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu	DiTacchio, Luciano/D-6341-2011; Panda, Satchidananda/J-6891-2012; Hatori, Megumi/GTY-3770-2022	DiTacchio, Luciano/0000-0001-9570-7348; Hatori, Megumi/0000-0001-7888-158X	NIH [EY 16807, DK 091618, S10 RR027450, F32GM082083]; Pew Scholars Program; Dana Foundation; Japan Society for the Promotion of Science; Blasker Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027450] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM082083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Program; Dana Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Blasker Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Kaelin for JARID1a antibodies, and Jarid1a<SUP>-/-</SUP> and Jarid1a<SUP>+/+</SUP> fibroblasts; and R. Janknecht for JARID1b and JARID1c cDNAs. Supported by NIH grants (EY 16807, DK 091618, and S10 RR027450), the Pew Scholars Program, and a Dana Foundation award to S. P.; a Japan Society for the Promotion of Science fellowship to M. H.; NIH grant F32GM082083 to L.D.; and a Blasker Foundation award to C.V.	Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Lee N, 2009, MOL CELL BIOL, V29, P1401, DOI 10.1128/MCB.01643-08; Li L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001221; Naruse Y, 2004, MOL CELL BIOL, V24, P6278, DOI 10.1128/MCB.24.14.6278-6287.2004; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102	9	163	182	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1881	1885		10.1126/science.1206022	http://dx.doi.org/10.1126/science.1206022			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960634	Green Accepted			2022-12-24	WOS:000295365800054
J	Mendiburo, MJ; Padeken, J; Fulop, S; Schepers, A; Heun, P				Mendiburo, Maria Jose; Padeken, Jan; Fueloep, Stefanie; Schepers, Aloys; Heun, Patrick			Drosophila CENH3 Is Sufficient for Centromere Formation	SCIENCE			English	Article							DE-NOVO KINETOCHORE; CHROMOSOME SEGREGATION; BUDDING YEAST; CHROMATIN; NUCLEOSOMES; DNA; MODIFIERS; BYPASSES; COMPLEX	CENH3 is a centromere-specific histone H3 variant essential for kinetochore assembly. Despite its central role in centromere function, there has been no conclusive evidence supporting CENH3 as sufficient to determine centromere identity. To address this question, we artificially targeted Drosophila CENH3 (CENP-A/CID) as a CID-GFP-LacI fusion protein to stably integrated lac operator (lacO) arrays. This ectopic CID focus assembles a functional kinetochore and directs incorporation of CID molecules without the LacI-anchor, providing evidence for the self-propagation of the epigenetic mark. CID-GFP-LacI-bound extrachromosomal lacO plasmids can assemble kinetochore proteins and bind microtubules, resulting in their stable transmission for several cell generations even after eliminating CID-GFP-LacI. We conclude that CID is both necessary and sufficient to serve as an epigenetic centromere mark and nucleate heritable centromere function.	[Mendiburo, Maria Jose; Padeken, Jan; Heun, Patrick] Max Planck Inst Immunobiol, D-79108 Freiburg, Germany; [Mendiburo, Maria Jose; Padeken, Jan] Univ Freiburg, Freiburg, Germany; [Fueloep, Stefanie; Schepers, Aloys] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Dept Gene Vectors, D-81377 Munich, Germany; [Heun, Patrick] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	Max Planck Society; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Freiburg	Heun, P (corresponding author), Max Planck Inst Immunobiol, Stubeweg 51, D-79108 Freiburg, Germany.	heun@ie-freiburg.mpg.de	Padeken, Jan/AFU-6352-2022; Heun, Patrick/AAH-7390-2020	Padeken, Jan/0000-0001-6538-0946; Heun, Patrick/0000-0001-8400-1892; Mendiburo, Maria Jose/0000-0002-7840-7754; Schepers, Aloys/0000-0002-5442-5608	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich (SFB) 646, SFB/TR05, Schwerpunktprogramm 1230]; Max Planck Society; Human Frontier Science Program; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; Max Planck Institute of Immunobiology and Epigenetics	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); Human Frontier Science Program(Human Frontier Science Program); Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; Max Planck Institute of Immunobiology and Epigenetics	We thank G. H. Karpen, A. Straight, T. Maresca, E. Salmon, C. Sunkel, S. Heidmann, and C. Lehner for reagents. We also thank L. Jansen for critical reading of the manuscript and the members of the Grosschedl Department, particularly S. Chlamydas for pioneering experiments and A. Olszak, H.-J. Schwarz, D. Venegas, S. Daujat, S. Saccani, and D. van Essen for reagents and helpful discussions. A. S. is supported by the Sonderforschungsbereich (SFB) 646, SFB/TR05, and Schwerpunktprogramm 1230 of the Deutsche Forschungsgemeinschaft. P. H. is funded by the Max Planck Society, the Human Frontier Science Program (Career Development Award; CDA), and the Excellence Initiative of the German Federal and State Governments (EXC 294). M.-J.M. and J.P. are grateful for an International Max Planck Research School (IMPRS) fellowship provided by the Max Planck Institute of Immunobiology and Epigenetics.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Black BE, 2007, MOL CELL, V25, P309, DOI 10.1016/j.molcel.2006.12.018; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; Gascoigne KE, 2011, CELL, V145, P410, DOI 10.1016/j.cell.2011.03.031; Guse A, 2011, NATURE, V477, P354, DOI 10.1038/nature10379; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kiermaier E, 2009, NAT CELL BIOL, V11, P1109, DOI 10.1038/ncb1924; Lacefield S, 2009, NAT CELL BIOL, V11, P1116, DOI 10.1038/ncb1925; McClintock B, 1941, GENETICS, V26, P234; Nakano M, 2008, DEV CELL, V14, P507, DOI 10.1016/j.devcel.2008.02.001; Olszak AM, 2011, NAT CELL BIOL, V13, P799, DOI 10.1038/ncb2272; Pich D, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn273; Przewloka MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000478; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Sekulic N, 2010, NATURE, V467, P347, DOI 10.1038/nature09323; Vierstra RD, 1999, PLANT MOL BIOL, V41, P435, DOI 10.1023/A:1006323317890	25	205	207	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					686	690		10.1126/science.1206880	http://dx.doi.org/10.1126/science.1206880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053052				2022-12-24	WOS:000296494700059
J	Kerlikowske, K; Hubbard, RA; Miglioretti, DL; Geller, BM; Yankaskas, BC; Lehman, CD; Taplin, SH; Sickles, EA				Kerlikowske, Karla; Hubbard, Rebecca A.; Miglioretti, Diana L.; Geller, Berta M.; Yankaskas, Bonnie C.; Lehman, Constance D.; Taplin, Stephen H.; Sickles, Edward A.		Breast Canc Surveillance Consortiu	Comparative Effectiveness of Digital Versus Film-Screen Mammography in Community Practice in the United States A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER SURVEILLANCE CONSORTIUM; CARCINOMA IN-SITU; BREAST-CANCER; THERAPY USE; POPULATION; ACCURACY; DENSITY; PROGRAM; PERFORMANCE; WOMEN	Background: Few studies have examined the comparative effectiveness of digital versus film-screen mammography in U. S. community practice. Objective: To determine whether the interpretive performance of digital and film-screen mammography differs. Design: Prospective cohort study. Setting: Mammography facilities in the Breast Cancer Surveillance Consortium. Participants: 329 261 women aged 40 to 79 years underwent 869 286 mammograms (231 034 digital; 638 252 film-screen). Measurements: Invasive cancer or ductal carcinoma in situ diagnosed within 12 months of a digital or film-screen examination and calculation of mammography sensitivity, specificity, cancer detection rates, and tumor outcomes. Results: Overall, cancer detection rates and tumor characteristics were similar for digital and film-screen mammography, but the sensitivity and specificity of each modality varied by age, tumor characteristics, breast density, and menopausal status. Compared with film-screen mammography, the sensitivity of digital mammography was significantly higher for women aged 60 to 69 years (89.9% vs. 83.0%; P = 0.014) and those with estrogen receptor-negative cancer (78.5% vs. 65.8%; P = 0.016); borderline significantly higher for women aged 40 to 49 years (82.4% vs. 75.6%; P = 0.071), those with extremely dense breasts (83.6% vs. 68.1%; P = 0.051), and pre- or perimenopausal women (87.1% vs. 81.7%; P = 0.057); and borderline significantly lower for women aged 50 to 59 years (80.5% vs. 85.1%; P = 0.097). The specificity of digital and film-screen mammography was similar by decade of age, except for women aged 40 to 49 years (88.0% vs. 89.7%; P < 0.001). Limitation: Statistical power for subgroup analyses was limited. Conclusion: Overall, cancer detection with digital or film-screen mammography is similar in U. S. women aged 50 to 79 years undergoing screening mammography. Women aged 40 to 49 years are more likely to have extremely dense breasts and estrogen receptor-negative tumors; if they are offered mammography screening, they may choose to undergo digital mammography to optimize cancer detection.	[Kerlikowske, Karla] San Francisco VA Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Washington, Sch Publ Hlth & Community Med, Grp Hlth Res Inst, Grp Hlth Cooperat, Seattle, WA 98195 USA; Univ Washington, Sch Med, Seattle, WA USA; Univ Vermont, Coll Med, Burlington, VT USA; Univ N Carolina, Chapel Hill, NC USA; NCI, Appl Res Program, Rockville, MD USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Kerlikowske, K (corresponding author), San Francisco VA Med Ctr, Gen Internal Med Sect, 111A1,4150 Clement St, San Francisco, CA 94121 USA.	Karla.Kerlikowske@ucsf.edu	Hubbard, Rebecca/Y-6500-2019	Hubbard, Rebecca/0000-0003-0879-0994	National Cancer Institute [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, R03CA150007, RC2CA148577]; NATIONAL CANCER INSTITUTE [U01CA070013, U01CA086076, U01CA069976, RC2CA148577, U01CA063736, R03CA150007, U01CA086082, U01CA063731, U01CA070040, U01CA063740] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute-funded BCSC cooperative agreement (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040) and National Cancer Institute grants R03CA150007 and RC2CA148577. The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States; for a full description of these sources, see http://breastscreening.cancer.gov/work/acknowledgement.html.	American College of Radiology (ACR), 2003, ILL BREAST IM REP DA; American Joint Committee on Cancer, 2002, MAN STAG CANC; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Buist DSM, 2011, RADIOLOGY, V259, P72, DOI 10.1148/radiol.10101698; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Ciatto S, 2005, BREAST, V14, P269, DOI 10.1016/j.breast.2004.12.004; Ernster VL, 2002, J NATL CANCER I, V94, P1546; Farhat GN, 2010, J CLIN ONCOL, V28, P5140, DOI 10.1200/JCO.2010.29.5121; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Ichikawa LE, 2010, RADIOLOGY, V256, P74, DOI 10.1148/radiol.10091881; Jiang YL, 2010, RADIOLOGY, V256, P29, DOI 10.1148/radiol.10091394; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 1998, J NATL CANCER I, V90, P1801, DOI 10.1093/jnci/90.23.1801; Kerlikowske K, 2003, J CLIN ONCOL, V21, P4314, DOI 10.1200/JCO.2003.05.151; Kerlikowske K, 2007, J NATL CANCER I, V99, P386, DOI 10.1093/jnci/djk066; Kerlikowske K, 2007, NEW ENGL J MED, V356, P297, DOI 10.1056/NEJMe068244; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Lewin JM, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790671; Neuhaus JM, 1998, BIOMETRICS, V54, P638, DOI 10.2307/3109770; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2008, RADIOLOGY, V246, P376, DOI 10.1148/radiol.2461070200; Roubidoux MA, 2004, RADIOLOGY, V230, P42, DOI 10.1148/radiol.2301020589; Sala M, 2009, RADIOLOGY, V252, P31, DOI 10.1148/radiol.2521080696; Skaane P, 2009, ACTA RADIOL, V50, P3, DOI 10.1080/02841850802563269; Skaane P, 2007, RADIOLOGY, V244, P708, DOI 10.1148/radiol.2443061478; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; U.S. Food and Drug Administration, 2011, MAMM QUAL STAND ACT; Vinnicombe S, 2009, RADIOLOGY, V251, P347, DOI 10.1148/radiol.2512081235; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048	30	189	193	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					493	U64		10.7326/0003-4819-155-8-201110180-00005	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00005			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007043	Green Accepted			2022-12-24	WOS:000296066300014
J	Cortes, JE; Curns, AT; Tate, JE; Cortese, MM; Patel, MM; Zhou, FJ; Parashar, UD				Cortes, Jennifer E.; Curns, Aaron T.; Tate, Jacqueline E.; Cortese, Margaret M.; Patel, Manish M.; Zhou, Fangjun; Parashar, Umesh D.			Rotavirus Vaccine and Health Care Utilization for Diarrhea in US Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; GASTROENTERITIS; HOSPITALIZATIONS; EFFICACY; SAFETY	Background Routine vaccination of U. S. infants with pentavalent rotavirus vaccine (RV5) began in 2006. Methods Using MarketScan databases, we assessed RV5 coverage and diarrhea-associated health care use from July 2007 through June 2009 versus July 2001 through June 2006 in children under 5 years of age. We compared the rates of diarrhea-associated health care use in unvaccinated children in the period from January through June (when rotavirus is most prevalent) in 2008 and 2009 with the prevaccine rates to estimate indirect benefits. We estimated national reductions in the number of hospitalizations for diarrhea, and associated costs, by extrapolation. Results By December 31, 2008, at least one dose of RV5 had been administered in 73% of children under 1 year of age, 64% of children 1 year of age, and 8% of children 2 to 4 years of age. Among children under 5 years of age, rates of hospitalization for diarrhea in 2001-2006, 2007-2008, and 2008-2009 were 52, 35, and 39 cases per 10,000 person-years, respectively, for relative reductions from 2001-2006 by 33% (95% confidence interval [CI], 31 to 35) in 2007-2008 and by 25% (95% CI, 23 to 27) in 2008-2009; rates of hospitalization specifically coded for rotavirus infection were 14, 4, and 6 cases per 10,000 person-years, respectively, for relative reductions in the rate from 2001-2006 by 75% (95% CI, 72 to 77) in 2007-2008 and by 60% (95% CI, 58 to 63) in 2008-2009. In the January-June periods of 2008 and 2009, the respective relative rate reductions among vaccinated children as compared with unvaccinated children were as follows: hospitalization for diarrhea, 44% (95% CI, 33 to 53) and 58% (95% CI, 52 to 64); rotavirus-coded hospitalization, 89% (95% CI, 79 to 94) and 89% (95% CI, 84 to 93); emergency department visits for diarrhea, 37% (95% CI, 31 to 43) and 48% (95% CI, 44 to 51); and outpatient visits for diarrhea, 9% (95% CI, 6 to 11) and 12% (95% CI, 10 to 15). Indirect benefits (in unvaccinated children) were seen in 2007-2008 but not in 2008-2009. Nationally, for the 2007-2009 period, there was an estimated reduction of 64,855 hospitalizations, saving approximately $278 million in treatment costs. Conclusions Since the introduction of rotavirus vaccine, diarrhea-associated health care utilization and medical expenditures for U. S. children have decreased substantially.	[Cortes, Jennifer E.; Curns, Aaron T.; Tate, Jacqueline E.; Cortese, Margaret M.; Patel, Manish M.; Parashar, Umesh D.] Ctr Dis Control & Prevent, Div Viral Dis, Atlanta, GA 30333 USA; [Cortes, Jennifer E.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Zhou, Fangjun] Ctr Dis Control & Prevent, Immunizat Serv Div, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Parashar, UD (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd,MS A-47, Atlanta, GA 30333 USA.	uparashar@cdc.gov			NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2010, MMWR RECOMM REP, V59, P1074; Atlanta: Centers for Disease Control and Prevention, 2008, MARKETSCAN; Block SL, 2007, PEDIATRICS, V119, P11, DOI 10.1542/peds.2006-2058; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Buttery JP, 2011, VACCINE, V29, P3061, DOI 10.1016/j.vaccine.2011.01.088; Clark HF, 2009, CLIN VACCINE IMMUNOL, V16, P382, DOI 10.1128/CVI.00382-08; Cortese M, 2010, ADV COMM IMM PRACT M; Cortese MM, 2010, PEDIATR INFECT DIS J, V29, P489, DOI 10.1097/INF.0b013e3181d95b53; Glass RI, 1996, J INFECT DIS, V174, pS5, DOI 10.1093/infdis/174.Supplement_1.S5; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Patel MM, 2011, VITALSTATS, V364, P2283; Payne DC, 2010, PEDIATR INFECT DIS J, V29, P287, DOI 10.1097/INF.0b013e3181d40e76; Payne DC, 2009, PEDIATR INFECT DIS J, V28, P948, DOI 10.1097/INF.0b013e3181a6ad6e; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rothman KJ, 1998, NAT IMM SURV EST VAC; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Tate JE, 2009, PEDIATRICS, V123, P744, DOI 10.1542/peds.2008-1200; US Department of Labor Bureau of Labor Statistics, CONS PRIC IND; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Wang FT, 2010, PEDIATRICS, V125, pE208, DOI 10.1542/peds.2009-1246; Widdowson MA, 2007, PEDIATRICS, V119, P684, DOI 10.1542/peds.2006-2876; Yen C, 2011, PEDIATRICS, V127, pE9, DOI 10.1542/peds.2010-1393	25	124	127	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1108	1117		10.1056/NEJMoa1000446	http://dx.doi.org/10.1056/NEJMoa1000446			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822WR	21992123				2022-12-24	WOS:000295081600010
J	McKellar, RC; Chatterton, BDE; Wolfe, AP; Currie, PJ				McKellar, Ryan C.; Chatterton, Brian D. E.; Wolfe, Alexander P.; Currie, Philip J.			A Diverse Assemblage of Late Cretaceous Dinosaur and Bird Feathers from Canadian Amber	SCIENCE			English	Article							EVOLUTIONARY ORIGIN; TRANSPORT; ALBERTA; WATER	The fossil record of early feathers has relied on carbonized compressions that lack fine structural detail. Specimens in amber are preserved in greater detail, but they are rare. Late Cretaceous coal-rich strata from western Canada provide the richest and most diverse Mesozoic feather assemblage yet reported from amber. The fossils include primitive structures closely matching the protofeathers of nonavian dinosaurs, offering new insights into their structure and function. Additional derived morphologies confirm that plumage specialized for flight and underwater diving had evolved in Late Cretaceous birds. Because amber preserves feather structure and pigmentation in unmatched detail, these fossils provide novel insights regarding feather evolution.	[McKellar, Ryan C.; Chatterton, Brian D. E.; Wolfe, Alexander P.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	University of Alberta; University of Alberta	McKellar, RC (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	rcm1@ualberta.ca	Currie, Philip J/A-2628-2014; Wolfe, Alexander P/G-6867-2011	Currie, Philip J/0000-0001-6857-3161; 	Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Alberta Ingenuity Fund	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity Fund	We thank the Leuck family and M. Schmidt (donated specimens); M. Caldwell, S. Ogg and M. Srayko (microscopy); E. Koppelhus and H. Proctor (discussions); and J. Gardner, B. Strilisky, A. Howell, and J. Hudon (TMP, Redpath Museum, and Royal Alberta Museum collections). Research was funded by Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants to B. D. E. C., A. P. W., and P. J. C. and NSERC and Alberta Ingenuity Fund support to R.C.M.	Alonso J, 2000, J PALEONTOL, V74, P158, DOI 10.1666/0022-3360(2000)074<0158:ANFRWB>2.0.CO;2; Brush AH, 2000, AM ZOOL, V40, P631, DOI 10.1668/0003-1569(2000)040[0631:EAPAFD]2.0.CO;2; Buffetaut E, 2010, GEOL MAG, V147, P469, DOI 10.1017/S0016756810000129; CADE TJ, 1967, CONDOR, V69, P323, DOI 10.2307/1366197; Chandler A. C., 1916, U CALIFORNIA PUBLICA, V13, P243; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Currie PJ, 2005, LIFE O PAST, P367; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dove Carla J., 2000, Ornithological Monographs, V51, P1; Fjeldsa J., 2004, GREBES PODICIPEDIDAE; Grimaldi David, 1995, American Museum Novitates, V3126, P1; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Kellner AWA, 2010, P ROY SOC B-BIOL SCI, V277, P321, DOI 10.1098/rspb.2009.0846; Longrich N, 2009, CRETACEOUS RES, V30, P161, DOI 10.1016/j.cretres.2008.06.007; Lucas A., 1972, AVIAN ANATOMY INTEGU; MACLEAN GL, 1983, BIOSCIENCE, V33, P365, DOI 10.2307/1309104; McKellar Ryan C., 2010, P149; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Perrichot V, 2008, P ROY SOC B-BIOL SCI, V275, P1197, DOI 10.1098/rspb.2008.0003; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Schlee D., 1978, STUTTGARTER BEITRA C, V8, P1; STETTENHEIM P, 1973, Living Bird, V12, P201; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	27	49	53	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1619	1622		10.1126/science.1203344	http://dx.doi.org/10.1126/science.1203344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921196	Green Submitted			2022-12-24	WOS:000294900900040
J	Cohen, D				Cohen, Deborah			NON-COMMUNICABLE DISEASES The prickly problem of access to insulin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIABETES CARE		BMJ, London WC1H 9JR, England		Cohen, D (corresponding author), BMJ, London WC1H 9JR, England.	dcohen@bmj.com						Abdraimova A, 2009, REPORT RAPID ASSESSM; BENNETT S, 2011, BLOOMBERG BUSIN 0906; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Beran D, 2010, DIABETES RES CLIN PR, V88, P217, DOI 10.1016/j.diabres.2010.03.029; Bliss M., 1984, DISCOVERY INSULIN; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; COHEN D, 2011, FINAL DECLARATION UN; *DIAB LEAD FOR AFR, 2010, DIAB HIDD PAND ITS I; *EUR MED AG, WITHDR ASS REP INS H; GHANGURDE A, 2011, SCRIP           0816; GHANGURDE A, 2010, SCRIP           1201; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Holden SE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000258; *I QUAL EFF HLTH C, 2011, IQWIG; *INT DIAB FED, ANN REP 2010 INT DIA; *INT DIAB FED, INT DIAB FED GLOB GU; International Diabetes Federation, LIF CHILD; International Diabetes Federation, DIAB ATL; Mendis S, 2007, B WORLD HEALTH ORGAN, V85, P279, DOI 10.2471/BLT.06.033647; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; *NCD ALL, ACC ESS MED TECHN NC; PAGODA PR, WHO WE ARE; PAGODA PR, OUR CLIENTS; SAWACKI PT, 2011, BRIT MED J, V343, pD5858; STRUMELLO S, 2007, COULD GENERIC INSULI; *WHO, 2011, EXP COMM SEL US ESS; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; 2009, SHARE           1112	29	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2011	343								d5782	10.1136/bmj.d5782	http://dx.doi.org/10.1136/bmj.d5782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917833				2022-12-24	WOS:000295078100009
J	Dheda, K; Migliori, GB				Dheda, Keertan; Migliori, Giovanni B.			The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue?	LANCET			English	Editorial Material							HEALTH-CARE WORKERS; XDR-TB; PULMONARY TUBERCULOSIS; MULTIDRUG-RESISTANT; SOUTH-AFRICA; EPIDEMIOLOGY; MANAGEMENT		[Dheda, Keertan] Univ Cape Town, Div Pulmonol, Lung Infect & Immun Unit, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Dept Med, UCT Lung Inst, ZA-7925 Cape Town, South Africa; [Dheda, Keertan] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Migliori, Giovanni B.] Fdn S Maugeri, Care & Res Inst, WHO Collaborating Ctr TB & Lung Dis, Tradate, Italy	University of Cape Town; University of Cape Town; University of Cape Town; Istituti Clinici Scientifici Maugeri IRCCS; World Health Organization	Dheda, K (corresponding author), Groote Schuur Hosp, Dept Med, H Floor,Old Main Bldg, ZA-7925 Cape Town, South Africa.	keertan.dheda@uct.ac.za	Migliori, Giovanni Battista/AAB-8589-2020	Migliori, Giovanni Battista/0000-0002-2597-574X				American S, 1914, TUBERCULOSIS BERLIN, V13, P129; Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; Dheda K, 2010, LANCET, V375, P1798, DOI 10.1016/S0140-6736(10)60492-8; Dietrich-Daum E., 2011, TUBERCULOSIS; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Migliori GB, 2007, EUROSURVEILLANCE, V12; Migliori GB, 2007, EMERG INFECT DIS, V13, P780, DOI 10.3201/eid1305.070200; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; News 24, 2011, NEWS 24         0324; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Rutledge J. A., 1919, AM REV TUBERC, V2, P755; Shah NS, 2011, EMERG INFECT DIS, V17, P510, DOI 10.3201/eid1703.101363; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Sotgiu G, 2009, EUR RESPIR J, V33, P871, DOI 10.1183/09031936.00168008; Sotgiu G, EUR RESP J IN PRESS; Styblo K, 1969, Bull Int Union Tuberc, V42, P1; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2011, WHO PROGRESS REPORT	25	75	77	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 25	2012	379	9817					773	775		10.1016/S0140-6736(11)61062-3	http://dx.doi.org/10.1016/S0140-6736(11)61062-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	899CU	22033020				2022-12-24	WOS:000300792600033
J	Saul, K; Thistlethwaite, JE				Saul, Krysia; Thistlethwaite, Jill E.			A PATIENT'S JOURNEY Facial disfigurement	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Saul, Krysia] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Thistlethwaite, Jill E.] Univ Queensland, Sch Med, Herston, Qld, Australia	University of Warwick; University of Queensland	Saul, K (corresponding author), Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England.	Krysia.saul@gmail.com		Thistlethwaite, Jill/0000-0001-8122-4679					0	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d5203	10.1136/bmj.d5203	http://dx.doi.org/10.1136/bmj.d5203			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012808	Green Submitted, Bronze			2022-12-24	WOS:000296183700001
J	Yang, WW; Xia, Y; Ji, HT; Zheng, YH; Liang, J; Huang, WH; Gao, X; Aldape, K; Lu, ZM				Yang, Weiwei; Xia, Yan; Ji, Haitao; Zheng, Yanhua; Liang, Ji; Huang, Wenhua; Gao, Xiang; Aldape, Kenneth; Lu, Zhimin			Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation	NATURE			English	Article							TUMOR-CELL INVASION; PYRUVATE-KINASE M2; DOWN-REGULATION; TYROSINE PHOSPHORYLATION; TRANSCRIPTIONAL ACTIVITY; CANCER METABOLISM; CARCINOMA CELLS; EXPRESSION; PROTEIN; SURVIVAL	The embryonic pyruvate kinase M2 (PKM2) isoform is highly expressed in human cancer. In contrast to the established role of PKM2 in aerobic glycolysis or the Warburg effect(1-3), its non-metabolic functions remain elusive. Here we demonstrate, in human cancer cells, that epidermal growth factor receptor (EGFR) activation induces translocation of PKM2, but not PKM1, into the nucleus, where K433 of PKM2 binds to c-Src-phosphorylated Y333 of beta-catenin. This interaction is required for both proteins to be recruited to the CCND1 promoter, leading to HDAC3 removal from the promoter, histone H3 acetylation and cyclin D1 expression. PKM2-dependent beta-catenin transactivation is instrumental in EGFR-promoted tumour cell proliferation and brain tumour development. In addition, positive correlations have been identified between c-Src activity, beta-catenin Y333 phosphorylation and PKM2 nuclear accumulation in human glioblastoma specimens. Furthermore, levels of beta-catenin phosphorylation and nuclear PKM2 have been correlated with grades of glioma malignancy and prognosis. These findings reveal that EGF induces beta-catenin transactivation via a mechanism distinct from that induced by Wnt/Wingless(4) and highlight the essential non-metabolic functions of PKM2 in EGFR-promoted beta-catenin transactivation, cell proliferation and tumorigenesis.	[Yang, Weiwei; Xia, Yan; Ji, Haitao; Zheng, Yanhua; Liang, Ji; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA; [Yang, Weiwei; Xia, Yan; Ji, Haitao; Zheng, Yanhua; Liang, Ji; Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Huang, Wenhua] Jiaxing Xinda Biotechnol Co, Jiaxing 314000, Zhejiang, Peoples R China; [Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, State Key Lab Pharmaceut Biotechnol, Nanjing 210061, Jiangsu, Peoples R China; [Aldape, Kenneth] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lu, Zhimin] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Nanjing University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Lu, ZM (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Houston, TX 77030 USA.	zhiminlu@mdanderson.org	Ji, Haitao/B-8204-2012; Ji, Haitao/L-1615-2013; yang, zheng/HGC-7753-2022	Yang, Weiwei/0000-0002-1661-9137	National Cancer Institute [5R01CA109035, 5 P50 CA127001-03, CA16672]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110252]; American Cancer Society [RSG-09-277-01-CSM]; University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA109035, P50CA127001] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Prevention and Research Institute of Texas (CPRIT); American Cancer Society(American Cancer Society); University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank T. Hunter (The Salk Institute for Biological Studies) for Abl and Src knockout cells, H. Clevers (Netherlands Institute for Developmental Biology) for the pTOP-FLASH and the pFOP-FLASH, and Y. Li (Baylor College of Medicine) for a WNT1 lenti-vector. This work was supported by National Cancer Institute grants 5R01CA109035 (Z.L.), 5 P50 CA127001-03 and CA16672 (Cancer Center Support Grant); a research grant (RP110252; Z.L.) from the Cancer Prevention and Research Institute of Texas (CPRIT), an American Cancer Society Research Scholar Award RSG-09-277-01-CSM (Z.L.), and a Sister Institution Network Fund from The University of Texas MD Anderson Cancer Center (Z.L.).	Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gomez-Manzano C, 2006, CLIN CANCER RES, V12, P556, DOI 10.1158/1078-0432.CCR-05-1892; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Le Mellay V, 2002, ADV ENZYME REGUL, V42, P317, DOI 10.1016/S0065-2571(01)00036-X; Lu ZM, 2004, CELL CYCLE, V3, P571; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Luo WB, 2011, CELL, V145, P732, DOI 10.1016/j.cell.2011.03.054; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; Miravet S, 2003, MOL CELL BIOL, V23, P7391, DOI 10.1128/MCB.23.20.7391-7402.2003; Petalidis LP, 2008, MOL CANCER THER, V7, P1013, DOI 10.1158/1535-7163.MCT-07-0177; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wykosky Jill, 2011, Chin J Cancer, V30, P5; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	26	678	704	5	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					118	U289		10.1038/nature10598	http://dx.doi.org/10.1038/nature10598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22056988	Green Accepted			2022-12-24	WOS:000298031900046
J	Bjarnason, I				Bjarnason, Ingvar			MORE SECRETS OF THE MMR SCARE Commentary: We came to an overwhelming and uniform opinion that these reports do not show colitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll Hosp London, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital	Bjarnason, I (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	ingvar.bjarnason@kcl.ac.uk						Deer B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1127; Godlee F, 2011, BRIT MED J, V343, P7284; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	3	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2011	343								d6979	10.1136/bmj.d6979	http://dx.doi.org/10.1136/bmj.d6979			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848NP	22077091	Bronze			2022-12-24	WOS:000297058600012
J	Kinzig, AP; Perrings, C; Chapin, FS; Polasky, S; Smith, VK; Tilman, D; Turner, BL				Kinzig, A. P.; Perrings, C.; Chapin, F. S., III; Polasky, S.; Smith, V. K.; Tilman, D.; Turner, B. L., II			Paying for Ecosystem Services-Promise and Peril	SCIENCE			English	Editorial Material							ENVIRONMENTAL SERVICES; PAYMENTS; DIVERSITY; LESSONS; FORESTS		[Turner, B. L., II] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA; [Turner, B. L., II] Arizona State Univ, Sch Sustainabil, Tempe, AZ 85287 USA; [Kinzig, A. P.; Perrings, C.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Chapin, F. S., III] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Polasky, S.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Smith, V. K.] Arizona State Univ, WP Carey Sch Business, Tempe, AZ 85287 USA; [Tilman, D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of Alaska System; University of Alaska Fairbanks; University of Minnesota System; University of Minnesota Twin Cities; Arizona State University; Arizona State University-Tempe; University of Minnesota System; University of Minnesota Twin Cities	Turner, BL (corresponding author), Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA.	Billie.L.Turner@asu.edu	Chapin, F Stuart/AAZ-3931-2020; Tilman, David/ABD-5309-2021; Polasky, Stephen/AAC-5341-2019	Chapin, F Stuart/0000-0002-2558-9910; 	Division Of Behavioral and Cognitive Sci [1134890] Funding Source: National Science Foundation	Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		[Anonymous], 2011, FED REGISTER, V76, P208; Arriagada R, 2011, AMBIO, V40, P798, DOI 10.1007/s13280-011-0156-2; Arrow K.J, 2010, 16599 NAT BUR EC RES; Barbier EB, 2008, RESOUR ENERGY ECON, V30, P229, DOI 10.1016/j.reseneeco.2007.08.002; Barbier EB, 2010, LAND USE POLICY, V27, P98, DOI 10.1016/j.landusepol.2009.02.001; Canadell JG, 2008, SCIENCE, V320, P1456, DOI 10.1126/science.1155458; Chichilnisky G, 1998, NATURE, V391, P629, DOI 10.1038/35481; Crockett S, 2009, ECON J, V119, P1162, DOI 10.1111/j.1468-0297.2009.02254.x; Dasgupta P., 2001, HUMAN WELL BEING NAT; Demsetz H, 1967, AM ECON REV, V57, P347; Dobbs TL, 2004, REV AGR ECON, V26, P220, DOI 10.1111/j.1467-9353.2004.00172.x; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Ferraro PJ, 2002, LAND ECON, V78, P339, DOI 10.2307/3146894; Ferraro PJ, 2002, SCIENCE, V298, P1718, DOI 10.1126/science.1078104; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Heal G, 2000, ECOSYSTEMS, V3, P24, DOI 10.1007/s100210000006; Horan RD, 2008, ENVIRON DEV ECON, V13, P415, DOI 10.1017/S1355770X08004269; Jorgenson DW, 2006, STUD INCOME, V66, P13; Kaul I., 1999, GLOBAL PUBLIC GOODS; Lange GM, 2007, ECOL ECON, V61, P589, DOI 10.1016/j.ecolecon.2006.09.003; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; MADSEN B, 2010, OFFSET COMPENSATION; *MILL EC ASS, 2005, EC HUM WELL BEING GE; Munoz-Pina C, 2008, ECOL ECON, V65, P725, DOI 10.1016/j.ecolecon.2007.07.031; Naeem S., 2009, BIODIVERSITY ECOSYST; Ostfeld R. S. et al., 2008, INFECT DIS ECOLOGY E; Pagiola S, 2008, ECOL ECON, V65, P712, DOI 10.1016/j.ecolecon.2007.07.033; Pagiola S, 2007, ECOL ECON, V64, P374, DOI 10.1016/j.ecolecon.2007.04.014; Sandler T., 2004, GLOBAL COLLECTIVE AC; Stavins RN, 2003, HANDB ECON, V20, P355; Stavins RN, 1998, J ECON PERSPECT, V12, P69, DOI 10.1257/jep.12.3.69; Tilman D, 2005, J ENVIRON ECON MANAG, V49, P405, DOI 10.1016/j.jeem.2004.03.008; Turpie JK, 2008, ECOL ECON, V65, P788, DOI 10.1016/j.ecolecon.2007.12.024; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Wunder S, 2008, ENVIRON DEV ECON, V13, P279, DOI 10.1017/S1355770X08004282; Wunder S, 2008, ECOL ECON, V65, P834, DOI 10.1016/j.ecolecon.2008.03.010	36	237	260	15	253	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					603	604		10.1126/science.1210297	http://dx.doi.org/10.1126/science.1210297			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841EG	22053032				2022-12-24	WOS:000296494700033
J	Fiore, LD; D'Avolio, LW				Fiore, Louis D.; D'Avolio, Leonard William			Detours on the Road to Personalized Medicine Barriers to Biomarker Validation and Implementation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fiore, Louis D.; D'Avolio, Leonard William] VA Boston Healthcare Syst, Cooperat Studies Program Coordinating Ctr, Massachusetts Vet Epidemiol Res & Informat Ctr MA, Jamaica Plain, MA USA; [Fiore, Louis D.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Fiore, Louis D.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA; [D'Avolio, Leonard William] Harvard Univ, Sch Med, Div Aging, Boston, MA 02115 USA; [D'Avolio, Leonard William] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Fiore, LD (corresponding author), Boston VA Healthcare Syst, MAVERIC, Jamaica Plain Campus,150 S Huntington Ave, Boston, MA 02130 USA.	louis.fiore@va.gov						Dana Farber Cancer Institute, 2011, ONCOMAP PROF TUM DNA; Fiore LD, 2011, CLIN TRIALS, V8, P183, DOI [10.1177/1740774510395635, 10.1177/1740774511398368]; Genomic Health&REG; Inc, ONC DX BREAST CANC A; Hunter DJ, 2007, NEW ENGL J MED, V357, P436, DOI 10.1056/NEJMp078120; Kohane IS, 2006, JAMA-J AM MED ASSOC, V296, P212, DOI 10.1001/jama.296.2.212; Partners HealthCare Center for Personalized Genetic Medicine, 2011, GEN INS SUIT; US Food and Drug Administration, 2007, GUID IND CL IN PRESS	7	16	16	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1914	1915		10.1001/jama.2011.1605	http://dx.doi.org/10.1001/jama.2011.1605			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	22045770				2022-12-24	WOS:000296376200027
J	Innocentin, YLS; Withers, DR; Roberts, NA; Gallagher, AR; Grigorieva, EF; Wilhelm, C; Veldhoen, M				Innocentin, Ying Li Silvia; Withers, David R.; Roberts, Natalie A.; Gallagher, Alec R.; Grigorieva, Elena F.; Wilhelm, Christoph; Veldhoen, Marc			Exogenous Stimuli Maintain Intraepithelial Lymphocytes via Aryl Hydrocarbon Receptor Activation	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; DELTA-T-CELLS; CROHNS-DISEASE; INTESTINAL EPITHELIUM; GENE-EXPRESSION; ALPHA-DEFENSINS; DEFICIENT MICE; CULTURE-MEDIUM; IMMUNE-SYSTEM; AH RECEPTOR	The body's surfaces form the interface with the external environment, protecting the host. These epithelial barriers are also colonized by a controlled diversity of microorganisms, disturbances of which can give rise to disease. Specialized intraepithelial lymphocytes (IELs), which reside at these sites, are important as a first line of defense as well as in epithelial barrier organization and wound repair. We show here that the aryl hydrocarbon receptor (AhR) is a crucial regulator in maintaining IEL numbers in both the skin and the intestine. In the intestine, AhR deficiency or the lack of AhR ligands compromises the maintenance of IELs and the control of the microbial load and composition, resulting in heightened immune activation and increased vulnerability to epithelial damage. AhR activity can be regulated by dietary components, such as those present in cruciferous vegetables, providing a mechanistic link between dietary compounds, the intestinal immune system, and the microbiota.	[Innocentin, Ying Li Silvia; Wilhelm, Christoph; Veldhoen, Marc] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Gallagher, Alec R.] MRC Natl Inst Med Res, Div Biol Serv, London NW7 1AA, England; [Grigorieva, Elena F.] MRC Natl Inst Med Res, Div Dev Neurobiol, London NW7 1AA, England; [Withers, David R.; Veldhoen, Marc] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Roberts, Natalie A.; Gallagher, Alec R.] Univ Birmingham, Sch Med, Inst Biomed Res, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Birmingham	Veldhoen, M (corresponding author), MRC Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	marc.veldhoen@babraham.ac.uk	Wilhelm, Christoph/ABE-7176-2020; Withers, David/C-7055-2015; Veldhoen, Marc/AAM-5357-2021; Veldhoen, Marc/AAJ-2759-2020	Wilhelm, Christoph/0000-0002-9839-0291; Withers, David/0000-0003-3757-7594; Veldhoen, Marc/0000-0002-1478-9562; /0000-0001-9113-6306	Medical Research Council UK [U117512792]; Biotechnology and Biological Sciences Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000S042] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish; BBSRC [BBS/E/B/0000S042] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Rae and G. Preece for assistance with cell sorting; H. Boyes, J. Holland, and T. Norton for assistance with maintenance of mouse strains; and Drs. B. Stockinger, E. Simpson, G. Butcher, and M. Turner for helpful discussions and advice. The work was supported by the Medical Research Council UK (Ref. U117512792) and the Biotechnology and Biological Sciences Research Council.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Amre DK, 2007, AM J GASTROENTEROL, V102, P2016, DOI 10.1111/j.1572-0241.2007.01411.x; Andoh A, 2011, J GASTROENTEROL, V46, P479, DOI 10.1007/s00535-010-0368-4; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; BERGSTRESSER PR, 1984, METHOD ENZYMOL, V108, P683; Bernstein CN, 2005, GASTROENTEROLOGY, V129, P827, DOI 10.1053/j.gastro.2005.06.021; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; CARDING SR, 1990, GENE DEV, V4, P1304, DOI 10.1101/gad.4.8.1304; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Cong YZ, 1998, J EXP MED, V187, P855, DOI 10.1084/jem.187.6.855; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; D'Souza S, 2008, INFLAMM BOWEL DIS, V14, P367, DOI 10.1002/ibd.20333; Davenport CM, 2002, INT IMMUNOPHARMACOL, V2, P653, DOI 10.1016/S1567-5769(01)00201-6; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FernandezSalguero PM, 1997, VET PATHOL, V34, P605, DOI 10.1177/030098589703400609; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fuss IJ, 1996, J IMMUNOL, V157, P1261; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Guerreiro CS, 2007, AM J GASTROENTEROL, V102, P2551, DOI 10.1111/j.1572-0241.2007.01439.x; HARPER PH, 1985, GUT, V26, P279, DOI 10.1136/gut.26.3.279; Hoffmann RM, 2004, INFLAMM BOWEL DIS, V10, P140, DOI 10.1097/00054725-200403000-00013; Ismail AS, 2009, J IMMUNOL, V182, P3047, DOI 10.4049/jimmunol.0802705; Ito SJ, 2007, J CLIN INVEST, V117, P1940, DOI 10.1172/JCI31647; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; King DP, 1999, J IMMUNOL, V162, P5033; Kliewer SA, 1999, SCIENCE, V284, P757, DOI 10.1126/science.284.5415.757; KNUTSON JC, 1982, CELL, V30, P225, DOI 10.1016/0092-8674(82)90028-9; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Lahvis GP, 1998, BIOCHEM PHARMACOL, V56, P781, DOI 10.1016/S0006-2952(98)00134-8; Leon F, 2006, J IMMUNOL, V177, P6974, DOI 10.4049/jimmunol.177.10.6974; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Najarian DJ, 2003, J AM ACAD DERMATOL, V48, P805, DOI 10.1067/mjd.2003.540; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; ROCHA B, 1994, J EXP MED, V180, P681, DOI 10.1084/jem.180.2.681; SADEK CM, 1994, J BIOL CHEM, V269, P16067; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; Shanahan F, 2000, SCIENCE, V289, P1311, DOI 10.1126/science.289.5483.1311; Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xiong N, 2002, IMMUNITY, V16, P453, DOI 10.1016/S1074-7613(02)00285-6	66	536	563	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					629	640		10.1016/j.cell.2011.09.025	http://dx.doi.org/10.1016/j.cell.2011.09.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	21999944	Bronze			2022-12-24	WOS:000296573700017
J	Fleming, TR; Emerson, SS				Fleming, Thomas R.; Emerson, Scott S.			Evaluating Rivaroxaban for Nonvalvular Atrial Fibrillation - Regulatory Considerations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fleming, Thomas R.; Emerson, Scott S.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fleming, TR (corresponding author), Univ Washington, Dept Biostat, Seattle, WA 98195 USA.				NIAID NIH HHS [R37 AI029168] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Fleming TR, 2011, CLIN TRIALS, V8, P432, DOI 10.1177/1740774511410994; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; US Government Printing Office, 1995, FED REGISTER, V60, P39180	4	32	33	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1557	1559		10.1056/NEJMp1110639	http://dx.doi.org/10.1056/NEJMp1110639			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HI	21992495				2022-12-24	WOS:000296181800011
J	Romm, J				Romm, Joseph			The next dust bowl	NATURE			English	Editorial Material							CLIMATE		Ctr Amer Progress Act Fund, Washington, DC USA		Romm, J (corresponding author), Ctr Amer Progress Act Fund, Washington, DC USA.	jromm@americanprogress.org						[Anonymous], 2009, GLOBAL CLIMATE CHANG; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Dai AG, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015541; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; RIND D, 1990, J GEOPHYS RES-ATMOS, V95, P9983, DOI 10.1029/JD095iD07p09983; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stewart IT, 2005, J CLIMATE, V18, P1136, DOI 10.1175/JCLI3321.1; Woodhouse CA, 2010, P NATL ACAD SCI USA, V107, P21283, DOI 10.1073/pnas.0911197107	10	106	110	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					450	451		10.1038/478450a	http://dx.doi.org/10.1038/478450a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031419	Bronze			2022-12-24	WOS:000296194200015
J	Penston, J				Penston, James			Should we use total mortality rather than cancer specific mortality to judge cancer screening programmes? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							ALL-CAUSE MORTALITY; COLORECTAL-CANCER; BREAST; TRIAL		Scunthorpe Gen Hosp, Scunthorpe DN15 7BH, England		Penston, J (corresponding author), Scunthorpe Gen Hosp, Scunthorpe DN15 7BH, England.	james.penston@nhs.net						Black WC, 2002, JNCI-J NATL CANCER I, V94, P167, DOI 10.1093/jnci/94.3.167; Gotzsche PC, 2011, J ROY SOC MED, V104, P361, DOI 10.1258/jrsm.2011.110078; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Moayyedi P, 2006, AM J GASTROENTEROL, V101, P380, DOI 10.1111/j.1572-0241.2006.00537.x; Newman DH, 2010, JNCI-J NATL CANCER I, V102, P1008, DOI 10.1093/jnci/djq190; Scholefield JH, 2002, GUT, V50, P840, DOI 10.1136/gut.50.6.840; Tabar L, 2002, J MED SCREEN, V9, P159, DOI 10.1136/jms.9.4.159	7	39	39	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 13	2011	343								d6395	10.1136/bmj.d6395	http://dx.doi.org/10.1136/bmj.d6395			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EQ	21998347				2022-12-24	WOS:000296018300005
J	Bardage, C; Persson, I; Ortqvist, A; Bergman, U; Ludvigsson, JF; Granath, F				Bardage, Carola; Persson, Ingemar; Ortqvist, Ake; Bergman, Ulf; Ludvigsson, Jonas F.; Granath, Fredrik			Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUILLAIN-BARRE-SYNDROME; BELLS-PALSY; ASSOCIATION; CHILDREN; SAFETY	Objective To examine the risk of neurological and autoimmune disorders of special interest in people vaccinated against pandemic influenza A (H1N1) with Pandemrix (GlaxoSmithKline, Middlesex, UK) compared with unvaccinated people over 8-10 months. Design Retrospective cohort study linking individualised data on pandemic vaccinations to an inpatient and specialist database on healthcare utilisation in Stockholm county for follow-up during and after the pandemic period. Setting Stockholm county, Sweden. Population All people registered in Stockholm county on 1 October 2009 and who had lived in this region since 1 January 1998; 1 024 019 were vaccinated against H1N1 and 921 005 remained unvaccinated. Main outcome measures Neurological and autoimmune diagnoses according to the European Medicines Agency strategy for monitoring of adverse events of special interest defined using ICD-10 codes for Guillain-Barre syndrome, Bell's palsy, multiple sclerosis, polyneuropathy, anaesthesia or hypoaesthesia, paraesthesia, narcolepsy (added), and autoimmune conditions such as rheumatoid arthritis, inflammatory bowel disease, and type 1 diabetes; and short term mortality according to vaccination status. Results Excess risks among vaccinated compared with unvaccinated people were of low magnitude for Bell's palsy (hazard ratio 1.25, 95% confidence interval 1.06 to 1.48) and paraesthesia (1.11, 1.00 to 1.23) after adjustment for age, sex, socioeconomic status, and healthcare utilisation. Risks for Guillain-Barre syndrome, multiple sclerosis, type 1 diabetes, and rheumatoid arthritis remained unchanged. The risks of paraesthesia and inflammatory bowel disease among those vaccinated in the early phase (within 45 days from 1 October 2009) of the vaccination campaign were significantly increased; the risk being increased within the first six weeks after vaccination. Those vaccinated in the early phase were at a slightly reduced risk of death than those who were unvaccinated (0.94, 0.91 to 0.98), whereas those vaccinated in the late phase had an overall reduced mortality (0.68, 0.64 to 0.71). These associations could be real or explained, partly or entirely, by residual confounding. Conclusions Results for the safety of Pandemrix over 8-10 months of follow-up were reassuring -notably, no change in the risk for Guillain-Barre syndrome, multiple sclerosis, type 1 diabetes, or rheumatoid arthritis. Relative risks were significantly increased for Bell's palsy, paraesthesia, and inflammatory bowel disease after vaccination, predominantly in the early phase of the vaccination campaign. Small numbers of children and adolescents with narcolepsy precluded any meaningful conclusions.	[Bardage, Carola; Persson, Ingemar] Med Prod Agcy, SE-75103 Uppsala, Sweden; [Persson, Ingemar; Bergman, Ulf; Ludvigsson, Jonas F.; Granath, Fredrik] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Ortqvist, Ake] Stockholm Cty Council, Dept Communicable Dis Control & Prevent, Stockholm, Sweden; [Ortqvist, Ake] Karolinska Inst, Karolinska Univ Hosp, Infect Dis Unit, Dept Med, Stockholm, Sweden; [Bergman, Ulf] Karolinska Inst, Div Clin Pharmacol, Reg Drug Safety Unit, Stockholm, Sweden; [Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Paediat, Orebro, Sweden	Medical Products Agency; Karolinska Institutet; Stockholm County Council; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University	Bardage, C (corresponding author), Med Prod Agcy, POB 26, SE-75103 Uppsala, Sweden.	Carola.Bardage@mpa.se	Ludvigsson, Jonas F/A-8560-2012	Ludvigsson, Jonas F/0000-0003-1024-5602; Bergman, Ulf/0000-0003-4654-2211	Stockholm County Council; Medical Products Agency	Stockholm County Council(Stockholm County Council); Medical Products Agency	Stockholm County Council and the Medical Products Agency.	[Anonymous], 2000, Diabetologia, V43, P47; [Anonymous], 2011, NAT NARC TASK FORC I; [Anonymous], 2009, EMEA3593812009 EMA; [Anonymous], 2011, OCC NARC CAT CHILDR; DeStefano F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.6.e112; Diez-Domingo J, 2010, PEDIATR INFECT DIS J, V29, pE35, DOI 10.1097/INF.0b013e3181daf921; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Hviid A, 2004, NEW ENGL J MED, V350, P1398, DOI 10.1056/NEJMoa032665; Johansen K, 2009, EUROSURVEILLANCE, V14, P12; Karvonen M, 1999, BRIT MED J, V318, P1169, DOI 10.1136/bmj.318.7192.1169; Kuroda Y, 2004, BIOMED PHARMACOTHER, V58, P325, DOI 10.1016/j.biopha.2004.04.009; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Liang XF, 2011, NEW ENGL J MED, V364, P638, DOI 10.1056/NEJMoa1008553; Lofgren S, 2010, SCAND J PUBLIC HEALT, V38, P418, DOI 10.1177/1403494810370232; Lu CC, 2011, VACCINE, V29, P444, DOI 10.1016/j.vaccine.2010.10.081; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Medical Products Agency, 2011, REG BAS COMP COH STU; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Park SW, 2011, AM J INFECT CONTROL, V39, P69, DOI 10.1016/j.ajic.2010.08.007; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SAFRANEK TJ, 1991, AM J EPIDEMIOL, V133, P940, DOI 10.1093/oxfordjournals.aje.a115973; Satoh M, 2003, J AUTOIMMUN, V21, P1, DOI 10.1016/S0896-8411(03)00083-0; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Silfverdal SA, 2010, ACTA PAEDIATR, V99, P1287, DOI [10.1111/j.1651-2227.2010.01839.x, 10.1111/j.1651-2227.2010.01901.x]; Stowe J, 2006, HUM VACCINES, V2, P110, DOI 10.4161/hv.2790; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Szego J.Bebyggelsensmosaik, 2009, 7 REG; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization, 2005, INFL PAND PREP RESP; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Zhou WG, 2004, PHARMACOEPIDEM DR S, V13, P505, DOI 10.1002/pds.998	32	130	132	1	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 12	2011	343								d5956	10.1136/bmj.d5956	http://dx.doi.org/10.1136/bmj.d5956			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835EO	21994316	Green Published, hybrid			2022-12-24	WOS:000296018100002
J	Taniguchi-Ikeda, M; Kobayashi, K; Kanagawa, M; Yu, C; Mori, K; Oda, T; Kuga, A; Kurahashi, H; Akman, HO; DiMauro, S; Kaji, R; Yokota, T; Takeda, S; Toda, T				Taniguchi-Ikeda, Mariko; Kobayashi, Kazuhiro; Kanagawa, Motoi; Yu, Chih-chieh; Mori, Kouhei; Oda, Tetsuya; Kuga, Atsushi; Kurahashi, Hiroki; Akman, Hasan O.; DiMauro, Salvatore; Kaji, Ryuji; Yokota, Toshifumi; Takeda, Shin'ichi; Toda, Tatsushi			Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy	NATURE			English	Article							DYSTROGLYCAN GLYCOSYLATION; TRANSPOSABLE ELEMENTS; GENOME EVOLUTION; GENE; INSERTION; EXPRESSION; DISEASE; PATHOLOGY; HUMANS; FAMILY	Fukuyama muscular dystrophy (FCMD; MIM253800), one of the most common autosomal recessive disorders in Japan, was the first human disease found to result from ancestral insertion of a SINE-VNTR-Alu (SVA) retrotransposon into a causative gene(1-3). In FCMD, the SVA insertion occurs in the 3' untranslated region (UTR) of the fukutin gene. The pathogenic mechanism for FCMD is unknown, and no effective clinical treatments exist. Here we show that aberrant messenger RNA (mRNA) splicing, induced by SVA exon-trapping, underlies the molecular pathogenesis of FCMD. Quantitative mRNA analysis pinpointed a region that was missing from transcripts in patients with FCMD. This region spans part of the 3' end of the fukutin coding region, a proximal part of the 3' UTR and the SVA insertion. Correspondingly, fukutin mRNA transcripts in patients with FCMD and SVA knock-in model mice were shorter than the expected length. Sequence analysis revealed an abnormal splicing event, provoked by a strong acceptor site in SVA and a rare alternative donor site in fukutin exon 10. The resulting product truncates the fukutin carboxy (C) terminus and adds 129 amino acids encoded by the SVA. Introduction of antisense oligonucleotides (AONs) targeting the splice acceptor, the predicted exonic splicing enhancer and the intronic splicing enhancer prevented pathogenic exon-trapping by SVA in cells of patients with FCMD and model mice, rescuing normal fukutin mRNA expression and protein production. AON treatment also restored fukutin functions, including O-glycosylation of alpha-dystroglycan (alpha-DG) and laminin binding by alpha-DG. Moreover, we observe exon-trapping in other SVA insertions associated with disease (hypercholesterolemia(4), neutral lipid storage disease(5)) and human-specific SVA insertion in a novel gene. Thus, although splicing into SVA is known(6-8), we have discovered in human disease a role for SVA-mediated exon-trapping and demonstrated the promise of splicing modulation therapy as the first radical clinical treatment for FCMD and other SVA-mediated diseases.	[Taniguchi-Ikeda, Mariko; Kobayashi, Kazuhiro; Kanagawa, Motoi; Yu, Chih-chieh; Mori, Kouhei; Oda, Tetsuya; Kuga, Atsushi; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan; [Taniguchi-Ikeda, Mariko] Kobe Univ, Grad Sch Med, Div Gen Pediat, Kobe, Hyogo 6500017, Japan; [Kurahashi, Hiroki] Fujita Hlth Univ, Inst Comprehens Med Sci, Div Mol Genet, Aichi 4701192, Japan; [Akman, Hasan O.; DiMauro, Salvatore] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Kaji, Ryuji] Univ Tokushima, Grad Sch, Dept Clin Neurosci, Tokushima 7708503, Japan; [Yokota, Toshifumi] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; [Takeda, Shin'ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo 1878502, Japan	Kobe University; Kobe University; Fujita Health University; Columbia University; Tokushima University; University of Alberta; National Center for Neurology & Psychiatry - Japan	Toda, T (corresponding author), Kobe Univ, Grad Sch Med, Div Neurol Mol Brain Sci, Kobe, Hyogo 6500017, Japan.	toda@med.kobe-u.ac.jp	Taniguchi-Ikeda, Mariko/GPP-1368-2022; Kobayashi, Kazuhiro/AAH-8638-2021; Taniguchi-Ikeda, Mariko/AGE-3152-2022	Kobayashi, Kazuhiro/0000-0001-7801-147X; Taniguchi-Ikeda, Mariko/0000-0002-1607-400X; Toda, Tatsushi/0000-0002-0717-1123; Yokota, Toshifumi/0000-0001-7316-3546; , toshifumi/0000-0001-6672-6742; Kanagawa, Motoi/0000-0003-0984-6398	National Center of Neurology and Psychiatry [20B-13]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [23249049, 21689030, 20790980]; Takeda Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056993] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23013019, 21390101, 23659182, 21689030, 22790980] Funding Source: KAKEN	National Center of Neurology and Psychiatry(National Center for Neurology & Psychiatry - Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank S. Nakagawa, K. Ohno, S. Tsujino, N. Taniguchi, and I. Nonaka for comments; M. Okabe and A. Kawai for generating the ES cell line from knock-in model mice; Y. Motoyoshi and J. C. Cohen for providing patients' samples; W. Sako and Y. Izumi for sending patients' samples; I. Mizuta, T. Mure, M. Furukawa, K. Kaneshiro, Y. Dainin and all laboratory members for technical support; and J. Logan for editing the manuscript. We thank the GAIN for providing chimpanzee brain samples. This work was supported by an Intramural Research Grant (20B-13) for Neurological and Psychiatric Disorders from the National Center of Neurology and Psychiatry (to T. T.), the Global COE Program (Frontier Biomedical Science Underlying Organelle Network Biology) (to T. T., M.T.-I. and M. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research (A) (23249049 to T. T.), and Young Scientists (A) (21689030 to K. K.) and (B) (20790980 to M.T.-I.) from the Japan Society for the Promotion of Science, and the Takeda Science Foundation (to K.K.).	Akman HO, 2010, NEUROMUSCULAR DISORD, V20, P397, DOI 10.1016/j.nmd.2010.04.004; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bantysh OB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1393, DOI 10.1134/S0006297909120153; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Crooke ST, 1998, ANTISENSE NUCLEIC A, V8, pVII, DOI 10.1089/oli.1.1998.8.vii; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Hancks DC, 2011, HUM MOL GENET, V20, P3386, DOI 10.1093/hmg/ddr245; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Hancks DC, 2009, GENOME RES, V19, P1983, DOI 10.1101/gr.093153.109; HASSOUN H, 1994, J CLIN INVEST, V94, P643, DOI 10.1172/JCI117380; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kanagawa M, 2009, HUM MOL GENET, V18, P621, DOI 10.1093/hmg/ddn387; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Legoix P, 2000, GENOMICS, V65, P62, DOI 10.1006/geno.2000.6139; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Makino S, 2007, AM J HUM GENET, V80, P393, DOI 10.1086/512129; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; O'Brien S, 2007, J CLIN ONCOL, V25, P1114, DOI 10.1200/JCO.2006.07.1191; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Rohrer J, 1999, CLIN IMMUNOL, V90, P28, DOI 10.1006/clim.1998.4629; Strichman-Almashanu LZ, 2003, GENOME RES, V13, P800, DOI 10.1101/gr.893803; Takeda S, 2003, HUM MOL GENET, V12, P1449, DOI 10.1093/hmg/ddg153; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Watanabe M, 2005, AM J MED GENET A, V138A, P344, DOI 10.1002/ajmg.a.30978; Wilund KR, 2002, HUM MOL GENET, V11, P3019, DOI 10.1093/hmg/11.24.3019; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yokota T, 2009, ANN NEUROL, V65, P667, DOI 10.1002/ana.21627	33	118	129	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					127	U143		10.1038/nature10456	http://dx.doi.org/10.1038/nature10456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979053	Green Accepted			2022-12-24	WOS:000295575400048
J	Manolio, TA; Green, ED				Manolio, Teri A.; Green, Eric D.			Genomics Reaches the Clinic: From Basic Discoveries to Clinical Impact	CELL			English	Editorial Material							MEDICINE	Today, more than ever, basic science research provides significant opportunities to advance our understanding about the genetic basis of human disease. Close interactions among laboratory, computational, and clinical research communities will be crucial to ensure that genomic discoveries advance medical science and, ultimately, improve human health.	[Manolio, Teri A.; Green, Eric D.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, ED (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Collins FS, 1999, ANN NY ACAD SCI, V882, P42, DOI 10.1111/j.1749-6632.1999.tb08532.x; COLLINS FS, 1999, ANN NY ACAD SCI, V882, P56; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Roden DM, 2010, CIRCULATION, V122, P445, DOI 10.1161/CIRCULATIONAHA.110.973362; St Hilaire C, 2011, NEW ENGL J MED, V364, P432, DOI [10.1056/NEJMoa0912923, 10.1056/NEJMc1102515]; Varmus H, 2010, NEW ENGL J MED, V362, P2028, DOI 10.1056/NEJMe0911933; Wilke RA, 2011, JAMA-J AM MED ASSOC, V306, P306, DOI 10.1001/jama.2011.998; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158	11	22	22	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					14	16		10.1016/j.cell.2011.09.012	http://dx.doi.org/10.1016/j.cell.2011.09.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962499	Bronze			2022-12-24	WOS:000295396700007
J	Raychaudhuri, S				Raychaudhuri, Soumya			Mapping Rare and Common Causal Alleles for Complex Human Diseases	CELL			English	Article							GENOME-WIDE ASSOCIATION; CHROMATIN SIGNATURES; GENE-EXPRESSION; LARGE-SCALE; VARIANTS; POPULATION; SEQUENCE; LOCI; RISK; IMPUTATION	Advances in genotyping and sequencing technologies have revolutionized the genetics of complex disease by locating rare and common variants that influence an individual's risk for diseases, such as diabetes, cancers, and psychiatric disorders. However, to capitalize on these data for prevention and therapies requires the identification of causal alleles and a mechanistic understanding for how these variants contribute to the disease. After discussing the strategies currently used to map variants for complex diseases, this Primer explores how variants may be prioritized for follow-up functional studies and the challenges and approaches for assessing the contributions of rare and common variants to disease phenotypes.	[Raychaudhuri, Soumya] Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya] MIT, Cambridge, MA 02142 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Raychaudhuri, S (corresponding author), Harvard Univ, Sch Med, Div Genet, Brigham & Womens Hosp, Boston, MA 02115 USA.	soumya@broadinstitute.org		Raychaudhuri, Soumya/0000-0002-1901-8265	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NIAMS NIH HHS [K08 AR055688-01A1S1, K08 AR055688, K08 AR055688-05, K08 AR055688-04] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000580; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Browning SR, 2008, HUM GENET, V124, P439, DOI 10.1007/s00439-008-0568-7; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Gusev A, 2011, AM J HUM GENET, V88, P706, DOI 10.1016/j.ajhg.2011.04.023; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hicks S, 2011, HUM MUTAT, V32, P661, DOI 10.1002/humu.21490; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoggart CJ, 2008, GENET EPIDEMIOL, V32, P179, DOI 10.1002/gepi.20292; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li H, 2010, BRIEF BIOINFORM, V11, P473, DOI 10.1093/bib/bbq015; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maxmen A, 2011, CELL, V144, P635, DOI 10.1016/j.cell.2011.02.033; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Montgomery SB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002144; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Raychaudhuri S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001097; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	91	72	78	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					57	69		10.1016/j.cell.2011.09.011	http://dx.doi.org/10.1016/j.cell.2011.09.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962507	Green Accepted, Bronze			2022-12-24	WOS:000295396700015
J	Visintin, C; Mugglestone, MA; James, D; Kilby, MD				Visintin, Cristina; Mugglestone, Moira A.; James, David; Kilby, Mark D.		Guideline Dev Grp	GUIDELINES Antenatal care for twin and triplet pregnancies: summary of NICE guidance	BRITISH MEDICAL JOURNAL			English	Editorial Material							GESTATIONS		[Visintin, Cristina; Mugglestone, Moira A.; James, David] Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England; [Kilby, Mark D.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England; [Kilby, Mark D.] Birmingham Womens Fdn Trust, Birmingham B15 2TG, W Midlands, England	University of Birmingham	Mugglestone, MA (corresponding author), Natl Collaborating Ctr Womens & Childrens Hlth, London W1T 2QA, England.	mmugglestone@ncc-wch.org.uk	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; Nherera, Leo/P-1567-2018	FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Bricker, Leanne/0000-0001-7713-2771; Nherera, Leo/0000-0003-1758-9504; Thilaganathan, Basky/0000-0002-5531-4301				[Anonymous], 2008, ANT CAR ROUT CAR HLT; CHAN A, 2008, PREGNANCY OUTCOME S; Department of Health, 2010, EQ EXC LIB NHS; EDWARDS MS, 1995, ULTRASOUND OBST GYN, V6, P43, DOI 10.1046/j.1469-0705.1995.06010043.x; Elliott JP, 2005, SEMIN PERINATOL, V29, P305, DOI 10.1053/j.semperi.2005.08.001; Laws PJ., 2008, AUSTR MOTHERS BABIES; LIPITZ S, 1994, AM J OBSTET GYNECOL, V170, P874, DOI 10.1016/S0002-9378(94)70301-9; Luke B, 2003, AM J OBSTET GYNECOL, V189, P934, DOI 10.1067/S0002-9378(03)01054-8; *NAT I HLTH CLIN E, 2006, SEPT AMN TREATM TWIN; *NAT I HLTH CLIN E, 2006, INTR LAS ABL PLAC VE; National Institute for Health and Clinical Excellence, 2011, MULT PREGN MAN TWIN; Roberts CL, 2002, INT J GYNECOL OBSTET, V78, P213, DOI 10.1016/S0020-7292(02)00147-9; *SEMACH, 2009, CONF ENQ MAT CHILD H; Tucker J, 2004, BRIT MED J, V329, P675, DOI 10.1136/bmj.329.7467.675	14	32	35	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 28	2011	343								d5714	10.1136/bmj.d5714	http://dx.doi.org/10.1136/bmj.d5714			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829JZ	21957208				2022-12-24	WOS:000295577100003
J	Michalczyk, L; Millard, AL; Martin, OY; Lumley, AJ; Emerson, BC; Chapman, T; Gage, MJG				Michalczyk, Lukasz; Millard, Anna L.; Martin, Oliver Y.; Lumley, Alyson J.; Emerson, Brent C.; Chapman, Tracey; Gage, Matthew J. G.			Inbreeding Promotes Female Promiscuity	SCIENCE			English	Article							POLYANDROUS FEMALES; SEXUAL SELECTION; SPERM SELECTION; EVOLUTION; FITNESS; SUCCESS; BEETLE	The widespread phenomenon of polyandry (mating by females with multiple males) is an evolutionary puzzle, because females can sustain costs from promiscuity, whereas full fertility can be provided by a single male. Using the red flour beetle, Tribolium castaneum, we identify major fitness benefits of polyandry to females under inbreeding, when the risks of fertilization by incompatible male haplotypes are especially high. Fifteen generations after inbred populations had passed through genetic bottlenecks, we recorded increased levels of female promiscuity compared with noninbred controls, most likely due to selection from prospective fitness gains through polyandry. These data illustrate how this common mating pattern can evolve if population genetic bottlenecks increase the risks of fitness depression due to fertilization by sperm carrying genetically incompatible haplotypes.	[Michalczyk, Lukasz; Millard, Anna L.; Martin, Oliver Y.; Lumley, Alyson J.; Emerson, Brent C.; Chapman, Tracey; Gage, Matthew J. G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Martin, Oliver Y.] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Emerson, Brent C.] Isl Ecol & Evolut Res Grp IPNA CSIC, Tenerife, Spain	University of East Anglia; Swiss Federal Institutes of Technology Domain; ETH Zurich; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Gage, MJG (corresponding author), Univ E Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	m.gage@uea.ac.uk	Gage, Matthew/E-5539-2011; Chapman, Tracey/E-5100-2011; MARTIN, OLIVER Y/A-4534-2009; Michalczyk, Łukasz/D-1362-2009	MARTIN, OLIVER Y/0000-0002-8601-7131; Michalczyk, Łukasz/0000-0002-2912-4870; Emerson, Brent/0000-0003-4067-9858	Natural Environment Research Council; University of East Anglia; Swiss National Science Foundation; NERC [NE/G006881/1] Funding Source: UKRI; Natural Environment Research Council [NE/C004639/1, NE/G006881/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of East Anglia; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Beeman and the Stored Product Insect Research Unit for providing Tribolium stocks, and C. Fricke, A. Bretman, and the referees and editors for manuscript improvements. Funded by the Natural Environment Research Council, the University of East Anglia, and the Swiss National Science Foundation. Data sets for all assays described in this paper are available in the DRYAD data repository under http://dx.doi.org/10.5061/dryad.2cn83.	Arnqvist Goran, 2005, pUnpaginated; Birkhead TR, 1998, SPERM COMPETITION SE; Bloch MC, 1996, ANN ENTOMOL SOC AM, V89, P892, DOI 10.1093/aesa/89.6.892; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; COCKBURN A, 1985, ANIM BEHAV, V33, P908, DOI 10.1016/S0003-3472(85)80025-7; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; Drury DW, 2009, J HERED, V100, P732, DOI 10.1093/jhered/esp077; Edvardsson M, 2000, P ROY SOC B-BIOL SCI, V267, P559, DOI 10.1098/rspb.2000.1037; Fisher DO, 2006, NATURE, V444, P89, DOI 10.1038/nature05206; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Frankham R, 2005, J EVOLUTION BIOL, V18, P750, DOI 10.1111/j.1420-9101.2005.00885.x; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Michalczyk L, 2011, EVOLUTION, V65, P713, DOI 10.1111/j.1558-5646.2010.01174.x; Michalczyk L, 2010, P ROY SOC B-BIOL SCI, V277, P3483, DOI 10.1098/rspb.2010.0514; Olsson M, 1996, NATURE, V383, P585, DOI 10.1038/383585a0; Pai A, 2003, CAN J ZOOL, V81, P888, DOI [10.1139/z03-070, 10.1139/Z03-070]; Parker G.A., 1979, SEXUAL SELECTION REP, P123, DOI DOI 10.1016/B978-0-12-108750-0.50010-0; Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Wade MJ, 1996, EVOLUTION, V50, P723, DOI 10.1111/j.1558-5646.1996.tb03882.x; Wright S, 1921, GENETICS, V6, P111; Yasui Y, 1997, AM NAT, V149, P573, DOI 10.1086/286006; Zeh JA, 1997, BEHAV ECOL SOCIOBIOL, V40, P111, DOI 10.1007/s002650050323; Zeh JA, 2001, ANIM BEHAV, V61, P1051, DOI 10.1006/anbe.2000.1705	30	77	77	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1739	1742		10.1126/science.1207314	http://dx.doi.org/10.1126/science.1207314			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940892				2022-12-24	WOS:000295121500040
J	Fine, AM; Nizet, V; Mandl, KD				Fine, Andrew M.; Nizet, Victor; Mandl, Kenneth D.			Improved Diagnostic Accuracy of Group A Streptococcal Pharyngitis With Use of Real-Time Biosurveillance	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; RETAIL CLINICS; DECISION RULE; STREP THROAT; SORE THROAT; SURVEILLANCE; CHILDREN; INFLUENZA; HEALTH; ADULTS	Background: Clinical prediction rules do not incorporate real-time incidence data to adjust estimates of disease risk in symptomatic patients. Objective: To measure the value of integrating local incidence data into a clinical decision rule for diagnosing group A streptococcal (GAS) pharyngitis in patients aged 15 years or older. Design: Retrospective analysis of clinical and biosurveillance predictors of GAS pharyngitis. Setting: Large U. S.-based retail health chain. Patients: 82 062 patient visits for pharyngitis. Measurements: Accuracy of the Centor score was compared with that of a biosurveillance-responsive score, which was essentially an adjusted Centor score based on real-time GAS pharyngitis information from the 14 days before a patient's visit: the recent local proportion positive (RLPP). Results: Increased RLPP correlated with the likelihood of GAS pharyngitis (r(2) = 0.79; P < 0.001). Local incidence data enhanced diagnostic models. For example, when the RLPP was greater than 0.30, managing patients with Centor scores of 1 as if the scores were 2 would identify 62 537 previously missed patients annually while misclassifying 18 446 patients without GAS pharyngitis. Decreasing the score of patients with Centor values of 3 by 1 point for an RLPP less than 0.20 would spare unnecessary antibiotics for 166 616 patients while missing 18 812 true-positive cases. Limitations: Analyses were conducted retrospectively. Real-time regional data on GAS pharyngitis are generally not yet available to clinicians. Conclusion: Incorporating live biosurveillance data into clinical guidelines for GAS pharyngitis and other communicable diseases should be considered for reducing missed cases when the contemporaneous incidence is elevated and for sparing unnecessary antibiotics when the contemporaneous incidence is low. Delivering epidemiologic data to the point of care will enable the use of real-time pretest probabilities in medical decision making.	[Fine, Andrew M.] Harvard Univ, Sch Med, Childrens Hosp Boston, Harvard MIT Hlth Sci & Technol, Boston, MA 02115 USA; Univ Calif San Diego, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego	Fine, AM (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Harvard MIT Hlth Sci & Technol, 300 Longwood Ave, Boston, MA 02115 USA.		Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422	Centers for Disease Control and Prevention (CDC) [K01HK000055, P01HK000088]; National Library of Medicine, National Institutes of Health [1G08LM009778, R01 LM007677]; NATIONAL LIBRARY OF MEDICINE [G08LM009778, R01LM007677] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Centers for Disease Control and Prevention and the National Library of Medicine, National Institutes of Health.; By the Mentored Public Health Research Scientist Development Award K01HK000055 from the Centers for Disease Control and Prevention (CDC), by Public Health Informatics Center of Excellence Award P01HK000088 from CDC, and by grants 1G08LM009778 and R01 LM007677 from the National Library of Medicine, National Institutes of Health.	[Anonymous], 2005, MMWR MORB MORTAL W S, V54, P1; Asteberg I, 2006, SCAND J INFECT DIS, V38, P988, DOI 10.1080/00365540600868370; Bisno AL, 2002, CLIN INFECT DIS, V35, P126, DOI 10.1086/342056; Bisno AL, 2001, NEW ENGL J MED, V344, P205, DOI 10.1056/NEJM200101183440308; Blumenthal D, 2010, NEW ENGL J MED, V362, P382, DOI 10.1056/NEJMp0912825; Brownstein JS, 2010, NEW ENGL J MED, V362, P1731, DOI 10.1056/NEJMsr1002707; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; Corneli HM, 2001, PEDIATR EMERG CARE, V17, P272, DOI 10.1097/00006565-200108000-00014; CORNFELD D, 1961, AM J PUBLIC HEALTH N, V51, P242, DOI 10.2105/AJPH.51.2.242; Costello D, 2008, HEALTH AFFAIR, V27, P1299, DOI 10.1377/hlthaff.27.5.1299; Croskerry P, 2003, ACAD MED, V78, P775, DOI 10.1097/00001888-200308000-00003; Danchin MH, 2007, PEDIATRICS, V120, P950, DOI 10.1542/peds.2006-3368; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Fine AM, 2007, J AM MED INFORM ASSN, V14, P206, DOI 10.1197/jamia.M2253; Fine AM, 2011, ARCH PEDIAT ADOL MED, V165, P61, DOI 10.1001/archpediatrics.2010.250; Fine AM, 2010, J AM MED INFORM ASSN, V17, P85, DOI 10.1197/jamia.M3061; Fisman DN, 2007, ANNU REV PUBL HEALTH, V28, P127, DOI 10.1146/annurev.publhealth.28.021406.144128; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Institute for Clinical Systems Improvement, STREP PHAR ALG; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Kaplan EL, 2001, LANCET, V358, P1334, DOI 10.1016/S0140-6736(01)06415-7; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; Martin JM, 2002, NEW ENGL J MED, V346, P1200, DOI 10.1056/NEJMoa013169; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Mehrotra A, 2009, ANN INTERN MED, V151, P321, DOI 10.7326/0003-4819-151-5-200909010-00006; Middleton Kimberly, 2007, Adv Data, P1; Pollack CE, 2009, ARCH INTERN MED, V169, P945, DOI 10.1001/archinternmed.2009.69; Rudavsky R, 2009, ANN INTERN MED, V151, P315, DOI 10.7326/0003-4819-151-5-200909010-00005; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Snyderman R, 2010, JAMA-J AM MED ASSOC, V303, P363, DOI 10.1001/jama.2010.34; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; WIGTON RS, 1986, ARCH INTERN MED, V146, P81, DOI 10.1001/archinte.146.1.81; Woodburn JA, 2007, AM J MED QUAL, V22, P457, DOI 10.1177/1062860607309626	37	14	15	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					345	U37		10.7326/0003-4819-155-6-201109200-00002	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00002			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930851	Green Accepted			2022-12-24	WOS:000295033400013
J	Drinnenberg, IA; Fink, GR; Bartel, DP				Drinnenberg, Ines A.; Fink, Gerald R.; Bartel, David P.			Compatibility with Killer Explains the Rise of RNAi-Deficient Fungi	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST		[Drinnenberg, Ines A.; Fink, Gerald R.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Drinnenberg, Ines A.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Fink, Gerald R.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM040266, R01 GM040266, GM0305010, R01 GM061835, GM061835, R37 GM061835] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040266, R37GM061835, R01GM061835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Ivannikova YV, 2007, RES MICROBIOL, V158, P638, DOI 10.1016/j.resmic.2007.07.008; Naumov G. A., 2005, Molekulyarnaya Genetika Mikrobiologiya i Virusologiya, P38; Schmitt MJ, 2006, NAT REV MICROBIOL, V4, P212, DOI 10.1038/nrmicro1347; VALLE RPC, 1993, J VIROL, V67, P2764, DOI 10.1128/JVI.67.5.2764-2771.1993; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996	7	148	151	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1592	1592		10.1126/science.1209575	http://dx.doi.org/10.1126/science.1209575			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921191	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000294900900033
J	Naidu, S; Friedrich, JK; Russell, J; Zomerdijk, JCBM				Naidu, Srivatsava; Friedrich, J. Karsten; Russell, Jackie; Zomerdijk, Joost C. B. M.			TAF1B Is a TFIIB-Like Component of the Basal Transcription Machinery for RNA Polymerase I	SCIENCE			English	Article							PREINITIATION COMPLEX; RDNA TRANSCRIPTION; ZINC RIBBON; FACTOR SL1; INITIATION; PROMOTER; SUBUNITS; RECRUITMENT; BINDING; TBP	Transcription by eukaryotic RNA polymerases (Pols) II and III and archaeal Pol requires structurally related general transcription factors TFIIB, Brf1, and TFB, respectively, which are essential for polymerase recruitment and initiation events. A TFIIB-like protein was not evident in the Pol I basal transcription machinery. We report that TAF1B, a subunit of human Pol I basal transcription factor SL1, is structurally related to TFIIB/TFIIB-like proteins, through predicted amino-terminal zinc ribbon and cyclin-like fold domains. SL1, essential for Pol I recruitment to the ribosomal RNA gene promoter, also has an essential postpolymerase recruitment role, operating through TAF1B. Therefore, a TFIIB-related protein is implicated in preinitiation complex assembly and postpolymerase recruitment events in Pol I transcription, underscoring the parallels between eukaryotic Pol I, II, and III and archaeal transcription machineries.	[Naidu, Srivatsava; Friedrich, J. Karsten; Russell, Jackie; Zomerdijk, Joost C. B. M.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Dundee	Zomerdijk, JCBM (corresponding author), Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland.	j.zomerdijk@dundee.ac.uk		Zomerdijk, Joost/0000-0003-1865-729X	Medical Research Council; Wellcome Trust [085441/Z/08/Z]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	We thank S. Hahn and B. Knutson (Fred Hutchinson Cancer Center, Seattle, WA) for sharing findings with us before publication; B. Knutson for insights regarding connecting region alignments; and S. Hahn, B. Knutson, T. Owen-Hughes (University of Dundee), and J.C.B.M.Z. lab members for advice and critique. This work was supported by a Medical Research Council-funded Ph.D. studentship (J.K.F.) and Wellcome Trust Programme Grant (085441/Z/08/Z) (J.C.B.M.Z.).	BELL SP, 1990, GENE DEV, V4, P943, DOI 10.1101/gad.4.6.943; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; COMAI L, 1994, SCIENCE, V266, P1966, DOI 10.1126/science.7801123; Deng WS, 2007, CHROMOSOMA, V116, P417, DOI 10.1007/s00412-007-0113-9; Elsby LM, 2008, BIOCHEM SOC T, V36, P595, DOI 10.1042/BST0360595; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hahn S, 2000, GENE DEV, V14, P719; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; Kassavetis GA, 2006, BIOCHEM SOC T, V34, P1082, DOI 10.1042/BST0341082; Kassavetis GA, 1998, P NATL ACAD SCI USA, V95, P9196, DOI 10.1073/pnas.95.16.9196; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; KEYS DA, 1994, GENE DEV, V8, P2349, DOI 10.1101/gad.8.19.2349; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tran K, 2008, J BIOL CHEM, V283, P15665, DOI 10.1074/jbc.M801439200; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	29	40	41	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1640	1642		10.1126/science.1207656	http://dx.doi.org/10.1126/science.1207656			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921199	Green Accepted			2022-12-24	WOS:000294900900046
J	Macke, E; Magalhaes, S; Bach, F; Olivieri, I				Macke, Emilie; Magalhaes, Sara; Bach, Fabien; Olivieri, Isabelle			Experimental Evolution of Reduced Sex Ratio Adjustment Under Local Mate Competition	SCIENCE			English	Article							MITE TETRANYCHUS-URTICAE; SPIDER-MITES; FIG WASPS; PHENOTYPIC PLASTICITY; SELECTION; ALLOCATION; DENSITY	Theory predicts that local mate competition (LMC) favors the evolution of female-biased sex ratios. Empirical support of this prediction is indirect and comes from comparative studies or from studies showing that individuals can adjust their offspring sex ratio in response to varying LMC intensities. Replicate lines from a population of the spider mite Tetranychus urticae were selected under three LMC intensities for up to 54 generations. Within each selection regime, the final sex ratio matched theoretical predictions. Furthermore, the ability of individuals to adjust their offspring sex ratio diminished in females evolving under strict LMC, but not in females evolving under relaxed LMC levels. These results provide direct experimental evidence for the evolutionary process by which LMC modifies sex-allocation strategies and suggest that evolution under strict and constant LMC may lead to a loss of phenotypic plasticity.	[Macke, Emilie; Bach, Fabien; Olivieri, Isabelle] Univ Montpellier 2, UMR 5554, Inst Sci Evolut, F-34095 Montpellier 05, France; [Magalhaes, Sara] Univ Lisbon, Fac Ciencias, Ctr Biol Ambiental, P-1749016 Lisbon, Portugal	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universidade de Lisboa	Macke, E (corresponding author), Univ Montpellier 2, UMR 5554, Inst Sci Evolut, Pl Eugene Bataillon, F-34095 Montpellier 05, France.	emilie.macke@univ-montp2.fr; snmagalhaes@fc.ul.pt; isabelle.olivieri@univ-montp2.fr	S., Magalhaes/B-9673-2012; Olivieri, Isabelle/E-5872-2016	S., Magalhaes/0000-0002-8609-7768; Macke, Emilie/0000-0002-5257-4968	University of Montpellier 2; Agence Nationale de la Recherche; Institut Universitaire de France; CNRS	University of Montpellier 2; Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Universitaire de France; CNRS(Centre National de la Recherche Scientifique (CNRS))	We thank D. Bonte, D. Bourguet, P. David, M. Egas, B. Facon, A. Janssen, G. Martin, Y. Michalakis, M. Navajas, C. Parmesan, M.-J. Perrot-Minot, A. Rivero, F. Vala, and S. West for useful discussion and comments. We particularly thank E. A. Herre for useful suggestions during the revision process of the manuscript. M. Weill kindly tested for the presence of Wolbachia and Cardinium in our base population. D. Carbonell provided technical help by growing plant material. F. Bach was supported by The University of Montpellier 2. The research was supported by Agence Nationale de la Recherche contract "GENEVOLSPE" and Institut Universitaire de France to I.O. and a Programme International de Cooperation Scientifique (PICS 2010-2012) from CNRS to I.O. and S. M. This is publication ISEM-2011-129 from The Institut des Sciences de l'Evolution, Montpellier. Data and SAS script files are available as supporting online material.	CHARNOV E L, 1982; COLWELL RK, 1981, NATURE, V290, P401, DOI 10.1038/290401a0; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Fellowes MDE, 1999, BEHAV ECOL SOCIOBIOL, V46, P95, DOI 10.1007/s002650050597; Fisher R.A., 1930, GENETICAL THEORY NAT; FRANK SA, 1985, EVOLUTION, V39, P949, DOI 10.1111/j.1558-5646.1985.tb00440.x; Greeff JM, 2011, EVOLUTION, V65, P203, DOI 10.1111/j.1558-5646.2010.01116.x; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; HERRE EA, 1987, NATURE, V329, P627, DOI 10.1038/329627a0; HERRE EA, 1985, SCIENCE, V228, P896, DOI 10.1126/science.228.4701.896; MITCHELL R, 1972, ENTOMOL EXP APPL, V15, P299, DOI 10.1007/BF00428294; Nagelkerke CJ, 1998, J EVOLUTION BIOL, V11, P649, DOI 10.1007/s000360050112; Orzack S. H., 1992, EVOLUTION DIVERSITY, P477; Roeder C, 1996, J EVOLUTION BIOL, V9, P143, DOI 10.1046/j.1420-9101.1996.9020143.x; ROEDER CM, 1992, CAN J ZOOL, V70, P1965, DOI 10.1139/z92-266; Sato Y, 2007, ECOL ENTOMOL, V32, P597, DOI 10.1111/j.1365-2311.2007.00908.x; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; TAYLOR PD, 1980, J THEOR BIOL, V86, P409, DOI 10.1016/0022-5193(80)90342-2; Tien N. A., 2010, THESIS U AMSTERDAM; Vala F, 2003, AM NAT, V161, P254, DOI 10.1086/345856; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; West S., 2009, SEX ALLOCATION; West SA, 1998, EVOLUTION, V52, P475, DOI 10.1111/j.1558-5646.1998.tb01647.x; West SA, 2000, SCIENCE, V290, P288, DOI 10.1126/science.290.5490.288; WRENSCH DL, 1978, ENVIRON ENTOMOL, V7, P499, DOI 10.1093/ee/7.4.499; YOUNG SSY, 1986, ENTOMOL EXP APPL, V40, P53, DOI 10.1007/BF00187023	27	57	59	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1127	1129		10.1126/science.1212177	http://dx.doi.org/10.1126/science.1212177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22052976				2022-12-24	WOS:000297313900049
J	Greer, EL; Maures, TJ; Ucar, D; Hauswirth, AG; Mancini, E; Lim, JP; Benayoun, BA; Shi, Y; Brunet, A				Greer, Eric L.; Maures, Travis J.; Ucar, Duygu; Hauswirth, Anna G.; Mancini, Elena; Lim, Jana P.; Benayoun, Berenice A.; Shi, Yang; Brunet, Anne			Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans	NATURE			English	Article							SYSTEMATIC RNAI SCREEN; LIFE-SPAN; C. ELEGANS; H3K4 TRIMETHYLATION; STRESS RESISTANCE; GENES; COMPLEX; METHYLATION; DEMETHYLATION; CHROMATIN	Chromatin modifiers regulate lifespan in several organisms, raising the question of whether changes in chromatin states in the parental generation could be incompletely reprogrammed in the next generation and thereby affect the lifespan of descendants. The histone H3 lysine 4 trimethylation (H3K4me3) complex, composed of ASH-2, WDR-5 and the histone methyltransferase SET-2, regulates Caenorhabditis elegans lifespan. Here we show that deficiencies in the H3K4me3 chromatin modifiers ASH-2, WDR-5 or SET-2 in the parental generation extend the lifespan of descendants up until the third generation. The transgenerational inheritance of lifespan extension by members of the ASH-2 complex is dependent on the H3K4me3 demethylase RBR-2, and requires the presence of a functioning germline in the descendants. Transgenerational inheritance of lifespan is specific for the H3K4me3 methylation complex and is associated with epigenetic changes in gene expression. Thus, manipulation of specific chromatin modifiers only in parents can induce an epigenetic memory of longevity in descendants.	[Greer, Eric L.; Maures, Travis J.; Ucar, Duygu; Hauswirth, Anna G.; Mancini, Elena; Lim, Jana P.; Benayoun, Berenice A.; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Greer, Eric L.; Shi, Yang] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Greer, Eric L.; Shi, Yang] Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA	Stanford University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Brunet, A (corresponding author), Stanford Univ, Dept Genet, 300 Pasteur Dr, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Benayoun, Bérénice A./K-7048-2012	Benayoun, Bérénice A./0000-0002-7401-4777; Ucar, Duygu/0000-0002-9772-3066; Greer, Eric/0000-0002-7501-7371	NIH [R01-AG31198, ARRA-AG31198, R01-GM058012, F32-AG037254, T32-MH020016]; NSF; Helen Hay Whitney Post-Doctoral fellowship;  [T32-CA009361]; NATIONAL CANCER INSTITUTE [T32CA009361, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG031198, R01AG031198, F32AG037254] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Helen Hay Whitney Post-Doctoral fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to J. Lieb, A. Rechtsteiner and S. Strome for sharing their ModENCODE data pre-publication and for helpful discussion. We thank K. Shen, M. W. Tan and T. Stiernagle and the Caenorhabditis Genetics Center for gifts of strains and reagents. We thank B. Meyer for her gift of the ASH-2 antibody. We thank A. Fire, S. Kim, J. Sage, S. Iwase, J. Lipsick, E. Pollina, A. Villeneuve and members of the Brunet lab for discussions and critical reading of the manuscript. We thank S. Han for screening different H3K4me3 antibodies for western blots in worm extracts. We thank R. Liefke and H. Tang for help with microarray analysis. This work was supported by NIH R01-AG31198 grant and by a generous gift from the Glenn Foundation for Medical Research to A. B.; E. L. G. was supported by an NSF graduate fellowship, by NIH ARRA-AG31198, by T32-CA009361, by a Helen Hay Whitney Post-Doctoral fellowship, and by a NIH R01-GM058012 (to Y.S.). T. J. M. was supported by NIH F32-AG037254. J. P. L. was supported by NIH T32-MH020016.	Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; BRINK RA, 1956, GENETICS, V41, P872; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Cavalli G, 1999, SCIENCE, V286, P955, DOI 10.1126/science.286.5441.955; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Fisher K, 2010, DEV BIOL, V341, P142, DOI 10.1016/j.ydbio.2010.02.023; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Haag ES, 2002, CURR BIOL, V12, P2035, DOI 10.1016/S0960-9822(02)01333-7; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Li TG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001349; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Muramoto T, 2010, CURR BIOL, V20, P397, DOI 10.1016/j.cub.2010.01.017; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pferdehirt RR, 2011, GENE DEV, V25, P499, DOI 10.1101/gad.2016011; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Seong KH, 2011, CELL, V145, P1049, DOI 10.1016/j.cell.2011.05.029; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Simonet T, 2007, DEV BIOL, V312, P367, DOI 10.1016/j.ydbio.2007.09.035; Spencer WC, 2011, GENOME RES, V21, P325, DOI 10.1101/gr.114595.110; Steward MM, 2006, NAT STRUCT MOL BIOL, V13, P852, DOI 10.1038/nsmb1131; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi Y, 2011, CELL METAB, V13, P505, DOI 10.1016/j.cmet.2011.03.017; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Woodhouse MR, 2006, PLOS BIOL, V4, P1678, DOI 10.1371/journal.pbio.0040339; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xiao Y, 2011, P NATL ACAD SCI USA, V108, P8305, DOI 10.1073/pnas.1019290108	45	418	441	7	139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					365	U204		10.1038/nature10572	http://dx.doi.org/10.1038/nature10572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22012258	Green Accepted			2022-12-24	WOS:000297059700038
J	Cruz-Migoni, A; Hautbergue, GM; Artymiuk, PJ; Baker, PJ; Bokori-Brown, M; Chang, CT; Dickman, MJ; Essex-Lopresti, A; Harding, SV; Mahadi, NM; Marshall, LE; Mobbs, GW; Mohamed, R; Nathan, S; Ngugi, SA; Ong, C; Ooi, WF; Partridge, LJ; Phillips, HL; Raih, MF; Ruzheinikov, S; Sarkar-Tyson, M; Sedelnikova, SE; Smither, SJ; Tan, P; Titball, RW; Wilson, SA; Rice, DW				Cruz-Migoni, Abimael; Hautbergue, Guillaume M.; Artymiuk, Peter J.; Baker, Patrick J.; Bokori-Brown, Monika; Chang, Chung-Te; Dickman, Mark J.; Essex-Lopresti, Angela; Harding, Sarah V.; Mahadi, Nor Muhammad; Marshall, Laura E.; Mobbs, George W.; Mohamed, Rahmah; Nathan, Sheila; Ngugi, Sarah A.; Ong, Catherine; Ooi, Wen Fong; Partridge, Lynda J.; Phillips, Helen L.; Raih, M. Firdaus; Ruzheinikov, Sergei; Sarkar-Tyson, Mitali; Sedelnikova, Svetlana E.; Smither, Sophie J.; Tan, Patrick; Titball, Richard W.; Wilson, Stuart A.; Rice, David W.			A Burkholderia pseudomallei Toxin Inhibits Helicase Activity of Translation Factor eIF4A	SCIENCE			English	Article							INITIATION; RNA; DEAMIDATION; MELIOIDOSIS; ACTIVATION; GLUTAMINE; COMPLEX; FAMILY; RHO	The structure of BPSL1549, a protein of unknown function from Burkholderia pseudomallei, reveals a similarity to Escherichia coli cytotoxic necrotizing factor 1. We found that BPSL1549 acted as a potent cytotoxin against eukaryotic cells and was lethal when administered to mice. Expression levels of bpsl1549 correlate with conditions expected to promote or suppress pathogenicity. BPSL1549 promotes deamidation of glutamine-339 of the translation initiation factor eIF4A, abolishing its helicase activity and inhibiting translation. We propose to name BPSL1549 Burkholderia lethal factor 1.	[Cruz-Migoni, Abimael; Hautbergue, Guillaume M.; Artymiuk, Peter J.; Baker, Patrick J.; Chang, Chung-Te; Mobbs, George W.; Partridge, Lynda J.; Ruzheinikov, Sergei; Sedelnikova, Svetlana E.; Wilson, Stuart A.; Rice, David W.] Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Bokori-Brown, Monika; Titball, Richard W.] Univ Exeter, Coll Life & Environm Sci, Exeter EX4 4QD, Devon, England; [Dickman, Mark J.; Phillips, Helen L.] Univ Sheffield, Dept Chem & Biol Engn, Chem Engn Life Sci Interface Inst, Sheffield S1 3JD, S Yorkshire, England; [Essex-Lopresti, Angela; Harding, Sarah V.; Marshall, Laura E.; Ngugi, Sarah A.; Sarkar-Tyson, Mitali; Smither, Sophie J.] Def Sci & Technol Lab, Salisbury SP4 OJQ, Wilts, England; [Mahadi, Nor Muhammad; Mohamed, Rahmah; Nathan, Sheila] Malaysia Genome Inst, Kajang 43000, Selangor DE, Malaysia; [Mohamed, Rahmah; Nathan, Sheila; Raih, M. Firdaus] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi 43600, Selangor DE, Malaysia; [Ong, Catherine] Def Med & Environm Res Inst, DSO Natl Labs, Singapore 117510, Singapore; [Ooi, Wen Fong; Tan, Patrick] Genome Inst Singapore, Singapore 138672, Singapore	University of Sheffield; University of Exeter; University of Sheffield; Defence Science & Technology Laboratory; Universiti Kebangsaan Malaysia; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Wilson, SA (corresponding author), Univ Sheffield, Krebs Inst, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	stuart.wilson@sheffield.ac.uk; d.rice@sheffield.ac.uk	Firdaus-Raih, Mohd/H-3286-2019; Bokori-Brown, Monika/Y-2302-2019; Nathan, Sheila/C-1182-2011; Firdaus-Raih, Mohd/A-9217-2011	Firdaus-Raih, Mohd/0000-0003-4275-4663; Nathan, Sheila/0000-0002-2132-2346; Firdaus-Raih, Mohd/0000-0003-4275-4663; Smither, Sophie/0000-0002-7835-3581; Cruz Migoni, Abimael/0000-0001-5937-4101; Baker, Patrick/0000-0003-1995-5643; wilson, stuart/0000-0003-3073-258X; Sarkar-Tyson, Mitali/0000-0002-6764-8499; Ruzheinikov, Sergey/0000-0002-3219-5004; Dickman, Mark/0000-0002-9236-0788; Chang, Chung-Te/0000-0002-4792-1646	Biotechnology and Biological Sciences Research Council; Ministry of Science, Technology and Innovation, Government of Malaysia [07-05-16-MGI-GMB08]; British Council PMI-2 Initiative; Consejo Nacional de Ciencia y Tecnologia; Ministry of Defense (UK); Engineering and Physical Sciences Research Council; Wellcome Trust [WT085162AIA]; BBSRC [BB/D524975/1, BB/E025293/1, BB/D011795/1] Funding Source: UKRI; EPSRC [EP/E036252/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D524975/1, BB/E025293/1, BB/D011795/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E036252/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Ministry of Science, Technology and Innovation, Government of Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); British Council PMI-2 Initiative; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ministry of Defense (UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Morley for providing translation factor antibodies, G. Flatau for samples of CNF1-C, C. Hellen for the eIF4B vector, A. Goldman and M. Ashe for helpful suggestions, F. Salguero (Veterinary Laboratories Agency) and C. Taylor ( Defence Science and Technology Laboratory) for histopathology analysis, and DSO National Laboratories, Singapore, for human sera. S. A. W. and M.J.D. acknowledge Biotechnology and Biological Sciences Research Council support. R. M., S.N., N.M.M., M. F. R., and D. W. R. acknowledge the Ministry of Science, Technology and Innovation, Government of Malaysia ( grant 07-05-16-MGI-GMB08) for support and the British Council PMI-2 Initiative. A. C.-M. thanks Consejo Nacional de Ciencia y Tecnologia for scholarship funding; M.S.-T. acknowledges Ministry of Defense (UK) support; M.J.D. acknowledges Engineering and Physical Sciences Research Council support; and R. W. T. acknowledges Wellcome Trust support ( grant WT085162AIA). We acknowledge the European Synchrotron Radiation Facility and Diamond Synchrotron for beamtime and thank C. Mueller-Dieckmann and R. Flaig for assistance with stations ID29 and I04. Atomic coordinates and structure factors have been deposited in the Protein Data Bank under accession codes 3TU8 and 3TUA. A patent application has been filed on the therapeutic use of the toxin and eIF4A mutants.	Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Buetow L, 2001, NAT STRUCT BIOL, V8, P584, DOI 10.1038/89610; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; ENDO Y, 1988, J BIOL CHEM, V263, P8735; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; Orth JHC, 2009, P NATL ACAD SCI USA, V106, P7179, DOI 10.1073/pnas.0900160106; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Stone R, 2007, SCIENCE, V317, P1022, DOI 10.1126/science.317.5841.1022; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385	16	75	80	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					821	824		10.1126/science.1211915	http://dx.doi.org/10.1126/science.1211915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076380	Green Accepted			2022-12-24	WOS:000296849600051
J	Lange, J; Pan, J; Cole, F; Thelen, MP; Jasin, M; Keeney, S				Lange, Julian; Pan, Jing; Cole, Francesca; Thelen, Michael P.; Jasin, Maria; Keeney, Scott			ATM controls meiotic double-strand-break formation	NATURE			English	Article							MOUSE SPERMATOCYTES; CHROMOSOME SYNAPSIS; PROPHASE ARREST; RECOMBINATION; MICE; SURVEILLANCE; DEFECTS; SPO11; GENE; PHOSPHORYLATION	In many organisms, developmentally programmed double-strand breaks (DSBs) formed by the SPO11 transesterase initiate meiotic recombination, which promotes pairing and segregation of homologous chromosomes(1). Because every chromosome must receive a minimum number of DSBs, attention has focused on factors that support DSB formation(2). However, improperly repaired DSBs can cause meiotic arrest or mutation(3,4); thus, having too many DSBs is probably as deleterious as having too few. Only a small fraction of SPO11 protein ever makes a DSB in yeast or mouse(5) and SPO11 and its accessory factors remain abundant long after most DSB formation ceases(1), implying the existence of mechanisms that restrain SPO11 activity to limit DSB numbers. Here we report that the number of meiotic DSBs in mouse is controlled by ATM, a kinase activated by DNA damage to trigger checkpoint signalling and promote DSB repair. Levels of SPO11-oligonucleotide complexes, by-products of meiotic DSB formation, are elevated at least tenfold in spermatocytes lacking ATM. Moreover, Atm mutation renders SPO11-oligonucleotide levels sensitive to genetic manipulations that modulate SPO11 protein levels. We propose that ATM restrains SPO11 via a negative feedback loop in which kinase activation by DSBs suppresses further DSB formation. Our findings explain previously puzzling phenotypes of Atm-null mice and provide a molecular basis for the gonadal dysgenesis observed in ataxia telangiectasia, the human syndrome caused by ATM deficiency.	[Lange, Julian; Pan, Jing; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Cole, Francesca; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Thelen, Michael P.] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, 1275 York Ave, New York, NY 10065 USA.	m-jasin@ski.mskcc.org; s-keeney@ski.mskcc.org	Keeney, Scott/GVR-8515-2022; Thelen, Michael/C-6834-2008; Thelen, Michael P/G-2032-2014	Thelen, Michael/0000-0002-2479-5480; Thelen, Michael P/0000-0002-2479-5480; Cole, Francesca/0000-0001-6391-2363; Keeney, Scott/0000-0002-1283-6417	NIH [HD040916, HD053855, GM058673]; Leukemia and Lymphoma Society; Ruth L. Kirschstein NRSA [F32HD51392]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053855] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Neale for discussions, R. Cha and K. McKim for sharing data before publication, and M. Hwang for assistance in monoclonal antibody development. This work was supported by NIH grants HD040916 and HD053855 (to M.J. and S. K.) and GM058673 (to S. K.). J.P. was supported in part by a Leukemia and Lymphoma Society Fellowship and F. C. by a Ruth L. Kirschstein NRSA (F32HD51392). S. K. is an Investigator of the Howard Hughes Medical Institute.	Barchi M, 2005, MOL CELL BIOL, V25, P7203, DOI 10.1128/MCB.25.16.7203-7215.2005; Barchi M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000076; Barlow C, 1998, DEVELOPMENT, V125, P4007; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Bellani MA, 2005, J CELL SCI, V118, P3233, DOI 10.1242/jcs.02466; Bellani MA, 2010, MOL CELL BIOL, V30, P4391, DOI 10.1128/MCB.00002-10; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Daniel K, 2011, NAT CELL BIOL, V13, P599, DOI 10.1038/ncb2213; Di Giacomo M, 2005, P NATL ACAD SCI USA, V102, P737, DOI 10.1073/pnas.0406212102; Eaker S, 2002, DEV BIOL, V249, P85, DOI 10.1006/dbio.2002.0708; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Kauppi L, 2011, SCIENCE, V331, P916, DOI 10.1126/science.1195774; Keeney S, 1999, GENOMICS, V61, P170, DOI 10.1006/geno.1999.5956; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Romanienko PJ, 1999, GENOMICS, V61, P156, DOI 10.1006/geno.1999.5955; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Sedgwick R, 1991, HDB CLIN NEUROLOGY, P347; Shannon M, 1999, FEBS LETT, V462, P329, DOI 10.1016/S0014-5793(99)01546-X; Terasawa M, 2008, GENES GENET SYST, V83, P209, DOI 10.1266/ggs.83.209; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411	30	172	173	3	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					237	U117		10.1038/nature10508	http://dx.doi.org/10.1038/nature10508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002603	Green Accepted			2022-12-24	WOS:000298030800044
J	Foroughi, J; Spinks, GM; Wallace, GG; Oh, J; Kozlov, ME; Fang, SL; Mirfakhrai, T; Madden, JDW; Shin, MK; Kim, SJ; Baughman, RH				Foroughi, Javad; Spinks, Geoffrey M.; Wallace, Gordon G.; Oh, Jiyoung; Kozlov, Mikhail E.; Fang, Shaoli; Mirfakhrai, Tissaphern; Madden, John D. W.; Shin, Min Kyoon; Kim, Seon Jeong; Baughman, Ray H.			Torsional Carbon Nanotube Artificial Muscles	SCIENCE			English	Article							YARNS; ACTUATORS; ELECTROLYTE; ARRAYS; MOTOR; TUBE	Rotary motors of conventional design can be rather complex and are therefore difficult to miniaturize; previous carbon nanotube artificial muscles provide contraction and bending, but not rotation. We show that an electrolyte-filled twist-spun carbon nanotube yarn, much thinner than a human hair, functions as a torsional artificial muscle in a simple three-electrode electrochemical system, providing a reversible 15,000 degrees rotation and 590 revolutions per minute. A hydrostatic actuation mechanism, as seen in muscular hydrostats in nature, explains the simultaneous occurrence of lengthwise contraction and torsional rotation during the yarn volume increase caused by electrochemical double-layer charge injection. The use of a torsional yarn muscle as a mixer for a fluidic chip is demonstrated.	[Foroughi, Javad; Spinks, Geoffrey M.; Wallace, Gordon G.] Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2522, Australia; [Oh, Jiyoung; Kozlov, Mikhail E.; Fang, Shaoli; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid Nanotech Inst, Richardson, TX 75083 USA; [Mirfakhrai, Tissaphern; Madden, John D. W.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada; [Shin, Min Kyoon; Kim, Seon Jeong] Hanyang Univ, Ctr Bioartificial Muscle, Seoul 133791, South Korea; [Shin, Min Kyoon; Kim, Seon Jeong] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea	University of Wollongong; University of Texas System; University of Texas Dallas; University of British Columbia; Hanyang University; Hanyang University	Spinks, GM (corresponding author), Univ Wollongong, Intelligent Polymer Res Inst, ARC Ctr Excellence Electromat Sci, Wollongong, NSW 2522, Australia.	gspinks@uow.edu.au; ray.baughman@utdallas.edu	Madden, John DW/B-8948-2009; Baughman, Ray/A-8628-2018; Spinks, Geoffrey/T-6363-2019; Foroughi, Javad/A-1439-2012; Wallace, Gordon G/H-1123-2011; Kim, Seon Jeong/AAR-8127-2021; Spinks, Geoffrey/E-5612-2011	Madden, John DW/0000-0002-0014-4712; Baughman, Ray/0000-0001-5845-5137; Spinks, Geoffrey/0000-0003-4656-9473; Foroughi, Javad/0000-0003-1979-5213; Wallace, Gordon G/0000-0002-0381-7273; Kim, Seon Jeong/0000-0002-2867-6737; Spinks, Geoffrey/0000-0003-4656-9473	Air Force Office of Scientific Research [FA9550-09-1-0537]; Air Force [AOARD-10-4067]; Office of Naval Research [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Creative Research Initiative Center for Bio-Artificial Muscle (Korea); Natural Sciences and Engineering Research Council of Canada; Australian Research Council	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force; Office of Naval Research(Office of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Creative Research Initiative Center for Bio-Artificial Muscle (Korea); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council)	Supported by Air Force Office of Scientific Research grant FA9550-09-1-0537, Air Force grant AOARD-10-4067, Office of Naval Research MURI grant N00014-08-1-0654, and Robert A. Welch Foundation grant AT-0029; the Creative Research Initiative Center for Bio-Artificial Muscle (Korea); the Natural Sciences and Engineering Research Council of Canada through a Discovery Grant and Graduate Scholarship (T.M.); and Centre of Excellence funding from the Australian Research Council. We thank K. E. Smith, G. L. Vanderford, and D. Hastie for technical assistance.	Barisci JN, 2003, J ELECTROCHEM SOC, V150, pE409, DOI 10.1149/1.1593045; Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Chou CP, 1996, IEEE T ROBOTIC AUTOM, V12, P90, DOI 10.1109/70.481753; Conway B. E., 1999, ELECTROCHEMICAL SUPE; Demirkoparan H, 2008, J ELASTICITY, V92, P61, DOI 10.1007/s10659-007-9149-6; Fang Y, 2011, IEEE-ASME T MECH, V16, P656, DOI 10.1109/TMECH.2010.2049366; Fennimore AM, 2003, NATURE, V424, P408, DOI 10.1038/nature01823; Hollerbach J., 1991, ROBOTICS REV, P301; Hughes M, 2005, ADV MATER, V17, P443, DOI 10.1002/adma.200401076; Keefe AC, 2000, SMART MATER STRUCT, V9, P665, DOI 10.1088/0964-1726/9/5/311; Kim J, 2001, SMART MATER STRUCT, V10, P750, DOI 10.1088/0964-1726/10/4/320; Li DB, 2009, MRS BULL, V34, P671, DOI 10.1557/mrs2009.179; Li QW, 2006, ADV MATER, V18, P3160, DOI 10.1002/adma.200601344; Lima MD, 2011, SCIENCE, V331, P51, DOI 10.1126/science.1195912; Madden JD, 2007, SCIENCE, V318, P1094, DOI 10.1126/science.1146351; Miao MH, 2010, CARBON, V48, P2802, DOI 10.1016/j.carbon.2010.04.009; Mirfakhrai T, 2007, SMART MATER STRUCT, V16, pS243, DOI 10.1088/0964-1726/16/2/S07; Nakayama Y, 2008, JPN J APPL PHYS, V47, P8149, DOI 10.1143/JJAP.47.8149; Ruch PW, 2009, ELECTROCHIM ACTA, V54, P4451, DOI 10.1016/j.electacta.2009.03.022; Smith K.K., 1989, American Scientist, V77, P28; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Trivedi Deepak, 2008, Applied Bionics and Biomechanics, V5, P99, DOI 10.1080/11762320802557865; Ue M, 2002, J ELECTROCHEM SOC, V149, pA1385, DOI 10.1149/1.1507593; Xiao L, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2909593; Yun Y, 2006, NANO LETT, V6, P689, DOI 10.1021/nl052435w; Zhang M, 2004, SCIENCE, V306, P1358, DOI 10.1126/science.1104276; Zhang S, 2008, J MATER SCI, V43, P4356, DOI 10.1007/s10853-008-2558-5; Zhang XB, 2006, ADV MATER, V18, P1505, DOI 10.1002/adma.200502528	29	409	424	44	688	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					494	497		10.1126/science.1211220	http://dx.doi.org/10.1126/science.1211220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21998253				2022-12-24	WOS:000296230500042
J	Cho, J; Jeon, S; Wilson, SA; Liu, LV; Kang, EA; Braymer, JJ; Lim, MH; Hedman, B; Hodgson, KO; Valentine, JS; Solomon, EI; Nam, W				Cho, Jaeheung; Jeon, Sujin; Wilson, Samuel A.; Liu, Lei V.; Kang, Eun A.; Braymer, Joseph J.; Lim, Mi Hee; Hedman, Britt; Hodgson, Keith O.; Valentine, Joan Selverstone; Solomon, Edward I.; Nam, Wonwoo			Structure and reactivity of a mononuclear non-haem iron(III)-peroxo complex	NATURE			English	Article							ELECTRONIC-STRUCTURE; SPECTROSCOPIC CHARACTERIZATION; CRYSTAL-STRUCTURE; PEROXO COMPLEX; IRON; BOND; DEFORMYLATION; BIOSYNTHESIS; INTERMEDIATE; DIOXYGENASE	Oxygen-containing mononuclear iron species-iron(III)-peroxo, iron(III)-hydroperoxo and iron(IV)-oxo-are key intermediates in the catalytic activation of dioxygen by iron-containing metalloenzymes(1-7). It has been difficult to generate synthetic analogues of these three active iron-oxygen species in identical host complexes, which is necessary to elucidate changes to the structure of the iron centre during catalysis and the factors that control their chemical reactivities with substrates. Here we report the high-resolution crystal structure of a mononuclear non-haem side-on iron(III)-peroxo complex, [Fe(III)(TMC)(OO)](+). We also report a series of chemical reactions in which this iron(III)-peroxo complex is cleanly converted to the iron(III)-hydroperoxo complex, [Fe(III)(TMC)(OOH)](2+), via a short-lived intermediate on protonation. This iron(III)-hydroperoxo complex then cleanly converts to the ferryl complex, [Fe(IV)(TMC)(O)](2+), via homolytic O-O bond cleavage of the iron(III)-hydroperoxo species. All three of these iron species-the three most biologically relevant iron-oxygen intermediates-have been spectroscopically characterized; we note that they have been obtained using a simple macrocyclic ligand. We have performed relative reactivity studies on these three iron species which reveal that the iron(III)-hydroperoxo complex is the most reactive of the three in the deformylation of aldehydes and that it has a similar reactivity to the iron(IV)-oxo complex in C-H bond activation of alkylaromatics. These reactivity results demonstrate that iron(III)-hydroperoxo species are viable oxidants in both nucleophilic and electrophilic reactions by iron-containing enzymes.	[Cho, Jaeheung; Jeon, Sujin; Kang, Eun A.; Valentine, Joan Selverstone; Nam, Wonwoo] Ewha Womans Univ, Dept Chem & Nano Sci, Ctr Biomimet Syst, Dept Bioinspired Sci, Seoul 120750, South Korea; [Wilson, Samuel A.; Liu, Lei V.; Hodgson, Keith O.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Braymer, Joseph J.; Lim, Mi Hee] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Braymer, Joseph J.; Lim, Mi Hee] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Hedman, Britt; Hodgson, Keith O.; Solomon, Edward I.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	Ewha Womans University; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California Los Angeles	Valentine, JS (corresponding author), Ewha Womans Univ, Dept Chem & Nano Sci, Ctr Biomimet Syst, Dept Bioinspired Sci, Seoul 120750, South Korea.	jsv@chem.ucla.edu; edward.solomon@stanford.edu; wwnam@ewha.ac.kr	Lim, Mi Hee/D-1913-2018; Liu, Lei/H-4942-2011; Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X; Solomon, Edward/0000-0003-0291-3199; Cho, Jaeheung/0000-0002-2712-4295; Nam, Wonwoo/0000-0001-8592-4867	NRF/MEST of Korea through the CRI; NRF/MEST of Korea through the GRL [2010-00353]; NRF/MEST of Korea through the WCU [R31-2008-000-10010-0]; NIH [GM 40392, RR-001209]; NSF [MCB 0919027]; NSF EAPSI [OISE-1014685]; University of Michigan; Department of Energy (DOE) Office of Science; DOE, Office of Biological and Environmental Research; NIH, National Center for Research Resources [5P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040392] Funding Source: NIH RePORTER	NRF/MEST of Korea through the CRI; NRF/MEST of Korea through the GRL; NRF/MEST of Korea through the WCU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NSF EAPSI(National Science Foundation (NSF)); University of Michigan(University of Michigan System); Department of Energy (DOE) Office of Science(United States Department of Energy (DOE)); DOE, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NRF/MEST of Korea through the CRI (W.N.), the GRL (2010-00353; W.N.), the WCU (R31-2008-000-10010-0; W.N. and J.S.V.) and the 2011 KRICT OASIS Project (W.N.), by NIH grants GM 40392 (E. I. S.) and RR-001209 (K.O.H.), and by NSF grant MCB 0919027 (E. I. S.). J.J.B. acknowledges a Fellowship from NSF EAPSI (OISE-1014685) and the Warner Linfield Award from the University of Michigan. SSRL operations are funded by the Department of Energy (DOE) Office of Science and operated by Stanford University. The SSRL Structural Molecular Biology programme is supported by the DOE, Office of Biological and Environmental Research, and by the NIH, National Center for Research Resources (grant 5P41RR001209), Biomedical Technology Program.	AKHTAR M, 1994, BIOCHEMISTRY-US, V33, P4410, DOI 10.1021/bi00180a039; Annaraj J, 2005, CHEM COMMUN, P4529, DOI 10.1039/b505562h; Blasiak LC, 2006, NATURE, V440, P368, DOI 10.1038/nature04544; Cho J, 2010, J AM CHEM SOC, V132, P16977, DOI 10.1021/ja107177m; Cho J, 2009, NAT CHEM, V1, P568, DOI [10.1038/NCHEM.366, 10.1038/nchem.366]; Cicchillo RM, 2009, NATURE, V459, P871, DOI 10.1038/nature07972; Cramer CJ, 2003, P NATL ACAD SCI USA, V100, P3635, DOI 10.1073/pnas.0535926100; Fukuzumi S, 2010, NAT CHEM, V2, P756, DOI [10.1038/NCHEM.731, 10.1038/nchem.731]; Jensen KB, 1999, CHEM COMMUN, P1313, DOI 10.1039/a902985k; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lehnert N, 2002, J AM CHEM SOC, V124, P10810, DOI 10.1021/ja012621d; Li FF, 2011, J AM CHEM SOC, V133, P7256, DOI 10.1021/ja111742z; Liu JG, 2009, ANGEW CHEM INT EDIT, V48, P9262, DOI 10.1002/anie.200904572; Mayer JM, 2011, ACCOUNTS CHEM RES, V44, P36, DOI 10.1021/ar100093z; Neese F, 1998, J AM CHEM SOC, V120, P12829, DOI 10.1021/ja981561h; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Sastri CV, 2007, P NATL ACAD SCI USA, V104, P19181, DOI 10.1073/pnas.0709471104; Selke M, 1998, J AM CHEM SOC, V120, P2652, DOI 10.1021/ja9733301; Seo MS, 2007, ANGEW CHEM INT EDIT, V46, P377, DOI 10.1002/anie.200603414; Shan X, 2007, INORG CHEM, V46, P8410, DOI 10.1021/ic700649w; Simaan AJ, 2001, INORG CHEM, V40, P6538, DOI 10.1021/ic010635e; Solomon EI, 2009, CURR OPIN CHEM BIOL, V13, P99, DOI 10.1016/j.cbpa.2009.02.011; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; VAZ ADN, 1991, J AM CHEM SOC, V113, P5886, DOI 10.1021/ja00015a066; Wada A, 2002, INORG CHEM, V41, P616, DOI 10.1021/ic001058h; Wertz DL, 2000, STRUCT BOND, V97, P37; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a	30	230	230	5	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					502	505		10.1038/nature10535	http://dx.doi.org/10.1038/nature10535			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031443	Green Accepted, Green Submitted			2022-12-24	WOS:000296194200040
J	Ouslander, JG; Berenson, RA				Ouslander, Joseph G.; Berenson, Robert A.			Reducing Unnecessary Hospitalizations of Nursing Home Residents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ouslander, Joseph G.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA; [Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA	State University System of Florida; Florida Atlantic University; Urban Institute	Ouslander, JG (corresponding author), Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.							Grabowski DC, 2007, MILBANK Q, V85, P579, DOI 10.1111/j.1468-0009.2007.00502.x; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Ouslander JG, 2011, J AM GERIATR SOC, V59, P745, DOI 10.1111/j.1532-5415.2011.03333.x; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x	5	120	120	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1165	1167		10.1056/NEJMp1105449	http://dx.doi.org/10.1056/NEJMp1105449			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21991889				2022-12-24	WOS:000295318400001
J	Lee, E; Kamlet, AS; Powers, DC; Neumann, CN; Boursalian, GB; Furuya, T; Choi, DC; Hooker, JM; Ritter, T				Lee, Eunsung; Kamlet, Adam S.; Powers, David C.; Neumann, Constanze N.; Boursalian, Gregory B.; Furuya, Takeru; Choi, Daniel C.; Hooker, Jacob M.; Ritter, Tobias			A Fluoride-Derived Electrophilic Late-Stage Fluorination Reagent for PET Imaging	SCIENCE			English	Article							REDUCTIVE ELIMINATION; RADIOSYNTHESIS; F-18	The unnatural isotope fluorine-18 (F-18) is used as a positron emitter in molecular imaging. Currently, many potentially useful F-18-labeled probe molecules are inaccessible for imaging because no fluorination chemistry is available to make them. The 110-minute half-life of F-18 requires rapid syntheses for which [F-18]fluoride is the preferred source of fluorine because of its practical access and suitable isotope enrichment. However, conventional [F-18]fluoride chemistry has been limited to nucleophilic fluorination reactions. We report the development of a palladium-based electrophilic fluorination reagent derived from fluoride and its application to the synthesis of aromatic F-18-labeled molecules via late-stage fluorination. Late-stage fluorination enables the synthesis of conventionally unavailable positron emission tomography (PET) tracers for anticipated applications in pharmaceutical development as well as preclinical and clinical PET imaging.	[Hooker, Jacob M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Lee, Eunsung; Kamlet, Adam S.; Powers, David C.; Neumann, Constanze N.; Boursalian, Gregory B.; Furuya, Takeru; Choi, Daniel C.; Ritter, Tobias] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Hooker, Jacob M.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Hooker, Jacob M.; Ritter, Tobias] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med & Mol Imaging, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital	Hooker, JM (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	hooker@nmr.mgh.harvard.edu; ritter@chemistry.harvard.edu	Ritter, Tobias/AAJ-8703-2021; Powers, David/J-8203-2015; Ritter, Tobias/A-6244-2013; Neumann, Constanze/AAL-3918-2020; Furuya, Takeru/A-6622-2012; Lee, Eunsung/F-5308-2013; Hooker, Jacob M/P-5716-2018; Boursalian, Gregory/M-7729-2016	Powers, David/0000-0003-3717-2001; Ritter, Tobias/0000-0002-5478-0036; Neumann, Constanze/0000-0003-1004-1140; Lee, Eunsung/0000-0002-1507-098X; Hooker, Jacob M/0000-0002-9394-7708; Boursalian, Gregory/0000-0002-6644-0987; Choi, Daniel/0000-0003-3406-9113	National Institute of General Medical Sciences [GM088237]; National Institute of Biomedical Imaging and Bioengineering [EB013042]; National Center for Research Resources [1S10RR017208-01A1]; National Institute on Drug Abuse [5P30DA028800-02]; Richard and Susan Smith Family Foundation; Massachusetts Life Science Center; Harvard Catalyst; NSF [DGE0644491]; Harvard Accelerator Fund; Sloan Research Fellowship; Eli Lilly and Co.; AstraZeneca; Camille Dreyfus; Amgen; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022976, S10RR026666, S10RR017208, S10RR029495, S10RR023385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA028800] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Richard and Susan Smith Family Foundation; Massachusetts Life Science Center; Harvard Catalyst; NSF(National Science Foundation (NSF)); Harvard Accelerator Fund; Sloan Research Fellowship(Alfred P. Sloan Foundation); Eli Lilly and Co.(Eli Lilly); AstraZeneca(AstraZeneca); Camille Dreyfus; Amgen(Amgen); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by National Institute of General Medical Sciences grant GM088237, National Institute of Biomedical Imaging and Bioengineering grant EB013042, National Center for Research Resources grant 1S10RR017208-01A1, National Institute on Drug Abuse grant 5P30DA028800-02, the Richard and Susan Smith Family Foundation, the Massachusetts Life Science Center, the Harvard Catalyst, NSF Graduate Research Fellowship Program grant DGE0644491, and the Harvard Accelerator Fund. T.R. was also supported by a Sloan Research Fellowship, grants from Eli Lilly and Co. and AstraZeneca, a Camille Dreyfus Teacher-Scholar Award, and an Amgen Young Investigators Award. We thank S.-L. Zheng for x-ray crystallographic analysis. DFT computation was performed using the computer facilities at the Odyssey cluster at Harvard University. Metrical parameters for the crystal structures of compounds 1, 2, 3, 8, and S10 are available free of charge from the Cambridge Crystallographic Data Centre under reference nos. CCDC 829427, 829428, 840744, 829429, and 839058, respectively. A patent application has been filed through Harvard on methods and reagents presented in this manuscript.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Bergman J, 1997, NUCL MED BIOL, V24, P677, DOI 10.1016/S0969-8051(97)00078-4; Brauner B. Z., 1894, Z ANORG CHEM, V7, P1; Chin FT, 2008, MOL IMAGING BIOL, V10, P82, DOI 10.1007/s11307-007-0122-3; CHRISTE KO, 1986, INORG CHEM, V25, P3721, DOI 10.1021/ic00241a001; Cotton F. A., 1990, CHEM APPL GROUP THEO; Fowler JS, 1997, ACCOUNTS CHEM RES, V30, P181, DOI 10.1021/ar960068c; Furuya T, 2008, J AM CHEM SOC, V130, P10060, DOI 10.1021/ja803187x; Furuya T, 2011, NATURE, V473, P470, DOI 10.1038/nature10108; Furuya T, 2008, ANGEW CHEM INT EDIT, V47, P5993, DOI 10.1002/anie.200802164; Furuya T, 2010, J AM CHEM SOC, V132, P3793, DOI 10.1021/ja909371t; HAIM A, 1983, PROG INORG CHEM, V30, P273, DOI 10.1002/9780470166314.ch6; Herrmann K, 2010, J NUCL MED, V51, DOI 10.2967/jnumed.108.059584; Hollingworth C, 2011, ANGEW CHEM INT EDIT, V50, P2613, DOI 10.1002/anie.201007307; Katcher MH, 2010, J AM CHEM SOC, V132, P17402, DOI 10.1021/ja109120n; Kozikowski AP, 2010, CHEMMEDCHEM, V5, P1221, DOI 10.1002/cmdc.201000186; Miller PW, 2008, ANGEW CHEM INT EDIT, V47, P8998, DOI 10.1002/anie.200800222; Noel T, 2011, ANGEW CHEM INT EDIT, V50, P8900, DOI 10.1002/anie.201104652; O'Hagan D, 2008, CHEM SOC REV, V37, P308, DOI 10.1039/b711844a; Phelps ME, 2000, P NATL ACAD SCI USA, V97, P9226, DOI 10.1073/pnas.97.16.9226; PIKE VW, 1995, J CHEM SOC CHEM COMM, P2215, DOI 10.1039/C39950002215; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Stahl SS, 1998, ANGEW CHEM INT EDIT, V37, P2181, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2180::AID-ANIE2180>3.0.CO;2-A; Sun H, 2006, ANGEW CHEM INT EDIT, V45, P2720, DOI 10.1002/anie.200504555; TAUBE H, 1954, J AM CHEM SOC, V76, P2103, DOI 10.1021/ja01637a020; Teare H, 2010, ANGEW CHEM INT EDIT, V49, P6821, DOI 10.1002/anie.201002310; Toyohara J, 2009, ANN NUCL MED, V23, P301, DOI 10.1007/s12149-009-0240-x; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Young S., 1881, J CHEM SOC, V39, P489	29	311	323	5	230	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					639	642		10.1126/science.1212625	http://dx.doi.org/10.1126/science.1212625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053044	Green Accepted, Green Submitted			2022-12-24	WOS:000296494700046
J	Chang, HJ				Chang, Huan J.			Indurated, Purplish Plaque on a Newborn Subcutaneous fat necrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPERCALCEMIA; COMPLICATIONS					tina.chang@jama-archives.org						Borgia F, 2006, J PAEDIATR CHILD H, V42, P316, DOI 10.1111/j.1440-1754.2006.00862.x; Burden AD, 1999, PEDIATR DERMATOL, V16, P384, DOI 10.1046/j.1525-1470.1999.00101.x; Mahe E, 2007, BRIT J DERMATOL, V156, P709, DOI 10.1111/j.1365-2133.2007.07782.x; Oza V, 2010, ARCH DERMATOL, V146, P882, DOI 10.1001/archdermatol.2010.176; Rapini R., 2021, PRACTICAL DERMATOPAT, V3rd; Rice AM, 1999, J PEDIATR-US, V134, P349, DOI 10.1016/S0022-3476(99)70462-2; Tran JT, 2003, PEDIATR DERMATOL, V20, P257, DOI 10.1046/j.1525-1470.2003.20315.x; Yuen NS, 2011, ARCH PEDIAT ADOL MED, V165, P563, DOI 10.1001/archpediatrics.2011.80-a	8	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1923	1924		10.1001/jama.2011.1577	http://dx.doi.org/10.1001/jama.2011.1577			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	22045773				2022-12-24	WOS:000296376200031
J	Peca, J; Ting, J; Feng, GP				Peca, Joao; Ting, Jonathan; Feng, Guoping			SnapShot: Autism and the Synapse	CELL			English	Editorial Material							BEHAVIORS		[Peca, Joao; Ting, Jonathan; Feng, Guoping] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Peca, J (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Feng, Guoping/Y-2827-2019; Peça, João/K-7900-2013	Peça, João/0000-0003-4989-2129; Ting, Jonathan/0000-0001-8266-0392				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Ehninger D, 2011, TRENDS MOL MED, V17, P78, DOI 10.1016/j.molmed.2010.10.002; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104	10	23	25	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					706	706		10.1016/j.cell.2011.10.015	http://dx.doi.org/10.1016/j.cell.2011.10.015			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036574	Bronze			2022-12-24	WOS:000296573700024
J	Nolan, JP; Soar, J				Nolan, Jerry P.; Soar, Jasmeet			Does the evidence support the use of mild hypothermia after cardiac arrest? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							THERAPEUTIC HYPOTHERMIA; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS		[Nolan, Jerry P.] Royal United Hosp NHS Trust, Bath BA2 7AJ, Avon, England; [Soar, Jasmeet] N Bristol NHS Trust, Southmead Hosp, Bristol, Avon, England	North Bristol NHS Trust; Southmead Hospital	Nolan, JP (corresponding author), Royal United Hosp NHS Trust, Bath BA2 7AJ, Avon, England.	jerry.nolan@nhs.net	Nolan, Jerry P./ABF-2561-2020; Soar, Jasmeet/HGA-2279-2022	Soar, Jasmeet/0000-0001-5970-6073; Nolan, Jerry/0000-0003-3141-3812				Arrich J, 2007, CRIT CARE MED, V35, P1041, DOI 10.1097/01.CCM.0000259383.48324.35; Bernard SA, 1997, ANN EMERG MED, V30, P146, DOI 10.1016/S0196-0644(97)70133-1; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Binks AC, 2010, ANAESTHESIA, V65, P260, DOI 10.1111/j.1365-2044.2009.06227.x; Deakin CD, 2010, RESUSCITATION, V81, pE93, DOI 10.1016/j.resuscitation.2010.08.027; Holzer M, 2002, NEW ENGL J MED, V346, P549; Holzer M, 2006, STROKE, V37, P1792, DOI 10.1161/01.STR.0000227265.52763.16; Kern KB, 2010, CATHETER CARDIO INTE, V75, P616, DOI 10.1002/ccd.22192; Mongardon N, 2011, CRIT CARE MED, V39, P1359, DOI 10.1097/CCM.0b013e3182120b56; Nolan JP, 2003, RESUSCITATION, V57, P231, DOI 10.1016/S0300-9572(03)00184-9; Nunnally ME, 2011, CRIT CARE MED, V39, P1113, DOI 10.1097/CCM.0b013e318206bab2; STERZ F, 1991, CRIT CARE MED, V19, P379, DOI 10.1097/00003246-199103000-00017; Tomte O, 2011, RESUSCITATION, V82, P1186, DOI 10.1016/j.resuscitation.2011.05.003; van der Wal G, 2011, CRIT CARE MED, V39, P84, DOI 10.1097/CCM.0b013e3181fd6aef; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021	15	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 23	2011	343								d5830	10.1136/bmj.d5830	http://dx.doi.org/10.1136/bmj.d5830			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	826AK	21948587				2022-12-24	WOS:000295323500001
J	Tan, MJ; Luo, H; Lee, S; Jin, FL; Yang, JS; Montellier, E; Buchou, T; Cheng, ZY; Rousseaux, S; Rajagopal, N; Lu, ZK; Ye, Z; Zhu, Q; Wysocka, J; Ye, Y; Khochbin, S; Ren, B; Zhao, YM				Tan, Minjia; Luo, Hao; Lee, Sangkyu; Jin, Fulai; Yang, Jeong Soo; Montellier, Emilie; Buchou, Thierry; Cheng, Zhongyi; Rousseaux, Sophie; Rajagopal, Nisha; Lu, Zhike; Ye, Zhen; Zhu, Qin; Wysocka, Joanna; Ye, Yang; Khochbin, Saadi; Ren, Bing; Zhao, Yingming			Identification of 67 Histone Marks and Histone Lysine Crotonylation as a New Type of Histone Modification	CELL			English	Article							MASS-SPECTROMETRY; POSTTRANSLATIONAL MODIFICATIONS; CHROMATIN MODIFICATIONS; HUMAN-CELLS; CODE; DISTINCT; H3; PHOSPHORYLATION; ACETYLATION; METHYLATION	We report the identification of 67 previously undescribed histone modifications, increasing the current number of known histone marks by about 70%. We further investigated one of the marks, lysine crotonylation (Kcr), confirming that it represents an evolutionarily-conserved histone posttranslational modification. The unique structure and genomic localization of histone Kcr suggest that it is mechanistically and functionally different from histone lysine acetylation (Kac). Specifically, in both human somatic and mouse male germ cell genomes, histone Kcr marks either active promoters or potential enhancers. In male germinal cells immediately following meiosis, Kcr is enriched on sex chromosomes and specifically marks testis-specific genes, including a significant proportion of X-linked genes that escape sex chromosome inactivation in haploid cells. These results therefore dramatically extend the repertoire of histone PTM sites and designate Kcr as a specific mark of active sex chromosome-linked genes in postmeiotic male germ cells.	[Tan, Minjia; Luo, Hao; Lee, Sangkyu; Yang, Jeong Soo; Cheng, Zhongyi; Lu, Zhike; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Jin, Fulai; Rajagopal, Nisha; Ye, Zhen; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, Sch Med, La Jolla, CA 92093 USA; [Jin, Fulai; Rajagopal, Nisha; Ye, Zhen; Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Zhu, Qin; Ye, Yang] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Sch Med, Stanford, CA 94305 USA; [Montellier, Emilie; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] INSERM, U823, F-38706 La Tronche, France; [Montellier, Emilie; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] Univ Grenoble 1, F-38706 La Tronche, France; [Montellier, Emilie; Buchou, Thierry; Rousseaux, Sophie; Khochbin, Saadi] Fac Med, Inst Albert Bonniot, F-38706 La Tronche, France	University of Chicago; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Stanford University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Zhao, YM (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	yingming.zhao@uchicago.edu	BUCHOU, Thierry/F-3136-2019; Tan, Minjia/C-4491-2014; zhu, qin/G-3520-2016; Montellier, Emilie/N-4071-2017; Khochbin, Saadi/M-8090-2013; Rousseaux, Sophie/G-1697-2013; BUCHOU, THIERRY/N-2553-2013; Montellier, Emilie/ABE-9802-2020	BUCHOU, Thierry/0000-0002-9206-2377; Tan, Minjia/0000-0002-6784-9653; zhu, qin/0000-0003-4093-9517; Khochbin, Saadi/0000-0002-0455-0857; Rousseaux, Sophie/0000-0001-5246-5350; Montellier, Emilie/0000-0001-5069-3536; Jin, Fulai/0000-0003-0025-4337	National Institute of Health; INCa-DHOS; ANR blanche "EpiSperm"; ARC; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INCa-DHOS; ANR blanche "EpiSperm"(French National Research Agency (ANR)); ARC(Australian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institute of Health grants to B.R., J.W., and Y.Z., by INCa-DHOS, ANR blanche "EpiSperm," and ARC research programs to S.K. Z.C. is a shareholder of PTM BioLab, Co., Ltd (Chicago, IL); Y.Z. is a member of the scientific advisory board of PTM BioLab, Co., Ltd (Chicago, IL).	ALLIS CD, 1985, P NATL ACAD SCI USA, V82, P8048, DOI 10.1073/pnas.82.23.8048; ARENTS G, 1993, P NATL ACAD SCI USA, V90, P10489, DOI 10.1073/pnas.90.22.10489; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Boussouar F, 2008, CELL CYCLE, V7, P3499, DOI 10.4161/cc.7.22.6975; Chen Y, 2005, J PROTEOME RES, V4, P998, DOI 10.1021/pr049754t; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; Chu FX, 2006, MOL CELL PROTEOMICS, V5, P194, DOI 10.1074/mcp.M500285-MCP200; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Fullgrabe J., 2011, HISTONE ONCO MODIFIC; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Garcia BA, 2007, NAT METHODS, V4, P487, DOI 10.1038/nmeth1052; Garcia BA, 2007, CURR OPIN CHEM BIOL, V11, P66, DOI 10.1016/j.cbpa.2006.11.022; Gaucher J, 2010, FEBS J, V277, P599, DOI 10.1111/j.1742-4658.2009.07504.x; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo H, 2008, J BIOL CHEM, V283, P19176, DOI 10.1074/jbc.M802299200; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; MCGHEE JD, 1980, ANNU REV BIOCHEM, V49, P1115, DOI 10.1146/annurev.bi.49.070180.005343; Mersfelder EL, 2006, NUCLEIC ACIDS RES, V34, P2653, DOI 10.1093/nar/gkl338; Mueller JL, 2008, NAT GENET, V40, P794, DOI 10.1038/ng.126; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhao M, 2004, GENESIS, V38, P200, DOI 10.1002/gene.20019	37	1104	1201	19	290	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					1015	1027		10.1016/j.cell.2011.08.008	http://dx.doi.org/10.1016/j.cell.2011.08.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925322	Bronze, Green Accepted			2022-12-24	WOS:000295258100022
J	Shallcross, LJ; Mbeledogu, CN; Hayward, AC				Shallcross, L. J.; Mbeledogu, C. N.; Hayward, A. C.			UNCERTAINTIES PAGE Should we screen and decolonise contacts of patients with Panton Valentine leukocidin associated Staphylococcus aureus infection?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Shallcross, L. J.] UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England; [Mbeledogu, C. N.] Springfield Univ Hosp, SW London Hlth Protect Unit, London SW17 7DJ, England; [Hayward, A. C.] Royal Free Hosp, Univ Coll London, Res Dept Infect & Populat Hlth, London NW3 2PF, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Shallcross, LJ (corresponding author), UCL, Res Dept Infect & Populat Hlth, London WC1E 6JB, England.	l.shallcross@ucl.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232; Shallcross, Laura/0000-0003-1713-2555	MRC [G0501879] Funding Source: UKRI; Medical Research Council [G0501879] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		del Giudice P, 2009, DERMATOLOGY, V219, P299, DOI 10.1159/000232391; Gorwitz RJ., 2006, STRATEGIES CLIN MANA; Health Protection Agency, 2008, GUID DIAGN MAN PVL A; *HLTH PROT AG LOC, 2010, MAN PVL STAPH AUR RE; Jappe U, 2008, J INVEST DERMATOL, V128, P2655, DOI 10.1038/jid.2008.133; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Shallcross LJ, 2010, CLIN MICROBIOL INFEC, V16, P1644, DOI 10.1111/j.1469-0691.2010.03153.x; VANRIJEN M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006216.PUB2	9	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 9	2011	343								d5479	10.1136/bmj.d5479	http://dx.doi.org/10.1136/bmj.d5479			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819SJ	21908526				2022-12-24	WOS:000294850000003
J	Geballe, TR; Najarro, F; Figer, DF; Schlegelmilch, BW; de la Fuente, D				Geballe, T. R.; Najarro, F.; Figer, D. F.; Schlegelmilch, B. W.; de la Fuente, D.			Infrared diffuse interstellar bands in the Galactic Centre region	NATURE			English	Article							FIELD STARS; CLOUDS; SPECTROSCOPY; QUINTUPLET; FEATURES; H-3(+); DUST	The spectrum of any star viewed through a sufficient quantity of diffuse interstellar material reveals a number of absorption features collectively called 'diffuse interstellar bands' (DIBs). The first DIBs were reported about 90 years ago(1), and currently well over 500 are known(2). None of them has been convincingly identified with any specific element or molecule, although recent studies suggest that the DIB carriers are polyatomic molecules containing carbon(3-5). Most of the DIBs currently known are at visible and very near-infrared wavelengths, with only two previously known at wavelengths beyond one micrometre (10,000 angstroms), the longer of which is at 1.318 micrometres (ref. 6). Here we report 13 diffuse interstellar bands in the 1.5-1.8 micrometre interval on high-extinction sightlines towards stars in the Galactic Centre. We argue that they originate almost entirely in the Galactic Centre region, a considerably warmer and harsher environment than where DIBs have been observed previously. The relative strengths of these DIBs towards the Galactic Centre and the Cygnus OB2 diffuse cloud are consistent with their strengths scaling mainly with the extinction by diffuse material.	[Geballe, T. R.] Gemini Observ, Hilo, HI 96720 USA; [Najarro, F.; de la Fuente, D.] Ctr Astrobiol CSIC INTA, Torrejon De Ardoz 28850, Spain; [Figer, D. F.] Rochester Inst Technol, Ctr Detectors, Rochester, NY 14623 USA; [Schlegelmilch, B. W.] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Rochester Institute of Technology; University of California System; University of California Los Angeles	Geballe, TR (corresponding author), Gemini Observ, 670 N Aohoku Pl, Hilo, HI 96720 USA.	tgeballe@gemini.edu	de la Fuente, Diego/L-2853-2017; Najarro, Francisco/G-7288-2015	de la Fuente, Diego/0000-0002-6193-7345; Najarro, Francisco/0000-0002-9124-0039	Spanish Ministerio de Ciencia e Innovacion	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This Letter is based on observations obtained at the Gemini Observatory, which is operated by the Association of Universities for Research in Astronomy, Inc., under a cooperative agreement with the NSF on behalf of the Gemini partnership: the National Science Foundation (US), the Science and Technology Facilities Council (UK), the National Research Council (Canada), CONICYT (Chile), the Australian Research Council (Australia), Ministerio da Ciencia e Tecnologia (Brazil) and Ministerio de Ciencia, Tecnologia e Innovacion Productiva (Argentina). This work was supported by the Spanish Ministerio de Ciencia e Innovacion. We thank A. Lenorzer for reductions of the H-band spectra of the Cygnus OB2 stars, and B. J. McCall and T. Oka for reviewing a preliminary version of the manuscript.	BROMAGE GE, 1973, ASTRON ASTROPHYS, V26, P17; Cox NLJ, 2011, EAS PUBLICATIONS, V46, P349, DOI 10.1051/eas/1146036; Draine B.T., 2011, PHYS INTERSTELLAR IN; Figer DF, 1999, ASTROPHYS J, V514, P202, DOI 10.1086/306931; Goto M, 2008, ASTROPHYS J, V688, P306, DOI 10.1086/591657; Heger M. L, 1922, LICK OBSERVATORY B, V10, P146; HERBIG GH, 1995, ANNU REV ASTRON ASTR, V33, P19, DOI 10.1146/annurev.aa.33.090195.000315; Hobbs LM, 2009, ASTROPHYS J, V705, P32, DOI 10.1088/0004-637X/705/1/32; HUMPHREYS RM, 1978, ASTROPHYS J SUPPL S, V38, P309, DOI 10.1086/190578; Indriolo N, 2007, ASTROPHYS J, V671, P1736, DOI 10.1086/523036; JOBLIN C, 1990, NATURE, V346, P729, DOI 10.1038/346729a0; Muno MP, 2006, ASTROPHYS J, V638, P183, DOI 10.1086/498701; NAGATA T, 1990, ASTROPHYS J, V351, P83, DOI 10.1086/168446; Oka T, 2005, ASTROPHYS J, V632, P882, DOI 10.1086/432679; Oka T, 2011, SCIENCE, V331, P293, DOI 10.1126/science.1200144; PENDLETON YJ, 1994, ASTROPHYS J, V437, P683, DOI 10.1086/175031; RAWLINGS M, 2011, IAU S, V280; Rawlings MG, 2003, MON NOT R ASTRON SOC, V341, P1121, DOI 10.1046/j.1365-8711.2003.06389.x; Snow TP, 2006, ANNU REV ASTRON ASTR, V44, P367, DOI 10.1146/annurev.astro.43.072103.150624; Whittet DCB, 1997, ASTROPHYS J, V490, P729, DOI 10.1086/304914	20	62	62	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2011	479	7372					200	202		10.1038/nature10527	http://dx.doi.org/10.1038/nature10527			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22048316	Green Submitted			2022-12-24	WOS:000298030800035
J	Cayla, G; Hulot, JS; O'Connor, SA; Pathak, A; Scott, SA; Gruel, Y; Silvain, J; Vignalou, JB; Huerre, Y; de la Briolle, A; Allanic, F; Beygui, F; Barthelemy, O; Montalescot, G; Collet, JP				Cayla, Guillaume; Hulot, Jean-Sebastien; O'Connor, Stephen A.; Pathak, Atul; Scott, Stuart A.; Gruel, Yves; Silvain, Johanne; Vignalou, Jean-Baptiste; Huerre, Yves; de la Briolle, Axel; Allanic, Frederick; Beygui, Farzin; Barthelemy, Olivier; Montalescot, Gilles; Collet, Jean-Philippe			Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLOPIDOGREL-TREATED PATIENTS; PLATELET REACTIVITY; CYP2C19 GENOTYPE; HEART-DISEASE; LONG-TERM; POLYMORPHISM; PARAOXONASE-1; THERAPY; RISK; METAANALYSIS	Context Despite dual antiplatelet therapy, stent thrombosis remains a devastating and unpredictable complication of percutaneous coronary intervention (PCI). Objective To perform a sequential analysis of clinical and genetic factors associated with definite early stent thrombosis. Design, Setting, and Participants Case-control study conducted in 10 centers in France between January 2007 and May 2010 among 123 patients undergoing PCI who had definite early stent thrombosis and DNA samples available, matched on age and sex with 246 stent thrombosis-free controls. Main Outcome Measure Accuracy of early stent thrombosis prediction by 23 genetic variants. Results Among the 23 genetic variants investigated in 15 different genes, the significant determinants of early stent thrombosis were CYP2C19 metabolic status (adjusted odds ratio [OR], 1.99; 95% CI, 1.47-2.69), ABCB1 3435 TT genotype (adjusted OR, 2.16; 95% CI, 1.21-3.88), and ITGB3 PLA2 carriage (adjusted OR, 0.52; 95% CI, 0.28-0.95). Nongenetic independent correlates were acuteness of PCI (adjusted OR, 3.05; 95% CI, 1.54-6.07), complex lesions (American College of Cardiology/American Heart Association type C) (adjusted OR, 2.33; 95% CI, 1.40-3.89), left ventricular function less than 40% (adjusted OR, 2.25; 95% CI, 1.09-4.70), diabetes mellitus (adjusted OR, 1.82; 95% CI, 1.02-3.24), use of proton pump inhibitors (adjusted OR, 2.19; 95% CI, 1.29-3.75), and higher clopidogrel loading doses (adjusted OR, 0.73; 95% CI, 0.57-0.93). The discriminative accuracy of the clinical-only model was similar to that of a genetic-only model (area under the curve, 0.73 [95% CI, 0.67-0.78] vs 0.68 [95% CI, 0.62-0.74], respectively; P=.34). A combined clinical and genetic model led to a statistically significant increase in the discriminatory power of the model compared with the clinical-only model (area under the curve, 0.78 [95% CI, 0.73-0.83] vs 0.73 [95% CI, 0.67-0.78]; P=.004). Conclusions This case-control study identified 3 genes (CYP2C19, ABCB1, and ITGB3) and 2 clopidogrel-related factors (loading dose and proton pump inhibitors) that were independently associated with early stent thrombosis. Future studies are needed to validate the prognostic accuracy of these risk factors in prospective cohorts. JAMA. 2011;306(16):1765-1774	[Montalescot, Gilles] Hop La Pitie Salpetriere, Inst Cardiol, Bur 236, INSERM,Unite Mixte Rech UMR S 937, F-75013 Paris, France; [Hulot, Jean-Sebastien; Allanic, Frederick] Univ Paris 06, UMR S 956, Paris, France; [Cayla, Guillaume] Ctr Hosp Univ CHU Nimes, Dept Cardiol, Nimes, France; [Cayla, Guillaume; Huerre, Yves] Univ Montpellier I, Fac Med, Montpellier, France; [Huerre, Yves] CHU Montpellier, Dept Cardiol, Montpellier, France; [Hulot, Jean-Sebastien] Mt Sinai Sch Med, Cardiovasc Res Ctr, New York, NY USA; [Scott, Stuart A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Pathak, Atul] Univ Toulouse, Fac Med, INSERM, U1048,Lab Pharmacol Med & Clin, Toulouse, France; [Pathak, Atul] CHU Rangueil, Serv Cardiol, F-31054 Toulouse, France; CNRS, UMR 6239, Dept Hematol Hemostasis, Tours, France; [de la Briolle, Axel] CHU Tours, Dept Cardiol, Tours, France; [Gruel, Yves; de la Briolle, Axel] Univ Tours, Fac Med, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CHU Tours; Universite de Tours	Montalescot, G (corresponding author), Hop La Pitie Salpetriere, Inst Cardiol, Bur 236, INSERM,Unite Mixte Rech UMR S 937, 47 Bd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	Hulot, Jean-Sébastien/A-2278-2016; Pathak, Atul/ABC-5223-2020; SILVAIN, Johanne/C-7521-2016	Hulot, Jean-Sébastien/0000-0001-5463-6117; Pathak, Atul/0000-0001-6151-0096; Scott, Stuart/0000-0001-5720-1864; SILVAIN, Johanne/0000-0002-1901-2808; O'Connor, Stephen/0000-0002-6539-0375	la Federation Francaise de Cardiologie; Abbott Vascular; AstraZeneca; CLS Behring; Daiichi Sankyo; Eli Lilly; Biotronik; Iroko Cardio; Fondation de France; INSERM; Federation Francaise de Cardiologie; Medco Research Institute; Medco Health Solutions; sanofi-aventis; Brahms; Societe Francaise de Cardiologie; Servier; Boston Scientific; Cordis; Guerbet Medical; ITC Edison; Medtronic; Pfizer; Stago; Bayer; Cardiovascular Research Foundation; Cleveland Clinic Research Foundation; Duke Institute; Europa; Lead-up; GlaxoSmithKline; Institut de Cardiologie de Montreal; Menarini; Nanospheres; Novartis; Portola; Medicines Company; TIMI Study Group; Bristol-Myers Squibb; ACTION; SGAM Foundation	la Federation Francaise de Cardiologie; Abbott Vascular(Abbott Laboratories); AstraZeneca(AstraZeneca); CLS Behring; Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Biotronik; Iroko Cardio; Fondation de France(Fondation de France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Federation Francaise de Cardiologie; Medco Research Institute; Medco Health Solutions; sanofi-aventis(Sanofi-Aventis); Brahms; Societe Francaise de Cardiologie; Servier(Servier); Boston Scientific(Boston Scientific); Cordis; Guerbet Medical; ITC Edison; Medtronic(Medtronic); Pfizer(Pfizer); Stago; Bayer(Bayer AG); Cardiovascular Research Foundation; Cleveland Clinic Research Foundation; Duke Institute; Europa; Lead-up; GlaxoSmithKline(GlaxoSmithKline); Institut de Cardiologie de Montreal; Menarini(Menarini Group); Nanospheres; Novartis(Novartis); Portola; Medicines Company; TIMI Study Group; Bristol-Myers Squibb(Bristol-Myers Squibb); ACTION; SGAM Foundation	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Cayla reports receiving a research grant from la Federation Francaise de Cardiologie; consultant fees from Abbott Vascular, AstraZeneca, CLS Behring, Daiichi Sankyo, and Eli Lilly; and lecture fees from Abbott Vascular, AstraZeneca, Biotronik, CLS Behring, Daiichi Sankyo, Eli Lilly, and Iroko Cardio. Dr Hulot reports receiving research grant support from Fondation de France, INSERM, Federation Francaise de Cardiologie, Biotronik, and Medco Research Institute; consulting fees from Biotronik and Medco Health Solutions; and lecture fees from sanofi-aventis, Daiichi Sankyo, and Eli Lilly. Dr Pathak reports receiving honoraria from BMS, AstraZeneca, and Daiichi. Dr Silvain reports that he has received research grants (to his institution) from sanofi-aventis, Daiichi Sankyo, Eli Lilly, Brahms, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; has served as a consultant to Daiichi Sankyo and Eli Lilly; and has received lecture fees from AstraZeneca, Daiichi Sankyo, Eli Lilly, Iroko Cardio, and Servier. Dr Montalescot reports receiving grant support from Abbott Vascular, Boston Scientific, Cordis, Eli Lilly, Federation Francaise de Cardiologie, Fondation de France, Guerbet Medical, INSERM, ITC Edison, Medtronic, Pfizer, sanofi-aventis, Societe Francaise de Cardiologie, and Stago and consulting or board fees and lecture fees from AstraZeneca, Bayer, Boehringer Ingelheim, Cardiovascular Research Foundation, Cleveland Clinic Research Foundation, Daiichi Sankyo, Duke Institute, Eli Lilly, Europa, Lead-up, GlaxoSmithKline, Institut de Cardiologie de Montreal, Menarini, Nanospheres, Novartis, Pfizer, Portola, sanofi-aventis, the Medicines Company, and the TIMI Study Group. Dr Collet reports receiving research grants from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly, Guerbet Medical, Medtronic, Boston Scientific, Cordis, Stago, Fondation de France, INSERM, Federation Francaise de Cardiologie, and Societe Francaise de Cardiologie; consulting fees from sanofi-aventis, Eli Lilly, and Bristol-Myers Squibb; and lecture fees from Bristol-Myers Squibb, sanofi-aventis, Eli Lilly and AstraZeneca. No other disclosures were reported.; This study was funded by ACTION, the Societe Francaise de Cardiologie, the Federation Francaise de Cardiologie, and INSERM. The ONASSIST program was also partially supported by an unrestricted grant from Eli Lilly and by a grant from the SGAM Foundation.	Angiolillo DJ, 2011, CLIN PHARMACOL THER, V89, P65, DOI 10.1038/clpt.2010.219; Angiolillo DJ, 2004, BLOOD COAGUL FIBRIN, V15, P89, DOI 10.1097/00001721-200401000-00014; Bhatt DL., 2009, TRANSC CARD THER TCT; Bonello L, 2010, J AM COLL CARDIOL, V56, P1630, DOI 10.1016/j.jacc.2010.07.004; Bonello L, 2010, J AM COLL CARDIOL, V56, P919, DOI 10.1016/j.jacc.2010.04.047; Bouman HJ, 2011, NAT MED, V17, P110, DOI 10.1038/nm.2281; Campo G, 2011, J AM COLL CARDIOL, V57, P2474, DOI 10.1016/j.jacc.2010.12.047; Collet JP, 2009, LANCET, V373, P1172, DOI 10.1016/S0140-6736(09)60682-6; Collet JP, 2008, CIRCULATION, V118, P1225, DOI [10.1161/CIRCULATIONAHA.108.776757, 10.1161/CIRCULATIONAHA.108.191108]; Collet JP, 2011, JACC-CARDIOVASC INTE, V4, P392, DOI 10.1016/j.jcin.2011.03.002; Cooke GE, 2006, J AM COLL CARDIOL, V47, P541, DOI 10.1016/j.jacc.2005.09.034; Cuisset T, 2011, NAT MED, V17, P1039, DOI 10.1038/nm.2367; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Dangas GD, 2011, CIRCULATION, V123, P1745, DOI 10.1161/CIRCULATIONAHA.110.981688; Dansette PM, 2011, NAT MED, V17, P1040, DOI 10.1038/nm.2436; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Kazui M, 2010, DRUG METAB DISPOS, V38, P92, DOI 10.1124/dmd.109.029132; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; L'Allier PL, 2008, J AM COLL CARDIOL, V51, P1066, DOI 10.1016/j.jacc.2007.12.013; Lev EI, 2007, THROMB RES, V119, P355, DOI 10.1016/j.thromres.2006.02.006; Marin F, 2009, J AM COLL CARDIOL, V54, P1041, DOI 10.1016/j.jacc.2009.04.084; Mega JL, 2010, LANCET, V376, P1312, DOI 10.1016/S0140-6736(10)61273-1; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Pellitero S, 2010, THROMB HAEMOSTASIS, V103, P630, DOI 10.1160/TH09-07-0453; Pena A, 2009, CIRCULATION, V119, P2854, DOI 10.1161/CIRCULATIONAHA.108.857722; Satra M, 2011, PHARMACOGENOMICS, V12, P195, DOI [10.2217/pgs.10.180, 10.2217/PGS.10.180]; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Shuldiner AR, 2009, JAMA-J AM MED ASSOC, V302, P849, DOI 10.1001/jama.2009.1232; Sibbing D, 2011, EUR HEART J, V32, P1605, DOI 10.1093/eurheartj/ehr155; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Stone GW, 2010, NEW ENGL J MED, V362, P1663, DOI 10.1056/NEJMoa0910496; [Task Force on Myocardial Revascularization of the European Society of Cardiology European Association for Cardio-Thoracic Surgery], 2010, EUR HEART J, V31, P2051; Taubert D, 2006, CLIN PHARMACOL THER, V80, P486, DOI 10.1016/j.clpt.2006.07.007; Trenk D, 2011, CIRC-CARDIOVASC GENE, V4, P429, DOI 10.1161/CIRCGENETICS.111.960112; van Werkum JW, 2009, J AM COLL CARDIOL, V53, P1399, DOI 10.1016/j.jacc.2008.12.055; van Werkum JW, 2009, CIRCULATION, V119, P828, DOI 10.1161/CIRCULATIONAHA.108.799403; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Wang YB, 2006, CIRCULATION, V113, P1615, DOI 10.1161/CIRCULATIONAHA.105.580167	44	166	178	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1765	1774		10.1001/jama.2011.1529	http://dx.doi.org/10.1001/jama.2011.1529			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028352	Bronze			2022-12-24	WOS:000296181600021
J	Zhou, M; Morgner, N; Barrera, NP; Politis, A; Isaacson, SC; Matak-Vinkovic, D; Murata, T; Bernal, RA; Stock, D; Robinson, CV				Zhou, Min; Morgner, Nina; Barrera, Nelson P.; Politis, Argyris; Isaacson, Shoshanna C.; Matak-Vinkovic, Dijana; Murata, Takeshi; Bernal, Ricardo A.; Stock, Daniela; Robinson, Carol V.			Mass Spectrometry of Intact V-Type ATPases Reveals Bound Lipids and the Effects of Nucleotide Binding	SCIENCE			English	Article							THERMOPHILUS H+-ATPASE/SYNTHASE; THERMUS-THERMOPHILUS; ENTEROCOCCUS-HIRAE; PERIPHERAL STALK; ATP SYNTHESIS; NA+-ATPASE; MACROMOLECULAR ASSEMBLIES; CRYSTAL-STRUCTURE; VACUOLAR ATPASE; ROTOR RING	The ability of electrospray to propel large viruses into a mass spectrometer is established and is rationalized by analogy to the atmospheric transmission of the common cold. Much less clear is the fate of membrane-embedded molecular machines in the gas phase. Here we show that rotary adenosine triphosphatases (ATPases)/synthases from Thermus thermophilus and Enterococcus hirae can be maintained intact with membrane and soluble subunit interactions preserved in vacuum. Mass spectra reveal subunit stoichiometries and the identity of tightly bound lipids within the membrane rotors. Moreover, subcomplexes formed in solution and gas phases reveal the regulatory effects of nucleotide binding on both ATP hydrolysis and proton translocation. Consequently, we can link specific lipid and nucleotide binding with distinct regulatory roles.	[Zhou, Min; Morgner, Nina; Politis, Argyris; Isaacson, Shoshanna C.; Robinson, Carol V.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England; [Barrera, Nelson P.; Matak-Vinkovic, Dijana] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Barrera, Nelson P.] Pontificia Univ Catolica Chile, Dept Physiol, Santiago, Chile; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Chiba 2638522, Japan; [Bernal, Ricardo A.] Univ Texas El Paso, Dept Chem, El Paso, TX 79968 USA; [Stock, Daniela] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia; [Stock, Daniela] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia	University of Oxford; University of Cambridge; Pontificia Universidad Catolica de Chile; Chiba University; University of Texas System; University of Texas El Paso; Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Robinson, CV (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, Oxford OX1 3QZ, England.	carol.robinson@chem.ox.ac.uk	Morgner, Nina/I-7975-2012; Bernal, Ricardo A/B-2124-2010; Morgner, Nina/O-7021-2018; Politis, Argyris/R-4333-2019; Murata, Takeshi/J-6181-2017	Morgner, Nina/0000-0002-1872-490X; Murata, Takeshi/0000-0002-5748-4670; Bernal, Ricardo A./0000-0001-5849-8647; Barrera, Nelson/0000-0001-7825-1406; robinson, carol/0000-0001-7829-5505	Wellcome Trust; European Union [HEALTHF4-2008-201648]; Royal Society; Australian National Health and Medical Research Council [573712]; FONDECYT [1100515]; Medical Research Council [G1000819] Funding Source: researchfish; MRC [G1000819] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); European Union(European Commission); Royal Society(Royal Society of London); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding from the Wellcome Trust and by the PROSPECTS (HEALTHF4-2008-201648) grant within the Research Framework of the European Union together with funding from the Royal Society (C.V.R.), the Australian National Health and Medical Research Council grant 573712 (D.S.), and the FONDECYT 1100515 (N.P.B.) is acknowledged.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Armbruster A, 2005, FEBS LETT, V579, P1961, DOI 10.1016/j.febslet.2005.02.042; Barrera NP, 2008, SCIENCE, V321, P243, DOI 10.1126/science.1159292; Barrera NP, 2009, NAT METHODS, V6, P585, DOI 10.1038/nmeth.1347; BELTRAN C, 1992, ACTA PHYSIOL SCAND, V146, P41; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017; CARSON D, 1979, BIOCHIM BIOPHYS ACTA, V575, P225, DOI 10.1016/0005-2760(79)90024-9; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Clare DK, 2006, STRUCTURE, V14, P1149, DOI 10.1016/j.str.2006.05.014; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Esteban O, 2008, J BIOL CHEM, V283, P2595, DOI 10.1074/jbc.M704941200; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Hildenbrand ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012588; Hoffmann J, 2010, PHYS CHEM CHEM PHYS, V12, P13375, DOI 10.1039/c0cp00733a; Hunte C, 2008, CURR OPIN STRUC BIOL, V18, P406, DOI 10.1016/j.sbi.2008.03.008; Iwata M, 2004, P NATL ACAD SCI USA, V101, P59, DOI 10.1073/pnas.0305165101; Jefferies KC, 2008, ARCH BIOCHEM BIOPHYS, V476, P33, DOI 10.1016/j.abb.2008.03.025; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Lau WCY, 2010, P NATL ACAD SCI USA, V107, P1367, DOI 10.1073/pnas.0911085107; Lee LK, 2010, NAT STRUCT MOL BIOL, V17, P373, DOI 10.1038/nsmb.1761; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2007, MOL MICROBIOL, V65, P1181, DOI 10.1111/j.1365-2958.2007.05857.x; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Murata T, 2003, J BIOL CHEM, V278, P21162, DOI 10.1074/jbc.M301620200; Murata T, 1999, J BIOCHEM, V125, P414, DOI 10.1093/oxfordjournals.jbchem.a022302; NUMOTO N, 2009, EMBO REP, V25, P25; Okazaki K, 2011, STRUCTURE, V19, P588, DOI 10.1016/j.str.2011.01.013; RAY PH, 1971, J BACTERIOL, V108, P227, DOI 10.1128/JB.108.1.227-235.1971; TAKASE K, 1994, J BIOL CHEM, V269, P11037; Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105; Uetrecht C, 2010, CHEM SOC REV, V39, P1633, DOI 10.1039/b914002f; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Yamamoto M, 2008, J BIOL CHEM, V283, P19422, DOI 10.1074/jbc.M801772200; Yokoyama K, 2003, J BIOL CHEM, V278, P42686, DOI 10.1074/jbc.M305853200; Yokoyama K, 2000, J BIOL CHEM, V275, P13955, DOI 10.1074/jbc.275.18.13955; ZHANG JM, 1992, J BIOL CHEM, V267, P9773	42	216	218	0	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					380	385		10.1126/science.1210148	http://dx.doi.org/10.1126/science.1210148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021858	Green Accepted			2022-12-24	WOS:000296052500054
J	[Anonymous]				[Anonymous]			GLOBAL WARMING Call for urgent action on climate change	BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2011	343								d6760	10.1136/bmj.d6760	http://dx.doi.org/10.1136/bmj.d6760			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HL	22008811				2022-12-24	WOS:000296183400016
J	Frieden, TR; Berwick, DM				Frieden, Thomas R.; Berwick, Donald M.			The "Million Hearts" Initiative - Preventing Heart Attacks and Strokes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATHS; US		[Frieden, Thomas R.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Berwick, Donald M.] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	Centers for Disease Control & Prevention - USA; Centers for Medicare & Medicaid Services	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Farley TA, 2010, AM J PREV MED, V38, P600, DOI 10.1016/j.amepre.2010.02.016; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Mehta RH, 2007, AM J MED, V120, P398, DOI 10.1016/j.amjmed.2006.12.018	5	236	243	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13							e27	10.1056/NEJMP1110421	http://dx.doi.org/10.1056/NEJMP1110421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21913835				2022-12-24	WOS:000295318400004
J	Brownell, KD; Ludwig, DS				Brownell, Kelly D.; Ludwig, David S.			The Supplemental Nutrition Assistance Program, Soda, and USDA Policy Who Benefits?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Yale University; Harvard University; Boston Children's Hospital	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, POB 208369, New Haven, CT 06520 USA.	kelly.brownell@yale.edu		Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barnhill A, 2011, AM J PUBLIC HEALTH, V101, P2037, DOI 10.2105/AJPH.2011.300225; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; DIMSDALE J, 2010, MARKETPLACE     1007; MCGEEHAN P, 2011, NY TIMES        0819; *NY CIT DEP HLTH M, REM SNAP SUBS SUG SW; POLHEMUS B, 2011, PEDIAT NUTR SURVEILL; SCOTTTHOMAS C, 2011, FOOD NAVIGATOR  0505; Shahn J., 2011, SUPPLEMENTAL NUTR AS; Shenkin JD, 2010, AM J PUBLIC HEALTH, V100, P1562, DOI 10.2105/AJPH.2010.198549	9	43	43	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1370	1371		10.1001/jama.2011.1382	http://dx.doi.org/10.1001/jama.2011.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825FQ	21954481				2022-12-24	WOS:000295257000026
J	Teijaro, JR; Walsh, KB; Cahalan, S; Fremgen, DM; Roberts, E; Scott, F; Martinborough, E; Peach, R; Oldstone, MBA; Rosen, H				Teijaro, John R.; Walsh, Kevin B.; Cahalan, Stuart; Fremgen, Daniel M.; Roberts, Edward; Scott, Fiona; Martinborough, Esther; Peach, Robert; Oldstone, Michael B. A.; Rosen, Hugh			Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection	CELL			English	Article							IMMUNE-RESPONSE; S1P(1) AGONIST; RECEPTORS; VIRULENCE	Cytokine storm during viral infection is a prospective predictor of morbidity and mortality, yet the cellular sources remain undefined. Here, using genetic and chemical tools to probe functions of the S1P(1) receptor, we elucidate cellular and signaling mechanisms that are important in initiating cytokine storm. Whereas S1P(1) receptor is expressed on endothelial cells and lymphocytes within lung tissue, S1P(1) agonism suppresses cytokines and innate immune cell recruitment in wild-type and lymphocyte-deficient mice, identifying endothelial cells as central regulators of cytokine storm. Furthermore, our data reveal immune cell infiltration and cytokine production as distinct events that are both orchestrated by endothelial cells. Moreover, we demonstrate that suppression of early innate immune responses through S1P(1) signaling results in reduced mortality during infection with a human pathogenic strain of influenza virus. Modulation of endothelium with a specific agonist suggests that diseases in which amplification of cytokine storm is a significant pathological component could be chemically tractable.	[Teijaro, John R.; Walsh, Kevin B.; Fremgen, Daniel M.; Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Cahalan, Stuart; Rosen, Hugh] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Roberts, Edward] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Scott, Fiona; Martinborough, Esther; Peach, Robert] Receptos Inc, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Oldstone, MBA (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mbaobo@scripps.edu; hrosen@scripps.edu			USPHS [AI074564, AI009484, AI05509, MH084512]; NIH [NS041219, AI007244, AI007364]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055509, T32AI007244, T32AI007364, U01AI074564, R37AI009484, R01AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH084512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041219] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This is Publication Number 21112 from the Department of Immunology and Microbial Science and the Department of Chemical Physiology and The Scripps Research Institute Molecular Screening Center, The Scripps Research Institute (TSRI). This work was supported, in part, by USPHS grants AI074564 (M.B.A.O., H.R., K.B.W., and J.R.T.), AI009484 (M.B.A.O.), AI05509 (H.R.), MH084512 (H.R.), and NIH training grants NS041219 (K.B.W.), AI007244 (K.B.W.), and AI007364 (J.R.T). We thank Marcus Boehm, Li-ming Huang, and Bryan Clemons (Receptos, Inc.) for helping provide RP-002 as a chemical tool. Hugh Rosen is a founder of Receptos. Edward Roberts is a consultant to Receptos. Fiona Scott, Esther Martinborough, and Robert Peach are employees of Receptos.	Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Borges AA, 2006, MICROBES INFECT, V8, P2324, DOI 10.1016/j.micinf.2006.04.019; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Cahalan SM, 2011, NAT CHEM BIOL, V7, P254, DOI 10.1038/nchembio.547; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garcia-Sastre A, 2010, AM J PATHOL, V176, P1584, DOI 10.2353/ajpath.2010.100066; Gonzalez-Cabrera PJ, 2008, MOL PHARMACOL, V74, P1308, DOI 10.1124/mol.108.049783; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Kaiser L, 2001, J MED VIROL, V64, P262, DOI 10.1002/jmv.1045; Kawane K, 2010, P NATL ACAD SCI USA, V107, P19432, DOI 10.1073/pnas.1010603107; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Link H, 1998, MULT SCLER, V4, P12, DOI 10.1191/135245898678909141; Marsolais D, 2008, MOL PHARMACOL, V74, P896, DOI 10.1124/mol.108.048769; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Martinborough M.F., 2011, Patent No. [wo 2011060392, 2011060392]; Openshaw PJM, 2010, MUCOSAL IMMUNOL, V3, P422, DOI 10.1038/mi.2010.34; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosen H, 2003, CURR OPIN CHEM BIOL, V7, P461, DOI 10.1016/S1367-5931(03)00085-1; ROSEN H, 1987, J EXP MED, V166, P1685, DOI 10.1084/jem.166.6.1685; Rosen H, 2008, IMMUNOL REV, V223, P221, DOI 10.1111/j.1600-065X.2008.00645.x; Rosen H, 2007, TRENDS IMMUNOL, V28, P102, DOI 10.1016/j.it.2007.01.007; Rosen H, 2009, ANNU REV BIOCHEM, V78, P743, DOI 10.1146/annurev.biochem.78.072407.103733; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947	35	474	512	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					980	991		10.1016/j.cell.2011.08.015	http://dx.doi.org/10.1016/j.cell.2011.08.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925319	Bronze, Green Published, Green Accepted			2022-12-24	WOS:000295258100019
J	Mahowald, N				Mahowald, Natalie			Aerosol Indirect Effect on Biogeochemical Cycles and Climate	SCIENCE			English	Article							NITROGEN DEPOSITION; DESERT DUST; ATMOSPHERIC NITROGEN; CARBON STORAGE; IMPACT; MODEL; CO2; SEQUESTRATION; LIMITATION; FEEDBACKS	The net effect of anthropogenic aerosols on climate is usually considered the sum of the direct radiative effect of anthropogenic aerosols, plus the indirect effect of these aerosols through aerosol-cloud interactions. However, an additional impact of aerosols on a longer time scale is their indirect effect on climate through biogeochemical feedbacks, largely due to changes in the atmospheric concentration of CO2. Aerosols can affect land and ocean biogeochemical cycles by physical forcing or by adding nutrients and pollutants to ecosystems. The net biogeochemical effect of aerosols is estimated to be equivalent to a radiative forcing of -0.5 +/- 0.4 watts per square meter, which suggests that reaching lower carbon targets will be even costlier than previously estimated.	Cornell Univ, Dept Earth & Atmospher Sci, Atkinson Ctr Sustainable Future, Ithaca, NY 14850 USA	Cornell University	Mahowald, N (corresponding author), Cornell Univ, Dept Earth & Atmospher Sci, Atkinson Ctr Sustainable Future, Ithaca, NY 14850 USA.		Mahowald, Natalie M/D-8388-2013	Mahowald, Natalie M/0000-0002-2873-997X	NSF [078369, 0832782, 0932946, 1021613, 1049033]; NASA [NNG06G127G]; Atkinson Center for Sustainable Future; Directorate For Geosciences [1003509, 0932946] Funding Source: National Science Foundation; Division Of Computer and Network Systems [0832782] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Atkinson Center for Sustainable Future; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by grants from NSF (078369, 0832782, 0932946, 1021613, 1049033), NASA (NNG06G127G), and the Atkinson Center for Sustainable Future. Discussions with C. Goodale, P. Hess, and D. Miller contributed to this paper. Comments by R. Scanza and two anonymous reviewers improved the paper.	Andreae MO, 2005, NATURE, V435, P1187, DOI 10.1038/nature03671; Clarke L., 2007, SCENARIOS GREENHOUSE; Doney SC, 2007, P NATL ACAD SCI USA, V104, P14580, DOI 10.1073/pnas.0702218104; Duce RA, 2008, SCIENCE, V320, P893, DOI 10.1126/science.1150369; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Feng Y, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2005JD006404; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Friedlingstein P, 2008, NATURE, V451, P297, DOI 10.1038/nature06593; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Hijoka Y., 2008, GLOBAL ENV ENG, V13, P97; Holland EA, 1997, J GEOPHYS RES-ATMOS, V102, P15849, DOI 10.1029/96JD03164; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Jones CD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016867; Krishnamurthy A, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG001115; LeBauer DS, 2008, ECOLOGY, V89, P371, DOI 10.1890/06-2057.1; Likens GE, 2010, FRONT ECOL ENVIRON, V8, pE1, DOI 10.1890/090132; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; Mahowald N, 2011, BIOGEOSCIENCES, V8, P387, DOI 10.5194/bg-8-387-2011; Mahowald NM, 2010, ATMOS CHEM PHYS, V10, P10875, DOI 10.5194/acp-10-10875-2010; Mahowald N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003240; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002541; MARTIN JH, 1991, LIMNOL OCEANOGR, V36, P1793, DOI 10.4319/lo.1991.36.8.1793; Matsuoka Y, 2006, ENERGY J, V3, P343; Melillo J.M., 1983, MAJOR BIOGEOCHEMICAL; Melillo J.M., 1983, MAJOR BIOGEOCHEMICAL; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Nadelhoffer KJ, 1999, NATURE, V398, P145, DOI 10.1038/18205; Paytan A, 2009, P NATL ACAD SCI USA, V106, P4601, DOI 10.1073/pnas.0811486106; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Reay DS, 2008, NAT GEOSCI, V1, P430, DOI 10.1038/ngeo230; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Schindler DW, 1981, ATMOSPHERE BIOSPHERE; Smith SJ, 2006, ENERG J, P373; Stevens B, 2009, NATURE, V461, P607, DOI 10.1038/nature08281; Thomas RQ, 2010, NAT GEOSCI, V3, P13, DOI 10.1038/NGEO721; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Townsend AR, 1996, ECOL APPL, V6, P806, DOI 10.2307/2269486; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; Wise M, 2009, SCIENCE, V324, P1183, DOI 10.1126/science.1168475; ZAEHLE S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI DOI 10.1029/2009GB003521	43	287	296	10	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					794	796		10.1126/science.1207374	http://dx.doi.org/10.1126/science.1207374			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076375				2022-12-24	WOS:000296849600043
J	Polymenidou, M; Cleveland, DW				Polymenidou, Magdalini; Cleveland, Don W.			The Seeds of Neurodegeneration: Prion-like Spreading in ALS	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MUTANT SUPEROXIDE-DISMUTASE; CEREBRAL BETA-AMYLOIDOSIS; MOTOR-NEURON DISEASE; BINDING PROTEIN 43; PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; MESSENGER-RNA; INCLUSION FORMATION	Misfolded proteins accumulating in several neurodegenerative diseases (including Alzheimer, Parkinson, and Huntington diseases) can cause aggregation of their native counterparts through a mechanism similar to the infectious prion protein's induction of a pathogenic conformation onto its cellular isoform. Evidence for such a prion-like mechanism has now spread to the main misfolded proteins, SOD1 and TDP-43, implicated in amyotrophic lateral sclerosis (ALS). The major neurodegenerative diseases may therefore have mechanistic parallels for non-cell-autonomous spread of disease within the nervous system.	[Polymenidou, Magdalini; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Polymenidou, Magdalini; Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Polymenidou, Magdalini/D-2254-2014; Cleveland, Don/AAN-9783-2021	Cleveland, Don/0000-0002-1934-3682	international Human Frontier Science Program Organization; National Institute of Neurological Disorders and Stroke [K99NS075216, R37NS27036]; Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS075216, R37NS027036] Funding Source: NIH RePORTER	international Human Frontier Science Program Organization(Human Frontier Science Program); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Ludwig Institute for Cancer Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank all members of the Cleveland lab for discussions. M.P. was the recipient of a long-term fellowship from the international Human Frontier Science Program Organization. The authors receive support from the National Institute of Neurological Disorders and Stroke-K99NS075216 to M.P. and R37NS27036 to D.W.C. D.W.C. receives salary support from the Ludwig Institute for Cancer Research.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Ayala YM, 2011, EMBO J, V30, P277, DOI 10.1038/emboj.2010.310; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chia R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010627; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Deng YP, 2004, J CHEM NEUROANAT, V27, P143, DOI 10.1016/j.jchemneu.2004.02.005; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Doi H, 2010, NEUROSCI RES, V66, P131, DOI 10.1016/j.neures.2009.10.004; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Fuentealba RA, 2010, J BIOL CHEM, V285, P26304, DOI 10.1074/jbc.M110.125039; Fujita K, 2008, ACTA NEUROPATHOL, V116, P439, DOI 10.1007/s00401-008-0415-x; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Guo WR, 2011, NAT STRUCT MOL BIOL, V18, P822, DOI 10.1038/nsmb.2053; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huang C, 2010, INT J BIOL SCI, V6, P396; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Igaz LM, 2011, J CLIN INVEST, V121, P726, DOI 10.1172/JCI44867; Ilieva H, 2009, J CELL BIOL, V187, P761, DOI 10.1083/jcb.200908164; Ito D, 2011, ANN NEUROL, V69, P152, DOI 10.1002/ana.22246; Jaarsma D, 2008, J NEUROSCI, V28, P2075, DOI 10.1523/JNEUROSCI.5258-07.2008; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Jucker M, 2010, NAT MED, V16, P1210, DOI 10.1038/nm.2224; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Kril JJ, 2011, J MOL NEUROSCI, V45, P379, DOI 10.1007/s12031-011-9528-0; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Moisse K, 2009, BRAIN RES, V1249, P202, DOI 10.1016/j.brainres.2008.10.021; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Pesiridis GS, 2011, J BIOL CHEM, V286, P18845, DOI 10.1074/jbc.M111.231118; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Ravits J, 2007, NEUROLOGY, V68, P1576, DOI 10.1212/01.wnl.0000261045.57095.56; Ravits J, 2007, NEUROLOGY, V68, P1571, DOI 10.1212/01.wnl.0000260965.20021.47; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Schwab C, 2008, J NEUROPATH EXP NEUR, V67, P1159, DOI 10.1097/NEN.0b013e31818e8951; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Thal DR, 2008, ACTA NEUROPATHOL, V115, P599, DOI 10.1007/s00401-008-0366-2; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Voigt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012247; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yokoseki A, 2008, ANN NEUROL, V63, P538, DOI 10.1002/ana.21392	103	259	264	1	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					498	508		10.1016/j.cell.2011.10.011	http://dx.doi.org/10.1016/j.cell.2011.10.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036560	Green Accepted, Bronze			2022-12-24	WOS:000296573700007
J	Nicholls, H				Nicholls, Henry			CLIMATE CHANGE AND HEALTH Unhealthier by degrees	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION					henry@henrynicholls.com						de Bruin KC, 2009, CLIMATIC CHANGE, V95, P63, DOI 10.1007/s10584-008-9535-5; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Stott R, 2006, BRIT MED J, V332, P1385, DOI 10.1136/bmj.332.7554.1385; Zhang DD, 2007, P NATL ACAD SCI USA, V104, P19214, DOI 10.1073/pnas.0703073104; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188	6	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2011	343								d6893	10.1136/bmj.d6893	http://dx.doi.org/10.1136/bmj.d6893			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CY	22031914				2022-12-24	WOS:000296417100016
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Off-label prescribing in macular degeneration	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, BRIT MED J, V343, pD6169, DOI DOI 10.1136/BMJ.D6169; 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI DOI 10.1001/ARCHOPHTHALMOL.2010.223; 2011, NEW ENGL J MED, V364, P1897, DOI DOI 10.1056/NEJMOA1102673	3	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 19	2011	343								d6778	10.1136/bmj.d6778	http://dx.doi.org/10.1136/bmj.d6778			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HN	22012651				2022-12-24	WOS:000296183700012
J	Ingelfinger, JR				Ingelfinger, Julie R.			Bariatric Surgery in Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	32	32	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1365	1367		10.1056/NEJMp1109981	http://dx.doi.org/10.1056/NEJMp1109981			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995381				2022-12-24	WOS:000295782500033
J	Arner, P; Bernard, S; Salehpour, M; Possnert, G; Liebl, J; Steier, P; Buchholz, BA; Eriksson, M; Arner, E; Hauner, H; Skurk, T; Ryden, M; Frayn, KN; Spalding, KL				Arner, Peter; Bernard, Samuel; Salehpour, Mehran; Possnert, Goran; Liebl, Jakob; Steier, Peter; Buchholz, Bruce A.; Eriksson, Mats; Arner, Erik; Hauner, Hans; Skurk, Thomas; Ryden, Mikael; Frayn, Keith N.; Spalding, Kirsty L.			Dynamics of human adipose lipid turnover in health and metabolic disease	NATURE			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; CELL TURNOVER; FATTY-ACIDS; IN-VIVO; TISSUE; ASSIMILATION; RADIOCARBON; OXIDATION; LIPOLYSIS	Adipose tissue mass is determined by the storage and removal of triglycerides in adipocytes(1). Little is known, however, about adipose lipid turnover in humans in health and pathology. To study this in vivo, here we determined lipid age by measuring C-14 derived from above ground nuclear bomb tests in adipocyte lipids. We report that during the average ten-year lifespan of human adipocytes, triglycerides are renewed six times. Lipid age is independent of adipocyte size, is very stable across a wide range of adult ages and does not differ between genders. Adipocyte lipid turnover, however, is strongly related to conditions with disturbed lipid metabolism. In obesity, triglyceride removal rate (lipolysis followed by oxidation) is decreased and the amount of triglycerides stored each year is increased. In contrast, both lipid removal and storage rates are decreased in non-obese patients diagnosed with the most common hereditary form of dyslipidaemia, familial combined hyperlipidaemia. Lipid removal rate is positively correlated with the capacity of adipocytes to break down triglycerides, as assessed through lipolysis, and is inversely related to insulin resistance. Our data support a mechanism in which adipocyte lipid storage and removal have different roles in health and pathology. High storage but low triglyceride removal promotes fat tissue accumulation and obesity. Reduction of both triglyceride storage and removal decreases lipid shunting through adipose tissue and thus promotes dyslipidaemia. We identify adipocyte lipid turnover as a novel target for prevention and treatment of metabolic disease.	[Arner, Peter; Eriksson, Mats; Arner, Erik; Ryden, Mikael] Karolinska Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon, CNRS UMR 5208, Inst Camille Jordan, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron, SE-75120 Uppsala, Sweden; [Liebl, Jakob; Steier, Peter] Univ Vienna, Fac Phys Isotope Res, A-1090 Vienna, Austria; [Buchholz, Bruce A.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94551 USA; [Hauner, Hans; Skurk, Thomas] Tech Univ Munich, Else Kroner Fresenius Ctr Nutr Med, D-85350 Weihenstephan, Germany; [Frayn, Keith N.] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Spalding, Kirsty L.] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; University of Vienna; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Technical University of Munich; University of Oxford; Karolinska Institutet	Arner, P (corresponding author), Karolinska Univ Hosp, Dept Med, SE-14186 Stockholm, Sweden.	peter.arner@ki.se; kirsty.spalding@ki.se	Spalding, Kirsty/CAF-4248-2022; Buchholz, Bruce A/G-1356-2011; Arner, Erik/A-1895-2010; Steier, Peter/AAZ-6043-2020; Bernard, Samuel/A-5623-2009; spalding, kirsty/I-6046-2017	Spalding, Kirsty/0000-0002-5189-7028; Buchholz, Bruce A/0000-0002-9531-551X; Arner, Erik/0000-0003-1225-4908; Bernard, Samuel/0000-0002-8442-9968; Eriksson, Mats/0000-0001-6481-5549; Skurk, Thomas/0000-0002-6875-1658; Arner, Peter/0000-0002-6208-6220	Swedish Research Council; Swedish Foundation for Strategic Research; Swedish Heart and Lung Foundation; Novo Nordic Foundation; Swedish Diabetes Foundation; Karolinska Institutet; Swedish Cancer Society; Uppsala BIO, Sweden; NIH/NCRR [RR13461]; ERC [261258-HUFATREG]; European Commission [LSHM-CT-2005-018734, HEALTH-F2-2008-201100]; US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103483] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordic Foundation(Novo Nordisk Foundation); Swedish Diabetes Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Uppsala BIO, Sweden; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); ERC(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Swedish Research Council, Swedish Foundation for Strategic Research, Swedish Heart and Lung Foundation, Novo Nordic Foundation, Swedish Diabetes Foundation, Strategic Research Program in Diabetes at the Karolinska Institutet, Swedish Cancer Society, Uppsala BIO, Sweden, NIH/NCRR Grant RR13461, ERC grant 261258-HUFATREG and by the projects 'Hepatic and adipose tissue and functions in the metabolic syndrome' (HEPADIP, http://www.hepadip.org/) and 'Adipokines as drug targets to combat adverse effects of excess adipose tissue' (ADAPT, http://www.adapt-eu.net), which were supported by the European Commission as an Integrated Project under the 6th and the 7th Framework Programmes (contract LSHM-CT-2005-018734 and contract HEALTH-F2-2008-201100). This work was performed in part under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. The authors would like to acknowledge E. Sjolin, K. Wahlen, B.-M. Leijonhufvud, K. Hertel and Y. Widlund for technical assistance. We would like to thank F. Barnabe-Heider and J. Frisen for useful comments on the manuscript.	Arner P, 1997, CURR OPIN LIPIDOL, V8, P89, DOI 10.1097/00041433-199704000-00006; Ayyobi AF, 2003, AM J CARDIOL, V92, p27J, DOI 10.1016/S0002-9149(03)00613-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bernard S, 2010, NUCL INSTRUM METH B, V268, P1295, DOI 10.1016/j.nimb.2009.10.156; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BJORNTORP P, 1974, METABOLISM, V23, P1091, DOI 10.1016/0026-0495(74)90076-6; Blaak EE, 2006, J CLIN ENDOCR METAB, V91, P1462, DOI 10.1210/jc.2005-1598; de Graaf J, 2002, J ROY SOC MED, V95, P46; EKSTEDT B, 1970, LIPIDS, V5, P858, DOI 10.1007/BF02531981; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; KERPEL S, 1961, BIOCHIM BIOPHYS ACTA, V46, P495, DOI 10.1016/0006-3002(61)90580-7; KLEIN RA, 1980, LIPIDS, V15, P572, DOI 10.1007/BF02534181; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Levin I, 2004, RADIOCARBON, V46, P1261, DOI 10.1017/S0033822200033130; MARIN P, 1995, J CLIN ENDOCR METAB, V80, P239, DOI 10.1210/jc.80.1.239; MARIN P, 1990, EUR J CLIN INVEST, V20, P158, DOI 10.1111/j.1365-2362.1990.tb02263.x; NYDAL R, 1965, NATURE, V206, P1029, DOI 10.1038/2061029a0; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; REYNISDOTTIR S, 1995, J CLIN INVEST, V95, P2161, DOI 10.1172/JCI117905; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; van der Kallen CJH, 2002, ATHEROSCLEROSIS, V164, P337, DOI 10.1016/S0021-9150(02)00109-0	24	244	250	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					110	113		10.1038/nature10426	http://dx.doi.org/10.1038/nature10426			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21947005	Green Accepted, Green Submitted			2022-12-24	WOS:000295575400044
J	Virgin, HW; Todd, JA				Virgin, Herbert W.; Todd, John A.			Metagenomics and Personalized Medicine	CELL			English	Article							INFLAMMATORY-BOWEL-DISEASE; TYPE-1 DIABETES-MELLITUS; DIABETOGENIC T-CELLS; GUT MICROBIOTA; INTESTINAL MICROBIOTA; CROHNS-DISEASE; IMMUNE-SYSTEM; ENTEROVIRUS INFECTION; COMMENSAL BACTERIA; VIRAL-INFECTION	The microbiome is a complex community of Bacteria, Archaea, Eukarya, and viruses that infect humans and live in our tissues. It contributes the majority of genetic information to our metagenome and, consequently, influences our resistance and susceptibility to diseases, especially common inflammatory diseases, such as type 1 diabetes, ulcerative colitis, and Crohn's disease. Here we discuss how host-gene-microbial interactions are major determinants for the development of these multifactorial chronic disorders and, thus, for the relationship between genotype and phenotype. We also explore how genome-wide association studies (GWAS) on autoimmune and inflammatory diseases are uncovering mechanism-based subtypes for these disorders. Applying these emerging concepts will permit a more complete understanding of the etiologies of complex diseases and underpin the development of both next-generation animal models and new therapeutic strategies for targeting personalized disease phenotypes.	[Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Midwest Reg Ctr Excellence Biodef & Emerging Infe, St Louis, MO 63110 USA; [Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England	Washington University (WUSTL); Washington University (WUSTL); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Dept Mol Microbiol, St Louis, MO 63110 USA.	virgin@wustl.edu; john.todd@cimr.cam.ac.uk	; Todd, John/A-3542-2010	Virgin, Herbert/0000-0001-8580-7628; Todd, John/0000-0003-2740-8148	NCI; NIAID; NCRR; Crohn's and Colitis Foundation of America; Broad Medical Foundation; NIDDK; NIHR; Wellcome Trust; Juvenile Diabetes Research Foundation International; European Union; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA074730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065982, R01AI084887, R01AI054483] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011170] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Crohn's and Colitis Foundation of America; Broad Medical Foundation; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors would like to acknowledge helpful conversations with Thad Stappenbeck, Ramnik Xavier, Emil Unanue, Jeff Gordon, Balfour Sartor, Adolfo Garcia-Sastre, and Dermot McGovern. We thank Tom Smith for providing the images of noroviruses used in Figure 4. H. W. V. is supported by the NCI, NIAID, NCRR, the Crohn's and Colitis Foundation of America, and the Broad Medical Foundation. J.A.T. is supported by the NIDDK, NIHR, the Wellcome Trust, the Juvenile Diabetes Research Foundation International, and the European Union.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Brehm MA, 2010, DIABETES, V59, P2265, DOI 10.2337/db10-0323; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1561, DOI 10.1073/pnas.1018973108; Calderon B, 2011, P NATL ACAD SCI USA, V108, P1567, DOI 10.1073/pnas.1018975108; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Cardwell CR, 2010, DIABETOLOGIA, V53, P641, DOI 10.1007/s00125-009-1648-5; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cooper JD, 2011, DIABETES, V60, P1624, DOI 10.2337/db10-1656; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Ehlers S, 2010, TRENDS IMMUNOL, V31, P184, DOI 10.1016/j.it.2010.02.003; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Gianani R, 2010, DIABETOLOGIA, V53, P690, DOI 10.1007/s00125-009-1642-y; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hansen EE, 2011, P NATL ACAD SCI USA, V108, P4599, DOI 10.1073/pnas.1000071108; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Ives A, 2011, SCIENCE, V331, P775, DOI 10.1126/science.1199326; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim YG, 2011, CELL HOST MICROBE, V9, P496, DOI 10.1016/j.chom.2011.05.006; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Long SA, 2011, GENES IMMUN, V12, P116, DOI 10.1038/gene.2010.54; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McCartney SA, 2011, J CLIN INVEST, V121, P1497, DOI 10.1172/JCI44005; McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248; Melmed GY, 2010, NAT REV GASTRO HEPAT, V7, P110, DOI 10.1038/nrgastro.2009.218; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Odze R, 2003, MODERN PATHOL, V16, P347, DOI 10.1097/01.MP.0000064746.82024.D1; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Pfluger M, 2010, HORM METAB RES, V42, P143, DOI 10.1055/s-0029-1241830; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sczesnak A, 2011, CELL HOST MICROBE, V10, P260, DOI 10.1016/j.chom.2011.08.005; Smyth DJ, 2011, DIABETES, V60, P3081, DOI 10.2337/db11-0638; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stappenbeck TS, 2011, AUTOPHAGY, V7, P355, DOI 10.4161/auto.7.2.13074; Stene LC, 2010, DIABETES, V59, P3174, DOI 10.2337/db10-0866; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; White DW, 2010, BLOOD, V115, P4377, DOI 10.1182/blood-2009-09-245464; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Yeung WCG, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d35	88	151	158	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					44	56		10.1016/j.cell.2011.09.009	http://dx.doi.org/10.1016/j.cell.2011.09.009			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962506	Green Accepted, Bronze			2022-12-24	WOS:000295396700014
J	Huang, JF; Millis, JM; Mao, YL; Millis, MA; Sang, XT; Zhong, SX				Huang, Jiefu; Millis, J. Michael; Mao, Yilei; Millis, M. Andrew; Sang, Xinting; Zhong, Shouxian			A pilot programme of organ donation after cardiac death in China	LANCET			English	Article							DONOR LIVER-TRANSPLANTATION; HEART-BEATING DONORS; EXECUTED PRISONERS; OUTCOMES; POLICY	China's aims are to develop an ethical and sustainable organ transplantation system for the Chinese people and to be accepted as a responsible member of the international transplantation community. In 2007, China implemented the Regulation on Human Organ Transplantation, which was the first step towards the establishment of a voluntary organ donation system. Although progress has been made, several ethical and legal issues associated with transplantation in China remain, including the use of organs from executed prisoners, organ scarcity, the illegal organ trade, and transplantation tourism. In this Health Policy article we outline the standards used to define cardiac death in China and a legal and procedural framework for an organ donation system based on voluntary donation after cardiac death that adheres to both China's social and cultural principles and international transplantation standards.	[Huang, Jiefu; Mao, Yilei; Sang, Xinting; Zhong, Shouxian] Beijing Union Med Coll Hosp, Dept Liver Surg, Beijing 100730, Peoples R China; [Millis, J. Michael; Millis, M. Andrew] Univ Chicago, Sect Transplantat Liver Transplantat & Hepatobili, Chicago, IL 60637 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Chicago	Huang, JF (corresponding author), Beijing Union Med Coll Hosp, Dept Liver Surg, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China.	jeffrey1301@hotmail.com	Millis, Michael/K-5346-2019		China Medical Board [CMB 06-837]	China Medical Board	This work was supported by a China Medical Board grant (CMB 06-837). We thank ST Fan, Youmin Wu, Haibo Wang, Zhonghua Chen, Yongfeng Liu, Zhongyang Shen, Xiaoshun He, Jiahong Dong, and Jiye Zhu for their kindly contributions to this work.	Adcock L, 2010, AM J TRANSPLANT, V10, P364, DOI 10.1111/j.1600-6143.2009.02950.x; [Anonymous], 2009, TRANSPLANT P, V41, P23; Cameron JS, 1999, KIDNEY INT, V55, P724, DOI 10.1046/j.1523-1755.1999.00286.x; Chen Z., 2006, AM J TRANSPLANT S, V6, P437; Chinese Ministry of Health, REG HUM ORG TRANSPL; Chinese Ministry of Health, 2011, CHIN J TRANSPLANT, V5, P72; Cronin DC, 2001, NEW ENGL J MED, V344, P1633, DOI 10.1056/NEJM200105243442112; Hillman H, 2001, BRIT MED J, V323, P1254, DOI 10.1136/bmj.323.7323.1254; Huang J, 2007, ZHONGHUA WAI KE ZA Z, V45, P297; Huang JF, 2007, LIVER TRANSPLANT, V13, P193, DOI 10.1002/lt.21081; Huang JF, 2008, LANCET, V372, P1937, DOI 10.1016/S0140-6736(08)61359-8; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; Liu J, 2009, CAIJING MAGAZIN 0831, P63; Minister of Public Security Bureau of Traffic Authority, REP 2009 NAT ROAD TR; Ministry of Health, 2006, CHIN HLTH STAT YB; Sanchez-Fructuoso AI, 2000, J AM SOC NEPHROL, V11, P350, DOI 10.1681/ASN.V112350; Shah SA, 2006, CAN J GASTROENTEROL, V20, P339, DOI 10.1155/2006/320530; Shan J, 2009, CHINA DAILY     0826, P3; Shang XM, 2010, LANCET, V376, P1033, DOI 10.1016/S0140-6736(10)60937-3; Standard for Brain Death Decision Drafting Group Ministry of Health, 2003, CHIN MED J, V83, P262; Tibell A, 2007, TRANSPLANTATION, V84, P292, DOI 10.1097/01.tp.0000275181.33071.07; [吴洪艳 Wu Hongyan], 2008, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V12, P6125; Yongfeng L., 2009, CHIN J TRANSPLANT, V3, P4; Yuan D, 2011, HEPATOB PANCREAT DIS, V10, P480, DOI 10.1016/S1499-3872(11)60082-9; Zhenyu M., 2009, CHIN J TRANSPLANT, V3, P273	25	92	124	2	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 3	2012	379	9818					862	865		10.1016/S0140-6736(11)61086-6	http://dx.doi.org/10.1016/S0140-6736(11)61086-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	901RB	22078722				2022-12-24	WOS:000300983400036
J	Cooper, WO; Habel, LA; Sox, CM; Chan, KA; Arbogast, PG; Cheetham, TC; Murray, KT; Quinn, VP; Stein, CM; Callahan, ST; Fireman, BH; Fish, FA; Kirshner, HS; O'Duffy, A; Connell, FA; Ray, WA				Cooper, William O.; Habel, Laurel A.; Sox, Colin M.; Chan, K. Arnold; Arbogast, Patrick G.; Cheetham, T. Craig; Murray, Katherine T.; Quinn, Virginia P.; Stein, C. Michael; Callahan, S. Todd; Fireman, Bruce H.; Fish, Frank A.; Kirshner, Howard S.; O'Duffy, Anne; Connell, Frederick A.; Ray, Wayne A.			ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; ACUTE MYOCARDIAL-INFARCTION; SUDDEN-DEATH; STIMULANT-DRUGS; CARDIAC SAFETY; ADOLESCENTS; STROKE; TRIALS; RISK	BACKGROUND Adverse-event reports from North America have raised concern that the use of drugs for attention deficit-hyperactivity disorder (ADHD) increases the risk of serious cardiovascular events. METHODS We conducted a retrospective cohort study with automated data from four health plans (Tennessee Medicaid, Washington State Medicaid, Kaiser Permanente California, and OptumInsight Epidemiology), with 1,200,438 children and young adults between the ages of 2 and 24 years and 2,579,104 person-years of follow-up, including 373,667 person-years of current use of ADHD drugs. We identified serious cardiovascular events (sudden cardiac death, acute myocardial infarction, and stroke) from health-plan data and vital records, with end points validated by medical-record review. We estimated the relative risk of end points among current users, as compared with non-users, with hazard ratios from Cox regression models. RESULTS Cohort members had 81 serious cardiovascular events (3.1 per 100,000 person-years). Current users of ADHD drugs were not at increased risk for serious cardiovascular events (adjusted hazard ratio, 0.75; 95% confidence interval [CI], 0.31 to 1.85). Risk was not increased for any of the individual end points, or for current users as compared with former users (adjusted hazard ratio, 0.70; 95% CI, 0.29 to 1.72). Alternative analyses addressing several study assumptions also showed no significant association between the use of an ADHD drug and the risk of a study end point. CONCLUSIONS This large study showed no evidence that current use of an ADHD drug was associated with an increased risk of serious cardiovascular events, although the upper limit of the 95% confidence interval indicated that a doubling of the risk could not be ruled out. However, the absolute magnitude of such an increased risk would be low. (Funded by the Agency for Healthcare Research and Quality and the Food and Drug Administration.)	[Cooper, William O.] Vanderbilt Univ, Div Gen Pediat, Nashville, TN USA; [Callahan, S. Todd] Vanderbilt Univ, Div Adolescent Med, Nashville, TN USA; [Fish, Frank A.] Vanderbilt Univ, Dept Pediat, Div Pediat Cardiol, Nashville, TN USA; [Arbogast, Patrick G.] Vanderbilt Univ, Dept Biostat, Nashville, TN USA; [Cooper, William O.; Ray, Wayne A.] Vanderbilt Univ, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN USA; [Murray, Katherine T.] Vanderbilt Univ, Div Cardiol, Nashville, TN 37232 USA; [Stein, C. Michael] Vanderbilt Univ, Div Rheumatol, Nashville, TN USA; [Murray, Katherine T.; Stein, C. Michael] Vanderbilt Univ, Dept Med, Div Clin Pharmacol, Nashville, TN USA; [Kirshner, Howard S.; O'Duffy, Anne] Vanderbilt Univ, Stroke Div, Dept Neurol, Nashville, TN USA; [Habel, Laurel A.; Fireman, Bruce H.] Kaiser Permanente No Calif, Div Res, Oakland, CA USA; [Sox, Colin M.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA USA; [Sox, Colin M.] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Chan, K. Arnold] OptumInsight Epidemiol, Waltham, MA USA; [Cheetham, T. Craig] Kaiser Permanente So Calif, Pharm Analyt Serv, Pasadena, CA USA; [Quinn, Virginia P.] Kaiser Permanente So Calif, Res & Evaluat Dept, Pasadena, CA USA; [Connell, Frederick A.] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Kaiser Permanente; Harvard University; Harvard Medical School; Boston University; Optum; Kaiser Permanente; Kaiser Permanente; University of Washington; University of Washington Seattle	Cooper, WO (corresponding author), Suite 313,Oxford House,1313 21st Ave S, Nashville, TN 37232 USA.	william.cooper@vanderbilt.edu		Chan, Kinwei/0000-0001-8161-1986; Habel, Laurel/0000-0002-7230-587X; Sox, Colin/0000-0002-0249-9656	Agency for Healthcare Research and Quality and the Food and Drug Administration; Agency for Healthcare Research and Quality, Department of Health and Human Services [HHSA290-2005-0042, HHSA290-2005-0033]; FDA [223-2005-10100C, 223-2005-10012, 223-2005-10006C, 223-2005-10012C]; Developing Evidence to Inform Decisions about Effectiveness program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096844] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality and the Food and Drug Administration; Agency for Healthcare Research and Quality, Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); FDA(United States Department of Health & Human Services); Developing Evidence to Inform Decisions about Effectiveness program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by the Agency for Healthcare Research and Quality and the Food and Drug Administration.; Supported by contracts (HHSA290-2005-0042, to Vanderbilt University; and HHSA290-2005-0033, to Harvard Pilgrim Health Care Institute) from the Agency for Healthcare Research and Quality, Department of Health and Human Services, as part of the Developing Evidence to Inform Decisions about Effectiveness program; and by contracts (223-2005-10100C, to Vanderbilt University; 223-2005-10012, to Kaiser Permanente Northern California; 223-2005-10006C, to OptumInsight Epidemiology; and 223-2005-10012C, to Harvard Pilgrim Health Care Institute) from the FDA.	Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; BRODERICK J, 1993, J CHILD NEUROL, V8, P250, DOI 10.1177/088307389300800308; Brown RT, 2005, PEDIATRICS, V115, pE749, DOI 10.1542/peds.2004-2560; Buck ML, 2002, PEDIAT PHARM, V8, P1; Elia J, 1999, NEW ENGL J MED, V340, P780, DOI 10.1056/NEJM199903113401007; Epstein AE, 1996, J AM COLL CARDIOL, V27, P433, DOI 10.1016/0735-1097(95)00482-3; Food and Drug Administration, 2006, DRUG SAF RISK MAN AD; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Gould MS, 2009, AM J PSYCHIAT, V166, P992, DOI 10.1176/appi.ajp.2009.09040472; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; Liu LY, 1999, CEREBROVASC DIS, V9, P224, DOI 10.1159/000015960; Mahaffey KW, 2005, AM J CARDIOL, V95, P1404, DOI 10.1016/j.amjcard.2005.02.005; Mahle WT, 2007, J PEDIATR-US, V151, P150, DOI 10.1016/j.jpeds.2007.02.045; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; McCarthy S, 2009, DRUG SAFETY, V32, P1089, DOI 10.2165/11317630-000000000-00000; Nissen SE, 2006, NEW ENGL J MED, V354, P1445, DOI 10.1056/NEJMp068049; Perrin JM, 2008, PEDIATRICS, V122, P451, DOI 10.1542/peds.2008-1573; Rappley MD, 2005, NEW ENGL J MED, V352, P165, DOI 10.1056/NEJMcp032387; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2010, ANN INTERN MED, V152, P337, DOI 10.7326/0003-4819-152-6-201003160-00003; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schelleman H, 2011, PEDIATRICS, V127, P1102, DOI 10.1542/peds.2010-3371; SCHOENBERG BS, 1978, NEUROLOGY, V28, P763, DOI 10.1212/WNL.28.8.763; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Vetter R, 2009, CIRCULATION, V120, pE55, DOI 10.1161/CIRCULATIONAHA.109.192623; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; Visser S. N., 2010, Morbidity and Mortality Weekly Report, V59, P1439; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wilens TE, 2008, J AM ACAD CHILD PSY, V47, P21, DOI 10.1097/chi.0b013e31815a56f1; Wilens TE, 2006, PEDIATRICS, V118, P1215, DOI 10.1542/peds.2006-0942; Winterstein AG, 2007, PEDIATRICS, V120, pE1494, DOI 10.1542/peds.2007-0675; Winterstein AG, 2009, PEDIATRICS, V124, pE75, DOI 10.1542/peds.2008-3138	38	264	266	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 17	2011	365	20					1896	1904		10.1056/NEJMoa1110212	http://dx.doi.org/10.1056/NEJMoa1110212			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	848HG	22043968	Green Accepted			2022-12-24	WOS:000297041900008
J	Hsin, JP; Sheth, A; Manley, JL				Hsin, Jing-Ping; Sheth, Amit; Manley, James L.			RNAP II CTD Phosphorylated on Threonine-4 Is Required for Histone mRNA 3 ' End Processing	SCIENCE			English	Article							CARBOXYL-TERMINAL DOMAIN; POLYMERASE-II; GENE-EXPRESSION; P-TEFB; TRANSCRIPTION; SERINE-7; ASF/SF2; EVENTS	The RNA polymerase II (RNAP II) largest subunit contains a C-terminal domain (CTD) with up to 52 Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7) consensus repeats. Serines 2, 5, and 7 are known to be phosphorylated, and these modifications help to orchestrate the interplay between transcription and processing of messenger RNA (mRNA) precursors. Here, we provide evidence that phosphorylation of CTD Thr(4) residues is required specifically for histone mRNA 3' end processing, functioning to facilitate recruitment of 3' processing factors to histone genes. Like Ser(2), Thr(4) phosphorylation requires the CTD kinase CDK9 and is evolutionarily conserved from yeast to human. Our data thus illustrate how a CTD modification can play a highly specific role in facilitating efficient gene expression.	[Hsin, Jing-Ping; Sheth, Amit; Manley, James L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu	Sheth, Amit/ABC-4600-2020	Sheth, Amit/0000-0002-0021-5293; Manley, James/0000-0002-8341-1459	NIH [R01 GM28983]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028983] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kashima for plasmids and help with construction of the DT40-Rpb1 cell line, W. Marzluff for the SLBP antibody, Z. Dominski for the Lsm11 antibody, and Novus Biologicals for the P-Thr4 antibody. This work was supported by NIH grant R01 GM28983.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; BASKARAN R, 1993, P NATL ACAD SCI USA, V90, P11167, DOI 10.1073/pnas.90.23.11167; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chapman RD, 2005, MOL CELL BIOL, V25, P7665, DOI 10.1128/MCB.25.17.7665-7674.2005; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Chen CY, 1996, MOL CELL BIOL, V16, P6582; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Hirose Y, 2000, GENE DEV, V14, P1415; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Pirngruber J, 2009, EMBO REP, V10, P894, DOI 10.1038/embor.2009.108; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sakurai H, 2002, GENES CELLS, V7, P273, DOI 10.1046/j.1365-2443.2002.00522.x; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Sullivan KD, 2009, RNA, V15, P459, DOI 10.1261/rna.1205409; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Wang J, 1996, GENE DEV, V10, P2588, DOI 10.1101/gad.10.20.2588; Wang J, 1998, GENE DEV, V12, P2222, DOI 10.1101/gad.12.14.2222	21	111	112	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					683	686		10.1126/science.1206034	http://dx.doi.org/10.1126/science.1206034			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053051	Green Accepted			2022-12-24	WOS:000296494700058
J	Kartal, B; Maalcke, WJ; de Almeida, NM; Cirpus, I; Gloerich, J; Geerts, W; den Camp, HJMO; Harhangi, HR; Janssen-Megens, EM; Francoijs, KJ; Stunnenberg, HG; Keltjens, JT; Jetten, MSM; Strous, M				Kartal, Boran; Maalcke, Wouter J.; de Almeida, Naomi M.; Cirpus, Irina; Gloerich, Jolein; Geerts, Wim; den Camp, Huub J. M. Op; Harhangi, Harry R.; Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Hendrik G.; Keltjens, Jan T.; Jetten, Mike S. M.; Strous, Marc			Molecular mechanism of anaerobic ammonium oxidation	NATURE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; HYDRAZINE-OXIDIZING ENZYME; NITRIC-OXIDE; NITROSOMONAS-EUROPAEA; ANAMMOX BACTERIUM; POLYACRYLAMIDE-GELS; MASS-SPECTROMETRY; MULTIHEME PROTEIN; MICROORGANISMS; MONOOXYGENASE	Two distinct microbial processes, denitrification and anaerobic ammonium oxidation (anammox), are responsible for the release of fixed nitrogen as dinitrogen gas (N(2)) to the atmosphere(1-4). Denitrification has been studied for over 100 years and its intermediates and enzymes are well known(5). Even though anammox is a key biogeochemical process of equal importance, its molecular mechanism is unknown, but it was proposed to proceed through hydrazine (N(2)H(4))(6,7). Here we show that N(2)H(4) is produced from the anammox substrates ammonium and nitrite and that nitric oxide (NO) is the direct precursor of N(2)H(4). We resolved the genes and proteins central to anammox metabolism and purified the key enzymes that catalyse N(2)H(4) synthesis and its oxidation to N(2). These results present a new biochemical reaction forging an N-N bond and fill a lacuna in our understanding of the biochemical synthesis of the N(2) in the atmosphere. Furthermore, they reinforce the role of nitric oxide in the evolution of the nitrogen cycle.	[Kartal, Boran; Maalcke, Wouter J.; de Almeida, Naomi M.; Cirpus, Irina; Geerts, Wim; den Camp, Huub J. M. Op; Harhangi, Harry R.; Keltjens, Jan T.; Jetten, Mike S. M.; Strous, Marc] Radboud Univ Nijmegen, Dept Microbiol, Inst Water & Wetland Res, NL-6525 AJ Nijmegen, Netherlands; [Gloerich, Jolein] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Nijmegen Prote Facil,Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Janssen-Megens, Eva M.; Francoijs, Kees-Jan; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Jetten, Mike S. M.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands; [Strous, Marc] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Delft University of Technology; Max Planck Society	Kartal, B (corresponding author), Radboud Univ Nijmegen, Dept Microbiol, Inst Water & Wetland Res, Heyendaalseweg 135, NL-6525 AJ Nijmegen, Netherlands.	kartal@science.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; Gloerich, Jolein/L-4327-2015; Camp, Huub J.M. Op den/F-5114-2011; Kartal, Boran/D-2488-2014; Strous, Marc/B-4064-2017; Keltjens, Jan/M-3002-2013; Kartal, Boran/ABD-5400-2021; Jetten, Mike/B-8834-2011	Stunnenberg, Hendrik G./0000-0002-0066-1576; Gloerich, Jolein/0000-0001-5976-8426; Camp, Huub J.M. Op den/0000-0003-1990-9030; Strous, Marc/0000-0001-9600-3828; Jetten, Mike/0000-0002-4691-7039; Kartal, Boran/0000-0003-4199-952X	Dutch Foundation for Applied Research [05987]; Darwin Center for Biogeosciences [142161201]; Netherlands Organization for Scientific Research [81802015]; European Research Council [242635]; ERC [232987]	Dutch Foundation for Applied Research; Darwin Center for Biogeosciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission)	B.K. was supported by a grant (05987) from the Dutch Foundation for Applied Research. W.J.M. was supported by a grant (142161201) from the Darwin Center for Biogeosciences. N.M.d.A. and I. C. were supported by a grant (81802015) from the Netherlands Organization for Scientific Research. M. S. was supported by a VIDI grant from the Netherlands Organization for Scientific Research and a European Research Council grant MASEM (242635). The anammox research of M.S.M.J. is supported by an advanced grant (232987) from the ERC. The authors acknowledge R. Klefoth for the initial tests for protein purification procedures.	Akaike T, 1996, METHOD ENZYMOL, V268, P211; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Audrieth L. F., 1951, CHEM HYDRAZINE; Brandes JA, 2007, CHEM REV, V107, P577, DOI 10.1021/cr050377t; Calvaruso MA, 2008, METHODS, V46, P281, DOI 10.1016/j.ymeth.2008.09.023; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Ducluzeau AL, 2009, TRENDS BIOCHEM SCI, V34, P9, DOI 10.1016/j.tibs.2008.10.005; Farhoud MH, 2005, MOL CELL PROTEOMICS, V4, P1653, DOI 10.1074/mcp.M500171-MCP200; Gilch S, 2009, MICROBIOL-SGM, V155, P279, DOI 10.1099/mic.0.023721-0; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Hooper AB, 1997, ANTON LEEUW INT J G, V71, P59, DOI 10.1023/A:1000133919203; HOOPER AB, 1965, J BIOL CHEM, V240, P4044; HYMAN MR, 1985, BIOCHEM J, V227, P719, DOI 10.1042/bj2270719; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Kartal B, 2008, FEMS MICROBIOL ECOL, V63, P46, DOI 10.1111/j.1574-6941.2007.00408.x; Kartal B, 2011, METHOD ENZYMOL, V486, P89, DOI [10.1016/S0076-6879(11)86004-0, 10.1016/B978-0-12-381294-0.00004-3]; Kartal B, 2010, APPL ENVIRON MICROB, V76, P6304, DOI 10.1128/AEM.00991-10; Keller M, 2009, MICROBIOL MOL BIOL R, V73, P62, DOI 10.1128/MMBR.00028-08; Klotz MG, 2008, ENVIRON MICROBIOL, V10, P3150, DOI 10.1111/j.1462-2920.2008.01733.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MCTAVISH H, 1993, J BACTERIOL, V175, P2436, DOI 10.1128/JB.175.8.2436-2444.1993; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Nagano T, 1999, LUMINESCENCE, V14, P283, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<283::AID-BIO572>3.0.CO;2-G; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; PAYNE WJ, 1973, BACTERIOL REV, V37, P409, DOI 10.1128/MMBR.37.4.409-452.1973; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schmid M, 2000, SYST APPL MICROBIOL, V23, P93, DOI 10.1016/S0723-2020(00)80050-8; Schmid MC, 2005, APPL ENVIRON MICROB, V71, P1677, DOI 10.1128/AEM.71.4.1677-1684.2005; Shimamura M, 2008, J BIOSCI BIOENG, V105, P243, DOI 10.1263/jbb.105.243; Shimamura M, 2007, APPL ENVIRON MICROB, V73, P1065, DOI 10.1128/AEM.01978-06; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Strous M, 1998, APPL MICROBIOL BIOT, V50, P589, DOI 10.1007/s002530051340; Van De Graaf Astrid A., 1996, Microbiology (Reading), V142, P2187; van der Star WRL, 2008, BIOTECHNOL BIOENG, V101, P286, DOI 10.1002/bit.21891; van Niftrik L, 2010, MOL MICROBIOL, V77, P701, DOI 10.1111/j.1365-2958.2010.07242.x; vandeGraaf AA, 1997, MICROBIOL-SGM, V143, P2415, DOI 10.1099/00221287-143-7-2415; WATT GW, 1952, ANAL CHEM, V24, P2006, DOI 10.1021/ac60072a044; Weatherly DB, 2005, MOL CELL PROTEOMICS, V4, P762, DOI 10.1074/mcp.M400215-MCP200; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	41	529	605	79	1173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2011	479	7371					127	U159		10.1038/nature10453	http://dx.doi.org/10.1038/nature10453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21964329				2022-12-24	WOS:000296422600045
J	Kane, M; Case, LK; Kopaskie, K; Kozlova, A; MacDearmid, C; Chervonsky, AV; Golovkina, TV				Kane, Melissa; Case, Laure K.; Kopaskie, Karyl; Kozlova, Alena; MacDearmid, Cameron; Chervonsky, Alexander V.; Golovkina, Tatyana V.			Successful Transmission of a Retrovirus Depends on the Commensal Microbiota	SCIENCE			English	Article							MAMMARY-TUMOR VIRUS; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; ORAL TOLERANCE; T-CELLS; RECOGNITION; MICROFLORA; INFECTION; FLORA; HIV	To establish chronic infections, viruses must develop strategies to evade the host's immune responses. Many retroviruses, including mouse mammary tumor virus (MMTV), are transmitted most efficiently through mucosal surfaces rich in microbiota. We found that MMTV, when ingested by newborn mice, stimulates a state of unresponsiveness toward viral antigens. This process required the intestinal microbiota, as antibiotic-treated mice or germ-free mice did not transmit infectious virus to their offspring. MMTV-bound bacterial lipopolysaccharide triggered Toll-like receptor 4 and subsequent interleukin-6 (IL-6)-dependent induction of the inhibitory cytokine IL-10. Thus, MMTV has evolved to rely on the interaction with the microbiota to induce an immune evasion pathway. Together, these findings reveal the fundamental importance of commensal microbiota in viral infections.	[Kane, Melissa; Case, Laure K.; Kopaskie, Karyl; Kozlova, Alena; MacDearmid, Cameron; Golovkina, Tatyana V.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Golovkina, TV (corresponding author), Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.	tgolovki@bsd.uchicago.edu		Chervonsky, Alexander/0000-0001-7547-871X; Kane, Melissa/0000-0002-4580-1210	Juvenile Diabetes Research Foundation [2005-204, 2007-353]; National Institute of Allergy and Infectious Diseases (NIAID) NIH [AI082418]; National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Digestive Disease Research Core Center [DK42086]; National Cancer Institute, NIH [CA100383]; NIAID [AI090084];  [T32GM007183];  [T32 AI065382-01];  [P30 CA014599]; NATIONAL CANCER INSTITUTE [R01CA100383, P30CA014599, R01CA134667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082418, R56AI090084, R01AI090084, T32AI065382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007183] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Allergy and Infectious Diseases (NIAID) NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Digestive Disease Research Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Theriault and A. Vest for their help in monitoring gnotobiotic animals. This work was supported by T32GM007183 to M. K., K. K., and C. M.; by T32 AI065382-01 to L. C.; by Juvenile Diabetes Research Foundation grants 2005-204 and 2007-353; by the National Institute of Allergy and Infectious Diseases (NIAID) NIH AI082418 and the National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Digestive Disease Research Core Center grant DK42086 to A. V. C.; by National Cancer Institute, NIH, grant CA100383 and NIAID grant AI090084 to T. V. G.; and by a grant (P30 CA014599) to The University of Chicago. A material transfer agreement is required for use of the SPF and GF C3H-based mutant strains of mice. The data reported in this paper are tabulated in the main paper and the supporting online material.	Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Browne EP, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000298; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dittmer U, 2004, IMMUNITY, V20, P293, DOI 10.1016/S1074-7613(04)00054-8; Golovkina TV, 1998, J IMMUNOL, V161, P2375; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Hardy AW, 2007, P NATL ACAD SCI USA, V104, P17453, DOI 10.1073/pnas.0707244104; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Humphrey JH, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6580; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Jude BA, 2003, NAT IMMUNOL, V4, P573, DOI 10.1038/ni926; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; MARRACK P, 1991, NATURE, V349, P524, DOI 10.1038/349524a0; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOREAU MC, 1988, INFECT IMMUN, V56, P2766, DOI 10.1128/IAI.56.10.2766-2768.1988; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rakoff-Nahoum S, 2008, MUCOSAL IMMUNOL, V1, pS10, DOI 10.1038/mi.2008.49; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Sudo N, 1997, J IMMUNOL, V159, P1739; Wargo MJ, 2006, CURR OPIN MICROBIOL, V9, P359, DOI 10.1016/j.mib.2006.06.001; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	28	253	262	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					245	249		10.1126/science.1210718	http://dx.doi.org/10.1126/science.1210718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998394	Green Accepted			2022-12-24	WOS:000295833600052
J	Liu, CL; Fu, XF; Liu, LL; Ren, XJ; Chau, CKL; Li, SH; Xiang, L; Zeng, HL; Chen, GH; Tang, LH; Lenz, P; Cui, XD; Huang, W; Hwa, T; Huang, JD				Liu, Chenli; Fu, Xiongfei; Liu, Lizhong; Ren, Xiaojing; Chau, Carlos K. L.; Li, Sihong; Xiang, Lu; Zeng, Hualing; Chen, Guanhua; Tang, Lei-Han; Lenz, Peter; Cui, Xiaodong; Huang, Wei; Hwa, Terence; Huang, Jian-Dong			Sequential Establishment of Stripe Patterns in an Expanding Cell Population	SCIENCE			English	Article							ESCHERICHIA-COLI; BACTERIA; MIGRATION; CHEMOTAXIS; MUTANTS; GROWTH; AGAR	Periodic stripe patterns are ubiquitous in living organisms, yet the underlying developmental processes are complex and difficult to disentangle. We describe a synthetic genetic circuit that couples cell density and motility. This system enabled programmed Escherichia coli cells to form periodic stripes of high and low cell densities sequentially and autonomously. Theoretical and experimental analyses reveal that the spatial structure arises from a recurrent aggregation process at the front of the continuously expanding cell population. The number of stripes formed could be tuned by modulating the basal expression of a single gene. The results establish motility control as a simple route to establishing recurrent structures without requiring an extrinsic pacemaker.	[Liu, Chenli; Liu, Lizhong; Chau, Carlos K. L.; Xiang, Lu; Huang, Wei; Huang, Jian-Dong] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Fu, Xiongfei; Li, Sihong; Zeng, Hualing; Cui, Xiaodong; Huang, Wei] Univ Hong Kong, Dept Phys, Pokfulam, Hong Kong, Peoples R China; [Ren, Xiaojing; Chen, Guanhua] Univ Hong Kong, Dept Chem, Pokfulam, Hong Kong, Peoples R China; [Tang, Lei-Han] Hong Kong Baptist Univ, Dept Phys, Kowloon, Hong Kong, Peoples R China; [Lenz, Peter] Univ Marburg, Dept Phys, D-35032 Marburg, Germany; [Lenz, Peter] Univ Marburg, Ctr Synthet Microbiol, D-35032 Marburg, Germany; [Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA	University of Hong Kong; University of Hong Kong; University of Hong Kong; Hong Kong Baptist University; Philipps University Marburg; Philipps University Marburg; University of California System; University of California San Diego	Huang, W (corresponding author), Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China.	huangwei@hku.hk; hwa@ucsd.edu; jdhuang@hku.hk	Cui, Xiaodong/C-2023-2009; Zeng, Hualing/J-4411-2014; Lenz, Peter/L-5980-2013; Liu, Chenli/D-8004-2013; Huang, Wei/AAW-1423-2021; Tang, Lei-Han/ABB-3219-2020; Hwa, Terence/J-4012-2013; Chen, GuanHua/G-6630-2014; Hwa, Terry/GOJ-9904-2022; Liu, Lizhong/GSD-9231-2022; /C-4277-2009	Cui, Xiaodong/0000-0002-2013-8336; Tang, Lei-Han/0000-0002-2925-4691; Hwa, Terence/0000-0003-1837-6842; Liu, Chenli/0000-0003-3029-7207; Lenz, Peter/0000-0001-7705-3950; /0000-0001-7531-2816; Fu, Xiongfei/0000-0003-3657-8296	Hong Kong University (HKU); HKU Committee; Research Grants Council (RGC) [HKU1/CRF/10]; HKU Faculty of Medicine; NSF through the Center for Theoretical Biological Physics [PHY-0822283]; State Hessen; RGC of the Hong Kong Special Administrative Region [201606]	Hong Kong University (HKU)(University of Hong Kong); HKU Committee; Research Grants Council (RGC)(Hong Kong Research Grants Council); HKU Faculty of Medicine; NSF through the Center for Theoretical Biological Physics(National Science Foundation (NSF)); State Hessen; RGC of the Hong Kong Special Administrative Region	We are grateful to members of the University of Hong Kong Team for The International Genetic Engineering Machine Competition (iGEM) 2008 for their contribution to the project. We thank H. Berg, A. Courey, A. Danchin, D. Smith, J. Tailleur, and C. Voigt for valuable comments. This project was supported by a Hong Kong University (HKU) University Development Fund, a Small Project Grant from the HKU Committee on Research and Conference Grants, and a Collaborative Research Fund from the Research Grants Council (RGC) (HKU1/CRF/10) to J.D.H., and a HKU Faculty of Medicine Development Fund to W.H. TH is supported by the NSF through the Center for Theoretical Biological Physics (grant PHY-0822283) and additionally acknowledges an HKU Distinguished Visiting Professorship. P.L. acknowledges support through the LOEWE program of the State Hessen. L.H.T. acknowledges support by the RGC of the Hong Kong Special Administrative Region under grant 201606. E. coli strains and plasmids are available under a material transfer agreement with the University of Hong Kong.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Ben-Jacob E, 2000, ADV PHYS, V49, P395, DOI 10.1080/000187300405228; BERG HC, 1975, ANNU REV BIOPHYS BIO, V4, P119, DOI 10.1146/annurev.bb.04.060175.001003; BUDRENE EO, 1991, NATURE, V349, P630, DOI 10.1038/349630a0; Cates ME, 2010, P NATL ACAD SCI USA, V107, P11715, DOI 10.1073/pnas.1001994107; Chuong CM, 2009, INT J DEV BIOL, V53, P653, DOI 10.1387/ijdb.082594cc; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; FUJIKAWA H, 1992, PHYSICA A, V189, P15, DOI 10.1016/0378-4371(92)90123-8; HELD LI, 1992, MODELS EMBRYONIC PER; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Matsuyama T, 2000, J BACTERIOL, V182, P385, DOI 10.1128/JB.182.2.385-393.2000; Montell DJ, 2006, CURR OPIN GENET DEV, V16, P374, DOI 10.1016/j.gde.2006.06.010; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Murray J.D., 2007, INTERDISCIPLINARY AP, V2, P1; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; PARKINSON JS, 1982, J BACTERIOL, V151, P106, DOI 10.1128/JB.151.1.106-113.1982; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Rorth P, 2007, TRENDS CELL BIOL, V17, P575, DOI 10.1016/j.tcb.2007.09.007; Sanna MG, 1996, J BACTERIOL, V178, P6275, DOI 10.1128/jb.178.21.6275-6280.1996; Tailleur J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.218103; Turing A. M., 1952, PHILOS T R SOC B, V237, P37; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Weiss LE, 2008, BIOTECHNOL BIOENG, V100, P1251, DOI 10.1002/bit.21862; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; WOODWARD DE, 1995, BIOPHYS J, V68, P2181	29	238	251	11	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					238	241		10.1126/science.1209042	http://dx.doi.org/10.1126/science.1209042			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998392	Green Submitted			2022-12-24	WOS:000295833600050
J	Bryson, D				Bryson, David			PERSONAL VIEW Care homes shouldn't profit from delays in assessing their residents for discharge from hospital	BRITISH MEDICAL JOURNAL			English	Editorial Material									Gen Hosp Kettering, Kettering, England		Bryson, D (corresponding author), Gen Hosp Kettering, Kettering, England.	davidjbryson@hotmail.com							0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 12	2011	343								d6570	10.1136/bmj.d6570	http://dx.doi.org/10.1136/bmj.d6570			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	835EO	21994319				2022-12-24	WOS:000296018100007
J	Robotham, JV; Graves, N; Cookson, BD; Barnett, AG; Wilson, JA; Edgeworth, JD; Batra, R; Cuthbertson, BH; Cooper, BS				Robotham, Julie V.; Graves, Nicholas; Cookson, Barry D.; Barnett, Adrian G.; Wilson, Jennie A.; Edgeworth, Jonathan D.; Batra, Rahul; Cuthbertson, Brian H.; Cooper, Ben S.			Screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus in intensive care units: cost effectiveness evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SURGICAL-SITE INFECTIONS; BLOOD-STREAM INFECTIONS; MRSA PCR ASSAY; LENGTH-OF-STAY; CHROMAGAR MRSA; NASAL CARRIAGE; HOSPITALIZED-PATIENTS; IMPACT; COLONIZATION; CHLORHEXIDINE	Objective To assess the cost effectiveness of screening, isolation, and decolonisation strategies in the control of meticillin resistant Staphylococcus aureus (MRSA) in intensive care units. Design Economic evaluation based on a dynamic transmission model. Setting England and Wales. Population Theoretical population of patients on an intensive care unit. Main outcome measures Infections, deaths, costs, quality adjusted life years (QALYs), incremental cost effectiveness ratios for alternative strategies, and net monetary benefits. Results All decolonisation strategies improved health outcomes and reduced costs. Although universal decolonisation (regardless of MRSA status) was the most cost effective in the short term, strategies using screening to target MRSA carriers may be preferred owing to the reduced risk of selecting for resistance. Among such targeted strategies, universal admission and weekly screening with polymerase chain reaction coupled with decolonisation using nasal mupirocin was the most cost effective. This finding was robust to the size of intensive care units, prevalence of MRSA on admission, proportion of patients classified as high risk, and precise value of willingness to pay for health benefits. All strategies using isolation but not decolonisation improved health outcomes but costs were increased. When the prevalence of MRSA on admission to the intensive care unit was 5% and the willingness to pay per QALY gained was between 20 pound 000 ((sic)23 000; $32 000) and 30 pound 000, the best such strategy was to isolate only those patients at high risk of carrying MRSA (either pre-emptively or after identification by admission and weekly screening for MRSA using chromogenic agar). Universal admission and weekly screening using polymerase chain reaction based detection of MRSA coupled with isolation was unlikely to be cost effective unless prevalence was high (10% of patients colonised with MRSA on admission). Conclusions MRSA control strategies that use decolonisation are likely to be cost saving in an intensive care unit setting provided resistance is lacking, and combining universal screening using polymerase chain reaction with decolonisation is likely to represent good value for money if untargeted decolonisation is considered unacceptable. In intensive care units where decolonisation is not implemented, evidence is insufficient to support universal screening for MRSA outside high prevalence settings.	[Robotham, Julie V.] Hlth Protect Agcy, London NW9 5EQ, England; [Graves, Nicholas; Barnett, Adrian G.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Cookson, Barry D.] Hlth Protect Agcy, Lab Healthcare Associated Infect, London NW9 5EQ, England; [Wilson, Jennie A.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, London, England; [Edgeworth, Jonathan D.] Kings Coll London, Dept Infect Dis, Sch Med, Guys Hosp, London WC2R 2LS, England; [Edgeworth, Jonathan D.; Batra, Rahul] Guys & St Thomas NHS Fdn Trust, Directorate Infect, London, England; [Cuthbertson, Brian H.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Cooper, Ben S.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Cooper, Ben S.] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford, England	Health Protection Agency; Queensland University of Technology (QUT); Health Protection Agency; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Robotham, JV (corresponding author), Hlth Protect Agcy, London NW9 5EQ, England.	julie.robotham@hpa.org.uk	Barnett, Adrian/I-9850-2012; Cooper, Ben/HGC-7082-2022	Barnett, Adrian/0000-0001-6339-0374; Robotham, Julie/0000-0003-2515-4084; Wilson, Jennie/0000-0002-4713-9662; Graves, Nicholas/0000-0002-5559-3267; Cooper, Ben/0000-0002-9445-7217	Department of Health Policy Research [PR-IP-0807-0410026]; Mastering Hospital Antimicrobial Resistance in Europe consortium; Oak Foundation; Wellcome Trust	Department of Health Policy Research; Mastering Hospital Antimicrobial Resistance in Europe consortium; Oak Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a grant from the Department of Health Policy Research Programme (PR-IP-0807-0410026). The views expressed are not necessarily those of the department. The authors' work was independent of the funders, who had no role in the study design, analysis of data, writing of the manuscript, or decision to submit for publication. We acknowledge support from the Mastering Hospital Antimicrobial Resistance in Europe consortium. BSC acknowledges support from the Oak Foundation. The Mahidol Oxford Research Unit is supported by the Wellcome Trust.	Apfalter P, 2002, DIAGN MICR INFEC DIS, V44, P209, DOI 10.1016/S0732-8893(02)00435-2; Barnett AG, 2009, AM J EPIDEMIOL, V170, P1186, DOI 10.1093/aje/kwp249; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Batra R, 2010, CLIN INFECT DIS, V50, P210, DOI 10.1086/648717; Ben Nsira S, 2006, INT J ANTIMICROB AG, V27, P561, DOI 10.1016/j.ijantimicag.2006.03.011; Beyersmann J, 2008, J CLIN EPIDEMIOL, V61, P1216, DOI 10.1016/j.jclinepi.2008.02.008; Bishop EJ, 2006, J CLIN MICROBIOL, V44, P2904, DOI 10.1128/JCM.02211-05; Bleasdale SC, 2007, ARCH INTERN MED, V167, P2073, DOI 10.1001/archinte.167.19.2073; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Brown J, 2010, PHARMACOECONOMICS, V28, P567, DOI 10.2165/11533020-000000000-00000; Cepeda JA, 2005, LANCET, V365, P295, DOI 10.1016/S0140-6736(05)17783-6; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Climo MW, 2009, CRIT CARE MED, V37, P1858, DOI 10.1097/CCM.0b013e31819ffe6d; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Compernolle V, 2007, J CLIN MICROBIOL, V45, P154, DOI 10.1128/JCM.01115-06; Cookson BD, 1998, J ANTIMICROB CHEMOTH, V41, P11, DOI 10.1093/jac/41.1.11; Cooper BS, 2004, BMJ-BRIT MED J, V329, P533, DOI 10.1136/bmj.329.7465.533; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; Cunningham R, 2007, J HOSP INFECT, V65, P24, DOI 10.1016/j.jhin.2006.09.019; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Dancer SJ, 2006, AM J INFECT CONTROL, V34, P10, DOI 10.1016/j.ajic.2005.08.009; de Vries R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013392; Evans HL, 2010, ARCH SURG-CHICAGO, V145, P240, DOI 10.1001/archsurg.2010.5; Eveillard M, 2006, AM J INFECT CONTROL, V34, P108, DOI 10.1016/j.ajic.2006.01.001; Girou E, 2004, J HOSP INFECT, V57, P162, DOI 10.1016/j.jhin.2004.03.010; Graves N, 2008, J HOSP INFECT, V69, P274, DOI 10.1016/j.jhin.2008.04.022; Graves N, 2006, EMERG INFECT DIS, V12, P831; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Graves N, 2007, INFECT CONT HOSP EP, V28, P178, DOI 10.1086/510787; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Harbarth S, 2006, CRIT CARE, V10, DOI 10.1186/cc3982; Hardy K, 2010, CLIN MICROBIOL INFEC, V16, P333, DOI 10.1111/j.1469-0691.2009.02899.x; Health Protection Scotland, 2011, PATHF IMPL STUD; Huletsky A, 2005, CLIN INFECT DIS, V40, P976, DOI 10.1086/428579; Jain R, 2011, NEW ENGL J MED, V364, P1419, DOI 10.1056/NEJMoa1007474; Jeyaratnam D, 2008, BMJ-BRIT MED J, V336, P927, DOI 10.1136/bmj.39525.579063.BE; Keshtgar MRS, 2008, BRIT J SURG, V95, P381, DOI 10.1002/bjs.6013; Kypraios T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-29; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P1174, DOI 10.1128/JCM.01253-07; Lee AS, 2011, CLIN INFECT DIS, V52, P1422, DOI 10.1093/cid/cir233; Lee BY, 2010, INFECT CONT HOSP EP, V31, P1130, DOI 10.1086/656591; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Nahimana I, 2006, CLIN MICROBIOL INFEC, V12, P1168, DOI 10.1111/j.1469-0691.2006.01534.x; National Health Service, 2011, CLEAN SAF CAR RED MR; Nelson RE, 2010, CLIN MICROBIOL INFEC, V16, P1740, DOI 10.1111/j.1469-0691.2010.03324.x; O'Hagan A., 2006, UNCERTAIN JUDGEMENTS; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Perry JD, 2004, J CLIN MICROBIOL, V42, P4519, DOI 10.1128/JCM.42.10.4519-4523.2004; Popovich KJ, 2009, INFECT CONT HOSP EP, V30, P959, DOI 10.1086/605925; Porter R, 2003, INTENS CARE MED, V29, P655, DOI 10.1007/s00134-003-1679-1; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; RITCHIE K, 2006, CONSULTATION REPORT; Roberts T, 2004, SEX TRANSM INFECT, V80, P324, DOI 10.1136/sti.2003.008458; Rohr U, 2003, J HOSP INFECT, V54, P305, DOI 10.1016/S0195-6701(03)00140-3; Rossney AS, 2007, EUR J CLIN MICROBIOL, V26, P459, DOI 10.1007/s10096-007-0303-7; Safdar N, 2003, J CLIN MICROBIOL, V41, P3163, DOI 10.1128/JCM.41.7.3163-3166.2003; Samad A, 2002, J HOSP INFECT, V51, P43, DOI 10.1053/jhin.2002.1182; Theaker C, 2001, J HOSP INFECT, V48, P98, DOI 10.1053/jhin.2001.0960; Thompson DS, 2004, J ROY SOC MED, V97, P521, DOI 10.1258/jrsm.97.11.521; Turner K, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7250; van Hal SJ, 2007, J CLIN MICROBIOL, V45, P2486, DOI 10.1128/JCM.00139-07; van Hal S, 2009, EUR J CLIN MICROBIOL, V28, P47, DOI 10.1007/s10096-008-0593-4; van Rijen M, 2008, COCHRANE DB SYST REV, V8; Warren DK, 2007, CRIT CARE MED, V35, P430, DOI 10.1097/01.CCM.0000253813.98431.28; Zhang SX, 2007, J CLIN MICROBIOL, V45, P2278, DOI 10.1128/JCM.00469-07	65	54	55	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2011	343								d5694	10.1136/bmj.d5694	http://dx.doi.org/10.1136/bmj.d5694			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CT	21980062	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000295779600001
J	Cockman, P; Dawson, L; Mathur, R; Hull, S				Cockman, Philippa; Dawson, Luise; Mathur, Rohini; Hull, Sally			QUALITY IMPROVEMENT REPORT Improving MMR vaccination rates: herd immunity is a realistic goal	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POPULATION; AUTISM	Problem As measles is a highly infectious disease, the United Kingdom recommendation is for at least 95% of children to receive a first vaccination with the measles, mumps, and rubella (MMR) vaccine before age 2 years and a booster before age 5 years to achieve herd immunity and prevent outbreaks. Reported vaccination rates for England have improved since a low level in 2003-4. Coverage for London is consistently lower than for England, however, and concerns have been expressed that there could be an epidemic of measles in the capital. Design Observational time series study. Setting London Borough of Tower Hamlets. Key measurements for improvement Uptake rates for childhood vaccinations. The key target was to reach 95% coverage for the first MMR vaccine before age 2 years. Strategies for change Financial support for the development of geographically based networks of general practices. Commissioning of care packages, incentivising delivery of high quality integrated care with network level vaccination targets of 95%. Innovative use of information technology to enable robust call and recall processes, active follow-up of defaulters, and increased knowledge about the demography of the children most difficult to reach. Effects of change The development of networks of practices facilitated collaborative working among primary care clinicians and other stakeholders; peer review of achievements; and an element of healthy competition. Uptake improved for all childhood vaccinations, and to herd immunity levels for most. Uptake of the first MMR vaccine before age 2 years rose from 80% in September 2009 to 94% in March 2011. Lessons learnt Achieving herd immunity for childhood vaccinations is an achievable target in an ethnically mixed, socially deprived inner city borough. The ability to identify characteristics of the difficult to reach groups, including significant differences in uptake across different ethnicities, will allow targeted interventions that may further improve overall coverage. Vaccination programmes are cost effective and have been shown to reduce health inequality worldwide. 1 As measles is a highly contagious disease(2) it requires vaccination levels to be at least 95% to maintain herd immunity and prevent outbreaks.(3) These levels of vaccination will also be needed to achieve the World Health Organization's goal of elimination of measles worldwide. The measles, mumps, and rubella (MMR) vaccine was introduced in the United Kingdom in 1988 and the booster dose was added to the programme in 1996.(4) Current recommendations are that every child should receive a first dose of MMR vaccine before the age of 2 years and a booster dose before the age of 5 years.(4) Uptake for the first dose of MMR vaccine (MMR1) in England reached 92% in 1992, and stayed above 90% until 1998 when rates started falling, down to 79% by 2003.(5) The decline in uptake of the MMR vaccine is thought to be caused partly by safety concerns but also, ironically, by the success of vaccination programmes leading to the impression that these childhood diseases are mild and uncommon.(6) MMR vaccination uptake rates are now increasing in England. However, the effects of the vaccine scare in the UK that followed Andrew Wakefield and colleagues' now discredited 1998 article (which had raised the possibility of a link between MMR vaccine and autism) are still present over a decade later.(7) Reported rates of uptake of all childhood vaccinations in London remain below those for England.(8) Ongoing low levels of MMR vaccination in London have raised concerns of the possibility of a serious outbreak of measles in the city.(9) The year 2008 saw the highest number of recorded confirmed cases of measles (1370) in England and Wales since the introduction of disease monitoring in 1995.(10) Most of the cases were concentrated in London.(11) Between 2006 and 2008 the inner London borough of Tower Hamlets had the highest rates of confirmed measles,(12) with 24.6 cases per 100 000 (46 confirmed cases) compared with a national figure of 2 per 100 000.	[Cockman, Philippa] St Stephens Hlth Ctr, London E3 5ED, England; [Dawson, Luise] NHS Tower Hamlets, London E1 1RD, England; [Mathur, Rohini; Hull, Sally] Queen Mary Univ London, Blizard Inst, London E1 2AT, England	University of London; Queen Mary University London	Cockman, P (corresponding author), St Stephens Hlth Ctr, London E3 5ED, England.	Philippa.Cockman@nhs.net	Mathur, Rohini/C-7788-2013	Mathur, Rohini/0000-0002-3817-8790; hull, Sally/0000-0002-8691-7519				Andre FE, 2006, B WHO, V86; Barnevik-Olsson M, 2010, DEV MED CHILD NEUROL, V52, P1167, DOI 10.1111/j.1469-8749.2010.03812.x; Berger A, 1999, BRIT MED J, V319, P1466; Bhatti N, 2011, DIV C U BRADF; Brown KF, 2010, VACCINE, V28, P4235, DOI 10.1016/j.vaccine.2010.04.052; Crowcroft NS, 2009, ARCH DIS CHILD, V94, P829, DOI 10.1136/adc.2008.138776; Department of Health, 2009, INT CAR PIL INTR GUI; Department of Health, 2007, MEASL IMM INF DIS; Gardner B, 2008, CAN MMR UPTAKE BE IN; Godlee Fiona, 2011, BMJ, V342, pc7452, DOI 10.1136/bmj.c7452; Health Protection Agency, 2011, VACC COV COVER COV V; Health Protection Agency, CONF CAS MEASL MUMPS; Health Protection Agency, ANN VACC COV STAT EN; HEATHCOCK R, 2008, EURO SURVEILL, V13; Hull SA, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X572544; London Assembly, 2007, STILL MISS POINT INF; Minnesota Department of Health, 2009, AUT SOM COMM REP STU; National Institute for Health and Clinical Excellence, 2009, RED DIFF UPT IMM INC, V21; Nelson J, WORKING SMARTER IMPR; Schickler P, 2010, IDENTIFYING BARRIERS; Tower Hamlets Council, ETHN; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; World Health Organization, 2009, MEASL FACT SHEET	24	31	31	0	62	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2011	343								d5703	10.1136/bmj.d5703	http://dx.doi.org/10.1136/bmj.d5703			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832CR	21971162				2022-12-24	WOS:000295779300003
J	McMurray, JJV; Smith, GL				McMurray, John J. V.; Smith, Godfrey L.			Calcium Handling in the Failing Heart and SUMO - Weighing the Evidence	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENE-TRANSFER; FAILURE; SERCA2A		[McMurray, John J. V.; Smith, Godfrey L.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Glasgow	McMurray, JJV (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.		mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Jessup M, 2011, CIRCULATION, V124, P304, DOI 10.1161/CIRCULATIONAHA.111.022889; Kawase Y, 2008, J AM COLL CARDIOL, V51, P1112, DOI 10.1016/j.jacc.2007.12.014; Kho C, 2011, NATURE, V477, P601, DOI 10.1038/nature10407; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130	6	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2011	365	18					1738	1739		10.1056/NEJMcibr1110758	http://dx.doi.org/10.1056/NEJMcibr1110758			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	840FL	22047567				2022-12-24	WOS:000296424200016
J	Takeda, Y; Costa, S; Delamarre, E; Roncal, C; de Oliveira, RL; Squadrito, ML; Finisguerra, V; Deschoemaeker, S; Bruyere, F; Wenes, M; Hamm, A; Serneels, J; Magat, J; Bhattacharyya, T; Anisimov, A; Jordan, BF; Alitalo, K; Maxwell, P; Gallez, B; Zhuang, ZW; Saito, Y; Simons, M; De Palma, M; Mazzone, M				Takeda, Yukiji; Costa, Sandra; Delamarre, Estelle; Roncal, Carmen; de Oliveira, Rodrigo Leite; Squadrito, Mario Leonardo; Finisguerra, Veronica; Deschoemaeker, Sofie; Bruyere, Francoise; Wenes, Mathias; Hamm, Alexander; Serneels, Jens; Magat, Julie; Bhattacharyya, Tapan; Anisimov, Andrey; Jordan, Benedicte F.; Alitalo, Kari; Maxwell, Patrick; Gallez, Bernard; Zhuang, Zhen W.; Saito, Yoshihiko; Simons, Michael; De Palma, Michele; Mazzone, Massimiliano			Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis	NATURE			English	Article							NF-KAPPA-B; TUMOR ANGIOGENESIS; IKK-BETA; INHIBITION; MOUSE; OXYGENATION; DEFICIENCY; INJURY; CELLS	PHD2 serves as an oxygen sensor that rescues blood supply by regulating vessel formation and shape in case of oxygen shortage(1-5). However, it is unknown whether PHD2 can influence arteriogenesis. Here we studied the role of PHD2 in collateral artery growth by using hindlimb ischaemia as a model, a process that compensates for the lack of blood flow in case of major arterial occlusion(6-8). We show that Phd2 (also known as Egln1) haplodeficient (Phd2(+/-)) mice displayed preformed collateral arteries that preserved limb perfusion and prevented tissue necrosis in ischaemia. Improved arteriogenesis in Phd2(+/-) mice was due to an expansion of tissue-resident, M2-like macrophages(9,10) and their increased release of arteriogenic factors, leading to enhanced smooth muscle cell (SMC) recruitment and growth. Both chronic and acute deletion of one Phd2 allele in macrophages was sufficient to skew their polarization towards a pro-arteriogenic phenotype. Mechanistically, collateral vessel preconditioning relied on the activation of canonical NF-kappa B pathway in Phd2(+/-) macrophages. These results unravel how PHD2 regulates arteriogenesis and artery homeostasis by controlling a specific differentiation state in macrophages and suggest new treatment options for ischaemic disorders.	[Takeda, Yukiji; Costa, Sandra; Delamarre, Estelle; Roncal, Carmen; de Oliveira, Rodrigo Leite; Finisguerra, Veronica; Deschoemaeker, Sofie; Wenes, Mathias; Hamm, Alexander; Serneels, Jens; Mazzone, Massimiliano] VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium; [Takeda, Yukiji; Costa, Sandra; Delamarre, Estelle; Roncal, Carmen; de Oliveira, Rodrigo Leite; Finisguerra, Veronica; Deschoemaeker, Sofie; Wenes, Mathias; Hamm, Alexander; Serneels, Jens; Mazzone, Massimiliano] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium; [Takeda, Yukiji; Roncal, Carmen; de Oliveira, Rodrigo Leite; Bruyere, Francoise] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Takeda, Yukiji; Roncal, Carmen; de Oliveira, Rodrigo Leite; Bruyere, Francoise] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Costa, Sandra] Univ Minho, Life & Hlth Sci Res Inst, P-4710057 Braga, Portugal; [Roncal, Carmen] CIMA Univ Navarra, Atherosclerosis Res Lab, Pamplona 31008, Spain; [Squadrito, Mario Leonardo; De Palma, Michele] San Raffaele Inst, Angiogenesis & Tumor Targeting Unit, I-20132 Milan, Italy; [Squadrito, Mario Leonardo; De Palma, Michele] San Raffaele Inst, HSR TIGET, I-20132 Milan, Italy; [Squadrito, Mario Leonardo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Magat, Julie; Jordan, Benedicte F.; Gallez, Bernard] Catholic Univ Louvain, Biomed Magnet Resonance Unit, B-1200 Brussels, Belgium; [Bhattacharyya, Tapan; Maxwell, Patrick] UCL, Rayne Inst, London WC1E 6JF, England; [Anisimov, Andrey; Alitalo, Kari] Biomedicum Helsinki, Res Programs Unit, Mol Canc Biol Lab, Helsinki 00014, Finland; [Anisimov, Andrey; Alitalo, Kari] Biomedicum Helsinki, Inst Mol Med, Helsinki 00014, Finland; [Zhuang, Zhen W.; Simons, Michael] Yale Univ, Sch Med, New Haven, CT 06510 USA; [Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara 6348522, Japan	Flanders Institute for Biotechnology (VIB); KU Leuven; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven; Universidade do Minho; University of Navarra; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Universite Catholique Louvain; University of London; King's College London; University College London; University of Helsinki; University of Helsinki; Yale University; Nara Medical University	Mazzone, M (corresponding author), VIB, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, B-3000 Louvain, Belgium.	massimiliano.mazzone@vib-kuleuven.be	Costa, Sandra/B-4253-2011; Finisguerra, Veronica/AGS-6956-2022; Deschoemaeker, Sofie/AAF-8321-2020; Costa, Sandra/AAV-7175-2020; Deschoemaeker, Sofie/AAE-1359-2022; Magat, Julie/ABC-5523-2021; De Palma, Michele/L-5350-2016; Maxwell, Patrick H/C-5557-2008; Alitalo, Kari K/J-5013-2014; Squadrito, Mario Leonardo/U-2090-2019; Simons, Michael/G-8553-2014	Costa, Sandra/0000-0001-6795-4245; Deschoemaeker, Sofie/0000-0001-5449-282X; Costa, Sandra/0000-0001-6795-4245; Deschoemaeker, Sofie/0000-0001-5449-282X; De Palma, Michele/0000-0001-9128-5459; Maxwell, Patrick H/0000-0002-0338-2679; Alitalo, Kari K/0000-0002-7331-0902; Simons, Michael/0000-0003-0348-7734; Wenes, Mathias/0000-0001-8478-8592; Leite de Oliveira, Rodrigo/0000-0002-9696-2014; Roncal, Carmen/0000-0003-0616-9600; Bhattacharyya, Tapan/0000-0003-3385-2536; Mazzone, Massimiliano/0000-0001-8824-4015; Magat, Julie/0000-0002-0967-9625; Squadrito, Mario Leonardo/0000-0002-1188-0299	FWO, Belgium [G.0726.10]; VIB; ARC; FCT; FWO; DFG; COST action [TD0901]; ERC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER	FWO, Belgium(FWO); VIB; ARC(Australian Research Council); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FWO(FWO); DFG(German Research Foundation (DFG)); COST action(European Cooperation in Science and Technology (COST)); ERC(European Research Council (ERC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from FWO (G.0726.10), Belgium, and from VIB. The authors are thankful to P. Carmeliet for the Phd2 KO and cKO mice, M. Karin for the Ikbkb cKO mice, P. Ratcliffe for the PHD2<SUP>H313A</SUP> construct, A. Luttun and P. Fazzari for comments, Y. Jonsson and T. Janssens for technical assistance. VE-Cadherin:CreERT and PDGFRB:Cre transgenic mice were generated at Cancer Research UK and kindly donated by R. Adams. E. D. was funded by ARC, S. C. by FCT, R.L.O. and V. F. by FWO, A. H. by DFG. C. R. was supported by COST action TD0901. M. D. P. was supported by an ERC starting grant.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Fong CHY, 2008, J EXP MED, V205, P1269, DOI 10.1084/jem.20080124; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Fu J, 2010, J BIOL CHEM, V285, P8927, DOI 10.1074/jbc.M109.078600; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Huang M, 2008, CIRCULATION, V118, pS226, DOI 10.1161/CIRCULATIONAHA.107.760785; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jordan BF, 2009, MAGN RESON MED, V61, P634, DOI 10.1002/mrm.21594; Karshovska E, 2008, J THROMB HAEMOST, V6, P1812, DOI 10.1111/j.1538-7836.2008.03086.x; Kumar MS, 2003, ARTERIOSCL THROM VAS, V23, P737, DOI 10.1161/01.ATV.0000065197.07635.BA; Loinard C, 2009, CIRCULATION, V120, P50, DOI 10.1161/CIRCULATIONAHA.108.813303; Lutgens E, 1999, CARDIOVASC RES, V41, P586, DOI 10.1016/S0008-6363(98)00216-8; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; MEERPOHL HG, 1976, EUR J IMMUNOL, V6, P213, DOI 10.1002/eji.1830060313; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Nangaku M, 2007, ARTERIOSCL THROM VAS, V27, P2548, DOI 10.1161/ATVBAHA.107.148551; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Schaper W, 2009, BASIC RES CARDIOL, V104, P5, DOI 10.1007/s00395-008-0760-x; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Wolf C, 1998, J MOL CELL CARDIOL, V30, P2291, DOI 10.1006/jmcc.1998.0790; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049	34	222	233	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					122	U153		10.1038/nature10507	http://dx.doi.org/10.1038/nature10507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21983962	Green Accepted			2022-12-24	WOS:000296422600044
J	Du, J; Say, RF; Lu, W; Fuchs, G; Einsle, O				Du, Juan; Say, Rafael F.; Lu, Wei; Fuchs, Georg; Einsle, Oliver			Active-site remodelling in the bifunctional fructose-1,6-bisphosphate aldolase/phosphatase	NATURE			English	Article							CRYSTAL-STRUCTURE; ALDOLASE; EVOLUTION; MECHANISM; MUSCLE; ARCHAEBACTERIA; EXPRESSION; ENZYMES; CLONING; GENE	Fructose-1,6-bisphosphate (FBP) aldolase/phosphatase is a bifunctional, thermostable enzyme that catalyses two subsequent steps in gluconeogenesis in most archaea and in deeply branching bacterial lineages(1-3). It mediates the aldol condensation of heat-labile dihydroxyacetone phosphate (DHAP) and glyceraldehyde-3-phosphate (GAP) to FBP4, as well as the subsequent, irreversible hydrolysis of the product to yield the stable fructose-6-phosphate (F6P) and inorganic phosphate; no reaction intermediates are released. Here we present a series of structural snapshots of the reaction that reveal a substantial remodelling of the active site through the movement of loop regions that create different catalytic functionalities at the same location. We have solved the three-dimensional structures of FBP aldolase/phosphatase from thermophilic Thermoproteus neutrophilus(5,6) in a ligand-free state as well as in complex with the substrates DHAP and FBP and the product F6P to resolutions up to 1.3 angstrom. In conjunction with mutagenesis data, this pinpoints the residues required for the two reaction steps and shows that the sequential binding of additional Mg2+ cations reversibly facilitates the reaction. FBP aldolase/phosphatase is an ancestral gluconeogenic enzyme optimized for high ambient temperatures(1,2), and our work resolves how consecutive structural rearrangements reorganize the catalytic centre of the protein to carry out two canonical reactions in a very non-canonical type of bifunctionality.	[Du, Juan; Lu, Wei; Einsle, Oliver] Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, D-79104 Freiburg, Germany; [Say, Rafael F.; Fuchs, Georg] Univ Freiburg, Lehrstuhl Mikrobiol, D-79104 Freiburg, Germany; [Einsle, Oliver] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Einsle, O (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Lehrstuhl Biochem, Albertstr 21, D-79104 Freiburg, Germany.	einsle@biochemie.uni-freiburg.de		Einsle, Oliver/0000-0001-8722-2893	Deutsche Forschungsgemeinschaft [Ei520/3-2, Fu118/15-4, Fu118/15-5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (grant Ei520/3-2 to O.E., Fu118/15-4 and 15-5 to G. F.). Diffraction data were collected at beam lines X06SA and X06DA at the Swiss Light Source (Villigen, Switzerland). The authors thank the beam line staff for assistance during data collection.	ALEFOUNDER PR, 1989, BIOCHEM J, V257, P529, DOI 10.1042/bj2570529; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Cooper SJ, 1996, STRUCTURE, V4, P1303, DOI 10.1016/S0969-2126(96)00138-4; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; GAMBLIN SJ, 1990, FEBS LETT, V262, P282, DOI 10.1016/0014-5793(90)80211-Z; GRAZI E, 1962, BIOCHEM BIOPH RES CO, V9, P38, DOI 10.1016/0006-291X(62)90083-9; HESTER G, 1991, FEBS LETT, V292, P237, DOI 10.1016/0014-5793(91)80875-4; Imanaka H, 2002, J BIOSCI BIOENG, V94, P237, DOI 10.1263/jbb.94.237; LAI CY, 1965, J BIOL CHEM, V240, P1347; LEBHERZ HG, 1969, BIOCHEMISTRY-US, V8, P109, DOI 10.1021/bi00829a016; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lorentzen E, 2004, BIOCHEM SOC T, V32, P259, DOI 10.1042/BST0320259; Lorentzen E, 2003, J BIOL CHEM, V278, P47253, DOI 10.1074/jbc.M305922200; MESSNER P, 1986, J BACTERIOL, V166, P1046, DOI 10.1128/jb.166.3.1046-1054.1986; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishimasu H, 2004, STRUCTURE, V12, P949, DOI 10.1016/j.str.2004.03.026; PENHOET E, 1967, BIOCHEMISTRY-US, V6, P2940, DOI 10.1021/bi00861a039; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Ronimus Ron S., 2003, Archaea, V1, P199, DOI 10.1155/2003/162593; ROSE IA, 1958, J BIOL CHEM, V231, P315; RUTTER WJ, 1964, FED PROC, V23, P1248; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Siebers B, 2001, J BIOL CHEM, V276, P28710, DOI 10.1074/jbc.M103447200; St-Jean M, 2005, J BIOL CHEM, V280, P27262, DOI 10.1074/jbc.M502413200; St-Jean M, 2009, BIOCHEMISTRY-US, V48, P4528, DOI 10.1021/bi8021558; Stetter KO, 2006, PHILOS T R SOC B, V361, P1837, DOI 10.1098/rstb.2006.1907; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; TOLAN DR, 1987, AM J HUM GENET, V41, P907; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; ZILLIG W, 1989, CAN J MICROBIOL, V35, P73, DOI 10.1139/m89-011	37	41	47	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					534	U134		10.1038/nature10458	http://dx.doi.org/10.1038/nature10458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21983965				2022-12-24	WOS:000296194200047
J	Bewley, S				Bewley, Susan			BREAST CANCER SCREENING The NHS breast screening programme needs independent review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; MAMMOGRAPHY		Kings Coll London, Div Womens Hlth, London, England	University of London; King's College London	Bewley, S (corresponding author), Kings Coll London, Div Womens Hlth, London, England.	susan.bewley@kcl.ac.uk		bewley, susan/0000-0001-8064-652X				Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Badwe RA, 1996, LANCET, V347, P325; Baum M, 2005, EUR J CANCER, V41, P508, DOI 10.1016/j.ejca.2004.09.031; Baum M, 1999, EUR J CANCER, V35, P886, DOI 10.1016/S0959-8049(99)00067-2; Baum M., 2009, TIMES           0219; Baum M, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6152; Cancer Research UK, MAMM BREAST SCREEN; Godlee F, 2010, BMJ-BRIT MED J, V341, pc4096; Gotzsche PC, 2011, J ROY SOC MED, V104, P361, DOI 10.1258/jrsm.2011.110078; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Jorgensen KJ, 2010, J ROY SOC MED, V103, P14, DOI 10.1258/jrsm.2009.090342; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; McPherson K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3106; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; NHS Cancer Screening Programmes, NHS BREAST SCREEN; NHS Cancer Screening Programmes, PSA PROST SCREEN ANT; Nordic Cochrane Centre, SCREEN BREAST CANC M; Prinjha S, 2011, J MED SCREEN, V18, P34, DOI 10.1258/jms.2011.010143; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; Welch HG, 2010, NEW ENGL J MED, V363, P13	21	26	26	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2011	343								d6894	10.1136/bmj.d6894	http://dx.doi.org/10.1136/bmj.d6894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840CW	22028484				2022-12-24	WOS:000296416900014
J	Glass, RI; Patel, M; Parashar, U				Glass, Roger I.; Patel, Manish; Parashar, Umesh			Lessons From the US Rotavirus Vaccination Program	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN		[Patel, Manish; Parashar, Umesh] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Glass, Roger I.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Patel, M (corresponding author), Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd,MS A34, Atlanta, GA 30333 USA.	mpatel@cdc.gov						Black Carla L., 2011, Morbidity and Mortality Weekly Report, V60, P1157; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Curns AT, 2010, J INFECT DIS, V201, P1617, DOI 10.1086/652403; Lopman BA, 2011, J INFECT DIS, V204, P980, DOI 10.1093/infdis/jir492; Parashar Umesh D., 2006, Morbidity and Mortality Weekly Report, V55, P1; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel MM, 2011, NEW ENGL J MED, V364, P2283, DOI 10.1056/NEJMoa1012952; Richardson V, 2010, NEW ENGL J MED, V362, P299, DOI 10.1056/NEJMoa0905211; Staat MA, 2011, PEDIATRICS, V128, pE267, DOI 10.1542/peds.2010-3722; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS56, DOI 10.1097/INF.0b013e3181fefdc0	10	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1701	1702		10.1001/jama.2011.1475	http://dx.doi.org/10.1001/jama.2011.1475			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	22009102				2022-12-24	WOS:000295963200030
J	Zaher, HS; Green, R				Zaher, Hani S.; Green, Rachel			A Primary Role for Release Factor 3 in Quality Control during Translation Elongation in Escherichia coli	CELL			English	Article							PEPTIDYL-TRANSFER-RNA; STOP CODON RECOGNITION; FACTOR RF3; CHAIN TERMINATION; MESSENGER-RNA; GTPASE ACTIVITY; IN-VITRO; P-SITE; RIBOSOME; DISSOCIATION	Release factor 3 (RF3) is a GTPase found in a broad range of bacteria where it is thought to play a critical "recycling" role in translation by facilitating the removal of class 1 release factors (RF1 and RF2) from the ribosome following peptide release. More recently, RF3 was shown in vitro to stimulate a retrospective editing reaction on the bacterial ribosome wherein peptides carrying mistakes are prematurely terminated during protein synthesis. Here, we examine the role of RF3 in the bacterial cell and show that the deletion of this gene sensitizes cells to other perturbations that reduce the overall fidelity of protein synthesis. We further document substantial effects on mRNA stability and protein expression using reporter systems, native mRNAs and proteins. We conclude that RF3 plays a primary role in vivo in specifying the fidelity of protein synthesis thus impacting overall protein quantity and quality.	[Zaher, Hani S.; Green, Rachel] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	ragreen@jhmi.edu			NIH [K99/R00]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425, K99GM094210, R00GM094210] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Beth Rogers for help in preparing reagents; Allen Buskirk, Nick Guydosh, and Chris Shoemaker for comments on the manuscript; Tord Hagervall (Umea University, Sweden) for strain JK463; Phil Farabaugh (University of Maryland) for the hyperaccurate and error-prone strains; and the Keio collection (Japan) for strain JW5873. The work was supported by the NIH and HHMI (R.G.) and an NIH K99/R00 (H.S.Z.)	ADAMSKI FM, 1994, J MOL BIOL, V238, P302, DOI 10.1006/jmbi.1994.1293; ANDERSSON DI, 1982, MOL GEN GENET, V187, P467, DOI 10.1007/BF00332630; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; CAPECCHI MR, 1967, P NATL ACAD SCI USA, V58, P1144, DOI 10.1073/pnas.58.3.1144; CAPECCHI MR, 1969, COLD SPRING HARB SYM, V34, P469, DOI 10.1101/SQB.1969.034.01.053; CASKEY T, 1969, COLD SPRING HARB SYM, V34, P479, DOI 10.1101/SQB.1969.034.01.054; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eyler DE, 2011, RNA, V17, P925, DOI 10.1261/rna.2623711; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Gao HX, 2007, CELL, V129, P929, DOI 10.1016/j.cell.2007.03.050; GRENTZMANN G, 1995, J BIOL CHEM, V270, P10595, DOI 10.1074/jbc.270.18.10595; GRENTZMANN G, 1994, P NATL ACAD SCI USA, V91, P5848, DOI 10.1073/pnas.91.13.5848; Heurgue-Hamard V, 2000, EMBO J, V19, P2701, DOI 10.1093/emboj/19.11.2701; Heurgue-Hamard V, 1998, EMBO J, V17, P808, DOI 10.1093/emboj/17.3.808; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; Jahn CE, 2008, J MICROBIOL METH, V75, P318, DOI 10.1016/j.mimet.2008.07.004; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; JORGENSEN F, 1993, J MOL BIOL, V230, P41, DOI 10.1006/jmbi.1993.1124; Karimi R, 1996, EMBO J, V15, P1149, DOI 10.1002/j.1460-2075.1996.tb00453.x; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kisselev L, 2003, EMBO J, V22, P175, DOI 10.1093/emboj/cdg017; Klaholz BP, 2004, NATURE, V427, P862, DOI 10.1038/nature02332; Kramer EB, 2010, RNA, V16, P1797, DOI 10.1261/rna.2201210; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Mathews MB, 2007, TRANSLATIONAL CONTRO, V1, P1; MIKUNI O, 1994, P NATL ACAD SCI USA, V91, P5798, DOI 10.1073/pnas.91.13.5798; MILMAN G, 1969, P NATL ACAD SCI USA, V63, P183, DOI 10.1073/pnas.63.1.183; Mora L, 2003, MOL MICROBIOL, V50, P1467, DOI 10.1046/j.1365-2958.2003.03799.x; Nakamura Y, 1996, CELL, V87, P147, DOI 10.1016/S0092-8674(00)81331-8; Nogueira T, 2001, J MOL BIOL, V310, P709, DOI 10.1006/jmbi.2001.4796; Pisareva VP, 2006, J BIOL CHEM, V281, P40224, DOI 10.1074/jbc.M607461200; PRECUP J, 1987, J BIOL CHEM, V262, P11351; RON EZ, 1966, SCIENCE, V153, P1119, DOI 10.1126/science.153.3740.1119; STERNBERG N, 1983, ANNU REV GENET, V17, P123, DOI 10.1146/annurev.ge.17.120183.001011; THOMPSON RC, 1982, P NATL ACAD SCI-BIOL, V79, P4922, DOI 10.1073/pnas.79.16.4922; Watanabe Y, 2010, FEBS LETT, V584, P790, DOI 10.1016/j.febslet.2009.12.048; Youngman EM, 2007, MOL CELL, V28, P533, DOI 10.1016/j.molcel.2007.09.015; Zaher HS, 2010, RNA, V16, P1980, DOI 10.1261/rna.2241810; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2003, CELL, V114, P113, DOI 10.1016/S0092-8674(03)00478-1; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	47	39	40	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					396	408		10.1016/j.cell.2011.08.045	http://dx.doi.org/10.1016/j.cell.2011.08.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000017	Green Accepted, Bronze			2022-12-24	WOS:000296199300017
J	Odadi, WO; Karachi, MK; Abdulrazak, SA; Young, TP				Odadi, Wilfred O.; Karachi, Moses K.; Abdulrazak, Shaukat A.; Young, Truman P.			African Wild Ungulates Compete with or Facilitate Cattle Depending on Season	SCIENCE			English	Article							SEMIARID SAVANNA; ELEPHANTS; SERENGETI; RANGELAND; SELECTION; LIVESTOCK; LAIKIPIA; KENYA	Savannas worldwide are vital for both socioeconomic and biodiversity values. In these ecosystems, management decisions are based on the perception that wildlife and livestock compete for food, yet there are virtually no experimental data to support this assumption. We examined the effects of wild African ungulates on cattle performance, food intake, and diet quality. Wild ungulates depressed cattle food intake and performance during the dry season (competition) but enhanced cattle diet quality and performance during the wet season (facilitation). These results extend our understanding of the context-dependent-competition-facilitation balance, in general, and are critical for better understanding and managing wildlife-livestock coexistence in human-occupied savanna landscapes.	[Odadi, Wilfred O.; Young, Truman P.] Mpala Res Ctr, Nanyuki 10400, Kenya; [Karachi, Moses K.] Egerton Univ, Dept Nat Resources, Egerton 20115, Kenya; [Abdulrazak, Shaukat A.] Natl Council Sci & Technol, Nairobi 00100, Kenya; [Young, Truman P.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Egerton University; University of California System; University of California Davis	Odadi, WO (corresponding author), Mpala Res Ctr, POB 555, Nanyuki 10400, Kenya.	woodadie@yahoo.com; tpyoung@ucdavis.edu			Smithsonian Institution; National Geographic Society; National Science Foundation [08-16453]; U.S. Fish and Wildlife Service; International Foundation for Science [B/4182-1]	Smithsonian Institution(Smithsonian Institution); National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); U.S. Fish and Wildlife Service(US Fish & Wildlife Service); International Foundation for Science(International Foundation for Science)	This research was supported by grants from the James Smithson Fund (Smithsonian Institution), the National Geographic Society, the National Science Foundation (grant 08-16453 to T.P.Y.), the African Elephant Program (U.S. Fish and Wildlife Service), and the International Foundation for Science (grant B/4182-1 to W.O.O.). We thank M. Kinnaird, M. Littlewood, and the Mpala Board of Trustees; K. Veblen, C. Riginos, and G. Aike for logistical support; and F. Erii, M. Namoni, R. Kibet, and P. Ekai for field assistance. We appreciate comments and suggestions by T. Palmer.	Arsenault R, 2002, OIKOS, V97, P313, DOI 10.1034/j.1600-0706.2002.970301.x; Beck JL, 2005, RANGELAND ECOL MANAG, V58, P135, DOI 10.2111/03-13.1; Bell R.H.V., 1970, ANIMAL POPULATIONS R, P111; BELL RHV, 1971, SCI AM, V225, P86, DOI 10.1038/scientificamerican0771-86; CASEBEER R L, 1970, East African Wildlife Journal, V8, P25; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUNCAN P, 1990, OECOLOGIA, V84, P411, DOI 10.1007/BF00329768; Georgiadis NJ, 2007, BIOL CONSERV, V137, P461, DOI 10.1016/j.biocon.2007.03.005; GWYNNE MD, 1968, NATURE, V220, P390, DOI 10.1038/220390a0; Hogan J. P., 1982, Nutritional limits to animal production from pastures., P245; Lima GFD, 1999, CROP SCI, V39, P1853, DOI 10.2135/cropsci1999.3961853x; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; McNaughton SJ, 1997, SCIENCE, V278, P1798, DOI 10.1126/science.278.5344.1798; Odadi WO, 2007, RANGELAND ECOL MANAG, V60, P179, DOI 10.2111/05-044R3.1; Odadi WO, 2011, EVOL ECOL RES, V13, P237; Odadi WO, 2009, APPL ANIM BEHAV SCI, V116, P120, DOI 10.1016/j.applanim.2008.08.010; OWAGA ML, 1975, THESIS U NAIROBI; POPPI DP, 1995, J ANIM SCI, V73, P278; Pringle RM, 2007, P NATL ACAD SCI USA, V104, P193, DOI 10.1073/pnas.0609840104; Prins HHT, 2000, WILDLIFE CONSERVATIO, P51, DOI DOI 10.1007/978-94-011-4012-6_5; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; Veblen KE, 2008, ECOLOGY, V89, P1532, DOI 10.1890/07-0973.1; Young TP, 2005, BIOL CONSERV, V122, P351, DOI 10.1016/j.biocon.2004.08.007	24	160	164	1	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1753	1755		10.1126/science.1208468	http://dx.doi.org/10.1126/science.1208468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940896				2022-12-24	WOS:000295121500044
J	Bhutani, N; Burns, DM; Blau, HM				Bhutani, Nidhi; Burns, David M.; Blau, Helen M.			DNA Demethylation Dynamics	CELL			English	Article							EMBRYONIC STEM-CELLS; BASE EXCISION-REPAIR; METHYLATION PATTERNS; PATERNAL GENOME; PREIMPLANTATION DEVELOPMENT; SOMATIC HYPERMUTATION; GENE-EXPRESSION; 5-HYDROXYMETHYLCYTOSINE; MOUSE; TET1	The discovery of cytosine hydroxymethylation (5hmC) suggested a simple means of demethylating DNA and activating genes. Further experiments, however, unearthed an unexpectedly complex process, entailing both passive and active mechanisms of DNA demethylation by the ten-eleven translocation (TET) and AID/APOBEC families of enzymes. The consensus emerging from these studies is that removal of cytosine methylation in mammalian cells can occur by DNA repair. These reports highlight that in certain contexts, DNA methylation is not fixed but dynamic, requiring continuous regulation.	[Bhutani, Nidhi; Burns, David M.; Blau, Helen M.] Stanford Univ, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol,Sch Med, Stanford, CA 94305 USA.	hblau@stanford.edu			PHS [5T32CA09151]; NIH [HL096113, HL100397, AG020961, AG009521]; JDRF [34-2008-623]; CIRM [RT1-01001, RB1-01292]; Baxter Foundation; NCI; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, R01HL096113] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG009521, R01AG020961] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF(Juvenile Diabetes Research Foundation); CIRM(California Institute for Regenerative Medicine); Baxter Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Steve Hennikoff, Mary Goll, Mark Ptashne, Peter Jones, Jason Pomerantz, and members of our laboratory for critical reading of the manuscript and constructive suggestions and Stephane Corbel for expert artwork. This work was funded by a PHS grant 5T32CA09151 awarded by NCI to D.M.B. and funding from NIH grants HL096113, HL100397, AG020961, and AG009521; JDRF grant 34-2008-623; CIRM grants RT1-01001 and RB1-01292; and the Baxter Foundation to H.M.B.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Delker RK, 2009, NAT IMMUNOL, V10, P1147, DOI 10.1038/ni.1799; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; FRANK D, 1990, PHILOS T ROY SOC B, V326, P241, DOI 10.1098/rstb.1990.0008; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; He Y-F, 2011, SCIENCE; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jullien J, 2011, NAT REV MOL CELL BIO, V12, P453, DOI 10.1038/nrm3140; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; MONK M, 1991, DEVELOPMENT, V112, P189; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Ono R, 2002, CANCER RES, V62, P4075; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; PAROUSH Z, 1990, CELL, V63, P1229, DOI 10.1016/0092-8674(90)90418-E; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ptashne M, 2009, CURR BIOL, V19, pR234, DOI 10.1016/j.cub.2009.02.015; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Ruzov A, 2011, CELL RES, V21, P1332, DOI 10.1038/cr.2011.113; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; to S, 2011, SCIENCE; Weiss A, 1996, CELL, V86, P709, DOI 10.1016/S0092-8674(00)80146-4; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; WYATT GR, 1952, NATURE, V170, P1072, DOI 10.1038/1701072a0; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	62	473	501	1	92	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					866	872		10.1016/j.cell.2011.08.042	http://dx.doi.org/10.1016/j.cell.2011.08.042			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925312	Green Accepted, Bronze			2022-12-24	WOS:000295258100010
J	James, S; Simmons, CP; James, AA				James, Stephanie; Simmons, Cameron P.; James, Anthony A.			Mosquito Trials	SCIENCE			English	Editorial Material							TRANSMISSION		[James, Stephanie] Fdn NIH, Bethesda, MD 20814 USA; [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Program, Ho Chi Minh City, Vietnam; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	National Institutes of Health (NIH) - USA; University of Oxford; University of California System; University of California Irvine; University of California System; University of California Irvine	James, S (corresponding author), Fdn NIH, Bethesda, MD 20814 USA.	sjames@fnih.org; csimmons@oucru.org; aajames@uci.edu	Simmons, Cameron P/ABA-3896-2021	Simmons, Cameron P/0000-0002-9039-7392; James, Anthony/0000-0001-5577-3308				Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Subbaraman N, 2011, NAT BIOTECHNOL, V29, P9, DOI 10.1038/nbt0111-9a	6	22	22	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					771	772		10.1126/science.1213798	http://dx.doi.org/10.1126/science.1213798			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	845US	22076370				2022-12-24	WOS:000296849600036
J	Jilek, C; Tzeis, S; Vrazic, H; Semmler, V; Andrikopoulos, G; Reents, T; Fichtner, S; Ammar, S; Rassias, I; Theodorakis, G; Weber, S; Hessling, G; Deisenhofer, I; Kolb, C				Jilek, Clemens; Tzeis, Stylianos; Vrazic, Hrvoje; Semmler, Verena; Andrikopoulos, Georgios; Reents, Tilko; Fichtner, Stephanie; Ammar, Sonia; Rassias, Ioannis; Theodorakis, Georgios; Weber, Stefan; Hessling, Gabriele; Deisenhofer, Isabel; Kolb, Christof			Safety of Screening Procedures With Hand-Held Metal Detectors Among Patients With Implanted Cardiac Rhythm Devices A Cross-sectional Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVERTER-DEFIBRILLATORS; ELECTROMAGNETIC-INTERFERENCE; PERMANENT PACEMAKERS; MEDIA PLAYERS; TELEMETRY	Background: Case reports suggest that the hand-held metal detectors used for security screening generate electromagnetic fields that may interfere with pacemaker and implantable cardioverter-defibrillator (ICD) function. Objective: To assess changes in function of pacemakers and ICDs after exposure to hand-held metal detectors. Design: Cross-sectional study. Setting: Two medical centers in Europe. Patients: 388 patients (209 with pacemakers and 179 with ICDs) presenting for routine follow-up of device function between September 2009 and December 2010. Measurements: Abnormalities on electrocardiography suggestive of rhythm device malfunction (pacing inhibition, loss of capture, inappropriate mode switch, ventricular oversensing, and spontaneous reprogramming) after 30 seconds of exposure to 2 widely used hand-held metal detectors with a maximal electromagnetic flux density of 6.3 mu T. Results: No change in device function, including pacing or sensing abnormalities or device reprogramming, was observed in any patient. Limitations: The study included a convenience sample of patients, and the number of different device models tested was small. Testing was conducted in 2 clinic settings. Conclusion: Hand-held metal detectors did not affect the function of pacemakers or ICDs in this sample. The use of hand-held metal detectors for security screening is probably safe for patients with pacemakers and ICDs, but these findings require confirmation. Primary Funding Source: None.	[Jilek, Clemens] Deutsch Herzzentrum Munich, D-80636 Munich, Germany; Tech Univ Munich, Fac Med, Med Klin Klinikum Rechts Isar 1, Munich, Germany; Henry Dunant Hosp, Athens 11526, Greece; Univ Hosp Dubrava, Zagreb 10000, Croatia; Univ Regensburg, Klin & Poliklin Innere Med 2, D-93042 Regensburg, Germany	German Heart Centre Munich; Technical University of Munich; Henry Dunant Hospital; University of Regensburg	Jilek, C (corresponding author), Deutsch Herzzentrum Munich, Lazarettstr 36, D-80636 Munich, Germany.	research@jilek.de	Vrazic, Hrvoje/F-6450-2012	Vrazic, Hrvoje/0000-0001-8151-9899; Deisenhofer, Isabel/0000-0001-5826-6846; Jilek, Clemens/0000-0001-9558-6240	European Heart Rhythm Association	European Heart Rhythm Association	Dr. Vrazic was supported by an educational fellowship of the European Heart Rhythm Association.	Burlington B, 1998, IMPORTANT INFORM ANT; Chiladakis JA, 2001, EUR HEART J, V22, P1337, DOI 10.1053/euhj.2000.2516; COPPERMAN Y, 1988, PACE, V11, P1386, DOI 10.1111/j.1540-8159.1988.tb04985.x; Kolb C, 2004, PACE, V27, P221, DOI 10.1111/j.1540-8159.2004.00414.x; Kolb C, 2003, J AM COLL CARDIOL, V41, P2054, DOI 10.1016/S0735-1097(03)00424-8; Kolb C, 2001, PACE, V24, P465, DOI 10.1046/j.1460-9592.2001.00465.x; Mugica J, 2000, PACE, V23, P333, DOI 10.1111/j.1540-8159.2000.tb06758.x; Pinski SL, 2002, PACE, V25, P1496, DOI 10.1046/j.1460-9592.2002.01496.x; Pinski SL, 2002, PACE, V25, P1367, DOI 10.1046/j.1460-9592.2002.01367.x; Rickli H, 2003, PACE, V26, P1494, DOI 10.1046/j.1460-9592.2003.t01-1-00216.x; Santucci PA, 1998, NEW ENGL J MED, V339, P1371, DOI 10.1056/NEJM199811053391905; Shah AJ, 2010, PACE, V33, P712, DOI [10.1111/J.1540-8159.2009.02672.X, 10.1111/j.1540-8159.2009.02672.x]; Thaker JP, 2008, HEART RHYTHM, V5, P538, DOI 10.1016/j.hrthm.2008.01.028; The European Society of Cardiology Guidelines for the diagnosis and management of syncope reviewed by Angel Moya, 2009, EUR HEART J, V30, P2539; Trigano A, 2005, HEART RHYTHM, V2, P837, DOI 10.1016/j.hrthm.2005.03.011; Webster G, 2008, HEART RHYTHM, V5, P545, DOI 10.1016/j.hrthm.2008.02.033	16	19	19	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2011	155	9					587	U53		10.7326/0003-4819-155-9-201111010-00005	http://dx.doi.org/10.7326/0003-4819-155-9-201111010-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842PW	22041947				2022-12-24	WOS:000296612400003
J	Lewis, KH; Rosenthal, MB				Lewis, Kristina H.; Rosenthal, Meredith B.			Individual Responsibility or a Policy Solution - Cap and Trade for the US Diet?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WORK		[Lewis, Kristina H.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Lewis, Kristina H.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Harvard University; Harvard T.H. Chan School of Public Health	Lewis, KH (corresponding author), Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA.			Lewis, Kristina/0000-0002-4921-7230; Rosenthal, Meredith/0000-0003-3410-0184				Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Chestnut LG, 2005, J ENVIRON MANAGE, V77, P252, DOI 10.1016/j.jenvman.2005.05.014; Forshee RA, 2008, NUTR REV, V66, P280, DOI 10.1111/j.1753-4887.2008.00033.x; Matisoff DC, 2010, ENVIRONMENT, V52, P10, DOI 10.1080/00139150903479530; Tietenberg T., 2010, Agricultural and Resource Economics Review, V39, P359	5	12	13	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2011	365	17					1561	1563		10.1056/NEJMp1105128	http://dx.doi.org/10.1056/NEJMp1105128			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	837HI	22029976				2022-12-24	WOS:000296181800013
J	Haas, JS; Zavala, B; Landisman, CE				Haas, Julie S.; Zavala, Baltazar; Landisman, Carole E.			Activity-Dependent Long-Term Depression of Electrical Synapses	SCIENCE			English	Article							THALAMIC RETICULAR NUCLEUS; INHIBITORY INTERNEURONS; GABAERGIC SYNAPSES; SPIKING NEURONS; MAMMALIAN BRAIN; ADULT-RAT; NEOCORTEX; NETWORK; MODULATION; PHOSPHORYLATION	Use-dependent forms of synaptic plasticity have been extensively characterized at chemical synapses, but a relationship between natural activity and strength at electrical synapses remains elusive. The thalamic reticular nucleus (TRN), a brain area rich in gap-junctional (electrical) synapses, regulates cortical attention to the sensory surround and participates in shifts between arousal states; plasticity of electrical synapses may be a key mechanism underlying these processes. We observed long-term depression resulting from coordinated burst firing in pairs of coupled TRN neurons. Changes in gap-junctional communication were asymmetrical, indicating that regulation of connectivity depends on the direction of use. Modification of electrical synapses resulting from activity in coupled neurons is likely to be a widespread and powerful mechanism for dynamic reorganization of electrically coupled neuronal networks.	[Haas, Julie S.; Landisman, Carole E.] Harvard Univ, Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Haas, Julie S.; Zavala, Baltazar; Landisman, Carole E.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University	Haas, JS (corresponding author), Harvard Univ, Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	julie.haas@gmail.com; carole.landisman@hms.harvard.edu		Haas, Julie/0000-0002-1571-8512	Milton Fund	Milton Fund	We thank D. Feldman and K. Bender for valuable feedback on previous version of the manuscript. This work was supported by the Milton Fund.	Alev C, 2008, P NATL ACAD SCI USA, V105, P20964, DOI 10.1073/pnas.0805408105; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Bennett MVL, 2004, NEURON, V41, P495, DOI 10.1016/S0896-6273(04)00043-1; Blatow M, 2003, NEURON, V38, P805, DOI 10.1016/S0896-6273(03)00300-3; Blethyn Kate L., 2008, Thalamus & Related Systems, V4, P13, DOI 10.1017/S1472928807000325; Chow CC, 2000, NEURAL COMPUT, V12, P1643, DOI 10.1162/089976600300015295; Chu ZG, 2003, J NEUROSCI, V23, P96; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; Devor A, 2002, J NEUROPHYSIOL, V87, P3048, DOI 10.1152/jn.2002.87.6.3048; Froemke Robert C, 2010, Front Synaptic Neurosci, V2, P19, DOI 10.3389/fnsyn.2010.00019; Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002; FURSHPAN EJ, 1959, J PHYSIOL-LONDON, V145, P289, DOI 10.1113/jphysiol.1959.sp006143; Galarreta M, 2001, NAT REV NEUROSCI, V2, P425, DOI 10.1038/35077566; Gibson JR, 2005, J NEUROPHYSIOL, V93, P467, DOI 10.1152/jn.00520.2004; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; HOUSER CR, 1980, BRAIN RES, V200, P341, DOI 10.1016/0006-8993(80)90925-7; INOUE M, 1993, BRAIN RES, V612, P35, DOI 10.1016/0006-8993(93)91641-5; Kothmann WW, 2007, VISUAL NEUROSCI, V24, P363, DOI 10.1017/S095252380707037X; Kothmann WW, 2009, J NEUROSCI, V29, P14903, DOI 10.1523/JNEUROSCI.3436-09.2009; Lamsa Karri P, 2010, Front Synaptic Neurosci, V2, P8, DOI 10.3389/fnsyn.2010.00008; Landisman CE, 2005, SCIENCE, V310, P1809, DOI 10.1126/science.1114655; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; Lewis TJ, 2003, J COMPUT NEUROSCI, V14, P283, DOI 10.1023/A:1023265027714; Long MA, 2004, J NEUROSCI, V24, P341, DOI 10.1523/JNEUROSCI.3358-03.2004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; Mitropoulou G, 2003, J NEUROSCI RES, V72, P147, DOI 10.1002/jnr.10572; Nugent FS, 2008, J PHYSIOL-LONDON, V586, P1487, DOI 10.1113/jphysiol.2007.148098; OHARA PT, 1985, J NEUROCYTOL, V14, P365, DOI 10.1007/BF01217752; Pereda AE, 1996, J NEUROSCI, V16, P983; Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z; Rorig B, 1996, MOL NEUROBIOL, V12, P225, DOI 10.1007/BF02755590; Rowe DL, 2005, INT J NEUROSCI, V115, P1273, DOI 10.1080/00207450590934499; Steriade M, 2005, TRENDS NEUROSCI, V28, P317, DOI 10.1016/j.tins.2005.03.007; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Vervaeke K, 2010, NEURON, V67, P435, DOI 10.1016/j.neuron.2010.06.028; ZOLNIK T, 2010, SOC NEUR C SAN DIEG	44	110	111	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					389	393		10.1126/science.1207502	http://dx.doi.org/10.1126/science.1207502			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021860				2022-12-24	WOS:000296052500056
J	Beck, B; Driessens, G; Goossens, S; Youssef, KK; Kuchnio, A; Caauwe, A; Sotiropoulou, PA; Loges, S; Lapouge, G; Candi, A; Mascre, G; Drogat, B; Dekoninck, S; Haigh, JJ; Carmeliet, P; Blanpain, C				Beck, Benjamin; Driessens, Gregory; Goossens, Steven; Youssef, Khalil Kass; Kuchnio, Anna; Caauwe, Amelie; Sotiropoulou, Panagiota A.; Loges, Sonja; Lapouge, Gaelle; Candi, Aurelie; Mascre, Guilhem; Drogat, Benjamin; Dekoninck, Sophie; Haigh, Jody J.; Carmeliet, Peter; Blanpain, Cedric			A vascular niche and a VEGF-Nrp1 loop regulate the initiation and stemness of skin tumours	NATURE			English	Article							VEGF-A; CANCER; GROWTH; CELLS; NEUROPILIN-1; CATENIN; MICE	Angiogenesis is critical during tumour initiation and malignant progression(1). Different strategies aimed at blocking vascular endothelial growth factor (VEGF) and its receptors have been developed to inhibit angiogenesis in cancer patients(2). It has become increasingly clear that in addition to its effect on angiogenesis, other mechanisms including a direct effect of VEGF on tumour cells may account for the efficiency of VEGF-blockade therapies(3). Cancer stem cells (CSCs) have been described in various cancers including squamous tumours of the skin(4,5). Here we use a mouse model of skin tumours to investigate the impact of the vascular niche and VEGF signalling on controlling the stemness (the ability to self renew and differentiate) of squamous skin tumours during the early stages of tumour progression. We show that CSCs of skin papillomas are localized in a perivascular niche, in the immediate vicinity of endothelial cells. Furthermore, blocking VEGFR2 caused tumour regression not only by decreasing the microvascular density, but also by reducing CSC pool size and impairing CSC renewal properties. Conditional deletion of Vegfa in tumour epithelial cells caused tumours to regress, whereas VEGF overexpression by tumour epithelial cells accelerated tumour growth. In addition to its well-known effect on angiogenesis, VEGF affected skin tumour growth by promoting cancer stemness and symmetric CSC division, leading to CSC expansion. Moreover, deletion of neuropilin-1 (Nrp1), a VEGF co-receptor expressed in cutaneous CSCs, blocked VEGF's ability to promote cancer stemness and renewal. Our results identify a dual role for tumour-cell-derived VEGF in promoting cancer stemness: by stimulating angiogenesis in a paracrine manner, VEGF creates a perivascular niche for CSCs, and by directly affecting CSCs through Nrp1 in an autocrine loop, VEGF stimulates cancer stemness and renewal. Finally, deletion of Nrp1 in normal epidermis prevents skin tumour initiation. These results may have important implications for the prevention and treatment of skin cancers.	[Beck, Benjamin; Driessens, Gregory; Youssef, Khalil Kass; Caauwe, Amelie; Sotiropoulou, Panagiota A.; Lapouge, Gaelle; Candi, Aurelie; Mascre, Guilhem; Drogat, Benjamin; Dekoninck, Sophie; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Goossens, Steven; Haigh, Jody J.] Univ Ghent VIB, Dept Mol Biomed Res, Vasc Cell Biol Unit, B-9052 Ghent, Belgium; [Goossens, Steven; Kuchnio, Anna; Haigh, Jody J.] UGent Dept Mol Biomed Res, B-9052 Ghent, Belgium; [Kuchnio, Anna; Loges, Sonja; Carmeliet, Peter] VIB, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium; [Loges, Sonja; Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Lab Angiogenesis & Neurovasc Link, B-3000 Louvain, Belgium	Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); KU Leuven	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, 808 Route Lennik, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; Carmeliet, Peter/AAQ-5140-2020; Youssef, Khalil Kass/AAB-6528-2021; Loges, Sonja/ABE-9868-2021	Carmeliet, Peter/0000-0001-7961-1821; Youssef, Khalil Kass/0000-0002-4572-3160; Loges, Sonja/0000-0002-7650-8527; Beck, Benjamin/0000-0001-8162-7566; haigh, jody/0000-0002-7319-8922; Goossens, Steven/0000-0002-5693-8570; benjamin, Drogat/0000-0002-0020-4826	Brussels Region; Deutsche Krebshilfe; Hamburger Krebsgesellschaft; Roggenbuck Stiftung; Flemish Government; FNRS; Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC); EMBO	Brussels Region; Deutsche Krebshilfe(Deutsche Krebshilfe); Hamburger Krebsgesellschaft; Roggenbuck Stiftung; Flemish Government(European Commission); FNRS(Fonds de la Recherche Scientifique - FNRS); Wallonia Region; Fondation Contre le Cancer; ULB foundation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank Genetech for providing blocking anti-Nrp1 antibodies and H. Fujisawa, N. Ferrara and A. Nagy for providing the Nrp1<SUP>fl/-</SUP>, Vegf<SUP>fl/fl</SUP> and ROSA26-VEGF-164 mice, respectively. C.B. is an investigator of Welbio. C.B. and P.A.S. are chercheur qualifie and B.B. is a charge de recherche of the FRS/FNRS; Am.C. and G.M. are research fellows of the FRS/FRIA. G.D. is supported by the Brussels Region, B.D. and K.K.Y. by TELEVIE and. S.G. is a postdoctoral fellow of the Basic Science Research Foundation-Flanders (FWO). S.L. is funded by the Max-Eder group leader program of the Deutsche Krebshilfe, by the Hamburger Krebsgesellschaft and by the Roggenbuck Stiftung. P.C. is funded by Long-term structural Methusalem funding by the Flemish Government. This work was supported by the FNRS, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB foundation and the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Ferrara N, 2007, ANNU REV MED, V58, P491, DOI 10.1146/annurev.med.58.061705.145635; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Larcher F, 1998, ONCOGENE, V17, P303, DOI 10.1038/sj.onc.1201928; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lichtenberger BM, 2010, CELL, V140, P268, DOI 10.1016/j.cell.2009.12.046; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Miller DW, 2005, AM J PATHOL, V167, P1389, DOI 10.1016/S0002-9440(10)61226-6; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Perez-Losada J, 2003, NAT REV CANCER, V3, P434, DOI 10.1038/nrc1095; Poulson ND, 2010, J CELL BIOL, V191, P915, DOI 10.1083/jcb.201008001; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158/0008-5472.CAN-03-2581; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427	29	316	336	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					399	+		10.1038/nature10525	http://dx.doi.org/10.1038/nature10525			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012397				2022-12-24	WOS:000296021100049
J	Lu, K; Heng, X; Garyu, L; Monti, S; Garcia, EL; Kharytonchyk, S; Dorjsuren, B; Kulandaivel, G; Jones, S; Hiremath, A; Divakaruni, SS; LaCotti, C; Barton, S; Tummillo, D; Hosic, A; Edme, K; Albrecht, S; Telesnitsky, A; Summers, MF				Lu, Kun; Heng, Xiao; Garyu, Lianko; Monti, Sarah; Garcia, Eric L.; Kharytonchyk, Siarhei; Dorjsuren, Bilguujin; Kulandaivel, Gowry; Jones, Simonne; Hiremath, Atheeth; Divakaruni, Sai Sachin; LaCotti, Courtney; Barton, Shawn; Tummillo, Daniel; Hosic, Azra; Edme, Kedy; Albrecht, Sara; Telesnitsky, Alice; Summers, Michael F.			NMR Detection of Structures in the HIV-1 5 '-Leader RNA That Regulate Genome Packaging	SCIENCE			English	Article							SECONDARY STRUCTURE; GAG GENE; REGION; SIGNAL; SITE; RETROVIRUSES; DIMERIZATION; TRANSLATION	The 5'-leader of the HIV-1 genome regulates multiple functions during viral replication via mechanisms that have yet to be established. We developed a nuclear magnetic resonance approach that enabled direct detection of structural elements within the intact leader (712-nucleotide dimer) that are critical for genome packaging. Residues spanning the gag start codon (AUG) form a hairpin in the monomeric leader and base pair with residues of the unique-5' region (U5) in the dimer. U5: AUG formation promotes dimerization by displacing and exposing a dimer-promoting hairpin and enhances binding by the nucleocapsid (NC) protein, which is the cognate domain of the viral Gag polyprotein that directs packaging. Our findings support a packaging mechanism in which translation, dimerization, NC binding, and packaging are regulated by a common RNA structural switch.	[Garcia, Eric L.; Kharytonchyk, Siarhei; Telesnitsky, Alice] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Lu, Kun; Heng, Xiao; Garyu, Lianko; Monti, Sarah; Dorjsuren, Bilguujin; Kulandaivel, Gowry; Jones, Simonne; Hiremath, Atheeth; Divakaruni, Sai Sachin; LaCotti, Courtney; Barton, Shawn; Tummillo, Daniel; Hosic, Azra; Edme, Kedy; Albrecht, Sara; Summers, Michael F.] Univ Maryland Baltimore Cty, Howard Hughes Med Inst, Baltimore, MD 21250 USA; [Lu, Kun; Heng, Xiao; Garyu, Lianko; Monti, Sarah; Dorjsuren, Bilguujin; Kulandaivel, Gowry; Jones, Simonne; Hiremath, Atheeth; Divakaruni, Sai Sachin; LaCotti, Courtney; Barton, Shawn; Tummillo, Daniel; Hosic, Azra; Edme, Kedy; Albrecht, Sara; Summers, Michael F.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Telesnitsky, A (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	ateles@umich.edu; summers@hhmi.umbc.edu	Garcia, Eric/C-5065-2015; Heng, Xiao/G-4950-2012	Garcia, Eric/0000-0002-6951-8268; Kharytonchyk, Siarhei/0000-0001-7031-8135; Divakaruni, Sai Sachin/0000-0003-3478-3229; Garcia, Eric/0000-0002-7690-6998	National Institute of General Medical Sciences (NIGMS) [R01 GM42561, R25 MBRS-IMSD GM55036, MARC U*STAR 2T34 GM008663]; HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008663, R01GM042561, R25GM055036, T32GM007315] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a grant (R01 GM42561) from the National Institute of General Medical Sciences (NIGMS). L. G. was supported by a NIGMS grant for maximizing doctoral diversity (R25 MBRS-IMSD GM55036). B. D., K. E., S.J., G. K., and S. B. were supported by a NIGMS grant for enhancing minority access to research careers (MARC U*STAR 2T34 GM008663). B. D., G. K., and S. B. were supported by a HHMI undergraduate education grant. We thank S. R. King (Michigan) and HHMI staff (UMBC) for technical assistance.	Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; Allain FHT, 1997, J MOL BIOL, V267, P338, DOI 10.1006/jmbi.1996.0855; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; CLEVER J, 1995, J VIROL, V69, P2101, DOI 10.1128/JVI.69.4.2101-2109.1995; Clever JL, 2002, J VIROL, V76, P12381, DOI 10.1128/JVI.76.23.12381-12387.2002; Coffin J, 1997, RETROVIRUSES; D'Souza V, 2005, NAT REV MICROBIOL, V3, P643, DOI 10.1038/nrmicro1210; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; Greatorex J., 2004, RETROVIROLOGY, V1, P23; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Jouvenet N, 2009, P NATL ACAD SCI USA, V106, P19114, DOI 10.1073/pnas.0907364106; Kerwood DJ, 2001, BIOCHEMISTRY-US, V40, P14518, DOI 10.1021/bi0111909; Kutluay SB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001200; Lever AML, 2007, ADV PHARMACOL, V55, P1, DOI 10.1016/S1054-3589(07)55001-5; Lu K, 2011, J MOL BIOL, V410, P609, DOI 10.1016/j.jmb.2011.04.029; McBride MS, 1996, J VIROL, V70, P2963, DOI 10.1128/JVI.70.5.2963-2973.1996; Miele G, 1996, J VIROL, V70, P944, DOI 10.1128/JVI.70.2.944-951.1996; Moore MD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000627; Nikolaitchik O, 2006, J VIROL, V80, P4691, DOI 10.1128/JVI.80.10.4691-4697.2006; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Paillart JC, 2004, J BIOL CHEM, V279, P48397, DOI 10.1074/jbc.M408294200; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; Poon DTK, 2002, VIROLOGY, V293, P368, DOI 10.1006/viro.2001.1283; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; SUMMERS MF, 1992, PROTEIN SCI, V1, P563, DOI 10.1002/pro.5560010502; Tolbert BS, 2010, J BIOMOL NMR, V47, P205, DOI 10.1007/s10858-010-9424-x; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Yu ET, 2008, P NATL ACAD SCI USA, V105, P12248, DOI 10.1073/pnas.0800509105	32	191	191	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					242	245		10.1126/science.1210460	http://dx.doi.org/10.1126/science.1210460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998393	Green Accepted			2022-12-24	WOS:000295833600051
J	Martin, WJ; Glass, RI; Balbus, JM; Collins, FS				Martin, William J., II; Glass, Roger I.; Balbus, John M.; Collins, Francis S.			A Major Environmental Cause of Death	SCIENCE			English	Editorial Material							INDOOR AIR-POLLUTION; SMOKE		[Martin, William J., II; Glass, Roger I.; Balbus, John M.; Collins, Francis S.] NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Martin, WJ (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	wjmartin@mail.nih.gov; glassr@mail.nih.gov			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2011, NIH WORKSH WASH DC 9; Arnold BF, 2010, P NATL ACAD SCI USA, V107, P22605, DOI 10.1073/pnas.1008944107; Bruce N, 2007, B WORLD HEALTH ORGAN, V85, P535, DOI 10.2471/BLT.06.035832; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Imai K, 2009, STAT SCI, V24, P29, DOI 10.1214/08-STS274; McCracken J, 2007, EPIDEMIOLOGY, V18, pS185; Nores P., 2011, SCIENCE, V334, P157; Patrick E, 2007, FORCED MIGRATION REV, V27, P40; Victora CG, 2011, LANCET, V377, P85, DOI 10.1016/S0140-6736(10)60810-0; World Bank, 2011, HOUS COOK STOV ENV H; World Health Organization, 2009, QUANT ENV HLTH IMP G; World Health Organization, 2009, GLOB HLTH RISKS MORT	12	123	127	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					180	181		10.1126/science.1213088	http://dx.doi.org/10.1126/science.1213088			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998373	Green Published			2022-12-24	WOS:000295833600029
J	Brookes, JD; Carey, CC				Brookes, Justin D.; Carey, Cayelan C.			Resilience to Blooms	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; CYANOBACTERIA DOMINANCE; NUTRIENT INPUTS; FRESH-WATER; LAKE; EUTROPHICATION; PHYTOPLANKTON; SHALLOW; PHOSPHORUS; NITROGEN		[Brookes, Justin D.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Carey, Cayelan C.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA	University of Adelaide; Cornell University	Brookes, JD (corresponding author), Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia.	justin.brookes@adelaide.edu.au; ccc99@cornell.edu	Brookes, Justin/G-4270-2013; Carey, Cayelan/D-4874-2016	Carey, Cayelan/0000-0001-8835-4476; Brookes, JUSTIN/0000-0001-8408-9142				Arnott SE, 2003, ENVIRON MONIT ASSESS, V88, P365, DOI 10.1023/A:1025537628078; Carpenter S.R., 1993, TROPHIC CASCADE LAKE; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Cooke G.D., 2005, RESTORATION MANAGEME, Vthird, DOI DOI 10.1002/RRR.3450090207; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Elliott JA, 2010, GLOBAL CHANGE BIOL, V16, P864, DOI 10.1111/j.1365-2486.2009.01998.x; Hamilton DP, 2002, INT VER THEOR ANGEW, V28, P467; Ibelings BW, 2007, ECOSYSTEMS, V10, P4, DOI 10.1007/s10021-006-9009-4; Jeppesen E., 2002, ECOSYST HEALTH, V5, P3; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Johnk KD, 2008, GLOBAL CHANGE BIOL, V14, P495, DOI 10.1111/j.1365-2486.2007.01510.x; Jones I, 2005, FRESHWATER BIOL, V50, P1239, DOI 10.1111/j.1365-2427.2005.01397.x; Kohler J, 2005, FRESHWATER BIOL, V50, P1639, DOI 10.1111/j.1365-2427.2005.01430.x; Kumagai Michio, 2000, Limnology, V1, P1, DOI 10.1007/s102010070022; Markensten H, 2010, ECOL APPL, V20, P752, DOI 10.1890/08-2109.1; McKee D, 2003, LIMNOL OCEANOGR, V48, P707, DOI 10.4319/lo.2003.48.2.0707; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moss B, 2003, J APPL ECOL, V40, P782, DOI 10.1046/j.1365-2664.2003.00839.x; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Rinke K, 2010, FRESHWATER BIOL, V55, P1674, DOI 10.1111/j.1365-2427.2010.02401.x; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Stich HB, 2010, GLOBAL CHANGE BIOL, V16, P877, DOI 10.1111/j.1365-2486.2009.02005.x; Wagner C, 2009, LIMNOL OCEANOGR, V54, P2460, DOI 10.4319/lo.2009.54.6_part_2.2460	23	189	219	8	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					46	47		10.1126/science.1207349	http://dx.doi.org/10.1126/science.1207349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980099				2022-12-24	WOS:000295580300031
J	Gozalo, P; Teno, JM; Mitchell, SL; Skinner, J; Bynum, J; Tyler, D; Mor, V				Gozalo, Pedro; Teno, Joan M.; Mitchell, Susan L.; Skinner, Jon; Bynum, Julie; Tyler, Denise; Mor, Vincent			End-of-Life Transitions among Nursing Home Residents with Cognitive Issues	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADVANCED DEMENTIA; COMMON OUTCOMES; ADVERSE EVENTS; CARE; MEDICARE; HOSPITALIZATION; MDS; REHOSPITALIZATIONS; IDENTIFICATION; HISTORIES	BACKGROUND Health care transitions in the last months of life can be burdensome and potentially of limited clinical benefit for patients with advanced cognitive and functional impairment. METHODS To examine health care transitions among Medicare decedents with advanced cognitive and functional impairment who were nursing home residents 120 days before death, we linked nationwide data from the Medicare Minimum Data Set and claims files from 2000 through 2007. We defined patterns of transition as burdensome if they occurred in the last 3 days of life, if there was a lack of continuity in nursing homes after hospitalization in the last 90 days of life, or if there were multiple hospitalizations in the last 90 days of life. We also considered various factors explaining variation in these rates of burdensome transition. We examined whether there was an association between regional rates of burdensome transition and the likelihood of feeding-tube insertion, hospitalization in an intensive care unit (ICU) in the last month of life, the presence of a stage IV decubitus ulcer, and hospice enrollment in the last 3 days of life. RESULTS Among 474,829 nursing home decedents, 19.0% had at least one burdensome transition (range, 2.1% in Alaska to 37.5% in Louisiana). In adjusted analyses, blacks, Hispanics, and those without an advance directive were at increased risk. Nursing home residents in regions in the highest quintile of burdensome transitions (as compared with those in the lowest quintile) were significantly more likely to have a feeding tube (adjusted risk ratio, 3.38), have spent time in an ICU in the last month of life (adjusted risk ratio, 2.10), have a stage IV decubitus ulcer (adjusted risk ratio, 2.28), or have had a late enrollment in hospice (adjusted risk ratio, 1.17). CONCLUSIONS Burdensome transitions are common, vary according to state, and are associated with markers of poor quality in end-of-life care. (Funded by the National Institute on Aging.)	[Teno, Joan M.] Brown Univ, Warren Alpert Med Sch, Ctr Gerontol & Hlth Care Res, Program Publ Hlth,Dept Hlth Serv Policy & Practic, Providence, RI 02912 USA; [Mitchell, Susan L.] Inst Aging Res, Boston, MA USA; [Skinner, Jon; Bynum, Julie] Dartmouth Med Sch, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Brown University; Dartmouth College	Teno, JM (corresponding author), Brown Univ, Warren Alpert Med Sch, Ctr Gerontol & Hlth Care Res, Program Publ Hlth,Dept Hlth Serv Policy & Practic, Providence, RI 02912 USA.	joan_teno@brown.edu		Tyler, Denise/0000-0001-8555-9011	National Institute on Aging [P01AG027296, K24AG033640]; NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants (P01AG027296, to Dr. Mor, and K24AG033640, to Dr. Mitchell) from the National Institute on Aging.	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; Carter MW, 2003, J AGING HEALTH, V15, P295, DOI 10.1177/0898264303015002001; Coleman E. A., 2002, INT J INTEGR CARE, V2, pe02; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; CORRIGAN JM, 1992, HEALTH SERV RES, V27, P81; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Forster AJ, 2003, ANN INTERN MED, V138, P161, DOI 10.7326/0003-4819-138-3-200302040-00007; GILLICK MR, 1982, SOC SCI MED, V16, P1033, DOI 10.1016/0277-9536(82)90175-7; Givens JL, 2011, ARCH INTERN MED, V171, P217; Givens JL, 2010, ARCH INTERN MED, V170, P1102, DOI 10.1001/archinternmed.2010.181; Grabowski DC, 2010, HEALTH SERV RES, V45, P1963, DOI 10.1111/j.1475-6773.2010.01104.x; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Gruneir A, 2007, GERONTOLOGIST, V47, P447, DOI 10.1093/geront/47.4.447; Harrison A, 2002, HEALTH SERV RES, V37, P1031, DOI 10.1034/j.1600-0560.2002.64_2.x; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Intrator O, 2007, HEALTH SERV RES, V42, P1651, DOI 10.1111/j.1475-6773.2006.00670.x; Intrator O, 2011, HEALTH SERV RES, V46, P120, DOI 10.1111/j.1475-6773.2010.01194.x; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kane RL, 2004, GERONTOLOGIST, V44, P95, DOI 10.1093/geront/44.1.95; Kane RL, 2003, J AM GERIATR SOC, V51, P1427, DOI 10.1046/j.1532-5415.2003.51461.x; Kruse RL, 2004, MED CARE, V42, P860, DOI 10.1097/01.mlr.0000135828.95415.b1; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mitchell SL, 2009, NEW ENGL J MED, V361, P1529, DOI 10.1056/NEJMoa0902234; Moore C, 2003, J GEN INTERN MED, V18, P646, DOI 10.1046/j.1525-1497.2003.20722.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Richardson SS, 2007, HEALTH SERV RES, V42, P183, DOI 10.1111/j.1475-6773.2006.00608.x; Roblin DW, 1999, MED CARE, V37, P1155, DOI 10.1097/00005650-199911000-00007; Saliba D, 2000, J AM GERIATR SOC, V48, P154, DOI 10.1111/j.1532-5415.2000.tb03906.x; Teno JM, 2011, J AM GERIATR SOC, V59, P881, DOI 10.1111/j.1532-5415.2011.03385.x; Thomas DR, 2008, J AM MED DIR ASSOC, V9, P292, DOI 10.1016/j.jamda.2008.03.006; Weissman JS, 1999, MED CARE, V37, P490, DOI 10.1097/00005650-199905000-00008; Wetle T, 2004, END LIFE NURSING HOM; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	40	311	313	1	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1212	1221		10.1056/NEJMsa1100347	http://dx.doi.org/10.1056/NEJMsa1100347			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	825YO	21991894	Green Accepted			2022-12-24	WOS:000295318400009
J	Sawicki, PT				Sawicki, Peter T.			Commentary: Does additional benefit justify additional costs of insulin analogues?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cologne, Inst Hlth Econ & Clin Epidemiol, Cologne, Germany	University of Cologne	Sawicki, PT (corresponding author), Univ Cologne, Inst Hlth Econ & Clin Epidemiol, Cologne, Germany.	peter.sawicki@uk-koeln.de						*G BA, VERF GEM BUND; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; *IQWIG, METH PAP IQWIG; *IQWIG, LONG ACT INS AN TREA; *IQWIG, RAP ACT INS AN CHILD; *IQWIG, RAP ACT INS AN TREAT; KNIEPS F, USE SCI EVIDENCE POL	7	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 14	2011	343								d5858	10.1136/bmj.d5858	http://dx.doi.org/10.1136/bmj.d5858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822VM	21917837				2022-12-24	WOS:000295078100016
J	Buchholz, U; Bernard, H; Werber, D; Bohmer, MM; Remschmidt, C; Wilking, H; Delere, Y; an der Heiden, M; Adlhoch, C; Dreesman, J; Ehlers, J; Ethelberg, S; Faber, M; Frank, C; Fricke, G; Greiner, M; Hohle, M; Ivarsson, S; Jark, U; Kirchner, M; Koch, J; Krause, G; Luber, P; Rosner, B; Stark, K; Kuhne, M				Buchholz, Udo; Bernard, Helen; Werber, Dirk; Boehmer, Merle M.; Remschmidt, Cornelius; Wilking, Hendrik; Delere, Yvonne; an der Heiden, Matthias; Adlhoch, Cornelia; Dreesman, Johannes; Ehlers, Joachim; Ethelberg, Steen; Faber, Mirko; Frank, Christina; Fricke, Gerd; Greiner, Matthias; Hoehle, Michael; Ivarsson, Sofie; Jark, Uwe; Kirchner, Markus; Koch, Judith; Krause, Gerard; Luber, Petra; Rosner, Bettina; Stark, Klaus; Kuehne, Michael			German Outbreak of Escherichia coli O104:H4 Associated with Sprouts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								BACKGROUND A large outbreak of the hemolytic-uremic syndrome caused by Shiga-toxin-producing Escherichia coli O104:H4 occurred in Germany in May 2011. The source of infection was undetermined. METHODS We conducted a matched case-control study and a recipe-based restaurant cohort study, along with environmental, trace-back, and trace-forward investigations, to determine the source of infection. RESULTS The case-control study included 26 case subjects with the hemolytic-uremic syndrome and 81 control subjects. The outbreak of illness was associated with sprout consumption in univariable analysis (matched odds ratio, 5.8; 95% confidence interval [CI], 1.2 to 29) and with sprout and cucumber consumption in multivariable analysis. Among case subjects, 25% reported having eaten sprouts, and 88% reported having eaten cucumbers. The recipe-based study among 10 groups of visitors to restaurant K included 152 persons, among whom bloody diarrhea or diarrhea confirmed to be associated with Shiga-toxin-producing E. coli developed in 31 (20%). Visitors who were served sprouts were significantly more likely to become ill (relative risk, 14.2; 95% CI, 2.6 to 8). Sprout consumption explained 100% of cases. Trace-back investigation of sprouts from the distributor that supplied restaurant K led to producer A. All 41 case clusters with known trading connections could be explained by producer A. The outbreak strain could not be identified on seeds from the implicated lot. CONCLUSIONS Our investigations identified sprouts as the most likely outbreak vehicle, underlining the need to take into account food items that may be overlooked during subjects' recall of consumption.	[Buchholz, Udo; Bernard, Helen; Werber, Dirk; Boehmer, Merle M.; Remschmidt, Cornelius; Wilking, Hendrik; Delere, Yvonne; an der Heiden, Matthias; Adlhoch, Cornelia; Faber, Mirko; Frank, Christina; Hoehle, Michael; Koch, Judith; Krause, Gerard; Rosner, Bettina; Stark, Klaus] Robert Koch Inst, Dept Infect Dis Epidemiol, D-13086 Berlin, Germany; [Wilking, Hendrik; Adlhoch, Cornelia] Robert Koch Inst, Postgrad Training Appl Epidemiol Program, D-13086 Berlin, Germany; [Fricke, Gerd; Luber, Petra] Fed Off Consumer Protect & Food Safety, Berlin, Germany; [Greiner, Matthias] Fed Inst Risk Assessment, Berlin, Germany; [Dreesman, Johannes; Kirchner, Markus] Govt Inst Publ Hlth Lower Saxony, Hannover, Germany; [Ehlers, Joachim; Jark, Uwe; Kuehne, Michael] Lower Saxony State Off Consumer Protect & Food Sa, Oldenburg, Germany; [Greiner, Matthias] Vet Univ, Hannover, Germany; [Ivarsson, Sofie] Swedish Inst Communicable Dis Control, Solna, Sweden; [Ethelberg, Steen] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark	Robert Koch Institute; Robert Koch Institute; Federal Institute for Risk Assessment; University of Veterinary Medicine Hannover, Foundation; Swedish Institute for Infectious Disease Control; Statens Serum Institut	Buchholz, U (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, DGZ Ring 1, D-13086 Berlin, Germany.	buchholzu@rki.de	Adlhoch, Cornelia/AAH-5888-2021; Werber, Dirk/L-2264-2019; Faber, MIrko/O-1191-2018; Greiner, Matthias/D-2812-2013; Höhle, Michael/AFM-0575-2022	Adlhoch, Cornelia/0000-0002-8842-0469; Faber, MIrko/0000-0002-9196-570X; Greiner, Matthias/0000-0003-4974-5970; Höhle, Michael/0000-0002-0423-6702; Krause, Gerard/0000-0003-3328-8808; Ethelberg, Steen/0000-0002-9709-356X; Werber, Dirk/0000-0002-8076-788X; Wilking, Hendrik/0000-0002-8574-5831; an der Heiden, Matthias/0000-0001-5863-4549; Frank, Christina/0000-0001-6776-8450	county health departments of Bremen; Bremerhaven; Cuxhaven; Lubeck	county health departments of Bremen; Bremerhaven; Cuxhaven; Lubeck	thank the senior and junior owner and particularly the chef of restaurant K in Lubeck for their support and patience; physicians, patients, and colleagues in the hospitals in Bremen (Klinikum Bremen Mitte), Bremerhaven (Klinikum Bremerhaven), and Lubeck (Universitatsklinikum Schleswig-Holstein, Campus Lubeck), as well as county health departments of Bremen, Bremerhaven, Cuxhaven, and Lubeck for their support in conducting the case-control study; and Johan Giesecke, Stephen Palmer, Kare Molbak, Henriette de Valk, Roland Salmon, Lyle Petersen, Robert Tauxe, and Hubert Deluyker for their input into the interpretation of study and surveillance data and the management of the outbreak.	Askar M, 2011, EUROSURVEILLANCE, V16, P2; Buchholz U, 2002, JAMA-J AM MED ASSOC, V288, P604, DOI 10.1001/jama.288.5.604; Bundesinstitut fur Risikobewertung (BfR), 2011, 0232011 BFR; European Centre for Disease Prevention and Control, 2011, ECDC RAP RISK ASS OU; European Food Safety Authority, 2011, TRAC SEEDS PART FEN; Frank C, 2011, EUROSURVEILLANCE, V16, P2; Frank C, 2011, NEW ENGL J MED, V365, P1771, DOI 10.1056/NEJMoa1106483; Gault G, 2011, EUROSURVEILLANCE, V16, P5; Hauri AM, 2011, EUROSURVEILLANCE, V16, P15; Michino H, 1999, AM J EPIDEMIOL, V150, P787, DOI 10.1093/oxfordjournals.aje.a010082; Mody RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016579; Robert Koch Institut, 2011, EPIDEMIOL B, V31, P295; Robert Koch-Institute, 2011, NEUE ERK EHEC AUSBR; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Wadl M, 2011, EUROSURVEILLANCE, V16, P11; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855; World Health Organization, INT HLTH REG EHEC OU; World Health Organization (WHO), 2008, FOODB DIS OUTBR GUID	19	501	508	0	96	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 10	2011	365	19					1763	1770		10.1056/NEJMoa1106482	http://dx.doi.org/10.1056/NEJMoa1106482			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844QQ	22029753				2022-12-24	WOS:000296762800005
J	Van Keymeulen, A; Rocha, AS; Ousset, M; Beck, B; Bouvencourt, G; Rock, J; Sharma, N; Dekoninck, S; Blanpain, C				Van Keymeulen, Alexandra; Rocha, Ana Sofia; Ousset, Marielle; Beck, Benjamin; Bouvencourt, Gaelle; Rock, Jason; Sharma, Neha; Dekoninck, Sophie; Blanpain, Cedric			Distinct stem cells contribute to mammary gland development and maintenance	NATURE			English	Article							BREAST-CANCER; IN-VITRO; MOUSE; MORPHOGENESIS; PROGENITOR; EPITHELIUM; SKIN; IDENTIFICATION; POPULATION; COMMITMENT	The mammary epithelium is composed of several cell lineages including luminal, alveolar and myoepithelial cells. Transplantation studies have suggested that the mammary epithelium is maintained by the presence of multipotent mammary stem cells. To define the cellular hierarchy of the mammary gland during physiological conditions, we performed genetic lineage-tracing experiments and clonal analysis of the mouse mammary gland during development, adulthood and pregnancy. We found that in postnatal unperturbed mammary gland, both luminal and myoepithelial lineages contain long-lived unipotent stem cells that display extensive renewing capacities, as demonstrated by their ability to clonally expand during morphogenesis and adult life as well as undergo massive expansion during several cycles of pregnancy. The demonstration that the mammary gland contains different types of long-lived stem cells has profound implications for our understanding of mammary gland physiology and will be instrumental in unravelling the cells at the origin of breast cancers.	[Van Keymeulen, Alexandra; Rocha, Ana Sofia; Ousset, Marielle; Beck, Benjamin; Bouvencourt, Gaelle; Sharma, Neha; Dekoninck, Sophie; Blanpain, Cedric] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Rock, Jason] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA	Universite Libre de Bruxelles; Duke University	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	Cedric.Blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021	Sharma, Neha/0000-0002-8062-1661; Beck, Benjamin/0000-0001-8162-7566; OUSSET, Marielle/0000-0002-2092-2729	TELEVIE; Portuguese Science Foundation (FCT); Fondation Contre le Cancer; FNRS; CIBLES of the Wallonia Region; ULB fondation; fond Gaston Ithier; European Research Council (ERC); EMBO;  [F32HL102920]	TELEVIE; Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology); Fondation Contre le Cancer; FNRS(Fonds de la Recherche Scientifique - FNRS); CIBLES of the Wallonia Region; ULB fondation; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); 	We thank our colleagues who provided us with reagents, which are cited in the text, and B. Hogan for sharing unpublished mice. We thank our colleagues from the Blanpain laboratory and C. Govaerts for their comments on the manuscript. We thank J. Rosen for discussion and M. Van Lohuizen and K. Nacerddine for their help with the transplantation assay. We thank F. Bollet-Quivogne and J.-M. Vanderwinden for their help with confocal imaging. C. B. and A. V. K. are chercheur qualifie, B. B. is charge de recherche and M.O. is a collaborateur scientifique of the FRS/FNRS. A. S. R. is supported by TELEVIE and the Portuguese Science Foundation (FCT). N.S. is supported by the Fondation Contre le Cancer. J. R. is supported by the grant F32HL102920. C. B. is an investigator of Welbio. This work was supported by the FNRS, TELEVIE, the program d'excellence CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer, the ULB fondation, the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program.	Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Booth BW, 2007, J CELL PHYSIOL, V212, P729, DOI 10.1002/jcp.21071; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fernandez-Gonzalez R, 2009, INTEGR BIOL, V1, P80, DOI 10.1039/b816933k; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Lim E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2560; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Naylor S, 2000, J CELL SCI, V113, P2129; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Pechoux C, 1999, DEV BIOL, V206, P88, DOI 10.1006/dbio.1998.9133; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; RUDLAND PS, 1989, J HISTOCHEM CYTOCHEM, V37, P1087, DOI 10.1177/37.7.2471725; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srinivasan K, 2003, DEV CELL, V4, P371, DOI 10.1016/S1534-5807(03)00054-6; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tsai YC, 1996, CANCER RES, V56, P402; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Visvader J. E., 2011, COLD SPRING HARBOR P, V3, P1; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wagner KU, 2002, DEVELOPMENT, V129, P1377; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002	37	572	584	0	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2011	479	7372					189	U58		10.1038/nature10573	http://dx.doi.org/10.1038/nature10573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	21983963				2022-12-24	WOS:000298030800033
J	de Sherbinin, A; Castro, M; Gemenne, F; Cernea, MM; Adamo, S; Fearnside, PM; Krieger, G; Lahmani, S; Oliver-Smith, A; Pankhurst, A; Scudder, T; Singer, B; Tan, Y; Wannier, G; Boncour, P; Ehrhart, C; Hugo, G; Pandey, B; Shi, G				de Sherbinin, A.; Castro, M.; Gemenne, F.; Cernea, M. M.; Adamo, S.; Fearnside, P. M.; Krieger, G.; Lahmani, S.; Oliver-Smith, A.; Pankhurst, A.; Scudder, T.; Singer, B.; Tan, Y.; Wannier, G.; Boncour, P.; Ehrhart, C.; Hugo, G.; Pandey, B.; Shi, G.			Preparing for Resettlement Associated with Climate Change	SCIENCE			English	Editorial Material							MIGRATION		[de Sherbinin, A.; Adamo, S.] Columbia Univ, Earth Inst, CIESIN, Palisades, NY 10964 USA; [Castro, M.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Gemenne, F.] Sci Po, Inst Sustainable Dev & Int Relat IDDRI, F-75007 Paris, France; [Cernea, M. M.] Brookings Inst, Washington, DC 20036 USA; [Fearnside, P. M.] Natl Inst Res Amazonia, BR-69083 Manaus, Amazonas, Brazil; [Krieger, G.] NewFields LLC, Denver, CO 80202 USA; [Lahmani, S.] Agence Francaise Dev, F-75012 Paris, France; [Oliver-Smith, A.] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Pankhurst, A.] Wageningen Univ, NL-6701 Wageningen, Netherlands; [Scudder, T.] CALTECH, Pasadena, CA 91125 USA; [Singer, B.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA; [Tan, Y.; Hugo, G.] Univ Adelaide, Discipline Geog Environm & Populat, Adelaide, SA 5000, Australia; [Wannier, G.] Columbia Law Sch, Ctr Climate Change Law, New York, NY 10027 USA; [Boncour, P.] Int Org Migrat, CH-1211 Geneva, Switzerland; [Ehrhart, C.] CARE Int, Hanoi, Vietnam; [Shi, G.] Hohai Univ, Natl Res Ctr Resettlement, Nanjing 210098, Peoples R China	Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Institut d'Etudes Politiques Paris (Sciences Po); Brookings Institution; Institute Nacional de Pesquisas da Amazonia; State University System of Florida; University of Florida; Wageningen University & Research; California Institute of Technology; State University System of Florida; University of Florida; University of Adelaide; Columbia University; International Organization for Migration; Hohai University	de Sherbinin, A (corresponding author), Columbia Univ, Earth Inst, CIESIN, Palisades, NY 10964 USA.	adesherbinin@ciesin.columbia.edu	Servamb, Inct/K-3437-2013; Krieger, Gerhard/D-5164-2012; Fearnside, Philip M/D-6559-2011; Castro, Marcia/S-2681-2019; Fearnside, Philip M/GQA-6023-2022	Krieger, Gerhard/0000-0002-4548-0285; Fearnside, Philip M/0000-0003-3672-9082; Castro, Marcia/0000-0003-4606-2795; Fearnside, Philip M/0000-0003-3672-9082; Pankhurst, Alula/0000-0002-3925-6834; Adamo, Susana Beatriz/0000-0002-9168-7172; Shi, Guoqing/0000-0003-4499-074X; de Sherbinin, Alex/0000-0002-8875-4864; Tan, Yan/0000-0002-4013-1713				[Anonymous], GUIDING PRINCIPLES I; *AS DEV BANK, CLIM IND MIGR; Black R, 2011, ENVIRON PLANN A, V43, P431, DOI 10.1068/a43154; Bronen Robin, 2008, FORCED MIGRATION REV, V31, P30; Cantero EA, 2011, PREVENTIVE RESETTLEM, P85; Cernea M. M., 2000, Risks and reconstruction: experiences of resettlers and refugees., P11; Cernea M. M., 2008, CAN COMPENSATION PRE, P15; Correa E, 2011, POPULATIONS RISK DIS; de Sherbinin A, 2011, SCI AM, V304, P64, DOI 10.1038/scientificamerican0111-64; Displacement Solutions, 2008, BOUG RES IN M REP, P4; Fearnside P. M., 2005, Mitigation and Adaptation Strategies for Global Change, V10, P675, DOI 10.1007/s11027-005-7303-7; Ferris Elizabeth, 2011, FRONT LINE CLIMATE C; Gemenne F, 2011, PHILOS T R SOC A, V369, P182, DOI 10.1098/rsta.2010.0287; Guerrier G, 2011, SCIENCE, V334, P38, DOI 10.1126/science.334.6052.38-a; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; McLeman R, 2006, CLIMATIC CHANGE, V76, P31, DOI 10.1007/s10584-005-9000-7; MERTI S, 2008, LOSING GROUND; New M, 2011, PHILOS T R SOC A, V369, P6, DOI 10.1098/rsta.2010.0303; Oliver-Smith A., 2009, ANTHR CLIMATE CHANGE, P116; Rogers S, 2006, POPUL ENVIRON, V28, P41, DOI 10.1007/s11111-007-0033-x; Scudder T., 2005, FUTURE LARGE DAMS DE; Tan Y., 2008, RESETTLEMENT 3 GORGE; *UN FRAM CONV CLIM, ENH ACT AD; NANSEN PRINCIPLES	24	159	161	3	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					456	457		10.1126/science.1208821	http://dx.doi.org/10.1126/science.1208821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	837UR	22034418				2022-12-24	WOS:000296230500026
J	Kesselheim, AS; Murtagh, L; Mello, MM				Kesselheim, Aaron S.; Murtagh, Lindsey; Mello, Michelle M.			"Pay for Delay" Settlements of Disputes over Pharmaceutical Patents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENERIC DRUGS; COMPETITION; RIGHTS		[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA; [Murtagh, Lindsey; Mello, Michelle M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Mello, Michelle/0000-0003-2877-4270				[Anonymous], 2010, OR BOOK APPR DRUG PR; Anton JJ, 2006, INNOV POLICY ECON, V6, P1; BELIAN D, 2010, GENERIC LINE, V27, P4; BELIAN D, 2010, GENERIC LINE, V27, P1; Bernard Kent S., 2005, FED CIRCUIT BAR J, V15, P617; Berndt ER, 2007, HEALTH AFFAIR, V26, P790, DOI 10.1377/hlthaff.26.3.790; Bhaven N.Sampat, 2011, EVERGREENING PATENT; Bigelow JP., 2004, ANTITRUST B, V49, P655, DOI 10.1177/0003603X0404900306; Carrier MA, 2009, MICH LAW REV, V108, P37; CRANE DA, 2002, FLA L REV, V54, P747; DICKEY B, 2010, PRELIMINARY EC ANAL; Engelberg A., 1999, IDEA, V39, P389; *FED TRAD COMM, 2002, GEN DRUG ENTR PRIOR; Federal Trade Commission, 2010, PAY FOR DEL DRUG CO; Federal Trade Commission, 2009, AUTH GEN INT REP AUTH GEN INT REP; *FTC, 2009, PAY FOR DEL SETTL MA; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Hemphill CS, 2009, COLUMBIA LAW REV, V109, P629; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; HOVENKAMP H, 2005, ANTITRUST ENTERPRISE; Kesselheim AS, 2006, HEALTH AFFAIR, V25, P1637, DOI 10.1377/hlthaff.25.6.1637; PERITZ RJR, 2011, RES PAPER SERIES NEW, V1011; Roin BN, 2009, TEX LAW REV, V87, P503; ROSCH JT, 2010, REMARKS FTC COMMISSI; Shrank WH, 2006, ARCH INTERN MED, V166, P332, DOI 10.1001/archinte.166.3.332; Shuchman M, 2006, NEW ENGL J MED, V355, P1297, DOI 10.1056/NEJMp068193; STOLBERG SG, 2000, NY TIMES        0723; Voet Martin A., 2005, GENERIC CHALLENGE UN	28	17	17	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1439	1445		10.1056/NEJMhle1102235	http://dx.doi.org/10.1056/NEJMhle1102235			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	832DQ	21916635				2022-12-24	WOS:000295782500014
J	Bruskotter, JT; Enzler, SA; Treves, A				Bruskotter, Jeremy T.; Enzler, Sherry A.; Treves, Adrian			Rescuing Wolves from Politics: Wildlife as a Public Trust Resource	SCIENCE			English	Editorial Material							NORTHERN ROCKY-MOUNTAINS; WOLF		[Bruskotter, Jeremy T.] Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA; [Enzler, Sherry A.] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Enzler, Sherry A.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Treves, Adrian] Univ Wisconsin Madison, Nelson Inst Environm Studies, Madison, WI 53706 USA	University System of Ohio; Ohio State University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Bruskotter, JT (corresponding author), Ohio State Univ, Sch Environm & Nat Resources, Columbus, OH 43210 USA.	bruskotter.9@osu.edu	Treves, Adrian/P-3707-2018; Bruskotter, Jeremy T/B-3240-2012	Treves, Adrian/0000-0002-3052-4708; Bruskotter, Jeremy T/0000-0002-1782-7835				Babcock Hope M., 2009, SC L REV, V61, P393; Bergstrom BJ, 2009, BIOSCIENCE, V59, P991, DOI 10.1525/bio.2009.59.11.11; BLUMM MC, 2005, ENV L, V35, P673; Bruskotter JT, 2010, BIOSCIENCE, V60, P941, DOI 10.1525/bio.2010.60.11.10; Carroll C, 2006, BIOSCIENCE, V56, P25, DOI 10.1641/0006-3568(2006)056[0025:DRGASF]2.0.CO;2; Enzler Sherry A., 2011, WILLIAMMARY ENV LAW, V35, P413; Feldman James W., 2007, Human-Wildlife Conflicts, V1, P112; GEHRKE R, 2011, SALT LAKE TRIBU 0208; Houston M. J., 2010, Human Dimensions of Wildlife, V15, P389, DOI 10.1080/10871209.2010.507563; HUDSON B, 2009, COLUMBIA J ENV LAW, V34, P99; Jacobson CA, 2010, J WILDLIFE MANAGE, V74, P203, DOI 10.2193/2008-485; Mech D., 2003, WOLVES BEHAV ECOLOGY; MUSIKER DG, 1995, LAW REV, V16, P87; Redmond P, 2009, NAT RESOUR J, V49, P249; SAX JL, 1970, MICH LAW REV, V68, P473; Treves A, 2011, SOC NATUR RESOUR, V24, P984, DOI 10.1080/08941920.2011.559654; US Fish and Wildlife Service Montana Fish Wildlife and Parks Nez Perce Tribe National Park Service Blackfeet Nation Confederated Salish and Kootenai Tribes Wind River Tribes Washington Department of Wildlife Oregon Department of Wildlife Utah Department of Natural Resources USDA Wildlife Services, 2011, ROCK MOUNT WOLF REC; Wood Mary Christina, 2004, ENV L, V34, P605, DOI DOI 10.1111/J.1752-1688.2007.00038.X	18	32	32	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1828	1829		10.1126/science.1207803	http://dx.doi.org/10.1126/science.1207803			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	826PJ	21960614				2022-12-24	WOS:000295365800034
J	Okie, S				Okie, Susan			Confronting Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Georgetown Univ, Sch Med, Washington, DC 20007 USA	Georgetown University	Okie, S (corresponding author), Georgetown Univ, Sch Med, Washington, DC 20007 USA.							Alzheimer's Association, NEW DIAGN CRIT GUID; Alzheimer's Association, 2010, CHANG TRAJ ALZH DIS; Alzheimer's Association, 2009, 2 ALZH ASS DARTM I H; BYNUM J, 2009, 1 ALZH ASS DARTM I H; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91	5	22	22	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 22	2011	365	12					1069	1072		10.1056/NEJMp1107288	http://dx.doi.org/10.1056/NEJMp1107288			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	822WR	21992119				2022-12-24	WOS:000295081600004
J	Chabner, BA				Chabner, Bruce A.			Drug Shortages - A Critical Challenge for the Generic-Drug Market	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Chabner, BA (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.		Mendoza, Elvia/A-9361-2012					[Anonymous], 2008, REUTERS         0515; Centers for Medicare and Medicaid Services, MEDICARE B; Food and Drug Adminstration, DRUG SHORT; 2011, PHARM BLOG      0613	4	70	72	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2011	365	23					2147	2149		10.1056/NEJMp1112633	http://dx.doi.org/10.1056/NEJMp1112633			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857PQ	22040167				2022-12-24	WOS:000297731400013
J	Xu, J; Peng, C; Sankaran, VG; Shao, Z; Esrick, EB; Chong, BG; Ippolito, GC; Fujiwara, Y; Ebert, BL; Tucker, PW; Orkin, SH				Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Ippolito, Gregory C.; Fujiwara, Yuko; Ebert, Benjamin L.; Tucker, Philip W.; Orkin, Stuart H.			Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing	SCIENCE			English	Article							MOUSE MODEL; GAMMA-GLOBIN; BCL11A; BETA; HAEMOGLOBIN; THALASSEMIA; FAMILIES; THERAPY	Persistence of human fetal hemoglobin (HbF, alpha(2)gamma(2)) in adults lessens the severity of sickle cell disease (SCD) and the beta-thalassemias. Here, we show that the repressor BCL11A is required in vivo for silencing of gamma-globin expression in adult animals, yet dispensable for red cell production. BCL11A serves as a barrier to HbF reactivation by known HbF inducing agents. In a proof-of-principle test of BCL11A as a potential therapeutic target, we demonstrate that inactivation of BCL11A in SCD transgenic mice corrects the hematologic and pathologic defects associated with SCD through high-level pancellular HbF induction. Thus, interference with HbF silencing by manipulation of a single target protein is sufficient to reverse SCD.	[Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Fujiwara, Yuko; Orkin, Stuart H.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Fujiwara, Yuko; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Xu, Jian; Peng, Cong; Sankaran, Vijay G.; Shao, Zhen; Esrick, Erica B.; Chong, Bryan G.; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Xu, Jian; Fujiwara, Yuko; Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Esrick, Erica B.; Ebert, Benjamin L.] Harvard Univ, Dana Farber Canc Inst, Brigham & Womens Hosp, Harvard Stem Cell Inst,Med Sch, Boston, MA 02115 USA; [Ippolito, Gregory C.; Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Sankaran, Vijay G.] Broad Inst, Cambridge, MA 02142 USA; [Sankaran, Vijay G.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; University of Texas Austin; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	Peng, Cong/H-2286-2011; Ippolito, Gregory C./AAR-2930-2021	Ippolito, Gregory C./0000-0002-7565-7002; Shao, Zhen/0000-0002-4934-4360	NIH; National Cancer Institute (NCI); Marie Betzner Morrow Endowment; National Institute of Diabetes and Digestive and Kidney Diseases; National Research Service Award/NCI; NATIONAL CANCER INSTITUTE [T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK093543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Marie Betzner Morrow Endowment; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Research Service Award/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank K. Peterson and H. Fedosyuk for beta-locus mice, K. Gaensler and M. Groudine for the A20 strain of beta-locus mice, T. M. Townes for the SCD mice, and M. Nguyen, R. Okabe, and J. Alves for technical assistance. We thank D. Higgs, D. A. Williams, L. I. Zon, D. E. Bauer, H. F. Xie, M. Kerenyi, T. Menne, J. Harriss, and J. Decker for advice and discussions. This work was supported by funding from NIH (S.H.O. and B. L. E.); the National Cancer Institute (NCI) and the Marie Betzner Morrow Endowment (P. W. T.); and a Center Award from the National Institute of Diabetes and Digestive and Kidney Diseases (S.H.O.). G. C. I. was supported by a National Research Service Award/NCI postdoctoral fellowship, and J. X. is a Howard Hughes Medical Institute-Helen Hay Whitney Foundation fellow. The authors declare no conflict of interest.	Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; CONLEY CL, 1963, BLOOD, V21, P261, DOI 10.1182/blood.V21.3.261.261; DESIMONE J, 1982, P NATL ACAD SCI-BIOL, V79, P4428, DOI 10.1073/pnas.79.14.4428; Dykxhoorn DM, 2006, CELL, V126, P231, DOI 10.1016/j.cell.2006.07.007; Fabry ME, 2001, BLOOD, V97, P410, DOI 10.1182/blood.V97.2.410; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Herrick J.B., 1910, ARCH INTERN MED, V6, P517; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Koehler AN, 2010, CURR OPIN CHEM BIOL, V14, P331, DOI 10.1016/j.cbpa.2010.03.022; KRAUS AP, 1961, BRIT MED J, V1, P1434, DOI 10.1136/bmj.1.5237.1434; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; LEY TJ, 1982, NEW ENGL J MED, V307, P1469, DOI 10.1056/NEJM198212093072401; Li CW, 2011, P NATL ACAD SCI USA, V108, P14258, DOI 10.1073/pnas.1109522108; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Pawliuk R, 2001, SCIENCE, V294, P2368, DOI 10.1126/science.1065806; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shaw KL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002594; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; Wilber A, 2011, BLOOD, V117, P3945, DOI 10.1182/blood-2010-11-316893; Wilber A, 2011, BLOOD, V117, P2817, DOI 10.1182/blood-2010-08-300723; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310	29	228	241	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					993	996		10.1126/science.1211053	http://dx.doi.org/10.1126/science.1211053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	21998251	Green Accepted			2022-12-24	WOS:000297101800060
J	Chang, HJ; Liang, MH				Chang, Huan J.; Liang, Matthew H.			The Quiet Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Liang, Matthew H.] Brigham & Womens Hosp, Rheumatol Sect, Boston VA Healthcare Syst, Rehabil Serv, Boston, MA 02115 USA; [Liang, Matthew H.] Brigham & Womens Hosp, Rheumatol Sect, Boston VA Healthcare Syst, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System		tina.chang@jama-archives.org						Lansdale TF, 2008, CLEV CLIN J MED, V75, P618, DOI 10.3949/ccjm.75.9.618	1	1	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1843	1844		10.1001/jama.2011.1587	http://dx.doi.org/10.1001/jama.2011.1587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	22045757				2022-12-24	WOS:000296376200001
J	Suter, LG; Paltiel, AD; Rome, BN; Solomon, DH; Golovaty, I; Gerlovin, H; Katz, JN; Losina, E				Suter, Lisa G.; Paltiel, A. David; Rome, Benjamin N.; Solomon, Daniel H.; Golovaty, Ilya; Gerlovin, Hanna; Katz, Jeffrey N.; Losina, Elena			Medical Device Innovation - Is "Better" Good Enough?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							UNITED-STATES		[Suter, Lisa G.] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Paltiel, A. David] Yale Univ, Sch Publ Hlth, New Haven, CT USA; [Suter, Lisa G.] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA; [Rome, Benjamin N.; Solomon, Daniel H.; Golovaty, Ilya; Gerlovin, Hanna; Katz, Jeffrey N.; Losina, Elena] Brigham & Womens Hosp, Boston, MA 02115 USA; [Solomon, Daniel H.; Losina, Elena] Harvard Univ, Sch Med, Boston, MA USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Boston, MA USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Suter, LG (corresponding author), Yale Univ, Sch Med, New Haven, CT 06520 USA.		Rome, Benjamin/I-4251-2012	Paltiel, A. David/0000-0002-4861-3290; Gerlovin, Hanna/0000-0002-6700-2129; Rome, Benjamin/0000-0001-5776-3293; Losina, ELENA/0000-0002-3424-0892	NIAMS NIH HHS [R01 AR053112, K24 AR057827] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053112, K24AR057827] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Institute of Medicine, 2011, MED DEV PUBL HLTH FD; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Losina E, 2011, ANN INTERN MED, V154, P217, DOI 10.7326/0003-4819-154-4-201102150-00001; OKEEFFE K, 2011, MED DEVICE DIAGNOSTI; Paxton EW, 2010, J BONE JOINT SURG AM, V92A, P117, DOI 10.2106/JBJS.J.00807	5	14	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2011	365	16					1464	1466		10.1056/NEJMp1109285	http://dx.doi.org/10.1056/NEJMp1109285			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835BW	22010911	Green Accepted			2022-12-24	WOS:000296009500013
J	Matos, J; Blanco, MG; Maslen, S; Skehel, JM; West, SC				Matos, Joao; Blanco, Miguel G.; Maslen, Sarah; Skehel, J. Mark; West, Stephen C.			Regulatory Control of the Resolution of DNA Recombination Intermediates during Meiosis and Mitosis	CELL			English	Article							HOLLIDAY JUNCTION RESOLUTION; DOUBLE-STRAND BREAK; MEIOTIC RECOMBINATION; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; KINASE CDC5; FUNCTIONAL OVERLAP; JOINT MOLECULES; ENDONUCLEASE	The efficient and timely resolution of DNA recombination intermediates is essential for bipolar chromosome segregation. Here, we show that the specialized chromosome segregation patterns of meiosis and mitosis, which require the coordination of recombination with cell-cycle progression, are achieved by regulating the timing of activation of two crossover-promoting endonucleases. In yeast meiosis, Mus81-Mms4 and Yen1 are controlled by phosphorylation events that lead to their sequential activation. Mus81-Mms4 is hyperactivated by Cdc5-mediated phosphorylation in meiosis I, generating the crossovers necessary for chromosome segregation. Yen1 is also tightly regulated and is activated in meiosis II to resolve persistent Holliday junctions. In yeast and human mitotic cells, a similar regulatory network restrains these nuclease activities until mitosis, biasing the outcome of recombination toward noncrossover products while also ensuring the elimination of any persistent joint molecules. Mitotic regulation thereby facilitates chromosome segregation while limiting the potential for loss of heterozygosity and sister-chromatid exchanges.	[Matos, Joao; Blanco, Miguel G.; Maslen, Sarah; Skehel, J. Mark; West, Stephen C.] Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England	Cancer Research UK	West, SC (corresponding author), Canc Res UK, Clare Hall Labs, London Res Inst, S Mimms EN6 3LD, Herts, England.	stephen.west@cancer.org.uk	Blanco, Miguel González/R-5754-2017; Matos, Joao/C-1488-2014; Blanco, Miguel González/J-6424-2012	Blanco, Miguel González/0000-0002-2883-7326; Matos, Joao/0000-0002-3754-3709; Blanco, Miguel González/0000-0002-2883-7326; West, Stephen/0000-0001-8848-9418	Cancer Research UK; European Research Council; Louis-Jeantet Foundation; Swiss Bridge Foundation; Breast Cancer Campaign; Human Frontiers Science Program long-term Fellowship; Xunta de Galicia (Spain); Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); Louis-Jeantet Foundation; Swiss Bridge Foundation; Breast Cancer Campaign; Human Frontiers Science Program long-term Fellowship; Xunta de Galicia (Spain)(Xunta de Galicia); Cancer Research UK(Cancer Research UK)	We thank Wolfgang Zachariae and Nancy Kleckner for strains and plasmids, Tony Hyman for the BAC tagging cassettes, Keun Kim for help with the physical analysis of recombination, and members of our laboratory for comments and criticisms. This work was supported by Cancer Research UK, the European Research Council, the Louis-Jeantet Foundation, the Swiss Bridge Foundation, and the Breast Cancer Campaign. J.M. was a recipient of a Human Frontiers Science Program long-term Fellowship, and M. G. B. by the Angeles Alvarino program of the Xunta de Galicia (Spain).	Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; de los Santos T, 2003, GENETICS, V164, P81; de los Santos T, 2001, GENETICS, V159, P1511; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Fu Y, 2003, DNA REPAIR, V2, P1435, DOI 10.1016/j.dnarep.2003.08.013; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Haber JE, 2001, CELL, V107, P551, DOI 10.1016/S0092-8674(01)00593-1; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Mullen JR, 2001, GENETICS, V157, P103; Niu HY, 2005, MOL BIOL CELL, V16, P5804, DOI 10.1091/mbc.E05-05-0465; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Petronczki M, 2006, CELL, V126, P1049, DOI 10.1016/j.cell.2006.07.029; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Schoffski P, 2009, ONCOLOGIST, V14, P559, DOI 10.1634/theoncologist.2009-0010; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253	40	212	213	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					158	172		10.1016/j.cell.2011.08.032	http://dx.doi.org/10.1016/j.cell.2011.08.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962513	Bronze, Green Accepted			2022-12-24	WOS:000295396700023
J	Knutson, BA; Hahn, S				Knutson, Bruce A.; Hahn, Steven			Yeast Rrn7 and Human TAF1B Are TFIIB-Related RNA Polymerase I General Transcription Factors	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; RDNA TRANSCRIPTION; INITIATION-FACTOR; BDP1 SUBUNITS; COMPLEX; BINDING; PROTEIN; SL1; TBP; RECRUITMENT	Eukaryotic and archaeal multisubunit RNA polymerases (Pols) are structurally related and require several similar components for transcription initiation. However, none of the Pol I factors were known to share homology with transcription factor IIB (TFIIB) or TFIIB-related proteins, key factors in the initiation mechanisms of the other Pols. Here we show that Rrn7, a subunit of the yeast Pol I core factor, and its human ortholog TAF1B are TFIIB-like factors. Although distantly related, Rrn7 shares many activities associated with TFIIB-like factors. Domain swaps between TFIIB-related factors show that Rrn7 is most closely related to the Pol III general factor Brf1. Our results point to the conservation of initiation mechanisms among multisubunit Pols and reveal a key function of yeast core factor/human SL1 in Pol I transcription.	[Knutson, Bruce A.; Hahn, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Hahn, S (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N,POB 19024,Mailstop A1-162, Seattle, WA 98109 USA.	shahn@fhcrc.org			NIH [GM053451, T32 CA09657]; NATIONAL CANCER INSTITUTE [T32CA009657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053451] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Moorefield for yeast strains and plasmids, J. Zomerdijk for comments and sharing results, and members of the Hahn laboratory, B. Moorefield, and E. Young for their comments and encouragement. Supported by NIH grants GM053451 (to S. H.) and T32 CA09657 (to B.A.K.).	Aprikian P, 2001, MOL CELL BIOL, V21, P4847, DOI 10.1128/MCB.21.15.4847-4855.2001; Boukhgalter B, 2002, GENE, V291, P187, DOI 10.1016/S0378-1119(02)00597-8; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Carter R, 2009, MOL BIOL EVOL, V26, P2515, DOI 10.1093/molbev/msp164; Cavel E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017216; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Friedrich JK, 2005, J BIOL CHEM, V280, P29551, DOI 10.1074/jbc.M501595200; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hahn S, 2009, NATURE, V462, P292, DOI 10.1038/462292a; Imamura S, 2008, EMBO J, V27, P2317, DOI 10.1038/emboj.2008.151; Kassavetis GA, 2006, J BIOL CHEM, V281, P14321, DOI 10.1074/jbc.M601702200; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; Lalo D, 1996, J BIOL CHEM, V271, P21062, DOI 10.1074/jbc.271.35.21062; Liao YL, 2003, J BIOL CHEM, V278, P44467, DOI 10.1074/jbc.M308354200; Lin CW, 1996, MOL CELL BIOL, V16, P6436; Liu X, 2010, SCIENCE, V327, P206, DOI 10.1126/science.1182015; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steffan JS, 1996, GENE DEV, V10, P2551, DOI 10.1101/gad.10.20.2551; ZOMERDIJK JCBM, 1994, SCIENCE, V266, P2015, DOI 10.1126/science.7801130	23	50	52	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 16	2011	333	6049					1637	1640		10.1126/science.1207699	http://dx.doi.org/10.1126/science.1207699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921198	Green Accepted			2022-12-24	WOS:000294900900045
J	Fricke, HC; Hencecroth, J; Hoerner, ME				Fricke, Henry C.; Hencecroth, Justin; Hoerner, Marie E.			Lowland-upland migration of sauropod dinosaurs during the Late Jurassic epoch	NATURE			English	Article							ISOTOPE COMPOSITIONS; HYDROGEN ISOTOPES; OXYGEN; ENAMEL	Sauropod dinosaurs were the largest vertebrates ever to walk the Earth, and as mega-herbivores they were important parts of terrestrial ecosystems. In the Late Jurassic-aged Morrison depositional basin of western North America, these animals occupied lowland river-floodplain settings characterized by a seasonally dry climate(1,2). Massive herbivores with high nutritional and water needs could periodically experience nutritional and water stress under these conditions, and thus the common occurrence of sauropods in this basin has remained a paradox. Energetic arguments and mammalian analogues have been used to suggest that migration allowed sauropods access to food and water resources over a wide region or during times of drought or both(3,4), but there has been no direct support for these hypotheses. Here we compare oxygen isotope ratios (delta O-18) of tooth-enamel carbonate from the sauropod Camarasaurus with those of ancient soil, lake and wetland (that is, 'authigenic') carbonates that formed in lowland settings. We demonstrate that certain populations of these animals did in fact undertake seasonal migrations of several hundred kilometres from lowland to upland environments. This ability to describe patterns of sauropod movement will help to elucidate the role that migration played in the ecology and evolution of gigantism of these and associated dinosaurs.	[Fricke, Henry C.; Hencecroth, Justin; Hoerner, Marie E.] Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA	Colorado College	Fricke, HC (corresponding author), Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA.	hfricke@coloradocollege.edu			National Science Foundation [EAR-0319041, EAR 0923831]; Colorado College	National Science Foundation(National Science Foundation (NSF)); Colorado College	We thank S. Hartman, D. Lovelace and D. Chure for providing context and fossil specimens. The research was funded in part by National Science Foundation EAR-0319041 and Colorado College. We thank G. Olack and A. Colman for the phosphate oxygen isotope analyses, supported by National Science Foundation Major Research Instrumentation award EAR 0923831.	Amiot R, 2004, EARTH PLANET SC LETT, V226, P255, DOI 10.1016/j.epsl.2004.07.015; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; DODSON P, 1980, PALEOBIOLOGY, V6, P6, DOI 10.1017/S0094837300012446; Dunagan SP, 2004, SEDIMENT GEOL, V167, P269, DOI 10.1016/j.sedgeo.2004.01.007; Engelmann GF, 2004, SEDIMENT GEOL, V167, P297, DOI 10.1016/j.sedgeo.2004.01.008; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Fallin M. J., 2005, THESIS U COLORADO BO; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Jennings DS, 2011, SEDIMENT GEOL, V238, P23, DOI 10.1016/j.sedgeo.2011.03.005; Kohn MJ, 2002, REV MINERAL GEOCHEM, V48, P455, DOI 10.2138/rmg.2002.48.12; Kohn MJ, 1998, CHEM GEOL, V152, P97, DOI 10.1016/S0009-2541(98)00099-0; Lovelace D, 2006, PALEONTOLOGY GEOLOGY, V36, P47; Parrish JT, 2004, SEDIMENT GEOL, V167, P137, DOI 10.1016/j.sedgeo.2004.01.004; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Rees P. M., 2003, INWARM CLIMATES EART, P297; Sellwood BW, 2008, P GEOLOGIST ASSOC, V119, P5, DOI 10.1016/S0016-7878(59)80068-7; Thomas KJS, 2004, PALAEOGEOGR PALAEOCL, V206, P257, DOI 10.1016/j.palaeo.2004.01.007; Turner CE, 2004, SEDIMENT GEOL, V167, P309, DOI 10.1016/j.sedgeo.2004.01.009	19	30	31	2	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					513	515		10.1038/nature10570	http://dx.doi.org/10.1038/nature10570			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22031326				2022-12-24	WOS:000298318000058
J	Nomura, DK; Morrison, BE; Blankman, JL; Long, JZ; Kinsey, SG; Marcondes, MCG; Ward, AM; Hahn, YK; Lichtman, AH; Conti, B; Cravatt, BF				Nomura, Daniel K.; Morrison, Bradley E.; Blankman, Jacqueline L.; Long, Jonathan Z.; Kinsey, Steven G.; Marcondes, Maria Cecilia G.; Ward, Anna M.; Hahn, Yun Kyung; Lichtman, Aron H.; Conti, Bruno; Cravatt, Benjamin F.			Endocannabinoid Hydrolysis Generates Brain Prostaglandins That Promote Neuroinflammation	SCIENCE			English	Article							MOUSE MODEL; PARKINSONS-DISEASE; PHOSPHOLIPASE A(2); MICE; INHIBITION; CYCLOOXYGENASE-2; INFLAMMATION; SYSTEM; INJURY; LIPOPOLYSACCHARIDE	Phospholipase A(2)(PLA(2)) enzymes are considered the primary source of arachidonic acid for cyclooxygenase (COX)-mediated biosynthesis of prostaglandins. Here, we show that a distinct pathway exists in brain, where monoacylglycerol lipase (MAGL) hydrolyzes the endocannabinoid 2-arachidonoylglycerol to generate a major arachidonate precursor pool for neuroinflammatory prostaglandins. MAGL-disrupted animals show neuroprotection in a parkinsonian mouse model. These animals are spared the hemorrhaging caused by COX inhibitors in the gut, where prostaglandins are instead regulated by cytosolic PLA(2). These findings identify MAGL as a distinct metabolic node that couples endocannabinoid to prostaglandin signaling networks in the nervous system and suggest that inhibition of this enzyme may be a new and potentially safer way to suppress the proinflammatory cascades that underlie neurodegenerative disorders.	[Nomura, Daniel K.; Blankman, Jacqueline L.; Long, Jonathan Z.; Ward, Anna M.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Nomura, Daniel K.; Blankman, Jacqueline L.; Long, Jonathan Z.; Ward, Anna M.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Program Metab Biol, Berkeley, CA 94720 USA; [Morrison, Bradley E.; Marcondes, Maria Cecilia G.; Conti, Bruno] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA; [Kinsey, Steven G.] W Virginia Univ, Dept Psychol, Morgantown, WV 26506 USA; [Hahn, Yun Kyung; Lichtman, Aron H.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California Berkeley; Scripps Research Institute; West Virginia University; Virginia Commonwealth University	Nomura, DK (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dnomura@berkeley.edu; cravatt@scripps.edu		Morrison, Brad/0000-0002-6356-7149; Long, Jonathan/0000-0003-2631-7463; Conti, Bruno/0000-0002-9185-5201	NIH [DA017259, K99DA030908, R00DA030908, 5P01DA009789, P01DA01725, AG028040, R03DA027936, DA026261, T32DA007027]; Institute for Drug and Alcohol Studies at Virginia Commonwealth University; Ellison Medical Foundation; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON AGING [R01AG028040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F31DA026261, P01DA017259, K99DA030908, T32DA007027, R03DA027936, P01DA009789, R00DA030908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Drug and Alcohol Studies at Virginia Commonwealth University; Ellison Medical Foundation(Lawrence Ellison Foundation); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the members of the Cravatt laboratory for helpful discussion and critical reading of the manuscript. This work was supported by the NIH (DA017259 (B.F.C.), K99DA030908, R00DA030908 (D.K.N.), 5P01DA009789 and P01DA01725 (A.H.L.), AG028040 (B.C. and B.E.M.), R03DA027936 (M.C.G.M.), DA026261 (J.L.B.), and T32DA007027 (S.G.K.); Institute for Drug and Alcohol Studies at Virginia Commonwealth University; the Ellison Medical Foundation; and the Skaggs Institute for Chemical Biology. A patent has been filed (U.S. Patent Application no. 12/998,642) "Methods and compositions related to targeting monoacylglycerol lipase," which relates to inhibitors of monoacylglycerol lipase and associated methods, compositions, and potential uses for treating human disorders that are associated with endocannabinoid signaling. Authors who are listed inventors are J.Z.L., D.K.N, and B.F.C. The data reported in this paper are tabulated in the main text and supporting online material. Author contributions: D.K.N. and B.F.C. wrote the paper; D.K.N., B.E.M., J.L.B., S.G.K., M.C.G.M., and A.M.W. performed experiments; J.Z.L. provided reagents; and D.K.N., B.F.C., B.C., and A.H. conceived and planned experiments.	Aid S, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-17; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Carrasco E, 2007, J NEUROSCI RES, V85, P3109, DOI 10.1002/jnr.21425; Choi SH, 2008, FASEB J, V22, P1491, DOI 10.1096/fj.07-9411com; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Farias SE, 2008, J LIPID RES, V49, P1990, DOI 10.1194/jlr.M800200-JLR200; Garcia-Bueno B, 2009, J NEUROSCI, V29, P12970, DOI 10.1523/JNEUROSCI.2373-09.2009; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Golovko MY, 2008, J LIPID RES, V49, P893, DOI 10.1194/jlr.D700030-JLR200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Kinsey SG, 2011, J PHARMACOL EXP THER, V338, P795, DOI 10.1124/jpet.110.175778; Lambeau G, 2008, ANNU REV BIOCHEM, V77, P495, DOI 10.1146/annurev.biochem.76.062405.154007; Lambert DM, 2005, J MED CHEM, V48, P5059, DOI 10.1021/jm058183t; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Ng SC, 2010, CURR OPIN GASTROEN, V26, P611, DOI 10.1097/MOG.0b013e32833e91eb; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Rosenberger TA, 2003, J LIPID RES, V44, P109, DOI 10.1194/jlr.M200298-JLR200; Rouzer CA, 2009, J LIPID RES, V50, pS29, DOI 10.1194/jlr.R800042-JLR200; Sanchez-Mejia RO, 2008, NAT NEUROSCI, V11, P1311, DOI 10.1038/nn.2213; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100	29	488	522	1	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					809	813		10.1126/science.1209200	http://dx.doi.org/10.1126/science.1209200			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22021672	Green Accepted			2022-12-24	WOS:000296849600048
J	Deer, B				Deer, Brian			MORE SECRETS OF THE MMR SCARE Pathology reports solve "new bowel disease" riddle	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RETRACTED ARTICLE. SEE; AUTISTIC ENTEROCOLITIS; NONSPECIFIC COLITIS; BIOPSY DIAGNOSIS; DISORDERS; CHILDREN; VACCINE											BARTRAM CI, 1994, BAILLIERE CLIN GASTR, V8, P101, DOI 10.1016/S0950-3528(06)80021-7; BEATTIE RM, 1995, ARCH DIS CHILD, V73, P354, DOI 10.1136/adc.73.4.354; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Carpenter HA, 2000, AM J GASTROENTEROL, V95, P878; Davies SE, 2010, BMJ; Deer B, TABULATION PATHOLOGY; Deer Brian, 2011, BMJ, V342, pc5347, DOI 10.1136/bmj.c5347; Deer B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1127; Dhillon A, 2007, HISTOPATHOLOGY, V50, P794, DOI 10.1111/j.1365-2559.2007.02668.x; Eisenberg RL, 2003, GASTROINTESTINAL PAT; Fiocchi C, 2003, INFLAMMATORY BOWEL D; Godlee Fiona, 2011, BMJ, V342, pc7452, DOI 10.1136/bmj.c7452; Jenkins D, 1997, J CLIN PATHOL, V50, P93, DOI 10.1136/jcp.50.2.93; LEVINE DS, 1989, AM J SURG PATHOL, V13, P966, DOI 10.1097/00000478-198911000-00008; MacDonald TT, 2007, HISTOPATHOLOGY, V50, P371, DOI 10.1111/j.1365-2559.2007.02606.x; Mantzaris GJ, 2005, ANN GASTROENTEROL, V18, P116; Molavi DW., 2008, PRACTICE SURG PATHOL; Montgomery EA, 2006, BIOPSY INT, P1; Murch S, 1998, LANCET, V351, P908, DOI 10.1016/S0140-6736(05)70323-8; Paski SC, 2007, AM J GASTROENTEROL, V102, P2294, DOI 10.1111/j.1572-0241.2007.01389.x; Tsang P, 1999, AM J SURG PATHOL, V23, P423, DOI 10.1097/00000478-199904000-00006; Villanacci V, 2007, DIGEST DIS SCI, V52, P321, DOI 10.1007/s10620-006-9476-7; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 1998, LANCET, V351, P908, DOI 10.1016/S0140-6736(05)70322-6; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285; Wakefield AJ, 1999, DEV DISORDERS CHILDR; Wakefield Andrew Jeremy, 2010, DETERMINATION SERIOU; Walker-Smith JA, 1983, PRACTICAL PAEDIAT GA; WILLIAMS CB, 1994, BAILLIERE CLIN GASTR, V8, P121, DOI 10.1016/S0950-3528(06)80022-9	29	6	6	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2011	343								d6823	10.1136/bmj.d6823	http://dx.doi.org/10.1136/bmj.d6823			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	848NP	22077090	Bronze			2022-12-24	WOS:000297058600011
J	Oricchio, E; Nanjangud, G; Wolfe, AL; Schatz, JH; Mavrakis, KJ; Jiang, M; Liu, XP; Bruno, J; Heguy, A; Olshen, AB; Socci, ND; Teruya-Feldstein, J; Weis-Garcia, F; Tam, W; Shaknovich, R; Melnick, A; Himanen, JP; Chaganti, RSK; Wendel, HG				Oricchio, Elisa; Nanjangud, Gouri; Wolfe, Andrew L.; Schatz, Jonathan H.; Mavrakis, Konstantinos J.; Jiang, Man; Liu, Xiaoping; Bruno, Joanne; Heguy, Adriana; Olshen, Adam B.; Socci, Nicholas D.; Teruya-Feldstein, Julie; Weis-Garcia, Frances; Tam, Wayne; Shaknovich, Rita; Melnick, Ari; Himanen, Juha P.; Chaganti, R. S. K.; Wendel, Hans-Guido			The Eph-Receptor A7 Is a Soluble Tumor Suppressor for Follicular Lymphoma	CELL			English	Article							NF-KAPPA-B; NON-HODGKIN-LYMPHOMA; SOMATIC MUTATIONS; P53 RESTORATION; TNFAIP3 A20; CELL; GENE; DELETIONS; INTERFERENCE; INACTIVATION	Insights into cancer genetics can lead to therapeutic opportunities. By cross-referencing chromosomal changes with an unbiased genetic screen we identify the ephrin receptor A7 (EPHA7) as a tumor suppressor in follicular lymphoma (FL). EPHA7 is a target of 6q deletions and inactivated in 72% of FLs. Knockdown of EPHA7 drives lymphoma development in a murine FL model. In analogy to its physiological function in brain development, a soluble splice variant of EPHA7 (EPHA7 TR) interferes with another Eph-receptor and blocks oncogenic signals in lymphoma cells. Consistent with this drug-like activity, administration of the purified EPHA7(TR) protein produces antitumor effects against xenografted human lymphomas. Further, by fusing EPHA7(TR) to the anti-CD20 antibody (rituximab) we can directly target this tumor suppressor to lymphomas in vivo. Our study attests to the power of combining descriptive tumor genomics with functional screens and reveals EPHA7 TR as tumor suppressor with immediate therapeutic potential.	[Oricchio, Elisa; Wolfe, Andrew L.; Schatz, Jonathan H.; Mavrakis, Konstantinos J.; Jiang, Man; Liu, Xiaoping; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Nanjangud, Gouri; Chaganti, R. S. K.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Wolfe, Andrew L.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Schatz, Jonathan H.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Schatz, Jonathan H.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Bruno, Joanne] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY 10065 USA; [Heguy, Adriana] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Olshen, Adam B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Weis-Garcia, Frances] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA; [Tam, Wayne] Weill Cornell Grad Sch Med Sci, Dept Pathol & Lab Med, New York, NY 10065 USA; [Shaknovich, Rita; Melnick, Ari] Weill Cornell Med Coll, Div Hematol Oncol, New York, NY 10065 USA; [Himanen, Juha P.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Memorial Sloan Kettering Cancer Center	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	wendelh@mskcc.org	Heguy, Adriana/GPP-3907-2022; Melnick, Ari/AAA-5763-2020	Schatz, Jonathan/0000-0003-1842-228X; Oricchio, Elisa/0000-0002-1690-0447; Wolfe, Andrew/0000-0003-0418-716X	NCI [R01-CA142798-01, R01 CA104348]; AIDS Malignancy Consortium (AMC); Leukemia Research Foundation; Louis V. Gerstner Foundation; WLBH Foundation; Society of MSKCC; Starr Cancer Consortium [I4-A410]; NIH MSTP [GM07739, NIH-K08 CA127353]; ASCO Cancer Foundation; LLS TRP; LLS SCOR [S 7032-04]; LLS scholar; Burroughs Wellcome Clinical Translational Scientist; Cancer Center [P30-CA008748]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [K08CA127353, R01CA142798, P30CA008748, R01CA104348] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AIDS Malignancy Consortium (AMC); Leukemia Research Foundation; Louis V. Gerstner Foundation; WLBH Foundation; Society of MSKCC; Starr Cancer Consortium; NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASCO Cancer Foundation; LLS TRP; LLS SCOR; LLS scholar; Burroughs Wellcome Clinical Translational Scientist; Cancer Center; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Pasqualucci, E. Papapetrou, S. L. Morrison, and M. Teitell for reagents; several MSK core facilities, including the Research Animal Facility, A. Viale of the Genomics Core, Elisa deStanchina of the Antitumor Assessment Core, A. Lash of the Computational Biology Core, Katy Huberman of the Geoffrey Beene Translational Oncology Core Facility, Aleksey V. Kamenshchikov of the Monoclonal Antibody Core Facility, and Irina Linkov of the Pathology Core. This work is supported by grants from the NCI (R01-CA142798-01), a P30 supplemental award from the NCI and the AIDS Malignancy Consortium (AMC) (H.G.-W.), the Leukemia Research Foundation (H.G.-W.), the Louis V. Gerstner Foundation (H.G.-W.), the WLBH Foundation (H.G.-W.), the Society of MSKCC (H.G.-W.), the Starr Cancer Consortium grant I4-A410 (H.G.-W. and J.H.), NIH MSTP grant GM07739 (J.B.), NIH-K08 CA127353 (R. S), the ASCO Cancer Foundation (J.H. S.), LLS TRP (R. S.), LLS SCOR S 7032-04 (A. M.), NCI R01 CA104348 (A. M.) LLS scholar (A. M.), Burroughs Wellcome Clinical Translational Scientist (A. M.), Cancer Center Support Grant P30-CA008748 (F. W.-G.) and a SCOR grant from The Leukemia and Lymphoma Society (R. S. K. C.).	Barr PM, 2008, CURR OPIN ONCOL, V20, P502, DOI 10.1097/CCO.0b013e32830b61ac; Bende RJ, 2007, LEUKEMIA, V21, P18, DOI 10.1038/sj.leu.2404426; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Calado DP, 2010, CANCER CELL, V18, P580, DOI 10.1016/j.ccr.2010.11.024; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dawson DW, 2007, ONCOGENE, V26, P4243, DOI 10.1038/sj.onc.1210211; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Egle A, 2004, BLOOD, V103, P2276, DOI 10.1182/blood-2003-07-2469; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; GAIDANO G, 1992, BLOOD, V80, P1781, DOI 10.1182/blood.V80.7.1781.bloodjournal8071781; Hauptschein RS, 1998, GENOMICS, V50, P170, DOI 10.1006/geno.1998.5321; Heyer J, 2010, NAT REV CANCER, V10, P470, DOI 10.1038/nrc2877; Himanen JP, 2010, P NATL ACAD SCI USA, V107, P10860, DOI 10.1073/pnas.1004148107; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kuang SQ, 2010, BLOOD, V115, P2412, DOI 10.1182/blood-2009-05-222208; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Maloney David G, 2003, Curr Hematol Rep, V2, P13; Mandelbaum J, 2010, CANCER CELL, V18, P568, DOI 10.1016/j.ccr.2010.10.030; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Nanjangud G, 2007, CYTOGENET GENOME RES, V118, P337, DOI 10.1159/000108318; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; OFFIT K, 1993, BLOOD, V82, P2157; Oricchio E, 2010, DIS MODEL MECH, V3, P701, DOI 10.1242/dmm.006296; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Pasqualucci L, 2006, J EXP MED, V203, P311, DOI 10.1084/jem.20052204; Relander T, 2010, J CLIN ONCOL, V28, P2902, DOI 10.1200/JCO.2009.26.1693; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Smith FM, 2004, J BIOL CHEM, V279, P9522, DOI 10.1074/jbc.M309326200; VALENZUELA DM, 1995, ONCOGENE, V10, P1573; Velculescu VE, 2008, CARCINOGENESIS, V29, P1087, DOI 10.1093/carcin/bgn096; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viardot A, 2002, J CLIN ONCOL, V20, P4523, DOI 10.1200/JCO.2002.12.006; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061	48	132	148	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					554	564		10.1016/j.cell.2011.09.035	http://dx.doi.org/10.1016/j.cell.2011.09.035			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036564	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000296573700011
J	Ettinger, WH				Ettinger, Walter H.			Can Hospitalization-Associated Disability Be Prevented?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ettinger, Walter H.] Univ Massachusetts, Med Ctr, Sch Med, Div Geriatr Med,Dept Med, Worcester, MA 01655 USA; [Ettinger, Walter H.] Univ Massachusetts, Med Ctr, UMass Mem Med Ctr, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Ettinger, WH (corresponding author), 55 N Lake Ave, Worcester, MA 01655 USA.	walter.ettinger@umassmemorial.org						[Anonymous], FED REG; Baztan JJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b50; Covinsky KE, 2011, JAMA-J AM MED ASSOC, V306, P1782, DOI 10.1001/jama.2011.1556; Department of Health and Human Services Office of Inspector General, 2010, OEI060900090 DEP HLT; Dykes PC, 2010, JAMA-J AM MED ASSOC, V304, P1912, DOI 10.1001/jama.2010.1567; Fryback DG, 2010, MEASURING HLTH RELAT; Gill TM, 2010, JAMA-J AM MED ASSOC, V304, P1919, DOI 10.1001/jama.2010.1568; Massachusetts Hospital Association, 2011, SUMM TRENDS SEL NURS; Mehta KM, 2011, J AM GERIATR SOC, V59, P1206, DOI 10.1111/j.1532-5415.2011.03409.x	9	18	18	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 26	2011	306	16					1800	1801		10.1001/jama.2011.1563	http://dx.doi.org/10.1001/jama.2011.1563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	837HH	22028358				2022-12-24	WOS:000296181600027
J	Inoue, A; Zhang, Y				Inoue, Azusa; Zhang, Yi			Replication-Dependent Loss of 5-Hydroxymethylcytosine in Mouse Preimplantation Embryos	SCIENCE			English	Article							ACTIVE DNA DEMETHYLATION; PATERNAL GENOME; MAMMALIAN DNA; TET PROTEINS; 5-METHYLCYTOSINE; 5-CARBOXYLCYTOSINE; CONVERSION		[Inoue, Azusa; Zhang, Yi] Univ N Carolina, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Inoue, Azusa; Zhang, Yi] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zhang, Y (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811	HHMI; NIH [GM68804]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Wu for critical reading of the manuscript. This work was supported by HHMI and NIH (GM68804). Y.Z. is an Investigator of HHMI.	Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950	9	368	386	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					194	194		10.1126/science.1212483	http://dx.doi.org/10.1126/science.1212483			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21940858	Green Accepted, Green Submitted			2022-12-24	WOS:000295833600037
J	Kuss, SK; Best, GT; Etheredge, CA; Pruijssers, AJ; Frierson, JM; Hooper, LV; Dermody, TS; Pfeiffer, JK				Kuss, Sharon K.; Best, Gavin T.; Etheredge, Chris A.; Pruijssers, Andrea J.; Frierson, Johnna M.; Hooper, Lora V.; Dermody, Terence S.; Pfeiffer, Julie K.			Intestinal Microbiota Promote Enteric Virus Replication and Systemic Pathogenesis	SCIENCE			English	Article							HUMAN POLIOVIRUS RECEPTOR; TRANSGENIC MICE	Intestinal bacteria aid host health and limit bacterial pathogen colonization. However, the influence of bacteria on enteric viruses is largely unknown. We depleted the intestinal microbiota of mice with antibiotics before inoculation with poliovirus, an enteric virus. Antibiotic-treated mice were less susceptible to poliovirus disease and supported minimal viral replication in the intestine. Exposure to bacteria or their N-acetylglucosamine-containing surface polysaccharides, including lipopolysaccharide and peptidoglycan, enhanced poliovirus infectivity. We found that poliovirus binds lipopolysaccharide, and exposure of poliovirus to bacteria enhanced host cell association and infection. The pathogenesis of reovirus, an unrelated enteric virus, also was more severe in the presence of intestinal microbes. These results suggest that antibiotic-mediated microbiota depletion diminishes enteric virus infection and that enteric viruses exploit intestinal microbes for replication and transmission.	[Kuss, Sharon K.; Best, Gavin T.; Etheredge, Chris A.; Hooper, Lora V.; Pfeiffer, Julie K.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Pruijssers, Andrea J.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37240 USA; [Pruijssers, Andrea J.; Frierson, Johnna M.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37240 USA; [Frierson, Johnna M.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37240 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Pfeiffer, JK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA.	julie.pfeiffer@utsouthwestern.edu	Pruijssers, Andrea J/S-5725-2018	Pruijssers, Andrea J/0000-0001-7910-626X	Public Health Service [T32 AI007520]; T32 AI07611; Elizabeth B. Lamb Center for Pediatric Research; Pew Scholar award;  [F32 NS071986];  [R37 AI38296];  [P30 CA68485];  [P60 DK20593];  [R01 AI74668]; NATIONAL CANCER INSTITUTE [T32CA009582, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007520, T32AI007611, R01AI074668, R37AI038296, R01AI038296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK070855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS071986] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); T32 AI07611; Elizabeth B. Lamb Center for Pediatric Research; Pew Scholar award; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank B. Duerkop, C. Behrendt-Boyd, J. Charles, J. Richardson, and S. Gore for assistance; B. Levine and V. Sperandio for manuscript comments; and S. Koike for PVRtg mice. This research was supported by Public Health Service awards T32 AI007520 (S. K. K.); F32 NS071986 (A. J. P.); T32 AI07611 (J. M. F.); R37 AI38296, P30 CA68485, and P60 DK20593 (T. S. D.); R01 AI74668 (J. K. P.); the Elizabeth B. Lamb Center for Pediatric Research (T. S. D.); and a Pew Scholar award (J. K. P.). The data reported in the paper are tabulated in the main manuscript and in the supporting online material. The sequence data are available in GenBank (accession no. BankIt1475845 SEq. 10 JN613288).	ABRAMS GD, 1967, P SOC EXP BIOL MED, V126, P301; [Anonymous], 2001, FIELDS VIROLOGY; Barton ES, 2003, J CLIN INVEST, V111, P1823, DOI 10.1172/JCI200316303; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Ida-Hosonuma M, 2003, ARCH VIROL, V148, P29, DOI 10.1007/s00705-002-0910-7; KOIKE S, 1991, P NATL ACAD SCI USA, V88, P951, DOI 10.1073/pnas.88.3.951; Kuss SK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000082; Ohka S, 2007, J VIROL, V81, P7902, DOI 10.1128/JVI.02675-06; PODOLSKY DK, 1985, J BIOL CHEM, V260, P8262; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; Tyler K. L., 2001, FIELDS VIROLOGY, V1, P1729	13	395	411	0	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					249	252		10.1126/science.1211057	http://dx.doi.org/10.1126/science.1211057			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998395	Green Accepted			2022-12-24	WOS:000295833600053
J	Lathrop, SK; Bloom, SM; Rao, SM; Nutsch, K; Lio, CW; Santacruz, N; Peterson, DA; Stappenbeck, TS; Hsieh, CS				Lathrop, Stephanie K.; Bloom, Seth M.; Rao, Sindhuja M.; Nutsch, Katherine; Lio, Chan-Wang; Santacruz, Nicole; Peterson, Daniel A.; Stappenbeck, Thaddeus S.; Hsieh, Chyi-Song			Peripheral education of the immune system by colonic commensal microbiota	NATURE			English	Article							REGULATORY T-CELLS; DIFFERENTIATION; SELF; GENE	The instruction of the immune system to be tolerant of self, thereby preventing autoimmunity, is facilitated by the education of T cells in a specialized organ, the thymus, in which self-reactive cells are either eliminated or differentiated into tolerogenic Foxp3(+) regulatory T (T-reg) cells(1). However, it is unknown whether T cells are also educated to be tolerant of foreign antigens, such as those from commensal bacteria, to prevent immunopathology such as inflammatory bowel disease(2-4). Here we show that encounter with commensal microbiota results in the peripheral generation of T-reg cells rather than pathogenic effectors. We observed that colonic T-reg cells used T-cell antigen receptors (TCRs) different from those used by T-reg cells in other locations, implying an important role for local antigens in shaping the colonic T-reg-cell population. Many of the local antigens seemed to be derived from commensal bacteria, on the basis of the in vitro reactivity of common colon T-reg TCRs. These TCRs did not facilitate thymic T-reg-cell development, implying that many colonic T-reg cells arise instead by means of antigen-driven peripheral T-reg-cell development. Further analysis of two of these TCRs by the creation of retroviral bone marrow chimaeras and a TCR transgenic line revealed that microbiota indigenous to our mouse colony was required for the generation of colonic T-reg cells from otherwise naive T cells. If T cells expressing these TCRs fail to undergo T-reg-cell development and instead become effector cells, they have the potential to induce colitis, as evidenced by adoptive transfer studies. These results suggest that the efficient peripheral generation of antigen-specific populations of T-reg cells in response to an individual's microbiota provides important post-thymic education of the immune system to foreign antigens, thereby providing tolerance to commensal microbiota.	[Lathrop, Stephanie K.; Rao, Sindhuja M.; Nutsch, Katherine; Lio, Chan-Wang; Santacruz, Nicole; Hsieh, Chyi-Song] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Bloom, Seth M.; Stappenbeck, Thaddeus S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Peterson, Daniel A.] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA	Washington University (WUSTL); Washington University (WUSTL); University of Nebraska System; University of Nebraska Lincoln	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	chsieh@wustl.edu		Bloom, Seth/0000-0002-0462-4596; Lio, Jerry/0000-0003-3876-6741; Hsieh, Chyi-Song/0000-0001-5976-9250	National Institute of Allergy and Infectious Diseases; Burroughs-Wellcome Fund; National Institutes of Health [5T32AI0071632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079187, R21AI071046, T32AI007163, K08AI076609] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Murphy, T. Egawa, Y. Zheng, J. Scott-Browne, J. Fontenot and S. Wetzel for discussion and reading of the manuscript; A. Kau and J. Gordon for discussions and generation of germ-free animals; N. P. Malvin for assistance with bacteriology; and J. Hunn for technical assistance. C. S. H. and co-workers are funded by the National Institute of Allergy and Infectious Diseases and the Burroughs-Wellcome Fund. S. M. B. was supported by National Institutes of Health training grant 5T32AI0071632.	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Benson MJ, 2007, J EXP MED, V204, P1765, DOI 10.1084/jem.20070719; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Holst J, 2006, NAT METHODS, V3, P191, DOI 10.1038/nmeth858; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Leung MWL, 2009, J EXP MED, V206, P2121, DOI 10.1084/jem.20091033; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Magurran A E, 1988, ECOLOGICAL DIVERSITY; Min B, 2007, EUR J IMMUNOL, V37, P1916, DOI 10.1002/eji.200737236; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Singh B, 2001, IMMUNOL REV, V182, P190, DOI 10.1034/j.1600-065X.2001.1820115.x; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	34	698	726	4	109	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					250	U142		10.1038/nature10434	http://dx.doi.org/10.1038/nature10434			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21937990	Green Accepted			2022-12-24	WOS:000295782800052
J	Qato, DM; Alexander, GC				Qato, Dima M.; Alexander, G. Caleb			Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Alexander, G. Caleb] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA; [Qato, Dima M.; Alexander, G. Caleb] Univ Chicago Hosp, Gen Internal Med Sect, Dept Med, Chicago, IL 60637 USA; [Qato, Dima M.] Univ Chicago, NORC, Ctr Demog & Econ Aging, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA; [Alexander, G. Caleb] Univ Illinois, Dept Pharm Practice, Chicago Sch Pharm, Chicago, IL USA	University of Chicago; University of Chicago; University of Illinois System; University of Chicago; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Alexander, GC (corresponding author), Univ Chicago, Ctr Hlth & Social Sci, 5841 S Maryland,MC 2007, Chicago, IL 60637 USA.	galexand@uchicago.edu		Qato, Dima/0000-0001-5411-6998	AHRQ HHS [R01 HS0189960] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Alexander GC, 2011, ANN INTERN MED, V154, P833, DOI 10.7326/0003-4819-154-12-201106210-00012; [Anonymous], 2011, TUFTS CTR STUDY DRUG, V13; [Anonymous], GUIDANCE IND FORMAT; [Anonymous], APPROVED RISK EVALUA; Dhalla IA, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5142; Institute of Medicine, FUT DRUG SAF PROM PR; Shrank WH, 2007, HEALTH AFFAIR, V26, P731, DOI 10.1377/hlthaff.26.3.731; Svarstad Bonnie L, 2003, J Am Pharm Assoc (2003), V43, P383, DOI 10.1331/154434503321831102; Willy M, 2011, 27 INT C PHARM THER	9	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 12	2011	306	14					1595	1596		10.1001/jama.2011.1457	http://dx.doi.org/10.1001/jama.2011.1457			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	831FS	21990303				2022-12-24	WOS:000295714700026
J	Zweig, SC; Popejoy, LL; Parker-Oliver, D; Meadows, SE				Zweig, Steven C.; Popejoy, Lori L.; Parker-Oliver, Debra; Meadows, Susan E.			The Physician's Role in Patients' Nursing Home Care "She's a Very Courageous and Lovely Woman. I Enjoy Caring for Her"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALL-INCLUSIVE CARE; LONG-TERM-CARE; PRESSURE ULCER SCALE; TRANSITIONAL CARE; OLDER AMERICANS; HOSPICE CARE; END; LIFE; RESIDENTS; SERVICES	More than 1.5 million adults live in US nursing homes, and approximately 30% of individuals in the United States will die with a nursing home as their last place of residence. Physicians play a pivotal role in the rehabilitation, complex medical care, and end-of-life care of this frail and vulnerable population. The reasons for admission are multifactorial and a comprehensive care plan based on the Minimum Data Set guides the multidisciplinary nursing home team in the care of the patient and provides assessments of the quality of care provided. Using the cases of 2 patients with different experiences, we describe the physician's role in planning for admission, participating as a team member in the ongoing assessment and care in the nursing home, and guiding care at the end of life. The increasing population of older adults has also promoted community-based and residential alternatives to traditional nursing homes. The future of longterm care will include additional challenges and rich innovations in services and options for older adults. JAMA. 2011;306(13):1468-1478 www.jama.com	[Zweig, Steven C.] Univ Missouri, Interdisciplinary Ctr Aging, Columbia, MO 65212 USA; [Zweig, Steven C.; Parker-Oliver, Debra; Meadows, Susan E.] Univ Missouri, Dept Family & Community Med, Sch Med, Columbia, MO 65212 USA; [Popejoy, Lori L.] Univ Missouri, Sinclair Sch Nursing, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Zweig, SC (corresponding author), Univ Missouri, Interdisciplinary Ctr Aging, Columbia, MO 65212 USA.	zweigs@missouri.edu	Parker-Oliver, Debra/F-7998-2010		National Institute of Nursing Research; SCAN Foundation	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); SCAN Foundation	Dr Parker-Oliver reports receipt of support from the National Institute of Nursing Research. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Aigner Mary J, 2004, J Am Med Dir Assoc, V5, P16, DOI 10.1016/S1525-8610(04)70039-0; American Medical Directors Association, 2005, J Am Med Dir Assoc, V6, P411; American Medical Directors Association, CLIN PRACT GUID LONG; Baer WM, 2000, J AM GERIATR SOC, V48, P879, DOI 10.1111/j.1532-5415.2000.tb06883.x; BERCOVITZ A, 2008, NATL HLTH SLAT REPOR, V9, P1; Bern-Klug Mercedes, 2003, J Am Med Dir Assoc, V4, P145, DOI 10.1097/01.JAM.0000061473.13422.CC; Biola H, 2007, J AM GERIATR SOC, V55, P846, DOI 10.1111/j.1532-5415.2007.01179.x; Black K, 2007, J SOC WORK END-LIFE, V3, P39, DOI 10.1300/J457v03n02_04; Blumenthal D, 2001, JAMA-J AM MED ASSOC, V286, P1027, DOI 10.1001/jama.286.9.1027; Boult C, 2010, JAMA-J AM MED ASSOC, V304, P1936, DOI 10.1001/jama.2010.1623; Burton LC, 2003, GERONTOLOGIST, V43, P230, DOI 10.1093/geront/43.2.230; Casarett D, 2005, JAMA-J AM MED ASSOC, V294, P211, DOI 10.1001/jama.294.2.211; Castle NG, 2007, MED CARE, V45, P729, DOI 10.1097/MLR.0b013e3180618b6e; Castle NG, 2010, GERONTOLOGIST, V50, P426, DOI 10.1093/geront/gnq052; Centers for Medicare and Medicaid Services, NURS HOM DAT COMP 20; CohenMansfield J, 1997, J GERONTOL A-BIOL, V52, pM369, DOI 10.1093/gerona/52A.6.M369; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; COWLES CM, 2007, NURSING HOME STAT YB, P56; Cravens DD, 2000, FAM MED, V32, P34; *CTR MED MED SERV, 2000, MED MED STAT OP MAN; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; *DEP VET AFF VIREC, RES ASS INSTR MIN DA; Dimant Jacob, 2003, J Am Med Dir Assoc, V4, P231, DOI 10.1097/01.JAM.0000075915.15039.B1; Dimant Jacob, 2002, J Am Med Dir Assoc, V3, P254, DOI 10.1097/00130535-200207000-00007; Doukas DJ, 2003, J AM GERIATR SOC, V51, P1155, DOI 10.1046/j.1532-5415.2003.51383.x; El-Solh AA, 2010, CHEST, V138, P1480, DOI 10.1378/chest.10-1135; ELON R, 1992, J AM GERIATR SOC, V40, P958, DOI 10.1111/j.1532-5415.1992.tb01996.x; EMANUEL LL, ED PHYS END OF LIFE; Feldt K S, 2000, Pain Manag Nurs, V1, P13, DOI 10.1053/jpmn.2000.5831; Field MJ, 1997, APPROACHING DEATH IM; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Friedemann ML, 2004, GERONTOLOGIST, V44, P520, DOI 10.1093/geront/44.4.520; Gardner SE, 2005, J GERONTOL A-BIOL, V60, P93, DOI 10.1093/gerona/60.1.93; Gaugler Joseph E, 2007, BMC Geriatr, V7, P13, DOI 10.1186/1471-2318-7-13; Gaugler JE, 2009, MED CARE, V47, P191, DOI 10.1097/MLR.0b013e31818457ce; Gillick M, 1999, J AM GERIATR SOC, V47, P227, DOI 10.1111/j.1532-5415.1999.tb04582.x; Grabowski DC, 2010, MED CARE, V48, P859, DOI 10.1097/MLR.0b013e3181f49ed9; Hawkins NA, 2005, GERONTOLOGIST, V45, P107, DOI 10.1093/geront/45.1.107; Hedrick SC, 2009, J AGING HEALTH, V21, P190, DOI 10.1177/0898264308328929; Herr K A, 1993, Appl Nurs Res, V6, P39; Hickman SE, 2010, J AM GERIATR SOC, V58, P1241, DOI 10.1111/j.1532-5415.2010.02955.x; INOUYE SK, 1990, ANN INTERN MED, V113, P941, DOI 10.7326/0003-4819-113-12-941; Institute of Medicine (US) Committee on Nursing Home Regulation, 1986, IMPR QUAL CAR NURS H; Jones Adrienne L, 2011, NCHS Data Brief, P1; Joseph A, 1998, J AM GERIATR SOC, V46, P1152; Kane RL, 2003, J AM GERIATR SOC, V51, P1427, DOI 10.1046/j.1532-5415.2003.51461.x; KANE RL, 1989, AM J PUBLIC HEALTH, V79, P1271, DOI 10.2105/AJPH.79.9.1271; Kane RL, 2007, GERONTOLOGIST, V47, P100, DOI 10.1093/geront/47.Supplement_1.100; Kane RL, 2011, JAMA-J AM MED ASSOC, V305, P284, DOI 10.1001/jama.2010.2015; Kane RL, 2010, J AGING SOC POLICY, V22, P321, DOI 10.1080/08959420.2010.507509; Kane RA, 2007, J AM GERIATR SOC, V55, P832, DOI 10.1111/j.1532-5415.2007.01169.x; Kelly A, 2010, J AM GERIATR SOC, V58, P1701, DOI 10.1111/j.1532-5415.2010.03005.x; Kinosian B, 2007, GERONTOLOGIST, V47, P356, DOI 10.1093/geront/47.3.356; Kolarik Russ C, 2002, J Palliat Med, V5, P697, DOI 10.1089/109662102320880516; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; LaMantia MA, 2010, J AM GERIATR SOC, V58, P777, DOI 10.1111/j.1532-5415.2010.02776.x; Lum TY, 2008, HEALTH CARE FINANC R, V30, P35; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Luppa M, 2009, INT PSYCHOGERIATR, V21, P1015, DOI 10.1017/S1041610209990238; Mehr DR, 2001, JAMA-J AM MED ASSOC, V286, P2427, DOI 10.1001/jama.286.19.2427; Miller SC, 2002, J AM GERIATR SOC, V50, P507, DOI 10.1046/j.1532-5415.2002.50118.x; Miller SC, 2010, J AM GERIATR SOC, V58, P1481, DOI 10.1111/j.1532-5415.2010.02968.x; Mukamel DB, 2008, HEALTH SERV RES, V43, P1244, DOI 10.1111/j.1475-6773.2007.00829.x; Muramatsu N, 2008, MED CARE, V46, P829, DOI 10.1097/MLR.0b013e3181791a79; Muramatsu N, 2007, J GERONTOL B-PSYCHOL, V62, pS169, DOI 10.1093/geronb/62.3.S169; Noel-Miller C, 2010, J GERONTOL B-PSYCHOL, V65, P370, DOI 10.1093/geronb/gbq020; Oliver Debra Parker, 2005, J Am Med Dir Assoc, V6, pS21, DOI 10.1016/j.jamda.2005.03.017; OUSLANDER JG, 1994, ANN INTERN MED, V120, P584, DOI 10.7326/0003-4819-120-7-199404010-00010; OUSLANDER JG, 1997, MED CARE NURSING HOM; Pavlik VN, 2001, J AM GERIATR SOC, V49, P45, DOI 10.1046/j.1532-5415.2001.49008.x; PIERCE RP, 1996, NURSING HOME EC, V3, P20; Popejoy LL, 2008, J NURS SCHOLARSHIP, V40, P326, DOI 10.1111/j.1547-5069.2008.00246.x; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Rantz MJ, 2006, J NURS MEAS, V14, P129, DOI 10.1891/jnm-v14i2a005; RANTZ MJ, 2009, FIND BEST ELDERCARE; Resnick HE, 2009, J AM MED DIR ASSOC, V10, P423, DOI 10.1016/j.jamda.2009.03.009; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; Reuben DB, 1999, J AM GERIATR SOC, V47, P131, DOI 10.1111/j.1532-5415.1999.tb04569.x; Romer Anna L, 2004, J Palliat Med, V7, P335, DOI 10.1089/109662104773709495; Saliba D, 2008, DEV VALIDATION REVIS; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Stone RI, 2007, GERONTOLOGIST, V47, P23, DOI 10.1093/geront/47.Supplement_1.23; Stotts NA, 2001, J GERONTOL A-BIOL, V56, pM795, DOI 10.1093/gerona/56.12.M795; Stuck AE, 2002, JAMA-J AM MED ASSOC, V287, P1022, DOI 10.1001/jama.287.8.1022; Tamura MK, 2009, NEW ENGL J MED, V361, P1539, DOI 10.1056/NEJMoa0904655; Temkin-Greener H, 2002, J AM GERIATR SOC, V50, P125, DOI 10.1046/j.1532-5415.2002.50018.x; Terrell KM, 2006, J AM MED DIR ASSOC, V7, P499, DOI 10.1016/j.jamda.2006.03.004; Thomas W.H., 2003, J SOCIAL WORK LONG T, V2, P141, DOI [DOI 10.1300/J181V02N01_10, 10.1300/J181v02n01_10]; Tombaugh TN, 1996, PSYCHOL ASSESSMENT, V8, P48, DOI 10.1037/1040-3590.8.1.48; U. S. Department of Health and Human Services Centers for Medicare & Medicaid Services, MDS 3 0 NURS HOM SWI; Unwin BK, 2010, AM FAM PHYSICIAN, V81, P1219; *US DEP HHS, NURS HOM CHECKL; US Department of Health and Human Services, NURS HOM COMP; Warshaw GA, 2010, J AM GERIATR SOC, V58, P1780, DOI 10.1111/j.1532-5415.2010.03029.x; Weaver FM, 2008, J AM GERIATR SOC, V56, P345, DOI 10.1111/j.1532-5415.2007.01538.x; Wieland D, 2010, J GERONTOL A-BIOL, V65, P721, DOI 10.1093/gerona/glq040	96	6	6	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1468	1478		10.1001/jama.2011.1420	http://dx.doi.org/10.1001/jama.2011.1420			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	828MZ	21972309				2022-12-24	WOS:000295506900026
J	Gershon, AS; Warner, L; Cascagnette, P; Victor, JC; To, T				Gershon, Andrea S.; Warner, Laura; Cascagnette, Paul; Victor, J. Charles; To, Teresa			Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study	LANCET			English	Article							HEALTH ADMINISTRATIVE DATABASES; ALZHEIMERS-DISEASE; DATA ALGORITHM; COPD; PREVALENCE; ONTARIO; MORTALITY; CHILDREN; CANADA; ASTHMA	Background Although chronic obstructive pulmonary disease (COPD) is one of the most deadly, prevalent, and costly chronic diseases, no comprehensive estimates of the risk of developing COPD in the general population have been published. We aimed to quantify the lifetime risk of developing physician-diagnosed COPD in a large, multicultural North American population. Methods We did a retrospective longitudinal cohort study using population-based health administrative data from Ontario, Canada (total population roughly 13 million). All individuals free of COPD in 1996 were monitored for up to 14 years for three possible outcomes; diagnosis of COPD by a physician, reached 80 years of age, or death. COPD was identified with a previously validated case definition based on COPD health services claims. The cumulative incidence of physician-diagnosed COPD over a lifetime adjusted for the competing risk of death was calculated by a modified survival analysis technique. Results were stratified by sex, socioeconomic status, and whether individuals lived in a rural or urban setting. Findings A total of 579466 individuals were diagnosed with COPD by a physician over the study period. The overall lifetime risk of physician-diagnosed COPD at age 80 years was 27.6%. Lifetime risk was higher in men than in women (29.7% vs 25.6%), individuals of lower socioeconomic status than in those of higher socioeconomic status (32.1% vs 23.0%), and individuals who lived in a rural setting than in those who lived in an urban setting (32.4% vs 26.7%). Interpretation About one in four individuals are likely to be diagnosed and receive medical attention for COPD during their lifetime. Clinical evidence-based approaches, public health action, and more research are needed to identify effective strategies to prevent COPD and ensure that those with the disease have the highest quality of life possible.	[Gershon, Andrea S.; Warner, Laura; Cascagnette, Paul; Victor, J. Charles; To, Teresa] Inst Clin Evaluat Sci, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Gershon, Andrea S.; Victor, J. Charles; To, Teresa] Univ Toronto, Toronto, ON, Canada; [Gershon, Andrea S.; To, Teresa] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Gershon, AS (corresponding author), Inst Clin Evaluat Sci, G1 06, Toronto, ON M4N 3M5, Canada.	andrea.gershon@ices.on.ca	Victor, J Charles/F-8765-2011	Victor, J Charles/0000-0003-1720-9356	Government of Ontario, Canada; Government of Ontario; Institute for Clinical Evaluative Sciences (ICES); Ontario Ministry of Health and Long-Term Care; University of Toronto, Toronto, Ontario, Canada	Government of Ontario, Canada; Government of Ontario; Institute for Clinical Evaluative Sciences (ICES)(University of Toronto); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); University of Toronto, Toronto, Ontario, Canada(University of Toronto)	Government of Ontario, Canada.; This study was funded in part by the Government of Ontario who had no role in study design, collection, analysis, interpretation of data, writing of the report, or in the decision to submit the report for publication. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The opinions, results, and conclusions reported in this paper are those of the authors and are independent of the funding sources. No endorsement by ICES or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. AG is supported by a Career Scientist Award from the Ontario Ministry of Health and Long Term Care. TT is supported by The Dales Award in Medical Research from the University of Toronto, Toronto, Ontario, Canada.	[Anonymous], 2008, WORLD HLTH STAT 2008; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barnes PJ, 2004, LANCET, V364, P564, DOI 10.1016/S0140-6736(04)16866-9; Beiser A, 2000, STAT MED, V19, P1495, DOI 10.1002/(SICI)1097-0258(20000615/30)19:11/12<1495::AID-SIM441>3.0.CO;2-E; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; *CANC CAR ONT, 2009, CANC CAR ONT DAT HOL; *CANC CAR ONT, 2010, CANC ONT OV STAT REP; DUPLESSIS V, 21601MIE STAT CAN; Fay MP, 2003, STAT MED, V22, P1837, DOI 10.1002/sim.1428; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2010, ARCH INTERN MED, V170, P560, DOI 10.1001/archinternmed.2010.17; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hall M. J., 2010, NATL HLTH STAT REPOR, V29, P24; Hall MJ, 2010, NATL HLTH STAT REPOR, P1, DOI DOI 10.3886/ICPSR28162.V1; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Lipscombe LL, 2007, LANCET, V369, P750, DOI 10.1016/S0140-6736(07)60361-4; Lloyd-Jones DM, 1999, LANCET, V353, P89, DOI 10.1016/S0140-6736(98)10279-9; Miravitlles M, 2006, RESP MED, V100, P1973, DOI 10.1016/j.rmed.2006.02.024; Murtaugh CM, 2011, J AGING HEALTH, V23, P554, DOI 10.1177/0898264310389491; *NAT HEART LUNG BL, 2011, COPD LEARN MOR BREAT; Pelkonen M, 2006, CHEST, V130, P1129, DOI 10.1378/chest.130.4.1129; Seshadri S, 1997, NEUROLOGY, V49, P1498, DOI 10.1212/WNL.49.6.1498; Soriano JB, 2009, LANCET, V374, P721, DOI 10.1016/S0140-6736(09)61290-3; Statistics Canada, 2010, LIF EXP BIRTH AG 65; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; To T, 2010, AM J RESP CRIT CARE, V181, P337, DOI 10.1164/rccm.200907-1035OC; UKCRC, 2006, UK HLTH RES AN; van Durme YMTA, 2009, CHEST, V135, P368, DOI 10.1378/chest.08-0684	30	198	205	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 10	2011	378	9795					991	996		10.1016/S0140-6736(11)60990-2	http://dx.doi.org/10.1016/S0140-6736(11)60990-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907862				2022-12-24	WOS:000295193200024
J	Becker, C; Hagmann, J; Muller, J; Koenig, D; Stegle, O; Borgwardt, K; Weigel, D				Becker, Claude; Hagmann, Joerg; Mueller, Jonas; Koenig, Daniel; Stegle, Oliver; Borgwardt, Karsten; Weigel, Detlef			Spontaneous epigenetic variation in the Arabidopsis thaliana methylome	NATURE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; SHORT READS; ALIGNMENT; PLANTS; GENES	Heritable epigenetic polymorphisms, such as differential cytosine methylation, can underlie phenotypic variation(1,2). Moreover, wild strains of the plant Arabidopsis thaliana differ in many epialleles(3,4), and these can influence the expression of nearby genes(1,2). However, to understand their role in evolution(5), it is imperative to ascertain the emergence rate and stability of epialleles, including those that are not due to structural variation. We have compared genome-wide DNA methylation among 10 A. thaliana lines, derived 30 generations ago from a common ancestor(6). Epimutations at individual positions were easily detected, and close to 30,000 cytosines in each strain were differentially methylated. In contrast, larger regions of contiguous methylation were much more stable, and the frequency of changes was in the same low range as that of DNA mutations(7). Like individual positions, the same regions were often affected by differential methylation in independent lines, with evidence for recurrent cycles of forward and reverse mutations. Transposable elements and short interfering RNAs have been causally linked to DNA methylation(8). In agreement, differentially methylated sites were farther from transposable elements and showed less association with short interfering RNA expression than invariant positions. The biased distribution and frequent reversion of epimutations have important implications for the potential contribution of sequence-independent epialleles to plant evolution.	[Becker, Claude; Hagmann, Joerg; Mueller, Jonas; Koenig, Daniel; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Stegle, Oliver; Borgwardt, Karsten] Max Planck Inst Dev Biol, Machine Learning & Computat Biol Res Grp, D-72076 Tubingen, Germany; [Stegle, Oliver; Borgwardt, Karsten] Max Planck Inst Intelligent Syst, D-72076 Tubingen, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Becker, Claude/H-9011-2019; Stegle, Oliver/AAU-9177-2020; Weigel, Detlef/AAR-3312-2021; Müller, Jonas/GQA-3371-2022	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Becker, Claude/0000-0003-3406-4670; Stegle, Oliver/0000-0002-8818-7193; Borgwardt, Karsten/0000-0001-7221-2393; Koenig, Daniel/0000-0002-1037-5346; Hagmann, Jorg/0000-0002-7232-3103	HFSP; Volkswagen Foundation; AENEAS [KBBE-2009-226477]; DFG; Max Planck Society	HFSP(Human Frontier Science Program); Volkswagen Foundation(Volkswagen); AENEAS; DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We are grateful to R. Shaw for providing seeds of the mutation accumulation lines. We thank C. Lanz for help with Illumina sequencing, J. Fitz for help with the Gbrowse implementation, K. Schneeberger for help with DNA mutation analysis, D. Zilberman for providing bisulphite sequencing protocols, and R. Clark, M. Pellegrini, R. Neher and J. Paszkowski for discussion. This work was supported by an HFSP Long-Term Fellowship (D. K.), the Volkswagen Foundation (O.S.), FP7 Collaborative Project AENEAS (contract KBBE-2009-226477), a Gottfried Wilhelm Leibniz Award of the DFG, and the Max Planck Society (D.W.).	Benjamini Y, 2001, ANN STAT, V29, P1165; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Fahlgren N, 2010, PLANT CELL, V22, P1074, DOI 10.1105/tpc.110.073999; HOLLISTER JD, 2011, ARABIDOPSIS, V108, P2322; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lisch D, 2009, ANNU REV PLANT BIOL, V60, P43, DOI 10.1146/annurev.arplant.59.032607.092744; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Rangwala SH, 2006, PLOS GENET, V2, P270, DOI 10.1371/journal.pgen.0020036; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Richards EJ, 2008, CURR OPIN GENET DEV, V18, P221, DOI 10.1016/j.gde.2008.01.014; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Shaw RG, 2000, GENETICS, V155, P369; Slatkin M, 2009, GENETICS, V182, P845, DOI 10.1534/genetics.109.102798; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Widman N, 2009, EPIGENETICS-US, V4, P119, DOI 10.4161/epi.4.2.8214; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr053; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	35	476	494	3	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					245	U127		10.1038/nature10555	http://dx.doi.org/10.1038/nature10555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22057020				2022-12-24	WOS:000297744200052
J	Koivomagi, M; Valk, E; Venta, R; Iofik, A; Lepiku, M; Balog, ERM; Rubin, SM; Morgan, DO; Loog, M				Koivomaegi, Mardo; Valk, Ervin; Venta, Rainis; Iofik, Anna; Lepiku, Martin; Balog, Eva Rose M.; Rubin, Seth M.; Morgan, David O.; Loog, Mart			Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase	NATURE			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; PROTEIN CKS1; INHIBITOR; COMPLEX; CDK1; G(1); ULTRASENSITIVITY; REPLICATION	Multisite phosphorylation of proteins has been proposed to transform a graded protein kinase signal into an ultrasensitive switch-like response(1-4). Although many multiphosphorylated targets have been identified, the dynamics and sequence of individual phosphorylation events within the multisite phosphorylation process have never been thoroughly studied. In Saccharomyces cerevisiae, the initiation of S phase is thought to be governed by complexes of Cdk1 and Cln cyclins that phosphorylate six or more sites on the Clb5-Cdk1 inhibitor Sic1, directing it to SCF-mediated destruction(1,5-8). The resulting Sic1-free Clb5-Cdk1 complex triggers S phase(9). Here, we demonstrate that Sic1 destruction depends on a more complex process in which both Cln2-Cdk1 and Clb5-Cdk1 act in processive multiphosphorylation cascades leading to the phosphorylation of a small number of specific phosphodegrons. The routes of these phosphorylation cascades are shaped by precisely oriented docking interactions mediated by cyclin-specific docking motifs in Sic1 and by Cks1, the phospho-adaptor subunit of Cdk1. Our results indicate that Clb5-Cdk1-dependent phosphorylation generates positive feedback that is required for switch-like Sic1 destruction. Our evidence for a docking network within clusters of phosphorylation sites uncovers a new level of complexity in Cdk1-dependent regulation of cell cycle transitions, and has general implications for the regulation of cellular processes by multisite phosphorylation.	[Koivomaegi, Mardo; Valk, Ervin; Venta, Rainis; Iofik, Anna; Lepiku, Martin; Loog, Mart] Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia; [Balog, Eva Rose M.; Rubin, Seth M.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of Tartu; University of California System; University of California Santa Cruz; University of California System; University of California San Francisco	Loog, M (corresponding author), Univ Tartu, Inst Technol, EE-50411 Tartu, Estonia.	Mart.Loog@ut.ee	Balog, Eva Rose M/P-7661-2014	Balog, Eva Rose M/0000-0001-6792-6914; Rubin, Seth/0000-0002-1670-4147; Morgan, David/0000-0001-8753-4416; Venta, Rainis/0000-0001-6635-992X	Wellcome Trust [079014/Z/06/Z]; EMBO; HHMI [1253]; Estonian Science Foundation [6766]; Estonian Ministry of Education and Research [SF0180071s07]; Norwegian government [08071N]; National Institute of General Medical Sciences; National Cancer Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069901] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); EMBO(European Molecular Biology Organization (EMBO)); HHMI(Howard Hughes Medical Institute); Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Norwegian government; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Kellogg for strains and L. Peil for advice on mass spectrometry. This work was supported by International Senior Research Fellowship No. 079014/Z/06/Z from the Wellcome Trust (M.Lo.), an installation grant from EMBO and HHMI (M.Lo.), no. 1253, grants no. 6766 from the Estonian Science Foundation (M.Lo.) and SF0180071s07 from Estonian Ministry of Education and Research (M.Lo.), EMP grant no. 08071N from the Norwegian government, and grants from the National Institute of General Medical Sciences (D.O.M.) and National Cancer Institute (S.M.R.).	ARVAI AS, 1995, J MOL BIOL, V249, P835, DOI 10.1006/jmbi.1995.0341; Borg M, 2007, P NATL ACAD SCI USA, V104, P9650, DOI 10.1073/pnas.0702580104; Bourne Y, 2000, STRUCT FOLD DES, V8, P841, DOI 10.1016/S0969-2126(00)00175-1; Cross FR, 2007, GENETICS, V176, P1541, DOI 10.1534/genetics.107.073494; Deshaies RJ, 2001, CELL, V107, P819, DOI 10.1016/S0092-8674(01)00620-1; HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Kim SY, 2007, CELL, V128, P1133, DOI 10.1016/j.cell.2007.01.039; Kinoshita E, 2005, J SEP SCI, V28, P155, DOI 10.1002/jssc.200401833; Koivomagi M, 2011, MOL CELL, V42, P610, DOI 10.1016/j.molcel.2011.05.016; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; McCusker D, 2007, NAT CELL BIOL, V9, P506, DOI 10.1038/ncb1568; Mittag T, 2010, STRUCTURE, V18, P494, DOI 10.1016/j.str.2010.01.020; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; Patra D, 1999, J BIOL CHEM, V274, P36839, DOI 10.1074/jbc.274.52.36839; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Reynard GJ, 2000, MOL CELL BIOL, V20, P5858, DOI 10.1128/MCB.20.16.5858-5864.2000; Schneider BL, 1996, SCIENCE, V272, P560, DOI 10.1126/science.272.5261.560; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; Thomson M, 2009, NATURE, V460, P274, DOI 10.1038/nature08102; Tyers M, 1996, P NATL ACAD SCI USA, V93, P7772, DOI 10.1073/pnas.93.15.7772; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455	25	155	156	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					128	U301		10.1038/nature10560	http://dx.doi.org/10.1038/nature10560			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	21993622	Green Submitted, Green Accepted			2022-12-24	WOS:000298031900048
J	van den Bogaart, G; Meyenberg, K; Risselada, HJ; Amin, H; Willig, KI; Hubrich, BE; Dier, M; Hell, SW; Grubmuller, H; Diederichsen, U; Jahn, R				van den Bogaart, Geert; Meyenberg, Karsten; Risselada, H. Jelger; Amin, Hayder; Willig, Katrin I.; Hubrich, Barbara E.; Dier, Markus; Hell, Stefan W.; Grubmueller, Helmut; Diederichsen, Ulf; Jahn, Reinhard			Membrane protein sequestering by ionic protein-lipid interactions	NATURE			English	Article							GIANT UNILAMELLAR VESICLES; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; SYNTAXIN CLUSTERS; PLASMA-MEMBRANE; FUSION; SNARES; MODEL; ORGANIZATION; CHOLESTEROL; DOMAINS	Neuronal exocytosis is catalysed by the SNAP receptor protein syntaxin-1A(1), which is clustered in the plasma membrane at sites where synaptic vesicles undergo exocytosis(2,3). However, how syntaxin-1A is sequestered is unknown. Here we show that syntaxin clustering is mediated by electrostatic interactions with the strongly anionic lipid phosphatidylinositol-4,5-bisphosphate (PIP2). Using super-resolution stimulated-emission depletion microscopy on the plasma membranes of PC12 cells, we found that PIP2 is the dominant inner-leaflet lipid in microdomains about 73 nanometres in size. This high accumulation of PIP2 was required for syntaxin-1A sequestering, as destruction of PIP2 by the phosphatase synaptojanin-1 reduced syntaxin-1A clustering. Furthermore, coreconstitution of PIP2 and the carboxy-terminal part of syntaxin-1A in artificial giant unilamellar vesicles resulted in segregation of PIP2 and syntaxin-1A into distinct domains even when cholesterol was absent. Our results demonstrate that electrostatic protein-lipid interactions can result in the formation of microdomains independently of cholesterol or lipid phases.	[van den Bogaart, Geert; Amin, Hayder; Dier, Markus; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Meyenberg, Karsten; Hubrich, Barbara E.; Diederichsen, Ulf] Univ Gottingen, Inst Organ & Biomol Chem, D-37077 Gottingen, Germany; [Risselada, H. Jelger; Grubmueller, Helmut] Max Planck Inst Biophys Chem, Dept Theoret & Computat Biophys, D-37077 Gottingen, Germany; [Willig, Katrin I.; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept Nanobiophoton, D-37077 Gottingen, Germany	Max Planck Society; University of Gottingen; Max Planck Society; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	r.jahn@gwdg.de	van den Bogaart, Geert/A-1089-2014; Willig, Katrin/AAH-5418-2020; van den Bogaart, Geert/GLV-3283-2022	van den Bogaart, Geert/0000-0003-2180-6735; Willig, Katrin/0000-0002-1860-334X; van den Bogaart, Geert/0000-0003-2180-6735; Jahn, Reinhard/0000-0003-1542-3498; Diederichsen, Ulf/0000-0002-2654-9160	Human Frontier Science Program; US National Institutes of Health [P01 GM072694]; Deutsche Forschungsgemeinschaft [SFB803]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Holt, G. Bunt, F. S. Wouters and C. Eggeling for advice, and V. Haucke and S. Joo for the red-fluorescent-protein-tagged synaptojanin-1 construct. G.v.d.B. is financed by the Human Frontier Science Program. This work was supported by the US National Institutes of Health (P01 GM072694, to R.J.) and the Deutsche Forschungsgemeinschaft (SFB803, to K.M., H.J.R., U.D., H.G. and R.J.).	Aoyagi K, 2005, J BIOL CHEM, V280, P17346, DOI 10.1074/jbc.M413307200; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Carvalho K, 2008, BIOPHYS J, V95, P4348, DOI 10.1529/biophysj.107.126912; Christian DA, 2009, NAT MATER, V8, P843, DOI [10.1038/NMAT2512, 10.1038/nmat2512]; Denisov G, 1998, BIOPHYS J, V74, P731, DOI 10.1016/S0006-3495(98)73998-0; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; HAY JC, 1993, NATURE, V366, P572, DOI 10.1038/366572a0; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kweon DH, 2002, BIOCHEMISTRY-US, V41, P9264, DOI 10.1021/bi025934+; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Levental I, 2009, BIOCHEMISTRY-US, V48, P8241, DOI 10.1021/bi9007879; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Sieber JJ, 2006, BIOPHYS J, V90, P2843, DOI 10.1529/biophysj.105.079574; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; van den Bogaart G, 2011, J MOL CELL BIOL, V3, P204, DOI 10.1093/jmcb/mjr004; Wen PJ, 2011, PROG LIPID RES, V50, P52, DOI 10.1016/j.plipres.2010.08.001; Williams D, 2009, MOL BIOL CELL, V20, P4910, DOI 10.1091/mbc.E09-04-0284; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	29	415	416	3	251	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					552	555		10.1038/nature10545	http://dx.doi.org/10.1038/nature10545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22020284	Green Accepted, Green Published			2022-12-24	WOS:000297285600056
J	Djamei, A; Schipper, K; Rabe, F; Ghosh, A; Vincon, V; Kahnt, J; Osorio, S; Tohge, T; Fernie, AR; Feussner, I; Feussner, K; Meinicke, P; Stierhof, YD; Schwarz, H; Macek, B; Mann, M; Kahmann, R				Djamei, Armin; Schipper, Kerstin; Rabe, Franziska; Ghosh, Anupama; Vincon, Volker; Kahnt, Joerg; Osorio, Sonia; Tohge, Takayuki; Fernie, Alisdair R.; Feussner, Ivo; Feussner, Kirstin; Meinicke, Peter; Stierhof, York-Dieter; Schwarz, Heinz; Macek, Boris; Mann, Matthias; Kahmann, Regine			Metabolic priming by a secreted fungal effector	NATURE			English	Article							PATHOGEN USTILAGO-MAYDIS; YEAST CHORISMATE MUTASE; ARABIDOPSIS-THALIANA; MAIZE; IDENTIFICATION; GENES; EXPRESSION; PROTEIN	Maize smut caused by the fungus Ustilago maydis is a widespread disease characterized by the development of large plant tumours. U. maydis is a biotrophic pathogen that requires living plant tissue for its development and establishes an intimate interaction zone between fungal hyphae and the plant plasma membrane. U. maydis actively suppresses plant defence responses by secreted protein effectors(1,2). Its effector repertoire comprises at least 386 genes mostly encoding proteins of unknown function(1,3,4) and expressed exclusively during the biotrophic stage(3). The U. maydis secretome also contains about 150 proteins with probable roles in fungal nutrition, fungal cell wall modification and host penetration as well as proteins unlikely to act in the fungal-host interface(4) like a chorismate mutase. Chorismate mutases are key enzymes of the shikimate pathway and catalyse the conversion of chorismate to prephenate, the precursor for tyrosine and phenylalanine synthesis. Root-knot nematodes inject a secreted chorismate mutase into plant cells likely to affect development(5,6). Here we show that the chorismate mutase Cmu1 secreted by U. maydis is a virulence factor. The enzyme is taken up by plant cells, can spread to neighbouring cells and changes the metabolic status of these cells through metabolic priming. Secreted chorismate mutases are found in many plant-associated microbes and might serve as general tools for host manipulation.	[Djamei, Armin; Schipper, Kerstin; Rabe, Franziska; Ghosh, Anupama; Vincon, Volker; Kahnt, Joerg; Kahmann, Regine] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Schipper, Kerstin] Univ Marburg, Zentrum Synthet Mikrobiol, D-35032 Marburg, Germany; [Osorio, Sonia; Tohge, Takayuki; Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst, D-37077 Gottingen, Germany; [Feussner, Kirstin; Meinicke, Peter] Univ Gottingen, Inst Microbiol & Genet, D-37077 Gottingen, Germany; [Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Schwarz, Heinz] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Macek, Boris; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society; Philipps University Marburg; Max Planck Society; University of Gottingen; University of Gottingen; Eberhard Karls University of Tubingen; Max Planck Society; Max Planck Society	Kahmann, R (corresponding author), Max Planck Inst Terr Microbiol, Karl von Frisch Str 10, D-35043 Marburg, Germany.	kahmann@mpi-marburg.mpg.de	Macek, Boris/N-1442-2015; Osorio, Sonia/M-2258-2014; Kahmann, Regine/AAS-1230-2021; Schipper, Kerstin/H-4656-2011; Mann, Matthias/A-3454-2013; Tohge, Takayuki/G-7924-2017; Djamei, Armin/AAL-8909-2021; Feussner, Ivo/H-9320-2013	Macek, Boris/0000-0002-1206-2458; Osorio, Sonia/0000-0002-0159-6091; Mann, Matthias/0000-0003-1292-4799; Tohge, Takayuki/0000-0001-5555-5650; Djamei, Armin/0000-0002-8087-9566; Feussner, Ivo/0000-0002-9888-7003; Ghosh, Anupama/0000-0002-4200-5091	DFG [DJ64/1-1]; collaborative research Center [SFB593]; LOEWE program of the State of Hesse	DFG(German Research Foundation (DFG)); collaborative research Center; LOEWE program of the State of Hesse	We are thankful to N. Amrhein and H.-U. Mosch for their comments on the manuscript. We thank B. Valent and C. H. Khang for alerting us to the fact that Magnaporthe grisea possesses a secreted chorismate mutase, and are grateful to M. Dickman for allowing us to cite his unpublished results. We thank T. Brefort, E. Morschel, A. Kaever and M. Landesfeind for experimental support. We acknowledge advice by P. Kast, thank P. Schulze-Lefert for the Gateway-compatible plant transformation vectors, and D. Sicker for providing DIBOA and DIMBOA standards. We acknowledge technical assistance by R. Wissel, S. Loser, D. Vogel, F. Raths, G. Sowa, K. Bolte, M. Johannsen and P. Meyer. Our work was supported through DFG project DJ64/1-1, the collaborative research Center SFB593, and the LOEWE program of the State of Hesse.	BANUETT F, 1989, P NATL ACAD SCI USA, V86, P5878, DOI 10.1073/pnas.86.15.5878; Basse CW, 2002, MOL MICROBIOL, V43, P75, DOI 10.1046/j.1365-2958.2002.02742.x; Bekal S, 2003, MOL PLANT MICROBE IN, V16, P439, DOI 10.1094/MPMI.2003.16.5.439; BOHLMANN R, 1996, THESIS L MAXIMILIAN; BOLKER M, 1995, CAN J BOT, V73, pS320; Brachmann A, 2001, MOL MICROBIOL, V42, P1047, DOI 10.1046/j.1365-2958.2001.02699.x; DEWIT PJGM, 1982, PHYSIOL PLANT PATHOL, V21, P1, DOI 10.1016/0048-4059(82)90002-9; Di Stasio M, 2009, MOL MICROBIOL, V73, P73, DOI 10.1111/j.1365-2958.2009.06747.x; Doehlemann G, 2008, PLANT J, V56, P181, DOI 10.1111/j.1365-313X.2008.03590.x; Doehlemann G, 2008, J PLANT PHYSIOL, V165, P29, DOI 10.1016/j.jplph.2007.05.016; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Doyle EA, 2003, MOL PLANT MICROBE IN, V16, P123, DOI 10.1094/MPMI.2003.16.2.123; Eberhard J, 1996, PLANT J, V10, P815, DOI 10.1046/j.1365-313X.1996.10050815.x; EBERHARD J, 1993, FEBS LETT, V334, P233, DOI 10.1016/0014-5793(93)81718-F; GILCHRIST DG, 1987, METHOD ENZYMOL, V142, P450; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Horst RJ, 2010, PLANT PHYSIOL, V152, P293, DOI 10.1104/pp.109.147702; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kaever A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-92; Krappmann S, 1999, J BIOL CHEM, V274, P22275, DOI 10.1074/jbc.274.32.22275; Loubradou G, 2001, MOL MICROBIOL, V40, P719, DOI 10.1046/j.1365-2958.2001.02424.x; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Naranjo MA, 2003, PLANTA, V217, P417, DOI 10.1007/s00425-003-1017-4; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Pommerrenig B, 2011, PLANT CELL, V23, P1904, DOI 10.1105/tpc.110.079657; SAMBROOK JFE, 1989, MOL CLONING LAB MANU, P1200; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Schnappauf G, 1997, P NATL ACAD SCI USA, V94, P8491, DOI 10.1073/pnas.94.16.8491; Schnappauf G, 1998, P NATL ACAD SCI USA, V95, P2868, DOI 10.1073/pnas.95.6.2868; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimada Y, 2009, AUST DENT J, V54, P347, DOI 10.1111/j.1834-7819.2009.01161.x; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; UEKI S, 2008, NAT PROTOC, V4, P71; WILLE AC, 1984, PLANTA, V160, P129, DOI 10.1007/BF00392861	39	363	380	9	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					395	+		10.1038/nature10454	http://dx.doi.org/10.1038/nature10454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21976020				2022-12-24	WOS:000296021100048
J	Noah, MA; Peek, GJ; Finney, SJ; Griffiths, MJ; Harrison, DA; Grieve, R; Sadique, MZ; Sekhon, JS; McAuley, DF; Firmin, RK; Harvey, C; Cordingley, JJ; Price, S; Vuylsteke, A; Jenkins, DP; Noble, DW; Bloomfield, R; Walsh, TS; Perkins, GD; Menon, D; Taylor, BL; Rowan, KM				Noah, Moronke A.; Peek, Giles J.; Finney, Simon J.; Griffiths, Mark J.; Harrison, David A.; Grieve, Richard; Sadique, M. Zia; Sekhon, Jasjeet S.; McAuley, Daniel F.; Firmin, Richard K.; Harvey, Christopher; Cordingley, Jeremy J.; Price, Susanna; Vuylsteke, Alain; Jenkins, David P.; Noble, David W.; Bloomfield, Roxanna; Walsh, Timothy S.; Perkins, Gavin D.; Menon, David; Taylor, Bruce L.; Rowan, Kathryn M.			Referral to an Extracorporeal Membrane Oxygenation Center and Mortality Among Patients With Severe 2009 Influenza A(H1N1)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; CRITICALLY-ILL PATIENTS; CRITICAL-CARE SERVICES; H1N1 INFLUENZA; ORGAN FAILURE; VOLUME; OPTIMIZATION; MULTIVARIATE; VENTILATION	Context Extracorporeal membrane oxygenation (ECMO) can support gas exchange in patients with severe acute respiratory distress syndrome (ARDS), but its role has remained controversial. ECMO was used to treat patients with ARDS during the 2009 influenza A(H1N1) pandemic. Objective To compare the hospital mortality of patients with H1N1-related ARDS referred, accepted, and transferred for ECMO with matched patients who were not referred for ECMO. Design, Setting, and Patients A cohort study in which ECMO-referred patients were defined as all patients with H1N1-related ARDS who were referred, accepted, and transferred to 1 of the 4 adult ECMO centers in the United Kingdom during the H1N1 pandemic in winter 2009-2010. The ECMO-referred patients and the non-ECMO-referred patients were matched using data from a concurrent, longitudinal cohort study (Swine Flu Triage study) of critically ill patients with suspected or confirmed H1N1. Detailed demographic, physiological, and comorbidity data were used in 3 different matching techniques (individual matching, propensity score matching, and GenMatch matching). Main Outcome Measure Survival to hospital discharge analyzed according to the intention-to-treat principle. Results Of 80 ECMO-referred patients, 69 received ECMO (86.3%) and 22 died (27.5%) prior to discharge from the hospital. From a pool of 1756 patients, there were 59 matched pairs of ECMO-referred patients and non-ECMO-referred patients identified using individual matching, 75 matched pairs identified using propensity score matching, and 75 matched pairs identified using GenMatch matching. The hospital mortality rate was 23.7% for ECMO-referred patients vs 52.5% for non-ECMO-referred patients (relative risk [RR], 0.45 [95% CI, 0.26-0.79]; P=.006) when individual matching was used; 24.0% vs 46.7%, respectively (RR, 0.51 [95% CI, 0.31-0.81]; P=.008) when propensity score matching was used; and 24.0% vs 50.7%, respectively (RR, 0.47 [95% CI, 0.31-0.72]; P=.001) when GenMatch matching was used. The results were robust to sensitivity analyses, including amending the inclusion criteria and restricting the location where the non-ECMO-referred patients were treated. Conclusion For patients with H1N1-related ARDS, referral and transfer to an ECMO center was associated with lower hospital mortality compared with matched non-ECMO-referred patients. JAMA. 2011;306(15):1659-1668 Published online October 5, 2011. doi:10.1001/jama.2011.1471 www.jama.com	[Noah, Moronke A.; Peek, Giles J.; Finney, Simon J.; Harvey, Christopher] Glenfield Hosp, Heartlink ECMO Ctr, Groby Rd, Leicester LE3 9QP, Leics, England; [Finney, Simon J.; Griffiths, Mark J.; Cordingley, Jeremy J.; Price, Susanna] Royal Brompton Hosp, Dept Anaesthesia, London SW3 6LY, England; [Harrison, David A.; Rowan, Kathryn M.] Intens Care Natl Audit & Res Ctr, London, England; [Grieve, Richard; Sadique, M. Zia] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Sekhon, Jasjeet S.] Univ Calif Berkeley, Travers Dept Polit Sci, Berkeley, CA 94720 USA; [McAuley, Daniel F.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Vuylsteke, Alain; Jenkins, David P.] Papworth Hosp, Dept Anaesthesia, Cambridge CB3 8RE, England; [Noble, David W.; Bloomfield, Roxanna] Aberdeen Royal Infirm, Dept Anaesthesia, Aberdeen, Scotland; [Walsh, Timothy S.] Univ Edinburgh, Dept Crit Care Med, Edinburgh, Midlothian, Scotland; [Perkins, Gavin D.] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Menon, David] Univ Cambridge, Div Anaesthesia, Cambridge, England; [Taylor, Bruce L.] Portsmouth Hosp NHS Trust, Dept Crit Care, Portsmouth, Hants, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Royal Brompton Hospital; Intensive Care National Audit & Research Centre; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Berkeley; Queens University Belfast; Papworth Hospital; University of Aberdeen; University of Edinburgh; University of Warwick; University of Cambridge; Portsmouth Hospitals NHS Trust	Peek, GJ (corresponding author), Glenfield Hosp, Heartlink ECMO Ctr, Groby Rd, Leicester LE3 9QP, Leics, England.	giles.peek@uhl-tr.nhs.uk	Perkins, Gavin/E-7613-2010; Finney, Simon/A-2168-2012; Harrison, David A/O-4355-2018; Peek, Giles/I-1530-2019; Price, Susanna/AAH-7515-2021; Vuylsteke, Alain/AAF-2108-2020	Finney, Simon/0000-0001-8219-1952; Harrison, David A/0000-0002-9002-9098; Perkins, Gavin/0000-0003-3027-7548; Grieve, Richard/0000-0001-8899-1301; Rowan, Kathryn/0000-0001-8217-5602; Noah, Abiodun Moronke/0000-0002-4008-8532; Griffiths, Mark/0000-0002-1615-1896; McAuley, Daniel/0000-0002-3283-1947; peek, giles/0000-0002-1313-6498; Sadique, Zia/0000-0001-5814-0258	Society of Critical Care Medicine; European Society of Intensive Care Medicine; Avalon Labs; GlaxoSmithKline; (Intensive Care National Audit AMP; Research Centre) from the National Institute for Health Research; AstraZeneca; Medtronic; National Institute for Health Research; UK Health Technology; Economic and Social Research Council [ES/G00188X/1] Funding Source: researchfish; Medical Research Council [G0901697, G106/1173] Funding Source: researchfish; National Institute for Health Research [09/86/01, PDA/03/07/026] Funding Source: researchfish; ESRC [ES/G00188X/1] Funding Source: UKRI; MRC [G106/1173, G0901697] Funding Source: UKRI	Society of Critical Care Medicine; European Society of Intensive Care Medicine; Avalon Labs; GlaxoSmithKline(GlaxoSmithKline); (Intensive Care National Audit AMP; Research Centre) from the National Institute for Health Research; AstraZeneca(AstraZeneca); Medtronic(Medtronic); National Institute for Health Research(National Institute for Health Research (NIHR)); UK Health Technology; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Peek reported that money has been paid to his institution (Glenfield Hospital) as grants from the Society of Critical Care Medicine, the European Society of Intensive Care Medicine, Avalon Labs, and Chalice Medical for travel and accommodation to facilitate his attendance at international conferences. Dr Griffiths reported that money was paid to him from GlaxoSmithKline for development of assets for acute lung injury and he has grants pending with GlaxoSmithKline for such development of assets. Dr Harrison reported that money has been paid to his institution (Intensive Care National Audit & Research Centre) from the National Institute for Health Research as research grant funding for the SwiFT study. Dr McAuley reported that he has consulted for, sat on advisory boards for, and received lecture fees from GlaxoSmithKline and received lecture fees from AstraZeneca for educational meetings. Dr Harvey reported that money has been paid to him from Avalon Labs for the cost of flights to attend an extracorporeal membrane oxygenation (ECMO) conference. Dr Price reported that she has received royalties as a textbook editor for cardiovascular critical care from Wiley-Blackwell; payment for the development of educational materials and honoraria from Medtronic; and reimbursement from Medtronic for travel undertaken to give educational lectures and accommodations for the European Society of Cardiology meeting in 2010 and 2011. Dr Jenkins reported that he has received reimbursement from Chalice Medical (UK distributor for Levitronix ECMO pump) for travel expenses to the Extracorporeal Life Support Organization conference in 2010. Dr Perkins reported that money was paid to his institution (University of Warwick) from GlaxoSmithKline for his work as a member of an advisory board for novel treatment of acute respiratory distress syndrome; and he received lecture fees from GlaxoSmithKline. Dr Menon reported that his institution has received grant support from the National Institute for Health Research, UK Health Technology; he serves as a paid consultant or member of a data and safety monitoring board for Solvay, GlaxoSmithKline, Brainscope, Ornim Medical, Shire Medical, and Neurovive; he has received an honorarium from GlaxoSmithKline for one lecture at the London Hospital; money is paid to his institution for a patent registered for a new positron emission tomography ligand for assessing mitochondrial function; and he receives royalties from the University of Cambridge Press as a co-editor of a textbook on neuroanesthesia and critical care. Dr Rowan reported that money was paid to her institution (Intensive Care National Audit & Research Centre) from the National Institute for Health Research as research grant funding for the SwiFT study. No other authors reported disclosures.r The SwiFT study was funded by the National Institute for Health Research and has been published in full in the Health Technology Assessment journal series.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Bellingan G, 2005, PLOS MED, V2, P480, DOI 10.1371/journal.pmed.0020130; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Diamond A, GENETIC MATCHING EST; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Freed DH, 2010, CAN J ANAESTH, V57, P240, DOI 10.1007/s12630-009-9253-0; Glance LG, 2007, MED CARE, V45, P292, DOI 10.1097/01.mlr.0000252225.26917.91; Hager DN, 2005, AM J RESP CRIT CARE, V172, P1241, DOI 10.1164/rccm.200501-048CP; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Mebane WR, 2011, J STAT SOFTW, V42, P1; Meduri GU, 2007, CHEST, V131, P954, DOI 10.1378/chest.06-2100; Monchi M, 1998, AM J RESP CRIT CARE, V158, P1076, DOI 10.1164/ajrccm.158.4.9802009; Morgan OW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009694; Morris AH, 2010, CHEST, V138, P778, DOI 10.1378/chest.10-1792; Park PK, 2010, CHEST, V138, P776, DOI 10.1378/chest.10-1791; Peek GJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14350; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Pinhu L, 2003, LANCET, V361, P332, DOI 10.1016/S0140-6736(03)12329-X; Rajan SS, 2011, MED CARE, V49, P649, DOI 10.1097/MLR.0b013e318215c42e; Ramsahai RR, 2011, HEALTH SERV OUTCOME, V11, P95, DOI 10.1007/s10742-011-0075-5; Roch A, 2010, INTENS CARE MED, V36, P1899, DOI 10.1007/s00134-010-2021-3; Rosenbaum PR, 2002, STAT SCI, V17, P286; Rowan KM, 2010, HEALTH TECHNOL ASSES, V14, P335, DOI 10.3310/hta14550-05; Sekhon J. S., 1998, POLIT ANAL, V7, P187, DOI DOI 10.HTTP://DX.D0I.0RG/10.1093/PAN/7.1.187; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Sekhon JS, 2012, HEALTH ECON, V21, P695, DOI 10.1002/hec.1748; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Suchyta MR, 2003, CHEST, V124, P1871, DOI 10.1378/chest.124.5.1871; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Terragni PP, 2009, ANESTHESIOLOGY, V111, P826, DOI 10.1097/ALN.0b013e3181b764d2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wiedemann HP, 2006, NEW ENGL J MED, V354, P2564; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; Zwischenberger JB, 2009, LANCET, V374, P1307, DOI 10.1016/S0140-6736(09)61630-5	43	549	589	2	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 19	2011	306	15					1659	1668		10.1001/jama.2011.1471	http://dx.doi.org/10.1001/jama.2011.1471			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	834MA	21976615	Bronze			2022-12-24	WOS:000295963200025
J	Staver, AC; Archibald, S; Levin, SA				Staver, A. Carla; Archibald, Sally; Levin, Simon A.			The Global Extent and Determinants of Savanna and Forest as Alternative Biome States	SCIENCE			English	Article							AMAZON RAIN-FOREST; AFRICAN SAVANNAS; WOODY COVER; SOUTHERN AFRICA; C-4 GRASSLANDS; TREE COVER; FIRE; DYNAMICS; VEGETATION; WOODLAND	Theoretically, fire-tree cover feedbacks can maintain savanna and forest as alternative stable states. However, the global extent of fire-driven discontinuities in tree cover is unknown, especially accounting for seasonality and soils. We use tree cover, climate, fire, and soils data sets to show that tree cover is globally discontinuous. Climate influences tree cover globally but, at intermediate rainfall (1000 to 2500 millimeters) with mild seasonality (less than 7 months), tree cover is bimodal, and only fire differentiates between savanna and forest. These may be alternative states over large areas, including parts of Amazonia and the Congo. Changes in biome distributions, whether at the cost of savanna (due to fragmentation) or forest (due to climate), will be neither smooth nor easily reversible.	[Staver, A. Carla; Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Archibald, Sally] CSIR, ZA-0001 Pretoria, South Africa	Princeton University; Council for Scientific & Industrial Research (CSIR) - South Africa	Staver, AC (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	astaver@princeton.edu	Levin, Simon A/J-1218-2014; Archibald, Sally/O-1659-2015; Staver, Ann Carla/B-4990-2015	Levin, Simon A/0000-0002-8216-5639; Archibald, Sally/0000-0003-2786-3976; 	Andrew W. Mellon Foundation	Andrew W. Mellon Foundation	We thank A. Wolf, S. Batterman, and S. Rabin for manuscript feedback. Funding was provided by the Andrew W. Mellon Foundation. All data are freely available at http://modis.gsfc.nasa.gov/, http://trmm.gsfc.nasa.gov/, and www.fao.org/nr/land/soils/harmonized-world-soil-database/en/.	Archibald S, 2005, ECOL APPL, V15, P96, DOI 10.1890/03-5210; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Asner GP, 2010, NEW PHYTOL, V187, P569, DOI 10.1111/j.1469-8137.2010.03310.x; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; CAHOON DR, 1992, NATURE, V359, P812, DOI 10.1038/359812a0; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Desjardins T, 1996, OECOLOGIA, V108, P749, DOI 10.1007/BF00329051; Goetze D, 2006, J BIOGEOGR, V33, P653, DOI 10.1111/j.1365-2699.2005.01312.x; Good SP, 2011, P NATL ACAD SCI USA, V108, P4902, DOI 10.1073/pnas.1013100108; Keeley JE, 2005, ECOL LETT, V8, P683, DOI 10.1111/j.1461-0248.2005.00767.x; Kumar KK, 1999, SCIENCE, V284, P2156, DOI 10.1126/science.284.5423.2156; Lehmann CER, 2011, NEW PHYTOL, V191, P197, DOI 10.1111/j.1469-8137.2011.03689.x; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; Mitchard ETA, 2009, EARTH INTERACT, V13, DOI 10.1175/2009EI278.1; Moreira AG, 2000, J BIOGEOGR, V27, P1021, DOI 10.1046/j.1365-2699.2000.00422.x; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; PRINS HHT, 1993, J ECOL, V81, P305, DOI 10.2307/2261500; Pueyo S, 2010, ECOL LETT, V13, P793, DOI 10.1111/j.1461-0248.2010.01497.x; Ruggiero PGC, 2002, PLANT ECOL, V160, P1, DOI 10.1023/A:1015819219386; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Sankaran M, 2008, GLOBAL ECOL BIOGEOGR, V17, P236, DOI 10.1111/j.1466-8238.2007.00360.x; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Staver AC, 2009, ECOL APPL, V19, P1909, DOI 10.1890/08-1907.1; SWAINE MD, 1992, BIOTROPICA, V24, P166, DOI 10.2307/2388670; Veenendaal EM, 2004, GLOBAL CHANGE BIOL, V10, P318, DOI 10.1111/j.1365-2486.2003.00699.x; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Willis KJ, 2004, SCIENCE, V304, P402, DOI 10.1126/science.1093991	30	797	810	20	363	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					230	232		10.1126/science.1210465	http://dx.doi.org/10.1126/science.1210465			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998389				2022-12-24	WOS:000295833600047
J	Arnon, TI; Xu, Y; Lo, C; Pham, T; An, J; Coughlin, S; Dorn, GW; Cyster, JG				Arnon, Tal I.; Xu, Ying; Lo, Charles; Trung Pham; An, Jinping; Coughlin, Shaun; Dorn, Gerald W.; Cyster, Jason G.			GRK2-Dependent S1PR1 Desensitization Is Required for Lymphocytes to Overcome Their Attraction to Blood	SCIENCE			English	Article							RECEPTOR KINASE 2; B-CELLS; LYMPH-NODES; EGRESS; RECIRCULATION; EXPRESSION; CHEMOKINES; AGONISTS; ROLES; GRK2	Lymphocytes egress from lymphoid organs in response to sphingosine-1-phosphate (S1P); minutes later they migrate from blood into tissue against the S1P gradient. The mechanisms facilitating cell movement against the gradient have not been defined. Here, we show that heterotrimeric guanine nucleotide-binding protein-coupled receptor kinase-2 (GRK2) functions in down-regulation of S1P receptor-1 (S1PR1) on blood-exposed lymphocytes. T and B cell movement from blood into lymph nodes is reduced in the absence of GRK2 but is restored in S1P-deficient mice. In the spleen, B cell movement between the blood-rich marginal zone and follicles is disrupted by GRK2 deficiency and by mutation of an S1PR1 desensitization motif. Moreover, delivery of systemic antigen into follicles is impaired. Thus, GRK2-dependent S1PR1 desensitization allows lymphocytes to escape circulatory fluids and migrate into lymphoid tissues.	[Arnon, Tal I.; Xu, Ying; Lo, Charles; Trung Pham; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Arnon, Tal I.; Xu, Ying; Lo, Charles; Trung Pham; An, Jinping; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Coughlin, Shaun] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Dorn, Gerald W.] Washington Univ, Sch Med, Dept Internal Med, Ctr Pharmacogenom, St Louis, MO 63110 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL)	Cyster, JG (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Arnon, Tal/0000-0003-4629-5820; Pham, Trung/0000-0003-2724-2547	NIH [AI74847]; Research Exchange Grant; Osaka University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Exchange Grant; Osaka University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Caron and M. von Zastrow for GRK2<SUP>+/-</SUP> mice; J. Green for helpful input; and O. Bannard, J. Green, A. Reboldi, and S. Rosen for comments on the manuscript. T. I. A. was a Jane Coffin Childs Memorial Fellow, and J. G. C. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by NIH grant AI74847 and by a Research Exchange Grant with Osaka University. The data reported in this paper are tabulated in the main text and in the supporting online material. Use of both the GRK2<SUP>f/f</SUP> mice and S1PR1<SUP>TSS</SUP> mice will require a material transfer agreement.	Alon R, 2009, MICROCIRCULATION, V16, P3, DOI 10.1080/10739680802026076; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Ferguson AR, 2004, INT IMMUNOL, V16, P1411, DOI 10.1093/intimm/dxh142; Grabovsky V, 2000, J EXP MED, V192, P495, DOI 10.1084/jem.192.4.495; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jo EJ, 2005, CHEM BIOL, V12, P703, DOI 10.1016/j.chembiol.2005.04.019; Johnston B, 2002, SEMIN IMMUNOL, V14, P83, DOI 10.1006/smim.2001.0345; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu CH, 1999, MOL BIOL CELL, V10, P1179, DOI 10.1091/mbc.10.4.1179; Lo CG, 2005, J EXP MED, V201, P291, DOI 10.1084/jem.20041509; Matkovich SJ, 2006, CIRC RES, V99, P996, DOI 10.1161/01.RES.0000247932.71270.2c; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Oo ML, 2007, J BIOL CHEM, V282, P9082, DOI 10.1074/jbc.M610318200; Oo ML, 2011, J CLIN INVEST, V121, P2290, DOI 10.1172/JCI45403; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Penela P, 2009, CELL ADHES MIGR, V3, P19, DOI 10.4161/cam.3.1.7149; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; SMITH ME, 1983, IMMUNOLOGY, V49, P83; Tang MLK, 1998, J IMMUNOL, V160, P5113; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Vroon A, 2005, J IMMUNOL, V174, P4400, DOI 10.4049/jimmunol.174.7.4400; Vroon A, 2004, J LEUKOCYTE BIOL, V75, P901, DOI 10.1189/jlb.0403136; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200	29	144	149	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1898	1903		10.1126/science.1208248	http://dx.doi.org/10.1126/science.1208248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960637	Green Accepted			2022-12-24	WOS:000295365800059
J	Yang, YL; Atasoy, D; Su, HH; Sternson, SM				Yang, Yunlei; Atasoy, Deniz; Su, Helen H.; Sternson, Scott M.			Hunger States Switch a Flip-Flop Memory Circuit via a Synaptic AMPK-Dependent Positive Feedback Loop	CELL			English	Article							ACTIVATED PROTEIN-KINASE; ARCUATE NUCLEUS; BETA-ENDORPHIN; SIGNAL-TRANSDUCTION; ENERGY HOMEOSTASIS; NPY/AGRP NEURONS; GHRELIN RECEPTOR; MESSENGER-RNA; FOOD-INTAKE; LEPTIN	Synaptic plasticity in response to changes in physiologic state is coordinated by hormonal signals across multiple neuronal cell types. Here, we combine cell-type-specific electrophysiological, pharmacological, and optogenetic techniques to dissect neural circuits and molecular pathways controlling synaptic plasticity onto AGRP neurons, a population that regulates feeding. We find that food deprivation elevates excitatory synaptic input, which is mediated by a presynaptic positive feedback loop involving AMP-activated protein kinase. Potentiation of glutamate release was triggered by the orexigenic hormone ghrelin and exhibited hysteresis, persisting for hours after ghrelin removal. Persistent activity was reversed by the anorexigenic hormone leptin, and optogenetic photostimulation demonstrated involvement of opioid release from POMC neurons. Based on these experiments, we propose a memory storage device for physiological state constructed from bistable synapses that are flipped between two sustained activity states by transient exposure to hormones signaling energy levels.	[Yang, Yunlei; Atasoy, Deniz; Su, Helen H.; Sternson, Scott M.] Howard Hughes Med Inst, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Sternson, SM (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	sternsons@janelia.hhmi.org	Atasoy, Deniz/AAR-7917-2020; Atasoy, Deniz/B-3414-2018	Atasoy, Deniz/0000-0002-3325-8820; 	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This research was funded by the Howard Hughes Medical Institute. We thank L. Scheffer for discussion of digital electronic circuits; J. Cox for mouse husbandry; Y. Aponte for assistance with animal studies; Y. Li and Z. Zhang for assistance with biochemistry; and K. Moses, S. Eddy, K. Svoboda, G. Murphy, and C. Zuker for comments on the manuscript. Leptin was provided by Amylin Pharmaceuticals. Y.Y. performed the experiments. H.S. performed western blots. D.A. made the initial finding of deprivation-induced plasticity. Y.Y. and S.M.S. designed the study, analyzed the data, and wrote the paper.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Appleyard SM, 2003, ENDOCRINOLOGY, V144, P1753, DOI 10.1210/en.2002-221096; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Boelen A, 2006, J ENDOCRINOL, V190, P537, DOI 10.1677/joe.1.06872; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cannon WB, 1929, PHYSIOL REV, V9, P399, DOI 10.1152/physrev.1929.9.3.399; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Endo K, 2000, J PHYSIOL-LONDON, V524, P769, DOI 10.1111/j.1469-7793.2000.00769.x; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Gordon GRJ, 2006, J PHYSIOL-LONDON, V576, P341, DOI 10.1113/jphysiol.2006.110270; GRANDISON L, 1977, NEUROPHARMACOLOGY, V16, P533, DOI 10.1016/0028-3908(77)90019-3; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HOLM S, 1979, SCAND J STAT, V6, P65; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Horowitz P., 2015, ART ELECT; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Li C, 1999, BRAIN RES, V824, P267, DOI 10.1016/S0006-8993(99)01217-2; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Martianez T, 2009, J BIOL CHEM, V284, P23902, DOI 10.1074/jbc.M109.026054; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Silva RM, 2001, J PHARMACOL EXP THER, V297, P590; Smith RG, 2005, ENDOCR REV, V26, P346, DOI 10.1210/er.2004-0019; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Takahashi KA, 2005, ENDOCRINOLOGY, V146, P1043, DOI 10.1210/en.2004-1397; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	44	296	300	2	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					991	1002		10.1016/j.cell.2011.07.039	http://dx.doi.org/10.1016/j.cell.2011.07.039			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925320	Green Accepted, Bronze			2022-12-24	WOS:000295258100020
J	Burrows, MT; Schoeman, DS; Buckley, LB; Moore, P; Poloczanska, ES; Brander, KM; Brown, C; Bruno, JF; Duarte, CM; Halpern, BS; Holding, J; Kappel, CV; Kiessling, W; O'Connor, MI; Pandolfi, JM; Parmesan, C; Schwing, FB; Sydeman, WJ; Richardson, AJ				Burrows, Michael T.; Schoeman, David S.; Buckley, Lauren B.; Moore, Pippa; Poloczanska, Elvira S.; Brander, Keith M.; Brown, Chris; Bruno, John F.; Duarte, Carlos M.; Halpern, Benjamin S.; Holding, Johnna; Kappel, Carrie V.; Kiessling, Wolfgang; O'Connor, Mary I.; Pandolfi, John M.; Parmesan, Camille; Schwing, Franklin B.; Sydeman, William J.; Richardson, Anthony J.			The Pace of Shifting Climate in Marine and Terrestrial Ecosystems	SCIENCE			English	Article							LONG-TERM CHANGES; RANGE SHIFTS; GLOBAL BIODIVERSITY; SCENARIOS; PATTERNS; IMPACTS; RATES	Climate change challenges organisms to adapt or move to track changes in environments in space and time. We used two measures of thermal shifts from analyses of global temperatures over the past 50 years to describe the pace of climate change that species should track: the velocity of climate change (geographic shifts of isotherms over time) and the shift in seasonal timing of temperatures. Both measures are higher in the ocean than on land at some latitudes, despite slower ocean warming. These indices give a complex mosaic of predicted range shifts and phenology changes that deviate from simple poleward migration and earlier springs or later falls. They also emphasize potential conservation concerns, because areas of high marine biodiversity often have greater velocities of climate change and seasonal shifts.	[Burrows, Michael T.] Scottish Assoc Marine Sci, Scottish Marine Inst, Dept Ecol, Oban PA37 1QA, Argyll, Scotland; [Schoeman, David S.] Univ Ulster, Environm Sci Res Inst, Sch Environm Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Schoeman, David S.] Nelson Mandela Metropolitan Univ, Dept Zool, ZA-6031 Port Elizabeth, South Africa; [Buckley, Lauren B.; Bruno, John F.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Moore, Pippa] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth SY23 3DA, Dyfed, Wales; [Moore, Pippa] Edith Cowan Univ, Ctr Marine Ecosyst Res, Perth, WA 6027, Australia; [Poloczanska, Elvira S.; Brown, Chris; Richardson, Anthony J.] Commonwealth Sci & Ind Res Org Marine & Atmospher, Brisbane, Qld 4001, Australia; [Brander, Keith M.] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Brown, Chris; Richardson, Anthony J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Duarte, Carlos M.] Univ Western Australia, Oceans Inst, Crawley, WA 6009, Australia; [Duarte, Carlos M.; Holding, Johnna] Univ Balearic Isl, Dept Global Change Res, Inst Mediterraneo Estudios Avanzados, Consejo Super Invest Cient, Esporles 07190, Spain; [Halpern, Benjamin S.; Kappel, Carrie V.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Kiessling, Wolfgang] Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany; [O'Connor, Mary I.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [O'Connor, Mary I.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Pandolfi, John M.] Univ Queensland, Australian Res Council Ctr Excellence Coral Reef, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Parmesan, Camille] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Schwing, Franklin B.] Fisheries Serv, SW Fisheries Sci Ctr, NOAA, Pacific Grove, CA 93950 USA; [Sydeman, William J.] Farallon Inst Adv Ecosyst Res, Petaluma, CA 94975 USA; [Richardson, Anthony J.] Univ Queensland, Sch Math & Phys, Ctr Applicat Nat Resource Math, St Lucia, Qld 4072, Australia	UHI Millennium Institute; Ulster University; Nelson Mandela University; University of North Carolina; University of North Carolina Chapel Hill; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Edith Cowan University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Technical University of Denmark; University of Queensland; University of Western Australia; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of British Columbia; University of British Columbia; University of Queensland; University of Texas System; University of Texas Austin; National Oceanic Atmospheric Admin (NOAA) - USA; University of Queensland	Burrows, MT (corresponding author), Scottish Assoc Marine Sci, Scottish Marine Inst, Dept Ecol, Oban PA37 1QA, Argyll, Scotland.	michael.burrows@sams.ac.uk	Richardson, Anthony J/B-3649-2010; O'Connor, Mary/R-2933-2019; poloczanska, elvira/P-5356-2014; Brown, Christopher J/G-4287-2011; Duarte Quesada, Carlos Manuel/ABD-6208-2021; Brander, Keith/AAN-6278-2021; Duarte, Carlos M/A-7670-2013; Buckley, Lauren/ABD-6759-2021; Kiessling, Wolfgang/E-2259-2015; Pandolfi, John M/A-3121-2009; Moore, Pippa/H-8079-2013; Hu, Lile/E-7961-2015; Parmesan, Camille/GVT-5674-2022; O'Connor, Mary I/F-2275-2010; Burrows, Michael/ABF-4844-2020; Poloczanska, Elvira/F-4366-2014; Moore, Pippa/HCH-3738-2022; Burrows, Michael T/D-9844-2013	Richardson, Anthony J/0000-0002-9289-7366; Brown, Christopher J/0000-0002-7271-4091; Duarte, Carlos M/0000-0002-1213-1361; Buckley, Lauren/0000-0003-1315-3818; Kiessling, Wolfgang/0000-0002-1088-2014; Pandolfi, John M/0000-0003-3047-6694; Moore, Pippa/0000-0002-9889-2216; O'Connor, Mary I/0000-0001-9583-1592; Burrows, Michael/0000-0003-4620-5899; Burrows, Michael T/0000-0003-4620-5899; Brander, Keith/0000-0001-9927-9600; poloczanska, elvira/0000-0001-8470-0925; Holding, Johnna M/0000-0002-7364-0055; Schoeman, David/0000-0003-1258-0885; Parmesan, Camille/0000-0002-1515-274X	National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; UK Natural Environment Research Council; Australian Research Council [DP0879365]; Future Fellowship [FT0991722]; NERC [dml010004] Funding Source: UKRI; Natural Environment Research Council [dml010004] Funding Source: researchfish	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council(Australian Research Council); Future Fellowship(Australian Research Council); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was conducted as a part of the Towards Understanding Marine Biological Impacts of Climate Change Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (grant no. EF-0553768); the University of California, Santa Barbara; and the State of California. M.T.B. thanks the UK Natural Environment Research Council Oceans 2025 program, J.P. thanks the Australian Research Council Centre of Excellence for Coral Reef Studies for additional support, and A.J.R. was supported by the Australian Research Council Discovery Grant DP0879365 and Future Fellowship Grant FT0991722. Data used in analyses are available from the University of East Anglia Climate Research Unit and the UK Meteorological Office Hadley Centre, with online access at the British Atmospheric Data Centre.	Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Mieszkowska N, 2007, J MAR BIOL ASSOC UK, V87, P537, DOI 10.1017/S0025315407053799; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Puce S, 2009, MAR ECOL-EVOL PERSP, V30, P313, DOI 10.1111/j.1439-0485.2009.00283.x; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Williams PH, 1997, P ROY SOC B-BIOL SCI, V264, P141, DOI 10.1098/rspb.1997.0021	21	856	872	20	756	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					652	655		10.1126/science.1210288	http://dx.doi.org/10.1126/science.1210288			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053045				2022-12-24	WOS:000296494700050
J	Sallet, J; Mars, RB; Noonan, MP; Andersson, JL; O'Reilly, JX; Jbabdi, S; Croxson, PL; Jenkinson, M; Miller, KL; Rushworth, MFS				Sallet, J.; Mars, R. B.; Noonan, M. P.; Andersson, J. L.; O'Reilly, J. X.; Jbabdi, S.; Croxson, P. L.; Jenkinson, M.; Miller, K. L.; Rushworth, M. F. S.			Social Network Size Affects Neural Circuits in Macaques	SCIENCE			English	Article							PREFRONTAL CORTEX; TEMPORAL CORTEX; RHESUS-MONKEYS; BRAIN; FACES	It has been suggested that variation in brain structure correlates with the sizes of individuals' social networks. Whether variation in social network size causes variation in brain structure, however, is unknown. To address this question, we neuroimaged 23 monkeys that had been living in social groups set to different sizes. Subject comparison revealed that living in larger groups caused increases in gray matter in mid-superior temporal sulcus and rostral prefrontal cortex and increased coupling of activity in frontal and temporal cortex. Social network size, therefore, contributes to changes both in brain structure and function. The changes have potential implications for an animal's success in a social context; gray matter differences in similar areas were also correlated with each animal's dominance within its social network.	[Sallet, J.; Mars, R. B.; Noonan, M. P.; Croxson, P. L.; Rushworth, M. F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Sallet, J.; Mars, R. B.; Noonan, M. P.; Andersson, J. L.; O'Reilly, J. X.; Jbabdi, S.; Jenkinson, M.; Miller, K. L.; Rushworth, M. F. S.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX1 3UD, England; [Croxson, P. L.] Mt Sinai Sch Med, Icahn Med Inst, New York, NY 10029 USA	University of Oxford; University of Oxford; Icahn School of Medicine at Mount Sinai	Sallet, J (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	jerome.sallet@psy.ox.ac.uk	, sallet/H-9761-2019; Mars, Rogier/G-2312-2018; Mars, Rogier/GWZ-9665-2022; Jenkinson, Mark/AAC-8861-2019; Jbabdi, Saad/A-2483-2012	, sallet/0000-0002-7878-0209; Mars, Rogier/0000-0001-6302-8631; Jenkinson, Mark/0000-0001-6043-0166; Croxson, Paula/0000-0002-4649-980X; Jbabdi, Saad/0000-0003-3234-5639; O'Reilly, Jill/0000-0002-6998-455X; Rushworth, Matthew/0000-0002-5578-9884; Miller, Karla/0000-0002-2511-3189	UK Medical Research Council; Wellcome Trust; MRC [G0902373, G0700399, G0800578, G0400593, G0802459] Funding Source: UKRI; Medical Research Council [G0800578, G0400593, G0902373, G0802459, G0700399] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by the UK Medical Research Council and Wellcome Trust (M.P.N., K. M.). We thank C. Bergmann and Biomedical services staff for their assistance and R. Dunbar for helpful discussion.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Barbas H, 1999, J COMP NEUROL, V410, P343, DOI 10.1002/(SICI)1096-9861(19990802)410:3<343::AID-CNE1>3.0.CO;2-1; Barton RA, 2007, J EVOLUTION BIOL, V20, P1504, DOI 10.1111/j.1420-9101.2007.01330.x; Behrens TEJ, 2008, NATURE, V456, P245, DOI 10.1038/nature07538; Behrens TEJ, 2009, SCIENCE, V324, P1160, DOI 10.1126/science.1169694; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; Flombaum JI, 2005, CURR BIOL, V15, P447, DOI 10.1016/j.cub.2004.12.076; Frith CD, 2007, PHILOS T R SOC B, V362, P671, DOI 10.1098/rstb.2006.2003; Fujii N, 2009, SOC NEUROSCI-UK, V4, P73, DOI 10.1080/17470910802046230; Izquierdo A, 2005, J NEUROSCI, V25, P8534, DOI 10.1523/JNEUROSCI.1232-05.2005; Kikuchi Y, 2010, J NEUROSCI, V30, P13021, DOI 10.1523/JNEUROSCI.2267-10.2010; Lerch JP, 2011, NEUROIMAGE, V54, P2086, DOI 10.1016/j.neuroimage.2010.09.086; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Mars RB, 2011, J NEUROSCI, V31, P4087, DOI 10.1523/JNEUROSCI.5102-10.2011; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; PERRETT DI, 1992, PHILOS T ROY SOC B, V335, P23, DOI 10.1098/rstb.1992.0003; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; Pinsk MA, 2009, J NEUROPHYSIOL, V101, P2581, DOI 10.1152/jn.91198.2008; Quallo MM, 2009, P NATL ACAD SCI USA, V106, P18379, DOI 10.1073/pnas.0909751106; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Schulke O, 2010, CURR BIOL, V20, P2207, DOI 10.1016/j.cub.2010.10.058; Seo H, 2008, PHILOS T R SOC B, V363, P3845, DOI 10.1098/rstb.2008.0158; Tsao DY, 2008, P NATL ACAD SCI USA, V105, P19514, DOI 10.1073/pnas.0809662105; Tsujimoto S, 2011, TRENDS COGN SCI, V15, P169, DOI 10.1016/j.tics.2011.02.001; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; ZUMPE D, 1986, AM J PRIMATOL, V10, P291, DOI 10.1002/ajp.1350100402	29	296	299	2	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					697	700		10.1126/science.1210027	http://dx.doi.org/10.1126/science.1210027			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053054				2022-12-24	WOS:000296494700062
J	Cheng, W; Arunajadai, SG; Moffitt, JR; Tinoco, I; Bustamante, C				Cheng, Wei; Arunajadai, Srikesh G.; Moffitt, Jeffrey R.; Tinoco, Ignacio, Jr.; Bustamante, Carlos			Single-Base Pair Unwinding and Asynchronous RNA Release by the Hepatitis C Virus NS3 Helicase	SCIENCE			English	Article							DNA HELICASES; MECHANISM; TRANSLOCATION; REVEAL; UVRD; RESOLUTION; DYNAMICS; MOLECULE; MONOMER; ATP	Nonhexameric helicases use adenosine triphosphate (ATP) to unzip base pairs in double-stranded nucleic acids (dsNAs). Studies have suggested that these helicases unzip dsNAs in single-base pair increments, consuming one ATP molecule per base pair, but direct evidence for this mechanism is lacking. We used optical tweezers to follow the unwinding of double-stranded RNA by the hepatitis C virus NS3 helicase. Single-base pair steps by NS3 were observed, along with nascent nucleotide release that was asynchronous with base pair opening. Asynchronous release of nascent nucleotides rationalizes various observations of its dsNA unwinding and may be used to coordinate the translocation speed of NS3 along the RNA during viral replication.	[Cheng, Wei] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA; [Arunajadai, Srikesh G.] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Moffitt, Jeffrey R.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Tinoco, Ignacio, Jr.; Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Dept Mol & Cellular Biol, Dept Phys, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; Columbia University; Harvard University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Cheng, W (corresponding author), Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, 428 Church St, Ann Arbor, MI 48109 USA.	chengwe@umich.edu; carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073	University of Michigan at Ann Arbor; University of Michigan; March of Dimes Foundation [5_FY10_490]; NIH [5R01GM010840, 5R01GM032543]; U.S. Department of Energy [LBNL_DE_AC0376SF00098]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032543, R01GM010840] Funding Source: NIH RePORTER	University of Michigan at Ann Arbor(University of Michigan System); University of Michigan(University of Michigan System); March of Dimes Foundation(March of Dimes); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cheng lab members, especially X. Hou and H. Song, for critical reading of the manuscript; J. Yu for critical discussions; J. Vieregg for providing the all-AU RNA hairpin for WLC calibration of RNA elasticity; and Henkel Corporation for providing Ablefilm adhesive film for making microfluidic chambers. Supported by the University of Michigan at Ann Arbor, the Ara Paul Professorship fund at the University of Michigan, and March of Dimes Foundation research grant 5_FY10_490 (W. C.); NIH grant 5R01GM010840 (I. T.); U.S. Department of Energy grant LBNL_DE_AC0376SF00098; and NIH grant 5R01GM032543 (C. B.). W. C. is a Basil O'Connor Starter Scholar of the March of Dimes Foundation. W. C. prepared experimental materials and conducted the experiments; W. C., S. G. A., and J. R. M. performed the analysis; and W. C., S. G. A., J. R. M., I. T., and C. B. wrote the paper. The authors declare no competing financial interests.	Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Arunajadai SG, 2009, MATH BIOSCI, V220, P57, DOI 10.1016/j.mbs.2009.04.003; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Cheng W, 2010, OPT LETT, V35, P2988, DOI 10.1364/OL.35.002988; Dessinges MN, 2004, P NATL ACAD SCI USA, V101, P6439, DOI 10.1073/pnas.0306713101; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331; Eoff RL, 2006, NAT STRUCT MOL BIOL, V13, P242, DOI 10.1038/nsmb1055; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; Jankowsky E, 2011, TRENDS BIOCHEM SCI, V36, P19, DOI 10.1016/j.tibs.2010.07.008; Jennings TA, 2009, J BIOL CHEM, V284, P4806, DOI 10.1074/jbc.M805540200; Johnson DS, 2007, CELL, V129, P1299, DOI 10.1016/j.cell.2007.04.038; Lam AMI, 2006, J VIROL, V80, P404, DOI 10.1128/JVI.80.1.404-411.2006; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rajagopal V, 2010, J BIOL CHEM, V285, P17821, DOI 10.1074/jbc.M110.114785; Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294; Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704; Serebrov V, 2009, J BIOL CHEM, V284, P2512, DOI 10.1074/jbc.M805460200; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3	28	106	106	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1746	1749		10.1126/science.1206023	http://dx.doi.org/10.1126/science.1206023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940894	Green Accepted			2022-12-24	WOS:000295121500042
J	Muhlebach, MD; Mateo, M; Sinn, PL; Prufer, S; Uhlig, KM; Leonard, VHJ; Navaratnarajah, CK; Frenzke, M; Wong, XX; Sawatsky, B; Ramachandran, S; McCray, PB; Cichutek, K; von Messling, V; Lopez, M; Cattaneo, R				Muhlebach, Michael D.; Mateo, Mathieu; Sinn, Patrick L.; Pruefer, Steffen; Uhlig, Katharina M.; Leonard, Vincent H. J.; Navaratnarajah, Chanakha K.; Frenzke, Marie; Wong, Xiao X.; Sawatsky, Bevan; Ramachandran, Shyam; McCray, Paul B., Jr.; Cichutek, Klaus; von Messling, Veronika; Lopez, Marc; Cattaneo, Roberto			Adherens junction protein nectin-4 is the epithelial receptor for measles virus	NATURE			English	Article							ACTIVATION MOLECULE SLAM; CELLULAR RECEPTOR; V-DOMAIN; INFECTION; CELLS; MEMBER; BLIND	Measles virus is an aerosol-transmitted virus that affects more than 10 million children each year and accounts for approximately 120,000 deaths(1,2). Although it was long believed to replicate in the respiratory epithelium before disseminating, it was recently shown to infect initially macrophages and dendritic cells of the airways using signalling lymphocytic activation molecule family member 1 (SLAMF1; also called CD150) as a receptor(3-6). These cells then cross the respiratory epithelium and transport the infection to lymphatic organs where measles virus replicates vigorously(7). How and where the virus crosses back into the airways has remained unknown. On the basis of functional analyses of surface proteins preferentially expressed on virus-permissive human epithelial cell lines, here we identify nectin-4 (ref. 8; also called poliovirus-receptor-like-4 (PVRL4)) as a candidate host exit receptor. This adherens junction protein of the immunoglobulin superfamily interacts with the viral attachment protein with high affinity through its membrane-distal domain. Nectin-4 sustains measles virus entry and non-cytopathic lateral spread in well-differentiated primary human airway epithelial sheets infected basolaterally. It is downregulated in infected epithelial cells, including those of macaque tracheae. Although other viruses use receptors to enter hosts or transit through their epithelial barriers, we suggest that measles virus targets nectin-4 to emerge in the airways. Nectin-4 is a cellular marker of several types of cancer(9-11), which has implications for ongoing measles-virus-based clinical trials of oncolysis(12).	[Mateo, Mathieu; Leonard, Vincent H. J.; Navaratnarajah, Chanakha K.; Frenzke, Marie; Cattaneo, Roberto] Mayo Clin, Dept Mol Med, Rochester, MN 55902 USA; [Muhlebach, Michael D.; Pruefer, Steffen; Uhlig, Katharina M.; Cichutek, Klaus] Paul Ehrlich Inst, Div Med Biotechnol, D-63225 Langen, Germany; [Sinn, Patrick L.; Ramachandran, Shyam; McCray, Paul B., Jr.] Univ Iowa, Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Wong, Xiao X.; Sawatsky, Bevan; von Messling, Veronika] Univ Quebec, INRS, Laval, PQ H7V 1B7, Canada; [Wong, Xiao X.; Sawatsky, Bevan; von Messling, Veronika] Univ Quebec, Inst Armand Frappier, Laval, PQ H7V 1B7, Canada; [von Messling, Veronika] Duke Univ, Singapore 169857, Singapore; [von Messling, Veronika] Natl Univ Singapore, Singapore 169857, Singapore; [Lopez, Marc] CRCM, INSERM, UMR891, F-13009 Marseille, France; [Lopez, Marc] Univ Aix Marseille, F-13009 Marseille, France	Mayo Clinic; Paul Ehrlich Institute; University of Iowa; University of Quebec; Institut national de la recherche scientifique (INRS); University of Quebec; National University of Singapore; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite	Cattaneo, R (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN 55902 USA.	Cattaneo.Roberto@mayo.edu	Sinn, Patrick/M-8026-2018; Navaratnarajah, Chanakha/AAB-6171-2019	Sinn, Patrick/0000-0002-9746-966X; Navaratnarajah, Chanakha/0000-0002-4513-8412; Sawatsky, Bevan/0000-0001-6908-1556; MATEO, Mathieu/0000-0001-7941-0245; Muehlebach, Michael/0000-0002-7069-5018; McCray, Paul/0000-0002-4067-577X	BMG [2510-FSB-705]; NIH [R01 AI063476, R01 CA090636]; Roy J. Carver Charitable Trust; Cell Culture Core and Cell Morphology Cores; Center for Gene Therapy for Cystic Fibrosis [NIH P30 DK-54759]; Cystic Fibrosis Foundation; CIHR [MOP-66989, CFI 9488]; INSERM; Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer; NATIONAL CANCER INSTITUTE [R01CA090636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER	BMG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roy J. Carver Charitable Trust; Cell Culture Core and Cell Morphology Cores; Center for Gene Therapy for Cystic Fibrosis; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Paoli-Calmettes; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Bruning, A. Schnoor Cancio, A. Peterson, I. Meunier and C. Thibault for technical assistance; Y. Yanagi for Vero-hSLAM cells and p(+)MV323-EGFP; T. Stehle for soluble SLAMF1; J. Fournier and G. Kobinger for facilitating the macaque studies; and R. Konig, D. Schilling-Leiss and T. Miest for discussions. This paper is dedicated to Heinz Schaller by one of his students. This work was supported by grants BMG 2510-FSB-705 to M. D. M.; NIH R01 AI063476 and NIH R01 CA090636 to R. C.; the Roy J. Carver Charitable Trust, Cell Culture Core and Cell Morphology Cores, partially supported by the Center for Gene Therapy for Cystic Fibrosis (NIH P30 DK-54759), and the Cystic Fibrosis Foundation to P. B. M.; and CIHR MOP-66989 and CFI 9488 to V. v. M.; INSERM, Institut Paoli-Calmettes and the Ligue Nationale Contre le Cancer (label 2009-11) to M. L. X. X. W. was supported by a CIHR Master's Award.	[Anonymous], 2011, Nature, V473, P434, DOI 10.1038/473434a; Bergelson JM, 2009, CELL HOST MICROBE, V5, P517, DOI 10.1016/j.chom.2009.05.009; Brancati F, 2010, AM J HUM GENET, V87, P265, DOI 10.1016/j.ajhg.2010.07.003; Campadelli-Fiume G, 2000, REV MED VIROL, V10, P305, DOI 10.1002/1099-1654(200009/10)10:5<305::AID-RMV286>3.0.CO;2-T; Cattaneo R, 2008, NAT REV MICROBIOL, V6, P529, DOI 10.1038/nrmicro1927; Chen SY, 2011, J INFECT DIS, V203, P1517, DOI 10.1093/infdis/jir115; de Swart RL, 2007, PLOS PATHOG, V3, P1771, DOI 10.1371/journal.ppat.0030178; DeRycke MS, 2010, AM J CLIN PATHOL, V134, P835, DOI 10.1309/AJCPGXK0FR4MHIHB; Fabre S, 2002, J BIOL CHEM, V277, P27006, DOI 10.1074/jbc.M203228200; Fabre-Lafay S, 2005, J BIOL CHEM, V280, P19543, DOI 10.1074/jbc.M410943200; Ferreira CSA, 2010, J VIROL, V84, P3033, DOI 10.1128/JVI.01559-09; Galanis E, 2010, CANCER RES, V70, P875, DOI 10.1158/0008-5472.CAN-09-2762; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Lemon K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001263; Leonard VHJ, 2008, J CLIN INVEST, V118, P2448, DOI 10.1172/JCI35454; Leonard VHJ, 2010, J VIROL, V84, P3413, DOI 10.1128/JVI.02304-09; Ludlow M, 2010, J GEN VIROL, V91, P971, DOI 10.1099/vir.0.016428-0; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Monto AS, 1999, CLIN INFECT DIS, V28, P200, DOI 10.1086/515113; Navaratnarajah CK, 2008, J BIOL CHEM, V283, P11763, DOI 10.1074/jbc.M800896200; Noyce RS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002240; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Tahara M, 2008, J VIROL, V82, P4630, DOI 10.1128/JVI.02691-07; Takano A, 2009, CANCER RES, V69, P6694, DOI 10.1158/0008-5472.CAN-09-0016; Takeda M, 2000, J VIROL, V74, P6643, DOI 10.1128/JVI.74.14.6643-6647.2000; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; WELSHMAN MD, 1989, VET REC, V124, P184, DOI 10.1136/vr.124.8.184	30	392	409	3	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					530	U153		10.1038/nature10639	http://dx.doi.org/10.1038/nature10639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22048310	Green Accepted			2022-12-24	WOS:000298318000062
J	Cyrklaff, M; Sanchez, CP; Kilian, N; Bisseye, C; Simpore, J; Frischknecht, F; Lanzer, M				Cyrklaff, Marek; Sanchez, Cecilia P.; Kilian, Nicole; Bisseye, Cyrille; Simpore, Jacques; Frischknecht, Friedrich; Lanzer, Michael			Hemoglobins S and C Interfere with Actin Remodeling in Plasmodium falciparum-Infected Erythrocytes	SCIENCE			English	Article							RED-CELL MEMBRANE; MAURERS CLEFTS; MALARIA; PROTEINS; BLOOD; VIRULENCE; SKELETON; REVEALS; SYSTEM	The hemoglobins S and C protect carriers from severe Plasmodium falciparum malaria. Here, we found that these hemoglobinopathies affected the trafficking system that directs parasite-encoded proteins to the surface of infected erythrocytes. Cryoelectron tomography revealed that the parasite generated a host-derived actin cytoskeleton within the cytoplasm of wild-type red blood cells that connected the Maurer's clefts with the host cell membrane and to which transport vesicles were attached. The actin cytoskeleton and the Maurer's clefts were aberrant in erythrocytes containing hemoglobin S or C. Hemoglobin oxidation products, enriched in hemoglobin S and C erythrocytes, inhibited actin polymerization in vitro and may account for the protective role in malaria.	[Cyrklaff, Marek; Sanchez, Cecilia P.; Kilian, Nicole; Frischknecht, Friedrich; Lanzer, Michael] Univ Heidelberg, Dept Infect Dis, D-69120 Heidelberg, Germany; [Bisseye, Cyrille; Simpore, Jacques] Biomol Res Ctr Pietro Annigoni, Ouagadougou, Burkina Faso	Ruprecht Karls University Heidelberg	Cyrklaff, M (corresponding author), Univ Heidelberg, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	marek.cyrklaff@med.uni-heidelberg.de; michael_lanzer@med.uni-heidelberg.de	Bisseye, Cyrille/AGP-8782-2022; SIMPORE, Jacques/ABA-4873-2020; Lanzer, Michael/E-9752-2013; Bisseye, C./AFO-0118-2022	Bisseye, Cyrille/0000-0002-6888-6317; SIMPORE, Jacques/0000-0002-0415-9161; Lanzer, Michael/0000-0002-0220-6526; Frischknecht, Friedrich/0000-0002-8332-6668; Kilian, Nicole/0000-0001-7489-9782	Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie; Chica and Heinz Schaller Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF)); Chica and Heinz Schaller Foundation	We thank S. Prior, L. Lemgruber, and D. Ouermi for technical assistance and help. We thank the Max Planck Institutes (Martinsried and Frankfurt), the European Molecular Biology Laboratory, Centre for Organismal Studies, and Bioquant (Heidelberg) for access to EM facilities. Supported by the Deutsche Forschungsgemeinschaft (research focus Host-Parasite Coevolution); the Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie, and the Chica and Heinz Schaller Foundation. M. L. and F. F. are members of the Heidelberg Excellence Cluster CellNetworks and the European Network of Excellence EVIMalaR.	Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; An XU, 2008, BRIT J HAEMATOL, V141, P367, DOI 10.1111/j.1365-2141.2008.07091.x; ATKINSON CT, 1988, EUR J CELL BIOL, V45, P192; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; Farah ME, 2011, CYTOSKELETON, V68, P340, DOI 10.1002/cm.20516; Chaves MAF, 2008, HEMATOLOGY, V13, P187, DOI 10.1179/102453308X343356; GIULIVI C, 1990, J BIOL CHEM, V265, P19453; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; HEBBEL RP, 1991, BLOOD, V77, P214; Henrich Philipp, 2009, Biotechnology Journal, V4, P888, DOI 10.1002/biot.200900058; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x; JAROLIM P, 1990, BLOOD, V76, P2125; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; LIU SC, 1987, J CELL BIOL, V104, P527, DOI 10.1083/jcb.104.3.527; LIU SC, 1984, J BIOL CHEM, V259, P1556; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; Pasternak ND, 2009, INT J BIOCHEM CELL B, V41, P1463, DOI 10.1016/j.biocel.2008.12.012; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Schmitz S, 2005, J MOL BIOL, V349, P113, DOI 10.1016/j.jmb.2005.03.056; SHEN BW, 1984, J CELL BIOL, V99, P810, DOI 10.1083/jcb.99.3.810; Svistunenko DA, 1997, J BIOL CHEM, V272, P7114, DOI 10.1074/jbc.272.11.7114; Taraschi TF, 2003, BLOOD, V102, P3420, DOI 10.1182/blood-2003-05-1448; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	29	166	168	4	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 2	2011	334	6060					1283	1286		10.1126/science.1213775	http://dx.doi.org/10.1126/science.1213775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22075726				2022-12-24	WOS:000297553600052
J	Rosen, BA; Salehi-Khojin, A; Thorson, MR; Zhu, W; Whipple, DT; Kenis, PJA; Masel, RI				Rosen, Brian A.; Salehi-Khojin, Amin; Thorson, Michael R.; Zhu, Wei; Whipple, Devin T.; Kenis, Paul J. A.; Masel, Richard I.			Ionic Liquid-Mediated Selective Conversion of CO2 to CO at Low Overpotentials	SCIENCE			English	Article							CARBON-DIOXIDE; REDUCTION; SOLUBILITY; METHANOL	Electroreduction of carbon dioxide (CO2)-a key component of artificial photosynthesis-has largely been stymied by the impractically high overpotentials necessary to drive the process. We report an electrocatalytic system that reduces CO2 to carbon monoxide (CO) at overpotentials below 0.2 volt. The system relies on an ionic liquid electrolyte to lower the energy of the (CO2)(-) intermediate, most likely by complexation, and thereby lower the initial reduction barrier. The silver cathode then catalyzes formation of the final products. Formation of gaseous CO is first observed at an applied voltage of 1.5 volts, just slightly above the minimum (i.e., equilibrium) voltage of 1.33 volts. The system continued producing CO for at least 7 hours at Faradaic efficiencies greater than 96%.	[Rosen, Brian A.; Salehi-Khojin, Amin; Zhu, Wei; Masel, Richard I.] Dioxide Mat, Champaign, IL 61820 USA; [Thorson, Michael R.; Whipple, Devin T.; Kenis, Paul J. A.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Masel, RI (corresponding author), Dioxide Mat, 60 Hazelwood Dr, Champaign, IL 61820 USA.	rich.masel@dioxidematerials.com	Masel, Richard I/E-1957-2011; Kenis, Paul J A/S-7229-2016	Masel, Richard I/0000-0002-7392-6299; Kenis, Paul J A/0000-0001-7348-0381	U.S. Department of Energy (DOE) [DE-SC0004453]; Dioxide Materials; DOE Office of Science; DOE [DE-AC05-06OR23100]	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Dioxide Materials; DOE Office of Science(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	Supported in part by the U.S. Department of Energy (DOE) under grant DE-SC0004453 and by Dioxide Materials. B.A.R. was supported in part by an award from the DOE Office of Science Graduate Fellowship Program (DOE SCGF). The DOE SCGF Program was made possible in part by the American Recovery and Reinvestment Act of 2009 and is administered by the Oak Ridge Institute for Science and Education (ORISE) for DOE. ORISE is managed by Oak Ridge Associated Universities (ORAU) under DOE contract DE-AC05-06OR23100. The following patent applications are related to the work here: 12/830338, "Novel Catalyst Mixtures" (R.I.M.); 13/174365, "Novel Catalyst Mixtures" (R.I.M.); PCT/US11/42809, "Novel Catalyst Mixtures" (R.I.M.); PCT/US/11/30098, "Novel Catalyst Mixtures" (R.I.M. and B.A.R.); and 61/499225, "Inexpensive Carbon Dioxide Sensor" (R.I.M. and B.A.R.). All opinions expressed in this paper are those of the authors and do not necessarily reflect the policies and views of DOE, ORAU, or ORISE. Author contributions: R.I.M. conceived the project and led the work; B.A.R., R.I.M., A.S.-K., P.J.A.K., and M.R.T. planned the experiments; D.T.W., P.J.A.K., and R.I.M. designed the cell; B.A.R. took all of the data that appear in the paper; all of the measurements in this paper were done at Dioxide Materials; A.S.-K., W.Z., and M.R.T. took confirming data; and R.I.M. and P.J.A.K. supervised the work. The paper was drafted by R.I.M., A.S.-K., and P.J.A.K. with other authors offering critical comments. We thank G. Kaul for assistance in the electrochemical work.	Barnes AS, 2008, J PHYS CHEM C, V112, P13709, DOI 10.1021/jp803349z; Bell A. T., 2008, PNNL17214 US DEP EN; BOCKRIS JO, 1989, J ELECTROCHEM SOC, V136, P2521, DOI 10.1149/1.2097455; CHANDRASEKARAN K, 1987, SURF SCI, V185, P495, DOI 10.1016/S0039-6028(87)80173-5; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; DuBois D. L., 2006, ENCY ELECTROCHEMIS A, P202; Dubois MR, 2009, ACCOUNTS CHEM RES, V42, P1974, DOI 10.1021/ar900110c; Hammarstrom L, 2009, ACCOUNTS CHEM RES, V42, P1859, DOI 10.1021/ar900267k; Hollinger AS, 2010, J POWER SOURCES, V195, P3523, DOI 10.1016/j.jpowsour.2009.12.063; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Islam MM, 2008, J PHYS CHEM C, V112, P1269, DOI 10.1021/jp7096185; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Lim BH, 2009, KOREAN J CHEM ENG, V26, P1130, DOI 10.1007/s11814-009-0188-5; Maiti A, 2009, CHEMSUSCHEM, V2, P628, DOI 10.1002/cssc.200900086; Masel R.I., 2001, CHEM KINETICS CATALY; Morris AJ, 2011, CHEMSUSCHEM, V4, P191, DOI 10.1002/cssc.201000379; SESHADRI G, 1994, J ELECTROANAL CHEM, V372, P145, DOI 10.1016/0022-0728(94)03300-5; Shokouhi M, 2010, J CHEM ENG DATA, V55, P1663, DOI 10.1021/je900716q; Soriano AN, 2008, J CHEM ENG DATA, V53, P2550, DOI 10.1021/je8003657; Tang JB, 2009, IND ENG CHEM RES, V48, P9113, DOI 10.1021/ie900292p; Tollefson J, 2010, NATURE, V466, P541, DOI 10.1038/466541a; Whipple DT, 2010, J PHYS CHEM LETT, V1, P3451, DOI 10.1021/jz1012627; Whipple DT, 2010, ELECTROCHEM SOLID ST, V13, pD109, DOI 10.1149/1.3456590	23	1031	1077	57	1454	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					643	644		10.1126/science.1209786	http://dx.doi.org/10.1126/science.1209786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21960532				2022-12-24	WOS:000296494700047
J	Macfarlane, RJ; Lee, B; Jones, MR; Harris, N; Schatz, GC; Mirkin, CA				Macfarlane, Robert J.; Lee, Byeongdu; Jones, Matthew R.; Harris, Nadine; Schatz, George C.; Mirkin, Chad A.			Nanoparticle Superlattice Engineering with DNA	SCIENCE			English	Article								A current limitation in nanoparticle superlattice engineering is that the identities of the particles being assembled often determine the structures that can be synthesized. Therefore, specific crystallographic symmetries or lattice parameters can only be achieved using specific nanoparticles as building blocks (and vice versa). We present six design rules that can be used to deliberately prepare nine distinct colloidal crystal structures, with control over lattice parameters on the 25- to 150-nanometer length scale. These design rules outline a strategy to independently adjust each of the relevant crystallographic parameters, including particle size (5 to 60 nanometers), periodicity, and interparticle distance. As such, this work represents an advance in synthesizing tailorable macroscale architectures comprising nanoscale materials in a predictable fashion.	[Macfarlane, Robert J.; Harris, Nadine; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Macfarlane, Robert J.; Jones, Matthew R.; Harris, Nadine; Schatz, George C.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Lee, Byeongdu; Mirkin, Chad A.] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Jones, Matthew R.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Schatz, George C./ABF-1341-2020; Mirkin, Chad A/E-3911-2010	Jones, Matthew/0000-0002-9289-291X; Mirkin, Chad/0000-0002-6634-7627	Defense Research & Engineering Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research; U.S. Department of Energy Office of Basic Energy Sciences [DE-SC0000989]; U.S. Department of Defense; NU; NSF; E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NSF-NSEC; NSF-MRSEC; Keck Foundation; NU Office for Research	Defense Research & Engineering Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research; U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Defense(United States Department of Defense); NU; NSF(National Science Foundation (NSF)); E. I. DuPont de Nemours Co.; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF-NSEC(National Science Foundation (NSF)); NSF-MRSEC(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Keck Foundation(W.M. Keck Foundation); NU Office for Research	Supported by the Defense Research & Engineering Multidisciplinary University Research Initiative of the Air Force Office of Scientific Research and by the U.S. Department of Energy Office of Basic Energy Sciences [award DE-SC0000989; Northwestern University (NU) Non-equilibrium Energy Research Center] (C.A.M. and G.C.S.); a National Security Science and Engineering Faculty Fellowship from the U.S. Department of Defense (C.A.M.); a NU Ryan Fellowship (R.J.M.); and a NU Ryan Fellowship and a NSF Graduate Research Fellowship (M.R.J.). Portions of this work were carried out at the DuPont-Northwestern-Dow Collaborative Access Team (DND-CAT) beamline located at Sector 5 of the Advanced Photon Source (APS). DND-CAT is supported by E. I. DuPont de Nemours & Co., Dow Chemical Company, and the state of Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. The transmission electron microscope work was carried out in the EPIC facility of the NU Atomic and Nanoscale Characterization Experimental Center, which is supported by NSF-NSEC, NSF-MRSEC, Keck Foundation, the state of Illinois, and NU. Ultrathin sectioning was carried out at the NU Biological Imaging Facility, supported by the NU Office for Research.	Bell AT, 2003, SCIENCE, V299, P1688, DOI 10.1126/science.1083671; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Bodnarchuk MI, 2010, J AM CHEM SOC, V132, P11967, DOI 10.1021/ja103083q; Chen CL, 2010, ANGEW CHEM INT EDIT, V49, P1924, DOI 10.1002/anie.200903572; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Grunes J, 2002, J PHYS CHEM B, V106, P11463, DOI 10.1021/jp021641e; Jones MR, 2011, CHEM REV, V111, P3736, DOI 10.1021/cr1004452; Jones MR, 2010, NAT MATER, V9, P913, DOI [10.1038/NMAT2870, 10.1038/nmat2870]; Kalsin AM, 2006, SCIENCE, V312, P420, DOI 10.1126/science.1125124; Kelly KL, 2003, J PHYS CHEM B, V107, P668, DOI 10.1021/jp026731y; Kiely CJ, 1998, NATURE, V396, P444, DOI 10.1038/24808; Macfarlane RJ, 2010, ANGEW CHEM INT EDIT, V49, P4589, DOI 10.1002/anie.201000633; Macfarlane RJ, 2009, P NATL ACAD SCI USA, V106, P10493, DOI 10.1073/pnas.0900630106; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SJ, 2004, J PHYS CHEM B, V108, P12375, DOI 10.1021/jp040242b; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Pauling L., 1960, NATURE CHEM BOND, V3rd; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Srivastava S, 2010, SCIENCE, V327, P1355, DOI 10.1126/science.1177218; Stebe KJ, 2009, SCIENCE, V325, P159, DOI 10.1126/science.1174401; Tkachenko AV, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148303; Wong S, 2003, J AM CHEM SOC, V125, P15589, DOI 10.1021/ja0379969; Woodcock LV, 1997, NATURE, V385, P141, DOI 10.1038/385141a0; Xiong HM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.015504; Zhao Y, 2009, NAT MATER, V8, P979, DOI [10.1038/NMAT2565, 10.1038/nmat2565]; ZHOU O, 1991, NATURE, V351, P462, DOI 10.1038/351462a0	28	859	871	13	615	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					204	208		10.1126/science.1210493	http://dx.doi.org/10.1126/science.1210493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998382				2022-12-24	WOS:000295833600040
J	Chiarle, R; Zhang, Y; Frock, RL; Lewis, SM; Molinie, B; Ho, YJ; Myers, DR; Choi, VW; Compagno, M; Malkin, DJ; Neuberg, D; Monti, S; Giallourakis, CC; Gostissa, M; Alt, FW				Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Molinie, Benoit; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Neuberg, Donna; Monti, Stefano; Giallourakis, Cosmas C.; Gostissa, Monica; Alt, Frederick W.			Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B Cells	CELL			English	Article							END-JOINING PATHWAY; CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; DNA BREAKS; C-MYC; HYPERMUTATION; LYMPHOCYTES; CANCER; IDENTIFICATION; TRANSCRIPTION	Whereas chromosomal translocations are common pathogenetic events in cancer, mechanisms that promote them are poorly understood. To elucidate translocation mechanisms in mammalian cells, we developed high-throughput, genome-wide translocation sequencing (HTGTS). We employed HTGTS to identify tens of thousands of independent translocation junctions involving fixed I-SceI meganuclease-generated DNA double-strand breaks (DSBs) within the c-myc oncogene or IgH locus of B lymphocytes induced for activation-induced cytidine deaminase (AID)-dependent IgH class switching. DSBs translocated widely across the genome but were preferentially targeted to transcribed chromosomal regions. Additionally, numerous AID-dependent and AID-independent hot spots were targeted, with the latter comprising mainly cryptic I-SceI targets. Comparison of translocation junctions with genome-wide nuclear run-ons revealed a marked association between transcription start sites and translocation targeting. The majority of translocation junctions were formed via end-joining with short microhomologies. Our findings have implications for diverse fields, including gene therapy and cancer genomics.	[Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Gostissa, Monica; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Gostissa, Monica; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Chiarle, Roberto; Zhang, Yu; Frock, Richard L.; Lewis, Susanna M.; Ho, Yu-Jui; Myers, Darienne R.; Choi, Vivian W.; Compagno, Mara; Malkin, Daniel J.; Gostissa, Monica; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Chiarle, Roberto; Compagno, Mara] Univ Turin, Dept Biomed Sci & Human Oncol, I-10126 Turin, Italy; [Chiarle, Roberto; Compagno, Mara] Univ Turin, CERMS, I-10126 Turin, Italy; [Molinie, Benoit; Giallourakis, Cosmas C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Neuberg, Donna] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02215 USA; [Monti, Stefano] 5 Cambridge Ctr, Broad Inst, Cambridge, MA 02142 USA; [Monti, Stefano] Boston Univ, Sch Med, Sect Computat Biomed, Boston, MA 02118 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Turin; University of Turin; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Zhang, Y (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA.	zhang@idi.harvard.edu; cgiallourakis@partners.org; gostissa@idi.harvard.edu; alt@enders.tch.harvard.edu	Frock, Richard/I-6934-2019	Frock, Richard/0000-0001-6963-4931; Monti, Stefano/0000-0002-9376-0660; Choi, Vivian/0000-0003-4787-0735; CHIARLE, Roberto/0000-0003-1564-8531; Ho, Yu-jui/0000-0002-7540-024X	NIH [5P01CA92625, AI070837, 5T32CA070083-13]; Leukemia and Lymphoma Society of America (LLS); AIRC [ERC-2009-StG, 242965]; V Foundation; CRI postdoctoral fellowship; NATIONAL CANCER INSTITUTE [T32CA070083, P01CA092625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS)(Leukemia and Lymphoma Society); AIRC(Fondazione AIRC per la ricerca sul cancro); V Foundation; CRI postdoctoral fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Barry Sleckman for providing unpublished information about circular PCR translocation cloning of RAG-generated DSBs. This work was supported by NIH grant 5P01CA92625 and a Leukemia and Lymphoma Society of America (LLS) SCOR grant to F. W. A., grants from AIRC and grant FP7 ERC-2009-StG (Proposal No. 242965-"Lunely'') to R. C., an NIH KO8 grant AI070837 to C. C. G., and a V Foundation Scholar award to M. G. Y.Z. was supported by CRI postdoctoral fellowship and R. L. F. by NIH training grant 5T32CA070083-13. F. W. A. is an Investigator of the Howard Hughes Medical Institute. F. W. A. is a member of the scientific advisory board of Cellectis Pharmaceuticals.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Arnould S, 2011, PROTEIN ENG DES SEL, V24, P27, DOI 10.1093/protein/gzq083; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Dudley DD, 2002, P NATL ACAD SCI USA, V99, P9984, DOI 10.1073/pnas.152333499; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Gostissa M, 2011, ANNU REV IMMUNOL, V29, P319, DOI 10.1146/annurev-immunol-031210-101329; Gostissa M, 2009, P NATL ACAD SCI USA, V106, P2265, DOI 10.1073/pnas.0812763106; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Haffner MC, 2011, CLIN CANCER RES, V17, P3858, DOI 10.1158/1078-0432.CCR-10-2044; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Kovalchuk AL, 2007, J EXP MED, V204, P2989, DOI 10.1084/jem.20070882; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Li XL, 2006, GENE DEV, V20, P1838, DOI 10.1101/gad.1438306; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavri R, 2011, ADV IMMUNOL, V110, P1, DOI 10.1016/B978-0-12-387663-8.00005-3; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Reynaud S, 2005, J IMMUNOL, V174, P6176, DOI 10.4049/jimmunol.174.10.6176; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Shaffer DR, 2006, NAT MED, V12, P14, DOI 10.1038/nm0106-14; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2007, SCIENCE, V315, P377, DOI 10.1126/science.1136386; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	46	330	342	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					107	119		10.1016/j.cell.2011.07.049	http://dx.doi.org/10.1016/j.cell.2011.07.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962511	Green Accepted, Bronze			2022-12-24	WOS:000295396700019
J	Klein, IA; Resch, W; Jankovic, M; Oliveira, T; Yamane, A; Nakahashi, H; Di Virgilio, M; Bothmer, A; Nussenzweig, A; Robbiani, DF; Casellas, R; Nussenzweig, MC				Klein, Isaac A.; Resch, Wolfgang; Jankovic, Mila; Oliveira, Thiago; Yamane, Arito; Nakahashi, Hirotaka; Di Virgilio, Michela; Bothmer, Anne; Nussenzweig, Andre; Robbiani, Davide F.; Casellas, Rafael; Nussenzweig, Michel C.			Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; CELL LYMPHOMA; C-MYC; DNA BREAKS; FOLLICULAR LYMPHOMA; GENOMIC INSTABILITY; CANCER GENOME; BCL6 GENE	Chromosomal rearrangements, including translocations, require formation and joining of DNA double strand breaks (DSBs). These events disrupt the integrity of the genome and are frequently involved in producing leukemias, lymphomas and sarcomas. Despite the importance of these events, current understanding of their genesis is limited. To examine the origins of chromosomal rearrangements we developed-Translocation Capture Sequencing (TC-Seq), a method to document chromosomal rearrangements genome-wide, in primary cells. We examined over 180,000 rearrangements obtained from 400 million B lymphocytes, revealing that proximity between DSBs, transcriptional activity and chromosome territories are key determinants of genome rearrangement. Specifically, rearrangements tend to occur in cis and to transcribed genes. Finally, we find that activation-induced cytidine deaminase (AID) induces the rearrangement of many genes found as translocation partners in mature B cell lymphoma.	[Yamane, Arito; Nakahashi, Hirotaka; Casellas, Rafael] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Klein, Isaac A.; Jankovic, Mila; Oliveira, Thiago; Di Virgilio, Michela; Bothmer, Anne; Robbiani, Davide F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Nussenzweig, Andre] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Resch, Wolfgang; Yamane, Arito; Nakahashi, Hirotaka; Casellas, Rafael] NIAMSD, NIH, Bethesda, MD 20892 USA; [Oliveira, Thiago] Univ Sao Paulo, Natl Inst Sci & Technol Stem Cells & Cell Therapy, Dept Genet, Med Sch Ribeirao Preto, BR-14051140 Ribeirao Preto, SP, Brazil; [Oliveira, Thiago] Ctr Cell Based Therapy, BR-14051140 Ribeirao Preto, SP, Brazil	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Universidade de Sao Paulo	Casellas, R (corresponding author), NCI, Ctr Canc Res, Bethesda, MD 20892 USA.	casellar@mail.nih.gov; nussen@mail.rockefeller.edu	Yamane, Arito/A-2959-2013; Di Virgilio, Michela/AAE-9298-2022; Oliveira, Thiago Y/HGA-3848-2022; Oliveira, Thiago Y/ABF-5186-2020; Robbiani, Davide F./AAF-7662-2019; Nussenzweig, Michel/AAE-7292-2019	Oliveira, Thiago Y/0000-0002-2654-0879; Oliveira, Thiago Y/0000-0002-2654-0879; Robbiani, Davide F./0000-0001-7379-3484; Di Virgilio, Michela/0000-0001-5189-0793; Resch, Wolfgang/0000-0001-7594-5963	NIH MSTP [GM07739]; NIH [AI037526]; NYSTEM [C023046]; Starr Cancer Consortium; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI037526, R01AI037526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTEM; Starr Cancer Consortium; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all the members of the Nussenzweig and Casellas labs for valuable input and advice; Klara Velinzon and Svetlana Mazel for FACSorting; and David Bosque and Thomas Eisenreich for animal management. We also thank Scott Dewell of the Rockefeller Genomics Resource Center and Gustavo Gutierrez of the NIAMS genome facility for high-throughput sequencing and guidance; as well as Christopher Mason of the Weill Cornell Medical College for assistance with data analysis. I. A. K. was supported by NIH MSTP grant GM07739, and is a Cancer Research Institute Predoctoral Fellow and a William Randolph Hearst Foundation Fellow. A. B. is a Cancer Research Institute Predoctoral Fellow. This work was supported by NIH grant #AI037526 to M.C.N., NYSTEM #C023046, The Starr Cancer Consortium and the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. M.C.N. is an HHMI investigator.	Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Akasaka T, 2003, BLOOD, V102, P1443, DOI 10.1182/blood-2002-08-2482; Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Bea S, 2009, BLOOD, V113, P3059, DOI 10.1182/blood-2008-07-170183; Bothmer A, 2011, MOL CELL, V42, P319, DOI 10.1016/j.molcel.2011.03.019; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chaudhuri J, 2004, NAT REV IMMUNOL, V4, P541, DOI 10.1038/nri1395; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; DAN L, 1992, NUCLEIC ACIDS RES, V20, P1967, DOI 10.1093/nar/20.8.1967; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Einerson RR, 2006, LEUKEMIA, V20, P1790, DOI 10.1038/sj.leu.2404340; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Gesk S, 2006, BLOOD, V108, P1109, DOI 10.1182/blood-2006-01-0015; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Honjo T, 2002, NAT IMMUNOL, V3, P800, DOI 10.1038/ni0902-800; HUPPI K, 1990, P NATL ACAD SCI USA, V87, P6964, DOI 10.1073/pnas.87.18.6964; Iida S, 1999, LEUKEMIA LYMPHOMA, V34, P25, DOI 10.3109/10428199909083377; Impera L, 2008, ONCOGENE, V27, P6187, DOI 10.1038/onc.2008.214; Jankovic M, 2010, P NATL ACAD SCI USA, V107, P187, DOI 10.1073/pnas.0908946107; Kuppers R, 2005, NAT REV CANCER, V5, P251, DOI 10.1038/nrc1589; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Mahowald GK, 2009, P NATL ACAD SCI USA, V106, P18339, DOI 10.1073/pnas.0902545106; Mao X, 2002, GENE CHROMOSOME CANC, V35, P144, DOI 10.1002/gcc.10104; Mottok A, 2009, BLOOD, V114, P4503, DOI 10.1182/blood-2009-06-225839; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Rabbitts TH, 2009, CELL, V137, P391, DOI 10.1016/j.cell.2009.04.034; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rosebeck S, 2011, SCIENCE, V331, P468, DOI 10.1126/science.1198946; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; Staszewski O, 2011, MOL CELL, V41, P232, DOI 10.1016/j.molcel.2011.01.007; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Storb U, 2007, ADV EXP MED BIOL, V596, P83; Takeuchi Y, 2003, GENE DEV, V17, P1497, DOI 10.1101/gad.1085403; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Tsai AG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S1; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Ueda C, 2002, ONCOGENE, V21, P368, DOI 10.1038/sj.onc.1205099; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yoshida S, 1999, ONCOGENE, V18, P7994, DOI 10.1038/sj.onc.1203293; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	66	268	272	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					95	106		10.1016/j.cell.2011.07.048	http://dx.doi.org/10.1016/j.cell.2011.07.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962510	Bronze, Green Accepted			2022-12-24	WOS:000295396700018
J	Nam, Y; Chen, C; Gregory, RI; Chou, JJ; Sliz, P				Nam, Yunsun; Chen, Casandra; Gregory, Richard I.; Chou, James J.; Sliz, Piotr			Molecular Basis for Interaction of let-7 MicroRNAs with Lin28	CELL			English	Article							GENOME-WIDE ASSOCIATION; COLD SHOCK PROTEIN; POSTTRANSCRIPTIONAL REGULATION; LIN-28; BIOGENESIS; RECOGNITION; IDENTIFICATION; MATURATION; BINDING; DROSHA	MicroRNAs (miRNAs) are small noncoding RNA molecules that regulate gene expression. Among these, members of the let-7 miRNA family control many cell-fate determination genes to influence pluripotency, differentiation, and transformation. Lin28 is a specific, posttranscriptional inhibitor of let-7 biogenesis. We report crystal structures of mouse Lin28 in complex with sequences from let-7d, let-7-f1, and let-7g precursors. The two folded domains of Lin28 recognize two distinct regions of the RNA and are sufficient for inhibition of let-7 in vivo. We also show by NMR spectroscopy that the linker connecting the two folded domains is flexible, accommodating Lin28 binding to diverse let-7 family members. Protein-RNA complex formation imposes specific conformations on both components that could affect downstream recognition by other processing factors. Our data provide a molecular explanation for Lin28 specificity and a model for how it regulates let-7.	[Nam, Yunsun; Chen, Casandra; Gregory, Richard I.; Chou, James J.; Sliz, Piotr] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Nam, Yunsun; Chen, Casandra; Sliz, Piotr] Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; [Nam, Yunsun; Chen, Casandra; Gregory, Richard I.; Sliz, Piotr] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Sliz, P (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	piotr_sliz@hms.harvard.edu	Chou, James J/N-9840-2013; Chou, James/AAD-6230-2022	Chou, James J/0000-0002-4442-0344; Chou, James/0000-0002-4442-0344; Nam, Yunsun/0000-0002-7939-8626; Sliz, Piotr/0000-0002-6522-0835	Center for Molecular and Cellular Dynamics at Harvard Medical School,; NIH [5U54GM094608]; Damon Runyon Cancer Research Foundation (DRG) [1953-07]; Charles A. King Trust N.A.; Bank of America; NATIONAL CANCER INSTITUTE [R01CA163647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094608] Funding Source: NIH RePORTER	Center for Molecular and Cellular Dynamics at Harvard Medical School,; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation (DRG); Charles A. King Trust N.A.; Bank of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Stephen C. Harrison for discussion and critical review of the manuscript, members of the Chou Lab for discussion about NMR experiments, Janet Iwasa for help with design of Figure 7, George Q. Daley for the pri-miR constructs for in vivo processing assays, Thomas Tuschl for Dicer expression construct, Katarzyna Szatkowski for technical assistance, and Elizabeth O'Day for participation during the early stages of the project. This work is based upon research conducted at the Advanced Photon Source (Northeastern Collaborative Access Team beamlines) and Brookhaven National Laboratory (beamline X25). This work was partially supported by Center for Molecular and Cellular Dynamics at Harvard Medical School, by NIH grant 5U54GM094608, and by postdoctoral fellowships to Y.N. from the Damon Runyon Cancer Research Foundation (DRG-# 1953-07) and the Charles A. King Trust, N.A., Bank of America, Co-Trustee. Y. N. performed experiments. C. C. provided technical assistance with experiments. R. G. provided the Lin28 clone and participated in discussions. J. C. helped with NMR spectroscopy. Y. N. and P. S. designed and interpreted experiments and prepared the manuscript.	Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Davis-Dusenbery Brandi N, 2010, Genes Cancer, V1, P1100, DOI 10.1177/1947601910396213; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; De N, 2011, METHODS MOL BIOL, V725, P107, DOI 10.1007/978-1-61779-046-1_8; Du Z, 2008, P NATL ACAD SCI USA, V105, P2391, DOI 10.1073/pnas.0711506105; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lu LG, 2009, EUR J CANCER, V45, P2212, DOI 10.1016/j.ejca.2009.05.003; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Max KEA, 2007, FEBS J, V274, P1265, DOI 10.1111/j.1742-4658.2007.05672.x; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Permuth-Wey J, 2011, CANCER RES, V71, P3896, DOI 10.1158/0008-5472.CAN-10-4167; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Wan GQ, 2010, RNA, V16, P1436, DOI 10.1261/rna.2001610; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2005, J BIOL CHEM, V280, P27595, DOI 10.1074/jbc.M504714200; Zhang XX, 2010, NUCLEIC ACIDS RES, V38, P7689, DOI 10.1093/nar/gkq645; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	53	275	293	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 23	2011	147	5					1080	1091		10.1016/j.cell.2011.10.020	http://dx.doi.org/10.1016/j.cell.2011.10.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852SA	22078496	Green Accepted, Bronze			2022-12-24	WOS:000297376600019
J	Licausi, F; Kosmacz, M; Weits, DA; Giuntoli, B; Giorgi, FM; Voesenek, LACJ; Perata, P; van Dongen, JT				Licausi, Francesco; Kosmacz, Monika; Weits, Daan A.; Giuntoli, Beatrice; Giorgi, Federico M.; Voesenek, Laurentius A. C. J.; Perata, Pierdomenico; van Dongen, Joost T.			Oxygen sensing in plants is mediated by an N-end rule pathway for protein destabilization	NATURE			English	Article							ETHYLENE RESPONSE FACTORS; EVOLUTIONARY CONSERVATION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; BINDING PROTEIN; HYPOXIA; STRESS; LOCALIZATION; SYSTEM; CELLS	The majority of eukaryotic organisms rely on molecular oxygen for respiratory energy production(1). When the supply of oxygen is compromised, a variety of acclimation responses are activated to reduce the detrimental effects of energy depletion(2-4). Various oxygen-sensing mechanisms have been described that are thought to trigger these responses(5-9), but they each seem to be kingdom specific and no sensing mechanism has been identified in plants until now. Here we show that one branch of the ubiquitin-dependent N-end rule pathway for protein degradation, which is active in both mammals and plants(10,11), functions as an oxygen-sensing mechanism in Arabidopsis thaliana. We identified a conserved amino-terminal amino acid sequence of the ethylene response factor (ERF)-transcription factor RAP2.12 to be dedicated to an oxygen-dependent sequence of post-translational modifications, which ultimately lead to degradation of RAP2.12 under aerobic conditions. When the oxygen concentration is low-as during flooding-RAP2.12 is released from the plasma membrane and accumulates in the nucleus to activate gene expression for hypoxia acclimation. Our discovery of an oxygen-sensing mechanism opens up new possibilities for improving flooding tolerance in crops.	[Licausi, Francesco; Kosmacz, Monika; Weits, Daan A.; Giorgi, Federico M.; van Dongen, Joost T.] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Licausi, Francesco; Giuntoli, Beatrice; Perata, Pierdomenico] Scuola Super Sant Anna, Inst Life Sci, PlantLab, I-56127 Pisa, Italy; [Voesenek, Laurentius A. C. J.] Univ Utrecht, Inst Environm Biol, NL-3584 CH Utrecht, Netherlands; [Voesenek, Laurentius A. C. J.] Ctr Biosyst Genom, NL-6708 PB Wageningen, Netherlands	Max Planck Society; Scuola Superiore Sant'Anna; Utrecht University; Centre for BioSystems Genomics	Licausi, F (corresponding author), Max Planck Inst Mol Plant Physiol, Muehlenberg 1, D-14476 Potsdam, Germany.	f.licausi@sssup.it; dongen@mpimp-golm.mpg.de	Giorgi, Federico M./AAD-5797-2020; Voesenek, Laurentius A.C.J./B-9661-2011; Perata, Pierdomenico/A-5658-2008; van Dongen, Joost T/F-5372-2016; Licausi, Francesco/F-7985-2011; GIUNTOLI, BEATRICE/HCH-7605-2022	Giorgi, Federico M./0000-0002-7325-9908; Perata, Pierdomenico/0000-0001-9444-0610; van Dongen, Joost T/0000-0001-7944-9289; GIUNTOLI, BEATRICE/0000-0003-4968-4071; Licausi, Francesco/0000-0003-4769-441X; Voesenek, Laurentius/0000-0002-3361-3837; Weits, Daniel/0000-0003-4423-5568	Max Planck Institute of Molecular Plant Physiology; Scuola Superiore Sant'Anna; Deutsche Forschungsgemeinschaft (DFG) [DO 1298/2-1]	Max Planck Institute of Molecular Plant Physiology; Scuola Superiore Sant'Anna; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We would like to thank H. van Veen and R. Sasidharan (for providing Rumex data), E. Maximova, F. Kragler (microscopy), W. Schulze and R. Bock (support and discussion), A. Fernie and R. Pierik (commenting on the manuscript) and S. Parlanti, L. Bartezko and K. Seehaus (plant cultivation). This work was financially supported by the Max Planck Institute of Molecular Plant Physiology, Scuola Superiore Sant'Anna, and the Deutsche Forschungsgemeinschaft (DFG) (DO 1298/2-1).	Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Gehl C, 2009, MOL PLANT, V2, P1051, DOI 10.1093/mp/ssp040; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Graciet E, 2010, PLANT J, V61, P741, DOI 10.1111/j.1365-313X.2009.04099.x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kelly DP, 2008, NAT GENET, V40, P132, DOI 10.1038/ng0208-132; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee Min Woo, 2006, V323, P225; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Li HY, 2004, PLANT MOL BIOL, V54, P233, DOI 10.1023/B:PLAN.0000028790.75090.ab; Li HY, 2003, PLANT MOL BIOL, V51, P483, DOI 10.1023/A:1022330304402; Licausi F, 2011, NEW PHYTOL, V190, P442, DOI 10.1111/j.1469-8137.2010.03451.x; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; Pierik R, 2011, NEW PHYTOL, V189, P122, DOI 10.1111/j.1469-8137.2010.03458.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; VALLON U, 1994, PROTOPLASMA, V182, P15, DOI 10.1007/BF01403684; van der Wel H, 2011, BIOCHEMISTRY-US, V50, P1700, DOI 10.1021/bi101977w; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Webb JD, 2009, CELL MOL LIFE SCI, V66, P3539, DOI 10.1007/s00018-009-0147-7; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97	35	473	497	8	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					419	U177		10.1038/nature10536	http://dx.doi.org/10.1038/nature10536			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22020282	Green Published			2022-12-24	WOS:000297059700050
J	Ho, VM; Lee, JA; Martin, KC				Ho, Victoria M.; Lee, Ji-Ann; Martin, Kelsey C.			The Cell Biology of Synaptic Plasticity	SCIENCE			English	Review							LONG-TERM POTENTIATION; DENDRITIC PROTEIN-SYNTHESIS; II MUTANT MICE; AMPA RECEPTORS; TRANSLATIONAL CONTROL; MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; DEPENDENT TRANSLATION; RECYCLING ENDOSOMES; HIPPOCAMPAL-NEURONS	Synaptic plasticity is the experience-dependent change in connectivity between neurons that is believed to underlie learning and memory. Here, we discuss the cellular and molecular processes that are altered when a neuron responds to external stimuli, and how these alterations lead to an increase or decrease in synaptic connectivity. Modification of synaptic components and changes in gene expression are necessary for many forms of plasticity. We focus on excitatory neurons in the mammalian hippocampus, one of the best-studied model systems of learning-related plasticity.	[Lee, Ji-Ann; Martin, Kelsey C.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Ho, Victoria M.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Martin, Kelsey C.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Martin, KC (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, BSRB 310,615 Charles E Young Dr S, Los Angeles, CA 90095 USA.	kcmartin@mednet.ucla.edu		Lee, Ji-Ann/0000-0002-9069-2113	NIH [R01 MH077022, R01 NS045324, T32 GM008042, T32 MH073526]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069645, T32MH073526, R01MH077022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045324] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize to those whose primary work could not be cited because of space constraints. We thank J. T. Braslow, T. J. O'Dell, and F. E. Schweizer for comments on the manuscript; J. Bourne and K. M. Harris for hippocampal electron microscopy images; and all members of the Martin lab for helpful discussions. Support comes from NIH grants R01 MH077022 and R01 NS045324 (to K.C.M.), the Medical Scientist Training Program (NIH T32 GM008042), and the Neurobehavioral Genetics Training Program (NIH grant T32 MH073526) (to V.M.H.). A glossary of terms used is included in the online (HTML) version of this article (Box 1).	Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Buard I, 2010, J NEUROSCI, V30, P8214, DOI 10.1523/JNEUROSCI.1469-10.2010; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Ch'ng TH, 2011, CURR OPIN NEUROBIOL, V21, P345, DOI 10.1016/j.conb.2011.01.011; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Deng LB, 2011, NEURON, V69, P317, DOI 10.1016/j.neuron.2011.01.005; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Filosa A, 2009, NAT NEUROSCI, V12, P1285, DOI 10.1038/nn.2394; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ju W, 2004, NAT NEUROSCI, V7, P244, DOI 10.1038/nn1189; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kaeser PS, 2011, CELL, V144, P282, DOI 10.1016/j.cell.2010.12.029; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Marsicano G, 2009, CURR TOP BEHAV NEURO, V1, P201, DOI 10.1007/978-3-540-88955-7_8; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STEWARD O, 1982, J NEUROSCI, V2, P284; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; van der Sluijs P, 2011, SEMIN CELL DEV BIOL, V22, P499, DOI 10.1016/j.semcdb.2011.06.008; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wells DG, 2001, J NEUROSCI, V21, P9541, DOI 10.1523/JNEUROSCI.21-24-09541.2001; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	63	294	302	13	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					623	628		10.1126/science.1209236	http://dx.doi.org/10.1126/science.1209236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053042	Green Accepted			2022-12-24	WOS:000296494700043
J	Pruszynski, JA; Kurtzer, I; Nashed, JY; Omrani, M; Brouwer, B; Scott, SH				Pruszynski, J. Andrew; Kurtzer, Isaac; Nashed, Joseph Y.; Omrani, Mohsen; Brouwer, Brenda; Scott, Stephen H.			Primary motor cortex underlies multi-joint integration for fast feedback control	NATURE			English	Article							LATENCY STRETCH REFLEXES; CORTICOMOTONEURONAL CELLS; HUMAN ARM; RESPONSES; MOTION; MONKEY; MOVEMENTS; NEURONS; PERTURBATIONS	A basic difficulty for the nervous system is integrating locally ambiguous sensory information to form accurate perceptions about the outside world(1-4). This local-to-global problem is also fundamental to motor control of the arm, because complex mechanical interactions between shoulder and elbow allow a particular amount of motion at one joint to arise from an infinite combination of shoulder and elbow torques(5). Here we show, in humans and rhesus monkeys, that a transcortical pathway through primary motor cortex (M1) resolves this ambiguity during fast feedback control. We demonstrate that single M1 neurons of behaving monkeys can integrate shoulder and elbow motion information into motor commands that appropriately counter the underlying torque within about 50 milliseconds of a mechanical perturbation. Moreover, we reveal a causal link between M1 processing and multi-joint integration in humans by showing that shoulder muscle responses occurring 50 milliseconds after pure elbow displacement can be potentiated by transcranial magnetic stimulation. Taken together, our results show that transcortical processing through M1 permits feedback responses to express a level of sophistication that rivals voluntary control; this provides neurophysiological support for influential theories positing that voluntary movement is generated by the intelligent manipulation of sensory feedback(6,7).	[Pruszynski, J. Andrew; Kurtzer, Isaac; Nashed, Joseph Y.; Omrani, Mohsen; Brouwer, Brenda; Scott, Stephen H.] Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada; [Pruszynski, J. Andrew] Umea Univ, Dept Integrat Med Biol, Physiol Sect, SE-90187 Umea, Sweden; [Kurtzer, Isaac] New York Coll Osteopath Med, Dept Neurosci & Histol, Old Westbury, NY 11568 USA; [Brouwer, Brenda] Queens Univ, Sch Rehabil Therapy, Kingston, ON K7L 3N6, Canada; [Scott, Stephen H.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada; [Scott, Stephen H.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Umea University; New York Institute Technology; Queens University - Canada; Queens University - Canada; Queens University - Canada	Scott, SH (corresponding author), Queens Univ, Ctr Neurosci Studies, Kingston, ON K7L 3N6, Canada.	steve.scott@queensu.ca	Pruszynski, J. Andrew/E-4522-2011	Pruszynski, J. Andrew/0000-0003-0786-0081; Omrani, Mohsen/0000-0002-0461-1947	Canadian Institutes of Health Research (CIHR); National Sciences and Engineering Research Council of Canada (NSERC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Canadian Institutes of Health Research (CIHR) and the National Sciences and Engineering Research Council of Canada (NSERC). J.A.P., I.K. and M.O. received salary awards from CIHR. We thank K. Moore and J. Peterson for technical support, and G. Blohm, B. Edin, R. Flanagan, R. Johansson, A. Kahn and D. Munoz for comments on the manuscript.	Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; CHENEY PD, 1984, J PHYSIOL-LONDON, V349, P249, DOI 10.1113/jphysiol.1984.sp015155; COLE KJ, 1984, EXP BRAIN RES, V56, P582; DAY BL, 1991, J PHYSIOL-LONDON, V433, P41, DOI 10.1113/jphysiol.1991.sp018413; EVARTS EV, 1973, SCIENCE, V179, P501, DOI 10.1126/science.179.4072.501; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; FETZ EE, 1980, J NEUROPHYSIOL, V44, P751, DOI 10.1152/jn.1980.44.4.751; FROMM C, 1977, NEUROSCI LETT, V5, P259, DOI 10.1016/0304-3940(77)90076-3; GIELEN CCAM, 1988, J PHYSIOL-LONDON, V407, P275, DOI 10.1113/jphysiol.1988.sp017415; Green AM, 2010, CURR OPIN NEUROBIOL, V20, P353, DOI 10.1016/j.conb.2010.04.009; Green DM, 1966, SIGNAL DETECTION THE; Herter TM, 2009, J NEUROPHYSIOL, V101, P150, DOI 10.1152/jn.90230.2008; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Kurtzer IL, 2008, CURR BIOL, V18, P449, DOI 10.1016/j.cub.2008.02.053; Lewis GN, 2004, EXP BRAIN RES, V156, P72, DOI 10.1007/s00221-003-1767-z; Pack CC, 2003, NEURON, V39, P671, DOI 10.1016/S0896-6273(03)00439-2; PALMER E, 1992, J PHYSIOL-LONDON, V449, P429, DOI 10.1113/jphysiol.1992.sp019094; Pei YC, 2011, NEURON, V69, P536, DOI 10.1016/j.neuron.2010.12.033; PICARD N, 1992, J NEUROPHYSIOL, V68, P1882, DOI 10.1152/jn.1992.68.5.1882; Porter R, 1993, CORTICOSPINAL FUNCTI; Pruszynski JA, 2008, J NEUROPHYSIOL, V100, P224, DOI 10.1152/jn.90262.2008; Scott SH, 1999, J NEUROSCI METH, V89, P119, DOI 10.1016/S0165-0270(99)00053-9; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Scott SH, 2003, CURR OPIN NEUROBIOL, V13, P671, DOI 10.1016/j.conb.2003.10.012; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; Shemmell J, 2010, CLIN NEUROPHYSIOL, V121, P1680, DOI 10.1016/j.clinph.2010.02.166; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963	30	193	195	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					387	+		10.1038/nature10436	http://dx.doi.org/10.1038/nature10436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21964335	Green Accepted			2022-12-24	WOS:000296021100046
J	Williams, SA; Maecker, HL; French, DM; Liu, JF; Gregg, A; Silverstein, LB; Cao, TC; Carano, RAD; Dixit, VM				Williams, Samuel A.; Maecker, Heather L.; French, Dorothy M.; Liu, Jinfeng; Gregg, Andrew; Silverstein, Leah B.; Cao, Tim C.; Carano, Richard A. D.; Dixit, Vishva M.			USP1 Deubiquitinates ID Proteins to Preserve a Mesenchymal Stem Cell Program in Osteosarcoma	CELL			English	Article							LOOP-HELIX PROTEINS; UBIQUITIN-PROTEASOME PATHWAY; FANCONI-ANEMIA PATHWAY; OSTEOBLAST DIFFERENTIATION; RETINOBLASTOMA PROTEIN; GROWTH ARREST; IN-VIVO; CANCER; GENE; MICE	Inhibitors of DNA binding (IDs) antagonize basic-helix-loop-helix (bHLH) transcription factors to inhibit differentiation and maintain stem cell fate. ID ubiquitination and proteasomal degradation occur in differentiated tissues, but IDs in many neoplasms appear to escape degradation. We show that the deubiquitinating enzyme USP1 promotes ID protein stability and stem cell-like characteristics in osteosarcoma. USP1 bound, deubiquitinated, and thereby stabilized ID1, ID2, and ID3. A subset of primary human osteosarcomas coordinately overexpressed USP1 and ID proteins. USP1 knockdown in osteosarcoma cells precipitated ID protein destabilization, cell-cycle arrest, and osteogenic differentiation. Conversely, ectopic USP1 expression in mesenchymal stem cells stabilized ID proteins, inhibited osteoblastic differentiation, and enhanced proliferation. Consistent with USP1 functioning in normal mesenchymal stem cells, USP1-deficient mice were osteopenic. Our observations implicate USP1 in preservation of the stem cell state that characterizes osteosarcoma and identify USP1 as a target for differentiation therapy.	[Williams, Samuel A.; Gregg, Andrew; Silverstein, Leah B.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Maecker, Heather L.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [French, Dorothy M.] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Cao, Tim C.; Carano, Richard A. D.] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	dixit, vishva m/A-4496-2012; 高, 雨莉/HGU-8187-2022	dixit, vishva m/0000-0001-6983-0326; Maecker, Heather/0000-0002-5378-1141; Liu, Jinfeng/0000-0002-0343-8222; Williams, Samuel/0000-0003-2642-3039				Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Ciarapica R, 2009, ONCOGENE, V28, P1881, DOI 10.1038/onc.2009.56; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; Di Fiore R, 2009, J CELL PHYSIOL, V219, P301, DOI 10.1002/jcp.21667; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Funato N, 2001, MOL CELL BIOL, V21, P7416, DOI 10.1128/MCB.21.21.7416-7428.2001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; KASTAN MB, 1991, CANCER RES, V51, P6304; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kim D, 1999, MOL CELL BIOL, V19, P8240; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maeda Y, 2004, J CELL BIOCHEM, V93, P337, DOI 10.1002/jcb.20154; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Matsumoto T, 1998, CANCER LETT, V129, P61, DOI 10.1016/S0304-3835(98)00080-9; Miller CW, 1996, CANCER GENET CYTOGEN, V86, P136, DOI 10.1016/0165-4608(95)00216-2; Nielsen GP, 1998, AM J PATHOL, V153, P159, DOI 10.1016/S0002-9440(10)65556-3; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nishimori H, 2002, ONCOGENE, V21, P8302, DOI 10.1038/sj.onc.1206025; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Oh JH, 2006, CLIN ORTHOP RELAT R, P216, DOI 10.1097/01.blo.0000188063.56091.69; Ozaki T, 2003, CANCER GENET CYTOGEN, V140, P145, DOI 10.1016/S0165-4608(02)00685-4; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Parmar K, 2010, STEM CELLS, V28, P1186, DOI 10.1002/stem.437; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Stock C, 2000, GENE CHROMOSOME CANC, V28, P329, DOI 10.1002/1098-2264(200007)28:3<329::AID-GCC11>3.0.CO;2-F; Suh JH, 2008, BIOCHEM BIOPH RES CO, V367, P97, DOI 10.1016/j.bbrc.2007.12.100; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tupler R, 2001, NATURE, V409, P832, DOI 10.1038/35057011; WEINTRAUB H, 1994, GENE DEV, V8, P2203, DOI 10.1101/gad.8.18.2203; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Yokota Y, 2002, J CELL PHYSIOL, V190, P21, DOI 10.1002/jcp.10042; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0	51	168	176	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					917	929		10.1016/j.cell.2011.07.040	http://dx.doi.org/10.1016/j.cell.2011.07.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925315	Bronze			2022-12-24	WOS:000295258100014
J	Chung, WJ; Oh, JW; Kwak, K; Lee, BY; Meyer, J; Wang, E; Hexemer, A; Lee, SW				Chung, Woo-Jae; Oh, Jin-Woo; Kwak, Kyungwon; Lee, Byung Yang; Meyer, Joel; Wang, Eddie; Hexemer, Alexander; Lee, Seung-Wuk			Biomimetic self-templating supramolecular structures	NATURE			English	Article							DERMAL COLLAGEN ARRAYS; CONVERGENT EVOLUTION; LIQUID-CRYSTALS; PHASE; BIOMATERIALS; COLORATION; PROTEIN; SKIN	In nature, helical macromolecules such as collagen, chitin and cellulose are critical to the morphogenesis and functionality of various hierarchically structured materials(1-3). During tissue formation, these chiral macromolecules are secreted and undergo self-templating assembly, a process whereby multiple kinetic factors influence the assembly of the incoming building blocks to produce non-equilibrium structures(1,4). A single macromolecule can form diverse functional structures when self-templated under different conditions. Collagen type I, for instance, forms transparent corneal tissues from orthogonally aligned nematic fibres(5), distinctively coloured skin tissues from cholesteric phase fibre bundles(6,7), and mineralized tissues from hierarchically organized fibres(8). Nature's self-templated materials surpass the functional and structural complexity achievable by current top-down and bottom-up fabrication methods(9-12). However, self-templating has not been thoroughly explored for engineering synthetic materials. Here we demonstrate the biomimetic, self-templating assembly of chiral colloidal particles (M13 phage) into functional materials. A single-step process produces long-range-ordered, supramolecular films showing multiple levels of hierarchical organization and helical twist. Three distinct supramolecular structures are created by this approach: nematic orthogonal twists, cholesteric helical ribbons and smectic helicolidal nanofilaments. Both chiral liquid crystalline phase transitions and competing interfacial forces at the interface are found to be critical factors in determining the morphology of the templated structures during assembly. The resulting materials show distinctive optical and photonic properties, functioning as chiral reflector/filters and structural colour matrices. In addition, M13 phages with genetically incorporated bioactive peptide ligands direct both soft and hard tissue growth in a hierarchically organized manner. Our assembly approach provides insight into the complexities of hierarchical assembly in nature and could be expanded to other chiral molecules to engineer sophisticated functional helical-twisted structures.	[Chung, Woo-Jae; Oh, Jin-Woo; Kwak, Kyungwon; Lee, Byung Yang; Meyer, Joel; Wang, Eddie; Lee, Seung-Wuk] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Chung, Woo-Jae; Oh, Jin-Woo; Kwak, Kyungwon; Lee, Byung Yang; Meyer, Joel; Wang, Eddie; Lee, Seung-Wuk] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Hexemer, Alexander] Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Lee, SW (corresponding author), Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA.	leesw@berkeley.edu	Lee, Seung-Wuk/AAS-3031-2020; Kwak, Kyungwon/D-8046-2015	Lee, Byung Yang/0000-0003-0125-2501; Wang, Eddie/0000-0002-9814-0102; Hexemer, Alexander/0000-0002-5269-0125	National Science Foundation [DMR-0747713]; Center of Integrated Nanomechanical Systems (COINS) of the National Science Foundation [EEC-0832819]; National Institute of Dental and Craniofacial Research [R21DE018360]; Defense Advanced Research Projects Agency (DARPA); Nanoscience and Nanotechnology Institute at the University of California, Berkeley; Lawrence Berkeley National Laboratory; Korea Research Foundation; Korean government (MOEHRD) [KRF-2006-352-D00048]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE018360] Funding Source: NIH RePORTER; Division Of Materials Research [0747713] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Center of Integrated Nanomechanical Systems (COINS) of the National Science Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Nanoscience and Nanotechnology Institute at the University of California, Berkeley; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Korea Research Foundation(National Research Foundation of Korea); Korean government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the National Science Foundation Early Career Development Award (DMR-0747713), the Center of Integrated Nanomechanical Systems (COINS) of the National Science Foundation (grant no. EEC-0832819), the National Institute of Dental and Craniofacial Research (R21DE018360), the Defense Advanced Research Projects Agency (DARPA) program on Tip-Based Nanofabrication (TBN), start-up funds from the Nanoscience and Nanotechnology Institute at the University of California, Berkeley, the Laboratory Directed Research and Development fund from the Lawrence Berkeley National Laboratory, and the Korea Research Foundation Grant (to W.J.C.) funded by the Korean government (MOEHRD) (KRF-2006-352-D00048).	Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Bawden FC, 1936, NATURE, V138, P1051, DOI 10.1038/1381051a0; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Capito RM, 2008, SCIENCE, V319, P1812, DOI 10.1126/science.1154586; de Gennes P. G., 1995, PHYS LIQUID CRYSTALS; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Dogic Z, 2000, LANGMUIR, V16, P7820, DOI 10.1021/la000446t; Dogic Z, 1997, PHYS REV LETT, V78, P2417, DOI 10.1103/PhysRevLett.78.2417; Douglas T, 1998, NATURE, V393, P152, DOI 10.1038/30211; GIRAUD MM, 1978, TISSUE CELL, V10, P671, DOI 10.1016/0040-8166(78)90054-X; He T, 2010, SMALL, V6, P2230, DOI 10.1002/smll.201001108; Holmes DF, 2001, P NATL ACAD SCI USA, V98, P7307, DOI 10.1073/pnas.111150598; Lanfer B, 2009, BIOMATERIALS, V30, P5950, DOI 10.1016/j.biomaterials.2009.07.039; Lee SW, 2003, LANGMUIR, V19, P1592, DOI 10.1021/la026387w; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; LEFORESTIER A, 1991, BIOL CELL, V71, P115, DOI 10.1016/0248-4900(91)90058-U; Merzlyak A, 2009, NANO LETT, V9, P846, DOI 10.1021/nl8036728; Nam KT, 2006, SCIENCE, V312, P885, DOI 10.1126/science.1122716; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Neville A. C., 1993, BIOL FIBROUS COMPOSI; Place ES, 2009, NAT MATER, V8, P457, DOI [10.1038/NMAT2441, 10.1038/nmat2441]; Prum RO, 2004, J EXP BIOL, V207, P2157, DOI 10.1242/jeb.00989; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X; Sharma V, 2009, SCIENCE, V325, P449, DOI 10.1126/science.1172051; Smalyukh II, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.177801; Smalyukh II, 2010, NAT MATER, V9, P139, DOI [10.1038/NMAT2592, 10.1038/nmat2592]; Stewart GT, 2003, LIQ CRYST, V30, P541, DOI 10.1080/0267829031000097457; Tamaoki N, 2001, ADV MATER, V13, P1135, DOI 10.1002/1521-4095(200108)13:15<1135::AID-ADMA1135>3.0.CO;2-S; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Wu LY, 2011, J MATER CHEM, V21, P8550, DOI 10.1039/c1jm00078k; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	33	329	342	12	680	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					364	368		10.1038/nature10513	http://dx.doi.org/10.1038/nature10513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012394				2022-12-24	WOS:000296021100041
J	Gabut, M; Samavarchi-Tehrani, P; Wang, XC; Slobodeniuc, V; O'Hanlon, D; Sung, HK; Alvarez, M; Talukder, S; Pan, Q; Mazzoni, EO; Nedelec, S; Wichterle, H; Woltjen, K; Hughes, TR; Zandstra, PW; Nagy, A; Wrana, JL; Blencowe, BJ				Gabut, Mathieu; Samavarchi-Tehrani, Payman; Wang, Xinchen; Slobodeniuc, Valentina; O'Hanlon, Dave; Sung, Hoon-Ki; Alvarez, Manuel; Talukder, Shaheynoor; Pan, Qun; Mazzoni, Esteban O.; Nedelec, Stephane; Wichterle, Hynek; Woltjen, Knut; Hughes, Timothy R.; Zandstra, Peter W.; Nagy, Andras; Wrana, Jeffrey L.; Blencowe, Benjamin J.			An Alternative Splicing Switch Regulates Embryonic Stem Cell Pluripotency and Reprogramming	CELL			English	Article							DNA-BINDING; TRANSCRIPTIONAL NETWORK; SEQUENCE SPECIFICITY; FOXP1; DIFFERENTIATION; PROLIFERATION; MICROARRAY; COMPLEXITY; DROSOPHILA; DIVERSITY	Alternative splicing (AS) is a key process underlying the expansion of proteomic diversity and the regulation of gene expression. Here, we identify an evolutionarily conserved embryonic stem cell (ESC)-specific AS event that changes the DNA-binding preference of the forkhead family transcription factor FOXP1. We show that the ESC-specific isoform of FOXP1 stimulates the expression of transcription factor genes required for pluripotency, including OCT4, NANOG, NR5A2, and GDF3, while concomitantly repressing genes required for ESC differentiation. This isoform also promotes the maintenance of ESC pluripotency and contributes to efficient reprogramming of somatic cells into induced pluripotent stem cells. These results reveal a pivotal role for an AS event in the regulation of pluripotency through the control of critical ESC-specific transcriptional programs.	[Gabut, Mathieu; Wang, Xinchen; Slobodeniuc, Valentina; O'Hanlon, Dave; Talukder, Shaheynoor; Pan, Qun; Hughes, Timothy R.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Gabut, Mathieu; Wang, Xinchen; Slobodeniuc, Valentina; O'Hanlon, Dave; Alvarez, Manuel; Talukder, Shaheynoor; Pan, Qun; Hughes, Timothy R.; Zandstra, Peter W.; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Samavarchi-Tehrani, Payman; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Sung, Hoon-Ki; Woltjen, Knut; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Stem Cells & Tissue Engn, Toronto, ON M5G 1X5, Canada; [Samavarchi-Tehrani, Payman; Nagy, Andras; Wrana, Jeffrey L.; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Alvarez, Manuel; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5T 1P7, Canada; [Mazzoni, Esteban O.; Nedelec, Stephane; Wichterle, Hynek] Columbia Univ, Med Ctr, New York, NY 10032 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; Columbia University	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	Hoon, Dave SB/C-7146-2018; Wrana, Jeffrey/F-8857-2013; Nagy, Andras/G-6465-2013; Nedelec, Stéphane/G-8469-2017; Sung, Hoon-Ki/G-3049-2013; GABUT, Mathieu/M-7624-2017; Sung, Hoon-Ki/A-1922-2016; Martinat, Cecile/F-6777-2010	Hoon, Dave SB/0000-0003-1915-3683; Nagy, Andras/0000-0003-4311-0413; Nedelec, Stéphane/0000-0001-8044-2498; GABUT, Mathieu/0000-0001-7343-5361; Sung, Hoon-Ki/0000-0001-6677-9385; Wichterle, Hynek/0000-0002-7817-0080; Woltjen, Knut/0000-0003-2293-1183; Wang, Xinchen/0000-0002-5198-6581; mazzoni, esteban/0000-0001-8994-681X; Martinat, Cecile/0000-0002-5234-1064	Canadian Institutes for Health Research (CIHR); Canadian Cancer Society; Genome Canada (through the Ontario Genomics Institute); Ontario Ministry of Research and Innovation; Ontario Research Fund; NIH [P01 NS055923]; C.H. Best Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS055923] Funding Source: NIH RePORTER	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada (through the Ontario Genomics Institute)(Genome Canada); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Research Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); C.H. Best Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	B.J.B. dedicates this paper to the memory of S. Levine (1911-2011). We are grateful to D. Schmidt, D. Odom, Q. Morris, N. Barbosa-Morais, S. Mavadadi, and H. van Bakel for advice on data analysis and to A. Golipour for assistance with the iPSC reprogramming experiments. L. Attisano, D. Geschwind, and K.-H. Krause kindly provided valuable reagents, and A. Saltzman, B. Raj, J. Calarco, J. Ellis, H. Han, N. Barbosa-Morais, and M. Q.-Vallieres provided helpful comments on the manuscript. Our research was supported by grants from the Canadian Institutes for Health Research (CIHR) to B. J. B., J. L. W., A. N., P.W.Z., and T. R. H., a grant from the Canadian Cancer Society to B. J. B., a grant from Genome Canada (through the Ontario Genomics Institute) to B. J. B. and others, a grant from the Ontario Ministry of Research and Innovation to A. N., and a grant from the Ontario Research Fund to J. L. W., B. J. B., and others. E.O.M., S. N., and H. W. were supported by NIH grant P01 NS055923. E.O.M. is the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation (DRG-1937-07). M. G. was supported by post-doctoral fellowships from the C.H. Best Foundation and CIHR. J. L. W. is an International Scholar of the HHMI.	Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Brown PJ, 2008, BLOOD, V111, P2816, DOI 10.1182/blood-2007-09-115113; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Fic W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000253; Forch P, 2003, Prog Mol Subcell Biol, V31, P127; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jaeger SA, 2010, GENOMICS, V95, P185, DOI 10.1016/j.ygeno.2010.01.002; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koh KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008109; Konstantoulas CJ, 2010, J NEUROCHEM, V113, P836, DOI 10.1111/j.1471-4159.2010.06650.x; Koon HB, 2007, EXPERT OPIN THER TAR, V11, P955, DOI 10.1517/14728222.11.7.955; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Kunarso G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-155; Lam KN, 2011, NUCLEIC ACIDS RES, V39, P4680, DOI 10.1093/nar/gkq1303; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Mayshar Y, 2008, STEM CELLS, V26, P767, DOI 10.1634/stemcells.2007-1037; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pritsker M, 2005, P NATL ACAD SCI USA, V102, P14290, DOI 10.1073/pnas.0502132102; Rao DS, 2010, IMMUNITY, V33, P48, DOI 10.1016/j.immuni.2010.06.013; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; Rowan S, 2010, GENE DEV, V24, P980, DOI 10.1101/gad.1890410; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Stroud JC, 2006, STRUCTURE, V14, P159, DOI 10.1016/j.str.2005.10.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wijchers PJEC, 2006, BIOCHEM J, V397, P233, DOI 10.1042/BJ20060387; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210	45	244	261	0	70	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					132	146		10.1016/j.cell.2011.08.023	http://dx.doi.org/10.1016/j.cell.2011.08.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21924763	Bronze			2022-12-24	WOS:000295396700021
J	Griffin, EE; Odde, DJ; Seydoux, G				Griffin, Erik E.; Odde, David J.; Seydoux, Geraldine			Regulation of the MEX-5 Gradient by a Spatially Segregated Kinase/Phosphatase Cycle	CELL			English	Article							C-ELEGANS EMBRYOS; PROTEIN PHOSPHATASE 2A; AU-RICH ELEMENT; PAR PROTEINS; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; KINASE; POLARITY; PHOSPHORYLATION; ASYMMETRY	Protein concentration gradients encode spatial information across cells and tissues and often depend on spatially localized protein synthesis. Here, we report that a different mechanism underlies the MEX-5 gradient. MEX-5 is an RNA-binding protein that becomes distributed in a cytoplasmic gradient along the anterior-to-posterior axis of the one-cell C. elegans embryo. We demonstrate that the MEX-5 gradient is a direct consequence of an underlying gradient in MEX-5 diffusivity. The MEX-5 diffusion gradient arises when the PAR-1 kinase stimulates the release of MEX-5 from slow-diffusive, RNA-containing complexes in the posterior cytoplasm. PAR-1 directly phosphorylates MEX-5 and is antagonized by the spatially uniform phosphatase PP2A. Mathematical modeling and in vivo observations demonstrate that spatially segregated phosphorylation and dephosphorylation reactions are sufficient to generate stable protein concentration gradients in the cytoplasm. The principles demonstrated here apply to any spatially segregated modification cycle that affects protein diffusion and do not require protein synthesis or degradation.	[Griffin, Erik E.; Seydoux, Geraldine] Johns Hopkins Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Ctr Cell Dynam, Baltimore, MD 21205 USA; [Odde, David J.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Minnesota System; University of Minnesota Twin Cities	Seydoux, G (corresponding author), Johns Hopkins Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Ctr Cell Dynam, 725 N Wolfe St,PCTB 706, Baltimore, MD 21205 USA.	gseydoux@jhmi.edu	Odde, David/H-4925-2011; SEYDOUX, Geraldine/AAA-2005-2020; Odde, David/AAY-1720-2020	Odde, David/0000-0001-7731-2799; Seydoux, Geraldine/0000-0001-8257-0493	National Institutes of Health [R01HD37047, R01 GM71522]; American Cancer Society [PF-08-158-01-DDC]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Motegi for providing the Dendra2 construct, S. He for help with sucrose gradients, and N. Perkins and E. Pryce at the JHU Integrated Imaging Center for assistance with FCS. We thank K. Kemphues for providing strains and antibodies. We thank A. Cuenca for generation of the GFP::PAR-1 transgenic strain. We thank S. Kuo for helpful conversations and members of the Seydoux lab for helpful comments on the manuscript. This work was supported by the National Institutes of Health (Grants R01HD37047 [G.S.] and R01 GM71522 [D.J.O.]) and the American Cancer Society (Grant PF-08-158-01-DDC [E.E.G.]). G.S. is an Investigator of the Howard Hughes Medical Institute.	Berg H, 1993, RANDOM WALKS BIOL EX; Boyd L, 1996, DEVELOPMENT, V122, P3075; Brown GC, 1999, FEBS LETT, V457, P452, DOI 10.1016/S0014-5793(99)01058-3; Budirahardja Y, 2008, DEVELOPMENT, V135, P1303, DOI 10.1242/dev.019075; Cheeks RJ, 2004, CURR BIOL, V14, P851, DOI 10.1016/j.cub.2004.05.022; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; Daniels BR, 2010, DEVELOPMENT, V137, P2579, DOI 10.1242/dev.051326; Ephrussi A, 2004, CELL, V116, P143, DOI 10.1016/S0092-8674(04)00037-6; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Gallo CM, 2008, DEV BIOL, V323, P76, DOI 10.1016/j.ydbio.2008.07.008; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; Hurd D, 2003, DEV BIOL, V253, P54, DOI 10.1006/dbio.2002.0866; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; Kao GT, 2004, DEVELOPMENT, V131, P755, DOI 10.1242/dev.00987; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011; Lai WS, 2002, J BIOL CHEM, V277, P9606, DOI 10.1074/jbc.M110395200; Lin J, 2009, J IMMUNOL, V183, P1215, DOI 10.4049/jimmunol.0803887; Lipkow K, 2008, CELL MOL BIOENG, V1, P84, DOI 10.1007/s12195-008-0008-8; Lippincott-Schwartz J, 2008, METHOD CELL BIOL, V85, P45, DOI 10.1016/S0091-679X(08)85003-0; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; Marx A, 2010, FASEB J, V24, P1637, DOI 10.1096/fj.09-148064; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Pagano JM, 2007, J BIOL CHEM, V282, P8883, DOI 10.1074/jbc.M700079200; Rivers DM, 2008, J CELL BIOL, V180, P877, DOI 10.1083/jcb.200710018; Schlaitz AL, 2007, CELL, V128, P115, DOI 10.1016/j.cell.2006.10.050; Schubert CM, 2000, MOL CELL, V5, P671, DOI 10.1016/S1097-2765(00)80246-4; Severson AF, 2003, J CELL BIOL, V161, P21, DOI 10.1083/jcb.200210171; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; St Johnston D, 2010, CELL, V141, P757, DOI 10.1016/j.cell.2010.05.011; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Tenlen JR, 2008, DEVELOPMENT, V135, P3665, DOI 10.1242/dev.027060; Vaknin A, 2004, P NATL ACAD SCI USA, V101, P17072, DOI 10.1073/pnas.0407812101; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Yoder JH, 2004, EMBO J, V23, P111, DOI 10.1038/sj.emboj.7600025	46	95	103	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					954	967		10.1016/j.cell.2011.08.012	http://dx.doi.org/10.1016/j.cell.2011.08.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925318	Green Accepted, Bronze			2022-12-24	WOS:000295258100017
J	Sugioka, K; Mizumoto, K; Sawa, H				Sugioka, Kenji; Mizumoto, Kota; Sawa, Hitoshi			Wnt Regulates Spindle Asymmetry to Generate Asymmetric Nuclear beta-Catenin in C. elegans	CELL			English	Article							ADENOMATOUS POLYPOSIS-COLI; CELL-DIVISION AXES; CAENORHABDITIS-ELEGANS; MITOTIC SPINDLE; MICROTUBULE GROWTH; TUMOR-SUPPRESSOR; FATE SPECIFICATION; EPITHELIAL-CELLS; APC; EMBRYOS	Extrinsic signals received by a cell can induce remodeling of the cytoskeleton, but the downstream effects of cytoskeletal changes on gene expression have not been well studied. Here, we show that during telophase of an asymmetric division in C. elegans, extrinsic Wnt signaling modulates spindle structures through APR-1/APC, which in turn promotes asymmetrical nuclear localization of WRM-1/beta-catenin and POP-1/TCF. APR-1 that localized asymmetrically along the cortex established asymmetric distribution of astral microtubules, with more microtubules found on the anterior side. Perturbation of the Wnt signaling pathway altered this microtubule asymmetry and led to changes in nuclear WRM-1 asymmetry, gene expression, and cell-fate determination. Direct manipulation of spindle asymmetry by laser irradiation altered the asymmetric distribution of nuclear WRM-1. Moreover, laser manipulation of the spindles rescued defects in nuclear POP-1 asymmetry in wnt mutants. Our results reveal a mechanism in which the nuclear localization of proteins is regulated through the modulation of microtubules.	[Sugioka, Kenji; Mizumoto, Kota; Sawa, Hitoshi] RIKEN Ctr Dev Biol, Lab Cell Fate Decis, Kobe, Hyogo 6500047, Japan; [Sugioka, Kenji; Sawa, Hitoshi] Kobe Univ, Dept Biol, Grad Sch Sci, Kobe, Hyogo 6578501, Japan; [Sawa, Hitoshi] Natl Inst Genet, Multicellular Org Lab, Mishima, Shizuoka 4118540, Japan	RIKEN; Kobe University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Sawa, H (corresponding author), RIKEN Ctr Dev Biol, Lab Cell Fate Decis, Kobe, Hyogo 6500047, Japan.	hisawa@lab.nig.ac.jp		Sugioka, Kenji/0000-0002-5830-9639; Sawa, Hitoshi/0000-0001-9774-7976; Mizumoto, Kota/0000-0001-8091-4483	National Institutes of Health National Center for Research Resources; Ministry of Education, Culture, Sports, Science, and Technology of Japan; RIKEN	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	We thank Rueyling Lin for the anti-POP-1 antibody, Morris Maduro for pMM414, Yuji Kohara for cDNAs, Geraldine Seydoux for the pID3.01B, Joel Rothman, Francis J. McNally, Shohei Mitani, and the Caenorhabditis Genetics Center (funded by the National Institutes of Health National Center for Research Resources) for strains, Asako Sugimoto, Mika Toya, Bob Goldstein, Kumiko Oishi, Yukinobu Arata, Yukimasa Shibata, and Shinji Ihara for technical advice and helpful discussion, and Hazuki Hiraga for proofreading of our manuscript. This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to H.S.K.S. was supported by the Junior Research Associate Program, RIKEN.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; BRENNER S, 1974, GENETICS, V77, P71; Brocardo M, 2008, TRENDS CELL BIOL, V18, P587, DOI 10.1016/j.tcb.2008.09.002; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Chen Z, 2001, DEVELOPMENT, V128, P4911; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corbit KC, 2008, NAT CELL BIOL, V10, P70, DOI 10.1038/ncb1670; Cui HY, 2002, EXP CELL RES, V280, P12, DOI 10.1006/excr.2002.5506; D'Agostino I, 2006, DEV BIOL, V292, P244, DOI 10.1016/j.ydbio.2005.11.046; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Eleftheriou A, 2001, J BIOL CHEM, V276, P25883, DOI 10.1074/jbc.M102656200; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; GOLDSTEIN B, 1995, J CELL BIOL, V129, P1071, DOI 10.1083/jcb.129.4.1071; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; GOLDSTEIN B, 1995, DEVELOPMENT, V121, P1227; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hopkins SC, 2000, BIOCHEMISTRY-US, V39, P2805, DOI 10.1021/bi992474k; HYMAN AA, 1987, J CELL BIOL, V105, P2123, DOI 10.1083/jcb.105.5.2123; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Labbe JC, 2004, J CELL BIOL, V167, P245, DOI 10.1083/jcb.200406008; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lee JY, 2003, DEVELOPMENT, V130, P307, DOI 10.1242/dev.00211; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Lo MC, 2004, CELL, V117, P95, DOI 10.1016/S0092-8674(04)00203-X; Maduro MF, 2005, DEV BIOL, V285, P510, DOI 10.1016/j.ydbio.2005.06.022; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizumoto K, 2007, TRENDS CELL BIOL, V17, P465, DOI 10.1016/j.tcb.2007.08.004; Mizumoto K, 2007, DEV CELL, V12, P287, DOI 10.1016/j.devcel.2007.01.004; Motegi F, 2006, DEV CELL, V10, P509, DOI 10.1016/j.devcel.2006.03.001; MUNEMITSU S, 1994, CANCER RES, V54, P3676; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Phillips BT, 2009, DEV CELL, V17, P27, DOI 10.1016/j.devcel.2009.07.002; Praitis V, 2001, GENETICS, V157, P1217; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Sawa H, 2000, MOL CELL, V6, P617, DOI 10.1016/S1097-2765(00)00060-5; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Schlessinger K, 2007, J CELL BIOL, V178, P355, DOI 10.1083/jcb.200701083; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Srayko M, 2005, DEV CELL, V9, P223, DOI 10.1016/j.devcel.2005.07.003; Sugioka K, 2010, GENES CELLS, V15, P397, DOI 10.1111/j.1365-2443.2010.01388.x; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Wiechens N, 2001, CURR BIOL, V11, P18, DOI 10.1016/S0960-9822(00)00045-2; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	60	59	68	1	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					941	953		10.1016/j.cell.2011.07.043	http://dx.doi.org/10.1016/j.cell.2011.07.043			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925317	Bronze			2022-12-24	WOS:000295258100016
J	Kriks, S; Shim, JW; Piao, JH; Ganat, YM; Wakeman, DR; Xie, Z; Carrillo-Reid, L; Auyeung, G; Antonacci, C; Buch, A; Yang, LC; Beal, MF; Surmeier, DJ; Kordower, JH; Tabar, V; Studer, L				Kriks, Sonja; Shim, Jae-Won; Piao, Jinghua; Ganat, Yosif M.; Wakeman, Dustin R.; Xie, Zhong; Carrillo-Reid, Luis; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Yang, Lichuan; Beal, M. Flint; Surmeier, D. James; Kordower, Jeffrey H.; Tabar, Viviane; Studer, Lorenz			Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease	NATURE			English	Article							STEM-CELLS; FLOOR PLATE; STRIATAL PROGENITORS; DIFFERENTIATION; TRANSPLANTATION; SPECIFICATION; DERIVATION; TISSUE; BRAIN	Human pluripotent stem cells (PSCs) are a promising source of cells for applications in regenerative medicine. Directed differentiation of PSCs into specialized cells such as spinal motoneurons(1) or midbrain dopamine (DA) neurons(2) has been achieved. However, the effective use of PSCs for cell therapy has lagged behind. Whereas mouse PSC-derived DA neurons have shown efficacy in models of Parkinson's disease(3,4), DA neurons from human PSCs generally show poor in vivo performance(5). There are also considerable safety concerns for PSCs related to their potential for teratoma formation or neural overgrowth(6,7). Here we present a novel floor-plate-based strategy for the derivation of human DA neurons that efficiently engraft in vivo, suggesting that past failures were due to incomplete specification rather than a specific vulnerability of the cells. Midbrain floor-plate precursors are derived from PSCs 11 days after exposure to small molecule activators of sonic hedgehog (SHH) and canonical WNT signalling. Engraftable midbrain DA neurons are obtained by day 25 and can be maintained in vitro for several months. Extensive molecular profiling, biochemical and electrophysiological data define developmental progression and confirm identity of PSC-derived midbrain DA neurons. In vivo survival and function is demonstrated in Parkinson's disease models using three host species. Long-term engraftment in 6-hydroxy-dopamine-lesioned mice and rats demonstrates robust survival of midbrain DA neurons derived from human embryonic stem (ES) cells, complete restoration of amphetamine-induced rotation behaviour and improvements in tests of forelimb use and akinesia. Finally, scalability is demonstrated by transplantation into parkinsonian monkeys. Excellent DA neuron survival, function and lack of neural overgrowth in the three animal models indicate promise for the development of cell-based therapies in Parkinson's disease.	[Kriks, Sonja; Shim, Jae-Won; Piao, Jinghua; Ganat, Yosif M.; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Tabar, Viviane; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, New York, NY 10065 USA; [Kriks, Sonja; Shim, Jae-Won; Ganat, Yosif M.; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Piao, Jinghua; Auyeung, Gordon; Antonacci, Chris; Buch, Amanda; Tabar, Viviane; Studer, Lorenz] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Wakeman, Dustin R.; Kordower, Jeffrey H.] Rush Univ, Dept Neurol Sci, Med Ctr, Chicago, IL 60612 USA; [Xie, Zhong; Carrillo-Reid, Luis; Surmeier, D. James] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Yang, Lichuan; Beal, M. Flint] Cornell Univ, Weill Med Coll, New York Presbyterian Hosp, Dept Neurol & Neurosci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Rush University; Northwestern University; Feinberg School of Medicine; Cornell University; NewYork-Presbyterian Hospital	Studer, L (corresponding author), Mem Sloan Kettering Canc Ctr, Ctr Stem Cell Biol, 1275 York Ave, New York, NY 10065 USA.	studerl@mskcc.org	Piao, Jinghua/A-7743-2010; Xie, Zhong/B-6829-2011; Studer, Lorenz/ABH-1491-2021	Xie, Zhong/0000-0002-8348-4455; Studer, Lorenz/0000-0003-0741-7987; Antonacci, Christopher/0000-0002-9793-0524; Carrillo-Reid, Luis/0000-0002-0511-2533; Buch, Amanda M./0000-0001-5889-3495	NIH/NINDS [NS052671, P50 NS047085]; European Commission; Starr foundation; NYSTEM [C024414, C024413]; Michael T. McCarthy Foundation; Elkus Family Foundation; Consolidated Anti-Aging Foundation; Falk Medical Research Trust; NYSCF; Starr stem cell scholar fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671, P50NS071669, P50NS047085] Funding Source: NIH RePORTER	NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Starr foundation; NYSTEM; Michael T. McCarthy Foundation; Elkus Family Foundation; Consolidated Anti-Aging Foundation; Falk Medical Research Trust; NYSCF; Starr stem cell scholar fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Manova, M. Tomishima and A. Viale for excellent technical support, and R. McKay for the anti-nestin antibody. The work was supported by NIH/NINDS grant NS052671, the European Commission project NeuroStemcell, the Starr foundation and NYSTEM contract C024414 to L. S.; by NYSTEM contract C024413, the Michael T. McCarthy Foundation and the Elkus Family Foundation to V. T.; by the Consolidated Anti-Aging Foundation to J.H.K.; by NIH/NINDS grant P50 NS047085, and support from Falk Medical Research Trust to D.J.S.; J.-W.S. was supported by NYSCF (Druckenmiller fellowship) and S. K. by a Starr stem cell scholar fellowship.	Aubry L, 2008, P NATL ACAD SCI USA, V105, P16707, DOI 10.1073/pnas.0808488105; Ban H, 2011, P NATL ACAD SCI USA, V108, P14234, DOI 10.1073/pnas.1103509108; Blume SR, 2009, EXP NEUROL, V219, P208, DOI 10.1016/j.expneurol.2009.05.017; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Fasano CA, 2010, CELL STEM CELL, V6, P336, DOI 10.1016/j.stem.2010.03.001; Ferrari D, 2006, EUR J NEUROSCI, V24, P1885, DOI 10.1111/j.1460-9568.2006.05093.x; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Guzman JN, 2009, J NEUROSCI, V29, P11011, DOI 10.1523/JNEUROSCI.2519-09.2009; Hargus G, 2010, P NATL ACAD SCI USA, V107, P15921, DOI 10.1073/pnas.1010209107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; Muroyama Y, 2002, GENE DEV, V16, P548, DOI 10.1101/gad.937102; NEDERGAARD S, 1993, J PHYSIOL-LONDON, V466, P727; Olanow CW, 1996, TRENDS NEUROSCI, V19, P102, DOI 10.1016/S0166-2236(96)80038-5; Paxinos G., 2000, RHESUS MONKEY BRAIN; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Studer L, 1996, BRAIN RES BULL, V41, P143, DOI 10.1016/0361-9230(96)00114-1; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Tabar V, 2005, NAT BIOTECHNOL, V23, P601, DOI 10.1038/nbt1088; Tabar V, 2008, NAT MED, V14, P379, DOI 10.1038/nm1732; VanDunk C, 2011, J NEUROSCI, V31, P6457, DOI 10.1523/JNEUROSCI.5385-10.2011; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	37	1222	1275	4	347	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2011	480	7378					547	U177		10.1038/nature10648	http://dx.doi.org/10.1038/nature10648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	865NQ	22056989	Green Accepted			2022-12-24	WOS:000298318000066
J	Tran, JC; Zamdborg, L; Ahlf, DR; Lee, JE; Catherman, AD; Durbin, KR; Tipton, JD; Vellaichamy, A; Kellie, JF; Li, MX; Wu, C; Sweet, SMM; Early, BP; Siuti, N; LeDuc, RD; Compton, PD; Thomas, PM; Kelleher, NL				Tran, John C.; Zamdborg, Leonid; Ahlf, Dorothy R.; Lee, Ji Eun; Catherman, Adam D.; Durbin, Kenneth R.; Tipton, Jeremiah D.; Vellaichamy, Adaikkalam; Kellie, John F.; Li, Mingxi; Wu, Cong; Sweet, Steve M. M.; Early, Bryan P.; Siuti, Nertila; LeDuc, Richard D.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.			Mapping intact protein isoforms in discovery mode using top-down proteomics	NATURE			English	Article							CHROMATOGRAPHY-MASS-SPECTROMETRY; CELLULAR SENESCENCE; QUANTITATIVE-ANALYSIS; LARGE-SCALE; IDENTIFICATION; TIME; ELECTROPHORESIS; DISSOCIATION; SEPARATION; PRECISE	A full description of the human proteome relies on the challenging task of detecting mature and changing forms of protein molecules in the body. Large-scale proteome analysis(1) has routinely involved digesting intact proteins followed by inferred protein identification using mass spectrometry(2). This 'bottom-up' process affords a high number of identifications (not always unique to a single gene). However, complications arise from incomplete or ambiguous(2) characterization of alternative splice forms, diverse modifications (for example, acetylation and methylation) and endogenous protein cleavages, especially when combinations of these create complex patterns of intact protein isoforms and species(3). 'Top-down' interrogation of whole proteins can overcome these problems for individual proteins(4,5), but has not been achieved on a proteome scale owing to the lack of intact protein fractionation methods that are well integrated with tandem mass spectrometry. Here we show, using a new four-dimensional separation system, identification of 1,043 gene products from human cells that are dispersed into more than 3,000 protein species created by post-translational modification (PTM), RNA splicing and proteolysis. The overall system produced greater than 20-fold increases in both separation power and proteome coverage, enabling the identification of proteins up to 105 kDa and those with up to 11 transmembrane helices. Many previously undetected isoforms of endogenous human proteins were mapped, including changes in multiply modified species in response to accelerated cellular ageing (senescence) induced by DNA damage. Integrated with the latest version of the Swiss-Prot database(6), the data provide precise correlations to individual genes and proof-of-concept for large-scale interrogation of whole protein molecules. The technology promises to improve the link between proteomics data and complex phenotypes in basic biology and disease research(7).	[Tran, John C.; Zamdborg, Leonid; Ahlf, Dorothy R.; Lee, Ji Eun; Catherman, Adam D.; Durbin, Kenneth R.; Vellaichamy, Adaikkalam; Kellie, John F.; Li, Mingxi; Wu, Cong; Sweet, Steve M. M.; Early, Bryan P.; Siuti, Nertila; Thomas, Paul M.; Kelleher, Neil L.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Tran, John C.; Zamdborg, Leonid; Ahlf, Dorothy R.; Lee, Ji Eun; Catherman, Adam D.; Durbin, Kenneth R.; Vellaichamy, Adaikkalam; Kellie, John F.; Li, Mingxi; Wu, Cong; Sweet, Steve M. M.; Early, Bryan P.; Siuti, Nertila; Thomas, Paul M.; Kelleher, Neil L.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Tran, John C.; Zamdborg, Leonid; Ahlf, Dorothy R.; Lee, Ji Eun; Catherman, Adam D.; Durbin, Kenneth R.; Vellaichamy, Adaikkalam; Kellie, John F.; Li, Mingxi; Wu, Cong; Sweet, Steve M. M.; Early, Bryan P.; Siuti, Nertila; Thomas, Paul M.; Kelleher, Neil L.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Tran, John C.; Ahlf, Dorothy R.; Catherman, Adam D.; Durbin, Kenneth R.; Tipton, Jeremiah D.; Kellie, John F.; Li, Mingxi; Sweet, Steve M. M.; Early, Bryan P.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Tran, John C.; Ahlf, Dorothy R.; Catherman, Adam D.; Durbin, Kenneth R.; Tipton, Jeremiah D.; Kellie, John F.; Li, Mingxi; Sweet, Steve M. M.; Early, Bryan P.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Dept Mol Sci, Evanston, IL 60208 USA; [Tran, John C.; Ahlf, Dorothy R.; Catherman, Adam D.; Durbin, Kenneth R.; Tipton, Jeremiah D.; Kellie, John F.; Li, Mingxi; Sweet, Steve M. M.; Early, Bryan P.; Compton, Philip D.; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA; [Lee, Ji Eun] Korea Inst Sci & Technol, Doping Control Ctr, Seoul, South Korea; [Lee, Ji Eun] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea; [LeDuc, Richard D.] Univ Wisconsin Madison, Dept Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); University of Wisconsin System; University of Wisconsin Madison	Kelleher, NL (corresponding author), Univ Illinois, Dept Chem, Urbana, IL 61801 USA.	n-kelleher@northwestern.edu	Compton, Philip/A-9921-2013; Vellaichamy, Adaikkalam/GWN-0713-2022; Tran, John/AAI-2593-2020; Tran, John/E-7195-2014; Thomas, Paul M/A-6233-2011; Compton, Philip/AAK-9633-2021; Sweet, Steve/B-5528-2008	Compton, Philip/0000-0001-5212-7175; Vellaichamy, Adaikkalam/0000-0002-1740-1252; Tran, John/0000-0003-1697-9404; Tran, John/0000-0003-1697-9404; Thomas, Paul M/0000-0003-2887-4765; Compton, Philip/0000-0001-5212-7175; Sweet, Steve/0000-0002-3962-0421; LeDuc, Richard/0000-0002-6951-2923; Tipton, Jeremiah/0000-0002-3671-8239	Chicago Community Trust; Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling through the National Institute on Drug Abuse [P30DA 018310]; Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling through the National Institute for General Medical Sciences [GM 067193-08]; Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling through the National Science Foundation [DMS 0800631]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F30DA026672, P30DA018310] Funding Source: NIH RePORTER	Chicago Community Trust; Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling through the National Institute on Drug Abuse; Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling through the National Institute for General Medical Sciences; Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling through the National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank all members of the group who contributed to development of top-down mass spectrometry over the years along with several private foundations: The Searle Scholars Program, The Burroughs Wellcome Fund, The David and Lucile Packard Foundation, The Richard and Camille Dreyfus Foundation, and The Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. We further acknowledge the Department of Chemistry at the University of Illinois, the Neuroproteomics Center on Cell to Cell Signaling supported through the National Institute on Drug Abuse (P30DA 018310), the National Institute for General Medical Sciences (GM 067193-08) and the National Science Foundation (DMS 0800631), whose combined investment in basic research over the past decade made this work possible. We dedicate this work in memory of Jonathan Widom.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boyne MT, 2009, J PROTEOME RES, V8, P374, DOI 10.1021/pr800635m; Boyne MT, 2006, J PROTEOME RES, V5, P248, DOI 10.1021/pr050269n; Bunger MK, 2008, ANAL CHEM, V80, P1459, DOI 10.1021/ac7018409; Capriotti A. L., J CHROMAT A IN PRESS; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Duncan MW, 2010, NAT BIOTECHNOL, V28, P659, DOI 10.1038/nbt0710-659; Durbin KR, 2010, PROTEOMICS, V10, P3589, DOI 10.1002/pmic.201000177; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Gomez SM, 2002, MOL CELL PROTEOMICS, V1, P46, DOI 10.1074/mcp.M100007-MCP200; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Horn DM, 2000, J AM SOC MASS SPECTR, V11, P320, DOI 10.1016/S1044-0305(99)00157-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LeDuc RD, 2004, NUCLEIC ACIDS RES, V32, pW340, DOI 10.1093/nar/gkh447; Lee JE, 2009, J AM SOC MASS SPECTR, V20, P2183, DOI 10.1016/j.jasms.2009.08.001; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazur MT, 2010, P NATL ACAD SCI USA, V107, P7728, DOI 10.1073/pnas.0910776107; Meng FY, 2001, NAT BIOTECHNOL, V19, P952, DOI 10.1038/nbt1001-952; Narita M, 2006, CELL, V126, P503, DOI 10.1016/j.cell.2006.05.052; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Papadopoulos P. M., 2001, Proceedings 2001 IEEE International Conference on Cluster Computing, P258, DOI 10.1109/CLUSTR.2001.959986; Parks BA, 2007, ANAL CHEM, V79, P7984, DOI 10.1021/ac070553t; Patrie SM, 2006, MOL CELL PROTEOMICS, V5, P14, DOI 10.1074/mcp.M500219-MCP200; Reiter L, 2009, MOL CELL PROTEOMICS, V8, P2405, DOI 10.1074/mcp.M900317-MCP200; Righetti PG, 2005, ELECTROPHORESIS, V26, P297, DOI 10.1002/elps.200406189; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Roth MJ, 2008, ANAL CHEM, V80, P2857, DOI 10.1021/ac800141g; Roth MJ, 2005, MOL CELL PROTEOMICS, V4, P1002, DOI 10.1074/mcp.M500064-MCP200; Schluter H, 2009, CHEM CENT J, V3, DOI 10.1186/1752-153X-3-11; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Service RF, 2008, SCIENCE, V321, P1758, DOI [10.1126/science.321.5897.1758, 10.1126/science.321.5897.1760]; Sgarra R, 2006, J BIOL CHEM, V281, P3764, DOI 10.1074/jbc.M510231200; Sgarra R, 2003, BIOCHEMISTRY-US, V42, P3575, DOI 10.1021/bi027338l; Soubeyrand S, 2010, MOL ONCOL, V4, P38, DOI 10.1016/j.molonc.2009.09.003; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tran JC, 2008, J PROTEOME RES, V7, P1761, DOI 10.1021/pr700677u; Tran JC, 2008, ANAL CHEM, V80, P1568, DOI 10.1021/ac702197w; Tran JC, 2009, ANAL CHEM, V81, P6201, DOI 10.1021/ac900729r; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Vellaichamy A, 2010, ANAL CHEM, V82, P1234, DOI 10.1021/ac9021083; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yawata T, 2003, ONCOGENE, V22, P281, DOI 10.1038/sj.onc.1206143; Zamdborg L, 2007, NUCLEIC ACIDS RES, V35, pW701, DOI 10.1093/nar/gkm371	47	481	488	2	315	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					254	U141		10.1038/nature10575	http://dx.doi.org/10.1038/nature10575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22037311	Green Accepted			2022-12-24	WOS:000297744200054
J	O'Doherty, JE; Lebedev, MA; Ifft, PJ; Zhuang, KZ; Shokur, S; Bleuler, H; Nicolelis, MAL				O'Doherty, Joseph E.; Lebedev, Mikhail A.; Ifft, Peter J.; Zhuang, Katie Z.; Shokur, Solaiman; Bleuler, Hannes; Nicolelis, Miguel A. L.			Active tactile exploration using a brain-machine-brain interface	NATURE			English	Article							CORTICAL CONTROL; CORTEX; ARM; NEURONS; STIMULATION; GRIP; SKIN	Brain-machine interfaces(1,2) use neuronal activity recorded from the brain to establish direct communication with external actuators, such as prosthetic arms. It is hoped that brain-machine interfaces can be used to restore the normal sensorimotor functions of the limbs, but so far they have lacked tactile sensation. Here we report the operation of a brain-machine-brain interface (BMBI) that both controls the exploratory reaching movements of an actuator and allows signalling of artificial tactile feedback through intracortical microstimulation (ICMS) of the primary somatosensory cortex. Monkeys performed an active exploration task in which an actuator (a computer cursor or a virtual-reality arm) was moved using a BMBI that derived motor commands from neuronal ensemble activity recorded in the primary motor cortex. ICMS feedback occurred whenever the actuator touched virtual objects. Temporal patterns of ICMS encoded the artificial tactile properties of each object. Neuronal recordings and ICMS epochs were temporally multiplexed to avoid interference. Two monkeys operated this BMBI to search for and distinguish one of three visually identical objects, using the virtual-reality arm to identify the unique artificial texture associated with each. These results suggest that clinical motor neuroprostheses might benefit from the addition of ICMS feedback to generate artificial somatic perceptions associated with mechanical, robotic or even virtual prostheses.	[O'Doherty, Joseph E.; Ifft, Peter J.; Zhuang, Katie Z.; Nicolelis, Miguel A. L.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [O'Doherty, Joseph E.; Lebedev, Mikhail A.; Ifft, Peter J.; Zhuang, Katie Z.; Nicolelis, Miguel A. L.] Duke Univ, Ctr Neuroengn, Durham, NC 27710 USA; [Lebedev, Mikhail A.; Nicolelis, Miguel A. L.] Duke Univ, Dept Neurobiol, Durham, NC 27710 USA; [Shokur, Solaiman; Bleuler, Hannes] Ecole Polytech Fed Lausanne, STIIMT, CH-1015 Lausanne, Switzerland; [Nicolelis, Miguel A. L.] Duke Univ, Dept Psychol & Neurosci, Durham, NC 27708 USA; [Nicolelis, Miguel A. L.] Edmond & Lily Safra Int Inst Neurosci Natal, BR-59066060 Natal, RN, Brazil	Duke University; Duke University; Duke University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Duke University	Nicolelis, MAL (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.	nicoleli@neuro.duke.edu	Lebedev, Mikhail A/H-5066-2016; Incemaq, Inct/J-8752-2013; O'Doherty, Joseph E/D-5116-2009	Lebedev, Mikhail A/0000-0003-0355-8723; O'Doherty, Joseph E/0000-0001-8175-5699; Shokur, Solaiman/0000-0003-2251-7142	DARPA [N66001-06-C-2019]; TATRC [W81XWH-08-2-0119]; NIH [NS073125, DP1OD006798]; NICHD/OD [RC1HD063390]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC1HD063390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073125] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006798] Funding Source: NIH RePORTER	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); TATRC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD/OD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Dimitrov for conducting the animal neurosurgeries; G. Lehew and J. Meloy for building brain implants; J. Fruh for rendering the virtual-reality monkey arm; T. Phillips, L. Oliveira and S. Halkiotis for technical support; and E. Thomson and Z. Li for comments. This research was supported by DARPA (award N66001-06-C-2019), TATRC (award W81XWH-08-2-0119), the NIH (award NS073125), NICHD/OD (award RC1HD063390) and NIH Director's Pioneer Award DP1OD006798, to M.A.L.N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the NIH Director or the NIH.	Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Chatterjee A, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-40; Cisek P, 2004, NATURE, V431, P993, DOI 10.1038/nature03005; Dushanova J, 2010, EUR J NEUROSCI, V31, P386, DOI 10.1111/j.1460-9568.2009.07067.x; Fitzsimmons NA, 2007, J NEUROSCI, V27, P5593, DOI 10.1523/JNEUROSCI.5297-06.2007; FLANAGAN JR, 1993, EXP BRAIN RES, V95, P131; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; James TW, 2007, CAN J EXP PSYCHOL, V61, P219, DOI 10.1037/cjep2007023; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; LEBEDEV MA, 1994, J NEUROPHYSIOL, V72, P1654, DOI 10.1152/jn.1994.72.4.1654; Lebedev MA, 2006, TRENDS NEUROSCI, V29, P536, DOI 10.1016/j.tins.2006.07.004; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; Li Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006243; Liu Y, 2005, EXP BRAIN RES, V167, P571, DOI 10.1007/s00221-005-0052-8; London BM, 2008, IEEE T NEUR SYS REH, V16, P32, DOI 10.1109/TNSRE.2007.907544; Marasco PD, 2009, BRAIN, V132, P1441, DOI 10.1093/brain/awp082; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; O'Doherty JE, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.020.2009; RICHER F, 1993, EXP BRAIN RES, V93, P173; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Tkach D, 2008, CURR OPIN NEUROBIOL, V18, P589, DOI 10.1016/j.conb.2008.09.016; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	30	374	396	15	267	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					228	U106		10.1038/nature10489	http://dx.doi.org/10.1038/nature10489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	21976021	Green Accepted			2022-12-24	WOS:000298030800042
J	Cesana, M; Cacchiarelli, D; Legnini, I; Santini, T; Sthandier, O; Chinappi, M; Tramontano, A; Bozzoni, I				Cesana, Marcella; Cacchiarelli, Davide; Legnini, Ivano; Santini, Tiziana; Sthandier, Olga; Chinappi, Mauro; Tramontano, Anna; Bozzoni, Irene			A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA	CELL			English	Article							TRANSCRIPTION; EXPRESSION; MICRORNA-206; GENE; REGENERATION; PTEN	Recently, a new regulatory circuitry has been identified in which RNAs can crosstalk with each other by competing for shared microRNAs. Such competing endogenous RNAs (ceRNAs) regulate the distribution of miRNA molecules on their targets and thereby impose an additional level of post-transcriptional regulation. Here we identify a muscle-specific long noncoding RNA, linc-MD1, which governs the time of muscle differentiation by acting as a ceRNA in mouse and human myoblasts. Downregulation or overexpression of linc-MD1 correlate with retardation or anticipation of the muscle differentiation program, respectively. We show that linc-MD1 "sponges" miR-133 and miR-135 to regulate the expression of MAML1 and MEF2C, transcription factors that activate muscle-specific gene expression. Finally, we demonstrate that linc-MD1 exerts the same control over differentiation timing in human myoblasts, and that its levels are strongly reduced in Duchenne muscle cells. We conclude that the ceRNA network plays an important role in muscle differentiation.	[Cesana, Marcella; Cacchiarelli, Davide; Legnini, Ivano; Santini, Tiziana; Sthandier, Olga; Bozzoni, Irene] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Chinappi, Mauro; Tramontano, Anna] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Tramontano, Anna; Bozzoni, Irene] Univ Roma La Sapienza, Inst Pasteur Fondaz Cenci Bolognetti, I-00185 Rome, Italy; [Tramontano, Anna; Bozzoni, Irene] Univ Roma La Sapienza, Ctr Life Nano Sci Sapienza, Ist Italiano Tecnol, I-00185 Rome, Italy; [Bozzoni, Irene] Univ Roma La Sapienza, IBPM Consiglio Nazl Ric CNR, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Bozzoni, I (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Ple A Moro 5, I-00185 Rome, Italy.	irene.bozzoni@uniroma1.it	Tramontano, anna/D-5378-2009; Cesana, Marcella/AAC-2697-2022; Cacchiarelli, Davide/AAC-2693-2022	Tramontano, anna/0000-0002-5610-3338; Cesana, Marcella/0000-0002-9099-8681; Cacchiarelli, Davide/0000-0002-9621-6716; Chinappi, Mauro/0000-0002-4509-1247; Legnini, Ivano/0000-0002-8984-5215; bozzoni, irene/0000-0002-3485-8537; Santini, Tiziana/0000-0002-7181-7267	Telethon [GGP07049]; Parent Project Italia; EU [LSHG-CT-2006-037900]; KAUST [KUK-I1-012-43]; AIRC; IIT "SEED"; FIRB; PRIN; BEMM	Telethon(Fondazione Telethon); Parent Project Italia; EU(European Commission); KAUST(King Abdullah University of Science & Technology); AIRC(Fondazione AIRC per la ricerca sul cancro); IIT "SEED"(Istituto Italiano di Tecnologia - IIT); FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); BEMM	We thank N. Proudfoot and K. Perkins for introducing M. C. to the 3C analysis; M. Mora and the Telethon Neuromuscular Biobank for providing material; J. Martone, V. Cazzella for useful discussion; and M. Marchioni for technical support. D.C. is a recipient of a Microsoft research PhD fellowship. This work was partially supported by grants from: Telethon (GGP07049), Parent Project Italia, EU project SIROCCO (LSHG-CT-2006-037900), KAUST KUK-I1-012-43, AIRC, IIT "SEED," FIRB, PRIN, and BEMM.	Amaral P. P., 2008, GENOME RES, V17, P556; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Ballarino M, 2009, MOL CELL BIOL, V29, P5632, DOI 10.1128/MCB.00664-09; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Buckingham M, 2009, CURR OPIN GENET DEV, V19, P444, DOI 10.1016/j.gde.2009.08.001; Cacchiarelli D, 2011, EMBO REP, V12, P136, DOI 10.1038/embor.2010.208; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; El Hassan MA, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp028; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Ginger MR, 2006, P NATL ACAD SCI USA, V103, P5781, DOI 10.1073/pnas.0600745103; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Incitti T, 2010, MOL THER, V18, P1675, DOI 10.1038/mt.2010.123; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Khaitan D, 2011, CANCER RES, V71, P3852, DOI 10.1158/0008-5472.CAN-10-4460; LILLY B, 1995, SCIENCE, V267, P688, DOI 10.1126/science.7839146; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Qureshi IA, 2010, BRAIN RES, V1338, P20, DOI 10.1016/j.brainres.2010.03.110; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shen HX, 2006, GENE DEV, V20, P675, DOI 10.1101/gad.1383706; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tan-Wong SM, 2008, P NATL ACAD SCI USA, V105, P5160, DOI 10.1073/pnas.0801048105; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; West AG, 2005, HUM MOL GENET, V14, pR101, DOI 10.1093/hmg/ddi104; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Wilson-Rawls J, 1999, MOL CELL BIOL, V19, P2853; Yuasa K, 2008, CELL STRUCT FUNCT, V33, P163, DOI 10.1247/csf.08022; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	43	1995	2146	4	321	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					358	369		10.1016/j.cell.2011.09.028	http://dx.doi.org/10.1016/j.cell.2011.09.028			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000014	Green Published, Bronze			2022-12-24	WOS:000296199300014
J	Maltagliati, L; Montmessin, F; Fedorova, A; Korablev, O; Forget, F; Bertaux, JL				Maltagliati, L.; Montmessin, F.; Fedorova, A.; Korablev, O.; Forget, F.; Bertaux, J. -L.			Evidence of Water Vapor in Excess of Saturation in the Atmosphere of Mars	SCIENCE			English	Article							GENERAL-CIRCULATION MODEL; MARTIAN ATMOSPHERE; ICE CLOUDS; VERTICAL-DISTRIBUTION; EXPRESS; TROPOSPHERE; DEUTERIUM; ABUNDANCE; BEHAVIOR	The vertical distribution of water vapor is key to the study of Mars' hydrological cycle. To date, it has been explored mainly through global climate models because of a lack of direct measurements. However, these models assume the absence of supersaturation in the atmosphere of Mars. Here, we report observations made using the SPICAM (Spectroscopy for the Investigation of the Characteristics of the Atmosphere of Mars) instrument onboard Mars Express that provide evidence of the frequent presence of water vapor in excess of saturation, by an amount far surpassing that encountered in Earth's atmosphere. This result contradicts the widespread assumption that atmospheric water on Mars cannot exist in a supersaturated state, directly affecting our long-term representation of water transport, accumulation, escape, and chemistry on a global scale.	[Maltagliati, L.; Montmessin, F.; Bertaux, J. -L.] Lab Atmospheres Milieux Observat Spatiales LATMOS, F-78280 Guyancourt, France; [Fedorova, A.; Korablev, O.] Space Res Inst IKI, Moscow 117997, Russia; [Forget, F.] Lab Meteorol Dynam LMD, F-75252 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Ecole des Ponts ParisTech; UDICE-French Research Universities; Sorbonne Universite	Maltagliati, L (corresponding author), Lab Atmospheres Milieux Observat Spatiales LATMOS, F-78280 Guyancourt, France.	luca.maltagliati@latmos.ipsl.fr	Fedorova, Anna A/L-5116-2013; Korablev, Oleg I/K-6770-2017; Korablev, Oleg/L-5083-2013	Korablev, Oleg I/0000-0003-1115-0656; Korablev, Oleg/0000-0003-1115-0656; Montmessin, Franck/0000-0002-4187-1457; Fedorova, Anna/0000-0002-4176-2955	Centre National d'Etudes Spatiales (CNES); Centre National de la Recherche Scientifique; Universite Versailles St Quentin en Yvelines in France; Roscosmos in Russia; Russian Foundation for Basic Research [10-02-93116]	Centre National d'Etudes Spatiales (CNES)(Centre National D'etudes Spatiales); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Versailles St Quentin en Yvelines in France; Roscosmos in Russia; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	We thank L. Montabone for his expertise on MCS data, A. Maattanen for the helpful discussions, and the three anonymous reviewers for their comments that greatly contributed to improve the paper. Mars Express is a space mission of ESA. We thank Centre National d'Etudes Spatiales (CNES), Centre National de la Recherche Scientifique, and Universite Versailles St Quentin en Yvelines in France and Roscosmos in Russia for funding SPICAM. The present analysis was performed with postdoctoral support provided by CNES to L. M. A. F. and O.K. acknowledge Russian Foundation for Basic Research grant 10-02-93116. SPICAM raw data are archived in the Planetary Data System.	Bertaux JL, 2001, J GEOPHYS RES-PLANET, V106, P32879, DOI 10.1029/2000JE001358; Clancy RT, 2000, J GEOPHYS RES-PLANET, V105, P9553, DOI 10.1029/1999JE001089; Clancy RT, 1996, ICARUS, V122, P36, DOI 10.1006/icar.1996.0108; DAVIES DW, 1979, J GEOPHYS RES, V84, P2875, DOI 10.1029/JB084iB06p02875; Fedorova AA, 2009, ICARUS, V200, P96, DOI 10.1016/j.icarus.2008.11.006; Fouchet T, 2007, ICARUS, V190, P32, DOI 10.1016/j.icarus.2007.03.003; Gettelman A, 2006, J CLIMATE, V19, P6089, DOI 10.1175/JCLI3955.1; Goff J. A., 1946, PROC 52 ANN M AM SOC, P95; JAKOSKY BM, 1982, J GEOPHYS RES, V87, P2999, DOI 10.1029/JB087iB04p02999; Kleinbohl A, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003358; Krasnopolsky V, 2000, ICARUS, V148, P597, DOI 10.1006/icar.2000.6534; Lammer H, 1996, GEOPHYS RES LETT, V23, P3353, DOI 10.1029/96GL03153; Lefevre F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002268; Lefevre F, 2008, NATURE, V454, P971, DOI 10.1038/nature07116; Maattanen A, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002308; Maltagliati L, 2011, ICARUS, V213, P480, DOI 10.1016/j.icarus.2011.03.030; MICHELANGELI DV, 1993, ICARUS, V102, P261, DOI 10.1006/icar.1993.1048; MILLOUR E, 2008, LPI CONTRIBUTIONS, V1447, P9029; Montmessin F, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002902; Montmessin F, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002284; Montmessin F, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001520; Richardson MI, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001804; Rodin AV, 1997, ICARUS, V125, P212, DOI 10.1006/icar.1996.5602; Smith M.D, 2008, MARS WAT CYCL WORKSH; Smith M. D., 2002, J GEOPHYS RES, V107, P25, DOI DOI 10.1029/2001JE001522; Smith MD, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003288; Sprague AL, 2006, ICARUS, V184, P372, DOI 10.1016/j.icarus.2006.05.021; Tschimmel A, 2008, ICARUS, V195, P557, DOI 10.1016/j.icarus.2008.01.018	28	101	102	3	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 30	2011	333	6051					1868	1871		10.1126/science.1207957	http://dx.doi.org/10.1126/science.1207957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960630				2022-12-24	WOS:000295365800050
J	Penagarikano, O; Abrahams, BS; Herman, EI; Winden, KD; Gdalyahu, A; Dong, HM; Sonnenblick, LI; Gruver, R; Almajano, J; Bragin, A; Golshani, P; Trachtenberg, JT; Peles, E; Geschwind, DH				Penagarikano, Olga; Abrahams, Brett S.; Herman, Edward I.; Winden, Kellen D.; Gdalyahu, Amos; Dong, Hongmei; Sonnenblick, Lisa I.; Gruver, Robin; Almajano, Joel; Bragin, Anatol; Golshani, Peyman; Trachtenberg, Joshua T.; Peles, Elior; Geschwind, Daniel H.			Absence of CNTNAP2 Leads to Epilepsy, Neuronal Migration Abnormalities, and Core Autism-Related Deficits	CELL			English	Article							ADHESION MOLECULE TAG-1; MOUSE MODELS; FUNCTIONAL CONNECTIVITY; CORTICAL INTERNEURONS; NEUREXIN SUPERFAMILY; MYELINATED AXONS; GENE-EXPRESSION; ANIMAL-MODELS; NETWORK; CHANNELS	Although many genes predisposing to autism spectrum disorders (ASD) have been identified, the biological mechanism(s) remain unclear. Mouse models based on human disease-causing mutations provide the potential for understanding gene function and novel treatment development. Here, we characterize a mouse knockout of the Cntnap2 gene, which is strongly associated with ASD and allied neurodevelopmental disorders. Cntnap2(-/-) mice show deficits in the three core ASD behavioral domains, as well as hyperactivity and epileptic seizures, as have been reported in humans with CNTNAP2 mutations. Neuropathological and physiological analyses of these mice before the onset of seizures reveal neuronal migration abnormalities, reduced number of interneurons, and abnormal neuronal network activity. In addition, treatment with the FDA-approved drug risperidone ameliorates the targeted repetitive behaviors in the mutant mice. These data demonstrate a functional role for CNTNAP2 in brain development and provide a new tool for mechanistic and therapeutic research in ASD.	[Penagarikano, Olga; Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA; [Penagarikano, Olga; Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Penagarikano, Olga; Abrahams, Brett S.; Geschwind, Daniel H.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Gdalyahu, Amos; Gruver, Robin; Trachtenberg, Joshua T.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Peles, Elior] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Weizmann Institute of Science	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet, Los Angeles, CA 90095 USA.	dhg@ucla.edu	Penagarikano, Olga/AAJ-2223-2020	Peles, Elior/0000-0002-3325-0597; Bragin, Anatol/0000-0003-1207-8481; Penagarikano, Olga/0000-0001-8153-8221	NIH/NIMH [R01 MH081754-02R]; NIH ACE Center [1P50-HD055784-01, 5R01-MH081754-04]; NIH [NS50220]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050220] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH ACE Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the UCLA behavioral testing core and its supervisor, Dr. Ravi Ponnusamy, for assistance with behavioral testing. We also thank Dr. Alcino Silva, codirector of the core, for his critical discussions about mouse behavioral testing; Dr. Stephanie White for the UsV equipment and software; Dr. Carolyn Houser for assistance with GAD1 IHC; and Dr. William Yang and Dr. Istvan Mody for helpful discussions. We would also like to thank Jamee Bomar and Dr. Asami Oguro-Ando for help with floating IHC and helpful discussions; Greg Osborn for help with UsV analysis; Clark Rosensweig for help with mouse genotyping; Dr. Irina Voineagu and Lauren Kawaguchi for critically reading the manuscript; and Dr. Eric Wexler for useful discussions on drug treatment. This work was supported by grants NIH/NIMH R01 MH081754-02R to D.H.G.; NIH ACE Center 1P50-HD055784-01 to D.H.G. (Project II) and Network grant 5R01-MH081754-04 to D. H. G.; NIH/NS50220 to E.P.; and Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to D.H.G. and E.P.E.P. is the Incumbent of the Hanna Hertz Professorial Chair for Multiple Sclerosis and Neuroscience.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; American Psychiatric Association (APA), 2000, DIAGN STAT MAN MENT; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; Chadman KK, 2009, AM J MED GENET B, V150B, P1, DOI 10.1002/ajmg.b.30777; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; COSTA RM, 2007, BRAIN PATHOL, V17, P448; Damarla SR, 2010, AUTISM RES, V3, P273, DOI 10.1002/aur.153; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Denaxa M, 2005, DEV BIOL, V288, P87, DOI 10.1016/j.ydbio.2005.09.021; Denaxa M, 2001, DEVELOPMENT, V128, P4635; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Horresh I, 2008, J NEUROSCI, V28, P14213, DOI 10.1523/JNEUROSCI.3398-08.2008; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kreitzer AC, 2008, NEURON, V60, P543, DOI 10.1016/j.neuron.2008.11.005; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Levitt P, 2004, TRENDS NEUROSCI, V27, P400, DOI 10.1016/j.tins.2004.05.008; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Marin O, 2001, SCIENCE, V293, P872, DOI 10.1126/science.1061891; McDougle CJ, 2008, J CLIN PSYCHIAT, V69, P15; McDougle CJ, 2000, CHILD ADOL PSYCH CL, V9, P201; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morante-Oria J, 2003, P NATL ACAD SCI USA, V100, P12468, DOI 10.1073/pnas.1633692100; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Nestler EJ, 2010, NAT NEUROSCI, V13, P1161, DOI 10.1038/nn.2647; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Strauss KA, 2006, NEW ENGL J MED, V354, P1370, DOI 10.1056/NEJMoa052773; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vernes SC, 2008, NEW ENGL J MED, V359, P2337, DOI 10.1056/NEJMoa0802828; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vitali R, 2004, BEHAV BRAIN RES, V153, P129, DOI 10.1016/j.bbr.2003.11.007; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou MM, 2010, P NATL ACAD SCI USA, V107, P4401, DOI 10.1073/pnas.0915173107	62	637	665	0	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					235	246		10.1016/j.cell.2011.08.040	http://dx.doi.org/10.1016/j.cell.2011.08.040			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962519	Bronze, Green Accepted			2022-12-24	WOS:000295396700029
J	Gunther, C; Martini, E; Wittkopf, N; Amann, K; Weigmann, B; Neumann, H; Waldner, MJ; Hedrick, SM; Tenzer, S; Neurath, MF; Becker, C				Guenther, Claudia; Martini, Eva; Wittkopf, Nadine; Amann, Kerstin; Weigmann, Benno; Neumann, Helmut; Waldner, Maximilian J.; Hedrick, Stephen M.; Tenzer, Stefan; Neurath, Markus F.; Becker, Christoph			Caspase-8 regulates TNF-alpha-induced epithelial necroptosis and terminal ileitis	NATURE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CELL-DEATH; INNATE IMMUNITY; CROHNS-DISEASE; APOPTOSIS; NECROSIS; GUT; EXPRESSION; INTESTINE; INTEGRITY	Dysfunction of the intestinal epithelium is believed to result in the excessive translocation of commensal bacteria into the bowel wall that drives chronic mucosal inflammation in Crohn's disease, an incurable inflammatory bowel disease in humans characterized by inflammation of the terminal ileum(1). In healthy individuals, the intestinal epithelium maintains a physical barrier, established by the tight contact of cells. Moreover, specialized epithelial cells such as Paneth cells and goblet cells provide innate immune defence functions by secreting mucus and antimicrobial peptides, which hamper access and survival of bacteria adjacent to the epithelium(2). Epithelial cell death is a hallmark of intestinal inflammation and has been discussed as a possible pathogenic mechanism driving Crohn's disease in humans(3). However, the regulation of epithelial cell death and its role in intestinal homeostasis remain poorly understood. Here we demonstrate a critical role for caspase-8 in regulating necroptosis of intestinal epithelial cells (IECs) and terminal ileitis. Mice with a conditional deletion of caspase-8 in the intestinal epithelium (Casp8(Delta IEC)) spontaneously developed inflammatory lesions in the terminal ileum and were highly susceptible to colitis. Casp8(Delta IEC) mice lacked Paneth cells and showed reduced numbers of goblet cells, indicating dysregulated antimicrobial immune cell functions of the intestinal epithelium. Casp8(Delta IEC) mice showed increased cell death in the Paneth cell area of small intestinal crypts. Epithelial cell death was induced by tumour necrosis factor (TNF)-alpha, was associated with increased expression of receptor-interacting protein 3 (Rip3; also known as Ripk3) and could be inhibited on blockade of necroptosis. Lastly, we identified high levels of RIP3 in human Paneth cells and increased necroptosis in the terminal ileum of patients with Crohn's disease, suggesting a potential role of necroptosis in the pathogenesis of this disease. Together, our data demonstrate a critical function of caspase-8 in regulating intestinal homeostasis and in protecting IECs from TNF-alpha-induced necroptotic cell death.	[Guenther, Claudia; Martini, Eva; Wittkopf, Nadine; Weigmann, Benno; Neumann, Helmut; Waldner, Maximilian J.; Neurath, Markus F.; Becker, Christoph] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, D-91054 Erlangen, Germany; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tenzer, Stefan] Johannes Gutenberg Univ Mainz, Inst Immunol, D-55131 Mainz, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of California System; University of California San Diego; Johannes Gutenberg University of Mainz	Becker, C (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany.	christoph.becker@uk-erlangen.de	Hedrick, Stephen M/E-9171-2010; Tenzer, Stefan/AAE-2180-2020; Becker, Christoph/A-6694-2008; hongbo, yi/G-9615-2011; Becker, Christoph/L-2996-2016	Tenzer, Stefan/0000-0003-3034-0017; Becker, Christoph/0000-0002-1388-1041; Hedrick, Stephen/0000-0002-6345-8751	Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; European Community [202230]; Welcome Trust [WT087768MA]; NIH [AI037988]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037988] Funding Source: NIH RePORTER	Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg; European Community(European Commission); Welcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research leading to these results has received funding from the Interdisciplinary Center for Clinical Research (IZKF) of the University Erlangen-Nuremberg and the European Community's 7th Framework Program (FP7/2007-2013) under grant agreement no. 202230, acronym GENINCA. E. M. received funding from the Welcome Trust (WT087768MA) and S. M. H. was supported by NIH grant AI037988. The authors thank A. Watson for critical reading of the manuscript, A. Nikolaev, S. Wallmuller, V. Buchert and M. Klewer for technical assistance and J. Mudter, R. Atreya and C. Neufert for sampling biopsies.	Arijs I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007984; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Elphick DA, 2005, GUT, V54, P1802, DOI 10.1136/gut.2005.068601; HALL PA, 1994, J CELL SCI, V107, P3569; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; LEWIN K, 1969, GUT, V10, P804, DOI 10.1136/gut.10.10.804; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maelfait J, 2008, BIOCHEM PHARMACOL, V76, P1365, DOI 10.1016/j.bcp.2008.07.034; Mayhew TM, 1999, HISTOL HISTOPATHOL, V14, P257, DOI 10.14670/HH-14.257; Mielgo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007879; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Sanders DSA, 2005, J CLIN PATHOL, V58, P568, DOI 10.1136/jcp.2004.021840; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Valmiki MG, 2009, CELL MOL LIFE SCI, V66, P814, DOI 10.1007/s00018-008-8489-0; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Wehkamp J, 2008, MUCOSAL IMMUNOL, V1, pS67, DOI 10.1038/mi.2008.48; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	30	600	630	2	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2011	477	7364					335	U108		10.1038/nature10400	http://dx.doi.org/10.1038/nature10400			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921917	Green Accepted			2022-12-24	WOS:000294852400032
J	Goldstone, DC; Ennis-Adeniran, V; Hedden, JJ; Groom, HCT; Rice, GI; Christodoulou, E; Walker, PA; Kelly, G; Haire, LF; Yap, MW; de Carvalho, LPS; Stoye, JP; Crow, YJ; Taylor, IA; Webb, M				Goldstone, David C.; Ennis-Adeniran, Valerie; Hedden, Joseph J.; Groom, Harriet C. T.; Rice, Gillian I.; Christodoulou, Evangelos; Walker, Philip A.; Kelly, Geoff; Haire, Lesley F.; Yap, Melvyn W.; de Carvalho, Luiz Pedro S.; Stoye, Jonathan P.; Crow, Yanick J.; Taylor, Ian A.; Webb, Michelle			HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase	NATURE			English	Article							AICARDI-GOUTIERES-SYNDROME; HUMAN DENDRITIC CELLS; REVERSE-TRANSCRIPTASE; DNTP TRIPHOSPHOHYDROLASE; INFECTION; PROTEIN; VPX; MACROPHAGE; MUTATIONS; TREX1	SAMHD1, an analogue of the murine interferon (IFN)-gamma-induced gene Mg11 (ref. 1), has recently been identified as a human immunodeficiency virus-1 (HIV-1) restriction factor that blocks early-stage virus replication in dendritic and other myeloid cells(2,3) and is the target of the lentiviral protein Vpx, which can relieve HIV-1 restriction(4-7). SAMHD1 is also associated with Aicardi-Goutieres syndrome (AGS), an inflammatory encephalopathy characterized by chronic cerebrospinal fluid lymphocytosis and elevated levels of the antiviral cytokine IFN-alpha(8). The pathology associated with AGS resembles congenital viral infection, such as transplacentally acquired HIV. Here we show that human SAMHD1 is a potent dGTP-stimulated triphosphohydrolase that converts deoxynucleoside triphosphates to the constituent deoxynucleoside and inorganic triphosphate. The crystal structure of the catalytic core of SAMHD1 reveals that the protein is dimeric and indicates a molecular basis for dGTP stimulation of catalytic activity against dNTPs. We propose that SAMHD1, which is highly expressed in dendritic cells, restricts HIV-1 replication by hydrolysing the majority of cellular dNTPs, thus inhibiting reverse transcription and viral complementary DNA (cDNA) synthesis.	[Goldstone, David C.; Ennis-Adeniran, Valerie; Hedden, Joseph J.; Christodoulou, Evangelos; Walker, Philip A.; Haire, Lesley F.; Taylor, Ian A.] MRC Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England; [Groom, Harriet C. T.; Yap, Melvyn W.; Stoye, Jonathan P.] MRC Natl Inst Med Res, Div Virol, London NW7 1AA, England; [Rice, Gillian I.; Crow, Yanick J.; Webb, Michelle] Univ Manchester, Cent Manchester Fdn Trust Univ Hosp, Manchester Acad Heath Sci Ctr, Manchester M13 9PT, Lancs, England; [Kelly, Geoff] Natl Inst Med Res, MRC Biomed NMR Ctr, London NW7 1AA, England; [de Carvalho, Luiz Pedro S.] MRC Natl Inst Med Res, Div Mycobacterial Res, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research; University of Manchester; MRC National Institute for Medical Research; MRC National Institute for Medical Research	Taylor, IA (corresponding author), MRC Natl Inst Med Res, Div Mol Struct, Mill Hill, London NW7 1AA, England.	itaylor@nimr.mrc.ac.uk; Michelle.Webb@manchester.ac.uk	Rice, Gillian I/G-3128-2015; Crow, Yanick J/N-6120-2014	Rice, Gillian I/0000-0002-4223-0571; Crow, Yanick J/0000-0001-7211-7564; Sorio de Carvalho, Luiz Pedro/0000-0003-2875-4552; Goldstone, David/0000-0003-0069-9408; Stoye, Jonathan/0000-0003-3377-323X; Christodoulou, Evangelos/0000-0001-8464-1558; Webb, Michelle/0000-0002-3228-7558	UK Medical Research Council [U117565647, U117512710]; European Union [241779]; European Leukodystrophy Association; MRC [MC_U117533887, MC_UP_A253_1111, MC_U117565647, MC_U117512710] Funding Source: UKRI; Medical Research Council [MC_U117533887, MC_U117565647, MC_U117512710, MC_UP_A253_1111] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); European Leukodystrophy Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank S. Gamblin for comments on the manuscript and we acknowledge the Diamond Light Source for synchrotron access. This work was supported by the UK Medical Research Council, file references U117565647 (I. A. T.) and U117512710 (J.P.S.). Y.J.C. acknowledges the European Union Seventh Framework Programme (FP7/2007-2013) grant agreement number 241779 (NIMBL: http://www.NIMBL.eu/), and the European Leukodystrophy Association. Y.J.C. and M. W. acknowledge the Manchester National Institute for Health Research Biomedical Research Centre.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Jamburuthugoda VK, 2008, J BIOL CHEM, V283, P9206, DOI 10.1074/jbc.M710149200; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Kennedy EM, 2010, J BIOL CHEM, V285, P39380, DOI 10.1074/jbc.M110.178582; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Li N, 2000, IMMUNOL LETT, V74, P221, DOI 10.1016/S0165-2478(00)00276-5; Lindahl T, 2009, BIOCHEM SOC T, V37, P535, DOI 10.1042/BST0370535; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SETO D, 1988, J BIOL CHEM, V263, P1494; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wilson PM, 2011, NUCLEIC ACIDS RES, V39, pE112, DOI 10.1093/nar/gkr350; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	30	587	605	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					379	U134		10.1038/nature10623	http://dx.doi.org/10.1038/nature10623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22056990				2022-12-24	WOS:000298033000054
J	Yang, LQ; Lin, CR; Liu, W; Zhang, J; Ohgi, KA; Grinstein, JD; Dorrestein, PC; Rosenfeld, MG				Yang, Liuqing; Lin, Chunru; Liu, Wen; Zhang, Jie; Ohgi, Kenneth A.; Grinstein, Jonathan D.; Dorrestein, Pieter C.; Rosenfeld, Michael G.			ncRNA- and Pc2 Methylation-Dependent Gene Relocation between Nuclear Structures Mediates Gene Activation Programs	CELL			English	Article							LONG NONCODING RNAS; HISTONE H3; LYSINE METHYLTRANSFERASE; CELL-CYCLE; PROTEIN; E2F; HETEROCHROMATIN; EXPRESSION; RECEPTOR; COMPLEXES	Although eukaryotic nuclei contain distinct architectural structures associated with noncoding RNAs (ncRNAs), their potential relationship to regulated transcriptional programs remains poorly understood. Here, we report that methylation/demethylation of Polycomb 2 protein (Pc2) controls relocation of growth-control genes between Polycomb bodies (PcGs) and interchromatin granules (ICGs) in response to growth signals. This movement is the consequence of binding of methylated and unmethylated Pc2 to the ncRNAs TUG1 and MALAT1/NEAT2, located in PcGs and ICGs, respectively. These ncRNAs mediate assembly of multiple corepressors/coactivators and can serve to switch mark recognition by "readers'' of the histone code. Additionally, binding of NEAT2 to unmethylated Pc2 promotes E2F1 SUMOylation, leading to activation of the growth-control gene program. These observations delineate a molecular pathway linking the actions of subnuclear structure-specific ncRNAs and nonhistone protein methylation to relocation of transcription units in the three-dimensional space of the nucleus, thus achieving coordinated gene expression programs.	[Yang, Liuqing; Lin, Chunru; Liu, Wen; Zhang, Jie; Ohgi, Kenneth A.; Grinstein, Jonathan D.; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Yang, Liuqing; Lin, Chunru; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Liu, Wen] Univ Calif San Diego, Sch Med, Grad Program Biol, La Jolla, CA 92093 USA; [Grinstein, Jonathan D.] Univ Calif San Diego, Sch Med, Grad Program Biomed Sci, La Jolla, CA 92093 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Sch Med, Dept Chem & Biochem, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Dorrestein, Pieter/D-5012-2012	Grinstein, Jonathan/0000-0003-2911-4506	Prostate Cancer Foundation; DoD [W81XWH-08-1-0554]; Susan G. Komen for the Cure Fellowship [KG080247];  [DK018477];  [DK74868];  [DK39949];  [CA97134];  [NS34934];  [W81XWH-08-1-0665]; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R37DK039949, P01DK074868, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Prostate Cancer Foundation; DoD(United States Department of Defense); Susan G. Komen for the Cure Fellowship(Susan G. Komen Breast Cancer Foundation); ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Nelson for assistance with cell culture; J. Hightower for artwork; D. Benson, M. Fisher, and R. Pardee for assistance with the manuscript; Dr. B. Tanasa for providing E2F1 target sites from previously published ChIP-Seq data; Dr. P. Sun and Dr. R. Liao for providing BJ cells and technical support for the senescence study; Dr. R. June for assistance with flow cytometry analysis; and Dr. M. Ghassemian and Wei Ting Liu for mass spectrometry analysis. Michael G. Rosenfeld is a Howard Hughes Medical Institute Investigator. This study was funded by grants from DK018477, DK74868, DK39949, CA97134, NS34934, W81XWH-08-1-0665, and the Prostate Cancer Foundation to M. G. R.; L.Y. is the recipient of a DoD Era of Hope Postdoctoral Award (W81XWH-08-1-0554); and C. L. is the recipient of a Susan G. Komen for the Cure Fellowship (KG080247).	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Ait-Si-Ali S, 2004, EMBO J, V23, P605, DOI 10.1038/sj.emboj.7600074; Akhtar A, 2000, NATURE, V407, P405, DOI 10.1038/35030169; BAGCHI S, 1991, CELL, V65, P1063, DOI 10.1016/0092-8674(91)90558-G; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Campanero MR, 1997, P NATL ACAD SCI USA, V94, P2221, DOI 10.1073/pnas.94.6.2221; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Czvitkovich S, 2001, MECH DEVELOP, V107, P141, DOI 10.1016/S0925-4773(01)00464-6; delaLuna S, 1996, J CELL SCI, V109, P2443; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Eddy SR, 2001, NAT REV GENET, V2, P919, DOI 10.1038/35103511; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Huang A, 2005, CANCER RES, V65, P5607, DOI 10.1158/0008-5472.CAN-05-0500; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lavrov S, 2004, METH MOL B, V247, P289; Liu W, 2010, NATURE, V466, P508, DOI 10.1038/nature09272; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Minsky N, 2008, NAT CELL BIOL, V10, P483, DOI 10.1038/ncb1712; Misteli T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000794; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Qi HH, 2010, NATURE, V466, P503, DOI 10.1038/nature09261; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Satijn DPE, 1997, MOL CELL BIOL, V17, P6076, DOI 10.1128/MCB.17.10.6076; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Szczerbal I, 2010, CHROMOSOME RES, V18, P887, DOI 10.1007/s10577-010-9176-1; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xu XJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-396; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027	50	459	487	0	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4					773	788		10.1016/j.cell.2011.08.054	http://dx.doi.org/10.1016/j.cell.2011.08.054			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078878	Bronze, Green Accepted			2022-12-24	WOS:000296902300012
J	Solmaz, SR; Chauhan, R; Blobel, G; Melcak, I				Solmaz, Sozanne R.; Chauhan, Radha; Blobel, Guenter; Melcak, Ivo			Molecular Architecture of the Transport Channel of the Nuclear Pore Complex	CELL			English	Article							BILATERAL STRIATAL NECROSIS; COILED-COIL; P62 COMPLEX; STRUCTURAL-ANALYSIS; IMPORTIN-BETA; NUCLEOPORIN; PROTEIN; MEMBRANE; DOMAIN; GLYCOPROTEINS	The nuclear pore complex encloses a central channel for nucleocytoplasmic transport, which is thought to consist of three nucleoporins, Nup54, Nup58, and Nup62. However, the structure and composition of the channel are elusive. We determined the crystal structures of the interacting domains between these nucleoporins and pieced together the molecular architecture of the mammalian transport channel. Located in the channel midplane is a flexible Nup54, Nup58 ring that can undergo large rearrangements yielding diameter changes from similar to 20 to similar to 40 nm. Nup62 . Nup54 triple helices project alternately up and down from either side of the midplane ring and form nucleoplasmic and cytoplasmic entries. The channel consists of as many as 224 copies of the three nucleoporins, amounting to a molar mass of 12.3 MDa and contributing 256 phenylalanine-glycine repeat regions. We propose that the occupancy of these repeat regions with transport receptors modulates ring diameter and transport activity.	[Solmaz, Sozanne R.; Chauhan, Radha; Blobel, Guenter; Melcak, Ivo] Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Blobel, G (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Cell Biol Lab, 1230 York Ave, New York, NY 10065 USA.	blobel@rockefeller.edu; melcaki@rockefeller.edu		Solmaz, Sozanne R/0000-0002-1703-3701	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Akey DL, 2001, BIOCHEMISTRY-US, V40, P6352, DOI 10.1021/bi002829w; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001; Basel-Vanagaite L, 2006, ANN NEUROL, V60, P214, DOI 10.1002/ana.20902; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Blobel G, 2010, COLD SH Q B, V75, P545, DOI 10.1101/sqb.2010.75.004; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169; Frenkiel-Krispin D, 2010, J MOL BIOL, V395, P578, DOI 10.1016/j.jmb.2009.11.010; GALL JG, 1967, J CELL BIOL, V32, P391, DOI 10.1083/jcb.32.2.391; GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x; Grandi P, 1997, MOL BIOL CELL, V8, P2017, DOI 10.1091/mbc.8.10.2017; GUAN TL, 1995, MOL BIOL CELL, V6, P1591, DOI 10.1091/mbc.6.11.1591; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Hu TH, 1998, GENE, V221, P245, DOI 10.1016/S0378-1119(98)00467-3; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007; King MC, 2006, NATURE, V442, P1003, DOI 10.1038/nature05075; Kiseleva E, 1998, J CELL SCI, V111, P223; KITA K, 1993, J BIOCHEM-TOKYO, V113, P377, DOI 10.1093/oxfordjournals.jbchem.a124054; LAU SYM, 1984, J BIOL CHEM, V259, P3253; Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980; LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013; Meinema AC, 2011, SCIENCE, V333, P90, DOI 10.1126/science.1205741; Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730; Miller BR, 2000, MOL BIOL CELL, V11, P3381, DOI 10.1091/mbc.11.10.3381; MITO T, 1986, ARCH NEUROL-CHICAGO, V43, P677, DOI 10.1001/archneur.1986.00520070035014; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Schrader N, 2008, MOL CELL, V29, P46, DOI 10.1016/j.molcel.2007.10.022; UNWIN PNT, 1982, J CELL BIOL, V93, P63, DOI 10.1083/jcb.93.1.63	36	83	84	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					590	602		10.1016/j.cell.2011.09.034	http://dx.doi.org/10.1016/j.cell.2011.09.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036567	Bronze, Green Accepted			2022-12-24	WOS:000296573700014
J	Cheong, R; Rhee, A; Wang, CJ; Nemenman, I; Levchenko, A				Cheong, Raymond; Rhee, Alex; Wang, Chiaochun Joanne; Nemenman, Ilya; Levchenko, Andre			Information Transduction Capacity of Noisy Biochemical Signaling Networks	SCIENCE			English	Article							NF-KAPPA-B; STOCHASTIC GENE-EXPRESSION; SINGLE-CELL; TEMPORAL CONTROL; DYNAMICS; POPULATION; OSCILLATIONS; VARIABILITY; ACTIVATION; ALPHA	Molecular noise restricts the ability of an individual cell to resolve input signals of different strengths and gather information about the external environment. Transmitting information through complex signaling networks with redundancies can overcome this limitation. We developed an integrative theoretical and experimental framework, based on the formalism of information theory, to quantitatively predict and measure the amount of information transduced by molecular and cellular networks. Analyzing tumor necrosis factor (TNF) signaling revealed that individual TNF signaling pathways transduce information sufficient for accurate binary decisions, and an upstream bottleneck limits the information gained via multiple integrated pathways. Negative feedback to this bottleneck could both alleviate and enhance its limiting effect, despite decreasing noise. Bottlenecks likewise constrain information attained by networks signaling through multiple genes or cells.	[Cheong, Raymond; Rhee, Alex; Wang, Chiaochun Joanne; Levchenko, Andre] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Nemenman, Ilya] Emory Univ, Dept Phys, Atlanta, GA 30322 USA; [Nemenman, Ilya] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Johns Hopkins University; Emory University; Emory University	Levchenko, A (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, 3400 N Charles St, Baltimore, MD 21218 USA.	alev@jhu.edu		Nemenman, Ilya/0000-0003-3024-4244	NIH [GM072024, RR020839, CA132629]; Johns Hopkins University; Los Alamos National Laboratory; NATIONAL CANCER INSTITUTE [R01CA132629] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072024] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins University(Johns Hopkins University); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hoffmann, M. Simon, S. Shvartsman, C. Cohen-Saidon, and U. Alon for sharing data and materials; A. Ganesan and H. Chang for experimental assistance; and P. Iglesias, Y. Qi, and A. Feinberg for insightful discussions and reviewing drafts of the manuscript. This work was supported by NIH grants GM072024 and RR020839 (R.C., A.R., C.J.W., and A.L.) and CA132629 (I.N.), the Medical Scientist Training Program at the Johns Hopkins University (R.C.), and, in early stages of the work, the Los Alamos National Laboratory Directed Research and Development program (I.N.).	Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Bao XR, 2010, BIOPHYS J, V99, P2414, DOI 10.1016/j.bpj.2010.08.043; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2009, MOL CELL PROTEOMICS, V8, P433, DOI 10.1074/mcp.M800291-MCP200; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Coppey M, 2008, CURR BIOL, V18, P915, DOI 10.1016/j.cub.2008.05.034; Cover TM, 1991, ELEMENTS INFORM THEO; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Francis K, 1997, P NATL ACAD SCI USA, V94, P12258, DOI 10.1073/pnas.94.23.12258; Fuller D, 2010, P NATL ACAD SCI USA, V107, P9656, DOI 10.1073/pnas.0911178107; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Krishna S, 2006, P NATL ACAD SCI USA, V103, P10840, DOI 10.1073/pnas.0604085103; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lestas I, 2010, NATURE, V467, P174, DOI 10.1038/nature09333; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Perkins TJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.83; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schneidman E, 2003, J NEUROSCI, V23, P11539; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Thierfelder S, 2011, APPL BIOCHEM BIOTECH, V163, P954, DOI 10.1007/s12010-010-9099-5; Tkacik G, 2008, P NATL ACAD SCI USA, V105, P12265, DOI 10.1073/pnas.0806077105; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; Ziv E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001077	41	307	310	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					354	358		10.1126/science.1204553	http://dx.doi.org/10.1126/science.1204553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21921160	Green Accepted			2022-12-24	WOS:000296052500047
J	Ringel, R; Sologub, M; Morozov, YI; Litonin, D; Cramer, P; Temiakov, D				Ringel, Rieke; Sologub, Marina; Morozov, Yaroslav I.; Litonin, Dmitry; Cramer, Patrick; Temiakov, Dmitry			Structure of human mitochondrial RNA polymerase	NATURE			English	Article							TRANSCRIPTION FACTOR-A; YEAST MITOCHONDRIAL; PROMOTER RECOGNITION; CRYSTAL-STRUCTURE; INITIATION; ELONGATION; COMPLEX; TRANSLATION; SPECIFICITY; TRANSITION	Transcription of the mitochondrial genome is performed by a single-subunit RNA polymerase (mtRNAP) that is distantly related to the RNAP of bacteriophage T7, the pol I family of DNA polymerases, and single-subunit RNAPs from chloroplasts(1-4). Whereas T7 RNAP can initiate transcription by itself, mtRNAP requires the factors TFAM and TFB2M for binding and melting promoter DNA(5-7). TFAM is an abundant protein that binds and bends promoter DNA 15-40 base pairs upstream of the transcription start site, and stimulates the recruitment of mtRNAP and TFB2M to the promoter(8,9). TFB2M assists mtRNAP in promoter melting and reaches the active site of mtRNAP to interact with the first base pair of the RNA-DNA hybrid(10). Here we report the X-ray structure of human mtRNAP at 2.5 angstrom resolution, which reveals a T7-like catalytic carboxy-terminal domain, an amino-terminal domain that remotely resembles the T7 promoter-binding domain, a novel pentatricopeptide repeat domain, and a flexible N-terminal extension. The pentatricopeptide repeat domain sequesters an AT-rich recognition loop, which binds promoter DNA in T7 RNAP, probably explaining the need for TFAM during promoter binding. Consistent with this, substitution of a conserved arginine residue in the AT-rich recognition loop, or release of this loop by deletion of the N-terminal part of mtRNAP, had no effect on transcription. The fingers domain and the intercalating hairpin, which melts DNA in phage RNAPs, are repositioned, explaining the need for TFB2M during promoter melting. Our results provide a new venue for the mechanistic analysis of mitochondrial transcription. They also indicate how an early phage-like mtRNAP lost functions in promoter binding and melting, which were provided by initiation factors in trans during evolution, to enable mitochondrial gene regulation and the adaptation of mitochondrial function to changes in the environment.	[Ringel, Rieke; Litonin, Dmitry; Cramer, Patrick] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Ringel, Rieke; Litonin, Dmitry; Cramer, Patrick] Univ Munich, Dept Biochem, CIPSM, D-81377 Munich, Germany; [Sologub, Marina; Morozov, Yaroslav I.; Litonin, Dmitry; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	University of Munich; University of Munich; Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Cramer, P (corresponding author), Univ Munich, Gene Ctr, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de; d.temiakov@umdnj.edu			US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Deutsche Forschungsgemeinschaft [SFB646, TR5, FOR1068]; Nanosystems Initiative Munich NIM; European Research Council ERC; Jung-Stiftung; UMDNJ Foundation [PC25-11]	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Nanosystems Initiative Munich NIM; European Research Council ERC(European Research Council (ERC)); Jung-Stiftung; UMDNJ Foundation	We thank A. Cheung and D. Kostrewa for help with crystallography, and W. T. McAllister and M. Anikin for the critical reading of the manuscript. We acknowledge the crystallization facility at the Max Planck Institute of Biochemistry, Martinsried. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institut, Villigen, Switzerland. Use of the Advanced Photon Source at Argonne National Laboratory was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility. P. C. was supported by the Deutsche Forschungsgemeinschaft, SFB646, TR5, FOR1068, the Nanosystems Initiative Munich NIM, an Advanced Investigator Grant from the European Research Council ERC, and the Jung-Stiftung. D. T. was supported by the UMDNJ Foundation, grant no. PC25-11.	Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Cliften PF, 1997, GENE DEV, V11, P2897, DOI 10.1101/gad.11.21.2897; DAIRAGHI DJ, 1995, BBA-MOL BASIS DIS, V1271, P127, DOI 10.1016/0925-4439(95)00019-Z; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Gleghorn ML, 2008, MOL CELL, V32, P707, DOI 10.1016/j.molcel.2008.11.010; Hammani K, 2011, J BIOL CHEM, V286, P21361, DOI 10.1074/jbc.M111.230516; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lightowlers Robert N, 2008, Biochem J, V416, pe5, DOI 10.1042/BJ20081942; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; Rodeheffer MS, 2001, J BIOL CHEM, V276, P8616, DOI 10.1074/jbc.M009901200; Savkina M, 2010, J BIOL CHEM, V285, P3957, DOI 10.1074/jbc.M109.051003; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Sologub M, 2009, CELL, V139, P934, DOI 10.1016/j.cell.2009.10.031; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	30	142	147	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					269	273		10.1038/nature10435	http://dx.doi.org/10.1038/nature10435			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21947009	Green Published			2022-12-24	WOS:000295782800056
J	Rasmussen, M; Guo, XS; Wang, Y; Lohmueller, KE; Rasmussen, S; Albrechtsen, A; Skotte, L; Lindgreen, S; Metspalu, M; Jombart, T; Kivisild, T; Zhai, WW; Eriksson, A; Manica, A; Orlando, L; De La Vega, FM; Tridico, S; Metspalu, E; Nielsen, K; Avila-Arcos, MC; Moreno-Mayar, JV; Muller, C; Dortch, J; Gilbert, MTP; Lund, O; Wesolowska, A; Karmin, M; Weinert, LA; Wang, B; Li, J; Tai, SS; Xiao, F; Hanihara, T; van Driem, G; Jha, AR; Ricaut, FX; de Knijff, P; Migliano, AB; Romero, IG; Kristiansen, K; Lambert, DM; Brunak, S; Forster, P; Brinkmann, B; Nehlich, O; Bunce, M; Richards, M; Gupta, R; Bustamante, CD; Krogh, A; Foley, RA; Lahr, MM; Balloux, F; Sicheritz-Ponten, T; Villems, R; Nielsen, R; Wang, J; Willerslev, E				Rasmussen, Morten; Guo, Xiaosen; Wang, Yong; Lohmueller, Kirk E.; Rasmussen, Simon; Albrechtsen, Anders; Skotte, Line; Lindgreen, Stinus; Metspalu, Mait; Jombart, Thibaut; Kivisild, Toomas; Zhai, Weiwei; Eriksson, Anders; Manica, Andrea; Orlando, Ludovic; De La Vega, Francisco M.; Tridico, Silvana; Metspalu, Ene; Nielsen, Kasper; Avila-Arcos, Maria C.; Moreno-Mayar, J. Victor; Muller, Craig; Dortch, Joe; Gilbert, M. Thomas P.; Lund, Ole; Wesolowska, Agata; Karmin, Monika; Weinert, Lucy A.; Wang, Bo; Li, Jun; Tai, Shuaishuai; Xiao, Fei; Hanihara, Tsunehiko; van Driem, George; Jha, Aashish R.; Ricaut, Francois-Xavier; de Knijff, Peter; Migliano, Andrea B.; Romero, Irene Gallego; Kristiansen, Karsten; Lambert, David M.; Brunak, Soren; Forster, Peter; Brinkmann, Bernd; Nehlich, Olaf; Bunce, Michael; Richards, Michael; Gupta, Ramneek; Bustamante, Carlos D.; Krogh, Anders; Foley, Robert A.; Lahr, Marta M.; Balloux, Francois; Sicheritz-Ponten, Thomas; Villems, Richard; Nielsen, Rasmus; Wang, Jun; Willerslev, Eske			An Aboriginal Australian Genome Reveals Separate Human Dispersals into Asia	SCIENCE			English	Article							Y-CHROMOSOME; NEW-GUINEA; SEQUENCE; SETTLEMENT; HISTORY; MODEL	We present an Aboriginal Australian genomic sequence obtained from a 100-year-old lock of hair donated by an Aboriginal man from southern Western Australia in the early 20th century. We detect no evidence of European admixture and estimate contamination levels to be below 0.5%. We show that Aboriginal Australians are descendants of an early human dispersal into eastern Asia, possibly 62,000 to 75,000 years ago. This dispersal is separate from the one that gave rise to modern Asians 25,000 to 38,000 years ago. We also find evidence of gene flow between populations of the two dispersal waves prior to the divergence of Native Americans from modern Asian ancestors. Our findings support the hypothesis that present-day Aboriginal Australians descend from the earliest humans to occupy Australia, likely representing one of the oldest continuous populations outside Africa.	[Wang, Yong; Lohmueller, Kirk E.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wang, Yong; Lohmueller, Kirk E.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Rasmussen, Morten; Lindgreen, Stinus; Orlando, Ludovic; Avila-Arcos, Maria C.; Moreno-Mayar, J. Victor; Gilbert, M. Thomas P.; Krogh, Anders; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen, Denmark; [Rasmussen, Morten; Lindgreen, Stinus; Orlando, Ludovic; Avila-Arcos, Maria C.; Moreno-Mayar, J. Victor; Gilbert, M. Thomas P.; Krogh, Anders; Willerslev, Eske] Univ Copenhagen, Dept Biol, DK-1350 Copenhagen, Denmark; [Rasmussen, Morten; Guo, Xiaosen; Gilbert, M. Thomas P.; Kristiansen, Karsten; Wang, Jun; Willerslev, Eske] BGI Shenzhen, Sino Danish Genom Ctr, Shenzhen 518083, Peoples R China; [Guo, Xiaosen; Wang, Bo; Li, Jun; Tai, Shuaishuai; Xiao, Fei; Kristiansen, Karsten; Wang, Jun] BGI Shenzhen, Shenzhen Key Lab Trans Biotechnol, Shenzhen 518083, Peoples R China; [Rasmussen, Simon; Nielsen, Kasper; Lund, Ole; Wesolowska, Agata; Brunak, Soren; Gupta, Ramneek; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Albrechtsen, Anders; Skotte, Line; Lindgreen, Stinus; Kristiansen, Karsten; Krogh, Anders; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Univ Tartu, Dept Evolutionary Biol, EE-510101 Tartu, Estonia; [Metspalu, Mait; Metspalu, Ene; Karmin, Monika; Villems, Richard] Estonian Bioctr, EE-510101 Tartu, Estonia; [Jombart, Thibaut; Weinert, Lucy A.; Balloux, Francois] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modeling, London W2 1PG, England; [Kivisild, Toomas; Migliano, Andrea B.; Foley, Robert A.; Lahr, Marta M.] Univ Cambridge, Dept Biol Anthropol, Leverhulme Ctr Human Evolutionary Studies, Cambridge CB2 1QH, England; [Zhai, Weiwei] Chinese Acad Sci, Beijing Inst Genom, Beijing 100029, Peoples R China; [Eriksson, Anders; Manica, Andrea] Univ Cambridge, Dept Zool, Evolutionary Ecol Grp, Cambridge CB2 3EJ, England; [De La Vega, Francisco M.; Bustamante, Carlos D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Tridico, Silvana; Bunce, Michael] Murdoch Univ, Sch Biol Sci & Biotechnol, Ancient DNA Lab, Murdoch, WA 6150, Australia; [Moreno-Mayar, J. Victor] Univ Nacl Autonoma Mexico, Undergrad Program Genom Sci, Cuernavaca 62210, Morelos, Mexico; [Muller, Craig] Goldfields Land & Sea Council Aboriginal Corp, Kalgoorlie, WA 6430, Australia; [Dortch, Joe] Univ Western Australia, Crawley, WA 6009, Australia; [Hanihara, Tsunehiko] Kitasato Univ, Sch Med, Dept Anat, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [van Driem, George] Univ Bern, Sprachwissensch Inst, CH-3000 Bern 9, Switzerland; [Jha, Aashish R.; Romero, Irene Gallego] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ricaut, Francois-Xavier] Univ Toulouse 3, CNRS, UMR 5288, Lab Anthropol Mol & Imagerie Synth, F-31073 Toulouse 3, France; [de Knijff, Peter] Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 ZA Leiden, Netherlands; [Migliano, Andrea B.] UCL, Dept Anthropol, London WC1E 6BT, England; [Lambert, David M.] Griffith Univ, Sch Biomol & Phys Sci, Nathan, Qld 4111, Australia; [Lambert, David M.] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Brunak, Soren] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Forster, Peter] Univ Cambridge, Murray Edwards Coll, Cambridge CB3 0DF, England; [Forster, Peter; Brinkmann, Bernd] Inst Forens Genet, D-48161 Munster, Germany; [Nehlich, Olaf; Richards, Michael] Max Planck Inst Evolutionary Anthropol, Dept Human Evoluat, D-04103 Leipzig, Germany; [Richards, Michael] Univ British Columbia, Dept Anthropol, Vancouver, BC V6T 1Z1, Canada; [Sicheritz-Ponten, Thomas] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Villems, Richard] Estonian Acad Sci, EE-10130 Tallinn, Estonia; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen, Denmark	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Copenhagen; University of Copenhagen; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI); Technical University of Denmark; University of Copenhagen; University of Tartu; Estonian Biocentre; Imperial College London; University of Cambridge; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Cambridge; Stanford University; Murdoch University; Universidad Nacional Autonoma de Mexico; University of Western Australia; Kitasato University; University of Bern; University of Chicago; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of London; University College London; Griffith University; Griffith University; University of Copenhagen; University of Cambridge; Max Planck Society; University of British Columbia; Technical University of Denmark; Estonian Academy of Sciences; Novo Nordisk Foundation; University of Copenhagen	Nielsen, R (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	rasmus_nielsen@berkeley.edu; wangj@genomics.org.cn; ewillerslev@snm.ku.dk	Kristiansen, Karsten/J-5148-2014; Wang, Jun/A-7261-2013; Kivisild, Toomas/P-5889-2017; Lund, Ole/F-4437-2014; de Knijff, Peter/Y-2519-2018; Lindgreen, Stinus/B-5594-2014; De La Vega, Francisco/H-3832-2011; wang, yong/G-8398-2011; Eriksson, Anders/C-9767-2010; Ricaut, Francois Xavier/G-1206-2010; wang, yong/J-6713-2013; Willerslev, Eske/A-9619-2011; Nehlich, Olaf/A-3767-2010; Orlando, Ludovic/A-8932-2013; Rasmussen, Simon/AAA-2308-2020; Gupta, Ramneek/G-7278-2012; Richards, Michael/O-3717-2016; Willerslev, Eske/AAA-5686-2019; Balloux, Francois/D-4783-2009; Gilbert, Marcus TP/A-8936-2013; Manica, Andrea/B-5497-2008; Albrechtsen, Anders/K-4281-2013; Nielsen, Rasmus/D-4405-2009; Rasmussen, Simon/G-6258-2016; Metspalu, Mait/G-8671-2015; Dortch, Joe/C-6296-2014; Manica, Andrea/N-9013-2019; Balloux, Francois/X-7856-2019; Moreno-Mayar, J. Víctor/AAB-3732-2022; Richards, Michael/A-9374-2008; Skotte, Line/F-7359-2014; Brunak, Soren/O-6621-2016; Sicheritz-Ponten, Thomas/A-4325-2017; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Krogh, Anders/M-1541-2014	Kristiansen, Karsten/0000-0002-6024-0917; Kivisild, Toomas/0000-0002-6297-7808; Lund, Ole/0000-0003-1108-0491; de Knijff, Peter/0000-0002-0899-771X; Lindgreen, Stinus/0000-0001-5104-1054; Eriksson, Anders/0000-0003-3436-3726; wang, yong/0000-0001-8772-7349; Willerslev, Eske/0000-0002-7081-6748; Nehlich, Olaf/0000-0002-4993-5013; Orlando, Ludovic/0000-0003-3936-1850; Rasmussen, Simon/0000-0001-6323-9041; Gupta, Ramneek/0000-0001-6841-6676; Richards, Michael/0000-0001-5274-8887; Balloux, Francois/0000-0003-1978-7715; Gilbert, Marcus TP/0000-0002-5805-7195; Manica, Andrea/0000-0003-1895-450X; Albrechtsen, Anders/0000-0001-7306-031X; Nielsen, Rasmus/0000-0003-0513-6591; Rasmussen, Simon/0000-0001-6323-9041; Metspalu, Mait/0000-0003-3099-9161; Dortch, Joe/0000-0002-0510-5456; Manica, Andrea/0000-0003-1895-450X; Balloux, Francois/0000-0003-1978-7715; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Richards, Michael/0000-0001-5274-8887; Skotte, Line/0000-0002-7398-1271; Zhai, Weiwei/0000-0001-7938-0226; Avila-Arcos, Maria C./0000-0003-1691-1696; Brunak, Soren/0000-0003-0316-5866; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Migliano, Andrea/0000-0003-4364-2735; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; Karmin, Monika/0000-0001-9827-5579; Bunce, Michael/0000-0002-0302-4206; Lambert, David/0000-0002-5821-3637; Mirazon Lahr, Marta/0000-0001-5752-5770; Jha, Aashish/0000-0003-3227-1086; Krogh, Anders/0000-0002-5147-6282; Gallego Romero, Irene/0000-0003-1613-8998; RICAUT, Francois-Xavier/0000-0001-7609-7898; van Driem, George/0000-0002-7185-0657; Bustamante, Carlos D./0000-0002-4187-7920; Nielsen, Kasper/0000-0002-5510-7767; Tai, Shuaishuai/0000-0001-8204-6982	Biotechnology and Biological Sciences Research Council [BB/H008802/1, BB/H005854/1] Funding Source: Medline; NHGRI NIH HHS [R01 HG003229] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/H008802/2] Funding Source: researchfish; Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; BBSRC [BB/H005854/1, BB/H008802/1, BB/H008802/2] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Novo Nordisk Fonden(Novo Nordisk Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Binladen J, 2006, GENETICS, V172, P733, DOI 10.1534/genetics.105.049718; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Endicott P, 2009, TRENDS ECOL EVOL, V24, P515, DOI 10.1016/j.tree.2009.04.006; Gilbert MTP, 2008, SCIENCE, V320, P1787, DOI 10.1126/science.1159750; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Karafet TM, 2010, MOL BIOL EVOL, V27, P1833, DOI 10.1093/molbev/msq063; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Lahr M. M, 1996, EVOLUTION MODERN HUM; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Lahr MM, 1998, YEARB PHYS ANTHROPOL, V41, P137; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Pellekaan SMV, 2006, AM J PHYS ANTHROPOL, V131, P282, DOI 10.1002/ajpa.20426; Whitehouse P, 2004, P NATL ACAD SCI USA, V101, P5692, DOI 10.1073/pnas.0400233101	27	428	437	4	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2011	334	6052					94	98		10.1126/science.1211177	http://dx.doi.org/10.1126/science.1211177			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21940856	Green Accepted, Green Published			2022-12-24	WOS:000295580300047
J	Franosch, T; Grimm, M; Belushkin, M; Mor, FM; Foffi, G; Forro, L; Jeney, S				Franosch, Thomas; Grimm, Matthias; Belushkin, Maxim; Mor, Flavio M.; Foffi, Giuseppe; Forro, Laszlo; Jeney, Sylvia			Resonances arising from hydrodynamic memory in Brownian motion	NATURE			English	Article							OPTICAL-TWEEZERS; COMPLEX FLUIDS; ACTIN NETWORKS; SINGLE CELLS; TECHNOLOGIES	Observation of the Brownian motion of a small probe interacting with its environment provides one of the main strategies for characterizing soft matter(1-4). Essentially, two counteracting forces govern the motion of the Brownian particle. First, the particle is driven by rapid collisions with the surrounding solvent molecules, referred to as thermal noise. Second, the friction between the particle and the viscous solvent damps its motion. Conventionally, the thermal force is assumed to be random and characterized by a Gaussian white noise spectrum. The friction is assumed to be given by the Stokes drag, suggesting that motion is overdamped at long times in particle tracking experiments, when inertia becomes negligible. However, as the particle receives momentum from the fluctuating fluid molecules, it also displaces the fluid in its immediate vicinity. The entrained fluid acts back on the particle and gives rise to long-range correlations(5,6). This hydrodynamic 'memory' translates to thermal forces, which have a coloured, that is, non-white, noise spectrum. One hundred years after Perrin's pioneering experiments on Brownian motion(7-9), direct experimental observation of this colour is still elusive(10). Here we measure the spectrum of thermal noise by confining the Brownian fluctuations of a microsphere in a strong optical trap. We show that hydrodynamic correlations result in a resonant peak in the power spectral density of the sphere's positional fluctuations, in strong contrast to overdamped systems. Furthermore, we demonstrate different strategies to achieve peak amplification. By analogy with microcantilever-based sensors(11,12), our results reveal that the particle-fluid-trap system can be considered a nanomechanical resonator in which the intrinsic hydrodynamic backflow enhances resonance. Therefore, instead of being treated as a disturbance, details in thermal noise could be exploited for the development of new types of sensor and particle-based assay in lab-on-a-chip applications(13,14).	[Grimm, Matthias; Jeney, Sylvia] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; [Franosch, Thomas] Univ Erlangen Nurnberg, Inst Theoret Phys, D-91058 Erlangen, Germany; [Grimm, Matthias; Mor, Flavio M.; Forro, Laszlo; Jeney, Sylvia] Ecole Polytech Fed Lausanne, Lab Phys Complex Matter, CH-1015 Lausanne, Switzerland; [Belushkin, Maxim; Foffi, Giuseppe] Ecole Polytech Fed Lausanne, Inst Theoret Phys, CH-1015 Lausanne, Switzerland	University of Basel; University of Erlangen Nuremberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Jeney, S (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.	sylvia.jeney@epfl.ch	Foffi, Giuseppe/C-3923-2009; Foffi, Giuseppe/AAZ-7559-2021	Foffi, Giuseppe/0000-0002-7444-1453; Foffi, Giuseppe/0000-0002-7444-1453	Swiss National Science Foundation (SNF) [200021-113529, 206021-121396]; NCCR Nanoscale Science; German Academic Exchange Service (DAAD); National Competence Center in Biomedical Imaging (NCCBI); SNF [PP0022_119006]	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NCCR Nanoscale Science(Swiss National Science Foundation (SNSF)European Commission); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Competence Center in Biomedical Imaging (NCCBI); SNF	S.J. acknowledges the Swiss National Science Foundation (SNF; grant nos 200021-113529 and 206021-121396). M. G. is supported by NCCR Nanoscale Science and the German Academic Exchange Service (DAAD) and F. M. M. is supported by the National Competence Center in Biomedical Imaging (NCCBI). M. B. and G. F. acknowledge support from the SNF (grant no. PP0022_119006). We thank W. Offner and R. Koszali for technical help and U. Aebi, B. U. Felderhof, H. Flyvbjerg, S. Melchionna, E. Sackmann and R. G. Winkler for discussions.	ALDER BJ, 1967, PHYS REV LETT, V18, P988, DOI 10.1103/PhysRevLett.18.988; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Berg-Sorensen K, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/038; Berg-Sorensen K, 2004, REV SCI INSTRUM, V75, P594, DOI 10.1063/1.1645654; Bormuth V, 2008, OPT EXPRESS, V16, P13831, DOI 10.1364/OE.16.013831; Braeckmans K, 2002, NAT REV DRUG DISCOV, V1, P447, DOI 10.1038/nrd817; Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; CLERCX HJH, 1992, PHYS REV A, V46, P1942, DOI 10.1103/PhysRevA.46.1942; Craighead H, 2006, NATURE, V442, P387, DOI 10.1038/nature05061; Di Leonardo R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.010601; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Gompper G, 2009, ADV POLYM SCI, V221, P1, DOI 10.1007/12_2008_5; Hanggi P, 2005, CHAOS, V15, DOI 10.1063/1.1895505; HINCH EJ, 1975, J FLUID MECH, V72, P499, DOI 10.1017/S0022112075003102; Huang RX, 2011, NAT PHYS, V7, P576, DOI [10.1038/NPHYS1953, 10.1038/nphys1953]; Jeney S, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/25/255102; Jeney S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.240604; Lukic B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011112; MASON TG, 1995, PHYS REV LETT, V74, P1250, DOI 10.1103/PhysRevLett.74.1250; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Pedersen L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.189801; Perrin J, 1909, ANN CHIM PHYS, V18, P5; Perrin J, 1920, ATOMS; Peterman EJG, 2003, REV SCI INSTRUM, V74, P3246, DOI 10.1063/1.1584085; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Vladimirsky V., 1945, ZH EKSP TEOR FIZ+, V15, P258; WANG MC, 1945, REV MOD PHYS, V17, P323, DOI 10.1103/RevModPhys.17.323	31	256	258	0	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					85	88		10.1038/nature10498	http://dx.doi.org/10.1038/nature10498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979048				2022-12-24	WOS:000295575400039
J	Najmabadi, H; Hu, H; Garshasbi, M; Zemojtel, T; Abedini, SS; Chen, W; Hosseini, M; Behjati, F; Haas, S; Jamali, P; Zecha, A; Mohseni, M; Puttmann, L; Vahid, LN; Jensen, C; Moheb, LA; Bienek, M; Larti, F; Mueller, I; Weissmann, R; Darvish, H; Wrogemann, K; Hadavi, V; Lipkowitz, B; Esmaeeli-Nieh, S; Wieczorek, D; Kariminejad, R; Firouzabadi, SG; Cohen, M; Fattahi, Z; Rost, I; Mojahedi, F; Hertzberg, C; Dehghan, A; Rajab, A; Banavandi, MJS; Hoffer, J; Falah, M; Musante, L; Kalscheuer, V; Ullmann, R; Kuss, AW; Tzschach, A; Kahrizi, K; Ropers, HH				Najmabadi, Hossein; Hu, Hao; Garshasbi, Masoud; Zemojtel, Tomasz; Abedini, Seyedeh Sedigheh; Chen, Wei; Hosseini, Masoumeh; Behjati, Farkhondeh; Haas, Stefan; Jamali, Payman; Zecha, Agnes; Mohseni, Marzieh; Puettmann, Lucia; Vahid, Leyla Nouri; Jensen, Corinna; Moheb, Lia Abbasi; Bienek, Melanie; Larti, Farzaneh; Mueller, Ines; Weissmann, Robert; Darvish, Hossein; Wrogemann, Klaus; Hadavi, Valeh; Lipkowitz, Bettina; Esmaeeli-Nieh, Sahar; Wieczorek, Dagmar; Kariminejad, Roxana; Firouzabadi, Saghar Ghasemi; Cohen, Monika; Fattahi, Zohreh; Rost, Imma; Mojahedi, Faezeh; Hertzberg, Christoph; Dehghan, Atefeh; Rajab, Anna; Banavandi, Mohammad Javad Soltani; Hoffer, Julia; Falah, Masoumeh; Musante, Luciana; Kalscheuer, Vera; Ullmann, Reinhard; Kuss, Andreas Walter; Tzschach, Andreas; Kahrizi, Kimia; Ropers, H. Hilger			Deep sequencing reveals 50 novel genes for recessive cognitive disorders	NATURE			English	Article							LINKED MENTAL-RETARDATION; INTELLECTUAL DISABILITY; BINDING-PROTEIN; FRAMESHIFT MUTATION; IDENTIFICATION; FAMILY; DISRUPTION; ENCODES; SRD5A3; SCREEN	Common diseases are often complex because they are genetically heterogeneous, with many different genetic defects giving rise to clinically indistinguishable phenotypes. This has been amply documented for early-onset cognitive impairment, or intellectual disability, one of the most complex disorders known and a very important health care problem worldwide. More than 90 different gene defects have been identified for X-chromosome-linked intellectual disability alone, but research into the more frequent autosomal forms of intellectual disability is still in its infancy. To expedite the molecular elucidation of autosomal-recessive intellectual disability, we have now performed homozygosity mapping, exon enrichment and next-generation sequencing in 136 consanguineous families with autosomal-recessive intellectual disability from Iran and elsewhere. This study, the largest published so far, has revealed additional mutations in 23 genes previously implicated in intellectual disability or related neurological disorders, as well as single, probably disease-causing variants in 50 novel candidate genes. Proteins encoded by several of these genes interact directly with products of known intellectual disability genes, and many are involved in fundamental cellular processes such as transcription and translation, cell-cycle control, energy metabolism and fatty-acid synthesis, which seem to be pivotal for normal brain development and function.	[Hu, Hao; Garshasbi, Masoud; Chen, Wei; Zecha, Agnes; Puettmann, Lucia; Jensen, Corinna; Moheb, Lia Abbasi; Bienek, Melanie; Mueller, Ines; Weissmann, Robert; Wrogemann, Klaus; Lipkowitz, Bettina; Esmaeeli-Nieh, Sahar; Hoffer, Julia; Musante, Luciana; Kalscheuer, Vera; Ullmann, Reinhard; Kuss, Andreas Walter; Tzschach, Andreas; Ropers, H. Hilger] Max Planck Inst Mol Genet, Dept Human Mol Genet, D-14195 Berlin, Germany; [Najmabadi, Hossein; Garshasbi, Masoud; Abedini, Seyedeh Sedigheh; Hosseini, Masoumeh; Behjati, Farkhondeh; Mohseni, Marzieh; Vahid, Leyla Nouri; Moheb, Lia Abbasi; Larti, Farzaneh; Darvish, Hossein; Firouzabadi, Saghar Ghasemi; Fattahi, Zohreh; Banavandi, Mohammad Javad Soltani; Falah, Masoumeh; Kahrizi, Kimia] Univ Social Welf & Rehabil Sci, Genet Res Ctr, Tehran 19857, Iran; [Najmabadi, Hossein; Hadavi, Valeh; Kariminejad, Roxana] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14667, Iran; [Zemojtel, Tomasz; Haas, Stefan] Max Planck Inst Mol Genet, Dept Computat Mol Biol, D-14195 Berlin, Germany; [Chen, Wei] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Jamali, Payman] Shahroud Welf Org, Semnan 36156, Iran; [Wrogemann, Klaus] Univ Manitoba, Dept Biochem & Mol Genet, Winnipeg, MB R3E0J9, Canada; [Wieczorek, Dagmar] Univ Klinikum Essen, Inst Humangenet, D-45122 Essen, Germany; [Cohen, Monika] Kinderzentrum Muenchen, D-81377 Munich, Germany; [Rost, Imma] Zentrum Humangenet & Lab Med Dr Klein & Dr Rost, D-82152 Martinsried, Germany; [Mojahedi, Faezeh] Mashhad Med Genet Counseling Ctr, Mashhad 91767, Iran; [Hertzberg, Christoph] Vivantes Klinikum Neukolln, D-12351 Berlin, Germany; [Dehghan, Atefeh] Yazd Welf Org, Yazd 89178, Iran; [Rajab, Anna] Royal Hosp, Genet Unit, Minist Hlth, Directorate Gen Hlth Affairs, Muscat 113, Oman	Max Planck Society; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Manitoba; University of Duisburg Essen; VIivantes Klinikum Neukolln; The Royal Hospital, Sultanate of Oman	Ropers, HH (corresponding author), Max Planck Inst Mol Genet, Dept Human Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kkahrizi@uswr.ac.ir; ropers@molgen.mpg.de	Najmabadi, Hossein/P-8182-2017; Falah, Masoumeh/L-2712-2018; Abedini, Seyedeh Sedigheh/AAG-3694-2021; Falah, Masoumeh/AAX-2996-2020; Tzschach, Andreas/I-2648-2019; Behjati, Farkhondeh/D-8497-2017; Chen, Wei/C-1273-2011; Wieczorek, Dagmar/AAU-6008-2021; Kahrizi, Kimia/D-7989-2017; Larti, Farzaneh/D-8522-2017; Fattahi, Zohreh/Z-5165-2019; banavandi, mohammad javad soltani/AAU-4254-2021; Musante, Luciana/AAA-5726-2021	Falah, Masoumeh/0000-0002-2800-4199; Falah, Masoumeh/0000-0002-2800-4199; Tzschach, Andreas/0000-0002-6840-965X; Behjati, Farkhondeh/0000-0001-6343-0452; Wieczorek, Dagmar/0000-0003-2812-6492; Musante, Luciana/0000-0002-2742-1484; Najmabadi, Hossein/0000-0002-6084-7778; Kuss, Andreas/0000-0002-9401-4627; Chen, Wei/0000-0003-3263-1627; Garshasbi, Masoud/0000-0002-5508-7903; Abedini, Seyedeh Sedigheh/0000-0003-2671-2295; Haas, Stefan/0000-0003-3418-3688; Kalscheuer, Vera/0000-0001-6898-3259	Max Planck Innovation Funds; German Federal Ministry of Education and Research through the MRNET [01GS08161]; Iranian National Science Foundation; EU	Max Planck Innovation Funds; German Federal Ministry of Education and Research through the MRNET; Iranian National Science Foundation(Iran National Science Foundation (INSF)); EU(European Commission)	We express our gratitude to the patients and their families for their participation in the study. We thank S. Nakhee and K. Javan for their support; S. Arzhangi, S. Banihashemi, M. Kasiri, H. Khodaee, M. Schlicht and M. Gerloff for contributing to this project in various ways; G. Eder for her assistance with the preparation of the manuscript; and S. Shoichet for critically reading the manuscript. This work was supported by the Max Planck Innovation Funds, the German Federal Ministry of Education and Research through the MRNET (grant 01GS08161, to H. H. R.), the Iranian National Science Foundation and the EU-FP7 project GENCODYS.	Abou Jamra R, 2011, AM J HUM GENET, V88, P788, DOI 10.1016/j.ajhg.2011.04.019; Alazami AM, 2011, NEUROGENETICS, V12, P333, DOI 10.1007/s10048-011-0291-8; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Boison D, 2002, P NATL ACAD SCI USA, V99, P6985, DOI 10.1073/pnas.092642899; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; D'Adamo P, 1998, NAT GENET, V19, P134, DOI 10.1038/487; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Garshasbi M, 2008, AM J HUM GENET, V82, P1158, DOI 10.1016/j.ajhg.2008.03.018; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hamdan FF, 2009, NEW ENGL J MED, V360, P599, DOI 10.1056/NEJMoa0805392; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jaffe AB, 2004, MOL CELL BIOL, V24, P1736, DOI 10.1128/MCB.24.4.1736-1746.2004; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Kahrizi K, 2011, EUR J HUM GENET, V19, P115, DOI 10.1038/ejhg.2010.132; Kaufman L, 2010, J NEURODEV DISORD, V2, P182, DOI 10.1007/s11689-010-9055-2; Klein U, 1997, J BIOL CHEM, V272, P19099, DOI 10.1074/jbc.272.31.19099; Kuss AW, 2011, HUM GENET, V129, P141, DOI 10.1007/s00439-010-0907-3; Laumonnier F, 2007, AM J HUM GENET, V80, P205, DOI 10.1086/511441; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mir A, 2009, AM J HUM GENET, V85, P909, DOI 10.1016/j.ajhg.2009.11.009; Moheb LA, 2008, EUR J HUM GENET, V16, P270, DOI 10.1038/sj.ejhg.5201967; Motazacker MM, 2007, AM J HUM GENET, V81, P792, DOI 10.1086/521275; Najmabadi H, 2007, HUM GENET, V121, P43, DOI 10.1007/s00439-006-0292-0; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Raas-Rothschild A, 2002, AM J HUM GENET, V70, P1062, DOI 10.1086/339766; Rafiq MA, 2011, AM J HUM GENET, V89, P176, DOI 10.1016/j.ajhg.2011.06.006; Ramser J, 2004, J MED GENET, V41, P679, DOI 10.1136/jmg.2004.019000; Ropers HH, 2010, ANNU REV GENOM HUM G, V11, P161, DOI 10.1146/annurev-genom-082509-141640; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Singh Baljinder, 2007, Hum Mutat, V28, P524, DOI 10.1002/humu.9491; Sodersten E, 2010, CELL CYCLE, V9, P4866, DOI 10.4161/cc.9.24.14154; Steinfeld R, 2009, AM J HUM GENET, V85, P354, DOI 10.1016/j.ajhg.2009.08.005; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Yildirim Y, 2011, HUM MOL GENET, V20, P1886, DOI 10.1093/hmg/ddr070; Zamponi GW, 2010, PFLUG ARCH EUR J PHY, V460, P395, DOI 10.1007/s00424-009-0772-x; Zhu XR, 2002, P NATL ACAD SCI USA, V99, P10293, DOI 10.1073/pnas.162352599	43	640	660	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					57	63		10.1038/nature10423	http://dx.doi.org/10.1038/nature10423			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21937992				2022-12-24	WOS:000295575400034
J	Surmeli, G; Akay, T; Ippolito, GC; Tucker, PW; Jessell, TM				Suermeli, Guelsen; Akay, Turgay; Ippolito, Gregory C.; Tucker, Philip W.; Jessell, Thomas M.			Patterns of Spinal Sensory-Motor Connectivity Prescribed by a Dorsoventral Positional Template	CELL			English	Article							NEURON POOL; VERTEBRATE LIMB; CHICK WINGS; HIND-LIMB; MUSCLE; SPECIFICITY; MOTONEURONS; MECHANISMS; AFFERENTS; IDENTITY	Sensory-motor circuits in the spinal cord are constructed with a fine specificity that coordinates motor behavior, but the mechanisms that direct sensory connections with their motor neuron partners remain unclear. The dorsoventral settling position of motor pools in the spinal cord is known to match the distal-to-proximal position of their muscle targets in the limb, but the significance of invariant motor neuron positioning is unknown. An analysis of sensory-motor connectivity patterns in FoxP1 mutant mice, where motor neuron position has been scrambled, shows that the final pattern of sensory-motor connections is initiated by the projection of sensory axons to discrete dorsoventral domains of the spinal cord without regard for motor neuron subtype or, indeed, the presence of motor neurons. By implication, the clustering and dorsoventral settling position of motor neuron pools serve as a determinant of the pattern of sensory input specificity and thus motor coordination.	[Suermeli, Guelsen; Akay, Turgay; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [Suermeli, Guelsen; Akay, Turgay; Jessell, Thomas M.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Ippolito, Gregory C.; Tucker, Philip W.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; University of Texas System; University of Texas Austin	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu	Ippolito, Gregory C./AAR-2930-2021; Surmeli, Gulsen/AAJ-1906-2020	Ippolito, Gregory C./0000-0002-7565-7002; SURMELI, GULSEN/0000-0002-3227-0641; Akay, Turgay/0000-0002-0466-2285	Gatsby Charitable Foundation; NIH [R01-CA31534, R01-NS033245, P01-NS055923]; Marie Betzer Morrow endowment; ProjectALS/P<SUP>2</SUP>ALS; Wellcome Trust; NYSTEM; Harold and Leila Mathers Foundation; NATIONAL CANCER INSTITUTE [R01CA031534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, R37NS033245, P01NS055923] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Betzer Morrow endowment; ProjectALS/P<SUP>2</SUP>ALS; Wellcome Trust(Wellcome TrustEuropean Commission); NYSTEM; Harold and Leila Mathers Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank George Romanes for enlightening discussions on motor neuron groupings, Jeremy Dasen for insight into FoxP function, Joriene De Noiij for help with dorsal root fills, Gert Holstege for motor pool maps, Julia Kaltschmidt for contributions to the design of sensory-motor specificity assays, Tim Machado for statistical analysis of neuronal distributions, Richard Nichols and Trevor Drew for insight into limb biomechanics, John Kelly for detective work, Kendall Doerr for a sense of place, and Ira Schieren for assistance with figures and graphics. Kaity Miao, Monica Mendelsohn, June Harriss, and Deborah Surman helped in mouse genotyping and husbandry. Silvia Arber, Richard Axel, Jeremy Dasen, Joriene de Nooij, Jennifer Morgan, Chris Henderson, John Kelly, George Mentis, Richard Nichols, Sebastian Poliak, and George Romanes provided helpful comments on the manuscript. G. S. was supported by the Gatsby Charitable Foundation, and P.W.T. by NIH grant R01-CA31534 and the Marie Betzer Morrow endowment. T.M.J. is an Investigator of the Howard Hughes Medical Institute and was supported by NIH grants R01-NS033245 and P01-NS055923, ProjectALS/P<SUP>2</SUP>ALS, The Wellcome Trust, NYSTEM, and The Harold and Leila Mathers Foundation.	Baldissera F., 1981, HDB PHYSL 1 1, V2, P509, DOI DOI 10.1002/CPHY.CP010212; Betley JN, 2009, CELL, V139, P161, DOI 10.1016/j.cell.2009.08.027; Brown A. G., 1981, ORG SPINAL CORD, DOI [10.1007/978-1-4471-1305-8, DOI 10.1007/978-1-4471-1305-8]; Burkholder TJ, 2004, J MORPHOL, V261, P118, DOI 10.1002/jmor.10233; Cooper KL, 2011, SCIENCE, V332, P1083, DOI 10.1126/science.1199499; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Demireva EY, 2011, CELL, V147, P641, DOI 10.1016/j.cell.2011.09.037; Dessaud E, 2007, NATURE, V450, P717, DOI 10.1038/nature06347; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; Feng XM, 2010, BLOOD, V115, P510, DOI 10.1182/blood-2009-07-232694; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033; Gibson CL, 1999, NEUROREPORT, V10, P231, DOI 10.1097/00001756-199902050-00006; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; HASAN Z, 1988, ANNU REV NEUROSCI, V11, P199, DOI 10.1146/annurev.ne.11.030188.001215; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; HONGO T, 1984, PROC R SOC SER B-BIO, V221, P261, DOI 10.1098/rspb.1984.0034; Hultborn H, 2006, PROG NEUROBIOL, V78, P215, DOI 10.1016/j.pneurobio.2006.04.001; Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; LEWIS J, 1981, J EMBRYOL EXP MORPH, V64, P211; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Maeder CI, 2011, CURR OPIN NEUROBIOL, V21, P93, DOI 10.1016/j.conb.2010.10.004; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; Mears SC, 1997, J NEUROSCI, V17, P3128; MENDELSON B, 1991, J NEUROSCI, V11, P1390; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; NICHOLS TR, 1994, ACTA ANAT, V151, P1; NICHOLS TR, 2002, PROGR MOTOR CONTROL, P179; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; PHELAN KA, 1990, J NEUROSCI, V10, P2699; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; ROMANES G. J., 1964, PROGR BRAIN RES, V11, P93; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; Romanes GJ, 1941, J ANAT, V75, P145; RONNEVI LO, 1974, BRAIN RES, V80, P335, DOI 10.1016/0006-8993(74)90696-9; Rosello-Diez A, 2011, SCIENCE, V332, P1086, DOI 10.1126/science.1199489; Rousso DL, 2008, NEURON, V59, P226, DOI 10.1016/j.neuron.2008.06.025; SEEBACH BS, 1994, J NEUROSCI, V14, P4520; Shneider NA, 2009, J NEUROSCI, V29, P4719, DOI 10.1523/JNEUROSCI.5790-08.2009; SNIDER WD, 1992, J NEUROSCI, V12, P3494; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Sperry RW, 1940, J COMP NEUROL, V73, P379, DOI 10.1002/cne.900730303; Stevens CF, 1998, CURR BIOL, V8, pR708, DOI 10.1016/S0960-9822(98)70454-3; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46; Wang B, 2004, DEVELOPMENT, V131, P4477, DOI 10.1242/dev.01287; Wenner P, 1995, J NEUROSCI, V15, P8191; Zagoraiou L, 2009, NEURON, V64, P645, DOI 10.1016/j.neuron.2009.10.017; Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135	55	115	116	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					653	665		10.1016/j.cell.2011.10.012	http://dx.doi.org/10.1016/j.cell.2011.10.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036571	Green Accepted, Bronze			2022-12-24	WOS:000296573700019
J	Pellegrino, M; Steinbach, N; Stensmyr, MC; Hansson, BS; Vosshall, LB				Pellegrino, Maurizio; Steinbach, Nicole; Stensmyr, Marcus C.; Hansson, Bill S.; Vosshall, Leslie B.			A natural polymorphism alters odour and DEET sensitivity in an insect odorant receptor	NATURE			English	Article							AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; REPELLENT DEET; CELLULAR BASIS; MOSQUITOS; DIPTERA; SUPERFAMILY; ATTRACTION; INHIBITION; CULICIDAE	Blood-feeding insects such as mosquitoes are efficient vectors of human infectious diseases because they are strongly attracted by body heat, carbon dioxide and odours produced by their vertebrate hosts. Insect repellents containing DEET (N,N-diethyl-meta-toluamide) are highly effective, but the mechanism by which this chemical wards off biting insects remains controversial despite decades of investigation(1-11). DEET seems to act both at close range as a contact chemo-repellent, by affecting insect gustatory receptors(12), and at long range, by affecting the olfactory system(1-11). Two opposing mechanisms for the observed behavioural effects of DEET in the gas phase have been proposed: that DEET interferes with the olfactory system to block host odour recognition(1-7) and that DEET actively repels insects by activating olfactory neurons that elicit avoidance behaviour(8-11). Here we show that DEET functions as a modulator of the odour-gated ion channel formed by the insect odorant receptor complex(13,14). The functional insect odorant receptor complex consists of a common co-receptor, ORCO (ref. 15) (formerly called OR83B; ref. 16), and one or more variable odorant receptor subunits that confer odour selectivity(17). DEET acts on this complex to potentiate or inhibit odour-evoked activity or to inhibit odour-evoked suppression of spontaneous activity. This modulation depends on the specific odorant receptor and the concentration and identity of the odour ligand. We identify a single amino-acid polymorphism in the second transmembrane domain of receptor OR59B in a Drosophila melanogaster strain from Brazil that renders OR59B insensitive to inhibition by the odour ligand and modulation by DEET. Our data indicate that natural variation can modify the sensitivity of an odour-specific insect odorant receptor to odour ligands and DEET. Furthermore, they support the hypothesis that DEET acts as a molecular 'confusant' that scrambles the insect odour code, and provide a compelling explanation for the broad-spectrum efficacy of DEET against multiple insect species.	[Pellegrino, Maurizio; Steinbach, Nicole; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Vosshall, Leslie B.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Stensmyr, Marcus C.; Hansson, Bill S.] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, D-07745 Jena, Germany	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Max Planck Society	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, 1230 York Ave,Box 63, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223; Vosshall, Leslie/0000-0002-6060-8099; Stensmyr, Marcus/0000-0003-4009-9212	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NIH [RO1 DC008600]; Max Planck Society; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008600] Funding Source: NIH RePORTER	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank C. Bargmann, K. Lee, K. Scott, L. Stowers and members of the Vosshall lab for discussion and comments on the manuscript; and K. Weniger for technical assistance with the SPME and GC-MS experiments. This work was funded in part by a grant to R. Axel and L. B. V. from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative and by a grant to L. B. V. from the NIH (RO1 DC008600). L. B. V. is an investigator of the Howard Hughes Medical Institute. M. C. S. and B. S. H. are supported by the Max Planck Society.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Bohbot JD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012138; DAVIS EE, 1976, J COMP PHYSIOL, V105, P43, DOI 10.1007/BF01380052; Ditzen M, 2008, SCIENCE, V319, P1838, DOI 10.1126/science.1153121; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dogan EB, 1999, MED VET ENTOMOL, V13, P97, DOI 10.1046/j.1365-2915.1999.00145.x; Dogan EB, 1999, J MED ENTOMOL, V36, P788, DOI 10.1093/jmedent/36.6.788; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gross SP, 2003, CURR BIOL, V13, P1660, DOI 10.1016/j.cub.2003.08.032; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Kline DL, 2003, J MED ENTOMOL, V40, P463, DOI 10.1603/0022-2585-40.4.463; Laish-Farkash A, 2010, J CARDIOVASC ELECTR, V21, P1365, DOI 10.1111/j.1540-8167.2010.01844.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lee Y, 2010, NEURON, V67, P555, DOI 10.1016/j.neuron.2010.07.006; Liu C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000467; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; MCIVER SB, 1981, J MED ENTOMOL, V18, P357, DOI 10.1093/jmedent/18.5.357; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Reeder NL, 2001, J ECON ENTOMOL, V94, P1584, DOI 10.1603/0022-0493-94.6.1584; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Stanczyk NM, 2010, P NATL ACAD SCI USA, V107, P8575, DOI 10.1073/pnas.1001313107; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	36	125	137	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					511	U106		10.1038/nature10438	http://dx.doi.org/10.1038/nature10438			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21937991	Green Accepted			2022-12-24	WOS:000296194200042
J	Ehret, GB; Munroe, PB; Rice, KM; Bochud, M; Johnson, AD; Chasman, DI; Smith, AV; Tobin, MD; Verwoert, GC; Hwang, SJ; Pihur, V; Vollenweider, P; O'Reilly, PF; Amin, N; Bragg-Gresham, JL; Teumer, A; Glazer, NL; Launer, L; Zhao, JH; Aulchenko, Y; Heath, S; Sober, S; Parsa, A; Luan, JA; Arora, P; Dehghan, A; Zhang, F; Lucas, G; Hicks, AA; Jackson, AU; Peden, JF; Tanaka, T; Wild, SH; Rudan, I; Igl, W; Milaneschi, Y; Parker, AN; Fava, C; Chambers, JC; Fox, ER; Kumari, M; Go, MJ; van der Harst, P; Kao, WHL; Sjogren, M; Vinay, DG; Alexander, M; Tabara, Y; Shaw-Hawkins, S; Whincup, PH; Liu, YM; Shi, G; Kuusisto, J; Tayo, B; Seielstad, M; Sim, X; Nguyen, KDH; Lehtimaki, T; Matullo, G; Wu, Y; Gaunt, TR; Onland-Moret, NC; Cooper, MN; Platou, CGP; Org, E; Hardy, R; Dahgam, S; Palmen, J; Vitart, V; Braund, PS; Kuznetsova, T; Uiterwaal, CSPM; Adeyemo, A; Palmas, W; Campbell, H; Ludwig, B; Tomaszewski, M; Tzoulaki, I; Palmer, ND; Aspelund, T; Garcia, M; Chang, YPC; O'Connell, JR; Steinle, NI; Grobbee, DE; Arking, DE; Kardia, SL; Morrison, AC; Hernandez, D; Najjar, S; McArdle, WL; Hadley, D; Brown, MJ; Connell, JM; Hingorani, AD; Day, INM; Lawlor, DA; Beilby, JP; Lawrence, RW; Clarke, R; Hopewell, JC; Ongen, H; Dreisbach, AW; Li, YL; Young, JH; Bis, JC; Kahonen, M; Viikari, J; Adair, LS; Lee, NR; Chen, MH; Olden, M; Pattaro, C; Bolton, JAH; Kottgen, A; Bergmann, S; Mooser, V; Chaturvedi, N; Frayling, TM; Islam, M; Jafar, TH; Erdmann, J; Kulkarni, SR; Bornstein, SR; Grassler, J; Groop, L; Voight, BF; Kettunen, J; Howard, P; Taylor, A; Guarrera, S; Ricceri, F; Emilsson, V; Plump, A; Barroso, IS; Khaw, KT; Weder, AB; Hunt, SC; Sun, YV; Bergman, RN; Collins, FS; Bonnycastle, LL; Scott, LJ; Stringham, HM; Peltonen, L; Perola, M; Vartiainen, E; Brand, SM; Staessen, JA; Wang, TJ; Burton, PR; Artigas, MS; Dong, YB; Snieder, H; Wang, XL; Zhu, HD; Lohman, KK; Rudock, ME; Heckbert, SR; Smith, NL; Wiggins, KL; Doumatey, A; Shriner, D; Veldre, G; Viigimaa, M; Kinra, S; Prabhakaran, D; Tripathy, V; Langefeld, CD; Rosengren, A; Thelle, DS; Corsi, AM; Singleton, A; Forrester, T; Hilton, G; McKenzie, CA; Salako, T; Iwai, N; Kita, Y; Ogihara, T; Ohkubo, T; Okamura, T; Ueshima, H; Umemura, S; Eyheramendy, S; Meitinger, T; Wichmann, HE; Cho, YS; Kim, HL; Lee, JY; Scott, J; Sehmi, JS; Zhang, WH; Hedblad, B; Nilsson, P; Smith, GD; Wong, A; Narisu, N; Stancakova, A; Raffel, LJ; Yao, J; Kathiresan, S; O'Donnell, CJ; Schwartz, SM; Ikram, MA; Longstreth, WT; Mosley, TH; Seshadri, S; Shrine, NRG; Wain, LV; Morken, MA; Swift, AJ; Laitinen, J; Prokopenko, I; Zitting, P; Cooper, JA; Humphries, SE; Danesh, J; Rasheed, A; Goel, A; Hamsten, A; Watkins, H; Bakker, SJL; van Gilst, WH; Janipalli, CS; Mani, KR; Yajnik, CS; Hofman, A; Mattace-Raso, FUS; Oostra, BA; Demirkan, A; Isaacs, A; Rivadeneira, F; Lakatta, EG; Orru, M; Scuteri, A; Ala-Korpela, M; Kangas, AJ; Lyytikainen, LP; Soininen, P; Tukiainen, T; Wurtz, P; Ong, RTH; Dorr, M; Kroemer, HK; Volker, U; Volzke, H; Galan, P; Hercberg, S; Lathrop, M; Zelenika, D; Deloukas, P; Mangino, M; Spector, TD; Zhai, GJ; Meschia, JF; Nalls, MA; Sharma, P; Terzic, J; Kumar, MVK; Denniff, M; Zukowska-Szczechowska, E; Wagenknecht, LE; Fowkes, FGR; Charchar, FJ; Schwarz, PEH; Hayward, C; Guo, XQ; Rotimi, C; Bots, ML; Brand, E; Samani, NJ; Polasek, O; Talmud, PJ; Nyberg, F; Kuh, D; Laan, M; Hveem, K; Palmer, LJ; van der Schouw, YT; Casas, JP; Mohlke, KL; Vineis, P; Raitakari, O; Ganesh, SK; Wong, TY; Tai, ES; Cooper, RS; Laakso, M; Rao, DC; Harris, TB; Morris, RW; Dominiczak, AF; Kivimaki, M; Marmot, MG; Miki, T; Saleheen, D; Chandak, GR; Coresh, J; Navis, G; Salomaa, V; Han, BG; Zhu, XF; Kooner, JS; Melander, O; Ridker, PM; Bandinelli, S; Gyllensten, UB; Wright, AF; Wilson, JF; Ferrucci, L; Farrall, M; Tuomilehto, J; Pramstaller, PP; Elosua, R; Soranzo, N; Sijbrands, EJG; Altshuler, D; Loos, RJF; Shuldiner, AR; Gieger, C; Meneton, P; Uitterlinden, AG; Wareham, NJ; Gudnason, V; Rotter, JI; Rettig, R; Uda, M; Strachan, DP; Witteman, JCM; Hartikainen, AL; Beckmann, JS; Boerwinkle, E; Vasan, RS; Boehnke, M; Larson, MG; Jarvelin, MR; Psaty, BM; Abecasis, GR; Chakravarti, A; Elliott, P; van Duijn, CM; Newton-Cheh, C; Levy, D; Caulfield, MJ; Johnson, T				Ehret, Georg B.; Munroe, Patricia B.; Rice, Kenneth M.; Bochud, Murielle; Johnson, Andrew D.; Chasman, Daniel I.; Smith, Albert V.; Tobin, Martin D.; Verwoert, Germaine C.; Hwang, Shih-Jen; Pihur, Vasyl; Vollenweider, Peter; O'Reilly, Paul F.; Amin, Najaf; Bragg-Gresham, Jennifer L.; Teumer, Alexander; Glazer, Nicole L.; Launer, Lenore; Zhao, Jing Hua; Aulchenko, Yurii; Heath, Simon; Sober, Siim; Parsa, Afshin; Luan, Jian'an; Arora, Pankaj; Dehghan, Abbas; Zhang, Feng; Lucas, Gavin; Hicks, Andrew A.; Jackson, Anne U.; Peden, John F.; Tanaka, Toshiko; Wild, Sarah H.; Rudan, Igor; Igl, Wilmar; Milaneschi, Yuri; Parker, Alex N.; Fava, Cristiano; Chambers, John C.; Fox, Ervin R.; Kumari, Meena; Go, Min Jin; van der Harst, Pim; Kao, Wen Hong Linda; Sjogren, Marketa; Vinay, D. G.; Alexander, Myriam; Tabara, Yasuharu; Shaw-Hawkins, Sue; Whincup, Peter H.; Liu, Yongmei; Shi, Gang; Kuusisto, Johanna; Tayo, Bamidele; Seielstad, Mark; Sim, Xueling; Khanh-Dung Hoang Nguyen; Lehtimaki, Terho; Matullo, Giuseppe; Wu, Ying; Gaunt, Tom R.; Onland-Moret, N. Charlotte; Cooper, Matthew N.; Platou, Carl G. P.; Org, Elin; Hardy, Rebecca; Dahgam, Santosh; Palmen, Jutta; Vitart, Veronique; Braund, Peter S.; Kuznetsova, Tatiana; Uiterwaal, Cuno S. P. M.; Adeyemo, Adebowale; Palmas, Walter; Campbell, Harry; Ludwig, Barbara; Tomaszewski, Maciej; Tzoulaki, Ioanna; Palmer, Nicholette D.; Aspelund, Thor; Garcia, Melissa; Chang, Yen-Pei C.; O'Connell, Jeffrey R.; Steinle, Nanette I.; Grobbee, Diederick E.; Arking, Dan E.; Kardia, Sharon L.; Morrison, Alanna C.; Hernandez, Dena; Najjar, Samer; McArdle, Wendy L.; Hadley, David; Brown, Morris J.; Connell, John M.; Hingorani, Aroon D.; Day, Ian N. M.; Lawlor, Debbie A.; Beilby, John P.; Lawrence, Robert W.; Clarke, Robert; Hopewell, Jemma C.; Ongen, Halit; Dreisbach, Albert W.; Li, Yali; Young, J. Hunter; Bis, Joshua C.; Kahonen, Mika; Viikari, Jorma; Adair, Linda S.; Lee, Nanette R.; Chen, Ming-Huei; Olden, Matthias; Pattaro, Cristian; Bolton, Judith A. Hoffman; Koettgen, Anna; Bergmann, Sven; Mooser, Vincent; Chaturvedi, Nish; Frayling, Timothy M.; Islam, Muhammad; Jafar, Tazeen H.; Erdmann, Jeanette; Kulkarni, Smita R.; Bornstein, Stefan R.; Graessler, Juergen; Groop, Leif; Voight, Benjamin F.; Kettunen, Johannes; Howard, Philip; Taylor, Andrew; Guarrera, Simonetta; Ricceri, Fulvio; Emilsson, Valur; Plump, Andrew; Barroso, Ine S.; Khaw, Kay-Tee; Weder, Alan B.; Hunt, Steven C.; Sun, Yan V.; Bergman, Richard N.; Collins, Francis S.; Bonnycastle, Lori L.; Scott, Laura J.; Stringham, Heather M.; Peltonen, Leena; Perola, Markus; Vartiainen, Erkki; Brand, Stefan-Martin; Staessen, Jan A.; Wang, Thomas J.; Burton, Paul R.; Artigas, Maria Soler; Dong, Yanbin; Snieder, Harold; Wang, Xiaoling; Zhu, Haidong; Lohman, Kurt K.; Rudock, Megan E.; Heckbert, Susan R.; Smith, Nicholas L.; Wiggins, Kerri L.; Doumatey, Ayo; Shriner, Daniel; Veldre, Gudrun; Viigimaa, Margus; Kinra, Sanjay; Prabhakaran, Dorairaj; Tripathy, Vikal; Langefeld, Carl D.; Rosengren, Annika; Thelle, Dag S.; Corsi, Anna Maria; Singleton, Andrew; Forrester, Terrence; Hilton, Gina; McKenzie, Colin A.; Salako, Tunde; Iwai, Naoharu; Kita, Yoshikuni; Ogihara, Toshio; Ohkubo, Takayoshi; Okamura, Tomonori; Ueshima, Hirotsugu; Umemura, Satoshi; Eyheramendy, Susana; Meitinger, Thomas; Wichmann, H. -Erich; Cho, Yoon Shin; Kim, Hyung-Lae; Lee, Jong-Young; Scott, James; Sehmi, Joban S.; Zhang, Weihua; Hedblad, Bo; Nilsson, Peter; Smith, George Davey; Wong, Andrew; Narisu, Narisu; Stancakova, Alena; Raffel, Leslie J.; Yao, Jie; Kathiresan, Sekar; O'Donnell, Christopher J.; Schwartz, Stephen M.; Ikram, M. Arfan; Longstreth, W. T., Jr.; Mosley, Thomas H.; Seshadri, Sudha; Shrine, Nick R. G.; Wain, Louise V.; Morken, Mario A.; Swift, Amy J.; Laitinen, Jaana; Prokopenko, Inga; Zitting, Paavo; Cooper, Jackie A.; Humphries, Steve E.; Danesh, John; Rasheed, Asif; Goel, Anuj; Hamsten, Anders; Watkins, Hugh; Bakker, Stephan J. L.; van Gilst, Wiek H.; Janipalli, Charles S.; Mani, K. Radha; Yajnik, Chittaranjan S.; Hofman, Albert; Mattace-Raso, Francesco U. S.; Oostra, Ben A.; Demirkan, Ayse; Isaacs, Aaron; Rivadeneira, Fernando; Lakatta, Edward G.; Orru, Marco; Scuteri, Angelo; Ala-Korpela, Mika; Kangas, Antti J.; Lyytikainen, Leo-Pekka; Soininen, Pasi; Tukiainen, Taru; Wurtz, Peter; Ong, Rick Twee-Hee; Doerr, Marcus; Kroemer, Heyo K.; Voelker, Uwe; Voelzke, Henry; Galan, Pilar; Hercberg, Serge; Lathrop, Mark; Zelenika, Diana; Deloukas, Panos; Mangino, Massimo; Spector, Tim D.; Zhai, Guangju; Meschia, James F.; Nalls, Michael A.; Sharma, Pankaj; Terzic, Janos; Kumar, M. V. Kranthi; Denniff, Matthew; Zukowska-Szczechowska, Ewa; Wagenknecht, Lynne E.; Fowkes, F. Gerald R.; Charchar, Fadi J.; Schwarz, Peter E. H.; Hayward, Caroline; Guo, Xiuqing; Rotimi, Charles; Bots, Michiel L.; Brand, Eva; Samani, Nilesh J.; Polasek, Ozren; Talmud, Philippa J.; Nyberg, Fredrik; Kuh, Diana; Laan, Maris; Hveem, Kristian; Palmer, Lyle J.; van der Schouw, Yvonne T.; Casas, Juan P.; Mohlke, Karen L.; Vineis, Paolo; Raitakari, Olli; Ganesh, Santhi K.; Wong, Tien Y.; Tai, E. Shyong; Cooper, Richard S.; Laakso, Markku; Rao, Dabeeru C.; Harris, Tamara B.; Morris, Richard W.; Dominiczak, Anna F.; Kivimaki, Mika; Marmot, Michael G.; Miki, Tetsuro; Saleheen, Danish; Chandak, Giriraj R.; Coresh, Josef; Navis, Gerjan; Salomaa, Veikko; Han, Bok-Ghee; Zhu, Xiaofeng; Kooner, Jaspal S.; Melander, Olle; Ridker, Paul M.; Bandinelli, Stefania; Gyllensten, Ulf B.; Wright, Alan F.; Wilson, James F.; Ferrucci, Luigi; Farrall, Martin; Tuomilehto, Jaakko; Pramstaller, Peter P.; Elosua, Roberto; Soranzo, Nicole; Sijbrands, Eric J. G.; Altshuler, David; Loos, Ruth J. F.; Shuldiner, Alan R.; Gieger, Christian; Meneton, Pierre; Uitterlinden, Andre G.; Wareham, Nicholas J.; Gudnason, Vilmundur; Rotter, Jerome I.; Rettig, Rainer; Uda, Manuela; Strachan, David P.; Witteman, Jacqueline C. M.; Hartikainen, Anna-Liisa; Beckmann, Jacques S.; Boerwinkle, Eric; Vasan, Ramachandran S.; Boehnke, Michael; Larson, Martin G.; Jarvelin, Marjo-Riitta; Psaty, Bruce M.; Abecasis, Goncalo R.; Chakravarti, Aravinda; Elliott, Paul; van Duijn, Cornelia M.; Newton-Cheh, Christopher; Levy, Daniel; Caulfield, Mark J.; Johnson, Toby		Int Consortium Blood Pressure Geno; CARDIoGRAM Consortium; CKDGen Consortium; KidneyGen Consortium; EchoGen Consortium; CHARGE-HF Consortium	Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; HYPERTENSION; LOCI; METAANALYSIS; POPULATION; CLONING; HEALTH	Blood pressure is a heritable trait(1) influenced by several biological pathways and responsive to environmental stimuli. Over one billion people worldwide have hypertension (>= 140 mm Hg systolic blood pressure or >= 90 mm Hg diastolic blood pressure)(2). Even small increments in blood pressure are associated with an increased risk of cardiovascular events(3). This genome-wide association study of systolic and diastolic blood pressure, which used a multi-stage design in 200,000 individuals of European descent, identified sixteen novel loci: six of these loci contain genes previously known or suspected to regulate blood pressure (GUCY1A3-GUCY1B3, NPR3-C5orf23, ADM, FURIN-FES, GOSR2, GNAS-EDN3); the other ten provide new clues to blood pressure physiology. A genetic risk score based on 29 genome-wide significant variants was associated with hypertension, left ventricular wall thickness, stroke and coronary artery disease, but not kidney disease or kidney function. We also observed associations with blood pressure in East Asian, South Asian and African ancestry individuals. Our findings provide new insights into the genetics and biology of blood pressure, and suggest potential novel therapeutic pathways for cardiovascular disease prevention.	[Ehret, Georg B.; Pihur, Vasyl; Khanh-Dung Hoang Nguyen; Arking, Dan E.; Hilton, Gina; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA; [Ehret, Georg B.; Bochud, Murielle] CHU Vaudois, Inst Social & Prevent Med IUMSP, CH-1005 Lausanne, Switzerland; [Ehret, Georg B.; Bochud, Murielle] Univ Lausanne, CH-1005 Lausanne, Switzerland; [Ehret, Georg B.] Univ Hosp Geneva, Dept Specialties Internal Med, CH-1211 Geneva 14, Switzerland; [Munroe, Patricia B.; Shaw-Hawkins, Sue; Caulfield, Mark J.; Johnson, Toby] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Genome Ctr, London EC1M 6BQ, England; [Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Johnson, Andrew D.; Hwang, Shih-Jen; Wang, Thomas J.; Vasan, Ramachandran S.; Larson, Martin G.; Levy, Daniel] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Johnson, Andrew D.; Hwang, Shih-Jen; Levy, Daniel] NHLBI, Bethesda, MD 20824 USA; [Chasman, Daniel I.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Univ Iceland, IS-101 Reykajvik, Iceland; [Smith, Albert V.; Aspelund, Thor; Gudnason, Vilmundur] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Tobin, Martin D.; Burton, Paul R.; Artigas, Maria Soler; Shrine, Nick R. G.; Wain, Louise V.] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Verwoert, Germaine C.; Amin, Najaf; Aulchenko, Yurii; Dehghan, Abbas; Ikram, M. Arfan; Hofman, Albert; Mattace-Raso, Francesco U. S.; Demirkan, Ayse; Isaacs, Aaron; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Verwoert, Germaine C.; Dehghan, Abbas; Mattace-Raso, Francesco U. S.; Rivadeneira, Fernando; Sijbrands, Eric J. G.; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, NL-3000 CA Rotterdam, Netherlands; [Verwoert, Germaine C.; Dehghan, Abbas; Ikram, M. Arfan; Uitterlinden, Andre G.; Witteman, Jacqueline C. M.] NGI, NCHA, NL-3000 CA Rotterdam, Netherlands; [Hwang, Shih-Jen; Levy, Daniel] NHLBI, Ctr Populat Studies, Bethesda, MD 20824 USA; [Vollenweider, Peter] CHU Vaudois, Dept Internal Med, CH-1011 Lausanne, Switzerland; [O'Reilly, Paul F.; Chambers, John C.; Zhang, Weihua; Wurtz, Peter; Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, Sch Publ Hlth, London W2 1PG, England; [Bragg-Gresham, Jennifer L.; Abecasis, Goncalo R.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48103 USA; [Teumer, Alexander; Voelker, Uwe] Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, D-17487 Greifswald, Germany; [Glazer, Nicole L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Glazer, Nicole L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Glazer, Nicole L.; Bis, Joshua C.; Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Launer, Lenore; Garcia, Melissa; Harris, Tamara B.] NIA, Lab Epidemiol, NIH, Bethesda, MD 20892 USA; [Zhao, Jing Hua; Luan, Jian'an; Loos, Ruth J. F.; Wareham, Nicholas J.] Inst Metab Sci, MRC Epidemiol Unit, Cambridge CB2 0QQ, England; [Heath, Simon; Lathrop, Mark; Zelenika, Diana] Commiss Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91057 Evry, France; [Sober, Siim; Org, Elin; Veldre, Gudrun; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Parsa, Afshin; Chang, Yen-Pei C.; O'Connell, Jeffrey R.; Steinle, Nanette I.; Shuldiner, Alan R.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Arora, Pankaj; Kathiresan, Sekar; O'Donnell, Christopher J.; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Ctr Human Genet Res, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Zhang, Feng; Mangino, Massimo; Spector, Tim D.; Zhai, Guangju; Soranzo, Nicole] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Lucas, Gavin; Elosua, Roberto] Inst Municipal Invest Med, E-08003 Barcelona, Spain; [Hicks, Andrew A.; Pattaro, Cristian; Pramstaller, Peter P.] European Acad Bozen Bolzano EURAC, Inst Med Genet, Bolzano, Italy; [Hicks, Andrew A.; Pattaro, Cristian; Pramstaller, Peter P.] Univ Lubeck, Affiliated Inst, Lubeck, Germany; [Jackson, Anne U.; Scott, Laura J.; Stringham, Heather M.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA; [Peden, John F.; Ongen, Halit; Goel, Anuj; Watkins, Hugh; Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; [Tanaka, Toshiko; Milaneschi, Yuri; Ferrucci, Luigi] NIA, Clin Res Branch, Baltimore, MD 21250 USA; [Wild, Sarah H.; Rudan, Igor; Campbell, Harry; Wilson, James F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor; Campbell, Harry] Univ Edinburgh, Coll Med & Vet Med, Inst Genet & Mol Med, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor] Univ Split, Croatian Ctr Global Hlth, Split 21000, Croatia; [Igl, Wilmar; Gyllensten, Ulf B.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Parker, Alex N.] Amgen Inc, Cambridge, MA 02139 USA; [Fava, Cristiano; Sjogren, Marketa; Hedblad, Bo; Nilsson, Peter; Melander, Olle] Lund Univ, Dept Clin Sci, S-20502 Malmo, Sweden; [Fava, Cristiano] Univ Verona, Dept Med, I-37134 Verona, Italy; [Chambers, John C.; Sehmi, Joban S.; Kooner, Jaspal S.] Ealing Gen Hosp, London UB1 3HJ, England; [Fox, Ervin R.; Dreisbach, Albert W.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Kumari, Meena; Taylor, Andrew] UCL, Genet Epidemiol Grp, London WC1E 6BT, England; [Go, Min Jin; Cho, Yoon Shin; Kim, Hyung-Lae; Lee, Jong-Young; Han, Bok-Ghee] Natl Inst Hlth, Ctr Genome Sci, Seoul 122701, South Korea; [van der Harst, Pim; van Gilst, Wiek H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, NL-9713 GZ Groningen, Netherlands; [Kao, Wen Hong Linda; Bolton, Judith A. Hoffman; Koettgen, Anna; Coresh, Josef] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA; [Kao, Wen Hong Linda; Young, J. Hunter; Coresh, Josef] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Vinay, D. G.; Janipalli, Charles S.; Mani, K. Radha; Kumar, M. V. Kranthi; Chandak, Giriraj R.] CSIR, CCMB, Hyderabad 500007, Andhra Pradesh, India; [Alexander, Myriam; Khaw, Kay-Tee; Danesh, John; Saleheen, Danish] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Tabara, Yasuharu; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Basic Med Res, Toon 7910295, Japan; [Tabara, Yasuharu; Miki, Tetsuro] Ehime Univ, Grad Sch Med, Dept Geriatr Med, Toon 7910295, Japan; [Whincup, Peter H.; Hadley, David; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Liu, Yongmei; Rudock, Megan E.; Prokopenko, Inga] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Shi, Gang] Washington Univ St Louis, Sch Med, Div Biostat, St Louis, MO USA; [Shi, Gang] Washington Univ St Louis, Sch Med, Dept Genet, St Louis, MO USA; [Kuusisto, Johanna; Stancakova, Alena; Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70210, Finland; [Kuusisto, Johanna; Stancakova, Alena; Laakso, Markku] Kuopio Univ Hosp, Kuopio 70210, Finland; [Tayo, Bamidele; Cooper, Richard S.] Loyola Univ, Sch Med, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; [Seielstad, Mark] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Seielstad, Mark] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Seielstad, Mark; Ong, Rick Twee-Hee] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore; [Sim, Xueling; Ong, Rick Twee-Hee; Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Mol Epidemiol, Singapore 117597, Singapore; [Lehtimaki, Terho; Lyytikainen, Leo-Pekka] Univ Tampere, Dept Clin Chem, Tampere 33521, Finland; [Lehtimaki, Terho; Kahonen, Mika; Lyytikainen, Leo-Pekka] Tampere Univ Hosp, Tampere 33521, Finland; [Matullo, Giuseppe; Ricceri, Fulvio] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Matullo, Giuseppe; Guarrera, Simonetta; Ricceri, Fulvio; Vineis, Paolo] Human Genet Fdn HUGEF, I-10126 Turin, Italy; [Wu, Ying; Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Gaunt, Tom R.; Day, Ian N. M.; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol BS8 2BN, Avon, England; [Onland-Moret, N. Charlotte; Uiterwaal, Cuno S. P. M.; Grobbee, Diederick E.; Bots, Michiel L.; van der Schouw, Yvonne T.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Onland-Moret, N. Charlotte] Univ Med Ctr Utrecht, Dept Med Genet DBG, Complex Genet Sect, NL-3508 GA Utrecht, Netherlands; [Cooper, Matthew N.; Lawrence, Robert W.] Univ Western Australia, Ctr Genet Epidemiol & Biostat, Crawley, WA 6009, Australia; [Platou, Carl G. P.; Hveem, Kristian] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, N-7600 Levanger, Norway; [Hardy, Rebecca; Wong, Andrew; Kuh, Diana] MRC Unit Lifelong Hlth & Ageing, London WC1B 5JU, England; [Dahgam, Santosh; Nyberg, Fredrik] Univ Gothenburg, Dept Publ Hlth & Community Med, Inst Med, Sahlgrenska Acad, S-40530 Gothenburg, Sweden; [Palmen, Jutta; Cooper, Jackie A.; Humphries, Steve E.; Talmud, Philippa J.] UCL, Ctr Cardiovasc Genet, London WC1E 6JF, England; [Vitart, Veronique; Hayward, Caroline; Wright, Alan F.] MRC Human Genet Unit, Edinburgh EH2, Midlothian, Scotland; [Vitart, Veronique; Hayward, Caroline; Wright, Alan F.] Inst Genet & Mol Med, Edinburgh EH2, Midlothian, Scotland; [Braund, Peter S.; Tomaszewski, Maciej; Denniff, Matthew; Samani, Nilesh J.] Univ Leicester, Glenfield Hosp, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Braund, Peter S.; Tomaszewski, Maciej; Burton, Paul R.; Samani, Nilesh J.] Glenfield Hosp, Leicester NIHR Biomed Res Unit Cardiovasc Dis, Leicester LE3 9QP, Leics, England; [Kuznetsova, Tatiana; Staessen, Jan A.] Univ Leuven, Studies Coordinating Ctr, Div Hypertens & Cardiac Rehabil, Dept Cardiovasc Dis, B-3000 Louvain, Belgium; [Adeyemo, Adebowale; Doumatey, Ayo; Shriner, Daniel; Rotimi, Charles] Natl Human Genome Res Inst, Ctr Res Genom & Global Hlth, New York, NY 10027 USA; [Palmas, Walter] Columbia Univ, New York, NY 10027 USA; [Ludwig, Barbara; Bornstein, Stefan R.; Graessler, Juergen] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany; [Tzoulaki, Ioanna] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, London W2 1PG, England; [Tzoulaki, Ioanna] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Palmer, Nicholette D.; Langefeld, Carl D.; Wagenknecht, Lynne E.] Wake Forest Univ Hlth Sci, Winston Salem, NC 27157 USA; [Kardia, Sharon L.; Sun, Yan V.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Morrison, Alanna C.] Univ Texas Houston Hlth Sci Ctr, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Hernandez, Dena; Singleton, Andrew; Nalls, Michael A.] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Najjar, Samer] NIA, Cardiovasc Sci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Najjar, Samer] Washington Hosp Ctr, Div Cardiol, Washington, DC 20010 USA; [McArdle, Wendy L.] Univ Bristol, ALSPAC Lab, Bristol BS8 2BN, Avon, England; [Hadley, David] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL 33612 USA; [Brown, Morris J.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; [Connell, John M.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Hingorani, Aroon D.] UCL, Genet Epidemiol Grp, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Beilby, John P.] PathW Lab Med, Mol Genet, Nedlands, WA 6009, Australia; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert; Hopewell, Jemma C.] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Li, Yali; Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, Tampere 33521, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku 20521, Finland; [Viikari, Jorma] Turku Univ Hosp, Turku 20521, Finland; [Adair, Linda S.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27599 USA; [Lee, Nanette R.] Univ San Carlos, Off Populat Studies Fdn, Cebu 6000, Philippines; [Chen, Ming-Huei] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Chen, Ming-Huei] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Olden, Matthias] Univ Med Ctr Regensburg, Dept Internal Med 2, D-93053 Regensburg, Germany; [Olden, Matthias] Univ Med Ctr Regensburg, Dept Epidemiol & Prevent Med, D-93053 Regensburg, Germany; [Koettgen, Anna] Univ Hosp Freiburg, Div Renal, D-79095 Freiburg, Germany; [Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Mooser, Vincent] GlaxoSmithKline, Div Genet, Philadelphia, PA 19101 USA; [Chaturvedi, Nish] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Int Ctr Circulatory Hlth, London SW7 2AZ, England; [Frayling, Timothy M.] Univ Exeter, Peninsula Med Sch, Exeter EX4 4QJ, Devon, England; [Islam, Muhammad; Jafar, Tazeen H.] Aga Khan Univ, Dept Community Hlth Sci, Karachi 74800, Pakistan; [Islam, Muhammad; Jafar, Tazeen H.] Aga Khan Univ, Dept Med, Karachi 74800, Pakistan; [Erdmann, Jeanette] Univ Lubeck, Med Klin 2, D-23538 Lubeck, Germany; [Kulkarni, Smita R.; Yajnik, Chittaranjan S.] KEM Hosp & Res Ctr, Diabet Unit, Pune 411011, Maharashtra, India; [Groop, Leif] Univ Hosp, Diabet & Endocrinol Res Unit, Dept Clin Sci, S-20502 Malmo, Sweden; [Groop, Leif] Lund Univ, S-20502 Malmo, Sweden; [Voight, Benjamin F.; Altshuler, David; Newton-Cheh, Christopher] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02139 USA; [Kettunen, Johannes] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki 00251, Finland; [Kettunen, Johannes; Peltonen, Leena] Biomedicum, Inst Mol Med, FIMM, Helsinki 00251, Finland; [Howard, Philip] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Emilsson, Valur; Plump, Andrew] Merck Res Lab, Rahway, NJ 07065 USA; [Barroso, Ine S.; Peltonen, Leena; Deloukas, Panos; Soranzo, Nicole] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, S Cambs, England; [Barroso, Ine S.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 OQQ, England; [Weder, Alan B.] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Hunt, Steven C.] Univ Utah, Sch Med, Salt Lake City, UT 84132 USA; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Phys & Biophys, Los Angeles, CA 90033 USA; [Collins, Francis S.; Bonnycastle, Lori L.; Narisu, Narisu; Morken, Mario A.; Swift, Amy J.] NHGRI, NIH, Bethesda, MD 20892 USA; [Peltonen, Leena; Perola, Markus; Vartiainen, Erkki; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Peltonen, Leena] Broad Inst, Cambridge, MA 02142 USA; [Brand, Stefan-Martin] Univ Munster, Dept Mol Genet Cardiovasc Dis, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany; [Brand, Stefan-Martin] Univ Munster, Fac Med, Dept Mol Genet Cardiovasc Dis, D-48149 Munster, Germany; [Wang, Thomas J.] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Dong, Yanbin; Snieder, Harold; Wang, Xiaoling; Zhu, Haidong] Med Coll Georgia, Dept Pediat, Georgia Prevent Inst, Augusta, GA 30912 USA; [Snieder, Harold] Univ Groningen, Univ Med Ctr Groningen, Unit Genet Epidemiol & Bioinformat, Dept Epidemiol, NL-9713 GZ Groningen, Netherlands; [Lohman, Kurt K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Heckbert, Susan R.; Smith, Nicholas L.; Schwartz, Stephen M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Heckbert, Susan R.; Smith, Nicholas L.; Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98124 USA; [Smith, Nicholas L.] Vet Hlth Adm Off Res & Dev, Seattle Epidemiol Res & Informat Ctr, Seattle, WA 98108 USA; [Wiggins, Kerri L.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Veldre, Gudrun] Univ Tartu, Dept Cardiol, EE-51014 Tartu, Estonia; [Viigimaa, Margus] Tallinn Univ Technol, Inst Biomed Engn, EE-19086 Tallinn, Estonia; [Viigimaa, Margus] N Estonia Med Ctr, Ctr Cardiol, EE-13419 Tallinn, Estonia; [Kinra, Sanjay] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Prabhakaran, Dorairaj; Tripathy, Vikal] Publ Hlth Fdn India, S Asia Network Chron Dis, New Delhi 100016, India; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Emergency & Cardiovasc Med, S-41685 Gothenburg, Sweden; [Thelle, Dag S.] Univ Oslo, Inst Basic Med Sci, Dept Biostat, N-0317 Oslo, Norway; [Corsi, Anna Maria] Tuscany Reg Hlth Agcy, I-50129 Florence, Italy; [Forrester, Terrence; McKenzie, Colin A.] Univ W Indies, Res Inst Trop Med, Kingston 7, Jamaica; [Salako, Tunde] Univ Ibadan, Ibadan, Nigeria; [Iwai, Naoharu; Okamura, Tomonori] Natl Cerebral & Cardiovasc Res Ctr, Dept Genom Med, Suita, Osaka 5658565, Japan; [Iwai, Naoharu; Okamura, Tomonori] Natl Cerebral & Cardiovasc Res Ctr, Dept Prevent Cardiol, Suita, Osaka 5658565, Japan; [Kita, Yoshikuni; Ohkubo, Takayoshi; Okamura, Tomonori; Ueshima, Hirotsugu] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 5202192, Japan; [Ogihara, Toshio] Osaka Univ, Grad Sch Med, Dept Geriatr Med, Suita, Osaka 5650871, Japan; [Ohkubo, Takayoshi] Tohoku Univ, Grad Sch Pharmaceut Sci & Med, Sendai, Miyagi 9808578, Japan; [Ueshima, Hirotsugu] Shiga Univ Med Sci, Lifestyle Related Dis Prevent Ctr, Otsu, Shiga 5202192, Japan; [Umemura, Satoshi] Yokohama City Univ, Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 2360004, Japan; [Eyheramendy, Susana] Pontificia Univ Catolica Chile, Dept Stat, Santiago, Chile; [Meitinger, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Human Genet, D-85764 Neuherberg, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany; [Wichmann, H. -Erich; Gieger, Christian] German Res Ctr Environm Hlth, Helmholtz Zentrum Munich, Inst Epidemiol, D-85764 Neuherberg, Germany; [Wichmann, H. -Erich] Univ Munich, Chair Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Wichmann, H. -Erich] Klinikum Grosshadern, D-81377 Munich, Germany; [Scott, James; Sehmi, Joban S.; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0HS, England; [Raffel, Leslie J.; Yao, Jie; Guo, Xiuqing; Rotter, Jerome I.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Kathiresan, Sekar] Broad Inst Harvard & MIT, Cambridge Ctr 5, Cambridge, MA 02142 USA; [O'Donnell, Christopher J.] NHLBI, Framingham, MA 01702 USA; [O'Donnell, Christopher J.] Framingham Heart Dis Epidemiol Study, Framingham, MA 01702 USA; [Longstreth, W. T., Jr.] Univ Washington, Dept Neurol & Med, Seattle, WA 98195 USA; [Mosley, Thomas H.] Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS 39216 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Oulu 90220, Finland; [Prokopenko, Inga] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Zitting, Paavo] Lapland Cent Hosp, Dept Physiatr, Rovaniemi 96101, Finland; [Rasheed, Asif; Saleheen, Danish] Ctr Noncommunicable Dis, Karachi 74800, Pakistan; [Hamsten, Anders] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, S-17177 Stockholm, Sweden; [Oostra, Ben A.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Lakatta, Edward G.; Scuteri, Angelo] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Orru, Marco; Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, I-09042 Cagliari, Italy; [Orru, Marco] Presidio Osped Santa Barbara, Div Med, Unita Operat Semplice Cardiol, I-09016 Iglesias, Italy; [Ala-Korpela, Mika; Kangas, Antti J.; Soininen, Pasi; Tukiainen, Taru; Wurtz, Peter] Univ Oulu, Inst Clin Med, Computat Med Res Grp, Oulu, Finland; [Ala-Korpela, Mika] 90014 Univ Oulu, Bioctr Oulu, Clin Res Ctr, Oulu, Finland; [Ala-Korpela, Mika; Soininen, Pasi] Univ Eastern Finland, Dept Biosci, NMR Metabon Lab, Kuopio 70211, Finland; [Ala-Korpela, Mika] 90014 Univ Oulu, Dept Internal Med, Oulu, Finland; [Tukiainen, Taru; Wurtz, Peter] 00014 Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Tukiainen, Taru] Aalto Univ, Dept Biomed Engn & Computat Sci, Sch Sci & Technol, Espoo 00076, Finland; [Ong, Rick Twee-Hee] NUS Grad Sch Integrat Sci & Engn NGS, Ctr Life Sci CeLS, Singapore 117456, Singapore; [Doerr, Marcus] Ernst Moritz Arndt Univ Greifswald, Dept Internal Med B, D-17487 Greifswald, Germany; [Kroemer, Heyo K.] Ernst Moritz Arndt Univ Greifswald, Inst Pharmacol, D-17487 Greifswald, Germany; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Galan, Pilar; Hercberg, Serge] Univ Paris 13, Inst Natl Rech Agron U1125, Inst Natl Sante & Rech Med U557, F-93017 Bobigny, France; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Sharma, Pankaj] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Cerebrovasc Unit ICCRU, London W6 8RF, England; [Terzic, Janos] Univ Split, Fac Med, Split 21000, Croatia; [Zukowska-Szczechowska, Ewa] Med Univ Silesia, Dept Internal Med Diabetol & Nephrol, PL-41800 Zabrze, Poland; [Fowkes, F. Gerald R.] Univ Edinburgh, Sch Med, Div Community Hlth Sci, Publ Hlth Sci Sect, Edinburgh EH8 9AG, Midlothian, Scotland; [Charchar, Fadi J.] Univ Ballarat, Sch Sci & Engn, Ballarat, Vic 3353, Australia; [Schwarz, Peter E. H.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Dept Med 3, D-01307 Dresden, Germany; [Brand, Eva] Univ Hosp Munster, Munster, Germany; [Polasek, Ozren] Univ Zagreb, Andrija Stampar Sch Publ Hlth, Dept Med Stat Epidemiol & Med Informat, Zagreb 10000, Croatia; [Nyberg, Fredrik] AstraZeneca R&D, S-43183 Molndal, Sweden; [Palmer, Lyle J.] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Palmer, Lyle J.] Univ Toronto, Samuel Lunenfeld Inst Med Res, Toronto, ON M5S 1A1, Canada; [Casas, Juan P.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Population Hlth, London WC1E 7HT, England; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Raitakari, Olli] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku 20521, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol, Turku 20521, Finland; [Ganesh, Santhi K.] Univ Michigan, Med Ctr, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Wong, Tien Y.] Singapore Eye Res Inst, Singapore 168751, Singapore; [Wong, Tien Y.] Natl Univ Singapore, Dept Ophthalmol, Singapore 119074, Singapore; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 119074, Singapore; [Tai, E. Shyong] Duke Natl Univ Singapore, Grad Sch Med, Singapore 169857, Singapore; [Rao, Dabeeru C.] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Morris, Richard W.] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Dominiczak, Anna F.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, NL-9713 GZ Groningen, Netherlands; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiol, Boston, MA 02215 USA; [Bandinelli, Stefania] ASF, Geriatr Rehabil Unit, I-50100 Florence, Italy; [Tuomilehto, Jaakko] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki 00271, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki 00014, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland; [Tuomilehto, Jaakko] Hosp Univ La Paz, Red RECAVA Grp RD06 0014 0015, Madrid 28046, Spain; [Pramstaller, Peter P.] Gen Cent Hosp, Dept Neurol, I-39100 Bolzano, Italy; [Elosua, Roberto] CIBER Epidemiol & Salud Publ, Barcelona 08003, Spain; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Clin Ctr, Baltimore, MD 21201 USA; [Meneton, Pierre] Ctr Rech Cordeliers, Inst Natl Sante & Rech Med U872, F-75006 Paris, France; [Rettig, Rainer] Ernst Moritz Arndt Univ Greifswald, Inst Physiol, D-17487 Greifswald, Germany; [Hartikainen, Anna-Liisa] Univ Oulu, Inst Clin Med Obstet & Gynecol, Oulu 90014, Finland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Boerwinkle, Eric] Ctr Human Genet, Houston, TX 77030 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Div Epidemiol & Prevent, Boston, MA 02215 USA; [Larson, Martin G.] Boston Univ, Dept Math, Boston, MA 02215 USA; [Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu 90014, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Oulu 90101, Finland; [Jarvelin, Marjo-Riitta; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [van Duijn, Cornelia M.] NGI Erasmus Med Ctr, Ctr Med Syst Biol CMSB 1 2, Rotterdam, Netherlands	Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Geneva; University of London; Queen Mary University London; University of Washington; University of Washington Seattle; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital; University of Iceland; Icelandic Heart Association; University of Leicester; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Imperial College London; University of Michigan System; University of Michigan; Ernst Moritz Arndt Universitat Greifswald; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Cambridge; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Tartu; University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; University of London; King's College London; European Academy of Bozen-Bolzano; University of Lubeck; University of Michigan System; University of Michigan; University of Oxford; Wellcome Centre for Human Genetics; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Edinburgh; University of Edinburgh; University of Split; Uppsala University; Amgen; Lund University; University of Verona; Imperial College London; University of Mississippi; University of Mississippi Medical Center; University of London; University College London; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; University of Groningen; Johns Hopkins University; Johns Hopkins University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Cambridge; Ehime University; Ehime University; St Georges University London; Wake Forest University; Wake Forest Baptist Medical Center; Washington University (WUSTL); Washington University (WUSTL); University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Loyola University Chicago; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Tampere University; Tampere University; Tampere University Hospital; University of Turin; University of North Carolina; University of North Carolina Chapel Hill; University of Bristol; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Western Australia; Norwegian University of Science & Technology (NTNU); University of Gothenburg; University of London; University College London; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; KU Leuven; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Columbia University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Imperial College London; University of Ioannina; Wake Forest University; Wake Forest University School of Medicine; University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); MedStar Washington Hospital Center; University of Bristol; State University System of Florida; University of South Florida; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Dundee; University of London; University College London; University of Oxford; University of Oxford; Case Western Reserve University; Tampere University; University of Turku; University of Turku; University of North Carolina; University of North Carolina Chapel Hill; University of San Carlos; Boston University; Boston University; Framingham Heart Study; University of Regensburg; University of Regensburg; University of Freiburg; University of Lausanne; Swiss Institute of Bioinformatics; GlaxoSmithKline; Imperial College London; University of Exeter; Aga Khan University; Aga Khan University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; Lund University; Skane University Hospital; Lund University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Finland National Institute for Health & Welfare; University of Helsinki; University of London; Queen Mary University London; Merck & Company; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Finland National Institute for Health & Welfare; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Munster; University of Munster; Harvard University; Massachusetts General Hospital; University System of Georgia; Augusta University; University of Groningen; Wake Forest University; Wake Forest Baptist Medical Center; University of Washington; University of Washington Seattle; Group Health Cooperative; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Tartu; Tallinn University of Technology; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India; University of Gothenburg; University of Oslo; University West Indies Mona Jamaica; University of Ibadan; Shiga University of Medical Science; Osaka University; Tohoku University; Shiga University of Medical Science; Yokohama City University; Pontificia Universidad Catolica de Chile; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Imperial College London; Cedars Sinai Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; University of Washington; University of Washington Seattle; University of Mississippi; University of Mississippi Medical Center; Boston University; Finnish Institute of Occupational Health; University of Oxford; Wellcome Centre for Human Genetics; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Consiglio Nazionale delle Ricerche (CNR); University of Oulu; University of Oulu; University of Eastern Finland; University of Oulu; University of Helsinki; Aalto University; National University of Singapore; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Mayo Clinic; Imperial College London; University of Split; Medical University Silesia; University of Edinburgh; Federation University Australia; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Munster; University of Zagreb; AstraZeneca; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Turku; University of Turku; University of Michigan System; University of Michigan; National University of Singapore; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore; Washington University (WUSTL); University of London; University College London; University of Glasgow; Johns Hopkins University; University of Groningen; Harvard University; Brigham & Women's Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Hospital Universitario La Paz; Krankenhaus Bozen; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ernst Moritz Arndt Universitat Greifswald; University of Oulu; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Boston University; Boston University; University of Oulu; Finland National Institute for Health & Welfare; Imperial College London	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21205 USA.	p.b.munroe@qmul.ac.uk; aravinda@jhmi.edu; cnewtoncheh@chgr.mgh.harvard.edu; levyd@nhlbi.nih.gov; m.j.caulfield@qmul.ac.uk	Ricceri, Fulvio/I-9910-2018; sharma, pankaj/HGE-4423-2022; Kronenberg, Florian/B-1736-2008; Munzel, Thomas/A-2912-2014; zhang, weihua/GXV-1334-2022; Spector, Tim D/F-6533-2012; DEMIRKAN, AYSE/G-9313-2016; Seielstad, Mark/T-7841-2019; van Gilst, Wiek/R-1806-2019; Prokopenko, Inga/AAU-9895-2020; Pilar, Galan/F-2908-2017; Cavalieri, Margherita/G-8053-2012; Aspelund, Thor/K-7022-2019; Mangino, Massimo/F-5134-2011; Abecasis, Goncalo R/B-7840-2010; Meitinger, Thomas/O-1318-2015; Davey Smith, George/A-7407-2013; Meschia, James/GPP-1636-2022; Ahmadi, Kourosh R/B-6379-2012; Rivadeneira, Fernando/O-5385-2015; Gale, Daniel/D-5594-2013; Prabhakaran, Dorairaj/B-4147-2011; Lakatta, Edward G/AAL-1447-2020; Wong, Andrew/M-8899-2016; Loos, Ruth J F/Q-2862-2016; Amin, Najaf N/D-1859-2012; Eggermann, Thomas/F-3807-2014; Tai, E Shyong/J-9831-2013; Peters, Annette/A-6117-2011; Palmer, Lyle John/K-3196-2014; Dörr, Marcus/F-1919-2010; HERCBERG, Serge/B-4429-2008; Prokopenko, Inga/H-3241-2014; bandinelli, stefania/AAL-4570-2020; Stark, Klaus/D-3813-2009; Giallauria, Francesco/B-5681-2013; Levy, Daniel/ABF-6873-2021; Rotter, Jerome/AAY-6598-2021; Grobbee, Diederick/C-7651-2014; Lee, Jong-Young/M-6319-2013; Fuchsberger, Christian/C-9646-2010; Ikram, M. Arfan/AAM-5225-2021; EHRET, Georg B/A-9532-2009; Kivimaki, Mika/B-3607-2012; Wilson, James F/A-5704-2009; Girelli, Domenico/B-1183-2008; Org, Elin/AAJ-9631-2021; Cooper, Matthew N/J-4420-2014; Schalling, Martin/F-1518-2015; Khaw, Kay-Tee/AAZ-3209-2021; Dehghan, Abbas/ABE-7377-2020; Shi, Gang/D-3301-2016; Fava, Cristiano/K-9590-2015; Charchar, Fadi/I-6656-2017; Pramstaller, Peter P/C-2357-2008; Okamura, Tomonori/L-1693-2013; Hayward, Caroline/M-8818-2016; Altshuler, David M/A-4476-2009; Feitosa, Mary F/K-8044-2012; Onland-Moret, N. Charlotte/G-9185-2011; Gudnason, Vilmundur/K-6885-2015; Boehm, Bernhard Otto/F-8750-2015; Meneton, Pierre/T-1216-2019; Maxwell, Patrick H/C-5557-2008; Hardy, Rebecca/AFR-1989-2022; Lyytikäinen, Leo-Pekka/C-8544-2016; Aspelund, Thor/C-5983-2008; Gudnason, Vilmundur/AAE-7126-2019; Sijbrands, Eric/A-1065-2009; Lehtimäki, Terho/AAD-1094-2022; Serge, Hercberg/F-3038-2017; Zgaga, Lina/Q-9415-2018; Narisu, Narisu/T-6908-2019; Rudan, Igor/I-1467-2012; Sim, Xueling/AAZ-6652-2020; Hadley, David/I-6902-2012; Erdmann, Jeanette/P-7513-2014; Colaus, PsyColaus/K-6607-2013; Artigas, María Soler/L-6529-2013; Rice, Kenneth M/A-4150-2013; Tzoulaki, Ioanna/ABE-6269-2020; Smith, Albert Vernon/K-5150-2015; Schnabel, Renate B/F-6527-2014; Uda, Manuela/AAC-2645-2019; Teumer, Alexander/S-7438-2019; Soininen, Pasi/B-9716-2008; Laan, Maris/A-4100-2011; Lucas, Gavin/D-4346-2012; Bakker, Stephan J. L./J-4023-2015; Kottgen, Anna/D-2920-2012; Franke, Andre/B-2151-2010; Aulchenko, Yurii/M-8270-2013; Matullo, Giuseppe/K-6383-2016; Beckmann, Jacques S/A-9772-2008; Arora, Pankaj/F-3437-2011; Thelle, Dag Steinar/ABD-1867-2020; Erdmann, Jeanette/A-4417-2009; Shukla, Sharvari/AAK-3469-2020; Loos, Ruth/GON-5877-2022; Marmot, M G/Y-3920-2019; König, Inke R/A-4544-2009; Hveem, Kristian/AFV-4683-2022; Ramachandran, Vasan/Y-2527-2019; Burton, Paul R/H-7527-2016; Wong, Tien Yin/AAC-9724-2020; Palmer, Lyle John/N-1948-2019; Heath, Simon C/J-4138-2012; Maria, Hernandez-Fuentes/B-5011-2010; Dominiczak, Anna F/P-9390-2017; Deloukas, Panos/B-2922-2013; Zhu, Xiaofeng/O-6874-2019; Levy, Daniel/ABB-2752-2021; Kuh, Diana/L-6019-2014; Kuznetsova, Tatiana/I-6882-2013; Stancakova, Alena/AAN-6723-2020; Kuznetsova, Tatiana/ABI-5662-2020; Viigimaa, Margus/AAX-3864-2020; Staessen, Jan A/A-1065-2011; gurrapu, gopi/A-9801-2011; Polasek, Ozren/B-6002-2011; Bochud, Murielle/A-3981-2010; Gaunt, Tom R/O-3918-2014; Johnson, Andrew D/G-6520-2013; Boban, Mladen/E-2777-2017; Raitakari, Olli/AAQ-7389-2021; Hicks, Andrew Anthony/E-9518-2017; Willenborg, Christina/D-2668-2012; Campbell, Harry/E-2959-2010; Hwang, Shih-Jen/HGU-5826-2022; Raso, Francesco Mattace-/L-2541-2015; Guarrera, Simonetta/AAB-8482-2022; Singleton, Andrew B/C-3010-2009; Wong, Andrew/AAE-6995-2019; Wichmann, Heinz Erich/AAA-5695-2022; van der Schouw, Yvonne T./F-8327-2014; Ziegler, Andreas/G-4246-2012; Dehghan, Abbas/B-9896-2008; Hypponen, Elina/B-2596-2014; Lightstone, Liz/M-4331-2014	Ricceri, Fulvio/0000-0001-8749-9737; Kronenberg, Florian/0000-0003-2229-1120; Munzel, Thomas/0000-0001-5503-4150; van Gilst, Wiek/0000-0003-2968-8585; Pilar, Galan/0000-0003-1706-3107; Aspelund, Thor/0000-0002-7998-5433; Mangino, Massimo/0000-0002-2167-7470; Davey Smith, George/0000-0002-1407-8314; Meschia, James/0000-0002-4475-8142; Rivadeneira, Fernando/0000-0001-9435-9441; Gale, Daniel/0000-0002-9170-1579; Prabhakaran, Dorairaj/0000-0002-3172-834X; Wong, Andrew/0000-0003-2079-4779; Loos, Ruth J F/0000-0002-8532-5087; Peters, Annette/0000-0001-6645-0985; Palmer, Lyle John/0000-0002-1628-3055; Dörr, Marcus/0000-0001-7471-475X; HERCBERG, Serge/0000-0002-3168-1350; Prokopenko, Inga/0000-0003-1624-7457; Stark, Klaus/0000-0002-7832-1942; Giallauria, Francesco/0000-0003-4119-9397; Levy, Daniel/0000-0003-1843-8724; Grobbee, Diederick/0000-0003-4472-4468; Lee, Jong-Young/0000-0002-0092-9958; EHRET, Georg B/0000-0002-5730-0675; Kivimaki, Mika/0000-0002-4699-5627; Wilson, James F/0000-0001-5751-9178; Girelli, Domenico/0000-0001-9684-1899; Cooper, Matthew N/0000-0003-1139-3682; Schalling, Martin/0000-0001-5011-2922; Fava, Cristiano/0000-0002-8910-7378; Charchar, Fadi/0000-0002-6164-9941; Okamura, Tomonori/0000-0003-0488-0351; Hayward, Caroline/0000-0002-9405-9550; Altshuler, David M/0000-0002-7250-4107; Feitosa, Mary F/0000-0002-0933-2410; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Gudnason, Vilmundur/0000-0001-5696-0084; Maxwell, Patrick H/0000-0002-0338-2679; Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Sijbrands, Eric/0000-0001-8857-7389; Lehtimäki, Terho/0000-0002-2555-4427; Serge, Hercberg/0000-0002-3168-1350; Zgaga, Lina/0000-0003-4089-9703; Rudan, Igor/0000-0001-6993-6884; Sim, Xueling/0000-0002-1233-7642; Erdmann, Jeanette/0000-0002-4486-6231; Artigas, María Soler/0000-0002-3213-1107; Rice, Kenneth M/0000-0001-5779-4495; Tzoulaki, Ioanna/0000-0002-4275-9328; Smith, Albert Vernon/0000-0003-1942-5845; Uda, Manuela/0000-0002-4890-6456; Teumer, Alexander/0000-0002-8309-094X; Laan, Maris/0000-0002-8519-243X; Bakker, Stephan J. L./0000-0003-3356-6791; Franke, Andre/0000-0003-1530-5811; Aulchenko, Yurii/0000-0002-7899-1575; Matullo, Giuseppe/0000-0003-0674-7757; Beckmann, Jacques S/0000-0002-9741-1900; Arora, Pankaj/0000-0003-2420-3550; Thelle, Dag Steinar/0000-0002-4417-5967; Shukla, Sharvari/0000-0002-7029-5532; Marmot, M G/0000-0002-2431-6419; König, Inke R/0000-0003-0504-6465; Ramachandran, Vasan/0000-0001-7357-5970; Wong, Tien Yin/0000-0002-8448-1264; Palmer, Lyle John/0000-0002-1628-3055; Heath, Simon C/0000-0002-9550-0897; Maria, Hernandez-Fuentes/0000-0002-7558-9441; Dominiczak, Anna F/0000-0003-4913-3608; Deloukas, Panos/0000-0001-9251-070X; Kuh, Diana/0000-0001-7386-2857; Kuznetsova, Tatiana/0000-0003-3564-7405; Stancakova, Alena/0000-0002-1375-0252; Kuznetsova, Tatiana/0000-0003-4293-4576; Staessen, Jan A/0000-0002-3026-1637; Polasek, Ozren/0000-0002-5765-1862; Bochud, Murielle/0000-0002-5727-0218; Gaunt, Tom R/0000-0003-0924-3247; Johnson, Andrew D/0000-0001-6369-5178; Boban, Mladen/0000-0003-1570-9621; Hicks, Andrew Anthony/0000-0001-6320-0411; Willenborg, Christina/0000-0001-5217-6882; Campbell, Harry/0000-0002-6169-6262; Wong, Andrew/0000-0003-2079-4779; van der Schouw, Yvonne T./0000-0002-4605-435X; Pramstaller, Peter P/0000-0002-9831-8302; Zhu, Xiaofeng/0000-0003-0037-411X; Lawlor, Debbie A/0000-0002-6793-2262; Nitsch, Dorothea/0000-0001-5767-248X; Beilby, John/0000-0002-4915-2254; Emilsson, Valur/0000-0001-9982-0524; Lucas, Gavin/0000-0003-4166-9416; Kovacs, Peter/0000-0002-0290-5423; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Wild, Philipp/0000-0003-4413-9752; ELOSUA, ROBERTO/0000-0001-8235-0095; Johnson, Toby/0000-0002-5998-3270; Wain, Louise/0000-0003-4951-1867; Wurtz, Peter/0000-0002-5832-0221; Couper, David/0000-0002-4313-9235; O'Reilly, Paul/0000-0001-7515-0845; Shuldiner, Alan/0000-0001-9921-4305; Tobin, Martin/0000-0002-3596-7874; Tukiainen, Taru/0000-0002-5404-8398; Kumari, Meena/0000-0001-9716-1035; Tomaszewski, Maciej/0000-0001-8215-6567; Magi, Reedik/0000-0002-2964-6011; Abecasis, Goncalo/0000-0003-1509-1825; Ziegler, Andreas/0000-0002-8386-5397; Tai, E Shyong/0000-0003-2929-8966; Melander, Olle/0000-0002-2581-484X; Terzic, Janos/0000-0003-3228-2076; Gieger, Christian/0000-0001-6986-9554; Ikram, Mohammad Arfan/0000-0003-0372-8585; Whincup, Peter/0000-0002-5589-4107; SCUTERI, ANGELO/0000-0003-4784-5441; Forouhi, Nita/0000-0002-5041-248X; Eyheramendy, Susana/0000-0003-4723-9660; Shrine, Nick/0000-0003-3641-4371; Voight, Benjamin/0000-0002-6205-9994; Ala-Korpela, Mika/0000-0001-5905-1206; Bergman, Richard/0000-0003-1539-4471; Org, Elin/0000-0001-8688-9717; s, hema/0000-0002-3440-9475; Devuyst, Olivier/0000-0003-3744-4767; Dehghan, Abbas/0000-0001-6403-016X; Alexander, Myriam/0000-0002-6848-9370; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Barroso, Ines/0000-0001-5800-4520; Kleber, Marcus/0000-0003-0663-7275; Aherrahrou, Zouhair/0000-0002-1241-8733; Org, Elin/0000-0003-1451-9375; Quertermous, Thomas/0000-0002-7645-9067; Shriner, Daniel/0000-0003-1928-5520; Wang, Thomas/0000-0003-4063-6508; Taylor, Andrew/0000-0003-4194-7113; Amin, Najaf/0000-0002-8944-1771; Mattace-Raso, Francesco/0000-0002-1688-6497; Demirkan, Ayse/0000-0002-7546-0867; Fuchsberger, Christian/0000-0002-5918-8947; Kangas, Antti/0000-0001-7492-1732; Watkins, Hugh/0000-0002-5287-9016; Chen, Ming-Huei/0000-0003-3551-8726; Stumvoll, Michael/0000-0001-6225-8240; Lord, Graham/0000-0003-2069-4743; Bergmann, Sven/0000-0002-6785-9034; Felix, Janine/0000-0002-9801-5774; Volker, Uwe/0000-0002-5689-3448; Munroe, Patricia/0000-0002-4176-2947; Hingorani, Aroon/0000-0001-8365-0081; Humphries, Stephen E/0000-0002-8221-6547; Adeyemo, Adebowale/0000-0002-3105-3231; Stritzke, Jan/0000-0003-3143-7005; Hypponen, Elina/0000-0003-3670-9399; Soranzo, Nicole/0000-0003-1095-3852; Ongen, Halit/0000-0002-4197-5790; Morris, Richard/0000-0001-7240-4563; Viigimaa, Margus/0000-0001-5575-5978; Hardy, Rebecca/0000-0001-9949-0799; Van Duijn, Cornelia/0000-0002-2374-9204; Glazer, Nicole/0000-0002-6397-609X; Seielstad, Mark/0000-0001-5783-1401; Preuss, Michael/0000-0001-5266-8465; Kahonen, Mika/0000-0002-4510-7341; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Meitinger, Thomas/0000-0002-8838-8403; Nyberg, Fredrik/0000-0003-0892-5668; Hopewell, Jemma/0000-0002-3870-8018; Elliott, Paul/0000-0002-7511-5684; Lakatta, Edward/0000-0002-4772-0035; Kleefstra, Nanne/0000-0003-1473-8519; Larson, Martin/0000-0002-9631-1254; Goel, Anuj/0000-0003-2307-4021; Seshadri, Sudha/0000-0001-6135-2622; Morrison, Alanna/0000-0001-6381-4296; Lightstone, Liz/0000-0002-4603-4076; Talmud, Philippa/0000-0002-5560-1933; Sternberg, Michael/0000-0002-1884-5445; Chandak, Giriraj Ratan/0000-0002-3095-9453; Caulfield, Mark/0000-0001-9295-3594	NIH/NHLBI; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC095165, N01HC055018, N01HC055019, N01HC095166, N01HC095163, N01HC055022, N01HC085085, N01HC095164, N01HC055222, N01HC095161, N01HC095169, N01HC085082, N01HC045133, N01HC015103, N01HC095162, N01HC055016, N01HC085084, N01HC085080, N01HC025195, N01HC085086, N01HC055020, N01HC095167, N01HC085081, N01HC055021, N01HC035129, N01HC095168, N01HC075150, N01HC095160, N01HC085079, N01HC085083, N01HC095159] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD013107] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW005596, R01TW008288, R03TW007165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA086308, P01CA055075, R01CA094143, P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023250, M01RR000425, M01RR016500, U54RR020278, UL1RR024156, M01RR010284, UL1RR025005, P20RR020649] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087641, R01HL088119, R01HL085251, R01HL073410, R37HL045508, R01HL060894, K23HL080025, R01HL053353, U01HL054471, R01HL071205, U01HL084756, U01HL084729, R01HL059367, R01HL045508, R01HL086694, R01HL098283, U01HL054466, R01HL071259, R01HL086718, R01HL043851, R01HL105756, R01HL071252, U01HL080295, R01HL060919, R01HL085144, R01HL087660, U01HL054473, R01HL071251, U01HL072515, R01HL089650, U10HL054512, R01HL087647, U01HL054527, R01HL071250, R37HL051021, R01HL036310, R01HL087652, U01HL054512, R01HL064278, R01HL061019, R01HL056931, R01HL071051, ZIAHL006002, R01HL087679, R01HL071258, ZIAHL006001] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004422, U01HG004738, U01HG004423, U01HG004446, RC2HG005581, U01HG004415, U01HG004399, U01HG004436, U01HG004402, U01HG004729, U01HG004735, R01HG003054, U01HG004726, U01HG004728, U01HG004438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE018903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, U01DK062370, R01DK072193, P30DK056350, R01DK062370, U01DK062418, R01DK075787, R01DK066574, R01DK078150, R56DK062370, P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126, P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518, S06GM008016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS069208, R01NS039987, R01NS042733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013196, N01AG062101, ZIAAG001050, R01AG017644, R37AG013196, R01AG018728, ZIAAG007480, N01AG062103, R01AG032098, N01AG012100] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 20545] Funding Source: researchfish; British Heart Foundation [RG/08/013/25942, RG/08/014/24067, RG/07/008/23674, RG/08/008/25291] Funding Source: researchfish; Kidney Research UK [RP24/2/2006] Funding Source: researchfish; Medical Research Council [G0100222, MC_U123092720, MC_U123092723, MC_PC_U127561128, G0701863, MC_U106188470, MC_UP_A100_1003, G0400874, G0600705, G0700931, G0902037, MC_PC_U127527180, G0401527, G9521010, G19/35, MC_U127561128, G1000143, G0501942, G0902313, G0801056B, G0000934, G0801056, MC_U106179471, G8802774, MC_U137686857, G0600331, G0601966] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10315] Funding Source: researchfish; Chief Scientist Office [CZB/4/710] Funding Source: researchfish; MRC [MC_U123092720, G0902037, MC_PC_U127561128, G0801056, G0501942, G0902313, G0701863, MC_UP_A100_1003, MC_U137686857, G0700931, G0600705, G9521010, MC_U123092723, MC_U127561128, G0400874, G0601966, MC_U106188470, G0600331, G0000934, MC_PC_U127527180] Funding Source: UKRI	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); British Heart Foundation(British Heart Foundation); Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	A number of the participating studies and authors are members of the CHARGE and Global BPgen consortia. Many funding mechanisms by NIH/NHLBI, European and private funding agencies contributed to this work and a full list is provided in section 21 of the Supplementary Materials.	BURT VL, 1995, HYPERTENSION, V26, P60, DOI 10.1161/01.HYP.26.1.60; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; He L, 2009, TOXICOL APPL PHARM, V238, P250, DOI 10.1016/j.taap.2009.02.017; Hinkes B, 2006, NAT GENET, V38, P1397, DOI 10.1038/ng1918; Ishimitsu T, 2006, PHARMACOL THERAPEUT, V111, P909, DOI 10.1016/j.pharmthera.2006.02.004; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewis JB, 2010, J AM SOC NEPHROL, V21, P1086, DOI 10.1681/ASN.2010030236; Li NF, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-124; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Meyer TE, 2009, AM J HYPERTENS, V22, P163, DOI 10.1038/ajh.2008.336; Mussig K, 2005, J CLIN ENDOCR METAB, V90, P4362, DOI 10.1210/jc.2005-0136; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pushkin A, 1999, J BIOL CHEM, V274, P16569, DOI 10.1074/jbc.274.23.16569; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; SCHENK DB, 1987, P NATL ACAD SCI USA, V84, P1521, DOI 10.1073/pnas.84.6.1521; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE	28	1463	1499	5	400	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					103	109		10.1038/nature10405	http://dx.doi.org/10.1038/nature10405			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21909115	Green Accepted, Green Submitted, Green Published			2022-12-24	WOS:000295575400043
J	Novarino, G; Akizu, N; Gleeson, JG				Novarino, Gaia; Akizu, Naiara; Gleeson, Joseph G.			Modeling Human Disease in Humans: The Ciliopathies	CELL			English	Review							BARDET-BIEDL-SYNDROME; POLYCYSTIC KIDNEY-DISEASE; MECKEL-GRUBER-SYNDROME; BASAL BODY PROTEOME; JOUBERT-SYNDROME; INTRAFLAGELLAR TRANSPORT; DEVELOPMENTAL DISORDER; TRIALLELIC INHERITANCE; RETINAL DEGENERATION; CILIA FUNCTION	Soon, the genetic basis of most human Mendelian diseases will be solved. The next challenge will be to leverage this information to uncover basic mechanisms of disease and develop new therapies. To understand how this transformation is already beginning to unfold, we focus on the ciliopathies, a class of multi-organ diseases caused by disruption of the primary cilium. Through a convergence of data involving mutant gene discovery, proteomics, and cell biology, more than a dozen phenotypically distinguishable conditions are now united as ciliopathies. Sitting at the interface between simple and complex genetic conditions, these diseases provide clues to the future direction of human genetics.	[Novarino, Gaia; Akizu, Naiara; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat,Inst Genom Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Gleeson, JG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Neurogenet Lab, Dept Neurosci & Pediat,Inst Genom Med, La Jolla, CA 92093 USA.	jogleeson@ucsd.edu			California Institute for Regenerative Medicine; Deutsche Forschungsgemeinschaft (DFG); NIH [R01NS041537, P01HD070494, R01NS052455, P30NS047101, R01NS048453]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453, R01NS041537, P30NS047101, R01NS052455] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	N.A. is supported by a training grant from the California Institute for Regenerative Medicine. G.N. is supported by a grant from the Deutsche Forschungsgemeinschaft (DFG). Work in the Gleeson lab is supported by grants from the NIH (R01NS041537, P01HD070494, R01NS052455, P30NS047101, and R01NS048453). J.G.G. is an Investigator of the Simons Foundation Autism Research Initiative (SFARI) and the Howard Hughes Medical Institute.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Arnaiz O, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap022; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; BRANCATI F, 1967, HUM MUTAT, V30, pE432; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Coppieters F, 2010, HUM MUTAT, V31, pE1709, DOI 10.1002/humu.21336; Coppieters F, 2010, HUM MUTAT, V31, P1097, DOI 10.1002/humu.21337; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Eichers ER, 2004, ANN MED, V36, P262, DOI 10.1080/07853890410026214; Eley L, 2008, KIDNEY INT, V74, P1139, DOI 10.1038/ki.2008.377; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Hoefele J, 2007, J AM SOC NEPHROL, V18, P2789, DOI 10.1681/ASN.2007020243; Hopp K, 2011, HUM MOL GENET, V20, P2524, DOI 10.1093/hmg/ddr151; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Iannicelli M, 2010, HUM MUTAT, V31, pE1319, DOI 10.1002/humu.21239; Inglis PN, 2006, TRENDS GENET, V22, P491, DOI 10.1016/j.tig.2006.07.006; Jacob LS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001225; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jiang ST, 2008, HUM MOL GENET, V17, P3368, DOI 10.1093/hmg/ddn231; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Lai CK, 2011, MOL BIOL CELL, V22, P1104, DOI 10.1091/mbc.E10-07-0596; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Mykytyn K, 2003, AM J HUM GENET, V72, P429, DOI 10.1086/346172; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; Piasecki BP, 2010, P NATL ACAD SCI USA, V107, P12969, DOI 10.1073/pnas.0914241107; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Tobin JL, 2008, PEDIATR NEPHROL, V23, P2095, DOI 10.1007/s00467-008-0898-7; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Williams CL, 2008, MOL BIOL CELL, V19, P2154, DOI 10.1091/mbc.E07-10-1070; Williams CL, 2011, J CELL BIOL, V192, P1023, DOI 10.1083/jcb.201012116; Wiszniewski W, 2011, HUM GENET, V129, P319, DOI 10.1007/s00439-010-0928-y; Yen HJ, 2006, HUM MOL GENET, V15, P667, DOI 10.1093/hmg/ddi468	68	126	132	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					70	79		10.1016/j.cell.2011.09.014	http://dx.doi.org/10.1016/j.cell.2011.09.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962508	Green Accepted, Bronze			2022-12-24	WOS:000295396700016
J	Zhu, H; Shyh-Chang, N; Segre, AV; Shinoda, G; Shah, SP; Einhorn, WS; Takeuchi, A; Engreitz, JM; Hagan, JP; Kharas, MG; Urbach, A; Thornton, JE; Triboulet, R; Gregory, RI; Altshuler, D; Daley, GQ				Zhu, Hao; Shyh-Chang, Ng; Segre, Ayellet V.; Shinoda, Gen; Shah, Samar P.; Einhorn, William S.; Takeuchi, Ayumu; Engreitz, Jesse M.; Hagan, John P.; Kharas, Michael G.; Urbach, Achia; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Altshuler, David; Daley, George Q.		DIAGRAM Consortium; MAGIC Investigators	The Lin28/let-7 Axis Regulates Glucose Metabolism	CELL			English	Article							LET-7 MICRORNA FAMILY; HUMAN HEPATOCELLULAR-CARCINOMA; CAENORHABDITIS-ELEGANS; PROMOTES TRANSFORMATION; INSULIN-RESISTANCE; TRANSGENIC MICE; MESSENGER-RNA; STEM-CELLS; LIN-28; LIN28	The let-7 tumor suppressor microRNAs are known for their regulation of oncogenes, while the RNA-binding proteins Lin28a/b promote malignancy by inhibiting let-7 biogenesis. We have uncovered unexpected roles for the Lin28/let-7 pathway in regulating-metabolism. When overexpressed in mice, both Lin28a and LIN28B promote an insulin-sensitized state that resists high-fat-diet induced diabetes. Conversely, muscle-specific loss of Lin28a or overexpression of let-7 results in insulin resistance and impaired glucose tolerance. These phenomena occur, in part, through the let-7-mediated repression of multiple components of the insulin-PI3K-mTOR pathway, including IGF1R, INSR, and IRS2. In addition, them TOR inhibitor, rapamycin, abrogates Lin28a-mediated insulin sensitivity and enhanced glucose uptake. Moreover, let-7 targets are enriched for genes containing SNPs associated with type 2 diabetes and control of fasting glucose in human genome-wide association studies. These data establish the Lin28/let-7 pathway as a central regulator of mammalian glucose metabolism.	[Zhu, Hao; Shyh-Chang, Ng; Shinoda, Gen; Shah, Samar P.; Einhorn, William S.; Takeuchi, Ayumu; Hagan, John P.; Kharas, Michael G.; Urbach, Achia; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Stem Cell Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Zhu, Hao; Shyh-Chang, Ng; Shinoda, Gen; Shah, Samar P.; Einhorn, William S.; Takeuchi, Ayumu; Hagan, John P.; Kharas, Michael G.; Urbach, Achia; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA USA; [Zhu, Hao] Dana Farber Canc Inst, Div Med Oncol, Boston, MA 02115 USA; [Zhu, Hao; Einhorn, William S.; Kharas, Michael G.; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Diabet Unit, Dept Med, Boston, MA 02114 USA; [Segre, Ayellet V.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Segre, Ayellet V.; Altshuler, David] Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA USA; [Engreitz, Jesse M.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Shyh-Chang, Ng; Hagan, John P.; Thornton, James E.; Triboulet, Robinson; Gregory, Richard I.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Hagan, John P.] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Daley, George Q.] Howard Hughes Med Inst, Boston, MA USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University System of Ohio; Ohio State University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Stem Cell Transplantat Program, Stem Cell Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Palmer, Lyle John/N-1948-2019; Mukherjee, Sutapa/U-7262-2017; Polasek, Ozren/B-6002-2011; Uda, Manuela/AAC-2645-2019; Boehm, Bernhard Otto/F-8750-2015; Singleton, Andrew B/C-3010-2009; Altshuler, David M/A-4476-2009; Palmer, Lyle John/K-3196-2014; Kyvik, Kirsten O/K-5680-2016; Benediktsson, Rafn/R-2457-2018; FROGUEL, Philippe/O-6799-2017; Hide, Winston A/V-2727-2017; Zhu, Hao/L-5114-2013; Kanoni, Stavroula/AAN-7161-2021; Meitinger, Thomas/O-1318-2015; Crisponi, Laura/AAC-2642-2019; Hide, Winston Hide/C-7217-2009; Langenberg, Claudia/ABG-9067-2021; Rudan, Igor/I-1467-2012; /GLR-9975-2022; Roden, Michael/AAD-3843-2019; Hide, Winston/R-3815-2019; Kaprio, Jaakko/A-1820-2008; Naitza, Silvia/D-5620-2017; Walters, G. Bragi/L-4215-2013; Visvikis-Siest, Sophie/H-2324-2014; Pattou, Francois/O-6151-2017; Colaus, PsyColaus/K-6607-2013; Ripatti, Samuli/H-9446-2014; Bonnefond, Amélie/O-2784-2017; de Geus, Eco J.C./M-9318-2015; Segre, Ayellet V/E-9800-2010; Aulchenko, Yurii/M-8270-2013; Willems van Dijk, Ko/A-1798-2008	Palmer, Lyle John/0000-0002-1628-3055; Mukherjee, Sutapa/0000-0001-5021-1648; Polasek, Ozren/0000-0002-5765-1862; Uda, Manuela/0000-0002-4890-6456; Altshuler, David M/0000-0002-7250-4107; Palmer, Lyle John/0000-0002-1628-3055; Kyvik, Kirsten O/0000-0003-2981-0245; Benediktsson, Rafn/0000-0002-2954-9801; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston A/0000-0002-8621-3271; Zhu, Hao/0000-0002-8417-9698; Kanoni, Stavroula/0000-0002-1691-9615; Crisponi, Laura/0000-0001-9128-8537; Hide, Winston Hide/0000-0002-8621-3271; Langenberg, Claudia/0000-0002-5017-7344; Rudan, Igor/0000-0001-6993-6884; Hide, Winston/0000-0002-8621-3271; Kaprio, Jaakko/0000-0002-3716-2455; Walters, G. Bragi/0000-0002-5415-6487; Visvikis-Siest, Sophie/0000-0001-8104-8425; Pattou, Francois/0000-0001-8388-3766; Ripatti, Samuli/0000-0002-0504-1202; Bonnefond, Amélie/0000-0001-9976-3005; de Geus, Eco J.C./0000-0001-6022-2666; Magi, Reedik/0000-0002-2964-6011; Pattaro, Cristian/0000-0002-4119-0109; Jorgensen, Torben/0000-0001-9453-2830; Van Duijn, Cornelia/0000-0002-2374-9204; Meitinger, Thomas/0000-0002-8838-8403; Aulchenko, Yurii/0000-0002-7899-1575; Posthuma, Danielle/0000-0001-7582-2365; Willemsen, Gonneke/0000-0003-3755-0236; Hagan, John/0000-0003-0295-4898; Couper, David/0000-0002-4313-9235; Dina, Christian/0000-0002-7722-7348; Stumvoll, Michael/0000-0001-6225-8240; Kivimaki, Mika/0000-0002-4699-5627; Kumari, Meena/0000-0001-9716-1035; bennett, amanda/0000-0003-2140-8710; Hattersley, Andrew/0000-0001-5620-473X; Seedorf, Udo/0000-0003-4652-5358; Willems van Dijk, Ko/0000-0002-2172-7394; Weedon, Michael/0000-0002-6174-6135; Zeggini, Eleftheria/0000-0003-4238-659X; Lindgren, Cecilia/0000-0002-4903-9374; Bergman, Richard/0000-0003-1539-4471; Shyh-Chang, Ng/0000-0003-3138-9525; Pichler, Irene/0000-0001-8251-0757; Gloyn, Anna/0000-0003-1205-1844; Urbach, Achia/0000-0001-9393-4504; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153	US NIH; Graduate Training in Cancer Research Grant; American Cancer Society; Agency for Science, Technology and Research, Singapore; NIH NIDDK; American Diabetes Association; National Human Genome Research Institute (NHGRI); US National Institute of General Medical Sciences (NIGMS); Burroughs Wellcome Fund; Leukemia and Lymphoma Society; MRC [MC_U127561128, G0902037, MC_UP_A100_1003, MC_UP_A620_1015, MC_PC_U127561128] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_UP_A620_1015, G8802774, MC_UP_A100_1003, G0902037, U1475000002, MC_PC_U127561128, G0100222, MC_U127561128, G19/35] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K08CA157727, T32CA009172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK070055] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Graduate Training in Cancer Research Grant; American Cancer Society(American Cancer Society); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank John Powers, Harith Rajagopalan, Jason Locasale, Abdel Saci, Akash Patnaik, Charles Kaufman, Christian Mosimann and Lewis Cantley for invaluable discussions and advice, Roderick Bronson and the Harvard Medical School Rodent Histopathology Core for mouse tissue pathology, and the Harvard Neurobehavior Laboratory for CLAMS experiments. This work was supported by grants from the US NIH to G. Q. D., a Graduate Training in Cancer Research Grant and a American Cancer Society Postdoctoral Fellowship to H.Z., the NSS Scholarship from the Agency for Science, Technology and Research, Singapore for N.S.C, an NIH NIDDK Diseases Career Development Award to M. G. K, and an American Diabetes Association Postdoctoral Fellowship for A. V. S. J.M.E. was supported by the National Human Genome Research Institute (NHGRI). R. I. G. was supported by US National Institute of General Medical Sciences (NIGMS) and is a Pew Research Scholar. D. A. is a Distinguished Clinical Scholar of the Doris Duke Charitable Foundation. G. Q. D. is a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. H.Z. and N.S.C designed and performed the experiments, and wrote the manuscript. A. V. S. and D. A. performed bioinformatic analysis on let-7 targets in GWAS. G. S. and S. P. S. performed expression analysis, metabolic assays and mouse husbandry. G. S., W. S. E. and A. T. generated the mouse strains. J.E.T, R. T. and R. I. G. assisted with the luciferase assays. J.P.H., R. I. G., G. S., and A. T generated the conditional knockout mice. M. G. K. helped to design the experiments. G. Q. D. designed and supervised experiments, and wrote the manuscript. The authors declare no competing financial interests.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Buller CL, 2008, AM J PHYSIOL-CELL PH, V295, pC836, DOI 10.1152/ajpcell.00554.2007; Chiefari E, 2011, JAMA-J AM MED ASSOC, V305, P903, DOI 10.1001/jama.2011.207; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hatley ME, 2010, CANCER CELL, V18, P282, DOI 10.1016/j.ccr.2010.08.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Lu L, 2007, CANCER RES, V67, P10117, DOI 10.1158/0008-5472.CAN-07-2544; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Xu BS, 2009, NUCLEIC ACIDS RES, V37, P4256, DOI 10.1093/nar/gkp372; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	55	647	679	2	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					81	94		10.1016/j.cell.2011.08.033	http://dx.doi.org/10.1016/j.cell.2011.08.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962509	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000295396700017
J	Choi, GB; Stettler, DD; Kallman, BR; Bhaskar, ST; Fleischmann, A; Axel, R				Choi, Gloria B.; Stettler, Dan D.; Kallman, Benjamin R.; Bhaskar, Shakthi T.; Fleischmann, Alexander; Axel, Richard			Driving Opposing Behaviors with Ensembles of Piriform Neurons	CELL			English	Article							MOUSE OLFACTORY-BULB; IN-VIVO; NEURAL ACTIVITY; EVOKED ACTIVITY; CORTEX; ODOR; MAP; MICE; REPRESENTATIONS; EXPRESSION	Anatomic and physiologic studies have suggested a model in which neurons of the piriform cortex receive convergent input from random collections of glomeruli. In this model, odor representations can only be afforded behavioral significance upon experience. We have devised an experimental strategy that permits us to ask whether the activation of an arbitrarily chosen subpopulation of neurons in piriform cortex can elicit different behavioral responses dependent upon learning. Activation of a small subpopulation of piriform neurons expressing channelr-hodopsin at multiple loci in the piriform cortex, when paired with reward or shock, elicits either appetitive or aversive behavior. Moreover, we demonstrate that different subpopulations of piriform neurons expressing ChR2 can be discriminated and independently entrained to elicit distinct behaviors. These observations demonstrate that the piriform cortex is sufficient to elicit learned behavioral outputs in the absence of sensory input. These data imply that the piriform does not use spatial order to map odorant identity or behavioral output.	[Choi, Gloria B.; Stettler, Dan D.; Kallman, Benjamin R.; Bhaskar, Shakthi T.; Fleischmann, Alexander; Axel, Richard] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Choi, Gloria B.; Stettler, Dan D.; Kallman, Benjamin R.; Bhaskar, Shakthi T.; Fleischmann, Alexander; Axel, Richard] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	ra27@columbia.edu		Axel, Richard/0000-0002-3141-4076	Howard Hughes Medical Institute; Mathers Foundation; Damon Runyon Cancer Research Foundation; EMBO; Human Frontiers Science Program	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Mathers Foundation; Damon Runyon Cancer Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); Human Frontiers Science Program(Human Frontier Science Program)	We thank Karl Deisseroth for ChR2 reagents; Nadia Propp for setting up lentiviral production method; Meredith Glinka, Justin Schwarz, and Dan Feng Mei for help with behavioral assays; Monica Mendelsohn, Jennifer Kirkland, and Nataliya Zabello for help with the mice; Anmo Kim for help with laser and olfactometer machines; Phyllis Kisloff for assistance in preparation of the manuscript; David J. Anderson, Larry Abbott, Thomas Jessell, Eric R. Kandel, and members of the Axel lab for critical reading of the manuscript and discussions; and Miriam Gutierrez for general laboratory support. This work was supported by the Howard Hughes Medical Institute and the Mathers Foundation. G.B.C. was supported by the Damon Runyon Cancer Research Foundation Postdoctoral Fellowship. A.F. was supported by long-term postdoctoral fellowships from EMBO and the Human Frontiers Science Program.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; [Anonymous], 1941, AM J OPHTHALMOL, DOI [10.1016/S0002-9394(41)91363-6, DOI 10.1016/S0002-9394(41)91363-6]; Araneda RC, 2004, J PHYSIOL-LONDON, V555, P743, DOI 10.1113/jphysiol.2003.058040; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Atasoy D, 2008, J NEUROSCI, V28, P7025, DOI 10.1523/JNEUROSCI.1954-08.2008; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brunet LJ, 1996, NEURON, V17, P681, DOI 10.1016/S0896-6273(00)80200-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CHANGEUX JP, 1973, P NATL ACAD SCI USA, V70, P2974, DOI 10.1073/pnas.70.10.2974; Colgin LL, 2008, TRENDS NEUROSCI, V31, P469, DOI 10.1016/j.tins.2008.06.008; Davison IG, 2011, NEURON, V70, P82, DOI 10.1016/j.neuron.2011.02.047; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Doty R W, 1969, Annu Rev Psychol, V20, P289, DOI 10.1146/annurev.ps.20.020169.001445; Edelman GM, 1987, NEURAL DARWINISM THE; Ghosh S, 2011, NATURE, V472, P217, DOI 10.1038/nature09945; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Gorski JA, 2002, J NEUROSCI, V22, P6309; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kugler S, 2003, GENE THER, V10, P337, DOI 10.1038/sj.gt.3301905; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Marshall WH, 1941, J NEUROPHYSIOL, V4, P1; Miyamichi K, 2011, NATURE, V472, P191, DOI 10.1038/nature09714; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P374, DOI 10.1152/jn.1957.20.4.374; Murphey DK, 2007, CURR BIOL, V17, P862, DOI 10.1016/j.cub.2007.03.066; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; O'Keefe J, 1998, PHILOS T ROY SOC B, V353, P1333, DOI 10.1098/rstb.1998.0287; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; PRICE JL, 1970, J CELL SCI, V7, P631; Redish AD, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-05-j0004.2001; Rennaker RL, 2007, J NEUROSCI, V27, P1534, DOI 10.1523/JNEUROSCI.4072-06.2007; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Schwabe K, 2004, NEUROSCIENCE, V126, P727, DOI 10.1016/j.neuroscience.2004.04.022; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Sugai T, 2005, NEUROSCIENCE, V130, P769, DOI 10.1016/j.neuroscience.2004.09.059; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Woolsey CN, 1942, B JOHNS HOPKINS HOSP, V71, P315; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211; Zhan C, 2010, J NEUROSCI, V30, P16662, DOI 10.1523/JNEUROSCI.4400-10.2010; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800	54	158	162	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					1003	1014		10.1016/j.cell.2011.07.041	http://dx.doi.org/10.1016/j.cell.2011.07.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925321	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000295258100021
J	Sato, M; Sato, K				Sato, Miyuki; Sato, Ken			Degradation of Paternal Mitochondria by Fertilization-Triggered Autophagy in C. elegans Embryos	SCIENCE			English	Article							DNA; INHERITANCE; COMPONENTS; MECHANISMS; OOCYTE; GENE	The mitochondrial genome is believed to be maternally inherited in many eukaryotes. Sperm-derived paternal mitochondria enter the oocyte cytoplasm upon fertilization and then normally disappear during early embryogenesis. However, the mechanism responsible for this clearance has been unknown. Here, we show that autophagy, which delivers cytosolic components to lysosomes for degradation, is required for the elimination of paternal mitochondria in Caenorhabditis elegans. Immediately after fertilization, sperm-derived components trigger the localized induction of autophagy around sperm mitochondria. Autophagosomes engulf paternal mitochondria, resulting in their lysosomal degradation during early embryogenesis. In autophagy-defective zygotes, paternal mitochondria and their genome remain even in the first larval stage. Thus, fertilization-triggered autophagy is required for selective degradation of paternal mitochondria and thereby maternal inheritance of mitochondrial DNA.	[Sato, Miyuki; Sato, Ken] Gunma Univ, Inst Mol & Cellular Regulat, Lab Mol Traff, Maebashi, Gunma 3718512, Japan	Gunma University	Sato, K (corresponding author), Gunma Univ, Inst Mol & Cellular Regulat, Lab Mol Traff, Maebashi, Gunma 3718512, Japan.	sato-ken@gunma-u.ac.jp	Sato, Miyuki/S-5112-2018	Sato, Miyuki/0000-0002-1944-4918	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT); Uehara Memorial Foundation; Naito Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation)	We thank K. Sato and other members of Sato's laboratory for technical assistance and discussions; Y. Ohsumi for discussions; S. Mitani, Y. Kohara, and the Caenorhabditis Genetic Center for supplying strains and an antibody. This research was supported by a Grant-in-Aid for Young Scientists (A), Japan Society for the Promotion of Science; a Grant-in-Aid for Scientific Research on Priority Areas "Protein Community" and Scientific Research on Innovative Areas "Intracellular Logistics," Ministry of Education, Culture, Sports, Science, and Technology (MEXT); the GCOE Program, MEXT. This research was also supported by the Uehara Memorial Foundation (to K. S.) and the Naito Foundation (to M.S.).	Aitken RJ, 1995, REPROD FERT DEVELOP, V7, P659, DOI 10.1071/RD9950659; AnkelSimons F, 1996, P NATL ACAD SCI USA, V93, P13859, DOI 10.1073/pnas.93.24.13859; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cummins JM, 1997, ZYGOTE, V5, P301, DOI 10.1017/S0967199400003889; Greenstein David, 2005, WormBook, P1, DOI 10.1895/wormbook.1.53.1; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HILL DP, 1989, DEV BIOL, V136, P154, DOI 10.1016/0012-1606(89)90138-3; Johnston WL, 2010, CURR BIOL, V20, P1932, DOI 10.1016/j.cub.2010.09.059; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; L'Hernault Steven W, 2006, WormBook, P1; LINDAHL KF, 1985, TRENDS GENET, V1, P135, DOI 10.1016/0168-9525(85)90055-1; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Melendez Alicia, 2009, WormBook, P1, DOI 10.1895/wormbook.1.147.1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Singson A, 1998, CELL, V93, P71, DOI 10.1016/S0092-8674(00)81147-2; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zhang YX, 2009, CELL, V136, P308, DOI 10.1016/j.cell.2008.12.022	28	305	320	6	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1141	1144		10.1126/science.1210333	http://dx.doi.org/10.1126/science.1210333			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	21998252				2022-12-24	WOS:000297313900053
J	Gibbs, DJ; Lee, SC; Isa, NM; Gramuglia, S; Fukao, T; Bassel, GW; Correia, CS; Corbineau, F; Theodoulou, FL; Bailey-Serres, J; Holdsworth, MJ				Gibbs, Daniel J.; Lee, Seung Cho; Isa, Nurulhikma Md; Gramuglia, Silvia; Fukao, Takeshi; Bassel, George W.; Correia, Cristina Sousa; Corbineau, Francoise; Theodoulou, Frederica L.; Bailey-Serres, Julia; Holdsworth, Michael J.			Homeostatic response to hypoxia is regulated by the N-end rule pathway in plants	NATURE			English	Article							SUBMERGENCE TOLERANCE; ARABIDOPSIS-THALIANA; PROTEIN; OXYGEN; RICE; SENSITIVITY; STRESS; DEGRADATION; ADJUSTMENTS; SENSOR	Plants and animals are obligate aerobes, requiring oxygen for mitochondrial respiration and energy production. In plants, an unanticipated decline in oxygen availability (hypoxia), as caused by roots becoming waterlogged or foliage submergence, triggers changes in gene transcription and messenger RNA translation that promote anaerobic metabolism and thus sustain substrate-level ATP production(1). In contrast to animals(2), oxygen sensing has not been ascribed to a mechanism of gene regulation in response to oxygen deprivation in plants. Here we show that the N-end rule pathway of targeted proteolysis acts as a homeostatic sensor of severe low oxygen levels in Arabidopsis, through its regulation of key hypoxia-response transcription factors. We found that plants lacking components of the N-end rule pathway constitutively express core hypoxia-response genes and are more tolerant of hypoxic stress. We identify the hypoxia-associated ethylene response factor group VII transcription factors of Arabidopsis as substrates of this pathway. Regulation of these proteins by the N-end rule pathway occurs through a characteristic conserved motif at the amino terminus initiating with Met-Cys. Enhanced stability of one of these proteins, HRE2, under low oxygen conditions improves hypoxia survival and reveals a molecular mechanism for oxygen sensing in plants via the evolutionarily conserved N-end rule pathway. SUB1A-1, a major determinant of submergence tolerance in rice(3), was shown not to be a substrate for the N-end rule pathway despite containing the N-terminal motif, indicating that it is uncoupled from N-end rule pathway regulation, and that enhanced stability may relate to the superior tolerance of Sub1 rice varieties to multiple abiotic stresses(4).	[Gibbs, Daniel J.; Isa, Nurulhikma Md; Gramuglia, Silvia; Bassel, George W.; Correia, Cristina Sousa; Holdsworth, Michael J.] Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough LE12 5RD, Leics, England; [Gibbs, Daniel J.; Isa, Nurulhikma Md; Gramuglia, Silvia; Bassel, George W.; Correia, Cristina Sousa; Holdsworth, Michael J.] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England; [Lee, Seung Cho; Fukao, Takeshi; Bailey-Serres, Julia] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Lee, Seung Cho; Fukao, Takeshi; Bailey-Serres, Julia] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Corbineau, Francoise] Univ Paris 06, CNRS, UPMC, EAC 7180 UR5, F-75005 Paris, France; [Theodoulou, Frederica L.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England	University of Nottingham; University of Nottingham; University of California System; University of California Riverside; University of California System; University of California Riverside; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Holdsworth, MJ (corresponding author), Univ Nottingham, Sch Biosci, Div Plant & Crop Sci, Loughborough LE12 5RD, Leics, England.	serres@ucr.edu; michael.holdsworth@nottingham.ac.uk	Gibbs, Daniel/ACT-4903-2022; Fukao, Takeshi/H-6548-2016; Holdsworth, Michael/ABA-8153-2020; Bailey-Serres, Julia/A-2470-2010	Gibbs, Daniel/0000-0002-4100-6682; Fukao, Takeshi/0000-0002-9930-1318; Holdsworth, Michael/0000-0002-3954-9215; Bailey-Serres, Julia/0000-0002-8568-7125; Bassel, George/0000-0002-3434-4499; Lee, Seung Cho/0000-0002-3626-8573; Theodoulou, Frederica/0000-0002-8306-0716	BBSRC [BB/G010595/1]; Marie Curie International Incoming Fellowship; Malaysian government;  [NSF IOS-0750811];  [NIFA 2008-35100-04528]; Biotechnology and Biological Sciences Research Council [BB/G010595/1, BBS/E/C/00004948] Funding Source: researchfish; BBSRC [BBS/E/C/00004948] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie International Incoming Fellowship(European Commission); Malaysian government; ; ; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	M.J.H., D.J.G., S. G. and C. S. C. were supported by BBSRC grant BB/G010595/1; G. W. B. by a Marie Curie International Incoming Fellowship; N.M.I. by a MARA PhD fellowship from the Malaysian government; S. C. L., T. F. and J.B.-S. by grants NSF IOS-0750811 and NIFA 2008-35100-04528. We thank S. Liddell. Rothamsted Research receives grant-aided support from the BBSRC.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bailey-Serres J, 2008, ANNU REV PLANT BIOL, V59, P313, DOI 10.1146/annurev.arplant.59.032607.092752; Branco-Price C, 2008, PLANT J, V56, P743, DOI 10.1111/j.1365-313X.2008.03642.x; Chung HJ, 1999, PLANT PHYSIOL, V121, P429, DOI 10.1104/pp.121.2.429; COME D, 1968, CR ACAD SCI D NAT, V266, P477; Dubin MJ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-3; Felle HH, 2005, ANN BOT-LONDON, V96, P519, DOI 10.1093/aob/mci207; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Garzon M, 2007, FEBS LETT, V581, P3189, DOI 10.1016/j.febslet.2007.06.005; Graciet E, 2010, TRENDS PLANT SCI, V15, P447, DOI 10.1016/j.tplants.2010.04.011; Graciet E, 2010, PLANT J, V61, P741, DOI 10.1111/j.1365-313X.2009.04099.x; Graciet E, 2009, P NATL ACAD SCI USA, V106, P13618, DOI 10.1073/pnas.0906404106; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Hinz M, 2010, PLANT PHYSIOL, V153, P757, DOI 10.1104/pp.110.155077; Holman TJ, 2009, P NATL ACAD SCI USA, V106, P4549, DOI 10.1073/pnas.0810280106; Horan K, 2008, PLANT PHYSIOL, V147, P41, DOI 10.1104/pp.108.117366; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leonard SE, 2011, CURR OPIN CHEM BIOL, V15, P88, DOI 10.1016/j.cbpa.2010.11.012; Licausi F, 2010, PLANT J, V62, P302, DOI 10.1111/j.1365-313X.2010.04149.x; Lucas M, 2011, PLANT PHYSIOL, V155, P384, DOI 10.1104/pp.110.165126; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; Mustroph A, 2010, PLANT PHYSIOL, V152, P1484, DOI 10.1104/pp.109.151845; Mustroph A, 2009, P NATL ACAD SCI USA, V106, P18843, DOI 10.1073/pnas.0906131106; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Takahashi H, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-39; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Williams AJ, 2003, PLANT PHYSIOL, V132, P2086, DOI 10.1104/pp.103.022749; Xu K, 2006, NATURE, V442, P705, DOI 10.1038/nature04920; Yoshida S, 2002, PLANT J, V32, P129, DOI 10.1046/j.1365-313X.2002.01407.x	38	442	455	5	239	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					415	U172		10.1038/nature10534	http://dx.doi.org/10.1038/nature10534			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22020279	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000297059700049
J	Venditti, C; Meade, A; Pagel, M				Venditti, Chris; Meade, Andrew; Pagel, Mark			Multiple routes to mammalian diversity	NATURE			English	Article							BODY-SIZE; EVOLUTIONARY PATTERNS; CLIMATE-CHANGE; FOSSIL RECORD; PHYLOGENIES; DISPARITY; RATES; MASS	The radiation of the mammals provides a 165-million-year test case for evolutionary theories of how species occupy and then fill ecological niches. It is widely assumed that species often diverge rapidly early in their evolution, and that this is followed by a longer, drawn-out period of slower evolutionary fine-tuning as natural selection fits organisms into an increasingly occupied niche space(1,2). But recent studies have hinted that the process may not be so simple(3-5). Here we apply statistical methods that automatically detect temporal shifts in the rate of evolution through time to a comprehensive mammalian phylogeny(6) and data set(7) of body sizes of 3,185 extant species. Unexpectedly, the majority of mammal species, including two of the most speciose orders (Rodentia and Chiroptera), have no history of substantial and sustained increases in the rates of evolution. Instead, a subset of the mammals has experienced an explosive increase (between 10- and 52-fold) in the rate of evolution along the single branch leading to the common ancestor of their monophyletic group (for example Chiroptera), followed by a quick return to lower or background levels. The remaining species are a taxonomically diverse assemblage showing a significant, sustained increase or decrease in their rates of evolution. These results necessarily decouple morphological diversification from speciation and suggest that the processes that give rise to the morphological diversity of a class of animals are far more free to vary than previously considered. Niches do not seem to fill up, and diversity seems to arise whenever, wherever and at whatever rate it is advantageous.	[Venditti, Chris] Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Meade, Andrew; Pagel, Mark] Univ Reading, Sch Biol Sci, Reading RG6 6BX, Berks, England; [Pagel, Mark] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Hull; University of Reading; The Santa Fe Institute	Venditti, C (corresponding author), Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	c.venditti@hull.ac.uk; m.pagel@reading.ac.uk			Leverhulme Trust [ECF/2009/0029]; Natural Environment Research Council, UK; European Research Council; Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a Leverhulme Trust Early Career Fellowship (ECF/2009/0029) to C. V., and by grants to M. P. from the Natural Environment Research Council, UK, the Leverhulme Trust and the European Research Council. We thank R. Freckleton for discussion regarding the implementation of our variable-rates model.	Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Bininda-Emonds ORP, 2008, NATURE, V456, P274, DOI 10.1038/nature07347; Clauset A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.038103; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Foote M, 1996, EVOLUTION, V50, P1, DOI 10.1111/j.1558-5646.1996.tb04467.x; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; GINGERICH PD, 1987, CAN J ZOOL, V65, P1053, DOI 10.1139/z87-169; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Harmon LJ, 2010, EVOLUTION, V64, P2385, DOI 10.1111/j.1558-5646.2010.01025.x; Hunt G, 2006, PALEOBIOLOGY, V32, P578, DOI 10.1666/05070.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Polly PD, 2001, AM NAT, V157, P596, DOI 10.1086/320622; RAFTERY AE, 1996, MARKOV CHAIN MONTE C, P163; READ AF, 1989, J ZOOL, V219, P329, DOI 10.1111/j.1469-7998.1989.tb02584.x; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Slater GJ, 2010, P ROY SOC B-BIOL SCI, V277, P3097, DOI 10.1098/rspb.2010.0408; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith FA, 1998, ECOGRAPHY, V21, P140, DOI 10.1111/j.1600-0587.1998.tb00668.x; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630	25	202	202	0	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 17	2011	479	7373					393	396		10.1038/nature10516	http://dx.doi.org/10.1038/nature10516			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22012260				2022-12-24	WOS:000297059700044
J	Courchesne, E; Mouton, PR; Calhoun, ME; Semendeferi, K; Ahrens-Barbeau, C; Hallet, MJ; Barnes, CC; Pierce, K				Courchesne, Eric; Mouton, Peter R.; Calhoun, Michael E.; Semendeferi, Katerina; Ahrens-Barbeau, Clelia; Hallet, Melodie J.; Barnes, Cynthia Carter; Pierce, Karen			Neuron Number and Size in Prefrontal Cortex of Children With Autism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRAIN OVERGROWTH; YOUNG-CHILDREN; LIFE; PATTERNS; IMPACT; LOBES; AREAS; CELLS	Context Autism often involves early brain overgrowth, including the prefrontal cortex (PFC). Although prefrontal abnormality has been theorized to underlie some autistic symptoms, the cellular defects that cause abnormal overgrowth remain unknown. Objective To investigate whether early brain overgrowth in children with autism involves excess neuron numbers in the PFC. Design, Setting, and Cases Postmortem prefrontal tissue from 7 autistic and 6 control male children aged 2 to 16 years was examined by expert anatomists who were blinded to diagnostic status. Number and size of neurons were quantified using stereological methods within the dorsolateral (DL-PFC) and mesial (M-PFC) subdivisions of the PFC. Cases were from the eastern and southeastern United States and died between 2000 and 2006. Main Outcome Measures Mean neuron number and size in the DL-PFC and M-PFC were compared between autistic and control postmortem cases. Correlations of neuron number with deviation in brain weight from normative values for age were also performed. Results Children with autism had 67% more neurons in the PFC (mean, 1.94 billion; 95% CI, 1.57-2.31) compared with control children (1.16 billion; 95% CI, 0.90-1.42; P=.002), including 79% more in DL-PFC (1.57 billion; 95% CI, 1.20-1.94 in autism cases vs 0.88 billion; 95% CI, 0.66-1.10 in controls; P=.003) and 29% more in M-PFC (0.36 billion; 95% CI, 0.33-0.40 in autism cases vs 0.28 billion; 95% CI, 0.23-0.34 in controls; P=.009). Brain weight in the autistic cases differed from normative mean weight for age by a mean of 17.6% (95% CI, 10.2%-25.0%; P=.001), while brains in controls differed by a mean of 0.2% (95% CI, -8.7% to 9.1%; P=.96). Plots of counts by weight showed autistic children had both greater total prefrontal neuron counts and brain weight for age than control children. Conclusion In this small preliminary study, brain overgrowth in males with autism involved an abnormal excess number of neurons in the PFC. JAMA. 2011;306(18):2001-2010	[Courchesne, Eric; Ahrens-Barbeau, Clelia; Hallet, Melodie J.; Barnes, Cynthia Carter; Pierce, Karen] Univ Calif San Diego, Dept Neurosci, NIH UCSD, Autism Ctr Excellence,Sch Med, La Jolla, CA 92093 USA; [Semendeferi, Katerina] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; [Mouton, Peter R.] Univ S Florida, Sch Med, Dept Pathol & Cell Biol, Alzheimers Inst & Res Ctr, Tampa, FL 33620 USA; [Calhoun, Michael E.] Sinq Syst Inc, Silver Spring, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; State University System of Florida; University of South Florida	Courchesne, E (corresponding author), Univ Calif San Diego, Dept Neurosci, NIH UCSD, Autism Ctr Excellence,Sch Med, La Jolla, CA 92093 USA.	ecourchesne@ucsd.edu		Calhoun, Michael/0000-0003-1342-7903; Semendeferi, Katerina/0000-0002-9867-9554	Autism Speaks; Cure Autism Now; Peter Emch Family Foundation; Simons Foundation; Thursday Club Juniors; University of California, San Diego-National Institutes of Health (UCSD-NIH) Autism Center of Excellence [P50-MH081755]; National Institute of Mental Health (NIMH) [MH076541-04]; National Institute of Child Health and Development (NICHD) Brain and Tissue Bank for Developmental Disorders [N01-HD-4-3368, N01-HD-4-3383]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036840, P50MH081755, R44MH076541] Funding Source: NIH RePORTER	Autism Speaks; Cure Autism Now; Peter Emch Family Foundation; Simons Foundation; Thursday Club Juniors; University of California, San Diego-National Institutes of Health (UCSD-NIH) Autism Center of Excellence; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Development (NICHD) Brain and Tissue Bank for Developmental Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by Autism Speaks, Cure Autism Now, The Peter Emch Family Foundation, the Simons Foundation, The Thursday Club Juniors, and the University of California, San Diego-National Institutes of Health (UCSD-NIH) Autism Center of Excellence (P50-MH081755) awarded to Dr Courchesne and by the National Institute of Mental Health (NIMH) (MH076541-04) awarded to Dr Mouton. Tissue was provided by the National Institute of Child Health and Development (NICHD) Brain and Tissue Bank for Developmental Disorders under contracts N01-HD-4-3368 and N01-HD-4-3383, the Brain and Tissue Bank for Developmental Disorders, Autism Tissue Program, and direct donations to the Courchesne laboratory.	Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Bucy PC, 1949, PRECENTRAL MOTOR COR; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Carper RA, 2002, NEUROIMAGE, V16, P1038, DOI 10.1006/nimg.2002.1099; Chawarska K, 2011, ARCH GEN PSYCHIAT, V68, P1021, DOI 10.1001/archgenpsychiatry.2011.106; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Courchesne E, 2005, INT J DEV NEUROSCI, V23, P153, DOI 10.1016/j.ijdevneu.2005.01.003; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Courchesne E, 2011, AUTISM SPECTRUM DISO; Dawson G, 2007, BIOL PSYCHIAT, V61, P458, DOI 10.1016/j.biopsych.2006.07.016; Gohlke JM, 2007, CEREB CORTEX, V17, P2433, DOI 10.1093/cercor/bhl151; Hadley JA, 2003, FORENSIC SCI INT, V133, P190, DOI 10.1016/S0379-0738(03)00069-0; Hazlett HC, 2005, ARCH GEN PSYCHIAT, V62, P1366, DOI 10.1001/archpsyc.62.12.1366; Hazlett HC, 2011, ARCH GEN PSYCHIAT, V68, P467, DOI 10.1001/archgenpsychiatry.2011.39; JENSEN EBV, 1993, J MICROSC-OXFORD, V170, P35, DOI 10.1111/j.1365-2818.1993.tb03321.x; Kanold PO, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.016.2009; Kennedy DP, 2007, BRAIN COGNITION, V64, P124, DOI 10.1016/j.bandc.2007.01.007; Kim WY, 2009, NAT NEUROSCI, V12, P1390, DOI 10.1038/nn.2408; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Larsen CC, 2006, NEUROSCIENCE, V139, P999, DOI 10.1016/j.neuroscience.2006.01.005; Mouton P.R., 2001, PRINCIPLES PRACTICES; Mouton PR, 2011, UNBIASED STEREOLOGY, P20; Mouton PR, 2010, TARGET ORGAN TOXICOL; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rabinowicz T, 1996, J NEUROPATH EXP NEUR, V55, P320, DOI 10.1097/00005072-199603000-00007; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P307, DOI 10.1093/cercor/5.4.307; Redcay E, 2005, BIOL PSYCHIAT, V58, P1, DOI 10.1016/j.biopsych.2005.03.026; Redcay E, 2008, BIOL PSYCHIAT, V64, P589, DOI 10.1016/j.biopsych.2008.05.020; Samuelsen GB, 2003, CEREB CORTEX, V13, P115, DOI 10.1093/cercor/13.2.115; Santos M, 2011, BRAIN RES, V1380, P206, DOI 10.1016/j.brainres.2010.08.067; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Sparks BF, 2002, NEUROLOGY, V59, P184, DOI 10.1212/WNL.59.2.184; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Uylings HBM, 2005, NEUROSCIENCE, V136, P715, DOI 10.1016/j.neuroscience.2005.07.048; Webb SJ, 2006, J AUTISM DEV DISORD, V36, P881, DOI 10.1007/s10803-006-0126-x; WEST MJ, 1993, NEUROBIOL AGING, V14, P275, DOI 10.1016/0197-4580(93)90112-O	39	466	486	0	71	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 9	2011	306	18					2001	2010		10.1001/jama.2011.1638	http://dx.doi.org/10.1001/jama.2011.1638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843VT	22068992				2022-12-24	WOS:000296704300023
J	Meredith, RW; Janecka, JE; Gatesy, J; Ryder, OA; Fisher, CA; Teeling, EC; Goodbla, A; Eizirik, E; Simao, TLL; Stadler, T; Rabosky, DL; Honeycutt, RL; Flynn, JJ; Ingram, CM; Steiner, C; Williams, TL; Robinson, TJ; Burk-Herrick, A; Westerman, M; Ayoub, NA; Springer, MS; Murphy, WJ				Meredith, Robert W.; Janecka, Jan E.; Gatesy, John; Ryder, Oliver A.; Fisher, Colleen A.; Teeling, Emma C.; Goodbla, Alisha; Eizirik, Eduardo; Simao, Taiz L. L.; Stadler, Tanja; Rabosky, Daniel L.; Honeycutt, Rodney L.; Flynn, John J.; Ingram, Colleen M.; Steiner, Cynthia; Williams, Tiffani L.; Robinson, Terence J.; Burk-Herrick, Angela; Westerman, Michael; Ayoub, Nadia A.; Springer, Mark S.; Murphy, William J.			Impacts of the Cretaceous Terrestrial Revolution and KPg Extinction on Mammal Diversification	SCIENCE			English	Article							PHYLOGENY; EVOLUTION; DIVERGENCE	Previous analyses of relations, divergence times, and diversification patterns among extant mammalian families have relied on supertree methods and local molecular clocks. We constructed a molecular supermatrix for mammalian families and analyzed these data with likelihood-based methods and relaxed molecular clocks. Phylogenetic analyses resulted in a robust phylogeny with better resolution than phylogenies from supertree methods. Relaxed clock analyses support the long-fuse model of diversification and highlight the importance of including multiple fossil calibrations that are spread across the tree. Molecular time trees and diversification analyses suggest important roles for the Cretaceous Terrestrial Revolution and Cretaceous-Paleogene (KPg) mass extinction in opening up ecospace that promoted interordinal and intraordinal diversification, respectively. By contrast, diversification analyses provide no support for the hypothesis concerning the delayed rise of present-day mammals during the Eocene Period.	[Meredith, Robert W.; Gatesy, John; Burk-Herrick, Angela; Ayoub, Nadia A.; Springer, Mark S.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Janecka, Jan E.; Fisher, Colleen A.; Murphy, William J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Ryder, Oliver A.; Steiner, Cynthia] San Diego Zoo, Inst Conservat Res, Escondido, CA 92027 USA; [Teeling, Emma C.; Goodbla, Alisha] Univ Coll Dublin, UCD Sch Biol & Environm Sci, Dublin 4, Ireland; [Eizirik, Eduardo; Simao, Taiz L. L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, BR-90619900 Porto Alegre, RS, Brazil; [Stadler, Tanja] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; [Rabosky, Daniel L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Honeycutt, Rodney L.] Pepperdine Univ, Div Nat Sci, Malibu, CA 90263 USA; [Flynn, John J.; Ingram, Colleen M.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Flynn, John J.; Ingram, Colleen M.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Flynn, John J.] Amer Museum Nat Hist, Richard Glider Grad Sch, New York, NY 10024 USA; [Williams, Tiffani L.] Texas A&M Univ, Dept Comp Sci, College Stn, TX 77843 USA; [Robinson, Terence J.] Univ Stellenbosch, Dept Bot & Zool, ZA-7602 Matieland, South Africa; [Burk-Herrick, Angela] Chaffey Coll, Rancho Cucamonga, CA 91737 USA; [Westerman, Michael] La Trobe Univ, Dept Genet, Bundoora, Vic 3086, Australia; [Ayoub, Nadia A.] Washington & Lee Univ, Dept Biol, Lexington, VA 24450 USA	University of California System; University of California Riverside; Texas A&M University System; Texas A&M University College Station; Zoological Society of San Diego; University College Dublin; Pontificia Universidade Catolica Do Rio Grande Do Sul; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; Pepperdine University; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Texas A&M University System; Texas A&M University College Station; Stellenbosch University; La Trobe University; Washington & Lee University	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	mark.springer@ucr.edu; wmurphy@cvm.tamu.edu	Eizirik, Eduardo/K-8034-2012; Rabosky, Daniel L/G-4530-2015; Stadler, Tanja/J-4742-2013; Robinson, Terence J./K-7342-2017	Eizirik, Eduardo/0000-0002-9658-0999; Stadler, Tanja/0000-0001-6431-535X; Ayoub, Nadia/0000-0003-4404-1472; Goodbla, Alisha/0000-0003-0416-2069; Robinson, Terence J./0000-0002-4298-4891; Teeling, Emma/0000-0002-3309-1346	NSF [EF0629860, EF0629849]; Science Foundation Ireland [06/YI3/B932]; CNPq-Brazil; South African National Research Foundation	NSF(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); CNPq-Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); South African National Research Foundation(National Research Foundation - South Africa)	Supported by NSF (EF0629860 to M. S. S. and J.G.; EF0629849 to W.J.M., R.L.H and T.L.W.), Science Foundation Ireland PIYRA 06/YI3/B932 to E.C.T., CNPq-Brazil to E.E., and South African National Research Foundation to T.J.R. New GenBank accession numbers: JN413803 to JN415086 and JN632710 to JN633870. TreeBase ID: S11872. The Zoological Society of San Diego provided samples for this project under materials transfer agreements as indicated in Materials and Methods. Requests for materials should be directed to authors and/or institutions as stipulated in Materials and Methods.	ADKINS RM, 1991, P NATL ACAD SCI USA, V88, P10317, DOI 10.1073/pnas.88.22.10317; [Anonymous], 1999, WALKERS MAMMALS WORL; Archibald J. David, 2001, Journal of Mammalian Evolution, V8, P107, DOI 10.1023/A:1011317930838; Benton MJ, 2010, PHILOS T R SOC B, V365, P3667, DOI 10.1098/rstb.2010.0269; Benton Michael J., 2009, P35; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Hallstrom BM, 2010, MOL BIOL EVOL, V27, P2804, DOI 10.1093/molbev/msq166; Hedges SB, 1996, NATURE, V381, P226, DOI 10.1038/381226a0; Hou ZC, 2009, MOL PHYLOGENET EVOL, V52, P660, DOI 10.1016/j.ympev.2009.05.002; Liu L, 2009, SYST BIOL, V58, P468, DOI 10.1093/sysbio/syp031; Liu L, 2009, MOL PHYLOGENET EVOL, V53, P320, DOI 10.1016/j.ympev.2009.05.033; Luo ZX, 2011, NATURE, V476, P442, DOI 10.1038/nature10291; MARSHALL CR, 1994, P NATL ACAD SCI USA, V91, P12283, DOI 10.1073/pnas.91.25.12283; Meredith RW, 2008, J MAMM EVOL, V15, P1, DOI 10.1007/s10914-007-9062-6; Meredith RW, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000634; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nishihara H, 2009, P NATL ACAD SCI USA, V106, P5235, DOI 10.1073/pnas.0809297106; PETTIGREW JD, 1986, SCIENCE, V231, P1304, DOI 10.1126/science.3945827; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Thuiller W, 2011, NATURE, V470, P531, DOI 10.1038/nature09705; VANVALEN L, 1971, EVOLUTION, V25, P420, DOI 10.1111/j.1558-5646.1971.tb01898.x; Wible JR, 2007, NATURE, V447, P1003, DOI 10.1038/nature05854; Wildman DE, 2007, P NATL ACAD SCI USA, V104, P14395, DOI 10.1073/pnas.0704342104; Wilson D. E., 2005, MAMMAL SPECIES WORLD; [No title captured]	32	967	989	7	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					521	524		10.1126/science.1211028	http://dx.doi.org/10.1126/science.1211028			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	21940861				2022-12-24	WOS:000296230500049
J	Wu, J; Petralia, RS; Kurushima, H; Patel, H; Jung, MY; Volk, L; Chowdhury, S; Shepherd, JD; Dehoff, M; Li, Y; Kuhl, D; Huganir, RL; Price, DL; Scannevin, R; Troncoso, JC; Wong, PC; Worley, PF				Wu, Jing; Petralia, Ronald S.; Kurushima, Hideaki; Patel, Hiral; Jung, Mi-Young; Volk, Lenora; Chowdhury, Shoaib; Shepherd, Jason D.; Dehoff, Marlin; Li, Yueming; Kuhl, Dietmar; Huganir, Richard L.; Price, Donald L.; Scannevin, Robert; Troncoso, Juan C.; Wong, Philip C.; Worley, Paul F.			Arc/Arg3.1 Regulates an Endosomal Pathway Essential for Activity-Dependent beta-Amyloid Generation	CELL			English	Article							GAMMA-SECRETASE ACTIVITY; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; PRECURSOR PROTEIN; CELL BIOLOGY; IN-VIVO; DEPOSITION; TRAFFICKING; PRESENILINS; FRAGMENTS	Assemblies of beta-amyloid (A beta) peptides are pathological mediators of Alzheimer's Disease (AD) and are produced by the sequential cleavages of amyloid precursor protein (APP) by beta-secretase (BACE1) and gamma-secretase. The generation of A beta is coupled to neuronal activity, but the molecular basis is unknown. Here, we report that the immediate early gene Arc is required for activity-dependent generation of A beta. Arc is a postsynaptic protein that recruits endophilin2/3 and dynamin to early/recycling endosomes that traffic AMPA receptors to reduce synaptic strength in both Hebbian and non-Hebbian forms of plasticity. The Arc-endosome also traffics APP and BACE1, and Arc physically associates with presenilin1 (PS1) to regulate gamma-secretase trafficking and confer activity dependence. Genetic deletion of Arc reduces A beta load in a transgenic mouse model of AD. In concert with the finding that patients with AD can express anomalously high levels of Arc, we hypothesize that Arc participates in the pathogenesis of AD.	[Wu, Jing; Kurushima, Hideaki; Volk, Lenora; Chowdhury, Shoaib; Shepherd, Jason D.; Dehoff, Marlin; Huganir, Richard L.; Price, Donald L.; Wong, Philip C.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Price, Donald L.; Troncoso, Juan C.; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Price, Donald L.; Troncoso, Juan C.; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Volk, Lenora; Huganir, Richard L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Petralia, Ronald S.] NIDCD, Lab Neurochem, NIH, Bethesda, MD 20892 USA; [Patel, Hiral; Jung, Mi-Young; Scannevin, Robert] Biogen Idec Inc, Cambridge, MA 02142 USA; [Li, Yueming] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA; [Kuhl, Dietmar] Univ Med Ctr Hamburg Eppendorf UKE, Ctr Mol Neurobiol ZMNH, Inst Mol & Cellular Cognit, D-20251 Hamburg, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Biogen; Memorial Sloan Kettering Cancer Center; University of Hamburg; University Medical Center Hamburg-Eppendorf	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Shepherd, Jason/N-8555-2018; Kuhl, Dietmar/A-4689-2009	Shepherd, Jason/0000-0001-7384-8289; Kuhl, Dietmar/0000-0002-4772-6701; Scannevin, Robert/0000-0002-5749-2785	NIMH [RO1 MH053608]; Johns Hopkins Alzheimer's Disease Research Center (NIH) [P50AG005146]; NIDCD; NIH [MH084020]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053608, P50MH084020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081, ZIADC000003] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johns Hopkins Alzheimer's Disease Research Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We would like to thank Gopal Thinakaran, Sangram Sisodia (University of Chicago), and Tong Li for critical reagents and helpful discussions. Thanks to Gay Rudow for helping with unbiased stereology. Thanks to Desheng Xu and Shi Yang for help with lentivirus packaging. Many thanks to Robert Ardiuni, Melissa Levesque, Darren Baker, and Stephan Miller from Biogen Idec for their excellent technical support on in vitro binding assay. We thank Ya-Xian Wang for help with the EM studies. We also thank Robert Malinow (University of California at San Diego) and Mike Ehlers (Duke University) for APP Sindbis virus constructs and GFP-Rab constructs. This work was supported by NIMH grant RO1 MH053608 (P.F.W.), the Johns Hopkins Alzheimer's Disease Research Center (NIH grant P50AG005146) and in part by the NIDCD Intramural Program (R.S.P.) and NIH grant MH084020.	Alberi L, 2011, NEURON, V69, P437, DOI 10.1016/j.neuron.2011.01.004; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cracchiolo JR, 2007, NEUROBIOL LEARN MEM, V88, P277, DOI 10.1016/j.nlm.2007.07.007; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Gao M, 2010, J NEUROSCI, V30, P7168, DOI 10.1523/JNEUROSCI.1067-10.2010; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Lewis SJ, 2005, BIOORG MED CHEM LETT, V15, P373, DOI 10.1016/j.bmcl.2004.10.062; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ribaut-Barassin C, 2000, SYNAPSE, V35, P96, DOI 10.1002/(SICI)1098-2396(200002)35:2<96::AID-SYN2>3.0.CO;2-0; Rosi S, 2005, J NEUROSCI, V25, P723, DOI 10.1523/JNEUROSCI.4469-04.2005; Shelton CC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-22; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tian Y, 2010, NAT STRUCT MOL BIOL, V17, P151, DOI 10.1038/nsmb.1743; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200	30	136	141	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					615	628		10.1016/j.cell.2011.09.036	http://dx.doi.org/10.1016/j.cell.2011.09.036			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036569	Green Accepted, Bronze			2022-12-24	WOS:000296573700016
J	Liu, XY; Liu, ZC; Sun, YG; Ross, M; Kim, S; Tsai, FF; Li, QF; Jeffry, J; Kim, JY; Loh, HH; Chen, ZF				Liu, Xian-Yu; Liu, Zhong-Chun; Sun, Yan-Gang; Ross, Michael; Kim, Seungil; Tsai, Feng-Fang; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Loh, Horace H.; Chen, Zhou-Feng			Unidirectional Cross-Activation of GRPR by MOR1D Uncouples Itch and Analgesia Induced by Opioids	CELL			English	Article							DORSAL-HORN NEURONS; MAMMALIAN BOMBESIN RECEPTORS; MORPHINE-INDUCED ANALGESIA; GASTROINTESTINAL TRANSIT; MOLECULAR-MECHANISMS; SPLICE VARIANTS; KNOCKOUT MICE; SPINAL-CORD; MU; PRURITUS	Spinal opioid-induced itch, a prevalent side effect of pain management, has been proposed to result from pain inhibition. We now report that the m-opioid receptor (MOR) isoform MOR1D is essential for morphine-induced scratching (MIS), whereas the isoform MOR1 is required only for morphine-induced analgesia (MIA). MOR1D heterodimerizes with gastrin-releasing peptide receptor (GRPR) in the spinal cord, relaying itch information. We show that morphine triggers internalization of both GRPR and MOR1D, whereas GRP specifically triggers GRPR internalization and morphine-independent scratching. Providing potential insight into opioid-induced itch prevention, we demonstrate that molecular and pharmacologic inhibition of PLC beta 3 and IP3R3, downstream effectors of GRPR, specifically block MIS but not MIA. In addition, blocking MOR1D-GRPR association attenuates MIS but not MIA. Together, these data suggest that opioid-induced itch is an active process concomitant with but independent of opioid analgesia, occurring via the unidirectional cross-activation of GRPR signaling by MOR1D heterodimerization.	[Liu, Xian-Yu; Liu, Zhong-Chun; Sun, Yan-Gang; Ross, Michael; Kim, Seungil; Tsai, Feng-Fang; Li, Qi-Fang; Jeffry, Joseph; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Ctr Study Itch, St Louis, MO 63110 USA; [Liu, Xian-Yu; Liu, Zhong-Chun; Kim, Seungil; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Liu, Xian-Yu; Liu, Zhong-Chun; Kim, Seungil; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; [Liu, Xian-Yu; Liu, Zhong-Chun; Kim, Seungil; Li, Qi-Fang; Jeffry, Joseph; Kim, Ji-Young; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Dev Biol, St Louis, MO 63110 USA; [Loh, Horace H.] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Chen, ZF (corresponding author), Washington Univ, Sch Med, Pain Ctr, Ctr Study Itch, St Louis, MO 63110 USA.	chenz@wustl.edu	LIU, XIANYU/B-8111-2014	Ross, Michael/0000-0002-5136-650X; Tsai, Feng-Fang/0000-0003-2390-3248; , qifang/0000-0002-5593-720X; Liu, Xianyu/0000-0001-6089-8826	NIDA; NIAMS; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Yin, S. Weng, Y.C. Pan, and Z.Q. Zhao for technical help and comments, C.J. Coscia, Y.X. Pan, and G.W. Pasternak for MOR1 and MOR1D plasmids, E. Wada and J. Battey for GRPR antibodies, P. Sternweis for PLC beta 3 antibody, E. Liman for IP3R3 antibody, D. Coy for a GRPR antagonist, B.W. Li for qRT-PCR help, and W. Huh for LCM. We also thank M. Bruchas for comments. J.J. has been supported by a NIDA training grant. The work was supported by a NIAMS grant to Z.-F.C.	Abbadie C, 2000, NEUROSCIENCE, V100, P141, DOI 10.1016/S0306-4522(00)00248-7; Agnati LF, 2003, PHARMACOL REV, V55, P509, DOI 10.1124/pr.55.3.2; Alvarez VA, 2002, J NEUROSCI, V22, P5769; Andoh T, 2008, J PHARMACOL SCI, V106, P667, DOI 10.1254/jphs.08004SC; BALLANTYNE JC, 1988, PAIN, V33, P149, DOI 10.1016/0304-3959(88)90085-1; Bergasa NV, 2005, J HEPATOL, V43, P1078, DOI 10.1016/j.jhep.2005.09.004; Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575; Carstens E, 1997, J NEUROPHYSIOL, V77, P2499, DOI 10.1152/jn.1997.77.5.2499; Carstens EE, 2010, NEUROREPORT, V21, P303, DOI 10.1097/WNR.0b013e328337310a; CHANEY MA, 1995, CAN J ANAESTH, V42, P891, DOI 10.1007/BF03011037; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; Davidson S, 2010, TRENDS NEUROSCI, V33, P550, DOI 10.1016/j.tins.2010.09.002; Fairbanks CA, 1999, J PHARMACOL EXP THER, V288, P1107; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; HALES P, 1980, LANCET, V2, P204; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Hipser C, 2010, MT SINAI J MED, V77, P374, DOI 10.1002/msj.20199; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; JONES EA, 1990, HEPATOLOGY, V11, P884, DOI 10.1002/hep.1840110526; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kieffer BL, 1999, TRENDS PHARMACOL SCI, V20, P19, DOI 10.1016/S0165-6147(98)01279-6; Ko MCH, 2000, ANESTHESIOLOGY, V92, P795, DOI 10.1097/00000542-200003000-00023; Ko MCH, 2004, J PHARMACOL EXP THER, V310, P169, DOI 10.1124/jpet.103.061101; Koch T, 2001, J BIOL CHEM, V276, P31408, DOI 10.1074/jbc.M100305200; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; Kuraishi Y, 2000, J BIOMED SCI, V7, P248, DOI 10.1159/000025455; Lagerstrom MC, 2010, NEURON, V68, P529, DOI 10.1016/j.neuron.2010.09.016; Law PY, 2000, ANNU REV PHARMACOL, V40, P389, DOI 10.1146/annurev.pharmtox.40.1.389; LING GSF, 1989, LIFE SCI, V45, P1627, DOI 10.1016/0024-3205(89)90272-5; Liu Y, 2010, NEURON, V68, P543, DOI 10.1016/j.neuron.2010.09.008; Loh HH, 1998, MOL BRAIN RES, V54, P321, DOI 10.1016/S0169-328X(97)00353-7; Lopez A, 2009, CELL MOL LIFE SCI, V66, P2093, DOI 10.1007/s00018-009-0008-4; MANARA L, 1986, J PHARMACOL EXP THER, V237, P945; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Metze D, 1999, J AM ACAD DERMATOL, V41, P533, DOI 10.1016/S0190-9622(99)80048-6; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Nichols ML, 1999, SCIENCE, V286, P1558, DOI 10.1126/science.286.5444.1558; Pan YX, 2005, DNA CELL BIOL, V24, P736, DOI 10.1089/dna.2005.24.736; Pasternak GW, 2010, CLIN J PAIN, V26, pS3, DOI 10.1097/AJP.0b013e3181c49d2e; Pasternak GW, 2004, NEUROPHARMACOLOGY, V47, P312, DOI 10.1016/j.neuropharm.2004.07.004; Patel KN, 2010, NEURON, V68, P334, DOI 10.1016/j.neuron.2010.10.018; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Pfeiffer M, 2002, J BIOL CHEM, V277, P19762, DOI 10.1074/jbc.M110373200; Ravindranathan A, 2009, P NATL ACAD SCI USA, V106, P10811, DOI 10.1073/pnas.0904509106; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Samways DSK, 2006, CELL SIGNAL, V18, P151, DOI 10.1016/j.cellsig.2005.08.005; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Szarvas S, 2003, J CLIN ANESTH, V15, P234, DOI 10.1016/S0952-8180(02)00501-9; Trafton JA, 2000, J NEUROSCI, V20, P8578; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Zhao ZQ, 2007, P NATL ACAD SCI USA, V104, P14519, DOI 10.1073/pnas.0705740104	62	199	211	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					447	458		10.1016/j.cell.2011.08.043	http://dx.doi.org/10.1016/j.cell.2011.08.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000021	Bronze, Green Accepted			2022-12-24	WOS:000296199300021
J	Seimetz, M; Parajuli, N; Pichl, A; Veit, F; Kwapiszewska, G; Weisel, FC; Milger, K; Egemnazarov, B; Turowska, A; Fuchs, B; Nikam, S; Roth, M; Sydykov, A; Medebach, T; Klepetko, W; Jaksch, P; Dumitrascu, R; Garn, H; Voswinckel, R; Kostin, S; Seeger, W; Schermuly, RT; Grimminger, F; Ghofrani, HA; Weissmann, N				Seimetz, Michael; Parajuli, Nirmal; Pichl, Alexandra; Veit, Florian; Kwapiszewska, Grazyna; Weisel, Friederike C.; Milger, Katrin; Egemnazarov, Bakytbek; Turowska, Agnieszka; Fuchs, Beate; Nikam, Sandeep; Roth, Markus; Sydykov, Akylbek; Medebach, Thomas; Klepetko, Walter; Jaksch, Peter; Dumitrascu, Rio; Garn, Holger; Voswinckel, Robert; Kostin, Sawa; Seeger, Werner; Schermuly, Ralph T.; Grimminger, Friedrich; Ghofrani, Hossein A.; Weissmann, Norbert			Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice	CELL			English	Article							NITRIC-OXIDE SYNTHASE; ABDOMINAL AORTIC-ANEURYSMS; BB-94 LIMITS EXPANSION; CIGARETTE-SMOKE; GUINEA-PIG; ARTERIAL-HYPERTENSION; PROGENITOR CELLS; IN-VITRO; T-CELLS; DISEASE	Chronic obstructive pulmonary disease (COPD) is one of the most common causes of death worldwide. We report in an emphysema model of mice chronically exposed to tobacco smoke that pulmonary vascular dysfunction, vascular remodeling, and pulmonary hypertension (PH) precede development of alveolar destruction. We provide evidence for a causative role of inducible nitric oxide synthase (iNOS) and peroxynitrite in this context. Mice lacking iNOS were protected against emphysema and PH. Treatment of wild-type mice with the iNOS inhibitor N-6-(1-iminoethyl)-L-lysine (L-NIL) prevented structural and functional alterations of both the lung vasculature and alveoli and also reversed established disease. In chimeric mice lacking iNOS in bone marrow (BM)-derived cells, PH was dependent on iNOS from BM-derived cells, whereas emphysema development was dependent on iNOS from non-BM-derived cells. Similar regulatory and structural alterations as seen in mouse lungs were found in lung tissue from humans with end-stage COPD.	[Seimetz, Michael; Parajuli, Nirmal; Pichl, Alexandra; Veit, Florian; Kwapiszewska, Grazyna; Weisel, Friederike C.; Milger, Katrin; Egemnazarov, Bakytbek; Fuchs, Beate; Roth, Markus; Sydykov, Akylbek; Medebach, Thomas; Dumitrascu, Rio; Seeger, Werner; Grimminger, Friedrich; Ghofrani, Hossein A.; Weissmann, Norbert] UGLC, Excellence Cluster Cardiopulm Syst ECCPS, D-35392 Giessen, Germany; [Nikam, Sandeep; Voswinckel, Robert; Kostin, Sawa; Schermuly, Ralph T.] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany; [Klepetko, Walter; Jaksch, Peter] Univ Hosp Vienna, Dept Cardiothorac Surg, A-1090 Vienna, Austria; [Turowska, Agnieszka; Garn, Holger] Biomed Res Ctr BMFZ, D-35043 Marburg, Germany	Max Planck Society; University Hospital Vienna	Weissmann, N (corresponding author), UGLC, Excellence Cluster Cardiopulm Syst ECCPS, D-35392 Giessen, Germany.	norbert.weissmann@innere.med.uni-giessen.de	Milger, Katrin/AFI-3881-2022; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Ghofrani, Ardeschir/AAD-5293-2020; Sydykov, Akylbek/O-1049-2017; Parajuli, Nirmal/E-2536-2016; Sydykov, Akylbek/K-8463-2019	Ghofrani, Ardeschir/0000-0002-2029-4419; Sydykov, Akylbek/0000-0002-8122-7033; Sydykov, Akylbek/0000-0002-8122-7033; Milger, Katrin/0000-0003-2914-8773; Kwapiszewska, grazyna/0000-0003-0518-9079; Egemnazarov, Bakytbek/0000-0002-1570-8322; Garn, Holger/0000-0002-5178-4023; Schermuly, Ralph/0000-0002-5167-6970; jaksch, peter/0000-0003-4635-3242; Weissmann, Norbert/0000-0003-2675-3871; Seeger, Werner/0000-0003-1946-0894; Parajuli, Nirmal/0000-0002-0799-6301	German Research Foundation; Excellence Cluster Cardiopulmonary System (ECCPS); BMBF [ASCONET SP10]; State of Hessen (LOEWE)	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System (ECCPS)(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); State of Hessen (LOEWE)	The authors thank Nadja Baumgartl, Ingrid Breitenborn-Muller, Uta Eule, Lisa Frohlich, Sabine Graf-Hochst, Carmen Homberger, Miriam Schmidt, and Karin Quanz for technical assistance. This work was in part funded by the German Research Foundation, Excellence Cluster Cardiopulmonary System (ECCPS), the BMBF (ASCONET SP10), and the State of Hessen (LOEWE).	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Asosingh K, 2008, AM J PATHOL, V172, P615, DOI 10.2353/ajpath.2008.070705; Austin ED, 2010, RESP MED, V104, P454, DOI 10.1016/j.rmed.2009.10.004; Baxter BT, 1999, J VASC SURG, V29, P138; Bigatel DA, 1999, J VASC SURG, V29, P130, DOI 10.1016/S0741-5214(99)70354-X; Black PN, 2008, EUR RESPIR J, V31, P998, DOI 10.1183/09031936.00017207; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brindicci C, 2009, CHEST, V135, P353, DOI 10.1378/chest.08-0964; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Cuttica MJ, 2011, AM J RESP CELL MOL, V45, P62, DOI 10.1165/rcmb.2009-0365OC; Ellisen LW, 2010, NAT MED, V16, P754, DOI 10.1038/nm0710-754; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; Ferrer E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-76; Huertas A, 2011, EUR RESPIR J, V37, P426, DOI 10.1183/09031936.00034810; Lawrence DM, 2004, J VASC SURG, V40, P334, DOI 10.1016/j.jvs.2004.05.020; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; Mittal M, 2007, CIRC RES, V101, P258, DOI 10.1161/CIRCRESAHA.107.148015; Moncada S, 2002, NAT REV MOL CELL BIO, V3, P214, DOI 10.1038/nrm762; MOORE WM, 1994, J MED CHEM, V37, P3886, DOI 10.1021/jm00049a007; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; MURRAY CJ, 1990, LANCET, V349, P1498, DOI DOI 10.1016/S0140-6736(96)07492-2; Niedbala W, 2007, P NATL ACAD SCI USA, V104, P15478, DOI 10.1073/pnas.0703725104; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Ponnuswamy P, 2009, AM J PATHOL, V174, P2400, DOI 10.2353/ajpath.2009.080730; Potoka DA, 2003, AM J PHYSIOL-GASTR L, V285, pG861, DOI 10.1152/ajpgi.00412.2002; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Stenger S, 1995, EUR J PHARMACOL, V294, P703, DOI 10.1016/0014-2999(95)00618-4; Stockley Robert A, 2009, Proc Am Thorac Soc, V6, P524, DOI 10.1513/pats.200904-016DS; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Tsoumakidou M, 2005, CHEST, V127, P1911, DOI 10.1378/chest.127.6.1911; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Voswinckel R, 2003, CIRC RES, V93, P372, DOI 10.1161/01.RES.0000087643.60150.C2; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Wright JL, 2006, J APPL PHYSIOL, V100, P672, DOI 10.1152/japplphysiol.00274.2005; WRIGHT JL, 1991, EXP LUNG RES, V17, P997, DOI 10.3109/01902149109064331; WRIGHT JL, 1990, AM REV RESPIR DIS, V142, P1422, DOI 10.1164/ajrccm/142.6_Pt_1.1422; Wright JL, 2011, AM J RESP CRIT CARE, V183, P50, DOI 10.1164/rccm.201003-0399OC; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Yoshida T, 2010, NAT MED, V16, P767, DOI 10.1038/nm.2157; Zuckerbraun BS, 2006, J EXP MED, V203, P2109, DOI 10.1084/jem.20052267	49	224	235	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					293	305		10.1016/j.cell.2011.08.035	http://dx.doi.org/10.1016/j.cell.2011.08.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000010	Bronze			2022-12-24	WOS:000296199300009
J	Yeeles, JTP; Marians, KJ				Yeeles, Joseph T. P.; Marians, Kenneth J.			The Escherichia coli Replisome Is Inherently DNA Damage Tolerant	SCIENCE			English	Article							STALLED REPLICATION FORKS; LEADING-STRAND; IN-VITRO; RECOMBINATIONAL REPAIR; RESTART; PROTEIN; STOICHIOMETRY; LESION	The Escherichia coli DNA replication machinery must frequently overcome template lesions under normal growth conditions. Yet, the outcome of a collision between the replisome and a leading-strand template lesion remains poorly understood. Here, we demonstrate that a single, site-specific, cyclobutane pyrimidine dimer leading-strand template lesion provides only a transient block to fork progression in vitro. The replisome remains stably associated with the fork after collision with the lesion. Leading-strand synthesis is then reinitiated downstream of the damage in a reaction that is dependent on the primase, DnaG, but independent of any of the known replication-restart proteins. These observations reveal that the replisome can tolerate leading-strand template lesions without dissociating by synthesizing the leading strand discontinuously.	[Yeeles, Joseph T. P.; Marians, Kenneth J.] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Marians, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	kmarians@sloankettering.edu		Yeeles, Joseph/0000-0002-2255-2119	NIH [GM34557]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034557, R37GM034557] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Bahng for establishing the protocol for replicating M13 DNA primed with the CPD oligonucleotide and C. Gabbai, S. Gupta, and S. Shuman for advice on the manuscript. These studies were supported by NIH grant GM34557.	Berdichevsky A, 2002, MOL CELL, V10, P917, DOI 10.1016/S1097-2765(02)00679-2; Carr KM, 2001, J BIOL CHEM, V276, P44919, DOI 10.1074/jbc.M107463200; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Guy CP, 2009, MOL CELL, V36, P654, DOI 10.1016/j.molcel.2009.11.009; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HIASA H, 1994, J BIOL CHEM, V269, P16371; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; IYER VN, 1971, BIOCHIM BIOPHYS ACTA, V228, P117, DOI 10.1016/0005-2787(71)90551-X; Marians KJ, 1998, J BIOL CHEM, V273, P2452, DOI 10.1074/jbc.273.4.2452; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McInerney P, 2004, J BIOL CHEM, V279, P21543, DOI 10.1074/jbc.M401649200; Merrikh H, 2011, NATURE, V470, P554, DOI 10.1038/nature09758; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; RUPP WD, 1968, J MOL BIOL, V31, P291, DOI 10.1016/0022-2836(68)90445-2; WU CA, 1992, J BIOL CHEM, V267, P4030	18	100	102	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					235	238		10.1126/science.1209111	http://dx.doi.org/10.1126/science.1209111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998391	Green Accepted			2022-12-24	WOS:000295833600049
J	Schmidt, MWI; Torn, MS; Abiven, S; Dittmar, T; Guggenberger, G; Janssens, IA; Kleber, M; Kogel-Knabner, I; Lehmann, J; Manning, DAC; Nannipieri, P; Rasse, DP; Weiner, S; Trumbore, SE				Schmidt, Michael W. I.; Torn, Margaret S.; Abiven, Samuel; Dittmar, Thorsten; Guggenberger, Georg; Janssens, Ivan A.; Kleber, Markus; Koegel-Knabner, Ingrid; Lehmann, Johannes; Manning, David A. C.; Nannipieri, Paolo; Rasse, Daniel P.; Weiner, Steve; Trumbore, Susan E.			Persistence of soil organic matter as an ecosystem property	NATURE			English	Article							BLACK CARBON; TEMPERATURE SENSITIVITY; MOLECULAR-STRUCTURE; MICROBIAL COMMUNITIES; LITTER DECOMPOSITION; PERMAFROST CARBON; HUMIC SUBSTANCES; NITROGEN; STABILIZATION; DYNAMICS	Globally, soil organic matter (SOM) contains more than three times as much carbon as either the atmosphere or terrestrial vegetation. Yet it remains largely unknown why some SOM persists for millennia whereas other SOM decomposes readily-and this limits our ability to predict how soils will respond to climate change. Recent analytical and experimental advances have demonstrated that molecular structure alone does not control SOM stability: in fact, environmental and biological controls predominate. Here we propose ways to include this understanding in a new generation of experiments and soil carbon models, thereby improving predictions of the SOM response to global warming.	[Schmidt, Michael W. I.; Abiven, Samuel] Univ Zurich, Dept Geog, CH-8050 Zurich, Switzerland; [Torn, Margaret S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Torn, Margaret S.] Univ Calif Berkeley, Energy & Resources Grp, Berkeley, CA 94720 USA; [Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Max Planck Res Grp Marine Geochem, Inst Chem & Biol Marine Environm, D-26129 Oldenburg, Germany; [Dittmar, Thorsten] Max Planck Inst Marine Microbiol, Max Planck Res Grp Marine Geochem, D-28359 Bremen, Germany; [Guggenberger, Georg] Leibniz Univ Hannover, Inst Soil Sci, D-30419 Hannover, Germany; [Janssens, Ivan A.] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Kleber, Markus] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Koegel-Knabner, Ingrid] Tech Univ Munich, Lehrstuhl Bodenkunde, D-85354 Freising Weihenstephan, Germany; [Lehmann, Johannes] Cornell Univ, Dept Crop & Soil Sci, Atkinson Ctr Sustainable Future, Ithaca, NY 14853 USA; [Manning, David A. C.] Newcastle Univ, Sch Civil Engn & Geosci, Inst Res Environm & Sustainabil, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Nannipieri, Paolo] Univ Florence, Dept Plant Soil & Environm Sci, I-50144 Florence, Italy; [Rasse, Daniel P.] Norwegian Inst Agr & Environm Res, N-1432 As, Norway; [Weiner, Steve] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Trumbore, Susan E.] Max Planck Inst Biogeochem, D-07745 Jena, Germany	University of Zurich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Carl von Ossietzky Universitat Oldenburg; Max Planck Society; Max Planck Society; Leibniz University Hannover; University of Antwerp; Oregon State University; Technical University of Munich; Cornell University; Newcastle University - UK; University of Florence; Bioforsk; Weizmann Institute of Science; Max Planck Society	Schmidt, MWI (corresponding author), Univ Zurich, Dept Geog, CH-8050 Zurich, Switzerland.	Michael.Schmidt@geo.uzh.ch; mstorn@lbl.gov	Lehmann, Johannes/H-2682-2014; Manning, David A C/I-3771-2012; Torn, Margaret/CAF-8960-2022; Guggenberger, Georg/C-8423-2013; Torn, Margaret S/D-2305-2015; Abiven, Samuel/J-5328-2013; Kögel-Knabner, Ingrid/A-7905-2008; Janssens, Ivan A/P-1331-2014; Rasse, Daniel/H-7279-2019; Kleber, Markus/M-1381-2019; Manning, David/P-3471-2019; Schmidt, Michael/G-5186-2012; Dittmar, Thorsten/L-7796-2013; Trumbore, Susan/B-1948-2013	Lehmann, Johannes/0000-0002-4701-2936; Torn, Margaret/0000-0002-8174-0099; Guggenberger, Georg/0000-0002-6962-8264; Torn, Margaret S/0000-0002-8174-0099; Abiven, Samuel/0000-0002-5663-0912; Kögel-Knabner, Ingrid/0000-0002-7216-8326; Janssens, Ivan A/0000-0002-5705-1787; Rasse, Daniel/0000-0002-5977-3863; Kleber, Markus/0000-0002-5681-2361; Manning, David/0000-0003-3473-120X; Schmidt, Michael/0000-0002-7227-0646; Dittmar, Thorsten/0000-0002-3462-0107; NANNIPIERI, PAOLO/0000-0002-5488-2593	European Science Foundation Network MOLTER; US Department of Energy [DE-AC02-05CH11231]	European Science Foundation Network MOLTER; US Department of Energy(United States Department of Energy (DOE))	The European Science Foundation Network MOLTER sponsored the workshop at which the idea for this Perspective was conceived. Support for M. W. I. S. and M. S. T. was also provided by the US Department of Energy (contract no. DE-AC02-05CH11231).	Agren GI, 2001, OECOLOGIA, V128, P94, DOI 10.1007/s004420100646; Amelung W, 2008, ADV AGRON, V100, P155, DOI 10.1016/S0065-2113(08)00606-8; AMUNDSON R, 1991, SOIL SCI, V151, P99, DOI 10.1097/00010694-199101000-00012; Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Balesdent J, 1996, SOIL BIOL BIOCHEM, V28, P1261, DOI 10.1016/0038-0717(96)00112-5; Bird JA, 2008, ORG GEOCHEM, V39, P465, DOI 10.1016/j.orggeochem.2007.12.003; Bird JA, 2006, BIOGEOCHEMISTRY, V79, P361, DOI 10.1007/s10533-005-5632-y; Brodowski S, 2006, EUR J SOIL SCI, V57, P539, DOI 10.1111/j.1365-2389.2006.00807.x; Chabbi A, 2009, SOIL BIOL BIOCHEM, V41, P256, DOI 10.1016/j.soilbio.2008.10.033; Cheng CH, 2009, CHEMOSPHERE, V75, P1021, DOI 10.1016/j.chemosphere.2009.01.045; Cohen-Ofri I, 2006, J ARCHAEOL SCI, V33, P428, DOI 10.1016/j.jas.2005.08.008; Craine JM, 2010, NAT GEOSCI, V3, P854, DOI [10.1038/ngeo1009, 10.1038/NGEO1009]; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dittmar T, 2009, NAT GEOSCI, V2, P175, DOI 10.1038/NGEO440; Ekschmitt K, 2008, J PLANT NUTR SOIL SC, V171, P27, DOI 10.1002/jpln.200700051; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; Fischlin A., 2007, CONTRIBUTION WORKING, P211; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Godbold DL, 2006, PLANT SOIL, V281, P15, DOI 10.1007/s11104-005-3701-6; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Hammes K, 2008, BIOGEOSCIENCES, V5, P1339, DOI 10.5194/bg-5-1339-2008; HAUMAIER L, 1995, ORG GEOCHEM, V23, P191, DOI 10.1016/0146-6380(95)00003-W; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Herrmann AM, 2007, SOIL BIOL BIOCHEM, V39, P1835, DOI 10.1016/j.soilbio.2007.03.011; Janssens IA, 2010, NAT GEOSCI, V3, P315, DOI [10.1038/NGEO844, 10.1038/ngeo844]; JENKINSON DS, 1990, PHILOS T R SOC B, V329, P361, DOI 10.1098/rstb.1990.0177; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kalbitz K, 2005, SOIL BIOL BIOCHEM, V37, P1319, DOI 10.1016/j.soilbio.2004.11.028; Kawahigashi M, 2006, GLOBAL CHANGE BIOL, V12, P1868, DOI 10.1111/j.1365-2486.2006.01203.x; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Kelleher BP, 2006, ENVIRON SCI TECHNOL, V40, P4605, DOI 10.1021/es0608085; Khvorostyanov DV, 2008, TELLUS B, V60, P250, DOI 10.1111/j.1600-0889.2007.00333.x; Kim SW, 2004, MAR CHEM, V92, P225, DOI 10.1016/j.marchem.2004.06.042; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; Kirschbaum MUF, 2006, SOIL BIOL BIOCHEM, V38, P2510, DOI 10.1016/j.soilbio.2006.01.030; Kleber M, 2010, ENVIRON CHEM, V7, P320, DOI 10.1071/EN10006; Kleber M, 2010, ADV AGRON, V106, P77, DOI 10.1016/S0065-2113(10)06003-7; Knorr M, 2005, ECOLOGY, V86, P3252, DOI 10.1890/05-0150; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Kong AYY, 2010, SOIL SCI SOC AM J, V74, P1201, DOI 10.2136/sssaj2009.0346; Kramer C, 2008, SOIL BIOL BIOCHEM, V40, P425, DOI 10.1016/j.soilbio.2007.09.016; Kramer C, 2010, SOIL BIOL BIOCHEM, V42, P1028, DOI 10.1016/j.soilbio.2010.02.021; Kucharik CJ, 2001, ECOSYSTEMS, V4, P237, DOI 10.1007/s10021\N001\N0007-2; Kuzyakov Y, 2010, SOIL BIOL BIOCHEM, V42, P1363, DOI 10.1016/j.soilbio.2010.04.003; Lehmann J, 2008, NAT GEOSCI, V1, P238, DOI 10.1038/ngeo155; Lehmann J, 2007, NATURE, V447, P143, DOI 10.1038/447143a; Lehmann J, 2008, NAT GEOSCI, V1, P832, DOI 10.1038/ngeo358; Liang B, 2008, GEOCHIM COSMOCHIM AC, V72, P6069, DOI 10.1016/j.gca.2008.09.028; Lorenz K, 2007, GEODERMA, V142, P1, DOI 10.1016/j.geoderma.2007.07.013; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Major J, 2010, GLOBAL CHANGE BIOL, V16, P1366, DOI 10.1111/j.1365-2486.2009.02044.x; Manzoni S, 2009, SOIL BIOL BIOCHEM, V41, P1355, DOI 10.1016/j.soilbio.2009.02.031; Marschner B, 2008, J PLANT NUTR SOIL SC, V171, P91, DOI 10.1002/jpln.200700049; McGuire KL, 2010, SOIL BIOL BIOCHEM, V42, P529, DOI 10.1016/j.soilbio.2009.11.016; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mendez-Millan M, 2010, SOIL BIOL BIOCHEM, V42, P169, DOI 10.1016/j.soilbio.2009.10.010; Morales SE, 2011, FEMS MICROBIOL ECOL, V75, P2, DOI 10.1111/j.1574-6941.2010.00938.x; Nguyen BT, 2010, ENVIRON SCI TECHNOL, V44, P3324, DOI 10.1021/es903016y; Nowinski NS, 2008, ECOSYSTEMS, V11, P16, DOI 10.1007/s10021-007-9104-1; Nowinski NS, 2010, OECOLOGIA, V163, P785, DOI 10.1007/s00442-009-1556-x; OADES JM, 1988, BIOGEOCHEMISTRY, V5, P35, DOI 10.1007/BF02180317; Olk DC, 2006, SOIL SCI SOC AM J, V70, P967, DOI 10.2136/sssaj2005.0111; PARTON WJ, 1994, SSSA SPEC PUBL, P147; Pascault N, 2010, MICROB ECOL, V60, P816, DOI 10.1007/s00248-010-9705-7; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Ranjard L, 2010, AGRON SUSTAIN DEV, V30, P359, DOI 10.1051/agro/2009033; Rasse DP, 2005, PLANT SOIL, V269, P341, DOI 10.1007/s11104-004-0907-y; Richter DD, 2007, SOIL SCI SOC AM J, V71, P266, DOI 10.2136/sssaj2006.0181; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; Schmidt MWI, 2000, GLOBAL BIOGEOCHEM CY, V14, P777, DOI 10.1029/1999GB001208; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Schuur EAG, 2009, NATURE, V459, P556, DOI 10.1038/nature08031; Sollins P, 1996, GEODERMA, V74, P65, DOI 10.1016/S0016-7061(96)00036-5; Sollins P, 2007, BIOGEOCHEMISTRY, V85, P1, DOI 10.1007/s10533-007-9099-x; STEVENSON F. J, 1994, HUMUS CHEM; Striegl RG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024413; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Thevenot M, 2010, SOIL BIOL BIOCHEM, V42, P1200, DOI 10.1016/j.soilbio.2010.03.017; Thornton PE, 2005, ECOL MODEL, V189, P25, DOI 10.1016/j.ecolmodel.2005.04.008; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260; Torn MS, 2002, GLOBAL CHANGE BIOL, V8, P941, DOI 10.1046/j.1365-2486.2002.00477.x; Totsche KU, 2010, J PLANT NUTR SOIL SC, V173, P88, DOI 10.1002/jpln.200900105; Trompowsky PM, 2005, ORG GEOCHEM, V36, P1480, DOI 10.1016/j.orggeochem.2005.08.001; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; van Hove ERA, 2010, J CHROMATOGR A, V1217, P3946, DOI 10.1016/j.chroma.2010.01.033; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; von Lutzow M, 2009, BIOL FERT SOILS, V46, P1, DOI 10.1007/s00374-009-0413-8; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Xu TF, 2008, VADOSE ZONE J, V7, P305, DOI 10.2136/vzj2006.0130; Ziolkowski LA, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043963	100	3257	3445	342	4490	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					49	56		10.1038/nature10386	http://dx.doi.org/10.1038/nature10386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979045	Green Submitted			2022-12-24	WOS:000295575400033
J	Musset, B; Smith, SME; Rajan, S; Morgan, D; Cherny, VV; DeCoursey, TE				Musset, Boris; Smith, Susan M. E.; Rajan, Sindhu; Morgan, Deri; Cherny, Vladimir V.; DeCoursey, Thomas E.			Aspartate 112 is the selectivity filter of the human voltage-gated proton channel	NATURE			English	Article							INFLUENZA-A VIRUS; ALVEOLAR EPITHELIAL-CELLS; HUMAN-NEUTROPHILS; NADPH OXIDASE; ION-CHANNEL; H+ CURRENTS; TRANSPORT; PERMEATION; SENSOR; PORE	The ion selectivity of pumps and channels is central to their ability to perform a multitude of functions. Here we investigate the mechanism of the extraordinary selectivity of the human voltage-gated proton channel(1), H(V)1 (also known as HVCN1). This selectivity is essential to its ability to regulate reactive oxygen species production by leukocytes(2-4), histamine secretion by basophils(5), sperm capacitation(6), and airway pH(7). The most selective ion channel known, H(V)1 shows no detectable permeability to other ions(1). Opposing classes of selectivity mechanisms postulate that (1) a titratable amino acid residue in the permeation pathway imparts proton selectivity(1,8-11), or (2) water molecules 'frozen' in a narrow pore conduct protons while excluding other ions(12). Here we identify aspartate 112 as a crucial component of the selectivity filter of H(V)1. When a neutral amino acid replaced Asp 112, the mutant channel lost proton specificity and became anion-selective or did not conduct. Only the glutamate mutant remained proton-specific. Mutation of the nearby Asp 185 did not impair proton selectivity, indicating that Asp 112 has a unique role. Although histidine shuttles protons in other proteins, when histidine or lysine replaced Asp 112, the mutant channel was still anion-permeable. Evidently, the proton specificity of H(V)1 requires an acidic group at the selectivity filter.	[Musset, Boris; Morgan, Deri; Cherny, Vladimir V.; DeCoursey, Thomas E.] Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA; [Smith, Susan M. E.] Emory Sch Med, Dept Pathol, Atlanta, GA 30322 USA; [Rajan, Sindhu] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Rush University; Emory University; University of Chicago	DeCoursey, TE (corresponding author), Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.	tdecours@rush.edu	Musset, Boris/J-2520-2013; DeCoursey, Thomas/A-6820-2009; Musset, Boris/AAD-4158-2022	Musset, Boris/0000-0001-8242-8817; DeCoursey, Thomas/0000-0002-4263-180X; Musset, Boris/0000-0001-8242-8817	NSF [MCB-0943362]; NIH [GM087507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087507] Funding Source: NIH RePORTER; Direct For Biological Sciences [0943362] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. H. Barry, D. Gillespie, V. S. Markin, J. F. Nagle, R. Pomes, D. Silverman and V. Sokolov for discussions or comments on the manuscript. Supported by NSF grant MCB-0943362 (S. M. E. S. and T. E. D.) and NIH grant GM087507 (T. E. D.). The content is solely the responsibility of the authors and does not necessarily represent the views of the National Institute of General Medical Sciences or the National Institutes of Health.	Acharya R, 2010, P NATL ACAD SCI USA, V107, P15075, DOI 10.1073/pnas.1007071107; Barry PH, 2006, CELL BIOCHEM BIOPHYS, V46, P143, DOI 10.1385/CBB:46:2:143; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 1997, J GEN PHYSIOL, V109, P415, DOI 10.1085/jgp.109.4.415; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; FELSENSTEIN J, 1993, PROTPARS PROTEIN SEQ; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; Hu FH, 2010, SCIENCE, V330, P505, DOI 10.1126/science.1191714; Iovannisci D, 2010, J GEN PHYSIOL, V136, P35, DOI 10.1085/jgp.200910379; Leiding T, 2010, P NATL ACAD SCI USA, V107, P15409, DOI 10.1073/pnas.1009997107; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LEVITT DG, 1978, BIOCHIM BIOPHYS ACTA, V512, P436, DOI 10.1016/0005-2736(78)90266-3; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; Musset B, 2008, P NATL ACAD SCI USA, V105, P11020, DOI 10.1073/pnas.0800886105; Musset B, 2010, J PHYSIOL-LONDON, V588, P1435, DOI 10.1113/jphysiol.2010.188318; NAGLE JF, 1978, P NATL ACAD SCI USA, V75, P298, DOI 10.1073/pnas.75.1.298; Nelson R D, 1999, J Mol Microbiol Biotechnol, V1, P281; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ramsey IS, 2010, NAT STRUCT MOL BIOL, V17, P869, DOI 10.1038/nsmb.1826; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sansom MSP, 1997, VIROLOGY, V233, P163, DOI 10.1006/viro.1997.8578; Sokolov S, 2010, J GEN PHYSIOL, V136, P225, DOI 10.1085/jgp.201010414; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Starace DM, 2001, J GEN PHYSIOL, V117, P469, DOI 10.1085/jgp.117.5.469; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TU CK, 1989, BIOCHEMISTRY-US, V28, P7913, DOI 10.1021/bi00445a054; Venkataraman P, 2005, J BIOL CHEM, V280, P21463, DOI 10.1074/jbc.M412406200	37	123	125	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					273	U167		10.1038/nature10557	http://dx.doi.org/10.1038/nature10557			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22020278	Green Accepted			2022-12-24	WOS:000297744200058
J	Treusch, S; Hamamichi, S; Goodman, JL; Matlack, KES; Chung, CY; Baru, V; Shulman, JM; Parrado, A; Bevis, BJ; Valastyan, JS; Han, H; Lindhagen-Persson, M; Reiman, EM; Evans, DA; Bennett, DA; Olofsson, A; DeJager, PL; Tanzi, RE; Caldwell, KA; Caldwell, GA; Lindquist, S				Treusch, Sebastian; Hamamichi, Shusei; Goodman, Jessica L.; Matlack, Kent E. S.; Chung, Chee Yeun; Baru, Valeriya; Shulman, Joshua M.; Parrado, Antonio; Bevis, Brooke J.; Valastyan, Julie S.; Han, Haesun; Lindhagen-Persson, Malin; Reiman, Eric M.; Evans, Denis A.; Bennett, David A.; Olofsson, Anders; DeJager, Philip L.; Tanzi, Rudolph E.; Caldwell, Kim A.; Caldwell, Guy A.; Lindquist, Susan			Functional Links Between A beta Toxicity, Endocytic Trafficking, and Alzheimer's Disease Risk Factors in Yeast	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; IDENTIFIES VARIANTS; COMMON VARIANTS; PEPTIDE; OLIGOMERS; MEMBRANE; CELLS	A beta (beta-amyloid peptide) is an important contributor to Alzheimer's disease (AD). We modeled A beta toxicity in yeast by directing the peptide to the secretory pathway. A genome-wide screen for toxicity modifiers identified the yeast homolog of phosphatidylinositol binding clathrin assembly protein (PICALM) and other endocytic factors connected to AD whose relationship to A beta was previously unknown. The factors identified in yeast modified A beta toxicity in glutamatergic neurons of Caenorhabditis elegans and in primary rat cortical neurons. In yeast, A beta impaired the endocytic trafficking of a plasma membrane receptor, which was ameliorated by endocytic pathway factors identified in the yeast screen. Thus, links between A beta, endocytosis, and human AD risk factors can be ascertained with yeast as a model system.	[Treusch, Sebastian; Hamamichi, Shusei; Goodman, Jessica L.; Matlack, Kent E. S.; Chung, Chee Yeun; Baru, Valeriya; Bevis, Brooke J.; Valastyan, Julie S.; Han, Haesun; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Treusch, Sebastian; Matlack, Kent E. S.; Baru, Valeriya; Valastyan, Julie S.; Lindquist, Susan] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Hamamichi, Shusei; Caldwell, Kim A.; Caldwell, Guy A.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Shulman, Joshua M.; DeJager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Neurol, Boston, MA 02115 USA; [Shulman, Joshua M.; DeJager, Philip L.] Brigham & Womens Hosp, Inst Neurosci, Program Translat NeuroPsychiat Genom, Dept Psychiat, Boston, MA 02115 USA; [Valastyan, Julie S.; DeJager, Philip L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Shulman, Joshua M.; DeJager, Philip L.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Parrado, Antonio; Tanzi, Rudolph E.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [Lindhagen-Persson, Malin; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Reiman, Eric M.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; [Reiman, Eric M.] Arizona Alzheimers Consortium, Phoenix, AZ 85004 USA; [Reiman, Eric M.] Univ Arizona, Banner Alzheimers Inst, Phoenix, AZ 85006 USA; [Reiman, Eric M.] Univ Arizona, Dept Psychiat, Phoenix, AZ 85006 USA; [Evans, Denis A.] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Alabama System; University of Alabama Tuscaloosa; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Umea University; Translational Genomics Research Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Arizona; University of Arizona; Rush University; Rush University	Lindquist, S (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Caldwell, Guy/0000-0002-8283-9090; Caldwell, Kim/0000-0003-1580-6122	Howard Hughes Medical Institute; National Research Service Award fellowship [F32 NS067782-02]; Cure Alzheimer's Fund; NIH [K08AG034290, P30AG10161, R01AG15819, R01AG17917]; Kempe foundation; Alzheimerfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS067782] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015819, P30AG019610, K08AG034290, P30AG010161, R01AG017917] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure Alzheimer's Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kempe foundation; Alzheimerfonden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank L. Chibnik, B. Keenan, and D. Ng for helpful discussions; D. Wittrup, V. Lee, M. Vidal, and C. Link for materials; and J. Corneveaux, M. Huentelman, and other Translational Genomics investigators for assistance with the human study cohorts and participants in the Religious Orders Study and the Rush Memory and Aging Project. This work was supported by a Howard Hughes Medical Institute Collaborative Innovation Award; National Research Service Award fellowship F32 NS067782-02; the Cure Alzheimer's Fund; NIH grants K08AG034290, P30AG10161, R01AG15819, and R01AG17917; the Kempe foundation; and Alzheimerfonden. This paper is dedicated to Nell Matheney, Zhao Xindi, Rochelle Glatt, Matyas Topolszki, their families, and the countless other victims of Alzheimer's disease.	Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Blacker D, 1997, NEUROLOGY, V48, P139, DOI 10.1212/WNL.48.1.139; Bozyczko-Coyne D, 2001, J NEUROCHEM, V77, P849, DOI 10.1046/j.1471-4159.2001.00294.x; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Gaidos G, 2007, J CELL SCI, V120, P2366, DOI 10.1242/jcs.004333; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; LaFerla FM, 2010, BIOCHEM SOC T, V38, P993, DOI 10.1042/BST0380993; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Maldonado-Baez L, 2008, MOL BIOL CELL, V19, P2936, DOI 10.1091/mbc.E07-10-1019; Minano-Molina AJ, 2011, J BIOL CHEM, V286, P27311, DOI 10.1074/jbc.M111.227504; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245; Qiang L, 2011, CELL, V146, P359, DOI 10.1016/j.cell.2011.07.007; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Stamenova SD, 2004, J BIOL CHEM, V279, P16017, DOI 10.1074/jbc.M313479200; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Thayanidhi N, 2010, MOL BIOL CELL, V21, P1850, DOI 10.1091/mbc.E09-09-0801; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Winslow AR, 2010, J CELL BIOL, V190, P1023, DOI 10.1083/jcb.201003122	42	265	274	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1241	1245		10.1126/science.1213210	http://dx.doi.org/10.1126/science.1213210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22033521	Green Submitted, Green Accepted			2022-12-24	WOS:000297553600041
J	Ramsden, S; Richardson, FM; Josse, G; Thomas, MSC; Ellis, C; Shakeshaft, C; Seghier, ML; Price, CJ				Ramsden, Sue; Richardson, Fiona M.; Josse, Goulven; Thomas, Michael S. C.; Ellis, Caroline; Shakeshaft, Clare; Seghier, Mohamed L.; Price, Cathy J.			Verbal and non-verbal intelligence changes in the teenage brain	NATURE			English	Article							PREFRONTAL CORTEX; CEREBELLUM; CHILDREN; ACQUISITION; CHILDHOOD; ABILITY; FMRI	Intelligence quotient (IQ) is a standardized measure of human intellectual capacity that takes into account a wide range of cognitive skills(1). IQ is generally considered to be stable across the lifespan, with scores at one time point used to predict educational achievement and employment prospects in later years(1). Neuroimaging allows us to test whether unexpected longitudinal fluctuations in measured IQ are related to brain development. Here we show that verbal and non-verbal IQ can rise or fall in the teenage years, with these changes in performance validated by their close correlation with changes in local brain structure. A combination of structural and functional imaging showed that verbal IQ changed with grey matter in a region that was activated by speech, whereas non-verbal IQ changed with grey matter in a region that was activated by finger movements. By using longitudinal assessments of the same individuals, we obviated the many sources of variation in brain structure that confound cross-sectional studies. This allowed us to dissociate neural markers for the two types of IQ and to show that general verbal and non-verbal abilities are closely linked to the sensorimotor skills involved in learning. More generally, our results emphasize the possibility that an individual's intellectual capacity relative to their peers can decrease or increase in the teenage years. This would be encouraging to those whose intellectual potential may improve, and would be a warning that early achievers may not maintain their potential.	[Ramsden, Sue; Richardson, Fiona M.; Josse, Goulven; Ellis, Caroline; Shakeshaft, Clare; Seghier, Mohamed L.; Price, Cathy J.] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England; [Thomas, Michael S. C.] Univ London, Birkbeck Coll, Dept Psychol Sci, Dev Neurocognit Lab, London WC1E 7HX, England	University of London; University College London; University of London; Birkbeck University London	Price, CJ (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England.	c.price@fil.ion.ucl.ac.uk	Seghier, Mohamed/O-8634-2019; Seghier, Mohamed L/C-6314-2009	Seghier, Mohamed/0000-0002-1146-8800; Seghier, Mohamed L/0000-0002-1146-8800; Price, Catherine/0000-0001-7448-4835; Thomas, Michael/0000-0002-8231-6011	Wellcome Trust; Medical Research Council [G0300188] Funding Source: researchfish; MRC [G0300188] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Wellcome Trust. We thank J. Glensman, A. Brennan, A. Peters, L. Stewart, K. Pitcher and R. Rutherford for their help with data collection; and W. Penny for his advice on statistical analyses.	Camara WJ, 2000, PROF PSYCHOL-RES PR, V31, P141, DOI 10.1037/0735-7028.31.2.141; Colom Roberto, 2010, Dialogues Clin Neurosci, V12, P489; Davis AS, 2009, ARCH CLIN NEUROPSYCH, V24, P273, DOI 10.1093/arclin/acp032; Davis EE, 2010, CORTEX, V46, P919, DOI 10.1016/j.cortex.2009.10.001; Deary IJ, 2000, INTELLIGENCE, V28, P49, DOI 10.1016/S0160-2896(99)00031-8; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Eckert MA, 2006, NEUROIMAGE, V32, P1001, DOI 10.1016/j.neuroimage.2006.05.014; Gong QY, 2005, NEUROIMAGE, V25, P1175, DOI 10.1016/j.neuroimage.2004.12.044; Haier RJ, 2004, NEUROIMAGE, V23, P425, DOI 10.1016/j.neuroimage.2004.04.025; Huang J, 2002, HUM BRAIN MAPP, V15, P39, DOI 10.1002/hbm.1060; JONES OP, 2011, CEREB CORTEX    0624; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; KAUFMAN A, 2006, ASSESSING ADOLESCENT, P209; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; MCCALL RB, 1977, SCIENCE, V197, P482, DOI 10.1126/science.197.4302.482; Nitschke MF, 1996, BRAIN, V119, P1023; Pangelinan MM, 2011, NEUROIMAGE, V54, P3093, DOI 10.1016/j.neuroimage.2010.11.021; Richardson FM, 2010, J COGNITIVE NEUROSCI, V22, P943, DOI 10.1162/jocn.2009.21238; Rosenbaum DA, 2001, ANNU REV PSYCHOL, V52, P453, DOI 10.1146/annurev.psych.52.1.453; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Seghier ML, 2009, NEUROIMAGE, V45, P349, DOI 10.1016/j.neuroimage.2008.12.017; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Stoodley CJ, 2010, BEHAV NEUROL, V23, P65, DOI [10.3233/BEN-2010-0268, 10.1155/2010/840942]; Wassenberg R, 2005, CHILD DEV, V76, P1092, DOI 10.1111/j.1467-8624.2005.00899.x; Wilke M, 2003, NEUROIMAGE, V20, P202, DOI 10.1016/S1053-8119(03)00199-X	25	125	125	4	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 3	2011	479	7371					113	116		10.1038/nature10514	http://dx.doi.org/10.1038/nature10514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	840FA	22012265	Green Accepted			2022-12-24	WOS:000296422600042
J	Shakya, R; Reid, LJ; Reczek, CR; Cole, F; Egli, D; Lin, CS; deRooij, DG; Hirsch, S; Ravi, K; Hicks, JB; Szabolcs, M; Jasin, M; Baer, R; Ludwig, T				Shakya, Reena; Reid, Latarsha J.; Reczek, Colleen R.; Cole, Francesca; Egli, Dieter; Lin, Chyuan-Sheng; deRooij, Dirk G.; Hirsch, Steffen; Ravi, Kandasamy; Hicks, James B.; Szabolcs, Matthias; Jasin, Maria; Baer, Richard; Ludwig, Thomas			BRCA1 Tumor Suppression Depends on BRCT Phosphoprotein Binding, But Not Its E3 Ligase Activity	SCIENCE			English	Article							BREAST-CANCER; BRCA1/BARD1 HETERODIMER; STRUCTURAL BASIS; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; MICE; TUMORIGENESIS; MUTATION; COMPLEX; IDENTIFICATION	Germline mutations of the breast cancer 1 (BRCA1) gene are a major cause of familial breast and ovarian cancer. The BRCA1 protein displays E3 ubiquitin ligase activity, and this enzymatic function is thought to be required for tumor suppression. To test this hypothesis, we generated mice that express an enzymatically defective Brca1. We found that this mutant Brca1 prevents tumor formation to the same degree as does wild-type Brca1 in three different genetically engineered mouse (GEM) models of cancer. In contrast, a mutation that ablates phosphoprotein recognition by the BRCA C terminus (BRCT) domains of BRCA1 elicits tumors in each of the three GEM models. Thus, BRCT phosphoprotein recognition, but not the E3 ligase activity, is required for BRCA1 tumor suppression.	[Shakya, Reena; Reid, Latarsha J.; Reczek, Colleen R.; Hirsch, Steffen; Baer, Richard; Ludwig, Thomas] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Shakya, Reena; Reid, Latarsha J.; Lin, Chyuan-Sheng; Hirsch, Steffen; Szabolcs, Matthias; Baer, Richard; Ludwig, Thomas] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Reczek, Colleen R.] Columbia Univ, Dept Nutr & Metab Biol, New York, NY 10032 USA; [Cole, Francesca; Jasin, Maria] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10021 USA; [Egli, Dieter] NYSCF, New York, NY 10032 USA; [deRooij, Dirk G.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Ravi, Kandasamy; Hicks, James B.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Szabolcs, Matthias; Baer, Richard; Ludwig, Thomas] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Memorial Sloan Kettering Cancer Center; The New York Stem Cell Foundation; University of Amsterdam; Academic Medical Center Amsterdam; Cold Spring Harbor Laboratory; Columbia University	Baer, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	rb670@columbia.edu; tl54@columbia.edu	Ludwig, Thomas/Q-6484-2016; de Rooij, D.G./AAW-1195-2021	Ludwig, Thomas/0000-0003-3461-2585; Cole, Francesca/0000-0001-6391-2363	NIH [R01-CA137023, P01-CA97403, R01-HD40916]; Susan G. Komen Breast Cancer fellowship; Kirschstein National Research Service [F31-CA132626, F32-HD51392]; National Cancer Institute [T32-CA09503]; U.S. Department of Defense (DOD) [BC083089]; DOD [W81XWH04-1-0477]; Breast Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040916, F32HD051392] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA097403, F31CA132626, T32CA009503, R01CA137023] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer fellowship(Susan G. Komen Breast Cancer Foundation); Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense (DOD)(United States Department of Defense); DOD(United States Department of Defense); Breast Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank X. Sun for technical assistance, V. Murty for advice, M. Wigler for discussions and encouragement, and NYSCF for access to the confocal microscope. This work was supported by NIH grants R01-CA137023 (R.B. and T.L.), P01-CA97403 (R.B. and T.L.), and R01-HD40916 (M.J.). R.S. was supported by a Susan G. Komen Breast Cancer fellowship, L.J.R. by a Kirschstein National Research Service Award fellowship (F31-CA132626), C.R.R. by fellowships from the National Cancer Institute (T32-CA09503) and U.S. Department of Defense (DOD) (BC083089), and F.C. by a Kirschstein National Research Service Award fellowship (F32-HD51392). K.R. and J.B.H. were supported by grants to M. Wigler and J.B.H. from DOD (W81XWH04-1-0477) and the Breast Cancer Research Foundation. Microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus (GEO) with GEO Series accession number GSE31673.	Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Coene ED, 2011, J CELL BIOL, V192, P497, DOI 10.1083/jcb.201004136; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Ludwig T, 2001, GENE DEV, V15, P1188, DOI 10.1101/gad.879201; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Sankaran S, 2006, CANCER RES, V66, P4100, DOI 10.1158/0008-5472.CAN-05-4430; Shakya R, 2008, P NATL ACAD SCI USA, V105, P7040, DOI 10.1073/pnas.0711032105; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Varma AK, 2005, BIOCHEMISTRY-US, V44, P10941, DOI 10.1021/bi0509651; Wijnhoven SWP, 2005, CANCER RES, V65, P8166, DOI 10.1158/0008-5472.CAN-05-1650; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Wu WW, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-1; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu XC, 2006, GENE DEV, V20, P1721, DOI 10.1101/gad.1431006	28	173	177	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 28	2011	334	6055					525	528		10.1126/science.1209909	http://dx.doi.org/10.1126/science.1209909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034435	Green Accepted			2022-12-24	WOS:000296230500050
J	Grotjohann, T; Testa, I; Leutenegger, M; Bock, H; Urban, NT; Lavoie-Cardinal, F; Willig, KI; Eggeling, C; Jakobs, S; Hell, SW				Grotjohann, Tim; Testa, Ilaria; Leutenegger, Marcel; Bock, Hannes; Urban, Nicolai T.; Lavoie-Cardinal, Flavie; Willig, Katrin I.; Eggeling, Christian; Jakobs, Stefan; Hell, Stefan W.			Diffraction-unlimited all-optical imaging and writing with a photochromic GFP	NATURE			English	Article							GREEN FLUORESCENT PROTEIN; STIMULATED-EMISSION; RESOLUTION BARRIER; DENDRITIC SPINES; STRUCTURAL BASIS; MICROSCOPY; NANOSCOPY; BREAKING; LIGHT; DEPLETION	Lens-based optical microscopy failed to discern fluorescent features closer than 200 nm for decades, but the recent breaking of the diffraction resolution barrier by sequentially switching the fluorescence capability of adjacent features on and off is making nanoscale imaging routine. Reported fluorescence nanoscopy variants switch these features either with intense beams at defined positions or randomly, molecule by molecule. Here we demonstrate an optical nanoscopy that records raw data images from living cells and tissues with low levels of light. This advance has been facilitated by the generation of reversibly switchable enhanced green fluorescent protein (rsEGFP), a fluorescent protein that can be reversibly photoswitched more than a thousand times. Distributions of functional rsEGFP-fusion proteins in living bacteria and mammalian cells are imaged at <40-nanometre resolution. Dendritic spines in living brain slices are super-resolved with about a million times lower light intensities than before. The reversible switching also enables all-optical writing of features with subdiffraction size and spacings, which can be used for data storage.	[Grotjohann, Tim; Testa, Ilaria; Leutenegger, Marcel; Bock, Hannes; Urban, Nicolai T.; Lavoie-Cardinal, Flavie; Willig, Katrin I.; Eggeling, Christian; Jakobs, Stefan; Hell, Stefan W.] Max Planck Inst Biophys Chem, Dept NanoBiophoton, D-37077 Gottingen, Germany; [Jakobs, Stefan] Univ Gottingen, Sch Med, D-37075 Gottingen, Germany	Max Planck Society; University of Gottingen	Jakobs, S (corresponding author), Max Planck Inst Biophys Chem, Dept NanoBiophoton, Fassberg 11, D-37077 Gottingen, Germany.	sjakobs@gwdg.de; shell@gwdg.de	Willig, Katrin/AAH-5418-2020; Jakobs, Stefan/F-4898-2012	Willig, Katrin/0000-0002-1860-334X; Jakobs, Stefan/0000-0002-8028-3121; Testa, Ilaria/0000-0003-4005-4997; Urban, Nicolai/0000-0001-7643-9755	Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center for Molecular Physiology of the Brain; DFG	Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center for Molecular Physiology of the Brain(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We thank J. Jethwa for careful reading and M. Andresen, T. Brakemann, S. Lobermann, R. Schmitz-Salue and A. C. Stiel for discussions and support, as well as T. Gilat and F. Voss (MPI of Neurobiology, Munich) for help with the slice culture preparation and A. Schonle for adapting the software Imspector. We thank The Project Gutenberg for making Grimm's Fairy Tales available in electronic format, L. Rothfield (University of Connecticut Health Center) for providing the plasmid pLE7, R. Wedlich-Soldner (MPI of Biochemistry, Munich) for the lifeact-YFP construct and V. Stein (MPI of Neurobiology, Munich) for the virus protocol. This work was supported by the Deutsche Forschungsgemeinschaft (DFG) through the DFG-Research Center for Molecular Physiology of the Brain (to S. J.) and by a Gottfried-Wilhelm-Leibniz prize of the DFG (to S.W.H.).	Adam V, 2010, J BIOTECHNOL, V149, P289, DOI 10.1016/j.jbiotec.2010.04.001; Adam V, 2008, P NATL ACAD SCI USA, V105, P18343, DOI 10.1073/pnas.0805949105; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Andresen M, 2007, P NATL ACAD SCI USA, V104, P13005, DOI 10.1073/pnas.0700629104; Andrew TL, 2009, SCIENCE, V324, P917, DOI 10.1126/science.1167704; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bizzarri R, 2010, J AM CHEM SOC, V132, P85, DOI 10.1021/ja9014953; Bossi M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/11/275; Brakemann T, 2010, J BIOL CHEM, V285, P14603, DOI 10.1074/jbc.M109.086314; Dedecker P, 2007, J AM CHEM SOC, V129, P16132, DOI 10.1021/ja076128z; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Fischer J, 2010, ADV MATER, V22, P3578, DOI 10.1002/adma.201000892; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Hein B, 2008, P NATL ACAD SCI USA, V105, P14271, DOI 10.1073/pnas.0807705105; Heintzmann R, 2002, J OPT SOC AM A, V19, P1599, DOI 10.1364/JOSAA.19.001599; Hell S.W., 1997, T FLUOR SP, P361; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Hell SW, 2009, NAT PHOTONICS, V3, P381, DOI 10.1038/NPHOTON.2009.112; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; Hell SW, 2004, CURR OPIN NEUROBIOL, V14, P599, DOI 10.1016/j.conb.2004.08.015; Hell SW, 2004, PHYS LETT A, V326, P140, DOI 10.1016/j.physleta.2004.03.082; Hell SW, 2003, NAT BIOTECHNOL, V21, P1347, DOI 10.1038/nbt895; Hell SW, 2003, APPL PHYS A-MATER, V77, P859, DOI 10.1007/s00339-003-2292-4; HELL SW, 1995, APPL PHYS B-LASERS O, V60, P495, DOI 10.1007/BF01081333; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henderson JN, 2007, P NATL ACAD SCI USA, V104, P6672, DOI 10.1073/pnas.0700059104; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Huang B, 2010, CELL, V143, P1047, DOI 10.1016/j.cell.2010.12.002; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Li LJ, 2009, SCIENCE, V324, P910, DOI 10.1126/science.1168996; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schwentker MA, 2007, MICROSC RES TECHNIQ, V70, P269, DOI 10.1002/jemt.20443; Scott TF, 2009, SCIENCE, V324, P913, DOI 10.1126/science.1167610; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vats P, 2007, P NATL ACAD SCI USA, V104, P17795, DOI 10.1073/pnas.0708739104; Westphal V, 2008, SCIENCE, V320, P246, DOI 10.1126/science.1154228; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	47	338	356	3	255	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					204	208		10.1038/nature10497	http://dx.doi.org/10.1038/nature10497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21909116				2022-12-24	WOS:000295782800041
J	Morse, RB; Hall, M; Fieldston, ES; McGwire, G; Anspacher, M; Sills, MR; Williams, K; Oyemwense, N; Mann, KJ; Simon, HK; Shah, SS				Morse, Rustin B.; Hall, Matthew; Fieldston, Evan S.; McGwire, Gerd; Anspacher, Melanie; Sills, Marion R.; Williams, Kristi; Oyemwense, Naomi; Mann, Keith J.; Simon, Harold K.; Shah, Samir S.			Hospital-Level Compliance With Asthma Care Quality Measures at Children's Hospitals and Subsequent Asthma-Related Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE-MEASURES; MORTALITY-RATES; HEART-FAILURE; US HOSPITALS; OF-CARE	Context The Children's Asthma Care (CAC) measure set evaluates whether children admitted to hospitals with asthma receive relievers (CAC-1) and systemic corticosteroids (CAC-2) and whether they are discharged with a home management plan of care (CAC-3). It is the only Joint Commission core measure applicable to evaluate the quality of care for hospitalized children. Objectives To evaluate longitudinal trends in CAC measure compliance and to determine if an association exists between compliance and outcomes. Design, Setting, and Patients Cross-sectional study using administrative data and CAC compliance data for 30 US children's hospitals. A total of 37 267 children admitted with asthma between January 1, 2008, and September 30, 2010, with follow-up through December 31, 2010, accounted for 45 499 hospital admissions. Hospital-level CAC measure compliance data were obtained from the National Association of Children's Hospitals and Related Institutions. Readmission and postdischarge emergency department (ED) utilization data were obtained from the Pediatric Health Information System. Main Outcome Measures Children's Asthma Care measure compliance trends; postdischarge ED utilization and asthma-related readmission rates at 7, 30, and 90 days. Results The minimum quarterly CAC-1 and CAC-2 measure compliance rates reported by any hospital were 97.1% and 89.5%, respectively. Individual hospital CAC-2 compliance exceeded 95% for 97.9% of the quarters. Lack of variability in CAC-1 and CAC-2 compliance precluded examination of their association with the specified outcomes. Mean CAC-3 compliance was 40.6% (95% CI, 34.1%-47.1%) and 72.9% (95% CI, 68.8%-76.9%) for the initial and final 3 quarters of the study, respectively. The mean 7-, 30-, and 90-day postdischarge ED utilization rates were 1.5% (95% CI, 1.3%-1.6%), 4.3% (95% CI, 4.0%-4.5%), and 11.1% (95% CI, 10.5%-11.7%) and the mean quarterly 7-, 30-, and 90-day readmission rates were 1.4% (95% CI, 1.2%-1.6%), 3.1% (95% CI, 2.8%-3.3%), and 7.6% (95% CI, 7.2%-8.1%). There was no significant association between overall CAC-3 compliance (odds ratio [OR] for 5% improvement in compliance) and post-discharge ED utilization rates at 7 days (OR, 1.00; 95% CI, 0.98-1.02), 30 days (OR, 0.97; 95% CI, 0.90-1.04), and 90 days (OR, 0.96; 95% CI, 0.77-1.18). In addition, there was no significant association between overall CAC-3 compliance (OR for 5% improvement in compliance) and readmission rates at 7 days (OR, 1.00; 95% CI, 0.99-1.02), 30 days (OR, 0.99; 95% CI, 0.96-1.02), and 90 days (OR, 1.01; 95% CI, 0.90-1.12). Conclusion Among children admitted to pediatric hospitals for asthma, there was high hospital-level compliance with CAC-1 and CAC-2 quality measures and moderate compliance with the CAC-3 measure but no association between CAC-3 compliance and subsequent ED visits and asthma-related readmissions. JAMA. 2011;306(13):1454-1460	[Morse, Rustin B.] Univ Arizona, Coll Med, Phoenix Childrens Hosp, Phoenix, AZ 85016 USA; [Hall, Matthew] Child Hlth Corp Amer, Shawnee Mission, KS USA; [Fieldston, Evan S.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [McGwire, Gerd] Ohio State Univ, Coll Med, Nationwide Childrens Hosp, Columbus, OH 43210 USA; [Anspacher, Melanie] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Sills, Marion R.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Aurora, CO USA; [Williams, Kristi; Mann, Keith J.] Univ Missouri Kansas City Sch Med, Childrens Mercy Hosp & Clin, Kansas City, KS USA; [Oyemwense, Naomi] Childrens Hosp, Boston, MA 02115 USA; [Simon, Harold K.] Emory Univ, Sch Med, Atlanta, GA USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	Phoenix Children's Hospital; University of Arizona; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Children's National Health System; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Mercy Hospital; Harvard University; Boston Children's Hospital; Emory University; Cincinnati Children's Hospital Medical Center	Morse, RB (corresponding author), Univ Arizona, Coll Med, Phoenix Childrens Hosp, 1919 E Thomas Rd, Phoenix, AZ 85016 USA.	rmorse@phoenixchildrens.com	McGwire, Gerd/E-3638-2011; Hall, Matt/AAT-1349-2021; Shah, Samir/B-2661-2015	Hall, Matt/0000-0001-7778-5887; Shah, Samir/0000-0001-7902-7000; Sills, Marion/0000-0003-1322-0822	Robert Wood Johnson Physician Faculty Scholars Program; Agency for Healthcare Research and Quality [R01 HS019862]; National Institute of Allergy and Infectious Diseases [K01 A173729]; Child Health Corporation of America	Robert Wood Johnson Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Child Health Corporation of America	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Shah's institution received money from the Robert Wood Johnson Physician Faculty Scholars Program and from grants R01 HS019862 from the Agency for Healthcare Research and Quality and K01 A173729 from the National Institute of Allergy and Infectious Diseases. Dr Shah's institution also receives funds from the Child Health Corporation of America for Dr Shah's role as Executive Council member of the Pediatric Research in Inpatient Settings Network, a research network affiliated with the Academic Pediatric Association, the American Academy of Pediatrics, and the Society of Hospital Medicine. Dr Sills has a grant or a grant pending from the Agency for Healthcare Research and Quality. No other disclosures were reported.	Agency for Healthcare research and Quality, UND QUAL MEAS; [Anonymous], SPEC MAN NAT HOSP IN; Bhogal S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005306.pub2; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Ducharme FM, 2011, AM J RESP CRIT CARE, V183, P195, DOI 10.1164/rccm.201001-0115OC; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Fonarow GC, 2009, JAMA-J AM MED ASSOC, V302, P792, DOI 10.1001/jama.2009.1180; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; *JOINT COMM, FACTS ORYX PERF MEAS; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Landon BE, 2006, ARCH INTERN MED, V166, P2511, DOI 10.1001/archinte.166.22.2511; Mongelluzzo J, 2008, JAMA-J AM MED ASSOC, V299, P2048, DOI 10.1001/jama.299.17.2048; *NAT ASS CHILDR HO, CHILDR ASTHM CAR CAC; National Quality Forum, NQF END STAND; Patterson ME, 2010, MED CARE, V48, P210, DOI 10.1097/MLR.0b013e3181ca3eb4; Shah SS, 2009, CLIN INFECT DIS, V49, P1369, DOI 10.1086/606048; The Joint Commission, CHILDR ASTHM CAR CAC; Toelle BG, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002171.PUB2; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	21	91	91	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 5	2011	306	13					1454	1460		10.1001/jama.2011.1385	http://dx.doi.org/10.1001/jama.2011.1385			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	828MZ	21972307	Bronze			2022-12-24	WOS:000295506900024
J	Nagalingum, NS; Marshall, CR; Quental, TB; Rai, HS; Little, DP; Mathews, S				Nagalingum, N. S.; Marshall, C. R.; Quental, T. B.; Rai, H. S.; Little, D. P.; Mathews, S.			Recent Synchronous Radiation of a Living Fossil	SCIENCE			English	Article							CERATOZAMIA ZAMIACEAE; EVOLUTION; CYCADS; POLLINATION; DIVERGENCE; PHYLOGENY; NUCLEAR; DNA	Modern survivors of previously more diverse lineages are regarded as living fossils, particularly when characterized by morphological stasis. Cycads are often cited as a classic example, reaching their greatest diversity during the Jurassic-Cretaceous (199.6 to 65.5 million years ago) then dwindling to their present diversity of similar to 300 species as flowering plants rose to dominance. Using fossil-calibrated molecular phylogenies, we show that cycads underwent a near synchronous global rediversification beginning in the late Miocene, followed by a slowdown toward the Recent. Although the cycad lineage is ancient, our timetrees indicate that living cycad species are not much older than similar to 12 million years. These data reject the hypothesized role of dinosaurs in generating extant diversity and the designation of today's cycad species as living fossils.	[Nagalingum, N. S.; Rai, H. S.; Mathews, S.] Arnold Arboretum Harvard Univ, Cambridge, MA 02138 USA; [Nagalingum, N. S.; Marshall, C. R.; Quental, T. B.] Univ Calif Berkeley, Univ Calif Museum Paleontol, Berkeley, CA 94720 USA; [Nagalingum, N. S.] Royal Bot Garden Sydney, Natl Herbarium New S Wales, Sydney, NSW 2000, Australia; [Quental, T. B.] Univ Sao Paulo, Dept Ecol, Sao Paulo, Brazil; [Rai, H. S.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Little, D. P.] New York Bot Garden, Cullman Program Mol Systemat, Bronx, NY 10458 USA	Harvard University; University of California System; University of California Berkeley; Universidade de Sao Paulo; Utah System of Higher Education; Utah State University; New York Botanical Garden	Nagalingum, NS (corresponding author), Arnold Arboretum Harvard Univ, 22 Divin Ave, Cambridge, MA 02138 USA.	nathalie.nagalingum@rbgsyd.nsw.gov.au; smathews@oeb.harvard.edu	Mathews, Sarah/A-6513-2015; Quental, Tiago B/C-7077-2013	Mathews, Sarah/0000-0002-5518-7541; 	NSF [EF-0629890]	NSF(National Science Foundation (NSF))	This work was supported by NSF's Assembling the Tree of Life program (grant EF-0629890 to S. M.). The data reported in this paper are tabulated in the supporting online material and archived in GenBank (JN655891 to JN656096) and TreeBase (11891). We thank M. Beilstein, M. Clements, and K. Schellenberg for discussions and technical assistance; A. Vo for help with cloning and sequencing; J. Hilton for information regarding fossil ages; S. Ho and M. Sanderson for advice on divergence time analyses; D. Stevenson for cycad tissue; and the reviewers for suggestions and comments.	Arakaki M, 2011, P NATL ACAD SCI USA, V108, P8379, DOI 10.1073/pnas.1100628108; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Butler RJ, 2009, BIOL REV, V84, P73, DOI 10.1111/j.1469-185X.2008.00065.x; C?lix M., 2018, EUROPEAN RED LIST SA; Chaw SM, 2005, MOL PHYLOGENET EVOL, V37, P214, DOI 10.1016/j.ympev.2005.01.006; Cibrian-Jaramillo A, 2010, MOL ECOL, V19, P2364, DOI 10.1111/j.1365-294X.2010.04638.x; Cooper A, 1998, TRENDS ECOL EVOL, V13, P151, DOI 10.1016/S0169-5347(97)01277-9; Crane P. R., 1987, ORIGIN ANGIOSPERMS T, P207; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; Crisp MD, 2009, EVOLUTION, V63, P2257, DOI 10.1111/j.1558-5646.2009.00728.x; Downie DA, 2008, MOL PHYLOGENET EVOL, V47, P102, DOI 10.1016/j.ympev.2008.01.023; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gonzalez D, 2002, SYST BOT, V27, P654; Hill KD, 2003, INT J PLANT SCI, V164, P933, DOI 10.1086/378538; HILL KD, 2007, MEMOIRS NEW YORK BOT, V97, P454; Ickert-Bond SM, 2009, J SYST EVOL, V47, P444, DOI 10.1111/j.1759-6831.2009.00053.x; Jones, 2002, CYCADS WORLD ANCIENT; Lohne C, 2008, TAXON, V57, P1123, DOI 10.1002/tax.574008; Mustoe G, 2007, CYCAD NEWSLETTER, V65, P6; Nicolalde-Morejon F, 2009, BRITTONIA, V61, P301, DOI 10.1007/s12228-009-9077-9; NORSTOG K, 1997, BIOL CYCADS; NORSTOG KJ, 1986, BIOTROPICA, V18, P300, DOI 10.2307/2388573; Potter PE, 2009, EARTH-SCI REV, V96, P279, DOI 10.1016/j.earscirev.2009.07.003; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Schneider D, 2002, NATURWISSENSCHAFTEN, V89, P281, DOI 10.1007/s00114-002-0330-2; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; Terry I, 2008, AUST J BOT, V56, P321, DOI 10.1071/BT06202; Terry I, 2007, SCIENCE, V318, P70, DOI 10.1126/science.1145147; Treutlein J, 2002, NATURWISSENSCHAFTEN, V89, P221, DOI 10.1007/s00114-002-0308-0; van der Bank H, 2001, BIOCHEM SYST ECOL, V29, P241, DOI 10.1016/S0305-1978(00)00064-8; Vovides A., 2003, CURR TOPICS PLANT BI, V4, P159; Vovides AP, 2008, BOT J LINN SOC, V157, P169, DOI 10.1111/j.1095-8339.2008.00793.x; Watson J., 2005, MONOGR PALAEONTOGR S, V622, P189; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zgurski JM, 2008, MOL PHYLOGENET EVOL, V47, P1232, DOI 10.1016/j.ympev.2008.03.002; Zhang Q, 2011, J SYST EVOL, V49, P315, DOI 10.1111/j.1759-6831.2011.00129.x	40	247	259	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					796	799		10.1126/science.1209926	http://dx.doi.org/10.1126/science.1209926			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22021670				2022-12-24	WOS:000296849600044
J	Ding, BS; Nolan, DJ; Guo, PP; Babazadeh, AO; Cao, ZW; Rosenwaks, Z; Crystal, RG; Simons, M; Sato, TN; Worgall, S; Shido, K; Rabbany, SY; Rafii, S				Ding, Bi-Sen; Nolan, Daniel J.; Guo, Peipei; Babazadeh, Alexander O.; Cao, Zhongwei; Rosenwaks, Zev; Crystal, Ronald G.; Simons, Michael; Sato, Thomas N.; Worgall, Stefan; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin			Endothelial-Derived Angiocrine Signals Induce and Sustain Regenerative Lung Alveolarization	CELL			English	Article							MATRIX METALLOPROTEINASES; GROWTH-FACTOR; PROGENITOR CELLS; VASCULAR NICHE; SELF-RENEWAL; CROSS-TALK; VEGF-A; REPAIR; MAINTENANCE; EXPRESSION	To identify pathways involved in adult lung regeneration, we employ a unilateral pneumonectomy (PNX) model that promotes regenerative alveolarization in the remaining intact lung. We show that PNX stimulates pulmonary capillary endothelial cells (PCECs) to produce angiocrine growth factors that induce proliferation of epithelial progenitor cells supporting alveologenesis. Endothelial cells trigger expansion of cocultured epithelial cells, forming three-dimensional angiospheres reminiscent of alveolar-capillary sacs. After PNX, endothelial-specific inducible genetic ablation of Vegfr2 and Fgfr1 in mice inhibits production of MMP14, impairing alveolarization. MMP14 promotes expansion of epithelial progenitor cells by unmasking cryptic EGF-like ectodomains that activate the EGF receptor (EGFR). Consistent with this, neutralization of MMP14 impairs EGFR-mediated alveolar regeneration, whereas administration of EGF or intravascular transplantation of MMP14(+) PCECs into pneumonectomized Vegfr2/Fgfr1-deficient mice restores alveologenesis and lung inspiratory volume and compliance function. VEGFR2 and FGFR1 activation in PCECs therefore increases MMP14-dependent bioavailability of EGFR ligands to initiate and sustain alveologenesis.	[Ding, Bi-Sen; Nolan, Daniel J.; Guo, Peipei; Babazadeh, Alexander O.; Cao, Zhongwei; Crystal, Ronald G.; Worgall, Stefan; Shido, Koji; Rabbany, Sina Y.; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA; [Rosenwaks, Zev] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Simons, Michael] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Sato, Thomas N.] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [Rabbany, Sina Y.] Hofstra Univ, Bioengn Program, Hempstead, NY 11549 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Yale University; Nara Institute of Science & Technology; Hofstra University	Rafii, S (corresponding author), Weill Cornell Med Coll, Dept Med Genet, Ansary Stem Cell Inst, Howard Hughes Med Inst, New York, NY 10065 USA.	srafii@med.cornell.edu	Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	Ansary Stem Cell Institute; Howard Hughes Medical Institute; Empire State Stem Cell Board and New York State Department of Health [NYSTEM, C024180, C026438, C026878]; National Heart Lung and Blood Institute; Qatar National Priorities Research Foundation [NPRP08-663-3-140]; Anbinder and Newmans Own Foundation; Takeda Science Foundation; Uehara Memorial Foundation; JSPS;  [R01HL53793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101846, R01HL097797, R01HL053793, P50HL084936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Ansary Stem Cell Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Empire State Stem Cell Board and New York State Department of Health; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities Research Foundation; Anbinder and Newmans Own Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	B.-S.D. is a Druckenmiller Fellow of New York Stem Cell Foundation. S. R. is supported by Ansary Stem Cell Institute; Howard Hughes Medical Institute; Empire State Stem Cell Board and New York State Department of Health grants (NYSTEM, C024180, C026438, C026878); National Heart Lung and Blood Institute; Qatar National Priorities Research Foundation NPRP08-663-3-140; and Anbinder and Newmans Own Foundation. T.N.S. is supported by Takeda Science Foundation, Uehara Memorial Foundation, JSPS (Kiban S). M. S. is supported by R01HL53793. VE-Cad-CreERT2 mice were gift from Dr. Ralf H. Adams (Max Planck Institute). SPC/CCSP-rtTA and (tetO)-cre mice were provided by Drs. Jeffrey A. Whitsett and Anne-Karina T. Perl (Cincinnati Children's Hospital Medical Centre). Fgfr1<SUP>loxP/loxP</SUP> mice were offered by Drs. Michael Simons and Masahiro Murakami (Yale University). The authors are grateful to Ms. Biin Sung for assistance in lung mechanics measurement.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alvarez DF, 2008, AM J PHYSIOL-LUNG C, V294, pL419, DOI 10.1152/ajplung.00314.2007; Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; BEERS MF, 1994, J BIOL CHEM, V269, P20318; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Bhattacharya J, 2005, CHEST, V128, p553S, DOI 10.1016/S0012-3692(15)30979-X; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chapman HA, 2011, ANNU REV PHYSIOL, V73, P413, DOI 10.1146/annurev-physiol-012110-142225; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; COWAN MJ, 1975, AM REV RESPIR DIS, V111, P267; Del Moral PM, 2006, DEV BIOL, V290, P177, DOI 10.1016/j.ydbio.2005.11.022; DeLisser HM, 2006, J BIOL CHEM, V281, P8724, DOI 10.1074/jbc.M511798200; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Giordano RJ, 2008, J BIOL CHEM, V283, P29447, DOI 10.1074/jbc.M804595200; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Irie Kazuharu, 2005, Medical Molecular Morphology, V38, P43, DOI 10.1007/s00795-004-0277-9; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Koshikawa N, 2010, CANCER RES, V70, P6093, DOI 10.1158/0008-5472.CAN-10-0346; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Leuwerke SM, 2002, AM J PHYSIOL-LUNG C, V282, pL1272, DOI 10.1152/ajplung.00490.2001; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Liu YR, 2011, J EXP MED, V208, P1473, DOI 10.1084/jem.20102041; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morris DG, 2003, NATURE, V422, P169, DOI 10.1038/nature01413; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; Nolen-Walston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL1158, DOI 10.1152/ajplung.00298.2007; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Petersen TH, 2010, SCIENCE, V329, P538, DOI 10.1126/science.1189345; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Ruoslahti E, 2000, ANNU REV IMMUNOL, V18, P813, DOI 10.1146/annurev.immunol.18.1.813; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Shu WG, 2002, DEVELOPMENT, V129, P4831; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; VAPORCIYAN AA, 1993, SCIENCE, V262, P1580, DOI 10.1126/science.8248808; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; White AC, 2007, DEVELOPMENT, V134, P3743, DOI 10.1242/dev.004879; Whitsett JA, 2010, ANNU REV MED, V61, P105, DOI 10.1146/annurev.med.60.041807.123500; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157	68	327	342	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					539	553		10.1016/j.cell.2011.10.003	http://dx.doi.org/10.1016/j.cell.2011.10.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036563	Green Accepted, Bronze			2022-12-24	WOS:000296573700010
J	Yun, BW; Feechan, A; Yin, MH; Saidi, NBB; Le Bihan, T; Yu, M; Moore, JW; Kang, JG; Kwon, E; Spoel, SH; Pallas, JA; Loake, GJ				Yun, Byung-Wook; Feechan, Angela; Yin, Minghui; Saidi, Noor B. B.; Le Bihan, Thierry; Yu, Manda; Moore, John W.; Kang, Jeong-Gu; Kwon, Eunjung; Spoel, Steven H.; Pallas, Jacqueline A.; Loake, Gary J.			S-nitrosylation of NADPH oxidase regulates cell death in plant immunity	NATURE			English	Article							NITRIC-OXIDE; DISEASE-RESISTANCE; SALICYLIC-ACID; HYPERSENSITIVE RESPONSE; SUPEROXIDE-PRODUCTION; ARABIDOPSIS-THALIANA; STRUCTURE PREDICTION; DEFENSE; TOBACCO; GENE	Changes in redox status are a conspicuous feature of immune responses in a variety of eukaryotes(1,2), but the associated signalling mechanisms are not well understood. In plants, attempted microbial infection triggers the rapid synthesis of nitric oxide(3,4) and a parallel accumulation of reactive oxygen intermediates, the latter generated by NADPH oxidases related to those responsible for the pathogen-activated respiratory burst in phagocytes(5). Both nitric oxide and reactive oxygen intermediates have been implicated in controlling the hypersensitive response, a programmed execution of plant cells at sites of attempted infection(3,5,6). However, the molecular mechanisms that underpin their function and coordinate their synthesis are unknown. Here we show genetic evidence that increases in cysteine thiols modified using nitric oxide, termed S-nitrosothiols, facilitate the hypersensitive response in the absence of the cell death agonist salicylic acid and the synthesis of reactive oxygen intermediates. Surprisingly, when concentrations of S-nitrosothiols were high, nitric oxide function also governed a negative feedback loop limiting the hypersensitive response, mediated by S-nitrosylation of the NADPH oxidase, AtRBOHD, at Cys 890, abolishing its ability to synthesize reactive oxygen intermediates. Accordingly, mutation of Cys 890 compromised S-nitrosothiol-mediated control of AtRBOHD activity, perturbing the magnitude of cell death development. This cysteine is evolutionarily conserved and specifically S-nitrosylated in both human and fly NADPH oxidase, suggesting that this mechanism may govern immune responses in both plants and animals.	[Yun, Byung-Wook; Feechan, Angela; Yin, Minghui; Saidi, Noor B. B.; Yu, Manda; Moore, John W.; Kang, Jeong-Gu; Kwon, Eunjung; Spoel, Steven H.; Loake, Gary J.] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Saidi, Noor B. B.] Univ Putra, Dept Cell & Mol Biol, Serdang 43400, Malaysia; [Le Bihan, Thierry] Univ Edinburgh, Ctr Syst Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Pallas, Jacqueline A.] Syngenta, Trait Res, Bracknell RG42 6EY, Berks, England	University of Edinburgh; Universiti Putra Malaysia; University of Edinburgh; Syngenta	Loake, GJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Kings Bldg, Edinburgh EH9 3JH, Midlothian, Scotland.	gloake@ed.ac.uk	Feechan, Angela/A-1296-2010; Le Bihan, Thierry/AAN-2534-2020; Saidi, Noor Baity/A-8423-2017; Yu, Manda/AAB-2472-2020	Saidi, Noor Baity/0000-0002-0715-2133; Yu, Manda/0000-0001-5932-9597; Feechan, Angela/0000-0002-4954-5613; Pallas, Jacqueline/0000-0002-2207-3185; Spoel, Steven/0000-0003-4340-7591; Loake, Gary/0000-0002-7989-9180; Le Bihan, Thierry/0000-0003-0498-8063; Yin, Minghui/0000-0003-3468-225X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D011809/1]; Physical Sciences Research Council (EPSRC); Darwin Trust; EPSRC [BB/D019621/1]; Ministry of Education Malaysia; Torrance Scholarship; BBSRC [BB/H000984/1, BB/D019621/1, BB/D011809/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1, BB/H000984/1, BB/D011809/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Darwin Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ministry of Education Malaysia(Ministry of Education, Malaysia); Torrance Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to acknowledge R. Innes and W. Gassmann for Pst DC3000 strains expressing either avrB or avrRps4, respectively. Arabidopsis transfer DNA insertion mutants were obtained from SAIL (Syngeneta) populations. We thank M. Tor for the H. arabidopsidis isolate Emwa1, and K. Kanchanawatee for the Drosophila cDNA clone and associated mutant. A. F. was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) CASE studentship. B.-W.Y. and E.K. were funded by BBSRC grant BB/D011809/1 awarded to G.J.L. J.W.M. received a grant from the Physical Sciences Research Council (EPSRC). M. Yu was the recipient of a Darwin Trust Scholarship. T. L. B. was supported by BBSRC and EPSRC grant BB/D019621/1. N.B.B.S. and M. Yin were funded by a Ministry of Education Malaysia scholarship and a Torrance Scholarship, respectively.	Aboul-Soud MAM, 2004, CHROMATOGRAPHIA, V59, P129, DOI 10.1365/s10337-003-0136-1; Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Dellagi A, 1998, MOL PLANT MICROBE IN, V11, P734, DOI 10.1094/MPMI.1998.11.8.734; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Durner J, 1998, P NATL ACAD SCI USA, V95, P10328, DOI 10.1073/pnas.95.17.10328; Feechan A, 2005, P NATL ACAD SCI USA, V102, P8054, DOI 10.1073/pnas.0501456102; Foissner I, 2000, PLANT J, V23, P817, DOI 10.1046/j.1365-313X.2000.00835.x; Gassmann W, 1999, PLANT J, V20, P265, DOI 10.1046/j.1365-313X.1999.t01-1-00600.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Ingelman M, 1997, J MOL BIOL, V268, P147, DOI 10.1006/jmbi.1997.0957; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Keller H, 1999, PLANT CELL, V11, P223, DOI 10.1105/tpc.11.2.223; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lindermayr C, 2010, PLANT CELL, V22, P2894, DOI 10.1105/tpc.109.066464; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Romero-Puertas MC, 2007, PLANT CELL, V19, P4120, DOI 10.1105/tpc.107.055061; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Selemidis S, 2007, CARDIOVASC RES, V75, P349, DOI 10.1016/j.cardiores.2007.03.030; Shen AL, 2000, J BIOL CHEM, V275, P41087, DOI 10.1074/jbc.M008380200; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Wang YQ, 2009, J BIOL CHEM, V284, P2131, DOI 10.1074/jbc.M806782200; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Yun BW, 2003, PLANT J, V34, P768, DOI 10.1046/j.1365-313X.2003.01773.x; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575	39	445	458	4	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					264	U161		10.1038/nature10427	http://dx.doi.org/10.1038/nature10427			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964330	Green Accepted			2022-12-24	WOS:000295782800055
J	Armon, S; Efrati, E; Kupferman, R; Sharon, E				Armon, Shahaf; Efrati, Efi; Kupferman, Raz; Sharon, Eran			Geometry and Mechanics in the Opening of Chiral Seed Pods	SCIENCE			English	Article							HELICAL RIBBONS; NANOBELTS	We studied the mechanical process of seed pods opening in Bauhinia variegate and found a chirality-creating mechanism, which turns an initially flat pod valve into a helix. We studied configurations of strips cut from pod valve tissue and from composite elastic materials that mimic its structure. The experiments reveal various helical configurations with sharp morphological transitions between them. Using the mathematical framework of "incompatible elasticity," we modeled the pod as a thin strip with a flat intrinsic metric and a saddle-like intrinsic curvature. Our theoretical analysis quantitatively predicts all observed configurations, thus linking the pod's microscopic structure and macroscopic conformation. We suggest that this type of incompatible strip is likely to play a role in the self-assembly of chiral macromolecules and could be used for the engineering of synthetic self-shaping devices.	[Armon, Shahaf; Efrati, Efi; Sharon, Eran] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Kupferman, Raz] Hebrew Univ Jerusalem, Inst Math, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Sharon, E (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	erans@vms.huji.ac.il			Israeli Science Foundation; European Research Council; Eshkol Scholarship; Israeli Ministry of Science	Israeli Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); Eshkol Scholarship; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel)	We are grateful to Y. Abraham and U. Raviv for performing the small-angle x-ray scattering measurements. R. K. was partially supported by the Israeli Science Foundation. E. S. was partially supported by the European Research Council SoftGrowth project. S. A. was supported by the Eshkol Scholarship sponsored by the Israeli Ministry of Science.	Efrati E, 2009, J MECH PHYS SOLIDS, V57, P762, DOI 10.1016/j.jmps.2008.12.004; Efrati E, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016602; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; FAHN A., 1955, PHYTOMORPHOLOGY [DELHI], V5, P99; Fahn A, 1972, SEED BIOL IMPORTANCE, P151; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gao PX, 2005, SCIENCE, V309, P1700, DOI 10.1126/science.1116495; Ghafouri R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.138101; Kong XY, 2004, SCIENCE, V303, P1348, DOI 10.1126/science.1092356; Kroner E., 1981, LESS HOUCHES SESSION, P282; Oda R, 1999, NATURE, V399, P566, DOI 10.1038/21154; Reyssat E, 2011, EPL-EUROPHYS LETT, V93, DOI 10.1209/0295-5075/93/54001; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Seffen KA, 1999, P ROY SOC A-MATH PHY, V455, P1003, DOI 10.1098/rspa.1999.0347; Selinger JV, 2001, J PHYS CHEM B, V105, P7157, DOI 10.1021/jp010452d; Selinger RLB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158103; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Struik Dirk Jan, 1961, LECT CLASSICAL DIFFE, P7; WANG CC, 1967, ARCH RATION MECH AN, V27, P33, DOI 10.1007/BF00276434; Zastavker YV, 1999, P NATL ACAD SCI USA, V96, P7883, DOI 10.1073/pnas.96.14.7883; Zhang L, 2005, NANOTECHNOLOGY, V16, P655, DOI 10.1088/0957-4484/16/6/006	21	483	497	27	393	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1726	1730		10.1126/science.1203874	http://dx.doi.org/10.1126/science.1203874			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940888				2022-12-24	WOS:000295121500036
J	Ramirez, SR; Eltz, T; Fujiwara, MK; Gerlach, G; Goldman-Huertas, B; Tsutsui, ND; Pierce, NE				Ramirez, Santiago R.; Eltz, Thomas; Fujiwara, Mikiko K.; Gerlach, Guenter; Goldman-Huertas, Benjamin; Tsutsui, Neil D.; Pierce, Naomi E.			Asynchronous Diversification in a Specialized Plant-Pollinator Mutualism	SCIENCE			English	Article							EUGLOSSINE BEES; ORCHID; EVOLUTION; MODELS	Most flowering plants establish mutualistic associations with insect pollinators to facilitate sexual reproduction. However, the evolutionary processes that gave rise to these associations remain poorly understood. We reconstructed the times of divergence, diversification patterns, and interaction networks of a diverse group of specialized orchids and their bee pollinators. In contrast to a scenario of coevolution by race formation, we show that fragrance-producing orchids originated at least three times independently after their fragrance-collecting bee mutualists. Whereas orchid diversification has apparently tracked the diversification of orchids' bee pollinators, bees appear to have depended on the diverse chemical environment of neotropical forests. We corroborated this apparent asymmetrical dependency by simulating co-extinction cascades in real interaction networks that lacked reciprocal specialization. These results suggest that the diversification of insect-pollinated angiosperms may have been facilitated by the exploitation of preexisting sensory biases of insect pollinators.	[Ramirez, Santiago R.; Fujiwara, Mikiko K.; Goldman-Huertas, Benjamin; Pierce, Naomi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Ramirez, Santiago R.; Tsutsui, Neil D.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Eltz, Thomas] Ruhr Univ Bochum, Dept Anim Ecol Evolut & Biodivers, D-44780 Bochum, Germany; [Gerlach, Guenter] Bot Garten Munchen Nymphenburg, D-80638 Munich, Germany	Harvard University; University of California System; University of California Berkeley; Ruhr University Bochum	Ramirez, SR (corresponding author), Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA.	sramirez@post.harvard.edu	Ramirez, Santiago/B-4948-2012	Goldman-Huertas, Benjamin/0000-0002-6741-5193; Gerlach, Gunter/0000-0002-2819-7218; Eltz, Thomas/0000-0002-8465-7944	NSF [DEB-0608409, SES-0750480, DGE-0646147]; Society of Systematic Biologists, Fundacion Alejandro Angel Escobar (Colombia Biodiversa); Putnam (Harvard); German Science Foundation [EL 249/6]	NSF(National Science Foundation (NSF)); Society of Systematic Biologists, Fundacion Alejandro Angel Escobar (Colombia Biodiversa); Putnam (Harvard); German Science Foundation(German Research Foundation (DFG))	We thank M. Blanco, R. L. Dressler, F. Pupulin, G. Romero, and M. W. Whitten for pollinaria identification; A. Link, M. Lopez, and C. Hernandez for assistance during field work; R. Kaiser for chemical data; and B. Pringle, C. C. Davis, S. V. Edwards, B. D. Farrell, B. Gravendeel, M. Patten, T. B. Quental, E. L. Rezende, D. L. Roberts, and F. Zapata for useful comments. Supported by NSF Doctoral Dissertation Improvement Grant DEB-0608409, NSF grants SES-0750480 and DGE-0646147, and grants from the Society of Systematic Biologists, Fundacion Alejandro Angel Escobar (Colombia Biodiversa), and Putnam (Harvard) (S. R. R., B. G. H., and N.E.P.) and by German Science Foundation grant EL 249/6 (T. E.). DNA sequences are deposited in GenBank (JF691905 to JF692160; EU421211 to EU421711). Matrices and trees are deposited in treebase.org (S11737).	ACKERMAN JD, 1983, BIOL J LINN SOC, V20, P301, DOI 10.1111/j.1095-8312.1983.tb01878.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; CHASE MW, 2003, ORCHID CONSERVATION, P69; Conran JG, 2009, AM J BOT, V96, P466, DOI 10.3732/ajb.0800269; Courtois EA, 2009, J CHEM ECOL, V35, P1349, DOI 10.1007/s10886-009-9718-1; Darwin C., 1877, VARIOUS CONTRIVANCES; Dodson C.H., 1975, P91; DODSON CH, 1969, SCIENCE, V164, P1243, DOI 10.1126/science.164.3885.1243; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eltz T, 2005, J COMP PHYSIOL A, V191, P575, DOI 10.1007/s00359-005-0603-2; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Gustafsson ALS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-177; JANZEN DH, 1971, SCIENCE, V171, P203, DOI 10.1126/science.171.3967.203; KIESTER AR, 1984, AM NAT, V124, P220, DOI 10.1086/284265; Labandeira CC, 2010, ANN MO BOT GARD, V97, P469, DOI 10.3417/2010037; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pemberton RW, 2006, ECOLOGY, V87, P1995, DOI 10.1890/0012-9658(2006)87[1995:OBDNOE]2.0.CO;2; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Ronsted N, 2005, P ROY SOC B-BIOL SCI, V272, P2593, DOI 10.1098/rspb.2005.3249; Roubik D. W., 2004, ORCHID BEES TROPICAL; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Thompson J. N., 2005, GEOGRAHIC MOSAIC COE; Whitten WM, 2000, AM J BOT, V87, P1842, DOI 10.2307/2656837; WHITTEN WM, 1993, J CHEM ECOL, V19, P3017, DOI 10.1007/BF00980599; Zimmermann Y, 2009, ECOLOGY, V90, P2994, DOI 10.1890/08-1858.1	29	107	114	3	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1742	1746		10.1126/science.1209175	http://dx.doi.org/10.1126/science.1209175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940893	Green Submitted			2022-12-24	WOS:000295121500041
J	Burnett, C; Valentini, S; Cabreiro, F; Goss, M; Somogyvari, M; Piper, MD; Hoddinott, M; Sutphin, GL; Leko, V; McElwee, JJ; Vazquez-Manrique, RP; Orfila, AM; Ackerman, D; Au, C; Vinti, G; Riesen, M; Howard, K; Neri, C; Bedalov, A; Kaeberlein, M; Soti, C; Partridge, L; Gems, D				Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Somogyvari, Milan; Piper, Matthew D.; Hoddinott, Matthew; Sutphin, George L.; Leko, Vid; McElwee, Joshua J.; Vazquez-Manrique, Rafael P.; Orfila, Anne-Marie; Ackerman, Daniel; Au, Catherine; Vinti, Giovanna; Riesen, Michele; Howard, Ken; Neri, Christian; Bedalov, Antonio; Kaeberlein, Matt; Soti, Csaba; Partridge, Linda; Gems, David			Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila	NATURE			English	Article							SMALL-MOLECULE ACTIVATORS; SACCHAROMYCES-CEREVISIAE; RESVERATROL; LONGEVITY; SIRTUINS; RESTRICTION; GENETICS; EXTENSION	Overexpression of sirtuins(NAD(+)-dependent protein deacetylases) has been reported to increase lifespan in budding yeast (Saccharomyces cerevisiae), Caenorhabditis elegans and Drosophila melanogaster(1-3). Studies of the effects of genes on ageing are vulnerable to confounding effects of genetic background(4). Here were-examined the reported effects of sirtuin overexpression on ageing and found that standardization of genetic background and the use of appropriate controls abolished the apparent effects in both C. elegans and Drosophila. In C. elegans, outcrossing of a line with high-level sir-2.1 overexpression(1) abrogated the longevity increase, but did not abrogate sir-2.1 overexpression. Instead, longevity co-segregated with a second-site mutation affecting sensory neurons. Outcrossing of a line with low-copy-number sir-2.1 overexpression(2) also abrogated longevity. A Drosophila strain with ubiquitous overexpression of dSir2 using the UAS-GAL4 system was long-lived relative to wild-type controls, as previously reported(3), but was not long-lived relative to the appropriate transgenic controls, and nor was a new line with stronger overexpression of dSir2. These findings underscore the importance of controlling for genetic background and for the mutagenic effects of transgene insertions in studies of genetic effects on lifespan. The life-extending effect of dietary restriction on ageing in Drosophila has also been reported to be dSir2 dependent(3). We found that dietary restriction increased fly lifespan independently of dSir2. Our findings do not rule out a role for sirtuins in determination of metazoan lifespan, but they do cast doubt on the robustness of the previously reported effects of sirtuins on lifespan in C. elegans and Drosophila.	[Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Piper, Matthew D.; Hoddinott, Matthew; McElwee, Joshua J.; Ackerman, Daniel; Au, Catherine; Vinti, Giovanna; Riesen, Michele; Partridge, Linda; Gems, David] UCL, Inst Hlth Ageing, London WC1E 6BT, England; [Burnett, Camilla; Valentini, Sara; Cabreiro, Filipe; Goss, Martin; Piper, Matthew D.; Hoddinott, Matthew; McElwee, Joshua J.; Ackerman, Daniel; Au, Catherine; Vinti, Giovanna; Riesen, Michele; Partridge, Linda; Gems, David] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Somogyvari, Milan; Soti, Csaba] Semmelweis Univ, Dept Med Chem, H-1094 Budapest, Hungary; [Sutphin, George L.; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Sutphin, George L.; Kaeberlein, Matt] Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; [Leko, Vid; Bedalov, Antonio] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Vazquez-Manrique, Rafael P.; Orfila, Anne-Marie; Neri, Christian] INSERM, Lab Neuronal Cell Biol & Pathol, U894, F-75014 Paris, France; [Vazquez-Manrique, Rafael P.; Orfila, Anne-Marie; Neri, Christian] Univ Paris 05, F-75014 Paris, France; [Howard, Ken] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England; [Partridge, Linda] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany	University of London; University College London; University of London; University College London; Semmelweis University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; MRC Laboratory Molecular Biology; University of London; University College London; Max Planck Society	Gems, D (corresponding author), UCL, Inst Hlth Ageing, Gower St, London WC1E 6BT, England.	david.gems@ucl.ac.uk	Partridge, Linda/E-7342-2015; Neri, Christian/F-6729-2013; Sutphin, George L./AAE-6151-2020; Sőti, Csaba/O-6070-2017; Piper, Matthew/C-1714-2008; Vázquez-Manrique, Rafael/K-7882-2014; Partridge, Linda/A-5501-2010	Neri, Christian/0000-0002-3790-2978; Sőti, Csaba/0000-0002-4057-7678; Piper, Matthew/0000-0003-3245-7219; Vázquez-Manrique, Rafael/0000-0002-1594-0033; Gems, David/0000-0002-6653-4676; Ackerman, Daniel/0000-0002-3466-5444; Cabreiro, Filipe/0000-0002-3696-4843; Somogyvari, Milan/0000-0002-6257-4849; Sutphin, George/0000-0002-3659-4678; Partridge, Linda/0000-0001-9615-0094; Kaeberlein, Matt/0000-0002-1311-3421; Au, Catherine/0000-0002-1923-9121	National Institutes of Health National Center for Research Resources; European Union [FP6-036894, FP6-518230]; Hungarian Science Foundation and Norway Grants [NNF-78794]; INSERM; ANR, Paris; National Institutes of Health [CA129132, R01AG031108, T32AG000057]; Wellcome Trust; NATIONAL CANCER INSTITUTE [R01CA129132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031108, T32AG000057] Funding Source: NIH RePORTER; Medical Research Council [G0700729B] Funding Source: researchfish	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); European Union(European Commission); Hungarian Science Foundation and Norway Grants; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ANR, Paris(French National Research Agency (ANR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Gartner for providing an antibody against C. elegans SIR-2.1; D. Chen, P. Kapahi, S. Pletcher and D. Skorupa for providing data; S. S. Lee for permission to cite unpublished results; S. Helfand and J. Rine for providing fly strains; W. Mair for performing preliminary trials and R. Baumeister for useful discussion. Some nematode strains were provided by the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. We acknowledge funding from the European Union (FP6-036894 to C. B., D. G., L. P. and S. V. and FP6-518230 to D. G. and C. S.), the Hungarian Science Foundation and Norway Grants (NNF-78794 to C. S.), INSERM and ANR, Paris (R. V., A.-M.O. and C.N.), the National Institutes of Health (CA129132 to A. B., R01AG031108 to M. K. and T32AG000057 to G. L. S.) and the Wellcome Trust (Strategic Award to C. A., F. C., D. G., L. P. and M. R.). C. S. is a Bolyai Research Scholar of the Hungarian Academy of Sciences and M. K. is an Ellison Medical Foundation New Scholar in Aging.	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Astrom SU, 2003, GENETICS, V163, P931; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENNER S, 1974, GENETICS, V77, P71; Garber K, 2008, NAT BIOTECHNOL, V26, P371, DOI 10.1038/nbt0408-371; Gems D, 1998, GENETICS, V150, P129; Grandison RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004067; Greiss S, 2008, GENE DEV, V22, P2831, DOI 10.1101/gad.482608; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2010, NATURE, V464, P513, DOI 10.1038/nature08981; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Newman BL, 2002, GENETICS, V162, P1675; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Parker JA, 2005, NAT GENET, V37, P349, DOI 10.1038/ng1534; Partridge L, 2007, NATURE, V450, P165, DOI 10.1038/450165a; Patel DS, 2008, GENETICS, V178, P931, DOI 10.1534/genetics.107.070813; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Wang YM, 2006, MECH AGEING DEV, V127, P48, DOI 10.1016/j.mad.2005.09.005; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	36	460	488	0	174	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 22	2011	477	7365					482	U136		10.1038/nature10296	http://dx.doi.org/10.1038/nature10296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938067	Green Accepted, Green Submitted			2022-12-24	WOS:000295080500044
J	Wong, TS; Kang, SH; Tang, SKY; Smythe, EJ; Hatton, BD; Grinthal, A; Aizenberg, J				Wong, Tak-Sing; Kang, Sung Hoon; Tang, Sindy K. Y.; Smythe, Elizabeth J.; Hatton, Benjamin D.; Grinthal, Alison; Aizenberg, Joanna			Bioinspired self-repairing slippery surfaces with pressure-stable omniphobicity	NATURE			English	Article							SOLID-SURFACES; WATER; RESISTANCE; DROPS	Creating a robust synthetic surface that repels various liquids would have broad technological implications for areas ranging from biomedical devices and fuel transport to architecture but has proved extremely challenging(1). Inspirations from natural non-wetting structures(2-6), particularly the leaves of the lotus, have led to the development of liquid-repellent microtextured surfaces that rely on the formation of a stable air-liquid interface(7-9). Despite over a decade of intense research, these surfaces are, however, still plagued with problems that restrict their practical applications: limited oleophobicity with high contact angle hysteresis(9), failure under pressure(10-12) and upon physical damage(1,7,11), inability to self-heal and high production cost(1,11). To address these challenges, here we report a strategy to create self-healing, slippery liquid-infused porous surface(s) (SLIPS) with exceptional liquid- and ice-repellency, pressure stability and enhanced optical transparency. Our approach-inspired by Nepenthes pitcher plants(13)-is conceptually different from the lotus effect, because we use nano/microstructured substrates to lock in place the infused lubricating fluid. We define the requirements for which the lubricant forms a stable, defect-free and inert 'slippery' interface. This surface outperforms its natural counterparts(2-6) and state-of-the-art synthetic liquid-repellent surfaces(8,9,14-16) in its capability to repel various simple and complex liquids (water, hydrocarbons, crude oil and blood), maintain low contact angle hysteresis (<2.5 degrees), quickly restore liquid-repellency after physical damage (within 0.1-1 s), resist ice adhesion, and function at high pressures (up to about 680 atm). We show that these properties are insensitive to the precise geometry of the underlying substrate, making our approach applicable to various inexpensive, low-surface-energy structured materials (such as porous Teflon membrane). We envision that these slippery surfaces will be useful in fluid handling and transportation, optical sensing, medicine, and as self-cleaning and antifouling materials operating in extreme environments.	[Wong, Tak-Sing; Kang, Sung Hoon; Tang, Sindy K. Y.; Hatton, Benjamin D.; Grinthal, Alison; Aizenberg, Joanna] Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Wong, Tak-Sing; Kang, Sung Hoon; Tang, Sindy K. Y.; Hatton, Benjamin D.; Grinthal, Alison; Aizenberg, Joanna] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA; [Smythe, Elizabeth J.] Schlumberger Doll Res Ctr, Cambridge, MA 02139 USA	Harvard University; Harvard University; Schlumberger	Aizenberg, J (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	jaiz@seas.harvard.edu	Wong, Tak Sing/L-9488-2013; Im, Hwon/B-5659-2012; Hatton, Benjamin D/I-4239-2012; Kang, Sung Hoon/AAA-9959-2020; Kang, Sung H/B-1084-2010	Wong, Tak Sing/0000-0001-5500-0575; Kang, Sung Hoon/0000-0002-9156-3348; Kang, Sung H/0000-0002-9156-3348	Croucher Foundation; AFOSR MURI [FA9550-09-1-0669-DOD35CAP]; ARO MURI [W911NF-09-1-0476]; NSF [ECS-0335765]	Croucher Foundation; AFOSR MURI(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)MURI); ARO MURI(MURI); NSF(National Science Foundation (NSF))	T.-S.W. acknowledges funding support from the Croucher Foundation Postdoctoral Fellowship. We thank K. E. Martin for help with the drop impact test. We also thank J. C. Weaver and P. Allen for help in manuscript preparation. The work was supported partially by the AFOSR MURI award FA9550-09-1-0669-DOD35CAP (optical properties), and ARO MURI award W911NF-09-1-0476 (robustness and self-repair). We acknowledge the use of the facilities at the Harvard Center for Nanoscale Systems supported by the NSF under award ECS-0335765.	Ahuja A, 2008, LANGMUIR, V24, P9, DOI 10.1021/la702327z; Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Bauer U, 2009, PLANT SIGNAL BEHAV, V4, P1019, DOI 10.4161/psb.4.11.9664; Bocquet L, 2011, NAT MATER, V10, P334, DOI 10.1038/nmat2994; Bohn HF, 2004, P NATL ACAD SCI USA, V101, P14138, DOI 10.1073/pnas.0405885101; Cassie ABD, 1944, T FARADAY SOC, V40, P0546, DOI 10.1039/tf9444000546; CASSIE ABD, 1945, NATURE, V155, P21, DOI 10.1038/155021a0; Chen W, 1999, LANGMUIR, V15, P3395, DOI 10.1021/la990074s; Courbin L, 2007, NAT MATER, V6, P661, DOI 10.1038/nmat1978; de Gennes P.-G., 2003, CAPILLARITY WETTING, P15; Delmas M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.136102; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Federle W, 2002, INTEGR COMP BIOL, V42, P1100, DOI 10.1093/icb/42.6.1100; FURMIDGE CG, 1962, J COLL SCI IMP U TOK, V17, P309, DOI 10.1016/0095-8522(62)90011-9; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gao XF, 2007, ADV MATER, V19, P2213, DOI 10.1002/adma.200601946; Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102; Ishino C, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/56005; Lee C, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.014502; Li Y, 2010, ANGEW CHEM INT EDIT, V49, P6129, DOI 10.1002/anie.201001258; Nakajima A, 1999, ADV MATER, V11, P1365, DOI 10.1002/(SICI)1521-4095(199911)11:16<1365::AID-ADMA1365>3.3.CO;2-6; Nguyen TPN, 2010, LANGMUIR, V26, P18369, DOI 10.1021/la103097y; Poetes R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.166104; Pokroy B, 2009, ADV MATER, V21, P463, DOI 10.1002/adma.200801432; Quere D, 2005, REP PROG PHYS, V68, P2495, DOI 10.1088/0034-4885/68/11/R01; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; SHAFRIN EG, 1960, J PHYS CHEM-US, V64, P519, DOI 10.1021/j100834a002; Tuteja A, 2007, SCIENCE, V318, P1618, DOI 10.1126/science.1148326; Tuteja A, 2008, P NATL ACAD SCI USA, V105, P18200, DOI 10.1073/pnas.0804872105; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024	30	2478	2624	196	3534	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					443	447		10.1038/nature10447	http://dx.doi.org/10.1038/nature10447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938066	Green Submitted			2022-12-24	WOS:000295080500036
J	Kayagaki, N; Warming, S; Lamkanfi, M; Vande Walle, L; Louie, S; Dong, J; Newton, K; Qu, Y; Liu, JF; Heldens, S; Zhang, J; Lee, WP; Roose-Girma, M; Dixit, VM				Kayagaki, Nobuhiko; Warming, Soren; Lamkanfi, Mohamed; Vande Walle, Lieselotte; Louie, Salina; Dong, Jennifer; Newton, Kim; Qu, Yan; Liu, Jinfeng; Heldens, Sherry; Zhang, Juan; Lee, Wyne P.; Roose-Girma, Merone; Dixit, Vishva M.			Non-canonical inflammasome activation targets caspase-11	NATURE			English	Article							INTERLEUKIN-1-BETA CONVERTING-ENZYME; GAMMA-INDUCING FACTOR; ANTHRAX LETHAL TOXIN; NLRP3 INFLAMMASOME; MICE DEFICIENT; RECOGNITION; IL-1-BETA; RECEPTORS; APOPTOSIS; RESPONSES	Caspase-1 activation by inflammasome scaffolds comprised of intracellular nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) and the adaptor ASC is believed to be essential for production of the pro-inflammatory cytokines interleukin (IL)-1 beta and IL-18 during the innate immune response(1-5). Here we show, with C57BL/6 Casp11 gene-targeted mice, that caspase-11 (also known as caspase-4)(6-8) is critical for caspase-1 activation and IL-1 beta production in macrophages infected with Escherichia coli, Citrobacter rodentium or Vibrio cholerae. Strain 129 mice, like Casp11(-/-) mice, exhibited defects in IL-1 beta production and harboured a mutation in the Casp11 locus that attenuated caspase-11 expression. This finding is important because published targeting of the Casp1 gene was done using strain 129 embryonic stem cells(9,10). Casp1 and Casp11 are too close in the genome to be segregated by recombination; consequently, the published Casp1(-/-) mice lack both caspase-11 and caspase-1. Interestingly, Casp11(-/-) macrophages secreted IL-1 beta normally in response to ATP and monosodium urate, indicating that caspase-11 is engaged by a non-canonical inflammasome. Casp1(-/-)Casp11(129mt/129mt) macrophages expressing caspase-11 from a C57BL/6 bacterial artificial chromosome transgene failed to secrete IL-1 beta regardless of stimulus, confirming an essential role for caspase-1 in IL-1 beta production. Caspase-11 rather than caspase-1, however, was required for non-canonical inflammasome-triggered macrophage cell death, indicating that caspase-11 orchestrates both caspase-1-dependent and -independent outputs. Caspase-1 activation by non-canonical stimuli required NLRP3 and ASC, but caspase-11 processing and cell death did not, implying that there is a distinct activator of caspase-11. Lastly, loss of caspase-11 rather than caspase-1 protected mice from a lethal dose of lipopolysaccharide. These data highlight a unique pro-inflammatory role for caspase-11 in the innate immune response to clinically significant bacterial infections.	[Kayagaki, Nobuhiko; Louie, Salina; Dong, Jennifer; Newton, Kim; Qu, Yan; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Warming, Soren; Heldens, Sherry; Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Lamkanfi, Mohamed; Vande Walle, Lieselotte] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed; Vande Walle, Lieselotte] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium; [Liu, Jinfeng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Zhang, Juan; Lee, Wyne P.] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Flanders Institute for Biotechnology (VIB); Ghent University; Roche Holding; Genentech; Roche Holding; Genentech	Kayagaki, N (corresponding author), Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA.	kayagaki@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Warming, Soren/ABD-5729-2021	dixit, vishva m/0000-0001-6983-0326; Warming, Soren/0000-0002-5721-0741; Liu, Jinfeng/0000-0002-0343-8222				Beddoe T, 2010, TRENDS BIOCHEM SCI, V35, P411, DOI 10.1016/j.tibs.2010.02.003; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dunne A, 2010, J IMMUNOL, V185, P1711, DOI 10.4049/jimmunol.1000105; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Freche B, 2007, SEMIN IMMUNOPATHOL, V29, P249, DOI 10.1007/s00281-007-0085-0; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kang SJ, 2000, J CELL BIOL, V149, P613, DOI 10.1083/jcb.149.3.613; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Lamkanfi M, 2010, J IMMUNOL, V185, P4385, DOI 10.4049/jimmunol.1000803; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Ng J, 2010, GASTROENTEROLOGY, V139, P542, DOI 10.1053/j.gastro.2010.04.005; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Toma C, 2010, J IMMUNOL, V184, P5287, DOI 10.4049/jimmunol.0903536; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Walsh JG, 2011, J BIOL CHEM, V286, P32513, DOI 10.1074/jbc.M111.225862; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x	35	1553	1610	13	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					117	U146		10.1038/nature10558	http://dx.doi.org/10.1038/nature10558			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22002608				2022-12-24	WOS:000296422600043
J	Vasiliauskas, D; Mazzoni, EO; Sprecher, SG; Brodetskiy, K; Johnston, RJ; Lidder, P; Vogt, N; Celik, A; Desplan, C				Vasiliauskas, Daniel; Mazzoni, Esteban O.; Sprecher, Simon G.; Brodetskiy, Konstantin; Johnston, Robert J., Jr.; Lidder, Preetmoninder; Vogt, Nina; Celik, Arzu; Desplan, Claude			Feedback from rhodopsin controls rhodopsin exclusion in Drosophila photoreceptors	NATURE			English	Article							TUMOR-SUPPRESSOR GENE; EXPRESSION; R7; IDENTIFICATION; TRANSGENESIS; SPECIFICITY; DISSECTION; ENCODES; SYSTEM; CELLS	Sensory systems with high discriminatory power use neurons that express only one of several alternative sensory receptor proteins. This exclusive receptor gene expression restricts the sensitivity spectrum of neurons and is coordinated with the choice of their synaptic targets(1-3). However, little is known about how it is maintained throughout the life of a neuron. Here we show that the green-light sensing receptor rhodopsin 6 (Rh6) acts to exclude an alternative blue-sensitive rhodopsin 5 (Rh5) from a subset of Drosophila R8 photoreceptor neurons(4). Loss of Rh6 leads to a gradual expansion of Rh5 expression into all R8 photoreceptors of the ageing adult retina. The Rh6 feedback signal results in repression of the rh5 promoter and can be mimicked by other Drosophila rhodopsins; it is partly dependent on activation of rhodopsin by light, and relies on G(alpha q) activity, but not on the subsequent steps of the phototransduction cascade(5). Our observations reveal a thus far unappreciated spectral plasticity of R8 photoreceptors, and identify rhodopsin feedback as an exclusion mechanism.	[Vasiliauskas, Daniel; Mazzoni, Esteban O.; Sprecher, Simon G.; Brodetskiy, Konstantin; Johnston, Robert J., Jr.; Lidder, Preetmoninder; Vogt, Nina; Celik, Arzu; Desplan, Claude] NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA	New York University	Desplan, C (corresponding author), NYU, Dept Biol, Ctr Dev Genet, New York, NY 10003 USA.	cd38@nyu.edu	Vasiliauskas, Daniel/AAV-1981-2020; Fuss, ARZU Celik/AAD-2870-2020; Sprecher, Simon/B-5188-2012; Sprecher, Simon/K-4249-2015	Vasiliauskas, Daniel/0000-0002-0570-2322; Fuss, ARZU Celik/0000-0001-9889-6957; Vogt, Nina/0000-0002-2658-9138; Sprecher, Simon/0000-0001-9060-3750; mazzoni, esteban/0000-0001-8994-681X; Desplan, Claude/0000-0002-6914-1413	National Institutes of Health [R01EY13012, F32EY016309]; NATIONAL EYE INSTITUTE [F32EY016309, R01EY013012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank J. Blau, B. Collins, M. Cols, T. Erclik, S. H. Fuss, D. Jukam, J. P. Kumar, E. Laufer, H.-S. Li, B. Minke, C. Montell, F. Pichaud, J. Rister and A. Tomlinson for suggestions and comments on the manuscript, V. Douard for help with qRT-PCR, J. Goodness for help identifying rh6<SUP>fs</SUP> allele, S. G. Britt, P. J. Dolph, P. R. Hiesinger, F. Pichaud, N. Pinal, D. F. Ready, C. S. Zuker, and the Bloomington Drosophila Stock Center for flies or antibodies. This work was funded by the National Institutes of Health R01EY13012 to C. D. and F32EY016309 to D.V.	Arikawa K, 2003, J NEUROSCI, V23, P4527; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Chou WH, 1999, DEVELOPMENT, V126, P607; Cook T, 2003, DEV CELL, V4, P853, DOI 10.1016/S1534-5807(03)00156-4; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Earl JB, 2006, GENE EXPR PATTERNS, V6, P687, DOI 10.1016/j.modgep.2006.01.003; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; FRANCESCHINI N, 1981, SCIENCE, V213, P1264, DOI 10.1126/science.7268434; Fuss SH, 2009, MOL CELL NEUROSCI, V41, P101, DOI 10.1016/j.mcn.2009.02.014; GERRESHEIM F, 1988, BEHAV GENET, V18, P227, DOI 10.1007/BF01067844; GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HOFBAUER A, 1989, NATURWISSENSCHAFTEN, V76, P335, DOI 10.1007/BF00368438; Huang JH, 2010, CURR BIOL, V20, P189, DOI 10.1016/j.cub.2009.12.019; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mazzoni EO, 2008, PLOS BIOL, V6, P825, DOI 10.1371/journal.pbio.0060097; Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; O'Keefe LV, 2011, HUM MOL GENET, V20, P497, DOI 10.1093/hmg/ddq495; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; Papatsenko D, 1997, DEVELOPMENT, V124, P1665; Papatsenko D, 2001, MECH DEVELOP, V101, P143, DOI 10.1016/S0925-4773(00)00581-5; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Rister J, 2011, DEV NEUROBIOL, V71, P1212, DOI 10.1002/dneu.20905; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Shen WL, 2011, SCIENCE, V331, P1333, DOI 10.1126/science.1198904; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Sprecher SG, 2008, NATURE, V454, P533, DOI 10.1038/nature07062; Sprecher SG, 2007, GENE DEV, V21, P2182, DOI 10.1101/gad.1565407; Stapleton M, 2002, GENOME RES, V12, P1294, DOI 10.1101/gr.269102; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Till BJ, 2003, METH MOL B, V236, P205; Wang T, 2007, PFLUG ARCH EUR J PHY, V454, P821, DOI 10.1007/s00424-007-0251-1; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; XU TA, 1995, DEVELOPMENT, V121, P1053; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0	48	33	33	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					108	+		10.1038/nature10451	http://dx.doi.org/10.1038/nature10451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21983964	Green Accepted, Green Submitted			2022-12-24	WOS:000296422600041
J	Goshen, I; Brodsky, M; Prakash, R; Wallace, J; Gradinaru, V; Ramakrishnan, C; Deisseroth, K				Goshen, Inbal; Brodsky, Matthew; Prakash, Rohit; Wallace, Jenelle; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl			Dynamics of Retrieval Strategies for Remote Memories	CELL			English	Article							RETROGRADE-AMNESIA; CONTEXTUAL FEAR; HIPPOCAMPAL-LESIONS; DORSAL HIPPOCAMPUS; SPATIAL MEMORY; PLACE CELLS; CONSOLIDATION; RECONSOLIDATION; REORGANIZATION; TRANSFORMATION	Prevailing theory suggests that long-term memories are encoded via a two-phase process requiring early involvement of the hippocampus followed by the neocortex. Contextual fear memories in rodents rely on the hippocampus immediately following training but are unaffected by hippocampal lesions or pharmacological inhibition weeks later. With fast optogenetic methods, we examine the real-time contribution of hippocampal CA1 excitatory neurons to remote memory and find that contextual fear memory recall, even weeks after training, can be reversibly abolished by temporally precise optogenetic inhibition of CA1. When this inhibition is extended to match the typical time course of pharmacological inhibition, remote hippocampus dependence converts to hippocampus independence, suggesting that long-term memory retrieval normally depends on the hippocampus but can adaptively shift to alternate structures. Further revealing the plasticity of mechanisms required for memory recall, we confirm the remote-timescale importance of the anterior cingulate cortex (ACC) and implicate CA1 in ACC recruitment for remote recall.	[Goshen, Inbal; Brodsky, Matthew; Prakash, Rohit; Wallace, Jenelle; Gradinaru, Viviana; Ramakrishnan, Charu; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Bioengn,Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, CNC Program, Dept Bioengn,Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	deissero@stanford.edu	Goshen, Inbal/GQI-2230-2022	Goshen, Inbal/0000-0001-7578-2615; Ramakrishnan, Charu/0000-0002-3474-6332; Wallace, Jenelle/0000-0002-9565-2751	Gatsby Charitable Foundation; Keck Foundation; Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM; NIMH; NINDS; NIDA; DARPA; Machiah Foundation; Weizmann Institute of Science; NIH; BioX undergraduate summer research program; Stanford Graduate Fellowship program	Gatsby Charitable Foundation; Keck Foundation(W.M. Keck Foundation); Snyder Foundation; Woo Foundation; Yu Foundation; McKnight Foundation; CIRM(California Institute for Regenerative Medicine); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Machiah Foundation; Weizmann Institute of Science; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BioX undergraduate summer research program; Stanford Graduate Fellowship program	We thank the entire Deisseroth laboratory for their support. K. D. is supported by the Gatsby Charitable Foundation and the Keck, Snyder, Woo, Yu, and McKnight Foundations, as well as by CIRM, NIMH, NINDS, NIDA, and the DARPA REPAIR program. I. G. is supported by the Machiah Foundation and the Weizmann Institute of Science National Postdoctoral Award Program for Advancing Women in Science, R.P. is supported by the NIH, J.W. is supported by the BioX undergraduate summer research program, and V.G. by the Stanford Graduate Fellowship program.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Broadbent NJ, 2006, LEARN MEMORY, V13, P187, DOI 10.1101/lm.134706; Cipolotti L, 2006, CURR OPIN NEUROL, V19, P593, DOI 10.1097/01.wco.0000247608.42320.f9; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kitamura T, 2009, CELL, V139, P814, DOI 10.1016/j.cell.2009.10.020; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 1997, BEHAV BRAIN RES, V88, P261, DOI 10.1016/S0166-4328(97)00088-0; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; McHugh TJ, 2007, BEHAV NEUROSCI, V121, P335, DOI 10.1037/0735-7044.121.2.335; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Moser EI, 2008, ANNU REV NEUROSCI, V31, P69, DOI 10.1146/annurev.neuro.31.061307.090723; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Sutherland RJ, 2008, HIPPOCAMPUS, V18, P710, DOI 10.1002/hipo.20431; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; Wang SH, 2010, ANNU REV PSYCHOL, V61, P49, DOI 10.1146/annurev.psych.093008.100523; Wang SH, 2009, NAT NEUROSCI, V12, P253, DOI 10.1038/nn.2263; Wiltgen BJ, 2010, CURR BIOL, V20, P1336, DOI 10.1016/j.cub.2010.06.068; Winocur G, 2007, NAT NEUROSCI, V10, P555, DOI 10.1038/nn1880; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Winocur G, 2009, LEARN MEMORY, V16, P722, DOI 10.1101/lm.1447209; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744	48	364	405	0	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					678	689		10.1016/j.cell.2011.09.033	http://dx.doi.org/10.1016/j.cell.2011.09.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22019004	Bronze			2022-12-24	WOS:000296573700021
J	Stigler, J; Ziegler, F; Gieseke, A; Gebhardt, JCM; Rief, M				Stigler, Johannes; Ziegler, Fabian; Gieseke, Anja; Gebhardt, J. Christof M.; Rief, Matthias			The Complex Folding Network of Single Calmodulin Molecules	SCIENCE			English	Article							PROTEIN; LANDSCAPE; STABILITY; DYNAMICS; REVEALS; DOMAINS; SPECTROSCOPY; SIMULATION; KINETICS; BINDING	Direct observation of the detailed conformational fluctuations of a single protein molecule en route to its folded state has so far been realized only in silico. We have used single-molecule force spectroscopy to study the folding transitions of single calmodulin molecules. High-resolution optical tweezers assays in combination with hidden Markov analysis reveal a complex network of on- and off-pathway intermediates. Cooperative and anticooperative interactions across domain boundaries can be observed directly. The folding network involves four intermediates. Two off-pathway intermediates exhibit non-native interdomain interactions and compete with the ultrafast productive folding pathway.	[Stigler, Johannes; Ziegler, Fabian; Gieseke, Anja; Gebhardt, J. Christof M.; Rief, Matthias] Tech Univ Munich, Phys Dept E22, D-85748 Garching, Germany; [Rief, Matthias] Munich Ctr Integrated Prot Sci, D-81377 Munich, Germany	Technical University of Munich; University of Munich	Rief, M (corresponding author), Tech Univ Munich, Phys Dept E22, James Franck Str, D-85748 Garching, Germany.	mrief@ph.tum.de	Gebhardt, J. Christof M./M-4851-2017	Gebhardt, J. Christof M./0000-0003-1900-600X; Stigler, Johannes/0000-0003-2472-5332	Deutsche Forschungsgemeinschaft through Institute for Advanced Study of Technische Universitat Munchen [SFB 863 A2]; International Graduate School "Materials Science of Complex Interfaces"	Deutsche Forschungsgemeinschaft through Institute for Advanced Study of Technische Universitat Munchen; International Graduate School "Materials Science of Complex Interfaces"	This work was supported by an SFB 863 A2 grant of Deutsche Forschungsgemeinschaft. M.R. acknowledges financial support through an instrument grant of the Institute for Advanced Study of Technische Universitat Munchen. J.S. was supported by the International Graduate School "Materials Science of Complex Interfaces."	Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Cecconi C, 2005, SCIENCE, V309, P2057, DOI 10.1126/science.1116702; Cecconi C, 2008, EUR BIOPHYS J BIOPHY, V37, P729, DOI 10.1007/s00249-007-0247-y; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; de Messieres M, 2011, BIOPHYS J, V100, P2736, DOI 10.1016/j.bpj.2011.03.067; Dietz H, 2006, P NATL ACAD SCI USA, V103, P1244, DOI 10.1073/pnas.0509217103; Fefeu S, 2000, BIOCHEMISTRY-US, V39, P15920, DOI 10.1021/bi001772a; Freddolino PL, 2008, BIOPHYS J, V94, pL75, DOI 10.1529/biophysj.108.131565; Gebhardt JCM, 2010, P NATL ACAD SCI USA, V107, P2013, DOI 10.1073/pnas.0909854107; GUO ZY, 1995, BIOPOLYMERS, V36, P83, DOI 10.1002/bip.360360108; Junker JP, 2010, ANGEW CHEM INT EDIT, V49, P3306, DOI 10.1002/anie.200905747; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Krebs J, 2007, N COMP BIOC, V41, P51; Lakowski TM, 2007, PROTEIN SCI, V16, P1119, DOI 10.1110/ps.072777107; Landry MP, 2009, BIOPHYS J, V97, P2128, DOI 10.1016/j.bpj.2009.07.048; Li HB, 2000, P NATL ACAD SCI USA, V97, P6527, DOI 10.1073/pnas.120048697; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Masino L, 2000, PROTEIN SCI, V9, P1519, DOI 10.1110/ps.9.8.1519; Nakashima K, 1999, BIOCHEMISTRY-US, V38, P98, DOI 10.1021/bi982067t; Oberhauser AF, 1999, NAT STRUCT BIOL, V6, P1025; Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Schlierf M, 2004, P NATL ACAD SCI USA, V101, P7299, DOI 10.1073/pnas.0400033101; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Shuman CF, 2006, J MOL BIOL, V358, P870, DOI 10.1016/j.jmb.2006.02.017; Thirumalai D, 2005, BIOCHEMISTRY-US, V44, P4957, DOI 10.1021/bi047314+; Voelz VA, 2010, J AM CHEM SOC, V132, P1526, DOI 10.1021/ja9090353; Woodside MT, 2006, SCIENCE, V314, P1001, DOI 10.1126/science.1133601; Zheng P, 2011, BIOPHYS J, V100, P1534, DOI 10.1016/j.bpj.2011.01.062	33	273	278	4	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					512	516		10.1126/science.1207598	http://dx.doi.org/10.1126/science.1207598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034433				2022-12-24	WOS:000296230500047
J	Brawand, D; Soumillon, M; Necsulea, A; Julien, P; Csardi, G; Harrigan, P; Weier, M; Liechti, A; Aximu-Petri, A; Kircher, M; Albert, FW; Zeller, U; Khaitovich, P; Grutzner, F; Bergmann, S; Nielsen, R; Paabo, S; Kaessmann, H				Brawand, David; Soumillon, Magali; Necsulea, Anamaria; Julien, Philippe; Csardi, Gabor; Harrigan, Patrick; Weier, Manuela; Liechti, Angelica; Aximu-Petri, Ayinuer; Kircher, Martin; Albert, Frank W.; Zeller, Ulrich; Khaitovich, Philipp; Gruetzner, Frank; Bergmann, Sven; Nielsen, Rasmus; Paeaebo, Svante; Kaessmann, Henrik			The evolution of gene expression levels in mammalian organs	NATURE			English	Article							SEX-CHROMOSOMES; X-CHROMOSOME; RNA-SEQ; DOSAGE COMPENSATION; HUMAN GENOME; PRIMATES; HUMANS; CONSERVATION; CHIMPANZEES; SEQUENCE	Changes in gene expression are thought to underlie many of the phenotypic differences between species. However, large-scale analyses of gene expression evolution were until recently prevented by technological limitations. Here we report the sequencing of polyadenylated RNA from six organs across ten species that represent all major mammalian lineages (placentals, marsupials and monotremes) and birds (the evolutionary outgroup), with the goal of understanding the dynamics of mammalian transcriptome evolution. We show that the rate of gene expression evolution varies among organs, lineages and chromosomes, owing to differences in selective pressures: transcriptome change was slow in nervous tissues and rapid in testes, slower in rodents than in apes and monotremes, and rapid for the X chromosome right after its formation. Although gene expression evolution in mammals was strongly shaped by purifying selection, we identify numerous potentially selectively driven expression switches, which occurred at different rates across lineages and tissues and which probably contributed to the specific organ biology of various mammals.	[Brawand, David; Soumillon, Magali; Necsulea, Anamaria; Julien, Philippe; Weier, Manuela; Liechti, Angelica; Kaessmann, Henrik] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Brawand, David; Soumillon, Magali; Necsulea, Anamaria; Julien, Philippe; Csardi, Gabor; Bergmann, Sven; Kaessmann, Henrik] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Csardi, Gabor; Bergmann, Sven] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Harrigan, Patrick; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Aximu-Petri, Ayinuer; Kircher, Martin; Albert, Frank W.; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; [Zeller, Ulrich] Humboldt Univ, Chair Systemat Zool, D-10099 Berlin, Germany; [Khaitovich, Philipp] CAS MPG Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Gruetzner, Frank] Univ Adelaide, Robinson Inst, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Nielsen, Rasmus] Univ Copenhagen, Bioinformat Ctr, DK-2200 Copenhagen, Denmark	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of California System; University of California Berkeley; Max Planck Society; Humboldt University of Berlin; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Robinson Research Institute; University of Adelaide; University of Copenhagen	Kaessmann, H (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	henrik.kaessmann@unil.ch	Kircher, Martin/H-6909-2019; Kaessmann, Henrik/B-4989-2013; Julien, Philippe/C-1295-2011; Kircher, Martin/HDL-9392-2022; Grutzner, Frank/AAD-5834-2020; Nielsen, Rasmus/D-4405-2009; Khaitovich, Philipp/HGC-8520-2022; Grutzner, Frank/ABB-2820-2021	Kircher, Martin/0000-0001-9278-5471; Kaessmann, Henrik/0000-0001-7563-839X; Nielsen, Rasmus/0000-0003-0513-6591; Grutzner, Frank/0000-0002-3088-7314; Albert, Frank/0000-0002-1380-8063; Bergmann, Sven/0000-0002-6785-9034; Csardi, Gabor/0000-0001-7098-9676	European Research Council [242597]; Swiss National Science Foundation [31003A_130287, 31003A_130691/1]; Swiss Institute of Bioinformatics; Max Planck Society; FEBS postdoctoral fellowship	European Research Council(European Research Council (ERC)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Institute of Bioinformatics; Max Planck Society(Max Planck SocietyFoundation CELLEX); FEBS postdoctoral fellowship	We thank K. Harshman and the LGTF for high-throughput sequencing support; I. Xenarios and the Vital-IT computational facility (Swiss Institute of Bioinformatics) for computational support; P. Jensen and L. Andersson for the red jungle fowl samples; E. Ait Yahya Graison and A. Reymond for C57BL/6J mouse RNA-seq data from male brain; C. Henrichsen and A. Reymond for wild-mouse samples; T. Daish, A. Casey, S. Lim, R. Jones and Glenrock station for platypus tissue collection and sample preparation; all other people and institutions that provided samples (Supplementary Table 1); W. Enard for ape sample organization; the members of the Kaessmann group for discussions; J. Meunier for statistical support; D. Cortez and M. Warnefors for comments on the manuscript; and R. Durbin and the Gorilla Genome Analysis Consortium for making the gorilla genome data available and for granting permission to use them for RNA-seq read mapping before publication. This research was supported by grants from the European Research Council (Starting Independent Researcher Grant: 242597, SexGenTransEvolution) and the Swiss National Science Foundation (grant 31003A_130287), to H.K. S.B. was supported by the Swiss National Science Foundation (grant 31003A_130691/1), the Swiss Institute of Bioinformatics and the European Framework Project 6 (AnEuploidy and EuroDia projects). S.P. was supported by the European Research Council (ERC-2008-AdG, TWOPAN) and by the Max Planck Society. A.N. was supported by a long-term FEBS postdoctoral fellowship. F.G. is an ARC Australian Research Fellow.	Babbitt CC, 2010, GENOME BIOL EVOL, V2, P67, DOI 10.1093/gbe/evq002; Bachtrog D, 2009, PLOS BIOL, V7, P712, DOI 10.1371/journal.pbio.1000082; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Chan Esther T., 2009, Journal of Biology (London), V8, P33, DOI 10.1186/jbiol130; CHARLESWORTH B, 1978, P NATL ACAD SCI USA, V75, P5618, DOI 10.1073/pnas.75.11.5618; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Fyfe JC, 2006, GENOME RES, V16, P1084, DOI 10.1101/gr.5268806; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Goodman M, 1999, AM J HUM GENET, V64, P31, DOI 10.1086/302218; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Haygood R, 2010, P NATL ACAD SCI USA, V107, P7853, DOI 10.1073/pnas.0911249107; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Ihmels J, 2004, BIOINFORMATICS, V20, P1993, DOI 10.1093/bioinformatics/bth166; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Kemkemer C, 2009, CHROMOSOME RES, V17, P811, DOI 10.1007/s10577-009-9072-8; KEMP TS, 2005, ORIGIN EVOLUTION MAM; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Marcus G., 2004, BIRTH MIND; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Picard F, 2007, BIOMETRICS, V63, P758, DOI 10.1111/j.1541-0420.2006.00729.x; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; Potrzebowski L, 2008, PLOS BIOL, V6, P709, DOI 10.1371/journal.pbio.0060080; Potrzebowski L, 2010, TRENDS GENET, V26, P1, DOI 10.1016/j.tig.2009.11.001; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Schoenemann PT, 2005, NAT NEUROSCI, V8, P242, DOI 10.1038/nn1394; Tong Y, 2010, NEUROGENETICS, V11, P41, DOI 10.1007/s10048-009-0201-5; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Vauti F, 2007, GENE, V389, P174, DOI 10.1016/j.gene.2006.11.004; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568; Xiong YY, 2010, NAT GENET, V42, P1043, DOI 10.1038/ng.711; Zhang Y, 2010, PLOS BIOL, V8, DOI [10.1371/journal.pbio.1000430, 10.1371/journal.pbio.1000494]	59	739	747	8	278	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					343	+		10.1038/nature10532	http://dx.doi.org/10.1038/nature10532			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012392				2022-12-24	WOS:000296021100037
J	de Tisi, J; Bell, GS; Peacock, JL; McEvoy, AW; Harkness, WFJ; Sander, JW; Duncan, JS				de Tisi, Jane; Bell, Gail S.; Peacock, Janet L.; McEvoy, Andrew W.; Harkness, William F. J.; Sander, Josemir W.; Duncan, John S.			The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study	LANCET			English	Article							TEMPORAL-LOBE EPILEPSY; VISUAL-FIELD DEFICITS; FOLLOW-UP; LOBECTOMY; SCLEROSIS; RESECTION; RECURRENCE	Background Surgery is increasingly used as treatment for refractory focal epilepsy; however, few rigorous reports of long-term outcome exist. We did this study to identify long-term outcome of epilepsy surgery in adults by establishing patterns of seizure remission and relapse after surgery. Methods We report long-term outcome of surgery for epilepsy in 615 adults (497 anterior temporal resections, 40 temporal lesionectomies, 40 extratemporal lesionectomies, 20 extratemporal resections, 11 hemispherectomies, and seven palliative procedures [corpus callosotomy, subpial transection]), with prospective annual follow-up fora median of 8 years (range 1-19). We used Kaplan-Meier survival analysis to estimate time to first seizure, and investigated patterns of seizure outcome. Findings We used survival methods to estimate that 52% (95% CI 48-56) of patients remained seizure free (apart from simple partial seizures [SPS]) at 5 years after surgery, and 47% (42-51) at 10 years. Patients who had extratemporal resections were more likely to have seizure recurrence than were those who had anterior temporal resections (hazard ratio [HR] 2.0, 1.1-3.6; p=0.02); whereas for those having lesionectomies, no difference from anterior lobe resection was recorded. Those with SPS in the first 2 years after temporal lobe surgery had a greater chance of subsequent seizures with impaired awareness than did those with no SPS (2.4, 1.5-3.9). Relapse was less likely the longer a person was seizure free and, conversely, remission was less likely the longer seizures continued. In 18 (19%) of 93 people, late remission was associated with introduction of a previously untried antiepileptic drug. 104 of 365 (28%) seizure-free individuals had discontinued drugs at latest follow-up. Interpretation Neurosurgical treatment is appealing for selected people with refractory focal epilepsy. Our data provide realistic expectations and indicate the scope for further improvements in presurgical assessment and surgical treatment of people with chronic epilepsy.	[de Tisi, Jane; Bell, Gail S.; McEvoy, Andrew W.; Harkness, William F. J.; Sander, Josemir W.; Duncan, John S.] UCL, Dept Clin & Expt Epilepsy, Inst Neurol, Natl Hosp Neurol & Neurosurg, London, England; [Bell, Gail S.; Sander, Josemir W.; Duncan, John S.] Epilepsy Soc, Gerrards Cross, Bucks, England; [Peacock, Janet L.] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Sander, Josemir W.] Netherlands Fdn, SEIN Epilepsy Inst, Heemstede, Netherlands	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; King's College London	Duncan, JS (corresponding author), Natl Hosp Neurol & Neurosurg, Dept Clin & Expt Epilepsy, UCL Inst Neurol, Queen Sq, London WC1N 3BG, England.	j.duncan@ucl.ac.uk	Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661; Peacock, Janet/0000-0002-0310-2518; de Tisi, Jane/0000-0002-7666-2268; Duncan, John S/0000-0002-1373-0681	Forth Medical; Eisai; GlaxoSmithKline; MedTronic; Pfizer; UCB; Cyberonics; VSM MedTech; UK Department of Health National Institute for Health Research (NIHR); Epilepsy Society; National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish	Forth Medical; Eisai(Eisai Co Ltd); GlaxoSmithKline(GlaxoSmithKline); MedTronic(Medtronic); Pfizer(Pfizer); UCB(UCB Pharma SA); Cyberonics; VSM MedTech; UK Department of Health National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Epilepsy Society; National Institute for Health Research(National Institute for Health Research (NIHR))	JDT, JLP, and AWMcE declare that they have no conflicts of interest. GSB's husband works for, and has shares in, GlaxoSmithlKline. WFH has been consulted by and received research grants and fees for lectures from Forth Medical. JWS has been consulted by and received fees for lectures and research grants from Eisai, GlaxoSmithKline, MedTronic, Pfizer, and UCB. JSD has been consulted by and received fees to his institution for lectures from Eisai, GE Healthcare, Pfizer, GlaxoSmithKline, Sanofi- Aventis, and UCB; he has had departmental and grant support from MedTronic, Cyberonics, and VSM MedTech.; Funding UK Department of Health National Institute for Health Research (NIHR) Biomedical Research Centres funding scheme, Epilepsy Society, Dr Marvin Weil Epilepsy Research Fund.	Altman D.G., 2000, STAT CONFIDENCE, Vsecond; Bell GS, 2010, J NEUROL NEUROSUR PS, V81, P716, DOI 10.1136/jnnp.2008.170837; BERKOVIC SF, 1995, NEUROLOGY, V45, P1358, DOI 10.1212/WNL.45.7.1358; Buckingham SE, 2010, EPILEPSIA, V51, P1987, DOI 10.1111/j.1528-1167.2010.02721.x; Burneo JG, 2008, SEIZURE-EUR J EPILEP, V17, P314, DOI 10.1016/j.seizure.2007.10.002; Chan CH, 2006, J NEUROSURG, V104, P62, DOI 10.3171/jns.2006.104.1.62; Chandrasekar T, 2008, EPILEPSY RES, V78, P195, DOI 10.1016/j.eplepsyres.2007.12.004; Clusmann H, 2004, NEUROSURGERY, V54, P847, DOI 10.1227/01.NEU.0000114141.37640.37; Clusmann H, 2002, J NEUROSURG, V97, P1131, DOI 10.3171/jns.2002.97.5.1131; Cohen-Gadol AA, 2006, J NEUROSURG, V104, P513, DOI 10.3171/jns.2006.104.4.513; Duncan JS, 2011, EPILEPSY BEHAV, V20, P230, DOI 10.1016/j.yebeh.2010.06.040; Dunlea O, 2010, SEIZURE-EUR J EPILEP, V19, P247, DOI 10.1016/j.seizure.2010.03.001; Dupont S, 2006, EPILEPSIA, V47, P2115, DOI 10.1111/j.1528-1167.2006.00852.x; ELWES RDC, 1991, J NEUROL NEUROSUR PS, V54, P949, DOI 10.1136/jnnp.54.11.949; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Janszky J, 2005, EPILEPSY RES, V64, P35, DOI 10.1016/j.eplepsyres.2005.02.004; Jeelani NUO, 2010, J NEUROL NEUROSUR PS, V81, P985, DOI 10.1136/jnnp.2009.182378; Jehi L, 2010, EPILEPSIA, V51, P994, DOI 10.1111/j.1528-1167.2010.02556.x; Lee SA, 2006, SEIZURE-EUR J EPILEP, V15, P397, DOI 10.1016/j.seizure.2006.05.003; McIntosh AM, 2004, BRAIN, V127, P2018, DOI 10.1093/brain/awh221; Paglioli E, 2004, EPILEPSIA, V45, P1383, DOI 10.1111/j.0013-9580.2004.22204.x; Salanova V, 1999, EPILEPSIA, V40, P1417, DOI 10.1111/j.1528-1157.1999.tb02014.x; Schwartz TH, 2006, EPILEPSIA, V47, P567, DOI 10.1111/j.1528-1167.2006.00469.x; Tellez-Zenteno JF, 2005, BRAIN, V128, P1188, DOI 10.1093/brain/awh449; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2001, EPILEPSIA, V42, P282, DOI 10.1046/j.1528-1157.2001.4220282.x; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114	27	518	525	5	48	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 15	2011	378	9800					1388	1395		10.1016/S0140-6736(11)60890-8	http://dx.doi.org/10.1016/S0140-6736(11)60890-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	22000136	Green Submitted, Bronze			2022-12-24	WOS:000296269600025
J	Parenteau, J; Durand, M; Morin, G; Gagnon, J; Lucier, JF; Wellinger, RJ; Chabot, B; Abou Elela, S				Parenteau, Julie; Durand, Mathieu; Morin, Genevieve; Gagnon, Jules; Lucier, Jean-Francois; Wellinger, Raymund J.; Chabot, Benoit; Abou Elela, Sherif			Introns within Ribosomal Protein Genes Regulate the Production and Function of Yeast Ribosomes	CELL			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; CARCINOMA CELLS; EVOLUTION; REVEALS; STAUROSPORINE; REDUNDANCY; EUKARYOTES; DIVERSITY; APOPTOSIS	In budding yeast, the most abundantly spliced pre-mRNAs encode ribosomal proteins (RPs). To investigate the contribution of splicing to ribosome production and function, we systematically eliminated introns from all RP genes to evaluate their impact on RNA expression, pre-rRNA processing, cell growth, and response to stress. The majority of introns were required for optimal cell fitness or growth under stress. Most introns are found in duplicated RP genes, and surprisingly, in the majority of cases, deleting the intron from one gene copy affected the expression of the other in a nonreciprocal manner. Consistently, 70% of all duplicated genes were asymmetrically expressed, and both introns and gene deletions displayed copy-specific phenotypic effects. Together, our results indicate that splicing in yeast RP genes mediates intergene regulation and implicate the expression ratio of duplicated RP genes in modulating ribosome function.	[Parenteau, Julie; Durand, Mathieu; Morin, Genevieve; Gagnon, Jules; Lucier, Jean-Francois; Wellinger, Raymund J.; Chabot, Benoit; Abou Elela, Sherif] Univ Sherbrooke, Lab Genom Fonct, Dept Microbiol & Infectiol, Fac Med & Sci Sante, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Abou Elela, S (corresponding author), Univ Sherbrooke, Lab Genom Fonct, Dept Microbiol & Infectiol, Fac Med & Sci Sante, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	sherif.abou.elela@usherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759; Abou Elela, Sherif/0000-0002-0630-3294; Chabot, Benoit/0000-0003-0994-0042	Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-97874]; Fonds de la Recherche en Sante du Quebec (FRSQ)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	We thank members of the S.A.E. lab for discussions and Jean-Philippe Brosseau and Philippe Thibault for help with the analysis of the qPCR data. This work was supported by grants from Natural Sciences and Engineering Research Council of Canada to S.A.E. and Canadian Institutes of Health Research to R.J.W. (grant MOP-97874). B.C. is the Canada Research Chair in Functional Genomics. R.J.W. is the Canada Research Chair in Telomere Biology. S.A.E. is a Chercheur National of the Fonds de la Recherche en Sante du Quebec (FRSQ). J.G. is supported by Fonds de la Recherche en Sante du Quebec (FRSQ).	Allmang C, 1996, RNA, V2, P63; Allmang C, 1998, J MOL BIOL, V278, P67, DOI 10.1006/jmbi.1998.1693; Ares M, 1999, RNA, V5, P1138, DOI 10.1017/S1355838299991379; Arvas M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-325; Babenko VN, 2004, NUCLEIC ACIDS RES, V32, P5029, DOI 10.1093/nar/gkh833; Benz E J Jr, 1997, Trans Am Clin Climatol Assoc, V108, P78; Brosseau JP, 2010, RNA, V16, P442, DOI 10.1261/rna.1877010; Bulman S, 2007, PROTIST, V158, P423, DOI 10.1016/j.protis.2007.04.005; Catala M, 2008, MOL CELL BIOL, V28, P619, DOI 10.1128/MCB.01805-07; Davidovich C, 2009, RES MICROBIOL, V160, P487, DOI 10.1016/j.resmic.2009.07.004; Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700; de Mayolo PA, 2003, J MOL BIOL, V333, P697, DOI 10.1016/j.jmb.2003.09.006; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Granneman S, 2005, MOL CELL BIOL, V25, P10352, DOI 10.1128/MCB.25.23.10352-10364.2005; Grate L, 2002, METHOD ENZYMOL, V350, P380, DOI 10.1016/S0076-6879(02)50975-7; Heerdt BG, 2000, CANCER RES, V60, P6704; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Juneau K, 2007, P NATL ACAD SCI USA, V104, P1522, DOI 10.1073/pnas.0610354104; Juneau K, 2009, GENETICS, V183, P185, DOI 10.1534/genetics.109.105155; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4; Lee C, 2010, RNA, V16, P91, DOI 10.1261/rna.1812710; Li JJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001187; Meskauskas A, 2008, NUCLEIC ACIDS RES, V36, P1826, DOI 10.1093/nar/gkn034; Nadano D, 2001, BIOCHEMISTRY-US, V40, P15184, DOI 10.1021/bi0108397; OHTA T, 1988, GENETICS, V120, P841; Parenteau J, 2008, MOL BIOL CELL, V19, P1932, DOI 10.1091/mbc.E07-12-1254; Preker PJ, 2006, RNA, V12, P994, DOI 10.1261/rna.6706; Rose MD., 1990, METHODS YEAST GENETI; Roy SW, 2006, GENOME RES, V16, P1270, DOI 10.1101/gr.5410606; Russell AG, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-45; Sakurai A, 2002, GENE, V300, P89, DOI 10.1016/S0378-1119(02)01035-1; Solis AS, 2008, FRONT BIOSCI-LANDMRK, V13, P1926, DOI 10.2741/2812; Spingola M, 1999, RNA, V5, P221, DOI 10.1017/S1355838299981682; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Sugino RP, 2006, TRENDS GENET, V22, P642, DOI 10.1016/j.tig.2006.09.014; Toussaint M, 2006, MUTAT RES-GEN TOX EN, V606, P92, DOI 10.1016/j.mrgentox.2006.03.006; TUHACKOVA Z, 1994, BIOCHEM MOL BIOL INT, V32, P545; VILARDELL J, 1994, GENE DEV, V8, P211, DOI 10.1101/gad.8.2.211; Vilardell J, 1997, MOL CELL BIOL, V17, P1959, DOI 10.1128/MCB.17.4.1959; Wang HF, 2007, BIOCHEM BIOPH RES CO, V354, P203, DOI 10.1016/j.bbrc.2006.12.184; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weng S, 2003, NUCLEIC ACIDS RES, V31, P216, DOI 10.1093/nar/gkg054; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; ZAKIAN VA, 1982, MOL CELL BIOL, V2, P221, DOI 10.1128/MCB.2.3.221; Zhuo DG, 2007, P NATL ACAD SCI USA, V104, P882, DOI 10.1073/pnas.0604777104	48	86	88	2	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 14	2011	147	2					320	331		10.1016/j.cell.2011.08.044	http://dx.doi.org/10.1016/j.cell.2011.08.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000012	Bronze			2022-12-24	WOS:000296199300011
J	Opitz, CA; Litzenburger, UM; Sahm, F; Ott, M; Tritschler, I; Trump, S; Schumacher, T; Jestaedt, L; Schrenk, D; Weller, M; Jugold, M; Guillemin, GJ; Miller, CL; Lutz, C; Radlwimmer, B; Lehmann, I; von Deimling, A; Wick, W; Platten, M				Opitz, Christiane A.; Litzenburger, Ulrike M.; Sahm, Felix; Ott, Martina; Tritschler, Isabel; Trump, Saskia; Schumacher, Theresa; Jestaedt, Leonie; Schrenk, Dieter; Weller, Michael; Jugold, Manfred; Guillemin, Gilles J.; Miller, Christine L.; Lutz, Christian; Radlwimmer, Bernhard; Lehmann, Irina; von Deimling, Andreas; Wick, Wolfgang; Platten, Michael			An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor	NATURE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN 2,3-DIOXYGENASE; T-CELLS; INHIBITION; KYNURENINE; DIFFERENTIATION; INFLAMMATION; DEGRADATION; SUPPRESSION; PATHWAY	Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals, for instance 2,3,7,8-tetrachlorodibenzo-p-dioxin (dioxin), has been implicated in a variety of cellular processes such as embryogenesis, transformation, tumorigenesis and inflammation. But the identity of an endogenous ligand activating the AHR under physiological conditions in the absence of environmental toxic chemicals is still unknown. Here we identify the tryptophan (Trp) catabolite kynurenine (Kyn) as an endogenous ligand of the human AHR that is constitutively generated by human tumour cells via tryptophan-2,3-dioxygenase (TDO), a liver-and neuron-derived Trp-degrading enzyme not yet implicated in cancer biology. TDO-derived Kyn suppresses antitumour immune responses and promotes tumour-cell survival and motility through the AHR in an autocrine/paracrine fashion. The TDO-AHR pathway is active in human brain tumours and is associated with malignant progression and poor survival. Because Kyn is produced during cancer progression and inflammation in the local microenvironment in amounts sufficient for activating the human AHR, these results provide evidence for a previously unidentified pathophysiological function of the AHR with profound implications for cancer and immune biology.	[Opitz, Christiane A.; Litzenburger, Ulrike M.; Ott, Martina; Schumacher, Theresa; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Neurol Clin, Dept Neurooncol, D-69120 Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Ott, Martina; Schumacher, Theresa; Wick, Wolfgang; Platten, Michael] Univ Heidelberg Hosp, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany; [Opitz, Christiane A.; Litzenburger, Ulrike M.; Ott, Martina; Schumacher, Theresa; Platten, Michael] German Canc Res Ctr, Expt Neuroimmunol Unit, D-69120 Heidelberg, Germany; [Sahm, Felix; von Deimling, Andreas] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany; [Sahm, Felix; von Deimling, Andreas] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Tritschler, Isabel; Weller, Michael] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Trump, Saskia; Lehmann, Irina] UFZ Helmholtz Ctr Environm Res, Dept Environm Immunol, D-04318 Leipzig, Germany; [Jestaedt, Leonie] Univ Heidelberg Hosp, Dept Neuroradiol, D-69120 Heidelberg, Germany; [Schrenk, Dieter] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany; [Jugold, Manfred] German Canc Res Ctr, Small Anim Imaging Ctr, D-69120 Heidelberg, Germany; [Guillemin, Gilles J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Miller, Christine L.] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA; [Lutz, Christian] Heidelberg Pharma AG, D-68526 Ladenburg, Germany; [Radlwimmer, Bernhard] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, Clin Cooperat Unit Neurooncol, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Zurich; University Zurich Hospital; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Ruprecht Karls University Heidelberg; University of Kaiserslautern; Helmholtz Association; German Cancer Research Center (DKFZ); University of New South Wales Sydney; Johns Hopkins University; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Platten, M (corresponding author), Univ Heidelberg Hosp, Neurol Clin, Dept Neurooncol, D-69120 Heidelberg, Germany.	m.platten@dkfz-heidelberg.de	von Deimling, Andreas/F-7774-2013; Trump, Saskia/ABG-5182-2021; Wick, Wolfgang/AAA-2545-2020; Bunse, Theresa/AAD-1719-2019; Opitz, Christiane A/I-9507-2012; Radlwimmer, Bernhard F/I-3229-2013; Platten, Michael/F-2902-2013; Guillemin, Gilles J/C-3878-2015; Sahm, Felix/GQY-8202-2022	von Deimling, Andreas/0000-0002-5863-540X; Wick, Wolfgang/0000-0002-6171-634X; Opitz, Christiane A/0000-0001-5575-9821; Radlwimmer, Bernhard F/0000-0002-4553-7800; Platten, Michael/0000-0002-4746-887X; Guillemin, Gilles J/0000-0001-8105-4470; Sahm, Felix/0000-0001-5441-1962; Weller, Michael/0000-0002-1748-174X; Trump, Saskia/0000-0002-9894-1807; Lehmann, Irina/0000-0001-8875-5587	Helmholtz Association [VH-NG-306]; German Research Foundation [SFB 938 TP K]; Hertie Foundation; Helmholtz Alliance on Systems Biology; DKFZ PhD Program stipend; Heidelberg University Medical Faculty	Helmholtz Association(Helmholtz Association); German Research Foundation(German Research Foundation (DFG)); Hertie Foundation; Helmholtz Alliance on Systems Biology; DKFZ PhD Program stipend; Heidelberg University Medical Faculty	We thank K. Rauschenbach, J. Reiert, S. Koch and A. Mlitzko for technical assistance, P.-N. Pfenning for help with the invasion assays, J. Blaes for help generating genetically modified cells, T. V. Lanz and I. Oezen for help with animal experiments, C. Esser for providing Ahr<SUP>-/-</SUP> mice, M. Schwarz for providing the human DRE-luciferase construct, D. Lemke for generating GICs, K. Ochs for providing human umbilical-vein endothelial cell cDNA, A. Hertenstein for generation of CD4<SUP>+</SUP> and CD8<SUP>+</SUP> T cells, M. Betts and R. B. Russel for modelling of the binding of Kyn to the AHR, R. Koch for performing quantitative reverse transcriptase polymerase chain reaction analyses, R. Tudoran for generation of GL261 cells overexpressing murine TDO, M. Deponte for help with the radioligand binding assay, D. Schemmer for collecting and banking serum samples, W. Roth for providing tissue specimens, M. Remke for suggestions regarding data analysis, and G. Hammerling, B. Arnold and M. Feuerer for discussions. This work was supported by grants from the Helmholtz Association (VH-NG-306) to M. P., the German Research Foundation to M. P. and W. W. (Deutsche Forschungsgemeinschaft SFB 938 TP K), the Hertie Foundation to W. W. and the Helmholtz Alliance on Systems Biology to S. T. and I. L. T. S. is supported by a DKFZ PhD Program stipend. C.A.O. is supported by a Heidelberg University Medical Faculty Postdoctoral Fellowship.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Dolusic E, 2011, J MED CHEM, V54, P5320, DOI 10.1021/jm2006782; Esser C, 2009, TRENDS IMMUNOL, V30, P447, DOI 10.1016/j.it.2009.06.005; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; Frericks M, 2008, TOXICOL APPL PHARM, V232, P268, DOI 10.1016/j.taap.2008.07.009; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; Gramatzki D, 2009, ONCOGENE, V28, P2593, DOI 10.1038/onc.2009.104; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Miller CL, 2004, NEUROBIOL DIS, V15, P618, DOI 10.1016/j.nbd.2003.12.015; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Muller AJ, 2008, P NATL ACAD SCI USA, V105, P17073, DOI 10.1073/pnas.0806173105; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; NewLink Genetics Corporation, 2008, IDO INH STUD REL REF; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Opitz CA, 2007, CELL MOL LIFE SCI, V64, P2542, DOI 10.1007/s00018-007-7140-9; Opitz CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019823; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Zudaire E, 2008, J CLIN INVEST, V118, P640, DOI 10.1172/JCI30024	33	1204	1289	7	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					197	203		10.1038/nature10491	http://dx.doi.org/10.1038/nature10491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21976023	Green Accepted, Bronze			2022-12-24	WOS:000295782800040
J	Chappie, JS; Mears, JA; Fang, SM; Leonard, M; Schmid, SL; Milligan, RA; Hinshaw, JE; Dyda, F				Chappie, Joshua S.; Mears, Jason A.; Fang, Shunming; Leonard, Marilyn; Schmid, Sandra L.; Milligan, Ronald A.; Hinshaw, Jenny E.; Dyda, Fred			A Pseudoatomic Model of the Dynamin Polymer Identifies a Hydrolysis-Dependent Powerstroke	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PLECKSTRIN HOMOLOGY DOMAIN; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; STALK REGION; IN-VIVO; MEMBRANE; CONSTRICTION; MECHANISM	The GTPase dynamin catalyzes membrane fission by forming a collar around the necks of clathrin-coated pits, but the specific structural interactions and conformational changes that drive this process remain a mystery. We present the GMPPCP-bound structures of the truncated human dynamin 1 helical polymer at 12.2 angstrom and a fusion protein, GG, linking human dynamin 1's catalytic G domain to its GTPase effector domain (GED) at 2.2 angstrom. The structures reveal the position and connectivity of dynamin fragments in the assembled structure, showing that G domain dimers only form between tetramers in sequential rungs of the dynamin helix. Using chemical crosslinking, we demonstrate that dynamin tetramers are made of two dimers, in which the G domain of one molecule interacts in trans with the GED of another. Structural comparison of GG(GMPPCP) to the GG transition-state complex identifies a hydrolysis-dependent powerstroke that may play a role in membrane-remodeling events necessary for fission.	[Mears, Jason A.; Fang, Shunming; Hinshaw, Jenny E.] NIDDKD, Lab Cell Biochem & Biol, Bethesda, MD 20892 USA; [Chappie, Joshua S.; Dyda, Fred] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Mears, Jason A.] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Leonard, Marilyn; Schmid, Sandra L.; Milligan, Ronald A.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Case Western Reserve University; Scripps Research Institute	Hinshaw, JE (corresponding author), NIDDKD, Lab Cell Biochem & Biol, Bethesda, MD 20892 USA.	jennyh@helix.nih.gov; dyda@helix.nih.gov	Chappie, Joshua S./AAV-6076-2021	Chappie, Joshua S./0000-0002-5733-7275; Schmid, Sandra/0000-0002-1690-7024; Mears, Jason/0000-0002-5199-4872	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH [GM52468, GM75820, GM42455]; National Institutes of Health through the National Center for Research Resources [RR017573]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060100, ZIADK075049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075820, R01GM052468, R37GM052468, R01GM042455] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Vasyl Lukiyanchuk and Sharmistha Acharya for assistance in cloning and purification, Rodolfo Ghirlando for assistance with sedimentation velocity experiments, Juha-Pekka Mattila for communication of unpublished data, Joshua Zimmerberg for insightful discussions, Alison B. Hickman for technical advice and critical reading of the manuscript, and Yihong Ye for critical reading of the manuscript. We especially thank Marijn Ford and Jodi Nunnari for the ongoing open dialogue regarding the intricacies of dynamin structure and assembly. This work was supported by the Intramural Program of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and NIH grants GM52468 and GM75820 (to R.A.M.) and GM42455 (to S.L.S.). J.S.C. was supported by a Nancy Nossal Fellowship award from NIDDK. A portion of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program (RR017573).	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Colombo Marina, ANNU REV CELL DEV BI, V30, P255, DOI [DOI 10.1146/ANNUREV-CELLBIO-100109-104016, 10.1146/annurev-cellbio-101512-122326, DOI 10.1146/ANNUREV-CELLBIO-101512-122326]; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Egelman EH, 2007, J STRUCT BIOL, V157, P83, DOI 10.1016/j.jsb.2006.05.015; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Leonard M, 2005, METHOD ENZYMOL, V404, P490, DOI 10.1016/S0076-6879(05)04043-7; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Mallick SP, 2005, ULTRAMICROSCOPY, V104, P8, DOI 10.1016/j.ultramic.2005.02.004; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Potter CS, 1999, ULTRAMICROSCOPY, V77, P153, DOI 10.1016/S0304-3991(99)00043-1; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Sever S, 2006, EMBO J, V25, P4163, DOI 10.1038/sj.emboj.7601298; Solomaha E, 2005, BIOCHEM J, V391, P601, DOI 10.1042/BJ20050707; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Tan RKZ, 2008, J STRUCT BIOL, V163, P163, DOI 10.1016/j.jsb.2008.05.001; Tan RKZ, 2006, J CHEM THEORY COMPUT, V2, P529, DOI 10.1021/ct050323r; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Wilson-Kubalek EM, 2010, METHOD ENZYMOL, V481, P45, DOI 10.1016/S0076-6879(10)81002-X; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	49	153	155	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					209	222		10.1016/j.cell.2011.09.003	http://dx.doi.org/10.1016/j.cell.2011.09.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962517	Green Accepted, Bronze			2022-12-24	WOS:000295396700027
J	Kraft, NJB; Comita, LS; Chase, JM; Sanders, NJ; Swenson, NG; Crist, TO; Stegen, JC; Vellend, M; Boyle, B; Anderson, MJ; Cornell, HV; Davies, KF; Freestone, AL; Inouye, BD; Harrison, SP; Myers, JA				Kraft, Nathan J. B.; Comita, Liza S.; Chase, Jonathan M.; Sanders, Nathan J.; Swenson, Nathan G.; Crist, Thomas O.; Stegen, James C.; Vellend, Mark; Boyle, Brad; Anderson, Marti J.; Cornell, Howard V.; Davies, Kendi F.; Freestone, Amy L.; Inouye, Brian D.; Harrison, Susan P.; Myers, Jonathan A.			Disentangling the Drivers of beta Diversity Along Latitudinal and Elevational Gradients	SCIENCE			English	Article							GAMMA-DIVERSITY; COMMUNITY DIVERSITY; SPECIES-DIVERSITY; AMAZONIAN FOREST; ALPHA-DIVERSITY; TREE COMMUNITY; SCALE; ENVIRONMENTS; BIODIVERSITY; RICHNESS	Understanding spatial variation in biodiversity along environmental gradients is a central theme in ecology. Differences in species compositional turnover among sites (beta diversity) occurring along gradients are often used to infer variation in the processes structuring communities. Here, we show that sampling alone predicts changes in beta diversity caused simply by changes in the sizes of species pools. For example, forest inventories sampled along latitudinal and elevational gradients show the well-documented pattern that beta diversity is higher in the tropics and at low elevations. However, after correcting for variation in pooled species richness (gamma diversity), these differences in beta diversity disappear. Therefore, there is no need to invoke differences in the mechanisms of community assembly in temperate versus tropical systems to explain these global-scale patterns of beta diversity.	[Kraft, Nathan J. B.; Vellend, Mark] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada; [Kraft, Nathan J. B.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Comita, Liza S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Chase, Jonathan M.; Myers, Jonathan A.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Sanders, Nathan J.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Sanders, Nathan J.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen O, Denmark; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Crist, Thomas O.] Miami Univ, Inst Environm & Sustainabil, Oxford, OH 45056 USA; [Crist, Thomas O.] Miami Univ, Dept Zool, Oxford, OH 45056 USA; [Stegen, James C.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Stegen, James C.] Pacific NW Natl Lab, Fundamental & Computat Sci Directorate, Div Biol Sci, Richland, WA 99352 USA; [Vellend, Mark] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada; [Boyle, Brad] Univ Arizona, Dept Ecol & Evolut, Tucson, AZ 85719 USA; [Anderson, Marti J.] Massey Univ, New Zealand Inst Adv Study, Auckland 0745, New Zealand; [Cornell, Howard V.; Harrison, Susan P.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Davies, Kendi F.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Freestone, Amy L.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Inouye, Brian D.] Florida State Univ, Tallahassee, FL 32306 USA	University of British Columbia; University System of Maryland; University of Maryland College Park; National Center for Ecological Analysis & Synthesis; Smithsonian Institution; Smithsonian Tropical Research Institute; Washington University (WUSTL); University of Tennessee System; University of Tennessee Knoxville; University of Copenhagen; Michigan State University; University System of Ohio; Miami University; University System of Ohio; Miami University; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Sherbrooke; University of Arizona; Massey University; University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University System of Florida; Florida State University	Kraft, NJB (corresponding author), Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada.	nkraft@biodiversity.ubc.ca	Sanders, Nathan/ABE-4335-2020; Stegen, James/Q-3078-2016; Sanders, Nathan/A-6945-2009; Kraft, Nathan J. B./A-2817-2012; B, A/AHB-5155-2022; Swenson, Nathan/A-3514-2012; Anderson, Marti J./AAQ-9038-2021	Stegen, James/0000-0001-9135-7424; Sanders, Nathan/0000-0001-6220-6731; Kraft, Nathan J. B./0000-0001-8867-7806; Swenson, Nathan/0000-0003-3819-9767; Anderson, Marti J./0000-0002-4018-4049; Comita, Liza/0000-0002-9169-1331	National Center for Ecological Analysis and Synthesis (NCEAS); NSF [EF-0553768, DBI-0906005]; University of California, Santa Barbara; state of California; National Science and Engineering Research Council of Canada; U.S. Department of Energy [DE-FG02-08ER64510]; Veterans Affairs [IK6RX002477] Funding Source: NIH RePORTER	National Center for Ecological Analysis and Synthesis (NCEAS); NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); state of California; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy(United States Department of Energy (DOE)); Veterans Affairs(US Department of Veterans Affairs)	We are grateful to A. H. Gentry, the Missouri Botanical Garden, and numerous additional collectors who contributed to the latitudinal data set. The data sets are available in the original publications or electronically from SALVIAS (www.salvias.net). This work was conducted as part of the Gradients of beta-diversity Working Group supported by the National Center for Ecological Analysis and Synthesis (NCEAS), a center funded by NSF (grant EF-0553768); the University of California, Santa Barbara; and the state of California. N.J.B.K. was supported by the National Science and Engineering Research Council of Canada CREATE Training Program in Biodiversity Research. L. S. C. was supported by an NCEAS postdoctoral fellowship. N.J.S. was supported by U.S. Department of Energy Program for Ecosystem Research DE-FG02-08ER64510. J.C.S. was supported by an NSF Postdoctoral Fellowship in Bioinformatics (DBI-0906005).	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Boyle B. L., 1996, THESIS WASHINGTON U; Caley MJ, 1997, ECOLOGY, V78, P70; Canham CD, 2004, CAN J FOREST RES, V34, P778, DOI [10.1139/x03-232, 10.1139/X03-232]; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Cornell HV, 2007, ECOLOGY, V88, P1707, DOI 10.1890/06-0742.1; Crist TO, 2006, ECOL LETT, V9, P923, DOI 10.1111/j.1461-0248.2006.00941.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Dahl C, 2009, J BIOGEOGR, V36, P896, DOI 10.1111/j.1365-2699.2008.02042.x; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Jost L, 2007, ECOLOGY, V88, P2427, DOI 10.1890/06-1736.1; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Phillips O, 2002, GLOBAL PATTERNS PLAN; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; RICKLEFS RE, 1987, SCIENCE, V235, P167, DOI 10.1126/science.235.4785.167; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Ricotta C, 2010, ECOLOGY, V91, P1981, DOI 10.1890/09-0126.1; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Svenning JC, 1999, J ECOL, V87, P55, DOI 10.1046/j.1365-2745.1999.00329.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Valencia R, 2004, J ECOL, V92, P214, DOI 10.1111/j.0022-0477.2004.00876.x; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	34	488	518	27	677	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1755	1758		10.1126/science.1208584	http://dx.doi.org/10.1126/science.1208584			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940897				2022-12-24	WOS:000295121500045
J	Bouchoux, C; Uhlmann, F				Bouchoux, Celine; Uhlmann, Frank			A Quantitative Model for Ordered Cdk Substrate Dephosphorylation during Mitotic Exit	CELL			English	Article							BUDDING YEAST; CELL-CYCLE; PHOSPHATASE CDC14; CHROMOSOME SEGREGATION; PROTEIN PHOSPHATASE; ANAPHASE ONSET; MITOSIS; KINASE; PHOSPHORYLATION; SEPARASE	After sister chromatid splitting at anaphase onset, exit from mitosis comprises an ordered series of events. Dephosphorylation of numerous mitotic substrates, which were phosphorylated by cyclin-dependent kinase (Cdk), is thought to bring about mitotic exit, but how temporal ordering of mitotic exit events is achieved is poorly understood. Here, we show, using budding yeast, that dephosphorylation of Cdk substrates involved in sequential mitotic exit events occurs with ordered timing. We test different models of how ordering might be achieved by modulating Cdk and Cdk-counteracting phosphatase Cdc14 activities in vivo, as well as by kinetic analysis of Cdk substrate phosphorylation and dephosphorylation in vitro. Our results suggest that the gradual change of the phosphatase to kinase ratio over the course of mitotic exit is read out by Cdk substrates that respond by dephosphorylation at distinct thresholds. This provides an example and a mechanistic explanation for a quantitative model of cell-cycle progression.	[Bouchoux, Celine; Uhlmann, Frank] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3LY, England	Cancer Research UK	Uhlmann, F (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Chromosome Segregat Lab, London WC2A 3LY, England.	frank.uhlmann@cancer.org.uk		Bouchoux, Celine/0000-0001-5064-4718; Uhlmann, Frank/0000-0002-3527-6619				Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; CULOTTI J, 1971, EXP CELL RES, V67, P389, DOI 10.1016/0014-4827(71)90424-1; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; Errico A, 2010, ADV ENZYME REGUL, V50, P375, DOI 10.1016/j.advenzreg.2009.12.001; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Higuchi T, 2005, NATURE, V433, P171, DOI 10.1038/nature03240; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jin FZ, 2008, P NATL ACAD SCI USA, V105, P16177, DOI 10.1073/pnas.0808719105; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Lopez-Aviles S, 2009, NATURE, V459, P592, DOI 10.1038/nature07984; Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Mochida S, 2009, EMBO J, V28, P2777, DOI 10.1038/emboj.2009.238; Mohl DA, 2009, J CELL BIOL, V184, P527, DOI 10.1083/jcb.200812022; MURRAY AW, 1989, SCIENCE, V246, P614, DOI 10.1126/science.2683077; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Nikolova N, 2008, CENT EUR J BIOL, V3, P345, DOI 10.2478/s11535-008-0035-4; Noton E, 2000, MOL CELL, V5, P85, DOI 10.1016/S1097-2765(00)80405-0; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Queralt E, 2006, CELL, V125, P719, DOI 10.1016/j.cell.2006.03.038; Queralt E, 2008, CURR OPIN CELL BIOL, V20, P661, DOI 10.1016/j.ceb.2008.09.003; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; SCHWOB E, 1993, GENE DEV, V7, P1160, DOI 10.1101/gad.7.7a.1160; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Stern Bodo, 1996, Trends in Genetics, V12, P345, DOI 10.1016/0168-9525(96)10036-6; Sullivan M, 2004, CELL, V117, P471, DOI 10.1016/S0092-8674(04)00415-5; Sullivan M, 2003, NAT CELL BIOL, V5, P249, DOI 10.1038/ncb940; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Wang WQ, 2004, J BIOL CHEM, V279, P30459, DOI 10.1074/jbc.M402217200; Wolf F, 2006, EMBO J, V25, P2802, DOI 10.1038/sj.emboj.7601163; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Zhai YL, 2010, J CELL SCI, V123, P3933, DOI 10.1242/jcs.075366	43	90	91	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					803	814		10.1016/j.cell.2011.09.047	http://dx.doi.org/10.1016/j.cell.2011.09.047			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078879	Bronze			2022-12-24	WOS:000296902300014
J	Fryer, JD; Yu, P; Kang, H; Mandel-Brehm, C; Carter, AN; Crespo-Barreto, J; Gao, Y; Flora, A; Shaw, C; Orr, HT; Zoghbi, HY				Fryer, John D.; Yu, Peng; Kang, Hyojin; Mandel-Brehm, Caleigh; Carter, Angela N.; Crespo-Barreto, Juan; Gao, Yan; Flora, Adriano; Shaw, Chad; Orr, Harry T.; Zoghbi, Huda Y.			Exercise and Genetic Rescue of SCA1 via the Transcriptional Repressor Capicua	SCIENCE			English	Article							SPINOCEREBELLAR ATAXIA TYPE-1; AMYOTROPHIC-LATERAL-SCLEROSIS; MOUSE MODEL; CAG REPEAT; EXPANSION; DISEASE	Spinocerebellar ataxia type 1 (SCA1) is a fatal neurodegenerative disease caused by expansion of a translated CAG repeat in Ataxin-1 (ATXN1). To determine the long-term effects of exercise, we implemented a mild exercise regimen in a mouse model of SCA1 and found a considerable improvement in survival accompanied by up-regulation of epidermal growth factor and consequential down-regulation of Capicua, which is an ATXN1 interactor. Offspring of Capicua mutant mice bred to SCA1 mice showed significant improvement of all disease phenotypes. Although polyglutamine-expanded Atxn1 caused some loss of Capicua function, further reduction of Capicua levels-either genetically or by exercise-mitigated the disease phenotypes by dampening the toxic gain of function. Thus, exercise might have long-term beneficial effects in other ataxias and neurodegenerative diseases.	[Fryer, John D.; Yu, Peng; Kang, Hyojin; Mandel-Brehm, Caleigh; Crespo-Barreto, Juan; Gao, Yan; Flora, Adriano; Shaw, Chad; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Carter, Angela N.; Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Shaw, Chad] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Orr, Harry T.] Univ Minnesota, Inst Translat Neurosci, Minneapolis, MN 55455 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Zoghbi, Huda/0000-0002-0700-3349; mandel-brehm, caleigh/0000-0001-7764-6529; Orr, Harry/0000-0001-6118-741X; Shaw, Chad/0000-0001-7267-5398	NIH (Baylor College of Medicine-Intellectual and Developmental Disabilities Research Center) [NS27699, NS27699-20S1-ARRA, HD24064]; NIH [1F32NS055545, NS022920, NS045667]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022920, R01NS027699, F32NS055545, R37NS022920, R37NS027699, R01NS045667, T32NS043124] Funding Source: NIH RePORTER	NIH (Baylor College of Medicine-Intellectual and Developmental Disabilities Research Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	J.D.F. and H.Y.Z. conceived of the study and designed experiments. J.D.F., C. M. B., A.N.C., and Y.G. performed behavioral assays and provided input on analysis. J.D.F. and J.C.-B. performed molecular work and analysis. P.Y., H. K., and C. S. analyzed microarray data. J.D.F. and H.Y.Z. wrote the manuscript with input from J.C.-.B, A. F., and H.T.O. We are grateful to G. Schuster for the generation of mutant mice and the members of the H.Y.Z. laboratory for comments and discussions on the manuscript. This research was supported by NIH grants NS27699, NS27699-20S1-ARRA, and HD24064 (Baylor College of Medicine-Intellectual and Developmental Disabilities Research Center) to H.Y.Z.; 1F32NS055545 to J.D.F.; and NS022920 and NS045667 to H.T.O. H.Y.Z. is an investigator with the Howard Hughes Medical Institute, holds a patent on SCA1 diagnostic testing, and is on the scientific advisory board of Pfizer Neuroscience Program.	Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Crespo-Barreto J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001021; Ilg W, 2009, NEUROLOGY, V73, P1823, DOI 10.1212/WNL.0b013e3181c33adf; Kawamura-Saito M, 2006, HUM MOL GENET, V15, P2125, DOI 10.1093/hmg/ddl136; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; Thomas PS, 2006, HUM MOL GENET, V15, P2225, DOI 10.1093/hmg/ddl148; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Vaz DV, 2008, CLIN REHABIL, V22, P234, DOI 10.1177/0269215507081578; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	15	103	106	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					690	693		10.1126/science.1212673	http://dx.doi.org/10.1126/science.1212673			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053053	Green Accepted			2022-12-24	WOS:000296494700060
J	Shukla, S; Kavak, E; Gregory, M; Imashimizu, M; Shutinoski, B; Kashlev, M; Oberdoerffer, P; Sandberg, R; Oberdoerffer, S				Shukla, Sanjeev; Kavak, Ersen; Gregory, Melissa; Imashimizu, Masahiko; Shutinoski, Bojan; Kashlev, Mikhail; Oberdoerffer, Philipp; Sandberg, Rickard; Oberdoerffer, Shalini			CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing	NATURE			English	Article							INSULATOR PROTEIN CTCF; BINDING-SITES; ZINC FINGERS; CD45; TRANSCRIPTION; IDENTIFICATION; ELONGATION; EXPRESSION; REPRESSOR; SEQUENCES	Alternative splicing of pre-messenger RNA is a key feature of transcriptome expansion in eukaryotic cells, yet its regulation is poorly understood. Spliceosome assembly occurs co-transcriptionally, raising the possibility that DNA structure may directly influence alternative splicing. Supporting such an association, recent reports have identified distinct histone methylation patterns, elevated nucleosome occupancy and enriched DNA methylation at exons relative to introns. Moreover, the rate of transcription elongation has been linked to alternative splicing. Here we provide the first evidence that a DNA-binding protein, CCCTC-binding factor (CTCF), can promote inclusion of weak upstream exons by mediating local RNA polymerase II pausing both in a mammalian model system for alternative splicing, CD45, and genome-wide. We further show that CTCF binding to CD45 exon 5 is inhibited by DNA methylation, leading to reciprocal effects on exon 5 inclusion. These findings provide a mechanistic basis for developmental regulation of splicing outcome through heritable epigenetic marks.	[Shukla, Sanjeev; Gregory, Melissa; Shutinoski, Bojan; Oberdoerffer, Philipp; Oberdoerffer, Shalini] Natl Canc Inst Frederick, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Kavak, Ersen; Sandberg, Rickard] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Kavak, Ersen; Sandberg, Rickard] Ludwig Inst Canc Res, SE-17177 Stockholm, Sweden; [Imashimizu, Masahiko; Kashlev, Mikhail] Natl Canc Inst Frederick, Ctr Canc Res, Gene Regulat & Chromosome Biol Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Karolinska Institutet; Ludwig Institute for Cancer Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Oberdoerffer, S (corresponding author), Natl Canc Inst Frederick, Ctr Canc Res, Mouse Canc Genet Program, Frederick, MD 21702 USA.	shalini.oberdoerffer@nih.gov	Shukla, Sanjeev/L-8391-2018; Imashimizu, Masahiko/M-4278-2018; Shutinoski, Bojan/M-5260-2016	Shukla, Sanjeev/0000-0003-3361-0588; Imashimizu, Masahiko/0000-0003-4891-5034; Sandberg, Rickard/0000-0001-6473-1740; Shutinoski, Bojan/0000-0003-4669-5656	NIH, the National Cancer Institute, The Center for Cancer Research; Swedish Research Council Foundation; Foundation for Strategic Research; NATIONAL CANCER INSTITUTE [ZIABC010795] Funding Source: NIH RePORTER	NIH, the National Cancer Institute, The Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Research Council Foundation; Foundation for Strategic Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Rao, C. Burge and K. Lynch for critical reading of this manuscript. We also thank A. Rao for reagents and K. Nyswaner and M. Prigge for technical assistance. This work is supported by the Intramural Research Program of NIH, the National Cancer Institute, The Center for Cancer Research (S.O., P.O., M. K.), and the Swedish Research Council Foundation and the Foundation for Strategic Research (R.S.).	Allo M, 2010, COLD SH Q B, V75, P103, DOI 10.1101/sqb.2010.75.023; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Hodges E, 2009, GENOME RES, V19, P1593, DOI 10.1101/gr.095190.109; HORGAN KJ, 1994, EUR J IMMUNOL, V24, P1240, DOI 10.1002/eji.1830240536; Huff JT, 2010, NAT STRUCT MOL BIOL, V17, P1495, DOI 10.1038/nsmb.1924; Jelinic P, 2007, J PATHOL, V211, P261, DOI 10.1002/path.2116; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kireeva ML, 2008, MOL CELL, V30, P557, DOI 10.1016/j.molcel.2008.04.017; Kireeva ML, 2003, METHOD ENZYMOL, V370, P138; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Kornblihtt AR, 2007, ADV EXP MED BIOL, V623, P175, DOI 10.1007/978-0-387-77374-2_11; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luco RF, 2011, CELL, V144, P16, DOI 10.1016/j.cell.2010.11.056; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Motta-Mena LB, 2010, MOL CELL, V37, P223, DOI 10.1016/j.molcel.2009.12.027; Oberdoerffer S, 2008, SCIENCE, V321, P686, DOI 10.1126/science.1157610; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ramskold D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000598; Renda M, 2007, J BIOL CHEM, V282, P33336, DOI 10.1074/jbc.M706213200; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Singh R, 2005, NAT STRUCT MOL BIOL, V12, P645, DOI 10.1038/nsmb961; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Tong A, 2005, J BIOL CHEM, V280, P38297, DOI 10.1074/jbc.M508123200; Topp JD, 2008, RNA, V14, P2038, DOI 10.1261/rna.1212008; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; UCSC Genome Browser, UCSC GEN BROWS GRC37; Wada Y, 2009, P NATL ACAD SCI USA, V106, P18357, DOI 10.1073/pnas.0902573106; Wall ME, 2001, BIOINFORMATICS, V17, P566, DOI 10.1093/bioinformatics/17.6.566; Wall ME, 2003, PRACTICAL APPROACH M, P91, DOI DOI 10.1007/0-306-47815-3_5; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	54	670	692	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					74	U99		10.1038/nature10442	http://dx.doi.org/10.1038/nature10442			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	21964334	Green Accepted, Green Published			2022-12-24	WOS:000296422600034
J	Sumazin, P; Yang, XR; Chiu, HS; Chung, WJ; Iyer, A; Llobet-Navas, D; Rajbhandari, P; Bansal, M; Guarnieri, P; Silva, J; Califano, A				Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng; Chung, Wei-Jen; Iyer, Archana; Llobet-Navas, David; Rajbhandari, Presha; Bansal, Mukesh; Guarnieri, Paolo; Silva, Jose; Califano, Andrea			An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma	CELL			English	Article							INTEGRATED GENOMIC ANALYSIS; WIDE IDENTIFICATION; GENES; PTEN; PROLIFERATION; EXPRESSION; PROTEIN; MIRNAS; MODEL	By analyzing gene expression data in glioblastoma in combination with matched microRNA profiles, we have uncovered a posttranscriptional regulation layer of surprising magnitude, comprising more than 248,000 microRNA (miR)-mediated interactions. These include similar to 7,000 genes whose transcripts act as miR "sponges" and 148 genes that act through alternative, nonsponge interactions. Biochemical analyses in cell lines confirmed that this network regulates established drivers of tumor initiation and subtype implementation, including PTEN, PDGFRA, RB1, VEGFA, STAT3, and RUNX1, suggesting that these interactions mediate crosstalk between canonical oncogenic pathways. siRNA silencing of 13 miR-mediated PTEN regulators, whose locus deletions are predictive of PTEN expression variability, was sufficient to downregulate PTEN in a 30UTR-dependent manner and to increase tumor cell growth rates. Thus, miR-mediated interactions provide a mechanistic, experimentally validated rationale for the loss of PTEN expression in a large number of glioma samples with an intact PTEN locus.	[Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng; Chung, Wei-Jen; Iyer, Archana; Rajbhandari, Presha; Bansal, Mukesh; Guarnieri, Paolo; Califano, Andrea] Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10032 USA; [Sumazin, Pavel; Yang, Xuerui; Chiu, Hua-Sheng; Chung, Wei-Jen; Bansal, Mukesh; Guarnieri, Paolo; Califano, Andrea] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Chiu, Hua-Sheng; Chung, Wei-Jen; Califano, Andrea] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Silva, Jose] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Califano, Andrea] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Llobet-Navas, David; Silva, Jose; Califano, Andrea] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Llobet-Navas, David; Silva, Jose; Califano, Andrea] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Califano, A (corresponding author), Columbia Univ, Columbia Initiat Syst Biol, New York, NY 10032 USA.	califano@c2b2.columbia.edu	Llobet-Navas, David/B-5660-2009; Sumazin, Pavel/AAE-6607-2020; Llobet-Navas, David/AAT-4676-2021	Llobet-Navas, David/0000-0003-1443-7003; Sumazin, Pavel/0000-0002-1215-4977; Califano, Andrea/0000-0003-4742-3679; Yang, Xuerui/0000-0002-7731-2147	NIH [U54CA121852, R01CA109755, NCI-caBIG 29XS192]; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA109755, RC2CA148308, R01CA190891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank James Chi-ping Chen and Mariano J. Alvarez for critical discussion and Katia Basso, Francesco Niola, Antonio Iavarone, and Anna Lasorella for support and suggestions. We would also like to acknowledge the generous funding provided by the NIH under the following grant awards: (1) Roadmap grant for a Center for the Multiscale Analysis of Genetic Networks (MAGNet) (U54CA121852), (2) Genetic Network Inference with Combinational Phenotypes (R01CA109755), and (3) In Silico Research Centre of Excellence NCI-caBIG 29XS192. P.S. and A.C. conceived and supervised the project and participated in its computational and experimental design. P.S., H.-S.C, W.-J.C., M.B., and P.G. designed and implemented the computational methods. P.S., X.Y., H.-S.C., and W.-J.C. analyzed data. P.S., X.Y., J.S., and A.C. designed the experimental assays. X.Y., A.I., D.L.-N., and P.R. performed the experiments. P.S., X.Y., H.-S.C., and A.C. wrote the paper.	Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chatterjee S, 2011, DEV CELL, V20, P388, DOI 10.1016/j.devcel.2011.02.008; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Eiring AM, 2010, CELL, V140, P652, DOI 10.1016/j.cell.2010.01.007; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwak HJ, 2011, ONCOGENE, V30, P2433, DOI 10.1038/onc.2010.620; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Marioni JC, 2006, BIOINFORMATICS, V22, P1144, DOI 10.1093/bioinformatics/btl089; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Su WL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.23; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang K, 2009, NAT BIOTECHNOL, V27, P829, DOI 10.1038/nbt.1563; Zhao X, 2009, DEV CELL, V17, P210, DOI 10.1016/j.devcel.2009.07.009; Zhou YM, 2010, P NATL ACAD SCI USA, V107, P7904, DOI 10.1073/pnas.0908441107	37	567	587	1	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					370	381		10.1016/j.cell.2011.09.041	http://dx.doi.org/10.1016/j.cell.2011.09.041			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000015	Bronze, Green Accepted			2022-12-24	WOS:000296199300015
J	Rosas-Ballina, M; Olofsson, PS; Ochani, M; Valdes-Ferrer, SI; Levine, YA; Reardon, C; Tusche, MW; Pavlov, VA; Andersson, U; Chavan, S; Mak, TW; Tracey, KJ				Rosas-Ballina, Mauricio; Olofsson, Peder S.; Ochani, Mahendar; Valdes-Ferrer, Sergio I.; Levine, Yaakov A.; Reardon, Colin; Tusche, Michael W.; Pavlov, Valentin A.; Andersson, Ulf; Chavan, Sangeeta; Mak, Tak W.; Tracey, Kevin J.			Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit	SCIENCE			English	Article							NORADRENERGIC SYMPATHETIC INNERVATION; CHOLINE-ACETYLTRANSFERASE ACTIVITY; IMPROVES SURVIVAL; RAT SPLEEN; STIMULATION; LYMPHOCYTES; TNF; ENDOTOXEMIA; RELEASE; SEPSIS	Neural circuits regulate cytokine production to prevent potentially damaging inflammation. A prototypical vagus nerve circuit, the inflammatory reflex, inhibits tumor necrosis factor-alpha production in spleen by a mechanism requiring acetylcholine signaling through the alpha 7 nicotinic acetylcholine receptor expressed on cytokine-producing macrophages. Nerve fibers in spleen lack the enzymatic machinery necessary for acetylcholine production; therefore, how does this neural circuit terminate in cholinergic signaling? We identified an acetylcholine-producing, memory phenotype T cell population in mice that is integral to the inflammatory reflex. These acetylcholine-producing T cells are required for inhibition of cytokine production by vagus nerve stimulation. Thus, action potentials originating in the vagus nerve regulate T cells, which in turn produce the neurotransmitter, acetylcholine, required to control innate immune responses.	[Rosas-Ballina, Mauricio; Olofsson, Peder S.; Ochani, Mahendar; Valdes-Ferrer, Sergio I.; Levine, Yaakov A.; Pavlov, Valentin A.; Chavan, Sangeeta; Tracey, Kevin J.] Feinstein Inst Med Res, Lab Biomed Sci, Manhasset, NY 11030 USA; [Valdes-Ferrer, Sergio I.] Feinstein Inst Med Res, Elmezzi Grad Sch Mol Med, Manhasset, NY 11030 USA; [Reardon, Colin; Tusche, Michael W.; Mak, Tak W.] Univ Hlth Network, Campbell Family Inst Breast Canc Res, Toronto, ON M5G 2C1, Canada; [Andersson, Ulf] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden	Northwell Health; Northwell Health; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Karolinska Institutet	Tracey, KJ (corresponding author), Feinstein Inst Med Res, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.	kjtracey@nshs.edu	Valdés-Ferrer, Sergio Iván/ABD-1057-2020; Andersson, Ulf/ABD-5162-2021; Levine, Yaakov/AAA-2578-2020	Valdés-Ferrer, Sergio Iván/0000-0002-4863-6484; Andersson, Ulf/0000-0003-0316-3860; Levine, Yaakov/0000-0002-3313-6858; Pavlov, Valentin/0000-0002-1994-2853; Tracey, Kevin J/0000-0003-1884-6314; Reardon, Colin/0000-0003-2204-8091; Chavan, Sangeeta S./0000-0002-4822-3356	National Institute of General Medical Sciences, NIH; Wenner-Gren Foundations in Stockholm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057226] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wenner-Gren Foundations in Stockholm; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from National Institute of General Medical Sciences, NIH, to K.J.T. and from the Wenner-Gren Foundations in Stockholm to P.S.O. We thank B. Diamond for helpful discussions, and H. Borrero and S. Matheravidathu for technical support. The data reported in this paper are tabulated in the main text and supporting online material.	BELLINGER D L, 1989, Brain Behavior and Immunity, V3, P291, DOI 10.1016/0889-1591(89)90029-9; BELLINGER DL, 1987, J NEUROSCI RES, V18, P55, DOI 10.1002/jnr.490180110; BELLINGER DL, 1993, BRAIN BEHAV IMMUN, V7, P191, DOI 10.1006/brbi.1993.1021; BERTHOUD HR, 1993, J AUTONOM NERV SYST, V42, P153, DOI 10.1016/0165-1838(93)90046-W; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; BRANDON KW, 1961, J PHYSIOL-LONDON, V157, P18, DOI 10.1113/jphysiol.1961.sp006702; Bulloch K, 1994, Int J Neurosci, V76, P141; Dale HH, 1929, J PHYSIOL-LONDON, V68, P97, DOI 10.1113/jphysiol.1929.sp002598; FELDMAN RD, 1987, J IMMUNOL, V139, P3355; FELTEN DL, 1985, J IMMUNOL, V135, P755; FELTEN SY, 1987, J NEUROSCI RES, V18, P37, DOI 10.1002/jnr.490180108; Fujii T, 1998, J NEUROIMMUNOL, V82, P101, DOI 10.1016/S0165-5728(97)00195-1; Giebelen IAJ, 2007, SHOCK, V28, P700, DOI 10.1097/shk.0b013e318054dd89; Guarini S, 2003, CIRCULATION, V107, P1189, DOI 10.1161/01.CIR.0000050627.90734.ED; Huston JM, 2007, CRIT CARE MED, V35, P2762, DOI 10.1097/01.CCM.0000288102.15975.BA; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Huston JM, 2009, J IMMUNOL, V183, P552, DOI 10.4049/jimmunol.0802684; KAWASHIMA K, 1989, NEUROSCI LETT, V104, P336, DOI 10.1016/0304-3940(89)90599-5; Kees MG, 2003, J NEUROIMMUNOL, V145, P77, DOI 10.1016/j.jneuroim.2003.09.011; Kohm AP, 2001, PHARMACOL REV, V53, P487; Kox M, 2009, BIOCHEM PHARMACOL, V78, P863, DOI 10.1016/j.bcp.2009.06.096; LEADERS FE, 1965, J PHARMACOL EXP THER, V147, P145; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Riether C, 2011, BRAIN BEHAV IMMUN, V25, P59, DOI 10.1016/j.bbi.2010.07.248; RINNER I, 1993, J NEUROSCI RES, V35, P188, DOI 10.1002/jnr.490350209; Rinner I, 1998, J NEUROIMMUNOL, V81, P31, DOI 10.1016/S0165-5728(97)00155-0; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2009, MOL MED, V15, P195, DOI 10.2119/molmed.2009.00039; STEPHENSNEWSHAM LG, 1979, GEN PHARMACOL-VASC S, V10, P385, DOI 10.1016/0306-3623(79)90076-4; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Todman D, 2008, EUR NEUROL, V60, P162, DOI 10.1159/000145336; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yeboah MM, 2008, KIDNEY INT, V74, P62, DOI 10.1038/ki.2008.94	35	835	870	10	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					98	101		10.1126/science.1209985	http://dx.doi.org/10.1126/science.1209985			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21921156	Green Accepted			2022-12-24	WOS:000295580300048
J	Navarro, C; Abelenda, JA; Cruz-Oro, E; Cuellar, CA; Tamaki, S; Silva, J; Shimamoto, K; Prat, S				Navarro, Cristina; Abelenda, Jose A.; Cruz-Oro, Eduard; Cuellar, Carlos A.; Tamaki, Shojiro; Silva, Javier; Shimamoto, Ko; Prat, Salome			Control of flowering and storage organ formation in potato by FLOWERING LOCUS T	NATURE			English	Article							FLORAL INDUCTION; FT PROTEIN; PHOTOPERIODIC CONTROL; REGULATE GROWTH; TUBER FORMATION; TIME; GENE; SIGNALS; HD3A; TUBERIZATION	Seasonal fluctuations in day length regulate important aspects of plant development such as the flowering transition or, in potato (Solanum tuberosum), the formation of tubers. Day length is sensed by the leaves, which produce a mobile signal transported to the shoot apex or underground stems to induce a flowering transition or, respectively, a tuberization transition. Work in Arabidopsis, tomato and rice (Oryza sativa) identified the mobile FLOWERING LOCUS T (FT) protein as a main component of the long-range 'florigen', or flowering hormone, signal(1-3). Here we show that expression of the Hd3a gene, the FT orthologue in rice, induces strict short-day potato types(4) to tuberize in long days. Tuber induction is graft transmissible and the Hd3a-GFP protein is detected in the stolons of grafted plants, transport of the fusion protein thus correlating with tuber formation. We provide evidence showing that the potato floral and tuberization transitions are controlled by two different FT-like paralogues (StSP3D and StSP6A) that respond to independent environmental cues, and show that an autorelay mechanism involving CONSTANS modulates expression of the tuberization-control StSP6A gene.	[Navarro, Cristina; Abelenda, Jose A.; Cruz-Oro, Eduard; Cuellar, Carlos A.; Silva, Javier; Prat, Salome] CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Madrid 28049, Spain; [Tamaki, Shojiro; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300101, Japan	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Nara Institute of Science & Technology	Prat, S (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Genet Mol Plantas, Calle Darwin 3, Madrid 28049, Spain.	sprat@cnb.csic.es	Abelenda, Jose A/L-8315-2017; Prat, Salome/L-9240-2014; Navarro, Cristina/L-5967-2014	Abelenda, Jose A/0000-0001-7952-4891; Prat, Salome/0000-0003-2684-5485; Navarro, Cristina/0000-0001-9876-2174	Spanish MCyT; EU-SOL European Union; JSPS; CSIC; MEXT of Japan	Spanish MCyT(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); EU-SOL European Union; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CSIC; MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank J. Paz-Ares, G. Bryan and C. Bachem for their comments on the manuscript. We also thank S. Yokoi for his help in this work. This research was supported by grants from the Spanish MCyT and the EU-SOL European Union Integrated Project. Support by the JSPS and CSIC under the Japan-Spain research cooperative programme and Grants-in-Aid for Scientific Research on Priority Areas of the MEXT of Japan are also acknowledged. C.N. was recipient of an I3P postdoctoral contract from the CSIC.	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Ben-Naim O, 2006, PLANT J, V46, P462, DOI 10.1111/j.1365-313X.2006.02706.x; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Carmel-Goren L, 2003, PLANT MOL BIOL, V52, P1215, DOI 10.1023/B:PLAN.0000004333.96451.11; CHAILAKHIAN MK, 1981, DOKL AKAD NAUK SSSR+, V257, P1276; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Ewing E. E., 1992, Horticultural Reviews, V14, P89; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Ishikawa R, 2005, PLANT CELL, V17, P3326, DOI 10.1105/tpc.105.037028; Jackson SD, 1999, PLANT PHYSIOL, V119, P1, DOI 10.1104/pp.119.1.1; Jackson SD, 1996, PLANT J, V9, P159, DOI 10.1046/j.1365-313X.1996.09020159.x; Jaeger KE, 2007, CURR BIOL, V17, P1050, DOI 10.1016/j.cub.2007.05.008; Kloosterman B, 2008, FUNCT INTEGR GENOMIC, V8, P329, DOI 10.1007/s10142-008-0083-x; Kloosterman B, 2007, PLANT J, V52, P362, DOI 10.1111/j.1365-313X.2007.03245.x; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Lagercrantz U, 2009, J EXP BOT, V60, P2501, DOI 10.1093/jxb/erp139; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Lifschitz E, 2006, J EXP BOT, V57, P3405, DOI 10.1093/jxb/erl106; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Garcia JF, 2002, P NATL ACAD SCI USA, V99, P15211, DOI 10.1073/pnas.222390599; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Rodriguez-Falcon M, 2006, ANNU REV PLANT BIOL, V57, P151, DOI 10.1146/annurev.arplant.57.032905.105224; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shalit A, 2009, P NATL ACAD SCI USA, V106, P8392, DOI 10.1073/pnas.0810810106; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Zeevaart JAD, 2008, CURR OPIN PLANT BIOL, V11, P541, DOI 10.1016/j.pbi.2008.06.009	39	393	439	14	342	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					119	U132		10.1038/nature10431	http://dx.doi.org/10.1038/nature10431			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21947007				2022-12-24	WOS:000295575400046
J	Howarth, RW; Ingraffea, A; Engelder, T				Howarth, Robert W.; Ingraffea, Anthony; Engelder, Terry			Natural gas: Should fracking stop?	NATURE			English	Editorial Material									[Howarth, Robert W.] Cornell Univ, Dept Ecology & Evolutionary Biol, Ithaca, NY 14853 USA; [Ingraffea, Anthony] Cornell Univ, Sch Civil & Environm Engn, Ithaca, NY 14853 USA; [Engelder, Terry] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA	Cornell University; Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Howarth, RW (corresponding author), Cornell Univ, Dept Ecology & Evolutionary Biol, Ithaca, NY 14853 USA.		ingraffea, anthony/AAU-6221-2021	Howarth, Robert/0000-0001-9531-4288					0	399	416	4	951	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					271	275		10.1038/477271a	http://dx.doi.org/10.1038/477271a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921896	Bronze			2022-12-24	WOS:000294852400038
J	Al Rawi, S; Louvet-Vallee, S; Djeddi, A; Sachse, M; Culetto, E; Hajjar, C; Boyd, L; Legouis, R; Galy, V				Al Rawi, Sara; Louvet-Vallee, Sophie; Djeddi, Abderazak; Sachse, Martin; Culetto, Emmanuel; Hajjar, Connie; Boyd, Lynn; Legouis, Renaud; Galy, Vincent			Postfertilization Autophagy of Sperm Organelles Prevents Paternal Mitochondrial DNA Transmission	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; C. ELEGANS; INHERITANCE; GENES; UBIQUITIN; ROLES	In sexual reproduction of most animals, the spermatozoon provides DNA and centrioles, together with some cytoplasm and organelles, to the oocyte that is being fertilized. Paternal mitochondria and their genomes are generally eliminated in the embryo by an unknown degradation mechanism. We show that, upon fertilization, a Caenorhabditis elegans spermatozoon triggers the recruitment of autophagosomes within minutes and subsequent paternal mitochondria degradation. Whereas the nematode-specific sperm membranous organelles are ubiquitinated before autophagosome formation, the mitochondria are not. The degradation of both paternal structures and mitochondrial DNA requires an LC3-dependent autophagy. Analysis of fertilized mouse embryos shows the localization of autophagy markers, which suggests that this autophagy event is evolutionarily conserved to prevent both the transmission of paternal mitochondrial DNA to the offspring and the establishment of heteroplasmy.	[Al Rawi, Sara; Louvet-Vallee, Sophie; Djeddi, Abderazak; Galy, Vincent] Univ Paris 06, Biol Dev UMR7622, F-75005 Paris, France; [Al Rawi, Sara; Louvet-Vallee, Sophie; Djeddi, Abderazak; Galy, Vincent] CNRS, Biol Dev UMR7622, F-75005 Paris, France; [Sachse, Martin] Inst Pasteur, F-75015 Paris, France; [Culetto, Emmanuel; Legouis, Renaud] Univ Paris 11, CNRS, UPR3404, Ctr Genet Mol, F-91198 Gif Sur Yvette, France; [Hajjar, Connie; Boyd, Lynn] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Alabama System; University of Alabama Huntsville	Galy, V (corresponding author), Univ Paris 06, Biol Dev UMR7622, 9 Quai St Bernard, F-75005 Paris, France.	vgaly@snv.jussieu.fr	Culetto, Emmanuel/AFQ-8565-2022; Legouis, Renaud/S-1250-2017; Legouis, Renaud/G-9088-2014; Sachse, Martin/W-7403-2019	Legouis, Renaud/0000-0002-2699-2584; Sachse, Martin/0000-0001-5981-9166; Louvet, Sophie/0000-0001-7577-2329; Culetto, Emmanuel/0000-0003-4725-2654	NIH National Center for Research Resources; NIH [GM065444-03]; Centre National de la Recherche Scientifique; Univ. of Pierre and Marie Curie; Agence Nationale de la Recherche [ANR 07-BLAN-0063-21]; Association pour la Recherche contre le Cancer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM065444] Funding Source: NIH RePORTER	NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Univ. of Pierre and Marie Curie; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Pappatico, T. Le, and C. Lefebvre for valuable technical assistance during all stages of this project; the staff of the IFR83 Imaging Platform for their efficient help with confocal imaging; K. Wassmann for providing access to research equipments; L. Kuras for advice for quantitative PCR; H. Zhang, S. Strome, and T. Ueno for sharing reagents; J. Plastino for generously providing unpublished reagents for MSP analysis; and A. Golden for assistance with the GFP::ubiquitin project. We also wish to thank P. Codogno and V.G.'s and R.L.'s lab members for careful reading of the manuscript. The LB138 strain was provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources. This research was supported by the NIH (grant GM065444-03 to L. B.), the Centre National de la Recherche Scientifique (R. L. and Action Thematique Incitative sur Programme grant to V. G.), the Univ. of Pierre and Marie Curie, the Agence Nationale de la Recherche (grant ANR 07-BLAN-0063-21 to V. G.), and the Association pour la Recherche contre le Cancer (R.L.).	Alberti A, 2010, AUTOPHAGY, V6, P622, DOI 10.4161/auto.6.5.12252; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Farina F, 2008, DEV DYNAM, V237, P1668, DOI 10.1002/dvdy.21578; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Nishimura Y, 2006, P NATL ACAD SCI USA, V103, P1382, DOI 10.1073/pnas.0506911103; Parry JM, 2009, CURR BIOL, V19, P1752, DOI 10.1016/j.cub.2009.09.015; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Tsang WY, 2002, BIOCHEM CELL BIOL, V80, P645, DOI [10.1139/o02-135, 10.1139/O02-135]; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; WARD S, 1981, J CELL BIOL, V91, P26, DOI 10.1083/jcb.91.1.26; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; Yoshimori T, 2008, CURR OPIN CELL BIOL, V20, P401, DOI 10.1016/j.ceb.2008.03.010	17	320	329	6	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1144	1147		10.1126/science.1211878	http://dx.doi.org/10.1126/science.1211878			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22033522				2022-12-24	WOS:000297313900054
J	Guruharsha, KG; Rual, JF; Zhai, B; Mintseris, J; Vaidya, P; Vaidya, N; Beekman, C; Wong, C; Rhee, DY; Cenaj, O; McKillip, E; Shah, S; Stapleton, M; Wan, KH; Yu, C; Parsa, B; Carlson, JW; Chen, X; Kapadia, B; VijayRaghavan, K; Gygi, SP; Celniker, SE; Obar, RA; Artavanis-Tsakonas, S				Guruharsha, K. G.; Rual, Jean-Francois; Zhai, Bo; Mintseris, Julian; Vaidya, Pujita; Vaidya, Namita; Beekman, Chapman; Wong, Christina; Rhee, David Y.; Cenaj, Odise; McKillip, Emily; Shah, Saumini; Stapleton, Mark; Wan, Kenneth H.; Yu, Charles; Parsa, Bayan; Carlson, Joseph W.; Chen, Xiao; Kapadia, Bhaveen; VijayRaghavan, K.; Gygi, Steven P.; Celniker, Susan E.; Obar, Robert A.; Artavanis-Tsakonas, Spyros			A Protein Complex Network of Drosophila melanogaster	CELL			English	Article							COMPREHENSIVE ANALYSIS; INTERACTION MAP; YEAST; GENE; RESOURCE; EVOLUTION; SUBUNIT; ORGANIZATION; INTERACTOME	Determining the composition of protein complexes is an essential step toward understanding the cell as an integrated system. Using coaffinity purification coupled to mass spectrometry analysis, we examined protein associations involving nearly 5,000 individual, FLAG-HA epitope-tagged Drosophila proteins. Stringent analysis of these data, based on a statistical framework designed to define individual protein-protein interactions, led to the generation of a Drosophila protein interaction map (DPiM) encompassing 556 protein complexes. The high quality of the DPiM and its usefulness as a paradigm for metazoan proteomes are apparent from the recovery of many known complexes, significant enrichment for shared functional attributes, and validation in human cells. The DPiM defines potential novel members for several important protein complexes and assigns functional links to 586 protein-coding genes lacking previous experimental annotation. The DPiM represents, to our knowledge, the largest metazoan protein complex map and provides a valuable resource for analysis of protein complex evolution.	[Guruharsha, K. G.; Rual, Jean-Francois; Zhai, Bo; Mintseris, Julian; Vaidya, Pujita; Vaidya, Namita; Beekman, Chapman; Wong, Christina; Rhee, David Y.; Cenaj, Odise; McKillip, Emily; Shah, Saumini; Gygi, Steven P.; Obar, Robert A.; Artavanis-Tsakonas, Spyros] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wan, Kenneth H.; Yu, Charles; Parsa, Bayan; Carlson, Joseph W.; Chen, Xiao; Kapadia, Bhaveen; Celniker, Susan E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; [VijayRaghavan, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Harvard University; Harvard Medical School; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Obar, RA (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	robert_obar@hms.harvard.edu; artavanis@hms.harvard.edu	Kapadia, Bhaveen/X-4068-2019; Kuthethur, Guruharsha/Z-2605-2019	Kapadia, Bhaveen/0000-0003-1335-891X; Kuthethur, Guruharsha/0000-0001-7292-4868; Rhee, David/0000-0002-6911-4941; Rual, Jean-Francois/0000-0003-4465-8819	National Institutes of Health (NIH) [5RO1HG003616]; Deutsche Jose Carreras Leukamie-Stiftung e.V.; National Human Genome Research Institute (NHGRI) [P41HG3487]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003616, P41HG003487] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Jose Carreras Leukamie-Stiftung e.V.; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by a grant from the National Institutes of Health (NIH 5RO1HG003616) to S.A.-T. and a fellowship from the Deutsche Jose Carreras Leukamie-Stiftung e.V. to J.-F.R. Generation of the clone set was supported by a grant from the National Human Genome Research Institute (NHGRI P41HG3487 to S.E.C.). Special thanks to Anne-Claude Gavin, Bernhard Kuster, and Charlie Cohen, whose help was critical in the initiation of the project, as well as Gerry Rubin for help throughout. We thank Norbert Perrimon for S2R+ cells, Lucy and Peter Cherbas for help in cell culture, William Gelbart and the FlyBase team for making DPiM data available on FlyBase, and Alexey Veraksa, Ashim Mukherjee, Kadalmani Krishnan, Mathew Sowa, Dan Finley, Robin Reed, Angeliki Louvi, and members of the S.A.-T., S.E.C., S.P.G., and K.V. labs for helpful discussion and comments. We thank members of CCSB, Vidal and Harper labs, and David Hill and Eric Bennett in particular, for help with the human ORFeome collection. We also thank Manolis Kellis and Rogerio Candeias for their help.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Belote JM, 2009, HEREDITY, V103, P23, DOI 10.1038/hdy.2009.23; Bennett D, 2006, J MOL BIOL, V364, P196, DOI 10.1016/j.jmb.2006.08.094; Bennett D, 2009, J MOL BIOL, V387, P518, DOI 10.1016/j.jmb.2006.08.101; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Breitkreutz A, 2010, SCIENCE, V328, P1043, DOI 10.1126/science.1176495; Cherbas L, 2011, GENOME RES, V21, P301, DOI 10.1101/gr.112961.110; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; DOMBRADI V, 1990, EUR J BIOCHEM, V194, P739, DOI 10.1111/j.1432-1033.1990.tb19464.x; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Fricke B, 2007, EMBO REP, V8, P1170, DOI 10.1038/sj.embor.7401091; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2011, CURR OPIN BIOTECH, V22, P42, DOI 10.1016/j.copbio.2010.09.007; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Goshima G, 2010, CURR OPIN CELL BIOL, V22, P44, DOI 10.1016/j.ceb.2009.11.012; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hart GT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-236; Herold N, 2009, MOL CELL BIOL, V29, P281, DOI 10.1128/MCB.01415-08; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kato JY, 2009, GENES CELLS, V14, P1209, DOI 10.1111/j.1365-2443.2009.01349.x; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Michelet X, 2010, BIOL CELL, V102, P191, DOI 10.1042/BC20090145; Mintseris J, 2005, P NATL ACAD SCI USA, V102, P10930, DOI 10.1073/pnas.0502667102; Murali T, 2011, NUCLEIC ACIDS RES, V39, pD736, DOI 10.1093/nar/gkq1092; Ohtaki A, 2010, FRONT BIOSCI-LANDMRK, V15, P708, DOI 10.2741/3641; Rees JS, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002386; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stanyon CA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r96; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; van Dam TJP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000132; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wee S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-15; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Williams RD, 2004, GENE CHROMOSOME CANC, V41, P65, DOI 10.1002/gcc.20060; Wuchty S, 2004, GENOME RES, V14, P1310, DOI 10.1101/gr.2300204; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Yu C, 2011, METHODS MOL BIOL, V723, P257, DOI 10.1007/978-1-61779-043-0_17; Yu JK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-461	65	442	449	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					690	703		10.1016/j.cell.2011.08.047	http://dx.doi.org/10.1016/j.cell.2011.08.047			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036573	Bronze, Green Accepted			2022-12-24	WOS:000296573700022
J	Ferreira, MAR; Matheson, MC; Duffy, DL; Marks, GB; Hui, JN; Le Souef, P; Danoy, P; Baltic, S; Nyholt, DR; Jenkins, M; Hayden, C; Willemsen, G; Ang, W; Kuokkanen, M; Beilby, J; Cheah, F; de Geus, EJC; Ramasamy, A; Vedantam, S; Salomaa, V; Madden, PA; Heath, AC; Hopper, JL; Visscher, PM; Musk, B; Leeder, SR; Jarvelin, MR; Pennell, C; Boomsma, DI; Hirschhorn, JN; Walters, H; Martin, NG; James, A; Jones, G; Abramson, MJ; Robertson, CF; Dharmage, SC; Brown, MA; Montgomery, GW; Thompson, PJ				Ferreira, Manuel A. R.; Matheson, Melanie C.; Duffy, David L.; Marks, Guy B.; Hui, Jennie; Le Souef, Peter; Danoy, Patrick; Baltic, Svetlana; Nyholt, Dale R.; Jenkins, Mark; Hayden, Catherine; Willemsen, Gonneke; Ang, Wei; Kuokkanen, Mikko; Beilby, John; Cheah, Faang; de Geus, Eco J. C.; Ramasamy, Adaikalavan; Vedantam, Sailaja; Salomaa, Veikko; Madden, Pamela A.; Heath, Andrew C.; Hopper, John L.; Visscher, Peter M.; Musk, Bill; Leeder, Stephen R.; Jarvelin, Marjo-Riitta; Pennell, Craig; Boomsma, Dorret I.; Hirschhorn, Joel N.; Walters, Haydn; Martin, Nicholas G.; James, Alan; Jones, Graham; Abramson, Michael J.; Robertson, Colin F.; Dharmage, Shyamali C.; Brown, Matthew A.; Montgomery, Grant W.; Thompson, Philip J.		Australian Asthma Genetics Consort	Identification of IL6R and chromosome 11q13.5 as risk loci for asthma	LANCET			English	Article							GENOME-WIDE ASSOCIATION; GENETIC RISK; DISEASE; VARIANTS; ECZEMA; HERITABILITY; METAANALYSIS; EXPRESSION; PREDICTION; CHILDHOOD	Background We aimed to identify novel genetic variants affecting asthma risk, since these might provide novel insights into molecular mechanisms underlying the disease. Methods We did a genome-wide association study (GWAS) in 2669 physician-diagnosed asthmatics and 4528 controls from Australia. Seven loci were prioritised for replication after combining our results with those from the GABRIEL consortium (n=26 475), and these were tested in an additional 25 358 independent samples from four in-silico cohorts. Quantitative multi-marker scores of genetic load were constructed on the basis of results from the GABRIEL study and tested for association with asthma in our Australian GWAS dataset. Findings Two loci were confirmed to associate with asthma risk in the replication cohorts and reached genome-wide significance in the combined analysis of all available studies (n=57 800): rs4129267 (OR 1.09, combined p=2.4x10(-8)) in the interleukin-6 receptor (IL6R) gene and rs7130588 (OR 1.09, p=1.8x10(-8)) on chromosome 11q13.5 near the leucine-rich repeat containing 32 gene (LRRC32, also known as GARP). The 11q13.5 locus was significantly associated with atopic status among asthmatics (OR 1.33, p=7x10(-4)), suggesting that it is a risk factor for allergic but not non-allergic asthma. Multi-marker association results are consistent with a highly polygenic contribution to asthma risk, including loci with weak effects that might be shared with other immune-related diseases, such as NDFIP1, HLA-B, LPP, and BACH2. Interpretation The IL6R association further supports the hypothesis that cytokine signalling dysregulation affects asthma risk, and raises the possibility that an IL6R antagonist (tocilizumab) may be effective to treat the disease, perhaps in a genotype-dependent manner. Results for the 11q13.5 locus suggest that it directly increases the risk of allergic sensitisation which, in turn, increases the risk of subsequent development of asthma. Larger or more functionally focused studies are needed to characterise the many loci with modest effects that remain to be identified for asthma.	[Ferreira, Manuel A. R.; Duffy, David L.; Nyholt, Dale R.; Visscher, Peter M.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Matheson, Melanie C.; Jenkins, Mark; Hopper, John L.; Dharmage, Shyamali C.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Marks, Guy B.] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Hui, Jennie; Beilby, John] Univ Western Australia, PathW Lab Med Western Australia, Nedlands, WA 6009, Australia; [Hui, Jennie; Musk, Bill] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Hui, Jennie; Beilby, John; Musk, Bill; James, Alan] Sir Charles Gairdner Hosp, Busselton Populat Med Res Fdn, Perth, WA, Australia; [Le Souef, Peter; Hayden, Catherine] Princess Margaret Hosp Children, Sch Paediat & Child Hlth, Perth, WA, Australia; [Danoy, Patrick; Brown, Matthew A.] Univ Queensland, Diamantina Inst, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Baltic, Svetlana; Cheah, Faang; Thompson, Philip J.] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia; [Baltic, Svetlana; Cheah, Faang; Thompson, Philip J.] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia; [Willemsen, Gonneke; de Geus, Eco J. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, EMGO & NCA Inst, Amsterdam, Netherlands; [Ang, Wei; Pennell, Craig] Univ Western Australia, Sch Womens & Infants Hlth, Subiaco, WA, Australia; [Kuokkanen, Mikko; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Ramasamy, Adaikalavan] Univ London Imperial Coll Sci Technol & Med, London, England; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vedantam, Sailaja; Hirschhorn, Joel N.] Broad Inst, Cambridge, MA USA; [Madden, Pamela A.; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Musk, Bill] Sir Charles Gairdner Hosp, Dept Resp Med, Perth, WA, Australia; [Musk, Bill; James, Alan] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Leeder, Stephen R.] Univ Sydney, Australian Hlth Policy Inst, Sydney, NSW 2006, Australia; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, London, England; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Walters, Haydn] Menzies Res Inst, Hobart, Tas, Australia; [James, Alan] W Australian Sleep Disorders Res Inst, Dept Pulm Physiol, Nedlands, WA, Australia; [Jones, Graham] Univ Western Sydney, Penrith, NSW 1797, Australia; [Abramson, Michael J.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Robertson, Colin F.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia	QIMR Berghofer Medical Research Institute; University of Melbourne; University of Sydney; Woolcock Institute of Medical Research; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; University of Queensland; University of Western Australia; University of Western Australia; Vrije Universiteit Amsterdam; University of Western Australia; Finland National Institute for Health & Welfare; Imperial College London; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL); University of Western Australia; University of Western Australia; University of Sydney; Imperial College London; Harvard University; Harvard Medical School; University of Tasmania; Menzies Institute for Medical Research; Western Sydney University; Monash University; Murdoch Children's Research Institute	Ferreira, MAR (corresponding author), Royal Brisbane Hosp, Queensland Inst Med Res, Locked Bag 2000, Herston, Qld 4029, Australia.	manuel.ferreira@qimr.edu.au	Mitrpant, Chalermchai/AAX-6699-2021; Warrington, Nicole/P-4868-2014; Marks, Guy B./F-5058-2013; Matheson, Melanie C/O-4721-2015; Le Souef, Peter N/H-5256-2014; Sly, Peter D/F-1486-2010; Wright, Margaret Jane/A-4560-2016; de Geus, Eco J.C./M-9318-2015; Visscher, Peter/ABB-6151-2020; Study, Raine/K-4517-2013; Wright, Margaret J/H-3308-2014; Montgomery, Grant W/B-7148-2008; Boomsma, Dorret I/AAX-4470-2020; Ferreira, Manuel A R/D-3609-2013; Palmer, Lyle John/K-3196-2014; Kuokkanen, Mikko/M-8247-2016; Nyholt, Dale Robert/J-3174-2017; Ramasamy, Adaikalavan/G-2632-2010; Martin, Nicholas/R-9235-2019; Brown, Matthew A/E-5749-2010; Hui, Jennie/A-9543-2013; Baltic, Svetlana/C-2313-2014; WALTERS, Eugene/AAL-2264-2021; Pennell, Craig/ABD-6902-2020; Abramson, Michael/AAQ-2671-2020; Duffy, David L/B-7392-2013; Jenkins, Mark/P-7803-2015	Mitrpant, Chalermchai/0000-0001-9311-7977; Warrington, Nicole/0000-0003-4195-775X; Marks, Guy B./0000-0002-8976-8053; Matheson, Melanie C/0000-0002-5822-3499; Sly, Peter D/0000-0001-6305-2201; Wright, Margaret Jane/0000-0001-7133-4970; de Geus, Eco J.C./0000-0001-6022-2666; Visscher, Peter/0000-0002-2143-8760; Montgomery, Grant W/0000-0002-4140-8139; Ferreira, Manuel A R/0000-0001-9059-1825; Palmer, Lyle John/0000-0002-1628-3055; Kuokkanen, Mikko/0000-0003-4375-9327; Nyholt, Dale Robert/0000-0001-7159-3040; Ramasamy, Adaikalavan/0000-0002-7598-2892; Martin, Nicholas/0000-0003-4069-8020; Brown, Matthew A/0000-0003-0538-8211; Hui, Jennie/0000-0002-1653-2496; Pennell, Craig/0000-0002-0937-6165; Abramson, Michael/0000-0002-9954-0538; Duffy, David L/0000-0001-7227-632X; Baltic, Svetlana/0000-0002-3428-940X; Dharmage, Shyamali/0000-0001-6063-1937; Flynn, Loren/0000-0001-5249-547X; Whitfield, John/0000-0002-1103-0876; Le Souef, Peter/0000-0003-0930-1654; Britton, Warwick/0000-0001-6721-9646; Willemsen, Gonneke/0000-0003-3755-0236; Jenkins, Mark/0000-0002-8964-6160; Walters, Eugene/0000-0002-0993-4374; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	GlaxoSmithKline; Novartis; Sunovion Inc; Boehringer Ingelheim; AstraZeneca; Merck; Australian National Health and Medical Research Council [613627]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042157] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278, R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066206, RL1MH083268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS062691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007535, P60AA011998, P50AA011998, R01AA010249, K05AA017688, R01AA013321, R01AA013320, R37AA007728, R01AA007728, R01AA014041, R01AA013326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER; Medical Research Council [G0801056B] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Sunovion Inc; Boehringer Ingelheim(Boehringer Ingelheim); AstraZeneca(AstraZeneca); Merck(Merck & Company); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MAF owns stock in Illumina, Roche, and Complete Genomics. PST's institution has received consulting fees from GlaxoSmithKline as a result of activities outside this work. PST has received lecture fees from GlaxoSmithKline and Novartis. GTO has received consulting fees from Novartis and Sunovion Inc, as a result of work unrelated to this study. G BM was a board member of Novartis; GBM's institution received fees for lectures and preparation of educational presentations from Boehringer Ingelheim and AstraZeneca. CFR received consulting fees from GlaxoSmithKline and Merck as a result of activities outside this work. ASK's institution received speaker's fees from Nutricia. All other authors declare that they have no conflicts of interest.; The Australian Asthma Genetics Consortium was supported by the Australian National Health and Medical Research Council (613627). Detailed acknowledgments and funding sources are provided in the webappendix (pp 27-30).	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Burgess JA, 2008, J ALLERGY CLIN IMMUN, V122, P280, DOI 10.1016/j.jaci.2008.05.018; Capon F, 2008, HUM MOL GENET, V17, P1938, DOI 10.1093/hmg/ddn091; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Evans DM, 2009, HUM MOL GENET, V18, P3525, DOI 10.1093/hmg/ddp295; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hindorff LA, CATALOG PUBLISHED GE; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P1624, DOI 10.1111/j.1365-2222.2007.02822.x; Lowe AJ, 2008, J ALLERGY CLIN IMMUN, V121, P1190, DOI 10.1016/j.jaci.2008.01.034; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marenholz I, 2011, HUM MOL GENET, V20, P2443, DOI 10.1093/hmg/ddr117; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Patel AM, 2010, DRUG DES DEV THER, V4, P263, DOI 10.2147/DDDT.S14099; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Schuttelaar MLA, 2009, ALLERGY, V64, P1758, DOI 10.1111/j.1398-9995.2009.02080.x; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yokoyama A, 1997, AM J RESP CRIT CARE, V156, P1688, DOI 10.1164/ajrccm.156.5.9610070	36	279	290	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2011	378	9795					1006	1014		10.1016/S0140-6736(11)60874-X	http://dx.doi.org/10.1016/S0140-6736(11)60874-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	824HO	21907864	Green Accepted			2022-12-24	WOS:000295193200026
J	Shearstone, JR; Pop, R; Bock, C; Boyle, P; Meissner, A; Socolovsky, M				Shearstone, Jeffrey R.; Pop, Ramona; Bock, Christoph; Boyle, Patrick; Meissner, Alexander; Socolovsky, Merav			Global DNA Demethylation During Mouse Erythropoiesis in Vivo	SCIENCE			English	Article							METHYLATION PATTERNS; CELLS; ERYTHROLEUKEMIA; MAINTENANCE	In the mammalian genome, 5'-CpG-3' dinucleotides are frequently methylated, correlating with transcriptional silencing. Genome-wide demethylation is thought to occur only twice during development, in primordial germ cells and in the pre-implantation embryo. These demethylation events are followed by de novo methylation, setting up a pattern inherited throughout development and modified only at tissue-specific loci. We studied DNA methylation in differentiating mouse erythroblasts in vivo by using genomic-scale reduced representation bisulfite sequencing (RRBS). Demethylation at the erythroid-specific beta-globin locus was coincident with global DNA demethylation at most genomic elements. Global demethylation was continuous throughout differentiation and required rapid DNA replication. Hence, DNA demethylation can occur globally during somatic cell differentiation, providing an experimental model for its study in development and disease.	[Shearstone, Jeffrey R.; Pop, Ramona; Socolovsky, Merav] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA; [Shearstone, Jeffrey R.; Pop, Ramona; Socolovsky, Merav] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Bock, Christoph; Boyle, Patrick; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Socolovsky, M (corresponding author), Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA 01605 USA.	merav.socolovsky@umassmed.edu	Bock, Christoph/AAE-7618-2019	Bock, Christoph/0000-0001-6091-3088; Socolovsky, Merav/0000-0001-6747-7960; Shearstone, Jeffrey/0000-0002-6875-1826	NIH/National Heart, Lung, and Blood Institute [R01 HL084168]; American Cancer Society [RSG06-051-01]; NIH CA [T32-130807]; Diabetes Endocrinology Research Center [DK32520]; Harvard Stem Cell Institute; Pew Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Cancer Society(American Cancer Society); NIH CA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; Harvard Stem Cell Institute; Pew Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Scully, P. A. Jones, R. Jaenisch, J. Dekker, C. Peterson, and S. Akbarian for helpful discussions; D. Hidalgo for technical assistance; E. Li for Dnmt cDNAs; R. Konz, T. Giehl, and the UMass Fluorescence-Activated Cell Sorting core; and S. Baker for statistical analysis. This work was funded by NIH/National Heart, Lung, and Blood Institute R01 HL084168, American Cancer Society grant RSG06-051-01, NIH CA T32-130807, Diabetes Endocrinology Research Center grant DK32520, the Harvard Stem Cell Institute, and the Pew Charitable Trust. The RRBS analysis may be accessed at http://erythrocyte-demethylation.computational-epigenetics.org/. Affymetrix microarray expression data for the S1 and S3 subsets are deposited in the Gene Expression Omnibus (GEO) database (www.ncbi.nlm.nih.gov/geo/), GEO accession number GSE32214.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; CEDAR H, 1979, NUCLEIC ACIDS RES, V6, P2125, DOI 10.1093/nar/6.6.2125; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Dover G J, 1983, Prog Clin Biol Res, V134, P475; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; IKEGAMI S, 1978, NATURE, V275, P458, DOI 10.1038/275458a0; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Karimi M, 2006, EXP CELL RES, V312, P1989, DOI 10.1016/j.yexcr.2006.03.006; Kowal-Vern A, 2000, AM J HEMATOL, V65, P5, DOI 10.1002/1096-8652(200009)65:1<5::AID-AJH2>3.0.CO;2-U; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; LOEB DD, 1986, MOL CELL BIOL, V6, P168, DOI 10.1128/MCB.6.1.168; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; MICHALOWSKY LA, 1989, MOL CELL BIOL, V9, P885, DOI 10.1128/MCB.9.3.885; PINKUS GS, 1981, AM J PATHOL, V102, P308; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Silver L. M., 1995, MOUSE GENETICS; Singh M, 2007, EXP HEMATOL, V35, P48, DOI 10.1016/j.exphem.2006.09.001; Socolovsky M, 2007, PLOS BIOL, V5, P2296, DOI 10.1371/journal.pbio.0050252	26	117	120	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2011	334	6057					799	802		10.1126/science.1207306	http://dx.doi.org/10.1126/science.1207306			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076376	Green Accepted, Green Submitted			2022-12-24	WOS:000296849600045
J	Wang, F; Zhu, J; Zhu, H; Zhang, Q; Lin, ZM; Hu, HL				Wang, Fei; Zhu, Jun; Zhu, Hong; Zhang, Qi; Lin, Zhanmin; Hu, Hailan			Bidirectional Control of Social Hierarchy by Synaptic Efficacy in Medial Prefrontal Cortex	SCIENCE			English	Article							AMPA RECEPTOR TRAFFICKING; DOMINANCE; MICE; PLASTICITY; RATS; ENVIRONMENT; MODULATION; BEHAVIOR; MOUSE; RAS	Dominance hierarchy has a profound impact on animals' survival, health, and reproductive success, but its neural circuit mechanism is virtually unknown. We found that dominance ranking in mice is transitive, relatively stable, and highly correlates among multiple behavior measures. Recording from layer V pyramidal neurons of the medial prefrontal cortex (mPFC) showed higher strength of excitatory synaptic inputs in mice with higher ranking, as compared with their subordinate cage mates. Furthermore, molecular manipulations that resulted in an increase and decrease in the synaptic efficacy in dorsal mPFC neurons caused an upward and downward movement in the social rank, respectively. These results provide direct evidence for mPFC's involvement in social hierarchy and suggest that social rank is plastic and can be tuned by altering synaptic strength in mPFC pyramidal cells.	[Wang, Fei; Zhu, Jun; Zhu, Hong; Zhang, Qi; Lin, Zhanmin; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; [Wang, Fei; Zhu, Jun; Zhu, Hong; Zhang, Qi; Lin, Zhanmin; Hu, Hailan] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Neurosci, Shanghai 200031, Peoples R China; [Wang, Fei; Zhu, Hong] Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Hu, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	hailan@ion.ac.cn		Hu, Hailan/0000-0002-0425-5057; Wang, Fei/0000-0002-8646-2411; zhang, qi/0000-0001-7622-1393	Chinese 973 Program [2011CBA00400]; Scientific Research Foundation; Hundreds of Talents Program; Shanghai Pujiang Talent Program	Chinese 973 Program(National Basic Research Program of China); Scientific Research Foundation; Hundreds of Talents Program(Chinese Academy of Sciences); Shanghai Pujiang Talent Program	We thank J. Zhu for the gifts of pSindbis GluR4 and R4Ct constructs and discussion on GluR4; R. Malinow for support of the initial exploration of the tube test in his laboratory; M. Poo, H. Kessels, J. Feldman, and R. Sapolsky for discussion and critical reading of the manuscript; J. Yan for help with statistics; B. Lu for the idea of agonistic behavior test; B. Zhang, K. Zhang, and M. Streets for technical help; Y. Yanagawa for the Gad67-GFP mouse; and X. Yu for ultrasound equipment. The work was supported by Chinese 973 Program (2011CBA00400), Projects of the Scientific Research Foundation, the Hundreds of Talents Program, and the Shanghai Pujiang Talent Program to H. H. Author contributions: F. W. performed most experiments. J.Z. participated in the behavioral and viral injection experiments. F. W., J.Z., and H. H. analyzed data and prepared the figures. H.Z, Q.Z., and Z.L. assisted in experiments. H. H. designed the study and wrote the manuscript.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Arakawa H, 2007, BEHAV BRAIN RES, V176, P27, DOI 10.1016/j.bbr.2006.07.027; BENTON D, 1980, ANIM BEHAV, V28, P1274, DOI 10.1016/S0003-3472(80)80115-1; BERNSTEIN IS, 1981, BEHAV BRAIN SCI, V4, P419, DOI 10.1017/S0140525X00009614; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cummins DD, 2000, SYNTHESE, V122, P3, DOI 10.1023/A:1005263825428; DEWSBURY DA, 1990, ANIM BEHAV, V39, P284, DOI 10.1016/S0003-3472(05)80872-3; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Drickamer LC, 2001, BEHAV PROCESS, V53, P113, DOI 10.1016/S0376-6357(00)00152-2; FRANKEL DG, 1980, INT J BEHAV DEV, V3, P287, DOI 10.1177/016502548000300305; Garfield AS, 2011, NATURE, V469, P534, DOI 10.1038/nature09651; Guillem K, 2011, SCIENCE, V333, P888, DOI 10.1126/science.1207079; HOLSON RR, 1986, PHYSIOL BEHAV, V37, P239, DOI 10.1016/0031-9384(86)90226-X; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; LONG SY, 1972, ANIM BEHAV, V20, P10, DOI 10.1016/S0003-3472(72)80167-2; Marie H, 2005, NEURON, V45, P741, DOI 10.1016/j.neuron.2005.01.039; MASUR J, 1974, NATURE, V249, P284, DOI 10.1038/249284a0; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Mehrabian A, 1996, CURR PSYCHOL, V14, P261, DOI 10.1007/BF02686918; NYBY J, 1976, BEHAV BIOL, V18, P285, DOI 10.1016/S0091-6773(76)92198-2; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; Tse D, 2011, SCIENCE, V333, P891, DOI 10.1126/science.1205274; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; Wilson E.O., 1975, P1; Yeh SR, 1996, SCIENCE, V271, P366, DOI 10.1126/science.271.5247.366; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Zhu JJ, 2009, J NEUROSCI, V29, P6320, DOI 10.1523/JNEUROSCI.4630-08.2009; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	34	260	264	23	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					693	697		10.1126/science.1209951	http://dx.doi.org/10.1126/science.1209951			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21960531				2022-12-24	WOS:000296494700061
J	Hubbard, RA; Kerlikowske, K; Flowers, CI; Yankaskas, BC; Zhu, WW; Miglioretti, DL				Hubbard, Rebecca A.; Kerlikowske, Karla; Flowers, Chris I.; Yankaskas, Bonnie C.; Zhu, Weiwei; Miglioretti, Diana L.			Cumulative Probability of False-Positive Recall or Biopsy Recommendation After 10 Years of Screening Mammography A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SERVICES TASK-FORCE; CANCER SURVEILLANCE CONSORTIUM; BREAST-CANCER; INTERPRETIVE PERFORMANCE; RANDOMIZED-TRIALS; FILM MAMMOGRAPHY; RISK; ACCURACY; RADIOLOGISTS; VARIABILITY	Background: False-positive mammography results are common. Biennial screening may decrease the cumulative probability of false-positive results across many years of repeated screening but could also delay cancer diagnosis. Objective: To compare the cumulative probability of false-positive results and the stage distribution of incident breast cancer after 10 years of annual or biennial screening mammography. Design: Prospective cohort study. Setting: 7 mammography registries in the National Cancer Institute-funded Breast Cancer Surveillance Consortium. Participants: 169 456 women who underwent first screening mammography at age 40 to 59 years between 1994 and 2006 and 4492 women with incident invasive breast cancer diagnosed between 1996 and 2006. Measurements: False-positive recalls and biopsy recommendations stage distribution of incident breast cancer. Results: False-positive recall probability was 16.3% at first and 9.6% at subsequent mammography. Probability of false-positive biopsy recommendation was 2.5% at first and 1.0% at subsequent examinations. Availability of comparison mammograms halved the odds of a false-positive recall (adjusted odds ratio, 0.50 [95% CI, 0.45 to 0.56]). When screening began at age 40 years, the cumulative probability of a woman receiving at least 1 false-positive recall after 10 years was 61.3% (CI, 59.4% to 63.1%) with annual and 41.6% (CI, 40.6% to 42.5%) with biennial screening. Cumulative probability of false-positive biopsy recommendation was 7.0% (CI, 6.1% to 7.8%) with annual and 4.8% (CI, 4.4% to 5.2%) with biennial screening. Estimates were similar when screening began at age 50 years. A non-statistically significant increase in the proportion of late-stage cancers was observed with biennial compared with annual screening (absolute increases, 3.3 percentage points [CI, -1.1 to 7.8 percentage points] for women age 40 to 49 years and 2.3 percentage points [CI, -1.0 to 5.7 percentage points] for women age 50 to 59 years) among women with incident breast cancer. Limitations: Few women underwent screening over the entire 10-year period. Radiologist characteristics influence recall rates and were unavailable. Most mammograms were film rather than digital. Incident cancer was analyzed in a small sample of women who developed cancer. Conclusion: After 10 years of annual screening, more than half of women will receive at least 1 false-positive recall, and 7% to 9% will receive a false-positive biopsy recommendation. Biennial screening appears to reduce the cumulative probability of false-positive results after 10 years but may be associated with a small absolute increase in the probability of late-stage cancer diagnosis.	Univ Washington, Grp Hlth Cooperat, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Univ N Carolina, Chapel Hill, NC USA	Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of North Carolina; University of North Carolina Chapel Hill	Hubbard, RA (corresponding author), Grp Hlth Res Inst, Suite 1600,1730 Minor Ave, Seattle, WA 98101 USA.	hubbard.r@ghc.org	Flowers, Chris/AAC-9097-2019; Hubbard, Rebecca/Y-6500-2019	Hubbard, Rebecca/0000-0003-0879-0994	National Cancer Institute [U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040, R03CA150007, RC2CA148577]; NCI/NIH; NATIONAL CANCER INSTITUTE [U01CA063740, U01CA086082, U01CA063731, U01CA063736, U01CA070040, R03CA150007, RC2CA148577, U01CA069976, U01CA086076, U01CA070013] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute-funded Breast Cancer Surveillance Consortium cooperative agreement (grants U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040) and the National Cancer Institute-funded grants R03CA150007 and RC2CA148577. The collection of cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see http://breastscreening.cancer.gov/work/acknowledgement.html.; Dr. Hubbard: Grant (money to institution): NCI; Grants/grants pending (money to institution): NCI. Dr. Kerlikowske: Grant (money to institution): NCI. Dr. Flowers: Payment for development of educational presentations: Oakstone Publishing. Dr. Yankaskas: Grant (money to institution): NCI/NIH; Support for travel to meetings for study or other purposes (money to institution): NCI/NIH. Dr. Zhu: Grant: NCI. Dr. Miglioretti: Grant (money to institution): NCI; Grants/grants pending (money to institution): NCI. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10- 2026.	American College of Radiology, 2003, BREAST IM REP DAT SY; American Joint Committee on Cancer, 2002, MAN STAG CANC; Baker Stuart G, 2003, BMC Med Res Methodol, V3, P11, DOI 10.1186/1471-2288-3-11; BallardBarbash R, 1997, AM J ROENTGENOL, V169, P1001, DOI 10.2214/ajr.169.4.9308451; Barlow WE, 2004, JNCI-J NATL CANCER I, V96, P1840, DOI 10.1093/jnci/djh333; Beam CA, 1996, ARCH INTERN MED, V156, P209, DOI 10.1001/archinte.156.2.209; Blanchard K, 2006, RADIOLOGY, V240, P335, DOI 10.1148/radiol.2402050107; Breas Cancer Surveillance Consortium, 2010, BCSC GLOSS TERMS; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Christiansen CL, 2000, JNCI-J NATL CANCER I, V92, P1657, DOI 10.1093/jnci/92.20.1657; Cook AJ, 2010, J CLIN EPIDEMIOL, V63, P441, DOI 10.1016/j.jclinepi.2009.06.008; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Elmore JG, 2002, JNCI-J NATL CANCER I, V94, P1373; Elmore JG, 2009, RADIOLOGY, V253, P641, DOI 10.1148/radiol.2533082308; Food and Drug Administration, MAMM QUAL STAND ACT; Gelfand AE, 2000, STAT MED, V19, P1865, DOI 10.1002/1097-0258(20000730)19:14<1865::AID-SIM512>3.0.CO;2-M; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hubbard RA, 2010, STAT METHODS MED RES, V19, P429, DOI 10.1177/0962280209359842; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Ichikawa LE, 2010, RADIOLOGY, V256, P74, DOI 10.1148/radiol.10091881; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Montgomery M, 2010, ONCOL NURS FORUM, V37, P77, DOI 10.1188/10.ONF.77-83; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Pisano ED, 2008, RADIOLOGY, V246, P376, DOI 10.1148/radiol.2461070200; Smith RA, 2004, RADIOL CLIN N AM, V42, P793, DOI 10.1016/j.rcl.2004.06.014; Smith-Bindman R, 2005, JNCI-J NATL CANCER I, V97, P358, DOI 10.1093/jnci/dji060; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Taplin SH, 2010, J NATL CANCER I, V102, P1040, DOI 10.1093/jnci/djq233; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; Xu JL, 2004, BIOMETRICS, V60, P651, DOI 10.1111/j.0006-341X.2004.00214.x; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yazici B, 2006, CLIN RADIOL, V61, P619, DOI 10.1016/j.crad.2006.03.008; Zagouri F, 2008, BREAST, V17, P71, DOI 10.1016/j.breast.2007.07.039	38	309	315	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2011	155	8					481	U46		10.7326/0003-4819-155-8-201110180-00004	http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00004			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	835WB	22007042	Green Accepted			2022-12-24	WOS:000296066300013
J	McDermott-Roe, C; Ye, JM; Ahmed, R; Sun, XM; Serafin, A; Ware, J; Bottolo, L; Muckett, P; Canas, X; Zhang, JS; Rowe, GC; Buchan, R; Lu, H; Braithwaite, A; Mancini, M; Hauton, D; Marti, R; Garcia-Arumi, E; Hubner, N; Jacob, H; Serikawa, T; Zidek, V; Papousek, F; Kolar, F; Cardona, M; Ruiz-Meana, M; Garcia-Dorado, D; Comella, JX; Felkin, LE; Barton, PJR; Arany, Z; Pravenec, M; Petretto, E; Sanchis, D; Cook, SA				McDermott-Roe, Chris; Ye, Junmei; Ahmed, Rizwan; Sun, Xi-Ming; Serafin, Anna; Ware, James; Bottolo, Leonardo; Muckett, Phil; Canas, Xavier; Zhang, Jisheng; Rowe, Glenn C.; Buchan, Rachel; Lu, Han; Braithwaite, Adam; Mancini, Massimiliano; Hauton, David; Marti, Ramon; Garcia-Arumi, Elena; Hubner, Norbert; Jacob, Howard; Serikawa, Tadao; Zidek, Vaclav; Papousek, Frantisek; Kolar, Frantisek; Cardona, Maria; Ruiz-Meana, Marisol; Garcia-Dorado, David; Comella, Joan X.; Felkin, Leanne E.; Barton, Paul J. R.; Arany, Zoltan; Pravenec, Michal; Petretto, Enrico; Sanchis, Daniel; Cook, Stuart A.			Endonuclease G is a novel determinant of cardiac hypertrophy and mitochondrial function	NATURE			English	Article							LEFT-VENTRICULAR MASS; OXIDATIVE STRESS; CARDIOMYOPATHY; DISEASE; DEATH; PATHOGENESIS; REPLICATION; BIOGENESIS; MECHANISMS; EXPRESSION	Left ventricular mass (LVM) is a highly heritable trait(1) and an independent risk factor for all-cause mortality(2). So far, genome-wide association studies have not identified the genetic factors that underlie LVM variation(3), and the regulatory mechanisms for blood-pressure-independent cardiac hypertrophy remain poorly understood(4,5). Unbiased systems genetics approaches in the rat(6,7) now provide a powerful complementary tool to genome-wide association studies, and we applied integrative genomics to dissect a highly replicated, blood-pressure-independent LVM locus on rat chromosome 3p. Here we identified endonuclease G (Endog), which previously was implicated in apoptosis(8) but not hypertrophy, as the gene at the locus, and we found a loss-of-function mutation in Endog that is associated with increased LVM and impaired cardiac function. Inhibition of Endog in cultured cardiomyocytes resulted in an increase in cell size and hypertrophic biomarkers in the absence of pro-hypertrophic stimulation. Genome-wide network analysis unexpectedly implicated ENDOG in fundamental mitochondrial processes that are unrelated to apoptosis. We showed direct regulation of ENDOG by ERR-alpha and PGC1 alpha (which are master regulators of mitochondrial and cardiac function)(9-11), interaction of ENDOG with the mitochondrial genome and ENDOG-mediated regulation of mitochondrial mass. At baseline, the Endog-deleted mouse heart had depleted mitochondria, mitochondrial dysfunction and elevated levels of reactive oxygen species, which were associated with enlarged and steatotic cardiomyocytes. Our study has further established the link between mitochondrial dysfunction, reactive oxygen species and heart disease and has uncovered a role for Endog in maladaptive cardiac hypertrophy.	[McDermott-Roe, Chris; Ahmed, Rizwan; Sun, Xi-Ming; Ware, James; Bottolo, Leonardo; Muckett, Phil; Buchan, Rachel; Lu, Han; Braithwaite, Adam; Petretto, Enrico; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Med Res Council Clin Sci Ctr, London W12 0NN, England; [Ye, Junmei; Zhang, Jisheng; Cardona, Maria; Sanchis, Daniel] Univ Lleida, Biomed Res Inst Lleida IRBLLEIDA, Cell Signaling & Apoptosis Grp, Lleida 25198, Spain; [Serafin, Anna; Canas, Xavier] Platform Appl Res Lab Anim, Barcelona 08028, Spain; [Rowe, Glenn C.; Arany, Zoltan] Beth Israel Deaconess Med Inst, Cardiovasc Inst, Boston, MA 02215 USA; [Mancini, Massimiliano] Univ Rome, Dept Radiol Oncol & Anatomopathol Sci, I-00161 Sapienza, Italy; [Hauton, David] Univ Birmingham, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Marti, Ramon; Garcia-Arumi, Elena] Univ Autonoma Barcelona, Inst Recerca Hosp Univ Vall dHebron, Unitat Patol Mitocondrial & Neuromuscular CIBERER, Barcelona 08035, Spain; [Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Hubner, Norbert] Charite Univ Med Berlin, Campus Charite Mitte, CC4, D-10117 Berlin, Germany; [Jacob, Howard] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Serikawa, Tadao] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan; [Zidek, Vaclav; Papousek, Frantisek; Kolar, Frantisek; Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Ruiz-Meana, Marisol; Garcia-Dorado, David] Univ Autonoma Barcelona, Inst Recerca Hosp Univ Vall dHebron, Grp Patol Cardiovasc, Barcelona 08035, Spain; [Comella, Joan X.] CIBERNED, Cell Signaling & Apoptosis Grp, Barcelona 08035, Spain; [Comella, Joan X.] VHIR, Barcelona 08035, Spain; [Comella, Joan X.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Barcelona 08035, Spain; [Comella, Joan X.] Univ Autonoma Barcelona, Inst Neurociencies, Barcelona 08035, Spain; [Felkin, Leanne E.; Barton, Paul J. R.] Harefield Hosp, Imperial Coll London, Natl Heart & Lung Inst, Heart Sci Ctr, Harefield UB9 6JH, Middx, England; [Barton, Paul J. R.; Cook, Stuart A.] Royal Brompton & Harefield NHS Trust, Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Biostat, London W2 1PG, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Universitat de Lleida; Harvard University; Beth Israel Deaconess Medical Center; Sapienza University Rome; University of Birmingham; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Medical College of Wisconsin; Kyoto University; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Autonomous University of Barcelona; CIBERNED; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London	Cook, SA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, Med Res Council Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	daniel.sanchis@cmb.udl.cat; stuart.cook@imperial.ac.uk	Comella, Joan X/D-7333-2012; Zhang, Jisheng/AAT-6495-2020; Cook, Stuart/G-9567-2011; Ware, James S/G-5139-2012; Zidek, Vaclav/C-6685-2012; Rowe, Glenn/N-5314-2019; MANCINI, MASSIMILIANO/AAC-1583-2022; Cañas, Xavier/D-7656-2015; Garcia-Arumi, Elena/ABH-4229-2020; Comella, Joan/GQA-4279-2022; Kolar, Frantisek/A-7852-2012; Braithwaite, Adam/R-4099-2016; Pravenec, Michal/B-1666-2012; Sanchis, Daniel/C-8077-2009; MANCINI, MASSIMILIANO/GWC-9347-2022; Zhang, Jisheng/A-1928-2010; Martí, Ramon/Q-3442-2016; Ahmed, Rizwan/P-3581-2019	Comella, Joan X/0000-0002-6218-0786; Ware, James S/0000-0002-6110-5880; MANCINI, MASSIMILIANO/0000-0001-7465-2229; Cañas, Xavier/0000-0002-0512-2248; Kolar, Frantisek/0000-0002-8723-1826; Braithwaite, Adam/0000-0003-3228-2172; Pravenec, Michal/0000-0001-9197-5871; Sanchis, Daniel/0000-0003-0047-8533; MANCINI, MASSIMILIANO/0000-0001-7465-2229; Martí, Ramon/0000-0002-8273-9540; Buchan, Rachel/0000-0003-2490-9289; Cook, Stuart/0000-0001-6628-194X; Rowe, Glenn/0000-0002-8195-9605; Barton, Paul/0000-0002-1165-7767; Serafin, Anna/0000-0002-9486-8948; Felkin, Leanne/0000-0003-1402-8314; Bottolo, Leonardo/0000-0002-6381-2327	Medical Research Council (UK); National Institute for Health Research (UK); Royal Brompton and Harefield Cardiovascular Biomedical Research Unit; Imperial College Healthcare Biomedical Research Centre; British Heart Foundation; Fondation Leducq; Wellcome Trust; Grant Agency of the Czech Republic [301/08/0166]; Ministry of Education of the Czech Republic [1M0520]; Ministerio de Ciencia e Innovacion (Spain) [PTQ-08-03-07880, SAF2008-02271, SAF2008-03067, SAF2010-19125]; Agencia de Gestio d'Ajuts Universitaris i Recerca (Spain) [2009-SGR-346]; Fondo de Investigaciones Sanitarias (Spain) [PS09/02034, PS09/01602, PS09/01591]; European Community [HEALTH-F4-2010-241504]; German National Genome Research Network (NGFN-Plus) Heart Failure; MRC [MC_U120085815, MC_U120097112] Funding Source: UKRI; British Heart Foundation [SP/10/10/28431] Funding Source: researchfish; Medical Research Council [MC_U120097112, MC_U120085815] Funding Source: researchfish; National Institute for Health Research [ACF-2007-21-004] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (UK)(National Institute for Health Research (NIHR)); Royal Brompton and Harefield Cardiovascular Biomedical Research Unit; Imperial College Healthcare Biomedical Research Centre; British Heart Foundation(British Heart Foundation); Fondation Leducq(Leducq Foundation); Wellcome Trust(Wellcome Trust); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia de Gestio d'Ajuts Universitaris i Recerca (Spain); Fondo de Investigaciones Sanitarias (Spain)(Instituto de Salud Carlos III); European Community(European Commission); German National Genome Research Network (NGFN-Plus) Heart Failure; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We acknowledge funding from the Medical Research Council (UK), the National Institute for Health Research (UK), the Royal Brompton and Harefield Cardiovascular Biomedical Research Unit, the Imperial College Healthcare Biomedical Research Centre, the British Heart Foundation, Fondation Leducq, the Wellcome Trust, the Grant Agency of the Czech Republic (301/08/0166), the Ministry of Education of the Czech Republic (1M0520), the Ministerio de Ciencia e Innovacion (Spain; PTQ-08-03-07880, SAF2008-02271, SAF2008-03067 and SAF2010-19125), the Agencia de Gestio d'Ajuts Universitaris i Recerca (Spain; 2009-SGR-346), the Fondo de Investigaciones Sanitarias (Spain; PS09/02034, PS09/01602 and PS09/01591), the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. HEALTH-F4-2010-241504 (EURATRANS), and the German National Genome Research Network (NGFN-Plus) Heart Failure. We thank M. R. Lieber for providing the Endog deleted mice and E. Wahle for providing the CG4930 expression plasmid. We thank the National BioResource Project for the Rat (http://www.anim.med.kyoto-u.ac.jp/NBR/) for providing rat strains.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bahi N, 2006, J BIOL CHEM, V281, P22943, DOI 10.1074/jbc.M601025200; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; COTE J, 1993, SCIENCE, V261, P765, DOI 10.1126/science.7688144; Dai DF, 2011, CIRC RES, V108, P837, DOI 10.1161/CIRCRESAHA.110.232306; David KK, 2006, CELL DEATH DIFFER, V13, P1147, DOI 10.1038/sj.cdd.4401787; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Heinig M, 2010, NATURE, V467, P460, DOI 10.1038/nature09386; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Inomata H, 2005, HYPERTENS RES, V28, P273, DOI 10.1291/hypres.28.273; Irvine RA, 2005, MOL CELL BIOL, V25, P294, DOI 10.1128/MCB.25.1.294-302.2005; Lewis W, 2007, LAB INVEST, V87, P326, DOI 10.1038/labinvest.3700523; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Lorell BH, 2000, CIRCULATION, V102, P470; McGavock JM, 2006, ANN INTERN MED, V144, P517, DOI 10.7326/0003-4819-144-7-200604040-00011; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; Rothfuss O, 2009, HUM MOL GENET, V18, P3832, DOI 10.1093/hmg/ddp327; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Siegel AK, 2003, ARTERIOSCL THROM VAS, V23, P1211, DOI 10.1161/01.ATV.0000079509.20542.C9; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Temme C, 2009, J BIOL CHEM, V284, P8337, DOI 10.1074/jbc.M808319200; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vasan RS, 2009, JAMA-J AM MED ASSOC, V302, P168, DOI 10.1001/jama.2009.978-a; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wong C, 2007, NAT CLIN PRACT CARD, V4, P436, DOI 10.1038/ncpcardio0943; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	30	112	116	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 6	2011	478	7367					114	118		10.1038/nature10490	http://dx.doi.org/10.1038/nature10490			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979051	Green Accepted			2022-12-24	WOS:000295575400045
J	Lupski, JR; Belmont, JW; Boerwinkle, E; Gibbs, RA				Lupski, James R.; Belmont, John W.; Boerwinkle, Eric; Gibbs, Richard A.			Clan Genomics and the Complex Architecture of Human Disease	CELL			English	Article							MARIE-TOOTH-DISEASE; CASSETTE TRANSPORTER GENE; SEVERE MENTAL-RETARDATION; CYSTIC-FIBROSIS GENE; COPY NUMBER; DENSITY-LIPOPROTEIN; STARGARDT-DISEASE; CHRONIC RHINOSINUSITIS; TREMOR/ATAXIA SYNDROME; HEREDITARY NEUROPATHY	Human diseases are caused by alleles that encompass the full range of variant types, from single-nucleotide changes to copy-number variants, and these variations span a broad frequency spectrum, from the very rare to the common. The picture emerging from analysis of whole-genome sequences, the 1000 Genomes Project pilot studies, and targeted genomic sequencing derived from very large sample sizes reveals an abundance of rare and private variants. One implication of this realization is that recent mutation may have a greater influence on disease susceptibility or protection than is conferred by variations that arose in distant ancestors.	[Lupski, James R.; Belmont, John W.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.; Belmont, John W.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Univ Texas Hlth Sci Ctr Houston, Texas Childrens Hosp, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu; agibbs@bcm.edu	Belmont, John W/AAI-2494-2019; Belmont, John/AAH-6084-2021	Belmont, John W/0000-0001-7409-3578; 	National Human Genome Research Institute [5 U54 HG003273]; National Institute of Neurological Disorders and Stroke [R01NS058529]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529, R01NS027042] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the National Human Genome Research Institute (5 U54 HG003273) to R. A. G. and the National Institute of Neurological Disorders and Stroke (R01NS058529) to J.R.L. J.R.L. is a consultant for Athena Diagnostics, has stock ownership in 23andMe and Ion Torrent Systems, and is a coinventor on multiple United States and European patents for DNA diagnostics. R. A. G. and J.W.B. are founding shareholders in Seq-Wright, Inc. The Department of Molecular and Human Genetics derives revenue from clinical testing by high-resolution human genome analyses.	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Athma P, 1996, CANCER GENET CYTOGEN, V92, P130, DOI 10.1016/S0165-4608(96)00328-7; Bacq Y, 2009, J MED GENET, V46, P711, DOI 10.1136/jmg.2009.067397; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bi WM, 2009, NAT GENET, V41, P168, DOI 10.1038/ng.302; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; BOERWINKLE E, 1988, AM J HUM GENET, V42, P104; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chung KW, 2005, NEUROGENETICS, V6, P159, DOI 10.1007/s10048-005-0217-4; Cohn JA, 1998, NEW ENGL J MED, V339, P653, DOI 10.1056/NEJM199809033391002; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; CONSORTIUM LS, 2008, NATURE, V455, P237; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Crow JF, 2008, J GENET, V87, P349, DOI 10.1007/s12041-008-0057-8; Del Colle R, 2003, NEUROL SCI, V24, P57, DOI 10.1007/s100720300073; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Divac Aleksandra, 2004, J Cyst Fibros, V3, P189, DOI 10.1016/j.jcf.2004.05.049; Douros K, 2008, INT J CLIN EXP MED, V1, P345; El-Hattab AW, 2010, GENET MED, V12, P573, DOI 10.1097/GIM.0b013e3181eb9b4a; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fellermann K, 2003, EUR J GASTROEN HEPAT, V15, P627, DOI 10.1097/00042737-200306000-00008; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; GOLDSTEIN JL, 1987, CIRCULATION, V76, P504, DOI 10.1161/01.CIR.76.3.504; Goldstein JL, 2001, SCIENCE, V292, P1310, DOI 10.1126/science.1061815; Gonzaga-Jauregui C, 2012, ANNU REV MED, V63, P35, DOI 10.1146/annurev-med-051010-162644; Greeley SAW, 2010, CURR OPIN ENDOCRINOL, V17, P13, DOI 10.1097/MED.0b013e328334f158; Guardamagna O, 2009, J PEDIATR-US, V155, P199, DOI 10.1016/j.jpeds.2009.02.022; Hagerman RJ, 2004, AM J HUM GENET, V74, P1051, DOI 10.1086/420700; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HEIM RA, 1992, MUTAT RES, V284, P25, DOI 10.1016/0027-5107(92)90022-T; Hersh CP, 2004, THORAX, V59, P843, DOI 10.1136/thx.2004.022541; Hodapp JA, 2006, ARCH NEUROL-CHICAGO, V63, P112, DOI 10.1001/archneur.63.1.112; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Jacquemont S, 2004, JAMA-J AM MED ASSOC, V291, P460, DOI 10.1001/jama.291.4.460; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Kurotaki N, 2005, GENET MED, V7, P479, DOI 10.1097/01.GIM.0000177419.43309.37; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Lupski JR, 2008, NATURE, V455, P178, DOI 10.1038/455178a; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2010, NAT GENET, V42, P1036, DOI 10.1038/ng1210-1036; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Meggouh F, 2005, ANN NEUROL, V57, P589, DOI 10.1002/ana.20434; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; MULLER HJ, 1950, AM J HUM GENET, V2, P111; POLLER W, 1990, EUR J CLIN INVEST, V20, P1; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Ramocki MB, 2009, ANN NEUROL, V66, P771, DOI 10.1002/ana.21715; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Roa BB, 1996, HUM GENET, V97, P642; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; Sharer N, 1998, NEW ENGL J MED, V339, P645, DOI 10.1056/NEJM199809033391001; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Shroyer NF, 2001, HUM MOL GENET, V10, P2671, DOI 10.1093/hmg/10.23.2671; Shroyer NF, 2001, INVEST OPHTH VIS SCI, V42, P2757; Shy ME, 2006, ANN NEUROL, V59, P358, DOI 10.1002/ana.20777; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vernimmen D, 2009, BLOOD, V114, P4253, DOI 10.1182/blood-2009-03-213439; Verny C, 2004, NEUROLOGY, V63, P1527; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wagner CA, 2008, J NEPHROL, V21, P632; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Wang XJ, 2005, ARCH OTOLARYNGOL, V131, P237, DOI 10.1001/archotol.131.3.237; Weiss FU, 2005, GUT, V54, P1456, DOI 10.1136/gut.2005.064808; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wittrup HH, 2006, J CLIN ENDOCR METAB, V91, P1438, DOI 10.1210/jc.2005-1725; Wittrup HH, 1997, J CLIN INVEST, V99, P1606, DOI 10.1172/JCI119323	119	259	261	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 30	2011	147	1					32	43		10.1016/j.cell.2011.09.008	http://dx.doi.org/10.1016/j.cell.2011.09.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962505	Bronze, Green Accepted			2022-12-24	WOS:000295396700013
J	Tantisira, KG; Lasky-Su, J; Harada, M; Murphy, A; Litonjua, AA; Himes, BE; Lange, C; Lazarus, R; Sylvia, J; Klanderman, B; Duan, QL; Qiu, WL; Hirota, T; Martinez, FD; Mauger, D; Sorkness, C; Szefler, S; Lazarus, SC; Lemanske, RF; Peters, SP; Lima, JJ; Nakamura, Y; Tamari, M; Weiss, ST				Tantisira, Kelan G.; Lasky-Su, Jessica; Harada, Michishige; Murphy, Amy; Litonjua, Augusto A.; Himes, Blanca E.; Lange, Christoph; Lazarus, Ross; Sylvia, Jody; Klanderman, Barbara; Duan, Qing Ling; Qiu, Weiliang; Hirota, Tomomitsu; Martinez, Fernando D.; Mauger, David; Sorkness, Christine; Szefler, Stanley; Lazarus, Stephen C.; Lemanske, Robert F., Jr.; Peters, Stephen P.; Lima, John J.; Nakamura, Yusuke; Tamari, Mayumi; Weiss, Scott T.			Genomewide Association between GLCCI1 and Response to Glucocorticoid Therapy in Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INHALED CORTICOSTEROIDS; PERSISTENT ASTHMA; REPLICATION; APOPTOSIS; GENOTYPE; VARIANT; ADULT; LOCI; GENE	BACKGROUND The response to treatment for asthma is characterized by wide interindividual variability, with a significant number of patients who have no response. We hypothesized that a genomewide association study would reveal novel pharmacogenetic determinants of the response to inhaled glucocorticoids. METHODS We analyzed a small number of statistically powerful variants selected on the basis of a family-based screening algorithm from among 534,290 single-nucleotide polymorphisms (SNPs) to determine changes in lung function in response to inhaled glucocorticoids. A significant, replicated association was found, and we characterized its functional effects. RESULTS We identified a significant pharmacogenetic association at SNP rs37972, replicated in four independent populations totaling 935 persons (P = 0.0007), which maps to the glucocorticoid-induced transcript 1 gene (GLCCI1) and is in complete linkage disequilibrium (i.e., perfectly correlated) with rs37973. Both rs37972 and rs37973 are associated with decrements in GLCCI1 expression. In isolated cell systems, the rs37973 variant is associated with significantly decreased luciferase reporter activity. Pooled data from treatment trials indicate reduced lung function in response to inhaled glucocorticoids in subjects with the variant allele (P = 0.0007 for pooled data). Overall, the mean (+/- SE) increase in forced expiratory volume in 1 second in the treated subjects who were homozygous for the mutant rs37973 allele was only about one third of that seen in similarly treated subjects who were homozygous for the wild-type allele (3.2 +/- 1.6% vs. 9.4 +/- 1.1%), and their risk of a poor response was significantly higher (odds ratio, 2.36; 95% confidence interval, 1.27 to 4.41), with genotype accounting for about 6.6% of overall inhaled glucocorticoid response variability. CONCLUSIONS A functional GLCCI1 variant is associated with substantial decrements in the response to inhaled glucocorticoids in patients with asthma. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT00000575.)	[Tantisira, Kelan G.; Lasky-Su, Jessica; Murphy, Amy; Litonjua, Augusto A.; Himes, Blanca E.; Lazarus, Ross; Sylvia, Jody; Klanderman, Barbara; Duan, Qing Ling; Qiu, Weiliang; Weiss, Scott T.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Tantisira, Kelan G.; Litonjua, Augusto A.] Brigham & Womens Hosp, Div Pulm, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; [Lange, Christoph] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Harada, Michishige; Hirota, Tomomitsu; Nakamura, Yusuke; Tamari, Mayumi] Inst Phys & Chem Res RIKEN, Ctr Genom Med, Kanagawa, Japan; [Lazarus, Stephen C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lemanske, Robert F., Jr.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Peters, Stephen P.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Gen, Sect Pulm Crit Care Allergy & Immunol Dis, Winston Salem, NC USA; [Martinez, Fernando D.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Martinez, Fernando D.] Univ Arizona, Dept Pediat, Tucson, AZ 85721 USA; [Mauger, David] Penn State Hershey Coll Med, Hershey, PA USA; [Szefler, Stanley] Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; [Lima, John J.] Nemours Clin, Jacksonville, FL USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; RIKEN; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison; Wake Forest University; Wake Forest Baptist Medical Center; University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Tantisira, KG (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	rekgt@channing.harvard.edu	Tamari, Mayumi/N-5378-2015	Lasky-Su, Jessica/0000-0001-6236-4705; Litonjua, Augusto/0000-0003-0422-5875; Szefler, Stanley/0000-0002-6911-3199; Qiu, Weiliang/0000-0002-9155-6957; lazarus, ross/0000-0003-3939-1961	National Institutes of Health (NIH) [U01 HL65899, P01 HL083069, R01 HG003646, R01 HL092197, K23 HG3983]; NIH Pharmacogenomics Research Network; Ministry of Education, Culture, Sports, Science, and Technology in Japan; National Heart, Lung, and Blood Institute (NHLBI) [U01 HL65899, P01 HL083069, U01 HL075419, R01 HL086601, T32 HL07427]; NHLBI [U01 HL51510, U01 HL51834, U01 HL51831, U01 HL51845, U01 HL51843, M01 RR00079, M01 RR03186, N02-HL-6-4278]; GlaxoSmithKline; Grants-in-Aid for Scientific Research [23791204] Funding Source: KAKEN; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186, M01RR000079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL051831, R01HL092197, U10HL051843, U10HL051845, U01HL075419, U01HL065899, R01HL086601, U10HL051834, T32HL007427, K99HL105663, R00HL096840, P01HL083069] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K23HG003983, R01HG003646] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); GlaxoSmithKline(GlaxoSmithKline); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported by grants from the National Institutes of Health (NIH U01 HL65899, P01 HL083069, R01 HG003646, R01 HL092197, and K23 HG3983), the NIH Pharmacogenomics Research Network, and the Ministry of Education, Culture, Sports, Science, and Technology in Japan. The Childhood Asthma Management Program (CAMP) Genetics Ancillary Study is supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (U01 HL075419, U01 HL65899, P01 HL083069, R01 HL086601, and T32 HL07427); the Single-Nucleotide Polymorphism Health Association Asthma Resource Project (SHARP) was funded by the NHLBI and was carried out by researchers from the Asthma Clinical Research Network, the CAMP, and the Childhood Asthma Research and Education (CARE) Network; the Asthma Clinical Research Network (ACRN) investigators and research teams were supported by grants from the NHLBI (U01 HL51510, U01 HL51834, U01 HL51831, U01 HL51845, U01 HL51843, M01 RR00079, and M01 RR03186); and the Leukotriene Modifier or Corticosteroid or Corticosteroid-Salmeterol (LOCCS) trial was supported by an unrestricted grant to the American Lung Association from GlaxoSmithKline. SHARP genotyping services were provided by Affymetrix under a contract (N02-HL-6-4278) from the NHLBI.	Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARMALY MF, 1966, ARCH OPHTHALMOL-CHIC, V75, P32; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bielory L, 2000, CLIN DRUG INVEST, V19, P93, DOI 10.2165/00044011-200019020-00002; CHAPMAN MS, 1995, MOL CELL ENDOCRINOL, V108, pR1, DOI 10.1016/0303-7207(95)03481-L; Chapman MS, 1996, MOL ENDOCRINOL, V10, P967, DOI 10.1210/me.10.8.967; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; *CHILDH ASTHM MAN, 2000, NEW ENGLAND J MED, V0343; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Drazen JM, 2000, BRIT MED BULL, V56, P1054, DOI 10.1258/0007142001903535; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Ho CY, 2002, CHEST, V122, P1751, DOI 10.1378/chest.122.5.1751; Inglis GC, 1999, J CLIN ENDOCR METAB, V84, P4132, DOI 10.1210/jc.84.11.4132; Israel E, 2004, LANCET, V364, P1505, DOI 10.1016/S0140-6736(04)17273-5; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Lazarus SC, 2001, JAMA-J AM MED ASSOC, V285, P2583, DOI 10.1001/jama.285.20.2583; Lemanske RF, 2001, JAMA-J AM MED ASSOC, V285, P2594, DOI 10.1001/jama.285.20.2594; Liptak T., 1958, MAGYAR TUD AKAD MAT, V3, P171; Litonjua AA, 2008, AM J RESP CRIT CARE, V178, P688, DOI 10.1164/rccm.200709-1363OC; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Peters SP, 2007, NEW ENGL J MED, V357, P728; SCHWARTZ JT, 1972, J MED GENET, V9, P137, DOI 10.1136/jmg.9.2.137; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V120, P285; Steptoe A, 2009, PSYCHONEUROENDOCRINO, V34, P273, DOI 10.1016/j.psyneuen.2008.09.006; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; Tantisira KG, 2004, HUM MOL GENET, V13, P1353, DOI 10.1093/hmg/ddh149; Tantisira KG, 2004, P NATL ACAD SCI USA, V101, P18099, DOI 10.1073/pnas.0408532102; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Won SH, 2009, STAT MED, V28, P1537, DOI 10.1002/sim.3569	39	261	274	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1173	1183		10.1056/NEJMoa0911353	http://dx.doi.org/10.1056/NEJMoa0911353			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21991891	Green Accepted, Green Published			2022-12-24	WOS:000295318400005
J	Lorch, JM; Meteyer, CU; Behr, MJ; Boyles, JG; Cryan, PM; Hicks, AC; Ballmann, AE; Coleman, JTH; Redell, DN; Reeder, DM; Blehert, DS				Lorch, Jeffrey M.; Meteyer, Carol U.; Behr, Melissa J.; Boyles, Justin G.; Cryan, Paul M.; Hicks, Alan C.; Ballmann, Anne E.; Coleman, Jeremy T. H.; Redell, David N.; Reeder, DeeAnn M.; Blehert, David S.			Experimental infection of bats with Geomyces destructans causes white-nose syndrome	NATURE			English	Article							MYOTIS-LUCIFUGUS; EXTINCTION; DISEASE; SPREAD; UPDATE	White-nose syndrome(WNS) has caused recent catastrophic declines among multiple species of bats in eastern North America(1,2). The disease's name derives from a visually apparent white growth of the newly discovered fungus Geomyces destructans on the skin (including the muzzle) of hibernating bats(1,3). Colonization of skin by this fungus is associated with characteristic cutaneous lesions that are the only consistent pathological finding related to WNS4. However, the role of G. destructans in WNS remains controversial because evidence to implicate the fungus as the primary cause of this disease is lacking. The debate is fuelled, in part, by the assumption that fungal infections in mammals are most commonly associated with immune system dysfunction(5-7). Additionally, the recent discovery that G. destructans commonly colonizes the skin of bats of Europe, where no unusual bat mortality events have been reported(8-10), has generated further speculation that the fungus is an opportunistic pathogen and that other unidentified factors are the primary cause of WNS11,12. Here we demonstrate that exposure of healthy little brown bats (Myotis lucifugus) to pure cultures of G. destructans causes WNS. Live G. destructans was subsequently cultured from diseased bats, successfully fulfilling established criteria for the determination of G. destructans as a primary pathogen(13). We also confirmed that WNS can be transmitted from infected bats to healthy bats through direct contact. Our results provide the first direct evidence that G. destructans is the causal agent of WNS and that the recent emergence of WNS in North America may represent translocation of the fungus to a region with a naive population of animals(8). Demonstration of causality is an instrumental step in elucidating the pathogenesis(14) and epidemiology(15) of WNS and in guiding management actions to preserve bat populations against the novel threat posed by this devastating infectious disease.	[Lorch, Jeffrey M.; Meteyer, Carol U.; Ballmann, Anne E.; Blehert, David S.] US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Lorch, Jeffrey M.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI 53706 USA; [Behr, Melissa J.] Wisconsin Vet Diagnost Lab, Madison, WI 53706 USA; [Boyles, Justin G.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Cryan, Paul M.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Hicks, Alan C.] New York Dept Environm Conservat, Albany, NY 12233 USA; [Coleman, Jeremy T. H.] US Fish & Wildlife Serv, Hadley, MA 01035 USA; [Redell, David N.] Wisconsin Dept Nat Resources, Madison, WI 53707 USA; [Reeder, DeeAnn M.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA	United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Knoxville; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Bucknell University	Blehert, DS (corresponding author), US Geol Survey, Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	dblehert@usgs.gov	Boyles, Justin G/A-5152-2010	Coleman, Jeremy/0000-0002-2762-947X; Lorch, Jeffrey/0000-0003-2239-1252; Blehert, David/0000-0002-1065-9760; Reeder, DeeAnn/0000-0001-8651-2012; Cryan, Paul/0000-0002-2915-8894	US Geological Survey; US Fish and Wildlife Service; Bat Conservation International; Indiana State University Center for North American Bat Research and Conservation	US Geological Survey(United States Geological Survey); US Fish and Wildlife Service(US Fish & Wildlife Service); Bat Conservation International; Indiana State University Center for North American Bat Research and Conservation	Financial support for this project was provided by the US Geological Survey, the US Fish and Wildlife Service, Bat Conservation International, and the Indiana State University Center for North American Bat Research and Conservation. Use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the US Government. We acknowledge E. Buckles, S. Darling and T. Tomasi for discussions during the development of this project. We thank N. Keller for comments during the preparation of this manuscript. We also thank J. P. White, R. Dusek, A. Klein, L. Leppert, K. Schuler, C. L. White and NWHC Animal Care Staff for their help with set-up and maintenance of animals, and D. Berndt, L. Muller, A. Pike and M. Verant for their assistance during necropsies. We thank X. Yu for help with statistical analyses.	Blanco JL, 2008, VET IMMUNOL IMMUNOP, V125, P47, DOI 10.1016/j.vetimm.2008.04.020; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Casadevall A, 2005, FUNGAL GENET BIOL, V42, P98, DOI 10.1016/j.fgb.2004.11.008; Cryan PM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-135; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Foley J, 2011, CONSERV BIOL, V25, P223, DOI 10.1111/j.1523-1739.2010.01638.x; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; KOCH R, 1884, MITT KAISER GESUNDH, V2, P1, DOI DOI 10.1016/S0174-3031(82)80099-1; Lorch JM, 2010, J VET DIAGN INVEST, V22, P224, DOI 10.1177/104063871002200208; Martinkova N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013853; Maschmeyer G, 2009, MED MYCOL, V47, P571, DOI 10.1080/13693780902946559; Meteyer CU, 2009, J VET DIAGN INVEST, V21, P411, DOI 10.1177/104063870902100401; Puechmaille SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019167; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Rajkumar SS, 2011, EMERG INFECT DIS, V17, P1273, DOI 10.3201/eid1707.102056; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Turner Gregory G., 2011, Bat Research News, V52, P13; Turner Gregory G., 2009, Bat Research News, V50, P47; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002	23	324	331	1	282	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					376	U129		10.1038/nature10590	http://dx.doi.org/10.1038/nature10590			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22031324				2022-12-24	WOS:000298033000053
J	Takeda, N; Jain, R; LeBoeuf, MR; Wang, QH; Lu, MM; Epstein, JA				Takeda, Norifumi; Jain, Rajan; LeBoeuf, Matthew R.; Wang, Qiaohong; Lu, Min Min; Epstein, Jonathan A.			Interconversion Between Intestinal Stem Cell Populations in Distinct Niches	SCIENCE			English	Article							PROGENITOR CELLS; MOUSE; MARKER; HOP; IDENTIFICATION; EXPRESSION; RENEWAL; PROTEIN; CANCER; GENE	Intestinal epithelial stem cell identity and location have been the subject of substantial research. Cells in the +4 niche are slow-cycling and label-retaining, whereas a different stem cell niche located at the crypt base is occupied by crypt base columnar (CBC) cells. CBCs are distinct from +4 cells, and the relationship between them is unknown, though both give rise to all intestinal epithelial lineages. We demonstrate that Hopx, an atypical homeobox protein, is a specific marker of +4 cells. Hopx-expressing cells give rise to CBCs and all mature intestinal epithelial lineages. Conversely, CBCs can give rise to +4 Hopx-positive cells. These findings demonstrate a bidirectional lineage relationship between active and quiescent stem cells in their niches.	[Takeda, Norifumi; Jain, Rajan; LeBoeuf, Matthew R.; Wang, Qiaohong; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Takeda, Norifumi; Jain, Rajan; Wang, Qiaohong; Lu, Min Min; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Penn Cardiovasc Inst, Philadelphia, PA 19104 USA; [Takeda, Norifumi; Jain, Rajan; Wang, Qiaohong; Epstein, Jonathan A.] Univ Penn, Perelman Sch Med, Inst Regenerat Med, Philadelphia, PA 19104 USA; [LeBoeuf, Matthew R.] Univ Penn, Perelman Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Epstein, JA (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	epsteinj@mail.med.upenn.edu		TAKEDA, NORIFUMI/0000-0003-4818-3347; Epstein, Jonathan/0000-0001-8637-4465	American Heart Association [AHA 0825548D]; NIH [R01 HL071546, U01 HL100405]; Spain fund for Regenerative Medicine; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100405, R01HL071546] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spain fund for Regenerative Medicine; W. W. Smith Endowed Chair; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the Epstein laboratory for helpful discussions; C. J. Lengner, A. Padmanabhan, N. Singh, and K. S. Zaret for critical reading of the manuscript; and the Penn Flow Cytometry core and C. Pletcher for assistance with FACS experiments. This work was supported by an American Heart Association Physician-Scientist/Postdoctoral fellowship to R. J. (AHA 0825548D) and funds from the NIH (R01 HL071546, U01 HL100405), the Spain fund for Regenerative Medicine, and W. W. Smith Endowed Chair to J.A.E.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Chen F, 2002, CELL, V110, P713, DOI 10.1016/S0092-8674(02)00932-7; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; De Toni A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-13; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Potten CS, 2002, J CELL SCI, V115, P2381; POTTEN CS, 1977, CELL TISSUE KINET, V10, P557, DOI 10.1111/j.1365-2184.1977.tb00312.x; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shin CH, 2002, CELL, V110, P725, DOI 10.1016/S0092-8674(02)00933-9; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Vries RGJ, 2010, MOL ONCOL, V4, P373, DOI 10.1016/j.molonc.2010.05.001	23	512	530	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 9	2011	334	6061					1420	1424		10.1126/science.1213214	http://dx.doi.org/10.1126/science.1213214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22075725	Green Accepted			2022-12-24	WOS:000297787700058
J	Pejchal, R; Doores, KJ; Walker, LM; Khayat, R; Huang, PS; Wang, SK; Stanfield, RL; Julien, JP; Ramos, A; Crispin, M; Depetris, R; Katpally, U; Marozsan, A; Cupo, A; Maloveste, S; Liu, Y; McBride, R; Ito, Y; Sanders, RW; Ogohara, C; Paulson, JC; Feizi, T; Scanlan, CN; Wong, CH; Moore, JP; Olson, WC; Ward, AB; Poignard, P; Schief, WR; Burton, DR; Wilson, IA				Pejchal, Robert; Doores, Katie J.; Walker, Laura M.; Khayat, Reza; Huang, Po-Ssu; Wang, Sheng-Kai; Stanfield, Robyn L.; Julien, Jean-Philippe; Ramos, Alejandra; Crispin, Max; Depetris, Rafael; Katpally, Umesh; Marozsan, Andre; Cupo, Albert; Maloveste, Sebastien; Liu, Yan; McBride, Ryan; Ito, Yukishige; Sanders, Rogier W.; Ogohara, Cassandra; Paulson, James C.; Feizi, Ten; Scanlan, Christopher N.; Wong, Chi-Huey; Moore, John P.; Olson, William C.; Ward, Andrew B.; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Wilson, Ian A.			A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN COMPLEX; GP120; PANEL	The HIV envelope (Env) protein gp120 is protected from antibody recognition by a dense glycan shield. However, several of the recently identified PGT broadly neutralizing antibodies appear to interact directly with the HIV glycan coat. Crystal structures of antigen-binding fragments (Fabs) PGT 127 and 128 with Man(9) at 1.65 and 1.29 angstrom resolution, respectively, and glycan binding data delineate a specific high mannose-binding site. Fab PGT 128 complexed with a fully glycosylated gp120 outer domain at 3.25 angstroms reveals that the antibody penetrates the glycan shield and recognizes two conserved glycans as well as a short beta-strand segment of the gp120 V3 loop, accounting for its high binding affinity and broad specificify. Furthermore, our data suggest that the high neutralization potency of PGT 127 and 128 immunoglobulin Gs may be mediated by cross-linking Env trimers on the viral surface.	[Doores, Katie J.; Walker, Laura M.; Ramos, Alejandra; Poignard, Pascal; Schief, William R.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Pejchal, Robert; Doores, Katie J.; Walker, Laura M.; Khayat, Reza; Stanfield, Robyn L.; Julien, Jean-Philippe; Ramos, Alejandra; Ward, Andrew B.; Poignard, Pascal; Schief, William R.; Burton, Dennis R.; Wilson, Ian A.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Pejchal, Robert; Khayat, Reza; Stanfield, Robyn L.; Julien, Jean-Philippe; Ward, Andrew B.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Doores, Katie J.; Burton, Dennis R.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02129 USA; [Huang, Po-Ssu; Ogohara, Cassandra; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Wang, Sheng-Kai; Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Crispin, Max; Scanlan, Christopher N.] Univ Oxford, Dept Biochem, Oxford Glycobiol Inst, Oxford OX1 3QU, England; [Depetris, Rafael; Sanders, Rogier W.; Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Katpally, Umesh; Marozsan, Andre; Cupo, Albert; Olson, William C.] Progen Pharmaceut, Tarrytown, NY 10591 USA; [Maloveste, Sebastien] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Liu, Yan; Feizi, Ten] Univ London Imperial Coll Sci Technol & Med, Dept Med, Glycosci Lab, London W12 0NN, England; [McBride, Ryan; Paulson, James C.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Ito, Yukishige] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Ito, Yukishige] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Wako, Saitama 3510198, Japan; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Poignard, Pascal] Int AIDS Vaccine Initiat, New York, NY 10038 USA	Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Washington; University of Washington Seattle; Scripps Research Institute; University of Oxford; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Imperial College London; Scripps Research Institute; RIKEN; Japan Science & Technology Agency (JST); University of Amsterdam; Academic Medical Center Amsterdam; International AIDS Vaccine Initiative	Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	burton@scripps.edu; wilson@scripps.edu	McBride, Ryan/E-6812-2011; Stanfield, Robyn/AAH-3190-2019; Liu, Yan/D-9117-2013; poignard, pascal/N-6678-2013; Crispin, Max/AAG-4098-2020; Paulson, James/AAG-3565-2019; Ward, Andrew B/F-9203-2014; Schief, William/ABF-3645-2020; poignard, pascal/AAB-4613-2020; Ward, Andrew/ABD-7728-2021; Ito, Yukishige/M-5119-2014; Ito, Yukishige/ACL-6203-2022	Crispin, Max/0000-0002-1072-2694; Ward, Andrew B/0000-0001-7153-3769; Schief, William/0000-0002-1120-0150; Ward, Andrew/0000-0001-7153-3769; Ito, Yukishige/0000-0001-6251-7249; Ito, Yukishige/0000-0001-6251-7249; Julien, Jean-Philippe/0000-0001-7602-3995; Poignard, Pascal/0000-0002-0021-7192; Huang, Possu/0000-0002-7948-2895; Wang, Sheng-Kai/0000-0002-3827-7983; Liu, Yan/0000-0002-2566-6867; Doores, Katie/0000-0002-5507-1725; Feizi, Ten/0000-0001-6495-0329	International AIDS Vaccine Initiative Neutralizing Antibody Center; NIH [AI84817, AI74372]; National Institute of Allergy and Infectious Diseases [AI33292]; Canadian Institutes of Health Research [FRN HFE-224662]; HIV Vaccine Research and Design grant [AI082362]; UK Research Councils' Basic Technology Initiative [GRS/79268]; Engineering and Physical Sciences Research Council [EP/G037604/1]; National Cancer Institute (NCI) [U01 CA128416, Y1-CO-1020]; Ragon Institute; NIH through the National Center for Research Resources' [RR017573]; DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources [P41RR001209]; National Institute of General Medical Sciences (NIGMS) [Y1-GM-1104]; DOE, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; EPSRC [EP/G037604/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/S79268/02] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA128416] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573, P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082362, R01AI084817, R56AI084817, R37AI033292, F32AI074372, R01AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); HIV Vaccine Research and Design grant; UK Research Councils' Basic Technology Initiative; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ragon Institute; NIH through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH's National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Hua, K. Le, and V. Thaney for technical assistance; D. Ekiert for help with initial cloning of PGTs 125 and 126; X. Dai and X. Zhu for help with x-ray data collection and analysis; C. Corbaci and C. Williams for help with figure preparation; B. Walker for helpful comments on the manuscript; and members of The Glycosciences Laboratory for their collaboration in the establishment of the neoglycolipid-based microarray system. This work was supported by the International AIDS Vaccine Initiative Neutralizing Antibody Center, NIH grant AI84817 (I. A. W.), National Institute of Allergy and Infectious Diseases grant AI33292 (D. R. B.), NIH/National Research Service Award fellowship AI74372 (R. P.), Canadian Institutes of Health Research fellowship FRN HFE-224662 (J.-P.J.), HIV Vaccine Research and Design grant AI082362 (W.C.O., J.P.M., and I. A. W.), UK Research Councils' Basic Technology Initiative "Glycoarrays" grant GRS/79268, Engineering and Physical Sciences Research Council Translational Grant EP/G037604/1, National Cancer Institute (NCI) Alliance of Glycobiologists for Detection of Cancer and Cancer Risk grant U01 CA128416, and the Ragon Institute. The three-dimensional reconstructions were conducted at the National Resource for Automated Molecular Microscopy, which is supported by NIH through the National Center for Research Resources' P41 program (RR017573). Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a Directorate of the SLAC National Accelerator Laboratory and an Office of Science User Facility operated for the U. S. Department of Energy (DOE) Office of Science by Stanford University. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research; NIH's National Center for Research Resources, Biomedical Technology Program (P41RR001209); and the National Institute of General Medical Sciences (NIGMS). Use of the Advanced Photon Source was supported by the DOE, Basic Energy Sciences, Office of Science, under contract no. DE-AC02-06CH11357. GM/CA CAT has been funded in whole or in part with federal funds from NCI (grant Y1-CO-1020) and NIGMS (grant Y1-GM-1104). Coordinates and structure factors for the Fab PGT 128/Man<INF>9</INF>, Fab PGT 127/Man<INF>9</INF>, and Fab PGT 128/eODmV3 structures have been deposited with the Protein Data Bank under accession codes 3TV3, 3TWC, and 3TYG. The Fab PGT 128/d664G trimer EM reconstruction density has been deposited with the Electron Microscopy Data Bank under accession code EMD-1970. Progenics Pharmaceuticals and the Cornell Research Foundation, on behalf of Cornell University, are the joint owners of U. S. Patent 7,939,083 and have additional patent applications on the stabilized Env trimer used in this manuscript. The IAVI and Theraclone hold U. S. patent 61/515,528 on the PGT antibodies. The Scripps Research Institute and IAVI have applied for a patent relating to the eODmV3 construct. Materials will be made available for noncommercial use under material transfer agreements with Progenics or Cornell (stabilized Env 664G trimer), IAVI (PGT antibodies), and TSRI (eODmV3). This is manuscript 21407-MB from The Scripps Research Institute.	Ansarah-Sobrinho C, 2008, VIROLOGY, V381, P67, DOI 10.1016/j.virol.2008.08.021; Beddows S, 2006, AIDS RES HUM RETROV, V22, P569, DOI 10.1089/aid.2006.22.569; Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2002, J VIROL, V76, P2606, DOI 10.1128/JVI.76.6.2606-2616.2002; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; Harris A, 2011, P NATL ACAD SCI USA, V108, P11440, DOI 10.1073/pnas.1101414108; Klasse PJ, 2007, VIROLOGY, V369, P245, DOI 10.1016/j.virol.2007.06.044; Klein JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000908; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Krause JC, 2011, MBIO, V2, DOI 10.1128/mBio.00345-10; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Le Doux JM, 1999, BIOTECHNOL BIOENG, V63, P654, DOI 10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Nandi A, 2010, VIROLOGY, V396, P339, DOI 10.1016/j.virol.2009.10.044; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Parren PWHI, 1998, J VIROL, V72, P3512, DOI 10.1128/JVI.72.5.3512-3519.1998; Parren PWHI, 2001, ADV IMMUNOL, V77, P195, DOI 10.1016/S0065-2776(01)77018-6; ROBEN P, 1994, J VIROL, V68, P4821, DOI 10.1128/JVI.68.8.4821-4828.1994; Ruprecht CR, 2011, J EXP MED, V208, P439, DOI 10.1084/jem.20101907; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; SATTENTAU QJ, 1995, J EXP MED, V182, P185, DOI 10.1084/jem.182.1.185; Stanfield RL, 2004, STRUCTURE, V12, P193, DOI 10.1016/j.str.2004.01.003; Tang HL, 2011, J VIROL, V85, P9286, DOI 10.1128/JVI.02286-10; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; WILSON IA, 1995, NAT STRUCT BIOL, V2, P433, DOI 10.1038/nsb0695-433; Wilson PC, 1998, J EXP MED, V187, P59, DOI 10.1084/jem.187.1.59; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	38	555	609	0	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2011	334	6059					1097	1103		10.1126/science.1213256	http://dx.doi.org/10.1126/science.1213256			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	21998254	Green Accepted			2022-12-24	WOS:000297313900041
J	Shomura, Y; Yoon, KS; Nishihara, H; Higuchi, Y				Shomura, Yasuhito; Yoon, Ki-Seok; Nishihara, Hirofumi; Higuchi, Yoshiki			Structural basis for a [4Fe-3S] cluster in the oxygen-tolerant membrane-bound [NiFe]-hydrogenase	NATURE			English	Article							RALSTONIA-EUTROPHA H16; NIFE HYDROGENASE; CRYSTAL-STRUCTURE; CATALYTIC CYCLE; ACTIVE-SITE; GAS ACCESS; REFINEMENT; ACTIVATION; ANGSTROM; CENTERS	Membrane-bound respiratory [NiFe]-hydrogenase (MBH), a H-2-uptake enzyme found in the periplasmic space of bacteria, catalyses the oxidation of dihydrogen: H-2 -> 2H(+) + 2e(-) (ref. 1). In contrast to the well-studied O-2-sensitive [NiFe]-hydrogenases (referred to as the standard enzymes), MBH has an O-2-tolerant H-2 oxidation activity(2-4); however, the mechanism of O-2 tolerance is unclear(5). Here we report the crystal structures of Hydrogenovibrio marinus MBH in three different redox conditions at resolutions between 1.18 and 1.32 angstrom. We find that the proximal iron-sulphur (Fe-S) cluster of MBH has a [4Fe-3S] structure coordinated by six cysteine residues-in contrast to the [4Fe-4S] cubane structure coordinated by four cysteine residues found in the proximal Fe-S cluster of the standard enzymes-and that an amide nitrogen of the polypeptide backbone is deprotonated and additionally coordinates the cluster when chemically oxidized, thus stabilizing the superoxidized state of the cluster. The structure of MBH is very similar to that of the O-2-sensitive standard enzymes except for the proximal Fe-S cluster. Our results give a reasonable explanation why the O-2 tolerance of MBH is attributable to the unique proximal Fe-S cluster; we propose that the cluster is not only a component of the electron transfer for the catalytic cycle, but that it also donates two electrons and one proton crucial for the appropriate reduction of O-2 in preventing the formation of an unready, inactive state of the enzyme.	[Shomura, Yasuhito; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Kamigori, Hyogo 6781297, Japan; [Shomura, Yasuhito; Higuchi, Yoshiki] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Yoon, Ki-Seok; Nishihara, Hirofumi] Ibaraki Univ, Coll Agr, Dept Bioresource Sci, Ami, Ibaraki 3000393, Japan; [Higuchi, Yoshiki] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	University of Hyogo; RIKEN; Ibaraki University; Japan Science & Technology Agency (JST)	Higuchi, Y (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, 3-2-1 Koto, Kamigori, Hyogo 6781297, Japan.	hig@sci.u-hyogo.ac.jp		Higuchi, Yoshiki/0000-0001-8284-5709	Academia Sinica; National Synchrotron Radiation Research Center (Taiwan); MEXT [20051022, 22770111, 18GS0207]; JSPS [20580094, 22370061, 22657031]; University of Hyogo; Hyogo Science and Technology Association; GCOE Program; Japanese Aerospace Exploration Agency Project; JST, Japan	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center (Taiwan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); University of Hyogo; Hyogo Science and Technology Association; GCOE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Aerospace Exploration Agency Project; JST, Japan(Japan Science & Technology Agency (JST))	We thank K. Hagiya for technical assistance at Ibaraki University. The synchrotron radiation experiments were performed at the BL41XU (proposal no. 2010A1223) and BL44XU (proposal no. 2010A/B6520) with the approval of JASRI. The CCD detector MX225-HE (Rayonix) at BL44XU was financially supported by Academia Sinica and National Synchrotron Radiation Research Center (Taiwan). This work was supported by a grant-in-aid for Scientific Research from MEXT (20051022 (Y.S.), 22770111 (Y.S.), 18GS0207 (Y.H.)), grant-in-aid for Scientific Research from JSPS (20580094 (H.N.), 22370061 (Y.H.) and 22657031 (Y.H.)), grant-in-aid for research and education from University of Hyogo (Y.S.), and grant-in-aid for young scientists from Hyogo Science and Technology Association (Y.S.). This work was also partially supported by the GCOE Program (Y.H.), the Japanese Aerospace Exploration Agency Project (Y.H.), and the basic research programs CREST type, 'Development of the Foundation for Nano-Interface Technology' from JST, Japan (Y.H.).	Aragao D, 2008, ACTA CRYSTALLOGR D, V64, P665, DOI 10.1107/S0907444908009165; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERNANDEZ VM, 1986, BIOCHIM BIOPHYS ACTA, V883, P145, DOI 10.1016/0304-4165(86)90145-5; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Luo XJ, 2009, J BIOL INORG CHEM, V14, P1275, DOI 10.1007/s00775-009-0572-y; Marques MC, 2010, J MOL BIOL, V396, P893, DOI 10.1016/j.jmb.2009.12.013; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shomura Y, 2011, ACTA CRYSTALLOGR F, V67, P827, DOI 10.1107/S1744309111019804; Teixeira VH, 2008, PROTEINS, V70, P1010, DOI 10.1002/prot.21588; Ueno G, 2005, J SYNCHROTRON RADIAT, V12, P380, DOI 10.1107/S0909049505004735; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Yoon KS, 2011, INT J HYDROGEN ENERG, V36, P7081, DOI 10.1016/j.ijhydene.2011.03.049	37	217	217	2	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					253	U143		10.1038/nature10504	http://dx.doi.org/10.1038/nature10504			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002607				2022-12-24	WOS:000298030800048
J	Colantuoni, C; Lipska, BK; Ye, TZ; Hyde, TM; Tao, R; Leek, JT; Colantuoni, EA; Elkahloun, AG; Herman, MM; Weinberger, DR; Kleinman, JE				Colantuoni, Carlo; Lipska, Barbara K.; Ye, Tianzhang; Hyde, Thomas M.; Tao, Ran; Leek, Jeffrey T.; Colantuoni, Elizabeth A.; Elkahloun, Abdel G.; Herman, Mary M.; Weinberger, Daniel R.; Kleinman, Joel E.			Temporal dynamics and genetic control of transcription in the human prefrontal cortex	NATURE			English	Article							HUMAN BRAIN; EXPRESSION; DISEASE; MOUSE; MICRORNA; RNA	Previous investigations have combined transcriptional and genetic analyses in human cell lines(1-3), but few have applied these techniques to human neural tissue(4-8). To gain a global molecular perspective on the role of the human genome in cortical development, function and ageing, we explore the temporal dynamics and genetic control of transcription in human prefrontal cortex in an extensive series of post-mortem brains from fetal development through ageing. We discover a wave of gene expression changes occurring during fetal development which are reversed in early postnatal life. One half-century later in life, this pattern of reversals is mirrored in ageing and in neurodegeneration. Although we identify thousands of robust associations of individual genetic polymorphisms with gene expression, we also demonstrate that there is no association between the total extent of genetic differences between subjects and the global similarity of their transcriptional profiles. Hence, the human genome produces a consistent molecular architecture in the prefrontal cortex, despite millions of genetic differences across individuals and races. To enable further discovery, this entire data set is freely available (from Gene Expression Omnibus: accession GSE30272; and dbGaP: accession phs000417.v1.p1) and can also be interrogated via a biologist-friendly stand-alone application (http://www.libd.org/braincloud).	[Colantuoni, Carlo; Lipska, Barbara K.; Ye, Tianzhang; Hyde, Thomas M.; Tao, Ran; Herman, Mary M.; Weinberger, Daniel R.; Kleinman, Joel E.] NIMH, Sect Neuropathol, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program,IRP,NIH, Bethesda, MD 20892 USA; [Colantuoni, Carlo; Leek, Jeffrey T.; Colantuoni, Elizabeth A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Colantuoni, Carlo] Illuminato Biotechnol Inc, Baltimore, MD 21211 USA; [Colantuoni, Carlo; Hyde, Thomas M.; Weinberger, Daniel R.] Johns Hopkins Univ, Med Ctr, Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Elkahloun, Abdel G.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kleinman, JE (corresponding author), NIMH, Sect Neuropathol, Clin Brain Disorders Branch, Genes Cognit & Psychosis Program,IRP,NIH, Bethesda, MD 20892 USA.	kleinmaj@mail.nih.gov	Lipska, Barbara K/E-4569-2017; Tao, Ran/C-2662-2013; Tao, Ran/L-3460-2014	Colantuoni, Carlo/0000-0001-6818-6380; Leek, Jeffrey/0000-0002-2873-2671	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002399, ZICMH002903] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIC HG200365-03, ZIC HG200365-02, ZIC HG200365-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Colantuoni C, 2002, BIOINFORMATICS, V18, P1540, DOI 10.1093/bioinformatics/18.11.1540; Coolen M, 2009, CURR OPIN NEUROBIOL, V19, P461, DOI 10.1016/j.conb.2009.09.006; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; De S, 2010, PHYSIOL GENOMICS, V42A, P162, DOI 10.1152/physiolgenomics.00008.2010; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schaeffer EM, 2008, ONCOGENE, V27, P7180, DOI 10.1038/onc.2008.327; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Torkamani A, 2010, GENOME RES, V20, P403, DOI 10.1101/gr.101956.109; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Zhang YQ, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-1	27	509	516	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					519	U117		10.1038/nature10524	http://dx.doi.org/10.1038/nature10524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031444	Green Accepted			2022-12-24	WOS:000296194200044
J	Saavedra, S; Stouffer, DB; Uzzi, B; Bascompte, J				Saavedra, Serguei; Stouffer, Daniel B.; Uzzi, Brian; Bascompte, Jordi			Strong contributors to network persistence are the most vulnerable to extinction	NATURE			English	Article							MUTUALISTIC NETWORKS; ARCHITECTURE; SYSTEMS	The architecture of mutualistic networks facilitates coexistence of individual participants by minimizing competition relative to facilitation(1,2). However, it is not known whether this benefit is received by each participant node in proportion to its overall contribution to network persistence. This issue is critical to understanding the trade-offs faced by individual nodes in a network(3-5). We address this question by applying a suite of structural and dynamic methods to an ensemble of flowering plant/insect pollinator networks. Here we report two main results. First, nodes contribute heterogeneously to the overall nested architecture of the network. From simulations, we confirm that the removal of a strong contributor tends to decrease overall network persistence more than the removal of a weak contributor. Second, strong contributors to collective persistence do not gain individual survival benefits but are in fact the nodes most vulnerable to extinction. We explore the generality of these results to other cooperative networks by analysing a 15-year time series of the interactions between designer and contractor firms in the New York City garment industry. As with the ecological networks, a firm's survival probability decreases as its individual nestedness contribution increases. Our results, therefore, introduce a new paradox into the study of the persistence of cooperative networks, and potentially address questions about the impact of invasive species in ecological systems and new competitors in economic systems.	[Stouffer, Daniel B.; Bascompte, Jordi] CSIC, Estn Biol Donana, Integrat Ecol Grp, E-41092 Seville, Spain; [Saavedra, Serguei; Uzzi, Brian] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA; [Saavedra, Serguei; Uzzi, Brian] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Saavedra, Serguei] Northwestern Univ, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Stouffer, Daniel B.] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Northwestern University; Northwestern University; Northwestern University; University of Canterbury	Bascompte, J (corresponding author), CSIC, Estn Biol Donana, Integrat Ecol Grp, Calle Americo Vespucio S-N, E-41092 Seville, Spain.	bascompte@ebd.csic.es	Bascompte, Jordi/B-7596-2008; Stouffer, Daniel/C-2223-2008	Bascompte, Jordi/0000-0002-0108-6411; Stouffer, Daniel/0000-0001-9436-9674	Kellogg School of Management, Northwestern University; Northwestern University Institute on Complex Systems; NUCATS [UL1RR025741]; CSIC-JAE postdoctoral fellowship; Army Research Laboratory [W911NF-09-2-0053]; European Research Council under the European Community [268543]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	Kellogg School of Management, Northwestern University; Northwestern University Institute on Complex Systems; NUCATS; CSIC-JAE postdoctoral fellowship; Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); European Research Council under the European Community(European Research Council (ERC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the Kellogg School of Management, Northwestern University, the Northwestern University Institute on Complex Systems (NICO; to S. S. and B. U.), NUCATS grant UL1RR025741 (to S. S.), a CSIC-JAE postdoctoral fellowship (to D. B. S.), the Army Research Laboratory (under cooperative agreement W911NF-09-2-0053 to B. U.), and the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) through an Advanced Grant (grant agreement 268543 to J.B.). Figures were generated with PyGrace (http://pygrace.sourceforge.net).	Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; DETONI A, 1995, OMEGA-INT J MANAGE S, V23, P403, DOI 10.1016/0305-0483(95)00024-I; Doeringer J., 1996, SOCIO-ECON REV, V4, P353; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Gintis H., 2005, MORAL SENTIMENTS MAT; Haldane AG, 2011, NATURE, V469, DOI 10.1038/nature09659; LEIGH EG, 1977, P NATL ACAD SCI USA, V74, P4542, DOI 10.1073/pnas.74.10.4542; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rezende EL, 2007, NATURE, V448, P925, DOI 10.1038/nature05956; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Saavedra S, 2010, PHYSICA A, V389, P1131, DOI 10.1016/j.physa.2009.10.038; Sugihara G, 2009, NATURE, V458, P979, DOI 10.1038/458979a; Uzzi B, 1996, AM SOCIOL REV, V61, P674, DOI 10.2307/2096399; Weyl EG, 2010, P NATL ACAD SCI USA, V107, P15712, DOI 10.1073/pnas.1005294107	22	205	211	1	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					233	235		10.1038/nature10433	http://dx.doi.org/10.1038/nature10433			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21918515	Green Submitted			2022-12-24	WOS:000295782800048
J	Hancock, AM; Brachi, B; Faure, N; Horton, MW; Jarymowycz, LB; Sperone, FG; Toomajian, C; Roux, F; Bergelson, J				Hancock, Angela M.; Brachi, Benjamin; Faure, Nathalie; Horton, Matthew W.; Jarymowycz, Lucien B.; Sperone, F. Gianluca; Toomajian, Chris; Roux, Fabrice; Bergelson, Joy			Adaptation to Climate Across the Arabidopsis thaliana Genome	SCIENCE			English	Article							COMPLEXITY; EVOLUTION; PATTERNS; PLANTS; SHIFT; LINES; COST	Understanding the genetic bases and modes of adaptation to current climatic conditions is essential to accurately predict responses to future environmental change. We conducted a genome-wide scan to identify climate-adaptive genetic loci and pathways in the plant Arabidopsis thaliana. Amino acid-changing variants were significantly enriched among the loci strongly correlated with climate, suggesting that our scan effectively detects adaptive alleles. Moreover, from our results, we successfully predicted relative fitness among a set of geographically diverse A. thaliana accessions when grown together in a common environment. Our results provide a set of candidates for dissecting the molecular bases of climate adaptations, as well as insights about the prevalence of selective sweeps, which has implications for predicting the rate of adaptation.	[Hancock, Angela M.; Horton, Matthew W.; Jarymowycz, Lucien B.; Sperone, F. Gianluca; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Brachi, Benjamin; Faure, Nathalie; Roux, Fabrice] Univ Sci & Technol Lille 1, FRE CNRS 3268, Lab Genet & Evolut Populat Vegetales, Villeneuve Dascq, France; [Toomajian, Chris] Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66502 USA	University of Chicago; Universite de Lille - ISITE; Universite de Lille; Kansas State University	Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Toomajian, Christopher/ABA-2615-2021	Toomajian, Christopher/0000-0002-6763-0678; Hancock, Angela/0000-0002-4768-3377; Brachi, Benjamin/0000-0001-5988-7150; Fabrice, Roux/0000-0001-8059-5638; Bergelson, Joy/0000-0001-7893-7387; Horton, Matthew/0000-0002-7537-0730	NIH [GM083068]; NSF [DEB0519961]; V. Dropkin Postdoctoral Fellowship; Graduate Assistance in Areas of National Need (GAANN) training grant; University of Lille; French Research Ministry; College Doctoral Europeen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083068] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); V. Dropkin Postdoctoral Fellowship; Graduate Assistance in Areas of National Need (GAANN) training grant(US Department of Education); University of Lille; French Research Ministry(Ministry of Research, France); College Doctoral Europeen; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by NIH GM083068 and NSF DEB0519961 to J.B. A. M. H. was supported by a V. Dropkin Postdoctoral Fellowship, and M. W. H. was supported by an NSF Predoctoral Fellowship and a Graduate Assistance in Areas of National Need (GAANN) training grant. F. R. was supported by a Bonus Qualite Reserche (BQR) grant from the University of Lille, and B. B. received funding from a Ph.D. fellowship from the French Research Ministry and a mobility grant from the College Doctoral Europeen. This is contribution 11-389-J from the Kansas Agricultural Experiment Station. We thank J. Borevitz, A. Fournier-Level, M. Nordborg, A. Platt, J. Schmitt, members of the Bergelson laboratory, and two anonymous reviewers for helpful input. Climate data for the 948 accessions used in these analyses, result files for the correlation analyses, and a browser that allows for viewing the results in their genomic context are available at http://bergelson.uchicago.edu/regmap-data/climate-genome-scan/. The genotype data used for these analyses resulted from the RegMap project (http://regmap.uchicago.edu).	ATHAR H, 2005, HDB PHOTOSYNTHESIS, P928; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Gillespie JH, 2000, GENETICS, V155, P909; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Kim DH, 2009, ANNU REV CELL DEV BI, V25, P277, DOI 10.1146/annurev.cellbio.042308.113411; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; LYNCH M, 1993, BIOTIC INTERACTIONS AND GLOBAL CHANGE, P234; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; RATHCKE B, 1985, ANNU REV ECOL SYST, V16, P179, DOI 10.1146/annurev.es.16.110185.001143; Roux F, 2004, GENETICS, V166, P449, DOI 10.1534/genetics.166.1.449; Toomajian C, 2006, PLOS BIOL, V4, P732, DOI 10.1371/journal.pbio.0040137; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wang Z, 2010, P NATL ACAD SCI USA, V107, P18034, DOI 10.1073/pnas.1004666107; Weinig C, 2002, GENETICS, V162, P1875	21	447	452	3	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					83	86		10.1126/science.1209244	http://dx.doi.org/10.1126/science.1209244			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980108				2022-12-24	WOS:000295580300044
J	Gkikopoulos, T; Schofield, P; Singh, V; Pinskaya, M; Mellor, J; Smolle, M; Workman, JL; Barton, GJ; Owen-Hughes, T				Gkikopoulos, Triantaffyllos; Schofield, Pieta; Singh, Vijender; Pinskaya, Marina; Mellor, Jane; Smolle, Michaela; Workman, Jerry L.; Barton, Geoffrey J.; Owen-Hughes, Tom			A Role for Snf2-Related Nucleosome-Spacing Enzymes in Genome-Wide Nucleosome Organization	SCIENCE			English	Article							CHROMATIN-REMODELING ENZYME; HISTONE-DNA INTERACTIONS; IN-VIVO; SACCHAROMYCES-CEREVISIAE; YEAST ISWI; CHD1; TRANSCRIPTION; IDENTIFICATION; MECHANISMS; POSITIONS	The positioning of nucleosomes within the coding regions of eukaryotic genes is aligned with respect to transcriptional start sites. This organization is likely to influence many genetic processes, requiring access to the underlying DNA. Here, we show that the combined action of Isw1 and Chd1 nucleosome-spacing enzymes is required to maintain this organization. In the absence of these enzymes, regular positioning of the majority of nucleosomes is lost. Exceptions include the region upstream of the promoter, the +1 nucleosome, and a subset of locations distributed throughout coding regions where other factors are likely to be involved. These observations indicate that adenosine triphosphate-dependent remodeling enzymes are responsible for directing the positioning of the majority of nucleosomes within the Saccharomyces cerevisiae genome.	[Gkikopoulos, Triantaffyllos; Schofield, Pieta; Singh, Vijender; Owen-Hughes, Tom] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland; [Schofield, Pieta; Barton, Geoffrey J.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Dundee DD1 5EH, Scotland; [Pinskaya, Marina; Mellor, Jane] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Smolle, Michaela; Workman, Jerry L.] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of Dundee; University of Dundee; University of Oxford; Stowers Institute for Medical Research	Owen-Hughes, T (corresponding author), Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Coll Life Sci, Dundee DD1 5EH, Scotland.	t.a.owenhughes@dundee.ac.uk	Barton, Geoffrey J/C-6267-2011; Barton, Geoffrey/N-1037-2019; GenePool, The/D-8812-2012; Schofield, Pieta/Q-4847-2019	Barton, Geoffrey/0000-0002-9014-5355; Schofield, Pieta/0000-0002-6398-2537; Pinskaya, Marina/0000-0003-1992-0264; Owen-Hughes, Tom/0000-0002-0618-8185; Smolle, Michaela/0000-0001-8900-1541	Wellcome Trust [064414]; Stowers Institute; MRC [G0900740] Funding Source: UKRI; Medical Research Council [G0900740] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Stowers Institute; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sequence data were generated at the Genepool Facility at the University of Edinburgh and Genotypic Technology Ltd, Bangalore. T. G., V. S., and T.O.H. were supported by Wellcome Trust Senior Fellowship 064414. M. S. and J.L.W. were supported by the Stowers Institute. We thank A. Nair for useful advice and sending strains, and J. Allan and members of the T.O.H. laboratory and Welcome Trust Centre for Gene Regulation and Expression for useful discussions. Sequence and microarray data sets are accessible at the National Center for Biotechnology Information Gene Expresssion Omnibus repository (www.ncbi.nlm.nih.gov/geo) under accession numbers GSE31015, GSE31301, and GSE31833.	Biswas D, 2007, MOL CELL BIOL, V27, P6279, DOI 10.1128/MCB.00978-07; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Fraser RM, 2006, J MOL BIOL, V364, P582, DOI 10.1016/j.jmb.2006.08.092; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7; Quan TK, 2010, GENETICS, V184, P321, DOI 10.1534/genetics.109.111526; Robinson KM, 2003, MOL CELL BIOL, V23, P7937, DOI 10.1128/MCB.23.22.7937-7946.2003; Ryan DP, 2011, EMBO J, V30, P2596, DOI 10.1038/emboj.2011.166; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; SIMPSON RT, 1990, NATURE, V343, P387, DOI 10.1038/343387a0; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Tillo D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-442; Tirosh I, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r49; Travers A, 2010, J BIOMOL STRUCT DYN, V27, P713, DOI 10.1080/073911010010524942; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Wippo CJ, 2011, EMBO J, V30, P1277, DOI 10.1038/emboj.2011.43; Xella B, 2006, MOL MICROBIOL, V59, P1531, DOI 10.1111/j.1365-2958.2005.05031.x; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2011, SCIENCE, V332, P977, DOI 10.1126/science.1200508; Zhang ZH, 2011, CELL, V144, P175, DOI 10.1016/j.cell.2011.01.003	30	197	199	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1758	1760		10.1126/science.1206097	http://dx.doi.org/10.1126/science.1206097			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940898	Green Accepted			2022-12-24	WOS:000295121500046
J	Fu, YV; Yardimci, H; Long, DT; Ho, TV; Guainazzi, A; Bermudez, VP; Hurwitz, J; van Oijen, A; Scharer, OD; Walter, JC				Fu, Yu V.; Yardimci, Hasan; Long, David T.; The Vinh Ho; Guainazzi, Angelo; Bermudez, Vladimir P.; Hurwitz, Jerard; van Oijen, Antoine; Schaerer, Orlando D.; Walter, Johannes C.			Selective Bypass of a Lagging Strand Roadblock by the Eukaryotic Replicative DNA Helicase	CELL			English	Article							MCM2-7 HELICASE; STRUCTURAL BASIS; INITIATION; MECHANISM; COMPLEX; ORIGIN; CDC45; PROTEIN; GINS; ASSOCIATION	The eukaryotic replicative DNA helicase, CMG, unwinds DNA by an unknown mechanism. In some models, CMG encircles and translocates along one strand of DNA while excluding the other strand. In others, CMG encircles and translocates along duplex DNA. To distinguish between these models, replisomes were confronted with strand-specific DNA roadblocks in Xenopus egg extracts. An ssDNA translocase should stall at an obstruction on the translocation strand but not the excluded strand, whereas a dsDNA translocase should stall at obstructions on either strand. We found that replisomes bypass large roadblocks on the lagging strand template much more readily than on the leading strand template. Our results indicate that CMG is a 3' to 5' ssDNA translocase, consistent with unwinding via "steric exclusion." Given that MCM2-7 encircles dsDNA in G1, the data imply that formation of CMG in S phase involves remodeling of MCM2-7 from a dsDNA to a ssDNA binding mode.	[Fu, Yu V.; Yardimci, Hasan; Long, David T.; van Oijen, Antoine; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [The Vinh Ho; Guainazzi, Angelo; Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci & Chem, Stony Brook, NY 11794 USA; [Bermudez, Vladimir P.; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Memorial Sloan Kettering Cancer Center	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Scharer, Orlando/B-8908-2008; Classen, Scott/AAY-8176-2020; Schärer, Orlando D./AAF-8613-2021; FU, YU Vincent/AAX-4936-2021; van Oijen, Antoine/I-3167-2014	Scharer, Orlando/0000-0003-2425-2715; FU, YU Vincent/0000-0001-8251-2306; van Oijen, Antoine/0000-0002-1794-5161; Long, David/0000-0001-9232-0316; Walter, Johannes/0000-0002-4186-7570; Yardimci, Hasan/0000-0001-5009-1391	National Institutes of Health (NIH) [GM62267, GM08454, CA092584, GM034559]; Leukemia and Lymphoma Scholar Award; American Cancer Society [RSG-08-234-01-GMC, PF-10-146-01-DMC, RSG-08-234-01]; Human Frontier Science Program [LT000307/2009]; New York State Office of Science and Technology and Academic Research NYSTAR [C040069]; Searle Scholarship [05-L-104]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062267, R01GM034559, R37GM034559] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); American Cancer Society(American Cancer Society); Human Frontier Science Program(Human Frontier Science Program); New York State Office of Science and Technology and Academic Research NYSTAR; Searle Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Milica Enoiu for the gift of pICL<SUP>Intra</SUP>, Anna Loveland, Puck Knipscheer, and Tatsuro Takahashi for helpful discussions, and the members of our laboratory for valuable feedback on the manuscript. J.C.W was supported by National Institutes of Health (NIH) grant GM62267, by a Leukemia and Lymphoma Scholar Award, and by the American Cancer Society grant RSG-08-234-01-GMC. Y.V.F. was supported by a Human Frontier Science Program Long-Term Fellowship (LT000307/2009). D.T.L was supported by a postdoctoral fellowship (PF-10-146-01-DMC) from the American Cancer Society. O.D.S. was supported by grants from the New York State Office of Science and Technology and Academic Research NYSTAR (C040069) and the NIH (GM08454 and CA092584). A.M.v.O. acknowledges support from the American Cancer Society grant RSG-08-234-01 and Searle Scholarship 05-L-104. J.H. was supported by NIH grant GM034559 and American Cancer Society grant RSG-08-234-01-GMC.	Angelov T, 2009, ORG LETT, V11, P661, DOI 10.1021/ol802719a; Arias EE, 2004, FRONT BIOSCI-LANDMRK, V9, P3029, DOI 10.2741/1457; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Evrin C, 2009, P NATL ACAD SCI USA, V106, P20240, DOI 10.1073/pnas.0911500106; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2011, J BIOL CHEM, V286, P11855, DOI 10.1074/jbc.M110.199521; Geraghty DS, 2000, J BIOL CHEM, V275, P18011, DOI 10.1074/jbc.M909787199; Guainazzi A, 2010, CHEM-EUR J, V16, P12100, DOI 10.1002/chem.201002041; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kanter DM, 2011, NUCLEIC ACIDS RES, V39, P2580, DOI 10.1093/nar/gkq1222; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kochaniak AB, 2009, J BIOL CHEM, V284, P17700, DOI 10.1074/jbc.M109.008706; Kuhn H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn107; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Laskey RA, 2003, EMBO REP, V4, P26, DOI 10.1038/sj.embor.embor706; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lucas I, 2000, J MOL BIOL, V296, P769, DOI 10.1006/jmbi.2000.3500; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Pape T, 2003, EMBO REP, V4, P1079, DOI 10.1038/sj.embor.7400010; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Shechter DF, 2000, J BIOL CHEM, V275, P15049, DOI 10.1074/jbc.M000398200; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Tremeau-Bravard A, 2004, J BIOL CHEM, V279, P7751, DOI 10.1074/jbc.M309853200; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; van Oijen AM, 2007, BIOPOLYMERS, V85, P144, DOI 10.1002/bip.20624; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Warren EM, 2008, STRUCTURE, V16, P1892, DOI 10.1016/j.str.2008.10.005; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yardimci H, 2010, MOL CELL, V40, P834, DOI 10.1016/j.molcel.2010.11.027	48	259	265	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 16	2011	146	6					930	940		10.1016/j.cell.2011.07.045	http://dx.doi.org/10.1016/j.cell.2011.07.045			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925316	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000295258100015
J	Ingolia, NT; Lareau, LF; Weissman, JS				Ingolia, Nicholas T.; Lareau, Liana F.; Weissman, Jonathan S.			Ribosome Profiling of Mouse Embryonic Stem Cells Reveals the Complexity and Dynamics of Mammalian Proteomes	CELL			English	Article							OPEN READING FRAMES; GENOME-WIDE ANALYSIS; MESSENGER-RNA; TRANSLATION INITIATION; GENE-EXPRESSION; MOLECULAR-CLONING; PROTEIN-SYNTHESIS; NONCODING RNAS; HUMAN ERM; IDENTIFICATION	The ability to sequence genomes has far outstripped approaches for deciphering the information they encode. Here we present a suite of techniques, based on ribosome profiling (the deep sequencing of ribosome-protected mRNA fragments), to provide genome-wide maps of protein synthesis as well as a pulse-chase strategy for determining rates of translation elongation. We exploit the propensity of harringtonine to cause ribosomes to accumulate at sites of translation initiation together with a machine learning algorithm to define protein products systematically. Analysis of translation in mouse embryonic stem cells reveals thousands of strong pause sites and unannotated translation products. These include amino-terminal extensions and truncations and upstream open reading frames with regulatory potential, initiated at both AUG and non-AUG codons, whose translation changes after differentiation. We also define a class of short, polycistronic ribosome-associated coding RNAs (sprcRNAs) that encode small proteins. Our studies reveal an unanticipated complexity to mammalian proteomes.	[Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Lareau, Liana F.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Stanford University	Ingolia, NT (corresponding author), Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21218 USA.	ingolia@ciwemb.edu		Weissman, Jonathan/0000-0003-2445-670X	NIH [AG10770]; Ruth L. Kirschstein NRSA [GM080853]; Damon Runyon Cancer Research Foundation [DRG-2033-09]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Barna, S. Luo, D. Ruggero G. Schroth, P. Brown, and members of the Weissman lab including A. Frost and S. Churchman for advice and helpful discussions; C. Chu for help with sequencing; S. Rouskin for help developing the ligation protocol; G. Brar for help developing rRNA depletion; and J. Hunkapiller and J. Reiter for E14 mESCs. This investigation was supported by the NIH P01 (AG10770) and a Ruth L. Kirschstein NRSA (GM080853) (N.T.I.), the Damon Runyon Cancer Research Foundation (DRG-2033-09) (L.F.L.), and the Howard Hughes Medical Institute (J.S.W.)	Akamatsu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001160; Alkalaeva EZ, 2006, CELL, V125, P1125, DOI 10.1016/j.cell.2006.04.035; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Atkins JF, 2010, NUCLEIC ACIDS MOL BI, V24, P1, DOI 10.1007/978-0-387-89382-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOSTROM K, 1986, J BIOL CHEM, V261, P3800; Brent MR, 2005, GENOME RES, V15, P1777, DOI 10.1101/gr.3866105; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hamilton TL, 2006, BIOCHEM SOC T, V34, P12, DOI 10.1042/BST0340012; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; Hansen MB, 2002, GENOMICS, V80, P344, DOI 10.1006/geno.2002.6838; Hassan AS, 2010, GENE EXPR PATTERNS, V10, P127, DOI 10.1016/j.gep.2010.02.001; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; HUANG MT, 1975, MOL PHARMACOL, V11, P511; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IRWIN B, 1995, J BIOL CHEM, V270, P22801, DOI 10.1074/jbc.270.39.22801; Ivanov IP, 2008, P NATL ACAD SCI USA, V105, P10079, DOI 10.1073/pnas.0801590105; Ivanov IP, 2011, NUCLEIC ACIDS RES, V39, P4220, DOI 10.1093/nar/gkr007; Joachims T., 1999, ADV KERNEL METHODS S; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Kraut-Cohen J, 2010, TRENDS BIOCHEM SCI, V35, P459, DOI 10.1016/j.tibs.2010.02.006; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; LAZAROWITZ SG, 1977, J BIOL CHEM, V252, P7842; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Malarkannan S, 1999, IMMUNITY, V10, P681, DOI 10.1016/S1074-7613(00)80067-9; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Mariappan M, 2010, NATURE, V466, P1120, DOI 10.1038/nature09296; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Medenbach J, 2011, CELL, V145, P902, DOI 10.1016/j.cell.2011.05.005; MONTE D, 1994, ONCOGENE, V9, P1397; Monte D, 1996, GENOMICS, V35, P236, DOI 10.1006/geno.1996.0345; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Nilsson T, 2010, NAT METHODS, V7, P681, DOI 10.1038/nmeth0910-681; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pisarev AV, 2008, EMBO J, V27, P1609, DOI 10.1038/emboj.2008.90; Robert F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005428; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Tremml Gabi, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c04s5; TSCHERNE JS, 1975, ANTIMICROB AGENTS CH, V8, P479, DOI 10.1128/AAC.8.4.479; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tupy JL, 2005, P NATL ACAD SCI USA, V102, P5495, DOI 10.1073/pnas.0501422102; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	78	1345	1383	7	276	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 11	2011	147	4					789	802		10.1016/j.cell.2011.10.002	http://dx.doi.org/10.1016/j.cell.2011.10.002			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22056041	Bronze, Green Accepted			2022-12-24	WOS:000296902300013
J	Baker, DJ; Wijshake, T; Tchkonia, T; LeBrasseur, NK; Childs, BG; van de Sluis, B; Kirkland, JL; van Deursen, JM				Baker, Darren J.; Wijshake, Tobias; Tchkonia, Tamar; LeBrasseur, Nathan K.; Childs, Bennett G.; van de Sluis, Bart; Kirkland, James L.; van Deursen, Jan M.			Clearance of p16(Ink4a)-positive senescent cells delays ageing-associated disorders	NATURE			English	Article							TUMOR-SUPPRESSOR; BUBR1 INSUFFICIENCY; ONCOGENIC RAS; MUTANT MICE; EXPRESSION; MOUSE; FIBROBLASTS; PHENOTYPES; INHIBITOR; BIOMARKER	Advanced age is the main risk factor for most chronic diseases and functional deficits in humans, but the fundamental mechanisms that drive ageing remain largely unknown, impeding the development of interventions that might delay or prevent age-related disorders and maximize healthy lifespan. Cellular senescence, which halts the proliferation of damaged or dysfunctional cells, is an important mechanism to constrain the malignant progression of tumour cells(1,2). Senescent cells accumulate in various tissues and organs with ageing(3) and have been hypothesized to disrupt tissue structure and function because of the components they secrete(4,5). However, whether senescent cells are causally implicated in age-related dysfunction and whether their removal is beneficial has remained unknown. To address these fundamental questions, we made use of a biomarker for senescence, p16(Ink4a), to design a novel transgene, INK-ATTAC, for inducible elimination of p16(Ink4a)-positive senescent cells upon administration of a drug. Here we show that in the BubR1 progeroid mouse background, INK-ATTAC removes p16(Ink4a)-positive senescent cells upon drug treatment. In tissues-such as adipose tissue, skeletal muscle and eye-in which p16(Ink4a) contributes to the acquisition of age-related pathologies, life-long removal of p16(Ink4a)-expressing cells delayed onset of these phenotypes. Furthermore, late-life clearance attenuated progression of already established age-related disorders. These data indicate that cellular senescence is causally implicated in generating age-related phenotypes and that removal of senescent cells can prevent or delay tissue dysfunction and extend healthspan.	[Baker, Darren J.; Wijshake, Tobias; Childs, Bennett G.; van Deursen, Jan M.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Baker, Darren J.; Tchkonia, Tamar; LeBrasseur, Nathan K.; Kirkland, James L.; van Deursen, Jan M.] Mayo Clin, Coll Med, Robert & Arlene Kogod Ctr Aging, Rochester, MN 55905 USA; [Wijshake, Tobias; van de Sluis, Bart] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9700 RB Groningen, Netherlands	Mayo Clinic; Mayo Clinic; University of Groningen	van Deursen, JM (corresponding author), Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu	Kirkland, James/F-9159-2016	Wijshake, Tobias/0000-0003-1784-2100; Tchkonia, Tamar/0000-0003-4623-7145; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365; Baker, Darren/0000-0001-9006-1939; LeBrasseur, Nathan/0000-0002-2002-0418	Ellison Medical Foundation; Noaber Foundation; Robert and Arlene Kogod Center on Aging; National Institutes of Health [CA96985, AG13925]; NATIONAL CANCER INSTITUTE [R01CA096985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013925, R01AG013925, P01AG041122] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); Noaber Foundation; Robert and Arlene Kogod Center on Aging; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank W. Zhou, D. Norris, T. Mann, U. Moedder, T. Pirtskhalava and S. Yamada for assistance; S. Khosla, T. von Zglinicki, L. Malureanu, R. Ricke and P. Galardy, and members of the J.M.v.D. laboratory for helpful discussions; and P. Scherer for the gift of the aP2-ATTAC plasmid. This work was supported by the Ellison Medical Foundation (J.M.v.D.), the Noaber Foundation (J.M.v.D. and J.L.K.), the Robert and Arlene Kogod Center on Aging, and the National Institutes of Health (CA96985, J.M.v.D. and AG13925, J.L.K.).	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2011, CURR OPIN GENET DEV, V21, P107, DOI 10.1016/j.gde.2010.10.005; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gan Q, 2008, J CELL SCI, V121, P2235, DOI 10.1242/jcs.026633; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Jun JI, 2010, NAT CELL BIOL, V12, P676, DOI 10.1038/ncb2070; Kim HG, 2002, EXP CELL RES, V272, P199, DOI 10.1006/excr.2001.5420; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kirkland JL, 1996, INT J OBESITY, V20, pS102; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Li JN, 2011, BIOCHEMISTRY-US, V50, P5566, DOI 10.1021/bi200642e; Malureanu L, 2010, J CELL BIOL, V191, P313, DOI 10.1083/jcb.201003090; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Martinez-Fernandez A, 2009, CIRC RES, V105, P648, DOI 10.1161/CIRCRESAHA.109.203109; Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Wang W, 2001, J BIOL CHEM, V276, P48655, DOI 10.1074/jbc.M108278200	30	2018	2134	17	326	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2011	479	7372					232	U112		10.1038/nature10600	http://dx.doi.org/10.1038/nature10600			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22048312	Green Accepted			2022-12-24	WOS:000298030800043
J	Mueller-Cajar, O; Stotz, M; Wendler, P; Hartl, FU; Bracher, A; Hayer-Hartl, M				Mueller-Cajar, Oliver; Stotz, Mathias; Wendler, Petra; Hartl, F. Ulrich; Bracher, Andreas; Hayer-Hartl, Manajit			Structure and function of the AAA(+) protein CbbX, a red-type Rubisco activase	NATURE			English	Article							RIBULOSE 1,5-BISPHOSPHATE CARBOXYLASE; HIGH-LEVEL EXPRESSION; FORM-I; BISPHOSPHATE CARBOXYLASE; CRYSTAL-STRUCTURE; ENCODED CBBX; CHAPERONE; VISUALIZATION; TRANSLOCATION; REFINEMENT	Ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) catalyses the fixation of atmospheric CO2 in photosynthesis, but tends to form inactive complexes with its substrate ribulose 1,5-bisphosphate (RuBP). In plants, Rubisco is reactivated by the AAA(+) (ATPases associated with various cellular activities) protein Rubisco activase (Rca), but no such protein is known for the Rubisco of red algae. Here we identify the protein CbbX as an activase of red-type Rubisco. The 3.0-angstrom crystal structure of unassembled CbbX from Rhodobacter sphaeroides revealed an AAA(+) protein architecture. Electron microscopy and biochemical analysis showed that ATP and RuBP must bind to convert CbbX into functionally active, hexameric rings. The CbbX ATPase is strongly stimulated by RuBP and Rubisco. Mutational analysis suggests that CbbX functions by transiently pulling the carboxy-terminal peptide of the Rubisco large subunit into the hexamer pore, resulting in the release of the inhibitory RuBP. Understanding Rubisco activation may facilitate efforts to improve CO2 uptake and biomass production by photosynthetic organisms.	[Mueller-Cajar, Oliver; Stotz, Mathias; Hartl, F. Ulrich; Bracher, Andreas; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Wendler, Petra] Univ Munich, Dept Biochem, Gene Ctr Munich, D-81377 Munich, Germany	Max Planck Society; University of Munich	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	bracher@biochem.mpg.de; mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017; Mueller-Cajar, Oliver/A-7237-2018; Wendler, Petra/C-9056-2014; Wendler, Petra/X-5799-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; Mueller-Cajar, Oliver/0000-0003-2866-5963; Wendler, Petra/0000-0002-8285-2199; 	Max Planck Institute of Biochemistry (MPIB); European Synchrotron Radiation Facility beamlines; Deutsche Forschungsgemeinschaft (DFG) [SFB 594, WE4628/1]; Korber Foundation	Max Planck Institute of Biochemistry (MPIB)(Max Planck Society); European Synchrotron Radiation Facility beamlines; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Korber Foundation	We thank S. Kaplan for providing the R. sphaeroides strain 2.4.1, S. Whitney for providing the pHue protein expression system, and R. Lange and N. Wischnewski for technical assistance. Support by the Max Planck Institute of Biochemistry (MPIB) Core Facility, the MPIB Crystallization Facility and the Joint Structural Biology Group staff at the European Synchrotron Radiation Facility beamlines is gratefully acknowledged. We thank the Deutsche Forschungsgemeinschaft (DFG) (SFB 594; DFG grant WE4628/1 to P. W.) and the Korber Foundation for financial support.	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Badger MR, 2008, J EXP BOT, V59, P1525, DOI 10.1093/jxb/erm297; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Bowien B, 2002, ARCH MICROBIOL, V178, P85, DOI 10.1007/s00203-002-0441-3; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; EDMONDSON DL, 1990, PLANT PHYSIOL, V93, P1376, DOI 10.1104/pp.93.4.1376; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esau BD, 1996, ARCH BIOCHEM BIOPHYS, V326, P100, DOI 10.1006/abbi.1996.0052; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Fujita K, 2008, GENES GENET SYST, V83, P135, DOI 10.1266/ggs.83.135; GIBSON JL, 1979, J BACTERIOL, V140, P1023, DOI 10.1128/JB.140.3.1023-1027.1979; Gibson JL, 1997, J BACTERIOL, V179, P663, DOI 10.1128/jb.179.3.663-669.1997; GIBSON JL, 1991, J BIOL CHEM, V266, P14646; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; JORDAN DB, 1983, J BIOL CHEM, V258, P3752; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu CM, 2010, NATURE, V463, P197, DOI 10.1038/nature08651; LORIMER GH, 1976, BIOCHEMISTRY-US, V15, P529, DOI 10.1021/bi00648a012; Maier UG, 2000, MOL BIOL EVOL, V17, P576, DOI 10.1093/oxfordjournals.molbev.a026337; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Massey TH, 2006, MOL CELL, V23, P457, DOI 10.1016/j.molcel.2006.06.019; Matias PM, 2006, J BIOL CHEM, V281, P38918, DOI 10.1074/jbc.M605625200; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okano Y, 2002, FEBS LETT, V527, P33, DOI 10.1016/S0014-5793(02)03148-4; Parry MAJ, 2008, J EXP BOT, V59, P1569, DOI 10.1093/jxb/ern084; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; ROBINSON SP, 1989, ARCH BIOCHEM BIOPHYS, V268, P93, DOI 10.1016/0003-9861(89)90568-7; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Sugawara H, 1999, J BIOL CHEM, V274, P15655, DOI 10.1074/jbc.274.22.15655; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; VONCAEMMERER S, 1986, AUST J PLANT PHYSIOL, V13, P669, DOI 10.1071/PP9860669; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x	62	117	120	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					194	U66		10.1038/nature10568	http://dx.doi.org/10.1038/nature10568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22048315				2022-12-24	WOS:000298030800034
J	Lindorff-Larsen, K; Piana, S; Dror, RO; Shaw, DE				Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Shaw, David E.			How Fast-Folding Proteins Fold	SCIENCE			English	Article							TRANSITION-STATES; PATHWAYS; MECHANISM; TOPOLOGY; RATES	An outstanding challenge in the field of molecular biology has been to understand the process by which proteins fold into their characteristic three-dimensional structures. Here, we report the results of atomic-level molecular dynamics simulations, over periods ranging between 100 mu s and 1 ms, that reveal a set of common principles underlying the folding of 12 structurally diverse proteins. In simulations conducted with a single physics-based energy function, the proteins, representing all three major structural classes, spontaneously and repeatedly fold to their experimentally determined native structures. Early in the folding process, the protein backbone adopts a nativelike topology while certain secondary structure elements and a small number of nonlocal contacts form. In most cases, folding follows a single dominant route in which elements of the native structure appear in an order highly correlated with their propensity to form in the unfolded state.	[Lindorff-Larsen, Kresten; Piana, Stefano; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Columbia University	Lindorff-Larsen, K (corresponding author), DE Shaw Res, New York, NY 10036 USA.	kresten.lindorff-larsen@DEShawResearch.com; stefano.piana-agostinetti@DEShawResearch.com; david.shaw@DEShawResearch.com	Lindorff-Larsen, Kresten/K-6469-2014	Lindorff-Larsen, Kresten/0000-0002-4750-6039; Dror, Ron/0000-0002-6418-2793				Best RB, 2005, P NATL ACAD SCI USA, V102, P6732, DOI 10.1073/pnas.0408098102; Daura X, 1999, ANGEW CHEM INT EDIT, V38, P236, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<236::AID-ANIE236>3.3.CO;2-D; Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654; Faver JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018868; FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869; Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713; Gin BC, 2009, J MOL BIOL, V392, P1303, DOI 10.1016/j.jmb.2009.06.058; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kuhlman B, 2004, CURR OPIN STRUC BIOL, V14, P89, DOI 10.1016/j.sbi.2004.01.002; Lenz P, 2009, CHEM PHYS LETT, V471, P310, DOI 10.1016/j.cplett.2009.02.054; Lindorff-Larsen K, 2005, TRENDS BIOCHEM SCI, V30, P13, DOI 10.1016/j.tibs.2004.11.008; Lindorff-Larsen K, 2004, NAT STRUCT MOL BIOL, V11, P443, DOI 10.1038/nsmb765; Modig K, 2007, FEBS LETT, V581, P4965, DOI 10.1016/j.febslet.2007.09.027; Paci E, 2005, J MOL BIOL, V352, P495, DOI 10.1016/j.jmb.2005.06.081; Pande VS, 1998, CURR OPIN STRUC BIOL, V8, P68, DOI 10.1016/S0959-440X(98)80012-2; Pandit AD, 2006, J MOL BIOL, V361, P755, DOI 10.1016/j.jmb.2006.06.041; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Rogen P, 2005, J PHYS-CONDENS MAT, V17, pS1523, DOI 10.1088/0953-8984/17/18/010; Settanni G, 2009, J MOL BIOL, V387, P993, DOI 10.1016/j.jmb.2009.02.014; Shah PS, 2007, J MOL BIOL, V372, P1, DOI 10.1016/j.jmb.2007.06.032; Shaw D.E., 2009, P C HIGH PERF COMP N, P1, DOI DOI 10.1145/1654059.1654126; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sosnick TR, 2008, PROTEIN SCI, V17, P1308, DOI 10.1110/ps.036319.108; Sosnick TR, 2011, CURR OPIN STRUC BIOL, V21, P12, DOI 10.1016/j.sbi.2010.11.002; Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947	25	1263	1276	7	536	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2011	334	6055					517	520		10.1126/science.1208351	http://dx.doi.org/10.1126/science.1208351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837UR	22034434				2022-12-24	WOS:000296230500048
J	Dawson, MA; Prinjha, RK; Dittmann, A; Giotopoulos, G; Bantscheff, M; Chan, WI; Robson, SC; Chung, CW; Hopf, C; Savitski, MM; Huthmacher, C; Gudgin, E; Lugo, D; Beinke, S; Chapman, TD; Roberts, EJ; Soden, PE; Auger, KR; Mirguet, O; Doehner, K; Delwel, R; Burnett, AK; Jeffrey, P; Drewes, G; Lee, K; Huntly, BJP; Kouzarides, T				Dawson, Mark A.; Prinjha, Rab K.; Dittmann, Antje; Giotopoulos, George; Bantscheff, Marcus; Chan, Wai-In; Robson, Samuel C.; Chung, Chun-wa; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Gudgin, Emma; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Auger, Kurt R.; Mirguet, Olivier; Doehner, Konstanze; Delwel, Ruud; Burnett, Alan K.; Jeffrey, Phillip; Drewes, Gerard; Lee, Kevin; Huntly, Brian J. P.; Kouzarides, Tony			Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia	NATURE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; TRANSCRIPTION; ELONGATION; COMPONENT; TARGET; CELLS	Recurrent chromosomal translocations involving the mixed lineage leukaemia (MLL) gene initiate aggressive forms of leukaemia, which are often refractory to conventional therapies(1). Many MLL-fusion partners are members of the super elongation complex (SEC), a critical regulator of transcriptional elongation, suggesting that aberrant control of this process has an important role in leukaemia induction(2,3). Here we use a global proteomic strategy to demonstrate that MLL fusions, as part of SEC(2,3) and the polymerase-associated factor complex (PAFc)(4,5), are associated with the BET family of acetyl-lysine recognizing, chromatin 'adaptor' proteins. These data provided the basis for therapeutic intervention in MLL-fusion leukaemia, via the displacement of the BET family of proteins from chromatin. We show that a novel small molecule inhibitor of the BET family, GSK1210151A (I-BET151), has profound efficacy against human and murine MLL-fusion leukaemic cell lines, through the induction of early cell cycle arrest and apoptosis. I-BET151 treatment in two human leukaemia cell lines with different MLL fusions alters the expression of a common set of genes whose function may account for these phenotypic changes. The mode of action of I-BET151 is, at least in part, due to the inhibition of transcription at key genes (BCL2, C-MYC and CDK6) through the displacement of BRD3/4, PAFc and SEC components from chromatin. In vivo studies indicate that I-BET151 has significant therapeutic value, providing survival benefit in two distinct mouse models of murine MLL-AF9 and human MLL-AF4 leukaemia. Finally, the efficacy of I-BET151 against human leukaemia stem cells is demonstrated, providing further evidence of its potent therapeutic potential. These findings establish the displacement of BET proteins from chromatin as a promising epigenetic therapy for these aggressive leukaemias.	[Dawson, Mark A.; Giotopoulos, George; Chan, Wai-In; Gudgin, Emma; Huntly, Brian J. P.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Dawson, Mark A.; Giotopoulos, George; Chan, Wai-In; Gudgin, Emma; Huntly, Brian J. P.] Univ Cambridge, Addenbrookes Hosp, Cambridge CB2 0XY, England; [Dawson, Mark A.; Robson, Samuel C.; Kouzarides, Tony] Gurdon Inst, Cambridge CB2 1QN, England; [Dawson, Mark A.; Robson, Samuel C.; Kouzarides, Tony] Dept Pathol, Cambridge CB2 1QN, England; [Prinjha, Rab K.; Lugo, Dave; Beinke, Soren; Chapman, Trevor D.; Roberts, Emma J.; Soden, Peter E.; Jeffrey, Phillip; Lee, Kevin] GlaxoSmithKline Inc, Med Res Ctr, Immunoinflammat Ctr Excellence Drug Discovery, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Dittmann, Antje; Bantscheff, Marcus; Hopf, Carsten; Savitski, Mikhail M.; Huthmacher, Carola; Drewes, Gerard] Cellzome AG, D-69117 Heidelberg, Germany; [Chung, Chun-wa] GlaxoSmithKline R&D, Mol Discovery Res, Stevenage SG1 2NY, Herts, England; [Auger, Kurt R.] GlaxoSmithKline Inc, Oncol R&D, Canc Epigenet DPU, Collegeville, PA 19426 USA; [Mirguet, Olivier] GlaxoSmithKline Res & Dev Ltd, Lipid Metab Discovery Performance Unit, F-91951 Les Ulis, France; [Doehner, Konstanze] Univ Hosp Ulm Internal Med 3, D-89081 Ulm, Germany; [Delwel, Ruud] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; [Burnett, Alan K.] Cardiff Univ, Sch Med, Dept Hematol, Cardiff CF14 4XN, S Glam, Wales	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; GlaxoSmithKline; GlaxoSmithKline; Cellzome GmbH; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Erasmus University Rotterdam; Erasmus MC; Cardiff University	Huntly, BJP (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England.	mafd2@cam.ac.uk; bjph2@cam.ac.uk; t.kouzarides@gurdon.cam.ac.uk	Bantscheff, Marcus/AAQ-2903-2021; Dawson, Mark A/B-9317-2017; Mirguet, Olivier/Q-1682-2018; huntly, brian JP/E-6725-2014; Hopf, Carsten/A-3275-2015	Bantscheff, Marcus/0000-0002-8343-8977; Dawson, Mark A/0000-0002-5464-5029; Mirguet, Olivier/0000-0002-5486-0386; huntly, brian JP/0000-0003-0312-161X; Kouzarides, Tony/0000-0002-8918-4162; Hopf, Carsten/0000-0003-0802-6451; Giotopoulos, George/0000-0003-1390-6592; Drewes, Gerard/0000-0003-0575-6766	Wellcome-Beit Intermediate Clinical Fellowship; Medical Research Council (UK); Leukaemia Lymphoma Research (UK); Wellcome Trust; Leukemia & Lymphoma Society of America; Cancer Research UK (CRUK); NIHR Cambridge Biomedical Research Centre; Medical Research Council [G0800784B, G0800784, G116/187] Funding Source: researchfish; MRC [G0800784, G116/187] Funding Source: UKRI	Wellcome-Beit Intermediate Clinical Fellowship; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Lymphoma Research (UK); Wellcome Trust(Wellcome TrustEuropean Commission); Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); Cancer Research UK (CRUK)(Cancer Research UK); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. J. Dawson, A. Bannister, S. Anand and all members of the Huntly and Kouzarides laboratories. We are grateful to H. Doehner, the NCRI AML trials biobank and A. Giles for the provision of patient samples. We acknowledge D. Huang for the BCL2 expression plasmid, L. Gordon for supplying fluorescence resonance energy transfer data and R. Woodward, C. Delves, E. Jones and P. Holmes for protein production. J. Witherington, N. Parr, S. Baddeley and J. Seal provided compound selectivity data. We thank N. Deeks and L. Cutler for providing sample and PK data analysis. We acknowledge K. Smitheman and A. Wyce for help with the cellular analysis of the BET inhibitors, P. Grandi for suggestions and discussion, S. Chan for biophysical assay data, and members of the Epinova team for discussion and suggestions. We thank staff at the ESRF at Grenoble for beamline assistance. We thank T. Werner for assistance with mass spectrometry experiments and data analysis, and the members of the Cellzome Biochemistry, Mass Spectrometry, and IT teams for outstanding expertise and diligence. This work was supported by a Wellcome-Beit Intermediate Clinical Fellowship to M. A. D. The Huntly lab is funded by the Medical Research Council (UK), Leukaemia Lymphoma Research (UK), the Wellcome Trust, The Leukemia & Lymphoma Society of America, Cancer Research UK (CRUK) and the NIHR Cambridge Biomedical Research Centre. This work in the Kouzarides laboratory was funded by a programme grant from Cancer Research UK (CRUK).	Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Dawson MA, 2009, NATURE, V461, P819, DOI 10.1038/nature08448; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Milne TA, 2010, MOL CELL, V38, P853, DOI 10.1016/j.molcel.2010.05.011; Muntean AG, 2010, CANCER CELL, V17, P609, DOI 10.1016/j.ccr.2010.04.012; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Robinson BW, 2008, BRIT J HAEMATOL, V141, P827, DOI 10.1111/j.1365-2141.2008.07100.x; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Wang J, 2005, EMBO J, V24, P368, DOI 10.1038/sj.emboj.7600521; Wang QF, 2011, BLOOD, V117, P6895, DOI 10.1182/blood-2010-12-324699; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Yokoyama A, 2010, CANCER CELL, V17, P198, DOI 10.1016/j.ccr.2009.12.040	20	1134	1269	3	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					529	533		10.1038/nature10509	http://dx.doi.org/10.1038/nature10509			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21964340	Green Accepted			2022-12-24	WOS:000296194200046
J	Lane, N				Lane, Nick			The Costs of Breathing	SCIENCE			English	Editorial Material							MITOCHONDRIAL; MUTATIONS		UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England	University of London; University College London	Lane, N (corresponding author), UCL, Dept Genet Evolut & Environm, Gower St, London WC1E 6BT, England.	nick.lane@ucl.ac.uk		Lane, Nick/0000-0002-5433-3973				Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Blackstone NW, 1999, BIOESSAYS, V21, P84, DOI 10.1002/(SICI)1521-1878(199901)21:1<84::AID-BIES11>3.0.CO;2-0; Ellison CK, 2008, EVOLUTION, V62, P631, DOI 10.1111/j.1558-5646.2007.00305.x; Fan WW, 2008, SCIENCE, V319, P958, DOI 10.1126/science.1147786; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Wallace DC, 2010, P NATL ACAD SCI USA, V107, P8947, DOI 10.1073/pnas.0914635107; Wolf JBW, 2010, PHILOS T R SOC B, V365, P1717, DOI 10.1098/rstb.2010.0023	9	32	34	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					184	185		10.1126/science.1214012	http://dx.doi.org/10.1126/science.1214012			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998376				2022-12-24	WOS:000295833600032
J	Minlebaev, M; Colonnese, M; Tsintsadze, T; Sirota, A; Khazipov, R				Minlebaev, Marat; Colonnese, Matthew; Tsintsadze, Timur; Sirota, Anton; Khazipov, Roustem			Early Gamma Oscillations Synchronize Developing Thalamus and Cortex	SCIENCE			English	Article							SOMATIC SENSORY CORTEX; RAT BARREL CORTEX; SOMATOSENSORY CORTEX; IN-VIVO; SYNAPTIC PLASTICITY; CORTICAL NETWORKS; INHIBITION; POTENTIALS; MECHANISMS; EXPERIENCE	During development, formation of topographic maps in sensory cortex requires precise temporal binding in thalamocortical networks. However, the physiological substrate for such synchronization is unknown. We report that early gamma oscillations (EGOs) enable precise spatiotemporal thalamocortical synchronization in the neonatal rat whisker sensory system. Driven by a thalamic gamma oscillator and initially independent of cortical inhibition, EGOs synchronize neurons in a single thalamic barreloid and corresponding cortical barrel and support plasticity at developing thalamocortical synapses. We propose that the multiple replay of sensory input in thalamocortical circuits during EGOs allows thalamic and cortical neurons to be organized into vertical topographic functional units before the development of horizontal binding in adult brain.	[Minlebaev, Marat; Colonnese, Matthew; Tsintsadze, Timur; Khazipov, Roustem] INSERM, U901, F-13273 Marseille, France; [Minlebaev, Marat; Colonnese, Matthew; Tsintsadze, Timur; Khazipov, Roustem] Univ Aix Marseille, F-13273 Marseille, France; [Sirota, Anton] Univ Tubingen, Ctr Integrat Neurosci, D-76072 Tubingen, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Eberhard Karls University of Tubingen	Khazipov, R (corresponding author), INSERM, U901, 163 Ave Luminy,BP 13, F-13273 Marseille, France.	khazipov@inmed.univ-mrs.fr	MINLEBAEV, Marat/B-4927-2015; Khazipov, Roustem/M-1834-2016; MINLEBAEV, Marat/R-4794-2019	MINLEBAEV, Marat/0000-0002-0722-7027; Khazipov, Roustem/0000-0002-6763-2841; MINLEBAEV, Marat/0000-0002-0722-7027; Colonnese, Matthew/0000-0002-2480-1270	Agence Nationale de la Recherche [ANR_09MNPS006]; Fondation pour la Recherche Medicale [FRM_DEq.20110421301]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank S. Beguin and D. Zaynutdinova for slice staining and morphology and G. Buzsaki, A. Destexhe, R. Cossart, Y. Ben-Ari, C. Hammond, D. Debanne, R. Miles, S. Feldt, and N. Burnashev for comments. Financial support was provided by the Agence Nationale de la Recherche (ANR_09MNPS006) and the Fondation pour la Recherche Medicale (FRM_DEq.20110421301).	AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Atallah BV, 2009, NEURON, V62, P566, DOI 10.1016/j.neuron.2009.04.027; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Borgdorff AJ, 2007, J NEUROPHYSIOL, V97, P2992, DOI 10.1152/jn.00013.2007; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Buzsaki G., 2006, RHYTHMS BRAIN; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; Colonnese MT, 2010, NEURON, V67, P480, DOI 10.1016/j.neuron.2010.07.015; Dan Y, 2006, PHYSIOL REV, V86, P1033, DOI 10.1152/physrev.00030.2005; Daw MI, 2007, NAT NEUROSCI, V10, P453, DOI 10.1038/nn1866; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; FOX K, 1992, J NEUROSCI, V12, P1826; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Golshani P, 2009, J NEUROSCI, V29, P10890, DOI 10.1523/JNEUROSCI.2012-09.2009; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Landers M, 2006, SOMATOSENS MOT RES, V23, P1, DOI 10.1080/08990220600700768; Minlebaev M, 2007, J NEUROPHYSIOL, V97, P692, DOI 10.1152/jn.00759.2006; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; PINAULT D, 1992, NEUROSCIENCE, V51, P245, DOI 10.1016/0306-4522(92)90312-P; Rochefort NL, 2009, P NATL ACAD SCI USA, V106, P15049, DOI 10.1073/pnas.0907660106; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Timofeev I, 1997, J PHYSIOL-LONDON, V504, P153, DOI 10.1111/j.1469-7793.1997.153bf.x; Uhlhaas PJ, 2010, TRENDS COGN SCI, V14, P72, DOI 10.1016/j.tics.2009.12.002; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008; Whittington MA, 2011, DEV NEUROBIOL, V71, P92, DOI 10.1002/dneu.20814; Yang JW, 2009, J NEUROSCI, V29, P9011, DOI 10.1523/JNEUROSCI.5646-08.2009	29	189	193	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					226	229		10.1126/science.1210574	http://dx.doi.org/10.1126/science.1210574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998388				2022-12-24	WOS:000295833600046
J	Noordermeer, D; Leleu, M; Splinter, E; Rougemont, J; De Laat, W; Duboule, D				Noordermeer, Daan; Leleu, Marion; Splinter, Erik; Rougemont, Jacques; De Laat, Wouter; Duboule, Denis			The Dynamic Architecture of Hox Gene Clusters	SCIENCE			English	Article							NUCLEAR REORGANIZATION; CHROMATIN; DIFFERENTIATION; EXPRESSION	The spatial and temporal control of Hox gene transcription is essential for patterning the vertebrate body axis. Although this process involves changes in histone posttranslational modifications, the existence of particular three-dimensional (3D) architectures remained to be assessed in vivo. Using high-resolution chromatin conformation capture methodology, we examined the spatial configuration of Hox clusters in embryonic mouse tissues where different Hox genes are active. When the cluster is transcriptionally inactive, Hox genes associate into a single 3D structure delimited from flanking regions. Once transcription starts, Hox clusters switch to a bimodal 3D organization where newly activated genes progressively cluster into a transcriptionally active compartment. This transition in spatial configurations coincides with the dynamics of chromatin marks, which label the progression of the gene clusters from a negative to a positive transcription status. This spatial compartmentalization may be key to process the colinear activation of these compact gene clusters.	[Noordermeer, Daan; Leleu, Marion; Rougemont, Jacques; Duboule, Denis] Ecole Polytech Fed EPFL, Sch Life Sci, Natl Res Ctr Frontiers Genet, CH-1015 Lausanne, Switzerland; [Splinter, Erik; De Laat, Wouter] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Splinter, Erik; De Laat, Wouter] Univ Med Ctr, NL-3584 CT Utrecht, Netherlands; [Rougemont, Jacques] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Duboule, Denis] Univ Geneva, Dept Genet & Evolut, CH-1211 Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Swiss Institute of Bioinformatics; University of Geneva	Duboule, D (corresponding author), Ecole Polytech Fed EPFL, Sch Life Sci, Natl Res Ctr Frontiers Genet, CH-1015 Lausanne, Switzerland.	denis.duboule@unige.ch	; Noordermeer, Daan/F-3306-2011	de Laat, Wouter/0000-0002-6393-595X; Noordermeer, Daan/0000-0002-9296-7002; duboule, denis/0000-0001-9961-2960	Ecole Polytechnique Federale (Lausanne); University of Geneva; Swiss National Research Fund; National Research Centre "Frontiers in Genetics"; European Research Council	Ecole Polytechnique Federale (Lausanne); University of Geneva; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Centre "Frontiers in Genetics"; European Research Council(European Research Council (ERC)European Commission)	We thank B. Mascrez for assistance with mouse handling and genotyping, P. Descombes and members of the National Research Centre genomics platform for high-throughput sequencing, and members of the Duboule laboratories for discussion. Computations were performed at the Vital-IT Center for high-performance computing (www.vital-it.ch) at the Swiss Institute of Bioinformatics. This work was supported by funds from the Ecole Polytechnique Federale (Lausanne), the University of Geneva, the Swiss National Research Fund, the National Research Centre "Frontiers in Genetics," and the European Research Council grant SystemsHox.ch (to D.D.). Data are all based on ENSEMBL Mouse assembly NCBIM37. 4C-seq patterns can be obtained from www.sciencemag.org/nnnnn or http://duboule-lab.epfl.ch/page-66605-en.html. Microarray and ChIP-seq data have been submitted to the Gene Expression Omnibus (GEO) repository (www.ncbi.nlm.nih.gov/geo/) under accession no. GSE31570.	Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Ferraiuolo MA, 2010, NUCLEIC ACIDS RES, V38, P7472, DOI 10.1093/nar/gkq644; Fraser J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r37; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lee AP, 2006, P NATL ACAD SCI USA, V103, P6994, DOI 10.1073/pnas.0601492103; Morey C, 2008, J CELL SCI, V121, P571, DOI 10.1242/jcs.023234; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Tschopp P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000398; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zeltser L, 1996, DEVELOPMENT, V122, P2475	16	287	298	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					222	225		10.1126/science.1207194	http://dx.doi.org/10.1126/science.1207194			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998387				2022-12-24	WOS:000295833600045
J	Isogai, Y; Si, S; Pont-Lezica, L; Tan, T; Kapoor, V; Murthy, VN; Dulac, C				Isogai, Yoh; Si, Sheng; Pont-Lezica, Lorena; Tan, Taralyn; Kapoor, Vikrant; Murthy, Venkatesh N.; Dulac, Catherine			Molecular organization of vomeronasal chemoreception	NATURE			English	Article							ACCESSORY OLFACTORY-BULB; PUTATIVE PHEROMONE RECEPTORS; GENETIC-ANALYSIS; SENSORY NEURONS; ORGAN; MICE; BEHAVIOR; EXPRESSION; FAMILY; AGGRESSION	The vomeronasal organ (VNO) has a key role in mediating the social and defensive responses of many terrestrial vertebrates to species- and sex-specific chemosignals(1). More than 250 putative pheromone receptors have been identified in the mouse VNO(2,3), but the nature of the signals detected by individual VNO receptors has not yet been elucidated. To gain insight into the molecular logic of VNO detection leading to mating, aggression or defensive responses, we sought to uncover the response profiles of individual vomeronasal receptors to a wide range of animal cues. Here we describe the repertoire of behaviourally and physiologically relevant stimuli detected by a large number of individual vomeronasal receptors in mice, and define a global map of vomeronasal signal detection. We demonstrate that the two classes (V1R and V2R) of vomeronasal receptors use fundamentally different strategies to encode chemosensory information, and that distinct receptor subfamilies have evolved towards the specific recognition of certain animal groups or chemical structures. The association of large subsets of vomeronasal receptors with cognate, ethologically and physiologically relevant stimuli establishes the molecular foundation of vomeronasal information coding, and opens new avenues for further investigating the neural mechanisms underlying behaviour specificity.	[Isogai, Yoh; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Ctr Brain Sci, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Grieshaber-Bouyer, Ricardo/R-7512-2016	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Si, Sheng/0000-0001-5825-7712; Tan, Taralyn/0000-0002-4917-3047; Dulac, Catherine/0000-0001-5024-5418; Murthy, Venkatesh/0000-0003-2443-4252	NIDCD at the National Institute of Health; Howard Hughes Medical Institute; Damon Runyon Cancer Research Foundation [DRG-1981-08]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009019, R01DC003903] Funding Source: NIH RePORTER	NIDCD at the National Institute of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We acknowledge H. Fisher, H. Hoekstra, E. Kay, M. Kirchgessner, N. Uchida, A. Wang, X.-D. Wang, B. Watson, W. Tong, Harvard Museum of Natural History, Harvard Concord Field Station, Museum of Science, Boston, and New England Wildlife Center, for providing stimulus materials used in this study, L. Looger for the G-CaMP3 construct, M. Wienisch, F. Markopoulos and D. Mak for help with electrophysiology and imaging experiments, and B. Goetze and the Harvard Center for Biological Imaging for help with microscopy. We also thank members of the Dulac laboratory for critical reading of the manuscript, S. Andreeva for technical support and R. Hellmiss for help with figure artwork. This work was supported by the NIDCD at the National Institute of Health, the Howard Hughes Medical Institute and the Damon Runyon Cancer Research Foundation (Y.I., DRG-1981-08).	Ben-Shaul Y, 2010, P NATL ACAD SCI USA, V107, P5172, DOI 10.1073/pnas.0915147107; Berghard A, 1996, J NEUROSCI, V16, P909; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BROWN JS, 1988, OECOLOGIA, V76, P408, DOI 10.1007/BF00377036; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; DANCIGER E, 1989, P NATL ACAD SCI USA, V86, P8565, DOI 10.1073/pnas.86.21.8565; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Holekamp TF, 2008, NEURON, V57, P661, DOI 10.1016/j.neuron.2008.01.011; Holy TE, 2000, SCIENCE, V289, P1569, DOI 10.1126/science.289.5484.1569; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Miller RA, 2000, J ZOOL, V250, P95, DOI 10.1111/j.1469-7998.2000.tb00580.x; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Samuelsen CL, 2009, NEUROSCIENCE, V164, P1468, DOI 10.1016/j.neuroscience.2009.09.030; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Stewart R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-253; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Sundell J, 2004, OECOLOGIA, V139, P157, DOI 10.1007/s00442-004-1490-x; Taha M, 2009, PHYSIOL BEHAV, V98, P147, DOI 10.1016/j.physbeh.2009.05.006; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Wagner S, 2006, NEURON, V50, P697, DOI 10.1016/j.neuron.2006.04.033; ZHANG X, 2010, NEUROSCIENCE, V4, P164	33	211	215	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					241	U130		10.1038/nature10437	http://dx.doi.org/10.1038/nature10437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21937988	Green Accepted, Green Submitted			2022-12-24	WOS:000295782800050
J	Ford, MGJ; Jenni, S; Nunnari, J				Ford, Marijn G. J.; Jenni, Simon; Nunnari, Jodi			The crystal structure of dynamin	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; CLATHRIN-MEDIATED ENDOCYTOSIS; GTPASE ACTIVITY; IN-VIVO; CONFORMATIONAL-CHANGES; BINDING PROTEINS; MECHANISM; FISSION; MITOCHONDRIAL; CONSTRICTION	Dynamin-related proteins (DRPs) are multi-domain GTPases that function via oligomerization and GTP-dependent conformational changes to play central roles in regulating membrane structure across phylogenetic kingdoms. How DRPs harness self-assembly and GTP-dependent conformational changes to remodel membranes is not understood. Here we present the crystal structure of an assembly-deficient mammalian endocytic DRP, dynamin 1, lacking the proline-rich domain, in its nucleotide-free state. The dynamin 1 monomer is an extended structure with the GTPase domain and bundle signalling element positioned on top of a long helical stalk with the pleckstrin homology domain flexibly attached on its opposing end. Dynamin 1 dimer and higher order dimer multimers form via interfaces located in the stalk. Analysis of these interfaces provides insight into DRP family member specificity and regulation and provides a framework for understanding the biogenesis of higher order DRP structures and the mechanism of DRP-mediated membrane scission events.	[Ford, Marijn G. J.; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Jenni, Simon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	University of California System; University of California Davis; Harvard University; Harvard Medical School	Nunnari, J (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			Howard Hughes Medical Institute [DRG-2004-09]; American Heart Innovator Award; NIH [R01GM062942S1, R01GM097432]; Office of Science, Office of Basic Energy Sciences, of the US Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942, R01GM097432] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Innovator Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Basic Energy Sciences, of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors would like to express thanks to I. Stokes-Rees for assistance with the Wide Space Molecular Replacement, J. Holton for advice and assistance with data collection and H. McMahon for the kind gift of the dynamin clone. We would also like to thank J. Al-Bassam, J. Chappie, A. McCoy, S. Harrison, D. Owen, A. Fisher, E. Baldwin, L. Lackner, G. Adamson, N. Varlakhanova and members of the Nunnari lab for extensive discussions. S. J. is a Damon Runyon Cancer Research Foundation Fellow supported by the Howard Hughes Medical Institute (DRG-2004-09). This work was supported by an American Heart Innovator Award and NIH grants (R01GM062942S1 and R01GM097432) to J. N. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under Contract No. DE-AC02-05CH11231.	Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Barylko B, 2010, BIOCHEMISTRY-US, V49, P10592, DOI 10.1021/bi101343p; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Ingerman E, 2005, METHOD ENZYMOL, V404, P611, DOI 10.1016/S0076-6879(05)04053-X; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lackner LL, 2009, SCIENCE, V325, P874, DOI 10.1126/science.1176921; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Song BD, 2004, MOL BIOL CELL, V15, P2243, DOI 10.1091/mbc.E04-01-0015; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	42	191	197	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 29	2011	477	7366					561	566		10.1038/nature10441	http://dx.doi.org/10.1038/nature10441			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21927001	Green Accepted			2022-12-24	WOS:000295320900033
J	Nallamothu, BK; Gurm, HS; Ting, HH; Goodney, PP; Rogers, MAM; Curtis, JP; Dimick, JB; Bates, ER; Krumholz, HM; Birkmeyer, JD				Nallamothu, Brahmajee K.; Gurm, Hitinder S.; Ting, Henry H.; Goodney, Philip P.; Rogers, Mary A. M.; Curtis, Jeptha P.; Dimick, Justin B.; Bates, Eric R.; Krumholz, Harlan M.; Birkmeyer, John D.			Operator Experience and Carotid Stenting Outcomes in Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEARNING-CURVE; ENDARTERECTOMY; COMPLICATIONS; COMPETENCE; STATEMENT; COMMITTEE; SKILLS	Context Although the efficacy of carotid stenting has been established in clinical trials, outcomes of the procedure based on operator experience are less certain in clinical practice. Objective To assess association between outcomes and 2 measures of operator experience: annual volume and experience at the time of the procedure among new operators who first performed carotid stenting after a national coverage decision by the Centers for Medicare & Medicaid Services (CMS). Design, Setting, and Patients Observational study using administrative data on fee-for-service Medicare beneficiaries aged 65 years or older undergoing carotid stenting between 2005 and 2007. Main Outcome Measure Thirty-day mortality stratified by very low, low, medium, and high annual operator volumes (<6, 6-11, 12-23, and >24 procedures per year, respectively) and treatment early vs late during a new operator's experience (1st to 11th procedure and 12th procedure or higher). Results During the study period, 24 701 procedures were performed by 2339 operators. Of these, 11 846 were performed by 1792 new operators who first performed carotid stenting after the CMS national coverage decision. Overall, 30-day mortality was 1.9% (n= 461) and rate of failure to use an embolic protection device was 4.8% (n= 1173). The median annual operator volume among Medicare beneficiaries was 3.0 per year (interquartile range, 1.4-6.5) and 11.6% of operators performed 12 or more procedures per year during the study period. Observed 30-day mortality was higher among patients treated by operators with lower annual volumes (2.5% [95% CI, 2.1%-2.9%], 1.9% [95% CI, 1.6%-2.3%], 1.6% [95% CI, 1.3%-1.9%], and 1.4% [95% CI, 1.1%-1.7%] across the 4 categories; P<.001) and among patients treated early (2.3%; 95% CI, 2.0%-2.7%) vs late (1.4%; 95% CI, 1.1%-1.9%; P<.001) during a new operator's experience. After multivariable adjustment, patients treated by very low-volume operators had a higher risk of 30-day mortality compared with patients treated by high-volume operators (adjusted odds ratio, 1.9; 95% CI, 1.4-2.7; P<.001). Similarly, we found a higher risk of 30-day mortality in patients treated early vs late during a new operator's experience (adjusted odds ratio, 1.7; 95% CI, 1.2-2.4; P=.001). Conclusion Among older patients undergoing carotid stenting, lower annual operator volume and early experience are associated with increased 30-day mortality. JAMA. 2011;306(12):1338-1343	[Nallamothu, Brahmajee K.] Univ Michigan, Sch Med, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Dimick, Justin B.; Birkmeyer, John D.] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.; Gurm, Hitinder S.; Dimick, Justin B.; Birkmeyer, John D.] Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Ting, Henry H.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Goodney, Philip P.] Dartmouth Hitchcock Med Ctr, Vasc Surg Sect, Lebanon, NH 03766 USA; [Curtis, Jeptha P.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Mayo Clinic; Dartmouth College; Yale University	Nallamothu, BK (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ctr Cardiovasc, SPC 5869, Ann Arbor, MI 48109 USA.	bnallamo@umich.edu	, Harlan/AAI-2875-2020	Gurm, Hitinder/0000-0002-1646-0218; Rogers, Mary/0000-0001-5519-3223	National Institutes of Health [5R21AG032155-02]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported by grant 5R21AG032155-02 from the National Institutes of Health.	*AG HEALTH RES QUA, HCUPNET HEALTHC COST; *AM MED ASS, 2009, CPT 2010 PROF ED; Anderson HV, 2010, CATHETER CARDIO INTE, V75, P519, DOI 10.1002/ccd.22333; Bates ER, 2007, J AM COLL CARDIOL, V49, P126, DOI 10.1016/j.jacc.2006.10.021; Brott TG, 2010, NEW ENGL J MED, V363, P11, DOI 10.1056/NEJMoa0912321; Cates CU, 2007, JAMA-J AM MED ASSOC, V297, P265, DOI 10.1001/jama.297.3.265-b; Centers for Medicare and Medicaid Services, 2005, CMS MAN SYST PUB; Clair DG, 2008, SEMIN VASC SURG, V21, P64, DOI 10.1053/j.semvascsurg.2008.03.006; Connors JJ, 2005, NEUROLOGY, V64, P190, DOI 10.1212/01.WNL.0000148958.34025.09; *CTR MED MED SERV, UN PHYS ID NUMB UPIN; *CTR MED MED SERV, 2010, CMS MAN SYST PUB; Davis SM, 2010, NEW ENGL J MED, V363, P80, DOI 10.1056/NEJMe1005220; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gallagher AG, 2004, JAMA-J AM MED ASSOC, V292, P3024, DOI 10.1001/jama.292.24.3024; Goodney PP, 2010, CIRC-CARDIOVASC QUAL, V3, P15, DOI 10.1161/CIRCOUTCOMES.109.864736; Grantcharov TP, 2008, BRIT MED J, V336, P1129, DOI 10.1136/bmj.39517.686956.47; Halm EA, 2010, ARCH INTERN MED, V170, P1225, DOI 10.1001/archinternmed.2010.223; Kastrup A, 2003, STROKE, V34, P813, DOI 10.1161/01.STR.0000058160.53040.5F; Lin PH, 2005, AM J SURG, V190, P850, DOI 10.1016/j.amsjurg.2005.08.008; Nallamothu BK, 2011, ARCH INTERN MED, V171, P1804, DOI 10.1001/archinternmed.2011.354; Ramsay C R, 2001, Health Technol Assess, V5, P1; Ramsay CR, 2000, INT J TECHNOL ASSESS, V16, P1095, DOI 10.1017/S0266462300103149; Reznick RK, 2006, NEW ENGL J MED, V355, P2664, DOI 10.1056/NEJMra054785; Rosenfield K, 2005, J AM COLL CARDIOL, V45, P165, DOI 10.1016/j.jacc.2004.11.016; Schreiber TL, 2010, J AM COLL CARDIOL, V56, P49, DOI 10.1016/j.jacc.2010.02.045; SEE WA, 1993, JAMA-J AM MED ASSOC, V270, P2689, DOI 10.1001/jama.270.22.2689; van Walraven Carl, 2009, Med Care, V47, P626, DOI 10.1097/MLR.0b013e31819432e5; Verzini F, 2006, J VASC SURG, V44, P1205, DOI 10.1016/j.jvs.2006.08.027; Wholey MH, 2000, CATHETER CARDIO INTE, V50, P160, DOI 10.1002/(SICI)1522-726X(200006)50:2<160::AID-CCD2>3.0.CO;2-E; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127	30	139	140	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 28	2011	306	12					1338	1343		10.1001/jama.2011.1357	http://dx.doi.org/10.1001/jama.2011.1357			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825FQ	21954477	Green Accepted, Bronze			2022-12-24	WOS:000295257000022
J	Adler, PB; Seabloom, EW; Borer, ET; Hillebrand, H; Hautier, Y; Hector, A; Harpole, WS; O'Halloran, LR; Grace, JB; Anderson, TM; Bakker, JD; Biederman, LA; Brown, CS; Buckley, YM; Calabrese, LB; Chu, CJ; Cleland, EE; Collins, SL; Cottingham, KL; Crawley, MJ; Damschen, EI; Davies, KF; DeCrappeo, NM; Fay, PA; Firn, J; Frater, P; Gasarch, EI; Gruner, DS; Hagenah, N; Lambers, JHR; Humphries, H; Jin, VL; Kay, AD; Kirkman, KP; Klein, JA; Knops, JMH; La Pierre, KJ; Lambrinos, JG; Li, W; MacDougall, AS; McCulley, RL; Melbourne, BA; Mitchell, CE; Moore, JL; Morgan, JW; Mortensen, B; Orrock, JL; Prober, SM; Pyke, DA; Risch, AC; Schuetz, M; Smith, MD; Stevens, CJ; Sullivan, LL; Wang, G; Wragg, PD; Wright, JP; Yang, LH				Adler, Peter B.; Seabloom, Eric W.; Borer, Elizabeth T.; Hillebrand, Helmut; Hautier, Yann; Hector, Andy; Harpole, W. Stanley; O'Halloran, Lydia R.; Grace, James B.; Anderson, T. Michael; Bakker, Jonathan D.; Biederman, Lori A.; Brown, Cynthia S.; Buckley, Yvonne M.; Calabrese, Laura B.; Chu, Cheng-Jin; Cleland, Elsa E.; Collins, Scott L.; Cottingham, Kathryn L.; Crawley, Michael J.; Damschen, Ellen I.; Davies, Kendi F.; DeCrappeo, Nicole M.; Fay, Philip A.; Firn, Jennifer; Frater, Paul; Gasarch, Eve I.; Gruner, Daniel S.; Hagenah, Nicole; Lambers, Janneke Hille Ris; Humphries, Hope; Jin, Virginia L.; Kay, Adam D.; Kirkman, Kevin P.; Klein, Julia A.; Knops, Johannes M. H.; La Pierre, Kimberly J.; Lambrinos, John G.; Li, Wei; MacDougall, Andrew S.; McCulley, Rebecca L.; Melbourne, Brett A.; Mitchell, Charles E.; Moore, Joslin L.; Morgan, John W.; Mortensen, Brent; Orrock, John L.; Prober, Suzanne M.; Pyke, David A.; Risch, Anita C.; Schuetz, Martin; Smith, Melinda D.; Stevens, Carly J.; Sullivan, Lauren L.; Wang, Gang; Wragg, Peter D.; Wright, Justin P.; Yang, Louie H.			Productivity Is a Poor Predictor of Plant Species Richness	SCIENCE			English	Article							DIVERSITY; BIODIVERSITY; HYPOTHESIS	For more than 30 years, the relationship between net primary productivity and species richness has generated intense debate in ecology about the processes regulating local diversity. The original view, which is still widely accepted, holds that the relationship is hump-shaped, with richness first rising and then declining with increasing productivity. Although recent meta-analyses questioned the generality of hump-shaped patterns, these syntheses have been criticized for failing to account for methodological differences among studies. We addressed such concerns by conducting standardized sampling in 48 herbaceous-dominated plant communities on five continents. We found no clear relationship between productivity and fine-scale (meters(-2)) richness within sites, within regions, or across the globe. Ecologists should focus on fresh, mechanistic approaches to understanding the multivariate links between productivity and richness.	[Adler, Peter B.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Adler, Peter B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Seabloom, Eric W.; Borer, Elizabeth T.; Wragg, Peter D.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Hillebrand, Helmut] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, D-26381 Wilhelmshaven, Germany; [Hautier, Yann; Hector, Andy] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Harpole, W. Stanley; Biederman, Lori A.; Frater, Paul; Li, Wei; Mortensen, Brent; Sullivan, Lauren L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [O'Halloran, Lydia R.] Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA; [Grace, James B.] US Geol Survey, Natl Wetlands Res Ctr, Lafayette, LA 70506 USA; [Anderson, T. Michael] Wake Forest Univ, Dept Biol, Reynolda Stn 7325, Winston Salem, NC 27109 USA; [Bakker, Jonathan D.] Univ Washington, Sch Forest Resources, Seattle, WA 98195 USA; [Brown, Cynthia S.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Buckley, Yvonne M.; Collins, Scott L.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Calabrese, Laura B.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Chu, Cheng-Jin; Wang, Gang] Lanzhou Univ, Minist Educ, Key Lab Arid & Grassland Ecol, Lanzhou 730000, Gansu, Peoples R China; [Cleland, Elsa E.] Univ Calif San Diego, Ecol Behav & Evolut Sect, La Jolla, CA 92093 USA; [Cottingham, Kathryn L.] Dartmouth Coll, Dept Biol Sci, Gilman Lab 6044, Hanover, NH 03755 USA; [Crawley, Michael J.] Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, Ascot SL5 7PY, Berks, England; [Damschen, Ellen I.; Orrock, John L.] Univ Wisconsin, Dept Zool, Madison, WI 53704 USA; [Davies, Kendi F.; Gasarch, Eve I.; Humphries, Hope; Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [DeCrappeo, Nicole M.; Pyke, David A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97331 USA; [Fay, Philip A.] USDA ARS, Grassland Soil & Water Res Lab, Temple, TX 76502 USA; [Firn, Jennifer] Queensland Univ Technol, Sch Biogeosci, Brisbane, Qld 4001, Australia; [Gruner, Daniel S.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Hagenah, Nicole; Kirkman, Kevin P.; La Pierre, Kimberly J.] Univ KwaZulu Natal, Sch Biol & Conservat Sci, ZA-3209 Kwa Zulu, South Africa; [Hagenah, Nicole; Smith, Melinda D.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Lambers, Janneke Hille Ris] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Jin, Virginia L.] USDA ARS, Agroecosyst Management Res Unit, Lincoln, NE 68583 USA; [Kay, Adam D.] Univ St Thomas, Dept Biol, St Paul, MN 55105 USA; [Klein, Julia A.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Lambrinos, John G.] Oregon State Univ, Dept Hort, Corvallis, OR 97331 USA; [MacDougall, Andrew S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [McCulley, Rebecca L.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Mitchell, Charles E.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Moore, Joslin L.] Univ Melbourne, Sch Bot, Parkville, Vic 3010, Australia; [Morgan, John W.] La Trobe Univ, Dept Bot, Bundoora, Vic 3086, Australia; [Prober, Suzanne M.] Commonwealth Sci & Ind Res Org Ecosyst Sci, Wembley, WA 6913, Australia; [Risch, Anita C.; Schuetz, Martin] Swiss Fed Inst Forest Snow & Landscape Res, CH-8903 Birmensdorf ZH, Switzerland; [Stevens, Carly J.] Open Univ, Dept Life Sci, Milton Keynes MK7 6AA, Bucks, England; [Stevens, Carly J.] Univ Lancaster, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Wright, Justin P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Yang, Louie H.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Minnesota System; University of Minnesota Twin Cities; Carl von Ossietzky Universitat Oldenburg; University of Zurich; Iowa State University; Oregon State University; United States Department of the Interior; United States Geological Survey; Wake Forest University; University of Washington; University of Washington Seattle; Colorado State University; University of Queensland; University of New Mexico; Lanzhou University; University of California System; University of California San Diego; Dartmouth College; Imperial College London; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; United States Department of the Interior; United States Geological Survey; United States Department of Agriculture (USDA); Queensland University of Technology (QUT); University System of Maryland; University of Maryland College Park; University of Kwazulu Natal; Yale University; University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); University of St Thomas Minnesota; Colorado State University; University of Nebraska System; University of Nebraska Lincoln; Oregon State University; University of Guelph; University of Kentucky; University of North Carolina; University of North Carolina Chapel Hill; University of Melbourne; La Trobe University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Open University - UK; Lancaster University; Duke University; University of California System; University of California Davis	Adler, PB (corresponding author), Utah State Univ, Dept Wildland Resources, 5230 Old Main, Logan, UT 84322 USA.	peter.adler@usu.edu	Gruner, Daniel Stephen/A-5166-2010; Cottingham, Kathryn L./AAV-3934-2021; Chu, Chu/T-6038-2019; Fay, Philip A./I-1853-2012; Mitchell, Charles E/I-3709-2014; Knops, Johannes/AAA-8546-2020; Brown, Cynthia/K-5814-2012; Wright, Justin/AAG-6461-2019; Moore, Joslin/AAE-3819-2020; Mortensen, Brent/AAD-2092-2021; Pyke, David A./AAW-8291-2020; Cottingham, Kathryn/H-1593-2012; Grace, James/B-8472-2009; Damschen, Ellen/E-4919-2011; Prober, Suzanne/G-6465-2010; Risch, Anita C./A-9836-2012; Hillebrand, Helmut/I-1717-2014; Buckley, Yvonne/B-1281-2008; Collins, Scott/P-7742-2014; Kirkman, Kevin/F-4160-2010; Hautier, Yann/D-5426-2015; Harpole, W Stanley/C-2814-2013; Wragg, Peter/C-8385-2009	Gruner, Daniel Stephen/0000-0002-3153-4297; Cottingham, Kathryn L./0000-0003-3169-5047; Fay, Philip A./0000-0002-8291-6316; Mitchell, Charles E/0000-0002-1633-1993; Wright, Justin/0000-0002-9102-5347; Moore, Joslin/0000-0001-9809-5092; Mortensen, Brent/0000-0002-4873-6127; Pyke, David A./0000-0002-4578-8335; Grace, James/0000-0001-6374-4726; Chu, Chengjin/0000-0002-0606-449X; Frater, Paul/0000-0002-7237-6563; Firn, Jennifer/0000-0001-6026-8912; MELBOURNE, BRETT/0000-0002-8843-4131; Damschen, Ellen/0000-0001-7435-0669; Prober, Suzanne/0000-0002-6518-239X; Biederman, Lori/0000-0003-2171-7898; Brown, Cynthia/0000-0001-8486-7119; Seabloom, Eric/0000-0001-6780-9259; Risch, Anita C./0000-0003-0531-8336; Hillebrand, Helmut/0000-0001-7449-1613; Borer, Elizabeth/0000-0003-2259-5853; Yang, Louie/0000-0002-9237-5357; Buckley, Yvonne/0000-0001-7599-3201; Collins, Scott/0000-0002-0193-2892; Stevens, Carly/0000-0002-2390-1763; Kirkman, Kevin/0000-0001-9580-5191; Bakker, Jonathan/0000-0002-8973-2771; Hautier, Yann/0000-0003-4347-7741; Harpole, W Stanley/0000-0002-3404-9174; Wragg, Peter/0000-0003-2361-4286; Komatsu, Kimberly/0000-0001-7056-4547	NSF [DEB-0741952]; Natural Environment Research Council [ceh010010] Funding Source: researchfish	NSF(National Science Foundation (NSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was generated using data from the Nutrient Network collaborative experiment, funded at the site-scale by individual researchers and coordinated through Research Coordination Network funding from NSF to E. Borer and E. Seabloom (grant DEB-0741952). The authors declare no competing interests. The data used in the primary analyses are available in the Supporting Online Material. We thank B. Enquist, A. Leakey, and three anonymous reviewers for suggestions that improved the manuscript.	ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; Cardinale BJ, 2009, ECOLOGY, V90, P1227, DOI 10.1890/08-1038.1; Cardinale BJ, 2009, ECOL LETT, V12, P475, DOI 10.1111/j.1461-0248.2009.01317.x; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Fukami T, 2003, NATURE, V424, P423, DOI 10.1038/nature01785; Gillman LN, 2006, ECOLOGY, V87, P1234, DOI 10.1890/0012-9658(2006)87[1234:TIOPOT]2.0.CO;2; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grace JB, 2007, ECOL LETT, V10, P680, DOI 10.1111/j.1461-0248.2007.01058.x; Grace JB, 1999, OIKOS, V85, P398, DOI 10.2307/3546689; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 1999, OIKOS, V86, P393, DOI 10.2307/3546645; Kondoh M, 2001, P ROY SOC B-BIOL SCI, V268, P269, DOI 10.1098/rspb.2000.1384; Ma WH, 2010, GLOBAL ECOL BIOGEOGR, V19, P233, DOI 10.1111/j.1466-8238.2009.00508.x; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; Oesterheld M, 2000, METHODS IN ECOSYSTEM SCIENCE, P151; Rosenzweig Michael L., 1993, P52; Scheiner SM, 2000, EVOL ECOL RES, V2, P791; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; Whittaker RJ, 2003, ECOLOGY, V84, P3384, DOI 10.1890/02-3128; Whittaker RJ, 2010, ECOLOGY, V91, P2522, DOI 10.1890/08-0968.1; Zobel M, 2008, GLOBAL ECOL BIOGEOGR, V17, P679, DOI 10.1111/j.1466-8238.2008.00400.x	30	396	436	23	708	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 23	2011	333	6050					1750	1753		10.1126/science.1204498	http://dx.doi.org/10.1126/science.1204498			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940895	Green Accepted			2022-12-24	WOS:000295121500043
J	Johnson, DDP; Fowler, JH				Johnson, Dominic D. P.; Fowler, James H.			The evolution of overconfidence	NATURE			English	Article							FIGHTING BEHAVIOR; BIASES; WAR	Confidence is an essential ingredient of success in a wide range of domains ranging from job performance and mental health to sports, business and combat(1-4). Some authors have suggested that not just confidence but overconfidence-believing you are better than you are in reality-is advantageous because it serves to increase ambition, morale, resolve, persistence or the credibility of bluffing, generating a self-fulfilling prophecy in which exaggerated confidence actually increases the probability of success(3-8). However, overconfidence also leads to faulty assessments, unrealistic expectations and hazardous decisions, so it remains a puzzle how such a false belief could evolve or remain stable in a population of competing strategies that include accurate, unbiased beliefs. Here we present an evolutionary model showing that, counterintuitively, overconfidence maximizes individual fitness and populations tend to become overconfident, as long as benefits from contested resources are sufficiently large compared with the cost of competition. In contrast, unbiased strategies are only stable under limited conditions. The fact that overconfident populations are evolutionarily stable in a wide range of environments may help to explain why overconfidence remains prevalent today, even if it contributes to hubris, market bubbles, financial collapses, policy failures, disasters and costly wars(9-13).	[Johnson, Dominic D. P.] Univ Edinburgh, Edinburgh EH8 9LD, Midlothian, Scotland; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Fowler, James H.] Univ Calif San Diego, Div Med Genet, La Jolla, CA 92093 USA	University of Edinburgh; University of California System; University of California San Diego; University of California System; University of California San Diego	Johnson, DDP (corresponding author), Univ Edinburgh, Edinburgh EH8 9LD, Midlothian, Scotland.	dominic.johnson@ed.ac.uk	Johnson, Dominic/GXH-1117-2022; Fowler, James H/C-2750-2008	Fowler, James H/0000-0001-7795-1638				Akerlof George, 2009, ANIMAL SPIRITS HUMAN; Camerer C, 1999, AM ECON REV, V89, P306, DOI 10.1257/aer.89.1.306; COSMIDES L, 1994, AM ECON REV, V84, P327; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; ENQUIST M, 1990, ANIM BEHAV, V39, P1, DOI 10.1016/S0003-3472(05)80721-3; FAMA EF, 1968, J AM STAT ASSOC, V63, P817, DOI 10.2307/2283875; FEARON JD, 1995, INT ORGAN, V49, P379, DOI 10.1017/S0020818300033324; FUDENBERG D, 1991, J ECON THEORY, V53, P236, DOI 10.1016/0022-0531(91)90155-W; Gigerenzer G, 2002, ADAPTIVE THINKING RA; Haselton MG, 2006, PERS SOC PSYCHOL REV, V10, P47, DOI 10.1207/s15327957pspr1001_3; Johnson DDP., 2004, OVERCONFIDENCE WAR H; Johnson D, 2009, CURR SCI INDIA, V97, P1593; Johnson DDP, 2011, INT SECURITY, V36, P7, DOI 10.1162/ISEC_a_00043; Johnson DDP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020851; Kanter RM, 2004, CONFIDENCE WINNING S; Malmendier U, 2005, J FINANC, V60, P2661, DOI 10.1111/j.1540-6261.2005.00813.x; McDermott R, 2008, J POLIT, V70, P335, DOI 10.1017/S0022381608080341; McKay RT, 2009, BEHAV BRAIN SCI, V32, P493, DOI 10.1017/S0140525X09990975; Nettle D., 2004, EMOTION EVOLUTION RA, P193, DOI 10.1093/acprof:oso/9780198528975.003.0010; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Peterson C, 2006, PRIMER POSITIVE PSYC, DOI DOI 10.1016/j.compedu.2004.08.013; Sharot T., 2011, OPTIMISM BIAS TOUR I; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; TAYLOR SE, 1994, PSYCHOL BULL, V116, P21, DOI 10.1037/0033-2909.116.1.21; Taylor SE, 1989, POSITIVE ILLUSIONS C; Trivers R, 2000, ANN NY ACAD SCI, V907, P114; Trivers Robert, 2011, DECEIT SELF DECEPTIO; Tuchman B., 1984, MARCH FOLLY TROY VIE; Wrangham R, 1999, EVOL HUM BEHAV, V20, P3, DOI 10.1016/S1090-5138(98)00040-3	30	270	279	10	184	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					317	320		10.1038/nature10384	http://dx.doi.org/10.1038/nature10384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819TD	21921915	Green Submitted			2022-12-24	WOS:000294852400028
J	Scott, DC; Monda, JK; Bennett, EJ; Harper, JW; Schulman, BA				Scott, Daniel C.; Monda, Julie K.; Bennett, Eric J.; Harper, J. Wade; Schulman, Brenda A.			N-Terminal Acetylation Acts as an Avidity Enhancer Within an Interconnected Multiprotein Complex	SCIENCE			English	Article							MEMBRANE-PROTEIN SYS1P; SACCHAROMYCES-CEREVISIAE; CULLIN NEDDYLATION; ALPHA-ACETYLATION; GTPASE ARL3P; YEAST; ACETYLTRANSFERASES; CONSERVATION; SUBUNITS; REQUIRES	Although many eukaryotic proteins are amino (N)-terminally acetylated, structural mechanisms by which N-terminal acetylation mediates protein interactions are largely unknown. Here, we found that N-terminal acetylation of the E2 enzyme, Ubc12, dictates distinctive E3-dependent ligation of the ubiquitin-like protein Nedd8 to Cul1. Structural, biochemical, biophysical, and genetic analyses revealed how complete burial of Ubc12's N-acetyl-methionine in a hydrophobic pocket in the E3, Dcn1, promotes cullin neddylation. The results suggest that the N-terminal acetyl both directs Ubc12's interactions with Dcn1 and prevents repulsion of a charged N terminus. Our data provide a link between acetylation and ubiquitin-like protein conjugation and define a mechanism for N-terminal acetylation-dependent recognition.	[Scott, Daniel C.; Monda, Julie K.; Schulman, Brenda A.] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Bennett, Eric J.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Harvard University; Harvard Medical School	Schulman, BA (corresponding author), St Jude Childrens Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Harper, Jeffrey/0000-0002-6944-7236	American Lebanese Syrian Associated Charities-St. Jude; NIH; Howard Hughes Medical Institute; Millennium Pharmaceuticals; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530, R01GM054137, R01GM070565] Funding Source: NIH RePORTER	American Lebanese Syrian Associated Charities-St. Jude; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This was supported by American Lebanese Syrian Associated Charities-St. Jude, NIH, and Howard Hughes Medical Institute (B. A. S.), grants from NIH and Millennium Pharmaceuticals (J.W.H.), and Damon Runyon Cancer Research Foundation (E.J.B.). We thank S. Gygi, I. Kurinov, C. Ralston, R. Cassell, P. Rodrigues, K. Kodali, V. Pagala, R. Schekman, D. W. Miller, S. Bozeman, D. J. Miller, J. Bollinger, and C. Rock for assistance, reagents, and/or discussions. D. C. S., J. K. M., B. A. S., and St. Jude Children's Research Hospital have applied for a patent on uses of Ubc12 N-terminal acetylation for inhibiting neddylation. Research Collaboratory for Structural Bioinformatics structural accession codes: 3TDI, 3TDU, 3TDZ. Author contributions: D. C. S., J. K. M., and E. J. B. designed, performed, and analyzed experiments; D. C. S. and B. A. S. wrote the manuscript, with all authors contributing; J. W. H. and B. A. S. advised and assisted on all aspects.	Arnesen T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001074; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bird GH, 2008, METHOD ENZYMOL, V446, P369, DOI 10.1016/S0076-6879(08)01622-4; Dixon SJ, 2008, P NATL ACAD SCI USA, V105, P16653, DOI 10.1073/pnas.0806261105; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huang GC, 2011, J BIOL CHEM, V286, P10297, DOI 10.1074/jbc.M110.203729; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kim AY, 2008, J BIOL CHEM, V283, P33211, DOI 10.1074/jbc.M804440200; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Kurz T, 2008, MOL CELL, V29, P23, DOI 10.1016/j.molcel.2007.12.012; Lammer D, 1998, GENE DEV, V12, P914, DOI 10.1101/gad.12.7.914; Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Polevoda B, 2001, J BIOL CHEM, V276, P20154, DOI 10.1074/jbc.M011440200; Sarkaria I, 2006, CANCER RES, V66, P9437, DOI 10.1158/0008-5472.CAN-06-2074; Scott DC, 2010, MOL CELL, V39, P784, DOI 10.1016/j.molcel.2010.08.030; Setty SRG, 2004, NAT CELL BIOL, V6, P414, DOI 10.1038/ncb1121; Van Damme P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002169; Yang XY, 2007, J BIOL CHEM, V282, P24490, DOI 10.1074/jbc.C700038200; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050	25	195	209	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					674	678		10.1126/science.1209307	http://dx.doi.org/10.1126/science.1209307			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21940857	Green Accepted			2022-12-24	WOS:000296494700056
J	Tripodi, M; Stepien, AE; Arber, S				Tripodi, Marco; Stepien, Anna E.; Arber, Silvia			Motor antagonism exposed by spatial segregation and timing of neurogenesis	NATURE			English	Article							FUNCTIONALLY COMPLEX MUSCLES; SPINAL-CORD; MODULAR ORGANIZATION; FLUORESCENT PROTEIN; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; CAT HINDLIMB; NEURONS; PATTERN; MOTONEURONS	Walking is a key motor behaviour of limbed animals, executed by contraction of functionally antagonistic muscle groups during swing and stance phases. Nevertheless, neuronal circuits regulating the activation of antagonistic extensor-flexor muscles remain poorly understood. Here we use monosynaptically restricted trans-synaptic viruses to elucidate premotor anatomical substrates for extensor-flexor control in mice. We observe a medio-lateral spatial segregation between extensor and flexor premotor interneurons in the dorsal spinal cord. These premotor interneuron populations are derived from common progenitor domains, but segregate by timing of neurogenesis. We find that proprioceptive sensory feedback from the periphery is targeted to medial extensor premotor populations and is required for extensor-specific connectivity profiles during development. Our findings provide evidence for a discriminating anatomical basis of antagonistic circuits at the level of premotor interneurons, and point to synaptic input and developmental ontogeny as key factors in the establishment of circuits regulating motor behavioural dichotomy.	[Tripodi, Marco; Stepien, Anna E.; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland; [Tripodi, Marco; Stepien, Anna E.; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	University of Basel; Friedrich Miescher Institute for Biomedical Research	Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.	silvia.arber@unibas.ch	Tripodi, Marco/AGN-5956-2022	Tripodi, Marco/0000-0002-6827-6690; Arber, Silvia/0000-0002-6261-250X	EMBO long-term fellowship; ERC Advanced Grant; Swiss National Science Foundation; Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation	EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); ERC Advanced Grant(European Research Council (ERC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kanton Basel-Stadt; EU Framework Program 7; Novartis Research Foundation	We are grateful to M. Sigrist for the generation of Tau<SUP>lox-stop-lox-SynGFP</SUP> mice, M. Mielich for help in the production of viruses, P. Schwarb, L. Gelman, A. Ponti and M. Stadler for help and advice with image acquisition and statistical analysis, and to P. Caroni, G. Courtine, T. Jessell, B. Roska and P. Scheiffele for discussions and comments on the manuscript. We thank E. Callaway and K. Conzelmann for advice on virus work, and C. Birchmeier for Lbx1<SUP>cre</SUP> mice and Tlx3 antibodies. M. T. was supported by an EMBO long-term fellowship, M. T., A. E. S. and S. A. by an ERC Advanced Grant, the Swiss National Science Foundation, the Kanton Basel-Stadt, EU Framework Program 7 and the Novartis Research Foundation.	Akay T, 2006, J NEUROPHYSIOL, V96, P642, DOI 10.1152/jn.00174.2006; Angel MJ, 2005, J PHYSIOL-LONDON, V563, P597, DOI 10.1113/jphysiol.2004.076034; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BAEV K V, 1979, Neirofiziologiya, V11, P329; Bizzi E, 2008, BRAIN RES REV, V57, P125, DOI 10.1016/j.brainresrev.2007.08.004; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Carrier L, 1997, J NEUROPHYSIOL, V77, P1979, DOI 10.1152/jn.1997.77.4.1979; CHANAUD CM, 1991, EXP BRAIN RES, V85, P271, DOI 10.1007/BF00229406; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; CONWAY BA, 1987, EXP BRAIN RES, V68, P643; de Leon RD, 1999, J NEUROPHYSIOL, V82, P359, DOI 10.1152/jn.1999.82.1.359; Deguchi Y, 2011, NAT NEUROSCI, V14, P495, DOI 10.1038/nn.2768; ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794; ECCLES RM, 1958, J PHYSIOL-LONDON, V144, P271, DOI 10.1113/jphysiol.1958.sp006101; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Greene E.C., 1935, T AM PHILOS SOC, V27, P1; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hiebert GW, 1999, J NEUROPHYSIOL, V81, P758, DOI 10.1152/jn.1999.81.2.758; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P613, DOI 10.1113/jphysiol.1971.sp009488; Imamura F, 2011, NAT NEUROSCI, V14, P331, DOI 10.1038/nn.2754; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207; Kaneko K, 2008, NEUROSCIENCE, V157, P781, DOI 10.1016/j.neuroscience.2008.09.029; Kiehn O, 2011, CURR OPIN NEUROBIOL, V21, P100, DOI 10.1016/j.conb.2010.09.004; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; LLOYD DPC, 1946, J NEUROPHYSIOL, V9, P439, DOI 10.1152/jn.1946.9.6.439; Luo WQ, 2009, NEURON, V64, P841, DOI 10.1016/j.neuron.2009.11.003; Marshel JH, 2010, NEURON, V67, P562, DOI 10.1016/j.neuron.2010.08.001; McCrea DA, 1998, ANN NY ACAD SCI, V860, P216, DOI 10.1111/j.1749-6632.1998.tb09051.x; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082; McLean DL, 2007, NATURE, V446, P71, DOI 10.1038/nature05588; Mears SC, 1997, J NEUROSCI, V17, P3128; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1; Pearson KG, 1998, ANN NY ACAD SCI, V860, P203, DOI 10.1111/j.1749-6632.1998.tb09050.x; Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000; PRATT CA, 1991, EXP BRAIN RES, V85, P281, DOI 10.1007/BF00229407; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Schouenborg J, 2002, BRAIN RES REV, V40, P80, DOI 10.1016/S0165-0173(02)00191-1; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Sieber MA, 2007, J NEUROSCI, V27, P4902, DOI 10.1523/JNEUROSCI.0717-07.2007; Stein PSG, 2008, BRAIN RES REV, V57, P118, DOI 10.1016/j.brainresrev.2007.07.008; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stuart DG, 2008, BRAIN RES REV, V59, P74, DOI 10.1016/j.brainresrev.2008.06.001; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; Wang Z, 2008, J NEUROPHYSIOL, V100, P185, DOI 10.1152/jn.90354.2008; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; Zeilhofer HU, 2005, J COMP NEUROL, V482, P123, DOI 10.1002/cne.20349; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	63	121	121	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2011	479	7371					61	U84		10.1038/nature10538	http://dx.doi.org/10.1038/nature10538			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	840FA	22012263				2022-12-24	WOS:000296422600032
J	Zhao, Y; Yang, JL; Shi, JJ; Gong, YN; Lu, QH; Xu, H; Liu, LP; Shao, F				Zhao, Yue; Yang, Jieling; Shi, Jianjin; Gong, Yi-Nan; Lu, Qiuhe; Xu, Hao; Liu, Liping; Shao, Feng			The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus	NATURE			English	Article							INDUCED CELL-DEATH; PHAGOSOME MATURATION; ACTIVATES CASPASE-1; LEGIONELLA; RECOGNITION; DOMAIN; INTERLEUKIN-1-BETA; SUSCEPTIBILITY; IL-1-BETA; INFECTION	Inflammasomes are large cytoplasmic complexes that sense microbial infections/danger molecules and induce caspase-1 activation-dependent cytokine production and macrophage inflammatory death(1,2). The inflammasome assembled by the NOD-like receptor (NLR) protein NLRC4 responds to bacterial flagellin and a conserved type III secretion system (TTSS) rod component(3-5). How the NLRC4 inflammasome detects the two bacterial products and the molecular mechanism of NLRC4 inflammasome activation are not understood. Here we show that NAIP5, a BIR-domain NLR protein required for Legionella pneumophila replication in mouse macrophages(6), is a universal component of the flagellin-NLRC4 pathway. NAIP5 directly and specifically interacted with flagellin, which determined the inflammasome-stimulation activities of different bacterial flagellins. NAIP5 engagement by flagellin promoted a physical NAIP5-NLRC4 association, rendering full reconstitution of a flagellin-responsive NLRC4 inflammasome in non-macrophage cells. The related NAIP2 functioned analogously to NAIP5, serving as a specific inflammasome receptor for TTSS rod proteins such as Salmonella PrgJ and Burkholderia BsaK. Genetic analysis of Chromobacterium violaceum infection revealed that the TTSS needle protein CprI can stimulate NLRC4 inflammasome activation in human macrophages. Similarly, CprI is specifically recognized by human NAIP, the sole NAIP family member in human. The finding that NAIP proteins are inflammasome receptors for bacterial flagellin and TTSS apparatus components further predicts that the remaining NAIP family members may recognize other unidentified microbial products to activate NLRC4 inflammasome-mediated innate immunity.	[Zhao, Yue; Yang, Jieling; Shi, Jianjin; Gong, Yi-Nan; Lu, Qiuhe; Xu, Hao; Liu, Liping; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhao, Yue; Yang, Jieling] Peking Union Med Coll, Beijing 100730, Peoples R China; [Zhao, Yue; Yang, Jieling] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Shao, F (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	liu, li/HGC-0900-2022; Zhao, Yue/A-5285-2018	Zhao, Yue/0000-0003-1509-9261; Shi, Jianjin/0000-0001-8048-5180; Lu, Qiuhe/0000-0002-0202-7448	National Basic Research Program of China (973 Programs) [2010CB835400, 2012CB518700]	National Basic Research Program of China (973 Programs)(National Basic Research Program of China)	We thank V. Dixit for providing Nlrc4 and Asc knockout mice, K. Fitzgerald, D. Radzioch and A. Ding for immortalized macrophages, R. Vance for Naip5<SUP>A/J</SUP> cDNA, M. Donnenberg and J. Giron for EPEC strains, E. Miao for flagellin-deficient S. typhimurium strain, D. Milton and T. Hoang for bacterial vectors and T. Miki for C. violaceum strains. We are grateful to C. Yao for helping with flow cytometry, and Y. Xu and the NIBS animal facility for handling mouse lines. We thank members of the F. S. laboratory for helpful discussions and technical assistance. This work was supported by the National Basic Research Program of China (973 Programs, 2010CB835400 and 2012CB518700).	Akhter A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000361; Amer A, 2006, J BIOL CHEM, V281, P35217, DOI 10.1074/jbc.M604933200; Barrett AR, 2008, APPL ENVIRON MICROB, V74, P4498, DOI 10.1128/AEM.00531-08; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Cui JX, 2010, SCIENCE, V329, P1215, DOI 10.1126/science.1193844; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Diez E, 2003, NAT GENET, V33, P55, DOI 10.1038/ng1065; Dong N, 2010, EMBO J, V29, P1363, DOI 10.1038/emboj.2010.33; Fortier A, 2007, CELL MICROBIOL, V9, P910, DOI 10.1111/j.1462-5822.2006.00839.x; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Lamkanfi M, 2007, J IMMUNOL, V178, P8022, DOI 10.4049/jimmunol.178.12.8022; Lamkanfi M, 2009, IMMUNOL REV, V227, P95, DOI 10.1111/j.1600-065X.2008.00730.x; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lightfield KL, 2011, INFECT IMMUN, V79, P1606, DOI 10.1128/IAI.01187-10; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miki T, 2010, MOL MICROBIOL, V77, P855, DOI 10.1111/j.1365-2958.2010.07248.x; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; Molofsky AB, 2006, J EXP MED, V203, P1093, DOI 10.1084/jem.20051659; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Poyraz O, 2010, NAT STRUCT MOL BIOL, V17, P788, DOI 10.1038/nsmb.1822; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; VOJTEK AB, 1995, CELL, V82, P527, DOI 10.1016/0092-8674(95)90023-3; Worrall LJ, 2011, CURR OPIN MICROBIOL, V14, P3, DOI 10.1016/j.mib.2010.10.009; Wright EK, 2003, CURR BIOL, V13, P27, DOI 10.1016/S0960-9822(02)01359-3; Yao Q, 2009, P NATL ACAD SCI USA, V106, P3716, DOI 10.1073/pnas.0900212106; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	37	825	861	4	153	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					596	U257		10.1038/nature10510	http://dx.doi.org/10.1038/nature10510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21918512				2022-12-24	WOS:000295320900041
J	Crump, C; Sundquist, K; Sundquist, J; Winkleby, MA				Crump, Casey; Sundquist, Kristina; Sundquist, Jan; Winkleby, Marilyn A.			Gestational Age at Birth and Mortality in Young Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-HEART-DISEASE; DANISH MEN BORN; PRETERM BIRTH; PRENATAL EXPOSURE; RISK-FACTORS; FOLLOW-UP; WEIGHT; ASSOCIATION; COHORT; SURVIVAL	Context Preterm birth is the leading cause of infant mortality in developed countries, but the association between gestational age at birth and mortality in adulthood remains unknown. Objective To examine the association between gestational age at birth and mortality in young adulthood. Design, Setting, and Participants National cohort study of 674 820 individuals born as singletons in Sweden in 1973 through 1979 who survived to age 1 year, including 27 979 born preterm (gestational age <37 weeks), followed up to 2008 (ages 29-36 years). Main Outcome Measures All-cause and cause-specific mortality. Results A total of 7095 deaths occurred in 20.8 million person-years of follow-up. Among individuals still alive at the beginning of each age range, a strong inverse association was found between gestational age at birth and mortality in early childhood (ages 1-5 years: adjusted hazard ratio [aHR] for each additional week of gestation, 0.92; 95% CI, 0.89-0.94; P<.001), which disappeared in late childhood (ages 6-12 years: aHR, 0.99; 95% CI, 0.95-1.03; P=.61) and adolescence (ages 13-17 years: aHR, 0.99; 95% CI, 0.95-1.03; P=.64) and then reappeared in young adulthood (ages 18-36 years: aHR, 0.96; 95% CI, 0.94-0.97; P<.001). In young adulthood, mortality rates (per 1000 person-years) by gestational age at birth were 0.94 for 22 to 27 weeks, 0.86 for 28 to 33 weeks, 0.65 for 34 to 36 weeks, 0.46 for 37 to 42 weeks (full-term), and 0.54 for 43 or more weeks. Preterm birth was associated with increased mortality in young adulthood even among individuals born late preterm (34-36 weeks, aHR, 1.31; 95% CI, 1.13-1.50; P<.001), relative to those born full-term. In young adulthood, gestational age at birth had the strongest inverse association with mortality from congenital anomalies and respiratory, endocrine, and cardiovascular disorders and was not associated with mortality from neurological disorders, cancer, or injury. Conclusion After excluding earlier deaths, low gestational age at birth was independently associated with increased mortality in early childhood and young adulthood. JAMA. 2011;306(11):1233-1240 www.jama.com	[Crump, Casey] Stanford Univ, Dept Med, Stanford, CA 94304 USA; [Sundquist, Kristina; Sundquist, Jan] Lund Univ, Ctr Primary Hlth Care Res, Malmo, Sweden; [Sundquist, Jan; Winkleby, Marilyn A.] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA	Stanford University; Lund University; Stanford University	Crump, C (corresponding author), Stanford Univ, Dept Med, 900 Blake Wilbur Dr, Stanford, CA 94304 USA.	kccrump@stanford.edu	Crump, Casey/AAO-8802-2021	Crump, Casey/0000-0002-2990-1166	National Institute of Child Health and Human Development [1R01HD052848-01]; Swedish Research Council [2008-3110, 2008-2638]; Swedish Council for Working Life and Social Research [2006-0386, 2007-1754, 2007-1962]; Avtal om Lakarutbildning och Forskning, Lund, Sweden; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD052848] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Avtal om Lakarutbildning och Forskning, Lund, Sweden; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from the National Institute of Child Health and Human Development (1R01HD052848-01), the Swedish Research Council (2008-3110 and 2008-2638), the Swedish Council for Working Life and Social Research (2006-0386, 2007-1754, and 2007-1962), and an ALF project grant (Avtal om Lakarutbildning och Forskning, or Agreement on Medical Training and Research), Lund, Sweden.	Ananth CV, 2005, OBSTET GYNECOL, V105, P1084, DOI 10.1097/01.AOG.0000158124.96300.c7; Andersen AMN, 2004, INT J EPIDEMIOL, V33, P92, DOI 10.1093/ije/dyg195; Archer JM, 2011, PEDIATRICS, V127, P293, DOI 10.1542/peds.2010-0418; Astolfi P, 1999, HUM REPROD, V14, P2891, DOI 10.1093/humrep/14.11.2891; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Behrman RE, 2007, PRETERM BIRTH CAUSES; Crump C, 2011, CLIN ENDOCRINOL, V75, P255, DOI 10.1111/j.1365-2265.2011.04034.x; Crump C, 2011, DIABETES CARE, V34, P1109, DOI 10.2337/dc10-2108; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Crump C, 2011, PEDIATRICS, V127, pE913, DOI 10.1542/peds.2010-2603; Crump C, 2010, INT J EPIDEMIOL, V39, P1522, DOI 10.1093/ije/dyq103; David R, 2001, INT J EPIDEMIOL, V30, P1241, DOI 10.1093/ije/30.6.1241; Doyle LW, 2003, PEDIATRICS, V112, P565, DOI 10.1542/peds.112.3.565; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Friedlander Y, 2003, PAEDIATR PERINAT EP, V17, P398, DOI 10.1046/j.1365-3016.2003.00522.x; Furberg H, 2006, ADDICTION, V101, P1509, DOI 10.1111/j.1360-0443.2006.01550.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Honein MA, 2009, MATERN CHILD HLTH J, V13, P164, DOI 10.1007/s10995-008-0348-y; Ijzerman RG, 2005, PAEDIATR PERINAT EP, V19, P10, DOI 10.1111/j.1365-3016.2005.00614.x; Jokela M, 2009, PEDIATRICS, V124, pE380, DOI 10.1542/peds.2009-0334; Kajantie E, 2005, INT J EPIDEMIOL, V34, P655, DOI 10.1093/ije/dyi048; Kase JS, 2007, J PERINAT MED, V35, P538, DOI 10.1515/JPM.2007.132; Lapidus Leif, 2008, Prim Care Diabetes, V2, P127, DOI 10.1016/j.pcd.2008.05.002; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; March of Dimes, PERISTATS; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McCalman J, 2008, SOC SCI MED, V66, P1070, DOI 10.1016/j.socscimed.2007.11.040; Modin B, 2002, SOC SCI MED, V54, P1051, DOI 10.1016/S0277-9536(01)00080-6; Nilsson PM, 2006, SCAND J PUBLIC HEALT, V34, P660, DOI 10.1080/14034940600607509; Osler M, 2003, J EPIDEMIOL COMMUN H, V57, P681, DOI 10.1136/jech.57.9.681; Painter RC, 2005, EUR J EPIDEMIOL, V20, P673, DOI 10.1007/s10654-005-7921-0; Power C, 2000, BRIT MED J, V320, P840, DOI 10.1136/bmj.320.7238.840; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Roseboom TJ, 2001, PAEDIATR PERINAT EP, V15, P220, DOI 10.1046/j.1365-3016.2001.00336.x; Rubin DB, 2004, MULTIPLE IMPUTATION; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Seckl JR, 2004, EUR J ENDOCRINOL, V151, pU49, DOI 10.1530/eje.0.151u049; SHIONO PH, 1986, JAMA-J AM MED ASSOC, V255, P82; StataCorp, 2010, STAT STAT SOFTW REL; Swamy GK, 2008, JAMA-J AM MED ASSOC, V299, P1429, DOI 10.1001/jama.299.12.1429; Syddall HE, 2005, AM J EPIDEMIOL, V161, P1074, DOI 10.1093/aje/kwi137; Tanner K, 2005, PEDIATRICS, V116, pE833, DOI 10.1542/peds.2005-0397; Wang Y, 2010, BIRTH DEFECTS RES A, V88, P1023, DOI 10.1002/bdra.20711; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233	49	241	246	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 21	2011	306	11					1233	1240		10.1001/jama.2011.1331	http://dx.doi.org/10.1001/jama.2011.1331			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HB	21934056				2022-12-24	WOS:000295033500024
J	Suh, J; Rivest, AJ; Nakashiba, T; Tominaga, T; Tonegawa, S				Suh, Junghyup; Rivest, Alexander J.; Nakashiba, Toshiaki; Tominaga, Takashi; Tonegawa, Susumu			Entorhinal Cortex Layer III Input to the Hippocampus Is Crucial for Temporal Association Memory	SCIENCE			English	Article							CA3 NMDA RECEPTORS; WORKING-MEMORY; SPATIAL MEMORY; PLACE CELLS; INFORMATION; NETWORK; NEURONS; RECALL	Associating temporally discontinuous elements is crucial for the formation of episodic and working memories that depend on the hippocampal-entorhinal network. However, the neural circuits subserving these associations have remained unknown. The layer III inputs of the entorhinal cortex to the hippocampus may contribute to this process. To test this hypothesis, we generated a transgenic mouse in which these inputs are specifically inhibited. The mutant mice displayed significant impairments in spatial working-memory tasks and in the encoding phase of trace fear-conditioning. These results indicate a critical role of the entorhinal cortex layer III inputs to the hippocampus in temporal association memory.	[Suh, Junghyup; Rivest, Alexander J.; Nakashiba, Toshiaki; Tonegawa, Susumu] MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Suh, Junghyup; Rivest, Alexander J.; Nakashiba, Toshiaki; Tonegawa, Susumu] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Tominaga, Takashi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Neurophysiol, Kagawa, Japan	Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Massachusetts Institute of Technology (MIT); Tokushima Bunri University	Tonegawa, S (corresponding author), MIT, Dept Biol, RIKEN MIT Ctr Neural Circuit Genet, Picower Inst Learning & Memory, Cambridge, MA 02139 USA.	tonegawa@mit.edu	Suh, Junghyup/AAO-8265-2020; Tominaga, Takashi/C-5332-2012	Tominaga, Takashi/0000-0003-1078-7989	NIH [R01-MH078821, P50-MH58880]; RIKEN Brain Science Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880, R01MH078821] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIKEN Brain Science Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Ragion, C. Twiss, M. Pfau, M. Ragion, C. Carr, and S. Perry for technical help; N. Arzoumanian for help with manuscript preparation; and D. Buh, J. Young, and other members of the Tonegawa lab for discussion. This work was supported by NIH grants R01-MH078821 and P50-MH58880 (to S. T.) and the RIKEN Brain Science Institute.	Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Esclassan F, 2009, J NEUROSCI, V29, P8087, DOI 10.1523/JNEUROSCI.0543-09.2009; Hasselmo ME, 2006, TRENDS COGN SCI, V10, P487, DOI 10.1016/j.tics.2006.09.005; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Misane I, 2005, HIPPOCAMPUS, V15, P418, DOI 10.1002/hipo.20067; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Tominaga T, 2000, J NEUROSCI METH, V102, P11, DOI 10.1016/S0165-0270(00)00270-3; Witter M., 2004, RAT NERVOUS SYSTEM, V3, P635, DOI [10.1016/B978-012547638-6/50022-5, DOI 10.1016/B978-012547638-6/50022-5]; Yoshida M, 2008, EUR J NEUROSCI, V28, P1116, DOI 10.1111/j.1460-9568.2008.06409.x	22	226	229	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 9	2011	334	6061					1415	1420		10.1126/science.1210125	http://dx.doi.org/10.1126/science.1210125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	858HW	22052975				2022-12-24	WOS:000297787700057
J	Faelber, K; Posor, Y; Gao, S; Held, M; Roske, Y; Schulze, D; Haucke, V; Noe, F; Daumke, O				Faelber, Katja; Posor, York; Gao, Song; Held, Martin; Roske, Yvette; Schulze, Dennis; Haucke, Volker; Noe, Frank; Daumke, Oliver			Crystal structure of nucleotide-free dynamin	NATURE			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; PARTICLE MESH EWALD; GTPASE DOMAIN; MIDDLE DOMAIN; PH DOMAIN; MODEL; PHOSPHORYLATION; IDENTIFICATION; RESOLUTION; MECHANISM	Dynamin is a mechanochemical GTPase that oligomerizes around the neck of clathrin-coated pits and catalyses vesicle scission in a GTP-hydrolysis-dependent manner. The molecular details of oligomerization and the mechanism of the mechanochemical coupling are currently unknown. Here we present the crystal structure of human dynamin 1 in the nucleotide-free state with a four-domain architecture comprising the GTPase domain, the bundle signalling element, the stalk and the pleckstrin homology domain. Dynamin 1 oligomerized in the crystals via the stalks, which assemble in a criss-cross fashion. The stalks further interact via conserved surfaces with the pleckstrin homology domain and the bundle signalling element of the neighbouring dynamin molecule. This intricate domain interaction rationalizes a number of disease-related mutations in dynamin 2 and suggests a structural model for the mechanochemical coupling that reconciles previous models of dynamin function.	[Faelber, Katja; Gao, Song; Roske, Yvette; Schulze, Dennis; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Posor, York; Gao, Song; Haucke, Volker] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany; [Held, Martin; Noe, Frank] Free Univ Berlin, Inst Math, D-14195 Berlin, Germany; [Daumke, Oliver] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Daumke, O (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	katja.faelber@mdc-berlin.de; oliver.daumke@mdc-berlin.de	Noe, Frank/Y-2766-2019	Haucke, Volker/0000-0003-3119-6993; Gao, Song/0000-0001-7427-6681	Deutsche Forschungsgemeinschaft [SFB 740/C7, SFB958/A12, SFB740/D7, SFB958/A04, SFB740/C8, SFB 958/A7]; International Human Frontier Science Program Organization; EMBO	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Human Frontier Science Program Organization(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO))	This project was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 740/C7 and SFB958/A12 to O.D., SFB740/D7 and SFB958/A04 to F.N., SFB740/C8 and SFB 958/A7 to V. H.), by a Career Development Fellowship of The International Human Frontier Science Program Organization and by the EMBO Young Investigator Program to O.D. We would like to thank S. Werner, M. Papst and S. Kraft for technical assistance, the BESSY staff at BL14.1 for help during data collection, G. Schroder for advice in DEN refinement and U. Heinemann for discussions.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Byrnes LJ, 2011, P NATL ACAD SCI USA, V108, P2216, DOI 10.1073/pnas.1012792108; Chang CR, 2010, J BIOL CHEM, V285, P32494, DOI 10.1074/jbc.M110.142430; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano WL, 2011, PYMOL MOL GRAPHICS S; Durieux AC, 2010, J MOL MED, V88, P339, DOI 10.1007/s00109-009-0587-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gao S, 2010, NATURE, V465, P502, DOI 10.1038/nature08972; Graham ME, 2007, J BIOL CHEM, V282, P14695, DOI 10.1074/jbc.M609713200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Klockow B, 2002, EMBO J, V21, P240, DOI 10.1093/emboj/21.3.240; Kochs G, 2005, METHOD ENZYMOL, V404, P632, DOI 10.1016/S0076-6879(05)04055-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Low HH, 2010, CURR OPIN STRUC BIOL, V20, P791, DOI 10.1016/j.sbi.2010.09.011; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Morlot S, 2010, BIOPHYS J, V99, P3580, DOI 10.1016/j.bpj.2010.10.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prinz JH, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565032; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salim K, 1996, EMBO J, V15, P6241, DOI 10.1002/j.1460-2075.1996.tb01014.x; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TIMM D, 1994, NAT STRUCT BIOL, V1, P782, DOI 10.1038/nsb1194-782; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	57	212	216	3	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2011	477	7366					556	U318		10.1038/nature10369	http://dx.doi.org/10.1038/nature10369			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZM	21927000				2022-12-24	WOS:000295320900032
J	Acuna, JL; Lopez-Urrutia, A; Colin, S				Luis Acuna, Jose; Lopez-Urrutia, Angel; Colin, Sean			Faking Giants: The Evolution of High Prey Clearance Rates in Jellyfishes	SCIENCE			English	Article							PELAGIC FISH; ECOSYSTEM; SEA; ZOOPLANKTON; OVERLAP	Jellyfishes have functionally replaced several overexploited commercial stocks of planktivorous fishes. This is paradoxical, because they use a primitive prey capture mechanism requiring direct contact with the prey, whereas fishes use more efficient visual detection. We have compiled published data to show that, in spite of their primitive life-style, jellyfishes exhibit similar instantaneous prey clearance and respiration rates as their fish competitors and similar potential for growth and reproduction. To achieve this production, they have evolved large, water-laden bodies that increase prey contact rates. Although larger bodies are less efficient for swimming, optimization analysis reveals that large collectors are advantageous if they move through the water sufficiently slowly.	[Luis Acuna, Jose] Univ Oviedo, Dept Biol Organismos & Sistemas, E-33071 Oviedo, Spain; [Lopez-Urrutia, Angel] Ctr Oceanog Gijon, Inst Espanol Oceanog, Gijon 33212, Spain; [Colin, Sean] Roger Williams Univ, Dept Marine Biol & Environm Sci, Bristol, RI 02809 USA	University of Oviedo; Spanish Institute of Oceanography	Acuna, JL (corresponding author), Univ Oviedo, Dept Biol Organismos & Sistemas, Calle Catedrat Rodrigo Uria, E-33071 Oviedo, Spain.	acuna@uniovi.es	Lopez-Urrutia, Angel/R-9475-2019; Fernández, José Luis Acuña/I-7482-2016; Lopez-Urrutia, Angel/L-2636-2014	Fernández, José Luis Acuña/0000-0003-3306-7212; Colin, Sean/0000-0003-4463-5588	Spanish Ministry of Science [MICINN-08-CSD2008-00077]; Administration of the Principality of Asturias to the University of Oviedo; European Commission [212085]; NSF [OCE-0623534, -0727544]; Office of Naval Research [N000140810654]	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Administration of the Principality of Asturias to the University of Oviedo; European Commission(European CommissionEuropean Commission Joint Research Centre); NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research)	We thank A. Bochdansky for fish respiration data and F. Gonzalez-Taboada for help with statistics. This research has been financed by project MALASPINA 2010 (MICINN-08-CSD2008-00077, Spanish Ministry of Science) to J.L.A. and A.L.-U., partially funded by a Campus of International Excellence grant from the Administration of the Principality of Asturias to the University of Oviedo, by Theme 6 of the European Commission Seventh Framework Programme through the Marine Ecosystem Evolution in a Changing Environment (MEECE No 212085) Collaborative Project to A.L.-U., and by awards from NSF to S. C. (OCE-0623534 and -0727544) and from the Office of Naval Research (N000140810654). The present data compilation is available in the form of tables in the SOM.	Arai M.N., 1997, FUNCTIONAL BIOL SCYP; Brodeur RD, 2008, MAR BIOL, V154, P649, DOI 10.1007/s00227-008-0958-3; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Dabiri JO, 2005, J EXP BIOL, V208, P1257, DOI 10.1242/jeb.01519; DANIEL TL, 1983, CAN J ZOOL, V61, P1406, DOI 10.1139/z83-190; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Huntley ME, 2004, MAR ECOL PROG SER, V273, P65, DOI 10.3354/meps273065; Kawasaki T., 1993, Fisheries Oceanography, V2, P244, DOI 10.1111/j.1365-2419.1993.tb00139.x; Kiorboe T., 2008, MECH APPROACH PLANKT; Lynam CP, 2006, CURR BIOL, V16, pR492, DOI 10.1016/j.cub.2006.06.018; Parsons T. R., 2002, Mer (Tokyo), V40, P111; PURCELL JE, 1990, CAN J FISH AQUAT SCI, V47, P505, DOI 10.1139/f90-056; Purcell JE, 2001, MAR ECOL PROG SER, V210, P67, DOI 10.3354/meps210067; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; SCHNEIDER G, 1992, HELGOLANDER MEERESUN, V46, P377, DOI 10.1007/BF02367205; Shadden SC, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2189885; Shiganova TA, 1998, FISH OCEANOGR, V7, P305, DOI 10.1046/j.1365-2419.1998.00080.x; Sornes TA, 2004, LIMNOL OCEANOGR, V49, P69, DOI 10.4319/lo.2004.49.1.0069; Vinogradov A., 1953, ELEMENTARY COMPOSITI; WARE DM, 1978, J FISH RES BOARD CAN, V35, P220, DOI 10.1139/f78-036	21	75	76	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2011	333	6049					1627	1629		10.1126/science.1205134	http://dx.doi.org/10.1126/science.1205134			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	820JE	21921197	Green Published			2022-12-24	WOS:000294900900042
J	Michelena, HI; Khanna, AD; Mahoney, D; Margaryan, E; Topilsky, Y; Suri, RM; Eidem, B; Edwards, WD; Sundt, TM; Enriquez-Sarano, M				Michelena, Hector I.; Khanna, Amber D.; Mahoney, Douglas; Margaryan, Edit; Topilsky, Yan; Suri, Rakesh M.; Eidem, Ben; Edwards, William D.; Sundt, Thoralf M., III; Enriquez-Sarano, Maurice			Incidence of Aortic Complications in Patients With Bicuspid Aortic Valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASCENDING AORTA; INTERNATIONAL REGISTRY; EJECTION FRACTION; DISSECTION IRAD; MARFAN-SYNDROME; HEART-DISEASE; RISK-FACTORS; ECHOCARDIOGRAPHY; ANEURYSMS; DILATATION	Context Bicuspid aortic valve (BAV), the most common congenital heart defect, has been thought to cause frequent and severe aortic complications; however, long-term, population-based data are lacking. Objective To determine the incidence of aortic complications in patients with BAV in a community cohort and in the general population. Design, Setting, and Participants In this retrospective cohort study, we conducted comprehensive assessment of aortic complications of patients with BAV living in a population-based setting in Olmsted County, Minnesota. We analyzed long-term follow-up of a cohort of all Olmsted County residents diagnosed with definite BAV by echocardiography from 1980 to 1999 and searched for aortic complications of patients whose bicuspid valves had gone undiagnosed. The last year of follow-up was 2008-2009. Main Outcome Measure Thoracic aortic dissection, ascending aortic aneurysm, and aortic surgery. Results The cohort included 416 consecutive patients with definite BAV diagnosed by echocardiography, mean (SD) follow-up of 16 (7) years (6530 patient-years). Aortic dissection occurred in 2 of 416 patients; incidence of 3.1 (95% CI, 0.5-9.5) cases per 10 000 patient-years, age-adjusted relative-risk 8.4 (95% CI, 2.1-33.5; P=.003) compared with the county's general population. Aortic dissection incidences for patients 50 years or older at baseline and bearers of aortic aneurysms at baseline were 17.4 (95% CI, 2.9-53.6) and 44.9(95% CI, 7.5-138.5) cases per 10 000 patient-years, respectively. Comprehensive search for aortic dissections in undiagnosed bicuspid valves revealed 2 additional patients, allowing estimation of aortic dissection incidence in bicuspid valve patients irrespective of diagnosis status (1.5; 95% CI, 0.4-3.8 cases per 10 000 patient-years), which was similar to the diagnosed cohort. Of 384 patients without baseline aneurysms, 49 developed aneurysms at follow-up, incidence of 84.9 (95% CI, 63.3-110.9) cases per 10 000 patient-years and an age-adjusted relative risk 86.2 (95% CI, 65.1-114; P<.001 compared with the general population). The 25-year rate of aortic surgery was 25% (95% CI, 17.2%-32.8%). Conclusions In the population of patients with BAV, the incidence of aortic dissection over a mean of 16 years of follow-up was low but significantly higher than in the general population. JAMA. 2011;306(10):1104-1113 www.jama.com	[Michelena, Hector I.; Khanna, Amber D.; Margaryan, Edit; Topilsky, Yan; Eidem, Ben; Enriquez-Sarano, Maurice] Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Mahoney, Douglas] Mayo Clin, Div Biomed Stat & Informat, Rochester, MN 55905 USA; [Suri, Rakesh M.] Mayo Clin, Div Cardiovasc Surg, Rochester, MN 55905 USA; [Edwards, William D.] Mayo Clin, Div Anat Pathol, Rochester, MN 55905 USA; [Sundt, Thoralf M., III] Massachusetts Gen Hosp, Div Cardiac Surg, Boston, MA 02114 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Harvard University; Massachusetts General Hospital	Michelena, HI (corresponding author), Mayo Clin, Div Cardiovasc Dis, 200 1st St SW, Rochester, MN 55905 USA.	michelena.hector@mayo.edu	Topilsky, Yan/AFK-7827-2022	Enriquez-Sarano, Maurice/0000-0003-0910-5450	Department of Internal Medicine of the Mayo Clinic, Rochester, Minnesot; Division of Cardiovascular Diseases of the Mayo Clinic	Department of Internal Medicine of the Mayo Clinic, Rochester, Minnesot; Division of Cardiovascular Diseases of the Mayo Clinic	Partially funded by a faculty development grant awarded to Dr Michelena by the Department of Internal Medicine of the Mayo Clinic, Rochester, Minnesot. The Division of Cardiovascular Diseases of the Mayo Clinic supported the costs of survey creation and mailings, as well as statistical analysis costs.	Beaton AZ, 2009, AM J CARDIOL, V103, P266, DOI 10.1016/j.amjcard.2008.09.062; BICKERSTAFF LK, 1982, SURGERY, V92, P1103; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Clouse WD, 1998, JAMA-J AM MED ASSOC, V280, P1926, DOI 10.1001/jama.280.22.1926; Coady MA, 1997, J THORAC CARDIOV SUR, V113, P476, DOI 10.1016/S0022-5223(97)70360-X; Coady MA, 1999, ANN THORAC SURG, V67, P1922, DOI 10.1016/S0003-4975(99)00431-2; Coady MA, 2010, CARDIOL CLIN, V28, P299, DOI 10.1016/j.ccl.2010.02.003; CURRIE PJ, 1985, CIRCULATION, V71, P1162, DOI 10.1161/01.CIR.71.6.1162; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.3.CO;2-S; Duran A C, 1995, J Heart Valve Dis, V4, P581; EDWARDS WD, 1978, CIRCULATION, V57, P1022, DOI 10.1161/01.CIR.57.5.1022; Fedak PWM, 2003, J THORAC CARDIOV SUR, V126, P797, DOI 10.1016/S0022-5223(03)00398-2; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Guntheroth WG, 2008, AM J CARDIOL, V102, P107, DOI 10.1016/j.amjcard.2008.02.106; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LARSON EW, 1984, AM J CARDIOL, V53, P849, DOI 10.1016/0002-9149(84)90418-1; Oliver JM, 2009, AM J CARDIOL, V104, P1001, DOI 10.1016/j.amjcard.2009.05.045; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Meszaros I, 2000, CHEST, V117, P1271, DOI 10.1378/chest.117.5.1271; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; MURDOCH JL, 1972, NEW ENGL J MED, V286, P804, DOI 10.1056/NEJM197204132861502; NISHIMURA RA, 1985, MAYO CLIN PROC, V60, P321, DOI 10.1016/S0025-6196(12)60540-0; Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A; Pape LA, 2007, CIRCULATION, V116, P1120, DOI 10.1161/CIRCULATIONAHA.107.702720; PATE JW, 1976, AM SURGEON, V42, P395; PERRY GJ, 1987, J AM COLL CARDIOL, V9, P952, DOI 10.1016/S0735-1097(87)80254-1; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; RICH S, 1982, AM HEART J, V104, P603, DOI 10.1016/0002-8703(82)90233-2; ROBERTS CS, 1991, J AM COLL CARDIOL, V17, P712, DOI 10.1016/S0735-1097(10)80188-3; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092; TAJIK AJ, 1978, MAYO CLIN PROC, V53, P271; Tzemos N, 2008, JAMA-J AM MED ASSOC, V300, P1317, DOI 10.1001/jama.300.11.1317; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Warren AE, 2006, HEART, V92, P1496, DOI 10.1136/hrt.2005.081539	40	520	531	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 14	2011	306	10					1104	1112		10.1001/jama.2011.1286	http://dx.doi.org/10.1001/jama.2011.1286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	819DS	21917581	Bronze			2022-12-24	WOS:000294806200024
J	Bertolotto, C; Lesueur, F; Giuliano, S; Strub, T; de Lichy, M; Bille, K; Dessen, P; d'Hayer, B; Mohamdi, H; Remenieras, A; Maubec, E; de la Fouchardiere, A; Molinie, V; Vabres, P; Dalle, S; Poulalhon, N; Martin-Denavit, T; Thomas, L; Andry-Benzaquen, P; Dupin, N; Boitier, F; Rossi, A; Perrot, JL; Labeille, B; Robert, C; Escudier, B; Caron, O; Brugieres, L; Saule, S; Gardie, B; Gad, S; Richard, S; Couturier, J; Teh, BT; Ghiorzo, P; Pastorino, L; Puig, S; Badenas, C; Olsson, H; Ingvar, C; Rouleau, E; Lidereau, R; Bahadoran, P; Vielh, P; Corda, E; Blanche, H; Zelenika, D; Galan, P; Chaudru, V; Lenoir, GM; Lathrop, M; Davidson, I; Avril, MF; Demenais, F; Ballotti, R; Bressac-de Paillerets, B				Bertolotto, Corine; Lesueur, Fabienne; Giuliano, Sandy; Strub, Thomas; de Lichy, Mahaut; Bille, Karine; Dessen, Philippe; d'Hayer, Benoit; Mohamdi, Hamida; Remenieras, Audrey; Maubec, Eve; de la Fouchardiere, Arnaud; Molinie, Vincent; Vabres, Pierre; Dalle, Stephane; Poulalhon, Nicolas; Martin-Denavit, Tanguy; Thomas, Luc; Andry-Benzaquen, Pascale; Dupin, Nicolas; Boitier, Francoise; Rossi, Annick; Perrot, Jean-Luc; Labeille, Bruno; Robert, Caroline; Escudier, Bernard; Caron, Olivier; Brugieres, Laurence; Saule, Simon; Gardie, Betty; Gad, Sophie; Richard, Stephane; Couturier, Jerome; Teh, Bin Tean; Ghiorzo, Paola; Pastorino, Lorenza; Puig, Susana; Badenas, Celia; Olsson, Hakan; Ingvar, Christian; Rouleau, Etienne; Lidereau, Rosette; Bahadoran, Philippe; Vielh, Philippe; Corda, Eve; Blanche, Helene; Zelenika, Diana; Galan, Pilar; Chaudru, Valerie; Lenoir, Gilbert M.; Lathrop, Mark; Davidson, Irwin; Avril, Marie-Francoise; Demenais, Florence; Ballotti, Robert; Bressac-de Paillerets, Brigitte		French Familial Melanoma Study Grp	A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma	NATURE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; CANCER; CELLS; HYPOXIA; SURVIVAL; SUMO; IDENTIFICATION; RECEPTOR	So far, no common environmental and/or phenotypic factor has been associated with melanoma and renal cell carcinoma (RCC). The known risk factors for melanoma include sun exposure, pigmentation and nevus phenotypes(1); risk factors associated with RCC include smoking, obesity and hypertension(2). A recent study of coexisting melanoma and RCC in the same patients supports a genetic predisposition underlying the association between these two cancers(3). The microphthalmia-associated transcription factor (MITF) has been proposed to act as a melanoma oncogene(4); it also stimulates the transcription of hypoxia inducible factor(5) (HIF1A), the pathway of which is targeted by kidney cancer susceptibility genes(6). We therefore proposed that MITF might have a role in conferring a genetic predisposition to co-occurring melanoma and RCC. Here we identify a germline missense substitution in MITF (Mi-E318K) that occurred at a significantly higher frequency in genetically enriched patients affected with melanoma, RCC or both cancers, when compared with controls. Overall, Mi-E318K carriers had a higher than fivefold increased risk of developing melanoma, RCC or both cancers. Codon 318 is located in a small-ubiquitin-like modifier (SUMO) consensus site (Psi KXE) and Mi-E318K severely impaired SUMOylation of MITF. Mi-E318K enhanced MITF protein binding to the HIF1A promoter and increased its transcriptional activity compared to wild-type MITF. Further, we observed a global increase in Mi-E318K occupied loci. In an RCC cell line, gene expression profiling identified a Mi-E318K signature related to cell growth, proliferation and inflammation. Lastly, the mutant protein enhanced melanocytic and renal cell clonogenicity, migration and invasion, consistent with a gain-of-function role in tumorigenesis. Our data provide insights into the link between SUMOylation, transcription and cancer.	[Bertolotto, Corine; Giuliano, Sandy; Bille, Karine; Ballotti, Robert] C3M, Equipe Labelisee Ligue Canc, INSERM, U895,Equipe 1, F-06204 Nice, France; [Bertolotto, Corine; Giuliano, Sandy; Ballotti, Robert] Univ Nice Sophia Antipolis, UFR Med, F-06204 Nice, France; [Bertolotto, Corine; Bahadoran, Philippe; Ballotti, Robert] Ctr Hosp Univ Nice, Serv Dermatol, F-06204 Nice, France; [Strub, Thomas; Davidson, Irwin] Univ Strasbourg, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Dessen, Philippe] Inst Cancerol Gustave Roussy, INSERM, UMR985, F-94805 Villejuif, France; [Mohamdi, Hamida; Maubec, Eve; Corda, Eve; Chaudru, Valerie; Demenais, Florence; Bressac-de Paillerets, Brigitte] INSERM, U946, Genet Variat & Human Dis Unit, F-75010 Paris, France; [Mohamdi, Hamida; Demenais, Florence] Univ Paris Diderot, Inst Univ Hematol, F-75010 Paris, France; [Mohamdi, Hamida; Corda, Eve; Blanche, Helene; Chaudru, Valerie; Lathrop, Mark; Demenais, Florence] Fdn Jean Dausset, CEPH, F-75010 Paris, France; [Maubec, Eve] Hop Bichat Claude Bernard, AP HP, Serv Dermatol, Fac Paris Diderot, F-75018 Paris, France; [de la Fouchardiere, Arnaud] Ctr Leon Berard, Dept Pathol, F-69008 Lyon, France; [Molinie, Vincent] Hop St Joseph, Dept Pathol, F-75014 Paris, France; [Vabres, Pierre] Ctr Hosp Univ, Dept Dermatol, F-21079 Dijon, France; [Dalle, Stephane; Poulalhon, Nicolas; Martin-Denavit, Tanguy; Thomas, Luc] Univ Lyon 1, F-69495 Pierre Benite, France; [Dalle, Stephane; Poulalhon, Nicolas; Martin-Denavit, Tanguy; Thomas, Luc] Ctr Hosp Lyon Sud, Dept Dermatol, F-69495 Pierre Benite, France; [Andry-Benzaquen, Pascale; Dupin, Nicolas; Boitier, Francoise; Avril, Marie-Francoise] Hop Cochin Tarnier, AP HP, Serv Dermatol, F-75006 Paris, France; [Andry-Benzaquen, Pascale; Dupin, Nicolas; Boitier, Francoise; Avril, Marie-Francoise] Univ Paris 05, F-75006 Paris, France; [Rossi, Annick] CHU Rouen, Hop Charles Nicolle, Unite Genet Clin, F-76038 Rouen, France; [Perrot, Jean-Luc; Labeille, Bruno] CHU Hop Nord, Dept Dermatol, F-42055 St Etienne, France; [Robert, Caroline; Escudier, Bernard; Caron, Olivier] Inst Cancerol Gustave Roussy, Dept Med, F-94805 Villejuif, France; [Brugieres, Laurence] Inst Cancerol Gustave Roussy, Dept Pediatry, F-94805 Villejuif, France; [Saule, Simon] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Saule, Simon] Univ Paris 11, Inst Curie, CNRS, UMR33, F-91405 Orsay, France; [Gardie, Betty; Gad, Sophie; Richard, Stephane] Univ Paris 11, Genet Oncol EPHE INSERM U753, Fac Med, F-94805 Villejuif, France; [Richard, Stephane] Hop Bicetre, Ctr Expert Natl Canc Rares PREDIR, INCa AP HP, Serv Urol, F-94275 Le Kremlin Bicetre, France; [Couturier, Jerome] Inst Curie, Serv Genet, F-75005 Paris, France; [Teh, Bin Tean] Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] Natl Canc Ctr Singapore, NCCS VARI Translat Res Lab, Singapore 16910, Singapore; [Ghiorzo, Paola; Pastorino, Lorenza] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Puig, Susana; Badenas, Celia] Hosp Clin Barcelona, Dept Dermatol, IDIBAPS, E-08036 Barcelona, Spain; [Puig, Susana; Badenas, Celia] Hosp Clin Barcelona, Melanoma Unit, IDIBAPS, E-08036 Barcelona, Spain; [Puig, Susana; Badenas, Celia] Inst Salud Carlos III, CIBER Enfermedades Raras, Barcelona 08036, Spain; [Olsson, Hakan] Lund Univ & Hosp, Dept Oncol, S-22185 Lund, Sweden; [Ingvar, Christian] Lund Univ & Hosp, Dept Surg, S-22185 Lund, Sweden; [Rouleau, Etienne; Lidereau, Rosette] Hop Rene Huguenin, Serv Oncogenet, F-92210 St Cloud, France; [Vielh, Philippe] Inst Cancerol Gustave Roussy, Dept Pathol, Translat Res Lab & Biobank, F-94805 Villejuif, France; [Galan, Pilar] CRNH Idf, INSERM, UMR557, INRA U1125,CNAM, F-93000 Bobigny, France; [Chaudru, Valerie] Univ Evry Val Essonne, F-91025 Evry, France; [Zelenika, Diana; Lathrop, Mark] CEA, Ctr Natl Genotypage, F-91057 Evry, France; [Lenoir, Gilbert M.] Univ Paris 11, Fac Med, F-94275 Le Kremlin Bicetre, France; [Lesueur, Fabienne; de Lichy, Mahaut; d'Hayer, Benoit; Remenieras, Audrey; Lenoir, Gilbert M.; Bressac-de Paillerets, Brigitte] Inst Cancerol Gustave Roussy, Serv Genet, F-94805 Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Foundation Jean Dausset-CEPH; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Leon Berard; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; CHU de St Etienne; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Van Andel Institute; National Cancer Centre Singapore (NCCS); University of Genoa; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Lund University; Skane University Hospital; Lund University; Skane University Hospital; Rene Huguenin Hospital; UNICANCER; Gustave Roussy; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Bressac-de Paillerets, B (corresponding author), Int Agcy Res Canc, Genet Canc Susceptibil Grp, 150 Cours Albert Thomas, F-69372 Lyon, France.	brigitte.bressac@igr.fr	Lesueur, Fabienne/R-2178-2017; Giuliano, Sandy/U-2498-2019; Maubec, Eve/V-4296-2017; Puig, Susana/AAB-2091-2020; BALLOTTI, Robert/F-8825-2013; Pilar, Galan/F-2908-2017; Vabres, Pierre/D-3906-2011; Ingvar, Christian/AAE-9841-2019; Dalle, Stephane/E-4552-2018; RICHARD, Stéphane/O-1005-2017; Bertolotto-Ballotti, Corine/O-2155-2016; Pastorino, Lorenza/E-6084-2018; Ghiorzo, Paola/CAG-0673-2022; Bertolotto, Corine/AAF-6634-2021; Badenas, Celia/ABH-5480-2020; de la Fouchardiere, Arnaud/I-2807-2019; Demenais, Florence/G-3298-2013; Paillerets, Brigitte Bressac-de/D-8954-2018; Gardie, Betty/K-9243-2015; Strub, Thomas/AAH-3573-2019; Vabres, Pierre/V-3850-2019; Robert, Caroline/G-6157-2018	Lesueur, Fabienne/0000-0001-7404-4549; Maubec, Eve/0000-0003-1658-6686; Puig, Susana/0000-0003-1337-9745; Pilar, Galan/0000-0003-1706-3107; Vabres, Pierre/0000-0001-8693-3183; Dalle, Stephane/0000-0002-3423-4548; RICHARD, Stéphane/0000-0002-9859-9773; Pastorino, Lorenza/0000-0002-2575-8331; Ghiorzo, Paola/0000-0002-3651-8173; Bertolotto, Corine/0000-0001-6971-7753; Badenas, Celia/0000-0002-0621-0477; de la Fouchardiere, Arnaud/0000-0003-2251-8241; Demenais, Florence/0000-0001-8361-0936; Paillerets, Brigitte Bressac-de/0000-0003-0245-8608; Vabres, Pierre/0000-0001-8693-3183; Robert, Caroline/0000-0002-9493-0238; Aubin, Francois/0000-0002-1421-4996; Davidson, Irwin/0000-0001-5533-1171; Bulai Livideanu, Cristina/0000-0002-5275-6868; Faivre, Laurence/0000-0001-9770-444X; Bahadoran, Philippe/0000-0002-2481-0556; Strub, Thomas/0000-0001-6252-0181; Teh, Bin Tean/0000-0003-1514-1124; VENAT-BOUVET, Laurence/0000-0002-0716-2550; GAD (LAPITEAU), Sophie/0000-0002-3158-6791; Grob, Jean-Jacques/0000-0002-0667-153X; Dupin, Nicolas/0000-0002-6237-4951; Olsson, Hakan/0000-0002-8794-9635; BALLOTTI, Robert/0000-0002-7322-4908	INSERM; Ligue Nationale Contre Le Cancer [PRE05/FD, PRE 09/FD]; Programme Hospitalier de Recherche Clinique (PHRC) [2007/AOM-07-195]; ARC [A09/5/5003, 4985]; Institut National du Cancer (INCa)-Canceropole Ile de France [13]; INCa-PNES rein; INCa [R08009AP]; Fondation de France; Fond de maturation IGR; Fondation Gustave Roussy; Societe Francaise de Dermatologie [SDF2004, SFD2009]; AGAUR [2009 SGR 1337]; Generalitat de Catalunya; Fondo de Investigaciones Sanitarias [FIS PS09/01393]; Instituto de Salud Carlos III, Spain	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue Nationale Contre Le Cancer(Ligue nationale contre le cancer); Programme Hospitalier de Recherche Clinique (PHRC); ARC(Australian Research Council); Institut National du Cancer (INCa)-Canceropole Ile de France(Institut National du Cancer (INCA) France); INCa-PNES rein; INCa(Institut National du Cancer (INCA) France); Fondation de France(Fondation de France); Fond de maturation IGR; Fondation Gustave Roussy; Societe Francaise de Dermatologie; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Generalitat de Catalunya(Generalitat de Catalunya); Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	We thank the patients and family members who participated in this study and the clinicians who identified these families, the French Familial Melanoma Study Group and the Inherited Predisposition to Kidney Cancer network. We acknowledge the contribution of the IGR Biobank for providing MELARISK samples and the CEPH Biobank for processing DNA samples. We thank L. Larue, J, Feunteun, A. Sarasin and E. Solary for critical reviews of the manuscript. We thank V. Lazar and S. Forget for coordination of the IGR's genomics and genetic platforms, N. Pata-Merci, V. Marty, S. Le Gras and A. Chabrier for their technical expertise, and M. Barrois for technical counselling. We also thank A. Boland for DNA extraction and quality control for genome-wide genotyping. This work was supported by grants from INSERM, Ligue Nationale Contre Le Cancer (PRE05/FD and PRE 09/FD) to F. D.; Programme Hospitalier de Recherche Clinique (PHRC 2007/AOM-07-195) to M.-F.A. and F. D.; ARC N<SUP>o</SUP>A09/5/5003 to B.B.-d.P.; ARC 4985 to C. B.; Institut National du Cancer (INCa)-Canceropole Ile de France (melanoma network RS#13) to B.B.-deP.; INCa-PNES rein to B. G., S.Ga. and S. R., INCa grant R08009AP to C. B.; Fondation de France 2010 to R. B.; INCa and Ligue National Contre le Cancer to I. D., Fond de maturation IGR and Fondation Gustave Roussy to B.B.-d.P.; Societe Francaise de Dermatologie SDF2004 to R. B. and P. B., SFD2009 to B.B.-d.P.; 2009 SGR 1337 from AGAUR, Generalitat de Catalunya, and FIS PS09/01393 from the Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain to S. P. and C. B.; and personal donations from C. and N. de Paillerets and M.-H.Wagner. to B.B.-d.P. B.B-d.P. holds an INSERM Research Fellowship for hospital-based scientists. Work at the Centre National de Genotypage (CNG) and Centre d'Etude du Polymorphisme Humain (CEPH) was supported in part by INCa.	Bedogni B, 2006, CELL CYCLE, V5, P1258, DOI 10.4161/cc.5.12.2810; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bertolotto C, 1996, J CELL BIOL, V134, P747, DOI 10.1083/jcb.134.3.747; Bischof O, 2006, MOL CELL, V22, P783, DOI 10.1016/j.molcel.2006.05.016; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Cheli Y, 2010, PIGM CELL MELANOMA R, V23, P27, DOI 10.1111/j.1755-148X.2009.00653.x; Datta D, 2010, J BIOL CHEM, V285, P36842, DOI 10.1074/jbc.M110.170324; Garcia-Dominguez M, 2009, BBA-GENE REGUL MECH, V1789, P451, DOI 10.1016/j.bbagrm.2009.07.001; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Goldstein AM, 2006, CANCER RES, V66, P9818, DOI 10.1158/0008-5472.CAN-06-0494; Granter SR, 2002, APPL IMMUNOHISTO M M, V10, P47, DOI 10.1097/00022744-200203000-00008; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hershey CL, 2005, GENE, V347, P73, DOI 10.1016/j.gene.2004.12.002; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Li Y, 2009, CANCER BIOL THER, V8, P322, DOI 10.4161/cbt.8.4.7332; Li ZZ, 2010, CURR TOP MICROBIOL, V345, P21, DOI 10.1007/82_2010_75; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Liu FY, 2011, ONCOL REP, V25, P383, DOI 10.3892/or.2010.1090; Manie S, 2001, TRENDS GENET, V17, P580, DOI 10.1016/S0168-9525(01)02420-9; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Martianov I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-530; Maubec E, 2010, CANCER-AM CANCER SOC, V116, P5716, DOI 10.1002/cncr.25562; Mullenders J, 2010, MOL CANCER RES, V8, P592, DOI 10.1158/1541-7786.MCR-09-0386; Murakami H, 2005, PIGM CELL RES, V18, P265, DOI 10.1111/j.1600-0749.2005.00234.x; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; Wang MJ, 2009, J BIOL CHEM, V284, P36500, DOI 10.1074/jbc.M109.008904; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365; Wysocki PJ, 2010, CANCER GENE THER, V17, P465, DOI 10.1038/cgt.2010.2; Yang Z, 2009, CURR CANCER DRUG TAR, V9, P915, DOI 10.2174/156800909790192383; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Yu JX, 2009, EMBO J, V28, P21, DOI 10.1038/emboj.2008.238; Zou AP, 2003, ACTA PHYSIOL SCAND, V179, P233, DOI 10.1046/j.0001-6772.2003.01206.x	37	346	351	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2011	480	7375					94	U259		10.1038/nature10539	http://dx.doi.org/10.1038/nature10539			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22012259				2022-12-24	WOS:000298031900041
J	Galland, C; Ghosh, Y; Steinbruck, A; Sykora, M; Hollingsworth, JA; Klimov, VI; Htoon, H				Galland, Christophe; Ghosh, Yagnaseni; Steinbrueck, Andrea; Sykora, Milan; Hollingsworth, Jennifer A.; Klimov, Victor I.; Htoon, Han			Two types of luminescence blinking revealed by spectroelectrochemistry of single quantum dots	NATURE			English	Article							SEMICONDUCTOR NANOCRYSTALS; CORE/SHELL NANOCRYSTALS; ELECTRON-TRANSFER; CDSE; FLUORESCENCE; SUPPRESSION; INTENSITY; PHOTOLUMINESCENCE; INTERMITTENCY; COMPLEXES	Photoluminescence blinking-random switching between states of high (ON) and low (OFF) emissivities-is a universal property of molecular emitters found in dyes(1), polymers(2), biological molecules(3) and artificial nanostructures such as nanocrystal quantum dots, carbon nanotubes and nanowires(4-6). For the past 15 years, colloidal nanocrystals have been used as a model system to study this phenomenon(5,6). The occurrence of OFF periods in nanocrystal emission has been commonly attributed to the presence of an additional charge(7), which leads to photoluminescence quenching by non-radiative recombination (the Auger mechanism)(8). However, this 'charging' model was recently challenged in several reports(9,10). Here we report time-resolved photoluminescence studies of individual nanocrystal quantum dots performed while electrochemically controlling the degree of their charging, with the goal of clarifying the role of charging in blinking. We find that two distinct types of blinking are possible: conventional (A-type) blinking due to charging and discharging of the nanocrystal core, in which lower photoluminescence intensities correlate with shorter photoluminescence lifetimes; and a second sort (B-type), in which large changes in the emission intensity are not accompanied by significant changes in emission dynamics. We attribute B-type blinking to charge fluctuations in the electron-accepting surface sites. When unoccupied, these sites intercept 'hot' electrons before they relax into emitting core states. Both blinking mechanisms can be electrochemically controlled and completely suppressed by application of an appropriate potential.	[Galland, Christophe; Sykora, Milan; Klimov, Victor I.; Htoon, Han] Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; [Galland, Christophe; Klimov, Victor I.; Htoon, Han] Los Alamos Natl Lab, Ctr Adv Solar Photophys, Los Alamos, NM 87545 USA; [Ghosh, Yagnaseni; Steinbrueck, Andrea; Hollingsworth, Jennifer A.; Htoon, Han] Los Alamos Natl Lab, Ctr Integrated Nanotechnol, Los Alamos, NM 87545 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory	Klimov, VI (corresponding author), Los Alamos Natl Lab, Div Chem, POB 1663, Los Alamos, NM 87545 USA.	sykoram@lanl.gov; klimov@lanl.gov; htoon@lanl.gov	Galland, Christophe/AAX-1624-2021; Galland, Christophe/A-1075-2013; Klimov, Victor/Y-2823-2019; Htoon, Han/HGF-0637-2022; Sykora, Milan/N-5743-2019	Galland, Christophe/0000-0001-5627-0796; Galland, Christophe/0000-0001-5627-0796; Klimov, Victor/0000-0003-1158-3179; Sykora, Milan/0000-0002-1747-0709; Htoon, Han/0000-0003-3696-2896	Center for Advanced Solar Photophysics, an Energy Frontier Research Center; US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES); Los Alamos National Laboratory; NIH-NIGMS [1R01GM084702-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084702] Funding Source: NIH RePORTER	Center for Advanced Solar Photophysics, an Energy Frontier Research Center; US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES)(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.G. and V. I. K. acknowledge support of the Center for Advanced Solar Photophysics, an Energy Frontier Research Center funded by the US Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES). Y.G. and A. S. are supported by Los Alamos National Laboratory Directed Research and Development Fund. M. S., J.A.H. and H. H. are supported by NIH-NIGMS grant 1R01GM084702-01. This work was conducted, in part, at the Center for Integrated Nanotechnologies, a DOE/BES user facility.	Chen Y, 2008, J AM CHEM SOC, V130, P5026, DOI 10.1021/ja711379k; DELAIVE PJ, 1980, J AM CHEM SOC, V102, P5627, DOI 10.1021/ja00537a037; Efros AL, 1997, PHYS REV LETT, V78, P1110, DOI 10.1103/PhysRevLett.78.1110; FERNANDO D, 2009, PHYS TODAY, V6, P34; Fisher BR, 2004, J PHYS CHEM B, V108, P143, DOI 10.1021/jp035756+; Fomenko V, 2008, NANO LETT, V8, P287, DOI 10.1021/nl0726609; Frantsuzov P, 2008, NAT PHYS, V4, P519, DOI 10.1038/nphys1001; Garcia-Santamaria F, 2011, NANO LETT, V11, P687, DOI 10.1021/nl103801e; Gomez DE, 2009, ACS NANO, V3, P2281, DOI 10.1021/nn900296q; Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w; Hoogenboom JP, 2007, CHEMPHYSCHEM, V8, P823, DOI 10.1002/cphc.200600783; Houtepen AJ, 2005, J PHYS CHEM B, V109, P19634, DOI 10.1021/jp053103i; Jeong S, 2005, J AM CHEM SOC, V127, P10126, DOI 10.1021/ja042591p; Jha PP, 2010, J PHYS CHEM C, V114, P21138, DOI 10.1021/jp1074626; Jha PP, 2009, ACS NANO, V3, P1011, DOI 10.1021/nn9001177; Jin SY, 2010, ACS NANO, V4, P1545, DOI 10.1021/nn901808f; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; Klimov VI, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195324; Klimov VI, 2000, SCIENCE, V287, P1011, DOI 10.1126/science.287.5455.1011; Li JJ, 2003, J AM CHEM SOC, V125, P12567, DOI 10.1021/ja0363563; Li S, 2009, ACS NANO, V3, P1267, DOI 10.1021/nn900189f; McGuire JA, 2010, ACS NANO, V4, P6087, DOI 10.1021/nn1016296; Nirmal M, 1996, NATURE, V383, P802, DOI 10.1038/383802a0; Park YS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.187401; Riley EA, 2011, PHYS CHEM CHEM PHYS, V13, P1879, DOI 10.1039/c0cp01716g; Rosen S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157404; Tisdale WA, 2010, SCIENCE, V328, P1543, DOI 10.1126/science.1185509; Tyagi P, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3561063; VandenBout DA, 1997, SCIENCE, V277, P1074, DOI 10.1126/science.277.5329.1074; Vela J, 2010, J BIOPHOTONICS, V3, P706, DOI 10.1002/jbio.201000058; Wang XY, 2009, NATURE, V459, P686, DOI 10.1038/nature08072; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhang K, 2006, NANO LETT, V6, P843, DOI 10.1021/nl060483q; Zhao J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157403	34	584	593	15	691	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					203	U75		10.1038/nature10569	http://dx.doi.org/10.1038/nature10569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22071764	Green Accepted			2022-12-24	WOS:000298030800036
J	Sandel, B; Arge, L; Dalsgaard, B; Davies, RG; Gaston, KJ; Sutherland, WJ; Svenning, JC				Sandel, B.; Arge, L.; Dalsgaard, B.; Davies, R. G.; Gaston, K. J.; Sutherland, W. J.; Svenning, J. -C.			The Influence of Late Quaternary Climate-Change Velocity on Species Endemism	SCIENCE			English	Article							RANGE SHIFTS; DIVERSITY; DISTRIBUTIONS; SCALE	The effects of climate change on biodiversity should depend in part on climate displacement rate (climate-change velocity) and its interaction with species' capacity to migrate. We estimated Late Quaternary glacial-interglacial climate-change velocity by integrating macroclimatic shifts since the Last Glacial Maximum with topoclimatic gradients. Globally, areas with high velocities were associated with marked absences of small-ranged amphibians, mammals, and birds. The association between endemism and velocity was weakest in the highly vagile birds and strongest in the weakly dispersing amphibians, linking dispersal ability to extinction risk due to climate change. High velocity was also associated with low endemism at regional scales, especially in wet and aseasonal regions. Overall, we show that low-velocity areas are essential refuges for Earth's many small-ranged species.	[Sandel, B.; Svenning, J. -C.] Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, DK-8000 Aarhus C, Denmark; [Sandel, B.; Arge, L.] Aarhus Univ, Dept Comp Sci, Ctr Mass Data Algorithm MADALGO, DK-8000 Aarhus C, Denmark; [Dalsgaard, B.; Sutherland, W. J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England; [Davies, R. G.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England	Aarhus University; Aarhus University; University of Cambridge; University of East Anglia	Sandel, B (corresponding author), Aarhus Univ, Dept Biosci, Ecoinformat & Biodivers Grp, DK-8000 Aarhus C, Denmark.	brody.sandel@biology.au.dk	Davies, Richard/H-7447-2019; Svenning, Jens-Christian/C-8977-2012; Sandel, Brody/I-8009-2013; Sutherland, William/B-1291-2013	Svenning, Jens-Christian/0000-0002-3415-0862; Dalsgaard, Bo/0000-0003-2867-2805; Gaston, Kevin J./0000-0002-7235-7928; Sutherland, William/0000-0002-6498-0437	Aarhus University Research Foundation; MADALGO-Center for Massive Data Algorithmics, a Center of the Danish National Research Foundation; Danish Council for Independent Research-Natural Sciences; Arcadia; Natural Environment Research Council [NER/O/S/2001/01230]	Aarhus University Research Foundation; MADALGO-Center for Massive Data Algorithmics, a Center of the Danish National Research Foundation; Danish Council for Independent Research-Natural Sciences(Det Frie Forskningsrad (DFF)); Arcadia; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Aarhus University Research Foundation for financial support. This study was also supported in part by MADALGO-Center for Massive Data Algorithmics, a Center of the Danish National Research Foundation. B. D. is supported by the Danish Council for Independent Research-Natural Sciences, and W.J.S. is funded by Arcadia. We thank international climate modeling groups for providing their data for analysis, the Laboratoire des Sciences du Climat et de l'Environnement for collecting and archiving the paleoclimate model data, the International Union for Conservation of Nature and Natural Resources for making the amphibian and mammal range data available, and the Natural Environment Research Council-funded Avian Diversity Hotspots Consortium (NER/O/S/2001/01230) for the use of the bird range data. We thank four anonymous reviewers whose constructive comments improved this manuscript. Data are archived at Dryad (http://dx.doi.org/10.5061/dryad.b13j1).	Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Currie DJ, 2004, ECOL LETT, V7, P1121, DOI 10.1111/j.1461-0248.2004.00671.x; Davies TJ, 2009, AM NAT, V174, P297, DOI 10.1086/603614; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Dynesius M, 2000, P NATL ACAD SCI USA, V97, P9115, DOI 10.1073/pnas.97.16.9115; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; HUNTLEY B, 1989, J BIOGEOGR, V16, P5, DOI 10.2307/2845307; Jansson R, 2003, P ROY SOC B-BIOL SCI, V270, P583, DOI 10.1098/rspb.2002.2283; Jansson R, 2008, ECOL LETT, V11, P173, DOI 10.1111/j.1461-0248.2007.01138.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; McGlone MS, 1996, GLOBAL ECOL BIOGEOGR, V5, P309, DOI 10.2307/2997586; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Nogues-Bravo D, 2010, EVOLUTION, V64, P2442, DOI 10.1111/j.1558-5646.2010.01009.x; Ohlemuller R, 2008, BIOL LETTERS, V4, P568, DOI 10.1098/rsbl.2008.0097; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Ruddiman WF, 2001, EARTHS CLIMATE FUTUR; Scherrer D, 2011, J BIOGEOGR, V38, P406, DOI 10.1111/j.1365-2699.2010.02407.x; SCHOONMAKER PK, 1991, BOT REV, V57, P204, DOI 10.1007/BF02858563; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2003, ECOL LETT, V6, P646, DOI 10.1046/j.1461-0248.2003.00477.x; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Svenning JC, 2007, GLOBAL ECOL BIOGEOGR, V16, P234, DOI 10.1111/j.1466-8238.2006.00280.x	29	537	558	15	352	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2011	334	6056					660	664		10.1126/science.1210173	http://dx.doi.org/10.1126/science.1210173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	21979937				2022-12-24	WOS:000296494700052
J	Yao, J; Gaffaney, JD; Kwon, SE; Chapman, ER				Yao, Jun; Gaffaney, Jon D.; Kwon, Sung E.; Chapman, Edwin R.			Doc2 Is a Ca2+ Sensor Required for Asynchronous Neurotransmitter Release	CELL			English	Article							DEPENDENT PHOSPHOLIPID-BINDING; CULTURED HIPPOCAMPAL-NEURONS; MEDIATED MEMBRANE-FUSION; DOUBLE C2 PROTEIN; SYNAPTOTAGMIN-I; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; CALCIUM SENSOR; PC12 CELLS; REVERBERATORY ACTIVITY	Synaptic transmission involves a fast synchronous phase and a slower asynchronous phase of neurotransmitter release that are regulated by distinct Ca2+ sensors. Though the Ca2+ sensor for rapid exocytosis, synaptotagmin I, has been studied in depth, the sensor for asynchronous release remains unknown. In a screen for neuronal Ca2+ sensors that respond to changes in [Ca2+] with markedly slower kinetics than synaptotagmin I, we observed that Doc2-another Ca2+, SNARE, and lipid-binding protein-operates on timescales consistent with asynchronous release. Moreover, up- and downregulation of Doc2 expression levels in hippocampal neurons increased or decreased, respectively, the slow phase of synaptic transmission. Synchronous release, when triggered by single action potentials, was unaffected by manipulation of Doc2 but was enhanced during repetitive stimulation in Doc2 knockdown neurons, potentially due to greater vesicle availability. In summary, we propose that Doc2 is a Ca2+ sensor that is kinetically tuned to regulate asynchronous neurotransmitter release.	[Yao, Jun; Gaffaney, Jon D.; Kwon, Sung E.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Yao, Jun; Gaffaney, Jon D.; Kwon, Sung E.; Chapman, Edwin R.] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	chapman@physiology.wisc.edu		Yao, Jun/0000-0002-4916-3412; Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health [MH 61876]; American Heart Association [11POST5720016]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Chapman lab and M. B. Jackson for critical comments. This study was supported by a grant from the National Institutes of Health (MH 61876). J.Y. is supported by an American Heart Association postdoctoral fellowship (11POST5720016). E.R.C. is an Investigator of the Howard Hughes Medical Institute.	Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Burgalossi A, 2010, NEURON, V68, P473, DOI 10.1016/j.neuron.2010.09.019; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fukuda M, 2000, BIOCHEM BIOPH RES CO, V276, P626, DOI 10.1006/bbrc.2000.3520; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P665, DOI 10.1007/s00401-006-0147-8; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Groffen AJA, 2004, J BIOL CHEM, V279, P23740, DOI 10.1074/jbc.M400731200; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Hagler DJ, 2001, J NEUROPHYSIOL, V85, P2324, DOI 10.1152/jn.2001.85.6.2324; Higashio H, 2008, J IMMUNOL, V180, P4774, DOI 10.4049/jimmunol.180.7.4774; Hjelmstad GO, 2006, J NEUROPHYSIOL, V95, P2020, DOI 10.1152/jn.01149.2005; Hui EF, 2005, P NATL ACAD SCI USA, V102, P5210, DOI 10.1073/pnas.0500941102; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Iremonger KJ, 2007, J NEUROSCI, V27, P6684, DOI 10.1523/JNEUROSCI.0934-07.2007; Johnson CP, 2010, J CELL BIOL, V191, P187, DOI 10.1083/jcb.201002089; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671; Korteweg N, 2000, EUR J NEUROSCI, V12, P165, DOI 10.1046/j.1460-9568.2000.00898.x; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lau PM, 2005, P NATL ACAD SCI USA, V102, P10333, DOI 10.1073/pnas.0500717102; Lewis JL, 2001, J BIOL CHEM, V276, P15458, DOI 10.1074/jbc.M011687200; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Makino H, 2009, NEURON, V64, P381, DOI 10.1016/j.neuron.2009.08.035; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2008, P NATL ACAD SCI USA, V105, P3986, DOI 10.1073/pnas.0712372105; Mochida S, 1998, P NATL ACAD SCI USA, V95, P11418, DOI 10.1073/pnas.95.19.11418; Naito A, 1997, MOL BRAIN RES, V44, P198, DOI 10.1016/S0169-328X(96)00198-2; Nishiki T, 2004, J NEUROSCI, V24, P6127, DOI 10.1523/JNEUROSCI.1563-04.2004; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Orita S, 1996, J BIOL CHEM, V271, P7257, DOI 10.1074/jbc.271.13.7257; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2011, NEURON, V70, P244, DOI 10.1016/j.neuron.2011.03.011; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Sakaguchi G, 1999, EUR J NEUROSCI, V11, P4262, DOI 10.1046/j.1460-9568.1999.00855.x; Sato M, 2010, J NEUROCHEM, V114, P171, DOI 10.1111/j.1471-4159.2010.06739.x; Shahrezaei V, 2005, J NEUROPHYSIOL, V94, P1912, DOI 10.1152/jn.00256.2005; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Thomson AM, 2000, PROG NEUROBIOL, V62, P159, DOI 10.1016/S0301-0082(00)00008-3; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Volman V, 2007, PHYS BIOL, V4, P91, DOI 10.1088/1478-3975/4/2/003; Wang P, 2005, MOL CELL BIOL, V25, P8693, DOI 10.1128/MCB.25.19.8693-8702.2005; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028	59	138	138	1	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					666	677		10.1016/j.cell.2011.09.046	http://dx.doi.org/10.1016/j.cell.2011.09.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036572	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000296573700020
J	Locke, JCW; Young, JW; Fontes, M; Jimenez, MJH; Elowitz, MB				Locke, James C. W.; Young, Jonathan W.; Fontes, Michelle; Jimenez, Maria Jesus Hernandez; Elowitz, Michael B.			Stochastic Pulse Regulation in Bacterial Stress Response	SCIENCE			English	Article							BACILLUS-SUBTILIS; TRANSCRIPTION FACTOR; GENE-REGULATION; SIGMA(B); EXPRESSION; GROWTH; DIFFERENTIATION; ACTIVATION; VIRULENCE; DYNAMICS	Gene regulatory circuits can use dynamic, and even stochastic, strategies to respond to environmental conditions. We examined activation of the general stress response mediated by the alternative sigma factor, sigma(B), in individual Bacillus subtilis cells. We observed that energy stress activates sigma(B) in discrete stochastic pulses, with increasing levels of stress leading to higher pulse frequencies. By perturbing and rewiring the endogenous system, we found that this behavior results from three key features of the sigma(B) circuit: an ultrasensitive phosphorylation switch; stochasticity ("noise"), which activates that switch; and a mixed (positive and negative) transcriptional feedback, which can both amplify a pulse and switch it off. Together, these results show how prokaryotes encode signals using stochastic pulse frequency modulation through a compact regulatory architecture.	[Locke, James C. W.; Young, Jonathan W.; Fontes, Michelle; Jimenez, Maria Jesus Hernandez; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol & Bioengn, Broad Ctr, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol & Bioengn, Broad Ctr, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Locke, James/0000-0003-0670-1943	NIH [R01GM079771, P50 GM068763]; U.S. National Science Foundation [0644463]; Packard Foundation; International Human Frontier Science Program Organization; European Molecular Biology Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068763, R01GM079771] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); International Human Frontier Science Program Organization(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Price and D. Rudner for providing strains. We thank A. Eldar, R. Kishony, C. Price, N. Wingreen, J. Levine, and other members of M. B. E's laboratory for helpful discussions. Work in M. B. E's laboratory was supported by NIH grants R01GM079771 and P50 GM068763, U.S. National Science Foundation CAREER Award 0644463, and the Packard Foundation. J.C.W.L was supported by the International Human Frontier Science Program Organization and the European Molecular Biology Organization.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; ALPER S, 1994, CELL, V77, P195, DOI 10.1016/0092-8674(94)90312-3; Brody MS, 2001, J BACTERIOL, V183, P6422, DOI 10.1128/JB.183.21.6422-6428.2001; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Cheng Z, 2009, BIOPHYS J, V97, P2867, DOI 10.1016/j.bpj.2009.09.008; DUFOUR A, 1994, J BACTERIOL, V176, P1813, DOI 10.1128/jb.176.7.1813-1820.1994; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; GOLDBETER A, 1981, P NATL ACAD SCI-BIOL, V78, P6840, DOI 10.1073/pnas.78.11.6840; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HALDENWANG WG, 1979, NATURE, V282, P256, DOI 10.1038/282256a0; Hecker M, 1998, MOL MICROBIOL, V29, P1129, DOI 10.1046/j.1365-2958.1998.00977.x; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Igoshin OA, 2007, J MOL BIOL, V369, P1333, DOI 10.1016/j.jmb.2007.04.021; Kazmierczak MJ, 2003, J BACTERIOL, V185, P5722, DOI 10.1128/JB.185.19.5722-5734.2003; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Lorenz U, 2008, MICROBES INFECT, V10, P217, DOI 10.1016/j.micinf.2007.11.006; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Melen GJ, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100036; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rotem E, 2010, P NATL ACAD SCI USA, V107, P12541, DOI 10.1073/pnas.1004333107; Schweder T, 1999, ARCH MICROBIOL, V171, P439, DOI 10.1007/s002030050731; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; WISE AA, 1995, J BACTERIOL, V177, P123, DOI 10.1128/jb.177.1.123-133.1995; Zhang SY, 2005, J BACTERIOL, V187, P7554, DOI 10.1128/JB.187.22.7554-7560.2005	30	138	141	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					366	369		10.1126/science.1208144	http://dx.doi.org/10.1126/science.1208144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21979936	Green Accepted			2022-12-24	WOS:000296052500050
J	Hu, NJ; Iwata, S; Cameron, AD; Drew, D				Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.; Drew, David			Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT	NATURE			English	Article							MEMBRANE-PROTEIN OVEREXPRESSION; NHAA NA+/H+ ANTIPORTER; ESCHERICHIA-COLI; MAXIMUM-LIKELIHOOD; ALTERNATING ACCESS; HUMAN ILEAL; TRANSPORT; MODEL; IDENTIFICATION; COTRANSPORTER	High cholesterol levels greatly increase the risk of cardiovascular disease. About 50 per cent of cholesterol is eliminated from the body by its conversion into bile acids. However, bile acids released from the bile duct are constantly recycled, being reabsorbed in the intestine by the apical sodium-dependent bile acid transporter (ASBT, also known as SLC10A2). It has been shown in animal models that plasma cholesterol levels are considerably lowered by specific inhibitors of ASBT(1,2), and ASBT is thus a target for hypercholesterolaemia drugs. Here we report the crystal structure of a bacterial homologue of ASBT from Neisseria meningitidis (ASBT(NM)) at 2.2 angstrom. ASBT(NM) contains two inverted structural repeats of five transmembrane helices. A core domain of six helices harbours two sodium ions, and the remaining four helices pack in a row to form a flat, 'panel'-like domain. Overall, the architecture of the protein is remarkably similar to the sodium/proton antiporter NhaA(3), despite having no detectable sequence homology. The ASBT(NM) structure was captured with the substrate taurocholate present, bound between the core and panel domains in a large, inward-facing, hydrophobic cavity. Residues near this cavity have been shown to affect the binding of specific inhibitors of human ASBT(4). The position of the taurocholate molecule, together with the molecular architecture, suggests the rudiments of a possible transport mechanism.	[Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.; Drew, David] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England; [Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.] Diamond Light Source, Membrane Prot Lab, Chilton OX11 0DE, England; [Hu, Nien-Jen; Iwata, So; Cameron, Alexander D.] Appleton Lab, Didcot OX11 0FA, Oxon, England; [Iwata, So; Cameron, Alexander D.] Japan Sci & Technol Agcy, ERATO, Human Crystallog Project, Sakyo Ku, Kyoto 606851, Japan; [Iwata, So] Kyoto Univ, Dept Cell Biol, Sch Med, Sakyo Ku, Kyoto 6068501, Japan	Imperial College London; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Japan Science & Technology Agency (JST); Kyoto University	Drew, D (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, London SW7 2AZ, England.	s.iwata@imperial.ac.uk; a.cameron@imperial.ac.uk; d.drew@imperial.ac.uk	Drew, David/D-3243-2018; Drew, David/AAY-3455-2020; Cameron, Alexander/L-7288-2013	Hu, Nien-Jen/0000-0002-0917-0677; Cameron, Alexander/0000-0001-8776-3518; Drew, David/0000-0001-8866-6349	Medical Research Council [MRC_G0900990(91997)]; European Union [LSHG-CT-2004-504601]; Biotechnology and Biological Sciences Research Council [BB/G023425/1]; MEXT, Japan; Japan Science and Technology Agency; Wellcome Trust [WT089809]; Medical Research Council [G0900990] Funding Source: researchfish; BBSRC [BB/G023425/1] Funding Source: UKRI; MRC [G0900990] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to C. Lee and Y. Sekiguchi for assistance with cloning and expression screening of ASBT<INF>NM</INF> mutants, and to S. van de Graaf for donating fluorescently labelled bile acid, which was used in the initial functional characterization of ASBTNM. Data were collected at the European Synchrotron Radiation Facility, France, and the Diamond Light Source, UK, with assistance from beamline scientists; in particular, we would like to thank J. Sanchez-Weatherby for help with the HCl. We are also grateful to K. Beis and G. von Heijne for reading the manuscript. This work was funded by the Medical Research Council (MRC_G0900990(91997), to A.D.C. and D.D.), the European Union (EMeP grant LSHG-CT-2004-504601, to S.I.) and the Biotechnology and Biological Sciences Research Council (BB/G023425/1, to S.I.). Part of this work was also supported by a grant from the Targeted Proteins Research Program of MEXT, Japan, and the ERATO Iwata Human Receptor Crystallography Project, Japan Science and Technology Agency. The authors are grateful for the use of the Membrane Protein Laboratory funded by the Wellcome Trust (WT089809) at the Diamond Light Source. D.D. acknowledges personal support from The Royal Society through the University Research Fellow scheme.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alexandrov AI, 2008, STRUCTURE, V16, P351, DOI 10.1016/j.str.2008.02.004; Appel M, 2009, J MOL BIOL, V388, P659, DOI 10.1016/j.jmb.2009.03.010; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P943, DOI 10.1021/bi052202j; Bhat BG, 2003, J LIPID RES, V44, P1614, DOI 10.1194/jlr.M200469-JLR200; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Chignard N, 2001, HEPATOLOGY, V33, P496, DOI 10.1053/jhep.2001.22345; Craddock AL, 1998, AM J PHYSIOL-GASTR L, V274, pG157, DOI 10.1152/ajpgi.1998.274.1.G157; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DeLano W.L., 2002, PYMOL MOL VIEWER; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Geyer J, 2006, N-S ARCH PHARMACOL, V372, P413, DOI 10.1007/s00210-006-0043-8; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Hagenbuch B, 1996, SEMIN LIVER DIS, V16, P129, DOI 10.1055/s-2007-1007226; Hallen S, 1999, BIOCHEMISTRY-US, V38, P11379, DOI 10.1021/bi990554i; Hallen S, 2002, BIOCHEMISTRY-US, V41, P14916, DOI 10.1021/bi0205404; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hussainzada N, 2006, MOL PHARMACOL, V70, P1565, DOI 10.1124/mol.106.028647; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kleywegt G.J., 1994, PROTEIN CRYSTALLOGR, V31, P9; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Knight SD, 2000, ACTA CRYSTALLOGR D, V56, P42, DOI 10.1107/S0907444999012913; Kramer W, 1996, EUR J CLIN INVEST, V26, P715, DOI 10.1111/j.1365-2362.1996.tb02383.x; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; LEWIS MC, 1995, J LIPID RES, V36, P1098; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Olkhova E, 2006, P NATL ACAD SCI USA, V103, P2629, DOI 10.1073/pnas.0510914103; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Shimamura T, 2010, SCIENCE, V328, P470, DOI 10.1126/science.1186303; Sonoda Y, 2011, STRUCTURE, V19, P17, DOI 10.1016/j.str.2010.12.001; Sun AQ, 2006, J BIOL CHEM, V281, P16410, DOI 10.1074/jbc.M600034200; Tzubery T, 2008, J BIOL CHEM, V283, P15975, DOI 10.1074/jbc.M800482200; Weinman SA, 1998, J BIOL CHEM, V273, P34691, DOI 10.1074/jbc.273.52.34691; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; WONG MH, 1994, J BIOL CHEM, V269, P1340; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahner D, 2003, EUR J BIOCHEM, V270, P1117, DOI 10.1046/j.1432-1033.2003.03463.x; Zheng XW, 2009, MOL PHARMACEUT, V6, P1591, DOI 10.1021/mp900163d	55	182	188	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					408	+		10.1038/nature10450	http://dx.doi.org/10.1038/nature10450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21976025	Green Accepted			2022-12-24	WOS:000296021100051
J	Liu, JL; Xia, HG; Kim, M; Xu, LH; Li, Y; Zhang, LH; Cai, Y; Norberg, HV; Zhang, T; Furuya, T; Jin, MZ; Zhu, ZM; Wang, HC; Yu, J; Li, YX; Hao, Y; Choi, A; Ke, HM; Ma, DW; Yuan, JY				Liu, Junli; Xia, Hongguang; Kim, Minsu; Xu, Lihua; Li, Ying; Zhang, Lihong; Cai, Yu; Norberg, Helin Vakifahmetoglu; Zhang, Tao; Furuya, Tsuyoshi; Jin, Minzhi; Zhu, Zhimin; Wang, Huanchen; Yu, Jia; Li, Yanxia; Hao, Yan; Choi, Augustine; Ke, Hengming; Ma, Dawei; Yuan, Junying			Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13	CELL			English	Article							TUMOR-SUPPRESSOR; AUTOPHAGY GENE; TUMORIGENESIS; PROTEINS; INHIBITION; COMPLEXES; RUBICON; SCREEN; ATG14L; VPS34	Autophagy is an important intracellular catabolic mechanism that mediates the degradation of cytoplasmic proteins and organelles. We report a potent small molecule inhibitor of autophagy named "spautin-1" for specific and potent autophagy inhibitor-1. Spautin-1 promotes the degradation of Vps34 PI3 kinase complexes by inhibiting two ubiquitin-specific peptidases, USP10 and USP13, that target the Beclin1 subunit of Vps34 complexes. Beclin1 is a tumor suppressor and frequently monoallelically lost in human cancers. Interestingly, Beclin1 also controls the protein stabilities of USP10 and USP13 by regulating their deubiquitinating activities. Since USP10 mediates the deubiquitination of p53, regulating deubiquitination activity of USP10 and USP13 by Beclin1 provides a mechanism for Beclin1 to control the levels of p53. Our study provides a molecular mechanism involving protein deubiquitination that connects two important tumor suppressors, p53 and Beclin1, and a potent small molecule inhibitor of autophagy as a possible lead compound for developing anticancer drugs.	[Liu, Junli; Xia, Hongguang; Xu, Lihua; Li, Ying; Zhang, Lihong; Cai, Yu; Zhang, Tao; Jin, Minzhi; Yu, Jia; Li, Yanxia; Hao, Yan; Ma, Dawei] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Kim, Minsu; Li, Ying; Norberg, Helin Vakifahmetoglu; Furuya, Tsuyoshi; Zhu, Zhimin; Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Wang, Huanchen; Ke, Hengming] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Choi, Augustine] Brigham & Womens Hosp, Boston, MA 02115 USA	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital	Ma, DW (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 354 Fenglin Lu, Shanghai 200032, Peoples R China.	madw@mail.sioc.ac.cn; jyuan@hms.harvard.edu	xu, li/GNH-3667-2022	Xia, hongguang/0000-0003-3044-9282; Wang, Huanchen/0000-0003-2701-7155; Liu, Junli/0000-0001-8861-3706; Li, Ying/0000-0002-3506-1255	NIH US; Chinese Academy of Sciences [KGCX2-SW-209, KJCX2-YW-H08]; National Natural Science Foundation of China [21020102037, 90813007]; National Institute on Aging US [R37 AG012859, PO1 AG027916]; Samsung Scholarship from South Korea; Swedish Society for Medical Research (SSMF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012859, P01AG027916] Funding Source: NIH RePORTER	NIH US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute on Aging US(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Samsung Scholarship from South Korea(Samsung); Swedish Society for Medical Research (SSMF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dan Finley, Bruce Yankner, Zhujun Yao, Dana Christofferson, Dimitry Ofengeim, and Benedicte Py for comments on the manuscript; Dr. Xin Xie of the National Center for Drug Screening in Shanghai for help with the original compound screen for autophagy regulators; Dr. Wade Harper for providing expression vectors of USP10 and USP13; Dr. Zhenkun Lou for mutant expression vector for USP10; Dr. Caroline Shamu (the director of the ICCB screening facility); and David Wrobel and Stewart Rudnicki for helps with siRNA screening. This work was supported in part by a NIH Director's Pioneer Award US (to J.Y.), grants from the Chinese Academy of Sciences (KGCX2-SW-209 and KJCX2-YW-H08 [to D.M.]), the National Natural Science Foundation of China (21020102037 [to D.M.], and 90813007 [to L.Z.]) and the National Institute on Aging US (R37 AG012859 and PO1 AG027916 [to J.Y.]). M.K. is a recipient of Samsung Scholarship from South Korea. H.V.N. is supported in part by a fellowship form the Swedish Society for Medical Research (SSMF).	Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; DOWLER S, 2002, SCI STKE, pPL6, DOI DOI 10.1126/STKE.2002.129.PL6; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Komander D, 2010, SUBCELL BIOCHEM, V54, P69, DOI 10.1007/978-1-4419-6676-6_6; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; MacPherson JD, 2006, J PHARMACOL EXP THER, V317, P188, DOI 10.1124/jpet.105.094763; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Wang HC, 2008, BIOCHEMISTRY-US, V47, P12760, DOI 10.1021/bi801487x; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	29	534	570	7	125	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					223	234		10.1016/j.cell.2011.08.037	http://dx.doi.org/10.1016/j.cell.2011.08.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962518	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000295396700028
J	Vestbo, J; Edwards, LD; Scanlon, PD; Yates, JC; Agusti, A; Bakke, P; Calverley, PMA; Celli, B; Coxson, HO; Crim, C; Lomas, DA; MacNee, W; Miller, BE; Silverman, EK; Tal-Singer, R; Wouters, E; Rennard, SI				Vestbo, Jorgen; Edwards, Lisa D.; Scanlon, Paul D.; Yates, Julie C.; Agusti, Alvar; Bakke, Per; Calverley, Peter M. A.; Celli, Bartolome; Coxson, Harvey O.; Crim, Courtney; Lomas, David A.; MacNee, William; Miller, Bruce E.; Silverman, Edwin K.; Tal-Singer, Ruth; Wouters, Emiel; Rennard, Stephen I.		ECLIPSE Investigators	Changes in Forced Expiratory Volume in 1 Second over Time in COPD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; NATURAL-HISTORY; ECLIPSE COHORT; DECLINE; EXACERBATION; EPIDEMIOLOGY; PROPIONATE; HEALTH	BACKGROUND A key feature of chronic obstructive pulmonary disease (COPD) is an accelerated rate of decline in forced expiratory volume in 1 second (FEV(1)), but data on the variability and determinants of this change in patients who have established disease are scarce. METHODS We analyzed the changes in FEV1 after administration of a bronchodilator over a 3-year period in 2163 patients. A random-coefficient model was used to evaluate possible predictors of both FEV1 levels and their changes over time. RESULTS The mean (+/- SE) rate of change in FEV1 was a decline of 33 +/- 2 ml per year, with significant variation among the patients studied. The between-patient standard deviation for the rate of decline was 59 ml per year. Over the 3-year study period, 38% of patients had an estimated decline in FEV1 of more than 40 ml per year, 31% had a decline of 21 to 40 ml per year, 23% had a change in FEV1 that ranged from a decrease of 20 ml per year to an increase of 20 ml per year, and 8% had an increase of more than 20 ml per year. The mean rate of decline in FEV1 was 21 +/- 4 ml per year greater in current smokers than in current nonsmokers, 13 +/- 4 ml per year greater in patients with emphysema than in those without emphysema, and 17 +/- 4 ml per year greater in patients with bronchodilator reversibility than in those without reversibility. CONCLUSIONS The rate of change in FEV1 among patients with COPD is highly variable, with increased rates of decline among current smokers, patients with bronchodilator reversibility, and patients with emphysema. (Funded by GlaxoSmithKline; ECLIPSE-ClinicalTrials.gov number, NCT00292552.)	[Vestbo, Jorgen] Univ Copenhagen, Hvidovre Hosp, Resp Sect, DK-2650 Hvidovre, Denmark; [Vestbo, Jorgen] Univ Copenhagen, Copenhagen, Denmark; [Vestbo, Jorgen] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Calverley, Peter M. A.] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [Lomas, David A.] Univ Cambridge, Cambridge, England; [MacNee, William] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Edwards, Lisa D.; Yates, Julie C.; Crim, Courtney] GlaxoSmithKline Inc, Res Triangle Pk, NC USA; [Miller, Bruce E.; Tal-Singer, Ruth] GlaxoSmithKline Inc, King Of Prussia, PA USA; [Scanlon, Paul D.] Mayo Clin, Rochester, MN USA; [Agusti, Alvar] Univ Barcelona, Thorax Inst, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Agusti, Alvar] CIBER Enfermedades Resp, Palma De Mallorca, Mallorca, Spain; [Bakke, Per] Univ Bergen, Inst Internal Med, Bergen, Norway; [Celli, Bartolome; Silverman, Edwin K.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Celli, Bartolome; Silverman, Edwin K.] Harvard Univ, Sch Med, Boston, MA USA; [Coxson, Harvey O.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Wouters, Emiel] Univ Maastricht, Maastricht, Netherlands; [Rennard, Stephen I.] Univ Nebraska Med Ctr, Omaha, NE USA	University of Copenhagen; University of Copenhagen; University of Manchester; University of Liverpool; University of Cambridge; University of Edinburgh; GlaxoSmithKline; GlaxoSmithKline; Mayo Clinic; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Bergen; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of British Columbia; Maastricht University; University of Nebraska System; University of Nebraska Medical Center	Vestbo, J (corresponding author), Univ Copenhagen, Hvidovre Hosp, Resp Sect 253, Kettegaard 30, DK-2650 Hvidovre, Denmark.	jvestbo@dadlnet.dk	Wouters, Emiel/ABD-6200-2021; Coxson, Harvey O/A-9861-2017; Garcia-Navarro, Alvar Agusti/F-4474-2015; Vestbo, Jorgen/Y-2912-2019; Tal-Singer, Ruth/AAQ-2925-2021	Coxson, Harvey O/0000-0001-5750-9711; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Tal-Singer, Ruth/0000-0002-5275-8062; MacNee, William/0000-0002-3692-1448; Edwards, Lisa/0000-0002-4867-2151; Vestbo, Jorgen/0000-0001-6355-6362	GlaxoSmithKline; AstraZeneca; Boehringer Ingelheim; Chiesi; Novartis; Nycomed; Pfizer; Forest Laboratories; Almirall; Esteve; Roche; Merck and Novartis; Aeris; Rox Medical; GlaxoSmithKline and Spiration; Able Associates; Adelphi Research; APT Pharma/Britnall; Aradigm; CommonHealth; Consult Complete; COPDforum; Datamonitor; Decision Resources; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Forest; Gerson; InfoMed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Mpex; Oriel Therapeutics; Otsuka; Pennside; Parma Ventures; Pearl; Pharmaxis; Price Waterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Sankyo; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; United BioSource; Uptake Medical; VantagePoint Management; Convergent Health Solutions for Reviews and Trends in COPD; COPD Foundation; Creative Educational Concepts; France Foundation; Information TV; Network for Continuing Education (CHARM); Novartis (Horsham); Biomarck; Centocor; Nabi; MRC [G0901786, G0901697] Funding Source: UKRI; Medical Research Council [G0901697, G0901786] Funding Source: researchfish	GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chiesi(Chiesi Pharmaceuticals Inc); Novartis(Novartis); Nycomed; Pfizer(Pfizer); Forest Laboratories; Almirall(Almirall); Esteve; Roche(Roche Holding); Merck and Novartis; Aeris; Rox Medical; GlaxoSmithKline and Spiration; Able Associates; Adelphi Research; APT Pharma/Britnall; Aradigm; CommonHealth; Consult Complete; COPDforum; Datamonitor; Decision Resources; Defined Health; Dey; Dunn Group; Easton Associates; Equinox; Forest; Gerson; InfoMed; KOL Connection; M. Pankove; MedaCorp; MDRx Financial; Mpex; Oriel Therapeutics; Otsuka(Otsuka Pharmaceutical); Pennside; Parma Ventures; Pearl(Luxembourg National Research Fund); Pharmaxis; Price Waterhouse; Propagate; Pulmatrix; Reckner Associates; Recruiting Resources; Sankyo; Schlesinger Medical; Scimed; Sudler and Hennessey; TargeGen; Theravance; United BioSource; Uptake Medical; VantagePoint Management; Convergent Health Solutions for Reviews and Trends in COPD; COPD Foundation; Creative Educational Concepts; France Foundation; Information TV; Network for Continuing Education (CHARM); Novartis (Horsham); Biomarck; Centocor; Nabi; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from GlaxoSmithKline (to Drs. Vestbo, Scanlon, Agusti, Bakke, Calverley, Celli, Coxson, Lomas, MacNee, Silverman, Wouters, and Rennard).; Dr. Vestbo reports receiving consulting fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Novartis, Nycomed, and Pfizer, speaking fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Novartis, and Nycomed, and grants on behalf of his institution from GlaxoSmithKline; Dr. Scanlon, receiving travel support from Boehringer Ingelheim and Novartis and receiving grants from Boehringer Ingelheim, Forest Laboratories, GlaxoSmithKline, Pfizer, and Novartis on behalf of his institution; Dr. Agusti, receiving fees for serving on the boards of Almirall, AstraZeneca, Boehringer Ingelheim, Esteve, GlaxoSmithKline, Novartis, Nycomed, and Roche, speaking fees from Almirall, AstraZeneca, Boehringer Ingelheim, Esteve, GlaxoSmithKline, and Nycomed, payment for the development of educational presentations from Nycomed, and receiving grants from Almirall, GlaxoSmithKline, and Nycomed on behalf of his institution; Dr. Bakke, receiving speaking fees from AstraZeneca, GlaxoSmithKline, and Pfizer; Dr. Calverley, receiving fees for serving on the boards of GlaxoSmithKline, Boehringer Ingelheim, and Nycomed, consulting fees from Merck and Novartis, payment for providing expert testimony for Forest, speaking fees from AstraZeneca and GlaxoSmithKline, travel support from Boehringer Ingelheim, and receiving speaking fees from Novartis and Pfizer on behalf of his institution; Dr. Celli, receiving consulting fees from Aeris, Almirall, AstraZeneca, Boehringer Ingelheim, Novartis, and Rox Medical; Dr. Coxson, receiving consulting fees from GlaxoSmithKline and Spiration, speaking fees from AstraZeneca, travel support from AstraZeneca and Spiration, and receiving grants from GlaxoSmithKline and Spiration on behalf of his institution; Dr. Lomas, receiving fees for serving on the board of GlaxoSmithKline, consulting fees from GlaxoSmithKline, speaking fees from GlaxoSmithKline, travel support from Boehringer Ingelheim and GlaxoSmithKline, and receiving grants from GlaxoSmithKline on behalf of his institution; Dr. MacNee, receiving travel support from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, and Pfizer, and he and his institution receiving consulting fees from Pfizer and fees for membership on the boards of Pfizer and GlaxoSmithKline; Dr. Rennard, receiving fees for membership on the boards of Almirall, Novartis, Nycomed, and Pfizer, consulting fees from Able Associates, Adelphi Research, APT Pharma/Britnall, Aradigm, AstraZeneca, Boehringer Ingelheim, Chiesi, CommonHealth, Consult Complete, COPDforum, Datamonitor, Decision Resources, Defined Health, Dey, Dunn Group, Easton Associates, Equinox, Forest, Gerson, GlaxoSmithKline, InfoMed, KOL Connection, M.; Pankove, MedaCorp, MDRx Financial, Mpex, Novartis, Nycomed, Oriel Therapeutics, Otsuka, Pennside, Parma Ventures, Pearl, Pharmaxis, Price Waterhouse, Propagate, Pulmatrix, Reckner Associates, Recruiting Resources, Roche, Sankyo, Schlesinger Medical, Scimed, Sudler and Hennessey, TargeGen, Theravance, United BioSource, Uptake Medical, and VantagePoint Management, speaking fees from AstraZeneca, Convergent Health Solutions for Reviews and Trends in COPD, COPD Foundation, Creative Educational Concepts, Dey, France Foundation, Information TV, Network for Continuing Education (CHARM), Novartis (Horsham), Nycomed, Otsuka, and Pfizer, travel support from Almirall, AstraZeneca, Boehringer Ingelheim, California Allergy Society, Creative Educational Concept, France Foundation, GlaxoSmithKline, Information TV, Network for Continuing Education, Novartis, Nycomed, and Pfizer, and receiving grantsfrom AstraZeneca, Biomarck, Boehringer Ingelheim, Centocor, Mpex, Nabi, Novartis, Nycomed, and Otsuka on behalf of his institution; Dr. Silverman, receiving consulting fees from AstraZeneca and GlaxoSmithKline, speaking fees from AstraZeneca and GlaxoSmithKline, and receiving grants from GlaxoSmithKline on behalf of his institution; and Dr. Wouters, receiving fees for membership on the board of Nycomed, speaking fees from AstraZeneca, GlaxoSmithKline, and Novartis, and grants from AstraZeneca and GlaxoSmithKline. Drs. Crim, Edwards, Miller, Tal- Singer, and Yates report being employees of and owning stock in GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Anthonisen NR, 2005, EUR RESPIR J, V26, P45, DOI 10.1183/09031936.05.00102604; Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Donaldson GC, 2008, THORAX, V63, P753; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fletcher CM, 1976, NATURAL HIST CHRONIC; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hansen EF, 1999, AM J RESP CRIT CARE, V159, P1267, DOI 10.1164/ajrccm.159.4.9807121; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Raherison C, 2009, EUR RESPIR REV, V18, P213, DOI 10.1183/09059180.00003609; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 2008, EUR RESPIR J, V31, P869, DOI 10.1183/09031936.00111707; Viegi G, 2007, EUR RESPIR J, V30, P993, DOI 10.1183/09031936.00082507	24	664	683	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 29	2011	365	13					1184	1192		10.1056/NEJMoa1105482	http://dx.doi.org/10.1056/NEJMoa1105482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	825YO	21991892	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000295318400006
J	Fawzi, NL; Ying, JF; Ghirlando, R; Torchia, DA; Clore, GM				Fawzi, Nicolas L.; Ying, Jinfa; Ghirlando, Rodolfo; Torchia, Dennis A.; Clore, G. Marius			Atomic-resolution dynamics on the surface of amyloid-beta protofibrils probed by solution NMR	NATURE			English	Article							ALZHEIMERS-DISEASE; EXPERIMENTAL CONSTRAINTS; CHEMICAL-EXCHANGE; FIBRIL FORMATION; PROTEIN; OLIGOMERS; MECHANISM; STATE; A-BETA(1-40); AGGREGATION	Exchange dynamics between molecules free in solution and bound to the surface of a large supramolecular structure, a polymer, a membrane or solid support are important in many phenomena in biology and materials science. Here we present a novel and generally applicable solution NMR technique, known as dark-state exchange saturation transfer (DEST), to probe such exchange phenomena with atomic resolution. This is illustrated by the exchange reaction between amyloid-beta (A beta) monomers and polydisperse, NMR-invisible ('dark') protofibrils, a process of significant interest because the accumulation of toxic, aggregated forms of A beta, from small oligomers to very large assemblies, has been implicated in the aetiology of Alzheimer's disease(1-6). The (15)N-DEST experiment imprints with single-residue-resolution dynamic information on the protofibril-bound species in the form of (15)N transverse relaxation rates ((15)N-R(2)) and exchange kinetics between monomers and protofibrils onto the easily observed two-dimensional (1)H-(15)N correlation spectrum of the monomer. The exchanging species on the protofibril surface comprise an ensemble of sparsely populated states where each residue is either tethered to (through other residues) or in direct contact with the surface. The first eight residues exist predominantly in a mobile tethered state, whereas the largely hydrophobic central region and part of the carboxy (C)-terminal hydrophobic region are in direct contact with the protofibril surface for a significant proportion of the time. The C-terminal residues of both A beta 40 and A beta 42 display lower affinity for the protofibril surface, indicating that they are likely to be surface exposed rather than buried as in structures of A beta fibrils(7-10), and might therefore comprise the critical nucleus for fibril formation(11,12). The (15)N-R(2)(tethered) values, however, are significantly larger for the C-terminal residues of A beta 42 than A beta 40, which might explain the former's higher propensity for rapid aggregation and fibril formation(13,14).	[Fawzi, Nicolas L.; Ying, Jinfa; Clore, G. Marius] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Ghirlando, Rodolfo] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Torchia, Dennis A.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Clore, GM (corresponding author), NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA.	mariusc@mail.nih.gov	Fawzi, Nicolas L/E-2555-2013; Clore, G Marius/L-2546-2018; Clore, G. Marius/A-3511-2008	Fawzi, Nicolas L/0000-0001-5483-0577; Clore, G Marius/0000-0003-3809-1027; Clore, G. Marius/0000-0003-3809-1027	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health; Office of the Director of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033007, ZIADK029023] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of the Director of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Tycko for discussions, D. Baber, D. Garrett and M. Cai for NMR technical assistance, F. Shewmaker for performing dot blots, and W. Qiang, B. Chen and K. Thurber for assistance with atomic force microscopy and electron microscopy imaging. This work was supported by the intramural program of the National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health and the AIDS Targeted Antiviral Program of the Office of the Director of the National Institutes of Health (to G.M.C.).	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Carulla N, 2010, ACCOUNTS CHEM RES, V43, P1072, DOI 10.1021/ar9002784; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fawzi NL, 2010, J AM CHEM SOC, V132, P9948, DOI 10.1021/ja1048253; Fawzi NL, 2007, J MOL BIOL, V365, P535, DOI 10.1016/j.jmb.2006.10.011; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Hansen DF, 2009, J AM CHEM SOC, V131, P12745, DOI 10.1021/ja903897e; Helgstrand M, 2000, J BIOMOL NMR, V18, P49, DOI 10.1023/A:1008309220156; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Ishima R, 2006, J BIOMOL NMR, V34, P209, DOI 10.1007/s10858-005-6226-7; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lee J, 2011, NAT CHEM BIOL, V7, P602, DOI [10.1038/nchembio.624, 10.1038/NCHEMBIO.624]; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Mastrangelo IA, 2006, J MOL BIOL, V358, P106, DOI 10.1016/j.jmb.2006.01.042; MCCONNELL HM, 1958, J CHEM PHYS, V28, P430, DOI 10.1063/1.1744152; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Powers ET, 2008, BIOPHYS J, V94, P379, DOI 10.1529/biophysj.107.117168; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Ruschak AM, 2010, NATURE, V467, P868, DOI 10.1038/nature09444; Scheidt HA, 2011, ANGEW CHEM INT EDIT, V50, P2837, DOI 10.1002/anie.201007265; SKLENAR V, 1987, J MAGN RESON, V73, P375, DOI 10.1016/0022-2364(87)90214-9; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046	32	307	306	4	209	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 8	2011	480	7376					268	U161		10.1038/nature10577	http://dx.doi.org/10.1038/nature10577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22037310	Green Accepted			2022-12-24	WOS:000297744200057
J	Orvedahl, A; Sumpter, R; Xiao, GH; Ng, A; Zou, ZJ; Tang, Y; Narimatsu, M; Gilpin, C; Sun, QH; Roth, M; Forst, CV; Wrana, JL; Zhang, YE; Luby-Phelps, K; Xavier, RJ; Xie, Y; Levine, B				Orvedahl, Anthony; Sumpter, Rhea, Jr.; Xiao, Guanghua; Ng, Aylwin; Zou, Zhongju; Tang, Yi; Narimatsu, Masahiro; Gilpin, Christopher; Sun, Qihua; Roth, Michael; Forst, Christian V.; Wrana, Jeffrey L.; Zhang, Ying E.; Luby-Phelps, Katherine; Xavier, Ramnik J.; Xie, Yang; Levine, Beth			Image-based genome-wide siRNA screen identifies selective autophagy factors	NATURE			English	Article							UBIQUITIN LIGASE; DEGRADATION; P62/SQSTM1; MITOPHAGY; PROTEIN; SYSTEM; PARKIN; VDAC1	Selective autophagy involves the recognition and targeting of specific cargo, such as damaged organelles, misfolded proteins, or invading pathogens for lysosomal destruction(1-4). Yeast genetic screens have identified proteins required for different forms of selective autophagy, including cytoplasm-to-vacuole targeting, pexophagy and mitophagy, and mammalian genetic screens have identified proteins required for autophagy regulation(5). However, there have been no systematic approaches to identify molecular determinants of selective autophagy in mammalian cells. Here, to identify mammalian genes required for selective autophagy, we performed a high-content, image-based, genome-wide small interfering RNA screen to detect genes required for the colocalization of Sindbis virus capsid protein with autophagolysosomes. We identified 141 candidate genes required for viral autophagy, which were enriched for cellular pathways related to messenger RNA processing, interferon signalling, vesicle trafficking, cytoskeletal motor function and metabolism. Ninety-six of these genes were also required for Parkin-mediated mitophagy, indicating that common molecular determinants may be involved in autophagic targeting of viral nucleocapsids and autophagic targeting of damaged mitochondria. Murine embryonic fibroblasts lacking one of these gene products, the C2-domain containing protein, SMURF1, are deficient in the autophagosomal targeting of Sindbis and herpes simplex viruses and in the clearance of damaged mitochondria. Moreover, SMURF1-deficient mice accumulate damaged mitochondria in the heart, brain and liver. Thus, our study identifies candidate determinants of selective autophagy, and defines SMURF1 as a newly recognized mediator of both viral autophagy and mitophagy.	[Orvedahl, Anthony; Sumpter, Rhea, Jr.; Zou, Zhongju; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Orvedahl, Anthony; Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA; [Sumpter, Rhea, Jr.; Zou, Zhongju; Sun, Qihua; Levine, Beth] Univ Texas SW Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Xiao, Guanghua; Forst, Christian V.; Xie, Yang] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin; Xavier, Ramnik J.] Broad Inst Harvard, Cambridge, MA 02142 USA; [Ng, Aylwin; Xavier, Ramnik J.] MIT, Cambridge, MA 02142 USA; [Zou, Zhongju; Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Tang, Yi; Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Narimatsu, Masahiro; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Gilpin, Christopher; Luby-Phelps, Katherine] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Roth, Michael] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Roth, Michael; Xie, Yang; Levine, Beth] Univ Texas SW Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto	Levine, B (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	beth.levine@utsouthwestern.edu	Wrana, Jeffrey/F-8857-2013; Ng, Aylwin/AAQ-6478-2020; Sumpter, Jr., Rhea/N-8152-2018; Zhang, Ying E/G-3657-2015	Zhang, Ying E/0000-0003-2753-7601; Luby-Phelps, Katherine/0000-0002-8378-1409; Roth, Michael/0000-0002-9056-332X; Forst, Christian/0000-0003-0229-9459	NIH [AI109617, CA84254, UL1 RR024982, AI062773, DK83756, DK086502, DK043351]; NSF [DMS-0907562]; Center for Cancer Research, National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA084254, ZIABC011168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, R01AI051367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, RC1DK086502, R01DK083756, P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Vishwanath, S. Wei and B. Posner for assistance with high-throughput siRNA screening; W. Sun for information technology support; K. Scudder for assistance with image analysis algorithms; A. Diehl for expert medical illustration; V. Stollar, M. McDonald, R. Kuhn and R. Youle for helpful discussions and providing reagents; A. Bugde for assistance in the UTSW Live Cell Imaging Facility; and L. Mueller and T. Januszewski for assistance with electron microscopy. This work was supported by NIH grants AI109617 (B. L.), CA84254 (B. L.), UL1 RR024982 (G. X., Y.X.), AI062773 (R.J.X.), DK83756 (R.J.X.), DK086502 (R.J.X.) and DK043351 (R.J.X. and A.N.); NSF grant DMS-0907562 (G. X.); and the Center for Cancer Research, National Cancer Institute Intramural Research Program (Y.E.Z.).	Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P838, DOI 10.1016/j.bbalip.2006.06.014; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Komatsu M, 2010, GENES CELLS, V15, P923, DOI 10.1111/j.1365-2443.2010.01433.x; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lipinski MM, 2010, DEV CELL, V18, P1041, DOI 10.1016/j.devcel.2010.05.005; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Lu KF, 2011, J BIOL CHEM, V286, P16861, DOI 10.1074/jbc.M110.211979; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Noda NN, 2010, FEBS LETT, V584, P1379, DOI 10.1016/j.febslet.2010.01.018; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Xing LP, 2010, J CELL BIOCHEM, V110, P554, DOI 10.1002/jcb.22586; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035	25	363	377	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					113	117		10.1038/nature10546	http://dx.doi.org/10.1038/nature10546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22020285	Green Accepted			2022-12-24	WOS:000298031900045
J	Hogerheijde, MR; Bergin, EA; Brinch, C; Cleeves, LI; Fogel, JKJ; Blake, GA; Dominik, C; Lis, DC; Melnick, G; Neufeld, D; Panic, O; Pearson, JC; Kristensen, L; Yildiz, UA; van Dishoeck, EF				Hogerheijde, Michiel R.; Bergin, Edwin A.; Brinch, Christian; Cleeves, L. Ilsedore; Fogel, Jeffrey K. J.; Blake, Geoffrey A.; Dominik, Carsten; Lis, Dariusz C.; Melnick, Gary; Neufeld, David; Panic, Olja; Pearson, John C.; Kristensen, Lars; Yildiz, Umut A.; van Dishoeck, Ewine F.			Detection of the Water Reservoir in a Forming Planetary System	SCIENCE			English	Article							T TAURI STARS; PROTOPLANETARY DISKS; HERSCHEL; LINES; ICE; INTERSTELLAR; EMISSION; SURFACE; REGION; GRAINS	Icy bodies may have delivered the oceans to the early Earth, yet little is known about water in the ice-dominated regions of extrasolar planet-forming disks. The Heterodyne Instrument for the Far-Infrared on board the Herschel Space Observatory has detected emission lines from both spin isomers of cold water vapor from the disk around the young star TW Hydrae. This water vapor likely originates from ice-coated solids near the disk surface, hinting at a water ice reservoir equivalent to several thousand Earth oceans in mass. The water's ortho-to-para ratio falls well below that of solar system comets, suggesting that comets contain heterogeneous ice mixtures collected across the entire solar nebula during the early stages of planetary birth.	[Hogerheijde, Michiel R.; Brinch, Christian; Kristensen, Lars; Yildiz, Umut A.; van Dishoeck, Ewine F.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Bergin, Edwin A.; Cleeves, L. Ilsedore; Fogel, Jeffrey K. J.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Blake, Geoffrey A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Dominik, Carsten] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 XH Amsterdam, Netherlands; [Lis, Dariusz C.] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Melnick, Gary] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Neufeld, David] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Panic, Olja] European So Observ, D-85748 Garching, Germany; [Pearson, John C.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [van Dishoeck, Ewine F.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	Leiden University; Leiden University - Excl LUMC; University of Michigan System; University of Michigan; California Institute of Technology; University of Amsterdam; California Institute of Technology; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Johns Hopkins University; European Southern Observatory; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society	Hogerheijde, MR (corresponding author), Leiden Univ, Leiden Observ, POB 9513, NL-2300 RA Leiden, Netherlands.	michiel@strw.leidenuniv.nl	Kristensen, Lars/F-4774-2011; Brinch, Christian/D-9622-2014; Yildiz, Umut/C-5257-2011; Brinch, Christian/G-5157-2015	Kristensen, Lars/0000-0003-1159-3721; Brinch, Christian/0000-0002-5074-7183; Yildiz, Umut/0000-0001-6197-2864; Brinch, Christian/0000-0002-5074-7183; Lis, Dariusz/0000-0002-0500-4700; Dominik, Carsten/0000-0002-3393-2459; Cleeves, L. Ilsedore/0000-0003-2076-8001	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [639.042.404]; NSF [0707777]; NASA	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA))	Herschel is a European Space Agency space observatory with science instruments provided by European-led principal investigator consortia and with important participation from NASA. This work was partially supported by Nederlandse Organisatie voor Wetenschappelijk Onderzoek grant 639.042.404, NSF grant 0707777, and, as part of the NASA Herschel HIFI guaranteed time program, NASA. The data presented here are archived at the Herschel Science Archive, http://archives.esac.esa.int/hda/ui, under OBSID 1342198337 and 1342201585.	Andersson S, 2008, ASTRON ASTROPHYS, V491, P907, DOI 10.1051/0004-6361:200810374; Bonev BP, 2007, ASTROPHYS J, V661, pL97, DOI 10.1086/518419; Calvet N, 2002, ASTROPHYS J, V568, P1008, DOI 10.1086/339061; Carr JS, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/102; De Graauw T, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014698; Dominik C, 2005, ASTROPHYS J, V635, pL85, DOI 10.1086/498942; Gorti U, 2011, ASTROPHYS J, V735, DOI 10.1088/0004-637X/735/2/90; Hayashi C., 1981, Progress of Theoretical Physics Supplement, P35, DOI 10.1143/PTPS.70.35; Honda M, 2009, ASTROPHYS J LETT, V690, pL110, DOI 10.1088/0004-637X/690/2/L110; Hughes AM, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/2/85; Kastner JH, 1997, SCIENCE, V277, P67, DOI 10.1126/science.277.5322.67; Limbach HH, 2006, CHEMPHYSCHEM, V7, P551, DOI 10.1002/cphc.200500559; MATSUI T, 1986, NATURE, V322, P526, DOI 10.1038/322526a0; Meijerink R, 2009, ASTROPHYS J, V704, P1471, DOI 10.1088/0004-637X/704/2/1471; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Pontoppidan KM, 2010, ASTROPHYS J LETT, V722, pL173, DOI 10.1088/2041-8205/722/2/L173; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Shinnaka Y, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/81; Terada H, 2007, ASTROPHYS J, V667, P303, DOI 10.1086/520951; Thi WF, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014578; Webb RA, 1999, ASTROPHYS J, V512, pL63, DOI 10.1086/311856; WEIDENSCHILLING SJ, 1977, MON NOT R ASTRON SOC, V180, P57, DOI 10.1093/mnras/180.2.57; Woitke P, 2009, ASTRON ASTROPHYS, V501, pL5, DOI 10.1051/0004-6361/200912249; Wooden DH, 2008, SPACE SCI REV, V138, P75, DOI 10.1007/s11214-008-9424-2	24	196	198	7	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					338	340		10.1126/science.1208931	http://dx.doi.org/10.1126/science.1208931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021851	Green Submitted			2022-12-24	WOS:000296052500042
J	Schmitz, RJ; Schultz, MD; Lewsey, MG; O'Malley, RC; Urich, MA; Libiger, O; Schork, NJ; Ecker, JR				Schmitz, Robert J.; Schultz, Matthew D.; Lewsey, Mathew G.; O'Malley, Ronan C.; Urich, Mark A.; Libiger, Ondrej; Schork, Nicholas J.; Ecker, Joseph R.			Transgenerational Epigenetic Instability Is a Source of Novel Methylation Variants	SCIENCE			English	Article							DNA METHYLATION; NATURAL VARIATION; GENE; MUTATION; EXPRESSION; TRANSPOSON; PATTERNS; ALLELES; SIRNAS	Epigenetic information, which may affect an organism's phenotype, can be stored and stably inherited in the form of cytosine DNA methylation. Changes in DNA methylation can produce meiotically stable epialleles that affect transcription and morphology, but the rates of spontaneous gain or loss of DNA methylation are unknown. We examined spontaneously occurring variation in DNA methylation in Arabidopsis thaliana plants propagated by single-seed descent for 30 generations. We identified 114,287 CG single methylation polymorphisms and 2485 CG differentially methylated regions (DMRs), both of which show patterns of divergence compared with the ancestral state. Thus, transgenerational epigenetic variation in DNA methylation may generate new allelic states that alter transcription, providing a mechanism for phenotypic diversity in the absence of genetic mutation.	[Schmitz, Robert J.; Schultz, Matthew D.; Lewsey, Mathew G.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Schmitz, Robert J.; Schultz, Matthew D.; Lewsey, Mathew G.; O'Malley, Ronan C.; Urich, Mark A.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Schultz, Matthew D.] Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Libiger, Ondrej; Schork, Nicholas J.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu	Ecker, Joseph R/B-9144-2008; Lewsey, Mathew G/AAE-8530-2019; Schmitz, Robert/AAY-7659-2020	Ecker, Joseph R/0000-0001-5799-5895; Schmitz, Robert/0000-0001-7538-6663; Schork, Nicholas/0000-0003-0920-5013; Lewsey, Mathew/0000-0002-2631-4337; omalley, ronan/0000-0002-4907-0339	NIH [F32-HG004830]; NSF [DGE-0504645, MCB-0929402, MCB1122246]; European Union [252475]; NIH/National Center for Research Resources [UL1 RR025774]; Mary K. Chapman Foundation; Howard Hughes Medical Institute; Gordon and Betty Moore Foundation (GBMF); NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004830, R01HG003523] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Union(European Commission); NIH/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mary K. Chapman Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation (GBMF)(Gordon and Betty Moore Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. White, R. Lister, M. Galli, and R. Amasino for discussions; R. Shaw and E. Darmo for seeds; J. Nery for sequencing operations; and M. Axtell for Southern blot protocol. R.J.S. was supported by an NIH National Research Service Award postdoctoral fellowship (F32-HG004830). M.D.S. was supported by a NSF Integrative Graduate Education and Research Traineeship grant (DGE-0504645). M.G.L. was supported by an European Union Framework Programme 7 Marie Curie International Outgoing Fellowship (project 252475). O.L. and N.J.S. are supported by NIH/National Center for Research Resources grant number UL1 RR025774. This work was supported by the Mary K. Chapman Foundation, the NSF (grants MCB-0929402 and MCB1122246), the Howard Hughes Medical Institute, and the Gordon and Betty Moore Foundation (GBMF) to J.R.E. J.R.E. is a HHMI-GBMF Investigator. Analyzed data sets can be viewed at http://neomorph.salk.edu/30_generations/browser.html. Sequence data can be downloaded from National Center for Biotechnology Information Sequence Read Archive (SRA035939). Correspondence and requests for materials should be addressed to J.R.E. (ecker@salk.edu).	BENDER J, 1995, CELL, V83, P725, DOI 10.1016/0092-8674(95)90185-X; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Melquist S, 1999, GENETICS, V153, P401; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nievergelt CM, 2006, AM J MED GENET B, V141B, P234, DOI 10.1002/ajmg.b.30252; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Saze H, 2007, EMBO J, V26, P3641, DOI 10.1038/sj.emboj.7601788; Shaw RG, 2000, GENETICS, V155, P369; Shibuya K, 2009, P NATL ACAD SCI USA, V106, P1660, DOI 10.1073/pnas.0809294106; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	29	421	434	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					369	373		10.1126/science.1212959	http://dx.doi.org/10.1126/science.1212959			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	21921155	Green Accepted			2022-12-24	WOS:000296052500051
J	Hirota, M; Holmgren, M; Van Nes, EH; Scheffer, M				Hirota, Marina; Holmgren, Milena; Van Nes, Egbert H.; Scheffer, Marten			Global Resilience of Tropical Forest and Savanna to Critical Transitions	SCIENCE			English	Article							ALTERNATIVE STABLE STATES; AFRICAN SAVANNAS; TREE COVER; AMAZON; DEFORESTATION; CLIMATE; FIRE; RAINFALL; SIMULATION; AUSTRALIA	It has been suggested that tropical forest and savanna could represent alternative stable states, implying critical transitions at tipping points in response to altered climate or other drivers. So far, evidence for this idea has remained elusive, and integrated climate models assume smooth vegetation responses. We analyzed data on the distribution of tree cover in Africa, Australia, and South America to reveal strong evidence for the existence of three distinct attractors: forest, savanna, and a treeless state. Empirical reconstruction of the basins of attraction indicates that the resilience of the states varies in a universal way with precipitation. These results allow the identification of regions where forest or savanna may most easily tip into an alternative state, and they pave the way to a new generation of coupled climate models.	[Holmgren, Milena] Wageningen Univ, Resource Ecol Grp, NL-6700 AA Wageningen, Netherlands; [Hirota, Marina; Van Nes, Egbert H.; Scheffer, Marten] Wageningen Univ, Dept Aquat Ecol & Water Qual Management, NL-6700 AA Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	Holmgren, M (corresponding author), Wageningen Univ, Resource Ecol Grp, POB 47, NL-6700 AA Wageningen, Netherlands.	milena.holmgren@wur.nl	van Nes, Egbert H/F-2681-2011; Scheffer, Marten/C-1852-2012; Hirota, Marina/E-6058-2012	Hirota, Marina/0000-0002-1958-3651; van Nes, Egbert/0000-0002-6345-104X	European Research Council; Spinoza award	European Research Council(European Research Council (ERC)European Commission); Spinoza award	This research was partly funded by the European Research Council-Early Warning grant and Spinoza award received by M.S. The data reported in this paper are extracted as described in the supporting online material from the publicly available sites of MODIS (www.glcf.umd.edu/data/vcf/) and the Climatic Research Unit (www.cru.uea.ac.uk/cru/data/hrg/).	Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Bond WJ, 2008, ANNU REV ECOL EVOL S, V39, P641, DOI 10.1146/annurev.ecolsys.39.110707.173411; Bowman DMJS, 2010, LANDSCAPE ECOL, V25, P1247, DOI 10.1007/s10980-010-9496-8; Brovkin V, 1998, J GEOPHYS RES-ATMOS, V103, P31613, DOI 10.1029/1998JD200006; Bucini G, 2007, GLOBAL ECOL BIOGEOGR, V16, P593, DOI 10.1111/j.1466-8238.2007.00325.x; DUBLIN HT, 1990, J ANIM ECOL, V59, P1147, DOI 10.2307/5037; ELTAHIR EAB, 1994, ADV WATER RESOUR, V17, P101, DOI 10.1016/0309-1708(94)90027-2; Higgins SI, 2007, ECOLOGY, V88, P1119, DOI 10.1890/06-1664; Hill MJ., 2011, ECOSYSTEM FUNCTION S; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; Liedloff AC, 2007, ECOL MODEL, V201, P269, DOI 10.1016/j.ecolmodel.2006.09.013; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Mayle FE, 2007, PHILOS T R SOC B, V362, P291, DOI 10.1098/rstb.2006.1987; Nepstad DC, 2008, PHILOS T R SOC B, V363, P1737, DOI 10.1098/rstb.2007.0036; Nobre CA, 2009, CURR OPIN ENV SUST, V1, P28, DOI 10.1016/j.cosust.2009.07.003; Oyama MD, 2004, J CLIMATE, V17, P3203, DOI [10.1175/1520-0442(2004)017<3203:CCOALD>2.0.CO;2, 10.1175/1520-0442(2004)017&lt;3203:CCOALD&gt;2.0.CO;2]; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Staver AC, 2011, ECOLOGY, V92, P1063, DOI 10.1890/i0012-9658-92-5-1063; Sternberg LDL, 2001, GLOBAL ECOL BIOGEOGR, V10, P369, DOI 10.1046/j.1466-822X.2001.00243.x; Warman L, 2009, LANDSCAPE ECOL, V24, P1, DOI 10.1007/s10980-008-9285-9; Williams RJ, 1996, J BIOGEOGR, V23, P747, DOI 10.1111/j.1365-2699.1996.tb00036.x; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525	29	721	732	20	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 14	2011	334	6053					232	235		10.1126/science.1210657	http://dx.doi.org/10.1126/science.1210657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998390				2022-12-24	WOS:000295833600048
J	Papaemmanuil, E; Cazzola, M; Boultwood, J; Malcovati, L; Vyas, P; Bowen, D; Pellagatti, A; Wainscoat, JS; Hellstrom-Lindberg, E; Gambacorti-Passerini, C; Godfrey, AL; Rapado, I; Cvejic, A; Rance, R; McGee, C; Ellis, P; Mudie, LJ; Stephens, PJ; McLaren, S; Massie, CE; Tarpey, PS; Varela, I; Nik-Zainal, S; Davies, HR; Shlien, A; Jones, D; Raine, K; Hinton, J; Butler, AP; Teague, JW; Baxter, EJ; Score, J; Galli, A; Della Porta, MG; Travaglino, E; Groves, M; Tauro, S; Munshi, NC; Anderson, KC; El-Naggar, A; Fischer, A; Mustonen, V; Warren, AJ; Cross, NCP; Green, AR; Futreal, PA; Stratton, MR; Campbell, PJ				Papaemmanuil, E.; Cazzola, M.; Boultwood, J.; Malcovati, L.; Vyas, P.; Bowen, D.; Pellagatti, A.; Wainscoat, J. S.; Hellstrom-Lindberg, E.; Gambacorti-Passerini, C.; Godfrey, A. L.; Rapado, I.; Cvejic, A.; Rance, R.; McGee, C.; Ellis, P.; Mudie, L. J.; Stephens, P. J.; McLaren, S.; Massie, C. E.; Tarpey, P. S.; Varela, I.; Nik-Zainal, S.; Davies, H. R.; Shlien, A.; Jones, D.; Raine, K.; Hinton, J.; Butler, A. P.; Teague, J. W.; Baxter, E. J.; Score, J.; Galli, A.; Della Porta, M. G.; Travaglino, E.; Groves, M.; Tauro, S.; Munshi, N. C.; Anderson, K. C.; El-Naggar, A.; Fischer, A.; Mustonen, V.; Warren, A. J.; Cross, N. C. P.; Green, A. R.; Futreal, P. A.; Stratton, M. R.; Campbell, P. J.		Int Canc Genome Consortium	Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DNMT3A MUTATIONS; FREQUENT MUTATION; GENE ASXL1; CLASSIFICATION; MECHANISMS; PATHWAYS; PATTERNS; TET2	BACKGROUND Myelodysplastic syndromes are a diverse and common group of chronic hematologic cancers. The identification of new genetic lesions could facilitate new diagnostic and therapeutic strategies. METHODS We used massively parallel sequencing technology to identify somatically acquired point mutations across all protein-coding exons in the genome in 9 patients with low-grade myelodysplasia. Targeted resequencing of the gene encoding RNA splicing factor 3B, subunit 1 (SF3B1), was also performed in a cohort of 2087 patients with myeloid or other cancers. RESULTS We identified 64 point mutations in the 9 patients. Recurrent somatically acquired mutations were identified in SF3B1. Follow-up revealed SF3B1 mutations in 72 of 354 patients (20%) with myelodysplastic syndromes, with particularly high frequency among patients whose disease was characterized by ring sideroblasts (53 of 82 [65%]). The gene was also mutated in 1 to 5% of patients with a variety of other tumor types. The observed mutations were less deleterious than was expected on the basis of chance, suggesting that the mutated protein retains structural integrity with altered function. SF3B1 mutations were associated with down-regulation of key gene networks, including core mitochondrial pathways. Clinically, patients with SF3B1 mutations had fewer cytopenias and longer event-free survival than patients without SF3B1 mutations. CONCLUSIONS Mutations in SF3B1 implicate abnormalities of messenger RNA splicing in the pathogenesis of myelodysplastic syndromes. (Funded by the Wellcome Trust and others.)	[Papaemmanuil, E.; Rapado, I.; Cvejic, A.; Rance, R.; McGee, C.; Ellis, P.; Mudie, L. J.; Stephens, P. J.; McLaren, S.; Tarpey, P. S.; Varela, I.; Nik-Zainal, S.; Davies, H. R.; Shlien, A.; Jones, D.; Raine, K.; Hinton, J.; Butler, A. P.; Teague, J. W.; Fischer, A.; Mustonen, V.; Futreal, P. A.; Stratton, M. R.; Campbell, P. J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Boultwood, J.; Pellagatti, A.] Univ Oxford, Nuffield Dept Clin Lab Sci, Oxford, England; [Vyas, P.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Bowen, D.] St James Hosp, St James Inst Oncol, Leeds LS9 7TF, W Yorkshire, England; [Godfrey, A. L.; Cvejic, A.; Massie, C. E.; Baxter, E. J.; Warren, A. J.; Green, A. R.; Campbell, P. J.] Univ Cambridge, Dept Haematol, Cambridge, England; [Warren, A. J.] Univ Cambridge, MRC, Mol Biol Lab, Cambridge, England; [Warren, A. J.; Green, A. R.; Campbell, P. J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 2QQ, England; [Score, J.; Cross, N. C. P.] Univ Southampton, Sch Med, Southampton, Hants, England; [Groves, M.; Tauro, S.] Univ Dundee, Div Med Sci, Dundee, Scotland; [Cazzola, M.; Malcovati, L.; Galli, A.; Della Porta, M. G.; Travaglino, E.] Univ Pavia, Policlin San Matteo, Fdn Ist Ricovero & Cura Carattere Sci, I-27100 Pavia, Italy; [Hellstrom-Lindberg, E.] Karolinska Inst, Dept Hematol, Stockholm, Sweden; [Gambacorti-Passerini, C.] S Gerardo Hosp, Dept Hematol, Monza, Italy; [Gambacorti-Passerini, C.] Univ Milano Bicocca, Milan, Italy; [Munshi, N. C.; Anderson, K. C.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Munshi, N. C.] VA Boston Healthcare Syst, Boston, MA USA; [El-Naggar, A.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Fischer, A.] Univ Cologne, Inst Theoret Phys, D-5000 Cologne, Germany	Wellcome Trust Sanger Institute; University of Oxford; University of Oxford; Saint James's University Hospital; University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Southampton; University of Dundee; IRCCS Fondazione San Matteo; University of Pavia; Karolinska Institutet; University of Milano-Bicocca; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; University of Texas System; UTMD Anderson Cancer Center; University of Cologne	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	pc8@sanger.ac.uk	Malcovati, Luca/CAJ-1695-2022; Munshi, Nikhil/ABE-2338-2021; Vyas, Paresh/B-5708-2009; Mustonen, Ville/J-1155-2018; Mustonen, Ville/X-1599-2019; Gallì, Anna/N-8109-2019; Varela, Ignacio/G-1699-2016; Cross, Nicholas/B-4817-2009; Varela, Ignacio/AAA-7680-2021; Nik-Zainal, Serena/ABD-4437-2020; Cazzola, Mario/AAQ-8854-2021	Malcovati, Luca/0000-0002-1460-1611; Vyas, Paresh/0000-0003-3931-0914; Mustonen, Ville/0000-0002-7270-1792; Mustonen, Ville/0000-0002-7270-1792; Gallì, Anna/0000-0002-4039-3756; Varela, Ignacio/0000-0002-0969-506X; Cross, Nicholas/0000-0001-5481-2555; Varela, Ignacio/0000-0002-0969-506X; Cazzola, Mario/0000-0001-6984-8817; Massie, Charlie/0000-0003-2314-4843; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Baxter, Elizabeth Joanna/0000-0002-5946-5238; Cvejic, Ana/0000-0003-3204-9311; Boultwood, Jacqueline/0000-0002-4330-2928; Della Porta, Matteo Giovanni/0000-0002-6915-5970; Pellagatti, Andrea/0000-0002-6122-0221; Green, Anthony/0000-0002-9795-0218; Nik-Zainal, Serena/0000-0001-5054-1727; Raine, Keiran/0000-0002-5634-1539	Wellcome Trust [077012/Z/05/Z, WT088340MA]; Kay Kendall Leukaemia Fund; Leukemia Lymphoma Research; Adenoid Cystic Carcinoma Research Foundation; Medical Research Council (MRC); Oxford National Institutes for Health Research Biomedical Research Centre; International Human Frontier Science Program Organization; Department of Veterans Affairs; National Institutes of Health [R01-124929, P01-155249, P50-100007, P01-78378]; Association for International Cancer Research; Leukemia Lymphoma Society; Associazione Italiana per la Ricerca sul Cancro; Fondazione Cariplo; MRC [G1000729, G0800784, MC_U105161083] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA124929, P01CA078378] Funding Source: NIH RePORTER; Medical Research Council [G0800784, G0800784B, MC_U105161083, G1000729, G1000801c] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Kay Kendall Leukaemia Fund; Leukemia Lymphoma Research; Adenoid Cystic Carcinoma Research Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford National Institutes for Health Research Biomedical Research Centre; International Human Frontier Science Program Organization(Human Frontier Science Program); Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association for International Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Wellcome Trust (077012/Z/05/Z, for the overall study, as well as WT088340MA, to Dr. Campbell), the Kay Kendall Leukaemia Fund, Leukemia Lymphoma Research (for the overall study and to Drs. Boultwood, Green, Vyas, and Wainscoat), the Adenoid Cystic Carcinoma Research Foundation, the Medical Research Council (MRC) (to Dr. Warren), the Oxford National Institutes for Health Research Biomedical Research Centre (to Drs. Boultwood, Vyas, and Wainscoat), the Swedish Cancer Society (to Dr. Hellstrom-Lindburg), the International Human Frontier Science Program Organization (to Dr. Varela), the Department of Veterans Affairs and the National Institutes of Health (R01-124929, P01-155249, P50-100007, and P01-78378, to Drs. Munshi and Anderson), the Association for International Cancer Research and the Leukemia Lymphoma Society (to Drs. Warren and Green), Associazione Italiana per la Ricerca sul Cancro (to the University of Pavia, the University of Milan Bicocca, and Dr. Cazzola), and Fondazione Cariplo (to the University of Pavia and the University of Milan Bicocca).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Boultwood J, 2010, LEUKEMIA, V24, P1062, DOI 10.1038/leu.2010.20; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Camaschella C, 2009, SEMIN HEMATOL, V46, P371, DOI 10.1053/j.seminhematol.2009.07.001; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ewalt M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.7; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer A, 2011, GENETICS, V188, P383, DOI 10.1534/genetics.111.127480; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Golas MM, 2005, MOL CELL, V17, P869, DOI 10.1016/j.molcel.2005.02.016; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Langemeijer SMC, 2009, NAT GENET, V41, P838, DOI 10.1038/ng.391; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Navarro I, 2006, LEUKEMIA RES, V30, P971, DOI 10.1016/j.leukres.2005.11.015; Notta F, 2010, NATURE, V471, P254; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; Pellagatti, 2006, BLOOD, V108, P1128; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Pellagatti A, 2007, P NATL ACAD SCI USA, V104, P11406, DOI 10.1073/pnas.0610477104; Pellagatti A, 2006, BLOOD, V108, P337, DOI 10.1182/blood-2005-12-4769; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Tehranchi R, 2005, BLOOD, V106, P247, DOI 10.1182/blood-2004-12-4649; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Walter MJ, 2011, LEUKEMIA, V25, P1153, DOI 10.1038/leu.2011.44; Wang CY, 1998, GENE DEV, V12, P1409, DOI 10.1101/gad.12.10.1409	40	847	891	4	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 13	2011	365	15					1384	1395		10.1056/NEJMoa1103283	http://dx.doi.org/10.1056/NEJMoa1103283			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	832DQ	21995386	Green Published, Green Accepted			2022-12-24	WOS:000295782500006
J	Yoshida, K; Sanada, M; Shiraishi, Y; Nowak, D; Nagata, Y; Yamamoto, R; Sato, Y; Sato-Otsubo, A; Kon, A; Nagasaki, M; Chalkidis, G; Suzuki, Y; Shiosaka, M; Kawahata, R; Yamaguchi, T; Otsu, M; Obara, N; Sakata-Yanagimoto, M; Ishiyama, K; Mori, H; Nolte, F; Hofmann, WK; Miyawaki, S; Sugano, S; Haferlach, C; Koeffler, HP; Shih, LY; Haferlach, T; Chiba, S; Nakauchi, H; Miyano, S; Ogawa, S				Yoshida, Kenichi; Sanada, Masashi; Shiraishi, Yuichi; Nowak, Daniel; Nagata, Yasunobu; Yamamoto, Ryo; Sato, Yusuke; Sato-Otsubo, Aiko; Kon, Ayana; Nagasaki, Masao; Chalkidis, George; Suzuki, Yutaka; Shiosaka, Masashi; Kawahata, Ryoichiro; Yamaguchi, Tomoyuki; Otsu, Makoto; Obara, Naoshi; Sakata-Yanagimoto, Mamiko; Ishiyama, Ken; Mori, Hiraku; Nolte, Florian; Hofmann, Wolf-Karsten; Miyawaki, Shuichi; Sugano, Sumio; Haferlach, Claudia; Koeffler, H. Phillip; Shih, Lee-Yung; Haferlach, Torsten; Chiba, Shigeru; Nakauchi, Hiromitsu; Miyano, Satoru; Ogawa, Seishi			Frequent pathway mutations of splicing machinery in myelodysplasia	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; PRE-MESSENGER-RNA; DEVELOPMENTAL DISORDER; SOMATIC MUTATIONS; U4ATAC SNRNA; GENOME; GENE; IDENTIFICATION; SPLICEOSOME; COMPONENT	Myelodysplastic syndromes and related disorders (myelodysplasia) are a heterogeneous group of myeloid neoplasms showing deregulated blood cell production with evidence of myeloid dysplasia and a predisposition to acute myeloid leukaemia, whose pathogenesis is only incompletely understood. Here we report whole-exome sequencing of 29 myelodysplasia specimens, which unexpectedly revealed novel pathway mutations involving multiple components of the RNA splicing machinery, including U2AF35, ZRSR2, SRSF2 and SF3B1. In a large series analysis, these splicing pathway mutations were frequent (similar to 45 to similar to 85%) in, and highly specific to, myeloid neoplasms showing features of myelodysplasia. Conspicuously, most of the mutations, which occurred in a mutually exclusive manner, affected genes involved in the 3'-splice site recognition during pre-mRNA processing, inducing abnormal RNA splicing and compromised haematopoiesis. Our results provide the first evidence indicating that genetic alterations of the major splicing components could be involved inhuman pathogenesis, also implicating a novel therapeutic possibility for myelodysplasia.	[Yoshida, Kenichi; Sanada, Masashi; Nagata, Yasunobu; Sato, Yusuke; Sato-Otsubo, Aiko; Kon, Ayana; Shiosaka, Masashi; Kawahata, Ryoichiro; Ogawa, Seishi] Univ Tokyo, Grad Sch Med, Canc Genom Project, Bunkyo Ku, Tokyo 1138655, Japan; [Shiraishi, Yuichi; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab DNA Informat Anal,Minato Ku, Tokyo 1088639, Japan; [Nowak, Daniel; Nolte, Florian; Hofmann, Wolf-Karsten] Univ Heidelberg, Dept Hematol & Oncol, Med Fac Manheim, D-68167 Mannheim, Germany; [Yamamoto, Ryo; Otsu, Makoto; Nakauchi, Hiromitsu] Univ Tokyo, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Nagasaki, Masao] Univ Tokyo, Lab Funct Genom, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Chalkidis, George; Miyano, Satoru] Univ Tokyo, Lab Sequence Data Anal, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Suzuki, Yutaka; Sugano, Sumio] Univ Tokyo, Div Syst Biomed Technol, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan; [Yamaguchi, Tomoyuki; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, Nakauchi Stem Cell & Organ Regenerat Project, Minato Ku, Tokyo 1088639, Japan; [Obara, Naoshi; Sakata-Yanagimoto, Mamiko; Chiba, Shigeru] Univ Tsukuba, Dept Hematol, Inst Clin Med, Tsukuba, Ibaraki 3058571, Japan; [Ishiyama, Ken; Miyawaki, Shuichi] Tokyo Metropolitan Otsuka Hosp, Div Hematol, Toshima Ku, Tokyo 1700005, Japan; [Mori, Hiraku] Showa Univ, Fujigaoka Hosp, Div Hematol, Aoba Ku, Kanagawa 2278501, Japan; [Haferlach, Claudia; Haferlach, Torsten] Munich Leukemia Lab, D-81377 Munich, Germany; [Koeffler, H. Phillip] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Koeffler, H. Phillip] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117456, Singapore; [Shih, Lee-Yung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Taipei 105, Taiwan	University of Tokyo; University of Tokyo; Ruprecht Karls University Heidelberg; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Japan Science & Technology Agency (JST); University of Tsukuba; Showa University; MLL Munich Leukemia Laboratory; Cedars Sinai Medical Center; National University of Singapore; Chang Gung Memorial Hospital; Chang Gung University	Ogawa, S (corresponding author), Univ Tokyo, Grad Sch Med, Canc Genom Project, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	sogawa-tky@umin.ac.jp	Mamiko, Sakata-yanagimoto/AAP-3298-2020; Ogawa, Seishi/AAE-7088-2019	Yoshida, Kenichi/0000-0003-4612-2778; Nagasaki, Masao/0000-0002-4292-8785; Miyano, Satoru/0000-0002-1753-6616; Nowak, Daniel/0000-0001-7130-7921; Otsu, Makoto/0000-0002-9769-0217	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [23791068, 22790895] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA026038] Funding Source: NIH RePORTER	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant-in-Aids from the Ministry of Health, Labor and Welfare of Japan and from the Ministry of Education, Culture, Sports, Science and Technology, and also by the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)', initiated by the Council for Science and Technology Policy (CSTP). pGCDNsamIRESEGFP vector was a gift from M. Onodera. We thank Y. Mori, O. Hagiwara, M. Nakamura and N. Mizota for their technical assistance. We are also grateful to K. Ikeuchi and M. Ueda for their continuous encouragement throughout the study.	Barlow JL, 2010, NAT MED, V16, P59, DOI 10.1038/nm.2063; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Calvo SE, 2010, NAT GENET, V42, P851, DOI 10.1038/ng.659; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Edery P, 2011, SCIENCE, V332, P240, DOI 10.1126/science.1202205; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Haase D, 2007, BLOOD, V110, P4385, DOI 10.1182/blood-2007-03-082404; He HL, 2011, SCIENCE, V332, P238, DOI 10.1126/science.1200587; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Ma X, 2007, CANCER-AM CANCER SOC, V109, P1536, DOI 10.1002/cncr.22570; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Shen HH, 2010, GENE DEV, V24, P2389, DOI 10.1101/gad.1974810; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tronchere H, 1997, NATURE, V388, P397, DOI 10.1038/41137; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	37	1246	1300	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					64	69		10.1038/nature10496	http://dx.doi.org/10.1038/nature10496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21909114				2022-12-24	WOS:000295575400035
J	Guo, CG; Yoon, HS; Franklin, A; Jain, S; Ebert, A; Cheng, HL; Hansen, E; Despo, O; Bossen, C; Vettermann, C; Bates, JG; Richards, N; Myers, D; Patel, H; Gallagher, M; Schlissel, MS; Murre, C; Busslinger, M; Giallourakis, CC; Alt, FW				Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew; Jain, Suvi; Ebert, Anja; Cheng, Hwei-Ling; Hansen, Erica; Despo, Orion; Bossen, Claudia; Vettermann, Christian; Bates, Jamie G.; Richards, Nicholas; Myers, Darienne; Patel, Harin; Gallagher, Michael; Schlissel, Mark S.; Murre, Cornelis; Busslinger, Meinrad; Giallourakis, Cosmas C.; Alt, Frederick W.			CTCF-binding elements mediate control of V(D)J recombination	NATURE			English	Article							B-CELL DEVELOPMENT; HEAVY-CHAIN LOCUS; VH GENE SEGMENTS; IGH LOCUS; REGULATORY ELEMENTS; INTRONIC ENHANCER; ANTISENSE TRANSCRIPTION; LYMPHOCYTE DEVELOPMENT; NUCLEAR-ORGANIZATION; REGION	Immunoglobulin heavy chain (IgH) variable region exons are assembled from V-H, D and J(H) gene segments in developing B lymphocytes. Within the 2.7-megabase mouse Igh locus, V(D)J recombination is regulated to ensure specific and diverse antibody repertoires. Here we report in mice a key Igh V(D)J recombination regulatory region, termed intergenic control region 1 (IGCR1), which lies between the V-H and D clusters. Functionally, IGCR1 uses CTCF looping/insulator factor-binding elements and, correspondingly, mediates Igh loops containing distant enhancers. IGCR1 promotes normal B-cell development and balances antibody repertoires by inhibiting transcription and rearrangement of D-H-proximal V-H gene segments and promoting rearrangement of distal V-H segments. IGCR1 maintains ordered and lineage-specific V-H(D)J(H) recombination by suppressing V-H joining to D segments not joined to J(H) segments, and V-H to DJ(H) joins in thymocytes, respectively. IGCR1 is also required for feedback regulation and allelic exclusion of proximal V-H-to-DJ(H) recombination. Our studies elucidate a long-sought Igh V(D) J recombination control region and indicate a new role for the generally expressed CTCF protein.	[Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew; Jain, Suvi; Cheng, Hwei-Ling; Hansen, Erica; Despo, Orion; Richards, Nicholas; Myers, Darienne; Patel, Harin; Gallagher, Michael; Giallourakis, Cosmas C.; Alt, Frederick W.] Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, Boston, MA 02115 USA; [Guo, Chunguang; Yoon, Hye Suk; Franklin, Andrew; Jain, Suvi; Cheng, Hwei-Ling; Hansen, Erica; Despo, Orion; Richards, Nicholas; Myers, Darienne; Patel, Harin; Gallagher, Michael; Giallourakis, Cosmas C.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ebert, Anja; Busslinger, Meinrad] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Bossen, Claudia; Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Vettermann, Christian; Bates, Jamie G.; Schlissel, Mark S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Giallourakis, Cosmas C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of California System; University of California San Diego; University of California System; University of California Berkeley; Harvard University; Massachusetts General Hospital	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Immune Dis Inst, 300 Longwood Ave, Boston, MA 02115 USA.	cgiallourakis@partners.org; alt@enders.tch.harvard.edu	Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351; Vettermann, Christian/0000-0003-3794-6441	NIH [RO1 AI20047, RO1 HL48702, RO1 AI40227, CA054198-20, K08 AI070839]; Austrian GEN-AU initiative; Boehringer Ingelheim; Cancer Research Institute; Marie Curie Fellowship; EMBO; NATIONAL CANCER INSTITUTE [T32CA009151, R37CA054198, R01CA054198] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020047, R37AI040227, K08AI070839, R01AI040227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian GEN-AU initiative; Boehringer Ingelheim(Boehringer Ingelheim); Cancer Research Institute; Marie Curie Fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Y. Fujiwara and P.-Y. Huang for generating chimaeric mice. This work was supported by NIH grants RO1 AI20047 (to F. W. A.), RO1 HL48702 and AI40227 (to M. S. S.), CA054198-20 (to C. M.) and K08 AI070839 (to C. C. G.). M. B. was supported by the Austrian GEN-AU initiative and Boehringer Ingelheim. C. G. is supported by an Irvington Institute Postdoctoral Fellowship from the Cancer Research Institute. C. V. is supported by a Marie Curie Fellowship. C. B. is supported by an EMBO fellowship. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; Barreto V, 2000, J IMMUNOL, V164, P893, DOI 10.4049/jimmunol.164.2.893; Bates JG, 2007, J EXP MED, V204, P3247, DOI 10.1084/jem.20071787; Bergman Y, 2010, SEMIN IMMUNOL, V22, P323, DOI 10.1016/j.smim.2010.07.003; Bulger M, 2010, DEV BIOL, V339, P250, DOI 10.1016/j.ydbio.2009.11.035; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; Corcoran AE, 2010, SEMIN IMMUNOL, V22, P353, DOI 10.1016/j.smim.2010.08.001; DECKER DJ, 1991, J IMMUNOL, V147, P1406; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Degner-Leisso SC, 2010, SEMIN IMMUNOL, V22, P346, DOI 10.1016/j.smim.2010.08.002; Dudley DD, 2003, J EXP MED, V198, P1439, DOI 10.1084/jem.20030627; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Featherstone K, 2010, J BIOL CHEM, V285, P9327, DOI 10.1074/jbc.M109.098251; Feeney A, 2010, SEMIN IMMUNOL, V22, P311, DOI 10.1016/j.smim.2010.09.002; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Giallourakis CC, 2010, P NATL ACAD SCI USA, V107, P22207, DOI 10.1073/pnas.1015954107; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Hirano SL, 2001, IMMUNOGENETICS, V53, P54, DOI 10.1007/s002510000287; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Jhunjhunwala S, 2009, CELL, V138, P435, DOI 10.1016/j.cell.2009.07.016; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kyrchanova O, 2008, NUCLEIC ACIDS RES, V36, P7019, DOI 10.1093/nar/gkn781; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; MacPherson MJ, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-101; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Perlot T, 2008, ADV IMMUNOL, V99, P1, DOI 10.1016/S0065-2776(08)00601-9; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; RETH MG, 1985, NATURE, V317, P353, DOI 10.1038/317353a0; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sakai E, 1999, P NATL ACAD SCI USA, V96, P1526, DOI 10.1073/pnas.96.4.1526; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subrahmanyam R, 2010, SEMIN IMMUNOL, V22, P337, DOI 10.1016/j.smim.2010.08.003; tenBoekel E, 1997, IMMUNITY, V7, P357; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; Zhang Y, 2010, ADV IMMUNOL, V106, P93, DOI 10.1016/S0065-2776(10)06004-9	53	193	202	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					424	U182		10.1038/nature10495	http://dx.doi.org/10.1038/nature10495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21909113	Green Accepted			2022-12-24	WOS:000295080500032
J	Cordenonsi, M; Zanconato, F; Azzolin, L; Forcato, M; Rosato, A; Frasson, C; Inui, M; Montagner, M; Parenti, AR; Poletti, A; Daidone, MG; Dupont, S; Basso, G; Bicciato, S; Piccolo, S				Cordenonsi, Michelangelo; Zanconato, Francesca; Azzolin, Luca; Forcato, Mattia; Rosato, Antonio; Frasson, Chiara; Inui, Masafumi; Montagner, Marco; Parenti, Anna R.; Poletti, Alessandro; Daidone, Maria Grazia; Dupont, Sirio; Basso, Giuseppe; Bicciato, Silvio; Piccolo, Stefano			The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION SIGNATURE; IN-VITRO PROPAGATION; TUMORIGENESIS; POLARITY; METASTASIS; PATHWAY; TUMORS	Cancer stem cells (CSCs) are proposed to drive tumor initiation and progression. Yet, our understanding of the cellular and molecular mechanisms that underlie CSC properties is limited. Here we show that the activity of TAZ, a transducer of the Hippo pathway, is required to sustain self-renewal and tumor-initiation capacities in breast CSCs. TAZ protein levels and activity are elevated in prospective CSCs and in poorly differentiated human tumors and have prognostic value. Gain of TAZ endows self-renewal capacity to non-CSCs. In epithelial cells, TAZ forms a complex with the cell-polarity determinant Scribble, and loss of Scribble- or induction of the epithelial-mesenchymal transition (EMT)disrupts the inhibitory association of TAZ with the core Hippo kinases MST and LATS. This study links the CSC concept to the Hippo pathway in breast cancer and reveals a mechanistic basis of the control of Hippo kinases by cell polarity.	[Cordenonsi, Michelangelo; Zanconato, Francesca; Azzolin, Luca; Inui, Masafumi; Montagner, Marco; Dupont, Sirio; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35126 Padua, Italy; [Forcato, Mattia; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy; [Rosato, Antonio] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Rosato, Antonio] Ist Oncol Veneto IOV, I-35126 Padua, Italy; [Frasson, Chiara; Basso, Giuseppe] Univ Padua, Dept Pediat, I-35128 Padua, Italy; [Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Poletti, Alessandro] Hosp San Bassiano, Div Anat Pathol, I-36061 Bassano Del Grappa, Italy; [Daidone, Maria Grazia] Ist Nazl Tumori, Fdn IRCCS, I-20133 Milan, Italy	University of Padua; Universita di Modena e Reggio Emilia; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; University of Padua; ULSS 7 Pedemontana; Ospedale San Bassiano; Fondazione IRCCS Istituto Nazionale Tumori Milan	Cordenonsi, M (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35126 Padua, Italy.	michelangelo.cordenonsi@unipd.it; piccolo@bio.unipd.it	Forcato, Mattia/B-7733-2015; BICCIATO, Silvio/J-4466-2019; Daidone, Maria Grazia/E-9232-2017; Montagner, Marco/AAY-3236-2020; Rosato, Antonio/E-8626-2010; Cordenonsi, Michelangelo/K-7692-2016; Bicciato, Silvio/C-9825-2009; Azzolin, Luca/K-8012-2016; Inui, Masafumi/GWZ-2521-2022; Dupont, Sirio/AAP-8133-2021	Forcato, Mattia/0000-0002-7383-6576; BICCIATO, Silvio/0000-0002-1944-7078; Daidone, Maria Grazia/0000-0002-4786-1321; Montagner, Marco/0000-0003-3080-2138; Rosato, Antonio/0000-0002-5263-8386; Cordenonsi, Michelangelo/0000-0002-8253-5724; Bicciato, Silvio/0000-0002-1944-7078; Azzolin, Luca/0000-0002-2425-6153; Inui, Masafumi/0000-0003-4720-007X; BASSO, GIUSEPPE/0000-0002-2634-9302; PICCOLO, STEFANO/0000-0002-2037-0004; Dupont, Sirio/0000-0002-6869-1966	Italian Welfare Ministry; AIRC (Italian Association for Cancer Research)-MFAG; AIRC; Fondazione Citta della Speranza; MIUR; P.R.I.N.; AIRC-PI; University of Padua; Italian Institute of Technology; Comitato Promotore Telethon	Italian Welfare Ministry; AIRC (Italian Association for Cancer Research)-MFAG(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione Citta della Speranza; MIUR(Ministry of Education, Universities and Research (MIUR)); P.R.I.N.(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC-PI(Fondazione AIRC per la ricerca sul cancro); University of Padua; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT); Comitato Promotore Telethon(Fondazione Telethon)	We thank O. Wessely for comments; S. Santner and R. A. Weinberg for cells and reagents; Vincenza Guzzardo, Vera Cappelletti, and Genesio Leo for help with clinical samples and immunohistochemistry; and L. Naldini for pMD2-VSVG vector. This work is supported by a "Young Italian Researchers'' grant of the Italian Welfare Ministry and AIRC (Italian Association for Cancer Research)-MFAG to M. C.; by AIRC interregional Pediatric Project Grant, Fondazione Citta della Speranza Grant, and MIUR and P.R.I.N. grants to G. B.; by AIRC Special Program Molecular Clinical Oncology "5 per mille'' grant to S.B.; and by AIRC-PI, AIRC Special Program Molecular Clinical Oncology "5 per mille'', University of Padua Strategic-grant, Seed-grant from Italian Institute of Technology, and Comitato Promotore Telethon grants to S.P.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	33	894	917	1	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4					759	772		10.1016/j.cell.2011.09.048	http://dx.doi.org/10.1016/j.cell.2011.09.048			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22078877	Bronze			2022-12-24	WOS:000296902300011
J	Engels, EA; Pfeiffer, RM; Fraumeni, JF; Kasiske, BL; Israni, AK; Snyder, JJ; Wolfe, RA; Goodrich, NP; Bayakly, AR; Clarke, CA; Copeland, G; Finch, JL; Fleissner, ML; Goodman, MT; Kahn, A; Koch, L; Lynch, CF; Madeleine, MM; Pawlish, K; Rao, C; Williams, MA; Castenson, D; Curry, M; Parsons, R; Fant, G; Lin, M				Engels, Eric A.; Pfeiffer, Ruth M.; Fraumeni, Joseph F., Jr.; Kasiske, Bertram L.; Israni, Ajay K.; Snyder, Jon J.; Wolfe, Robert A.; Goodrich, Nathan P.; Bayakly, A. Rana; Clarke, Christina A.; Copeland, Glenn; Finch, Jack L.; Fleissner, Mary Lou; Goodman, Marc T.; Kahn, Amy; Koch, Lori; Lynch, Charles F.; Madeleine, Margaret M.; Pawlish, Karen; Rao, Chandrika; Williams, Melanie A.; Castenson, David; Curry, Michael; Parsons, Ruth; Fant, Gregory; Lin, Monica			Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; KIDNEY-TRANSPLANTATION; BRONCHOGENIC-CARCINOMA; LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION; LUNG TRANSPLANTATION; CELL CARCINOMA; DISEASE; PEOPLE; AGENTS	Context Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. Objective To describe the overall pattern of cancer following solid organ transplantion. Design, Setting, and Participants Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. Main Outcome Measures Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. Results The registry linkages yielded data on 175 732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10 656 cases and an incidence of 1375 per 100 000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100 000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n=1504; incidence: 194.0 per 100 000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100 000 person-years) and cancers of the lung (n=1344; incidence: 173.4 per 100 000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100 000 person-years), liver (n= 930; incidence: 120.0 per 100 000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100 000 person-years), and kidney (n= 752; incidence: 97.0 per 100 000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100 000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). Conclusion Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers. JAMA. 2011; 306(17): 1891-1901	[Engels, Eric A.; Pfeiffer, Ruth M.; Fraumeni, Joseph F., Jr.] NCI, Rockville, MD 20892 USA; [Kasiske, Bertram L.; Israni, Ajay K.; Snyder, Jon J.] Sci Registry Transplant Recipients, Minneapolis, MN USA; [Kasiske, Bertram L.; Israni, Ajay K.; Snyder, Jon J.] Minneapolis Med Res Fdn Inc, Minneapolis, MN USA; [Wolfe, Robert A.; Goodrich, Nathan P.] Sci Registry Transplant Recipients, Ann Arbor, MI USA; [Wolfe, Robert A.; Goodrich, Nathan P.] Arbor Res Collaborat Hlth, Ann Arbor, MI USA; [Bayakly, A. Rana] Georgia Comprehens Canc Registry, Atlanta, GA USA; [Clarke, Christina A.] Canc Prevent Inst Calif, Fremont, CA USA; [Copeland, Glenn] Michigan Dept Community Hlth, Lansing, MI USA; [Finch, Jack L.] Colorado Cent Canc Registry, Denver, CO USA; [Fleissner, Mary Lou] Connecticut Tumor Registry, Hartford, CT USA; [Goodman, Marc T.] Univ Hawaii, Program Epidemiol, Honolulu, HI 96822 USA; [Kahn, Amy] New York State Canc Registry, Albany, NY USA; [Koch, Lori] Illinois State Canc Registry, Springfield, IL USA; [Lynch, Charles F.] Univ Iowa, Dept Epidemiol, Iowa City, IA USA; [Madeleine, Margaret M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Pawlish, Karen] New Jersey Dept Hlth & Senior Serv, Trenton, NJ USA; [Rao, Chandrika] N Carolina Cent Canc Registry, Raleigh, NC USA; [Williams, Melanie A.] Texas Dept State Hlth Serv, Austin, TX USA; [Castenson, David; Curry, Michael; Parsons, Ruth] Informat Management Serv Inc, Rockville, MD USA; [Fant, Gregory; Lin, Monica] US Hlth Resources & Serv Adm, Rockville, MD 20857 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Minneapolis Medical Research Foundation; Arbor Research Collaborative for Health; Cancer Prevention Institute of California; MDHHS - Michigan Department of Health & Human Services; University of Hawaii System; University of Iowa; Fred Hutchinson Cancer Center; New Jersey Department of Health & Senior Services; Texas Department of State Health Services; Information Management Services, Inc.; United States Health Resources & Service Administration (HRSA)	Engels, EA (corresponding author), NCI, 6120 Execut Blvd,EPS 7076, Rockville, MD 20892 USA.	engelse@exchange.nih.gov		Goodman, Marc/0000-0002-4839-3021	Bristol-Myers Squibb; Roche; Genzyme; American Society of Nephrology; RTI International; Arbor Research Collaborative for Health [HHSH234200537009C]; Minneapolis Medical Research Foundation [HHSH250201000018C]; Centers for Disease Control and Prevention: California [1U58 DP000807-01]; Centers for Disease Control and Prevention: Colorado [U58 DP000848-04]; Centers for Disease Control and Prevention: Georgia [5U58DP000817-05]; Centers for Disease Control and Prevention: Illinois [5658DP000805-04]; Centers for Disease Control and Prevention: Michigan [5U58DP000812-03]; Centers for Disease Control and Prevention: New Jersey [5U58/DP000808-03]; Centers for Disease Control and Prevention: NewYork [15-0351]; Centers for Disease Control and Prevention: North Carolina [U58DP000832]; Centers for Disease Control and Prevention: Texas [5U58DP000824-04]; National Cancer Institute: California [HHSN261201000036C, HHSN261201000035C, HHSN261201000034C]; National Cancer Institute: Connecticut [HHSN261201000024C]; National Cancer Institute: Hawaii [HHSN261201000037C, N01-PC35137, N01-PC-35139]; National Cancer Institute: Iowa [N01-PC35143]; National Cancer Institute: New Jersey [HHSN261200544005C ADB, N01-PC-54405]; National Cancer Institute: Seattle-Puget Sound [N01-PC-35142]; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010150] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000812, U58DP000808, U58DP000848, U58DP000807, U58DP000805, U58DP000824, U58DP000832, U58DP000817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Roche(Roche Holding); Genzyme(Sanofi-AventisGenzyme Corporation); American Society of Nephrology; RTI International; Arbor Research Collaborative for Health; Minneapolis Medical Research Foundation; Centers for Disease Control and Prevention: California; Centers for Disease Control and Prevention: Colorado; Centers for Disease Control and Prevention: Georgia; Centers for Disease Control and Prevention: Illinois; Centers for Disease Control and Prevention: Michigan; Centers for Disease Control and Prevention: New Jersey; Centers for Disease Control and Prevention: NewYork; Centers for Disease Control and Prevention: North Carolina; Centers for Disease Control and Prevention: Texas; National Cancer Institute: California; National Cancer Institute: Connecticut; National Cancer Institute: Hawaii; National Cancer Institute: Iowa; National Cancer Institute: New Jersey; National Cancer Institute: Seattle-Puget Sound; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kasiske reported that he receives grant funding from Bristol-Myers Squibb. Dr Israni reported that he receives grant funding from Bristol-Myers Squibb, Roche, and Genzyme. Dr Snyder reported that he receives consultancy fees from Genzyme for his participation on a scientific review board; research support is paid to his institution by Bristol-Myers Squibb and Genzyme; and he has received payment from the American Society of Nephrology for his work as an invited educational speaker. Mr Finch reported that consulting fees were paid to his institution by RTI International; he received travel expenses from RTI International for his work in Michigan to assist with electronic data match. No other disclosures were reported.; During most of the period in which the study was conducted, the Scientific Registry of Transplant Recipients was managed by Arbor Research Collaborative for Health (contract HHSH234200537009C). Beginning in September 2010, the Scientific Registry of Transplant Recipients was managed by Minneapolis Medical Research Foundation (contract HHSH250201000018C). The following cancer registries were supported by the National Program of Cancer Registries of the Centers for Disease Control and Prevention: California (agreement 1U58 DP000807-01), Colorado (agreement U58 DP000848-04), Georgia (agreement 5U58DP000817-05), Illinois (agreement 5658DP000805-04), Michigan (agreement 5U58DP000812-03), New Jersey (agreement 5U58/DP000808-03), NewYork (agreement 15-0351), North Carolina (agreement U58DP000832), and Texas (agreement 5U58DP000824-04). The following cancer registries were supported by the Surveillance, Epidemiology and End Results Program of the National Cancer Institute: California (contracts HHSN261201000036C, HHSN261201000035C, and HHSN261201000034C), Connecticut (contract HHSN261201000024C), Hawaii (contracts HHSN261201000037C, N01-PC35137, and N01-PC-35139), Iowa (contract N01-PC35143), New Jersey (contract HHSN261200544005C ADB No. N01-PC-54405), and Seattle-Puget Sound (contract N01-PC-35142). Additional support was provided by California, Colorado, Connecticut, Illinois, Iowa, New Jersey, and New York (Cancer Surveillance Improvement Initiative No. 14-2491), Texas, and Washington, as well as the Fred Hutchinson Cancer Research Center. This research was supported in part by the Intramural Research Program of the National Cancer Institute.	Abrahams NA, 2004, TRANSPL P, V36, P2808, DOI 10.1016/j.transproceed.2004.10.014; Adami J, 2003, BRIT J CANCER, V89, P1221, DOI 10.1038/sj.bjc.6601219; Andreome P, 2003, ARCH INTERN MED, V163, P1997, DOI 10.1001/archinte.163.17.1997; [Anonymous], SURVEILLANCE EPIDEMI; BIRKELAND SA, 1995, INT J CANCER, V60, P183, DOI 10.1002/ijc.2910600209; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Breslow NE, 1987, DESIGN ANAL COHORT S, VII; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chaturvedi AK, 2008, ANN EPIDEMIOL, V18, P230, DOI 10.1016/j.annepidem.2007.10.005; Cockfield S M, 2001, Transpl Infect Dis, V3, P70; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; de Mattos AM, 2000, AM J KIDNEY DIS, V35, P333, DOI 10.1016/S0272-6386(00)70348-9; Dickson RP, 2006, J HEART LUNG TRANSPL, V25, P1297, DOI 10.1016/j.healun.2006.09.009; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Faull RJ, 2005, TRANSPLANTATION, V80, P193, DOI 10.1097/01.TP.0000165098.49658.F3; Goh A, 2011, AM J TRANSPLANT, V11, P86, DOI 10.1111/j.1600-6143.2010.03303.x; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Guba M, 2004, TRANSPLANTATION, V77, P1777, DOI 10.1097/01.tp.0000120181.89206.54; Harris NL, 2001, WHO CLASSIFICATION T, P264; HEINZPEER G, 1995, RADIOLOGY, V195, P667, DOI 10.1148/radiology.195.3.7753991; Hoffmann CJ, 2008, TRANSPLANTATION, V86, P784, DOI 10.1097/TP.0b013e3181837761; Kasiske BL, 2004, AM J TRANSPLANT, V4, P905, DOI 10.1111/j.1600-6143.2004.00450.x; Kasiske BL, 2000, J AM SOC NEPHROL, V11, pS1; Kyllonen L, 2000, Transpl Int, V13 Suppl 1, pS394, DOI 10.1007/s001470050369; Layman AB, 2008, JAIDS-J ACQ IMM DEF, V48, P365, DOI 10.1097/QAI.0b013e31817ae5da; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Minai OA, 2008, J THORAC ONCOL, V3, P1404, DOI 10.1097/JTO.0b013e31818e1259; Opelz G, 2004, AM J TRANSPLANT, V4, P222, DOI 10.1046/j.1600-6143.2003.00325.x; Quinlan SC, 2011, AM J HEMATOL, V86, P206, DOI 10.1002/ajh.21911; Ritchie AJ, 2007, J HEART LUNG TRANSPL, V26, P1206, DOI 10.1016/j.healun.2007.07.017; Serraino D, 2005, BRIT J CANCER, V92, P572, DOI 10.1038/sj.bjc.6602346; Swindle P, 1998, BRIT J UROL, V81, P229; Thuluvath PJ, 2010, AM J TRANSPLANT, V10, P1003, DOI 10.1111/j.1600-6143.2010.03037.x; US Department of Health and Human Services, ORG PROC TRANSPL NET; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vajdic CM, 2009, INT J CANCER, V125, P1747, DOI 10.1002/ijc.24439; van Leeuwen MT, 2009, BLOOD, V114, P630, DOI 10.1182/blood-2009-02-202507; Villeneuve PJ, 2007, AM J TRANSPLANT, V7, P941, DOI 10.1111/j.1600-6143.2007.01736.x; Welch HG, 2010, J NATL CANCER I, V102, P605, DOI 10.1093/jnci/djq099	39	930	955	3	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1891	1901		10.1001/jama.2011.1592	http://dx.doi.org/10.1001/jama.2011.1592			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	22045767	Green Accepted			2022-12-24	WOS:000296376200023
J	Mackelprang, R; Waldrop, MP; DeAngelis, KM; David, MM; Chavarria, KL; Blazewicz, SJ; Rubin, EM; Jansson, JK				Mackelprang, Rachel; Waldrop, Mark P.; DeAngelis, Kristen M.; David, Maude M.; Chavarria, Krystle L.; Blazewicz, Steven J.; Rubin, Edward M.; Jansson, Janet K.			Metagenomic analysis of a permafrost microbial community reveals a rapid response to thaw	NATURE			English	Article							BACTERIAL COMMUNITY; R-PACKAGE; DIVERSITY; CARBON; SOIL; RNA; DISCOVERY; ALIGNMENT; SEARCH; GENES	Permafrost contains an estimated 1672 Pg carbon (C), an amount roughly equivalent to the total currently contained within land plants and the atmosphere(1-3). This reservoir of C is vulnerable to decomposition as rising global temperatures cause the permafrost to thaw(2). During thaw, trapped organic matter may become more accessible for microbial degradation and result in greenhouse gas emissions(4,5). Despite recent advances in the use of molecular tools to study permafrost microbial communities(6-9), their response to thaw remains unclear. Here we use deep metagenomic sequencing to determine the impact of thaw on microbial phylogenetic and functional genes, and relate these data to measurements of methane emissions. Metagenomics, the direct sequencing of DNA from the environment, allows the examination of whole biochemical pathways and associated processes, as opposed to individual pieces of the metabolic puzzle. Our metagenome analyses reveal that during transition from a frozen to a thawed state there are rapid shifts in many microbial, phylogenetic and functional gene abundances and pathways. After one week of incubation at 5 degrees C, permafrost metagenomes converge to be more similar to each other than while they are frozen. We find that multiple genes involved in cycling of C and nitrogen shift rapidly during thaw. We also construct the first draft genome from a complex soil metagenome, which corresponds to a novel methanogen. Methane previously accumulated in permafrost is released during thaw and subsequently consumed by methanotrophic bacteria. Together these data point towards the importance of rapid cycling of methane and nitrogen in thawing permafrost.	[Mackelprang, Rachel; Rubin, Edward M.; Jansson, Janet K.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Mackelprang, Rachel] Calif State Univ Northridge, Dept Biol, Northridge, CA 91330 USA; [Waldrop, Mark P.] US Geol Survey, Menlo Pk, CA 94025 USA; [DeAngelis, Kristen M.; David, Maude M.; Chavarria, Krystle L.; Jansson, Janet K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Earth Sci, Berkeley, CA 94720 USA; [Blazewicz, Steven J.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; California State University System; California State University Northridge; United States Department of the Interior; United States Geological Survey; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Jansson, JK (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.	jrjansson@lbl.gov	Jansson, Janet/H-5478-2018	Jansson, Janet/0000-0002-5487-4315; Waldrop, Mark/0000-0003-1829-7140; DeAngelis, Kristen/0000-0002-5585-4551; Blazewicz, Steven/0000-0001-7517-1750; David, Maude/0000-0003-1561-418X	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Venture Capital; United States Geological Survey	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Venture Capital; United States Geological Survey(United States Geological Survey)	The work conducted by the Lawrence Berkeley National Laboratory Earth Sciences Division (Laboratory Directed Research Development) and the Joint Genome Institute was supported in part by the Office of Science of the US Department of Energy under Contract no. DE-AC02-05CH11231. This study was also supported by the Venture Capital and Yukon River Basin project of the United States Geological Survey. We acknowledge the technical support by the Joint Genome Institute production team. We thank A. Sczyrba, R. Egan and S. Canon for discussions and advice.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2010, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blow MJ, 2008, GENOME RES, V18, P1347, DOI 10.1101/gr.076091.108; Brodie E, 2002, MICROB ECOL, V44, P260, DOI 10.1007/s00248-002-2012-1; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; David MM, 2008, J MICROBIOL METH, V73, P73, DOI 10.1016/j.mimet.2008.01.001; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ferry JG, 2010, ANNU REV MICROBIOL, V64, P453, DOI 10.1146/annurev.micro.112408.134051; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hansen AA, 2007, ENVIRON MICROBIOL, V9, P2870, DOI 10.1111/j.1462-2920.2007.01403.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; MURRAY PA, 1984, NATURE, V312, P284, DOI 10.1038/312284a0; Oksanen J., 2016, R PACKAG; Osterkamp TE, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000578; Prater JL, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002866; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rivkina E, 2007, FEMS MICROBIOL ECOL, V61, P1, DOI 10.1111/j.1574-6941.2007.00315.x; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Schuur EAG, 2008, BIOSCIENCE, V58, P701, DOI 10.1641/B580807; Steven B, 2008, ENVIRON MICROBIOL, V10, P3388, DOI 10.1111/j.1462-2920.2008.01746.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tarnocai C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003327; Trotsenko YA, 2005, FEMS MICROBIOL ECOL, V53, P15, DOI 10.1016/j.femsec.2005.02.010; Waldrop MP, 2010, GLOBAL CHANGE BIOL, V16, P2543, DOI 10.1111/j.1365-2486.2009.02141.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Williams R, 2006, NAT METHODS, V3, P545, DOI 10.1038/NMETH896; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	44	465	490	32	746	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					368	U120		10.1038/nature10576	http://dx.doi.org/10.1038/nature10576			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22056985	Green Submitted			2022-12-24	WOS:000298033000051
J	Zielke, N; Kim, KJ; Tran, V; Shibutani, ST; Bravo, MJ; Nagarajan, S; van Straaten, M; Woods, B; von Dassow, G; Rottig, C; Lehner, CF; Grewal, SS; Duronio, RJ; Edgar, BA				Zielke, Norman; Kim, Kerry J.; Vuong Tran; Shibutani, Shusaku T.; Bravo, Maria-Jose; Nagarajan, Sabarish; van Straaten, Monique; Woods, Brigitte; von Dassow, George; Rottig, Carmen; Lehner, Christian F.; Grewal, Savraj S.; Duronio, Robert J.; Edgar, Bruce A.			Control of Drosophila endocycles by E2F and CRL4(CDT2)	NATURE			English	Article							DEPENDENT KINASE INHIBITOR; CYCLIN-E; CELL-PROLIFERATION; S-PHASE; DNA-REPLICATION; TRANSCRIPTIONAL PROGRAM; ENDOREPLICATION CYCLES; DEVELOPMENTAL CONTROL; PROGRESSION; EXPRESSION	Endocycles are variant cell cycles comprised of DNA synthesis (S)- and gap (G)-phases but lacking mitosis(1,2). Such cycles facilitate post-mitotic growth in many invertebrate and plant cells, and are so ubiquitous that they may account for up to half the world's biomass(3,4). DNA replication in endocycling Drosophila cells is triggered by cyclin E/cyclin dependent kinase 2 (CYCE/CDK2), but this kinase must be inactivated during each G-phase to allow the assembly of pre-Replication Complexes (preRCs) for the next S-phase(5,6). How CYCE/CDK2 is periodically silenced to allow re-replication has not been established. Here, using genetic tests in parallel with computational modelling, we show that the endocycles of Drosophila are driven by a molecular oscillator in which the E2F1 transcription factor promotes CycE expression and S-phase initiation, S-phase then activates the CRL4(CDT2) ubiquitin ligase, and this in turn mediates the destruction of E2F1 (ref. 7). We propose that it is the transient loss of E2F1 during S phases that creates the window of low Cdk activity required for preRC formation. In support of this model overexpressed E2F1 accelerated endocycling, whereas a stabilized variant of E2F1 blocked endocycling by de-regulating target genes, including CycE, as well as Cdk1 and mitotic cyclins. Moreover, we find that altering cell growth by changing nutrition or target of rapamycin (TOR) signalling impacts E2F1 translation, thereby making endocycle progression growth-dependent. Many of the regulatory interactions essential to this novel cell cycle oscillator are conserved in animals and plants(1,2,8), indicating that elements of this mechanism act in most growth-dependent cell cycles.	[Zielke, Norman; van Straaten, Monique; Edgar, Bruce A.] Univ Heidelberg ZMBH Alliance, Zentrum Mol Biol, German Canc Res Ctr DKFZ, D-69120 Heidelberg, Germany; [Zielke, Norman; Vuong Tran; Bravo, Maria-Jose; Woods, Brigitte; Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Kim, Kerry J.; von Dassow, George] Univ Washington, Friday Harbor Labs, Ctr Cell Dynam, Friday Harbor, WA 98250 USA; [Shibutani, Shusaku T.; Duronio, Robert J.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Nagarajan, Sabarish; Grewal, Savraj S.] Univ Calgary, Clark H Smith Brain Tumor Ctr, So Alberta Canc Res Inst, Calgary, AB T2N 4N1, Canada; [Nagarajan, Sabarish; Grewal, Savraj S.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada; [Rottig, Carmen; Lehner, Christian F.] Univ Zurich, Inst Mol & Life Sci IMLS, CH-8057 Zurich, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Fred Hutchinson Cancer Center; University of Washington; University of North Carolina; University of North Carolina Chapel Hill; University of Calgary; University of Calgary; University of Zurich	Edgar, BA (corresponding author), Univ Heidelberg ZMBH Alliance, Zentrum Mol Biol, German Canc Res Ctr DKFZ, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	b.edgar@dkfz.de		van Straaten, Monique/0000-0003-1100-8676; Duronio, Robert/0000-0001-6469-6965	NIH [GM51186, GM57859]; DAAD; NIGMS [5 P50 GM66050]; NSF [MCB0090835]; DFG [LE987/5-1]; CIHR [MOP-86622]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057859, R01GM051186, P50GM066050] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); DFG(German Research Foundation (DFG)); CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH GM51186 to B. A. E., a DAAD fellowship to N.Z., NIGMS 5 P50 GM66050 and NSF MCB0090835 to G. v. D. and K.J.K, DFG LE987/5-1 to C. F. L., CIHR MOP-86622 to S. G., and NIH GM57859 to R.J.D. We thank Y. Liu for help with statistics.	Asano M, 1996, GENE DEV, V10, P1422, DOI 10.1101/gad.10.11.1422; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DURONIO RJ, 1994, DEVELOPMENT, V120, P1503; Duronio RJ, 1998, MOL CELL BIOL, V18, P141, DOI 10.1128/MCB.18.1.141; DURONIO RJ, 1995, GENE DEV, V9, P1445, DOI 10.1101/gad.9.12.1445; DURONIO RJ, 1995, GENE DEV, V9, P1456, DOI 10.1101/gad.9.12.1456; DYNLACHT BD, 1994, P NATL ACAD SCI USA, V91, P6359, DOI 10.1073/pnas.91.14.6359; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Frolov MV, 2005, MOL CELL BIOL, V25, P3027, DOI 10.1128/MCB.25.8.3027-3039.2005; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; HAMMOND MP, 1985, CHROMOSOMA, V91, P279, DOI 10.1007/BF00328223; Heriche JK, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-9; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; Lane ME, 2000, GENETICS, V155, P233; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Maqbool SB, 2010, J CELL SCI, V123, P4095, DOI 10.1242/jcs.064519; Moberg KH, 2004, CURR BIOL, V14, P965, DOI 10.1016/j.cub.2004.04.040; Narbonne-Reveau K, 2008, DEVELOPMENT, V135, P1451, DOI 10.1242/dev.016295; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; RICHARDSON HE, 1993, DEVELOPMENT, V119, P673; Roodbarkelari F, 2010, P NATL ACAD SCI USA, V107, P15275, DOI 10.1073/pnas.1006941107; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Shibutani ST, 2008, DEV CELL, V15, P890, DOI 10.1016/j.devcel.2008.10.003; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; Sugimoto-Shirasu K, 2003, CURR OPIN PLANT BIOL, V6, P544, DOI 10.1016/j.pbi.2003.09.009; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; Weng L, 2003, EMBO J, V22, P3865, DOI 10.1093/emboj/cdg373; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Xin SJ, 2002, DEVELOPMENT, V129, P1345; Zielke N, 2008, GENE DEV, V22, P1690, DOI 10.1101/gad.469108	45	102	104	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 1	2011	480	7375					123	U296		10.1038/nature10579	http://dx.doi.org/10.1038/nature10579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PO	22037307	Green Accepted, Green Submitted			2022-12-24	WOS:000298031900047
J	Du, JT; Zhou, YY; Su, XY; Yu, JJ; Khan, S; Jiang, H; Kim, J; Woo, J; Kim, JH; Choi, BH; He, B; Chen, W; Zhang, S; Cerione, RA; Auwerx, J; Hao, Q; Lin, HN				Du, Jintang; Zhou, Yeyun; Su, Xiaoyang; Yu, Jiu Jiu; Khan, Saba; Jiang, Hong; Kim, Jungwoo; Woo, Jimin; Kim, Jun Huyn; Choi, Brian Hyun; He, Bin; Chen, Wei; Zhang, Sheng; Cerione, Richard A.; Auwerx, Johan; Hao, Quan; Lin, Hening			Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase	SCIENCE			English	Article							STRUCTURAL BASIS; MALONYL-COA; DEACETYLASES; MECHANISM; INSIGHTS; ACETYLATION; INHIBITION; SIRTUINS; PEPTIDE; CELLS	Silent information regulator 2 (Sir2) proteins (sirtuins) are nicotinamide adenine dinucleotide-dependent deacetylases that regulate important biological processes. Mammals have seven sirtuins, Sirt1 to Sirt7. Four of them (Sirt4 to Sirt7) have no detectable or very weak deacetylase activity. We found that Sirt5 is an efficient protein lysine desuccinylase and demalonylase in vitro. The preference for succinyl and malonyl groups was explained by the presence of an arginine residue (Arg(105)) and tyrosine residue (Tyr(102)) in the acyl pocket of Sirt5. Several mammalian proteins were identified with mass spectrometry to have succinyl or malonyl lysine modifications. Deletion of Sirt5 in mice appeared to increase the level of succinylation on carbamoyl phosphate synthase 1, which is a known target of Sirt5. Thus, protein lysine succinylation may represent a posttranslational modification that can be reversed by Sirt5 in vivo.	[Zhou, Yeyun; Hao, Quan] Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA; [Du, Jintang; Su, Xiaoyang; Khan, Saba; Jiang, Hong; Kim, Jungwoo; Woo, Jimin; Kim, Jun Huyn; Choi, Brian Hyun; He, Bin; Cerione, Richard A.; Lin, Hening] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Yu, Jiu Jiu; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Chen, Wei; Zhang, Sheng] Cornell Univ, Prote & Mass Spectrometry Core Facil, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Hao, Quan] Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China	Cornell University; Cornell University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Cornell University; Cornell University; University of Hong Kong	Hao, Q (corresponding author), Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA.	qhao@hku.hk; hl379@cornell.edu	Yu, Jiujiu/H-7181-2013; Su, Xiaoyang/Q-4884-2018; Su, Xiaoyang/B-3398-2008; Hao, Quan/C-4304-2009; Auwerx, Johan/ABE-9307-2021	Kim, Jungwoo/0000-0002-5215-2044; Hao, Quan/0000-0002-9642-0514; Su, Xiaoyang/0000-0001-8081-1396; Auwerx, Johan/0000-0002-5065-5393	Dreyfus Foundation; NIH [R01GM086703, RR01646]; Hong Kong [GRF766510]; NIH PPG [DK58920]; European Union [ERC-2008-AdG-23118]; Ecole Polytechnique Federale de Lausanne; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086703] Funding Source: NIH RePORTER	Dreyfus Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hong Kong; NIH PPG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Ecole Polytechnique Federale de Lausanne; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported in part by Dreyfus Foundation (H.L.); grants NIH R01GM086703 (H.L.), Hong Kong GRF766510 (Q.H.), NIH RR01646 (R.A.C. and Q.H.), and NIH PPG DK58920 (J.A.); the European Union Ideas program (sirtuins; ERC-2008-AdG-23118 to J.A.); and the Ecole Polytechnique Federale de Lausanne (J.A.). Atomic coordinates and structure factors were deposited in the Protein Data Bank (accession codes 3RIG and 3RIY).	Cosgrove MS, 2006, BIOCHEMISTRY-US, V45, P7511, DOI 10.1021/bi0526332; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Gao L, 2007, J CHROMATOGR B, V853, P303, DOI 10.1016/j.jchromb.2007.03.029; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hawse WF, 2008, STRUCTURE, V16, P1368, DOI 10.1016/j.str.2008.05.015; Hoff KG, 2006, STRUCTURE, V14, P1231, DOI 10.1016/j.str.2006.06.006; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Kim KH, 1997, ANNU REV NUTR, V17, P77, DOI 10.1146/annurev.nutr.17.1.77; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Rosen R, 2004, FEBS LETT, V577, P386, DOI 10.1016/j.febslet.2004.10.037; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith BC, 2007, BIOCHEMISTRY-US, V46, P14478, DOI 10.1021/bi7013294; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Zhang ZH, 2011, NAT CHEM BIOL, V7, P58, DOI [10.1038/nchembio.495, 10.1038/NCHEMBIO.495]; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	25	892	933	8	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 11	2011	334	6057					806	809		10.1126/science.1207861	http://dx.doi.org/10.1126/science.1207861			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845US	22076378	Green Submitted, Green Accepted			2022-12-24	WOS:000296849600047
J	Mullen, AC; Orlando, DA; Newman, JJ; Loven, J; Kumar, RM; Bilodeau, S; Reddy, J; Guenther, MG; DeKoter, RP; Young, RA				Mullen, Alan C.; Orlando, David A.; Newman, Jamie J.; Loven, Jakob; Kumar, Roshan M.; Bilodeau, Steve; Reddy, Jessica; Guenther, Matthew G.; DeKoter, Rodney P.; Young, Richard A.			Master Transcription Factors Determine Cell-Type-Specific Responses to TGF-beta Signaling	CELL			English	Article							EMBRYONIC STEM-CELLS; REGULATORY CIRCUITRY; MAINTAINS PLURIPOTENCY; HISTONE MODIFICATIONS; GENE-EXPRESSION; SELF-RENEWAL; C-MYC; SMAD; PATHWAYS; FIBROBLASTS	Transforming growth factor beta (TGF-beta) signaling, mediated through the transcription factors Smad2 and Smad3 (Smad2/3), directs different responses in different cell types. Here we report that Smad3 co-occupies the genome with cell-type-specific master transcription factors. Thus, Smad3 occupies the genome with Oct4 in embryonic stem cells (ESCs), Myod1 in myotubes, and PU.1 in pro-B cells. We find that these master transcription factors are required for Smad3 occupancy and that TGF-beta signaling largely affects the genes bound by the master transcription factors. Furthermore, we show that induction of Myod1 in nonmuscle cells is sufficient to redirect Smad3 to Myod1 sites. We conclude that cell-type-specific master transcription factors determine the genes bound by Smad2/3 and are thus responsible for orchestrating the cell-type-specific effects of TGF-beta signaling.	[Mullen, Alan C.; Orlando, David A.; Newman, Jamie J.; Loven, Jakob; Kumar, Roshan M.; Bilodeau, Steve; Reddy, Jessica; Guenther, Matthew G.; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Mullen, Alan C.] Harvard Univ, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Newman, Jamie J.; Reddy, Jessica; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA; [DeKoter, Rodney P.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Western University (University of Western Ontario)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012; DeKoter, Rodney/A-9415-2009	Young, Richard A/0000-0001-8855-8647; DeKoter, Rodney/0000-0002-9201-1983; Mullen, Alan/0000-0002-4096-3106; Bilodeau, Steve/0000-0002-9799-3832	American Gastroenterological Association; NIH [DK090122, HG002668]; Canadian Institutes of Health Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090122] Funding Source: NIH RePORTER	American Gastroenterological Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to M.S.H. Ko for the gift of ES[MC1R(20)]:tetMyod1 cells, D. Wotton for the gift of Smad2/3 antibody, and H. Singh for providing the 38B9 cells with permission from N. Rosenberg. We thank T. Lee and L. Lawton for helpful discussions; J. Love, J-A. Kwon, V. Dhanapal, S. Gupta, and T. Volkert for Illumina sequencing and microarray preparation; G. Frampton and B. Yuan for help with computational analysis; and T. DiCesare for help with graphics. We also thank A. Blais for assistance with siRNA transfection. This work was supported by fellowships from the American Gastroenterological Association and NIH grant DK090122 (A.C.M.), the Canadian Institutes of Health Research (S.B.), and NIH grant HG002668 (R.A.Y.).	BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen X, 1996, NATURE, V383, P691, DOI 10.1038/383691a0; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Dejosez M, 2010, GENE DEV, V24, P1479, DOI 10.1101/gad.1935210; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Germain S, 2000, GENE DEV, V14, P435; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Seoane J, 2004, CANCER BIOL THER, V3, P226, DOI 10.4161/cbt.3.2.717; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Trompouki E, 2011, CELL, V147, P577, DOI 10.1016/j.cell.2011.09.044; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	62	420	428	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					565	576		10.1016/j.cell.2011.08.050	http://dx.doi.org/10.1016/j.cell.2011.08.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036565	Bronze, Green Accepted, Green Submitted			2022-12-24	WOS:000296573700012
J	Hua, YM; Sahashi, K; Rigo, F; Hung, G; Horev, G; Bennett, CF; Krainer, AR				Hua, Yimin; Sahashi, Kentaro; Rigo, Frank; Hung, Gene; Horev, Guy; Bennett, C. Frank; Krainer, Adrian R.			Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model	NATURE			English	Article							IGF-I; CARDIAC DEFECTS; MICE; DELIVERY; PHENOTYPE; GROWTH; SURVIVAL; DISEASES	Spinal muscular atrophy (SMA) is a motor neuron disease and the leading genetic cause of infant mortality; it results from loss-of-function mutations in the survival motor neuron 1 (SMN1) gene(1). Humans have a paralogue, SMN2, whose exon 7 is predominantly skipped(2), but the limited amount of functional, full-length SMN protein expressed from SMN2 cannot fully compensate for a lack of SMN1. SMN is important for the biogenesis of spliceosomal small nuclear ribonucleoprotein particles(3), but downstream splicing targets involved in pathogenesis remain elusive. There is no effective SMA treatment, but SMN restoration in spinal cord motor neurons is thought to be necessary and sufficient(4). Non-central nervous system (CNS) pathologies, including cardiovascular defects, were recently reported in severe SMA mouse models and patients(5-8), reflecting autonomic dysfunction or direct effects in cardiac tissues. Here we compared systemic versus CNS restoration of SMN in a severe mouse model(9,10). We used an antisense oligonucleotide (ASO), ASO-10-27, that effectively corrects SMN2 splicing and restores SMN expression in motor neurons after intracerebroventricular injection(11,12). Systemic administration of ASO-10-27 to neonates robustly rescued severe SMA mice, much more effectively than intracerebroventricular administration; subcutaneous injections extended the median lifespan by 25 fold. Furthermore, neonatal SMA mice had decreased hepatic Igfals expression, leading to a pronounced reduction in circulating insulin-like growth factor 1 (IGF1), and ASO-10-27 treatment restored IGF1 to normal levels. These results suggest that the liver is important in SMA pathogenesis, underscoring the importance of SMN in peripheral tissues, and demonstrate the efficacy of a promising drug candidate.	[Hua, Yimin; Sahashi, Kentaro; Horev, Guy; Krainer, Adrian R.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Rigo, Frank; Hung, Gene; Bennett, C. Frank] ISIS Pharmaceut, Carlsbad, CA 92010 USA	Cold Spring Harbor Laboratory; Isis Pharmaceuticals Inc	Krainer, AR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	Krainer@cshl.edu	Hua, Yimin/U-6911-2018	Hua, Yimin/0000-0003-0905-7989; Krainer, Adrian/0000-0001-9024-9501	Muscular Dystrophy Association; National Institute of General Medical Sciences; St. Giles Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042699, R37GM042699] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); St. Giles Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from the Muscular Dystrophy Association, the National Institute of General Medical Sciences and St. Giles Foundation. We thank J. Bu and M. Passini for protocols and advice on NMJ staining, and S. Hearn for assistance with microscope imaging.	Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Colao A, 2008, CLIN ENDOCRINOL, V69, P347, DOI 10.1111/j.1365-2265.2008.03292.x; Domene HM, 2009, HORM RES, V72, P129, DOI 10.1159/000232486; Dominguez E, 2011, HUM MOL GENET, V20, P681, DOI 10.1093/hmg/ddq514; Ek CJ, 2003, J COMP NEUROL, V460, P451, DOI 10.1002/cne.10661; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2010, BIOCHEM BIOPH RES CO, V391, P517, DOI 10.1016/j.bbrc.2009.11.090; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lorson CL, 2010, HUM MOL GENET, V19, pR111, DOI 10.1093/hmg/ddq147; Millino C, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-14; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Riessland M, 2010, HUM MOL GENET, V19, P1492, DOI 10.1093/hmg/ddq023; Rudnik-Schoneborn S, 2008, J MED GENET, V45, P635, DOI 10.1136/jmg.2008.057950; Shababi M, 2011, HUM GENE THER, V22, P135, DOI 10.1089/hum.2010.114; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Sorenson EJ, 2008, NEUROLOGY, V71, P1770, DOI 10.1212/01.wnl.0000335970.78664.36; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Trejo JL, 2004, J MOL MED, V82, P156, DOI 10.1007/s00109-003-0499-7; Wu YJ, 2009, ENDOCRINOLOGY, V150, P4395, DOI 10.1210/en.2009-0272	30	497	533	3	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 6	2011	478	7367					123	126		10.1038/nature10485	http://dx.doi.org/10.1038/nature10485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829JN	21979052	Green Accepted			2022-12-24	WOS:000295575400047
J	Chonghaile, TN; Sarosiek, KA; Vo, TT; Ryan, JA; Tammareddi, A; Moore, VD; Deng, J; Anderson, KC; Richardson, P; Tai, YT; Mitsiades, CS; Matulonis, UA; Drapkin, R; Stone, R; DeAngelo, DJ; McConkey, DJ; Sallan, SE; Silverman, L; Hirsch, MS; Carrasco, DR; Letai, A				Chonghaile, Triona Ni; Sarosiek, Kristopher A.; Thanh-Trang Vo; Ryan, Jeremy A.; Tammareddi, Anupama; Moore, Victoria Del Gaizo; Deng, Jing; Anderson, Kenneth C.; Richardson, Paul; Tai, Yu-Tzu; Mitsiades, Constantine S.; Matulonis, Ursula A.; Drapkin, Ronny; Stone, Richard; DeAngelo, Daniel J.; McConkey, David J.; Sallan, Stephen E.; Silverman, Lewis; Hirsch, Michelle S.; Carrasco, Daniel Ruben; Letai, Anthony			Pretreatment Mitochondrial Priming Correlates with Clinical Response to Cytotoxic Chemotherapy	SCIENCE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; MULTIPLE-MYELOMA CELLS; IN-VIVO; APOPTOSIS; PROLIFERATION; INHIBITOR; PROTEINS; THERAPY; DEATH; LENALIDOMIDE	Cytotoxic chemotherapy targets elements common to all nucleated human cells, such as DNA and microtubules, yet it selectively kills tumor cells. Here we show that clinical response to these drugs correlates with, and may be partially governed by, the pretreatment proximity of tumor cell mitochondria to the apoptotic threshold, a property called mitochondrial priming. We used BH3 profiling to measure priming in tumor cells from patients with multiple myeloma, acute myelogenous and lymphoblastic leukemia, and ovarian cancer. This assay measures mitochondrial response to peptides derived from proapoptotic BH3 domains of proteins critical for death signaling to mitochondria. Patients with highly primed cancers exhibited superior clinical response to chemotherapy. In contrast, chemoresistant cancers and normal tissues were poorly primed. Manipulation of mitochondrial priming might enhance the efficacy of cytotoxic agents.	[Chonghaile, Triona Ni; Sarosiek, Kristopher A.; Thanh-Trang Vo; Ryan, Jeremy A.; Tammareddi, Anupama; Deng, Jing; Anderson, Kenneth C.; Richardson, Paul; Tai, Yu-Tzu; Mitsiades, Constantine S.; Matulonis, Ursula A.; Drapkin, Ronny; Stone, Richard; DeAngelo, Daniel J.; Carrasco, Daniel Ruben; Letai, Anthony] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Moore, Victoria Del Gaizo] Elon Univ, Dept Chem, Elon, NC 27244 USA; [McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Thanh-Trang Vo] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Drapkin, Ronny; Hirsch, Michelle S.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Sallan, Stephen E.; Silverman, Lewis] Childrens Hosp Boston, Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Elon University; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute	Letai, A (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	anthony_letai@dfci.harvard.edu	Chonghaile, Triona Ni/L-9418-2015; Drapkin, Ronny/E-9944-2016	Chonghaile, Triona Ni/0000-0002-3041-4031; Drapkin, Ronny/0000-0002-6912-6977; Del Gaizo Moore, Victoria/0000-0002-6317-7693; Ryan, Jeremy/0000-0002-3327-1283; Sarosiek, Kristopher/0000-0002-4618-5085	Multiple Myeloma Research Foundation; American Cancer Society [121360-PF-11-256-01-TBG]; Dana-Farber Cancer Institute; Gabrielle's Angel Foundation for Cancer Research; FLAMES Fund of the Pan-Mass Challenge; NIH [RO1CA129974, P01CA068484, P01CA139980]; NATIONAL CANCER INSTITUTE [P01CA139980, R01CA129974, P01CA068484] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; American Cancer Society(American Cancer Society); Dana-Farber Cancer Institute; Gabrielle's Angel Foundation for Cancer Research; FLAMES Fund of the Pan-Mass Challenge; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank I. Galinsky, J. Feather, R. Berkowitz, N. Horowitz, C. Feltmate, M. Muto, E. Kantoff, K. Daniels, and C. Doyle for assistance with human tumor sample procurement; K.-K. Wong and T. Mitchison for critical review; and K. Stevenson for help with biostatistical analysis. We thank Abbott Laboratories for providing ABT-737. We gratefully acknowledge funding from the Multiple Myeloma Research Foundation (T. N. C.), American Cancer Society Postdoctoral Fellowship 121360-PF-11-256-01-TBG (K. A. S.), Women's Cancers Program at the Dana-Farber Cancer Institute (K. A. S.), Gabrielle's Angel Foundation for Cancer Research (T.-T.V.), FLAMES Fund of the Pan-Mass Challenge, and NIH grants RO1CA129974, P01CA068484, and P01CA139980. A. L. is a Leukemia and Lymphoma Society Scholar. A. L. is a cofounder of and a paid advisor to Eutropics Pharmaceuticals, which has purchased a license for BH3 profiling from Dana-Farber Cancer Institute. P. R. is a paid advisor to Millennium Pharmaceuticals, Celgene Corporation, Novartis Pharmaceuticals, Johnson & Johnson, and Bristol Myers Squibb. T. N. C. and J. A. R. are paid consultants to Eutropics Pharmaceuticals. R. D. is a paid consultant for Novartis Pharmaceuticals and Forma Therapeutics. C. S. M. is a paid consultant for Millennium, Celgene, Novartis, Bristol-Myers Squibb, Merck & Co., Kosan Pharmaceuticals, Pharmion, Centocor, and Amnis Therapeutics. The authors (A. L.) and Dana-Farber Cancer Institute have applied for a patent relating to the use of BH3 profiling in predicting chemosensitivity.	Anderson KC, 2005, SEMIN HEMATOL, V42, pS3, DOI 10.1053/j.seminhematol.2005.10.001; Bosch F, 2008, CLIN CANCER RES, V14, P155, DOI 10.1158/1078-0432.CCR-07-1371; Brunelle JK, 2009, J CELL BIOL, V187, P429, DOI 10.1083/jcb.200904049; Burnett A, 2011, J CLIN ONCOL, V29, P487, DOI 10.1200/JCO.2010.30.1820; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chauhan D, 1997, ONCOGENE, V15, P837, DOI 10.1038/sj.onc.1201253; Chauhan D, 2010, BLOOD, V115, P834, DOI 10.1182/blood-2009-03-213009; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hideshima T, 2001, CANCER RES, V61, P3071; Hurwitz JL, 2009, ONCOLOGIST, V14, P986, DOI 10.1634/theoncologist.2009-0026; KUBBEN FJGM, 1994, GUT, V35, P530, DOI 10.1136/gut.35.4.530; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Marcus R, 2005, BLOOD, V105, P1417, DOI 10.1182/blood-2004-08-3175; Moore VD, 2007, J CLIN INVEST, V117, P112, DOI 10.1172/JCI28281; Noguchi S, 2006, CANCER SCI, V97, P813, DOI 10.1111/j.1349-7006.2006.00265.x; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pasieka JL, 2003, CURR OPIN ONCOL, V15, P78, DOI 10.1097/00001622-200301000-00012; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; SKIPPER HE, 1971, CANCER-AM CANCER SOC, V28, P1479, DOI 10.1002/1097-0142(197112)28:6<1479::AID-CNCR2820280622>3.0.CO;2-M; van Delft MF, 2010, CELL DEATH DIFFER, V17, P821, DOI 10.1038/cdd.2009.166; van Gent R, 2008, CANCER RES, V68, P10137, DOI 10.1158/0008-5472.CAN-08-2325; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WEINSTEIN GD, 1984, J INVEST DERMATOL, V82, P623, DOI 10.1111/1523-1747.ep12261462	31	406	428	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 25	2011	334	6059					1129	1133		10.1126/science.1206727	http://dx.doi.org/10.1126/science.1206727			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852AF	22033517	Green Accepted			2022-12-24	WOS:000297313900050
J	Smear, M; Shusterman, R; O'Connor, R; Bozza, T; Rinberg, D				Smear, Matthew; Shusterman, Roman; O'Connor, Rodney; Bozza, Thomas; Rinberg, Dmitry			Perception of sniff phase in mouse olfaction	NATURE			English	Article							NEURONS; BULB; REPRESENTATIONS; COMPUTATION; RESPONSES; DYNAMICS; PATTERNS; UNITS	Olfactory systems encode odours by which neurons respond and by when they respond(1-3). In mammals, every sniff evokes a precise, odour-specific sequence of activity across olfactory neurons(4-6). Likewise, in a variety of neural systems, ranging from sensory periphery(7,8) to cognitive centres(9), neuronal activity is timed relative to sampling behaviour and/or internally generated oscillations. As in these neural systems, relative timing of activity may represent information in the olfactory system(10,11). However, there is no evidence that mammalian olfactory systems read such cues(12,13). To test whether mice perceive the timing of olfactory activation relative to the sniff cycle ('sniff phase'), we used optogenetics in gene-targeted mice to generate spatially constant, temporally controllable olfactory input. Here we show that mice can behaviourally report the sniff phase of optogenetically driven activation of olfactory sensory neurons. Furthermore, mice can discriminate between light-evoked inputs that are shifted in the sniff cycle by as little as 10 milliseconds, which is similar to the temporal precision of olfactory bulb odour responses(14,15). Electrophysiological recordings in the olfactory bulb of awake mice show that individual cells encode the timing of photoactivation in relation to the sniff in both the timing and the amplitude of their responses. Our work provides evidence that the mammalian olfactory system can read temporal patterns, and suggests that timing of activity relative to sampling behaviour is a potent cue that may enable accurate olfactory percepts to form quickly(11,16).	[Smear, Matthew; Shusterman, Roman; O'Connor, Rodney; Bozza, Thomas; Rinberg, Dmitry] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Smear, Matthew; Bozza, Thomas] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	bozza@northwestern.edu; rinbergd@janelia.hhmi.org	Shusterman, Roman/B-9514-2008	Shusterman, Roman/0000-0002-1081-2884; O'Connor, Rodney/0000-0002-3916-3101	JFRC; NIDCD [R01DC009640, R21DC010911]; Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009640, R21DC010911] Funding Source: NIH RePORTER	JFRC; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Whitehall Foundation; Brain Research Foundation; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Doglio and the Transgenic and Targeted Mutagenesis Laboratory at Northwestern University for generation of chimaeric mice, B. Weiland for technical help with cloning and gene targeting, D. Huber, D. O'Connor and T. Komiyama for advice on mouse behaviour, D. Wesson and M. Wachowiak for instruction on sniff measurement, J. Nunez-Iglesias for assistance with statistics, G. Shtengel for advice on laser set-up, and T. Tabachnik and H. Davidowitz for help designing the behavioural rig. J. Osborne fabricated the microdrive. G. Lott provided digital acquisition software. A. Koulakov contributed to spike-sorting and classification algorithms. We thank W. Denk, K. Svoboda, R. Gutig, R. Egnor, M. Orger and A. Resulaj for comments on the manuscript. This work was supported by the Visiting Scientist Program at JFRC. T. B. was supported by NIDCD (R01DC009640, R21DC010911), the Whitehall Foundation and the Brain Research Foundation.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Cang JH, 2003, J NEUROSCI, V23, P4108; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; Curtis JC, 2009, NAT NEUROSCI, V12, P492, DOI 10.1038/nn.2283; Cury KM, 2010, NEURON, V68, P570, DOI 10.1016/j.neuron.2010.09.040; Di Lorenzo PM, 2009, BEHAV NEUROSCI, V123, P14, DOI 10.1037/a0014176; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Garthwaite P., 2002, STAT INFERENCE; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; HALL C, 1995, J COMP PHYSIOL A, V177, P29; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Junek S, 2010, NEURON, V67, P872, DOI 10.1016/j.neuron.2010.08.005; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leon M, 2009, CELL MOL LIFE SCI, V66, P2135, DOI 10.1007/s00018-009-0011-9; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; MONOD B, 1989, BEHAV BRAIN RES, V33, P51, DOI 10.1016/S0166-4328(89)80018-X; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Perkel D. H., 1968, NEUROSCI RES PROGRAM, V6, P219; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Schaefer AT, 2007, TRENDS NEUROSCI, V30, P92, DOI 10.1016/j.tins.2007.01.001; Shusterman R, 2011, NAT NEUROSCI, V14, P1039, DOI 10.1038/nn.2877; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; SZABO T, 1967, PHYSIOL BEHAV, V2, P331, DOI 10.1016/0031-9384(67)90047-9; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010	33	154	157	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					397	U149		10.1038/nature10521	http://dx.doi.org/10.1038/nature10521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	21993623				2022-12-24	WOS:000297059700045
J	Shin, SC; Kim, SH; You, H; Kim, B; Kim, AC; Lee, KA; Yoon, JH; Ryu, JH; Lee, WJ				Shin, Seung Chul; Kim, Sung-Hee; You, Hyejin; Kim, Boram; Kim, Aeri C.; Lee, Kyung-Ah; Yoon, Joo-Heon; Ryu, Ji-Hwan; Lee, Won-Jae			Drosophila Microbiome Modulates Host Developmental and Metabolic Homeostasis via Insulin Signaling	SCIENCE			English	Article							INNATE IMMUNE HOMEOSTASIS; LIFE-SPAN; BACTERIAL MUTUALISM; GUT MICROBIOME; RECEPTOR; COMMENSAL; FLIES; ABLATION; HOMOLOG; GROWTH	The symbiotic microbiota profoundly affect many aspects of host physiology; however, the molecular mechanisms underlying host-microbe cross-talk are largely unknown. Here, we show that the pyrroloquinoline quinone-dependent alcohol dehydrogenase (PQQ-ADH) activity of a commensal bacterium, Acetobacter pomorum, modulates insulin/insulin-like growth factor signaling (IIS) in Drosophila to regulate host homeostatic programs controlling developmental rate, body size, energy metabolism, and intestinal stem cell activity. Germ-free animals monoassociated with PQQ-ADH mutant bacteria displayed severe deregulation of developmental and metabolic homeostasis. Importantly, these defects were reversed by enhancing host IIS or by supplementing the diet with acetic acid, the metabolic product of PQQ-ADH.	[Shin, Seung Chul; Kim, Sung-Hee; You, Hyejin; Kim, Boram; Kim, Aeri C.; Lee, Kyung-Ah; Lee, Won-Jae] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Shin, Seung Chul; Kim, Sung-Hee; You, Hyejin; Kim, Boram; Kim, Aeri C.; Lee, Kyung-Ah; Lee, Won-Jae] Natl Creat Res Initiat Ctr Symbiosyst, Seoul 151742, South Korea; [You, Hyejin; Kim, Boram; Kim, Aeri C.] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [You, Hyejin; Kim, Boram; Kim, Aeri C.] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Shin, Seung Chul; Yoon, Joo-Heon; Ryu, Ji-Hwan] Yonsei Univ, Coll Med, Res Ctr Human Nat Def Syst, Seoul, South Korea	Seoul National University (SNU); Ewha Womans University; Ewha Womans University; Yonsei University; Yonsei University Health System	Lee, WJ (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	lwj@snu.ac.kr	Yoon, Joo-Heon/E-5781-2016; rchnds, rchnds/D-7595-2016	Yoon, Joo-Heon/0000-0003-2404-7156	National Creative Research Initiative Program; BK 21 program; Basic Science Research Program [2011-0001168]; Gwangju Institute of Science and Technology of the Ministry of Science and Technology Korea	National Creative Research Initiative Program(Ministry of Science & Technology (MOST), Republic of Korea); BK 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Basic Science Research Program; Gwangju Institute of Science and Technology of the Ministry of Science and Technology Korea	This work was supported by the National Creative Research Initiative Program (to W.-J.L.), the BK 21 program, the Basic Science Research Program (2011-0001168, to J.-H.R. and J.-H.Y.), and a Gwangju Institute of Science and Technology-Systems Biology grant (2011) of the Ministry of Science and Technology Korea. We thank D. Daffonchio and K. Matsushita for helpful comments on Acetobacter. The A. pomorum draft genome sequence is deposited in DNA Data Bank of Japan/European Molecular Biology Laboratory/GenBank with accession no. AEUP01000000.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104; Johnston CS, 2010, ANN NUTR METAB, V56, P74, DOI 10.1159/000272133; Koropatnick TA, 2004, SCIENCE, V306, P1186, DOI 10.1126/science.1102218; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Roh SW, 2008, APPL ENVIRON MICROB, V74, P6171, DOI 10.1128/AEM.00301-08; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x; Yakushi T, 2010, APPL MICROBIOL BIOT, V86, P1257, DOI 10.1007/s00253-010-2529-z	25	591	634	13	251	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					670	674		10.1126/science.1212782	http://dx.doi.org/10.1126/science.1212782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053049				2022-12-24	WOS:000296494700055
J	Azoitei, ML; Correia, BE; Ban, YEA; Carrico, C; Kalyuzhniy, O; Chen, L; Schroeter, A; Huang, PS; McLellan, JS; Kwong, PD; Baker, D; Strong, RK; Schief, WR				Azoitei, Mihai L.; Correia, Bruno E.; Ban, Yih-En Andrew; Carrico, Chris; Kalyuzhniy, Oleksandr; Chen, Lei; Schroeter, Alexandria; Huang, Po-Ssu; McLellan, Jason S.; Kwong, Peter D.; Baker, David; Strong, Roland K.; Schief, William R.			Computation-Guided Backbone Grafting of a Discontinuous Motif onto a Protein Scaffold	SCIENCE			English	Article							EPITOPE-SCAFFOLDS; HIV-1 GP120; DESIGN; ANTIBODIES; NEUTRALIZATION; SITE	The manipulation of protein backbone structure to control interaction and function is a challenge for protein engineering. We integrated computational design with experimental selection for grafting the backbone and side chains of a two-segment HIV gp120 epitope, targeted by the cross-neutralizing antibody b12, onto an unrelated scaffold protein. The final scaffolds bound b12 with high specificity and with affinity similar to that of gp120, and crystallographic analysis of a scaffold bound to b12 revealed high structural mimicry of the gp120-b12 complex structure. The method can be generalized to design other functional proteins through backbone grafting.	[Azoitei, Mihai L.; Correia, Bruno E.; Ban, Yih-En Andrew; Carrico, Chris; Kalyuzhniy, Oleksandr; Schroeter, Alexandria; Huang, Po-Ssu; Baker, David; Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Correia, Bruno E.] Inst Gulbenkian Ciencias, PhD Program Computat Biol, Oeiras, Portugal; [Carrico, Chris; Strong, Roland K.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; [Chen, Lei; McLellan, Jason S.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Schief, William R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Schief, William R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Washington; University of Washington Seattle; Instituto Gulbenkian de Ciencia; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; International AIDS Vaccine Initiative; Scripps Research Institute; Scripps Research Institute	Schief, WR (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	schief@scripps.edu	Baker, David/K-8941-2012; Schief, William/ABF-3645-2020; McLellan, Jason/A-6874-2010	Baker, David/0000-0001-7896-6217; Schief, William/0000-0002-1120-0150; Huang, Possu/0000-0002-7948-2895; McLellan, Jason/0000-0003-3991-542X; Carrico, Chris/0000-0003-0939-9006; Kalyuzhniy, Oleksandr/0000-0002-5273-1951	International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Bill and Melinda Gates Foundation Consortium for AIDS Vaccine Discovery; Portuguese Fundacao para a Ciencia e a Tecnologia [SFRH/774 BD/32958/2006]; PDB [3RPT, 3RU8]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005024] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative Neutralizing Antibody Consortium; Bill and Melinda Gates Foundation Consortium for AIDS Vaccine Discovery; Portuguese Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); PDB; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the International AIDS Vaccine Initiative Neutralizing Antibody Consortium and the Bill and Melinda Gates Foundation Consortium for AIDS Vaccine Discovery. B.E.C. was supported by a fellowship from the Portuguese Fundacao para a Ciencia e a Tecnologia (SFRH/774 BD/32958/2006). We thank I. Wilson for comments on the manuscript; D. Burton, A. Hessell, and the IAVI Neutralizing Antibody Consortium Reagent Repository for providing b6, b12, and b13; J. Mascola for VRC01 and VRC03; Progenics Inc. for CD4-IgG2; D. Dimitrov for m6, m14, and m18; J. Robinson for 15E; and R. Wyatt for F105 and HxB2 gp120. We thank G. Nabel, M. Kanekiyo, and Z.-Y. Yang for experiments on early generations of b12 scaffolds. Coordinates and structure factors were deposited in the PDB as entries 3RPT and 3RU8. The University of Washington has filed a patent application on the b12 scaffolds and the scaffolding method developed in this study. Materials and information will be provided to noncommercial users under the Uniform Biological Materials Transfer Agreement. The Multigraft software developed in this work is freely available to noncommercial users through the Rosetta Commons agreement (www.rosettacommons.org).	Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Correia BE, 2010, STRUCTURE, V18, P1116, DOI 10.1016/j.str.2010.06.010; Drakopoulou E, 1996, J BIOL CHEM, V271, P11979, DOI 10.1074/jbc.271.20.11979; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; JIN L, 1992, J MOL BIOL, V226, P851, DOI 10.1016/0022-2836(92)90636-X; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Lu SM, 2002, J BIOL CHEM, V277, P23515, DOI 10.1074/jbc.M201981200; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Martin L, 2003, NAT BIOTECHNOL, V21, P71, DOI 10.1038/nbt768; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; Rutledge SE, 2003, J AM CHEM SOC, V125, P14336, DOI 10.1021/ja034508o; Sia SK, 2003, P NATL ACAD SCI USA, V100, P9756, DOI 10.1073/pnas.1733910100; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	23	162	165	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 21	2011	334	6054					373	376		10.1126/science.1209368	http://dx.doi.org/10.1126/science.1209368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021856				2022-12-24	WOS:000296052500052
J	Vaishnava, S; Yamamoto, M; Severson, KM; Ruhn, KA; Yu, XF; Koren, O; Ley, R; Wakeland, EK; Hooper, LV				Vaishnava, Shipra; Yamamoto, Miwako; Severson, Kari M.; Ruhn, Kelly A.; Yu, Xiaofei; Koren, Omry; Ley, Ruth; Wakeland, Edward K.; Hooper, Lora V.			The Antibacterial Lectin RegIII gamma Promotes the Spatial Segregation of Microbiota and Host in the Intestine	SCIENCE			English	Article							GERM-FREE; EXPRESSION; MICE; COLONIZATION; HOMEOSTASIS; COMMENSAL; INNATE; CELLS	The mammalian intestine is home to similar to 100 trillion bacteria that perform important metabolic functions for their hosts. The proximity of vast numbers of bacteria to host intestinal tissues raises the question of how symbiotic host-bacterial relationships are maintained without eliciting potentially harmful immune responses. Here, we show that RegIII gamma, a secreted antibacterial lectin, is essential for maintaining a similar to 50-micrometer zone that physically separates the microbiota from the small intestinal epithelial surface. Loss of host-bacterial segregation in RegIII gamma(-/-) mice was coupled to increased bacterial colonization of the intestinal epithelial surface and enhanced activation of intestinal adaptive immune responses by the microbiota. Together, our findings reveal that RegIII gamma is a fundamental immune mechanism that promotes host-bacterial mutualism by regulating the spatial relationships between microbiota and host.	[Vaishnava, Shipra; Yamamoto, Miwako; Severson, Kari M.; Ruhn, Kelly A.; Yu, Xiaofei; Wakeland, Edward K.; Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Hooper, Lora V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Koren, Omry; Ley, Ruth] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Cornell University	Hooper, LV (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	lora.hooper@utsouthwestern.edu	Yu, Xiaofei/J-9245-2017; yu, Xiaofei/E-7100-2011; Ley, Ruth E/M-8542-2014; Koren, Omry/A-5222-2016	Yu, Xiaofei/0000-0002-1712-331X; Ley, Ruth E/0000-0002-9087-1672; Koren, Omry/0000-0002-7738-1337	NIH [R01 DK070855]; Crohn's and Colitis Foundation of America; Human Microbiome Project Data Analysis and Coordination Center; Packard Fellowship in Science and Engineering; Hartwell Foundation; Beckman Young Investigator award; Burroughs Wellcome Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Human Microbiome Project Data Analysis and Coordination Center; Packard Fellowship in Science and Engineering; Hartwell Foundation; Beckman Young Investigator award; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. DeFranco for the Myd88<SUP>fl/fl</SUP> mice, R. Medzhitov for the FLAG-MyD88 transgene, and A. Mobley for assistance with flow cytometry. This work was supported by NIH R01 DK070855 (L. V. H.), a Crohn's and Colitis Foundation of America Fellowship Award (S. V.), the Human Microbiome Project Data Analysis and Coordination Center (O.K.), a Packard Fellowship in Science and Engineering (R. L.), a Hartwell Foundation investigator award (R. L.), a Beckman Young Investigator award (R. L.), a Burroughs Wellcome Foundation New Investigators in the Pathogenesis of Infectious Diseases Award (L. V. H.), and the Howard Hughes Medical Institute (L. V. H.). The data reported in this paper are tabulated in the main text and the supporting online material, and the sequencing data have been deposited in RG-RAST (accession no. MGP135).	Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Ogawa H, 2003, INFLAMM BOWEL DIS, V9, P162, DOI 10.1097/00054725-200305000-00003; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105	18	915	948	9	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 14	2011	334	6053					255	258		10.1126/science.1209791	http://dx.doi.org/10.1126/science.1209791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832UI	21998396	Green Accepted			2022-12-24	WOS:000295833600055
J	Ehrlicher, AJ; Nakamura, F; Hartwig, JH; Weitz, DA; Stossel, TP				Ehrlicher, A. J.; Nakamura, F.; Hartwig, J. H.; Weitz, D. A.; Stossel, T. P.			Mechanical strain in actin networks regulates FilGAP and integrin binding to filamin A	NATURE			English	Article							MOLECULAR MOTORS; AUTO-INHIBITION; CROSS-LINKING; LIVING CELLS; MECHANOTRANSDUCTION; PROTEINS	Mechanical stresses elicit cellular reactions mediated by chemical signals. Defective responses to forces underlie human medical disorders(1-4) such as cardiac failure(5) and pulmonary injury(6). The actin cytoskeleton's connectivity enables it to transmit forces rapidly over large distances(7), implicating it in these physiological and pathological responses. Despite detailed knowledge of the cytoskeletal structure, the specific molecular switches that convert mechanical stimuli into chemical signals have remained elusive. Here we identify the actin-binding protein filamin A (FLNA)(8,9) as a central mechanotransduction element of the cytoskeleton. We reconstituted a minimal system consisting of actin filaments, FLNA and two FLNA-binding partners: the cytoplasmic tail of beta-integrin, and FilGAP. Integrins form an essential mechanical linkage between extracellular and intracellular environments, with beta-integrin tails connecting to the actin cytoskeleton by binding directly to filamin(4). FilGAP is an FLNA-binding GTPase-activating protein specific for RAC, which in vivo regulates cell spreading and bleb formation(10). Using fluorescence loss after photoconversion, a novel, high-speed alternative to fluorescence recovery after photobleaching(11), we demonstrate that both externally imposed bulk shear and myosin-II-driven forces differentially regulate the binding of these partners to FLNA. Consistent with structural predictions, strain increases beta-integrin binding to FLNA, whereas it causes FilGAP to dissociate from FLNA, providing a direct and specific molecular basis for cellular mechanotransduction. These results identify a molecular mechanotransduction element within the actin cytoskeleton, revealing that mechanical strain of key proteins regulates the binding of signalling molecules.	[Ehrlicher, A. J.; Nakamura, F.; Hartwig, J. H.; Stossel, T. P.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Translat Med Div, Boston, MA 02115 USA; [Ehrlicher, A. J.; Weitz, D. A.] Harvard Univ, Dept Phys, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University	Nakamura, F (corresponding author), Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Translat Med Div, Boston, MA 02115 USA.	aje@seas.harvard.edu; fnakamura@rics.bwh.harvard.edu	Nakamura, Fumihiko/N-5476-2016	Ehrlicher, Allen/0000-0003-3030-979X; Nakamura, Fumihiko/0000-0002-6872-4246	NIH [R01 HL19429, T32 HL07680]; Harvard University Science and Engineering Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429, T32HL007680] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Science and Engineering Committee; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors acknowledge the Harvard Materials Research and Engineering Center (DMR-0820484) for confocal imaging, and M. Ginsberg, J. Lippincott-Schwartz and V. Verkhusha for providing complementary DNA for PA-GFP and PA-mCherry constructs. We thank T. Collins for technical assistance, L. Jawerth and V. Zaburdaev for discussions, and J. Wilking and K. Guenthner for help with the manuscript. This work was supported by grants NIH R01 HL19429 (T. P. S.) and NIH T32 HL07680 (A. J. E.) and by the Harvard University Science and Engineering Committee Seed Fund for Interdisciplinary Science (D.A.W., T.P.S., F.N.).	Birukov KG, 2009, MICROVASC RES, V77, P46, DOI 10.1016/j.mvr.2008.09.006; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Chen HS, 2009, BIOPHYS J, V97, P3095, DOI 10.1016/j.bpj.2009.08.059; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Heikkinen OK, 2009, J BIOL CHEM, V284, P25450, DOI 10.1074/jbc.M109.019661; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Krieger CC, 2011, P NATL ACAD SCI USA, V108, P8269, DOI 10.1073/pnas.1018887108; Kruger M, 2009, J MOL CELL CARDIOL, V46, P490, DOI 10.1016/j.yjmcc.2009.01.004; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Moore SW, 2010, DEV CELL, V19, P194, DOI 10.1016/j.devcel.2010.07.018; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Nakamura F, 2002, J BIOL CHEM, V277, P9148, DOI 10.1074/jbc.M111297200; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pentikainen U, 2009, J MOL BIOL, V393, P644, DOI 10.1016/j.jmb.2009.08.035; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; Smith D, 2007, BIOPHYS J, V93, P4445, DOI 10.1529/biophysj.106.095919; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Weissmann C, 2009, TRAFFIC, V10, P1655, DOI 10.1111/j.1600-0854.2009.00977.x	34	252	257	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					260	U154		10.1038/nature10430	http://dx.doi.org/10.1038/nature10430			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21926999	Green Accepted			2022-12-24	WOS:000295782800054
J	Wiedenheft, B; Lander, GC; Zhou, KH; Jore, MM; Brouns, SJJ; van der Oost, J; Doudna, JA; Nogales, E				Wiedenheft, Blake; Lander, Gabriel C.; Zhou, Kaihong; Jore, Matthijs M.; Brouns, Stan J. J.; van der Oost, John; Doudna, Jennifer A.; Nogales, Eva			Structures of the RNA-guided surveillance complex from a bacterial immune system	NATURE			English	Article							CRISPR RNA; ELECTRON-MICROSCOPY; TARGET RECOGNITION; SEED SEQUENCE; PROKARYOTES; INTERFERENCE; REPEATS; DNA; ENDORIBONUCLEASE; MATURATION	Bacteria and archaea acquire resistance to viruses and plasmids by integrating short fragments of foreign DNA into clustered regularly interspaced short palindromic repeats (CRISPRs). These repetitive loci maintain a genetic record of all prior encounters with foreign transgressors(1-6). CRISPRs are transcribed and the long primary transcript is processed into a library of short CRISPR-derived RNAs (crRNAs) that contain a unique sequence complementary to a foreign nucleic-acid challenger(7-12). In Escherichia coli, crRNAs are incorporated into a multisubunit surveillance complex called Cascade (CRISPR-associated complex for antiviral defence), which is required for protection against bacteriophages(13,14). Here we use cryo-electron microscopy to determine the subnanometre structures of Cascade before and after binding to a target sequence. These structures reveal a sea-horse-shaped architecture in which the crRNA is displayed along a helical arrangement of protein subunits that protect the crRNA from degradation while maintaining its availability for base pairing. Cascade engages invading nucleic acids through high-affinity base-pairing interactions near the 5' end of the crRNA. Base pairing extends along the crRNA, resulting in a series of short helical segments that trigger a concerted conformational change. This conformational rearrangement may serve as a signal that recruits a trans-acting nuclease (Cas3) for destruction of invading nucleic-acid sequences.	[Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.; Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Wiedenheft, Blake; Zhou, Kaihong; Doudna, Jennifer A.; Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lander, Gabriel C.; Nogales, Eva] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Jore, Matthijs M.; Brouns, Stan J. J.; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Wageningen University & Research; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Doudna, JA (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	doudna@berkeley.edu; enogales@lbl.gov	Jore, Matthijs/F-7852-2018; van+der+Oost, John/Y-2548-2019	Jore, Matthijs/0000-0002-0686-370X; Brouns, Stan/0000-0002-9573-1724; Lander, Gabriel C./0000-0003-4921-1135	National Science Foundation; Veni grant [863.08.014]; NWO [865.05.001]; Damon Runyon Cancer Research Foundation	National Science Foundation(National Science Foundation (NSF)); Veni grant; NWO(Netherlands Organization for Scientific Research (NWO)); Damon Runyon Cancer Research Foundation	We are grateful to the Doudna and Nogales lab members for their reading of this manuscript, and to P. Grob, S. Hill, R. Hall and T. Houweling for technical support. This project was funded by a National Science Foundation grant to J.A.D., a Veni grant to S.J.J.B. (863.08.014) and a NWO Vici grant to J.v.d.O. (865.05.001). G. C. L. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation. B. W. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. E.N. and J.A.D. are Howard Hughes Medical Institute investigators.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang RY, 2011, STRUCTURE, V19, P257, DOI 10.1016/j.str.2010.11.014; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	31	273	314	4	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 22	2011	477	7365					486	U141		10.1038/nature10402	http://dx.doi.org/10.1038/nature10402			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822WH	21938068	Green Accepted			2022-12-24	WOS:000295080500045
J	Diskin, R; Scheid, JF; Marcovecchio, PM; West, AP; Klein, F; Gao, H; Gnanapragasam, PNP; Abadir, A; Seaman, MS; Nussenzweig, MC; Bjorkman, PJ				Diskin, Ron; Scheid, Johannes F.; Marcovecchio, Paola M.; West, Anthony P., Jr.; Klein, Florian; Gao, Han; Gnanapragasam, Priyanthi N. P.; Abadir, Alexander; Seaman, Michael S.; Nussenzweig, Michel C.; Bjorkman, Pamela J.			Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; BROAD; VACCINE; BINDING; GP120; RECEPTOR; INDIVIDUALS; PROTECTION	Antibodies against the CD4 binding site (CD4bs) on the HIV-1 spike protein gp120 can show exceptional potency and breadth. We determined structures of NIH45-46, a more potent clonal variant of VRC01, alone and bound to gp120. Comparisons with VRC01-gp120 revealed that a four-residue insertion in heavy chain complementarity-determining region 3 (CDRH3) contributed to increased interaction between NIH45-46 and the gp120 inner domain, which correlated with enhanced neutralization. We used structure-based design to create NIH45-46(G54W), a single substitution in CDRH2 that increases contact with the gp120 bridging sheet and improves breadth and potency, critical properties for potential clinical use, by an order of magnitude. Together with the NIH45-46-gp120 structure, these results indicate that gp120 inner domain and bridging sheet residues should be included in immunogens to elicit CD4bs antibodies.	[Diskin, Ron; Marcovecchio, Paola M.; West, Anthony P., Jr.; Gao, Han; Gnanapragasam, Priyanthi N. P.; Bjorkman, Pamela J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Scheid, Johannes F.; Klein, Florian; Abadir, Alexander; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.] Charite, D-10117 Berlin, Germany; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Rockefeller University; California Institute of Technology; Howard Hughes Medical Institute	Bjorkman, PJ (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	Cheng, Yushao/E-6256-2011; Nussenzweig, Michel/AAE-7292-2019		Collaboration for AIDS Vaccine Discovery (CAVD); Bill and Melinda Gates Foundation [38660, 38619, 38619s]; NIH [P01 AI081677-01, RR00862, RR022220]; Molecular Observatory at Caltech; Gordon and Betty Moore Foundation; Sanofi-Aventis; German Research Foundation (DFG) [KL 2389/1-1]; U.S. Department of Energy; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR022220, P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081677] Funding Source: NIH RePORTER	Collaboration for AIDS Vaccine Discovery (CAVD); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Observatory at Caltech; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Sanofi-Aventis(Sanofi-Aventis); German Research Foundation (DFG)(German Research Foundation (DFG)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank B. Hahn, J. Baalwa, F. McCutchan, G. Shaw, D. Montefiori, M. Thomson, J. Overbaugh, R. Swanstrom, L. Morris, J. Kim, L. Zhang, D. Ellenberger, and C. Williamson for contributing the HIV-1 envelope plasmids used in our neutralization panel; the Caltech Protein Expression Center; T. Oliveira and A. Halper-Stromberg for calculations and helpful discussions; and members of the Bjorkman and Nussenzweig laboratories for critical reading of the manuscript. R. D., J.F.S., M.C.N., and P.J.B. have pending patent applications with the U. S. Patent and Trademark Office, patent numbers U. S. 61/486,960 and 61/523,244, titled "Human immunodeficiency virus neutralizing antibodies and methods of use thereof" and "Anti-HIV antibodies and related methods and compositions," respectively. The reagents are available with a Materials Transfer Agreement. This work was supported by Collaboration for AIDS Vaccine Discovery (CAVD) grants with support from the Bill and Melinda Gates Foundation [grant 38660 (P.J.B.), grant 38619 (M. S. S.) and grant 38619s (M.C.N.)]; NIH grants P01 AI081677-01 (M.C.N.), RR00862, and RR022220; and the Molecular Observatory at Caltech, supported by the Gordon and Betty Moore Foundation and the Sanofi-Aventis Bioengineering Research Program. F. K. was supported by the German Research Foundation (DFG, KL 2389/1-1). Operations at Stanford Synchrotron Radiation Lightsource are supported by the U.S. Department of Energy and NIH. The data reported in this paper are tabulated in the main text and the supporting online material, and coordinates and x-ray crystallographic data for the NIH45-46-gp120 complex and NIH45-46 Fab have been deposited in the PDB (accession codes 3U7Y and 3U7W, respectively).	Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Madani N, 2008, STRUCTURE, V16, P1689, DOI 10.1016/j.str.2008.09.005; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Nabel GJ, 2011, PHILOS T R SOC B, V366, P2759, DOI 10.1098/rstb.2011.0096; SATTENTAU QJ, 1988, CELL, V52, P631, DOI 10.1016/0092-8674(88)90397-2; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2010, NAT REV IMMUNOL, V10, P527, DOI 10.1038/nri2801	30	307	320	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2011	334	6060					1289	1293		10.1126/science.1213782	http://dx.doi.org/10.1126/science.1213782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855HD	22033520	Green Accepted			2022-12-24	WOS:000297553600054
J	Berer, K; Mues, M; Koutrolos, M; Al Rasbi, Z; Boziki, M; Johner, C; Wekerle, H; Krishnamoorthy, G				Berer, Kerstin; Mues, Marsilius; Koutrolos, Michail; Al Rasbi, Zakeya; Boziki, Marina; Johner, Caroline; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy			Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination	NATURE			English	Article							T-CELL RESPONSES; MULTIPLE-SCLEROSIS; B-CELLS; TRANSGENIC MICE; AUTOANTIBODIES; INDUCTION; BACTERIA; DISEASE; MOG	Active multiple sclerosis lesions show inflammatory changes suggestive of a combined attack by autoreactive T and B lymphocytes against brain white matter(1). These pathogenic immune cells derive from progenitors that are normal, innocuous components of the healthy immune repertoire but become autoaggressive upon pathological activation. The stimuli triggering this autoimmune conversion have been commonly attributed to environmental factors, in particular microbial infection(2). However, using the relapsing-remitting mouse model of spontaneously developing experimental autoimmune encephalomyelitis(3), here we show that the commensal gut flora-in the absence of pathogenic agents-is essential in triggering immune processes, leading to a relapsing-remitting autoimmune disease driven by myelin-specific CD4(+) T cells. We show further that recruitment and activation of autoantibody-producing B cells from the endogenous immune repertoire depends on availability of the target autoantigen, myelin oligodendrocyte glycoprotein (MOG), and commensal microbiota. Our observations identify a sequence of events triggering organ-specific autoimmune disease and these processes may offer novel therapeutic targets.	[Berer, Kerstin; Mues, Marsilius; Koutrolos, Michail; Al Rasbi, Zakeya; Boziki, Marina; Wekerle, Hartmut; Krishnamoorthy, Gurumoorthy] Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany; [Johner, Caroline] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	Max Planck Society; Max Planck Society	Wekerle, H (corresponding author), Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany.	hwekerle@neuro.mpg.de; guru@neuro.mpg.de	Boziki, Marina/AAV-2196-2021; Krishnamoorthy, Gurumoorthy/O-1650-2013	Boziki, Marina/0000-0002-6601-5163; Krishnamoorthy, Gurumoorthy/0000-0002-7798-6707	German Competence Network on Multiple Sclerosis (KKNMS); ARSEP (France); Max Planck Society; Emirates Foundation; Hellenic Neurological Society;  [SFB 571]	German Competence Network on Multiple Sclerosis (KKNMS); ARSEP (France); Max Planck Society(Max Planck Society); Emirates Foundation; Hellenic Neurological Society; 	We thank I. Arnold-Ammer, N. Reisser and L. Penner for technical assistance, and M. Pfunder, U. Stauffer, C. Hornung and N. Joswig for maintaining our germ-free colony and technical support. We are much obliged to R. Kemler for his support. This work was funded by SFB 571 (Project B6), the German Competence Network on Multiple Sclerosis (KKNMS), ARSEP (France), and by the Max Planck Society. K. B. is supported by a fellowship from ARSEP. Z.A.R. is supported by a PhD fellowship from the Emirates Foundation. M. B. receives a fellowship from the Hellenic Neurological Society.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; CSERR HF, 1992, BRAIN PATHOL, V2, P269, DOI 10.1111/j.1750-3639.1992.tb00703.x; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Ercolini AM, 2007, J IMMUNOL, V179, P6604, DOI 10.4049/jimmunol.179.10.6604; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Hohfeld R, 2009, EUR J IMMUNOL, V39, P2036, DOI 10.1002/eji.200939545; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kira J, 1999, J NEUROL SCI, V166, P53, DOI 10.1016/S0022-510X(99)00115-X; Kirvan CA, 2007, J IMMUNOL, V178, P7412, DOI 10.4049/jimmunol.178.11.7412; Knip M, 2010, NEW ENGL J MED, V363, P1900, DOI 10.1056/NEJMoa1004809; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lauer K, 1997, NEUROLOGY, V49, pS55, DOI 10.1212/WNL.49.2_Suppl_2.S55; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Pollinger B, 2009, J EXP MED, V206, P1303, DOI 10.1084/jem.20090299; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Vaahtovuo J, 2008, J RHEUMATOL, V35, P1500	28	806	833	0	128	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2011	479	7374					538	U266		10.1038/nature10554	http://dx.doi.org/10.1038/nature10554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22031325				2022-12-24	WOS:000297285600053
J	Jiang, FG; Ramanathan, A; Miller, MT; Tang, GQ; Gale, M; Patel, SS; Marcotrigiano, J				Jiang, Fuguo; Ramanathan, Anand; Miller, Matthew T.; Tang, Guo-Qing; Gale, Michael, Jr.; Patel, Smita S.; Marcotrigiano, Joseph			Structural basis of RNA recognition and activation by innate immune receptor RIG-I	NATURE			English	Article							COOPERATIVE BINDING; ADAPTER PROTEIN; NUCLEOTIDE; MECHANISM; HELICASES; LIGAND; DOMAIN; ATP	Retinoic-acid-inducible gene-I (RIG-I; also known as DDX58) is a cytoplasmic pathogen recognition receptor that recognizes pathogen-associated molecular pattern (PAMP) motifs to differentiate between viral and cellular RNAs. RIG-I is activated by blunt-ended double-stranded (ds)RNA with or without a 5'-triphosphate (ppp), by single-stranded RNA marked by a 5'-ppp(1) and by polyuridine sequences(2,3). Upon binding to such PAMP motifs, RIG-I initiates a signalling cascade that induces innate immune defences and inflammatory cytokines to establish an antiviral state. The RIG-I pathway is highly regulated and aberrant signalling leads to apoptosis, altered cell differentiation, inflammation, autoimmune diseases and cancer(4,5). The helicase and repressor domains (RD) of RIG-I recognize dsRNA and 5'-ppp RNA to activate the two amino-terminal caspase recruitment domains (CARDs) for signalling. Here, to understand the synergy between the helicase and the RD for RNA binding, and the contribution of ATP hydrolysis to RIG-I activation, we determined the structure of human RIG-I helicase-RD in complex with dsRNA and an ATP analogue. The helicase-RD organizes into a ring around dsRNA, capping one end, while contacting both strands using previously uncharacterized motifs to recognize dsRNA. Small-angle X-ray scattering, limited proteolysis and differential scanning fluorimetry indicate that RIG-I is in an extended and flexible conformation that compacts upon binding RNA. These results provide a detailed view of the role of helicase in dsRNA recognition, the synergy between the RD and the helicase for RNA binding and the organization of full-length RIG-I bound to dsRNA, and provide evidence of a conformational change upon RNA binding. The RIG-I helicase-RD structure is consistent with dsRNA translocation without unwinding and cooperative binding to RNA. The structure yields unprecedented insight into innate immunity and has a broader impact on other areas of biology, including RNA interference and DNA repair, which utilize homologous helicase domains within DICER and FANCM.	[Jiang, Fuguo; Miller, Matthew T.; Marcotrigiano, Joseph] Rutgers State Univ, Dept Chem & Chem Biol, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Ramanathan, Anand; Tang, Guo-Qing; Patel, Smita S.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA; [Gale, Michael, Jr.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Washington; University of Washington Seattle	Marcotrigiano, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Ctr Adv Biotechnol & Med, 679 Hoes Lane W, Piscataway, NJ 08854 USA.	patelss@umdnj.edu; jmarco@cabm.rutgers.edu	Marcotrigiano, Joseph/K-6697-2016; JIANG, FUGUO/G-6581-2012	Marcotrigiano, Joseph/0000-0003-0346-3353; JIANG, FUGUO/0000-0003-4469-1803; Gale, Michael/0000-0002-6332-7436	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886, DE-AC02-06CH11357]; NSF; NIH/NIGMS through NSF [DMR-0936384]; NIH/NCRR [RR-01646]; NIH [GM55310, AI080659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080659, R01AI060389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310] Funding Source: NIH RePORTER	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); NIH/NIGMS through NSF(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge access to beamlines X29 at the NSLS (National Synchrotron Light Source), LRL-CAT at APS (Advanced Photon Source), and G1 and F1 at CHESS (Cornell High Energy Synchrotron Source) and thank the NSLS, APS and CHESS staff. NSLS and APS are supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886 and DE-AC02-06CH11357, respectively. CHESS is supported by the NSF and NIH/NIGMS through NSF award DMR-0936384, and the MacCHESS resource is supported by NIH/NCRR award RR-01646. Use of the LRL-CAT beamline facilities at Sector 31 was provided by Eli Lilly & Company. We would like to thank V. Rajagopal for initiating the biochemical experiments and guiding the project in the early stages. We thank E. Arnold, H. Berman, S. K. Burley, R. Gillilian, L. Morisco, W. Olson, T. Saito, A. Shatkin, A. Stock, H. Yang and M. Zhuravieva for providing helpful comments and assistance. This work was supported by NIH grants GM55310 to S.S.P. and AI080659 to J.M.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Binder M., 2011, J BIOL CHEM; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lam AMI, 2003, J BIOL CHEM, V278, P44514, DOI 10.1074/jbc.M306444200; Loo YM, 2006, P NATL ACAD SCI USA, V103, P6001, DOI 10.1073/pnas.0601523103; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	41	302	324	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					423	U184		10.1038/nature10537	http://dx.doi.org/10.1038/nature10537			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	21947008	Green Accepted			2022-12-24	WOS:000297059700051
J	Walker, AK; Jacobs, RL; Watts, JL; Rottiers, V; Jiang, K; Finnegan, DM; Shioda, T; Hansen, M; Yang, F; Niebergall, LJ; Vance, DE; Tzoneva, M; Hart, AC; Naar, AM				Walker, Amy K.; Jacobs, Rene L.; Watts, Jennifer L.; Rottiers, Veerle; Jiang, Karen; Finnegan, Deirdre M.; Shioda, Toshi; Hansen, Malene; Yang, Fajun; Niebergall, Lorissa J.; Vance, Dennis E.; Tzoneva, Monika; Hart, Anne C.; Naeaer, Anders M.			A Conserved SREBP-1/Phosphatidylcholine Feedback Circuit Regulates Lipogenesis in Metazoans	CELL			English	Article							PHOSPHATIDYLETHANOLAMINE-N-METHYLTRANSFERASE; PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE-ALPHA; ENDOPLASMIC-RETICULUM STRESS; NUCLEOTIDE-EXCHANGE PROTEIN; FATTY-ACID SYNTHESIS; PLASMA HIGH-DENSITY; CAENORHABDITIS-ELEGANS; HEPATIC STEATOSIS; LIVER-DISEASE; BREFELDIN-A	Sterol regulatory element-binding proteins (SREBPs) activate genes involved in the synthesis and trafficking of cholesterol and other lipids and are critical for maintaining lipid homeostasis. Aberrant SREBP activity, however, can contribute to obesity, fatty liver disease, and insulin resistance, hallmarks of metabolic syndrome. Our studies identify a conserved regulatory circuit in which SREBP-1 controls genes in the one-carbon cycle, which produces the methyl donor S-adenosylmethionine (SAMe). Methylation is critical for the synthesis of phosphatidylcholine (PC), a major membrane component, and we find that blocking SAMe or PC synthesis in C. elegans, mouse liver, and human cells causes elevated SREBP-1-dependent transcription and lipid droplet accumulation. Distinct from negative regulation of SREBP-2 by cholesterol, our data suggest a feedback mechanism whereby maturation of nuclear, transcriptionally active SREBP-1 is controlled by levels of PC. Thus, nutritional or genetic conditions limiting SAMe or PC production may activate SREBP-1, contributing to human metabolic disorders.	[Walker, Amy K.; Jiang, Karen; Finnegan, Deirdre M.; Shioda, Toshi; Yang, Fajun; Hart, Anne C.; Naeaer, Anders M.] Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; [Rottiers, Veerle; Yang, Fajun; Naeaer, Anders M.] Harvard Univ, Dept Cell Biol, Sch Med, Boston, MA 02115 USA; [Jacobs, Rene L.] Univ Alberta, Dept Agr Food & Nutr Sci, Ag Ctr D 1 32, Edmonton, AB T6G 2M7, Canada; [Watts, Jennifer L.; Tzoneva, Monika] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [Hansen, Malene] Sanford Burnham Inst Med Res, La Jolla, CA 92037 USA; [Niebergall, Lorissa J.; Vance, Dennis E.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2M7, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Alberta; Washington State University; Sanford Burnham Prebys Medical Discovery Institute; University of Alberta	Walker, AK (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Bldg 149,13th St, Charlestown, MA 02129 USA.	amy_walker@mac.com; naar@helix.mgh.harvard.edu	Watts, Jennifer/AAC-7425-2020	Jacobs, Rene/0000-0002-5525-1355; Watts, Jennifer/0000-0003-4349-0639	Claflin Distinguished Scholar Award [R01DK084352]; The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School; NIH [R01DK078332, R01GM071449, R01DK074114]; Canadian Institutes of Health Research [MOP 5182, 4487]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078332, R01DK084352, R01DK074114, R01DK093623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071449] Funding Source: NIH RePORTER	Claflin Distinguished Scholar Award; The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Keith Blackwell for advice on examining ER stress in C. elegans as well as members of the Naar lab and Drs. Nick Dyson, Johnathan Whetstine, Andrew Gladden, and Tom Rapoport for helpful discussions. We express our gratitude to Drs. Stefan Taubert and Raul Mostoslavsky for critical reading of the manuscript. We thank Dr. Michael Brown for the SRD13A, SCAP-deficient cells and Dr. Joachim Seemann for advice on S1P staining. We thank the Caenorhabditis Genetics Center for strains. Funding for A. K. W. was provided by the Claflin Distinguished Scholar Award and R01DK084352. Funding for A.M.N. was provided by The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School and the following grants from NIH: R01DK078332 and R01GM071449. Funding for J.L.W. was provided by NIH grant R01DK074114. Funding for research in the D.E.V. and R.L.J. labs was from the Canadian Institutes of Health Research (MOP 5182 and 4487).	Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bartz R, 2008, EMBO J, V27, P948, DOI 10.1038/emboj.2008.36; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Brendza KM, 2007, BIOCHEM J, V404, P439, DOI 10.1042/BJ20061815; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; BUCHMAN AL, 1995, HEPATOLOGY, V22, P1399, DOI 10.1002/hep.1840220510; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Citterio C, 2008, P NATL ACAD SCI USA, V105, P2877, DOI 10.1073/pnas.0712224105; Colombo C, 1998, SEMIN LIVER DIS, V18, P227, DOI 10.1055/s-2007-1007159; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Donaldson JG, 2000, CELL, V101, P693, DOI 10.1016/S0092-8674(00)80881-8; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hagen RM, 2010, FEBS LETT, V584, P2689, DOI 10.1016/j.febslet.2010.04.004; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Innis SM, 2007, AM J CLIN NUTR, V85, P702, DOI 10.1093/ajcn/85.3.702; Jacobs RL, 2008, J BIOL CHEM, V283, P2147, DOI 10.1074/jbc.M706628200; Jacobs RL, 2010, J BIOL CHEM, V285, P22403, DOI 10.1074/jbc.M110.108514; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; Kharbanda KK, 2009, SEMIN LIVER DIS, V29, P155, DOI 10.1055/s-0029-1214371; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lev S, 2006, BIOCHEM SOC T, V34, P363, DOI 10.1042/BST0340363; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Lim HY, 2011, GENE DEV, V25, P189, DOI 10.1101/gad.1992411; Lu SC, 2001, P NATL ACAD SCI USA, V98, P5560, DOI 10.1073/pnas.091016398; Mansour SJ, 1999, P NATL ACAD SCI USA, V96, P7968, DOI 10.1073/pnas.96.14.7968; Mato JM, 2005, HEPATOLOGY, V41, P976, DOI 10.1002/hep.20708; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; McKay RM, 2003, DEV CELL, V4, P131, DOI 10.1016/S1534-5807(02)00411-2; Osborne TF, 2009, GENE DEV, V23, P2578, DOI 10.1101/gad.1854309; Palavalli LH, 2006, BIOCHEMISTRY-US, V45, P6056, DOI 10.1021/bi060199d; Peyroche A, 1999, MOL CELL, V3, P275, DOI 10.1016/S1097-2765(00)80455-4; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Song JN, 2005, FASEB J, V19, P1266, DOI 10.1096/fj.04-3580com; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Testerink N, 2009, J LIPID RES, V50, P2182, DOI 10.1194/jlr.M800660-JLR200; Vance DE, 2007, J BIOL CHEM, V282, P33237, DOI 10.1074/jbc.R700028200; Vance JE, 2004, BIOCHEM CELL BIOL, V82, P113, DOI 10.1139/o03-073; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zeisel SH, 2008, BRAIN RES, V1237, P5, DOI 10.1016/j.brainres.2008.08.059	55	263	283	1	45	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	NOV 11	2011	147	4					840	852		10.1016/j.cell.2011.09.045	http://dx.doi.org/10.1016/j.cell.2011.09.045			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846LM	22035958	Green Accepted, Bronze			2022-12-24	WOS:000296902300017
J	Garcia, V; Phelps, SEL; Gray, S; Neale, MJ				Garcia, Valerie; Phelps, Sarah E. L.; Gray, Stephen; Neale, Matthew J.			Bidirectional resection of DNA double-strand breaks by Mre11 and Exo1	NATURE			English	Article							RAD32(MRE11) NUCLEASE; MEIOSIS; CTP1(CTIP); MUTATION; REMOVAL; REPAIR; ROLES; AXIS; SAE2	Repair of DNA double-strand breaks (DSBs) by homologous recombination requires resection of 5'-termini to generate 3'-single-strand DNA tails(1). Key components of this reaction are exonuclease 1 and the bifunctional endo/exonuclease, Mre11 (refs 2-4). Mre11 endonuclease activity is critical when DSB termini are blocked by bound protein-such as by the DNA end-joining complex(5), topoisomerases(6) or the meiotic transesterase Spo11 (refs 7-13)-but a specific function for the Mre11 3'-5' exonuclease activity has remained elusive. Here we use Saccharomyces cerevisiae to reveal a role for the Mre11 exonuclease during the resection of Spo11-linked 5'-DNA termini in vivo. We show that the residual resection observed in Exo1-mutant cells is dependent on Mre11, and that both exonuclease activities are required for efficient DSB repair. Previous work has indicated that resection traverses unidirectionally(1). Using a combination of physical assays for 5'-end processing, our results indicate an alternative mechanism involving bidirectional resection. First, Mre11 nicks the strand to be resected up to 300 nucleotides from the 5'-terminus of the DSB-much further away than previously assumed. Second, this nick enables resection in a bidirectional manner, using Exo1 in the 5'-3' direction away from the DSB, and Mre11 in the 3'-5' direction towards the DSB end. Mre11 exonuclease activity also confers resistance to DNA damage in cycling cells, suggesting that Mre11-catalysed resection may be a general feature of various DNA repair pathways.	[Garcia, Valerie; Phelps, Sarah E. L.; Gray, Stephen; Neale, Matthew J.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Neale, MJ (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England.	m.neale@sussex.ac.uk	Garcia, Valerie/R-4543-2016	Neale, Matthew/0000-0002-6453-1877; Gray, Stephen/0000-0003-1483-560X; Garcia, Valerie/0000-0002-4941-0989	MRC; Royal Society; Human Frontiers Science Program Organisation; Medical Research Council [G0800005] Funding Source: researchfish; MRC [G0800005] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Human Frontiers Science Program Organisation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Cha, E. Hoffmann, N. Hunter, S. Keeney and J. Nitiss for yeast strains; L. Symington for plasmids; F. Klein and J. Petrini for antisera. V. G. is supported by an MRC New Investigator Grant to M. J. N. M. J. N. is supported by a University Research Fellowship from the Royal Society and a Career Development Award from the Human Frontiers Science Program Organisation.	Carballo JA, 2008, CELL, V132, P758, DOI 10.1016/j.cell.2008.01.035; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Hartsuiker E, 2009, MOL CELL BIOL, V29, P1671, DOI 10.1128/MCB.01182-08; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Hodgson A, 2011, DNA REPAIR, V10, P138, DOI 10.1016/j.dnarep.2010.11.008; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Keelagher RE, 2011, DNA REPAIR, V10, P126, DOI 10.1016/j.dnarep.2010.09.024; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Kim KP, 2010, CELL, V143, P924, DOI 10.1016/j.cell.2010.11.015; Manfrini N, 2010, J BIOL CHEM, V285, P11628, DOI 10.1074/jbc.M110.104083; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Moreau S, 1999, MOL CELL BIOL, V19, P556; Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Pan J, 2011, CELL, V144, P719, DOI 10.1016/j.cell.2011.02.009; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Rothenberg M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000722; SZANKASI P, 1992, J BIOL CHEM, V267, P3014; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	30	277	281	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					241	U123		10.1038/nature10515	http://dx.doi.org/10.1038/nature10515			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002605	Green Accepted			2022-12-24	WOS:000298030800045
J	Kim, EB; Fang, XD; Fushan, AA; Huang, ZY; Lobanov, AV; Han, LJ; Marino, SM; Sun, XQ; Turanov, AA; Yang, PC; Yim, SH; Zhao, X; Kasaikina, MV; Stoletzki, N; Peng, CF; Polak, P; Xiong, ZQ; Kiezun, A; Zhu, YB; Chen, YX; Kryukov, GV; Zhang, Q; Peshkin, L; Yang, L; Bronson, RT; Buffenstein, R; Wang, B; Han, CL; Li, QY; Chen, L; Zhao, W; Sunyaev, SR; Park, TJ; Zhang, GJ; Wang, J; Gladyshev, VN				Kim, Eun Bae; Fang, Xiaodong; Fushan, Alexey A.; Huang, Zhiyong; Lobanov, Alexei V.; Han, Lijuan; Marino, Stefano M.; Sun, Xiaoqing; Turanov, Anton A.; Yang, Pengcheng; Yim, Sun Hee; Zhao, Xiang; Kasaikina, Marina V.; Stoletzki, Nina; Peng, Chunfang; Polak, Paz; Xiong, Zhiqiang; Kiezun, Adam; Zhu, Yabing; Chen, Yuanxin; Kryukov, Gregory V.; Zhang, Qiang; Peshkin, Leonid; Yang, Lan; Bronson, Roderick T.; Buffenstein, Rochelle; Wang, Bo; Han, Changlei; Li, Qiye; Chen, Li; Zhao, Wei; Sunyaev, Shamil R.; Park, Thomas J.; Zhang, Guojie; Wang, Jun; Gladyshev, Vadim N.			Genome sequencing reveals insights into physiology and longevity of the naked mole rat	NATURE			English	Article							LONGEST-LIVING RODENT; HETEROCEPHALUS-GLABER; RESISTANCE; FOSSORIAL; PROTEIN-1; CELLS	The naked mole rat (Heterocephalus glaber) is a strictly subterranean, extraordinarily long-lived eusocial mammal(1). Although it is the size of a mouse, its maximum lifespan exceeds 30 years, making this animal the longest-living rodent. Naked mole rats show negligible senescence, no age-related increase in mortality, and high fecundity until death(2). In addition to delayed ageing, they are resistant to both spontaneous cancer and experimentally induced tumorigenesis(3,4). Naked mole rats pose a challenge to the theories that link ageing, cancer and redox homeostasis. Although characterized by significant oxidative stress(5), the naked mole rat proteome does not show age-related susceptibility to oxidative damage or increased ubiquitination(6). Naked mole rats naturally reside in large colonies with a single breeding female, the 'queen', who suppresses the sexual maturity of her subordinates(7). They also live in full darkness, at low oxygen and high carbon dioxide concentrations(8), and are unable to sustain thermogenesis(9) nor feel certain types of pain(10,11). Here we report the sequencing and analysis of the naked mole rat genome, which reveals unique genome features and molecular adaptations consistent with cancer resistance, poikilothermy, hairlessness and insensitivity to low oxygen, and altered visual function, circadian rythms and taste sensing. This information provides insights into the naked mole rat's exceptional longevity and ability to live in hostile conditions, in the dark and at low oxygen. The extreme traits of the naked mole rat, together with the reported genome and transcriptome information, offer opportunities for understanding ageing and advancing other areas of biological and biomedical research.	[Fang, Xiaodong; Huang, Zhiyong; Han, Lijuan; Sun, Xiaoqing; Yang, Pengcheng; Zhao, Xiang; Peng, Chunfang; Xiong, Zhiqiang; Zhu, Yabing; Chen, Yuanxin; Zhang, Qiang; Yang, Lan; Wang, Bo; Han, Changlei; Li, Qiye; Chen, Li; Zhao, Wei; Zhang, Guojie; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Kim, Eun Bae; Fushan, Alexey A.; Gladyshev, Vadim N.] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea; [Lobanov, Alexei V.; Marino, Stefano M.; Turanov, Anton A.; Yim, Sun Hee; Kasaikina, Marina V.; Stoletzki, Nina; Polak, Paz; Kiezun, Adam; Kryukov, Gregory V.; Sunyaev, Shamil R.; Gladyshev, Vadim N.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Genet, Boston, MA 02115 USA; [Kryukov, Gregory V.; Sunyaev, Shamil R.; Gladyshev, Vadim N.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Peshkin, Leonid] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Univ, Sch Med, Rodent Histopathol Lab, Boston, MA 02115 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78245 USA; [Buffenstein, Rochelle] Univ Texas Hlth Sci Ctr San Antonio, Sam & Ann Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA; [Park, Thomas J.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-2200 Copenhagen N, Denmark; [Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen N, Denmark	Beijing Genomics Institute (BGI); Ewha Womans University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen	Zhang, GJ (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	zhanggj@genomics.org.cn; wangj@genomics.org.cn; vgladyshev@rics.bwh.harvard.edu	Gladyshev, Vadim N/A-9894-2013; Polak, Paz/AAH-9380-2020; Wang, Jun/A-7261-2013; Fang, Xiaodong/K-6743-2018; Zhang, Guojie/J-7273-2019; Gladyshev, Vadim N/J-6187-2013; Zhang, Guojie/B-6188-2014; Yang, Pengcheng/N-1037-2014; 高, 雨莉/HGU-8187-2022; Li, Qiye/C-1348-2015; Kryukov, Gregory V/A-9592-2008; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Fang, Xiaodong/0000-0001-7061-3337; Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Yang, Pengcheng/0000-0001-5496-8357; Li, Qiye/0000-0002-5993-0312; Gladyshev, Vadim/0000-0002-0372-7016; Stoletzki, Nina/0000-0002-4648-3103; Peshkin, Leonid/0000-0002-6420-848X; Kryukov, Gregory/0000-0002-6131-9483; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	WCU [R31-2008-000-10010-0]; NIH [AG038004, AG021518, CA080946]; Shenzhen Municipal Government [ZYC200903240077A]; National Natural Science Foundation of China [30725008]; National Science Foundation [0744979]; NATIONAL CANCER INSTITUTE [R01CA080946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038004, R01AG021518] Funding Source: NIH RePORTER; Direct For Biological Sciences [0744979] Funding Source: National Science Foundation	WCU; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shenzhen Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank P. C. LaVinka for help in preparing NMR tissues and N. Estologa for help in preparing the manuscript. We acknowledge financial support from the WCU Program (R31-2008-000-10010-0), the NIH (AG038004, AG021518 and CA080946), the Shenzhen Municipal Government (ZYC200903240077A), the National Natural Science Foundation of China (30725008) and the National Science Foundation (0744979).	Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Bhattacharyya S, 2009, J BIOL CHEM, V284, P14966, DOI 10.1074/jbc.M900195200; Bienengraeber M, 1998, BIOCHEMISTRY-US, V37, P3, DOI 10.1021/bi972463w; Buffenstein R, 2001, AM J PHYSIOL-REG I, V280, pR149, DOI 10.1152/ajpregu.2001.280.1.R149; Buffenstein R, 2008, J COMP PHYSIOL B, V178, P439, DOI 10.1007/s00360-007-0237-5; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Edrey YH, 2011, EXP GERONTOL, V46, P116, DOI 10.1016/j.exger.2010.09.005; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Hong MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003024; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JOHANSEN K, 1976, RESP PHYSIOL, V28, P303, DOI 10.1016/0034-5687(76)90025-6; Larson J, 2009, NEUROREPORT, V20, P1634, DOI 10.1097/WNR.0b013e32833370cf; Liang ST, 2010, AGING CELL, V9, P626, DOI 10.1111/j.1474-9726.2010.00588.x; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; Nikitina NV, 2004, ANAT REC PART A, V277A, P317, DOI 10.1002/ar.a.20025; Park TJ, 2008, PLOS BIOL, V6, P156, DOI 10.1371/journal.pbio.0060013; Perez VI, 2009, P NATL ACAD SCI USA, V106, P3059, DOI 10.1073/pnas.0809620106; Porter RK, 2008, J BIOENERG BIOMEMBR, V40, P457, DOI 10.1007/s10863-008-9172-8; QUAY WB, 1981, J NEURAL TRANSM, V52, P107, DOI 10.1007/BF01253102; Riccio AP, 2000, PHYSIOL BEHAV, V71, P1, DOI 10.1016/S0031-9384(00)00281-X; Schneider A, 2009, GENOME BIOL EVOL, V1, P114, DOI 10.1093/gbe/evp012; Seluanov A, 2009, P NATL ACAD SCI USA, V106, P19352, DOI 10.1073/pnas.0905252106; Smith ES, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-29; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Woodley R, 2002, COMP BIOCHEM PHYS A, V133, P827, DOI 10.1016/S1095-6433(02)00199-X; Wuehlbauer E, 2009, EUR J PHARMACOL, V606, P61, DOI 10.1016/j.ejphar.2009.01.029	29	387	417	1	368	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					223	227		10.1038/nature10533	http://dx.doi.org/10.1038/nature10533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	21993625	Green Accepted, hybrid			2022-12-24	WOS:000298030800041
J	Tian, H; Biehs, B; Warming, S; Leong, KG; Rangell, L; Klein, OD; de Sauvage, FJ				Tian, Hua; Biehs, Brian; Warming, Soren; Leong, Kevin G.; Rangell, Linda; Klein, Ophir D.; de Sauvage, Frederic J.			A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable	NATURE			English	Article							TRANSGENIC MICE; HAIR FOLLICLE; IN-VIVO; DIFFERENTIATION; EXPRESSION; RENEWAL; MARKS; LGR5; HOMEOSTASIS; DYNAMICS	The small intestine epithelium renews every 2 to 5 days, making it one of the most regenerative mammalian tissues. Genetic inducible fate mapping studies have identified two principal epithelial stem cell pools in this tissue. One pool consists of columnar Lgr5-expressing cells that cycle rapidly and are present predominantly at the crypt base(1). The other pool consists of Bmi1-expressing cells that largely reside above the crypt base(2). However, the relative functions of these two pools and their interrelationship are not understood. Here we specifically ablated Lgr5-expressing cells in mice using a human diphtheria toxin receptor (DTR) gene knocked into the Lgr5 locus. We found that complete loss of the Lgr5-expressing cells did not perturb homeostasis of the epithelium, indicating that other cell types can compensate for the elimination of this population. After ablation of Lgr5-expressing cells, progeny production by Bmi1-expressing cells increased, indicating that Bmi1-expressing stem cells compensate for the loss of Lgr5-expressing cells. Indeed, lineage tracing showed that Bmi1-expressing cells gave rise to Lgr5-expressing cells, pointing to a hierarchy of stem cells in the intestinal epithelium. Our results demonstrate that Lgr5-expressing cells are dispensable for normal intestinal homeostasis, and that in the absence of these cells, Bmi1-expressing cells can serve as an alternative stem cell pool. These data provide the first experimental evidence for the interrelationship between these populations. The Bmi1-expressing stem cells may represent both a reserve stem cell pool in case of injury to the small intestine epithelium and a source for replenishment of the Lgr5-expressing cells under non-pathological conditions.	[Tian, Hua; Warming, Soren; de Sauvage, Frederic J.] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Biehs, Brian; Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Biehs, Brian; Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, Dept Pediat, San Francisco, CA 94143 USA; [Biehs, Brian; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94143 USA; [Leong, Kevin G.] Genentech Inc, Dept Res Oncol, San Francisco, CA 94080 USA; [Rangell, Linda] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Roche Holding; Genentech; Roche Holding; Genentech	de Sauvage, FJ (corresponding author), Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA.	ophir.klein@ucsf.edu; desauvage.fred@gene.com	Parry, Lee/A-9623-2011; Warming, Soren/ABD-5729-2021; de Sauvage, Frederic/ABE-8400-2020	Parry, Lee/0000-0002-4467-9196; de Sauvage, Frederic/0000-0002-5275-2584; Warming, Soren/0000-0002-5721-0741; Klein, Ophir/0000-0002-6254-7082	National Institutes of Health [1-DP2-OD007191];  [R01-DE021420]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021420] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007191] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We gratefully acknowledge efforts by all the members of the Genentech mouse facility, in particular R. Ybarra and G. Morrow. We are grateful to N. Strauli, D.-K. Tran and A. Rathnayake for assistance with mouse breeding. We thank M. Roose-Girma, X. Rairdan and the members of the embryonic stem cell and microinjection groups for embryonic stem cell work and transgenic line generation and members of the F.J.d.S. laboratory for discussions and ideas. This work was funded in part by the National Institutes of Health through the NIH Director's New Innovator Award Program, 1-DP2-OD007191 and by R01-DE021420, both to O.D.K.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gregorieff A, 2010, CURR PROTOC STEM CEL; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lobachevsky PN, 2006, CELL PROLIFERAT, V39, P379, DOI 10.1111/j.1365-2184.2006.00395.x; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Keuren ML, 2009, TRANSGENIC RES, V18, P769, DOI 10.1007/s11248-009-9271-2; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	31	794	822	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					255	U148		10.1038/nature10408	http://dx.doi.org/10.1038/nature10408			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21927002	Green Accepted			2022-12-24	WOS:000295782800053
J	Janssen, A; van der Burg, M; Szuhai, K; Kops, GJPL; Medema, RH				Janssen, Aniek; van der Burg, Marja; Szuhai, Karoly; Kops, Geert J. P. L.; Medema, Rene H.			Chromosome Segregation Errors as a Cause of DNA Damage and Structural Chromosome Aberrations	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HUMAN-CELLS; CELLULAR-RESPONSE; MITOTIC ARREST; IN-VIVO; INSTABILITY; KINASE; ANEUPLOIDY; CANCER; INHIBITORS	Various types of chromosomal aberrations, including numerical (aneuploidy) and structural (e. g., translocations, deletions), are commonly found in human tumors and are linked to tumorigenesis. Aneuploidy is a direct consequence of chromosome segregation errors in mitosis, whereas structural aberrations are caused by improperly repaired DNA breaks. Here, we demonstrate that chromosome segregation errors can also result in structural chromosome aberrations. Chromosomes that missegregate are frequently damaged during cytokinesis, triggering a DNA double-strand break response in the respective daughter cells involving ATM, Chk2, and p53. We show that these double-strand breaks can lead to unbalanced translocations in the daughter cells. Our data show that segregation errors can cause translocations and provide insights into the role of whole-chromosome instability in tumorigenesis.	[Kops, Geert J. P. L.] Univ Med Ctr Utrecht, Dept Mol Canc Res, NL-3584 CG Utrecht, Netherlands; [Janssen, Aniek; Kops, Geert J. P. L.; Medema, Rene H.] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands; [Janssen, Aniek; Medema, Rene H.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CG Utrecht, Netherlands; [van der Burg, Marja; Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kops, GJPL (corresponding author), Univ Med Ctr Utrecht, Dept Mol Canc Res, Univ Sweg 100, NL-3584 CG Utrecht, Netherlands.	g.j.p.l.kops@umcutrecht.nl; rh.medema@nki.nl	Szuhai, Karoly/A-1100-2008; Medema, Rene H/E-2981-2013	Szuhai, Karoly/0000-0002-1228-4245; Kops, Geert/0000-0003-3555-5295; Medema, Rene/0000-0002-6754-0381; Janssen, Aniek/0000-0001-6731-6657	Netherlands Organisation for Scientific Research (NWO) [ZonMw 918.46.616, VIDI-91776336]; TI Pharma [T3-105]; European Research Council; Netherlands Genomic Initiative of NWO	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); TI Pharma; European Research Council(European Research Council (ERC)European Commission); Netherlands Genomic Initiative of NWO	We thank L. Kleij for technical assistance and the Medema, Lens, and Kops laboratories for discussions. We thank J. Raaijmakers, M. Tanenbaum, A. Maia, and S. Suijkerbuijk for critically reading the manuscript. We are grateful to M. van Vugt and R. Beijersbergen for sharing plasmids and cell lines. This work was supported by the Netherlands Organisation for Scientific Research (NWO) (R. H. M. and A. J.: ZonMw 918.46.616; G. J. P. L. K.: VIDI-91776336), TI Pharma (R. H. M and A. J.: T3-105) and the European Research Council (G. J. P. L. K.: ERC-StG KINSIGN). R. H. M. was additionally funded by the Netherlands Genomic Initiative of NWO.	Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Dalton WB, 2010, ONCOGENE, V29, P1929, DOI 10.1038/onc.2009.477; Dalton WB, 2007, CANCER RES, V67, P11487, DOI 10.1158/0008-5472.CAN-07-5162; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Giunta S, 2010, J CELL BIOL, V190, P197, DOI 10.1083/jcb.200911156; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Mortlock AA, 2007, J MED CHEM, V50, P2213, DOI 10.1021/jm061335f; Obe G, 2010, CYTOGENET GENOME RES, V128, P8, DOI 10.1159/000303328; Petrini JHJ, 2003, TRENDS CELL BIOL, V13, P458, DOI 10.1016/S0962-8924(03)00170-3; Quignon F, 2007, ONCOGENE, V26, P165, DOI 10.1038/sj.onc.1209787; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Thompson SL, 2011, CHROMOSOME RES, V19, P433, DOI 10.1007/s10577-010-9179-y; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287	25	390	397	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 30	2011	333	6051					1895	1898		10.1126/science.1210214	http://dx.doi.org/10.1126/science.1210214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	826PJ	21960636				2022-12-24	WOS:000295365800058
J	Vogels, TP; Sprekeler, H; Zenke, F; Clopath, C; Gerstner, W				Vogels, T. P.; Sprekeler, H.; Zenke, F.; Clopath, C.; Gerstner, W.			Inhibitory Plasticity Balances Excitation and Inhibition in Sensory Pathways and Memory Networks	SCIENCE			English	Article							NEURONAL NETWORKS; AUDITORY-CORTEX; SPIKING; PROPAGATION; POPULATION; DYNAMICS; STATE	Cortical neurons receive balanced excitatory and inhibitory synaptic currents. Such a balance could be established and maintained in an experience-dependent manner by synaptic plasticity at inhibitory synapses. We show that this mechanism provides an explanation for the sparse firing patterns observed in response to natural stimuli and fits well with a recently observed interaction of excitatory and inhibitory receptive field plasticity. The introduction of inhibitory plasticity in suitable recurrent networks provides a homeostatic mechanism that leads to asynchronous irregular network states. Further, it can accommodate synaptic memories with activity patterns that become indiscernible from the background state but can be reactivated by external stimuli. Our results suggest an essential role of inhibitory plasticity in the formation and maintenance of functional cortical circuitry.	[Vogels, T. P.; Sprekeler, H.; Zenke, F.; Clopath, C.; Gerstner, W.] Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, CH-1015 Lausanne Epfl, Switzerland; [Vogels, T. P.; Sprekeler, H.; Zenke, F.; Clopath, C.; Gerstner, W.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne Epfl, Switzerland; [Clopath, C.] Univ Paris 05, CNRS, UMR 8119, F-75270 Paris 06, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Vogels, TP (corresponding author), Ecole Polytech Fed Lausanne, Sch Comp & Commun Sci, CH-1015 Lausanne Epfl, Switzerland.	tim.vogels@epfl.ch	Sprekeler, Henning/B-8779-2012	Sprekeler, Henning/0000-0003-0690-3553	Swiss National Science Foundation [200020 13287]; CRSIK0 [122697]; European Community [268436, 243914, 237955]; French National Science [ANR-08-SYSC-005]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CRSIK0; European Community(European Commission); French National Science	Research was supported by Swiss National Science Foundation grant no. 200020 13287 (Coding Characteristics) and CRSIK0 122697 (Sinergia). Additionally, T. P. V. was supported by the European Community's Seventh Framework Marie Curie International Reintegration grant no. 268436, and H. S. and F.Z. by the European Community's Seventh Framework Program under grant agreement no. 243914 (BRAIN-I-NETS) and 237955 (FACETS-ITN), respectively. C. C. received additional support from a French National Science grant ANR-08-SYSC-005. Thanks to G. Hennequin and A. Woodruff for helpful discussions.	AITKIN LM, 1970, J NEUROPHYSIOL, V33, P421, DOI 10.1152/jn.1970.33.3.421; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Balena T, 2011, INHIBITORY SYNAPTIC PLASTICITY, P137, DOI 10.1007/978-1-4419-6978-1_10; Beck J, 2011, NEURAL COMPUT, V23, P1484, DOI 10.1162/NECO_a_00125; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Cafaro J, 2010, NATURE, V468, P964, DOI 10.1038/nature09570; Crochet S, 2011, NEURON, V69, P1160, DOI 10.1016/j.neuron.2011.02.022; de la Rocha J, 2008, J NEUROSCI, V28, P9151, DOI 10.1523/JNEUROSCI.1789-08.2008; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; Gerstner W, 2000, NEURAL COMPUT, V12, P43, DOI 10.1162/089976600300015899; Hartmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002979; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kumar A, 2010, NAT REV NEUROSCI, V11, P615, DOI 10.1038/nrn2886; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Series P, 2004, NAT NEUROSCI, V7, P1129, DOI 10.1038/nn1321; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; TSODYKS MV, 1995, NETWORK-COMP NEURAL, V6, P111, DOI 10.1088/0954-898X/6/2/001; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2009, NAT NEUROSCI, V12, P483, DOI 10.1038/nn.2276; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; VOLKOV IO, 1991, NEUROSCIENCE, V43, P307, DOI 10.1016/0306-4522(91)90295-Y; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Yao HS, 2007, NAT NEUROSCI, V10, P772, DOI 10.1038/nn1895	31	349	354	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 16	2011	334	6062					1569	1573		10.1126/science.1211095	http://dx.doi.org/10.1126/science.1211095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	862LE	22075724	Green Submitted			2022-12-24	WOS:000298091400057
J	Liu, J; Renault, L; Veaute, X; Fabre, F; Stahlberg, H; Heyer, WD				Liu, Jie; Renault, Ludovic; Veaute, Xavier; Fabre, Francis; Stahlberg, Henning; Heyer, Wolf-Dietrich			Rad51 paralogues Rad55-Rad57 balance the antirecombinase Srs2 in Rad51 filament formation	NATURE			English	Article							DOUBLE-STRAND-BREAK; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; DNA-REPAIR; PROTEIN; HELICASE; GENE; MUTATIONS; EXCHANGE	Homologous recombination is a high-fidelity DNA repair pathway. Besides a critical role in accurate chromosome segregation during meiosis, recombination functions in DNA repair and in the recovery of stalled or broken replication forks to ensure genomic stability. In contrast, inappropriate recombination contributes to genomic instability, leading to loss of heterozygosity, chromosome rearrangements and cell death. The RecA/UvsX/RadA/Rad51 family of proteins catalyses the signature reactions of recombination, homology search and DNA strand invasion(1,2). Eukaryotes also possess Rad51 paralogues, whose exact role in recombination remains to be defined(3). Here we show that the Saccharomyces cerevisiae Rad51 paralogues, the Rad55-Rad57 heterodimer, counteract the antirecombination activity of the Srs2 helicase. The Rad55-Rad57 heterodimer associates with the Rad51-single-stranded DNA filament, rendering it more stable than a nucleoprotein filament containing Rad51 alone. The Rad51-Rad55-Rad57 co-filament resists disruption by the Srs2 antirecombinase by blocking Srs2 translocation, involving a direct protein interaction between Rad55-Rad57 and Srs2. Our results demonstrate an unexpected role of the Rad51 paralogues in stabilizing the Rad51 filament against a biologically important antagonist, the Srs2 antirecombination helicase. The biological significance of this mechanism is indicated by a complete suppression of the ionizing radiation sensitivity of rad55 or rad57 mutants by concomitant deletion of SRS2, as expected for biological antagonists. We propose that the Rad51 presynaptic filament is a meta-stable reversible intermediate, whose assembly and disassembly is governed by the balance between Rad55-Rad57 and Srs2, providing a key regulatory mechanism controlling the initiation of homologous recombination. These data provide a paradigm for the potential function of the human RAD51 paralogues, which are known to be involved in cancer predisposition and human disease.	[Liu, Jie; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Renault, Ludovic; Stahlberg, Henning; Heyer, Wolf-Dietrich] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Veaute, Xavier; Fabre, Francis] CEA, CNRS, UMR217, CEA DSV Inst Radiobiol Cellulaire & Mol, F-92265 Fontenay Aux Roses, France; [Stahlberg, Henning] Univ Basel, Ctr Cellular Imaging & Nanoanalyt, CH-4056 Basel, Switzerland	University of California System; University of California Davis; University of California System; University of California Davis; CEA; Centre National de la Recherche Scientifique (CNRS); University of Basel	Heyer, WD (corresponding author), Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA.	wdheyer@ucdavis.edu	Stahlberg, Henning/H-1868-2011	Stahlberg, Henning/0000-0002-1185-4592; Renault, Ludovic/0000-0001-6464-8808; Liu, Jie/0000-0001-5817-9144	Tobacco-Related Disease Research Program [17FT-0046]; European Community [LSHG-CT-2003-503303]; Centre National de la Recherche Scientifique; Commissariat a l'Energie Atomique; SystemsX.ch; National Institutes of Health [U54GM74929, CA92267, GM58015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058015, U54GM074929] Funding Source: NIH RePORTER	Tobacco-Related Disease Research Program(University of California System); European Community(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); SystemsX.ch; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Alexeeva for the cell culture support. We thank P. Sung, R. Kolodner and L. Symington for plasmids and yeast strains. We are grateful to S. Kowalczykowski, N. Hunter, D. Castano-Diez, P. Ringler and all members of the Heyer laboratory for discussions and comments on the manuscript. This work was supported by Postdoctoral Fellowship 17FT-0046 from the Tobacco-Related Disease Research Program (J.L.), by the European Community (LSHG-CT-2003-503303) and the Centre National de la Recherche Scientifique, the Commissariat a l'Energie Atomique (X. V., F. F.), by SystemsX.ch (H. S.), and the National Institutes of Health grants U54GM74929 (H. S.), CA92267 and GM58015 (W.-D.H.).	ABOUSSEKHRA A, 1989, NUCLEIC ACIDS RES, V17, P7211, DOI 10.1093/nar/17.18.7211; AGUILERA A, 1988, GENETICS, V119, P779; Antony E, 2009, MOL CELL, V35, P105, DOI 10.1016/j.molcel.2009.05.026; Bashkirov VI, 2006, METHOD ENZYMOL, V409, P166, DOI 10.1016/S0076-6879(05)09010-5; Beernink HTH, 1999, TRENDS BIOCHEM SCI, V24, P385, DOI 10.1016/S0968-0004(99)01451-6; Bugreev DV, 2007, GENE DEV, V21, P3085, DOI 10.1101/gad.1609007; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Dupaigne P, 2008, MOL CELL, V29, P243, DOI 10.1016/j.molcel.2007.11.033; Fugger K, 2009, J CELL BIOL, V186, P655, DOI 10.1083/jcb.200812138; Fung CW, 2009, GENETICS, V181, P1195, DOI 10.1534/genetics.109.100842; Herzberg K, 2006, MOL CELL BIOL, V26, P8396, DOI 10.1128/MCB.01317-06; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Hilario J, 2009, P NATL ACAD SCI USA, V106, P361, DOI 10.1073/pnas.0811965106; Hu Y, 2007, GENE DEV, V21, P3073, DOI 10.1101/gad.1609107; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; LOVETT ST, 1987, GENETICS, V116, P547; Mazin AV, 2003, J BIOL CHEM, V278, P14029, DOI 10.1074/jbc.M212779200; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Modesti M, 2007, STRUCTURE, V15, P599, DOI 10.1016/j.str.2007.04.003; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Saponaro M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000858; SCHIESTL RH, 1990, GENETICS, V124, P817; Schwendener S, 2010, J BIOL CHEM, V285, P15739, DOI 10.1074/jbc.M110.110478; Solinger JA, 2002, MOL CELL, V10, P1175, DOI 10.1016/S1097-2765(02)00743-8; Sommers JA, 2009, J BIOL CHEM, V284, P7505, DOI 10.1074/jbc.M809019200; Spell Rachelle Miller, 2004, Methods Mol Biol, V262, P3; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Thacker J, 2005, CANCER LETT, V219, P125, DOI 10.1016/j.canlet.2004.08.018; Van Dyck E, 1998, J MOL BIOL, V284, P1027, DOI 10.1006/jmbi.1998.2203; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Zhang XP, 2011, METHODS MOL BIOL, V745, P329, DOI 10.1007/978-1-61779-129-1_19	39	141	141	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 10	2011	479	7372					245	U129		10.1038/nature10522	http://dx.doi.org/10.1038/nature10522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22020281	Green Submitted, Green Accepted			2022-12-24	WOS:000298030800046
J	Zoncu, R; Bar-Peled, L; Efeyan, A; Wang, SY; Sancak, Y; Sabatini, DM				Zoncu, Roberto; Bar-Peled, Liron; Efeyan, Alejo; Wang, Shuyu; Sancak, Yasemin; Sabatini, David M.			mTORC1 Senses Lysosomal Amino Acids Through an Inside-Out Mechanism That Requires the Vacuolar H+-ATPase	SCIENCE			English	Article							V-ATPASE; RAG GTPASES; COMPLEX; TARGET; ACIDIFICATION; AVAILABILITY; TRANSPORTER; DROSOPHILA; PATHWAY; KINASE	The mTOR complex 1 (mTORC1) protein kinase is a master growth regulator that is stimulated by amino acids. Amino acids activate the Rag guanosine triphosphatases (GTPases), which promote the translocation of mTORC1 to the lysosomal surface, the site of mTORC1 activation. We found that the vacuolar H+-adenosine triphosphatase ATPase (v-ATPase) is necessary for amino acids to activate mTORC1. The v-ATPase engages in extensive amino acid-sensitive interactions with the Ragulator, a scaffolding complex that anchors the Rag GTPases to the lysosome. In a cell-free system, ATP hydrolysis by the v-ATPase was necessary for amino acids to regulate the v-ATPase-Ragulator interaction and promote mTORC1 translocation. Results obtained in vitro and in human cells suggest that amino acid signaling begins within the lysosomal lumen. These results identify the v-ATPase as a component of the mTOR pathway and delineate a lysosome-associated machinery for amino acid sensing.	[Zoncu, Roberto; Bar-Peled, Liron; Efeyan, Alejo; Wang, Shuyu; Sancak, Yasemin; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Zoncu, Roberto; Bar-Peled, Liron; Efeyan, Alejo; Wang, Shuyu; Sancak, Yasemin; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Zoncu, Roberto; Bar-Peled, Liron; Efeyan, Alejo; Wang, Shuyu; Sancak, Yasemin; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Zoncu, Roberto; Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Efeyan, Alejo/J-8197-2016; Wang, shuyu/GZM-3462-2022	Efeyan, Alejo/0000-0002-3806-6799; 	National Institutes of Health [CA103866, AI47389]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM Foundation; Jane Coffin Childs Memorial Fund for Medical Research; Human Frontier Science Program; Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [R01CA103866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047389, R01AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Jane Coffin Childs Memorial Fund for Medical Research; Human Frontier Science Program(Human Frontier Science Program); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sabatini Lab as well as R. Perera for helpful suggestions, E. Spooner for the mass spectrometric analysis, and J. De Brabander (University of Texas Southwestern) for salicylihalamide A. Supported by grants from the National Institutes of Health (CA103866 and AI47389) and Department of Defense (W81XWH-07-0448) to D. M. S., awards from the W.M. Keck Foundation and LAM Foundation to D. M. S., and fellowship support from the Jane Coffin Childs Memorial Fund for Medical Research and the LAM Foundation to R.Z., from the Human Frontier Science Program to A. E., and from the Medical Scientist Training Program to S. W. D. M. S. is an investigator of the Howard Hughes Medical Institute.	Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bohe J, 2003, J PHYSIOL-LONDON, V552, P315, DOI 10.1113/jphysiol.2003.050674; Bond S, 2008, J BIOL CHEM, V283, P36513, DOI 10.1074/jbc.M805232200; Bowman BJ, 2006, J BIOL CHEM, V281, P31885, DOI 10.1074/jbc.M605532200; Boyd MR, 2001, J PHARMACOL EXP THER, V297, P114; Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200; Cruciat CM, 2010, SCIENCE, V327, P459, DOI 10.1126/science.1179802; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; REEVES JP, 1979, J BIOL CHEM, V254, P8914; Sagne C, 2001, P NATL ACAD SCI USA, V98, P7206, DOI 10.1073/pnas.121183498; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Yan Y, 2009, DEV CELL, V17, P387, DOI 10.1016/j.devcel.2009.07.001; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	25	1082	1108	14	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 4	2011	334	6056					678	683		10.1126/science.1207056	http://dx.doi.org/10.1126/science.1207056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841EG	22053050	Green Submitted, Green Accepted			2022-12-24	WOS:000296494700057
J	Login, FH; Balmand, S; Vallier, A; Vincent-Monegat, C; Vigneron, A; Weiss-Gayet, M; Rochat, D; Heddi, A				Login, Frederic H.; Balmand, Severine; Vallier, Agnes; Vincent-Monegat, Carole; Vigneron, Aurelien; Weiss-Gayet, Michele; Rochat, Didier; Heddi, Abdelaziz			Antimicrobial Peptides Keep Insect Endosymbionts Under Control	SCIENCE			English	Article							WEEVIL SITOPHILUS-ORYZAE; SYMBIOTIC BACTERIA; GENE-EXPRESSION; DIFFERENTIATION; EVOLUTION; APHIDS	Vertically transmitted endosymbionts persist for millions of years in invertebrates and play an important role in animal evolution. However, the functional basis underlying the maintenance of these long-term resident bacteria is unknown. We report that the weevil coleoptericin-A (ColA) antimicrobial peptide selectively targets endosymbionts within the bacteriocytes and regulates their growth through the inhibition of cell division. Silencing the colA gene with RNA interference resulted in a decrease in size of the giant filamentous endosymbionts, which escaped from the bacteriocytes and spread into insect tissues. Although this family of peptides is commonly linked with microbe clearance, this work shows that endosymbiosis benefits from ColA, suggesting that long-term host-symbiont coevolution might have shaped immune effectors for symbiont maintenance.	[Login, Frederic H.; Balmand, Severine; Vallier, Agnes; Vincent-Monegat, Carole; Vigneron, Aurelien; Heddi, Abdelaziz] INSA Lyon, INRA, UMR203 BF2I, F-69621 Villeurbanne, France; [Login, Frederic H.; Balmand, Severine; Vallier, Agnes; Vincent-Monegat, Carole; Vigneron, Aurelien; Weiss-Gayet, Michele; Heddi, Abdelaziz] Univ Lyon, F-69003 Lyon, France; [Weiss-Gayet, Michele] Univ Lyon 1, CNRS UMR5534, Ctr Genet & Physiol Mol & Cellulaire, F-69622 Villeurbanne, France; [Rochat, Didier] Univ Paris 06, INRA, Physiol Insecte Signalisat & Commun UMR1272, F-78026 Versailles, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; INRAE; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Heddi, A (corresponding author), INSA Lyon, INRA, UMR203 BF2I, F-69621 Villeurbanne, France.	abdelaziz.heddi@insa-lyon.fr	Vincent-Monégat, Carole/G-7287-2011; agnes, vallier/G-7281-2011; hongbo, yi/G-9615-2011; Vigneron, Aurélien/G-7268-2011	Vigneron, Aurélien/0000-0003-4986-6465	INRA; INSA de Lyon; Region Rhone-Alpes; COST action [FA0701]; NSF [EF-0523818]; Ministerio de Educacion y Ciencia [BFU2006-06003/BMC];  [ANR-06-BLAN-0316];  [ANR-2010-BLAN-170101]	INRA; INSA de Lyon; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); COST action(European Cooperation in Science and Technology (COST)); NSF(National Science Foundation (NSF)); Ministerio de Educacion y Ciencia(Spanish Government); ; 	This work was supported by INRA, INSA de Lyon, the French ANR-06-BLAN-0316 (EndoSymArt) and ANR-2010-BLAN-170101 (ImmunSymbArt), a grant from Region Rhone-Alpes (cluster infectiologie), and the COST action FA0701 (Arthropod Symbioses). The data reported in this paper are posted in the supporting online material (14). colA (EY122872) and colB (EY122826) sequences are published in GenBank. SPE omp sequences (GenBank JN575265, JN575266, JN575267) were provided by C. Dale and R. B. Weiss (University of Utah) from an ongoing SPE genome sequencing and annotation project supported by NSF grant EF-0523818 and the Ministerio de Educacion y Ciencia project BFU2006-06003/BMC to A. Moya and A. Latorre (University of Valencia). We thank R. Gil and K. Oakeson for omp sequence analysis; V. E. Shevchik, G. Condemine, and M. Lemaire for supplying E. coli and S. cerevisiae strains; W. J. Miller and B. Loppin for critical reading of the manuscript; and V. James for correction of English. Electron microscopy was carried out in Centre Technologique des Microstructures (UCBL). This paper is an homage to the work of Paul Nardon.	Anselme C, 2006, APPL ENVIRON MICROB, V72, P6766, DOI 10.1128/AEM.00942-06; Anselme C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-43; BULET P, 1991, J BIOL CHEM, V266, P24520; Chapman E, 2006, P NATL ACAD SCI USA, V103, P15800, DOI 10.1073/pnas.0607534103; Charles H, 2001, CR ACAD SCI III-VIE, V324, P489, DOI 10.1016/S0764-4469(01)01328-2; Charles H, 1997, INSECT BIOCHEM MOLEC, V27, P345, DOI 10.1016/S0965-1748(97)00005-2; Charles H, 1997, BIOCHEM BIOPH RES CO, V239, P769, DOI 10.1006/bbrc.1997.7552; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; FOUREL D, 1990, J BACTERIOL, V172, P3675, DOI 10.1128/jb.172.7.3675-3680.1990; Heddi A, 1998, J MOL EVOL, V47, P52, DOI 10.1007/PL00006362; Heddi A, 1999, P NATL ACAD SCI USA, V96, P6814, DOI 10.1073/pnas.96.12.6814; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sagisaka A, 2001, INSECT MOL BIOL, V10, P293, DOI 10.1046/j.0962-1075.2001.00261.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Van de Velde W, 2010, SCIENCE, V327, P1122, DOI 10.1126/science.1184057; Weiss BL, 2008, P NATL ACAD SCI USA, V105, P15088, DOI 10.1073/pnas.0805666105	23	231	241	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 21	2011	334	6054					362	365		10.1126/science.1209728	http://dx.doi.org/10.1126/science.1209728			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835RC	22021855				2022-12-24	WOS:000296052500049
J	Jezek, K; Henriksen, EJ; Treves, A; Moser, EI; Moser, MB				Jezek, Karel; Henriksen, Espen J.; Treves, Alessandro; Moser, Edvard I.; Moser, May-Britt			Theta-paced flickering between place-cell maps in the hippocampus	NATURE			English	Article							PATH-INTEGRATION; ATTRACTOR DYNAMICS; NEURAL NETWORKS; ENVIRONMENT; CA1; MODEL; REPRESENTATIONS; INFORMATION; ASSEMBLIES; DISCHARGE	The ability to recall discrete memories is thought to depend on the formation of attractor states in recurrent neural networks(1-4). In such networks, representations can be reactivated reliably from subsets of the cues that were present when the memory was encoded, at the same time as interference from competing representations is minimized. Theoretical studies have pointed to the recurrent CA3 system of the hippocampus as a possible attractor network(3,4). Consistent with predictions from these studies, experiments have shown that place representations in CA3 and downstream CA1 tolerate small changes in the configuration of the environment but switch to uncorrelated representations when dissimilarities become larger(5-9). However, the kinetics supporting such network transitions, at the subsecond timescale, is poorly understood. Here we show in rats that instantaneous transformation of the spatial context does not change the hippocampal representation all at once but is followed by temporary bistability in the discharge activity of CA3 ensembles. Rather than sliding through a continuum of intermediate activity states, the CA3 network undergoes a short period of competitive flickering between preformed representations of the past and present environment before settling on the latter. Network flickers are extremely fast, often with complete replacement of the active ensemble from one theta cycle to the next. Within individual cycles, segregation is stronger towards the end, when firing starts to decline, pointing to the theta cycle as a temporal unit for expression of attractor states in the hippocampus. Repetition of pattern-completion processes across successive theta cycles may facilitate error correction and enhance discriminative power in the presence of weak and ambiguous input cues.	[Jezek, Karel; Henriksen, Espen J.; Treves, Alessandro; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, N-7489 Trondheim, Norway; [Jezek, Karel; Henriksen, Espen J.; Treves, Alessandro; Moser, Edvard I.; Moser, May-Britt] Norwegian Univ Sci & Technol, Ctr Biol Memory, MTFS, N-7489 Trondheim, Norway; [Jezek, Karel] Acad Sci Czech Republic, Inst Physiol, Dept Physiol Memory, CR-14220 Prague 4, Krc, Czech Republic; [Treves, Alessandro] SISSA Int Sch Adv Studies, Cognit Neurosci Sect, I-34136 Trieste, Italy	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; International School for Advanced Studies (SISSA)	Jezek, K (corresponding author), Norwegian Univ Sci & Technol, Kavli Inst Syst Neurosci, MTFS, Olav Kyrres Gate 9, N-7489 Trondheim, Norway.	karel.jezek@biomed.cas.cz; edvard.moser@ntnu.no	Jezek, Karel/A-9581-2012	Jezek, Karel/0000-0001-7559-3689; TREVES, Alessandro/0000-0001-7246-5673	European Commission [200873]; European Research Council ('ENSEMBLE'); Kavli Foundation; Norwegian Research Council; Academy of Sciences of the Czech Republic [MSMT CR LC554, 1M0517, AV0Z50110509]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council ('ENSEMBLE')(European Research Council (ERC)); Kavli Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	We thank R. Skjerpeng, A. M. Amundsgard, K. Haugen, K. Jenssen, E. Krakvik and H. Waade for technical assistance. The work was supported by the 7th Framework Programme of the European Commission ('SPACEBRAIN', grant agreement no. 200873), an Advanced Investigator Grant to M.-B.M. from the European Research Council ('ENSEMBLE'), the Kavli Foundation, a Centre of Excellence grant from the Norwegian Research Council, and research projects MSMT CR LC554, 1M0517 and AV0Z50110509 at the Academy of Sciences of the Czech Republic.	Akrami A, 2009, CEREB CORTEX, V19, P760, DOI 10.1093/cercor/bhn125; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; Blumenfeld B, 2006, NEURON, V52, P383, DOI 10.1016/j.neuron.2006.08.016; Colgin LL, 2010, J NEUROPHYSIOL, V104, P35, DOI 10.1152/jn.00202.2010; Colgin LL, 2009, NATURE, V462, P353, DOI 10.1038/nature08573; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Gothard KM, 1996, J NEUROSCI, V16, P8027; Gothard KM, 1996, J NEUROSCI, V16, P823; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Jackson J, 2007, HIPPOCAMPUS, V17, P1209, DOI 10.1002/hipo.20359; Johnson A, 2007, J NEUROSCI, V27, P12176, DOI 10.1523/JNEUROSCI.3761-07.2007; Kelemen E, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000403; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1951; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1987, EXP BRAIN RES, V68, P1; Olypher AV, 2002, NEUROSCIENCE, V111, P553, DOI 10.1016/S0306-4522(01)00586-3; Romani S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000869; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Skaggs WE, 1998, J NEUROSCI, V18, P8455; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1995, INT J NEURAL SYS S, V6, P81; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	30	192	193	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 13	2011	478	7368					246	U136		10.1038/nature10439	http://dx.doi.org/10.1038/nature10439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964339				2022-12-24	WOS:000295782800051
J	Holzer, RG; Park, EJ; Li, N; Tran, H; Chen, M; Choi, C; Solinas, G; Karin, M				Holzer, Ryan G.; Park, Eek-Joong; Li, Ning; Tran, Helen; Chen, Monica; Choi, Crystal; Solinas, Giovanni; Karin, Michael			Saturated Fatty Acids Induce c-Src Clustering within Membrane Subdomains, Leading to JNK Activation	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; MIXED-LINEAGE KINASES; LIPID RAFTS; ADIPOSE-TISSUE; PLASMA-MEMBRANE; FISH OIL; OBESITY; INFLAMMATION; RECEPTOR	Saturated fatty acids (FA) exert adverse health effects and are more likely to cause insulin resistance and type 2 diabetes than unsaturated FA, some of which exert protective and beneficial effects. Saturated FA, but not unsaturated FA, activate Jun N-terminal kinase (JNK), which has been linked to obesity and insulin resistance in mice and humans. However, it is unknown how saturated and unsaturated FA are discriminated. We now demonstrate that saturated FA activate JNK and inhibit insulin signaling through c-Src activation. FA alter the membrane distribution of c-Src, causing it to partition into intracellular membrane subdomains, where it likely becomes activated. Conversely, unsaturated FA with known beneficial effects on glucose metabolism prevent c-Src membrane partitioning and activation, which are dependent on its myristoylation, and block JNK activation. Consumption of a diabetogenic high-fat diet causes the partitioning and activation of c-Src within detergent insoluble membrane subdomains of murine adipocytes.	[Holzer, Ryan G.; Park, Eek-Joong; Li, Ning; Tran, Helen; Chen, Monica; Choi, Crystal; Karin, Michael] Univ Calif San Diego, Dept Pharmacol, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Solinas, Giovanni] Univ Fribourg, Lab Metab Stress Biol, Dept Med, CH-1700 Fribourg, Switzerland	University of California System; University of California San Diego; University of Fribourg	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Sch Med, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Solinas, Giovanni/P-6596-2017; Solinas, Giovanni/R-4777-2019	Solinas, Giovanni/0000-0002-0140-2621; Solinas, Giovanni/0000-0002-0140-2621	National Institutes of Health [ES006376, ES0100337]; American Diabetes Association (ADA) [7-08-MN-29]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376, R37ES004151] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association (ADA)(American Diabetes Association); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the individuals mentioned in the Extended Experimental Procedures who provided us with essential reagents. Research was supported by grants from the National Institutes of Health (ES006376, ES0100337) and the American Diabetes Association (ADA 7-08-MN-29) to M. K., who is an American Cancer Society Research Professor.	Agostino Nicole M, 2011, J Oncol Pharm Pract, V17, P197, DOI 10.1177/1078155210378913; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Arcaro A, 2007, CELL SIGNAL, V19, P1081, DOI 10.1016/j.cellsig.2006.12.003; Breccia M, 2008, LEUKEMIA RES, V32, P1626, DOI 10.1016/j.leukres.2008.01.015; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; Browning LM, 2007, DIABETES OBES METAB, V9, P70, DOI 10.1111/j.1463-1326.2006.00576.x; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200; Clamp AG, 1997, LIPIDS, V32, P179, DOI 10.1007/s11745-997-0022-3; CLANDININ MT, 1991, FASEB J, V5, P2761, DOI 10.1096/fasebj.5.13.1916101; CULP BR, 1980, PROSTAG OTH LIPID M, V20, P1021, DOI 10.1016/0090-6980(80)90056-8; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Faloia E, 1999, EUR J CLIN INVEST, V29, P432, DOI 10.1046/j.1365-2362.1999.00458.x; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Handley ME, 2007, INT J EXP PATHOL, V88, P111, DOI 10.1111/j.1365-2613.2007.00531.x; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jaeschke A, 2004, GENE DEV, V18, P1976, DOI 10.1101/gad.1216504; Jaeschke A, 2007, MOL CELL, V27, P498, DOI 10.1016/j.molcel.2007.07.008; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Jorgensen ME, 2006, AM J CLIN NUTR, V84, P29, DOI 10.1093/ajcn/84.1.29; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; Kahn CR, 1996, ANNU REV MED, V47, P509; Karin M, 2005, IUBMB LIFE, V57, P283, DOI 10.1080/15216540500097111; KARNOVSKY MJ, 1982, J CELL BIOL, V94, P1, DOI 10.1083/jcb.94.1.1; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; KROMANN N, 1980, ACTA MED SCAND, V208, P401; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Liu GM, 2001, P NATL ACAD SCI USA, V98, P7510, DOI 10.1073/pnas.131195198; Luo J, 1996, J NUTR, V126, P1951; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; OKADA M, 1991, J BIOL CHEM, V266, P24249; Ostrom Rennolds S., 2006, V332, P181; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Rajendran L, 2007, BIOL CHEM, V388, P307, DOI 10.1515/BC.2007.034; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; RINTOUL DA, 1978, J BIOL CHEM, V253, P7447; Robinson LE, 2007, APPL PHYSIOL NUTR ME, V32, P1008, DOI 10.1139/H07-087; Ryan M, 2000, QJM-MON J ASSOC PHYS, V93, P85, DOI 10.1093/qjmed/93.2.85; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sandilands E, 2004, DEV CELL, V7, P855, DOI 10.1016/j.devcel.2004.09.019; Seong JH, 2009, CHEM BIOL, V16, P48, DOI 10.1016/j.chembiol.2008.11.007; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STORLIEN LH, 1987, SCIENCE, V237, P885, DOI 10.1126/science.3303333; Stulnig TM, 1998, J CELL BIOL, V143, P637, DOI 10.1083/jcb.143.3.637; Stulnig TM, 2001, J BIOL CHEM, V276, P37335, DOI 10.1074/jbc.M106193200; Taniguchi CM, 2007, MOL CELL BIOL, V27, P2830, DOI 10.1128/MCB.00079-07; Thorsdottir I, 2004, PREV MED, V39, P630, DOI 10.1016/j.ypmed.2004.02.031; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vallerie SN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003151; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; WATALA C, 1992, EUR J CLIN CHEM CLIN, V30, P513; Webb Y, 2000, J BIOL CHEM, V275, P261, DOI 10.1074/jbc.275.1.261; Wu YT, 2008, CELL DEATH DIFFER, V15, P386, DOI 10.1038/sj.cdd.4402273	71	200	209	2	39	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					173	184		10.1016/j.cell.2011.08.034	http://dx.doi.org/10.1016/j.cell.2011.08.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962514	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000295396700024
J	Smillie, CS; Smith, MB; Friedman, J; Cordero, OX; David, LA; Alm, EJ				Smillie, Chris S.; Smith, Mark B.; Friedman, Jonathan; Cordero, Otto X.; David, Lawrence A.; Alm, Eric J.			Ecology drives a global network of gene exchange connecting the human microbiome	NATURE			English	Article							EVOLUTION; BACTERIA; PATHOGENESIS; GENOMES; SEARCH	Horizontal gene transfer (HGT), the acquisition of genetic material from non-parental lineages, is known to be important in bacterial evolution(1,2). In particular, HGT provides rapid access to genetic innovations, allowing traits such as virulence(3), antibiotic resistance(4) and xenobiotic metabolism(5) to spread through the human microbiome. Recent anecdotal studies providing snapshots of active gene flow on the human body have highlighted the need to determine the frequency of such recent transfers and the forces that govern these events(4,5). Here we report the discovery and characterization of a vast, human-associated network of gene exchange, large enough to directly compare the principal forces shaping HGT. We show that this network of 10,770 unique, recently transferred (more than 99% nucleotide identity) genes found in 2,235 full bacterial genomes, is shaped principally by ecology rather than geography or phylogeny, with most gene exchange occurring between isolates from ecologically similar, but geographically separated, environments. For example, we observe 25-fold more HGT between human-associated bacteria than among ecologically diverse non-human isolates (P = 3.0 x 10(-270)). We show that within the human microbiome this ecological architecture continues across multiple spatial scales, functional classes and ecological niches with transfer further enriched among bacteria that inhabit the same body site, have the same oxygen tolerance or have the same ability to cause disease. This structure offers a window into the molecular traits that define ecological niches, insight that we use to uncover sources of antibiotic resistance and identify genes associated with the pathology of meningitis and other diseases.	[Cordero, Otto X.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Smillie, Chris S.; Friedman, Jonathan] MIT, Computat & Syst Biol Initiat, Cambridge, MA 02139 USA; [Smith, Mark B.] MIT, Microbiol Grad Program, Cambridge, MA 02139 USA; [David, Lawrence A.] Harvard Univ, Soc Fellows, Cambridge, MA 02138 USA; [Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Alm, Eric J.] Broad Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Alm, EJ (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu	David, Lawrence Anthony/HCJ-0062-2022; Friedman, Jonathan/I-6930-2019; David, Lawrence/B-1044-2010	David, Lawrence Anthony/0000-0002-3570-4767; Friedman, Jonathan/0000-0001-8476-8030; David, Lawrence/0000-0002-3570-4767; Smillie, Chris/0000-0002-7606-3433	National Science Foundation [0918333, 0936234]; Department of Energy's ENIGMA Scientific Focus Area; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Department of Energy's ENIGMA Scientific Focus Area; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Science Foundation awards 0918333 and 0936234 to E.J.A., and by the Department of Energy's ENIGMA Scientific Focus Area. This work is part of the National Institutes of Health Human Microbiome Project.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Boucher Y, 2011, MBIO, V2, DOI 10.1128/mBio.00335-10; Caro-Quintero A, 2011, ISME J, V5, P131, DOI 10.1038/ismej.2010.93; Chen J, 2009, SCIENCE, V323, P139, DOI 10.1126/science.1164783; Clatworthy AE, 2007, NAT CHEM BIOL, V3, P541, DOI 10.1038/nchembio.2007.24; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kim KS, 2003, NAT REV NEUROSCI, V4, P376, DOI 10.1038/nrn1103; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; Lester CH, 2006, ANTIMICROB AGENTS CH, V50, P596, DOI 10.1128/AAC.50.2.596-599.2006; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Markowitz VM, 2006, NUCLEIC ACIDS RES, V34, pD344, DOI 10.1093/nar/gkj024; Mazodier P., 2011, ANNU REV GENET, V25, P147; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OCHMAN H, 1987, J MOL EVOL, V26, P74, DOI 10.1007/BF02111283; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tuller T., 2011, NUCLEIC ACIDS RES, V39, P1; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	29	524	553	11	329	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2011	480	7376					241	244		10.1038/nature10571	http://dx.doi.org/10.1038/nature10571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857TR	22037308				2022-12-24	WOS:000297744200051
J	Fast, EM; Toomey, ME; Panaram, K; Desjardins, D; Kolaczyk, ED; Frydman, HM				Fast, Eva M.; Toomey, Michelle E.; Panaram, Kanchana; Desjardins, Danielle; Kolaczyk, Eric D.; Frydman, Horacio M.			Wolbachia Enhance Drosophila Stem Cell Proliferation and Target the Germline Stem Cell Niche	SCIENCE			English	Article							LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI; RAPID SPREAD; INFECTION; INCOMPATIBILITY; MELANOGASTER; SIMULANS; BIOLOGY; FUSOME; DEATH	Wolbachia are widespread maternally transmitted intracellular bacteria that infect most insect species and are able to alter the reproduction of innumerous hosts. The cellular bases of these alterations remain largely unknown. Here, we report that Drosophila mauritiana infected with a native Wolbachia wMau strain produces about four times more eggs than the noninfected counterpart. Wolbachia infection leads to an increase in the mitotic activity of germline stem cells (GSCs), as well as a decrease in programmed cell death in the germarium. Our results suggest that up-regulation of GSC division is mediated by a tropism of Wolbachia for the GSC niche, the cellular microenvironment that supports GSCs.	[Fast, Eva M.; Toomey, Michelle E.; Panaram, Kanchana; Desjardins, Danielle; Frydman, Horacio M.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Toomey, Michelle E.; Frydman, Horacio M.] Boston Univ, Natl Emerging Infect Dis Lab, Boston, MA 02118 USA; [Kolaczyk, Eric D.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Frydman, HM (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	hfrydman@bu.edu		Frydman, Horacio/0000-0003-0191-7948; Fast, Eva/0000-0002-4261-5244	Boston Univ.; National Institute of Allergy and Infectious Diseases [1K22AI74909-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI074909] Funding Source: NIH RePORTER	Boston Univ.; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. McCall, G. Cooper, D. Waxman, C. Bradham, and A. Boxer for valuable suggestions in the manuscript; E. Wieschaus, the McCall Lab, T. Blute, D. Gantz, and M. Bisher for help and support with PCD and EM experiments; E. Wieschaus, T. Schupbach, R. Lehmann, P. Lasko, D. Stern, V. Orgogozo, and M. Ramos for fly stocks and reagents; members of the Frydman Lab for assistance and suggestions during the realization of this work; J. Li and D. Robson for help with MatLab software; and A. Mahowald for sharing his unpublished results and encouraging us to analyze Wolbachia in the testis. Finally, we would like to thank the anonymous reviewers for their helpful comments. This work was supported by funds from Boston Univ. and National Institute of Allergy and Infectious Diseases (grant 1K22AI74909-01A1 to H. M. F.). The data described in this paper are available in the SOM.	Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x; Bourtzis K, 2008, ADV EXP MED BIOL, V627, P104, DOI 10.1007/978-0-387-78225-6_9; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; de Cuevas M, 2011, DEVELOPMENT, V138, P2861, DOI 10.1242/dev.056242; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Frydman HM, 2006, NATURE, V441, P509, DOI 10.1038/nature04756; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; HOFFMANN AA, 1990, GENETICS, V126, P933; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; LIN HF, 1994, DEVELOPMENT, V120, P947; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Pfarr KM, 2006, MINI-REV MED CHEM, V6, P203, DOI 10.2174/138955706775475984; Poinsot D, 1997, EVOLUTION, V51, P180, DOI 10.1111/j.1558-5646.1997.tb02399.x; Pritchett TL, 2009, APOPTOSIS, V14, P969, DOI 10.1007/s10495-009-0369-z; Reynolds KT, 2003, GENETICS, V164, P1027; Sacchi L, 2010, TISSUE CELL, V42, P328, DOI 10.1016/j.tice.2010.07.009; Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Weiss B., 2011, TRENDS PARASITOL; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Werren JH, 2011, P NATL ACAD SCI USA, V108, P10863, DOI 10.1073/pnas.1102343108; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	30	124	132	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					990	992		10.1126/science.1209609	http://dx.doi.org/10.1126/science.1209609			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22021671	Green Accepted			2022-12-24	WOS:000297101800059
J	Gatesman, ML; Smith, TJ				Gatesman, Mandy L.; Smith, Thomas J.			The Shortage of Essential Chemotherapy Drugs in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gatesman, Mandy L.] Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA; [Smith, Thomas J.] Sidney Kimmel Comprehens Canc Ctr, Johns Hopkins Med, Baltimore, MD USA	Virginia Commonwealth University; Johns Hopkins University; Johns Hopkins Medicine	Gatesman, ML (corresponding author), Virginia Commonwealth Univ Hlth Syst, Richmond, VA USA.			Smith, Thomas/0000-0003-3040-6434				Food and Drug Administration, CURR DRUG SHORT; Jacobson M, 2010, HEALTH AFFAIR, V29, P1391, DOI 10.1377/hlthaff.2009.0563; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Neubauer MA, 2010, J ONCOL PRACT, V6, P12, DOI 10.1200/JOP.091058; Twombly R, 2004, J NATL CANCER I, V96, P1268, DOI 10.1093/jnci/96.17.1268	5	85	86	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2011	365	18					1653	1655		10.1056/NEJMp1109772	http://dx.doi.org/10.1056/NEJMp1109772			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	840FL	22040130				2022-12-24	WOS:000296424200001
J	Trompouki, E; Bowman, TV; Lawton, LN; Fan, ZP; Wu, DC; DiBiase, A; Martin, CS; Cech, JN; Sessa, AK; Leblanc, JL; Li, PL; Durand, EM; Mosimann, C; Heffner, GC; Daley, GQ; Paulson, RF; Young, RA; Zon, LI				Trompouki, Eirini; Bowman, Teresa V.; Lawton, Lee N.; Fan, Zi Peng; Wu, Dai-Chen; DiBiase, Anthony; Martin, Corey S.; Cech, Jennifer N.; Sessa, Anna K.; Leblanc, Jocelyn L.; Li, Pulin; Durand, Ellen M.; Mosimann, Christian; Heffner, Garrett C.; Daley, George Q.; Paulson, Robert F.; Young, Richard A.; Zon, Leonard I.			Lineage Regulators Direct BMP and Wnt Pathways to Cell-Specific Programs during Differentiation and Regeneration	CELL			English	Article							EMBRYONIC STEM-CELLS; UCSC GENOME BROWSER; TRANSCRIPTION FACTORS; BETA-CATENIN; MEGAKARYOCYTIC DIFFERENTIATION; HEMATOPOIETIC PROGENITORS; SIGNALING PATHWAYS; GENE ACTIVATION; GAMMA-CATENIN; PROTEIN	BMP and Wnt signaling pathways control essential cellular responses through activation of the transcription factors SMAD (BMP) and TCF (Wnt). Here, we show that regeneration of hematopoietic lineages following acute injury depends on the activation of each of these signaling pathways to induce expression of key blood genes. Both SMAD1 and TCF7L2 co-occupy sites with master regulators adjacent to hematopoietic genes. In addition, both SMAD1 and TCF7L2 follow the binding of the predominant lineage regulator during differentiation from multipotent hematopoietic progenitor cells to erythroid cells. Furthermore, induction of the myeloid lineage regulator C/EBP alpha in erythroid cells shifts binding of SMAD1 to sites newly occupied by C/EBP alpha, whereas expression of the erythroid regulator GATA1 directs SMAD1 loss on nonerythroid targets. We conclude that the regenerative response mediated by BMP and Wnt signaling pathways is coupled with the lineage master regulators to control the gene programs defining cellular identity.	[Trompouki, Eirini; Bowman, Teresa V.; DiBiase, Anthony; Martin, Corey S.; Cech, Jennifer N.; Sessa, Anna K.; Leblanc, Jocelyn L.; Li, Pulin; Durand, Ellen M.; Mosimann, Christian; Zon, Leonard I.] Harvard Univ, Sch Med, Stem Cell Program, Boston, MA 02115 USA; [Trompouki, Eirini; Bowman, Teresa V.; DiBiase, Anthony; Martin, Corey S.; Cech, Jennifer N.; Sessa, Anna K.; Leblanc, Jocelyn L.; Li, Pulin; Durand, Ellen M.; Mosimann, Christian; Zon, Leonard I.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston,Harvard Stem Cell Inst, Boston, MA 02115 USA; [Trompouki, Eirini; Bowman, Teresa V.; DiBiase, Anthony; Martin, Corey S.; Cech, Jennifer N.; Sessa, Anna K.; Leblanc, Jocelyn L.; Li, Pulin; Durand, Ellen M.; Mosimann, Christian; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Lawton, Lee N.; Fan, Zi Peng; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wu, Dai-Chen; Paulson, Robert F.] Penn State Univ, Grad Program Biochem Microbiol & Mol Biol, University Pk, PA 16802 USA; [Wu, Dai-Chen; Paulson, Robert F.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Heffner, Garrett C.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Heffner, Garrett C.; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Heffner, Garrett C.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Fan, Zi Peng] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Zon, LI (corresponding author), Harvard Univ, Sch Med, Stem Cell Program, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Trompouki, Eirini/AAX-9539-2020; cheng, yong/I-4270-2012	Trompouki, Eirini/0000-0002-7242-8810; Li, Pulin/0000-0002-8525-4936; /0000-0001-8855-8647; Mosimann, Christian/0000-0002-0749-2576	NIH [P50-NS40828, NIH-P30-HD18655, 5PO1HL32262-29, 5R01HL048801-18, 1R01DK080040-01, R01-HG002668, K01 DK085270-02, U01 HL100001, 1 RC2HL102815, T32HL007623]; ROFAR; HHMI; EMBO; Jane Coffin Childs Memorial Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623, F32HL082448, P01HL032262, R01HL048801, U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085270, R01DK080040, P30DK056465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS040828] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ROFAR; HHMI(Howard Hughes Medical Institute); EMBO(European Molecular Biology Organization (EMBO)); Jane Coffin Childs Memorial Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge A. Mullen and D. Orlando for helpful discussions and sharing critical insights prior to publication and G. Frampton for analytical advice and development of the ChIP-seq analysis platform. We thank F. Rentzsch and M. Hammerschmidt for the Hs: BMP zebrafish line, J. Tucker and M. Mullins for the Hs: Chordin zebrafish line, and T. Schlaeger for the GATA2 expression plasmid. We are grateful to X. Bai and R. White for critical reviews of the manuscript and O. Tamplin for computational advice. The Whitehead Genome Technology Core was instrumental in timely data production and analysis support, especially S. Gupta. Microarray studies were performed by the Molecular Genetics Core Facility at Children's Hospital Boston, supported by NIH-P50-NS40828 and NIH-P30-HD18655. This work was supported by NIH # 5PO1HL32262-29 and # 5R01HL048801-18 (to L.I.Z), NIH 1R01DK080040-01 (to R. F. P.), R01-HG002668 (to R. A. Y.), NIH K01 DK085270-02 (to T. V. B.), NIH U01 HL100001, NIH 1 RC2HL102815, and ROFAR (to G. Q. D.), NIH T32HL007623 (to G. C. H.), HHMI (to L.I.Z. and G. Q. D.), and EMBO fellowship and Jane Coffin Childs Memorial Fund (to E. T.). L.I.Z. is a founder and stock holder of Fate, Inc. and a scientific advisor for Stemgent. G. Q. D. is a member of the Scientific Advisory Boards of MPM Capital, Inc., Epizyme, Inc., and iPierian, Inc.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Cantor AB, 2005, INT J HEMATOL, V81, P378, DOI 10.1532/IJH97.04180; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; D'Alo F, 2003, BLOOD, V102, P3163, DOI 10.1182/blood-2003-02-0479; Detmer K, 2002, CYTOKINE, V17, P36, DOI 10.1006/cyto.2001.0984; Fuchs O, 2002, BLOOD CELL MOL DIS, V28, P221, DOI 10.1006/bcmd.2002.0487; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Hecht A, 2003, J BIOL CHEM, V278, P3776, DOI 10.1074/jbc.M210081200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Ide Y, 2004, BLOOD, V104, P4097, DOI 10.1182/blood-2004-04-1476; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jeanpierre S, 2008, BLOOD, V112, P3154, DOI 10.1182/blood-2008-03-145326; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kurisaki K, 2003, MOL CELL BIOL, V23, P4494, DOI 10.1128/MCB.23.13.4494-4510.2003; Landry JR, 2009, BLOOD, V113, P5783, DOI 10.1182/blood-2008-11-187757; Larsson J, 2005, ONCOGENE, V24, P5676, DOI 10.1038/sj.onc.1208920; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; McReynolds LJ, 2007, BLOOD, V110, P3881, DOI 10.1182/blood-2007-04-085753; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Pearson KL, 1999, BBA-GENE STRUCT EXPR, V1489, P354, DOI 10.1016/S0167-4781(99)00166-9; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rentzsch F, 2006, DEVELOPMENT, V133, P801, DOI 10.1242/dev.02250; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; Schier AF, 2005, ANNU REV GENET, V39, P561, DOI 10.1146/annurev.genet.37.110801.143752; Singbrant S, 2010, BLOOD, V115, P4689, DOI 10.1182/blood-2009-05-220988; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Staal FJT, 2010, J CELL BIOCHEM, V109, P844, DOI 10.1002/jcb.22467; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tran HT, 2010, P NATL ACAD SCI USA, V107, P16160, DOI 10.1073/pnas.1007725107; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Verzi MP, 2010, P NATL ACAD SCI USA, V107, P15157, DOI 10.1073/pnas.1003822107; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, P1; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002	60	218	227	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 28	2011	147	3					577	589		10.1016/j.cell.2011.09.044	http://dx.doi.org/10.1016/j.cell.2011.09.044			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036566	Green Accepted, Green Published, Green Submitted, Bronze			2022-12-24	WOS:000296573700013
J	Chatterjee, A; Abeydeera, ND; Bale, S; Pai, PJ; Dorrestein, PC; Russell, DH; Ealick, SE; Begley, TP				Chatterjee, Abhishek; Abeydeera, N. Dinuka; Bale, Shridhar; Pai, Pei-Jing; Dorrestein, Pieter C.; Russell, David H.; Ealick, Steven E.; Begley, Tadhg P.			Saccharomyces cerevisiae THI4p is a suicide thiamine thiazole synthase	NATURE			English	Article							ESCHERICHIA-COLI; BIOSYNTHESIS; ENZYME; EUKARYOTES; GENE; IDENTIFICATION; PROTEIN	Thiamine pyrophosphate 1 is an essential cofactor in all living systems(1). Its biosynthesis involves the separate syntheses of the pyrimidine 2 and thiazole 3 precursors, which are then coupled(2). Two biosynthetic routes to the thiamine thiazole have been identified. In prokaryotes, five enzymes act on three substrates to produce the thiazole via a complex oxidative condensation reaction, the mechanistic details of which are now well established(2-6). In contrast, only one gene product is involved in thiazole biosynthesis in eukaryotes (THI4p in Saccharomyces cerevisiae)(7). Here we report the preparation of fully active recombinant wild-type THI4p, the identification of an iron-dependent sulphide transfer reaction from a conserved cysteine residue of the protein to a reaction intermediate and the demonstration that THI4p is a suicide enzyme undergoing only a single turnover.	[Abeydeera, N. Dinuka; Pai, Pei-Jing; Russell, David H.; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA; [Chatterjee, Abhishek; Bale, Shridhar; Ealick, Steven E.] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Dorrestein, Pieter C.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Texas A&M University System; Texas A&M University College Station; Cornell University; University of California System; University of California San Diego	Begley, TP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	see3@cornell.edu; begley@chem.tamu.edu	Russell, David H/C-3618-2015; chatterjee, abhishek/N-9443-2019; Dorrestein, Pieter/D-5012-2012; Dorrestein, Pieter/ABF-2930-2020; Begley, Tadhg/B-5801-2015	Russell, David H/0000-0003-0830-3914; chatterjee, abhishek/0000-0002-6231-5302; 	NIH [DK44083]; Robert E. Welch Foundation [A-0034, DK67081]; NSF [DBI0821700]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067081, R37DK044083, R01DK044083] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert E. Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. W. McLafferty for initial FTMS analysis of THI4p. This research was funded by NIH grant DK44083 (to T. P. B.), the Robert E. Welch Foundation grant A-0034 (to T. P. B.), DK67081 (to S. E. E.) and NSF grant DBI0821700 (to D. H. R.).	Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Begley TP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P547; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; Chatterjee A, 2008, J AM CHEM SOC, V130, P11394, DOI 10.1021/ja802140a; Chatterjee A, 2007, J AM CHEM SOC, V129, P2914, DOI 10.1021/ja067606t; Chatterjee A, 2006, J AM CHEM SOC, V128, P7158, DOI 10.1021/ja061413o; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEMPLE B, 1985, P NATL ACAD SCI USA, V82, P2688, DOI 10.1073/pnas.82.9.2688; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faou P, 2004, J MOL BIOL, V344, P1147, DOI 10.1016/j.jmb.2004.09.097; Godoi PHC, 2006, J BIOL CHEM, V281, P30957, DOI 10.1074/jbc.M604469200; Hazra AB, 2011, J AM CHEM SOC, V133, P9311, DOI 10.1021/ja1110514; Jordan F, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P561; Jurgenson CT, 2006, BIOCHEMISTRY-US, V45, P11061, DOI 10.1021/bi061025z; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Medina-Silva R, 2006, RES MICROBIOL, V157, P275, DOI 10.1016/j.resmic.2005.07.004; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; PRAEKELT UM, 1994, YEAST, V10, P481, DOI 10.1002/yea.320100407; Ruiz-Roldan C, 2008, FUNGAL GENET BIOL, V45, P6, DOI 10.1016/j.fgb.2007.09.003; SEDGWICK B, 1988, J BIOL CHEM, V263, P4430; Suter B, 2007, GENOME RES, V17, P1774, DOI 10.1101/gr.6667007; TEO I, 1986, CELL, V45, P315, DOI 10.1016/0092-8674(86)90396-X	25	110	117	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					542	U146		10.1038/nature10503	http://dx.doi.org/10.1038/nature10503			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031445	Green Accepted			2022-12-24	WOS:000296194200049
J	Musallam, KM; Tamim, HM; Richards, T; Spahn, DR; Rosendaal, FR; Habbal, A; Khreiss, M; Dandaleh, FS; Khavandi, K; Sfeir, PM; Soweid, A; Hoballah, JJ; Taher, AT; Jamali, FR				Musallam, Khaled M.; Tamim, Hani M.; Richards, Toby; Spahn, Donat R.; Rosendaal, Frits R.; Habbal, Aida; Khreiss, Mohammad; Dandaleh, Fadi S.; Khavandi, Kaivan; Sfeir, Pierre M.; Soweid, Assaad; Hoballah, Jamal J.; Taher, Ali T.; Jamali, Faek R.			Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study	LANCET			English	Article							PATIENT BLOOD MANAGEMENT; HEMOGLOBIN LEVEL; 30-DAY MORTALITY; CARDIAC-SURGERY; OLDER PATIENTS; TRANSFUSION; PREDICTION; MORBIDITY; IMPACT	Background Preoperative anaemia is associated with adverse outcomes after cardiac surgery but outcomes after non-cardiac surgery are not well established. We aimed to assess the effect of preoperative anaemia on 30-day postoperative morbidity and mortality in patients undergoing major non-cardiac surgery. Methods We analysed data for patients undergoing major non-cardiac surgery in 2008 from The American College of Surgeons' National Surgical Quality Improvement Program database (a prospective validated outcomes registry from 211 hospitals worldwide in 2008). We obtained anonymised data for 30-day mortality and morbidity (cardiac, respiratory, CNS, urinary tract, wound, sepsis, and venous thromboembolism outcomes), demographics, and preoperative and perioperative risk factors. We used multivariate logistic regression to assess the adjusted and modified (nine predefined risk factor subgroups) effect of anaemia, which was defined as mild (haematocrit concentration >29-<39% in men and >29-<36% in women) or moderate-to-severe (<= 29% in men and women) on postoperative outcomes. Findings We obtained data for 227 425 patients, of whom 69 229 (30.44%) had preoperative anaemia. After adjustment, postoperative mortality at 30 days was higher in patients with anaemia than in those without anaemia (odds ratio [OR] 1.42, 95% CI 1.31-1.54); this difference was consistent in mild anaemia (1 41, 1.30-1.53) and moderate-to-severe anaemia (1.44, 1.29-1.60). Composite postoperative morbidity at 30 days was also higher in patients with anaemia than in those without anaemia (adjusted OR 1.35, 1.30-1.40), again consistent in patients with mild anaemia (1.31, 1.26-1.36) and moderate-to-severe anaemia (1.56, 1.47-1.66). When compared with patients without anaemia or a defined risk factor, patients with anaemia and most risk factors had a higher adjusted OR for 30-day mortality and morbidity than did patients with either anaemia or the risk factor alone. Interpretation Preoperative anaemia, even to a mild degree, is independently associated with an increased risk of 30-day morbidity and mortality in patients undergoing major non-cardiac surgery.	[Musallam, Khaled M.; Tamim, Hani M.; Soweid, Assaad; Taher, Ali T.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut 11072020, Lebanon; [Habbal, Aida; Khreiss, Mohammad; Dandaleh, Fadi S.; Sfeir, Pierre M.; Hoballah, Jamal J.; Jamali, Faek R.] Amer Univ Beirut, Med Ctr, Dept Surg, Beirut 11072020, Lebanon; [Musallam, Khaled M.] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, Milan, Italy; [Tamim, Hani M.] King Saud bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Coll Med, Riyadh, Saudi Arabia; [Richards, Toby] Univ Coll London Hosp, Div Surg & Intervent Sci, London, England; [Spahn, Donat R.] Univ Hosp, Inst Anesthesiol, Zurich, Switzerland; [Spahn, Donat R.] Univ Zurich, Zurich, Switzerland; [Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Khavandi, Kaivan] Kings Coll London, British Heart Fdn Ctr, Rayne Inst, St Thomas Hosp,Kings Hlth Partners AHSC, London WC2R 2LS, England	American University of Beirut; American University of Beirut; IRCCS Ca Granda Ospedale Maggiore Policlinico; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Zurich; University Zurich Hospital; University of Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Guy's & St Thomas' NHS Foundation Trust; King's Health Partners; University of London; King's College London	Jamali, FR (corresponding author), Amer Univ Beirut, Med Ctr, Dept Surg, POB 11-0236, Beirut 11072020, Lebanon.	fj03@aub.edu.lb	Richards, Toby/K-6547-2013; Rosendaal, Frits/Q-3842-2017; Girelli, Domenico/B-1183-2008	Rosendaal, Frits/0000-0003-2558-7496; Girelli, Domenico/0000-0001-9684-1899; Taher, Ali/0000-0001-8515-2238; Musallam, Khaled/0000-0003-3935-903X	Vifor Pharma; Swiss National Science Foundation in Bern (Switzerland) [33CM30_124117, 406440-131268]; Swiss Society of Anesthesiology and Reanimation in Bern; Swiss Foundation for Anaesthesia Research in Zurich (Switzerland); Bundesprogramm Chancengleichheit in Bern; CSL Behring in Bern; Vifor SA in Villars-sur-Glane (Switzerland); Novo Nordisk in Bagsvard (Denmark); CSL Behring in Hattersheim am Main (Germany)	Vifor Pharma; Swiss National Science Foundation in Bern (Switzerland); Swiss Society of Anesthesiology and Reanimation in Bern; Swiss Foundation for Anaesthesia Research in Zurich (Switzerland); Bundesprogramm Chancengleichheit in Bern; CSL Behring in Bern; Vifor SA in Villars-sur-Glane (Switzerland); Novo Nordisk in Bagsvard (Denmark); CSL Behring in Hattersheim am Main (Germany)	TR's department receives consultancy fees and research funding from Vifor Pharma. DRS receives consultancy fees and travel support from Vifor Pharma. DRS's department receives research funding from the Swiss National Science Foundation in Bern (Switzerland; grant numbers 33CM30_124117 and 406440-131268), the Swiss Society of Anesthesiology and Reanimation in Bern, the Swiss Foundation for Anaesthesia Research in Zurich (Switzerland), the Bundesprogramm Chancengleichheit in Bern, CSL Behring in Bern, and Vifor SA in Villars-sur-Glane (Switzerland). DRS was the chairman of the ABC Faculty and is a member of the ABC Trauma Faculty, which both are massaged by Thomson Physicians World GmbH in Mannheim (Germany) and sponsored by an unrestricted educational grant from Novo Nordisk in Bagsvard (Denmark) and CSL Behring in Hattersheim am Main (Germany). In the past 5 years, DRS has received honoraria or travel support for consulting or lecturing from Abbott (Baar, Switzerland), AstraZeneca (Zug, Switzerland), Bayer (Schweiz; Zurich), Baxter (Rome, Italy), B Braun Melsungen (Melsungen, Germany), Boehringer Ingelheim (Schweiz; Basel, Switzerland), Bristol-Myers Squibb (Rueil-Malmaison Cedex, France), CSL Behring (Hattersheim am Main and Bern), Curacyte (Munich, Germany), Ethicon Biosurgery (Sommerville, NJ, USA), Fresenius (Bad Homburg vor der Hohe, Germany), Galenica (Bern), Switzerland, including Vifor SA), GlaxoSmithKline (Hamburg, Germany), Janssen-Cilag (Baar, Switzerland), Janssen-Cilag EMEA (Beerse, Belgium), Novo Nordisk (Bagsvard), Octapharma (Lachen, Switzerland), Organon (Pfaffikon, Switzerland), Oxygen Biotherapeutics (Costa Mesa, CA, USA), tem Innovations (Munich), Roche Pharma (Schweiz; Reinach, Switzerland), and Schering-Plough (Kenilworth, NJ, USA). ATT is a member of Novartis speakers' bureau. All other authors declare that they have no conflicts of interest.	[Anonymous], 1968, NUTR AN; [Anonymous], 2009, AM COLL SURG    0210; Beattie WS, 2009, ANESTHESIOLOGY, V110, P574, DOI 10.1097/ALN.0b013e31819878d3; Bernard AC, 2009, J AM COLL SURGEONS, V208, P931, DOI 10.1016/j.jamcollsurg.2008.11.019; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CARSON JL, 1988, LANCET, V1, P727; Fink AS, 2002, ANN SURG, V236, P344, DOI 10.1097/00000658-200209000-00011; Glance LG, 2011, ANESTHESIOLOGY, V114, P283, DOI 10.1097/ALN.0b013e3182054d06; Glance LG, 2010, ANESTHESIOLOGY, V113, P859, DOI 10.1097/ALN.0b013e3181eff32e; Goodnough LT, 2011, BRIT J ANAESTH, V106, P13, DOI 10.1093/bja/aeq361; Goodnough LT, 2005, ANESTH ANALG, V101, P1858, DOI 10.1213/01.ANE.0000184124.29397.EB; Hogue CW, 1998, TRANSFUSION, V38, P924, DOI 10.1046/j.1537-2995.1998.381098440856.x; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Khuri SF, 2007, J AM COLL SURGEONS, V204, P1089, DOI 10.1016/j.jamcollsurg.2007.03.028; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Leichtle SW, 2011, J AM COLL SURGEONS, V212, P187, DOI 10.1016/j.jamcollsurg.2010.09.013; McCluskey SA, 2006, LIVER TRANSPLANT, V12, P1584, DOI 10.1002/lt.20868; Moskowitz DM, 2010, ANN THORAC SURG, V90, P451, DOI 10.1016/j.athoracsur.2010.04.089; NELSON AH, 1993, CRIT CARE MED, V21, P860, DOI 10.1097/00003246-199306000-00013; Ong A. H., 1997, Annals Academy of Medicine Singapore, V26, P430; Rashiq S, 2006, CAN J SURG, V49, P391; Shander A, 2004, AM J MED, V116, P58, DOI 10.1016/j.amjmed.2003.12.013; Spahn DR, 2010, ANESTHESIOLOGY, V113, P482, DOI 10.1097/ALN.0b013e3181e08e97; Spahn DR, 2008, ANESTHESIOLOGY, V109, P951, DOI 10.1097/ALN.0b013e31818e3d75; SPENCE RK, 1990, AM J SURG, V159, P320, DOI 10.1016/S0002-9610(05)81227-9; van Klei WA, 2001, BRIT J ANAESTH, V87, P250, DOI 10.1093/bja/87.2.250; van Straten AHM, 2009, CIRCULATION, V120, P118, DOI 10.1161/CIRCULATIONAHA.109.854216; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Wu WC, 2010, ANN SURG, V252, P11, DOI 10.1097/SLA.0b013e3181e3e43f	29	703	729	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2011	378	9800					1396	1407		10.1016/S0140-6736(11)61381-0	http://dx.doi.org/10.1016/S0140-6736(11)61381-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	838EM	21982521				2022-12-24	WOS:000296269600026
J	Emanuele, MJ; Elia, AEH; Xu, QK; Thoma, CR; Izhar, L; Leng, YM; Guo, AL; Chen, YN; Rush, J; Hsu, PWC; Yen, HCS; Elledge, SJ				Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Guo, Ailan; Chen, Yi-Ning; Rush, John; Hsu, Paul Wei-Che; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.			Global Identification of Modular Cullin-RING Ligase Substrates	CELL			English	Article							CUL3-BASED E3 LIGASE; UBIQUITIN-LIGASE; PROTEIN; SCF; INHIBITOR; NUSAP; DEGRADATION; ACTIVATION; EXPRESSION; CATALYZES	Cullin-RING ligases (CRLs) represent the largest E3 ubiquitin ligase family in eukaryotes, and the identification of their substrates is critical to understanding regulation of the proteome. Using genetic and pharmacologic Cullin inactivation coupled with genetic (GPS) and proteomic (QUAINT) assays, we have identified hundreds of proteins whose stabilities or ubiquitylation status are regulated by CRLs. Together, these approaches yielded many known CRL substrates as well as a multitude of previously unknown putative substrates. We demonstrate that one substrate, NUSAP1, is an SCFCyclin F substrate during S and G2 phases of the cell cycle and is also degraded in response to DNA damage. This collection of regulated substrates is highly enriched for nodes in protein interaction networks, representing critical connections between regulatory pathways. This demonstrates the broad role of CRL ubiquitylation in all aspects of cellular biology and provides a set of proteins likely to be key indicators of cellular physiology.	[Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Elia, Andrew E. H.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Guo, Ailan; Rush, John] Cell Signaling Technol, Danvers, MA 01923 USA; [Chen, Yi-Ning; Hsu, Paul Wei-Che; Yen, Hsueh-Chi Sherry] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Emanuele, Michael J.; Elia, Andrew E. H.; Xu, Qikai; Thoma, Claudio R.; Izhar, Lior; Leng, Yumei; Yen, Hsueh-Chi Sherry; Elledge, Stephen J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Academia Sinica - Taiwan; Howard Hughes Medical Institute	Yen, HCS (corresponding author), Brigham & Womens Hosp, Div Genet, 75 Francis St, Boston, MA 02115 USA.	hyen@imb.sinica.edu.tw; selledge@genetics.med.harvard.edu	Yen, Hsueh-Chi Sherry/AAA-3907-2021	Yen, Hsueh-Chi Sherry/0000-0003-3511-4414	The Jane Coffin Childs Foundation; The American Society for Radiation Oncology; EMBO and HFSP fellowship; American Cancer Society; NSC [NSC100-2628-B-001-014-MY3]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	The Jane Coffin Childs Foundation; The American Society for Radiation Oncology; EMBO and HFSP fellowship; American Cancer Society(American Cancer Society); NSC(Ministry of Science and Technology, Taiwan); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the members of the Elledge lab for helpful discussions. We thank W. Harper for the Cul3 and Cul4 dominant-negative clones and F box siRNA; S. Gygi for access to and assistance with MS/MS analysis software; the IMB Bioinformatics Services Core of Academia Sinica for technical support; and Michele Pagano for cyclin F plasmids. We thank Marc Vidal and David Hill for the ORFeome library. M.J.E. is the Philip O'Bryan Montgomery Jr., MD fellow of the Damon Runyon Cancer Research Foundation (DRG-1996-08). A.E.H.E. is supported by fellowships from The Jane Coffin Childs Foundation and The American Society for Radiation Oncology. C.R.T. is funded by an EMBO and HFSP fellowship. Q.X. is supported by a fellowship from the American Cancer Society. H.-C.S.Y. was supported by an NSC grant (NSC100-2628-B-001-014-MY3). This work was supported by an NIH grant to S.J.E. S.J.E. is an Investigator with the Howard Hughes Medical Institute.	Abbas T, 2011, CELL CYCLE, V10, P241, DOI 10.4161/cc.10.2.14530; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Benanti JA, 2007, NAT CELL BIOL, V9, P1184, DOI 10.1038/ncb1639; Bennett EJ, 2010, CELL, V143, P951, DOI 10.1016/j.cell.2010.11.017; Brownell JE, 2010, MOL CELL, V37, P102, DOI 10.1016/j.molcel.2009.12.024; Cheng IH, 2002, J BIOL CHEM, V277, P41706, DOI 10.1074/jbc.M205793200; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Deshaies RJ, 2010, SUBCELL BIOCHEM, V54, P41, DOI 10.1007/978-1-4419-6676-6_4; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Emanuele MJ, 2011, P NATL ACAD SCI USA, V108, P9845, DOI 10.1073/pnas.1106136108; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Jun L, 2002, DEV DYNAM, V224, P116, DOI 10.1002/dvdy.10090; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Munera J, 2011, STEM CELLS, V29, P430, DOI 10.1002/stem.599; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ou YY, 2002, J CELL SCI, V115, P1825; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Ribbeck K, 2007, CURR BIOL, V17, P230, DOI 10.1016/j.cub.2006.11.050; Ribbeck K, 2006, MOL BIOL CELL, V17, P2646, DOI 10.1091/mbc.E05-12-1178; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skaar JR, 2009, CURR OPIN CELL BIOL, V21, P816, DOI 10.1016/j.ceb.2009.08.004; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Tan PL, 1999, MOL CELL, V3, P527, DOI 10.1016/S1097-2765(00)80481-5; Wen F, 2007, DEV BIOL, V312, P284, DOI 10.1016/j.ydbio.2007.09.024; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xie P, 2011, BIOCHEM BIOPH RES CO, V404, P413, DOI 10.1016/j.bbrc.2010.11.135; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yen HCS, 2008, SCIENCE, V322, P923, DOI 10.1126/science.1160462; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	49	310	318	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					459	474		10.1016/j.cell.2011.09.019	http://dx.doi.org/10.1016/j.cell.2011.09.019			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	21963094	Green Accepted, Bronze			2022-12-24	WOS:000296199300022
J	Tay, Y; Kats, L; Salmena, L; Weiss, D; Tan, SM; Ala, U; Karreth, F; Poliseno, L; Provero, P; Di Cunto, F; Lieberman, J; Rigoutsos, I; Pandolfi, PP				Tay, Yvonne; Kats, Lev; Salmena, Leonardo; Weiss, Dror; Tan, Shen Mynn; Ala, Ugo; Karreth, Florian; Poliseno, Laura; Provero, Paolo; Di Cunto, Ferdinando; Lieberman, Judy; Rigoutsos, Isidore; Pandolfi, Pier Paolo			Coding-Independent Regulation of the Tumor Suppressor PTEN by Competing Endogenous mRNAs	CELL			English	Article							MICRORNA; IDENTIFICATION; EXPRESSION; GENE; REGIONS; TARGETS; PROTEIN; CLUSTER	Here, we demonstrate that protein-coding RNA transcripts can crosstalk by competing for common microRNAs, with microRNA response elements as the foundation of this interaction. We have termed such RNA transcripts as competing endogenous RNAs (ceRNAs). We tested this hypothesis in the context of PTEN, a key tumor suppressor whose abundance determines critical outcomes in tumorigenesis. By a combined computational and experimental approach, we identified and validated endogenous protein-coding transcripts that regulate PTEN, antagonize PI3K/AKT signaling, and possess growth-and tumor-suppressive properties. Notably, we also show that these genes display concordant expression patterns with PTEN and copy number loss in cancers. Our study presents a road map for the prediction and validation of ceRNA activity and networks and thus imparts a trans-regulatory function to protein-coding mRNAs.	[Tay, Yvonne; Kats, Lev; Salmena, Leonardo; Weiss, Dror; Ala, Ugo; Karreth, Florian; Poliseno, Laura; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Canc Genet Program,Beth Israel Deaconess Med Ctr, Div Genet,Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02115 USA; [Tan, Shen Mynn; Lieberman, Judy] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Tan, Shen Mynn; Lieberman, Judy] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp Boston, Boston, MA 02115 USA; [Tan, Shen Mynn; Lieberman, Judy] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Ala, Ugo; Provero, Paolo; Di Cunto, Ferdinando] Univ Turin, Mol Biotechnol Ctr, Turin, Italy; [Ala, Ugo; Provero, Paolo; Di Cunto, Ferdinando] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Rigoutsos, Isidore] Thomas Jefferson Univ, Computat Med Ctr, Jefferson Med Coll, Philadelphia, PA 19107 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; University of Turin; University of Turin; Jefferson University	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Canc Genet Program,Beth Israel Deaconess Med Ctr, Div Genet,Beth Israel Deaconess Canc Ctr,Dept Med, Boston, MA 02115 USA.	ppandolf@bidmc.harvard.edu	Rigoutsos, Isidore/C-5381-2012; Provero, Paolo/AAC-1930-2019; Ala, Ugo/K-2029-2016; Kats, Lev/AAW-3252-2021; Di Cunto, Ferdinando/K-5575-2016; Lieberman, Judy/A-2717-2015; Poliseno, Laura/B-5711-2012	Ala, Ugo/0000-0001-5408-6397; Kats, Lev/0000-0001-8742-8138; Rigoutsos, Isidore/0000-0003-1529-8631; di cunto, ferdinando/0000-0001-9367-6357; Salmena, Leonardo/0000-0003-4023-658X; Pandolfi, Pier Paolo/0000-0002-5352-5295; Poliseno, Laura/0000-0001-6557-955X	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]; Human Frontier Science Program; Canadian Institutes of Health Research; Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense (DOD); Italian Association for Cancer Research (AIRC) [IG-9408]; Jefferson Medical College of Thomas Jefferson University; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense (DOD)(United States Department of Defense); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Jefferson Medical College of Thomas Jefferson University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Pandolfi laboratory members for critical discussions. Real-time PCR analysis was conducted through the Harvard Catalyst Laboratory for Innovative Translational Technologies with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NIH Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. We thank B. Vogelstein for DICER<SUP>Ex5</SUP> cells, M. Gorospe for the pMS2 plasmids, and I. Legnini for experimental support. Y.T. was supported by a Special Fellow Award from The Leukemia & Lymphoma Society. L. K. was supported by an NHMRC Overseas Postdoctoral Fellowship. L. S. was supported by fellowships from the Human Frontier Science Program and the Canadian Institutes of Health Research. U. A. was supported by a fellowship from the Fondazione per la Ricerca Biomedica ONLUS of Torino. S. M. T. was supported by a Department of Defense (DOD) Breast Cancer Research Program (BCRP) postdoctoral fellowship award. P. P. and U. A. gratefully acknowledge support from the Italian Association for Cancer Research (AIRC) under grant IG-9408. I. R. was supported by funding from the Jefferson Medical College of Thomas Jefferson University. This work was supported, in part, by NIH grant R01 CA-82328-09 to P.P.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arvey A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.24; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Berger A. H., 2011, NATURE IN PRESS; Cazalla D, 2010, SCIENCE, V328, P1563, DOI 10.1126/science.1187197; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jeyapalan Z, 2011, NUCLEIC ACIDS RES, V39, P3026, DOI 10.1093/nar/gkq1003; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kloc M, 2008, DEV BIOL, V317, P401, DOI 10.1016/j.ydbio.2008.03.003; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Mercer TR, 2011, NUCLEIC ACIDS RES, V39, P2393, DOI 10.1093/nar/gkq1158; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mu P, 2009, GENE DEV, V23, P2806, DOI 10.1101/gad.1872909; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Piro R. M., 2011, EUR J HUM GENET, DOI [10.1038/ehg.2011.96, DOI 10.1038/EHG.2011.96]; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Prosser DC, 2008, J CELL SCI, V121, P3052, DOI 10.1242/jcs.028696; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575	38	778	834	3	127	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					344	357		10.1016/j.cell.2011.09.029	http://dx.doi.org/10.1016/j.cell.2011.09.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000013	Green Accepted, Green Submitted, Bronze			2022-12-24	WOS:000296199300013
J	Terkelsen, CJ; Jensen, LO; Tilsted, HH; Trautner, S; Johnsen, SP; Vach, W; Botker, HE; Thuesen, L; Lassen, JF				Terkelsen, Christian Juhl; Jensen, Lisette Okkels; Tilsted, Hans-Henrik; Trautner, Sven; Johnsen, Soren Paaske; Vach, Werner; Botker, Hans Erik; Thuesen, Leif; Lassen, Jens Flensted			Health Care System Delay and Heart Failure in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Follow-up of Population-Based Medical Registry Data	ANNALS OF INTERNAL MEDICINE			English	Article							REPERFUSION THERAPY; TIME; DIAGNOSIS; COHORT; MATTER; STEMI	Background: In patients with ST-segment elevation myocardial infarction (STEMI), delay between contact with the health care system and initiation of reperfusion therapy (system delay) is associated with mortality, but data on the associated risk for congestive heart failure (CHF) among survivors are limited. Objective: To evaluate the association between system delay and the risk for readmissions or outpatient contacts due to CHF after primary percutaneous coronary intervention (PPCI) in patients with STEMI. Design: Historical follow-up study using population-based medical registries. Setting: Western Denmark. Patients: Patients with STEMI who were transported by emergency medical service from 1 January 1999 to 7 February 2010 and treated with PPCI within 12 hours of symptom onset and who had a system delay of 6 hours or less (n = 7952). The median duration of follow-up was 3.1 years. Measurements: Cumulative incidence of readmissions or outpatient contacts due to CHF was determined by using competing-risk regression analysis, with death as the competing risk. Crude and adjusted cause-specific hazard ratios for readmissions or outpatient contacts due to CHF were determined for system delay and other covariates. Results: System delays of 60 minutes or less (n = 451), 61 to 120 minutes (n = 3457), 121 to 180 minutes (n = 2655), and 181 to 360 minutes (n = 1389) corresponded with long-term risks for readmissions or outpatient contacts due to CHF of 10.1%, 10.6%, 12.3%, and 14.1%, respectively (P < 0.001). In multivariable analysis, system delay was an independent predictor of readmissions or outpatient contacts due to CHF (adjusted hazard ratio per hour increase in delay, 1.10 [95% CI, 1.02 to 1.17]). Limitation: In any nonrandomized study, there are risks for selection bias and residual confounding. Conclusion: In patients with STEMI, shorter delay to PPCI is associated with lower risk for readmissions or outpatient contacts due to CHF during follow-up.	[Terkelsen, Christian Juhl] Aarhus Univ Hosp, Dept Cardiol B, DK-8200 Aarhus, Denmark; Odense Univ Hosp, DK-5000 Odense, Denmark; Aalborg Univ Hosp, Aalborg, Denmark; Falck Emergency Med Serv, Copenhagen, Denmark; Univ Med Ctr, Freiburg, Germany	Aarhus University; University of Southern Denmark; Odense University Hospital; Aalborg University; Aalborg University Hospital; University of Freiburg	Terkelsen, CJ (corresponding author), Aarhus Univ Hosp, Dept Cardiol B, DK-8200 Aarhus, Denmark.	Christian_Juhl_Terkelsen@hotmail.com	Vach, Werner/F-2512-2011; Lassen, Jens Flensted/AAY-2127-2021; terkelsen, christian/ABD-6294-2021	Vach, Werner/0000-0003-1865-8399; Lassen, Jens Flensted/0000-0001-7972-9192; terkelsen, christian juhl/0000-0003-0205-9551; Botker, Hans Erik/0000-0001-6358-8962; Jensen, Lisette Okkels/0000-0002-4838-2429	Karl G. Andersen Foundation; Helga and Peter Korning Foundation; Health Research Fund of Central Denmark Region; Research Foundation at Skejby University Hospital; Riisfort Foundation; Arvid Nilsson Foundation	Karl G. Andersen Foundation; Helga and Peter Korning Foundation; Health Research Fund of Central Denmark Region; Research Foundation at Skejby University Hospital; Riisfort Foundation; Arvid Nilsson Foundation	The Karl G. Andersen Foundation, the Helga and Peter Korning Foundation, the Health Research Fund of Central Denmark Region, the Research Foundation at Skejby University Hospital, the Riisfort Foundation, and the Arvid Nilsson Foundation.	Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Andersen TF, 1999, DAN MED BULL, V46, P263; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Aquaro GD, 2007, AM J CARDIOL, V100, P28, DOI 10.1016/j.amjcard.2007.02.050; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Lambert L, 2010, JAMA-J AM MED ASSOC, V303, P2148, DOI 10.1001/jama.2010.712; Pedersen CB, 2006, DAN MED BULL, V53, P441; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Schmidt Morten, 2010, Clin Epidemiol, V2, P137; Sorensen H T, 1997, Int J Risk Saf Med, V10, P1, DOI 10.3233/JRS-1997-10101; Terkelsen CJ, 2009, HEART, V95, P362, DOI 10.1136/hrt.2007.139493; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Terkelsen CJ, 2005, EUR HEART J, V26, P770, DOI 10.1093/eurheartj/ehi100; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618	19	73	73	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 20	2011	155	6					361	U54		10.7326/0003-4819-155-6-201109200-00004	http://dx.doi.org/10.7326/0003-4819-155-6-201109200-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	822HA	21930853				2022-12-24	WOS:000295033400015
J	Yalcin, B; Wong, K; Agam, A; Goodson, M; Keane, TM; Gan, XC; Nellaker, C; Goodstadt, L; Nicod, J; Bhomra, A; Hernandez-Pliego, P; Whitley, H; Cleak, J; Dutton, R; Janowitz, D; Mott, R; Adams, DJ; Flint, J				Yalcin, Binnaz; Wong, Kim; Agam, Avigail; Goodson, Martin; Keane, Thomas M.; Gan, Xiangchao; Nellaker, Christoffer; Goodstadt, Leo; Nicod, Jerome; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Whitley, Helen; Cleak, James; Dutton, Rebekah; Janowitz, Deborah; Mott, Richard; Adams, David J.; Flint, Jonathan			Sequence-based characterization of structural variation in the mouse genome	NATURE			English	Article							COPY NUMBER VARIATION; HETEROGENEOUS STOCK MICE; GENE-EXPRESSION; T-CELLS; DISEASE; REARRANGEMENTS; MECHANISM	Structural variation is widespread in mammalian genomes(1,2) and is an important cause of disease(3), but just how abundant and important structural variants (SVs) are in shaping phenotypic variation remains unclear(4,5). Without knowing how many SVs there are, and how they arise, it is difficult to discover what they do. Combining experimental with automated analyses, we identified 711,920 SVs at 281,243 sites in the genomes of thirteen classical and four wild-derived inbred mouse strains. The majority of SVs are less than 1 kilobase in size and 98% are deletions or insertions. The breakpoints of 160,000 SVs were mapped to base pair resolution, allowing us to infer that insertion of retrotransposons causes more than half of SVs. Yet, despite their prevalence, SVs are less likely than other sequence variants to cause gene expression or quantitative phenotypic variation. We identified 24 SVs that disrupt coding exons, acting as rare variants of large effect on gene function. One-third of the genes so affected have immunological functions.	[Yalcin, Binnaz; Agam, Avigail; Goodson, Martin; Gan, Xiangchao; Goodstadt, Leo; Nicod, Jerome; Bhomra, Amarjit; Hernandez-Pliego, Polinka; Whitley, Helen; Cleak, James; Dutton, Rebekah; Janowitz, Deborah; Mott, Richard; Flint, Jonathan] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Wong, Kim; Keane, Thomas M.; Adams, David J.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Agam, Avigail; Nellaker, Christoffer] Univ Oxford, Dept Physiol Anat & Genet, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Janowitz, Deborah] Ernst Moritz Arndt Univ Greifswald, Klinikum Hansestadt Stralsund, Dept Psychiat & Psychotherapy, D-18437 Stralsund, Germany	University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Oxford; Ernst Moritz Arndt Universitat Greifswald	Flint, J (corresponding author), Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	da1@sanger.ac.uk; jf@well.ox.ac.uk	Yalcin, Binnaz/P-5482-2016; Yalcin, Binnaz/ABB-7735-2020	Yalcin, Binnaz/0000-0002-1924-6807; Yalcin, Binnaz/0000-0002-1924-6807; Gan, Xiangchao/0000-0001-6398-5191; Wong, Kim/0000-0002-0984-1477; Flint, Jonathan/0000-0002-9427-4429; Adams, David/0000-0001-9490-0306; Keane, Thomas/0000-0001-7532-6898; Dutton, Rebekah/0000-0001-7539-2633; BHOMRA, AMARJIT/0000-0002-0439-0128; Mott, Richard/0000-0002-1022-9330; Nellaker, Christoffer/0000-0002-2887-2068	Medical Research Council, UK; Wellcome Trust; Cancer Research UK; MRC [MC_EX_G0802457, MC_U137761446, G0800024] Funding Source: UKRI; Medical Research Council [MC_U137761446, MC_EX_G0802457, G0800024] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A. Whitley, G. Durrant, A. M. Hammond, D. J. Fabrigar, L. Chen, M. Johannesson, E. Cong and G. Blazquez for helping B.Y. with various laboratory-based work. We also thank C. P. Ponting for comments on the manuscript. This project was supported by The Medical Research Council, UK, and the Wellcome Trust. D. J. A. is supported by Cancer Research UK.	Agam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012839; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Hastings PJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000327; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Huang GJ, 2009, GENOME RES, V19, P1133, DOI 10.1101/gr.088120.108; Ma JL, 2003, MOL CELL BIOL, V23, P8820, DOI 10.1128/MCB.23.23.8820-8828.2003; Manske HM, 2009, GENOME RES, V19, P2125, DOI 10.1101/gr.093443.109; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nelson TM, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-32; Persson K, 1999, MAMM GENOME, V10, P784, DOI 10.1007/s003359901092; Quinlan AR, 2010, GENOME RES, V20, P623, DOI 10.1101/gr.102970.109; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Simpson JT, 2010, BIOINFORMATICS, V26, P565, DOI 10.1093/bioinformatics/btp693; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tareen SU, 2009, VIROLOGY, V385, P473, DOI 10.1016/j.virol.2008.12.018; Taylor K, 2009, EUR J IMMUNOL, V39, P1353, DOI 10.1002/eji.200838566; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wu BJ, 2010, J INVEST DERMATOL, V130, P2666, DOI 10.1038/jid.2010.168; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902; Yalcin B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001085; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	29	219	219	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 15	2011	477	7364					326	329		10.1038/nature10432	http://dx.doi.org/10.1038/nature10432			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819TD	21921916	Green Accepted, Green Published			2022-12-24	WOS:000294852400030
J	Grijalva, CG; Chen, L; Delzell, E; Baddley, JW; Beukelman, T; Winthrop, KL; Griffin, MR; Herrinton, LJ; Liu, LY; Ouellet-Hellstrom, R; Patkar, NM; Solomon, DH; Lewis, JD; Xie, FL; Saag, KG; Curtis, JR				Grijalva, Carlos G.; Chen, Lang; Delzell, Elizabeth; Baddley, John W.; Beukelman, Timothy; Winthrop, Kevin L.; Griffin, Marie R.; Herrinton, Lisa J.; Liu, Liyan; Ouellet-Hellstrom, Rita; Patkar, Nivedita M.; Solomon, Daniel H.; Lewis, James D.; Xie, Fenglong; Saag, Kenneth G.; Curtis, Jeffrey R.			Initiation of Tumor Necrosis Factor-alpha Antagonists and the Risk of Hospitalization for Infection in Patients With Autoimmune Diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; SERIOUS BACTERIAL-INFECTIONS; RHEUMATOID-ARTHRITIS; OPPORTUNISTIC INFECTIONS; BRITISH-SOCIETY; THERAPY; METAANALYSIS; SAFETY; ASSOCIATION; INFLIXIMAB	Context Although tumor necrosis factor (TNF)-alpha antagonists are increasingly used in place of nonbiologic comparator medications, their safety profile remains incomplete. Objectives To determine whether initiation of TNF-alpha antagonists compared with nonbiologic comparators is associated with an increased risk of serious infections requiring hospitalization. Design, Setting, and Patients Within a US multi-institutional collaboration, we assembled retrospective cohorts (1998-2007) of patients with rheumatoid arthritis (RA), inflammatory bowel disease (IBD), and psoriasis, psoriatic arthritis, or ankylosing spondylitis (psoriasis and spondyloarthropathies) combining data from Kaiser Permanente Northern California, New Jersey and Pennsylvania Pharmaceutical Assistance programs, Tennessee Medicaid, and national Medicaid/Medicare. TNF-alpha antagonists and nonbiologic regimens were compared in disease-specific propensity score (PS)-matched cohorts using Cox regression models with nonbiologics as the reference. Baseline glucocorticoid use was evaluated as a separate covariate. Main Outcome Measure Infections requiring hospitalization (serious infections) during the first 12 months after initiation of TNF-alpha antagonists or nonbiologic regimens. Results Study cohorts included 10 484 RA, 2323 IBD, and 3215 psoriasis and spondyloarthropathies matched pairs using TNF-alpha antagonists and comparator medications. Overall, we identified 1172 serious infections, most of which (53%) were pneumonia and skin and soft tissue infections. Among patients with RA, serious infection hospitalization rates were 8.16 (TNF-alpha antagonists) and 7.78 (comparator regimens) per 100 person-years (adjusted hazard ratio [aHR], 1.05 [95% CI, 0.91-1.21]). Among patients with IBD, rates were 10.91 (TNF-alpha antagonists) and 9.60 (comparator) per 100 person-years (aHR, 1.10 [95% CI, 0.83-1.46]). Among patients with psoriasis and spondyloarthropathies, rates were 5.41 (TNF-alpha antagonists) and 5.37 (comparator) per 100 person-years (aHR, 1.05 [95% CI, 0.76-1.45]). Among patients with RA, infliximab was associated with a significant increase in serious infections compared with etanercept (aHR, 1.26 [95% CI, 1.07-1.47]) and adalimumab (aHR, 1.23 [95% CI, 1.02-1.48]). Baseline glucocorticoid use was associated with a dose-dependent increase in infections. Conclusion Among patients with autoimmune diseases, compared with treatment with nonbiologic regimens, initiation of TNF-alpha antagonists was not associated with an increased risk of hospitalizations for serious infections. JAMA. 2011;306(21):2331-2339 Published online November 6, 2011. doi:10.1001/jama.2011.1692	[Grijalva, Carlos G.] Vanderbilt Univ, Sch Med, Div Pharmacoepidemiol, Dept Prevent Med, Nashville, TN 37212 USA; [Chen, Lang; Delzell, Elizabeth; Baddley, John W.; Beukelman, Timothy; Patkar, Nivedita M.; Xie, Fenglong; Saag, Kenneth G.; Curtis, Jeffrey R.] Univ Alabama Birmingham, Birmingham, AL USA; [Baddley, John W.] Birmingham VA Med Ctr, Birmingham, AL USA; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Herrinton, Lisa J.; Liu, Liyan] Kaiser Permanente No Calif, Oakland, CA USA; [Ouellet-Hellstrom, Rita] US FDA, Silver Spring, MD USA; [Solomon, Daniel H.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Solomon, Daniel H.] Harvard Univ, Boston, MA 02115 USA; [Lewis, James D.] Univ Penn, Dept Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Lewis, James D.] Univ Penn, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA	Vanderbilt University; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Oregon Health & Science University; Kaiser Permanente; US Food & Drug Administration (FDA); Harvard University; Brigham & Women's Hospital; Harvard University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Grijalva, CG (corresponding author), Vanderbilt Univ, Sch Med, Div Pharmacoepidemiol, Dept Prevent Med, 1500 21st Ave S,Ste 2600, Nashville, TN 37212 USA.	carlos.grijalva@vanderbilt.edu		Beukelman, Timothy/0000-0001-9463-6306; Grijalva, Carlos/0000-0002-2329-7797	Amgen; Genentech; Centocor; Procter Gamble; Abbott; Eli Lilly; Bristol-Myers Squibb; Takeda; Shire; Pfizer; Roche/Genentech; UCB biopharma; CORRONA; Crescendo; Food and Drug Administration (FDA); US Department of Health and Human Services (DHHS); Agency for Healthcare Research and Quality (AHRQ) [U18 HS17919, R01HS018517]; National Institutes of Health (NIH) [AR053351]; NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science [5KL2 RR025776-03]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [5P60AR56116]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018517, U18HS017919] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR053351, P60AR056116] Funding Source: NIH RePORTER	Amgen(Amgen); Genentech(Roche HoldingGenentech); Centocor; Procter Gamble(Procter & Gamble); Abbott(Abbott Laboratories); Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Takeda(Takeda Pharmaceutical Company Ltd); Shire; Pfizer(Pfizer); Roche/Genentech(Roche HoldingGenentech); UCB biopharma; CORRONA; Crescendo(European Commission); Food and Drug Administration (FDA)(United States Department of Health & Human Services); US Department of Health and Human Services (DHHS); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH via the University of Alabama at Birmingham Center for Clinical and Translational Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Delzell reported receiving research support from Amgen. Dr Baddley reported consulting for Abbott and Merck. Dr Herrinton reported receiving research support from Genentech, Centocor, and Procter & Gamble. Dr Solomon reported receiving research support from Amgen, Abbott, Eli Lilly, and Bristol-Myers Squibb. Dr Lewis reported consulting for Genentech, Abbott, CORRONA (Consortium of Rheumatology Researchers of North America Inc), Millennium Pharmaceuticals, Elan, AstraZeneca, Procter & Gamble, GlaxoSmithKline, Alios Therapeutics, Roche, and Amgen; he also reported receiving research support from Centocor, Takeda, and Shire, and consultant honoraria from Amgen and Pfizer. Dr Winthrop reported receiving consultant fees from Genentech and Abbott, research support from Pfizer, and speakers honoraria from Amgen and Pfizer. Dr Saag reported receiving research support from Amgen, Genentech, and Pfizer. Dr Curtis reported receiving consultant fees and research grants from Roche/Genentech, UCB biopharma, Centocor, CORRONA, Amgen, Pfizer, Bristol-Myers Squibb, Crescendo, and Abbott. Other authors reported no conflicts.; This work was supported by the Food and Drug Administration (FDA), US Department of Health and Human Services (DHHS), and the Agency for Healthcare Research and Quality (AHRQ) grant U18 HS17919. Dr Curtis receives support from the National Institutes of Health (NIH; AR053351) and AHRQ (R01HS018517). Dr Beukelman was supported by NIH grant 5KL2 RR025776-03 via the University of Alabama at Birmingham Center for Clinical and Translational Science. Drs Grijalva and Griffin receive support from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, grant 5P60AR56116.	Askling J, 2007, ANN RHEUM DIS, V66, P1339, DOI 10.1136/ard.2006.062760; Au K, 2011, ANN RHEUM DIS, V70, P785, DOI 10.1136/ard.2010.128637; Bernatsky S, 2010, J RHEUMATOL, V37, P928, DOI 10.3899/jrheum.091107; Bijlsma JWJ, 2003, ANN RHEUM DIS, V62, P1033, DOI 10.1136/ard.62.11.1033; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Buttgereit F, 2002, ANN RHEUM DIS, V61, P718, DOI 10.1136/ard.61.8.718; Curtis JR, 2007, ARTHRIT RHEUM-ARTHR, V57, P343, DOI 10.1002/art.22544; Curtis JR, 2007, ARTHRITIS RHEUM, V56, P4226, DOI 10.1002/art.23050; Curtis JR, 2007, ARTHRITIS RHEUM-US, V56, P1125, DOI 10.1002/art.22504; Curtis JR, 2011, ANN RHEUM DIS, V70, P1401, DOI 10.1136/ard.2010.146365; Dixon WG, 2007, ARTHRITIS RHEUM, V56, P2896, DOI 10.1002/art.22808; Dixon WG, 2006, ARTHRITIS RHEUM-US, V54, P2368, DOI 10.1002/art.21978; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2294, DOI 10.1002/art.10529; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; Fouque-Aubert A, 2010, ANN RHEUM DIS, V69, P1756, DOI 10.1136/ard.2008.098822; Furst DE, 2010, SEMIN ARTHRITIS RHEU, V39, P327, DOI 10.1016/j.semarthrit.2008.10.002; Galloway JB, 2011, RHEUMATOLOGY, V50, P124, DOI 10.1093/rheumatology/keq242; Greenberg JD, 2010, ANN RHEUM DIS, V69, P380, DOI 10.1136/ard.2008.089276; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Grijalva CG, 2008, PHARMACOEPIDEM DR S, V17, P890, DOI 10.1002/pds.1625; Grijalva CG, 2010, RHEUMATOLOGY, V49, P82, DOI 10.1093/rheumatology/kep325; Herrinton LJ, 2011, PHARMACOEPIDEM DR S, V20, P1199, DOI 10.1002/pds.2196; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hudson M, 2010, ARTHRIT CARE RES, V62, P805, DOI 10.1002/acr.20124; Lane MA, 2011, MEDICINE, V90, P139, DOI 10.1097/MD.0b013e318211106a; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Listing J, 2005, ARTHRITIS RHEUM-US, V52, P3403, DOI 10.1002/art.21386; Patkar NM, 2009, J CLIN EPIDEMIOL, V62, P321, DOI 10.1016/j.jclinepi.2008.06.006; Peyrin-Biroulet L, 2008, CLIN GASTROENTEROL H, V6, P644, DOI 10.1016/j.cgh.2008.03.014; Rassen JA, 2010, MED CARE, V48, pS83, DOI 10.1097/MLR.0b013e3181d59541; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Rigby WFC, 2007, NAT CLIN PRACT RHEUM, V3, P227, DOI 10.1038/ncprheum0438; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schmajuk G, 2011, JAMA-J AM MED ASSOC, V305, P480, DOI 10.1001/jama.2011.67; Schneeweiss S, 2009, ALIMENT PHARM THER, V30, P253, DOI 10.1111/j.1365-2036.2009.04037.x; Schneeweiss S, 2007, ARTHRITIS RHEUM-US, V56, P1754, DOI 10.1002/art.22600; Schneeweiss S, 2007, J CLIN EPIDEMIOL, V60, P397, DOI 10.1016/j.jclinepi.2006.07.011; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Solomon DH, 2008, ARTHRITIS RHEUM-US, V58, P919, DOI 10.1002/art.23396; Solomon DH, 2006, ARTHRITIS RHEUM-US, V54, P3790, DOI 10.1002/art.22255; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; STUCK AE, 1989, REV INFECT DIS, V11, P954; Ting G, 2005, J RHEUMATOL, V32, P1679; Westhovens R, 2006, ARTHRITIS RHEUM-US, V54, P1075, DOI 10.1002/art.21734; Wolfe F, 2006, ARTHRITIS RHEUM-US, V54, P628, DOI 10.1002/art.21568; Yu O, 2011, EPIDEMIOL INFECT, V139, P1296, DOI 10.1017/S0950268810002529	49	264	274	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 7	2011	306	21					2331	2339		10.1001/jama.2011.1692	http://dx.doi.org/10.1001/jama.2011.1692			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856YH	22056398	Green Accepted, Bronze			2022-12-24	WOS:000297680300018
J	Vivian, JP; Duncan, RC; Berry, R; O'Connor, GM; Reid, HH; Beddoe, T; Gras, S; Saunders, PM; Olshina, MA; Widjaja, JML; Harpur, CM; Lin, J; Maloveste, SM; Price, DA; Lafont, BAP; McVicar, DW; Clements, CS; Brooks, AG; Rossjohn, J				Vivian, Julian P.; Duncan, Renee C.; Berry, Richard; O'Connor, Geraldine M.; Reid, Hugh H.; Beddoe, Travis; Gras, Stephanie; Saunders, Philippa M.; Olshina, Maya A.; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Lin, Jie; Maloveste, Sebastien M.; Price, David A.; Lafont, Bernard A. P.; McVicar, Daniel W.; Clements, Craig S.; Brooks, Andrew G.; Rossjohn, Jamie			Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B	NATURE			English	Article							COMPLEX CLASS-I; HLA-B; CRYSTAL-STRUCTURE; POLYMORPHISMS; PROGRESSION; MOLECULES; SELECTION; SUBTYPES; HISTORY; KIR3DS1	Members of the killer cell immunoglobulin-like receptor (KIR) family, a large group of polymorphic receptors expressed on natural killer (NK) cells, recognize particular peptide-laden human leukocyte antigen (pHLA) class I molecules and have a pivotal role in innate immune responses(1). Allelic variation and extensive polymorphism within the three-domain KIR family (KIR3D, domains D0-D1-D2) affects pHLA binding specificity and is linked to the control of viral replication and the treatment outcome of certain haematological malignancies(1-3). Here we describe the structure of a human KIR3DL1 receptor bound to HLA-B*5701 complexed with a self-peptide. KIR3DL1 clamped around the carboxy-terminal end of the HLA-B*5701 antigen-binding cleft, resulting in two discontinuous footprints on the pHLA. First, the D0 domain, a distinguishing feature of the KIR3D family, extended towards beta 2-microglobulin and abutted a region of the HLA molecule with limited polymorphism, thereby acting as an 'innate HLA sensor' domain. Second, whereas the D2-HLAB*5701 interface exhibited a high degree of complementarity, the D1-pHLA-B*5701 contacts were suboptimal and accommodated a degree of sequence variation both within the peptide and the polymorphic region of the HLA molecule. Although the two-domain KIR (KIR2D) and KIR3DL1 docked similarly onto HLA-C-4,C-5 and HLA-B respectively, the corresponding D1-mediated interactions differed markedly, thereby providing insight into the specificity of KIR3DL1 for discrete HLA-A and HLA-B allotypes. Collectively, in association with extensive mutagenesis studies at the KIR3DL1-pHLA-B*5701 interface, we provide a framework for understanding the intricate interplay between peptide variability, KIR3D and HLA polymorphism in determining the specificity requirements of this essential innate interaction that is conserved across primate species.	[Saunders, Philippa M.; Widjaja, Jacqueline M. L.; Harpur, Christopher M.; Lin, Jie; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Vivian, Julian P.; Duncan, Renee C.; Berry, Richard; Reid, Hugh H.; Beddoe, Travis; Gras, Stephanie; Olshina, Maya A.; Clements, Craig S.; Rossjohn, Jamie] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [O'Connor, Geraldine M.; McVicar, Daniel W.] NCI, Canc & Inflammat Program, Frederick, MD 21702 USA; [Maloveste, Sebastien M.; Lafont, Bernard A. P.] NIAID, Nonhuman Primate Immunogenet & Cellular Immunol U, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA; [Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Price, David A.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	University of Melbourne; Monash University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.	agbrooks@unimelb.edu.au; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013; McVicar, Daniel/G-1970-2015; gras, stephanie/C-8307-2013; Lafont, Bernard A. P./B-7236-2014; Beddoe, Travis/F-3415-2014; Price, David A/C-7876-2013	Rossjohn, Jamie/0000-0002-2020-7522; Lafont, Bernard A. P./0000-0003-2140-6205; Beddoe, Travis/0000-0003-4550-2277; Price, David A/0000-0001-9416-2737; Widjaja, Jacqueline/0000-0002-4946-5584; gras, stephanie/0000-0001-7416-038X; Brooks, Andrew/0000-0002-4085-9683; Harpur, Chris/0000-0002-3238-9861; Vivian, Julian/0000-0002-9400-4437; O'Connor, Geraldine/0000-0002-7440-162X; McVicar, Daniel/0000-0002-1112-5111; berry, richard/0000-0001-7043-0469	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council (ARC); National Cancer Institute, National Institutes of Health; National Institute of Allergy and Infectious Diseases, National Institutes of Health; National Institutes of Health; NHMRC; Medical Research Council (UK); ARC QEII; Medical Research Council [G0501963] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZIABC010747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001026] Funding Source: NIH RePORTER; MRC [G0501963] Funding Source: UKRI	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ARC QEII(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff at the MX2 beamline of the Australian synchrotron for assistance with data collection. We thank A. Radu Aricescu for the gift of the pHLsec vector. This research was supported by the National Health and Medical Research Council of Australia (NHMRC), the Australian Research Council (ARC) and the Intramural Research Programs of the National Cancer Institute and the National Institute of Allergy and Infectious Diseases, National Institutes of Health. D. W. M. and G.M.O'C. were supported by the Intramural AIDS Targeted Antiviral Program of the National Institutes of Health. J.P.V. is supported by an NHMRC Peter Doherty Research Fellowship; D. A. P. is supported by a Medical Research Council (UK) Senior Clinical Fellowship; B. A. P. L. is supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; C. S. C. is supported by an ARC QEII Fellowship; J.R. is supported by an ARC Federation Fellowship.	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; COLONNA M, 1995, SCIENCE, V268, P405, DOI 10.1126/science.7716543; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dohring C, 1996, J IMMUNOL, V156, P3098; Fadda L, 2010, P NATL ACAD SCI USA, V107, P10160, DOI 10.1073/pnas.0913745107; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Godfrey DI, 2008, IMMUNITY, V28, P304, DOI 10.1016/j.immuni.2008.02.004; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; Hansasuta P, 2004, EUR J IMMUNOL, V34, P1673, DOI 10.1002/eji.200425089; Hulsmeyer M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047; Khakoo SI, 2002, J EXP MED, V196, P911, DOI 10.1084/jem.20020304; LITWIN V, 1994, J EXP MED, V180, P537, DOI 10.1084/jem.180.2.537; Maenaka K, 1999, J BIOL CHEM, V274, P28329, DOI 10.1074/jbc.274.40.28329; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Connor GM, 2011, J IMMUNOL, V187, P2162, DOI 10.4049/jimmunol.1002906; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Peruzzi M, 1996, J IMMUNOL, V157, P3350; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Sanjanwala B, 2008, J IMMUNOL, V181, P6293, DOI 10.4049/jimmunol.181.9.6293; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	29	147	152	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2011	479	7373					401	U155		10.1038/nature10517	http://dx.doi.org/10.1038/nature10517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	848OA	22020283	Green Accepted			2022-12-24	WOS:000297059700046
J	Konhauser, KO; Lalonde, SV; Planavsky, NJ; Pecoits, E; Lyons, TW; Mojzsis, SJ; Rouxel, OJ; Barley, ME; Rosiere, C; Fralick, PW; Kump, LR; Bekker, A				Konhauser, Kurt O.; Lalonde, Stefan V.; Planavsky, Noah J.; Pecoits, Ernesto; Lyons, Timothy W.; Mojzsis, Stephen J.; Rouxel, Olivier J.; Barley, Mark E.; Rosiere, Carlos; Fralick, Phillip W.; Kump, Lee R.; Bekker, Andrey			Aerobic bacterial pyrite oxidation and acid rock drainage during the Great Oxidation Event	NATURE			English	Article							BANDED IRON-FORMATIONS; ATMOSPHERIC OXYGEN; HEXAVALENT CHROMIUM; DISSOLVED-OXYGEN; SULFUR ISOTOPES; GEOCHEMISTRY; RISE; EVOLUTION; SEDIMENTS; GENESIS	The enrichment of redox-sensitive trace metals in ancient marine sedimentary rocks has been used to determine the timing of the oxidation of the Earth's land surface(1,2). Chromium (Cr) is among the emerging proxies for tracking the effects of atmospheric oxygenation on continental weathering; this is because its supply to the oceans is dominated by terrestrial processes that can be recorded in the Cr isotope composition of Precambrian iron formations(3). However, the factors controlling past and present seawater Cr isotope composition are poorly understood. Here we provide an independent and complementary record of marine Cr supply, in the form of Cr concentrations and authigenic enrichment in iron-rich sedimentary rocks. Our data suggest that Cr was largely immobile on land until around 2.48 Gyr ago, but within the 160 Myr that followed-and synchronous with independent evidence for oxygenation associated with the Great Oxidation Event (see, for example, refs 4-6)-marked excursions in Cr content and Cr/Ti ratios indicate that Cr was solubilized at a scale unrivalled in history. As Cr isotope fractionations at that time were muted, Cr must have been mobilized predominantly in reduced, Cr(III), form. We demonstrate that only the oxidation of an abundant and previously stable crustal pyrite reservoir by aerobic-respiring, chemolithoautotrophic bacteria could have generated the degree of acidity required to solubilize Cr(III) from ultramafic source rocks and residual soils(7). This profound shift in weathering regimes beginning at 2.48 Gyr ago constitutes the earliest known geochemical evidence for acidophilic aerobes and the resulting acid rock drainage, and accounts for independent evidence of an increased supply of dissolved sulphate(8) and sulphide-hosted trace elements to the oceans around that time(1,9). Our model adds to amassing evidence that the Archaean-Palaeoproterozoic boundary was marked by a substantial shift in terrestrial geochemistry and biology.	[Konhauser, Kurt O.; Lalonde, Stefan V.; Pecoits, Ernesto] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Lalonde, Stefan V.; Rouxel, Olivier J.] Univ Europeene Bretagne, Inst Univ Europeen Mer, F-29280 Plouzane, France; [Planavsky, Noah J.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Mojzsis, Stephen J.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Rouxel, Olivier J.] IFREMER, Ctr Brest, F-29280 Plouzane, France; [Barley, Mark E.] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Rosiere, Carlos] Univ Fed Minas Gerais, Inst Geociencias, BR-3127091 Belo Horizonte, MG, Brazil; [Fralick, Phillip W.] Lakehead Univ, Dept Geol, Thunder Bay, ON P7B 5E1, Canada; [Kump, Lee R.] Penn State Univ, Dept Geosci, University Pk, PA 16827 USA; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada	University of Alberta; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); University of California System; University of California Riverside; University of Colorado System; University of Colorado Boulder; Ifremer; University of Western Australia; Universidade Federal de Minas Gerais; Lakehead University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Manitoba	Konhauser, KO (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada.	kurtk@ualberta.ca	Lalonde, Stefan V/I-8879-2014; Rosière, Carlos/E-3479-2013; Rouxel, Olivier J/F-3954-2014; Kump, Lee/H-8287-2012; MOJZSIS, STEPHEN/AAU-9527-2020	Lalonde, Stefan V/0000-0003-1318-2280; Rosière, Carlos/0000-0003-2364-6536; Rouxel, Olivier J/0000-0002-1431-222X; MOJZSIS, STEPHEN/0000-0003-0000-125X; Bekker, Andrey/0000-0002-1154-0585; Konhauser, Kurt/0000-0001-7722-7068	Natural Sciences and Engineering Research Council of Canada; National Science Foundation Division of Earth Sciences; National Science Foundation; Agouron Institute; NASA; NASA's Astrobiology Institute; Australian Research Council; Conselho Nacional de Desenvolvimento Cientifico e Technologico	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation Division of Earth Sciences(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Agouron Institute(Pfizer); NASA(National Aeronautics & Space Administration (NASA)); NASA's Astrobiology Institute; Australian Research Council(Australian Research Council); Conselho Nacional de Desenvolvimento Cientifico e Technologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Natural Sciences and Engineering Research Council of Canada (K.O.K., S.V.L., A.B., P.W.F.), the National Science Foundation Division of Earth Sciences (T.W.L., O.J.R., L.R.K.), the National Science Foundation's Graduate Research Program (N.J.P.), the Agouron Institute (E.P., T.W.L.), NASA's Exobiology Program (T.W.L., S.J.M.), NASA's Astrobiology Institute (T.W.L., L.R.K., N.J.P.), the Australian Research Council (M.E.B.), and the Conselho Nacional de Desenvolvimento Cientifico e Technologico (C.R.) We also thank V. Suckau (USIMINAS) for sample collection, G. Chen for assistance with LA-ICP-MS analyses, and J. Robbins for data compilation.	Aharon P, 2005, PRECAMBRIAN RES, V137, P207, DOI 10.1016/j.precamres.2005.03.008; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; Blank CE, 2004, GEOBIOLOGY, V2, P1, DOI 10.1111/j.1472-4677.2004.00020.x; Chester R., 2000, MARINE GEOCHEMISTRY; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; Dorland H.C., 1999, THESIS RAND AFRIKAAN; ERIKSSON KA, 1973, J SEDIMENT PETROL, V43, P1046; FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Gleisner M, 2006, CHEM GEOL, V225, P16, DOI 10.1016/j.chemgeo.2005.07.020; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Gustafsson J. P, VISUAL MINTEQ; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Klein C, 2005, AM MINERAL, V90, P1473, DOI 10.2138/am.2005.1871; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Lyons TW, 2009, GEOBIOLOGY, V7, P489, DOI 10.1111/j.1472-4669.2009.00222.x; Morgan JJ, 2005, GEOCHIM COSMOCHIM AC, V69, P35, DOI 10.1016/j.gca.2004.06.013; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Nordstrom DK, 1997, REV MINERAL, V35, P361; Oze C, 2004, INT GEOL REV, V46, P97, DOI 10.2747/0020-6814.46.2.97; Oze C, 2007, P NATL ACAD SCI USA, V104, P6544, DOI 10.1073/pnas.0701085104; Papineau D, 2007, EARTH PLANET SC LETT, V255, P188, DOI 10.1016/j.epsl.2006.12.015; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; RAI D, 1989, SCI TOTAL ENVIRON, V86, P15, DOI 10.1016/0048-9697(89)90189-7; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Schauble E, 2004, CHEM GEOL, V205, P99, DOI 10.1016/j.chemgeo.2003.12.015; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shiraki K., 1997, SHIGEN CHISHITSU, V47, P319, DOI 10.11456/shigenchishitsu1992.47.319; SINGER PC, 1970, SCIENCE, V167, P1121, DOI 10.1126/science.167.3921.1121; Spier CA, 2007, PRECAMBRIAN RES, V152, P170, DOI 10.1016/j.precamres.2006.10.003; WANG PC, 1989, APPL ENVIRON MICROB, V55, P1665, DOI 10.1128/AEM.55.7.1665-1669.1989; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019	37	232	239	10	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 20	2011	478	7369					369	+		10.1038/nature10511	http://dx.doi.org/10.1038/nature10511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	22012395				2022-12-24	WOS:000296021100042
J	Karreth, FA; Tay, Y; Perna, D; Ala, U; Tan, SM; Rust, AG; DeNicola, G; Webster, KA; Weiss, D; Perez-Mancera, PA; Krauthammer, M; Halaban, R; Provero, P; Adams, DJ; Tuveson, DA; Pandolfi, PP				Karreth, Florian A.; Tay, Yvonne; Perna, Daniele; Ala, Ugo; Tan, Shen Mynn; Rust, Alistair G.; DeNicola, Gina; Webster, Kaitlyn A.; Weiss, Dror; Perez-Mancera, Pedro A.; Krauthammer, Michael; Halaban, Ruth; Provero, Paolo; Adams, David J.; Tuveson, David A.; Pandolfi, Pier Paolo			In Vivo Identification of Tumor-Suppressive PTEN ceRNAs in an Oncogenic BRAF-Induced Mouse Model of Melanoma	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; REPRESSORS ZEB1; TARGETING ZEB1; MESSENGER-RNAS; MICRORNAS; CANCER; GENE; MUTATIONS	We recently proposed that competitive endogenous RNAs (ceRNAs) sequester microRNAs to regulate mRNA transcripts containing common microRNA recognition elements (MREs). However, the functional role of ceRNAs in cancer remains unknown. Loss of PTEN, a tumor suppressor regulated by ceRNA activity, frequently occurs in melanoma. Here, we report the discovery of significant enrichment of putative PTEN ceRNAs among genes whose loss accelerates tumorigenesis following Sleeping Beauty insertional mutagenesis in a mouse model of melanoma. We validated several putative PTEN ceRNAs and further characterized one, the ZEB2 transcript. We show that ZEB2 modulates PTEN protein levels in a microRNA-dependent, protein coding-independent manner. Attenuation of ZEB2 expression activates the PI3K/AKT pathway, enhances cell transformation, and commonly occurs in human melanomas and other cancers expressing low PTEN levels. Our study genetically identifies multiple putative microRNA decoys for PTEN, validates ZEB2 mRNA as a bona fide PTEN ceRNA, and demonstrates that abrogated ZEB2 expression cooperates with BRAF(V600E) to promote melanomagenesis.	[Karreth, Florian A.; Tay, Yvonne; Ala, Ugo; Webster, Kaitlyn A.; Weiss, Dror; Pandolfi, Pier Paolo] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol,Me, Boston, MA 02215 USA; [DeNicola, Gina] Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Div Signal Transduct,Dept Med & Pathol,Med Sch, Boston, MA 02215 USA; [Perna, Daniele; Perez-Mancera, Pedro A.; Tuveson, David A.] CRUK, Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Ala, Ugo; Provero, Paolo] Univ Turin, Mol Biotechnol Ctr, Turin, Italy; [Ala, Ugo; Provero, Paolo] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Tan, Shen Mynn] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02215 USA; [Tan, Shen Mynn] Harvard Univ, Sch Med, Program Cellular & Mol Med, Childrens Hosp Boston, Boston, MA 02215 USA; [Tan, Shen Mynn] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02215 USA; [Rust, Alistair G.; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, England; [Krauthammer, Michael] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Halaban, Ruth] Yale Univ, Dept Dermatol, New Haven, CT 06520 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; CRUK Cambridge Institute; University of Cambridge; University of Turin; University of Turin; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Wellcome Trust Sanger Institute; Yale University; Yale University	Pandolfi, PP (corresponding author), Harvard Univ, Beth Israel Deaconess Canc Ctr, Beth Israel Deaconess Med Ctr, Canc Genet Program,Div Genet,Dept Med & Pathol,Me, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Ala, Ugo/K-2029-2016; Provero, Paolo/AAC-1930-2019	Ala, Ugo/0000-0001-5408-6397; Krauthammer, Michael/0000-0002-4808-1845; Webster, Kaitlyn/0000-0001-9902-0500; DeNicola, Gina/0000-0001-6611-6696; Rust, Alistair/0000-0001-7287-192X; Adams, David/0000-0001-9490-0306; Pandolfi, Pier Paolo/0000-0002-5352-5295	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH) [UL1 RR 025758]; Harvard University and its affiliated academic health care centers; University of Cambridge,; Cancer Research UK; The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre; The Wellcome Trust; The Leukemia & Lymphoma Society; Italian Association for Cancer Research (AIRC); Fundacion Ibercaja; Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense; AIRC [IG-9408]; Yale SPORE in Skin Cancer; National Cancer Institute [1 P50 CA121974]; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [P50CA121974, R01CA082328] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst; The Harvard Clinical and Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University and its affiliated academic health care centers; University of Cambridge,(University of Cambridge); Cancer Research UK(Cancer Research UK); The Li Ka Shing Foundation; Hutchison Whampoa Limited; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); The Wellcome Trust(Wellcome Trust); The Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fundacion Ibercaja; Fondazione per la Ricerca Biomedica ONLUS of Torino; Department of Defense(United States Department of Defense); AIRC(Fondazione AIRC per la ricerca sul cancro); Yale SPORE in Skin Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Pandolfi and Tuveson laboratory members for critical discussions. qRT-PCR analysis was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (NIH award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. We thank B. Vogelstein for DICER<SUP>-/-</SUP> cells and M. Bosenberg for TyrCreERt2 mice. We thank F. Connor and other members of the Tuveson lab for assistance and the animal care staff and histology core at CRI. Mice were maintained in compliance with the UK home office regulations. This research was supported by the University of Cambridge, Cancer Research UK, The Li Ka Shing Foundation, Hutchison Whampoa Limited, the NIHR Cambridge Biomedical Research Centre, and The Wellcome Trust. Y.T. was supported by a Special Fellow Award from The Leukemia & Lymphoma Society. D. P. received an International Fellowship in Cancer Research from the Italian Association for Cancer Research (AIRC). P.A.P.-M. was supported by the Fundacion Ibercaja. U. A. received a fellowship from the Fondazione per la Ricerca Biomedica ONLUS of Torino. S. M. T. was supported by a Department of Defense Breast Cancer Research Program fellowship. P. P. and U. A. received support from AIRC under grant IG-9408. This work was supported by the Yale SPORE in Skin Cancer funded by the National Cancer Institute grant number 1 P50 CA121974 to R. H. and by NIH grant R01 CA-82328-09 to P.P.P.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Brose MS, 2002, CANCER RES, V62, P6997; Candeias MM, 2008, NAT CELL BIOL, V10, P1098, DOI 10.1038/ncb1770; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee DY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013599; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mezzanzanica D, 2010, INT J BIOCHEM CELL B, V42, P1262, DOI 10.1016/j.biocel.2009.12.017; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Pang YX, 2010, ACTA BIOCH BIOPH SIN, V42, P363, DOI 10.1093/abbs/gmq038; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Piro RM, 2011, EUR J HUM GENET, V19, P1173, DOI 10.1038/ejhg.2011.96; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; van Helden J, 2004, BIOINFORMATICS, V20, P399, DOI 10.1093/bioinformatics/btg425; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335	36	515	549	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					382	395		10.1016/j.cell.2011.09.032	http://dx.doi.org/10.1016/j.cell.2011.09.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000016	Green Accepted, Bronze			2022-12-24	WOS:000296199300016
J	Luo, DH; Ding, SC; Vela, A; Kohlway, A; Lindenbach, BD; Pyle, AM				Luo, Dahai; Ding, Steve C.; Vela, Adriana; Kohlway, Andrew; Lindenbach, Brett D.; Pyle, Anna Marie			Structural Insights into RNA Recognition by RIG-I	CELL			English	Article							DICERS HELICASE DOMAIN; CRYSTAL-STRUCTURE; PATTERN-RECOGNITION; REGULATORY DOMAIN; TERMINAL DOMAIN; NS3 HELICASE; PROTEIN; ACTIVATION; COMPLEX; TRANSLOCATION	Intracellular RIG-I-like receptors (RLRs, including RIG-I, MDA-5, and LGP2) recognize viral RNAs as pathogen-associated molecular patterns (PAMPs) and initiate an antiviral immune response. To understand the molecular basis of this process, we determined the crystal structure of RIG-I in complex with double-stranded RNA (dsRNA). The dsRNA is sheathed within a network of protein domains that include a conserved "helicase" domain (regions HEL1 and HEL2), a specialized insertion domain (HEL2i), and a C-terminal regulatory domain (CTD). A V-shaped pincer connects HEL2 and the CTD by gripping an a-helical shaft that extends from HEL1. In this way, the pincer coordinates functions of all the domains and couples RNA binding with ATP hydrolysis. RIG-I falls within the Dicer-RIG-I clade of the superfamily 2 helicases, and this structure reveals complex interplay between motor domains, accessory mechanical domains, and RNA that has implications for understanding the nanomechanical function of this protein family and other ATPases more broadly.	[Luo, Dahai; Pyle, Anna Marie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Ding, Steve C.; Vela, Adriana; Kohlway, Andrew] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Lindenbach, Brett D.] Yale Univ, Sect Microbial Pathogenesis, New Haven, CT 06520 USA; [Pyle, Anna Marie] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Luo, Dahai; Pyle, Anna Marie] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	anna.pyle@yale.edu	Luo, Dahai/J-6022-2012	Luo, Dahai/0000-0001-7637-7275	NIH [AI089826]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089826] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Marco Marcia, Dr. Kevin Keating, Dr. Vivien Nagy, Dr. Olga Fedorova, and other members of the Pyle Lab for their generous help and insightful discussions. We thank scientists (Drs. Kanagalaghatta Rajashankar, Frank Murphy, Kay Perry, Narayanasami Sukumar, and Malcolm Capel) from APS NECAT 24-ID and scientists (Drs. Marc Allaire and Lin Yang) from NSLS X9 for the beamline access and technical support. We would like to thank Kevin Smith, Ganes C. Sen, Jurg Tschopp, Wang Penghua, and Erol Fikrig for providing us with reagents. We also thank Wenxiang Cao and Enrique De la Cruz for advice on the ATPase assay. B.D.L. was supported by NIH grant AI089826. This research was funded by Howard Hughes Medical Institute. D.L. is a postdoctoral associate, and A.M.P. is an Investigator with the Howard Hughes Medical Institute. D.L. and A.M.P. designed the experiments. D.L. performed protein expression, purification, crystallization, X-ray diffraction data collection and analysis, and structure determination and refinement. D.L. carried out RNAse digestion and SEC. D.L. and S.C.D. collected SAXS data. S.C.D. performed mutagenesis and purified the mutant proteins. A.S.K. and S.C.D. performed the ATPase assays. A.V. and S.C.D. carried out the cloning and the initial expression and purification studies. D.L. and B.D.L. performed the cell-based assay. D.L. and A.M.P. wrote the manuscript with input from all authors.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Appleby TC, 2011, J MOL BIOL, V405, P1139, DOI 10.1016/j.jmb.2010.11.034; Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; De la Cruz EM, 2000, BIOPHYS J, V79, P1524, DOI 10.1016/S0006-3495(00)76403-4; Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032; DeLano W.L., 2002, PVMOL USERS MANUAL; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fujita T, 2007, BIOCHIMIE, V89, P754, DOI 10.1016/j.biochi.2007.01.013; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Kubler K, 2010, CANCER RES, V70, P5293, DOI 10.1158/0008-5472.CAN-10-0825; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; Lindsley JE, 2000, METH MOL B, V95, P57; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Matranga C, 2010, J BIOL CHEM, V285, P25363, DOI 10.1074/jbc.M110.117010; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myong S, 2007, SCIENCE, V317, P513, DOI 10.1126/science.1144130; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schutz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012791; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Soifer HS, 2008, NUCLEIC ACIDS RES, V36, P6511, DOI 10.1093/nar/gkn687; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang Y, 2010, J BIOL CHEM, V285, P36836, DOI 10.1074/jbc.M110.167973; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Welker NC, 2011, MOL CELL, V41, P589, DOI 10.1016/j.molcel.2011.02.005; Welker NC, 2010, RNA, V16, P893, DOI 10.1261/rna.2122010; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zitvogel L, 2009, J CLIN INVEST, V119, P2127, DOI 10.1172/JCI39991; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	77	290	303	1	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					409	422		10.1016/j.cell.2011.09.023	http://dx.doi.org/10.1016/j.cell.2011.09.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000018	Green Accepted, Bronze			2022-12-24	WOS:000296199300018
J	Fournier-Level, A; Korte, A; Cooper, MD; Nordborg, M; Schmitt, J; Wilczek, AM				Fournier-Level, A.; Korte, A.; Cooper, M. D.; Nordborg, M.; Schmitt, J.; Wilczek, A. M.			A Map of Local Adaptation in Arabidopsis thaliana	SCIENCE			English	Article							RECENT POSITIVE SELECTION; GENOME-WIDE ASSOCIATION; CLIMATE-CHANGE; GENETIC-BASIS; TRADE-OFFS; STRESS; PLANTS; TREE	Local adaptation is critical for species persistence in the face of rapid environmental change, but its genetic basis is not well understood. Growing the model plant Arabidopsis thaliana in field experiments in four sites across the species' native range, we identified candidate loci for local adaptation from a genome-wide association study of lifetime fitness in geographically diverse accessions. Fitness-associated loci exhibited both geographic and climatic signatures of local adaptation. Relative to genomic controls, high-fitness alleles were generally distributed closer to the site where they increased fitness, occupying specific and distinct climate spaces. Independent loci with different molecular functions contributed most strongly to fitness variation in each site. Independent local adaptation by distinct genetic mechanisms may facilitate a flexible evolutionary response to changing environment across a species range.	[Fournier-Level, A.; Cooper, M. D.; Schmitt, J.; Wilczek, A. M.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Korte, A.; Nordborg, M.] Austrian Acad Sci, Gregor Mendel Inst, A-1030 Vienna, Austria; [Wilczek, A. M.] Deep Springs Coll, Big Pine, CA 93513 USA	Brown University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Schmitt, J (corresponding author), Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA.	johanna_schmitt@brown.edu	Korte, Arthur/H-3190-2019	Korte, Arthur/0000-0003-0831-1463; Nordborg, Magnus/0000-0001-7178-9748; FOURNIER-LEVEL, ALEXANDRE/0000-0002-6047-7164	NSF [EF-0425759]; Alexander von Humboldt Research Award	NSF(National Science Foundation (NSF)); Alexander von Humboldt Research Award(Alexander von Humboldt Foundation)	We thank M. Blazquez, C. Dean, M. Hoffmann, H. Kuittinen, and O. Savolainen for hosting the experiments; J. Anderson, D. Eaton, J. F. Egan, C. Lopez-Gallego, L. J. Martin, C. D. Muir, R. Petipas, J. Roe, and R. N. Schaeffer for managing the field experiments; Brown undergraduates for fruit counts; and J. Bergelson, A. Hancock, and J. Mossman for comments on the manuscript. Supported by NSF grant EF-0425759 and an Alexander von Humboldt Research Award. Supplemental data for the phenotypes and the associated SNPs are available at http://dx.doi.org/10.5061/dryad.37f9t. Genotype data for the SNPs used in this study are available at http://regmap.uchicago.edu.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Bergelson J, 2010, NAT REV GENET, V11, P867, DOI 10.1038/nrg2896; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; De Carvalho D, 2010, MOL ECOL, V19, P1638, DOI 10.1111/j.1365-294X.2010.04595.x; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Hall MC, 2010, MOL ECOL, V19, P2739, DOI 10.1111/j.1365-294X.2010.04680.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Mariac C, 2011, MOL ECOL, V20, P80, DOI 10.1111/j.1365-294X.2010.04893.x; MCCORMAC AC, 1992, J PLANT PHYSIOL, V140, P707, DOI 10.1016/S0176-1617(11)81027-8; Molinier J, 2005, MUTAT RES-FUND MOL M, V571, P235, DOI 10.1016/j.mrfmmm.2004.09.016; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Reed DH, 2001, EVOLUTION, V55, P1095, DOI 10.1111/j.0014-3820.2001.tb00629.x; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stapley J, 2010, TRENDS ECOL EVOL, V25, P705, DOI 10.1016/j.tree.2010.09.002; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	24	477	482	4	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 7	2011	334	6052					86	89		10.1126/science.1209271	http://dx.doi.org/10.1126/science.1209271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	829KW	21980109				2022-12-24	WOS:000295580300045
J	Zhang, QC; Lambert, G; Liao, D; Kim, H; Robin, K; Tung, CK; Pourmand, N; Austin, RH				Zhang, Qiucen; Lambert, Guillaume; Liao, David; Kim, Hyunsung; Robin, Kristelle; Tung, Chih-kuan; Pourmand, Nader; Austin, Robert H.			Acceleration of Emergence of Bacterial Antibiotic Resistance in Connected Microenvironments	SCIENCE			English	Article							ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; EVOLUTION; INFECTIONS; MUTATION	The emergence of bacterial antibiotic resistance is a growing problem, yet the variables that influence the rate of emergence of resistance are not well understood. In a microfluidic device designed to mimic naturally occurring bacterial niches, resistance of Escherichia coli to the antibiotic ciprofloxacin developed within 10 hours. Resistance emerged with as few as 100 bacteria in the initial inoculation. Whole-genome sequencing of the resistant organisms revealed that four functional single-nucleotide polymorphisms attained fixation. Knowledge about the rapid emergence of antibiotic resistance in the heterogeneous conditions within the mammalian body may be helpful in understanding the emergence of drug resistance during cancer chemotherapy.	[Zhang, Qiucen; Lambert, Guillaume; Austin, Robert H.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Liao, David] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Kim, Hyunsung; Pourmand, Nader] Univ Calif Santa Cruz, Santa Cruz Genome Sequencing Ctr, Santa Cruz, CA 95064 USA; [Robin, Kristelle; Austin, Robert H.] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Tung, Chih-kuan] Univ Pittsburgh, Dept Phys, Pittsburgh, PA 15260 USA	Princeton University; University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; Hong Kong University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Austin, RH (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	austin@princeton.edu	Bougot-Robin, Kristelle/J-9926-2012; Zhang, Qiucen/G-4130-2013	Pourmand, Nader/0000-0003-0251-9060; Tung, Chih-kuan/0000-0002-0017-7880; Lambert, Guillaume/0000-0003-4779-287X	NSF [NSF0750323]; National Cancer Institute [U54CA143803]; NATIONAL CANCER INSTITUTE [U54CA143803] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by NSF grant NSF0750323 and National Cancer Institute grant U54CA143803. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. We thank T. Cox, T. Hwa, N. Goldenfeld, J. Pedersen, S. J. Rahi, S. Rosenberg, and S. Vyawahare for useful discussions, and the referees for useful comments. The reference sequence for the E. coli strain K-12 was obtained from GenBank (accession no. NC000913.2). The sequence of the E. coli mutant strain was uploaded on the National Center for Biotechnology Information Sequence Read Archive (accession no. SRP007391.10).	Alekshun MN, 1999, TRENDS MICROBIOL, V7, P410, DOI 10.1016/S0966-842X(99)01589-9; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Drlica K, 2003, CURR TOP MED CHEM, V3, P249, DOI 10.2174/1568026033452537; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Hermsen R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.248104; Keymer JE, 2008, P NATL ACAD SCI USA, V105, P20269, DOI 10.1073/pnas.0810792105; Klaus W, 2000, J BIOMOL NMR, V16, P357, DOI 10.1023/A:1008383508219; Lambert G, 2011, NAT REV CANCER, V11, P375, DOI 10.1038/nrc3039; Lautcnbach E, 2002, ARCH INTERN MED, V162, P2469, DOI 10.1001/archinte.162.21.2469; Lee HH, 2010, NATURE, V467, P82, DOI 10.1038/nature09354; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lindgren PK, 2003, ANTIMICROB AGENTS CH, V47, P3222, DOI 10.1128/AAC.47.10.3222-3232.2003; May R., 2007, THEORETICAL ECOLOGY, V3rd; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Rosenberg SM, 2001, NAT REV GENET, V2, P504, DOI 10.1038/35080556; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wright S, 1931, J AM STAT ASSOC, V26, P201, DOI 10.2307/2277618	23	350	354	4	301	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 23	2011	333	6050					1764	1767		10.1126/science.1208747	http://dx.doi.org/10.1126/science.1208747			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	823KQ	21940899				2022-12-24	WOS:000295121500048
J	Smith, SA; Wilson, NG; Goetz, FE; Feehery, C; Andrade, SCS; Rouse, GW; Giribet, G; Dunn, CW				Smith, Stephen A.; Wilson, Nerida G.; Goetz, Freya E.; Feehery, Caitlin; Andrade, Sonia C. S.; Rouse, Greg W.; Giribet, Gonzalo; Dunn, Casey W.			Resolving the evolutionary relationships of molluscs with phylogenomic tools	NATURE			English	Article							CEPHALOPODA; MONOPLACOPHORAN; RECONSTRUCTION; APLACOPHORA; ALGORITHMS; ALIGNMENT; GENOMES; CHITONS; RADULA; FOSSIL	Molluscs (snails, octopuses, clams and their relatives) have a great disparity of body plans and, among the animals, only arthropods surpass them in species number. This diversity has made Mollusca one of the best-studied groups of animals, yet their evolutionary relationships remain poorly resolved(1). Open questions have important implications for the origin of Mollusca and for morphological evolution within the group. These questions include whether the shell-less, vermiform aplacophoran molluscs diverged before the origin of the shelled molluscs (Conchifera)(2-4) or lost their shells secondarily. Monoplacophorans were not included in molecular studies until recently(5,6), when it was proposed that they constitute a clade named Serialia together with Polyplacophora (chitons), reflecting the serial repetition of body organs in both groups(5). Attempts to understand the early evolution of molluscs become even more complex when considering the large diversity of Cambrian fossils. These can have multiple dorsal shell plates and sclerites(7-10) or can be shell-less but with a typical molluscan radula and serially repeated gills(11). To better resolve the relationships among molluscs, we generated transcriptome data for 15 species that, in combination with existing data, represent for the first time all major molluscan groups. We analysed multiple data sets containing up to 216,402 sites and 1,185 gene regions using multiple models and methods. Our results support the clade Aculifera, containing the three molluscan groups with spicules but without true shells, and they support the monophyly of Conchifera. Monoplacophora is not the sister group to other Conchifera but to Cephalopoda. Strong support is found for a clade that comprises Scaphopoda (tusk shells), Gastropoda and Bivalvia, with most analyses placing Scaphopoda and Gastropoda as sister groups. This well-resolved tree will constitute a framework for further studies of mollusc evolution, development and anatomy.	[Wilson, Nerida G.] Australian Museum, Sydney, NSW 2010, Australia; [Smith, Stephen A.; Goetz, Freya E.; Feehery, Caitlin; Dunn, Casey W.] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Smith, Stephen A.] Heidelberg Inst Theoret Studies, D-69118 Heidelberg, Germany; [Wilson, Nerida G.; Feehery, Caitlin; Rouse, Greg W.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Andrade, Sonia C. S.; Giribet, Gonzalo] Harvard Univ, Dept Organism & Evolutionary Biol, Museum Comparat Zool, Cambridge, MA 02138 USA	Australian Museum; Brown University; Heidelberg Institute for Theoretical Studies; University of California System; University of California San Diego; Scripps Institution of Oceanography; Harvard University	Wilson, NG (corresponding author), Australian Museum, Sydney, NSW 2010, Australia.	nerida.wilson@austmus.gov.au; ggiribet@oeb.harvard.edu; casey_dunn@brown.edu	Smith, Stephen/AAE-8623-2019; Wilson, Nerida/G-8433-2011; Rouse, Gregory/AAW-1494-2021; Rouse, Greg W/F-2611-2010; Wilson, Nerida G./AAC-1456-2019; Andrade, Sonia/I-9263-2012; Giribet, Gonzalo/P-1086-2015; Andrade, Sonia/F-8267-2014	Smith, Stephen/0000-0003-2035-9531; Wilson, Nerida/0000-0002-0784-0200; Rouse, Gregory/0000-0001-9036-9263; Rouse, Greg W/0000-0001-9036-9263; Giribet, Gonzalo/0000-0002-5467-8429; Dunn, Casey/0000-0003-0628-5150; Andrade, Sonia/0000-0002-1302-5261	US National Science Foundation [0844596, 0844881, 0844652]; AToL Program [EF-0531757]; EPSCoR (Infrastructure to Advance Life Sciences in the Ocean State) [1004057]; iPlant Collaborative [0735191]; Scripps Institution of Oceanography; University of California Ship Funds; Museum of Comparative Zoology; Carlsberg Foundation; Division Of Environmental Biology [0844596, 0844652] Funding Source: National Science Foundation; Office of Integrative Activities [1004057] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); AToL Program; EPSCoR (Infrastructure to Advance Life Sciences in the Ocean State); iPlant Collaborative(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Scripps Institution of Oceanography(University of California System); University of California Ship Funds(University of California System); Museum of Comparative Zoology; Carlsberg Foundation(Carlsberg Foundation); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by the US National Science Foundation through the Systematics Program (awards 0844596, 0844881 and 0844652), the AToL Program (EF-0531757), EPSCoR (Infrastructure to Advance Life Sciences in the Ocean State, 1004057) and the iPlant Collaborative (0735191). Support was also provided by the Scripps Institution of Oceanography, the University of California Ship Funds and the Museum of Comparative Zoology. Collecting in Greenland was supported by the Carlsberg Foundation. A. Riesgo and J. Harasewych provided tissue samples of Octopus and Perotrochus, respectively. E. Rottinger assisted with Nautilus. C. Palacin allowed us to use an Octopus vulgaris photograph. At Brown University, Illumina sequencing was enabled by the Genomics Core Facility, and computational analyses were facilitated by L. Dong and the Center for Computing and Visualization. At Harvard University, Illumina sequencing was enabled by the Bauer Core in the Faculty of Arts and Sciences (FAS) Center for Systems Biology, and analyses were supported by the staff of the Research Computing cluster Odyssey facility in the FAS.	Aktipis SW, 2010, INVERTEBR BIOL, V129, P220, DOI 10.1111/j.1744-7410.2010.00198.x; Aktipis Stephanie W., 2008, P201; Apeltsin L, 2011, BIOINFORMATICS, V27, P326, DOI 10.1093/bioinformatics/btq655; Caron JB, 2006, NATURE, V442, P159, DOI 10.1038/nature04894; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Giribet G, 2003, SM S COMP E, P45; Giribet G, 2006, P NATL ACAD SCI USA, V103, P7723, DOI 10.1073/pnas.0602578103; Haszprunar G, 2000, AM MALACOL BULL, V15, P115; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; HUELSENBECK JP, 2005, MRBAYES BAYESIAN ANA; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lindgren AR, 2004, CLADISTICS, V20, P454, DOI 10.1111/j.1096-0031.2004.00032.x; Morris SC, 2007, SCIENCE, V315, P1255, DOI 10.1126/science.1137187; Nielsen C, 2007, ACTA ZOOL-STOCKHOLM, V88, P231, DOI 10.1111/j.1463-6395.2007.00270.x; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Passamaneck YJ, 2004, MOL PHYLOGENET EVOL, V32, P25, DOI 10.1016/j.ympev.2003.12.016; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Ponder WF, 2008, PHYLOGENY EVOLUTION; Prendini L, 2001, SYST BIOL, V50, P290, DOI 10.1080/10635150118650; Rokas A, 2005, SCIENCE, V310, P1933, DOI 10.1126/science.1116759; RUNNEGAR B, 1974, SCIENCE, V186, P311, DOI 10.1126/science.186.4161.311; Runnegar Bruce, 1996, P77; Salvini-Plawen Luitfried v., 1996, P29; Scheltema AH, 2003, J MORPHOL, V257, P219, DOI 10.1002/jmor.10121; Scheltema Amelie H., 1996, P53; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Strugnell J, 2007, J MOLLUS STUD, V73, P399, DOI 10.1093/mollus/eym038; Sutton MD, 2004, PALAEONTOLOGY, V47, P293, DOI 10.1111/j.0031-0239.2004.00374.x; van Dongen Stijn, 2000, INFORM SYSTEMS INS R, V2000; Vendrasco MJ, 2004, NATURE, V429, P288, DOI 10.1038/nature02548; Vinther J, 2005, ZOOL SCR, V34, P81, DOI 10.1111/j.1463-6409.2005.00177.x; Waller Thomas R., 1998, P1; Wanninger Andreas, 2008, P427; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wilson NG, 2010, MOL PHYLOGENET EVOL, V54, P187, DOI 10.1016/j.ympev.2009.07.028; Wilson NG, 2009, J MOLLUS STUD, V75, P195, DOI 10.1093/mollus/eyp013; YOCHELSON EL, 1978, MALACOLOGIA, V17, P165; YOCHELSON EL, 1973, LETHAIA, V6, P275, DOI 10.1111/j.1502-3931.1973.tb01199.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	311	320	4	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					364	U114		10.1038/nature10526	http://dx.doi.org/10.1038/nature10526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22031330				2022-12-24	WOS:000298033000050
J	Sun, F; Park, KK; Belin, S; Wang, DQ; Lu, T; Chen, G; Zhang, K; Yeung, CC; Feng, GP; Yankner, BA; He, ZG				Sun, Fang; Park, Kevin K.; Belin, Stephane; Wang, Dongqing; Lu, Tao; Chen, Gang; Zhang, Kang; Yeung, Cecil; Feng, Guoping; Yankner, Bruce A.; He, Zhigang			Sustained axon regeneration induced by co-deletion of PTEN and SOCS3	NATURE			English	Article							MYELIN-ASSOCIATED INHIBITOR; CILIARY NEUROTROPHIC FACTOR; SIGNAL TRANSDUCER; GROWTH; REQUIRES; CNS; TRANSCRIPTION-3; ACTIVATION; SUPPRESSOR; EXPRESSION	A formidable challenge in neural repair in the adult central nervous system (CNS) is the long distances that regenerating axons often need to travel in order to reconnect with their targets. Thus, a sustained capacity for axon regeneration is critical for achieving functional restoration. Although deletion of either phosphatase and tensin homologue (PTEN), a negative regulator of mammalian target of rapamycin (mTOR), or suppressor of cytokine signalling 3 (SOCS3), a negative regulator of Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, in adult retinal ganglion cells (RGCs) individually promoted significant optic nerve regeneration, such regrowth tapered off around 2 weeks after the crush injury(1,2). Here we show that, remarkably, simultaneous deletion of both PTEN and SOCS3 enables robust and sustained axon regeneration. We further show that PTEN and SOCS3 regulate two independent pathways that act synergistically to promote enhanced axon regeneration. Gene expression analyses suggest that double deletion not only results in the induction of many growth-related genes, but also allows RGCs to maintain the expression of a repertoire of genes at the physiological level after injury. Our results reveal concurrent activation of mTOR and STAT3 pathways as key for sustaining long-distance axon regeneration in adult CNS, a crucial step towards functional recovery.	[Sun, Fang; Belin, Stephane; Chen, Gang; Yeung, Cecil; He, Zhigang] Harvard Univ, Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med, Boston, MA 02115 USA; [Sun, Fang; Belin, Stephane; Chen, Gang; Yeung, Cecil; He, Zhigang] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Park, Kevin K.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Wang, Dongqing; Feng, Guoping] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Lu, Tao; Yankner, Bruce A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of Miami; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of California System; University of California San Diego	He, ZG (corresponding author), Harvard Univ, Childrens Hosp, FM Kirby Neurobiol Ctr, Sch Med, 300 Longwood Ave, Boston, MA 02115 USA.	Zhigang.he@childrens.harvard.edu	Zhang, Kang/Y-2740-2019; Feng, Guoping/Y-2827-2019	Zhang, Kang/0000-0002-4549-1697; Belin, Stephane/0000-0001-7074-6885	Wings for Life; Miami Project to Cure Paralysis; NEI; NATIONAL EYE INSTITUTE [R01EY021342, R01EY021526, R01EY018660, R01EY021374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP1AG044161] Funding Source: NIH RePORTER	Wings for Life; Miami Project to Cure Paralysis; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Curry and C. Wang for technical support, H. Sasaki and F. Wang for providing Stat3<SUP>f/f</SUP> and Rosa-lox-STOP-lox-Tomato mice, J. Gray, M. Hemberg, J. Choi, J. Ngai and W. Wang for advice on microarray and data analysis, and J. Gray, X. He, T. Schwarz, F. Wang, W. Wang and C. Woolf for reading the manuscript. This study was supported by grants from Wings for Life (to F. S.), Miami Project to Cure Paralysis (to K. K. P.) and NEI (to Z.H.).	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Abe N, 2010, J BIOL CHEM, V285, P28034, DOI 10.1074/jbc.M110.125336; Bareyre FM, 2011, P NATL ACAD SCI USA, V108, P6282, DOI 10.1073/pnas.1015239108; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Ernst M, 2004, TRENDS GENET, V20, P23, DOI 10.1016/j.tig.2003.11.003; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Fawcett J, 2009, PROG BRAIN RES, V175, P501, DOI 10.1016/S0079-6123(09)17534-9; Filbin MT, 2006, PHILOS T R SOC B, V361, P1565, DOI 10.1098/rstb.2006.1885; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hannila SS, 2008, EXP NEUROL, V209, P321, DOI 10.1016/j.expneurol.2007.06.020; Hanz S, 2006, J NEUROCHEM, V99, P13, DOI 10.1111/j.1471-4159.2006.04089.x; Hellal F, 2011, SCIENCE, V331, P928, DOI 10.1126/science.1201148; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Joset P, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-22; Junghans D, 2005, CURR OPIN CELL BIOL, V17, P446, DOI 10.1016/j.ceb.2005.08.008; Leibinger M, 2009, J NEUROSCI, V29, P14334, DOI 10.1523/JNEUROSCI.2770-09.2009; Low K, 2008, J NEUROSCI, V28, P1099, DOI 10.1523/JNEUROSCI.4906-07.2008; Miao T, 2006, J NEUROSCI, V26, P9512, DOI 10.1523/JNEUROSCI.2160-06.2006; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071; Nix P, 2011, P NATL ACAD SCI USA, V108, P10738, DOI 10.1073/pnas.1104830108; Park K, 2004, J NEUROSCI, V24, P10806, DOI 10.1523/JNEUROSCI.3532-04.2004; Park KK, 2010, EXP NEUROL, V223, P45, DOI 10.1016/j.expneurol.2009.12.032; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Winzeler AM, 2011, J NEUROSCI, V31, P6481, DOI 10.1523/JNEUROSCI.3004-10.2011	30	484	502	2	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2011	480	7377					372	U125		10.1038/nature10594	http://dx.doi.org/10.1038/nature10594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PZ	22056987	Green Accepted, Green Submitted			2022-12-24	WOS:000298033000052
J	Baillie, JK; Barnett, MW; Upton, KR; Gerhardt, DJ; Richmond, TA; De Sapio, F; Brennan, P; Rizzu, P; Smith, S; Fell, M; Talbot, RT; Gustincich, S; Freeman, TC; Mattick, JS; Hume, DA; Heutink, P; Carninci, P; Jeddeloh, JA; Faulkner, GJ				Baillie, J. Kenneth; Barnett, Mark W.; Upton, Kyle R.; Gerhardt, Daniel J.; Richmond, Todd A.; De Sapio, Fioravante; Brennan, Paul; Rizzu, Patrizia; Smith, Sarah; Fell, Mark; Talbot, Richard T.; Gustincich, Stefano; Freeman, Thomas C.; Mattick, John S.; Hume, David A.; Heutink, Peter; Carninci, Piero; Jeddeloh, Jeffrey A.; Faulkner, Geoffrey J.			Somatic retrotransposition alters the genetic landscape of the human brain	NATURE			English	Article							L1 RETROTRANSPOSITION; HUMAN GENOME; LINE-1 RETROTRANSPOSITION; MOBILE ELEMENTS; CELLS; EVOLUTION; ENDONUCLEASE; DISRUPTION; MOSAICISM; INSERTION	Retrotransposons are mobile genetic elements that use a germline 'copy-and-paste' mechanism to spread throughout metazoan genomes(1). At least 50 per cent of the human genome is derived from retrotransposons, with three active families (L1, Alu and SVA) associated with insertional mutagenesis and disease(2,3). Epigenetic and post-transcriptional suppression block retrotransposition in somatic cells(4,5), excluding early embryo development and some malignancies(6,7). Recent reports of L1 expression(8,9) and copy number variation(10,11) in the human brain suggest that L1 mobilization may also occur during later development. However, the corresponding integration sites have not been mapped. Here we apply a high-throughput method to identify numerous L1, Alu and SVA germline mutations, as well as 7,743 putative somatic L1 insertions, in the hippocampus and caudate nucleus of three individuals. Surprisingly, we also found 13,692 somatic Alu insertions and 1,350 SVA insertions. Our results demonstrate that retrotransposons mobilize to protein-coding genes differentially expressed and active in the brain. Thus, somatic genome mosaicism driven by retrotransposition may reshape the genetic circuitry that underpins normal and abnormal neurobiological processes.	[Baillie, J. Kenneth; Barnett, Mark W.; Upton, Kyle R.; De Sapio, Fioravante; Smith, Sarah; Fell, Mark; Talbot, Richard T.; Freeman, Thomas C.; Hume, David A.; Faulkner, Geoffrey J.] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH25 9RG, Midlothian, Scotland; [Baillie, J. Kenneth; Barnett, Mark W.; Upton, Kyle R.; De Sapio, Fioravante; Smith, Sarah; Fell, Mark; Talbot, Richard T.; Freeman, Thomas C.; Hume, David A.; Faulkner, Geoffrey J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH25 9RG, Midlothian, Scotland; [Gerhardt, Daniel J.; Richmond, Todd A.; Jeddeloh, Jeffrey A.] Roche NimbleGen Inc, Madison, WI 53719 USA; [Brennan, Paul] Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland; [Rizzu, Patrizia; Heutink, Peter] Vrije Univ Amsterdam Med Ctr, Sect Med Genom, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; [Gustincich, Stefano] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34136 Trieste, Italy; [Mattick, John S.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Carninci, Piero] RIKEN Yokohama Inst, Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Roche Holding; University of Edinburgh; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; International School for Advanced Studies (SISSA); University of Queensland; RIKEN	Faulkner, GJ (corresponding author), Univ Edinburgh, Roslin Inst, Div Genet & Genom, Edinburgh EH25 9RG, Midlothian, Scotland.	faulknergj@gmail.com	Baillie, John Kenneth/F-3124-2011; Faulkner, Geoffrey J/M-3168-2014; Mattick, John/ABH-6130-2020; Mattick, John S/I-7789-2012; Baillie, Kenneth/AEK-6650-2022; Upton, Kyle R./M-4772-2014; Carninci, Piero/K-1568-2014; Hume, David A/C-7695-2013	Baillie, John Kenneth/0000-0001-5258-793X; Faulkner, Geoffrey J/0000-0001-5769-4494; Mattick, John/0000-0002-7680-7527; Mattick, John S/0000-0002-7680-7527; Baillie, Kenneth/0000-0001-5258-793X; Upton, Kyle R./0000-0003-1101-8081; Carninci, Piero/0000-0001-7202-7243; Freeman, Thomas/0000-0001-5235-8483; Heutink, Peter/0000-0001-5218-1737; Brennan, Paul/0000-0002-7347-830X; Gustincich, Stefano/0000-0002-2749-2514; Hume, David/0000-0002-2615-1478	Wellcome Trust [090385/Z/09/Z]; Institute Strategic Programme Grant; British BBSRC [BB/H005935/1]; Australian NHMRC [575585]; BBSRC [BBS/E/D/05191131, BBS/E/D/05191130, BB/H005935/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/05191130, BB/H005935/1, BBS/E/D/05191131] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Institute Strategic Programme Grant; British BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.K.B. is supported by a Wellcome Trust Clinical Fellowship (090385/Z/09/Z) through the Edinburgh Clinical Academic Track. G.J.F. is funded by an Institute Strategic Programme Grant and a New Investigator Award from the British BBSRC (BB/H005935/1) and a C. J. Martin Overseas Based Biomedical Fellowship from the Australian NHMRC (575585). Human brain tissues were provided by the Netherlands Brain Bank to P. H. with ethical consent for them to be used as described in the study.	Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 2001, NUCLEIC ACIDS RES, V29, P573, DOI 10.1093/nar/29.2.573; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Garcia-Perez JL, 2010, NATURE, V466, P769, DOI 10.1038/nature09209; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Mattick JS, 2010, BIOESSAYS, V32, P548, DOI 10.1002/bies.201000028; MIKI Y, 1992, CANCER RES, V52, P643; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Singer T, 2010, TRENDS NEUROSCI, V33, P345, DOI 10.1016/j.tins.2010.04.001; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	30	479	489	2	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 24	2011	479	7374					534	537		10.1038/nature10531	http://dx.doi.org/10.1038/nature10531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	851QI	22037309	Green Accepted			2022-12-24	WOS:000297285600052
J	Klinge, S; Voigts-Hoffmann, F; Leibundgut, M; Arpagaus, S; Ban, N				Klinge, Sebastian; Voigts-Hoffmann, Felix; Leibundgut, Marc; Arpagaus, Sofia; Ban, Nenad			Crystal Structure of the Eukaryotic 60S Ribosomal Subunit in Complex with Initiation Factor 6	SCIENCE			English	Article							SHWACHMAN-DIAMOND SYNDROME; TRANSFER-RNA; CYCLOHEXIMIDE RESISTANCE; TRANSLATION ELONGATION; BLACKFAN ANEMIA; MESSENGER-RNA; 80S RIBOSOME; EXIT TUNNEL; PROTEIN; YEAST	Protein synthesis in all organisms is catalyzed by ribosomes. In comparison to their prokaryotic counterparts, eukaryotic ribosomes are considerably larger and are subject to more complex regulation. The large ribosomal subunit (60S) catalyzes peptide bond formation and contains the nascent polypeptide exit tunnel. We present the structure of the 60S ribosomal subunit from Tetrahymena thermophila in complex with eukaryotic initiation factor 6 (eIF6), cocrystallized with the antibiotic cycloheximide (a eukaryotic-specific inhibitor of protein synthesis), at a resolution of 3.5 angstroms. The structure illustrates the complex functional architecture of the eukaryotic 60S subunit, which comprises an intricate network of interactions between eukaryotic-specific ribosomal protein features and RNA expansion segments. It reveals the roles of eukaryotic ribosomal protein elements in the stabilization of the active site and the extent of eukaryotic-specific differences in other functional regions of the subunit. Furthermore, it elucidates the molecular basis of the interaction with eIF6 and provides a structural framework for further studies of ribosome-associated diseases and the role of the 60S subunit in the initiation of protein synthesis.	[Klinge, Sebastian; Voigts-Hoffmann, Felix; Leibundgut, Marc; Arpagaus, Sofia; Ban, Nenad] ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Ban, N (corresponding author), ETH, Inst Mol Biol & Biophys, CH-8092 Zurich, Switzerland.	ban@mol.biol.ethz.ch			Swiss National Science Foundation (SNSF); National Center of Excellence in Research (NCCR) of the SNSF; European Research Council [250071]; European Community; EMBO; Human Frontier Science Program fellowships	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); National Center of Excellence in Research (NCCR) of the SNSF(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); European Community(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program fellowships	All data were collected at the Swiss Light Source (SLS, Paul Scherrer Institut, Villigen). We thank T. Tomizaki, M. Muller, V. Olieric, G. Pompidor, and A. Pauluhn for their outstanding support at the SLS; J. Rabl for advice on cell growth and ribosome purification as well as a clone of eIF6; T. Maier for advice on data collection; T. Bucher for the preparation of crystals; J. Erzberger and T. Bucher for critically reading the manuscript; and all members of the Ban laboratory for suggestions and discussions. Supported by the Swiss National Science Foundation (SNSF), the National Center of Excellence in Research (NCCR) Structural Biology program of the SNSF, and European Research Council grant 250071 under the European Community's Seventh Framework Programme (N.B.) and by EMBO and Human Frontier Science Program fellowships (S. K.). Coordinates and structure factors have been deposited in the Protein Data Bank (accession codes for molecule 1: 4A1E and 4A18; molecule 2, 4A17 and 4A19; molecule 3, 4A1A and 4A1B; molecule 4, 4A1C and 4A1D). ETH Zurich has filed a patent application to use the crystals and the coordinates of the 60S ribosomal subunit for developing compounds that can interfere with eukaryotic translation.	Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Benelli D, 2009, NUCLEIC ACIDS RES, V37, P256, DOI 10.1093/nar/gkn959; Bingel-Erlenmeyer R, 2008, NATURE, V452, P108, DOI 10.1038/nature06683; Bulkley D, 2010, P NATL ACAD SCI USA, V107, P17158, DOI 10.1073/pnas.1008685107; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chao JA, 2004, STRUCTURE, V12, P1165, DOI 10.1016/j.str.2004.04.023; DeLabre ML, 2002, BBA-GENE STRUCT EXPR, V1574, P255, DOI 10.1016/S0167-4781(01)00372-4; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; FRIED HM, 1982, NUCLEIC ACIDS RES, V10, P3133, DOI 10.1093/nar/10.10.3133; Gartmann M, 2010, J BIOL CHEM, V285, P14848, DOI 10.1074/jbc.C109.096057; Gazda HT, 2008, AM J HUM GENET, V83, P769, DOI 10.1016/j.ajhg.2008.11.004; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Gurel G, 2009, ANTIMICROB AGENTS CH, V53, P5010, DOI 10.1128/AAC.00817-09; Halic M, 2005, NAT STRUCT MOL BIOL, V12, P467, DOI 10.1038/nsmb933; Hartzoulakis B, 2007, BIOORG MED CHEM LETT, V17, P3953, DOI 10.1016/j.bmcl.2007.04.095; Houmani JL, 2009, J VIROL, V83, P9844, DOI 10.1128/JVI.01014-09; Johnson AW, 2011, GENE DEV, V25, P898, DOI 10.1101/gad.2053011; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; Kirn-Safran CB, 2007, DEV DYNAM, V236, P447, DOI 10.1002/dvdy.21046; Kondrashov N, 2011, CELL, V145, P383, DOI 10.1016/j.cell.2011.03.028; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lacombe T, 2009, MOL MICROBIOL, V72, P69, DOI 10.1111/j.1365-2958.2009.06622.x; Lawrence MG, 2008, J BACTERIOL, V190, P5862, DOI 10.1128/JB.00632-08; Li L, 2006, NATURE, V443, P302, DOI 10.1038/nature05151; Lo KY, 2010, MOL CELL, V39, P196, DOI 10.1016/j.molcel.2010.06.018; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Moore JB, 2010, HAEMATOL-HEMATOL J, V95, P57, DOI 10.3324/haematol.2009.012450; Nakao A, 2004, NUCLEIC ACIDS RES, V32, pD168, DOI 10.1093/nar/gkh004; Panse VG, 2010, TRENDS BIOCHEM SCI, V35, P260, DOI 10.1016/j.tibs.2010.01.001; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schmeing TM, 2003, RNA, V9, P1345, DOI 10.1261/rna.5120503; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schroeder SJ, 2007, ANTIMICROB AGENTS CH, V51, P4462, DOI 10.1128/AAC.00455-07; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Stevens DR, 2001, MOL GEN GENET, V264, P790, DOI 10.1007/s004380000368; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; Zaman S, 2007, MOL MICROBIOL, V66, P1039, DOI 10.1111/j.1365-2958.2007.05975.x; Zhang JY, 2007, GENE DEV, V21, P2580, DOI 10.1101/gad.1569307	50	262	289	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 18	2011	334	6058					941	948		10.1126/science.1211204	http://dx.doi.org/10.1126/science.1211204			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CA	22052974				2022-12-24	WOS:000297101800046
J	Fritsch, J; Scheerer, P; Frielingsdorf, S; Kroschinsky, S; Friedrich, B; Lenz, O; Spahn, CMT				Fritsch, Johannes; Scheerer, Patrick; Frielingsdorf, Stefan; Kroschinsky, Sebastian; Friedrich, Baerbel; Lenz, Oliver; Spahn, Christian M. T.			The crystal structure of an oxygen-tolerant hydrogenase uncovers a novel iron-sulphur centre	NATURE			English	Article							MEMBRANE-BOUND HYDROGENASE; NIFE HYDROGENASE; ALCALIGENES-EUTROPHUS; PROTEIN; CRYSTALLOGRAPHY; POTENTIALS; CONVERSION; CLUSTER; O-2; H-2	Hydrogenases are abundant enzymes that catalyse the reversible interconversion of H-2 into protons and electrons at high rates(1). Those hydrogenases maintaining their activity in the presence of O-2 are considered to be central to H-2-based technologies, such as enzymatic fuel cells and for light-driven H-2 production(2). Despite comprehensive genetic, biochemical, electrochemical and spectroscopic investigations(3-8), the molecular background allowing a structural interpretation of how the catalytic centre is protected from irreversible inactivation by O-2 has remained unclear. Here we present the crystal structure of an O-2-tolerant [NiFe]-hydrogenase from the aerobic H-2 oxidizer Ralstonia eutropha H16 at 1.5 angstrom resolution. The heterodimeric enzyme consists of a large subunit harbouring the catalytic centre in the H-2-reduced state and a small subunit containing an electron relay consisting of three different iron-sulphur clusters. The cluster proximal to the active site displays an unprecedented [4Fe-3S] structure and is coordinated by six cysteines. According to the current model, this cofactor operates as an electronic switch depending on the nature of the gas molecule approaching the active site. It serves as an electron acceptor in the course of H-2 oxidation and as an electron-delivering device upon O-2 attack at the active site. This dual function is supported by the capability of the novel iron-sulphur cluster to adopt three redox states at physiological redox potentials(7-9). The second structural feature is a network of extended water cavities that may act as a channel facilitating the removal of water produced at the [NiFe] active site. These discoveries will have an impact on the design of biological and chemical H-2-converting catalysts that are capable of cycling H-2 in air.	[Scheerer, Patrick; Kroschinsky, Sebastian; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Fritsch, Johannes; Frielingsdorf, Stefan; Friedrich, Baerbel; Lenz, Oliver] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Spahn, Christian M. T.] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Scheerer, P (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	patrick.scheerer@charite.de; oliver.lenz@cms.hu-berlin.de; christian.spahn@charite.de	Frielingsdorf, Stefan/AAD-8065-2019; vedha, angeline/F-7272-2012; Lenz, Oliver/N-5130-2019; Lenz, Oliver/C-1582-2019	Frielingsdorf, Stefan/0000-0002-4141-7836; Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128; Scheerer, Patrick/0000-0001-5028-2075	EU; DFG Cluster of Excellence 'Unifying Concepts in Catalysis'; ERC [ERC-2009/249910-TUDOR];  [Sfb740]	EU(European Commission); DFG Cluster of Excellence 'Unifying Concepts in Catalysis'(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission); 	We are grateful to U. Muller, M. Weiss and the scientific staff of the BESSY-MX/Helmholtz Zentrum Berlin fur Materialien und Energie at beamlines BL 14.1 and BL 14.2, D. von Stetten and A. Royant of the ID29S-Cryobench (ESRF, Grenoble) and the European Synchrotron Radiation Facility (ESRF, Grenoble) at beamlines ID23-1, ID23-2, ID14-1 and ID 14-4, where the data were collected, for support. This work was supported by the EU/FP7 programme Solar-H2 (to J.F.), the DFG Cluster of Excellence 'Unifying Concepts in Catalysis' (to S. F., B. F., O.L.), and the Sfb740 (to C. M. T. S.). P. S. acknowledges K. P. Hofmann and his advanced investigator ERC grant (ERC-2009/249910-TUDOR) for support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAMMACK R, 1973, BIOCHEM BIOPH RES CO, V54, P548, DOI 10.1016/0006-291X(73)91457-5; Cammack R., 2001, HYDROGEN FUEL LEARNI; Capozzi F, 1998, STRUCT BOND, V90, P127; CARTER CW, 1977, J BIOL CHEM, V252, P7802; Cracknell JA, 2009, P NATL ACAD SCI USA, V106, P20681, DOI 10.1073/pnas.0905959106; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dey A, 2007, SCIENCE, V318, P1464, DOI 10.1126/science.1147753; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Friedrich B, 2011, CURR OPIN BIOTECH, V22, P358, DOI 10.1016/j.copbio.2011.01.006; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; HEERING HA, 1995, BIOCHEMISTRY-US, V34, P14675, DOI 10.1021/bi00045a008; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, APPL CRYST, V26, P283; Lenz O, 2010, CHEMPHYSCHEM, V11, P1107, DOI 10.1002/cphc.200901002; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Lukey MJ, 2010, J BIOL CHEM, V285, P3928, DOI 10.1074/jbc.M109.067751; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Peters JW, 1997, BIOCHEMISTRY-US, V36, P1181, DOI 10.1021/bi9626665; Saggu M, 2009, J BIOL CHEM, V284, P16264, DOI 10.1074/jbc.M805690200; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P496, DOI 10.1007/0-387-30742-7_17; Seefeldt LC, 2009, ANNU REV BIOCHEM, V78, P701, DOI 10.1146/annurev.biochem.78.070907.103812; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; THOMSON AJ, 1981, BIOCHIM BIOPHYS ACTA, V637, P423, DOI 10.1016/0005-2728(81)90047-5; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127	48	272	272	2	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2011	479	7372					249	U134		10.1038/nature10505	http://dx.doi.org/10.1038/nature10505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861PD	22002606				2022-12-24	WOS:000298030800047
J	O'Brien, LE; Soliman, SS; Li, XH; Bilder, D				O'Brien, Lucy Erin; Soliman, Sarah S.; Li, Xinghua; Bilder, David			Altered Modes of Stem Cell Division Drive Adaptive Intestinal Growth	CELL			English	Article							BACTERIAL-INFECTION; TISSUE HOMEOSTASIS; DROSOPHILA MIDGUT; SELF-RENEWAL; INSULIN; PROLIFERATION; METABOLISM; PEPTIDES; GUT	Throughout life, adult organs continually adapt to variable environmental factors. Adaptive mechanisms must fundamentally differ from homeostatic maintenance, but little is known about how physiological factors elicit tissue remodeling. Here, we show that specialized stem cell responses underlie the adaptive resizing of a mature organ. In the adult Drosophila midgut, intestinal stem cells interpret a nutrient cue to "break homeostasis" and drive growth when food is abundant. Activated in part by niche production of insulin, stem cells direct a growth program through two altered modes of behavior: accelerated division rates and predominance of symmetric division fates. Together, these altered modes produce a net increase in total intestinal cells, which is reversed upon withdrawal of food. Thus, tissue renewal programs are not committed to maintain cellular equilibrium; stem cells can remodel organs in response to physiological triggers.	[O'Brien, Lucy Erin; Soliman, Sarah S.; Li, Xinghua; Bilder, David] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Bilder, D (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	bilder@berkeley.edu		Bilder, David/0000-0002-1842-4966	NIH [K01DK083505, R01GM068675, R01GM090150]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK083505] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068675, R01GM084947, R01GM090150] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We appreciate generous gifts of reagents from the following: B. Ohlstein, B. Edgar, J. Veenstra, H. Stocker, E. Rulifson, L. Jones, T. Lee, and the Bloomington Drosophila Stock Center. We thank TRiP at Harvard Medical School (NIH/NIGMS R01-GM084947) for fly stocks and S. Stowers and the Developmental Studies Hybridoma Bank for antibodies. We are particularly grateful to B. Ohlstein for technical advice and helpful discussions. We further thank J. Freimer for MATLAB coding and T. Nystul, S. Siegrist, J. Thaler, K. Siller, L. Skwarek, A. Wurmser, L. Jones, J. Schoenfeld, and I. Hariharan for invaluable comments. L.E.O. was a Genentech Foundation Fellow of the Life Sciences Research Foundation and is supported by NIH K01DK083505. This work was supported by NIH R01GM068675 and R01GM090150 to D.B.	Ambrosio F, 2009, AM J PHYS MED REHAB, V88, P145, DOI 10.1097/PHM.0b013e3181951fc5; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2011, DEVELOPMENT, V138, P1045, DOI 10.1242/dev.056671; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; BROWN HO, 1963, AM J PHYSIOL, V205, P868, DOI 10.1152/ajplegacy.1963.205.5.868; Buchon N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-152; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; CAREY HV, 1990, AM J PHYSIOL, V259, pR385, DOI 10.1152/ajpregu.1990.259.2.R385; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chell JM, 2010, CELL, V143, P1161, DOI 10.1016/j.cell.2010.12.007; Drozdowski L, 2006, WORLD J GASTROENTERO, V12, P4614, DOI 10.3748/wjg.v12.i29.4614; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Dunel-Erb S, 2001, COMP BIOCHEM PHYS A, V129, P933, DOI 10.1016/S1095-6433(01)00360-9; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Jiang HQ, 2011, CELL STEM CELL, V8, P84, DOI 10.1016/j.stem.2010.11.026; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Koury MJ, 2005, EXP HEMATOL, V33, P1263, DOI 10.1016/j.exphem.2005.06.031; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Losick VP, 2011, DEV CELL, V21, P159, DOI 10.1016/j.devcel.2011.06.018; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Meyers LA, 2002, TRENDS ECOL EVOL, V17, P551, DOI 10.1016/S0169-5347(02)02633-2; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miller A., 1950, BIOL DROSOPHILA, P420; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Piersma T, 1997, TRENDS ECOL EVOL, V12, P134, DOI 10.1016/S0169-5347(97)01003-3; Pucilowska JB, 2000, AM J PHYSIOL-GASTR L, V279, pG1307, DOI 10.1152/ajpgi.2000.279.6.G1307; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Secor SM, 1998, NATURE, V395, P659, DOI 10.1038/27131; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; WINESETT DE, 1995, AM J PHYSIOL-GASTR L, V268, pG631, DOI 10.1152/ajpgi.1995.268.4.G631; Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345	48	283	285	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 28	2011	147	3					603	614		10.1016/j.cell.2011.08.048	http://dx.doi.org/10.1016/j.cell.2011.08.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	842EH	22036568	Bronze, Green Accepted			2022-12-24	WOS:000296573700015
J	Burdette, DL; Monroe, KM; Sotelo-Troha, K; Iwig, JS; Eckert, B; Hyodo, M; Hayakawa, Y; Vance, RE				Burdette, Dara L.; Monroe, Kathryn M.; Sotelo-Troha, Katia; Iwig, Jeff S.; Eckert, Barbara; Hyodo, Mamoru; Hayakawa, Yoshihiro; Vance, Russell E.			STING is a direct innate immune sensor of cyclic di-GMP	NATURE			English	Article							I INTERFERON RESPONSE; CYTOSOLIC DNA; PSEUDOMONAS-AERUGINOSA; INTRACELLULAR DNA; BIS-(3'-5')-CYCLIC-GMP; DIGUANYLATE; REVEALS; ADAPTER	The innate immune system detects infection by using germline-encoded receptors that are specific for conserved microbial molecules. The recognition of microbial ligands leads to the production of cytokines, such as type I interferons (IFNs), that are essential for successful pathogen elimination. Cytosolic detection of pathogen-derived DNA is one major mechanism of inducing IFN production(1,2), and this process requires signalling through TANK binding kinase 1 (TBK1) and its downstream transcription factor, IFN-regulatory factor 3 (IRF3). In addition, a transmembrane protein called STING (stimulator of IFN genes; also known as MITA, ERIS, MPYS and TMEM173) functions as an essential signalling adaptor, linking the cytosolic detection of DNA to the TBK1-IRF3 signalling axis(3-7). Recently, unique nucleic acids called cyclic dinucleotides, which function as conserved signalling molecules in bacteria(8), have also been shown to induce a STING-dependent type I IFN response(9-12). However, a mammalian sensor of cyclic dinucleotides has not been identified. Here we report evidence that STING itself is an innate immune sensor of cyclic dinucleotides. We demonstrate that STING binds directly to radiolabelled cyclic diguanylate monophosphate (c-di-GMP), and we show that unlabelled cyclic dinucleotides, but not other nucleotides or nucleic acids, compete with c-di-GMP for binding to STING. Furthermore, we identify mutations in STING that selectively affect the response to cyclic dinucleotides without affecting the response to DNA. Thus, STING seems to function as a direct sensor of cyclic dinucleotides, in addition to its established role as a signalling adaptor in the IFN response to cytosolic DNA. Cyclic dinucleotides have shown promise as novel vaccine adjuvants and immunotherapeutics(9,13), and our results provide insight into the mechanism by which cyclic dinucleotides are sensed by the innate immune system.	[Burdette, Dara L.; Monroe, Kathryn M.; Sotelo-Troha, Katia; Iwig, Jeff S.; Eckert, Barbara; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Iwig, Jeff S.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Chem, Berkeley, CA 94720 USA; [Hyodo, Mamoru] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Hayakawa, Yoshihiro] Aichi Inst Technol, Fac Engn, Dept Appl Chem, Toyota 4700392, Japan	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Hokkaido University	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu	Hyodo, Mamoru/D-5496-2012	Hyodo, Mamoru/0000-0002-1766-3949; Troha, Katia/0000-0001-9389-4952	Burroughs Wellcome Fund; Cancer Research Institute; National Institutes of Health (NIH) [AI075039, AI080749, AI063302, F32 (AI091100)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, F32AI091100, R01AI080749, R01AI075039] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23700552] Funding Source: KAKEN	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Cancer Research Institute; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Carlson, K. Collins, S. McWhirter, D. Raulet, K. Sjolander and members of the Vance, Barton and Portnoy laboratories at the University of California, Berkeley, for advice and discussions. We thank J. Woodward and D. Portnoy for their gift of purified c-di-AMP. Work in R.E.V.'s laboratory is supported by investigator awards from the Burroughs Wellcome Fund and the Cancer Research Institute and by National Institutes of Health (NIH) grants AI075039, AI080749 and AI063302. D. L. B. is supported by an NIH National Research Service Award fellowship F32 (AI091100).	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Chen WX, 2010, VACCINE, V28, P3080, DOI 10.1016/j.vaccine.2010.02.081; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Chodosh L A, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1205s36; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Hyodo M, 2004, B CHEM SOC JPN, V77, P2089, DOI 10.1246/bcsj.77.2089; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Simm R, 2009, J BACTERIOL, V191, P3928, DOI 10.1128/JB.00290-09; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	26	934	1005	11	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 27	2011	478	7370					515	U111		10.1038/nature10429	http://dx.doi.org/10.1038/nature10429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	21947006	Green Accepted			2022-12-24	WOS:000296194200043
J	Kowalinski, E; Lunardi, T; McCarthy, AA; Louber, J; Brunel, J; Grigorov, B; Gerlier, D; Cusack, S				Kowalinski, Eva; Lunardi, Thomas; McCarthy, Andrew A.; Louber, Jade; Brunel, Joanna; Grigorov, Boyan; Gerlier, Denis; Cusack, Stephen			Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA	CELL			English	Article							ANTIVIRAL SIGNALING PROTEIN; DOUBLE-STRANDED-RNA; HEPATITIS-C-VIRUS; INDUCIBLE GENE-I; INTERFERON INDUCTION; 5'-TRIPHOSPHATE RNA; UBIQUITIN LIGASE; ADAPTER PROTEIN; IFN-BETA; HELICASE	RIG-I is a key innate immune pattern-recognition receptor that triggers interferon expression upon detection of intracellular 5'triphosphate double-stranded RNA (5'ppp-dsRNA) of viral origin. RIG-I comprises N-terminal caspase activation and recruitment domains (CARDs), a DECH helicase, and a C-terminal domain (CTD). We present crystal structures of the ligand-free, autorepressed, and RNA-bound, activated states of RIG-I. Inactive RIG-I has an open conformation with the CARDs sequestered by a helical domain inserted between the two helicase moieties. ATP and dsRNA binding induce a major rearrangement to a closed conformation in which the helicase and CTD bind the blunt end 5'ppp-dsRNA with perfect complementarity but incompatibly with continued CARD binding. We propose that after initial binding of 5'ppp-dsRNA to the flexibly linked CTD, co-operative tight binding of ATP and RNA to the helicase domain liberates the CARDs for downstream signaling. These findings significantly advance our molecular understanding of the activation of innate immune signaling helicases.	[Kowalinski, Eva; Lunardi, Thomas; McCarthy, Andrew A.; Cusack, Stephen] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Kowalinski, Eva; Lunardi, Thomas; McCarthy, Andrew A.; Cusack, Stephen] UJF EMBL CNRS, UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France; [Louber, Jade; Brunel, Joanna; Grigorov, Boyan; Gerlier, Denis] Univ Lyon 1, INSERM, U758, ENS Lyon, F-69007 Lyon, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Cusack, S (corresponding author), European Mol Biol Lab, Grenoble Outstn, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	cusack@embl.fr	McCarthy, Andrew A/A-5926-2013; BRUNEL, JOANNA/C-6322-2015; Grigorov, Boyan/AFT-7687-2022; Gerlier, Denis/L-6094-2014	McCarthy, Andrew A/0000-0003-4478-0136; BRUNEL, JOANNA/0000-0002-3978-9833; Grigorov, Boyan/0000-0003-0376-7779; Gerlier, Denis/0000-0001-5539-456X; Kowalinski, Eva/0000-0002-9785-9027; Cusack, Stephen/0000-0002-9324-0796	EU; FINOVI Foundation	EU(European Commission); FINOVI Foundation	The authors thank the ESRF-EMBL Joint Structural Biology Group for access to ESRF beamlines and the EMBL-ESRF-ILL-IBS Partnership for Structural Biology for access to structural biology instrumentation, notably the high-throughput crystallization platform (J. Marquez and colleagues), the eukaryotic expression facility (I. Berger and colleagues), MALLS (M. Jamin), and mass-spectroscopy (L. Signor). We also used the flow cytometry (T. Andrieu, S. Dussurgey) and qPCR (B. Blanquier) facilities of the SFR Biosciences Gerland-Lyon Sud (UMS344/US8). We thank T. Fujita, J. Perrault, C. Rice, D. Trono, R. Iggo, and D. Garcin for reagents; D. Kolakofsky for insightful discussions; and C. Petosa for a critical reading of the manuscript. The project was partially supported by the EU FP7 SPINE2-Complexes Project and the FINOVI Foundation.	Bamming D, 2009, J BIOL CHEM, V284, P9700, DOI 10.1074/jbc.M807365200; Banroques J, 2010, J MOL BIOL, V396, P949, DOI 10.1016/j.jmb.2009.12.025; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Binder M, 2011, J BIOL CHEM, V286, P27278, DOI 10.1074/jbc.M111.256974; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Datta AB, 2009, J MOL BIOL, V392, P1117, DOI 10.1016/j.jmb.2009.07.090; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Karpala AJ, 2011, J IMMUNOL, V186, P5397, DOI 10.4049/jimmunol.1003712; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kersse K, 2011, TRENDS BIOCHEM SCI, V36, P541, DOI 10.1016/j.tibs.2011.06.006; Kuo RL, 2010, VIROLOGY, V408, P146, DOI 10.1016/j.virol.2010.09.012; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	57	453	470	4	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 14	2011	147	2					423	435		10.1016/j.cell.2011.09.039	http://dx.doi.org/10.1016/j.cell.2011.09.039			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	837KD	22000019	Bronze			2022-12-24	WOS:000296199300019
J	Grosjean, Y; Rytz, R; Farine, JP; Abuin, L; Cortot, J; Jefferis, GSXE; Benton, R				Grosjean, Yael; Rytz, Raphael; Farine, Jean-Pierre; Abuin, Liliane; Cortot, Jerome; Jefferis, Gregory S. X. E.; Benton, Richard			An olfactory receptor for food-derived odours promotes male courtship in Drosophila	NATURE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; PHENYLACETIC ACID; SEX-PHEROMONE; BEHAVIOR; MELANOGASTER; NEURONS; REPRESENTATION; ARCHITECTURE; ALGORITHM; RESPONSES	Many animals attract mating partners through the release of volatile sex pheromones, which can convey information on the species, gender and receptivity of the sender to induce innate courtship and mating behaviours by the receiver(1). Male Drosophila melanogaster fruitflies display stereotyped reproductive behaviours towards females, and these behaviours are controlled by the neural circuitry expressing male-specific isoforms of the transcription factor Fruitless (FRUM)(2-5). However, the volatile pheromone ligands, receptors and olfactory sensory neurons (OSNs) that promote male courtship have not been identified in this important model organism. Here we describe a novel courtship function of Ionotropic receptor 84a (IR84a), which is a member of the chemosensory ionotropic glutamate receptor family(6), in a previously uncharacterized population of FRUM-positive OSNs. IR84a-expressing neurons are activated not by fly-derived chemicals but by the aromatic odours phenylacetic acid and phenylacetaldehyde, which are widely found in fruit and other plant tissues(7) that serve as food sources and oviposition sites for drosophilid flies(8). Mutation of Ir84a abolishes both odour-evoked and spontaneous electrophysiological activity in these neurons and markedly reduces male courtship behaviour. Conversely, male courtship is increased-in an IR84a-dependent manner-in the presence of phenylacetic acid but not in the presence of another fruit odour that does not activate IR84a. Interneurons downstream of IR84a-expressing OSNs innervate a pheromone-processing centre in the brain. Whereas IR84a orthologues and phenylacetic-acid-responsive neurons are present in diverse drosophilid species, IR84a is absent from insects that rely on long-range sex pheromones. Our results suggest a model in which IR84a couples food presence to the activation of the fru(M) courtship circuitry in fruitflies. These findings reveal an unusual but effective evolutionary solution to coordinate feeding and oviposition site selection with reproductive behaviours through a specific sensory pathway.	[Grosjean, Yael; Rytz, Raphael; Abuin, Liliane; Benton, Richard] Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Grosjean, Yael; Farine, Jean-Pierre; Cortot, Jerome] Univ Bourgogne, INRA, UMR 1324, Ctr Sci Gout & Alimentat,CNRS,UMR 6265, F-21000 Dijon, France; [Jefferis, Gregory S. X. E.] MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 0QH, England	University of Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; MRC Laboratory Molecular Biology	Benton, R (corresponding author), Univ Lausanne, Fac Biol & Med, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.	Richard.Benton@unil.ch	Grosjean, Yael/E-2634-2017; Jefferis, Gregory/C-6386-2012	Grosjean, Yael/0000-0003-0689-8344; Jefferis, Gregory/0000-0002-0587-9355; Benton, Richard/0000-0003-4305-8301	Centre National de la Recherche Scientifique (CNRS); Agence Nationale de la Recherche (ANR) [GGCB-2010]; Conseil Regional de Bourgogne (FABER); Roche Research Foundation; Medical Research Council; European Research Council; University of Lausanne; Swiss National Science Foundation; MRC [MC_U105188491] Funding Source: UKRI; Medical Research Council [MC_U105188491] Funding Source: researchfish	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Conseil Regional de Bourgogne (FABER)(Region Bourgogne-Franche-Comte); Roche Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); University of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to B. Dickson, A. Hofbauer, T. Lee, the Bloomington Drosophila Stock Center, the Drosophila Species Stock Center and the Developmental Studies Hybridoma Bank for provision of plasmid vectors, Drosophila strains and antibodies. We are also grateful to A. Wong, J. Wang, R. Axel, H.-H. Yu and T. Lee for sharing raw image data. We thank D. Featherstone, J.-F. Ferveur, T. Kawecki, L. Keller, S. Martin and members of the Benton laboratory for comments on the manuscript. Y.G., J.-P. F. and J. C. are supported by the Centre National de la Recherche Scientifique (CNRS), the Agence Nationale de la Recherche (ANR; JCJC, GGCB-2010) and the Conseil Regional de Bourgogne (FABER). R. R. was supported by a Roche Research Foundation fellowship. G. S. X. E. J. is supported by the Medical Research Council and a European Research Council Starting Investigator Grant. Research in R.B.'s laboratory is supported by the University of Lausanne, a European Research Council Starting Independent Researcher Grant and the Swiss National Science Foundation.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; ALCORTA E, 1989, BEHAV GENET, V19, P285, DOI 10.1007/BF01065911; [Anonymous], 2014, PHEROMONES ANIMAL BE; Barata A, 2011, J AGR FOOD CHEM, V59, P2543, DOI 10.1021/jf104141f; Barber CB, 1996, ACM T MATH SOFTWARE, V22, P469, DOI 10.1145/235815.235821; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004; EWING ARTHUR W., 1963, ANIMAL BEHAVIOUR, V11, P596, DOI 10.1016/0003-3472(63)90283-5; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Han DD, 2000, DEVELOPMENT, V127, P573; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Kim J, 2007, J MICROBIOL BIOTECHN, V17, P1727; Kohatsu S, 2011, NEURON, V69, P498, DOI 10.1016/j.neuron.2010.12.017; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; SHOREY HH, 1970, ANIM BEHAV, V18, P159, DOI 10.1016/0003-3472(70)90085-0; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; WIGHTMAN F, 1982, PHYSIOL PLANTARUM, V55, P17, DOI 10.1111/j.1399-3054.1982.tb00278.x; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yu HH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000461; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	44	223	230	9	122	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2011	478	7368					236	U123		10.1038/nature10428	http://dx.doi.org/10.1038/nature10428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	832DT	21964331				2022-12-24	WOS:000295782800049
J	Hoover, RN; Hyer, M; Pfeiffer, RM; Adam, E; Bond, B; Cheville, AL; Colton, T; Hartge, P; Hatch, EE; Herbst, AL; Karlan, BY; Kaufman, R; Noller, KL; Palmer, JR; Robboy, SJ; Saal, RC; Strohsnitter, W; Titus-Ernstoff, L; Troisi, R				Hoover, Robert N.; Hyer, Marianne; Pfeiffer, Ruth M.; Adam, Ervin; Bond, Brian; Cheville, Andrea L.; Colton, Theodore; Hartge, Patricia; Hatch, Elizabeth E.; Herbst, Arthur L.; Karlan, Beth Y.; Kaufman, Raymond; Noller, Kenneth L.; Palmer, Julie R.; Robboy, Stanley J.; Saal, Robert C.; Strohsnitter, William; Titus-Ernstoff, Linda; Troisi, Rebecca			Adverse Health Outcomes in Women Exposed In Utero to Diethylstilbestrol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							YOUNG-WOMEN; MEDICAL RECORDS; BREAST-CANCER; FOLLOW-UP; PREGNANCY; STILBESTROL; RISK; VAGINA; NATIONAL-COOPERATIVE-DIETHYLSTILBESTROL-ADENOSIS-(DESAD)-PROJECT; ADENOCARCINOMA	BACKGROUND Before 1971, several million women were exposed in utero to diethylstilbestrol (DES) given to their mothers to prevent pregnancy complications. Several adverse outcomes have been linked to such exposure, but their cumulative effects are not well understood. METHODS We combined data from three studies initiated in the 1970s with continued long-term follow-up of 4653 women exposed in utero to DES and 1927 unexposed controls. We assessed the risks of 12 adverse outcomes linked to DES exposure, including cumulative risks to 45 years of age for reproductive outcomes and to 55 years of age for other outcomes, and their relationships to the baseline presence or absence of vaginal epithelial changes, which are correlated with a higher dose of, and earlier exposure to, DES in utero. RESULTS Cumulative risks in women exposed to DES, as compared with those not exposed, were as follows: for infertility, 33.3% vs. 15.5% (hazard ratio, 2.37; 95% confidence interval [CI], 2.05 to 2.75); spontaneous abortion, 50.3% vs. 38.6% (hazard ratio, 1.64; 95% CI, 1.42 to 1.88); preterm delivery, 53.3% vs. 17.8% (hazard ratio, 4.68; 95% CI, 3.74 to 5.86); loss of second-trimester pregnancy, 16.4% vs. 1.7% (hazard ratio, 3.77; 95% CI, 2.56 to 5.54); ectopic pregnancy, 14.6% vs. 2.9% (hazard ratio, 3.72; 95% CI, 2.58 to 5.38); preeclampsia, 26.4% vs. 13.7% (hazard ratio 1.42; 95% CI, 1.07 to 1.89); stillbirth, 8.9% vs. 2.6% (hazard ratio, 2.45; 95% CI, 1.33 to 4.54); early menopause, 5.1% vs. 1.7% (hazard ratio, 2.35; 95% CI, 1.67 to 3.31); grade 2 or higher cervical intraepithelial neoplasia, 6.9% vs. 3.4% (hazard ratio, 2.28; 95% CI, 1.59 to 3.27); and breast cancer at 40 years of age or older, 3.9% vs. 2.2% (hazard ratio, 1.82; 95% CI, 1.04 to 3.18). For most outcomes, the risks among exposed women were higher for those with vaginal epithelial changes than for those without such changes. CONCLUSIONS In utero exposure of women to DES is associated with a high lifetime risk of a broad spectrum of adverse health outcomes. (Funded by the National Cancer Institute.)	[Hoover, Robert N.; Pfeiffer, Ruth M.; Hartge, Patricia; Troisi, Rebecca] NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hyer, Marianne] Informat Management Serv Inc, Rockville, MD USA; [Saal, Robert C.] Westat Corp, Rockville, MD USA; [Adam, Ervin] Baylor Coll Med, Dept Virol & Epidemiol, Houston, TX 77030 USA; [Kaufman, Raymond] Methodist Hosp, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Bond, Brian; Strohsnitter, William] Boston Univ, Sch Publ Hlth, Dept Obstet & Gynecol, Tufts Med Ctr, Boston, MA USA; [Colton, Theodore; Hatch, Elizabeth E.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Palmer, Julie R.] Boston Univ, Slone Epidemiol Ctr, Boston, MA USA; [Cheville, Andrea L.] Mayo Clin, Dept Phys Med & Rehabil, Rochester, MN USA; [Herbst, Arthur L.] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Karlan, Beth Y.] Cedars Sinai Med Ctr, Div Gynecol Oncol, Los Angeles, CA 90048 USA; [Noller, Kenneth L.] Amer Board Obstet & Gynecol, Dallas, TX USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Titus-Ernstoff, Linda] Dartmouth Med Sch, Dept Community & Family Med, Lebanon, NH USA; [Titus-Ernstoff, Linda] Dartmouth Med Sch, Dept Pediat, Lebanon, NH USA; [Titus-Ernstoff, Linda] Norris Cotton Canc Ctr, Lebanon, NH USA; [Titus-Ernstoff, Linda] Hood Ctr Children & Families, Lebanon, NH USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Westat; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Boston University; Tufts Medical Center; Boston University; Boston University; Mayo Clinic; University of Chicago; Cedars Sinai Medical Center; Duke University; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center	Hoover, RN (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hooverr@mail.nih.gov		Palmer, Julie/0000-0002-6534-335X; Hatch, Elizabeth/0000-0001-7901-3928; Colton, Theodore/0000-0001-6329-0955	Division of Cancer Epidemiology and Genetics of the National Cancer Institute; UCB, Belgium; IRIS International; NATIONAL CANCER INSTITUTE [ZIACP010168] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); UCB, Belgium(UCB Pharma SA); IRIS International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute.; Dr. Robboy reports receiving consulting fees from UCB, Belgium. Dr. Karlan reports holding stock in and receiving board membership fees from IRIS International. No other potential conflict of interest relevant to this article was reported.	Baird DD, 2005, REPROD TOXICOL, V20, P81, DOI 10.1016/j.reprotox.2005.01.002; BARNES AB, 1980, NEW ENGL J MED, V302, P609, DOI 10.1056/NEJM198003133021105; BIBBO M, 1977, OBSTET GYNECOL, V49, P1; Breslow NE, 1972, J R STAT SOC B, V34, P216, DOI DOI 10.1111/J.2517-6161.1972.TB00900.X; Cox D. R., 1984, ANAL SURVIVAL DATA; D'Aloisio AA, 2010, ENVIRON HEALTH PERSP, V118, P375, DOI 10.1289/ehp.0901423; DALOISIO AA, 2010, ENV HLTH PERSPECT, V118, P380; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DIECKMANN WJ, 1953, AM J OBSTET GYNECOL, V66, P1062; Dodds EC, 1938, NATURE, V141, P247, DOI 10.1038/141247b0; FERGUSON JH, 1953, AM J OBSTET GYNECOL, V65, P592, DOI 10.1016/0002-9378(83)90615-4; GREENBERG ER, 1984, NEW ENGL J MED, V311, P1393, DOI 10.1056/NEJM198411293112201; HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129; Hatch EE, 2001, CANCER CAUSE CONTROL, V12, P837, DOI 10.1023/A:1012229112696; Hatch EE, 2006, AM J EPIDEMIOL, V164, P682, DOI 10.1093/aje/kwj257; HERBST AL, 1970, CANCER, V25, P745, DOI 10.1002/1097-0142(197004)25:4<745::AID-CNCR2820250402>3.0.CO;2-2; HERBST AL, 1975, NEW ENGL J MED, V292, P334, DOI 10.1056/NEJM197502132920704; HERBST AL, 1972, OBSTET GYNECOL, V40, P287; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; Kaufman RH, 2000, OBSTET GYNECOL, V96, P483, DOI 10.1016/S0029-7844(00)00959-5; LABARTHE D, 1978, OBSTET GYNECOL, V51, P453, DOI 10.1097/00006250-197804000-00014; Missmer SA, 2004, FERTIL STERIL, V82, P1501, DOI 10.1016/j.fertnstert.2004.04.065; O'Reilly EJ, 2010, AM J EPIDEMIOL, V171, P876, DOI 10.1093/aje/kwq023; OBRIEN PC, 1979, OBSTET GYNECOL, V53, P300; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Palmer JR, 2001, AM J EPIDEMIOL, V154, P316, DOI 10.1093/aje/154.4.316; Palmer JR, 2006, CANCER EPIDEM BIOMAR, V15, P1509, DOI 10.1158/1055-9965.EPI-06-0109; ROBBOY SJ, 1979, OBSTET GYNECOL, V53, P309; SAS Institute, 2008, SAS STAT 9 2 US GUID; SMITH OW, 1948, AM J OBSTET GYNECOL, V56, P821; SWYER GIM, 1953, J ENDOCRINOL, V10, pR6; Tilghman SL, 2010, STEROIDS, V75, P520, DOI 10.1016/j.steroids.2010.05.004; TILLEY BC, 1985, AM J EPIDEMIOL, V121, P269, DOI 10.1093/oxfordjournals.aje.a113997; Titus-Ernstoff L, 2003, EPIDEMIOLOGY, V14, P155, DOI 10.1097/00001648-200303000-00008; Troisi R, 2007, OBSTET GYNECOL, V110, P113, DOI 10.1097/01.AOG.0000268796.75591.02; Troisi R, 2007, INT J CANCER, V121, P356, DOI 10.1002/ijc.22631; ULFELDER H, 1980, CANCER, V45, P3008, DOI 10.1002/1097-0142(19800615)45:12<3008::AID-CNCR2820451222>3.0.CO;2-A; Verloop J, 2010, CANCER CAUSE CONTROL, V21, P999, DOI 10.1007/s10552-010-9526-5; Wise LA, 2005, OBSTET GYNECOL, V105, P167, DOI 10.1097/01.AOG.0000147839.74848.7c; 1955, LANCET, V269, P833	41	260	271	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 6	2011	365	14					1304	1314		10.1056/NEJMoa1013961	http://dx.doi.org/10.1056/NEJMoa1013961			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	829KL	21991952				2022-12-24	WOS:000295578700008
J	Fong, YW; Inouye, C; Yamaguchi, T; Cattoglio, C; Grubisic, I; Tjian, R				Fong, Yick W.; Inouye, Carla; Yamaguchi, Teppei; Cattoglio, Claudia; Grubisic, Ivan; Tjian, Robert			A DNA Repair Complex Functions as an Oct4/Sox2 Coactivator in Embryonic Stem Cells	CELL			English	Article							NUCLEOTIDE EXCISION-REPAIR; TRANSCRIPTIONAL REGULATORY CIRCUITRY; PROTEIN-INTERACTION NETWORK; NANOG GENE-EXPRESSION; GROUP-C PROTEIN; SELF-RENEWAL; TARGET GENES; XPC PROTEIN; IN-VITRO; PLURIPOTENCY	The transcriptional activators Oct4, Sox2, and Nanog cooperate with a wide array of cofactors to orchestrate an embryonic stem (ES) cell-specific gene expression program that forms the molecular basis of pluripotency. Here, we report using an unbiased in vitro transcription-biochemical complementation assay to discover a multisubunit stem cell coactivator complex (SCC) that is selectively required for the synergistic activation of the Nanog gene by Oct4 and Sox2. Purification, identification, and reconstitution of SCC revealed this coactivator to be the trimeric XPC-nucleotide excision repair complex. SCC interacts directly with Oct4 and Sox2 and is recruited to the Nanog and Oct4 promoters as well as a majority of genomic regions that are occupied by Oct4 and Sox2. Depletion of SCC/XPC compromised both pluripotency in ES cells and somatic cell reprogramming of fibroblasts to induced pluripotent stem (iPS) cells. This study identifies a transcriptional coactivator with diversified functions in maintaining ES cell pluripotency and safeguarding genome integrity.	[Fong, Yick W.; Inouye, Carla; Yamaguchi, Teppei; Cattoglio, Claudia; Tjian, Robert] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Grubisic, Ivan] Univ Calif Berkeley, UC Berkeley UCSF Grad Program Bioengn, Berkeley, CA 94720 USA; [Tjian, Robert] Univ Calif Berkeley, Li Ka Shing Ctr Biomed & Hlth Sci, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University; Li Ka Shing Center; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	jmlim@berkeley.edu		Grubisic, Ivan/0000-0002-4200-0653	California Institute for Regenerative Medicine (CIRM) [T1-00007]; Swiss National Science Foundation; Siebel Stem Cell Institute; NATIONAL CANCER INSTITUTE [R37CA025417] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Siebel Stem Cell Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors wish to thank A. Fischer and M. Richner at the Tissue Culture Facility (University of California, Berkeley); S. Zheng, G. Dailey, M. Haggart, and E. Bourbon for technical assistance; S. Chen at National Institute of Biological Sciences (Beijing, China) for mass spectrometry analysis; S. Zhou for initial mass spectrometry analysis; J. Hoeijmakers for knockout MEFs; G. Mostoslavsky for STEMCCA; O. Puig for pGL3-CAT plasmid; S. Ryu for purified rTBP and G3BCAT plasmid; K. Hochedlinger, M. Stadtfeld, J. de Wit, and M. Holmes for technical advice; and M. Botchan, M. Holmes, M. Levine, S. Martin, M. Rape, D. Rio, and all members of our laboratory for critical reading of the manuscript. Y.W.F. was a California Institute for Regenerative Medicine Scholar (CIRM training grant T1-00007). T.Y. was supported by the Swiss National Science Foundation and the Siebel Stem Cell Institute and is a Jane Coffin Childs fellow.	Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camenisch U, 2009, EMBO J, V28, P2387, DOI 10.1038/emboj.2009.187; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chakravarthy H, 2008, J CELL PHYSIOL, V216, P651, DOI 10.1002/jcp.21440; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Jesus BMB, 2008, MOL CELL BIOL, V28, P7225, DOI 10.1128/MCB.00781-08; Engelen E, 2011, NAT GENET, V43, P607, DOI 10.1038/ng.825; Gao XL, 2008, P NATL ACAD SCI USA, V105, P6656, DOI 10.1073/pnas.0801802105; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Le May N, 2010, MOL CELL, V38, P54, DOI 10.1016/j.molcel.2010.03.004; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu Z, 2011, CELL, V146, P720, DOI 10.1016/j.cell.2011.08.005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maillard O, 2007, PLOS BIOL, V5, P717, DOI 10.1371/journal.pbio.0050079; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Naar AM, 2002, GENE DEV, V16, P1339, DOI 10.1101/gad.987602; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Naar AM, 1998, GENE DEV, V12, P3020, DOI 10.1101/gad.12.19.3020; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Pal R, 2006, CELL PROLIFERAT, V39, P585, DOI 10.1111/j.1365-2184.2006.00400.x; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; Schwartz CM, 2005, STEM CELLS DEV, V14, P517, DOI 10.1089/scd.2005.14.517; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Sugasawa K, 1996, MOL CELL BIOL, V16, P4852; Taatjes DJ, 2004, NAT REV MOL CELL BIO, V5, P403, DOI 10.1038/nrm1369; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tutter AV, 2009, J BIOL CHEM, V284, P3709, DOI 10.1074/jbc.M805677200; Uchida A, 2002, DNA REPAIR, V1, P449, DOI 10.1016/S1568-7864(02)00031-9; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yasuda G, 2007, MOL CELL BIOL, V27, P6606, DOI 10.1128/MCB.02166-06; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	53	124	128	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 30	2011	147	1					120	131		10.1016/j.cell.2011.08.038	http://dx.doi.org/10.1016/j.cell.2011.08.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	827AJ	21962512	Bronze, Green Accepted			2022-12-24	WOS:000295396700020
J	Molaro, A; Hodges, E; Fang, F; Song, Q; McCombie, WR; Hannon, GJ; Smith, AD				Molaro, Antoine; Hodges, Emily; Fang, Fang; Song, Qiang; McCombie, W. Richard; Hannon, Gregory J.; Smith, Andrew D.			Sperm Methylation Profiles Reveal Features of Epigenetic Inheritance and Evolution in Primates	CELL			English	Article							DE-NOVO METHYLATION; DNA METHYLATION; CYTOSINE METHYLATION; HUMAN GENOME; CPG ISLANDS; VERTEBRATE GENOMES; BINDING-PROTEIN; SVA ELEMENTS; STEM-CELLS; GERM-CELLS	During germ cell and preimplantation development, mammalian cells undergo nearly complete reprogramming of DNA methylation patterns. We profiled the methylomes of human and chimp sperm as a basis for comparison to methylation patterns of ESCs. Although the majority of promoters escape methylation in both ESCs and sperm, the corresponding hypomethylated regions show substantial structural differences. Repeat elements are heavily methylated in both germ and somatic cells; however, retrotransposons from several subfamilies evade methylation more effectively during male germ cell development, whereas other subfamilies show the opposite trend. Comparing methylomes of human and chimp sperm revealed a subset of differentially methylated promoters and strikingly divergent methylation in retrotransposon subfamilies, with an evolutionary impact that is apparent in the underlying genomic sequence. Thus, the features that determine DNA methylation patterns differ between male germ cells and somatic cells, and elements of these features have diverged between humans and chimpanzees.	[Molaro, Antoine; Hodges, Emily; McCombie, W. Richard; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; [Fang, Fang; Song, Qiang; Smith, Andrew D.] Univ So Calif, Los Angeles, CA 90089 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Southern California	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu; andrewds@usc.edu	Hannon, Gregory/AAB-3568-2019; Song, Qiang/I-7887-2013; Smith, Andrew D./G-4104-2013	Song, Qiang/0000-0002-5923-0842; Smith, Andrew D./0000-0002-3337-1970; FANG, FANG/0000-0001-9829-2934; Hodges, Emily/0000-0001-6513-610X; Molaro, Antoine/0000-0002-3756-3793; McCombie, W. Richard/0000-0003-1899-0682	NIH [R01HG005238, 1RC2HD064459]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC2HD064459] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Michelle Rooks, Pramod Thekkat, and Colin Malone for help with experimental procedures and Assaf Gordon, Luigi Manna, and the CSHL and USC High Performance Computing Centers for computational support. We thank Babette Fontenot (New Iberia Research Center) and Jerilyn Pecotte (Southwest National Primate Center) for help with chimp sperm collection. We thank Sergey Nuzhdin, Ed Green, Peter Calabrese, Maren Friesen, Magnus Norborg, and Marie-Stanislas Remigereau for helpful discussions. This work was supported in part by grants from the NIH (R01HG005238 and 1RC2HD064459) and by a kind gift from Kathryn W. Davis.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Aravin AA, 2008, COLD SH Q B, V73, P283, DOI 10.1101/sqb.2008.73.058; Bantysh OB, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1393, DOI 10.1134/S0006297909120153; Bestor TH, 1998, AM J HUM GENET, V62, P1269, DOI 10.1086/301891; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; CHESNOKOV IN, 1995, J BIOL CHEM, V270, P18539, DOI 10.1074/jbc.270.31.18539; Cohen NM, 2011, CELL, V145, P773, DOI 10.1016/j.cell.2011.04.024; COOPER DN, 1989, HUM GENET, V83, P181, DOI 10.1007/BF00286715; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dalal Y, 2009, BIOCHEM CELL BIOL, V87, P273, DOI 10.1139/O08-135; Damert A, 2009, GENOME RES, V19, P1992, DOI 10.1101/gr.093435.109; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Edwards JR, 2010, GENOME RES, V20, P972, DOI 10.1101/gr.101535.109; EHRLICH M, 1990, MUTAT RES, V238, P277, DOI 10.1016/0165-1110(90)90019-8; Enard W, 2004, CURR BIOL, V14, pR148, DOI 10.1016/j.cub.2004.01.042; Frescas D, 2008, CELL CYCLE, V7, P3539, DOI 10.4161/cc.7.22.7062; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Hammoud SS, 2009, NATURE, V460, P473, DOI 10.1038/nature08162; Hodges E., 2011, MOL CELL, DOI [10.1016/j.cell.2008.06.028, DOI 10.1016/J.CELL.2008.06.028]; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; KOCHANEK S, 1993, EMBO J, V12, P1141, DOI 10.1002/j.1460-2075.1993.tb05755.x; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011353; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LIU WM, 1994, NUCLEIC ACIDS RES, V22, P1087, DOI 10.1093/nar/22.6.1087; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Ostertag EM, 2003, AM J HUM GENET, V73, P1444, DOI 10.1086/380207; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Probst AV, 2010, DEV CELL, V19, P625, DOI 10.1016/j.devcel.2010.09.002; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; SCHMID CW, 1991, NUCLEIC ACIDS RES, V19, P5613, DOI 10.1093/nar/19.20.5613; SHEN LM, 1994, J BIOL CHEM, V269, P8466; Smith AD, 2009, BIOINFORMATICS, V25, P2841, DOI 10.1093/bioinformatics/btp533; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041; Yu XP, 2005, J BIOL CHEM, V280, P35184, DOI 10.1074/jbc.M508138200; Zaidi SK, 2010, NAT REV GENET, V11, P583, DOI 10.1038/nrg2827; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147	55	261	269	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 16	2011	146	6					1028	1040		10.1016/j.cell.2011.08.016	http://dx.doi.org/10.1016/j.cell.2011.08.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	825GB	21925323	Bronze, Green Accepted			2022-12-24	WOS:000295258100023
J	Chen, WY; Rosner, B; Hankinson, SE; Colditz, GA; Willett, WC				Chen, Wendy Y.; Rosner, Bernard; Hankinson, Susan E.; Colditz, Graham A.; Willett, Walter C.			Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGESTERONE-RECEPTOR STATUS; POSTMENOPAUSAL WOMEN; PROSPECTIVE COHORT; ESTROGEN; DISEASE; HEALTH; AGE; PREMENOPAUSAL; ASSOCIATION; NUTRITION	Context Multiple studies have linked alcohol consumption to breast cancer risk, but the risk of lower levels of consumption has not been well quantified. In addition, the role of drinking patterns (ie, frequency of drinking and "binge" drinking) and consumption at different times of adult life are not well understood. Objective To evaluate the association of breast cancer with alcohol consumption during adult life, including quantity, frequency, and age at consumption. Design, Setting, and Participants Prospective observational study of 105 986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 with an early adult alcohol assessment and 8 updated alcohol assessments. Main Outcome Measures Relative risks of developing invasive breast cancer. Results During 2.4 million person-years of follow-up, 7690 cases of invasive breast cancer were diagnosed. Increasing alcohol consumption was associated with increased breast cancer risk that was statistically significant at levels as low as 5.0 to 9.9 g per day, equivalent to 3 to 6 drinks per week (relative risk, 1.15; 95% CI, 1.06-1.24; 333 cases/100 000 person-years). Binge drinking, but not frequency of drinking, was associated with breast cancer risk after controlling for cumulative alcohol intake. Alcohol intake both earlier and later in adult life was independently associated with risk. Conclusions Low levels of alcohol consumption were associated with a small increase in breast cancer risk, with the most consistent measure being cumulative alcohol intake throughout adult life. Alcohol intake both earlier and later in adult life was independently associated with risk. JAMA. 2011; 306(17): 1884-1890	[Chen, Wendy Y.; Rosner, Bernard; Hankinson, Susan E.; Willett, Walter C.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Chen, Wendy Y.; Rosner, Bernard; Hankinson, Susan E.; Willett, Walter C.] Harvard Univ, Sch Med, Boston, MA USA; [Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA; [Chen, Wendy Y.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hankinson, Susan E.; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hankinson, Susan E.] Univ Massachusetts, Div Biostat & Epidemiol, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Siteman Cancer Center; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Massachusetts System; University of Massachusetts Amherst	Chen, WY (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	wendy.chen@channing.harvard.edu	Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	National Institutes of Health [P01 CA87969]; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work reported herein was supported by the National Institutes of Health (grant P01 CA87969).	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; Colditz GA, 2004, JNCI-J NATL CANCER I, V96, P218, DOI 10.1093/jnci/djh025; Deandrea S, 2008, CANCER EPIDEM BIOMAR, V17, P2025, DOI 10.1158/1055-9965.EPI-08-0157; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Dumeaux V, 2004, CANCER EPIDEM BIOMAR, V13, P1302; Ellison RC, 2001, AM J EPIDEMIOL, V154, P740, DOI 10.1093/aje/154.8.740; Enger SM, 1999, BRIT J CANCER, V79, P1308, DOI 10.1038/sj.bjc.6690210; Fan SJ, 2000, CANCER RES, V60, P5635; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; HANCOCK SL, 1993, J NATL CANCER I, V85, P25, DOI 10.1093/jnci/85.1.25; HANKINSON SE, 1995, J NATL CANCER I, V87, P1297, DOI 10.1093/jnci/87.17.1297; Horn-Ross PL, 2004, CANCER EPIDEM BIOMAR, V13, P405; Kinney AY, 2000, CANCER CAUSE CONTROL, V11, P345, DOI 10.1023/A:1008973709917; Lew JQ, 2009, AM J EPIDEMIOL, V170, P308, DOI 10.1093/aje/kwp120; Li CI, 2010, J NATL CANCER I, V102, P1422, DOI 10.1093/jnci/djq316; Li CI, 2003, CANCER EPIDEM BIOMAR, V12, P1061; Li Y, 2009, EUR J CANCER, V45, P843, DOI 10.1016/j.ejca.2008.11.001; LONGNECKER MP, 1995, JNCI-J NATL CANCER I, V87, P923, DOI 10.1093/jnci/87.12.923; Mattisson I, 2004, INT J CANCER, V110, P589, DOI 10.1002/ijc.20166; McDonald JA, 2004, CANCER EPIDEM BIOMAR, V13, P2106; MIDANIK LT, 1994, AM J PUBLIC HEALTH, V84, P1218, DOI 10.2105/AJPH.84.8.1218; Morch LS, 2007, EUR J PUBLIC HEALTH, V17, P624, DOI 10.1093/eurpub/ckm036; Onland-Moret NC, 2005, J CLIN ENDOCR METAB, V90, P1414, DOI 10.1210/jc.2004-0614; Purohit V, 2000, ALCOHOL, V22, P123, DOI 10.1016/S0741-8329(00)00124-5; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rinaldi S, 2006, CANCER CAUSE CONTROL, V17, P1033, DOI 10.1007/s10552-006-0041-7; Rohan TE, 2000, CANCER CAUSE CONTROL, V11, P239, DOI 10.1023/A:1008933824645; Ronksley PE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d671; Rosner BA, 1996, STAT MED, V15, P293, DOI 10.1002/(SICI)1097-0258(19960215)15:3<293::AID-SIM166>3.0.CO;2-E; Sarkola T, 2001, J CLIN ENDOCR METAB, V86, P1981, DOI 10.1210/jc.86.5.1981; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singletary KW, 2001, CANCER LETT, V165, P131, DOI 10.1016/S0304-3835(01)00419-0; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Suzuki R, 2005, JNCI-J NATL CANCER I, V97, P1601, DOI 10.1093/jnci/dji341; Suzuki R, 2010, INT J CANCER, V127, P685, DOI 10.1002/ijc.25079; Swanson CA, 1997, EPIDEMIOLOGY, V8, P231, DOI 10.1097/00001648-199705000-00001; Terry MB, 2006, ANN EPIDEMIOL, V16, P230, DOI 10.1016/j.annepidem.2005.06.048; Tjonneland A, 2004, J NUTR, V134, P173, DOI 10.1093/jn/134.1.173; Tjonneland A, 2003, CANCER CAUSE CONTROL, V14, P277, DOI 10.1023/A:1023640720385; Tjonneland A, 2007, CANCER CAUSE CONTROL, V18, P361, DOI 10.1007/s10552-006-0112-9; *USDA, 1997, USDA NUTR DAT STAND	44	278	290	1	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 2	2011	306	17					1884	1890		10.1001/jama.2011.1590	http://dx.doi.org/10.1001/jama.2011.1590			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	839OD	22045766	Green Accepted, Bronze			2022-12-24	WOS:000296376200022
J	Kang, HJ; Kawasawa, YI; Cheng, F; Zhu, Y; Xu, XM; Li, MF; Sousa, AMM; Pletikos, M; Meyer, KA; Sedmak, G; Guennel, T; Shin, Y; Johnson, MB; Krsnik, Z; Mayer, S; Fertuzinhos, S; Umlauf, S; Lisgo, SN; Vortmeyer, A; Weinberger, DR; Mane, S; Hyde, TM; Huttner, A; Reimers, M; Kleinman, JE; Sestan, N				Kang, Hyo Jung; Kawasawa, Yuka Imamura; Cheng, Feng; Zhu, Ying; Xu, Xuming; Li, Mingfeng; Sousa, Andre M. M.; Pletikos, Mihovil; Meyer, Kyle A.; Sedmak, Goran; Guennel, Tobias; Shin, Yurae; Johnson, Matthew B.; Krsnik, Zeljka; Mayer, Simone; Fertuzinhos, Sofia; Umlauf, Sheila; Lisgo, Steven N.; Vortmeyer, Alexander; Weinberger, Daniel R.; Mane, Shrikant; Hyde, Thomas M.; Huttner, Anita; Reimers, Mark; Kleinman, Joel E.; Sestan, Nenad			Spatio-temporal transcriptome of the human brain	NATURE			English	Article							GENE-EXPRESSION; PYRAMIDAL NEURONS; LIFE-SPAN; INSIGHTS; DIFFERENTIATION; TBR1; NEUROLIGINS; PROJECTIONS; MUTATIONS; EVOLUTION	Brain development and function depend on the precise regulation of gene expression. However, our understanding of the complexity and dynamics of the transcriptome of the human brain is incomplete. Here we report the generation and analysis of exon-level transcriptome and associated genotyping data, representing males and females of different ethnicities, from multiple brain regions and neocortical areas of developing and adult post-mortem human brains. We found that 86 per cent of the genes analysed were expressed, and that 90 per cent of these were differentially regulated at the whole-transcript or exon level across brain regions and/or time. The majority of these spatio-temporal differences were detected before birth, with subsequent increases in the similarity among regional transcriptomes. The transcriptome is organized into distinct co-expression networks, and shows sex-biased gene expression and exon usage. We also profiled trajectories of genes associated with neurobiological categories and diseases, and identified associations between single nucleotide polymorphisms and gene expression. This study provides a comprehensive data set on the human brain transcriptome and insights into the transcriptional foundations of human neurodevelopment.	[Kang, Hyo Jung; Kawasawa, Yuka Imamura; Cheng, Feng; Zhu, Ying; Xu, Xuming; Li, Mingfeng; Sousa, Andre M. M.; Pletikos, Mihovil; Meyer, Kyle A.; Sedmak, Goran; Shin, Yurae; Johnson, Matthew B.; Krsnik, Zeljka; Mayer, Simone; Fertuzinhos, Sofia; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Kang, Hyo Jung; Kawasawa, Yuka Imamura; Cheng, Feng; Zhu, Ying; Xu, Xuming; Li, Mingfeng; Sousa, Andre M. M.; Pletikos, Mihovil; Meyer, Kyle A.; Sedmak, Goran; Shin, Yurae; Johnson, Matthew B.; Krsnik, Zeljka; Mayer, Simone; Fertuzinhos, Sofia; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Sousa, Andre M. M.] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099003 Oporto, Portugal; [Pletikos, Mihovil; Sedmak, Goran] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Grad Program Neurosci, Zagreb 10000, Croatia; [Guennel, Tobias; Reimers, Mark] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Mayer, Simone] Int Max Planck Res Sch Mol Biol, Msc PhD Mol Biol Program, D-37077 Gottingen, Germany; [Umlauf, Sheila; Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, New Haven, CT 06510 USA; [Lisgo, Steven N.] Newcastle Univ, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Vortmeyer, Alexander; Huttner, Anita] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Weinberger, Daniel R.; Hyde, Thomas M.; Kleinman, Joel E.] NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20892 USA; [Hyde, Thomas M.] Johns Hopkins Univ Med Campus, Lieber Inst Brain Dev, Baltimore, MD 21205 USA	Yale University; Yale University; Universidade do Porto; University of Zagreb; Virginia Commonwealth University; Max Planck Society; Yale University; Newcastle University - UK; Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Johns Hopkins University; Johns Hopkins Medicine	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Sousa, André M. M. M. M./C-1203-2015; Zhu, Ying/T-2268-2019; Krsnik, Zeljka/AAI-2999-2020; Fertuzinhos, Sofia MS/G-8316-2011; Cheng, Feng/A-9760-2009; Sedmak, Goran/AAK-3342-2021; Sedmak, Goran/AAB-3436-2019; Mayer, Simone/H-1840-2015	Sousa, André M. M. M. M./0000-0003-1740-5066; Cheng, Feng/0000-0003-3619-8090; Sedmak, Goran/0000-0002-9049-2461; Sedmak, Goran/0000-0002-9049-2461; Mayer, Simone/0000-0002-6381-2474; Krsnik, Zeljka/0000-0001-5238-6820; Lisgo, Steven/0000-0001-5186-3971; Zhu, Ying/0000-0002-6594-3734	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD000836]; China Scholarship Council; Portuguese Foundation for Science and Technology; Samsung Scholarship Foundation; German Academic Exchange Service - DAAD; NIDA [DA026119]; US National Institutes of Health [MH081896, MH089929, NS054273]; Kavli Foundation; NARSAD; James S. McDonnell Foundation;  [G0700089];  [GR082557]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD000836] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD000836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089929, U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273, U24NS051869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER; Medical Research Council [G9900837, G0700089] Funding Source: researchfish; MRC [G0700089, G9900837] Funding Source: UKRI	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); China Scholarship Council(China Scholarship Council); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Samsung Scholarship Foundation(Samsung); German Academic Exchange Service - DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Foundation; NARSAD(NARSAD); James S. McDonnell Foundation; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Belanger, V. Imamovic, R. Johnson, P. Larton, S. Lindsay, B. Poulos, J. Rajan, D. Rimm and R. Zielke for assistance with tissue acquisition, D. Singh for technical assistance, I. Kostovic and Z. Petanjek for dendrite measurements, P. Levitt for suggesting the inclusion of ITC in the study, and D. Karolchik and A. Zweig for help in creating tracks for the UCSC Genome Browser. We also thank A. Beckel-Mitchener, M. Freund, M. Gerstein, D. Geschwind, T. Insel, M. Judas, J. Knowles, E. Lein, P. Levitt, N. Parikshak and members of the Sestan laboratory for discussions and criticism. Tissue was obtained from several sources including the Human Fetal Tissue Repository at the Albert Einstein College of Medicine, the NICHD Brain and Tissue Bank for Developmental Disorders at the University of Maryland, the Laboratory of Developmental Biology at the University of Washington (supported by grant HD000836 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development) and the Joint MRC/Wellcome Trust Human Developmental Biology Resource (http://hdbr.org) at the IHG, Newcastle Upon Tyne (UK funding awards G0700089 and GR082557). Support for predoctoral fellowships was provided by the China Scholarship Council (Y.Z.), the Portuguese Foundation for Science and Technology (A. M. M. S.), the Samsung Scholarship Foundation (Y.S.), a Fellowship of the German Academic Exchange Service - DAAD (S. Mayer) and NIDA grant DA026119 (T. G.). This work was supported by grants from the US National Institutes of Health (MH081896, MH089929, NS054273), the Kavli Foundation and NARSAD, and by a James S. McDonnell Foundation Scholar Award (N.S.).	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Ariani F, 2008, AM J HUM GENET, V83, P89, DOI 10.1016/j.ajhg.2008.05.015; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Chen B, 2005, P NATL ACAD SCI USA, V102, P17184, DOI 10.1073/pnas.0508732102; Chen DY, 2011, NATURE, V469, P491, DOI 10.1038/nature09667; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Han WQ, 2011, P NATL ACAD SCI USA, V108, P3041, DOI 10.1073/pnas.1016723108; Hansen DV, 2011, NEURON, V70, P645, DOI 10.1016/j.neuron.2011.05.006; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Insel TR, 2010, NATURE, V468, P187, DOI 10.1038/nature09552; Ip BK, 2010, J ANAT, V217, P300, DOI 10.1111/j.1469-7580.2010.01259.x; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kostovic I, 2006, DEV MED CHILD NEUROL, V48, P388, DOI 10.1017/S0012162206000831; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Licatalosi DD, 2006, NEURON, V52, P93, DOI 10.1016/j.neuron.2006.09.017; Liu C, 2010, MOL PSYCHIATR, V15, P779, DOI 10.1038/mp.2009.128; McKenna WL, 2011, J NEUROSCI, V31, P549, DOI 10.1523/JNEUROSCI.4131-10.2011; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Molyneaux BJ, 2005, NEURON, V47, P817, DOI 10.1016/j.neuron.2005.08.030; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Perroud N., 2010, PHARMACOGENOMICS J; Petanjek Z, 2008, CEREB CORTEX, V18, P915, DOI 10.1093/cercor/bhm124; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reinius B, 2009, MOL PSYCHIATR, V14, P988, DOI 10.1038/mp.2009.79; Ren CZ, 2006, GENOMICS, V88, P163, DOI 10.1016/j.ygeno.2006.03.021; Rubenstein JLR, 2011, J CHILD PSYCHOL PSYC, V52, P339, DOI 10.1111/j.1469-7610.2010.02307.x; Somel M, 2010, GENOME RES, V20, P1207, DOI 10.1101/gr.106849.110; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Vawter MP, 2004, NEUROPSYCHOPHARMACOL, V29, P373, DOI 10.1038/sj.npp.1300337; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	49	1236	1252	8	154	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2011	478	7370					483	489		10.1038/nature10523	http://dx.doi.org/10.1038/nature10523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837JI	22031440	Green Accepted			2022-12-24	WOS:000296194200036
J	Sanai, N; Nguyen, T; Ihrie, RA; Mirzadeh, Z; Tsai, HH; Wong, M; Gupta, N; Berger, MS; Huang, E; Garcia-Verdugo, JM; Rowitch, DH; Alvarez-Buylla, A				Sanai, Nader; Thuhien Nguyen; Ihrie, Rebecca A.; Mirzadeh, Zaman; Tsai, Hui-Hsin; Wong, Michael; Gupta, Nalin; Berger, Mitchel S.; Huang, Eric; Garcia-Verdugo, Jose-Manuel; Rowitch, David H.; Alvarez-Buylla, Arturo			Corridors of migrating neurons in the human brain and their decline during infancy	NATURE			English	Article							NEURAL STEM-CELLS; VENTROMEDIAL PREFRONTAL CORTEX; SUBVENTRICULAR ZONE; OLFACTORY-BULB; ADULT NEUROGENESIS; LATERAL VENTRICLE; PLASTICITY; FOREBRAIN; NEUROBLASTS; EPENDYMA	The subventricular zone of many adult non-human mammals generates large numbers of new neurons destined for the olfactory bulb(1-6). Along the walls of the lateral ventricles, immature neuronal progeny migrate in tangentially oriented chains that coalesce into a rostral migratory stream (RMS) connecting the subventricular zone to the olfactory bulb. The adult human subventricular zone, in contrast, contains a hypocellular gap layer separating the ependymal lining from a periventricular ribbon of astrocytes(7). Some of these subventricular zone astrocytes can function as neural stem cells in vitro, but their function in vivo remains controversial. An initial report found few subventricular zone proliferating cells and rare migrating immature neurons in the RMS of adult humans(7). In contrast, a subsequent study indicated robust proliferation and migration in the human subventricular zone and RMS8,9. Here we find that the infant human subventricular zone and RMS contain an extensive corridor of migrating immature neurons before 18 months of age but, contrary to previous reports(8), this germinal activity subsides in older children and is nearly extinct by adulthood. Surprisingly, during this limited window of neurogenesis, not all new neurons in the human subventricular zone are destined for the olfactory bulb-we describe a major migratory pathway that targets the prefrontal cortex in humans. Together, these findings reveal robust streams of tangentially migrating immature neurons in human early postnatal subventricular zone and cortex. These pathways represent potential targets of neurological injuries affecting neonates.	[Sanai, Nader; Thuhien Nguyen; Ihrie, Rebecca A.; Mirzadeh, Zaman; Tsai, Hui-Hsin; Wong, Michael; Rowitch, David H.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Inst Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Sanai, Nader; Thuhien Nguyen; Ihrie, Rebecca A.; Mirzadeh, Zaman; Tsai, Hui-Hsin; Wong, Michael; Rowitch, David H.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Sanai, Nader; Gupta, Nalin; Berger, Mitchel S.; Rowitch, David H.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Sanai, Nader; Mirzadeh, Zaman] Barrow Neurol Inst, Barrow Brain Tumor Res Ctr, Phoenix, AZ 85013 USA; [Huang, Eric] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Garcia-Verdugo, Jose-Manuel] CIBERNED, Unidad Mixta CIPF UVEG, Lab Morfol Celular, Valencia 46012, Spain; [Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Barrow Neurological Institute; University of California System; University of California San Francisco; CIBERNED; Prince Felipe Research Center; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Inst Regenerat Med & Stem Cell, San Francisco, CA 94143 USA.	rowitchd@peds.ucsf.edu; abuylla@stemcell.ucsf.edu	Huang, Eric J./AAH-7997-2019; García-Verdugo, José Manuel/L-8421-2017	Huang, Eric J./0000-0002-5381-3801; García-Verdugo, José Manuel/0000-0001-9872-6499; Ihrie, Rebecca/0000-0003-0439-0141; Rowitch, David/0000-0002-0079-0060; Alvarez-Buylla, Arturo/0000-0003-4426-8925	NIH [NS 058180]; Damon Runyon Cancer Research Foundation [DRG1935-07]; American Association for Cancer Research/National Brain Tumor Society; American Association for Cancer Research; Pediatric Brain Tumor Foundation of the United States; John G. Bowes Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR024858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082745, R01NS028478, R37NS028478, F32NS058180, R01NS059893] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD010927] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; American Association for Cancer Research/National Brain Tumor Society; American Association for Cancer Research; Pediatric Brain Tumor Foundation of the United States; John G. Bowes Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are grateful to J. Agudelo and R. Romero for expert technical assistance and to K. X. Probst for illustrations. N.S. was supported by an NIH F32 NRSA postdoctoral fellowship (NS 058180). R.I. was supported by fellowships from the Damon Runyon Cancer Research Foundation (DRG1935-07) and American Association for Cancer Research/National Brain Tumor Society. R.A.I. thanks the American Association for Cancer Research for support. A.A.-B. is the Heather and Melanie Muss Endowed Chair of Neurological Surgery at UCSF. This work was supported by grants from the NIH (to A.A.-B., E.H. and D.H.R.), the Pediatric Brain Tumor Foundation of the United States and by the John G. Bowes Research Fund. D.H.R. is a Howard Hughes Medical Institute Investigator.	Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; Bovetti S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006359; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Guerrero-Cazares H, 2011, J COMP NEUROL, V519, P1165, DOI 10.1002/cne.22566; Herholz K, 2002, NEUROIMAGE, V17, P302, DOI 10.1006/nimg.2002.1208; Humphrey T, 1940, J COMP NEUROL, V73, P431, DOI 10.1002/cne.900730305; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Longe O, 2009, J COGNITIVE NEUROSCI, V21, P141, DOI 10.1162/jocn.2009.21012; MEYER G, 1989, J COMP NEUROL, V284, P405, DOI 10.1002/cne.902840308; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nissant A, 2009, NAT NEUROSCI, V12, P728, DOI 10.1038/nn.2298; Nottebohm F, 2004, ANN NY ACAD SCI, V1016, P628, DOI 10.1196/annals.1298.027; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Perez-Martin M, 2000, CELL TISSUE RES, V300, P11, DOI 10.1007/s004410000190; Ponti G, 2006, J COMP NEUROL, V498, P491, DOI 10.1002/cne.21043; Rodriguez-Perez LM, 2003, CELL TISSUE RES, V314, P325, DOI 10.1007/s00441-003-0794-1; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sanai N, 2007, SCIENCE, V318, DOI 10.1126/science.1145011; Southwell DG, 2010, SCIENCE, V327, P1145, DOI 10.1126/science.1183962; Szatkowska I, 2004, NEUROSCI LETT, V364, P71, DOI 10.1016/j.neulet.2004.03.084; Wang C., 2011, CELL RES; Weickert CS, 2000, J COMP NEUROL, V423, P359, DOI 10.1002/1096-9861(20000731)423:3<359::AID-CNE1>3.0.CO;2-0; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007; Zecevic N, 2004, GLIA, V48, P27, DOI 10.1002/glia.20044; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	31	566	577	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2011	478	7369					382	+		10.1038/nature10487	http://dx.doi.org/10.1038/nature10487			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	835FO	21964341	Green Accepted, Green Submitted			2022-12-24	WOS:000296021100045
